<SEC-DOCUMENT>0000950123-15-006811.txt : 20150814
<SEC-HEADER>0000950123-15-006811.hdr.sgml : 20150814
<ACCEPTANCE-DATETIME>20150609165923
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950123-15-006811
CONFORMED SUBMISSION TYPE:	DRS
PUBLIC DOCUMENT COUNT:		51
FILED AS OF DATE:		20150609
<PUBLIC-REL-DATE>20150814
DATE AS OF CHANGE:		20150706

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Penumbra Inc
		CENTRAL INDEX KEY:			0001321732
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		DRS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-01037
		FILM NUMBER:		15921508

	BUSINESS ADDRESS:	
		STREET 1:		1351 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
		BUSINESS PHONE:		(510) 748-3251

	MAIL ADDRESS:	
		STREET 1:		1351 HARBOR BAY PARKWAY
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94502
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>DRS</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As confidentially submitted to the Securities and Exchange Commission on June&nbsp;9, 2015
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM S-1
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Penumbra, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
Name of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><B>3841</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center"><B>05-0605598</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or Other Jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Incorporation or Organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Primary Standard Industrial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Classification Code Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>One Penumbra Place </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>1351
Harbor Bay Parkway </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Alameda, California 94502 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(510) 748-3200 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address,
Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#146;s Principal Executive Offices) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Adam Elsesser
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Chairman, Chief Executive Officer and President </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Penumbra, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>One
Penumbra Place </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>1351 Harbor Bay Parkway </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Alameda, California 94502 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(510) 748-3200 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name,
Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to:
</I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Alan F. Denenberg</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Davis Polk &amp; Wardwell LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>1600 El Camino Real</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Menlo
Park, California 94025</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(650) 752-2000</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Robert D. Evans</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Executive&nbsp;Vice&nbsp;President&nbsp;and&nbsp;General&nbsp;Counsel</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Penumbra, Inc.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>One Penumbra
Place</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>1351 Harbor Bay Parkway</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Alameda, California 94502</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(510) 748-3200</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Rezwan D. Pavri</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Richard A. Kline</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Goodwin
Procter LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>135 Commonwealth Drive</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Menlo Park, California 94025</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(650) 752-3100</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public</B>: As soon as practicable after the effective date of this
Registration Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415
under the Securities Act of 1933, check the following box.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this form is filed to register
additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this form is a post-effective amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule 12b-2 of the Exchange Act. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">(Do not check if a smaller reporting company)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title Of Each Class Of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Securities To Be Registered</B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Proposed Maximum</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Aggregate Offering Price<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount Of<BR>Registration Fee</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common Stock, par value $0.001 per share</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares that the underwriters have the right to purchase from us. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall
file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933 or until the registration statement shall become effective on
such date as the Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:arial"><FONT COLOR="#cc062a"><B>The information in this prospectus is not complete and may be changed. We may not sell these
securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any state where the
offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:arial" ALIGN="center"><FONT COLOR="#cc062a"><B>Subject to
completion, dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015 </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:arial"><B>Preliminary Prospectus </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:arial" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923792g60a08.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:arial" ALIGN="center"><B><I>Common Stock </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:arial" ALIGN="center"><B>$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">This is the initial public offering of
common stock of Penumbra, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are offering &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock. Prior to this
offering, there has been no public market for our common stock. We anticipate that the initial public offering price will be between $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We intend to apply to list our common stock on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; under the symbol &#147;PEN.&#148; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Initial public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Underwriting discounts and commissions<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Proceeds to Penumbra before expenses<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See the section titled &#147;Underwriting&#148; for additional disclosure regarding underwriter compensation and offering expenses. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We have granted the underwriters the right to purchase an additional &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock
from us. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial">We are an &#147;emerging growth company&#148; as defined under the federal securities laws, and as such, we have elected to comply with reduced reporting requirements
for this prospectus and may elect to do so in future filings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Investing in our common stock involves a high degree of risk. See the section titled &#147;<A HREF="#toc923792_2">Risk
 Factors</A>&#148; beginning on page 10. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of
these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The underwriters expect to
deliver the shares of common stock to purchasers on or about &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:16pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:arial; font-size:16pt">
<TD VALIGN="top"><B>J.P. Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>BofA Merrill Lynch</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:arial; font-size:12pt">
<TD VALIGN="top"><B>Wells Fargo Securities</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Canaccord Genuity</B></TD></TR>
</TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015 </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="88%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_1">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_2">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_3">Special Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_4">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_5">Dividend Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_6">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_7">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_8">Selected Consolidated Financial Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_9">Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_10">Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_11">Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
</DIV><DIV STYLE="position:relative;float:left; margin-left:2%; width:48%;padding-right:1%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_12">Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_13">Certain Relationships and Related Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_14">Principal Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_15">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_16">Material U.S. Federal Income and Estate Tax Consequences for Non-U.S. Holders of Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_17">Shares Eligible for Future Sale</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_18">Underwriting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_19">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_20">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_21">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#toc923792_22">Index to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> </DIV><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In this prospectus,
&#147;Penumbra,&#148; &#147;Penumbra, Inc.,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to Penumbra, Inc. and its consolidated subsidiaries. We and the underwriters have not authorized anyone to provide
any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses we have prepared. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability
of, any other information that others may provide you. We are offering to sell, and seeking offers to buy, shares of common stock only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate
only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of the common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">This prospectus
includes industry and market data that we obtained from industry publications, internal estimates and other third-party sources. These sources may include government and industry sources. Industry publications and surveys generally state that the
information contained therein has been obtained from sources believed to be reliable. Although we believe the industry and market data to be reliable as of the date of this prospectus, this information could prove to be inaccurate. Industry and
market data could be wrong because of the method by which sources obtained their data and because information cannot always be verified with complete certainty due to the limits on the availability and reliability of raw data, the voluntary nature
of the data gathering process and other limitations and uncertainties. In addition, we do not know all of the assumptions regarding general economic conditions or growth that were used in preparing the forecasts from the sources relied upon or cited
herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><B>Through and including
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015 (the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day after the date of this prospectus), all dealers that
buy, sell or trade our common stock, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#146; obligation to deliver a prospectus when acting as underwriters and with respect to
their unsold allotments or subscriptions. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">i </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>This summary highlights information contained elsewhere in this prospectus. This summary may not contain all of the information that you should
consider before deciding to invest in our common stock. You should read this entire prospectus carefully, including the sections titled &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results
of Operations&#148; and the consolidated financial statements and the notes to those statements contained elsewhere in this prospectus. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Penumbra is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. We have a broad
portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic
stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are one of the largest
independent companies focused on the neuro market, and we recently expanded our business to include the peripheral vascular market. We sell our products to hospitals, primarily through our salesforce, as well as through distributors in select
international markets. We focus on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular
surgeons. We design our products to provide these specialist physicians with a means to drive improved clinical outcomes through faster and safer procedures and generally at a significantly lower overall cost to the healthcare system relative to
procedures using other products. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We attribute our success to our culture built on cooperation, our highly efficient product innovation process, our
disciplined approach to product and commercial development, our deep understanding of our target end markets and our relationships with specialist physicians. We believe these factors have enabled us to rapidly innovate in a highly capital-efficient
manner. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Since our founding in 2004, we have had a strong track record of organic product development and commercial expansion that has established
the foundation of our global organization. Some of our key accomplishments include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">launching our first product, for neurovascular access, in the United States in 2007; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing our direct neuro salesforce in the United States and Europe in 2008; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">launching the first 510(k)-cleared, aspiration-based product for the treatment of ischemic stroke patients in 2008, and launching four subsequent generations of that product; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">launching our first neurovascular coil for the treatment of brain aneurysms in 2011; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">launching our first peripheral vascular product in 2013; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing our direct peripheral vascular salesforce in the United States and Europe in 2014. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of
March&nbsp;31, 2015, we had approximately 850 employees worldwide. We sell our products to hospitals primarily through our direct sales organization in the United States, most of Europe, Canada and Australia, as well as through distributors in
select international markets. For the year ended December&nbsp;31, 2014, we generated revenue of $125.5 million, which represents a 41.3% increase over 2013, and $3.0 million in operating income as compared to an operating loss of $1.1 million in
2013. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Market Opportunity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We estimate that the market
for our current neuro and peripheral vascular products in the United States and Europe combined was approximately $1.3 billion in 2014, which we estimate represents growth of </P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
approximately 3.2%&nbsp;per year from 2012. While reliable third-party data is not available for markets outside the United States and Europe, we believe that there is a substantial additional
market for our neuro and peripheral vascular products in the rest of the world. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">According to the American Heart Association (AHA), the worldwide
incidence of all forms of stroke was 33 million in 2010. Furthermore, according to a paper published in the journal <I>The Lancet</I>, 202&nbsp;million people globally were living with peripheral artery disease in 2010. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe the market for our products remains substantially under-penetrated today, and that this market will experience significant growth as we and
our competitors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">generate additional clinical evidence supporting endovascular treatment of vascular disease; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">improve existing technologies to enable physicians to treat vascular disease faster and more safely than previously possible; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">support and educate the growing number of specialist physicians who treat vascular disease in the use of endovascular treatment; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">grow the number of hospitals where endovascular treatment of vascular disease is available; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">raise patient awareness of endovascular treatment of vascular disease. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Industry Background </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Vascular disease refers to any condition that affects the circulatory system and typically manifests as a blockage or rupture of an artery or a vein. It
may occur in any part of the body, and is a condition that leads most often to blood vessel narrowing and obstruction, but can also lead to expansion of the blood vessel wall and blood vessel wall weakening and rupture. Vascular disease can cause a
range of conditions, from pain to functional impairment, and it can require the amputation of a limb or result in death. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">When the treatment for
vascular disease is performed from within a vessel, it is referred to as an endovascular procedure. Endovascular device markets are conventionally classified according to the anatomic location of the disorder. We currently focus our efforts on the
neuro and peripheral vascular markets. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Neuro products.</I></B> Our neuro products are used to treat patients with vascular disease and disorders in the brain, including patients with strokes caused by either vascular occlusion or rupture or weakening
of the vessel walls. Our neuro products are generally catheter-based technologies that are administered by an interventional neuroradiologist, a neurosurgeon or an interventional neurologist. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Peripheral products.</I></B> Our peripheral products are used to treat patients with vascular disease in all vasculature other than that which exists in the brain or the heart, including the upper and lower
extremities, kidneys, neck and lungs. Our products that address peripheral vascular disorders are catheter-based technologies that are typically administered by an interventional radiologist or a vascular surgeon. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Our Strengths </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As we have grown as an organization, we have
been able to scale our business from development stage in 2004 to a company with approximately 850 employees focused on multiple product categories in two target end markets. We believe the following strengths have enabled us to develop our broad
and differentiated product portfolio and have been, and will continue to be, significant factors in our continued success and growth: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our culture built on cooperation, which we have institutionalized through our unique organizational structure; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our highly efficient product innovation process; </TD></TR></TABLE>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our disciplined approach to clinical and commercial development; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our deep understanding of our target end markets; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our relationships with specialist physicians. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Our Products </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Since our founding in 2004, we have invested in expanding our product development and marketing capabilities. These investments have included engineering
and materials science capabilities, pre-clinical and bench-testing infrastructure and in-house clinical and regulatory infrastructure. Our fully-integrated organization has enabled us to launch 14 product brands for access, thrombectomy and
embolization since 2007 to service our two target end markets. Our current portfolio provides a range of products that are designed to enable specialist physicians to drive improved clinical outcomes in a cost effective manner. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table summarizes our product offerings in each of our target end markets: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923792g22q56.jpg" ALT="LOGO">
 </P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Our Growth Strategies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe the following strategies will continue to play a critical role in our future growth: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">expanding the penetration of our products in our target end markets; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">growing the acceptance of our innovative products as the standard of care in their targeted clinical applications; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">continuing to leverage our development capabilities to drive efficient, rapid product development; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">scaling our organizational culture of cooperative product development and commercial execution. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Risks Associated
With Our Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our business is subject to numerous risks, as more fully described in the section titled &#147;Risk Factors&#148; immediately
following this prospectus summary. These risks include, among others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we have a limited operating history and may not be able to sustain or grow our profitability or generate positive cash flows from operations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our existing products may be rendered obsolete and we may be unable to effectively introduce and market new products or may fail to keep pace with advances in technology; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays in product introductions could adversely affect our business, results of operations, financial condition or cash flows; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we face significant competition, and if we are unable to compete effectively, we may not be able to achieve or maintain significant market penetration or improve our results of operations; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our future growth depends, in part, on our ability to further penetrate our current customer base and increase the frequency of use of our products by our customers; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our future growth depends, in part, on significantly expanding our user base to include additional specialist physicians in both our existing and future target end markets; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the marketing and sales of our products require a significant amount of time and expense and we may not have the resources to successfully market and sell our products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">third-party reimbursement may not be available or adequate for the procedures in which our products are used; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we are subject to stringent domestic and foreign medical device regulation, which may impede the approval or clearance process for our products, hinder our development activities and manufacturing processes and, in some
cases, result in the recall or seizure of previously approved or cleared products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we rely on a variety of intellectual property rights, and if we are unable to maintain or protect our intellectual property, our business and results of operations will be harmed; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may become involved in lawsuits or other proceedings to protect or enforce our patents or other intellectual property rights or to defend against accusations of infringement, which could be expensive, time consuming
and unsuccessful. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We were incorporated in 2004 as a Delaware corporation under the name Penumbra, Inc. Our principal executive offices are located at One Penumbra Place,
1351 Harbor Bay Parkway, Alameda, California 94502, and our telephone number is (510)&nbsp;748-3200. Our website address is www.penumbrainc.com. The information on, or that can be accessed through, our website is not part of this prospectus. We have
included our website address as an inactive textual reference only. </P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We use &#147;Penumbra System<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>,&#148;
&#147;ACE&#153;,&#148; &#147;Penumbra Coil 400&#153;,&#148; &#147;Penumbra SMART&#153; Coil,&#148; &#147;LIBERTY&#153; Stent,&#148; &#147;Apollo&#153; System,&#148; &#147;Ruby<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> Coil,&#148;
&#147;Indigo<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> System&#148; and other marks as trademarks in the United States and other countries. This prospectus contains references to our trademarks and service marks and to those
belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus, including logos, artwork and other visual displays, may appear without the <SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> or
&#153; symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not
intend our use or display of other entities&#146; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Implications of Being an Emerging Growth Company </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are an
&#147;emerging growth company,&#148; as defined in the Jumpstart Our Business Startups Act of 2012. We will remain an emerging growth company until the earlier of (1)&nbsp;December&nbsp;31, 2020 (the last day of the fiscal year following the fifth
anniversary of our initial public offering), (2)&nbsp;the last day of the fiscal year in which we have total annual gross revenue of at least $1.0 billion, (3)&nbsp;the last day of the fiscal year in which we are deemed to be a large accelerated
filer, which means the market value of our common stock that is held by non-affiliates is equal to or exceeds $700 million as of the prior June&nbsp;30th, and (4)&nbsp;the date on which we have issued more than $1.0 billion in non-convertible debt
during the prior three-year period. We refer to the Jumpstart Our Business Startups Act of 2012 herein as the &#147;JOBS Act,&#148; and any reference herein to &#147;emerging growth company&#148; has the meaning ascribed to it in the JOBS Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">An emerging growth company may take advantage of reduced reporting requirements that are otherwise applicable to public companies. These provisions
include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">being permitted to present only two years of audited financial statements and only two years of related &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; in this
prospectus; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act of 2002, as amended; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and registration statements, including in this prospectus; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have elected to take advantage of certain of the reduced disclosure obligations in this prospectus and may elect to take advantage of other reduced
reporting requirements in our future filings with the U.S. Securities and Exchange Commission (the SEC). As a result, the information that we provide to our stockholders may be different than you might receive from other public reporting companies
in which you hold equity interests. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The JOBS Act also provides that an emerging growth company can take advantage of an extended transition period
for complying with new or revised accounting standards. We have irrevocably elected not to avail ourselves of this exemption and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not
emerging growth companies. </P>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>THE OFFERING </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial">Common stock offered by us </P></TD>
<TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial">Common stock to be outstanding after this offering </P></TD>
<TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial">Option to purchase additional shares of our common stock from us </P></TD>
<TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial">Use of proceeds </P></TD>
<TD>We estimate that the net proceeds to us from this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million if the underwriters exercise
their option to purchase additional shares in full, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share (which is the midpoint of the estimated initial public offering price range set forth on the
cover page of this prospectus), after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We intend to use the net proceeds from this offering for product development, including research and development and clinical trials, expansion of our salesforce and working capital and general corporate purposes. From
time to time, we may consider the acquisition of complementary technologies or businesses, though we have no agreements or understandings with respect to any such acquisitions at this time. Pending the use of the net proceeds from this offering, we
intend to invest the net proceeds in investment grade, interest bearing securities. See the section titled &#147;Use of Proceeds&#148; for additional information. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE="margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:arial">Proposed &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stock symbol </P></TD>
<TD>&#147;PEN&#148; </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The number of shares of common stock to be outstanding after this offering is based upon 24,771,191 shares
outstanding (including preferred stock on an as-converted basis) as of March&nbsp;31, 2015, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">3,265,591 shares of common stock issuable upon the exercise of options to purchase shares of our common stock outstanding as of March&nbsp;31, 2015, at a weighted average exercise price of $3.96 per share;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,199,713 shares of common stock reserved for future grant or issuance under our 2014 Equity Incentive Plan as of March&nbsp;31, 2015; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock reserved for future issuance under our Amended and Restated 2014 Equity Incentive Plan, which will become effective
immediately prior to the completion of this offering, as well as any automatic increases in the number of shares of our common stock reserved for future issuance pursuant to this plan. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Unless otherwise indicated, this prospectus reflects and assumes the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">outstanding shares include 23,176 shares of common stock issued upon early exercise of stock options and subject to repurchase; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">outstanding shares include 316,501 shares of unvested restricted stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">no exercise of options outstanding as of March&nbsp;31, 2015, or subsequently issued; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the automatic conversion of all of our outstanding shares of preferred stock into an aggregate of 19,510,410 shares of common stock immediately prior to the completion of this offering, assuming a one-to-one conversion
ratio of our outstanding shares of preferred stock into common stock; </TD></TR></TABLE>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">no exercise by the underwriters of their option to purchase up to &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares of our common stock from us; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the filing and effectiveness of our amended and restated certificate of incorporation in Delaware and the adoption and effectiveness of our amended and restated bylaws immediately prior to the completion of this
offering. </TD></TR></TABLE>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>SUMMARY CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following tables summarize our consolidated financial data. We have derived the summary consolidated statement of operations data for the years ended
December&nbsp;31, 2013 and 2014, from our audited consolidated financial statements included elsewhere in this prospectus. We have derived the summary consolidated statement of operations data for the year ended December&nbsp;31, 2012, from our
audited consolidated financial statements not included in this prospectus. We have derived the summary consolidated statement of operations data for the three months ended March&nbsp;31, 2014 and 2015, and our balance sheet data as of March&nbsp;31,
2015, from our unaudited interim consolidated financial statements included elsewhere in this prospectus. The unaudited interim consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements
and reflect, in our opinion, all adjustments of a normal, recurring nature that are necessary for a fair statement of the unaudited interim consolidated financial statements. Our historical results are not necessarily indicative of the results that
may be expected in the future and the results for the three months ended March&nbsp;31, 2015, are not necessarily indicative of results to be expected for the full year or any other period. The following summary consolidated financial data should be
read in conjunction with the section titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and our consolidated financial statements and related notes included elsewhere in this prospectus.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8.5pt" ALIGN="center">


<TR>
<TD WIDTH="53%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2012</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" NOWRAP ALIGN="center"><B>(in thousands, except share and per share amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial"><B>Statement of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Gross profit</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,963</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Operating expenses:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Selling, general and administrative</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,918</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Total operating expenses</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,613</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Income (loss) from operations</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,126</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Interest income (expense), net</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Other income (expense), net</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(474</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(309</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(37</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Income (loss) before provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,255</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Net income</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Net income (loss) attributable to common stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">887</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(833</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">280</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">503</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Net income (loss) per share attributable to common stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(0.18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(0.18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.04</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Weighted average shares used to compute net income (loss) per share attributable to common stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,153,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,304,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,609,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,430,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,903,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,886,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,500,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,609,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,705,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,193,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Pro forma net income per share &#151; Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Pro forma net income per share &#151; Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Weighted average shares used to compute the pro forma net income per share</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">&#151;Basic (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">&#151;Diluted (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px;MARGIN-RIGHT:0px;WIDTH:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of March&nbsp;31, 2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Pro Forma<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Pro&nbsp;Forma&nbsp;As<BR>Adjusted<SUP STYLE="font-size:85%; vertical-align:top">(2)(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial"><B>Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Marketable investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">127,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">127,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Working capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,991</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">101,476</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The pro forma column reflects (i)&nbsp;the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 19,510,410 shares of our common stock, which conversion will occur immediately prior
to the completion of this offering, as if such conversion had occurred on March&nbsp;31, 2015, and (ii)&nbsp;the filing and effectiveness of our amended and restated certificate of incorporation. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The pro forma as adjusted column gives effect to (a)&nbsp;the pro forma adjustments set forth in (1)&nbsp;above and (b)&nbsp;the sale and issuance by us of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock in this offering, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of
the estimated initial public offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Each $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the estimated initial public offering price range set
forth on the cover page of this prospectus, would increase or decrease, as applicable, the amount of our cash and cash equivalents, total assets, working capital and stockholders&#146; equity by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, after deducting underwriting discounts and commissions payable by us. An increase or decrease of 1.0&nbsp;million shares
in the number of shares offered by us would increase or decrease, as applicable, the amount of our cash and cash equivalents, total assets, working capital and stockholders&#146; equity by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million,
assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus, after deducting
underwriting discounts and commissions payable by us. </TD></TR></TABLE>
 <P STYLE="margin-top:0pt;margin-bottom:0pt; font-size:8pt">&nbsp;</P></div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_2"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>You should carefully consider the risks described below before making an investment decision. Additional risks not presently known to us or that we
currently deem immaterial may also impair our business. Our business could be harmed by any of these risks. The trading price of our common stock could decline due to any of these risks, and you may lose all or part of your investment. In assessing
these risks, you should also refer to the other information contained in this prospectus, including the section titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and our consolidated
financial statements and related notes, before making a decision to invest in our common stock. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Business Risks </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We have a limited operating history and may not be able to sustain or grow our profitability or generate positive cash flows from operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We were founded in 2004 and did not generate any revenue until 2007. Moreover, while we have successfully developed, obtained regulatory clearance or
approval for, and introduced a number of products in the neuro market since 2007, we first introduced products in the peripheral vascular and neurosurgical markets in 2013 and 2014, respectively. Accordingly, we only have a limited operating history
upon which investors can evaluate our business and prospects, and this limited operating history may not be indicative of our future results. Since 2009, we have been generally profitable on an annual basis; however, we incurred operating losses in
2013, and we are not currently <FONT STYLE="white-space:nowrap">cash-flow</FONT> positive. We can give no assurance that we will be profitable or <FONT STYLE="white-space:nowrap">cash-flow</FONT> positive in the future. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We expect that our general and administrative and sales and marketing expenses will increase to support our anticipated growth as well as the additional
operational and reporting costs associated with being a public company. We have also expended significant amounts on research and development to develop and fund clinical testing of our products, and we expect to continue to do so. We also expend
significant amounts on maintaining inventory levels of raw materials, components and finished products to meet anticipated customer demand. In addition, our coil products are sold on a consignment basis, which requires us to expend significant
amounts on inventory that is placed at many customer locations. Our ability to sustain our growth and profitability and become cash-flow positive may be influenced by many factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to achieve and maintain market acceptance of our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">unanticipated problems and additional costs relating to the development and testing of new products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to introduce, manufacture at scale and commercialize new products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to produce sufficient quantities of our products to meet demand and to smoothly transition to new products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the impact of competition; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing and impact of market and regulatory developments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to expand into new markets; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pricing pressure from competitors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the availability and adequacy of third-party reimbursement for procedures in which our products are used; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to obtain and maintain adequate intellectual property protection for our products and technologies. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If we encounter difficulties with any of the foregoing or unexpected expenses, it could materially adversely affect our business, results of operations,
financial condition or cash flows. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our existing products may be rendered obsolete and we may be unable to effectively introduce and market new products
or may fail to keep pace with advances in technology. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The medical device market is characterized by rapidly advancing technology. Our
success depends, in part, on our ability to anticipate technological advancements and competitive innovations and introduce new products to adapt to these advancements and innovations. To compete in the marketplace, we have made, and we must
continue to make, substantial investments in new product development, whether internally through research and development or externally through licensing or acquisitions. We can give no assurance that we will be successful in identifying, developing
or acquiring, and marketing new products or enhancing our existing products. In addition, we can give no assurance that new products or alternative treatment techniques developed by competitors will not render our current or future products obsolete
or inferior, technologically or economically. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The success of any new products that we develop or acquire depends on achieving and maintaining market
acceptance. Market acceptance for our current and new products could be affected by a number of factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to market and distribute our products effectively; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the availability, perceived efficacy and pricing of alternative products from our competitors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the development of new products or alternative treatments by others that render our products and technologies obsolete; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the price, quality, effectiveness and reliability of our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our customer service and reputation; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to convince specialist physicians to use our products on their patients; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing of market entry of new products or alternative treatments. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our competition may respond more
quickly to new or emerging technologies or a changing clinical landscape, undertake more extensive marketing campaigns, have greater financial, marketing and other resources than us or be more successful in attracting potential customers and
strategic partners. Given these factors, we cannot assure you that we will be able to continue or increase our level of success. Our failure to introduce new and innovative products in a timely manner, and our inability to maintain or grow the
market acceptance of our existing products, could result in permanent write-downs or write-offs of our inventory and otherwise have a material and adverse effect on our business, results of operations, financial condition or cash flows. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Delays in product introductions could adversely affect our business, results of operations, financial condition or cash flows. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The medical device market is highly competitive and designs change often to adjust to shifting market preferences and other factors. Therefore, product
life cycles are relatively short. As a result, any delays in our product launches may significantly impede our ability to enter or compete in a given market and may reduce the sales that we are able to generate from these products. We may experience
delays in any phase of a product launch, including during research and development, clinical trials, regulatory review, manufacturing and marketing. Delays in product introductions could materially adversely affect our business, results of
operations, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We face significant competition, and if we are unable to compete effectively, we may not be able to achieve or
maintain significant market penetration or improve our results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The medical device industry is intensely competitive, subject
to rapid change and significantly affected by new product introductions and other market activities of industry participants. We compete with a number of manufacturers and distributors of neuro and peripheral vascular devices. Our most notable
competitors are Boston Scientific, Johnson&nbsp;&amp; Johnson, Medtronic, Stryker and Terumo. All of these competitors are large, well-capitalized companies with longer operating histories and significantly greater resources than us. We also
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
compete with a number of smaller medical device companies that have a single product or a limited range of products. Our competitors may be able to spend more on product development, marketing,
sales and other product initiatives, or be more focused in their spending and activities, than we can. Some of our competitors have: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">significantly greater name recognition; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">broader or deeper relations with healthcare professionals, customers and third-party payors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">more established distribution networks; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">additional lines of products and the ability to offer rebates or bundle products to offer greater discounts or other incentives to gain a competitive advantage; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">greater experience in conducting research and development, manufacturing, clinical trials, marketing and obtaining regulatory clearance or approval for products; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">greater financial and human resources for product development, sales and marketing and patent litigation. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We compete primarily on the basis that our products are able to treat patients with neurovascular and peripheral vascular diseases and disorders safely
and effectively, with improved outcomes and procedural cost savings. Our continued success depends on our ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">develop innovative, proprietary products that can cost-effectively address significant clinical needs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">continue to innovate and develop scientifically advanced technology; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obtain and maintain regulatory clearances or approvals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">demonstrate efficacy in Penumbra-sponsored and third-party clinical trials and studies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">apply technology across product lines and markets; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">attract and retain skilled research and development and sales personnel; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">cost-effectively manufacture and successfully market and sell products. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We cannot assure you that we
will be able to compete effectively on the basis of these factors. Additionally, our competitors with greater financial resources could acquire or develop new technologies or products that effectively compete with our existing or future products. If
we are unable to effectively compete, it would materially adversely affect our business, results of operations, financial condition and cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our
future growth depends, in part, on our ability to further penetrate our current customer base and increase the frequency of use of our products by our customers. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We will need to continue to make specialist physicians and other hospital staff aware of the benefits of our products to generate increased demand and
frequency of use, and thus increase sales to our hospital customers. Although we are attempting to increase the number of patients treated with procedures that use our products through our established relationships and focused sales efforts, we
cannot provide assurance that our efforts will increase the use of our products. If we are unable to increase the frequency of use of our products by specialist physicians, this could materially adversely affect our business, results of operations,
financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our future growth depends, in part, on significantly expanding our user base to include additional specialist physicians
in both our existing and future target end markets. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Currently, the primary users of our neuro products are neuro interventionalists who
perform endovascular neuro interventions. We also began selling in the peripheral vascular market in 2013 with the introduction of our Ruby Coil and the neurosurgery market in 2014 with the introduction of our Apollo System, and we may enter new
target end markets in the future. Our revenue growth will depend in part on our ability to convince </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
specialist physicians in our existing and future target end markets of our products&#146; efficacy, to educate them in the proper use of our products and to sell our products to their affiliated
hospitals. Convincing specialist physicians to use new products and to dedicate the time and energy necessary for adequate education in the use of our products is challenging, especially in new markets where treatments using our products are not
established. Expanding our customer base in existing or new target end markets may require, among other things, additional clinical evidence supporting patient benefits, training in a manner to which we are not accustomed, or other resources that we
do not readily have available or are not cost effective for us to provide. If we are unable to convert specialist physicians in existing or new target end markets to the use of our products, our sales growth will be limited, which could materially
adversely affect our business, results of operations, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The marketing and sales of our products require a significant amount
of time and expense and we may not have the resources to successfully market and sell our products, which would adversely affect our business and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The marketing and sales of our products requires us to invest in training and education and employ a salesforce that is large enough to interact with the
specialist physicians who use our products. Entering new markets also requires a significant amount of time and expense in order to identify and establish relationships with key opinion leaders among the specialist physicians who may use our
products in those markets. We may not have adequate resources to market and sell our products successfully against larger competitors. For example, when we began selling in the peripheral vascular market in 2013, we did not have a dedicated direct
peripheral vascular sales team and our neuro sales team was required to dedicate a portion of its efforts to the sales of our peripheral vascular products. We subsequently expended significant sums to develop a direct salesforce focused on
peripheral vascular product sales. If we do not have adequate resources to market and sell our products effectively, or cannot otherwise market and sell our products successfully, it could materially adversely affect our business, results of
operations, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Third-party reimbursement may not be available or adequate for the procedures in which our products are used.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our ability to commercialize new products successfully in both the United States and international markets depends in part on the
availability of, and hospitals&#146; ability to obtain, adequate levels of third-party reimbursement for the procedures in which our products are used. In the United States, the cost of medical care is funded, in substantial part, by government
insurance programs, such as Medicare and Medicaid, and private and corporate health insurance plans. Third-party payors may deny reimbursement if they determine that a device used in a procedure has not received appropriate FDA or other governmental
regulatory clearances or approvals, is not used in accordance with cost-effective treatment methods as determined by the payor, or is experimental, unnecessary or inappropriate. Our ability to commercialize our products successfully will depend, in
large part, on the extent to which adequate reimbursement levels for the cost of their use are obtained from government authorities, private health insurers and other organizations, such as health maintenance organizations. Further, healthcare in
the United States and international markets is also being affected by economic pressure to contain reimbursement levels and costs. Changing reimbursement models could materially adversely affect our business, results of operations, financial
condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We have generated a significant portion of our revenue from products that are used in connection with the treatment of neurovascular
diseases, and our revenue and business prospects would be adversely affected if our neuro product sales were to decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have generated
most of our revenue from our neurovascular products, including our Penumbra System, Penumbra Coil 400 and Neuron products. If any one or more of these products, or any successor products, were no longer available for sale in any key market because
of regulatory, third-party reimbursement or intellectual property issues or any other reason, or if one of our competitors introduced one or more products that specialist physicians believe are superior to our products, our revenue from these
products would </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
decline. A significant decline in our sales of neurovascular products could also negatively impact our financial condition and our ability to conduct product development activities, and therefore
negatively impact our business prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We must maintain and further develop relationships with specialist physicians. If specialist physicians do not
recommend and endorse, or use, our products or if our relationships with specialist physicians deteriorate, our products may not be accepted or maintain acceptance in the marketplace, which would adversely affect our business and results of
operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our products are sold to hospitals for use by specialist physicians practicing at their facilities. In order for us to sell our
products, specialist physicians must recommend and endorse them for the hospital to purchase them, and must use them in treating their patients to generate follow-on sales. We may not obtain the necessary recommendations or endorsements for new
products from specialist physicians, nor may we be able to maintain the current or future level of acceptance and usage of our products. Acceptance of our products depends on educating the medical community as to the distinctive characteristics,
perceived benefits, safety, clinical efficacy and cost-effectiveness of our products compared to products of our competitors or treatments that do not use our products, and on training specialist physicians in the proper application and use of our
products. We invest in significant training and education of our sales representatives and specialist physicians to achieve market acceptance of our products, with no assurance of success. If we are not successful in obtaining and maintaining the
recommendations or endorsements of specialist physicians for our products, if specialist physicians prefer our competitors&#146; products or other alternative treatments that do not use our products, or if our products otherwise do not gain or
maintain market acceptance, our business could be adversely affected. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, the research, development, marketing and sales of our products
are dependent, in part, upon our working relationships with specialist physicians. We rely on them to provide us with knowledge and feedback regarding our products and the marketing of our products. If we are unable to develop or maintain strong
relationships with specialist physicians and receive their advice and input, the development and marketing of our products could suffer, which could materially adversely affect our business, results of operations, financial condition or cash flows.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may not be able to achieve or maintain satisfactory pricing and margins for our products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Manufacturers of medical devices have a history of price competition, and we can give no assurance that we will be able to achieve satisfactory prices
for our products or maintain prices at the levels we have historically achieved. If we are unable to achieve or maintain our prices, or if our costs increase and we are unable to offset such increase with an increase in our prices, our margins could
erode and we may be unable to maintain profitable operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We cannot be certain that we will be able to manufacture our products in high volumes at
commercially reasonable costs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We currently maintain our manufacturing operations in buildings located at our campus in Alameda, California.
We currently produce substantially all of our products at this facility, and we do not have redundant facilities. We may need to expend significant capital resources and increase the size of our manufacturing capabilities as we grow our business. We
could, however, encounter problems related to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">capacity constraints; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">production yields; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">quality control; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">equipment availability; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">shortages of qualified personnel. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our continuous product innovation limits our ability to identify and implement manufacturing efficiencies.
Failure to do so may reduce our ability to manufacture our products at commercially reasonable costs. If we are unable to manufacture our products in high volumes at commercially reasonable costs, it could materially affect our ability to adequately
increase production of our products and fulfill customer orders on a timely basis, which could have a material adverse effect on our business, results of operations, financial condition or cash flows. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We are required to maintain high levels of inventory, which consume a significant amount of our working capital and could lead to permanent write-downs or
write-offs of our inventory. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We maintain a significant inventory of raw materials, components and finished goods, which subjects us to a
number of risks and challenges. Our hospital customers typically maintain only small quantities of our products at their facilities, so as products are used, they order replacements that typically require prompt delivery. As a result, we must
maintain sufficient levels of finished goods to permit rapid shipment of products following receipt of a customer order. In turn, we must also maintain a sufficient supply of raw materials and components inventory to permit rapid manufacturing and
re-stocking of finished goods. Furthermore, our coil inventory is supplied to hospital customers on a consignment basis, which means that it is classified as part of our inventory for financial reporting purposes but is maintained at the hospital
location until it is used. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Maintaining a significant inventory of raw materials, components and finished goods consumes a significant amount of our
working capital. This working capital could be used for other purposes, such as research and development or sales and marketing activities. As we grow our business, we may need substantial additional capital to fund higher levels of inventory, which
may materially adversely affect our liquidity or result in dilution to our stockholders if we sell additional equity securities or leverage if we raise debt capital to finance our working capital requirements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Maintaining a significant inventory of raw materials, components and finished goods also subjects us to the risk of inventory excess and obsolescence,
which may lead to a permanent write-down or write-off of our inventory. While in inventory, our components and finished goods may become obsolete, and we may over-estimate the amount of inventory needed, which may lead to excessive inventory. In
these circumstances, we would write-down or write-off our inventory, and we may be required to expend additional resources or be constrained in the amount of end product that we can produce. Furthermore, our products have a limited shelf life due to
sterilization requirements, and part or all of a given product or component may expire, resulting in a decrease in value and potentially a permanent write-down of our inventory. For example, we recorded write downs of $0.9 million and $1.9 million
for excess and obsolete inventory in 2013 and 2014, respectively. In the event that a substantial portion of our inventory becomes excess or obsolete, it could materially adversely affect our results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Defects or failures associated with our products could lead to recalls, safety alerts or litigation, as well as significant costs and negative publicity.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Manufacturing flaws, component failures, design defects, off-label uses or inadequate disclosure of product-related information could result
in an unsafe condition or the injury or death of a patient. These problems could lead to a recall of, or issuance of a safety alert relating to, our products and result in significant costs, negative publicity and adverse competitive pressure. While
we have had product recalls, they have all been voluntary, based on our own internal safety and quality monitoring and testing data, and none of our past product recalls has been material. The circumstances giving rise to recalls are, however,
unpredictable, and any future recalls of existing or future products could materially adversely affect our business, results of operations, financial condition or cash flows. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The medical device industry has historically been subject to extensive litigation over product liability claims. There are high rates of mortality and
other complications associated with some of the medical conditions suffered by the patients whom specialist physicians use our devices to treat, and we may be subject to product liability claims if our products cause, or merely appear to have
caused, an injury or death. In addition, an injury or death that is caused by the activities of our suppliers, such as those that provide us with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
components and raw materials, or by an aspect of a treatment used in combination with our products, such as a complementary drug or anesthesia, may be the basis for a claim against us by
patients, hospitals, health-care providers or others purchasing or using our products, even if our products were not the actual cause of such injury or death. An adverse outcome involving one of our products could result in reduced market acceptance
and demand for all of our products, and could harm our reputation and our ability to market our products in the future. In some circumstances, adverse events arising from or associated with the design, manufacture or marketing of our products could
result in the suspension or delay of regulatory reviews of our premarket notifications or applications for marketing. Any of the foregoing problems could disrupt our business and have a material adverse effect on our business, results of operation,
financial condition or cash flows. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Although we carry product liability insurance in the United States and in other countries in which we conduct
business, including for clinical trials and product marketing, we can give no assurance that such coverage will be available or adequate to satisfy any claims. Product liability insurance is expensive, subject to significant deductibles and
exclusions, and may not be available on acceptable terms, if at all. If we are unable to obtain or maintain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability
claims, we could be exposed to significant liabilities. A product liability claim, recall or other claim with respect to uninsured liabilities or for amounts in excess of insured liabilities could materially adversely affect our business, financial
condition and results of operations. Defending a suit, regardless of its merit or eventual outcome, could be costly, could divert management&#146;s attention from our business and might result in adverse publicity, which could result in reduced
acceptance of our products in the market, product recalls or market withdrawals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our products are continually the subject of clinical trials conducted by us,
our competitors, or other third parties, the results of which may be unfavorable, or perceived as unfavorable, and which could materially adversely affect our business, financial condition and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As a part of the regulatory process of obtaining marketing clearance or approval for new products and new indications for existing products, as well as
to provide specialist physicians with ongoing information regarding the efficacy of our products, we conduct and participate in numerous clinical trials with a variety of study designs, patient populations and trial endpoints. Our competitors and
third parties also conduct clinical trials of our products without our participation. Unfavorable or inconsistent clinical data from existing or future clinical trials conducted by us, our competitors or third parties, or the market&#146;s or
regulators&#146; perception of clinical data, could materially adversely affect our business, results of operations, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our
future success depends in part upon establishing an interventional stroke care pathway in the United States that integrates the use of endovascular thrombectomy into the treatment of ischemic stroke. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The stroke care pathway in the United States generally begins with emergency responders who are responsible for transporting the patient to a hospital
facility. With a small number of exceptions (such as for trauma), emergency responders in the United States generally operate under a protocol that transports patients to the nearest hospital, which decreases the likelihood that the patient will be
transported to a stroke center that has a developed stroke team and an interventional approach to the treatment of stroke. Further, there is no agreed upon standard of care among physicians or hospitals regarding the treatment of ischemic stroke
patients, and treatment protocols vary according to the particular hospital, often resulting in significant delays and gaps in patients being assessed for and receiving interventional treatment. The absence of a uniform protocol among hospitals and
among physicians within the same hospital means that we have to educate each hospital and stroke center about protocols that integrate our products for the treatment of stroke. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe that the stroke care system in the United States has not been historically geared towards interventional treatment of stroke due to the
absence of clinical evidence that interventional techniques were effective. Our and our competitors&#146; ability to alter the existing stroke care pathway may depend on whether we and our competitors are successful in using recent positive clinical
studies to convince specialist physicians that intervention yields superior clinical results relative to cases where intervention is not used. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Establishing an interventional stroke pathway that integrates the use of interventional treatments,
including our products, will depend upon many factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">continuing to educate hospitals and specialist physicians about the clinical evidence supporting intervention, as well as the use, benefits and cost-effectiveness of our products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">improving the speed with which patients are assessed for and receive interventional treatments; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">increasing the likelihood that patients are transported to a hospital or stroke center where interventional treatments are available. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Even if these efforts are successful, it may be years before existing systems and care pathways are changed. These factors may make it difficult to grow
our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Any data that is gathered in the course of clinical trials may be significantly more favorable than the typical results achieved by practicing
specialist physicians, which could negatively impact rates of adoption of our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Even if the data collected from clinical trials
indicates positive results, each specialist physician&#146;s actual experience with our products will vary. Clinical trials often involve procedures performed by specialist physicians who are technically proficient and high volume users.
Consequently, the results reported in clinical trials may be significantly more favorable than typical results of other users. If specialist physicians&#146; experiences indicate, or they otherwise believe, that our products are not as safe or
effective as other treatment options with which they are more familiar, or clinical trial data indicates the same, adoption of our products may suffer, which could materially adversely affect our business, results of operations, financial condition
or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Negative publicity regarding our products or marketing tactics by competitors could reduce demand for our products, which would adversely
affect sales and our financial performance. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We may experience, from time to time, negative exposure in clinical publications or in marketing
campaigns of our competitors. Such publications or campaigns may present negative individual physician experience regarding the safety or effectiveness of our products or may suggest our competitors&#146; products are superior to ours, based on
studies or clinical trials conducted or funded by competitors or that involved competitive products. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our reputation and competitive position may
also be harmed by other publicly available information suggesting that our products are not safe. For example, we file adverse event reports under Medical Device Reporting, or MDR, obligations with the FDA that are publicly available on the
FDA&#146;s website. We are required to file MDRs if our products may have caused or contributed to a serious injury or death or malfunctioned in a way that could likely cause or contribute to a serious injury or death if it were to recur. Any such
MDR that reports a significant adverse event could result in negative publicity and could harm our reputation and future sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our dependence on key
suppliers puts us at risk of interruptions in the availability of our products, which could reduce our revenue and adversely affect our results of operations. In addition, increases in prices for raw materials and components used in our products
could adversely affect our results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We require the timely delivery of sufficient amounts of components and materials to
manufacture our products. For reasons of quality assurance, cost effectiveness or availability, we procure certain raw materials and components from a single or limited number of suppliers. We generally acquire such raw materials and components
through purchase orders placed in the ordinary course of business, and as a result we may not have a significant inventory of these materials and components and generally do not have any guaranteed or contractual supply arrangements with many of
these suppliers. Our reliance on these suppliers subjects us to risks that could harm our business, including, but not limited to, difficulty locating and qualifying alternative suppliers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our dependence on third-party suppliers involves several other risks, including limited control over
pricing, availability, quality and delivery schedules. Suppliers of raw materials and components may decide, or be required, for reasons beyond our control, to cease supplying raw materials and components to us or to raise their prices. Shortages of
raw materials, quality control problems, production capacity constraints or delays by our suppliers could negatively affect our ability to meet our production requirements and result in increased prices for affected materials or components. We may
also face delays, yield issues and quality control problems if we are required to locate and secure new sources of supply. While we have not experienced any to date, any material shortage, constraint or delay may result in delays in shipments of our
products, which could materially adversely affect our results of operations. Increases in prices for raw materials and components used in our products could also materially adversely affect our results of operations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, the FDA and regulators outside of the United States may require additional testing of any raw materials or components from new suppliers
prior to our use of these materials or components. In the case of a device with clearance under section 510(k) of the U.S. Federal Food, Drug, and Cosmetic Act, referred to as a 510(k), we may be required to submit a new 510(k) if a change in a raw
material or component supplier results in a change in a material or component supplied that is not within the 510(k) cleared device specifications. If we need to establish additional or replacement suppliers for some of these materials or
components, our access to the materials or components might be delayed while we qualify such suppliers and obtain any necessary FDA approvals or clearances. Our suppliers may also be subject to regulatory inspection and scrutiny. Any adverse
regulatory finding or action against those suppliers could impact their ability to supply us with raw materials and components for our products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our
corporate culture has contributed to our success, and if we cannot maintain this culture as we grow, we could lose the innovative approach, creativity, and teamwork fostered by our culture, and our business may be harmed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe that a critical contributor to our success has been our corporate culture, which we believe fosters innovation, teamwork, and a focus on
execution, as well as facilitating critical knowledge transfer and knowledge sharing. As we grow, we may find it difficult to maintain these important aspects of our corporate culture, which could limit our ability to innovate and operate
effectively. Any failure to preserve our culture could also negatively affect our ability to retain and recruit personnel or execute on our business strategy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If our facilities were to become inoperable, we would be unable to continue to develop and manufacture our products until we were able to restore full research,
manufacturing and administrative capabilities at our facilities or secure a new facility, and as a result, our business would be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We
currently maintain our research and development, manufacturing and administrative operations in buildings located at our campus in Alameda, California, and we do not have redundant facilities. Alameda is situated on or near earthquake fault lines,
and our facilities are built on filled land, which could be prone to liquefaction in a major earthquake. Should one or more of our buildings be significantly damaged or destroyed by natural or man-made disasters, such as earthquakes, fires or other
events, it could take months to relocate or rebuild, during which time our employees may seek other positions, our research, development and manufacturing would cease or be delayed and our products may be unavailable. Moreover, because of the time
required to approve and license a manufacturing facility under FDA and non-U.S. regulatory requirements, we may not be able to resume production on a timely basis even if we are able to replace production capacity in the event we lose manufacturing
capacity. While we maintain property and business interruption insurance, such insurance has limits and would only cover the cost of rebuilding and relocating and lost profits, but not losses we may suffer due to our products being replaced by
competitors&#146; products. The inability to perform our research, development and manufacturing activities, combined with our limited inventory of raw materials and components and manufactured products, may cause specialist physicians to
discontinue using our products or harm our reputation, and we may be unable to reestablish relationships with those specialist physicians in the future. Consequently, a catastrophic event at our facility could materially adversely affect our
business, results of operations, financial condition or cash flows. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>To successfully market and sell our products internationally, we must address a number of unique challenges
applicable to international markets. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">For 2014 and the three months ended March&nbsp;31, 2015, we derived 34% and 32%, respectively, of our
revenue from international sales. International sales are subject to a number of risks and challenges, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reliance on distributors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">varying coverage and reimbursement policies, processes and procedures; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">difficulties in staffing and managing international operations from which sales are conducted; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">difficulties in penetrating markets in which our competitors&#146; products or alternative procedures that do not use our products are more established; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reduced protection for intellectual property rights in some countries; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">export licensing requirements or restrictions, trade regulations and foreign tax laws; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">fluctuating foreign currency exchange rates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">foreign certification, regulatory requirements and legal requirements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">lengthy payment cycles and difficulty in collecting accounts receivable; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">customs clearance and shipping delays; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pricing pressure in international markets; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">political and economic instability; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">preference for locally produced products. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If we are unable to successfully address these challenges, we
may not be able to grow our international sales and our results of operations may suffer as a result. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Over the long term, we intend to grow our
business internationally and to do so, we will need to either spend substantial sums to expand or develop direct sales capabilities in existing and new geographic areas or generate additional sales through existing distributors or attract additional
distributors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As a result of our international operations, we are required to comply with tax requirements in multiple jurisdictions, the scope and
impact of which may be unclear. Moreover, tax authorities in jurisdictions in which we do business could disagree with tax positions that we take, including, for example, our inter-company pricing policies, or could assert that we owe more taxes
than we currently pay due to the level and nature of our activities in such jurisdictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We rely on our distributors to market and sell our products in
certain international markets. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have established a direct sales capability in the United States, most of Europe, Canada and Australia,
which we have complemented with distributors in Japan and certain other international markets. Sales to distributors represented 17.7% and 17.9% of our revenue in 2014 and the three months ended March&nbsp;31, 2015, respectively. In addition, sales
to our Japanese distributor represented approximately 11.7% of our revenue in 2014. Our success outside of the United States, most of Europe, Canada and Australia depends largely upon marketing arrangements with distributors, in particular their
sales expertise and their relationships with specialist physicians and affiliated hospitals in their geographic areas. Distributors may terminate their relationship with us, sell competitive products or devote insufficient sales efforts or other
resources to our products. We do not control our distributors, and they may not be successful in implementing our marketing plans. In addition, many of our distributors initially obtain and maintain foreign regulatory approval for the sale of our
products in their respective countries, and their efforts in obtaining and maintaining regulatory approval may not be as robust as we desire or expect. Our failure to maintain our existing relationships with our distributors, or our failure to
recruit and retain additional skilled distributors in existing or new international </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
markets, could have an adverse effect on our operations. If current or future distributors do not perform adequately, or if we lose a significant distributor, such as our Japanese distributor, we
may not be able to maintain existing levels of international revenue or realize expected long term international revenue growth. We have also experienced turnover with some of our distributors in the past that has adversely affected sales in the
countries in which those distributors operate. Similar occurrences could happen in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Most of our customer relationships outside of the United
States are with governmental entities, and we could be materially adversely affected by violations of the U.S. Foreign Corrupt Practices Act and similar anti-bribery laws in non-U.S. jurisdictions. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The FCPA and similar anti-bribery laws in non-U.S. jurisdictions generally prohibit companies and their intermediaries from making improper payments to
non-U.S. officials for the purpose of obtaining or retaining business. Because of the predominance of government-sponsored healthcare systems around the world, most of our customer relationships outside of the United States are with governmental
entities, and physicians practicing in those systems are considered &#147;government officials;&#148; our sale to these entities are therefore subject to such anti-bribery laws. Our policies mandate compliance with these anti-bribery laws. We
operate in many parts of the world that have experienced governmental corruption, and in certain circumstances strict compliance with anti-bribery laws may be at variance with local customs and practices. Despite our training and compliance
programs, our internal control policies and procedures may not always protect us from reckless or criminal acts committed by our employees, distributors or agents. Violations of the FCPA or other anti-bribery laws, or allegations of such violations,
could disrupt our business and materially adversely affect our business, results of operations, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Foreign currency exchange
rates may adversely affect our results. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are exposed to the effects of changes in foreign currency exchange rates, and we have not
historically hedged our foreign currency exposure. Approximately 34% and 32% of our revenue for 2014 and the three months ended March&nbsp;31, 2015, respectively, were derived from sales in non-U.S. markets, and we expect sales from non-U.S. markets
to continue to represent a significant portion of our revenue. For direct sales in our international markets, we are paid by our customers in their local currency, which is primarily euros. For sales to distributors in our international markets, we
are paid in either U.S. dollars, euros or Japanese yen. Therefore, when the U.S. dollar strengthens relative to the euro, yen or other local currency, as it has in recent periods, our U.S. dollar reported revenue from non-U.S. dollar denominated
sales will decrease, or we will need to increase our non-U.S. dollar denominated prices, which may not be commercially practical. Conversely, when the U.S. dollar weakens relative to the euro, yen or other local currency, our U.S. dollar reported
expenses from non-U.S. dollar denominated operating costs will increase. Changes in the relative values of currencies occur regularly and, in some instances, could materially adversely affect our business, results of operations, financial condition
or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We have experienced rapid growth in recent periods, and if we fail to manage our growth effectively, our business and results of operations
may suffer. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have significantly expanded our overall business, research and development, customer base, product portfolio, employee
headcount and operations in recent periods. We have also established new operations in other countries. We have increased our total number of full-time employees from 468 as of December&nbsp;31, 2013, to approximately 850 as of March&nbsp;31, 2015.
Our expansion has placed, and our expected future growth will continue to place, a significant strain on our managerial, operational, product development, sales and marketing, administrative, financial and other resources. More systems, facilities,
processes and management employees are needed to allow us to continue to grow successfully. We also plan to continue to increase our salesforce. Our experience has been that it takes at least six months, and often longer, before new sales personnel
generate enough sales to cover their costs, resulting in increased costs without offsetting revenue during periods in which we are increasing the size of our salesforce. To meet anticipated demand for our products, we will also have to obtain
additional space, buy additional equipment and hire additional research </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
and development and manufacturing employees, including quality control personnel and other personnel involved in the production process. If we are unable to manage our growth successfully, it
could have a material and adverse effect on our business, results of operations, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We depend on key personnel to operate our
business and develop our products, and if we are unable to retain, attract and integrate qualified personnel, our ability to develop and successfully grow our business could be harmed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe that our future success is highly dependent on the contributions of our executive officers, particularly our chief executive officer, as well
as our ability to attract and retain highly skilled and experienced sales and marketing, technical and other personnel in the United States and in international markets. Each of these persons&#146; efforts will be critical to us as we continue to
develop our products and business. If we were to lose one or more of our key employees, including to competitors, we may experience difficulties in competing effectively, developing our products and implementing our business strategies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our research and development and sales and marketing programs depend on our ability to attract and retain highly skilled technicians, engineers and
salespeople. We may not be able to attract or retain qualified employees in the future due to the intense competition for qualified personnel among life science businesses, particularly in the San Francisco Bay Area, where our corporate
headquarters, research and development and manufacturing facilities are located. If we are not able to identify, recruit and retain highly qualified personnel, we may experience constraints that will adversely affect our ability to support our
research, development, manufacturing and sales programs, and ultimately our ability to compete. If we are unable to identify, recruit and retain qualified salespeople, there could be a delay or decline in the adoption of our products. If key
personnel were to leave Penumbra, either to join our competitors or otherwise, we may not be able to attract and retain equally qualified personnel to replace them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We depend on information technology systems to operate our business and a cyber-attack or other breach of these systems could have a material adverse effect on
our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We rely on information technology systems to process, transmit and store electronic information in our day-to-day operations.
Our information technology systems are vulnerable to a cyber-attack, malicious intrusion, breakdown, destruction, loss of data privacy or other significant disruption. Any such successful attacks could result in the theft of intellectual property or
other misappropriation of assets, or otherwise compromise our confidential or proprietary information and disrupt our operations. Cyber-attacks are becoming more sophisticated and frequent, and our systems could be the target of malware and other
cyber-attacks. We have invested in our systems and the protection of our data to reduce the risk of an intrusion or interruption, and we monitor our systems on an ongoing basis for any current or potential threats. We can give no assurances that
these measures and efforts will prevent interruptions or breakdowns. If we fail to maintain or protect our information technology systems and data integrity effectively or fail to anticipate, plan for or manage significant disruptions to these
systems, our competitive position could be harmed, we could lose existing customers, have difficulty preventing, detecting, and controlling fraud, have disputes with customers, specialist physicians and other health care professionals, have
regulatory sanctions or penalties imposed, incur expenses or lose revenues as a result of a data privacy breach or theft of intellectual property or suffer other adverse consequences, any of which could have a material adverse effect on our
business, results of operations, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Cost-containment efforts of our customers, purchasing groups and governmental
organizations could have a material adverse effect on our sales and profitability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In an effort to reduce costs, many hospitals within the
United States have become members of Group Purchasing Organizations (GPOs) and Integrated Delivery Networks (IDNs). GPOs and IDNs negotiate pricing arrangements with medical device companies and distributors and offer the negotiated prices to
affiliated hospitals and other members. GPOs and IDNs typically award contracts on a category-by-category basis through a competitive bidding process. Bids are generally solicited from multiple providers with the intention of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
driving down pricing or reducing the number of vendors. Due to the highly competitive nature of the GPO and IDN contracting processes, we may not be able to obtain or maintain contract positions
with major GPOs and IDNs. Furthermore, the increasing leverage of organized buying groups may reduce market prices for our products, thereby reducing our profitability. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">While having a contract with a GPO or IDN for a given product category can facilitate sales to members of that GPO or IDN, such contract positions can
offer no assurance that any level of sales will be achieved, as sales are typically made pursuant to purchase orders. Even when a provider is the sole contracted supplier of a GPO or IDN for a certain product category, members of the GPO or IDN
generally are free to purchase from other suppliers. Furthermore, GPO and IDN contracts typically are terminable without cause by the GPO or IDN upon 60 to 90 days&#146; notice. Accordingly, although we have multiple contracts with many major GPOs
and IDNs, the members of such groups may choose to purchase from our competitors due to the price or quality offered by such competitors, which could result in a decline in our sales and profitability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The successful use of our products depends, in part, on our ability to educate specialist physicians in the proper use of our products, which may be more complex
than competitive products or alternative treatments that do not use our products. If we are unable to educate specialist physicians in the proper use of our products, we may experience a high risk of product liability. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The successful use of our products depends, in part, on our ability to educate specialist physicians in the proper use of our products, which may be more
complex than competitive products or alternative treatments that do not use our products. We educate specialist physicians on the proper techniques in using our products to achieve the intended outcome. However, our products may be more complicated
to operate than competitive products or alternative treatments that do not use our products. In the event that specialist physicians perceive that our products are complex relative to alternative products or established treatments that do not use
our products, we may have difficulty gaining or increasing adoption of our products. Further, we may be unable to provide adequate education on the use of our products to specialist physicians, and some specialist physicians may not be willing to
invest the time required to become properly educated on the use of our products. If we are unable to educate specialist physicians to properly use our products, this may lead to inadequate demand for our products and materially adversely affect our
business, results of operations, financial condition or cash flows. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If we do not adequately educate specialist physicians on the use of our
products, and our products are used incorrectly during procedures, we may also be subject to claims against us by such specialist physicians, their hospitals or their patients. Our business, including our reputation, may consequently be adversely
affected by any litigation that may occur based on error in the use of our products, and such litigation could also materially adversely affect our results of operations, financial condition or cash flows. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Regulatory Risks </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We are subject to stringent domestic and foreign
medical device regulation, which may impede the approval or clearance process for our products, hinder our development activities and manufacturing processes and, in some cases, result in the recall or seizure of previously approved or cleared
products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our products, development activities and manufacturing processes are subject to extensive and rigorous regulation by the U.S. Food
and Drug Administration (FDA) and by comparable agencies in foreign countries and by other regulatory agencies and governing bodies. Manufacturers of medical devices such as us must comply with certain regulations that cover the composition,
labeling, testing, clinical study, manufacturing, packaging and distribution of medical devices. In addition, medical devices must receive FDA clearance or approval before they can be commercially marketed in the United States. The FDA may require
testing and surveillance programs to monitor the effects of cleared or approved products that have been commercialized and can prevent or limit further marketing of a product based on the results of these post-marketing programs. Furthermore, most
major markets for medical devices outside the United States require clearance, approval or compliance with certain standards and requirements before a product can be commercially marketed. The process of obtaining marketing approval or clearance
from the FDA and foreign regulatory agencies for new </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
products could take a significant period of time, require the expenditure of substantial resources, involve rigorous pre-clinical and clinical testing, require changes to our products and result
in limitations on the indicated uses of our products. We cannot provide assurance that we will receive the required approval or clearance from the FDA and foreign regulatory agencies for future products on a timely basis. Results from pre-clinical
studies and early clinical trials may not allow us to predict results in later-stage testing. We cannot be certain that our future clinical trials will demonstrate the safety and effectiveness of any of our future products or will result in
clearance or approval to market any of these products. The failure to receive approval or clearance for significant new products on a timely basis could have a material adverse effect on our business, results of operation, financial condition or
cash flows. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The FDA also conducts periodic inspections of our facilities to determine compliance with both the FDA&#146;s Quality System Regulation
(QSR) requirements and/or MDR regulations. Product approvals or clearances by the FDA can be withdrawn, and new product approvals or clearances by the FDA and foreign regulatory bodies can be delayed, due to failure to comply with regulatory
requirements or the occurrence of unforeseen problems following initial approval or clearance of a product. The failure to comply with regulatory requirements or the discovery of previously unknown problems with a product or manufacturer could
result in fines, delays or suspensions of regulatory approvals or clearances, seizures or recalls of products (with the attendant expenses and adverse competitive impact), the banning of a particular device, an order to replace or refund the cost of
any device previously manufactured or distributed, operating restrictions and criminal prosecution, as well as decreased sales as a result of negative publicity and product liability claims, all of which could have a material adverse effect on our
business, results of operation, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The implementation of healthcare reform in the United States could have a material adverse
effect on our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education
Reconciliation Act of 2010 (the Affordable Care Act) was enacted into law in the United States. The Affordable Care Act includes provisions that, among other things, reduce and/or limit Medicare reimbursement, require all individuals to have health
insurance (with limited exceptions) and impose new and/or increased taxes. Specifically, the law imposes a 2.3% excise tax on the sale in the United States of certain medical devices by a manufacturer, producer or importer of such devices starting
after December&nbsp;31, 2012. The Affordable Care Act also reduces Medicare and Medicaid payments to hospitals and clinical laboratories, which could reduce medical procedure volumes and impact the demand for our products or the prices at which we
sell them. While this legislation is intended to expand health insurance coverage to uninsured persons in the United States, the impact of any overall increase in access to healthcare on sales of our products remains uncertain. Various healthcare
reform proposals have also emerged at the state level. The impact of the Affordable Care Act and these proposals could have a material adverse effect on our business, results of operation, financial condition or cash flows. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If we modify our FDA cleared products, we may need to seek and obtain new clearances, which, if not granted, would prevent us from selling our modified products
or require us to redesign our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">A component of our strategy is to continue to modify and upgrade our products that have been cleared
by the FDA. The FDA requires device manufacturers to make a determination of whether or not a modification requires a clearance; however, the FDA can review a manufacturer&#146;s decision not to submit for additional clearances. Any modifications to
an FDA cleared device that would significantly affect its safety or effectiveness or that would constitute a major change in its intended use would require a new 510(k) clearance or possibly a premarket approval. We may not be able to obtain
additional 510(k) clearances or premarket approvals for new products or for modifications to, or additional indications for, our existing products in a timely fashion, or at all. We also cannot provide any assurance that the FDA will agree with our
decisions not to seek clearances for particular device modifications. Delays in obtaining future clearances would adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn would harm our revenue and future
profitability. We have made modifications to our products in the past and may make additional modifications in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the future that we believe do not or will not require additional clearances. If the FDA disagrees, and requires new clearances or approvals for any modifications, and we fail to obtain such
approvals or clearances or fail to secure approvals or clearances in a timely manner, we may be required to recall and to stop the manufacturing and marketing of the modified device until we obtain FDA approval or clearance, and we may be subject to
significant regulatory fines or penalties, all of which could harm our results of operations and require us to redesign our products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may not receive
necessary foreign regulatory approvals or clearances or otherwise comply with foreign regulations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In 2014 and for the three months ended
March&nbsp;31, 2015, sales outside the United States accounted for approximately 34% and 32%, respectively, of our total sales, and we expect this percentage to increase in future years. Foreign regulatory bodies have established varying
regulations. Specifically, the European Union has promulgated rules that require that medical device products receive the right to affix the CE mark, an international symbol of adherence to quality assurance standards and compliance with applicable
European medical device directives. Although we have received CE markings for all of the products we currently sell in the European Union, we can give no assurance that we will be able to obtain European Union approval for any of our future
products. Our inability or failure, or the inability or failure of our international distributors, to comply with varying foreign regulations or the imposition of new regulations could restrict or, in certain countries, result in the prohibition of
the sale of our products, and thereby adversely affect our business, financial condition and results of operations. In addition, our profitability from our international operations may be limited by risks and uncertainties related to economic
conditions in these regions, foreign currency fluctuations, regulatory and reimbursement approvals, competitive offerings, infrastructure development, rights to intellectual property and our ability to implement our overall business strategy. Any
significant changes in the competitive, political, legal, regulatory, reimbursement or economic environment where we conduct international operations may have a material adverse effect on our business, results of operation, financial condition or
cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may not be able to meet regulatory quality requirements applicable to our manufacturing process. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are required to register with the FDA as a device manufacturer and as a result, we are subject to periodic inspection by the FDA for compliance with
the FDA&#146;s QSR requirements, which require manufacturers of medical devices to adhere to certain regulations, including testing, quality control and documentation procedures. In addition, the federal MDR regulations require us to provide
information to the FDA whenever there is evidence that reasonably suggests that a device may have caused or contributed to a death or serious injury, or has malfunctioned, and if the malfunction were to recur, it would be likely to cause or
contribute to a death or serious injury. Compliance with applicable regulatory requirements is subject to continual review and is rigorously monitored through periodic inspections by the FDA. In the European Community, we are required to maintain
certain International Organization for Standardization (ISO) certifications in order to sell products and we undergo periodic inspections by notified bodies to obtain and maintain these certifications. Some foreign countries, most notably Japan and
Brazil, have similar requirements or may require inspections of our manufacturing facilities before approving a product for sale in their country. Some of our suppliers are subject to the same or similar scrutiny. If we or our suppliers fail to
adhere to QSR, ISO or similar requirements, this could delay production of our products and lead to fines, difficulties in obtaining regulatory clearances or approvals, recalls or other consequences, which could in turn have a material adverse
effect on our business, results of operation, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We are subject to healthcare fraud and abuse regulations that could result
in significant liability, require us to change our business practices and restrict our operations in the future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are subject to various
federal, state and local laws targeting fraud and abuse in the healthcare industry, including anti-kickback and false claims laws. Violations of these laws are punishable by criminal or civil sanctions, including substantial fines, imprisonment and
exclusion from participation in healthcare programs such as Medicare and Medicaid. These laws and regulations are wide ranging and subject to changing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
interpretation and application, which could restrict our sales or marketing practices. Furthermore, since many of our customers rely on reimbursement from Medicare, Medicaid and other
governmental programs to cover a substantial portion of their expenditures, our exclusion from such programs as a result of a violation of these laws could have a material adverse effect on our business, results of operation, financial condition or
cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The FDA and other regulatory agencies strictly regulate the promotional claims that may be made about medical devices. If we are found to have
improperly promoted our products for off-label uses, we may become subject to significant fines and other liability. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The FDA and other
regulatory agencies strictly regulate the promotional claims that may be made about medical devices. For example, devices cleared under section 510(k) cannot be marketed for any intended use that is outside of the FDA&#146;s substantial equivalence
determination for such devices. Physicians nevertheless may use our products on their patients in a manner that is inconsistent with the intended use cleared by the FDA. If we are found to have promoted such &#147;off-label&#148; uses, we may become
subject to significant government fines and other related liability. The federal government has levied large civil and criminal fines against companies for alleged improper promotion and has enjoined several companies from engaging in off-label
promotion. The FDA has also requested that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is changed or curtailed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our operations are subject to environmental, health and safety laws and regulations, with which compliance may be costly. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our business is subject to federal, state, and local laws and regulations relating to the protection of the environment, worker health and safety and the
use, management, storage, and disposal of hazardous substances and wastes. Failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions. In addition, environmental laws and regulations could require
us to pay for environmental remediation and response costs, or subject us to third party claims for personal injury, natural resource or property damage, relating to environmental contamination. Liability may be imposed whether or not we knew of, or
were responsible for, such environmental contamination. The cost of defending against environmental claims, of compliance with environmental, health and safety regulatory requirements or of remediating contamination could materially adversely affect
our business, assets or results of operations and, consequently, amounts available for distribution to our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Risks Related to Our Intellectual
Property </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We rely on a variety of intellectual property rights, and if we are unable to maintain or protect our intellectual property, our business and
results of operations will be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our commercial success will depend, in part, on our ability to obtain and maintain intellectual
property protection for our products and related technologies both in the United States and elsewhere, successfully defend our intellectual property rights against third-party challenges and successfully enforce our intellectual property rights to
prevent third-party infringement. While we rely primarily upon a combination of patents, trademarks and trade secret protection, as well as nondisclosure, confidentiality and other contractual agreements to protect the intellectual property related
to our brands, products and other proprietary technologies, protection derived from patents is relatively limited. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The process of obtaining patent
protection is expensive and time-consuming, and we may not be able to prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. We may choose not to seek patent protection for certain innovations or
products and may choose not to pursue patent protection in certain jurisdictions, and under the laws of certain jurisdictions, patents or other intellectual property rights may be unavailable or limited in scope and, in any event, any patent
protection we obtain may be limited. As a result, some of our products are not, and in the future may not be, protected by patents. We generally apply for patents in those countries where we intend to make, have made, use or sell products and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
where we assess the risk of infringement to justify the cost of seeking patent protection. However, we do not seek protection in all countries where we sell products and we may not accurately
predict all the countries where patent protection would ultimately be desirable. If we fail to timely file a patent application in any such country or major market, we may be precluded from doing so at a later date. Competitors may use our
technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories in which we have patent protection that may not be sufficient to terminate
infringing activities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Furthermore, we cannot guarantee that any patents will be issued from any pending or future owned or licensed patent
applications, or if any current or future patents will provide us with any meaningful protection or competitive advantage. Even if issued, existing or future patents may be challenged, including with respect to ownership, narrowed, invalidated, held
unenforceable or circumvented, any of which could limit our ability to prevent competitors and other third parties from developing and marketing similar products or limit the length of terms of patent protection we may have for our products and
technologies. Other companies may also design around technologies we have patented, licensed or developed. In addition, the issuance of a patent does not give us the right to practice the patented invention. Third parties may have blocking patents
that could prevent us from marketing our products or practicing our own patented technology. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The patent positions of medical device companies can be
highly uncertain and involve complex legal, scientific and factual questions for which important legal principles remain unresolved. The standards that the United States Patent and Trademark Office (USPTO) and its foreign counterparts use to grant
patents are not always applied predictably or uniformly. Changes in either the patent laws, implementing regulations or the interpretation of patent laws may diminish the value of our rights. The legal systems of certain countries do not protect
intellectual property rights to the same extent as the laws of the United States, and many companies have encountered significant problems in protecting and defending such rights in foreign jurisdictions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Because patent applications in the United States, Europe and many other jurisdictions are typically not published until 18 months after filing, or in
some cases not at all, and because publications of discoveries in scientific literature lag behind actual discoveries, we cannot be certain that we were the first to make the inventions claimed in our issued patents or pending patent applications,
or that we were the first to file for protection of the inventions set forth in our patents or applications. We can give no assurance that all of the potentially relevant art relating to our patents and patent applications has been found; overlooked
prior art could be used by a third party to challenge the validity, enforceability and scope of our patents or prevent a patent from issuing from a pending patent application. As a result, we may not be able to obtain or maintain protection for
certain inventions. Therefore, the validity, enforceability and scope of our patents in the United States, Europe and in other countries cannot be predicted with certainty and, as a result, any patents that we own or license may not provide
sufficient protection against our competitors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Third parties may challenge any existing patent or future patent we own or license through
adversarial proceedings in the issuing offices or in court proceedings, including as a response to any assertion of our patents against them. In any of these proceedings, a court or agency with jurisdiction may find our patents invalid and/or
unenforceable, or even if valid and enforceable, insufficient to provide protection against competing products and services sufficient to achieve our business objectives. We may be subject to a third party pre-issuance submission of prior art to the
USPTO, or reexamination by the USPTO if a third party asserts a substantial question of patentability against any claim of a U.S. patent we own or license. The adoption of the Leahy-Smith America Invents Act (Leahy-Smith Act) in September 2011
established additional opportunities for third parties to invalidate U.S. patent claims, including <I>inter partes</I> review and post-grant review proceedings. Outside of the United States, patents we own or license may become subject to patent
opposition or similar proceedings, which may result in loss of scope of some claims or the entire patent. In addition, such proceedings are very complex and expensive, and may divert our management&#146;s attention from our core business. If any of
our patents are challenged, invalidated, circumvented by third parties or otherwise limited or expire prior to the commercialization of our product candidates, and if we do not own or have exclusive rights to other enforceable patents protecting our
products or other technologies, competitors and other third parties could market products and use processes that are substantially similar to, or superior to, ours and our business would suffer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The degree of future protection for our proprietary rights is uncertain because legal means afford only
limited protection and may not adequately protect our rights or permit us to gain or keep a competitive advantage. For example: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">others may be able to develop products that are similar to, or better than, ours in a way that is not covered by the claims of our patents; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we might not have been the first to make the inventions covered by our patents or pending patent applications; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we might not have been the first to file patent applications for these inventions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any patents that we obtain may not provide us with any competitive advantages or may ultimately be found invalid or unenforceable; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may not develop additional proprietary technologies that are patentable. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may file lawsuits or initiate
other proceedings to protect or enforce our patents or other intellectual property rights, which could be expensive, time consuming and unsuccessful. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Competitors may infringe our issued patents or other intellectual property. To counter infringement or unauthorized use, we may be required to file
infringement claims, which can be expensive and time-consuming. Any claims we assert against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their intellectual property. In addition, in a
patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent&#146;s claims narrowly or refuse to stop the other party from using the technology at issue on the grounds
that our patents do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly, which could adversely affect our competitive business
position, business prospects and financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our commercial success depends significantly on our ability to operate without infringing upon the
intellectual property rights of third parties. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The medical device industry is subject to rapid technological change and substantial
litigation regarding patent and other intellectual property rights. Our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial investments in patent portfolios and competing
technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit or otherwise interfere with our ability to make, use and sell our products. Numerous third party patents exist in the fields
relating to our products, and it is difficult for industry participants, including us, to identify all third-party patent rights relevant to our products and technologies. Moreover, because some patent applications are maintained as confidential for
a certain period of time, we cannot be certain that third parties have not filed patent applications that cover our products and technologies. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Patents could be issued to third parties that we may ultimately be found to infringe. Third parties may have or obtain valid and enforceable patents or
proprietary rights that could block us from developing product candidates using our technology. Our failure to obtain or maintain a license to any technology that we require may materially harm our business, financial condition and results of
operations. Furthermore, we would be exposed to a threat of litigation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">From time to time, we may be party to, or threatened with, litigation or
other proceedings with third parties, including non-practicing entities, who allege that our products, components of our products and/or proprietary technologies infringe, misappropriate or otherwise violate their intellectual property rights. The
types of situations in which we may become a party to such litigation or proceedings include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we or our collaborators may initiate litigation or other proceedings against third parties seeking to invalidate the patents held by those third parties or to obtain a judgment that our products or processes do not
infringe those third parties&#146; patents; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we or our collaborators may participate at substantial cost in International Trade Commission proceedings to abate importation of products that would compete unfairly with our products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if our competitors file patent applications that claim technology also claimed by us or our licensors, we or our licensors may be required to participate in interference, derivation or opposition proceedings to
determine the priority of invention, which could jeopardize our patent rights and potentially provide a third party with a dominant patent position; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if third parties initiate litigation claiming that our processes or products infringe their patent or other intellectual property rights, we and our collaborators will need to defend against such proceedings;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if third parties initiate litigation or other proceedings seeking to invalidate patents owned by or licensed to us or to obtain a declaratory judgment that their product or technology does not infringe our patents or
patents licensed to us, we will need to defend against such proceedings; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we may be subject to ownership disputes relating to intellectual property, including disputes arising from conflicting obligations of consultants or others who are involved in developing our products; and
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">if a license to necessary technology is terminated, the licensor may initiate litigation claiming that our processes or products infringe or misappropriate their patent or other intellectual property rights and/or that
we breached our obligations under the license agreement, and we and our collaborators would need to defend against such proceedings. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">These lawsuits and proceedings, regardless of merit, are time-consuming and expensive to initiate, maintain, defend or settle, and could divert the time
and attention of managerial and technical personnel, which could materially adversely affect our business. Any such claim could also force use to do one or more of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">incur substantial monetary liability for infringement or other violations of intellectual property rights, which we may have to pay if a court decides that the product or technology at issue infringes or violates the
third party&#146;s rights, and if the court finds that the infringement was willful, we could be ordered to pay treble damages and the third party&#146;s attorneys&#146; fees; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pay substantial damages to our customers or end users to discontinue use or replace infringing technology with non-infringing technology; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">stop manufacturing, selling, using, exporting or licensing the product or technology incorporating the allegedly infringing technology or stop incorporating the allegedly infringing technology into such product or
technology; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obtain from the owner of the infringed intellectual property right a license, which may require us to pay substantial upfront fees or royalties to sell or use the relevant technology and which may not be available on
commercially reasonable terms, or at all; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">redesign our products and technology so they do not infringe or violate the third party&#146;s intellectual property rights, which may not be possible or may require substantial monetary expenditures and time;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">enter into cross-licenses with our competitors, which could weaken our overall intellectual property position; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">lose the opportunity to license our technology to others or to collect royalty payments based upon successful protection and assertion of our intellectual property against others; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">find alternative suppliers for non-infringing products and technologies, which could be costly and create significant delay; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">relinquish rights associated with one or more of our patent claims, if our claims are held invalid or otherwise unenforceable. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Some of our competitors may be able to sustain the costs of complex intellectual property litigation more effectively than we can because they have
substantially greater resources. In addition, intellectual property </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
litigation, regardless of its outcome, may cause negative publicity, adversely impact prospective customers, cause product shipment delays, or prohibit us from manufacturing, marketing or
otherwise commercializing our products and technology. Any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise additional funds or otherwise have a material
adverse effect on our business, results of operation, financial condition or cash flows. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, we may indemnify our customers and
distributors against claims relating to the infringement of intellectual property rights of third parties related to our products. Third parties may assert infringement claims against our customers or distributors. These claims may require us to
initiate or defend protracted and costly litigation on behalf of our customers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers, suppliers or
distributors, or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of
our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or
investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock. The occurrence of any of these events may have a material adverse effect on our business, results of operation, financial
condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Changes in patent law could diminish the value of patents in general, thereby impairing our ability to protect our existing and
future products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Recent patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent
applications and the enforcement or defense of our issued patents. On September&nbsp;16, 2011, the Leahy-Smith Act was signed into law. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These include provisions that
affect the way patent applications are prosecuted, redefine prior art, and may also affect patent litigation. The USPTO developed new regulations and procedures to govern administration of the Leahy-Smith Act, including switching the United States
patent system from a &#147;first-to-invent&#148; system to a &#147;first-to-file&#148; system. Under a &#147;first-to-file&#148; system, assuming the other requirements for patentability are met, the first inventor to file a patent application
generally will be entitled to the patent on an invention regardless of whether another inventor had made the invention earlier. Many of the substantive changes to patent law associated with the Leahy-Smith Act, in particular, the first-to-file
provisions, only became effective recently. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. The Leahy-Smith Act and its implementation could increase the uncertainties and costs
surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, results of operation, financial condition or cash flows. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, patent reform legislation may pass in the future that could lead to additional uncertainties and increased costs surrounding the
prosecution, enforcement and defense of our patents and applications. Furthermore, the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit have made, and will likely continue to make, changes in how the patent laws of the United
States are interpreted. Similarly, foreign courts have made, and will likely continue to make, changes in how the patent laws in their respective jurisdictions are interpreted. We cannot predict future changes in the interpretation of patent laws or
changes to patent laws that might be enacted into law by United States and foreign legislative bodies. Those changes may materially affect our patents or patent applications and our ability to obtain additional patent protection in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee
payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The USPTO and various foreign patent offices require compliance with a number of procedural, documentary, fee payment and other similar provisions. In
addition, periodic maintenance fees on our owned and in-licensed patents are due to be paid to governmental patent agencies over the lifetime of the patents. Future maintenance fees will also need to be paid on other patents that may be issued to
us. We have systems in place to remind us to pay these fees, and we employ outside firms to remind us or our licensor to pay annuity fees due to patent agencies on our patents and pending patent applications. In certain cases, an inadvertent lapse
can be cured by payment of a late fee or by other means in accordance with the applicable rules. However, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or
complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors might be able to enter the market and this circumstance would have a material adverse effect on our business, results of operation, financial condition or
cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and
our business may be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We currently own seven trademarks, related to our company name, logo, products and technology, that
are registered with the USPTO as well as six trademarks registered in Europe and Japan. Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented, declared generic or determined to be infringing on other
marks or names. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition with potential customers in our markets of interest. There is no guarantee we will be able to secure
registration for any of our pending trademark applications with the USPTO or comparable foreign authorities. In addition, third parties have registered trademarks similar and identical to our trademarks, and may in the future file for registration
of such trademarks. If they succeed in registering or developing common law rights in such trademarks, and if we are not successful in challenging such third-party rights, we may not be able to use these trademarks to market our products in those
countries where such third parties have registered such trademarks or obtained such common law rights. In any case, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete
effectively and our business may be adversely affected. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, we may be involved in litigation or other proceedings to protect our trademark
rights associated with our company name or the names used with our products. For example, the United States application for registration of our Apollo trademark is currently subject to an opposition proceeding before the Trademark Trial and Appeal
Board. An adverse decision in such proceeding could require us to establish an alternative name for our Apollo product line. Any objections we receive from the USPTO, foreign trademark authorities or third parties relating to our pending
applications could require us to incur significant expense in defending the objections or establishing alternative names. Names used with our products may be claimed to infringe names held by others or to be ineligible for proprietary protection. If
we have to change the name of our company or any product, we may experience a loss in goodwill associated with our brand name, customer confusion or a loss of sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If we are unable to protect the confidentiality of our trade secrets and other proprietary information, our business and competitive position may be harmed.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition to patent protection, we also rely on confidential proprietary information, including trade secrets and know-how, to develop and
maintain our competitive position. We seek to protect our confidential proprietary information, in part, by entering into confidentiality agreements with our employees, consultants, collaborators and others upon the commencement of their
relationships with us. These agreements require that all confidential information developed by the individual or made known to the individual by us during the course of the individual&#146;s relationship with us be kept confidential. Our agreements
with employees and our personnel policies also provide that any inventions conceived by the individual in the course of rendering </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
services to us shall be our exclusive property. However, we may not obtain these agreements in all circumstances, and individuals with whom we have these agreements may not comply with their
terms. Thus, despite such agreements, such inventions may become assigned to third parties. Monitoring unauthorized uses and disclosures of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our
intellectual property will be effective. In the event of unauthorized use or disclosure of our trade secrets or proprietary information, these agreements, even if obtained, may not provide meaningful protection, particularly for our trade secrets or
other confidential information. To the extent that our employees, consultants or contractors use technology or know-how owned by third parties in their work for us, disputes may arise between us and those third parties as to the rights in related
inventions. To the extent that an individual who is not obligated to assign rights in intellectual property to us is rightfully an inventor of intellectual property, we may need to obtain an assignment or a license to that intellectual property from
that individual, or a third party or from that individual&#146;s assignee. Such assignment or license may not be available on commercially reasonable terms or at all. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Adequate remedies may not exist in the event of unauthorized use or disclosure of our proprietary information. The disclosure of our trade secrets would
impair our competitive position and may materially harm our business, financial condition and results of operations. Costly and time consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to
maintain trade secret protection could adversely affect our competitive business position. In addition, others may independently discover or develop our trade secrets and proprietary information, and the existence of our own trade secrets affords no
protection against such independent discovery. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We may also employ individuals who were previously or concurrently employed at research institutions
and/or other medical device companies, including our competitors or potential competitors. We may be subject to claims that these employees, or we, have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of
their former employers, or that patents and applications we have filed to protect inventions of these employees, even those related to one or more of our products, are rightfully owned by their former or concurrent employer. Litigation may be
necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Risks Related to Our Finances and Capital Requirements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>It is difficult
to forecast future performance, which may cause our financial results to fluctuate unpredictably. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">A number of factors over which we have
limited or no control may contribute to fluctuations in our financial results, such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">seasonal variations in revenue due to the unavailability of specialist physicians who use our products during certain times of the year, such as those periods when there are major conferences on conditions they treat or
those periods when high volume users of our products take time off of work; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">positive or negative media coverage of our products or the procedures or products of our competitors or our industry; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">publication of clinical trial results or studies by us or our competitors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in our sales process due to industry changes, such as changes in the stroke care pathway; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays in receipt of anticipated purchase orders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays in customers receiving products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">performance of our independent distributors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to obtain further regulatory clearances or approvals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the timing of product development and clinical trial activities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delays in, or failure of, product and component deliveries by our suppliers; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in reimbursement policies or levels; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">customer response to the introduction of new products or alternative treatments, and the degree to we which we are effective in transitioning customers to our products; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">fluctuations in foreign currency. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In the event our actual revenue and results of operations do not meet
our or others&#146; forecasts for a particular period, the market price of our common stock may decline substantially. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We may require additional financing in
the future and may not be able to obtain such financing on favorable terms, if at all, which could force us to delay, reduce or eliminate our research and development activities or otherwise harm our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">To date, we have financed our operations primarily through our operations, private placements of our equity securities and borrowings under a line of
credit with a financial institution. We are unable to predict the extent of any future operating cash flows or whether we will be able to maintain or grow our profitability. If we require additional financing to continue or expand our operations,
for research and development, for acquisitions or for other purposes, we may determine to engage in equity or debt financings or incur other indebtedness. We may not be able to timely secure additional debt or equity financing on favorable terms, or
at all. If we raise additional funds through the issuance of equity or convertible debt or other equity-linked securities, our existing stockholders could suffer significant dilution. Any debt financing obtained by us in the future could involve
restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential
acquisitions. If needed funds are not available in adequate amounts or on acceptable terms from additional financing sources, our business will be materially adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If we engage in any acquisitions, we will incur a variety of costs and may potentially face numerous risks that could adversely affect our business and
operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If appropriate opportunities become available, we may seek to acquire additional businesses, assets, technologies or products to
enhance our business. In connection with any acquisitions, we could issue additional equity securities or convertible debt or equity-linked securities, which would dilute our stockholders, cause us to incur substantial debt to fund the acquisitions,
or assume significant liabilities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Acquisitions involve numerous risks, including problems integrating the purchased operations, technologies or
products, unanticipated costs and other liabilities, diversion of management&#146;s attention from our core businesses, adverse effects on existing business relationships with current and/or prospective customers and/or suppliers, risks associated
with entering markets in which we have no or limited prior experience and potential loss of key employees. Acquisitions may also require us to record goodwill and non-amortizable intangible assets that will be subject to impairment testing on a
regular basis and potential periodic impairment charges, incur amortization expenses related to certain intangible assets, and incur write offs and restructuring and other related expenses, any of which could harm our results of operations and
financial condition. If we fail in our integration efforts with respect to any of our acquisitions and are unable to efficiently operate as a combined organization, our business and financial condition may be adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Risks Relating to Securities Markets and Investment in Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>A viable trading market for our common stock may not develop or be sustained. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Prior to this offering, there has been no public market for shares of our common stock. Although we intend to list our common stock on the
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, an active trading market for our shares may never develop or be sustained following this offering. We and the underwriters will determine the initial public offering price of
our common stock through negotiation. This price will not necessarily reflect the price at which investors in the market will be willing to buy and sell our shares following this offering. The initial public offering price may vary from the market
price of our common stock after the offering. In addition, the trading volume of companies </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
such as ours is often very low, and thus your ability to resell your shares may be severely constrained. As a result of these and other factors, you may be unable to resell your shares of our
common stock at or above the initial public offering price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The price of our common stock may be volatile, and you could lose all or part of your investment.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Stock markets have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. These
broad market fluctuations may adversely affect the trading price of our common stock. In addition, limited trading volume of our stock may contribute to its future volatility. Price declines in our common stock could result from general market and
economic conditions, some of which are beyond our control, and a variety of other factors, including any of the risk factors described in this prospectus. These broad market and industry factors may harm the market price of our common stock,
regardless of our operating performance, and could cause you to lose all or part of your investment in our common stock since you might be unable to sell your shares at or above the price you paid in this offering. Factors that could cause
fluctuations in the market price of our common stock include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">price and volume fluctuations in the overall stock market from time to time; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">volatility in the market prices and trading volumes of medical device company stocks; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in operating performance and stock market valuations of other medical device companies generally, or those in our industry in particular; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">sales of shares of our common stock by us or our stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">failure of securities analysts to maintain coverage of us, changes in financial estimates by securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the financial projections we may provide to the public, any changes in those projections or our failure to meet those projections; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">announcements by us or our competitors of new products or services; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the public&#146;s reaction to our press releases, other public announcements and filings with the SEC; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">rumors and market speculation involving us or other companies in our industry; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">actual or anticipated changes in our results of operations or fluctuations in our results of operations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">actual or anticipated developments in our business, our competitors&#146; businesses or the competitive landscape generally; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">litigation involving us, our industry or both, or investigations by regulators into our operations or those of our competitors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">developments or disputes concerning our intellectual property or other proprietary rights; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">announced or completed acquisitions of businesses or technologies by us or our competitors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">new laws or regulations or new interpretations of existing laws or regulations applicable to our business; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">changes in accounting standards, policies, guidelines, interpretations or principles; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any significant change in our management; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">general economic conditions and slow or negative growth of our markets. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, in the past,
following periods of volatility in the overall market and the market price of a particular company&#146;s securities, securities class action litigation has often been instituted against these companies. This litigation, if instituted against us,
could result in substantial costs and a diversion of our management&#146;s attention and resources. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Purchasers in this offering will experience immediate and substantial dilution in the book value of their investment.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The initial public offering price of our common stock is substantially higher than the net tangible book value per share of our outstanding
common stock immediately prior to this offering. Therefore, if you purchase our common stock in this offering, you will incur an immediate dilution of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in net tangible book value per share from the
price you paid, based on an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share (which is the midpoint of the estimated initial public offering price range set forth on the cover page of this
prospectus). In addition, purchasers who bought shares from us in this offering will have contributed &nbsp;&nbsp;&nbsp;&nbsp;% of the total consideration paid to us by our stockholders to purchase shares of our common stock, in exchange for
acquiring approximately &nbsp;&nbsp;&nbsp;&nbsp;% of the outstanding shares of our capital stock as of March&nbsp;31, 2015 after giving effect to this offering. The exercise of outstanding options will result in further dilution. For a further
description of the dilution that you will experience immediately after this offering, see the section titled &#147;Dilution.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If our executive officers,
directors and largest stockholders choose to act together, they may be able to significantly influence our management and operations, acting in their own best interests and not necessarily those of other stockholders. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of March&nbsp;31, 2015, our executive officers, directors and holders of 5% or more of our outstanding stock and their affiliates beneficially owned
approximately 35% of our voting stock in the aggregate, and we expect that immediately following the completion of this offering the same group will continue to hold at least &nbsp;&nbsp;&nbsp;&nbsp;% of our outstanding voting stock, based on the
number of shares outstanding as of March&nbsp;31, 2015. As a result, these stockholders, acting together, would be able to significantly influence all matters requiring approval by our stockholders, including the election of directors and the
approval of mergers or other business combination transactions. The interests of this group of stockholders may not always coincide with the interests of other stockholders, and they may act in a manner that advances their best interests and not
necessarily those of other stockholders. This concentration of ownership may have the effect of delaying, preventing or deterring a change in control of our company, could deprive our stockholders of an opportunity to receive a premium for their
common stock as part of a sale of our company and might ultimately affect the market price of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>A significant portion of our outstanding
shares of common stock is restricted from immediate resale but may be sold into the market in the near future. This could cause the market price of our common stock to drop significantly, even if our business is doing well. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Sales of a substantial number of shares of our common stock in the public market could occur at any time, subject to the 180-day lock-up periods under
the lock-up agreements described in the section of this prospectus titled &#147;Underwriting.&#148; These sales, or the perception in the market that the holders of a large number of shares of common stock intend to sell shares, could reduce the
market price of our common stock. As of March&nbsp;31, 2015, our directors, executive officers and holders of 5% or more of our outstanding stock beneficially owned approximately 35% of our outstanding stock in the aggregate. If one or more of them
were to sell a substantial portion of the shares they hold, it could cause our stock price to decline. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, as of March&nbsp;31, 2015, there
were 3,265,591 shares subject to outstanding options that will become eligible for sale in the public market upon exercise of such options to the extent permitted by any applicable vesting requirements, the lock-up agreements and Rules 144 and 701
under the Securities Act of 1933, as amended (Securities Act). Moreover, after this offering, holders of an aggregate of 21,641,495 shares of our common stock will have rights, subject to some conditions, to require us to file registration
statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We also
intend to register all &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock that we may issue under our Amended and Restated 2014 Equity Incentive Plan. Once we register these shares, they can be freely sold
in the public market upon issuance and once vested and exercised, as applicable, subject to the 180-day lock-up periods under the lock-up agreements described in the section of this prospectus titled &#147;Underwriting.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Sales of our common stock as restrictions end or pursuant to registration rights may make it more difficult
for us to sell equity securities in the future at a time and at a price that we deem appropriate. These sales also could cause the price of our common stock to fall and make it more difficult for you to sell shares of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our amended and restated certificate of incorporation, our amended and restated bylaws and Delaware law contain provisions that could discourage another company
from acquiring us and may prevent attempts by our stockholders to replace or remove our current management. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Provisions of Delaware law
(where we are incorporated), our amended and restated certificate of incorporation and amended and restated bylaws may discourage, delay or prevent a merger or acquisition that stockholders may consider favorable, including transactions in which you
might otherwise receive a premium for your shares. In addition, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace or remove
our board of directors. These provisions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">authorizing the issuance of &#147;blank check&#148; preferred stock without any need for action by stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">requiring supermajority stockholder voting to effect certain amendments to our amended and restated certificate of incorporation and amended and restated bylaws; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">eliminating the ability of stockholders to call and bring business before special meetings of stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">prohibiting stockholder action by written consent; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted on by stockholders at stockholder meetings; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">dividing our board of directors into three classes so that only one third of our directors will be up for election in any given year; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">providing that our directors may be removed by our stockholders only for cause. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, we are
subject to Section&nbsp;203 of the Delaware General Corporation Law, which may have an anti-takeover effect with respect to transactions not approved in advance by our board of directors, including discouraging takeover attempts that could have
resulted in a premium over the market price for shares of our common stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">These provisions apply even if a takeover offer may be considered
beneficial by some stockholders and could delay or prevent an acquisition that our board of directors determines is not in our and our stockholders&#146; best interests and could also affect the price that some investors are willing to pay for our
common stock. See the section titled &#147;Description of Capital Stock.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Our amended and restated certificate of incorporation will provide that the
Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our
directors, officers or employees. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of
Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf; any action asserting a breach of fiduciary duty; any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our
amended and restated certificate of incorporation or our amended and restated bylaws; or any action asserting a claim against us that is governed by the internal affairs doctrine. The choice of forum provision may limit a stockholder&#146;s ability
to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. If a court were to find
the choice of forum provision contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business and financial condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>As a public company, our expenses and administrative burden will increase. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, our
administrative staff will be required to perform additional tasks. For example, in anticipation of becoming a public company, we will need to adopt additional internal controls and disclosure controls and procedures and bear all of the internal and
external costs of preparing and distributing periodic public reports in compliance with our obligations under applicable securities laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In
addition, laws, regulations and standards relating to corporate governance and public disclosure, including the Sarbanes-Oxley Act of 2002 and related regulations implemented by the SEC and the
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, have increased legal and financial compliance costs and made some regulatory and compliance activities more time consuming. We are currently evaluating and monitoring
developments with respect to new and proposed rules and cannot predict or estimate the amount of additional costs we may incur or the timing of such costs. These laws, regulations and standards are subject to varying interpretations, in many cases
due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and
higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative
expenses and a diversion of management&#146;s time and attention from revenue-generating activities to compliance activities. We also expect that being a public company, and being subject to these new rules and regulations, will make it more
expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and
retain qualified members of our board of directors, particularly to serve on our audit committee and compensation committee, and attract and retain qualified executive officers. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The increased costs associated with operating as a public company may decrease our net income or increase any future net loss and may cause us to reduce
costs in other areas of our business or increase the prices of our products to offset the effect of such increased costs. Additionally, if these requirements divert our management&#146;s attention from other business concerns, they could have a
material adverse effect on our business, results of operation, financial condition or cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We are an &#147;emerging growth company,&#148; and we
cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our common stock less attractive to investors. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are an &#147;emerging growth company,&#148; as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take
advantage of exemptions from various reporting requirements that are applicable to other public companies but not to &#147;emerging growth companies,&#148; including, but not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced &#147;Management&#146;s Discussion and Analysis
of Financial Condition and Results of Operations&#148; disclosure; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting under Section&nbsp;404 of the Sarbanes-Oxley Act; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#146;s report providing
additional information about the audit and the financial statements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We will remain an emerging growth company until the earlier of (1)&nbsp;the last day of the fiscal year
(a)&nbsp;following the fifth anniversary of the completion of this offering, (b)&nbsp;in which we have total annual gross revenue of at least $1 billion, or (c)&nbsp;in which we are deemed to be a large accelerated filer, which means the market
value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June&nbsp;30th, and (2)&nbsp;the date on which we have issued more than $1 billion in non-convertible debt during the prior three-year period. We cannot
predict if investors will find our common stock less attractive if we choose to rely on these exemptions. If some investors find our common stock less attractive as a result of any choices to reduce future disclosure, there may be a less active
trading market for our common stock and the price of our common stock may be more volatile. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Under the JOBS Act, emerging growth companies can also
delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, will be
subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If we fail to maintain an effective
system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the Exchange Act), the
Sarbanes-Oxley Act, and the listing standards of the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. We expect that the requirements of these rules and regulations will continue to increase our legal, accounting and financial compliance costs,
make some activities more difficult, time consuming and costly, and place significant strain on our personnel, systems and resources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The
Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that
are designed to ensure that information required to be disclosed by us in the reports that we will file with the SEC is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that information
required to be disclosed in reports under the Exchange Act is accumulated and communicated to our principal executive and financial officers. We are also continuing to improve our internal control over financial reporting. In order to maintain and
improve the effectiveness of our disclosure controls and procedures and internal control over financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and
significant management oversight. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our current controls and any new controls that we develop may become inadequate because of changes in our
business. Further, weaknesses in our disclosure controls or our internal control over financial reporting may be discovered in the future. Any failure to develop or maintain effective controls, or any difficulties encountered in their implementation
or improvement, could harm our operating results or cause us to fail to meet our reporting obligations and may result in errors in our financial statements or a restatement of our financial statements for prior periods. Any failure to implement and
maintain effective internal control over financial reporting also could adversely affect the results of management evaluations and independent registered public accounting firm audits of our internal control over financial reporting that we will
eventually be required to include in our periodic reports that will be filed with the SEC. Ineffective disclosure controls and procedures and internal control over financial reporting could also cause investors to lose confidence in our reported
financial and other information, which would likely have a negative effect on the trading price of our common stock. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on the
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are not currently required to comply with the SEC rules that implement Section 404 of the
Sarbanes-Oxley Act, and are therefore not required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. As a public company, we will be required to provide an annual
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
management report on the effectiveness of our internal control over financial reporting commencing with our second annual report on Form 10-K. Our independent registered public accounting firm is
not required to audit the effectiveness of our internal control over financial reporting until after we are no longer an &#147;emerging growth company,&#148; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. At such
time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal control over financial reporting is documented, designed or operating. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Any failure to maintain effective disclosure controls and internal control over financial reporting could have a material and adverse effect on our
business and results of operations, and cause a decline in the price of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We will have broad discretion in the use of the net proceeds from
this offering and may not use them effectively. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We will have broad discretion in the use of the net proceeds from this offering and could
spend the proceeds in ways that do not improve our results of operations or enhance the value of our common stock. Our failure to apply these funds effectively could have a material adverse effect on our business, delay the development and
commercialization of our products and cause the price of our common stock to decline. Until the net proceeds are used, they may be placed in investments that do not produce significant income or that may lose value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>If securities or industry analysts do not publish or cease publishing research or publish inaccurate or unfavorable research about our business, our stock price
and trading volume could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The trading market for our common stock will depend in part on the research and reports that securities or
industry analysts publish about us or our business. We may never obtain research coverage by securities and industry analysts. If no securities or industry analysts commence coverage of our company, the trading price for our stock would be
negatively impacted. In the event we obtain securities or industry analyst coverage, if one or more of the analysts who cover us downgrade our stock or publish inaccurate or unfavorable research about our business, our stock price would likely
decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>We do not anticipate paying cash dividends, and accordingly, stockholders must rely on stock appreciation for any return on their investment. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We do not anticipate paying cash dividends in the future. As a result, only appreciation of the price of our common stock, which may never occur, would
provide a return to stockholders. Investors seeking cash dividends should not invest in our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_3"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have made statements under the sections titled &#147;Prospectus Summary,&#148; &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion and
Analysis of Financial Condition and Results of Operations,&#148; &#147;Business&#148; and in other sections of this prospectus that are forward-looking statements. In some cases, you can identify these statements by forward-looking words such as
&#147;may,&#148; &#147;might,&#148; &#147;will,&#148; &#147;should,&#148; &#147;expects,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;predicts,&#148; &#147;potential&#148; or
&#147;continue,&#148; the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance,
our anticipated growth strategies and anticipated trends in our business. Forward-looking statements contained in this prospectus include, but are not limited to statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to design, develop, manufacture and market innovative products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our expected future growth, including growth in international sales; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the size and growth potential of the markets for our products, and our ability to address those markets; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the market acceptance of our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the performance of our salesforce and distributors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">regulatory developments in the United States and other markets in which we sell our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to obtain and maintain regulatory approval or clearance of our products on expected timelines; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to scale our organizational culture; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">competition; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our use of the proceeds from this offering; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our results of operations and capital requirements; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our ability to obtain and maintain intellectual property protection for our products, as well as our ability to operate our business without infringing the intellectual property rights of others. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">These statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause
our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors discussed in the
section titled &#147;Risk Factors.&#148; You should specifically consider the numerous risks outlined in the section titled &#147;Risk Factors.&#148; Although we believe the expectations reflected in the forward-looking statements are reasonable, we
cannot guarantee future results, level of activity, performance or achievements. We undertake no obligation to update any forward-looking statements made in this prospectus to reflect events or circumstances after the date of this prospectus or to
reflect new information or the occurrence of unanticipated events, except as required by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_4"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We estimate that the net proceeds to us from this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, or
approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million if the underwriters exercise their option to purchase additional shares from us in full, assuming an initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and
estimated offering expenses payable by us. Each $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the estimated initial public offering
price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, our net proceeds from this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming that the number of shares offered by
us, as set forth on the cover page of this prospectus, remains the same, after deducting underwriting discounts and commissions payable by us. An increase or decrease of 1.0&nbsp;million shares in the number of shares offered by us would increase or
decrease, as applicable, our net proceeds from this offering by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming an initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the
midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions payable by us. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We intend to use the net proceeds from this offering for product development, including research and development and clinical trials, expansion of our
salesforce and for working capital and general corporate purposes. From time to time, we may consider the acquisition of complementary technologies or businesses, though we have no agreements or understandings with respect to any such acquisitions
at this time. Pending the use of the net proceeds from this offering, we intend to invest the net proceeds in investment grade, interest bearing securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_5"></A>DIVIDEND POLICY </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We
have never declared or paid cash dividends on our capital stock. We currently intend to retain all available funds for use in the operation and expansion of our business, and do not anticipate paying any cash dividends in the foreseeable future. Any
future determination related to dividend policy will be made at the discretion of our board of directors, subject to applicable laws, and will depend on a number of factors, including our financial condition, results of operations, capital
requirements, contractual restrictions, general business conditions and other factors that our board of directors may deem relevant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_6"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table sets forth our cash and cash equivalents and capitalization as of March&nbsp;31, 2015: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on an actual basis; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on a pro forma basis, giving effect to (i)&nbsp;the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 19,510,410 shares of our common stock, which conversion will occur
immediately prior to the completion of this offering, as if such conversion had occurred on March&nbsp;31, 2015, and (ii)&nbsp;the filing and effectiveness of our amended and restated certificate of incorporation; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">on a pro forma as adjusted basis, giving effect to the pro forma adjustments set forth above, and the sale and issuance by us of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common
stock in this offering, at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the estimated initial public offering price range set forth on the cover page of this
prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">This table
should be read in conjunction with the section titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and the consolidated financial statements and notes thereto appearing elsewhere in this
prospectus. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March&nbsp;31, 2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Pro Forma</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Pro&nbsp;Forma&nbsp;As<BR>Adjusted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except share<BR>and per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents and marketable investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term debt</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Preferred stock, $0.001 par value per share, 25,000,000 shares authorized, 19,510,410 shares issued and outstanding, actual; no shares
authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Stockholders&#146; equity (deficit):</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Preferred stock, $0.001 par value per share, no shares authorized, issued or outstanding, actual;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares authorized, no shares issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Common stock, $0.001 par value per share, 40,000,000 shares authorized, 4,921,104 shares issued and outstanding, actual;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; authorized, 24,431,514 shares issued and outstanding, pro forma; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; authorized,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares issued and outstanding, pro forma as adjusted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Additional paid-in capital</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Notes receivable from stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accumulated deficit</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,338</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,338</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,991</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101,476</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total capitalization</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">101,476</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">101,476</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE="font-family:arial; font-size:9pt">Each $1.00 increase or decrease in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the
midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the amount of our pro forma as adjusted cash and cash equivalents, additional paid-in capital,
total stockholders&#146; equity and total capitalization by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains
the same, after deducting underwriting </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
discounts and commissions payable by us. An increase or decrease of 1.0&nbsp;million shares in the number of shares offered by us would increase or decrease, as applicable, the amount of our pro
forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders&#146; equity and total capitalization by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, assuming an initial public offering
price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions
payable by us. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The actual column in the table above is based on 4,921,104 shares of our common stock issued and outstanding and
excludes 23,176 shares of common stock issued upon early exercise of stock options and subject to repurchase and 316,501 shares of unvested restricted stock. See Notes 10 and 12 to our Consolidated Financial Statements. The pro forma and pro forma
as adjusted columns in the table above are based on 24,431,514&nbsp;shares of our common stock (including preferred stock on an as-converted basis) outstanding as of March&nbsp;31, 2015, and exclude the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">3,265,591 shares of common stock issuable upon the exercise of options to purchase shares of our common stock outstanding as of March&nbsp;31, 2015, at a weighted average exercise price of $3.96 per share;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,199,713 shares of common stock reserved for future grant or issuance under our 2014 Equity Incentive Plan as of March&nbsp;31, 2015; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">23,176 shares of common stock issued upon early exercise of stock options and subject to repurchase; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">316,501 shares of unvested restricted stock; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock reserved for future issuance under our Amended and Restated 2014 Equity Incentive Plan, which will become effective
immediately prior to the completion of this offering, as well as any automatic increases in the number of shares of our common stock reserved for future issuance pursuant to this plan. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_7"></A>DILUTION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If you invest in our common stock in this offering, your ownership interest will be diluted to the extent of the difference between the initial public
offering price per share of our common stock and the pro forma as adjusted net tangible book value per share of our common stock immediately after this offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our pro forma net tangible book value as of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015 was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of
common stock. Pro forma net tangible book value per share represents tangible assets, less liabilities, divided by the aggregate number of shares of common stock outstanding, after giving effect to the automatic conversion of all outstanding shares
of our preferred stock into an aggregate of 19,510,410 shares of our common stock, which conversion will occur immediately prior to the completion of this offering. After giving effect to the sale by us of the
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock in this offering, at an assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of
the estimated initial public offering price range set forth on the cover page of this prospectus, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book
value as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015, would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. This represents an immediate increase in pro forma net tangible book value to existing stockholders of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share and an immediate dilution
to new investors of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. The following table illustrates this per share dilution: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Assumed initial public offering price</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma net tangible book value per share as of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Increase in pro forma net tangible book value per share attributable to new investors</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma as adjusted net tangible book value per share after offering</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Dilution per share to new investors</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Each $1.00 increase or decrease in the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, our pro forma as
adjusted net tangible book value per share to new investors by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and would increase or decrease, as applicable, dilution per share to new investors in this offering by
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and
commissions and estimated offering expenses payable by us. Similarly, each increase or decrease of 1.0&nbsp;million shares in the number of shares offered by us would increase or decrease, as applicable, our pro forma as adjusted net tangible book
value by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share and increase or decrease, as applicable, the dilution to new investors by $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, assuming the assumed initial
public offering price remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If
the underwriters&#146; option to purchase additional shares is exercised in full, the pro forma as adjusted net tangible book value per share of our common stock, as adjusted to give effect to this offering, would be
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, and the dilution in pro forma net tangible book value per share to new investors in this offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table sets forth, on a pro forma as adjusted basis, as of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015, the number of shares of common stock purchased from us, the total consideration paid, or to be paid, and the average
price per share paid, or to be paid, by existing stockholders and by the new investors, at an assumed initial public offering price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated initial public
offering range set forth on the cover page of this prospectus, before deducting underwriting discounts and commissions and estimated offering expenses payable by us: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total&nbsp;Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Average&nbsp;Price<BR>Per Share</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:26.85pt; font-size:8pt; font-family:arial"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Existing stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">New investors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Each $1.00 increase or decrease in the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the total
consideration paid by new investors and total consideration paid by all stockholders by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million, assuming that the number of shares offered by us, as set forth on the cover page of this
prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The number of
shares of common stock to be outstanding after this offering is based upon 24,771,191&nbsp;shares outstanding (including preferred stock on an as-converted basis) as of March&nbsp;31, 2015, and excludes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">3,265,591 shares of common stock issuable upon the exercise of options to purchase shares of our common stock outstanding as of March&nbsp;31, 2015, at a weighted average exercise price of $3.96 per share;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">2,199,713 shares of common stock reserved for future grant or issuance under our 2014 Equity Incentive Plan as of March&nbsp;31, 2015; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock reserved for future issuance under our Amended and Restated 2014 Equity Incentive Plan, which will become effective
immediately prior to the completion of this offering, as well as any automatic increases in the number of shares of our common stock reserved for future issuance pursuant to this plan. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">To the extent options are exercised, there will be further dilution to new investors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_8"></A>SELECTED CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following selected consolidated financial data of Penumbra, Inc. should be read in conjunction with, and are qualified by reference to, the section
titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and the consolidated financial statements and notes thereto included elsewhere in this prospectus. The consolidated statement of operations
data for the years ended December&nbsp;31, 2013 and 2014, and the consolidated balance sheet data as of December&nbsp;31, 2013 and 2014, are derived from, and qualified by reference to, our audited consolidated financial statements included
elsewhere in this prospectus and should be read in conjunction with those consolidated financial statements and notes thereto. The consolidated statement of operations data for the year ended December&nbsp;31, 2012, and the consolidated balance
sheet data as of December&nbsp;31, 2012, are derived from our audited consolidated financial statements not included in this prospectus. The consolidated statement of income data for the three month periods ended March&nbsp;31, 2014 and 2015, and
the consolidated balance sheet data as of March&nbsp;31, 2015, are derived from our unaudited consolidated financial statements included elsewhere in this prospectus which, in our opinion, have been prepared on the same basis as the audited
consolidated financial statements and reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of our results of operations and financial position. Our historical results are not necessarily
indicative of the results that may be expected in the future and the results for the three months ended March&nbsp;31, 2015 are not necessarily indicative of results to be expected for the full year or any other period. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8.5pt" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2012</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>(in thousands, except share and per share amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial"><B>Consolidated Statement of Operations Data:</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Revenue</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">73,141</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">88,848</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">125,510</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">26,163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">38,952</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Cost of revenue</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">24,178</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">30,972</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">42,668</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">8,709</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">12,224</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Gross profit</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">48,963</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">57,876</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">82,842</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">17,454</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">26,728</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Operating expenses:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">12,548</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">14,084</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">15,575</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">3,461</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">3,191</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Selling, general and administrative</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">32,987</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">44,918</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">64,258</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">12,152</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">19,547</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Total operating expenses</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">45,535</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">59,002</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">79,833</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">15,613</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">22,738</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Income (loss) from operations</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">3,428</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(1,126</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">3,009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">1,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">3,990</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Interest income (expense), net</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">244</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">345</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">439</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">208</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Other income (expense), net</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">220</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(309</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(37</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Income (loss) before provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">3,892</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(1,255</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">3,139</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">1,797</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">4,242</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">1,934</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(5,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">894</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">531</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">1,740</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Net income</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">1,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">4,099</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">2,245</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">1,266</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">2,502</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Net income (loss) attributable to common stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">412</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">887</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(833</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">280</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">503</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Net income (loss) per share attributable to common stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(0.18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">(0.18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.04</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8.5pt">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-size:8.5pt">0.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-size:8.5pt">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Weighted average shares used to compute net income (loss) per share attributable to common stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,153,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,304,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,609,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,430,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,903,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,886,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,500,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,609,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,705,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,193,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Pro forma net income per share&#151;Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Pro forma net income per share&#151;Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">Weighted average shares used to compute the pro forma net income per share</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">&#151;Basic (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8.5pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:8.5pt; font-family:arial">&#151;Diluted (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As&nbsp;of&nbsp;March&nbsp;31,<BR>2015</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Marketable investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">121,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">127,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term debt</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Working capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">46,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">56,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8,062</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(12,370</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,991</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_9"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>The following discussion and analysis contains forward-looking statements that involve risks and uncertainties. Our actual results may differ
materially from those discussed in the forward-looking statements as a result of various factors, including those set forth in the sections titled &#147;Risk Factors&#148; and &#147;Special Note Regarding Forward-Looking Statements.&#148; The
following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements included elsewhere in this prospectus, as well as the information presented under the section titled
&#147;Selected Consolidated Financial Data.&#148; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Penumbra is a global interventional therapies company that designs, develops, manufactures and markets innovative medical devices. We have a broad
portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic
stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are one of the largest
independent companies focused on the neuro market, and we recently expanded our business to include the peripheral vascular market. We focus on developing, manufacturing and marketing products for use by specialist physicians, including
interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. We design our products to provide these specialist physicians with a means to drive improved clinical outcomes through
faster and safer procedures and generally at a significantly lower overall cost to the healthcare system relative to procedures using other products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Since our founding in 2004, we have invested heavily in our product development capabilities in our two key markets: neuro and peripheral vascular. We
launched our first neurovascular product in 2007, our first peripheral vascular product in 2013 and our first neurosurgical product in 2014. To date, we have launched 14 product brands, and we expect to continue to develop and build our portfolio of
products based on our thrombectomy, embolization and access technologies. Our research and development activities are centered around the development of new products and clinical activities designed to support our regulatory submissions and
demonstrate the effectiveness of our products. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We manufacture substantially all of our products at our campus in Alameda, California and stock
inventory of raw materials, components and finished goods at that location. We rely on a single or limited number of suppliers for certain raw materials and components, and we generally have no long-term supply arrangements with our suppliers, as we
order on a purchase order basis. We ship all of our products from Alameda to our hospital customers and distributors worldwide pursuant to purchase orders. We typically recognize revenue when products are delivered to our hospital customers or
distributors, other than our coils, which we ship to our hospital customers on a consignment basis, and for which we recognize revenue when the hospital customers utilize products in a procedure. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Hospitals purchase our products for use in procedures performed by their specialist physicians, generally seeking reimbursement from third party payors
for procedures performed. We believe that the cost-effectiveness of our products is attractive to our hospital customers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In 2014, 34% of our
revenue was generated from customers located outside of the United States. Our sales outside of the United States are denominated principally in the euro and Japanese yen. As a result, we have foreign exchange exposure, but do not currently engage
in hedging. In 2014, no single hospital and only one distributor accounted for more than 10% of our sales. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of March&nbsp;31, 2015, we had
approximately 850 employees worldwide. We sell our products to hospitals primarily through our direct sales organization in the United States, most of Europe, Canada and Australia, as well as through distributors in select international markets. In
2014, we generated revenue of $125.5 million, which represents a 41.3% increase over 2013, and $3.0 million in operating income as compared to an operating loss of $1.1 million in 2013. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">47 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Factors Affecting Our Performance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">There are a number of factors that have impacted, and we believe will continue to impact, our results of operations and growth. These factors include:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The rate at which we grow our salesforce and the speed at which newly hired salespeople become fully effective can impact our revenue growth or our costs incurred in anticipation of such growth. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Our industry is intensely competitive and, in particular, we compete with a number of large, well-capitalized companies. We must continue to successfully compete in light of our competitors&#146; existing and future
products and their resources to successfully market to the specialist physicians who use our products. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We must continue to successfully introduce new products that gain acceptance with specialist physicians and successfully transition from existing products to new products, ensuring adequate supply while avoiding excess
inventory of older products and resulting inventory write-downs or write-offs. In addition, as we introduce new products, we generally build our inventory of components and finished goods in advance of sales, which may cause quarterly fluctuations
in our results of operations. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Publications of clinical results by us, our competitors and other third parties can have a significant influence on whether, and the degree to which, our products are used by specialist physicians and the procedures and
treatments those physicians choose to administer for a given condition. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, we have experienced and expect to continue to
experience meaningful variability in our quarterly revenue and gross profit as a result of a number of factors, including, but not limited to: the number of available selling days, which can be impacted by holidays; the mix of products sold; the
geographic mix of where products are sold; the demand for our products and the products of our competitors; the timing of or failure to obtain regulatory approvals or clearances for products; increased competition; the timing of customer orders;
inventory write-offs and write-downs; costs, benefits and timing of new product introductions; the availability and cost of components and raw materials; and fluctuations in foreign currency exchange rates. We experience quarters in which we have
significant revenue growth sequentially followed by quarters of little or no revenue growth. Additionally, we experience quarters in which operating expenses, in particular research and development expenses, fluctuate depending on the stage and
timing of product development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Components of Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Revenue.</I></B> We sell our products directly to hospitals and through distributors for use in procedures performed by specialist physicians to treat patients in
two key markets: neuro and peripheral vascular disease. We sell our products through purchase orders, and we do not have long term purchase commitments from our customers. We typically recognize revenue when products are delivered to our hospital
customers or distributors. However, with respect to products that we consign to hospitals, which primarily consist of coils, we recognize revenue at the time hospitals utilize products in a procedure. Revenue also includes shipping and handling
costs that we charge to customers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Cost of Revenue.</I></B> Cost of revenue consists primarily of the cost of raw materials and components, personnel costs,
including stock-based compensation, inbound freight charges, receiving costs, inspection and testing costs, warehousing costs, royalty expense, shipping and handling costs and other labor and overhead costs incurred in the manufacturing of products.
We manufacture substantially all of our products in our manufacturing facility at our campus in Alameda, California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Operating Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Research and Development.</I> Research and development expenses include product development, clinical and regulatory expenses, materials, depreciation and other costs
associated with the development of our products. Research and development expenses also include salaries, benefits and other related costs, including stock-based compensation, for personnel and consultants. We expense research and development costs
as they are incurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">48 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We expect to incur additional research and development costs as we continue to innovate and develop new
products and engage in ongoing clinical research. These costs will generally increase in absolute terms as we continue to expand our product pipeline and add personnel. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Sales, General and Administrative.</I> Sales, general and administrative expenses primarily consist of salaries, benefits and other related costs, including
stock-based compensation, for personnel and consultants engaged in sales, marketing, finance, legal, compliance, administrative, information technology, medical education and training and human resource activities. Our sales, general and
administrative expenses also include commissions, generally based on a percentage of sales, to direct sales representatives and the medical device excise tax, which is approximately 2.3% of U.S. sales. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We expect our sales, general and administrative expenses to continue to increase in absolute terms as we expand our salesforce and operations.
Additionally, we expect to incur increased expenses related to headcount, professional service fees, systems and other infrastructure related to operating as a public company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Income Tax Expense.</I></B> We are taxed at the rates applicable within each jurisdiction where we sell products. The composite income tax rate, tax provisions,
deferred tax assets and deferred tax liabilities will vary according to the jurisdiction in which profits arise. Tax laws are complex and subject to different interpretations by management and the respective governmental taxing authorities, and
require us to exercise judgment in determining our income tax provision, our deferred tax assets and liabilities and the potential valuation allowance recorded against our net deferred tax assets. Deferred tax assets and liabilities are determined
using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not that the future realization of all or some of the deferred tax assets
will not be achieved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Results of Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The
following table sets forth the components of our consolidated statements of operations in dollars and as a percentage of revenue for the periods presented: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three Months Ended March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="30" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">88,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">38,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Gross profit</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating expenses:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sales, general and administrative</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,918</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total operating expenses</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,613</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income (loss) from operations</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,126</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.3</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest income (expense), net</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense), net</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(474</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.5</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(309</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.2</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(37</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.1</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income (loss) before provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,255</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.4</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6.0</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net income</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">49 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Three Months Ended March&nbsp;31, 2015 Compared to Three Months Ended March&nbsp;31, 2014 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Revenue </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Neuro</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Peripheral Vascular</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">38,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue increased $12.8 million, or 48.9%, to $39.0 million in the three months ended March&nbsp;31, 2015, from $26.2
million in the three months ended March&nbsp;31, 2014. Our revenue growth was due to positive market developments for our products, expansion of our salesforce headcount by 56.1%, further market penetration of our existing products and sales of new
products. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue from sales in the United States increased $9.5 million, or 56.0%, to $26.4 million in the three months ended March&nbsp;31, 2015,
from $16.9 million in the three months ended March&nbsp;31, 2014. Revenue from sales in international markets increased $3.3 million, or 35.9%, to $12.6 million in the three months ended March&nbsp;31, 2015, from $9.3 million in the three months
ended March&nbsp;31, 2014. Revenue from international sales represented 32% and 35% of our total revenue for the three months ended March&nbsp;31, 2015 and 2014, respectively. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue from our neuro products increased $8.6 million, or 37.2%, to $31.7 million in the three months ended March&nbsp;31, 2015, from $23.1 million in
the three months ended March&nbsp;31, 2014. Our neuro product sales saw strong momentum due to further market penetration and growth in the market following several recently published trial results, which support endovascular treatment of stroke.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue from our peripheral vascular products increased $4.2 million, or 135.9%, to $7.3 million in the three months ended March&nbsp;31, 2015, from
$3.1 million in the three months ended March&nbsp;31, 2014. Our peripheral embolization and peripheral thrombectomy products both saw strong growth in the quarter, primarily due to the focused efforts of our dedicated peripheral vascular salesforce,
which was established in the second half of 2014, further market penetration and sales from our recently launched Indigo product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Gross Profit and Gross
Margin </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>Gross margin %</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>66.7</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>68.6</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Gross profit increased $9.3 million, or 53.1%, to $26.7 million in the three months ended March&nbsp;31, 2015, from $17.5
million in the three months ended March&nbsp;31, 2014. The increase in gross profit was primarily due to an increase in revenue from sales of our neuro and peripheral vascular products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Gross margin increased 1.9 percentage points, to 68.6%, in the three months ended March&nbsp;31, 2015, from 66.7% in the three months ended
March&nbsp;31, 2014. The increase in gross margin was primarily due to geographic and product mix and improved manufacturing efficiency. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Research and
Development (R&amp;D) Expenses </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">R&amp;D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(270</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7.8</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>R&amp;D as a percentage of revenue</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>13.2</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>8.2</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">50 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">R&amp;D expenses decreased $0.3 million, or 7.8%, to $3.2 million in the three months ended March&nbsp;31,
2015, from $3.5 million in the three months ended March&nbsp;31, 2014. The $0.3 million decrease in R&amp;D expenses was primarily due to $0.6 million in reduced spending as a result of the stage and timing of product development activities,
partially offset by a $0.3 million increase in compensation expense resulting from increased headcount to support continued research and development activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Sales, General and Administrative (SG&amp;A) Expenses </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">SG&amp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,395</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>SG&amp;A as a percentage of revenue</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>46.4</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>50.2</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">SG&amp;A expenses increased by $7.4 million, or 60.9%, to $19.5 million in the three months ended March&nbsp;31, 2015,
from $12.2 million in the three months ended March&nbsp;31, 2014. The $7.4 million increase in SG&amp;A expenses was primarily due to a $4.7 million increase in compensation expense resulting from increased sales and administrative headcount, a $0.9
million increase due to expanded marketing programs, a $0.6 million increase in travel-related expenses for our salesforce to support our sales activities and a $0.6 million increase in legal, professional and consulting expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Provision for Income Taxes </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="67%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">nm</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>Effective tax rate</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>29.5</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>41.0</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our provision for income taxes increased $1.2 million, to $1.7 million in the three months ended March&nbsp;31, 2015,
from $0.5 million in the three months ended March&nbsp;31, 2014. Our effective tax rate increased to 41.0% for the three months ended March&nbsp;31, 2015, compared to 29.5% for the three months ended March&nbsp;31, 2014. The effective tax rate is
based on a projection of our full year results. The higher effective tax rate for the three months ended March&nbsp;31, 2015 was due to the decrease of the effect of permanent items relative to higher pretax income in the quarter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Year Ended December&nbsp;31, 2014 Compared to Year Ended December&nbsp;31, 2013 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Revenue </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Neuro</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">81,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">106,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Peripheral Vascular</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">88,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">36,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue increased $36.7 million, or 41.3%, to $125.5 million in 2014, from $88.8 million in 2013. Our revenue growth was
primarily due to expansion of our salesforce headcount by 55.8%, further market penetration of our existing products and sales of new products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue from sales in the United States increased $24.7 million, or 42.3%, to $83.0 million in 2014, from $58.3 million in 2013. Revenue from sales in
international markets increased $12.0 million, or 39.3%, to $42.5&nbsp;million in 2014, from $30.5 million in 2013. Revenue from international sales represented 34% and 34% of our total revenue for 2014 and 2013, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">51 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue from our neuro products increased $24.9 million, or 30.6%, to $106.2&nbsp;million in 2014, from
$81.3&nbsp;million in 2013. Our neuro product sales saw strong momentum due to further market penetration and growth in the market following several recently published trial results, which support endovascular treatment of stroke. Additionally, our
neuro product sales benefited from the launch of our ACE Reperfusion Catheter in July 2013. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue from our peripheral vascular products increased
$11.8 million, or 156.7%, to $19.3&nbsp;million in 2014, from $7.5&nbsp;million in 2013. Peripheral vascular product revenue benefited from the focused efforts of our dedicated peripheral vascular salesforce, which was established in the second half
of 2014, further market penetration and sales from our recently launched Indigo product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Gross Profit and Gross Margin </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">82,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>Gross margin %</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>65.1</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>66.0</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Gross profit increased $25.0 million, or 43.1%, to $82.8 million in 2014, from $57.9 million in 2013. The increase in
gross profit was primarily driven by an increase in revenue from sales of our neuro and peripheral vascular products. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Gross margin increased 0.9
percentage points, to 66.0% in 2014, from 65.1% in 2013. The increase in gross margin is attributable to geographic and product mix and improved manufacturing efficiency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Research and Development (R&amp;D) Expenses </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">R&amp;D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>R&amp;D as a percentage of revenue</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>15.9</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>12.4</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">R&amp;D expenses increased $1.5 million, or 10.6%, to $15.6 million in 2014, from $14.1 million in 2013. The $1.5 million
increase was primarily due to a $1.2 million increase in compensation expense resulting from increased headcount to support continued research and development in our products and a $0.3 million increase in consulting costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Sales, General and Administrative (SG&amp;A) Expenses </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">SG&amp;A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">44,918</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">64,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>SG&amp;A as a percentage of revenue</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>50.6</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>51.2</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">SG&amp;A expenses increased by $19.3 million, or 43.1%, to $64.3 million in 2014, from $44.9 million in 2013. The $19.3
million increase was primarily due to a $10.9 million increase in compensation expense resulting from increased headcount, a $2.1 million increase in legal, professional and consulting fees, a $2.1 million increase in marketing expenses due to
expanded marketing programs and a $1.5 million increase in travel-related expenses for our salesforce to support our sales activities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">52 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Provision for Income Taxes </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except for percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(5,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">nm</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>Effective tax rate</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>nm</I></TD>
<TD NOWRAP VALIGN="bottom"><I>&nbsp;&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>&nbsp;</I></TD>
<TD VALIGN="bottom" ALIGN="right"><I>28.5</I></TD>
<TD NOWRAP VALIGN="bottom"><I>%&nbsp;</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our provision for income taxes was $0.9 million in 2014 compared to a tax benefit of $5.4 million in 2013. The higher tax
provision in 2014 was due to the release of a valuation allowance of $5.0 million against net deferred tax assets in 2013 and the reduced availability of net operating loss carryforwards in 2014. Our effective tax rate was 28.5% in 2014. The
effective tax rate in 2014 was lower than the U.S. federal statutory rate due to the impact of federal income tax credits. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Prior to 2013, we
recorded a valuation allowance in the full amount of our net deferred tax assets, as we had assessed our cumulative loss position and determined that the future benefits were not more likely than not to be realized. As of December&nbsp;31, 2013, we
determined that it is more likely than not that a portion of the net deferred tax assets will be realized for federal and state income tax purposes in the U.S., except in California, and released $5.0 million of the valuation allowance. We continue
to record a valuation allowance in the full amount of the net deferred tax assets attributable to California and certain foreign jurisdictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Liquidity and
Capital Resources </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Since our inception, we have financed our operations through private placements of preferred stock. As of March&nbsp;31, 2015,
we had $95.1 million in working capital, which included $8.1 million in cash and cash equivalents and $39.5 million in marketable investments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In
addition to our existing cash and cash equivalents and marketable investment balances, our principal source of liquidity is our accounts receivable. We believe these sources will provide sufficient liquidity for us to meet our liquidity requirements
for at least the next 12 months. Our principal liquidity requirements are to fund our operations, including our research and development, and capital expenditures. To facilitate our expansion, we may also lease or purchase additional facilities. We
expect to continue to make investments as we launch new products, expand our manufacturing operations and further expand into international markets. We may, however, require or elect to secure additional financing as we continue to execute our
business strategy. If we require additional funds, we may seek to raise capital through equity or debt financing, which may not be available on acceptable terms, could result in dilution to our stockholders and could require us to agree to covenants
that limit our operating flexibility. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Marketable investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Working capital<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">46,401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,478</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">95,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Working capital consists of total current assets less total current liabilities. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">53 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table sets forth, for the periods indicated, our beginning balance of cash and cash
equivalents, net cash flows provided by (used in) operating, investing and financing activities and our ending balance of cash and cash equivalents: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3,396</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(6,389</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(132</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2,662</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash provided by (used in) investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,251</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(37,001</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(642</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cash and cash equivalents at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Net Cash Used in Operating Activities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Cash provided by (used in) operating activities consists primarily of net income adjusted for certain non-cash items (including depreciation and
amortization, inventory write downs, stock-based compensation expense, provision for doubtful accounts, provision for sales returns, loss on minority investment, loss on disposal of property and equipment, provision for product warranty), and the
effect of changes in working capital and other activities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Net cash used in operating activities was $2.7 million during the three months ended
March&nbsp;31, 2015, and consisted of net income of $2.5&nbsp;million and non-cash items of $0.7&nbsp;million, offset by net changes in operating assets and liabilities of $5.8&nbsp;million. The significant items in the change in operating assets
and liabilities include the increase in inventories of $7.1 million to support our revenue growth, an increase in accounts receivable of $2.9&nbsp;million, offset by an increase in accounts payable, and accrued expenses and other non-current
liabilities of $1.6 million and $1.6&nbsp;million, respectively, as a result of the growth in our business activities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Net cash used in operating
activities was $0.1&nbsp;million during the three months ended March&nbsp;31, 2014 and consisted of a net income of $1.3&nbsp;million and non-cash items of $1.1&nbsp;million, offset by net changes in operating assets and liabilities of
$2.5&nbsp;million. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Net cash used by operating activities was $6.4&nbsp;million in 2014 and consisted of net income of $2.2 million and non-cash
items of $3.5&nbsp;million, offset by net changes in operating assets and liabilities of $12.1&nbsp;million. The significant items in the change in operating assets and liabilities include an increase in inventories of $9.4&nbsp;million to support
our revenue growth and a corresponding increase in accounts receivable of $7.4&nbsp;million, an increase in prepaid expenses and other current and non-current assets of $1.9&nbsp;million offset by increase in accounts payable, and accrued expenses
and other non-current liabilities of $1.3 million and $5.4&nbsp;million, respectively, as a result of the growth in our business activities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Net
cash used by operating activities was $3.4&nbsp;million in 2013 and consisted of net income of $4.1&nbsp;million, and a change in non-cash items of $2.5&nbsp;million, which includes a release of a valuation allowance of $5.0 million and a change in
deferred tax benefits of $0.3&nbsp;million, offset by net changes in operating assets and liabilities of $5.0&nbsp;million. The significant items in the change in operating assets and liabilities include increases in inventories and accounts
receivable of $3.8 million and $1.6 million, respectively, offset by increase in accrued expenses and other non-current liabilities of $1.7 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Net Cash
Provided by (Used in) Investing Activities </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Cash provided by (used in) investing activities relates primarily to divestures or purchases of
marketable investments and capital expenditures. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Net cash provided by investing activities was $7.5 million during the three months ended
March&nbsp;31, 2015 and consisted of net proceeds from sales of marketable investments of $8.8 million offset by capital expenditures of $1.3 million. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Net cash used in investing activities was $0.6 million during the three months ended March&nbsp;31, 2014 and consisted of capital expenditures of $0.5
million and purchase of marketable investments of $0.1 million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">54 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Net cash used in investing activities was $37.0 million in 2014 and consisted of net purchase of marketable
investments of $33.1 million and capital expenditures of $3.9 million. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Net cash used in investing activities was $1.3 million during in 2013 and
consisted of capital expenditures of $0.8 million and net purchase of marketable investments of $0.5 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Net Cash Provided by Financing Activities
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Cash from financing activities primarily relates to capital raising activities through equity or debt financing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Financing activities during the three months ended March&nbsp;31, 2015 and 2014 primarily consisted of proceeds from exercises of stock options. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Financing activities in 2014 provided $42.9 million and consisted of proceeds from issuance of Series&nbsp;F Preferred Stock of $57.2 million, net of
issuance costs and proceeds from exercises of stock options of $1.0 million. These proceeds were partially offset by repurchases of preferred stock, common stock and stock options of $9.4 million and the repayment of amounts outstanding under our
credit facility of $6.0 million upon its termination in May 2014. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Financing activities in 2013 provided $2.2 million and consisted of proceeds from
our credit facility of $2.0 million and proceeds from exercises of stock options of $0.2 million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Indebtedness </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In May 2012, we entered into a $15.0 million revolving credit facility with Wells Fargo Bank, National Association. The credit facility was
collateralized by our investment balances. The interest on the credit facility was based on the daily one-month London Inter-Bank Offered Rate (LIBOR), plus 1.75% and was payable monthly. The outstanding balance on the credit facility was due in
full on June&nbsp;1, 2015. The credit facility contained customary covenants for credit facilities of this type, including limitations on disposition of assets and changes in control. In May 2014, in conjunction with our Series F Preferred Stock
financing, we paid the then outstanding balance on the credit facility and terminated the credit facility. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Contractual Obligations and Commitments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table summarizes our contractual obligations as of December&nbsp;31, 2014: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Payments Due by Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Less&nbsp;Than<BR>One Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>1-3&nbsp;Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>3-5&nbsp;Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>More&nbsp;than<BR>Five&nbsp;Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Rent obligations<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,711</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,405</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Equipment lease obligations<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">138</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Purchase commitments<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,693</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We lease our corporate headquarters and a manufacturing facility at our campus in Alameda, California pursuant to lease agreements that expire in November 2029. Additionally, we lease offices in Germany, Australia and
Brazil. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We lease equipment and automobiles under operating leases. These leases expire at various dates through 2018. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We have non-cancellable purchase commitments directly with suppliers to purchase raw materials to be used in the future to manufacture products. Obligations under contracts that we can cancel without a significant
penalty are not included in the table above. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The amounts in the table above exclude $0.6 million of income tax liabilities included
in current liabilities as we are unable to reasonably&nbsp;estimate the timing of settlement. See Note 15 to our Consolidated Financial Statements. In addition, the table above does not reflect royalty obligations under a license agreement as
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">55 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
amounts due thereunder fluctuate depending on sales levels. See Note 7 to our Consolidated Financial Statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Off-Balance Sheet Arrangements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We do not have any
off-balance sheet arrangements or any holdings in variable interest entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Quantitative and Qualitative Disclosure about Market Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are exposed to various market risks, which may result in potential losses arising from adverse changes in market rates, such as interest rates and
foreign exchange rates. We do not enter into derivatives or other financial instruments for trading or speculative purposes and do not believe we are exposed to material market risk with respect to our cash and cash equivalents and/or our marketable
investments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Interest Rate Risk.</I></B> We had cash and cash equivalents of $3.3 million and $8.1 million as of December&nbsp;31, 2014 and March&nbsp;31,
2015, respectively, which consisted of cash and highly liquid money market funds. In addition, we had marketable investments of $48.3 million and $39.5 million as of December&nbsp;31, 2014 and March&nbsp;31, 2015, respectively, which consist
primarily of U.S. Treasury, U.S. Agency securities, corporate bonds and mutual funds. The primary objective of our investment activities is to preserve capital and support our liquidity requirements. We do not enter into investments for trading or
speculative purposes. Our marketable investments are exposed to market risks due to a fluctuation in interest rates, which may affect our interest income and the fair value of our marketable investments. We do not believe an immediate 10% increase
in interest rates would have a material effect on the fair market value of our portfolio, and therefore, we do not expect our operating results or cash flows to be materially affected by a sudden change in market interest rates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Foreign Exchange Risk Management.</I></B> We operate in countries other than the United States, and, therefore, we are exposed to foreign currency risks. We bill
most sales outside of the United States in local currencies, primarily the euro and Japanese yen. We expect that the percentage of our sales denominated in foreign currencies will increase in the foreseeable future as we continue to expand into
international markets. When sales or expenses are not denominated in U.S. dollars, a fluctuation in exchange rates could affect our net income. We do not believe an immediate 10% adverse change in foreign exchange rates would have a material effect
on our results of operations. We do not currently hedge our exposure to foreign currency exchange rate fluctuations; however, we may choose to hedge our exposure in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Related-Party Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">For a description of our
related-party transactions, see the section titled &#147;Certain Relationships and Related-Party Transactions.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Critical Accounting Policies and Estimates
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The
preparation of our consolidated financial statements requires management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the
consolidated financial statements and the reported amounts of revenues and expenses during the applicable periods. Management bases its estimates, assumptions and judgments on historical experience and on various other factors that it believes to be
reasonable under the circumstances. Different assumptions and judgments would change the estimates used in the preparation of our consolidated financial statements, which, in turn, could materially change our results from those reported. Management
evaluates its estimates, assumptions and judgments on an ongoing basis. Historically, our critical accounting estimates have not differed materially from actual results. However, if our assumptions change, we may need to revise our estimates, or
take other corrective actions, either of which may also have a material adverse effect on our consolidated statements of operations, liquidity and financial condition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">56 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe the following critical accounting policies involve significant areas where management applies
judgments and estimates in the preparation of our consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Segments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have determined our operating segment on the same basis that we use to evaluate our performance internally. We have one business activity: the design,
development, manufacturing and marketing of innovative medical devices, and we operate as one operating segment. Our chief operating decision-maker, our Chief Executive Officer, reviews our operating results for the purpose of allocating resources
and evaluating financial performance. We determine revenue by geographic area, based on the destination to which we ship our products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Revenue Recognition
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue is comprised of product revenue net of returns, discounts and administration fees. We recognize revenue when persuasive evidence of an
arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably assured. Evidence of an arrangement consists of customer orders, and we typically consider delivery to have occurred once title and
risk of loss has been transferred and the product has been delivered to our customers. We typically recognize revenue when products are delivered to our hospital customers or distributors. However, with respect to products that we consign to
hospitals, which primarily consist of coils, we recognize revenue at the time hospitals utilize our products used in a procedure. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We defer revenue
for amounts that we have already invoiced our customers for and are ultimately expected to be recognized as revenue, but for which not all revenue recognition criteria have been met. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our terms and conditions permit product returns and exchanges, and we record returns reserves in the period when revenue is recognized. Estimates are
based on actual historical returns over the prior three years and are recorded as reductions in revenue at the time of sale. Upon recognition, we reduce revenue and cost of revenue for the estimated return. Return rates can fluctuate over time, but
are sufficiently predictable to allow us to estimate expected future product returns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Accounts Receivable </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Accounts receivable are stated at invoice value less estimated allowances for returns and doubtful accounts. We continually monitor customer payments and
maintain a reserve for estimated losses resulting from our customers&#146; inability to make required payments. We consider factors such as historical experience, credit quality, age of the accounts receivable balances, geographic related risks and
economic conditions that may affect a customer&#146;s ability to pay. In cases where there are circumstances that may impair a specific customer&#146;s ability to meet its financial obligations, a specific allowance is recorded against amounts due,
and thereby reduces the net recognized receivable to the amount reasonably believed to be collectible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Inventories </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Inventories are stated at the lower of cost (determined under the first-in first-out method) or market. Write-downs are provided for finished goods
expected to become nonsaleable and provisions are specifically made for excessive, slow-moving or obsolete items. Market value is determined as the lower of replacement cost or net realizable value. We regularly review inventory quantities in
consideration of actual loss experiences, projected future demand, and remaining shelf life to record a provision for excess and obsolete inventory when appropriate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The estimate of excess quantities is subjective and primarily dependent on our estimate of future demand for a particular product. If the estimate of
future demand is inaccurate based on actual sales, we may increase the write down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive income.
We periodically evaluate the carrying value of inventory on hand for potential excess amount over demand using the same lower of cost or market approach as that has been used to value the inventory. We also periodically evaluate inventory quantities
in consideration of actual loss experience. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">57 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Cost of Revenue </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Cost of revenue includes direct and indirect costs associated with the manufacture of our products. Direct costs include material and labor, while
indirect costs include, but are not limited to, inbound freight charges, receiving costs, inspection and testing costs, warehousing costs, royalty expense and other labor and overhead costs incurred in the manufacturing of products. Cost of revenue
also includes stock-based compensation, warranty replacement costs, cost of revenue related to product return reserves, and excess and obsolete inventory write-downs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Research and Development (R&amp;D) Expenses </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">R&amp;D costs
include personnel-related costs, including stock-based compensation, regulatory, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative
sites and other indirect costs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our clinical trial accruals are based on estimates of patient enrollment and related costs at clinical investigator
sites. We estimate preclinical and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage preclinical studies and clinical trials on our
behalf. In accruing service fees, we estimate the time period over which services will be performed and the level of patient enrollment and activity expended in each period. If the actual timing of the performance of services or the level of effort
varies from the estimate, we will adjust the accrual accordingly. Payments made to third parties under these arrangements in advance of the receipt of the related services are recorded as prepaid expenses until the services are rendered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Stock-based compensation costs
related to stock options granted to employees are measured at the date of grant based on the estimated fair value of the award, net of estimated forfeitures. We estimate the grant date fair value, and the resulting stock-based compensation expense,
using the Black-Scholes option-pricing model on a straight-line basis over the requisite service period of the award, which is generally the vesting term of four years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Black-Scholes option-pricing model requires the use of highly subjective assumptions which determine the fair value of stock-based awards. The
assumptions used in our option-pricing model represent management&#146;s best estimates. These estimates are complex, involve a number of variables, uncertainties and assumptions and the application of management&#146;s judgment, so that they are
inherently subjective. If factors change and different assumptions are used, our stock-based compensation expense could be materially different in the future. These assumptions are estimated as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I></I><B><I>Fair Value of Common Stock.</I></B><I></I> Because our stock is not publicly traded, we must estimate its fair value, as discussed in
&#147;Common Stock Valuations&#148; below. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I></I><B><I>Risk-Free Interest Rate.</I></B><I> </I>We base the risk-free interest rate used in the
Black-Scholes valuation model on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent remaining term of the options for each option group. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I></I><B><I>Expected Term.</I></B><I></I> The expected term represents the period that our stock-based awards are expected to be outstanding. Because of
the limitations on the sale or transfer or our common stock as a privately held company, we do not believe our historical exercise pattern is indicative of the pattern we will experience as a publicly traded company. We have consequently used the
Staff Accounting Bulletin, or SAB, 110, simplified method to calculate the expected term, which is the average of the contractual term and vesting period. We plan to continue to use the SAB&nbsp;110 simplified method until we have sufficient trading
history as a publicly traded company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><B><I>Volatility.</I></B> We determine the price volatility factor based on the historical volatilities of our
peer group as we do not have a trading history for our common stock. Industry peers consist of several public companies in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">58 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the medical device technology industry with comparable characteristics including enterprise value, risk profiles and position within the industry. We intend to continue to consistently apply this
process using the same or similar public companies until a sufficient amount of historical information regarding the volatility of our own common stock share price becomes available, or unless circumstances change such that the identified companies
are no longer similar to us, in which case, more suitable companies whose share prices are publicly available would be utilized in the calculation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><B><I>Dividend Yield.</I></B> The expected dividend assumption is based on our current expectations about our anticipated dividend policy. We currently
do not expect to issue any dividends. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition to assumptions used in the Black-Scholes option-pricing model, we must also estimate a forfeiture
rate to calculate the stock-based compensation for our awards. We will continue to use judgment in evaluating the assumptions related to our stock-based compensation on a prospective basis. As we continue to accumulate additional data, we may have
refinements to our estimates, which could materially impact our future stock-based compensation expense. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We used the following assumptions in our
Black-Scholes option pricing model to determine the fair value of employee stock options: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center"><B>(unaudited)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.25</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">6.25</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">45%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">45%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">45%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">45%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="white-space:nowrap">0.63&nbsp;-&nbsp;0.90%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="white-space:nowrap">1.76&nbsp;-&nbsp;2.02%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><FONT STYLE="white-space:nowrap">1.76&nbsp;-&nbsp;2.02%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.56%</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected dividend rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">0%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">0%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">0%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">0%</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table sets forth the stock-based compensation expense included in the consolidated statements of operations
(in thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="58%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cost of sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sales, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of March&nbsp;31, 2015, we had approximately $5.5 million of total unrecognized compensation expense, net of related
forfeiture estimates, which we expect to recognize over a weighted average period of approximately 3.2 years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The intrinsic value of all outstanding
options as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; was $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; million based on the estimated fair value of our common stock of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, which is the midpoint of the estimated initial public offering price range set forth on the cover page of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Common Stock Valuations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The fair value of the shares
of common stock underlying our stock options has historically been determined by our board of directors. Because there has been no public market for our common stock and in the absence of recent arm&#146;s-length cash sales transactions of our
common stock with independent third parties, our board of directors has determined the fair value of our common stock by considering at the time of grant a number of objective and subjective factors. Our board of directors intends all options
granted to be exercisable at a price per share not less than the per share fair value of our common stock underlying those options on the date of grant. The estimated fair value of our common stock was determined at each valuation date in accordance
with the guidelines outlined in the American Institute of Certified Public Accountants Practice Aid, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">59 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Valuation of Privately-Held-Company Equity Securities Issued as Compensation. Our board of directors, with the assistance of management, developed these valuations using significant judgment and
taking into account numerous factors, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">independent third-party valuations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">progress of research and development activities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our operating and financial performance, including our levels of available capital resources; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">rights and preferences of our common stock compared to the rights and preferences of our other outstanding equity securities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">equity market conditions affecting comparable public companies, as reflected in comparable companies&#146; market multiples, IPO valuations and other metrics; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the achievement of enterprise milestones, including our progress in clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the likelihood of achieving a liquidity event for the shares of common stock, such as an IPO given prevailing market and medical device sector conditions; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">sales of our preferred stock in arms-length transactions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the illiquidity of our securities by virtue of being a private company; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">business risks; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">management and board experience. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We considered the following approaches in the preparation of our
valuations: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Market Approach</I>.&nbsp;The market approach values a business by reference to guideline companies, for which enterprise values are known. This approach has two principal methodologies. The guideline public company
methodology derives valuation multiples from the operating data and share prices of similar publicly traded companies. The guideline acquisition methodology focuses on comparisons between the subject company and guideline acquired public or private
companies. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Option-Pricing Method Backsolve, or OPM backsolve</I>. The OPM backsolve method derives the implied equity value for a company from a recent transaction involving the company&#146;s own securities issued on an
arms-length basis. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Probability Weighted Expected Return Method</I>.&nbsp;Using the probability weighted expected return, or PWERM, method, the value of a company&#146;s common stock is estimated based upon the analysis of future values
for the company assuming various possible future liquidity events like an initial public offering, sale or merger. Share value is based upon the probability-weighted present value of expected future net cash flows, considering each of the possible
future events, as well as the rights and preferences of each share class. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, we also considered an enterprise value
allocation method: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Option-Pricing Method, or OPM</I>.&nbsp;Under this method, each class of stock is modeled as a call option with a distinct claim on the enterprise value of the company. The option&#146;s exercise prices would be
based on a comparison with the enterprise value. The method assumes that a formula, such as the Black-Scholes model, would calculate the fair value when provided with certain values, including share price, expiration date, volatility and the risk
free interest rate. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The per share common stock value was estimated by allocating our enterprise value using the OPM method in
October&nbsp;1, 2013 , May&nbsp;16, 2014, and September&nbsp;30, 2014, which determined the common stock value to be $7.75, $9.06 and $10.92, respectively. The per share common stock value was estimated in December&nbsp;31, 2014 and March&nbsp;31,
2015, which utilized the PWERM method, which determined the common stock value to be $12.36 and $14.46, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">60 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In determining the estimated fair value of our common stock, our board of directors also considered the
fact that our stockholders could not freely trade our common stock in the public markets. Accordingly, we applied discounts to reflect the lack of marketability of our common stock based on the expected time to liquidity. The estimated fair value of
our common stock at each grant date reflected a non-marketability discount partially based on the anticipated likelihood and timing of a future liquidity event. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The key subjective factors and assumptions used in our valuations primarily consisted of: (i)&nbsp;the selection of the appropriate market comparable
transactions, (ii)&nbsp;the selection of the appropriate comparable publicly traded companies, (iii)&nbsp;the financial forecasts utilized to determine future cash balances and necessary capital requirements, (iv)&nbsp;the probability and timing of
the various possible liquidity events, (v)&nbsp;the estimated weighted average cost of capital and (vi)&nbsp;the discount for lack of marketability of our common stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">At each grant date the board of directors reviewed any recent events and their potential impact on the estimated fair value per share of the common
stock. As is provided for in Internal Revenue Code Section&nbsp;409A, we generally rely on our valuations for up to twelve months unless we have experienced a material event that would have affected the estimated fair value per common share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Income Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We account for income taxes using the asset and
liability method, whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities, and are measured using the enacted tax rates and laws that will
be in effect when the differences are expected to reverse. We provide a valuation allowance to reduce the net deferred tax assets to their estimated realizable value. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">At December&nbsp;31, 2014, we had approximately $17.8&nbsp;million and $2.0&nbsp;million of state and foreign net operating loss carryforwards,
respectively, available to offset future taxable income. The state net operating loss carryforwards will begin to expire in 2017. At December&nbsp;31, 2014, we had research credits available to offset federal and state tax liabilities in the amount
of $0.7&nbsp;million and $2.8&nbsp;million, respectively. Federal credits will begin to expire in 2027 and California state tax credits have no expiration. As of December&nbsp;31, 2014, we had fully used $22.6&nbsp;million of federal net operating
losses, which we had accumulated in our first six years of operations, from 2004 through 2009. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The calculation of our current provision for income
taxes involves the use of estimates, assumptions and judgments while taking into account current tax laws, interpretation of current tax laws and possible outcomes of future tax audits. We have established reserves to address potential exposures
related to tax positions that could be challenged by tax authorities. Although we believe our estimates, assumptions and judgments to be reasonable, any changes in tax law or its interpretation of tax laws and the resolutions of potential tax audits
could significantly impact the amounts provided for income taxes in our consolidated financial statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The calculation of our deferred tax asset
balance involves the use of estimates, assumptions and judgments while taking into account estimates of the amounts and type of future taxable income. Actual future operating results and the underlying amount and type of income could differ
materially from our estimates, assumptions and judgments thereby impacting our financial position and results of operations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have adopted ASC
740-10 &#147;Accounting for Uncertainty in Income Taxes&#148; that prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in our
income tax return, and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We include interest and penalties related to unrecognized tax benefits within income tax expense in the accompanying consolidated statements of
operations. We have not incurred any interest or penalties related to unrecognized tax benefits in any of the periods presented. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">61 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Recently Issued Accounting Standards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In May 2014, the FASB issued ASU No.&nbsp;2014-09, <I>Revenue from Contracts with Customers</I>, which outlines a comprehensive new revenue recognition
model designed to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The accounting standard is effective
for annual reporting periods (including interim reporting periods within those periods) beginning after December&nbsp;15, 2016. Early adoption is not permitted. We are currently evaluating the impact of this accounting standard. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In April 2015, the FASB proposed deferring the effective date by one year to December&nbsp;15, 2017 for annual reporting periods beginning after that
date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date of December&nbsp;15, 2016. Presently, the FASB&#146;s proposed deferral is not a final decision. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In November 2014, the FASB issued ASU No.&nbsp;2014-17, <I>Pushdown Accounting</I>, which provides an acquired entity to elect the option to apply
pushdown accounting in the reporting period in which the change-in-control event occurs and allows the acquired entity to determine whether to elect to apply pushdown accounting for each individual change-in-control event in which the acquirer
obtains control of the acquired entity. This accounting standard is effective as of November&nbsp;18, 2014 and we will apply the guidance to future change-in control events. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">62 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_10"></A>BUSINESS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Penumbra is a global interventional therapies
company that designs, develops, manufactures and markets innovative medical devices. We have a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral
vascular. The conditions that our products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are one of the largest independent companies focused on the neuro market, and we recently expanded our business to include the peripheral vascular
market. We sell our products to hospitals, primarily through our salesforce, as well as through distributors in select international markets. We focus on developing, manufacturing and marketing products for use by specialist physicians, including
interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. We design our products to provide these specialist physicians with a means to drive improved clinical outcomes through
faster and safer procedures and generally at a significantly lower overall cost to the healthcare system relative to procedures using other products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We attribute our success to our culture built on cooperation, our highly efficient product innovation process, our disciplined approach to product and
commercial development, our deep understanding of our target end markets and our relationships with specialist physicians. We believe these factors have enabled us to rapidly innovate in a highly capital-efficient manner. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Since our founding in 2004, we have had a strong track record of organic product development and commercial expansion that has established the foundation
of our global organization. Some of our key accomplishments include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">launching our first product, for neurovascular access, in the United States in 2007; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing our direct neuro salesforce in the United States and Europe in 2008; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">launching the first 510(k)-cleared, aspiration-based product for the treatment of ischemic stroke patients in 2008, and launching four subsequent generations of that product; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">launching our first neurovascular coil for the treatment of brain aneurysms in 2011; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">launching our first peripheral vascular product in 2013; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing our direct peripheral vascular salesforce in the United States and Europe in 2014. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of
March&nbsp;31, 2015, we had approximately 850 employees worldwide. We sell our products to hospitals primarily through our direct sales organization in the United States, most of Europe, Canada and Australia, as well as through distributors in
select international markets. For the year ended December&nbsp;31, 2014, we generated revenue of $125.5 million, which represents a 41.3% increase over 2013, and $3.0&nbsp;million in operating income as compared to an operating loss of
$1.1&nbsp;million in 2013. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Market Opportunity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We
estimate that the market for our current neuro and peripheral vascular products in the United States and Europe combined was approximately $1.3 billion in 2014, which we estimate represents growth of approximately 3.2%&nbsp;per year from 2012. While
reliable third-party data is not available for markets outside the United States and Europe, we believe that there is a substantial additional market for our neuro and peripheral vascular products in the rest of the world. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe the market for our products remains substantially underpenetrated today, and that this market will experience significant growth as we and our
competitors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">generate additional clinical evidence supporting endovascular treatment of vascular disease; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">improve existing technologies to enable physicians to treat vascular disease faster and more safely than previously possible; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">63 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">support and educate the growing number of specialist physicians who treat vascular disease in the use of endovascular treatment; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">grow the number of hospitals where endovascular treatment of vascular disease is available; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">raise patient awareness of endovascular treatment of vascular disease. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We estimate that the market for
our neuro products in the United States and Europe combined was over $500 million in 2014. According to the American Heart Association (AHA), the worldwide incidence of all forms of stroke was 33&nbsp;million in 2010. We believe the recent
publication of several major clinical trials demonstrating the benefit of endovascular treatment of ischemic stroke patients over the standard medical therapy will significantly expand the neuro market and support increased future growth. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We estimate that the market for our peripheral vascular products in the United States and Europe combined was over $750 million in 2014. Furthermore,
according to a paper published in the journal <I>The Lancet</I>, 202&nbsp;million people globally were living with peripheral artery disease in 2010. We believe that expanded adoption of new technologies developed to treat peripheral vascular
disease will drive continued growth in this market. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Industry Background </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B></B><B><I>Vascular Disease</I></B><B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Vascular disease refers
to any condition that affects the circulatory system and typically manifests as a blockage or rupture of an artery or a vein. It may occur in any part of the body and is a condition that leads most often to blood vessel narrowing and obstruction,
but can also lead to expansion of the blood vessel wall and blood vessel wall weakening and rupture. Vascular disease can cause a range of conditions, from pain to functional impairment, and it can require the amputation of a limb or result in
death. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">When the treatment for vascular disease is performed from within a vessel, it is referred to as an endovascular procedure. Endovascular
procedures are minimally invasive means of treating the two major vascular problems that can develop within blood vessels: an occlusion, where the vessel is blocked or narrowed, and an aneurysm, or weakening of the vessel wall that forms a
balloon-like pouch that fills with blood. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Endovascular procedures are performed by utilizing an accessible artery to reach an occlusion or aneurysm.
During most endovascular procedures, a catheter is placed into the femoral artery in the groin, and X-ray imaging or fluoroscopy is used to help the physician visually navigate the catheter to the area to be treated. Endovascular procedures are less
invasive and require a smaller incision than conventional open surgery, and we believe they are safer procedures for patients, reduce hospital stays and recovery times, and are more cost effective to the healthcare system. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Endovascular device markets are conventionally classified according to the anatomic location of the disorder. We currently focus our efforts on the neuro
and peripheral vascular markets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Neurovascular Disease </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Neurovascular diseases are vascular diseases and disorders in the brain. A devastating complication of neurovascular disease is stroke. A stroke is
caused by either an occlusion or rupture of an artery or vein. According to the AHA, the worldwide incidence of all forms of stroke was 33&nbsp;million in 2010, and stroke was the second leading cause of death globally. The AHA estimates that there
are approximately 795,000 strokes annually in the United States, making stroke the fourth leading cause of death, and the leading cause of long-term disability. The AHA estimates that stroke results in total direct and indirect costs of
approximately $33 billion in the United States annually. There are two principal forms of stroke: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">ischemic strokes, which are caused by the blockage of an artery to the brain and affect approximately 690,000 patients annually in the United States; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">hemorrhagic strokes, which are caused by a sudden rupture of a brain artery that leads to bleeding into or around the brain and affect approximately 105,000 patients annually in the United States. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">64 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Both forms of stroke may result in permanent brain damage or death. Patients who survive a stroke are often
left with disabilities, including paralysis, coma, impaired cognition, decreased coordination, loss of visual acuity, loss of speech, loss of sensation or some combination of these conditions. The devastating effects of stroke are one of the
greatest costs to the healthcare system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Ischemic Stroke </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Ischemic strokes can be caused by several kinds of disease and can be characterized as either thrombotic or embolic. A thrombotic stroke is the most
common and occurs when arteries in the brain become blocked by the formation of a clot within the brain. An embolic stroke occurs when a clot or small piece of plaque formed in one of the arteries leading to the brain travels through the bloodstream
where it lodges in narrower arteries in the brain and blocks blood flow. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Treatment for patients with a blocked blood vessel in the brain that has
caused an ischemic stroke consists of two basic methodologies to restore blood flow to the brain: intravenous (IV) lysis of the clot with administration of tissue plasminogen activator (tPA), the standard medical therapy, and more recently,
endovascular removal of the clot with catheter based devices, or thrombectomy. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">tPA is a clot dissolving drug that is administered to patients
presenting with ischemic stroke symptoms within 3 hours, in most patients, and up to 4.5 hours in certain eligible patients. However, a large percentage of stroke patients do not arrive at a hospital in time for tPA treatment, and a significant
percentage of patients treated with tPA do not immediately experience improved blood flow, or perfusion, to the brain. Such delays in perfusion can lead to prolonging or exacerbating the symptoms of ischemic stroke. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Currently, thrombectomy products are 510(k) cleared by the FDA for use within eight hours of stroke onset to restore blood flow in patients experiencing
an ischemic stroke. Thrombectomy is performed by advancing a catheter to the site of the blocked blood vessel in the brain and then aspirating the clot into an aspiration catheter at the site of the clot, deploying a stent-like device and retracting
it through the cerebral vasculature into a large catheter in the neck, or a combination of the two approaches. Ischemic stroke patients with large vessel occlusions and those with sufficient salvageable tissue are candidates for endovascular
thrombectomy. According to a paper published in the journal <I>Stroke</I>, only 0.6% of stroke patients in the United States in 2009 underwent such a procedure. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In the past year, several major clinical trials have produced clinical data demonstrating the benefit of endovascular treatment of stroke patients over
standard medical therapy. The MR CLEAN study, published in <I>The New England Journal of Medicine</I> in January 2015, demonstrated the benefit of endovascular thrombectomy plus standard medical therapy over standard medical therapy alone. The MR
CLEAN study demonstrated the benefit of endovascular treatment across the range of clinical outcomes at 90 days, judged by the modified Rankin Scale (mRS), which is a commonly used scale measuring the degree of disability or dependence in the daily
activities of people who have suffered a stroke or other causes of neurological disability. In the MR CLEAN study, where patients received endovascular treatment for stroke, there was a significant increase in the number achieving functional
independence at 90 days, with 32.6% of the endovascular treatment group achieving a 0 to 2 on the mRS, which indicates no symptoms or only slight disability, compared to 19.1% of the control group. The results of this study have now been
independently confirmed by several additional clinical trials: ESCAPE, SWIFT PRIME, EXTEND IA, REVASCAT, THRACE and our own THERAPY study. These studies support endovascular stroke treatment across a range of different patient selection criteria.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">With the recent clinical data supporting the benefits of endovascular thrombectomy, the Society of NeuroInterventional Surgery (SNIS) has stated
endovascular thrombectomy is a new standard of care for stroke patients who qualify for the procedure. SNIS published the Report of its Standard and Guidelines Committee in the <I>Journal of NeuroInterventional Surgery</I> in May 2015, including the
following specific language: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:arial">&#147;For patients with anterior circulation stroke and documented E[mergent] L[arge] V[essel]
O[cclusion] affecting the ICA or M1 segment of the MCA and a corresponding clinical deficit, the addition of endovascular embolectomy results in superior clinical outcomes compared with best medical therapy alone. Embolectomy needs to be performed
as rapidly as possible for the greatest clinical benefit, and is best when performed within 6 h[ours] from onset of symptoms (AHA Class I, level of evidence A.).&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">65 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The ICA or M1 Segment of the MCA refers to the specific anatomical location of the occlusion in the vasculature. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Given the recent clinical data supporting endovascular treatment of ischemic stroke patients and the substantial clinical need and economic burden of
ischemic stroke, we believe that the market for endovascular treatment of ischemic stroke is in its early stages of development and will continue to expand significantly over time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Hemorrhagic Stroke </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Hemorrhagic strokes are caused by a
sudden rupture of a brain artery leading to bleeding into or around the brain. A cerebral aneurysm is usually located along the major arteries deep within brain structures. A major cause of hemorrhagic stroke is the rupture of a cerebral aneurysm.
Aneurysms can vary in shape and size, typically grow over time and, due to pressure placed on the wall of the aneurysm, are prone to rupture. Ruptured aneurysms can cause death as a result of massive intracranial bleeding and loss of perfusion to
the brain in the area affected by the aneurysm rupture. If an aneurysm ruptures, it leaks blood into the space around the brain. This is called a subarachnoid hemorrhage. If the hemorrhage bleeds into the brain itself, causing damage to the brain
directly, this results in a hemorrhagic stroke. According to the AHA, once an aneurysm bleeds, there is an approximately 30% to 40% likelihood of death and an approximately 20% to 35% likelihood of moderate to severe brain damage, even if the
aneurysm is successfully treated. If the aneurysm is not treated quickly, additional bleeding may occur from the already ruptured aneurysm. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The
optimal treatment for an aneurysm depends upon many factors, including whether the aneurysm has ruptured or not. If an aneurysm has not ruptured, the optimal treatment will depend upon its size, location and shape and the patient&#146;s symptoms.
Small, unruptured aneurysms that are not creating any symptoms may not need treatment unless they grow, trigger symptoms, or rupture. A ruptured aneurysm usually requires immediate treatment because the re-bleeding rate remains quite high. However,
the treatment time and options for treatment depend upon the size, location and shape of the aneurysm, as well as the patient&#146;s overall medical condition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Depending on an individual&#146;s risk factors, surgical clipping of an aneurysm had been traditionally recommended. In this open surgical procedure,
patients are placed under general anesthesia, an opening is made in the skull, the brain tissue is spread apart, and the aneurysm is surgically exposed. The neurosurgeon then places a clip around the aneurysm&#146;s base. The clip seals off the
aneurysm so that blood cannot enter. Possible complications from surgical clipping include infection at the incision site, rupturing of the aneurysm during surgery, damage to the artery and bleeding into the brain which could result in brain damage.
As with other open surgical procedures, there are risks associated with the use of anesthesia during the procedure. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The primary endovascular
procedure for treating both unruptured and ruptured aneurysms uses a repair technique called embolization. The objective of embolization is to induce a blood clot, or thrombus, in the diseased vasculature to limit blood flow through the diseased
vascular anatomy, thereby reducing blood pressure and flow to a ruptured area or the likelihood of rupture in an unruptured area. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The endovascular
embolization of cerebral aneurysms usually involves the deployment of small platinum coils into the aneurysm. During such an embolic coiling procedure, the physician accesses the femoral artery to allow the introduction of a catheter which is
inserted and guided towards the brain. A microcatheter is then introduced through the larger catheter and used to deliver coils through the neck and into the sac of the aneurysm. They are individually placed and often detached by a small electric
current or mechanical detachment. This process is generally repeated until the aneurysm is filled with many coils, generally in progressively smaller sizes. Coiling may be done under local or general anesthesia. Possible complications include
rupture of the aneurysm during treatment and damage to the artery and bleeding into the brain that could result in brain damage or death, as well as risks from the anesthesia. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Following the release of results from the International Subarachnoid Aneurysm Trial (ISAT) which were published in the journal <I>The Lancet</I>, the
treatment of aneurysms shifted from open surgical techniques, such as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">66 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
surgical clipping, to minimally invasive, endovascular techniques, such as embolic coiling. The ISAT was a clinical trial involving 2,143 patients in Europe, North America and Australia that
compared aneurysm clipping with embolic coiling as a method of treating cerebral aneurysms. The trial concluded that endovascular intervention with detachable platinum coils resulted in a 23% relative and 7% absolute reduction in the risk of major
brain injury or death at one-year follow up compared with surgical clipping of the aneurysm. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">According to the American Association of Neurological
Surgeons, up to 6% of the general population in the United States may be living with an unruptured aneurysm. In addition, an estimated 30,000 people per year in the United States suffer from a ruptured cerebral aneurysm. According to the AHA,
annually, 0.5% to 3.0% of people with a brain aneurysm may suffer from bleeding. If a patient has one aneurysm, there is a 15% to 20% likelihood that the patient has at least one or more additional aneurysms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Peripheral Vascular Disease </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Peripheral vascular
disease is defined as vascular disease occurring in vessels outside of the brain or heart. Peripheral vascular disease is characterized by the narrowing or occlusion of blood vessels and can cause pain or loss of function and lead to amputation and
death. Mortality from peripheral vascular disease can occur as a result of stroke, kidney failure or diabetes-related vascular complications. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">According to a paper published in the journal <I>The Lancet</I>, the worldwide prevalence of peripheral artery disease was 202&nbsp;million in 2010.
Within the United States, the AHA estimates that approximately 8&nbsp;million adults have peripheral artery disease. Patients with peripheral artery disease have a nearly threefold increase in the risk of suffering a heart attack or stroke. Over
half of the population with peripheral artery disease does not display classic symptoms of the disease, leading to substantial underdiagnosis. Massachusetts General Hospital estimates that only approximately 25% of patients with peripheral artery
disease in the United States undergo treatment for the disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">More particularly, in <I>Deep Vein Thrombosis</I>, Dr. Camerota estimated that
approximately 1 million people in the United States are diagnosed with deep vein thrombosis (DVT) each year. Approximately 300,000 people die of a venous thromboembolism complication, which exceeds that of acute myocardial infarction or acute
stroke. In addition, according to <I>The New England Journal of Medicine</I>, acute limb ischemia, a sudden decrease in limb perfusion that threatens the viability of the limb, is found in approximately 1.5 out of 10,000 people per year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Peripheral thrombectomy </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">When blood is unable to flow
smoothly through a vessel, it can begin to coagulate, turning from a free-flowing liquid to a semisolid gel, a process known as blood clotting. A blood clot, or thrombus, that forms within a blood vessel may continue to grow, blocking off the blood
supply to certain parts of the body and causing damage to tissues and organs. In some patients, blood clots come from other sources and dislodge in relatively small vessels, thereby causing a blockage or embolization. If left untreated, a vascular
blockage can lead to limb ischemia, a potentially lethal clinical event. Limb ischemia is a sudden decrease in blood supply to the limb that threatens the viability of the limb. The rapid onset of this condition reduces or prevents the delivery of
nutrients to the metabolically active tissues of the limb, including skin, muscle, and nerves. Symptoms of limb ischemia include pain, pulselessness, pale color, perishing cold feeling and paraesthetic feeling, such as burning or tingling, and
paralysis. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Thrombotic occlusion is the most common cause of limb ischemia. Immediate surgical or endovascular removal of the clot is recommended in
order to restore blood flow to the limb and prevent amputation. In these situations, thrombectomy and thrombolysis are often performed as a less invasive alternative to bypass surgery, where clot removal is imperative for the patient&#146;s
survival. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Minimally invasive endovascular procedures for the treatment of blood clots in the peripheral vasculature consist primarily of
thrombolytic drug infusion, syringe aspiration or mechanical removal. In thrombolytic drug infusion, a catheter with holes allowing for drug infusion is inserted into the blocked or narrowed part of the artery over a previously positioned guidewire
that directs the catheter to the affected area. A thrombolytic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">67 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
drug, such as tPA, is then infused at a set infusion rate for a period of 18 to 48 hours, during which time, these patients are closely monitored in an Intensive Care Unit (ICU) to ensure there
are no complications associated with infusion of the drug. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Clot removal using syringe aspiration is accomplished through the use of a catheter
delivered to the clot, and then a syringe is hooked to the end of the catheter. This syringe creates an initial vacuum, and hence can remove very short, soft segments of the clot in small vessels. As clot segments get longer, and more fibrous in
nature, these syringe aspiration techniques are no longer effective, and a more robust mode of endovascular treatment is required. Some new techniques are evolving, where there is now the ability to maintain a continuous vacuum using a mechanical
pump, and the addition of another wire-based tool along with the catheter to help keep the catheter option for the duration of the procedure. This is proving to be able to handle longer segments of the clot, as well as a clot that has been in place
for a longer period of time. Other techniques involve the combination of the tPA drug along with a mechanical component, with the risk of bleeding, albeit lower, as well as added procedural cost. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Percutaneous thrombectomy devices are increasingly used to remove clots from peripheral and coronary vessels because they offer a faster treatment option
than the traditional standard of care, systemic thrombolysis. The advantages of thrombectomy over thrombolytic drug administration alone can include rapid reperfusion of ischemic limbs, reduced procedural times, potentially shorter hospital stays,
and lower recurrence of thrombosis. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">With proper endovascular or surgical care, acute limb ischemia is a highly treatable condition; however, delayed
treatment beyond six to 12 hours can result in permanent disability, amputation and death. Despite currently available treatments, according to <I>The New England Journal of Medicine</I>, it is estimated that acute limb ischemia has an associated
one-year mortality rate of between 15% and 20% and an in-hospital amputation rate of between 10% and 15%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Peripheral embolization </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Aneurysms are another potential result of peripheral vascular disease. Peripheral aneurysms vary in size, shape and location. Peripheral vascular
aneurysms occur in the renal arteries, the lower extremities and the visceral arteries, which are located in the abdomen and feed several important organs, such as the liver and spleen. Ruptured aneurysms can result in death as a result of massive
bleeding and loss of perfusion to the organ that the vessel feeds. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Internal hemorrhaging can be difficult to control, and interventional
radiologists will often perform an embolization to occlude the bleeding vessel. Leading causes of internal hemorrhaging where embolization is used include trauma (generally major organ or gastrointestinal), pre- and post-surgical organ removal,
hemoptysis (respiratory tract bleeding resulting in the excessive coughing up of blood), epistaxis (excessive and uncontrollable nosebleed), pseudoaneurysm hemorrhage and pulmonary AVM (arterial venous malformation) hemorrhage. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">A peripheral aneurysm requires surgical or endovascular repair because of the risk of rupture. If the aneurysm is small and there are no symptoms, the
physician will monitor its size to determine when repair is needed. Endovascular repair makes use of a catheter to place embolization coils that occlude the aneurysm and prevent blood flow to the area, thereby preventing further growth of the
aneurysm. Open surgical repair of a peripheral aneurysm may be recommended if the aneurysm anatomy does not allow for endovascular repair. In this procedure, the damaged vasculature is removed and replaced with a graft or surgically ligated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Minimally invasive endovascular procedures for the treatment of peripheral aneurysms or blood vessel sacrifice involve the placement of a catheter at the
targeted location. The interventional radiologist then delivers metallic occlusion devices such as embolization coils or plugs to the target location to obstruct the aneurysm or vessel. Coils can be either pushable or detachable. Pushable coils are
pushed out of the catheter without exact control of placement and delivery. Detachable coils offer precise physician control and can be carefully positioned until the physician is satisfied with the coil placement at the desired location. At this
point, the physician uses a trigger mechanism, which can be mechanical or electrolytic, to detach the coil and release it into the target vessel. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">68 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Peripheral vascular embolization coils (PV coils) are used in a variety of clinical applications.
Detachable PV coils are becoming more popular among interventional radiologists due to their clinical benefits relative to pushable coils, their ease of use and their predictability. Clinical applications involving the use of coils include: active
extravasations; selective embolization in patients with visceral aneurysms; exclusion of branches prior to chemoembolization and radioembolization; embolization in patients with gastrointestinal bleeding; embolization of branches prior to stent
graft procedures; procedures after stent grafting in patients with persistent type II endoleaks and sac enlargement; treatment of patients with varicocele and pelvic congestion syndrome; high flow AVM; post trans intrahepatic shunt placement;
balloon retrograde transvenous obliteration; and exclusion of hepatic branches prior to liver resection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Our Strengths </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe the following strengths have enabled us to develop our broad and differentiated product portfolio and will continue to be significant factors
in our success and growth. We plan to continue investing in our organization to preserve these strengths as we grow our business. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Our culture built on cooperation, which we have institutionalized through our unique organizational structure.</I></B> From our inception, we structured Penumbra in a unique way, designed to optimize the level of
cooperation and communication between functional areas of the organization. This structure is highlighted by the application of distinctive methodologies to almost every important aspect of management, including research and development (R&amp;D)
project selection, budgeting, hiring and compensation. We believe our success in maintaining this structure over the past ten years demonstrates that our corporate structure and approach to culture and cooperation should be scalable as we continue
to grow. We also seek to ensure maximum control of our development, manufacturing and commercialization processes, and accordingly, we currently conduct substantially all of our own product development, manufacture substantially all of our own
products and, where cost effective, sell our own products through our direct sales organization. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Our highly efficient product innovation process.</I></B> Our differentiated products have been a significant factor in our commercial success. We believe our ability to rapidly develop innovative products is in
large part attributable to the fully integrated product innovation process that we have implemented and the management philosophy behind that process. From project initiation, we staff projects with a development team that includes our R&amp;D
engineers, personnel with manufacturing and quality control competencies, as well as employees focused on clinical, regulatory and marketing. This enables us to have a broad perspective on the design, manufacturing and clinical needs for the
product, and ensures that members of the team share in the ownership of any given project. In addition, we rotate our project team leaders from our various functional areas to ensure cooperation and communication. We empower each project team to
foster and encourage long-term innovative success by discouraging the fear of failure. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Our disciplined approach to product and commercial development.</I></B> One of the benefits of our organizational structure and product innovation process is our ability to approach our development and
commercialization in a disciplined manner. In our product development, this discipline includes incorporating the feedback of our cross-functional teams to optimize the materials selection or physician ease-of-use objectives early in the process,
which enables us to accelerate the development process. Of equal importance, this also enables us to eliminate a project more expeditiously should it not meet the requirements for success defined by one of our functional teams. In our commercial
development, we believe that we have applied the same discipline to our selection of target end markets and our identification of new sales and marketing talent. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE="font-family:arial; font-size:10pt"><B><I>Our deep understanding of our target end markets.</I></B> We have assembled a team with in-depth knowledge of both of the target end markets in which we
currently compete. We entered the neuro market in 2007, and we have a highly experienced team with extensive expertise and long tenure in this market. We believe our experience and expertise in this market has enabled us to effectively address
specific clinical challenges with innovative products and technologies. In our peripheral vascular business, we have built </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">69 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-family:arial; font-size:10pt">
a team with vast experience in peripheral vascular disease. We have also sought expertise and gained insight from many of the physician thought leaders in the interventional and vascular surgery
community. The combination of internal expertise and access to external expertise has enabled us to engage in focused product development. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Our relationships with specialist physicians.</I></B> Many of the specialist physicians who use our products have been responsible for developing clinical treatments in the neuro and peripheral vascular markets.
Given our deep understanding of the clinical challenges in these markets, we have been able to develop very strong relationships with many of the leading specialist physicians. These physicians range from those in the specialist residency programs
in endovascular treatment of stroke to influential thought leaders who are developing some of the most innovative research and techniques in the field. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Our Growth Strategies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe the following strategies
will continue to play a critical role in our future growth: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Expanding the penetration of our products in our target end markets.</I></B> In order to grow our business, we plan to continue to establish and strengthen our presence in our target end markets of neuro and
peripheral vascular disease. We sell our products through our direct sales organization in the United States, most of Europe, Canada and Australia and through distributors in select international markets. We plan to expand the reach and penetration
of our products by growing our direct sales organization and establishing new relationships with specialist physicians who have not used our products. We also plan to establish deeper relationships with hospital customers for whom we believe the
cost effectiveness of our products is very attractive relative to alternatives. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Growing the acceptance of our innovative products as the standard of care in their targeted clinical applications.</I></B> We develop innovative products to improve the clinical outcomes in our targeted
applications in a cost effective manner. Improving a clinical outcome can have many implications, ranging from improving post-procedure reperfusion in ischemic stroke or limb ischemia to generating rapid occlusion in hemorrhagic stroke patients and
reducing procedure times. We have evaluated some of our products in clinical studies to obtain U.S. regulatory clearance, and many of our products have been studied post-marketing in either Penumbra or third-party sponsored clinical trials. We
believe that our strategy of continuing to invest in clinical studies for our products will help us differentiate our products for specialist physicians, hospital customers and patients. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Continuing to leverage our product development capabilities to drive efficient, rapid product development.</I></B> We believe our highly efficient product development process has been a significant factor in our
success to date. We plan to continue investing in product development, applying our integrated development approach and core technology expertise, to drive efficient, rapid product development in our target end markets. We expect to maintain our
disciplined approach to product development in markets where we believe we can improve clinical outcomes in a cost-effective manner. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Scaling our culture of cooperative product development and commercial execution.</I></B> We believe that our organizational structure has been an important differentiating factor because it has enabled us to
innovate and commercialize our products in a capital efficient manner. As we have grown as an organization, we have been able to scale our business from development stage in 2004 to a company with approximately 850 employees currently focused on
multiple product categories in two target end markets. We believe our experience in maintaining our unique structure while scaling our business will help us considerably as we grow our business going forward. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">70 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Our Products </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Since our founding in 2004, we have invested in expanding our product development and marketing capabilities. These investments have included engineering
and materials science capabilities, pre-clinical and bench-testing infrastructure and in-house clinical and regulatory infrastructure. Our fully-integrated organization has enabled us to launch 14 product brands for access, thrombectomy and
embolization since 2007 to service our two target end markets. Our current portfolio provides a range of products that are designed to enable specialist physicians to drive improved clinical outcomes in a cost effective manner. Numerous independent
clinical studies have supported the cost-effectiveness of our products for hospital customers through comparative cost data. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table
summarizes our product offerings in each of our target end markets: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923792g99m70.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">71 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>OUR NEURO PRODUCTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Neurovascular Access </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Accessing the brain through the tortuous
neurovasculature has been a substantial challenge for physicians treating vascular disorders in the brain. Companies developing products for neurovascular applications have historically leveraged technologies developed for use in coronary or
peripheral vascular interventions. This approach created challenges given the vastly different anatomy, structure and sizing of the neurovascular vessels. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our portfolio of neurovascular access products includes our Neuron Access System catheters, BENCHMARK Intracranial Access System catheters and a variety
of microcatheters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Neuron Access System </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We
recognized the challenges posed by existing access technologies and focused our initial efforts on developing a guide catheter system designed specifically for neurointerventional procedures. Our Neuron delivery catheter is a variable stiffness
guide catheter with increased support in the aortic arch, which enables trackability to access the intracranial vasculature. The design of Neuron enables physicians to position the catheter much higher in the anatomy than conventional guide
catheters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe the Neuron family of guide catheters and the Penumbra distal delivery catheters that we subsequently introduced have enabled
many neuro-endovascular procedures that previously had not been possible in the tortuous anatomy of the neurovasculature. We have continued our development and currently offer a wide range of catheters that enable delivery of the different
therapeutic catheters that are required for ischemic and hemorrhagic stroke interventions. Our Neuron products include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>The Neuron Intracranial Access System</I> is indicated for the introduction of interventional devices into the peripheral, coronary and neuro vasculature. The system is a two-catheter system comprised of the Neuron
Delivery Catheter and the Select Catheter. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>The Neuron Delivery Catheter</I> is a variable stiffness, large lumen catheter that combines proximal arch support with a microcatheter-like distal segment that is designed to access the intracranial anatomy. The
Neuron can be used individually with a 0.038 inch guidewire, or together with the Neuron Select Catheter, to access the desired location. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>The Select Catheter</I> is a single lumen, braid-reinforced, torquable catheter with a radiopaque distal end and a hub on the proximal end. The Select Catheter enables primary access with the Neuron Delivery
Catheters, obviating the need for an extra guide catheter. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>The Neuron MAX System</I> is an additional configuration to the currently available Neuron Intracranial Access System. The Neuron MAX System is a long sheath catheter with a flexible distal tip for neurovascular use
and provides a larger lumen to enable a wide range of device compatibility in neurovascular procedures. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>BENCHMARK Intracranial Access System
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Advances in our catheter technology, driven largely by our advances in ischemic stroke therapy, have enabled us to further develop our
intracranial access category of products. Our latest development in this category is the BENCHMARK catheter, which features additional improvements in ease-of-use, trackability, and aortic arch support that we believe will further enhance our
position in the neurovascular access market. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The BENCHMARK catheter technology achieves these improvements by combining our advanced tracking
technology with the original Neuron intracranial access concept. In addition to improved proximal support in the arch through multi-geometry metal reinforcement, the distal tip is softer and more trackable, while maintaining complete distal shaft
radiopacity for improved visualization. The BENCHMARK also is available pre-packaged with a Select catheter to obviate the need for a neurovascular guide catheter exchange, which reduces the number of devices needed per procedure and shortens
procedure times. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">72 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Ischemic Stroke </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Penumbra
System </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We developed our aspiration-based Penumbra System family of products to enable specialist physicians to revascularize blood vessels
that are blocked by clots in the intracranial vasculature. We launched our first Penumbra System product in 2008 in the United States. We believe ACE, launched in June 2013, and ACE 64, launched in May 2015, represent significant advancements over
prior generations of the Penumbra System, enabling physicians to treat patients with ischemic stroke quickly, safely and cost effectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:arial"><I>Overview of the Penumbra System </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our Penumbra
System family of products is comprised of several principal components, which include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Penumbra Reperfusion Catheters</I> are the cornerstone of the Penumbra System and are manufactured using a variety of proprietary processes and materials science innovations. We have launched five successive
generations of Reperfusion Catheters since 2008. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:6%; font-size:10pt; font-family:arial">The latest generation of our Reperfusion Catheters, the ACE family of catheters,
represents our most powerful and trackable Reperfusion Catheters launched to date. Its design enables specialist physicians to track these large bore aspiration catheters to the distal locations of occluded vessels. Once at the site of the
occlusion, ACE provides significantly greater aspiration power than our prior Reperfusion Catheters, which we believe contributes to improved clinical outcomes and reduced procedure times. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:6%; font-size:10pt; font-family:arial">ACE 64, our latest generation of ACE catheter, is designed to offer enhanced aspiration power relative to prior generations of the product, while
maintaining trackability. ACE 64 launched in the United States in late May 2015. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Penumbra Separators</I> are a component of the earlier generations of the Penumbra System and enable a physician to remove an aspirated clot that has aggregated in the Reperfusion Catheter during the procedure. The
Separators were an important component of our earlier Penumbra System due to the smaller diameter of our original Reperfusion Catheters, which resulted in frequent obstruction of the catheter. With the launch of our larger diameter ACE, Separators
are less frequently used by physicians. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>3D</I> is a stent retriever component of the Penumbra System that allows a physician to combine direct aspiration with stent retriever technology in a procedure commonly called &#147;Solumbra.&#148; 3D is currently
being evaluated in a clinical study pursuant to an Investigational Device Exemption (IDE) to obtain 510(k) clearance. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Penumbra Aspiration Pumps</I> are attached to our Reperfusion Catheters and provide the aspirating suction force. Our second generation MAX Aspiration Pump features increased aspiration capabilities and an improved,
easier to use design. We have standardized the MAX Aspiration Pump to work with all generations of our Reperfusion Catheters. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:arial"><I>Evolution of Penumbra System&#146;s Reperfusion Catheters </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Penumbra System Reperfusion Catheters are the foundation of the Penumbra System. The principal generations of our Reperfusion Catheters include the
original Penumbra System, Penumbra System MAX, Penumbra System ACE and Penumbra System ACE 64. We have introduced five successive generations of these catheters since early 2008. Each subsequent generation of our Reperfusion Catheters has
incorporated significant performance enhancements relative to prior generations with regard to trackability and aspiration power. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">73 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>The Generations of the Penumbra System </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923792g69x68.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:arial"><I>The Original Penumbra System </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our original Penumbra System was CE&#150;marked in September 2006 and 510(k) cleared by the FDA in December 2007. The Penumbra System is intended for use
in the revascularization of patients with ischemic stroke within eight hours of symptom onset. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our original Penumbra System was evaluated in the
Penumbra Pivotal study, a 125 patient clinical study to assess the safety and effectiveness of the Penumbra System in the revascularization of patients presenting with ischemic stroke. The Penumbra Pivotal study demonstrated an 81.6% success rate in
achieving successful revascularization. The study was completed in 2007 and the results were published in the journal <I>Stroke</I> in 2009. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We had
commissioned and subsequently evaluated the Penumbra System in our THERAPY study, a clinical study comparing the clinical outcomes in the medical management of stroke patients with IV recombinant tPA (rtPA) to stroke patients treated with a
combination of IV rtPA and the Penumbra System. The THERAPY study was commenced in March 2012, and was designed to enroll up to 692 patients, but was stopped early in October 2014, because the positive results of the MR CLEAN study made it unethical
to continue to treat the control group in the THERAPY study with medical management rather than with endovascular treatment. The MR CLEAN study demonstrated the superiority of endovascular treatment of stroke over medical management. As a result,
the steering committee for THERAPY recommended stopping enrollment for the trial. The THERAPY study results, after the randomization of 108 patients, were presented in April 2015 at the European Stroke Organization Conference and the manuscript is
being prepared for submission to a peer-reviewed journal. Despite the early termination of the study, the pre-specified per protocol analysis demonstrated a significant benefit of combined treatment with IV rtPA and the Penumbra System over IV rtPA
alone. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">74 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:arial"><I>Penumbra System MAX </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Penumbra System MAX applies our advanced tracking technology and improved aspiration power to the Penumbra System&#146;s aspiration platform.
Launched in 2011, the 3MAX and 4MAX Systems feature MAX Tracking Technology that allows access over a solo guidewire for an even faster, easier procedure than with our original Penumbra System. The proximal shaft of these specialized catheters
incorporates tapering, larger diameters, enabling increased aspiration power. In August 2012, we launched the 5MAX, which added our MAX Tracking Technology to an even larger dimension Reperfusion Catheter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:arial"><I>ACE </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Almost a decade of research and product
development culminated in the introduction of our first ACE Reperfusion Catheter in July 2013. ACE features a unique tapered design, large lumen diameter and other developments that result in significantly greater aspiration power and improved
trackability compared to our earlier original Penumbra System and Penumbra MAX products. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Given its improved aspiration power and larger lumen size,
our ACE Reperfusion Catheter can enable the extraction of a fibrous thrombus without fragmentation and often in one solid piece. This leaves the longitudinal fibrin strands in the clot intact, allowing the thrombus to retain its integrity. We
believe this is evidenced in our post-launch clinical experience, in which clinicians have seen high rates of TICI 3 revascularization, representing complete recanalization of the affected area, using our ACE catheters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our ACE 64 Reperfusion Catheter was launched in the United States in May 2015. It is built on our ACE platform and offers an increased lumen diameter,
which leads to further increased aspiration power and which we believe will aid in the removal of clot from the neurovasculature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>ACE Reperfusion
Catheter </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923792g52i76.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">75 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:arial"><I>Penumbra System Clinical Experience </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">There have been a number of clinical studies that have confirmed that mechanical thrombectomy results in generally better clinical outcomes than
non-interventional treatments. Generations of our Penumbra System have been evaluated in several post-market clinical studies that demonstrate improved clinical outcomes and cost effectiveness. The following table summarizes certain key findings
from certain clinical studies involving the Penumbra System and competitive technologies for treatment of ischemic stroke. In these clinical studies, the Penumbra System demonstrated robust clinical performance. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR BGCOLOR="#051e68" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt"><FONT COLOR="#ffffff"><B>Product</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#ffffff"><B>Merci</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#ffffff"><B>Original<BR>Penumbra<BR>System</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#ffffff"><B>Stent<BR>Retriever</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#ffffff"><B>&#147;Solumbra&#148;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#ffffff"><B>5MAX</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><FONT COLOR="#ffffff"><B>ACE</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-right:8pt">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"><B>Author</B></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="center"><B>Kass-Hout<BR></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="center"><B>(JNIS 2014)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="center"><B>Humphries<BR></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="center"><B>(JNIS</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="center"><B>2014)<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:arial" ALIGN="center"><B>Turk<BR></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="center"><B>(JNIS&nbsp;2014)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt">&nbsp;</TD></TR>


<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Number of patients</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">115</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">TICI 2b/3</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:arial"><I>(Successful revascularization (includes partial and complete revascularization))</I></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">70%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">78%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">86%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">88%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">96%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">98%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">TICI 3</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:arial"><I>(Complete revascularization)</I></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">14%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">9%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">37%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">44%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">41%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">61%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Puncture to
revascularization</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:arial"><I>(Time from groin puncture to successful revascularization)</I></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">91&nbsp;min</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">75&nbsp;min</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">79&nbsp;min</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">57&nbsp;min</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">38&nbsp;min</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">36&nbsp;min</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">sICH</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:arial"><I>(Symptomatic intracranial hemorrhage)</I></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">7%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">6%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">7%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">5%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">0%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">0%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">mRS <FONT
STYLE="font-family:Times New Roman"><FONT STYLE="FONT-FAMILY:SYMBOL">&#163;</FONT></FONT> 2 at 90 days</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:arial"><I>(Modified Rankin scale)</I></P></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">25%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">41%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">36%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">44%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">34%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000" ALIGN="right">50%</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8pt">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>(1)</TD>
<TD ALIGN="left" VALIGN="top">Kass-Hout T, Kass-Hout O, Sun C-H J, et al. (2014) Clinical, angiographic and radiographic outcome differences among mechanical thrombectomy devices: initial experience of a large-volume center. <I>J NeuroIntervent
Surg</I>. Advance online publication doi:10.1136/neurintsurg-2013-011037. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Humphries W, Hoit D, Doss VT, et al. (2014) Distal aspiration with retrievable stent assisted thrombectomy for the treatment of ischemic stroke. <I>J NeuroIntervent Surg</I>. Advance online publication
doi:10.1136/neurintsurg-2013-010986. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Turk AS, Frei D, Fiorella D, et al. (2014) ADAPT FAST study: a direct aspiration first pass technique for stroke thrombectomy. <I>J NeuroIntervent Surg</I>. Advance online publication
doi:10.1136/neurintsurg-2014-011125. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe the advancements offered by the Penumbra System, and in particular the ACE Reperfusion
Catheter, have changed and will continue to change the way specialist physicians treat ischemic stroke. Some of the principal benefits include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Improved trackability:</I> The ACE Reperfusion Catheter&#146;s design features significant improvements in trackability, enabling greater ease-of-use in accessing the middle cerebral artery in a highly reproducible
manner. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Reduced procedure times:</I> We believe the improved trackability and the significantly greater aspiration power, which can be applied directly to the site of the clot, can enable clinicians using ACE to achieve
revascularization faster than has been possible historically. Once our catheter has been navigated to the clot site, aspiration is typically rapid and the clot removed, often intact. The ADAPT FAST study demonstrated that ACE procedures averaged
revascularization in 36 minutes from groin access. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Reduced need for general anesthesia:</I> We believe ACE also may offer clinicians the ability to reduce the need for general anesthesia during the procedure. In some cases, ACE procedures can be performed without
general anesthesia. It has been demonstrated that performing thrombectomy procedures without general anesthesia has been associated with better clinical outcomes for the patient. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">76 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Significant cost advantage:</I> We designed ACE to offer significant economic advantages to our hospital customers relative to prior generations of the Penumbra System and our competitors&#146; offerings. These cost
savings relative to competitive revascularization products are driven by lower total direct product costs as well as reduced procedure times. Based on current list prices, ACE procedures can be performed more cost effectively than procedures using
stent retrievers based on device costs alone. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>3D </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">3D is a stent retriever that is designed to be used in conjunction with our Penumbra System. We believe that it will be useful in treating a small
percentage of very difficult to treat ischemic clots that may not be removed with our catheters and aspiration pumps alone. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>3D </B></P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923792g47d02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>(side view of deployed 3D stent retriever) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are currently evaluating 3D in a clinical trial pursuant to an Investigational Device Exemption (IDE) study to obtain 510(k) clearance. The 230
patient clinical study compares the safety and effectiveness of 3D as part of the Penumbra System with that of the standard Penumbra System alone. This study is actively enrolling patients. As of March&nbsp;31, 2015, we have recruited 50 centers in
the United States to participate in the trial and have enrolled 174 patients. We expect to complete enrollment of the study in 2016 and anticipate being in a position to file for 510(k) clearance by the end of 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Neurovascular Embolization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Given the minimal product
differentiation among the existing coils on the market, we concluded that to initially penetrate this market successfully we would have to develop a coil that was materially easier to deliver, and provided a procedural economic advantage. We also
identified a segment of aneurysms that traditional neurovascular coils could not effectively treat on a cost effective basis. These included larger aneurysms and other larger, more complex lesions. We estimate that these aneurysms and lesions
currently represent less than 10% of the addressable aneurysms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The Penumbra Coil 400 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We developed our Penumbra Coil 400 to offer an improved alternative for the treatment of larger aneurysms and other larger, more complex lesions. We
implemented several proprietary design innovations to enable the coil to maintain shape while achieving biomechanically stable occlusion. Our coil system is composed of a platinum embolization coil complemented by a nitinol inner structure and
stretch resistant nitinol wire. It is attached to a composite delivery pusher with a radiopaque positioning marker. The Penumbra Detachment Handle offers instant mechanical detachment of the coil and can be controlled by the physician in the sterile
field. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">77 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We received 510(k) clearance for the Penumbra Coil 400 in 2011. The Penumbra Coil system is FDA cleared for
endovascular embolization of intracranial aneurysms and other neurovascular abnormalities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra Coil 400 Design Relative to Traditional Coils
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923792g09m51.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:arial"><I>Review of Penumbra Coil 400 Clinical Performance </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Given the size and handling of the Penumbra Coil 400, it is able to achieve higher packing density with fewer coils compared to competitive coiling
systems. These findings have been confirmed in numerous physician sponsored post-marketing studies. Collectively, the clinical studies have shown that use of the Penumbra Coil 400 resulted in: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">less retreatments or worsening occlusions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">larger aneurysm treatment capabilities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">higher packing density; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">fewer coils per aneurysm. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Clinical studies evaluating the Penumbra Coil 400 have shown the clinical and
economic benefit of using the large volume Penumbra Coil 400. Some of the principle conclusions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In their study of 75 patients, Patel et al. reported their single-center experience with the Penumbra Coil 400 and compared it to their results with conventional coils. They concluded that the Penumbra Coil 400 is more
efficient in the embolization of cerebral aneurysms, achieves greater packing density with fewer coils, and the related procedure takes less time to perform without compromising safety. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">In their study of 58 patients, Milburn et al. reported their single-center experience with the Penumbra Coil 400 and compared it to their results with conventional coils. In consecutive cases, they reported a greater
than 90% rate of stable occlusion on average follow-up time of 8.6 months. They evaluated and compared the number and total length of coils used per unit volume of aneurysm and experienced a 67% cost savings using the Penumbra Coil 400.
</TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Penumbra SMART Coil </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Leveraging our
initial experience treating larger aneurysms and more complex lesions with the Penumbra Coil 400, we turned our efforts to developing a standard sized coil to compete in the traditional, smaller neurovascular coil market. While the market has seen
significant growth over the last 15 years, there has been very little innovation in the last several years with regard to coil design, material science and performance. As a result, neurovascular coils built on the traditional, smaller-coil platform
offer very little differentiation in terms of materials, ease-of-use and trackability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">78 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In light of these dynamics, we focused our development efforts on a coil that would improve ease of
delivery, or &#147;feel&#148; of the coil compared to the leading established coils. In order to accomplish this, our engineering team developed a highly sophisticated coil that dramatically changes its softness profile within the span of a single
individual coil. This progressive softness feature enables physicians to pack the coil into a delicate lesion and mitigate catheter kick-back at the end of delivery, which can preclude the successful complete embolization of the lesion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Penumbra SMART Coil is designed to treat patients with a wide range of neurovascular lesions, including the small and medium sized aneurysms that
comprise the majority of the neurovascular coiling market. Alternative products available to physicians in this market are offered in single levels of softness &#150; standard, soft or extra soft. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The three principal levels of softness that competitors offer are derived from using smaller platinum filaments to increase the level of softness.
However, this methodology does not allow for changes to the softness level within an individual coil. The design of the Penumbra SMART Coil allows the level of softness to be determined not only by the diameter of the platinum filament, but also by
a structural component inside the coil itself. This development enables the Penumbra SMART Coil to become progressively softer within the span of an individual coil. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We anticipate launching our SMART Coil in the second half of 2015. We believe that it will provide us with another important opportunity to offer
specialist physicians a broader suite of products to address their neurovascular coiling needs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>LIBERTY Stent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As the market for neurovascular coils grew over the past 15 years, the need arose to optimize coil performance using additional structural support
devices. Neurovascular stents were initially developed as a means to complement these coil embolization procedures by enabling the treatment of wide-necked aneurysms that could not be treated with coils alone. These stents have historically had
several shortcomings, which include lack of complete coverage of the neck of the aneurysm, challenging stent delivery through neurovascular tortuosity and limited vessel wall opposition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">To expand our presence in the market for the treatment of aneurysms, we began developing a next generation aneurysm stent that could overcome the
limitations of existing stents. The objectives were to develop a stent that could: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide enhanced coverage of the neck of the aneurysm and increased flow diversion; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">improve ease-of-use and stent delivery; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide improved opposition to the vessel wall through a self-expanding stent with excellent conformability. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The LIBERTY stent is Penumbra&#146;s product for stent-assisted coil embolization. The product incorporates a self-expanding nitinol stent technology
developed from a laser-cut hypotube processed to create high coverage with many thin struts supported by a larger structure. This laser-cut nitinol design, complete with thin stent struts, address many of the limitations of other products in the
market. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Unlike currently marketed flow-diverting stents, the LIBERTY stent allows the physician to penetrate the stent with a microcatheter and
place coils for immediate protection from the possibility of aneurysm rupture, while establishing a scaffold for healing across the aneurysm neck. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">79 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>LIBERTY Stent System </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923792g52x14.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are currently evaluating LIBERTY in a 120 patient international clinical study, the results of which, if positive,
will be submitted to support our premarket approval application, or PMA. As of March&nbsp;31, 2015, we had enrolled 113&nbsp;patients in the study. We expect to complete enrollment of the study by the end of 2015 and anticipate being in a position
to file for PMA approval by the FDA upon completion of the last patient&#146;s 12-month follow-up. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Neurosurgical Tools </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>The Apollo System </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We received 510(k) clearance from
the FDA for our first neurosurgical product, the Apollo System, in 2014. The Apollo system leverages our expertise in thrombectomy and access to offer a minimally invasive approach to surgical removal of fluid and tissue from the ventricles in the
brain. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Apollo system is comprised of two primary components: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Apollo wand that is inserted into the brain through an endoscope, which, in turn, is inserted through a small burr hole into the skull; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a reusable hardware device that delivers vacuum, irrigation and vibrational energy along the disposable wand to the site of the hemorrhage. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">80 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>


<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Apollo System</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>Apollo Wand</B></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g923792g57t30.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt" ALIGN="center">


<IMG SRC="g923792g36f76.jpg" ALT="LOGO">
&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>OUR PERIPHERAL VASCULAR PRODUCTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">After initially focusing our business on our neuro products, we identified the peripheral vascular market as an ideal opportunity to leverage our neuro
experience and our core expertise in thrombectomy, embolization and access technologies to develop new products that could address significant clinical needs cost effectively. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The peripheral vasculature suffers from disorders that are very similar to those experienced in the neurovasculature that our products already
successfully address. For example, weakening of the vascular walls can result in aneurysms, and blockages can form as the result of embolism or advanced atherosclerosis. Just as the disruption of blood flow to the brain has high mortality and
morbidity, disruptions in the peripheral vasculature can also have serious adverse consequences. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The peripheral vasculature also presents unique
challenges that do not apply to interventional efforts in the brain. Many peripheral arteries and veins are significantly larger than those found in the brain and therefore have higher blood flow rates. More importantly, they must be able to
accommodate larger pressure gradients and sustain structural integrity despite substantial movement and flexing of the organs and musculature that surround them. Imaging can also be more challenging as physicians have to view their equipment through
many more layers of organs and tissue than in the brain. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In 2012, we began investing further in research and development to evaluate and identify
potential solutions to address significant clinical needs in the peripheral vasculature. Our products for the treatment of peripheral vascular disease focus on: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">peripheral vascular embolization; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">vessel occlusion; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">peripheral vascular thrombectomy. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Peripheral Embolization </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Ruby Coil System </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">After completing research and
development focusing on the specific requirements of the peripheral embolization market, we launched our Ruby Coil System for use in the peripheral vascular market in 2013. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">81 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Ruby Coil System consists of detachable coils that are specifically designed for peripheral applications. The Ruby coils have a controlled mechanical detachment mechanism that permits the
physician to deliver and reposition the coil until the final satisfactory position is reached before detachment. Compared to pushable coils, this minimizes costly complications like embolizing unintended vessels. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Ruby Coil System is used in a variety of clinical applications, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">active extravasations, or the escape of blood into surrounding tissue; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">selective embolization in patients with visceral aneurysms; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">exclusion of branches prior to chemoembolization and radioembolization; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">embolization in patients with gastrointestinal bleeding; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">embolization of branches prior to stent graft procedures; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">procedures after stent grafting in patients with persistent type II endoleaks and sac enlargement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">treatment of patients with varicocele and pelvic congestion syndrome; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">high flow arterial venous malformations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">post trans intrahepatic shunt placement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">balloon retrograde transvenous obliteration; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">exclusion of hepatic branches prior to liver resection. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe our Ruby Coil System offers
specialist physicians a differentiated, cost-effective solution in the treatment of peripheral embolization patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>POD (Penumbra Occlusion Device)
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We developed POD, our peripheral vascular occlusion device, to address a specific need in the peripheral embolization market to rapidly and
precisely occlude a target vessel. Current options for vessel occlusion in the periphery are limited, either requiring multiple devices or difficult to deliver vascular plugs. Microcatheter deliverable devices, such as coils, are not ideally suited
for vessel embolization due to their tendency to migrate with antegrade flow and generally require the deployment of several devices to achieve occlusion. Vascular plug technology for larger peripheral vessels requires access with large diagnostic
catheters or even larger bore sheaths. Additionally, these devices often require the placement of adjunctive devices, such as coils, to achieve complete occlusion. Our POD device utilizes technology that delivers both variable sizing and variable
softness to provide a single device solution for rapid and precise embolization of the target vessel. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Unlike conventional vascular plugs, our POD
technology enables the occlusive device to be delivered through a microcatheter. Additionally, a single POD can occlude a range of vessel diameters, reducing the need for sophisticated measurement prior to embolization. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our POD technology leverages the key features of a dedicated vessel embolization device to improve ease-of-use. These include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">microcatheter deliverability; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">instant detachment; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">immediate and precise anchoring; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a single device to treat a range of vessel diameters; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">dense occlusion in a short segment. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The technology achieves this range of features through the design of
a distal anchoring segment, thereby immediately anchoring the device in a range of vessel diameters. The proximal segment of the POD achieves </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">82 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
dense occlusion by packing a softer, smaller diameter segment tightly behind the anchored portion. Once POD is deployed, it can be detached instantly with the sterile detachment handle. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>POD technology deployment </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>


<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g923792g84m45.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center">


<IMG SRC="g923792g65f54.jpg" ALT="LOGO">
&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B><I>Step 1: Anchor</I></B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B><I>Step 2: Pack</I></B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Peripheral Thrombectomy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Indigo System
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our Indigo System, which we launched in 2014, was designed for continuous aspiration mechanical thrombectomy (CAT), leveraging the success
of the Penumbra System in ischemic stroke. The Indigo System is designed to remove clots in the peripheral arteries, including in patients with limb ischemia. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our Indigo System family of products and accessories is an easy to use thrombectomy system that is powerful, highly trackable, and suited to a wide range
of clot morphology. The principal components include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Continuous Aspiration Mechanical Thrombectomy Catheters</I> are the foundation of the system and are ideally suited to reach anatomy below the knee. Much like our MAX and ACE catheters, the CAT catheters are robust,
durable, trackable and suited for the peripheral anatomy. The initial launch of the Indigo System included our CAT5 catheter and the device made for more distal access, CAT3, which is able to reach the distal peripheral vessels of the upper and
lower extremities. On May 26, 2015, we received FDA clearance for two larger sizes of the Indigo System, as well as to market the Indigo System for use in the vessels of both the peripheral arterial and venous systems. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Indigo Separator</I> enables the peripheral interventionalist to remove a difficult to aspirate clot from the CAT catheter. In the peripheral vessels, clots often form in long segments, and are more resistant to
traditional aspiration techniques. The Indigo System with the Separator enables a wide range of clot morphology to be removed from the body. In clinical settings, we have demonstrated that the Indigo System with the Separator removes clots that were
resistant to hours of revascularization attempts with other technologies and thrombolytic agents. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Penumbra Aspiration Pump</I> is the power source that provides the aspirating suction force to remove waste, such as blood and clots. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our initial clinical experience with the Indigo System has demonstrated high rates of revascularization and reduced procedure times in a range of case
applications including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">revascularization of visceral vessels; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">upper extremity revascularization in the brachial, radial, ulnar and digital arteries; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">above and below the knee revascularization of arteries such as the superficial femoral, popliteal, peroneal, tibial and pedal arteries; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">rescue revascularization following failed revascularization or embolic showering during angioplasty/stenting, complete total occlusion (CTO) procedures, atherectomy, mechanical thrombectomy and thrombolytic infusion.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">83 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Procedure times with current treatment options often range from several hours up to 24 to 72 hours when
thrombolytic therapy is administered. Procedures using the Indigo Systems can generally achieve revascularization in times similar to the neuro experience with the Penumbra System in ischemic stroke. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are working with leaders in the peripheral interventional field to collect clinical data in our PRISM study, which is a retrospective analysis of
technical success using the Penumbra and Indigo Systems for mechanical thrombectomy in the periphery. Initial results of the PRISM study were presented at the 2015 Annual Scientific Meeting of the Society of Interventional Radiology (SIR). In the
study, 44.7% of patients were treated initially with Indigo and 44.7% of patients were treated following failed lytic therapy with the remaining patients treated following failed pharmaco-mechanical therapy. In the presented data, 97.3% of patients
were successfully revascularized, and there were no device-related complications. The data illustrates the benefits of the Indigo System in achieving revascularization of these patients, many of whom had the Indigo System used in the first line
therapy. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="26%"></TD>
<TD></TD></TR>


<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>CAT 5 &amp; SEP 5, CAT 3 &amp; SEP 3</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="center"><B>Indigo Pump</B></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:1pt" ALIGN="center">


<IMG SRC="g923792g98k18.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:1pt; margin-top:0pt" ALIGN="center">


<IMG SRC="g923792g07k32.jpg" ALT="LOGO">
&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Research and Development </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We
direct our research efforts towards the development of clinical therapies that expand the therapeutic alternatives available to specialist physicians and improve upon our existing product offerings. Our research and development team has a track
record of product innovation and significant product improvements. Since inception, we have introduced 14 products brands in either the United States, international markets, or both. Our research and development expenses totaled $15.6 million and
$14.1 million for the years ended December&nbsp;31, 2014 and 2013, respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe our ability to rapidly develop innovative products is in
large part attributable to the fully integrated product innovation process that we have implemented, and the management philosophy behind that process. In addition, we have recruited and retained engineers with both significant experience in the
development of medical devices as well as engineers directly from undergraduate and graduate programs that have become immediately productive within our development process. We have a pipeline of products in various stages of development that are
expected to provide additional commercial opportunities. All of our research and development efforts are based at our campus in Alameda, California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Manufacturing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We currently maintain one manufacturing
facility at our campus in Alameda, California, which, together with our research and development space, totals 180,000 square feet. The manufacturing facilities run two eight-hour shifts per weekday. In addition, we have capacity to increase
production, and can expand adjacent to our current facilities. We currently produce substantially all of our products in house. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our rigorous quality
control management programs have earned us a number of quality-related manufacturing designations. Our manufacturing facilities are EN ISO 13485 compliant with ISO 13485-2003 certification achieved in 2005. In 2007, we achieved compliance with MDD
standards, allowing our products to be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">84 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
CE marked. We use annual internal audits, combined with external audits by regulatory agencies to help ensure strong quality control practices. An internal, on-going staff training and education
program contributes to our quality assurance program; training is documented and considered part of the employee evaluation process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Sales and Marketing
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have dedicated substantial resources to establish a direct sales capability in the United States, most of Europe, Canada and Australia, which
we have complemented with distributors in Japan and certain other international markets. We have regulatory clearance to sell many of our products in the majority of markets worldwide and believe our global presence enables us to capitalize on the
markets for neuro and peripheral vascular devices that exist outside of the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We currently sell our products to hospitals in the United
States through our dedicated salesforce in two target end markets, neuro and peripheral vascular. Our sales representatives and sales managers generally have substantial medical device experience and market our products directly to a variety of
specialist physicians engaged in the treatment of neurovascular and peripheral vascular disorders, who are the end users of our products and significantly influence hospital buying decisions relating to medical devices. We are focused on developing
strong relationships with specialist physicians and devote significant resources to training and educating physicians in the use and benefits of our products. The principal specialist physicians in our two target end markets include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Neuro:</I></B> Interventional neuroradiologists, neurosurgeons and interventional neurologists. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B><I>Peripheral vascular:</I></B> Interventional radiologists and vascular surgeons. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition to our
direct sales organizations, we work with distributors in certain geographies where we have determined that selling through distributors is likely to be more effective. The largest market where we sell our products through a distributor is Japan.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our direct sales have been, and we anticipate will continue to represent, a majority of our revenues. In 2014, direct sales accounted for
approximately 82.3% of our revenue, with the balance generated by independent distributors that sell our products outside of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Backlog </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We typically accept and ship orders on the day purchase orders are received or the next business day. Furthermore, if requested, we generally permit
customers to cancel or reschedule without penalty. As a result, we do not believe that our backlog at any particular time is material, nor is it a reliable indication of future revenue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Reimbursement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In the United States, hospitals are the
purchasers of our products. Hospitals in turn bill various third-party payors, such as Medicare, Medicaid and private health insurance plans, for the total healthcare services required to treat the patient. Government agencies, private insurers and
other payors determine whether to provide coverage for a particular procedure and to reimburse hospitals for inpatient treatment at a fixed rate based on the diagnosis-related group (DRG) as determined by the U.S. Centers for Medicare and Medicaid
Services (CMS). The fixed rate of reimbursement is based on the procedure performed, and is unrelated to the specific medical device used in that procedure. Medicare rates for the same or similar procedures vary due to geographic location, nature of
facility in which the procedure is performed (i.e., teaching or community hospital) and other factors. While private payors vary in their coverage and payment policies, most look to coverage and payment by Medicare as a benchmark by which to make
their own decisions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Some payors may deny reimbursement if they determine that the device used in a treatment was unnecessary, not cost-effective,
or used for a non-approved indication. We cannot assure you that government or private third-party payors will cover and reimburse the procedures using our products in whole or in part in the future or that payment rates will be adequate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">85 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Outside the United States, market acceptance of medical devices depends partly upon the availability of
reimbursement within the prevailing healthcare payment system. Reimbursement levels vary significantly by country, and by region within some countries. Reimbursement is obtained from a variety of sources, including government-sponsored and private
health insurance plans, and combinations of both. A small number of countries may require us to gather additional clinical data before recognizing coverage and reimbursement for our products. It is our intent to complete the requisite clinical
studies and obtain coverage and reimbursement approval in countries where it makes economic sense to do so. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The increased emphasis on managed
healthcare in the United States and on country and regional pricing and reimbursement controls in international markets will put additional pressure on product pricing, reimbursement and usage, which may adversely affect our product sales and
results of operations. These pressures can arise from rules and practices of insurers and managed care organizations, judicial decisions and governmental laws and regulations related to Medicare, Medicaid and healthcare reform, medical device
reimbursement policies and pricing in general. Our ability to achieve market acceptance or significant sales volume will depend in large part on the availability of coverage and the level of reimbursement for procedures performed using our products
under healthcare payment systems in such markets. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">All third-party reimbursement programs, whether government funded or insured commercially, whether
in the United States or internationally, are developing increasingly sophisticated methods of controlling health care costs through prospective reimbursement and capitation programs, group purchasing, redesign of benefits, second opinions required
prior to major surgery, careful review of bills, encouragement of healthier lifestyles and exploration of more cost-effective methods of delivering health care. These types of programs and legislative or regulatory changes to reimbursement policies
could potentially limit the amount which healthcare providers may be willing to pay for medical devices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Competition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The medical device industry is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market
activities of industry participants. We compete with a number of manufacturers and distributors of neurovascular and peripheral vascular medical devices. Our most notable competitors are Boston Scientific, Johnson&nbsp;&amp; Johnson, Medtronic,
Stryker and Terumo. All of these competitors are large, well-capitalized companies with significantly more market share and resources than we have. As a consequence, they are able to spend more on product development, marketing, sales and other
product initiatives than we can. We also compete with a number of smaller medical device companies that have single products or a limited range of products. Some of our competitors have: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">significantly greater name recognition; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">broader or deeper relations with healthcare professionals, customers and third-party payors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">more established distribution networks; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">additional lines of products and the ability to offer rebates or bundle products to offer greater discounts or other incentives to gain a competitive advantage; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">greater experience in conducting research and development, manufacturing, clinical trials, marketing and obtaining regulatory clearance or approval for products; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">greater financial and human resources for product development, sales and marketing and patent litigation. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We compete primarily on the basis that our products are able to treat patients with neurovascular and peripheral vascular diseases and disorders safely
and effectively, with improved outcomes and procedural cost savings. Our continued success depends on our ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">develop innovative, proprietary products that can cost-effectively address significant clinical needs; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">continue to innovate and develop scientifically advanced technology; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">86 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">obtain and maintain regulatory clearances or approvals; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">demonstrate efficacy in Penumbra-sponsored and third-party clinical trials and studies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">apply technology across product lines and markets; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">attract and retain skilled research and development and sales personnel; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">cost-effectively manufacture and successfully market and sell products. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Intellectual Property </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our success depends in part on our ability to protect our proprietary technology and intellectual property and operate without infringing the patents and
other proprietary rights of third parties. We rely on a combination of patent, trademark, trade secret, copyright and other intellectual property rights and measures to protect our intellectual property rights that we consider important to our
business. We also rely on know-how and continuing technological innovation to develop and maintain our competitive position. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of March&nbsp;31,
2015, we owned 18 issued patents globally, of which seven were U.S. patents. As of March&nbsp;31, 2015, we owned 31 pending patent applications, of which 14 were patent applications pending in the United States. Subject to payment of required
maintenance fees, annuities and other charges, eight of our issued patents are currently expected to expire between 2024 and 2025; five of these patents relate to components of the Penumbra System and the Indigo System and one of these patents
relates to methods performed by the Apollo System. An additional four of our issued patents, which relate to components of devices that have not been commercialized, are expected to expire between 2026 and 2027. The remaining six of our issued
patents, which relate to the components of the Penumbra Coil and Ruby Coil, are currently expected to expire after 2027. Our issued patents relate to the following main areas: mechanical thrombectomy, coil embolization, treatment of aneurysm and
treatment of intracranial hemorrhage. Our pending patent applications relate primarily to the following five main areas: mechanical thrombectomy, coil embolization, coronary atherectomy, blood filtration and treatment of patients with intracranial
hemorrhage. Some of our pending patent applications pertain to components and methods of use associated with currently commercialized products. Our pending patent applications may not result in issued patents and we can give no assurance that any
patents that have issued or might issue in the future will protect our current or future products or provide us with any competitive advantage. See the section titled &#147;Risk Factors&#151;Risks Related to Our Intellectual Property&#148; for
additional information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Additionally, we own or have rights to trademarks or trade names that are used in our business and in conjunction with the
sale of our products, including seven U.S. trademark registrations and six foreign trademark registrations as of March&nbsp;31, 2015. Included in the registered trademarks is a mark with our company name and logo. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We also seek to protect our proprietary rights through a variety of methods, including confidentiality agreements and proprietary information agreements
with suppliers, employees, consultants and others who may have access to our proprietary information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Government Regulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>United States </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our products are medical devices subject to
extensive and ongoing regulation by the FDA under the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act), and its implementing regulations, as well as other federal and state regulatory bodies in the United States and comparable authorities in
other countries under other statutes and regulations. The laws and regulations govern, among other things, product design and development, pre- clinical and clinical testing, manufacturing, packaging, labeling, storage, recordkeeping and reporting,
clearance or approval, marketing, distribution, promotion, import and export, and post-marketing surveillance. Failure to comply with applicable requirements may subject a device and/or its manufacturer to a variety of administrative sanctions, such
as issuance of Warning letters, import detentions, civil monetary penalties, and/or judicial sanctions, such as product seizures, injunctions and criminal prosecution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">87 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>FDA&#146;s Premarket Clearance and Approval Requirements </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Each medical device we seek to commercially distribute in the United States will require either a prior 510(k) clearance, unless it is exempt, or a
premarket approval from the FDA. Medical devices are classified into one of three classes&#151;Class I, Class II or Class III&#151;depending on the degree of risk associated with each medical device and the extent of control needed to provide
reasonable assurance of safety and effectiveness. Class I devices are deemed to be low risk and are subject to the general controls of the FD&amp;C Act, such as provisions that relate to adulteration; misbranding; registration and listing;
notification, including repair, replacement, or refund; records and reports; and good manufacturing practices. Most Class I devices are classified as exempt from premarket notification under section 510(k) of the FD&amp;C Act, and therefore may be
commercially distributed without obtaining 510(k) clearance from the FDA., Class II devices are subject to both general controls and special controls to provide reasonable assurance of safety and effectiveness. Special controls include performance
standards, postmarket surveillance, patient registries, and guidance documents. A manufacturer may be required to submit to the FDA a premarket notification requesting permission to commercially distribute some Class II devices. Devices deemed by
the FDA to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices, or devices deemed not substantially equivalent to a previously cleared 510(k) device, are placed in Class III. A Class III device cannot be marketed
in the United States unless the FDA approves the device after submission of a premarket approval application, or PMA. However, there are some Class III devices for which FDA has not yet called for a PMA. For these devices, the manufacturer must
submit a premarket notification and obtain 510(k) clearance in orders to commercially distribute these devices. The FDA can also impose sales, marketing or other restrictions on devices in order to assure that they are used in a safe and effective
manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>510(k) Clearance Pathway </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">When a 510(k)
clearance is required, we must submit a premarket notification to the FDA demonstrating that our proposed device is substantially equivalent to a predicate device, which is a previously cleared and legally marketed 510(k) device or a device that was
in commercial distribution before May&nbsp;28, 1976. By regulation, a premarket notification must be submitted to the FDA at least 90 days before we intend to distribute a device. As a practical matter, clearance often takes significantly longer. To
demonstrate substantial equivalence, the manufacturer must show that the proposed device has the same intended use as the predicate device, and it either has the same technological characteristics, or different technological characteristics and the
information in the premarket notification demonstrates that the device is equally safe and effective and does not raise different questions of safety and effectiveness. The FDA may require further information, including clinical data, to make a
determination regarding substantial equivalence. If the FDA determines that the device, or its intended use, is not substantially equivalent to a previously cleared device or use, the FDA will place the device into Class III. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">There are three types of 510(k)s: traditional, special and abbreviated. Special 510(k)s are for devices that are modified and the modification needs a
new 510(k) but does not affect the intended use or alter the fundamental scientific technology of the device. Abbreviated 510(k)s are for devices that conform to a recognized standard. The special and abbreviated 510(k)s are intended to streamline
review, and the FDA intends to process special 510(k)s within 30 days of receipt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Premarket Approval Pathway </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">A premarket approval application must be submitted to the FDA for Class III devices for which the FDA has required a PMA. The premarket approval
application process is much more demanding than the 510(k) premarket notification process. A premarket approval application must be supported by extensive data, including but not limited to technical, preclinical, clinical trials, manufacturing and
labeling to demonstrate to the FDA&#146;s satisfaction reasonable evidence of safety and effectiveness of the device. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">After a premarket approval
application is submitted, the FDA has 45 days to determine whether the application is sufficiently complete to permit a substantive review and thus whether the FDA will file the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">88 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
application for review. The FDA has 180 days to review a filed premarket approval application, although the review of an application generally occurs over a significantly longer period of time
and can take up to several years. During this review period, the FDA may request additional information or clarification of the information already provided. Also, an advisory panel of experts from outside the FDA may be convened to review and
evaluate the application and provide recommendations to the FDA as to the approvability of the device. Although the FDA is not bound by the advisory panel decision, the panel&#146;s recommendations are important to the FDA&#146;s overall decision
making process. In addition, the FDA may conduct a preapproval inspection of the manufacturing facility to ensure compliance with the Quality System Regulation or QSR. The agency also may inspect one or more clinical sites to assure compliance with
FDA&#146;s regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Upon completion of the PMA review, the FDA may: (i)&nbsp;approve the PMA which authorizes commercial marketing with specific
prescribing information for one or more indications, which can be more limited than those originally sought; (ii)&nbsp;issue an approvable letter which indicates the FDA&#146;s belief that the PMA is approvable and states what additional information
the FDA requires, or the post-approval commitments that must be agreed to prior to approval; (iii)&nbsp;issue a not approvable letter which outlines steps required for approval, but which are typically more onerous than those in an approvable
letter, and may require additional clinical trials that are often expensive and time consuming and can delay approval for months or even years; or (iv)&nbsp;deny the application. If the FDA issues an approvable or not approvable letter, the
applicant has 180 days to respond, after which the FDA&#146;s review clock is reset. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Clinical Trials </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Clinical trials are almost always required to support premarket approval and are sometimes required for 510(k) clearance. In the United States, for
significant risk devices, these trials require submission of an application for an Investigational Device Exemption, or IDE, to the FDA. The IDE application must be supported by appropriate data, such as animal and laboratory testing results,
showing it is safe to test the device in humans and that the testing protocol is scientifically sound. The IDE must be approved in advance by the FDA for a specific number of patients at specified study sites. During the trial, the sponsor must
comply with the FDA&#146;s IDE requirements for investigator selection, trial monitoring, reporting, and recordkeeping. The investigators must obtain patient informed consent, rigorously follow the investigational plan and study protocol, control
the disposition of investigational devices, and comply with all reporting and recordkeeping requirements. Clinical trials for significant risk devices may not begin until the IDE application is approved by the FDA and the appropriate institutional
review boards, or IRBs, at the clinical trial sites. An IRB is an appropriately constituted group that has been formally designated to review and monitor medical research involving subjects and which has the authority to approve, require
modifications in, or disapprove research to protect the rights, safety and welfare of human research subjects. A nonsignificant risk device does not require FDA approval of an IDE; however, the clinical trial must still be conducted in compliance
with various requirements of FDA&#146;s IDE regulations and be approved by an IRB at the clinical trials sites. We, the FDA or the IRB at each site at which a clinical trial is being performed may withdraw approval of a clinical trial at any time
for various reasons, including a belief that the risks to study subjects outweigh the benefits or a failure to comply with FDA or IRB requirements. Even if a trial is completed, the results of clinical testing may not demonstrate the safety and
effectiveness of the device, may be equivocal or may otherwise not be sufficient to obtain approval or clearance of the product. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Sponsors of
clinical trials of devices are required to register with clinicaltrials.gov, a public database of clinical trial information. Information related to the device, patient population, phase of investigation, study sites and investigators, and other
aspects of the clinical trial is made public as part of the registration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Ongoing Regulation by the FDA </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Even after a device receives clearance or approval and is placed on the market, numerous regulatory requirements apply. These include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishment registration and device listing; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">89 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the QSR, which requires manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation, and other quality assurance procedures during all aspects of the manufacturing
process; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">labeling regulations and the FDA prohibitions against the promotion of products for un-cleared, unapproved or &#147;off-label&#148; uses, and other requirements related to promotional activities; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">medical device reporting regulations, which require that manufactures report to the FDA if their device may have caused or contributed to a death or serious injury or if their device malfunctioned and the device or a
similar device marketed by the manufacturer would be likely to cause or contribute to a death or serious injury if the malfunction were to recur; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">corrections and removal reporting regulations, which require that manufactures report to the FDA field corrections or removals if undertaken to reduce a risk to health posed by a device or to remedy a violation of the
Federal Food, Drug, and Cosmetic Act that may present a risk to health; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">post market surveillance regulations, which apply to certain class II or III devices when necessary to protect the public health or to provide additional safety and effectiveness data for the device. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a major
change in its intended use, will require a new clearance or possibly a premarket approval. The FDA requires each manufacturer to make this determination initially, but the FDA can review any such decision and can disagree with a manufacturer&#146;s
determination. If the FDA disagrees with our determination not to seek a new 510(k) clearance, the FDA may retroactively require us to seek 510(k) clearance or possibly a premarket approval. The FDA could also require us to cease marketing and
distribution and/or recall the modified device until 510(k) clearance or premarket approval is obtained. Also, in these circumstances, we may be subject to significant regulatory fines and penalties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Some changes to an approved PMA device, including changes in indications, labeling, or manufacturing processes or facilities, require submission and FDA
approval of a new PMA or PMA supplement, as appropriate, before the change can be implemented. Supplements to a PMA often require the submission of the same type of information required for an original PMA, except that the supplement is generally
limited to that information needed to support the proposed change from the device covered by the original PMA. The FDA uses the same procedures and actions in reviewing PMA supplements as it does in reviewing original PMAs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">FDA regulations require us to register as a medical device manufacturer with the FDA. Additionally, the California Department of Health Services, or
CDHS, requires us to register as a medical device manufacturer within the state. Because of this, the FDA and the CDHS inspect us on a routine basis for compliance with the QSR. These regulations require that we manufacture our products and maintain
related documentation in a prescribed manner with respect to manufacturing, testing and control activities. We have undergone and expect to continue to undergo regular QSR inspections in connection with the manufacture of our products at our
facilities. Further, the FDA requires us to comply with various FDA regulations regarding labeling. Failure by us or by our suppliers to comply with applicable regulatory requirements can result in enforcement action by the FDA or state authorities,
which may include any of the following sanctions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">warning or untitled letters, fines, injunctions, consent decrees and civil penalties; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">customer notifications, voluntary or mandatory recall or seizure of our products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">operating restrictions, partial suspension or total shutdown of production; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">delay in processing submissions or applications for new products or modifications to existing products; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">withdrawing approvals that have already been granted; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">criminal prosecution. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Medical Device Reporting laws and regulations require us to provide
information to the FDA when we receive or otherwise become aware of information that reasonably suggests our device may have caused or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">90 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
contributed to a death or serious injury as well as a device malfunction that likely would cause or contribute to death or serious injury if the malfunction were to recur. In addition, the FDA
prohibits an approved device from being marketed for off-label use. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label
uses may be subject to significant liability, including substantial monetary penalties and criminal prosecution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Newly discovered or developed
safety or effectiveness data may require changes to a product&#146;s labeling, including the addition of new warnings and contraindications, and also may require the implementation of other risk management measures. Also, new government
requirements, including those resulting from new legislation, may be established, or the FDA&#146;s policies may change, which could delay or prevent regulatory clearance or approval of our products under development. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are also subject to other federal, state and local laws, and regulations relating to safe working conditions, laboratory, and manufacturing practices.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>European Union </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our products are regulated in the
European Union as medical devices per the European Union Directive (93/42/EEC), also known as the Medical Device Directive. An authorized third party, Notified Body, must approve products for CE marking. The CE mark is contingent upon continued
compliance to the applicable regulations and the quality system requirements of the ISO 13485 standard. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Other Regions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Most major markets have different levels of regulatory requirements for medical devices. Modifications to the cleared or approved products may require a
new regulatory submission in all major markets. The regulatory requirements, and the review time, vary significantly from country to country. Products can also be marketed in other countries that have minimal requirements for medical devices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Fraud and Abuse and Other Healthcare Regulation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I>Anti-Kickback
Statute </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are subject to various federal and state healthcare laws, including, but not limited to, anti-kickback laws. In particular, the
federal Anti-Kickback Statute prohibits persons or entities from knowingly and willfully soliciting, offering, receiving or paying any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, in exchange for or to induce either
the referral of an individual for the furnishing or arranging for a good or service, or for the purchasing, leasing, ordering, or arranging for or recommending any good, facility, service or item for which payment may be made in whole or in part
under federal healthcare programs, such as the Medicare and Medicaid programs. The federal Anti-Kickback Statute is broad and prohibits many arrangements and practices that are lawful in businesses outside of the healthcare industry. The term
&#147;remuneration&#148; expressly includes kickbacks, bribes, or rebates and also has been broadly interpreted to include anything of value, including, for example, gifts, discounts, the furnishing of supplies or equipment, credit arrangements,
payments of cash, waivers of payments, ownership interests and providing anything at less than its fair market value. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">There are a number of
statutory exceptions and regulatory safe harbors protecting certain business arrangements from prosecution under the federal Anti-Kickback Statute. These statutory exceptions and safe harbors set forth provisions that, if all their applicable
requirements are met, will assure healthcare providers and other parties that they may not be prosecuted under the federal Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more applicable statutory
exceptions or safe harbors does not necessarily mean that it is illegal or that prosecution will be pursued. However, conduct and business arrangements that do not fully satisfy all requirements of an applicable safe harbor may result in increased
scrutiny by government enforcement authorities and will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. Additionally, the intent standard under the federal Anti-Kickback Statute was amended
under the Affordable Care Act, to a stricter standard such that a person or entity </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">91 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
no longer needs to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. The Affordable Care Act provides that the government may assert
that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act which is discussed below. Penalties for violations of
the anti-kickback statute include, but are not limited to, criminal, civil and/or administrative penalties, damages, fines, disgorgement, individual imprisonment, possible exclusion from Medicare, Medicaid and other federal healthcare programs, and
the curtailment or restructuring of operations. Various states have adopted laws similar to the federal Anti-Kickback Statute, and some of these state laws may be broader in scope in that some of these state laws extend to all payors and may not
contain safe harbors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Federal Civil False Claims Act.</I> The federal civil False Claims Act prohibits, among other things, persons or entities
from knowingly presenting or causing to be presented a false or fraudulent claim to, or the knowing use of false statements to obtain payment from or approval by, the federal government. Suits filed under the federal civil False Claims Act, known as
&#147;<I>qui tam</I>&#148; actions, can be brought by any individual on behalf of the government. These individuals, sometimes known as &#147;relators&#148; or, more commonly, as &#147;whistleblowers,&#148; may share in any amounts paid by the
entity to the government in fines or settlement. The number of filings of <I>qui tam</I> actions has increased significantly in recent years, causing more healthcare companies to have to defend a case brought under the federal civil False Claim Act.
If an entity is determined to have violated the federal civil False Claims Act, it may be required to pay up to three times the actual damages sustained by the government, plus civil penalties for each separate false claim. Various states have
adopted laws similar to the federal civil False Claims Act, and many of these state laws are broader in scope and apply to all payors, and therefore, are not limited to only those claims submitted to the federal government. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Federal Civil Monetary Penalties Statute.</I> The federal Civil Monetary Penalties Statute, among other things, imposes fines against any person who
is determined to have presented, or caused to be presented, claims to a federal healthcare program that the person knows, or should know, is for an item or service that was not provided as claimed or is false or fraudulent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Sunshine Act.</I> The Affordable Care Act also included a provision, commonly referred to as the Sunshine Act. This provision requires that any
manufacturer of a covered device that provides payment or other transfer of value to a physician or teaching hospital, or to a third party at the request of a physician or teaching hospital, must submit to the Centers for Medicare and Medicaid
Services information about the payment or other transfer of value annually, with the reported information to be made public on a searchable website. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Health Insurance Portability and Accountability Act of 1996.</I> The federal Health Insurance Portability and Accountability Act (HIPAA) created
several new federal crimes, including healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully executing a scheme to defraud any healthcare benefit program, including
private third-party payors. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or
payment for healthcare benefits, items or services. In addition, HIPAA and its implementing regulations established uniform standards for certain covered entities, which are healthcare providers, health plans and healthcare clearinghouses, as well
as their business associates, governing the conduct of specified electronic healthcare transactions and protecting the security and privacy of protected health information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The American Recovery and Reinvestment Act of 2009, commonly referred to as the economic stimulus package, included an expansion of HIPAA&#146;s privacy
and security standards called the Health Information Technology for Economic and Clinical Health Act (HITECH). Among other things, HITECH created four new tiers of civil monetary penalties and gave state attorneys general new authority to file civil
actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal civil actions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">92 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Employees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of
March&nbsp;31, 2015, we had approximately 850 employees worldwide. None of our employees are represented by a collective bargaining agreement and we have never experienced a work stoppage. We believe our employee relations are good. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Facilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We maintain a 180,000 square foot research and
development and manufacturing facility in three buildings at our campus in Alameda, California. We leased the initial 75,000 square feet of the Alameda campus in 2008 and we added the additional space over several lease amendments and additional
leases. The leases for all three buildings expire in 2029, subject to our option to renew any or all three leases for an additional ten years. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We
also lease office space in Berlin, Germany; Sydney, Australia; and Sao Paulo, Brazil. The offices in Berlin and Sydney support our direct sales operations in Europe and Australia, respectively, and the office in Sao Paulo supports our Latin America
marketing efforts through our distribution partners. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Legal Proceedings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are not currently party to any material legal proceedings. We currently are and in the future may at times be involved in litigation and other legal
claims in the ordinary course of business. When appropriate in our estimation, we may record reserves in our financial statements for pending litigation and other claims. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">93 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_11"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Executive Officers and Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table sets
forth information regarding our executive officers and directors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="62%"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:19.25pt; font-size:8pt; font-family:arial"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1.00px solid #000000; width:27.35pt; font-size:8pt; font-family:arial"><B>Position</B></P></TD></TR>


<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Adam Elsesser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chairman, Chief Executive Officer and President</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Arani Bose, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Innovator and Director</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sri Kosaraju</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Financial Officer and Head of Strategy</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Daniel Davis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, North America</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">James Pray</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, International</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Lynn Rothman</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President and Chief Business Officer</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Robert Evans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Executive Vice President, General Counsel and Secretary</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Don Kassing<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Walter Wang<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Harpreet Grewal<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the audit committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the compensation committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Member of the nominating and corporate governance committee. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Executive Officers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Adam Elsesser</I> co-founded Penumbra and has served as Chief Executive Officer and a member of our board of directors since our inception in 2004 and
as President and Chairman of our board of directors since January 2015. Prior to Penumbra, Mr.&nbsp;Elsesser led SMART Therapeutics, Inc., a medical device company focused on devices for neuro-intervention, as its Chief Executive Officer from 2000
to 2002 and, after its acquisition by Boston Scientific Corporation, President of SMART Therapeutics within Boston Scientific Corporation from 2002 to 2005. Before his work in the medical device industry, Mr.&nbsp;Elsesser was a partner in the law
firm of Shartsis Friese, LLP. Mr.&nbsp;Elsesser received a B.A. from Stanford University and a J.D. from Hastings College of the Law. Mr.&nbsp;Elsesser is qualified to serve on our board of directors based on his extensive knowledge of our company,
the medical device industry and the competitive landscape, as well as his expertise in building and leading successful medical device companies and commercializing devices. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Arani Bose</I>, M.D. co-founded Penumbra in 2004 and has served as a member of our board of directors since our inception. Dr.&nbsp;Bose was Chairman
of our board of directors and Chief Medical Officer from 2005 until 2015 and currently serves as Chief Innovator. Prior to founding Penumbra, Dr.&nbsp;Bose was an Assistant Professor of Radiology and Neurology at New York University (NYU) School of
Medicine from 1997 to 2004, where he also had a clinical practice. While at NYU, Dr.&nbsp;Bose co-founded SMART Therapeutics. Dr.&nbsp;Bose received a B.A. from Stanford University and a M.D. from the University of Colorado School of Medicine with
residency and fellowships at Yale University School of Medicine and NYU Medical Center. Dr.&nbsp;Bose is qualified to serve on our board of directors based on his extensive knowledge of our company and the medical device industry, as well as his
training and expertise in interventional radiology and neurology and his skills and experience in clinical research and device development and commercialization. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Sri Kosaraju</I> joined Penumbra as Chief Financial Officer and Head of Strategy in 2015. Prior to joining Penumbra, Mr.&nbsp;Kosaraju worked in
investment banking for J.P. Morgan Securities LLC (J.P. Morgan) from 1999 until 2015, where he held a variety of positions with successively greater responsibility, most recently Managing Director of Equity Capital Markets, Head of Healthcare Equity
Capital Markets and co-Head of Technology, Media, Telecom Equity Capital Markets. Prior to entering J.P. Morgan&#146;s equity capital markets group in 2006, Mr.&nbsp;Kosaraju served in various practice groups at J.P. Morgan, including Equity
Derivatives from 2003 to 2006 and Technology, Media, Telecom Investment Banking Coverage from 1999 to 2003. Mr.&nbsp;Kosaraju received a B.S. from Massachusetts Institute of Technology in 1999. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">94 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Daniel Davis</I> joined Penumbra in 2007. He has served as President, North America, since 2015.
Mr.&nbsp;Davis previously served as Vice President of Strategy from 2013 to 2014 and as Director of Marketing from 2011 to 2012. Mr.&nbsp;Davis joined our sales team in 2007, serving as a Sales Trainer from 2008 to 2011. Before joining Penumbra,
Mr.&nbsp;Davis held various sales and marketing positions at Boston Scientific Corporation. Mr.&nbsp;Davis received a B.A. from Duke University. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>James Pray</I> joined Penumbra in 2005. He has served as President, International, since 2015 and as President from 2005 to 2015. Mr.&nbsp;Pray joined
Penumbra with over 15 years of experience in the medical device industry, much of that in the neurovascular arena. Prior to joining Penumbra, Mr.&nbsp;Pray worked for Boston Scientific Corporation, including as the Director of Marketing for the
neurovascular division from 2000 to 2005. Mr.&nbsp;Pray also worked as a Research and Development Engineer and Engineering Manager for SCIMED Life Systems, a medical device company, from 1990 to 1996. Mr.&nbsp;Pray received a B.S. and M.S. from the
University of Minnesota. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Lynn Rothman</I> joined Penumbra in 2007. She has served as Executive Vice President and Chief Business Officer since
January 2015; as Chief Financial Officer from March 2009 to January 2015; as Vice President, Administration from January 2009 to March 2009, and as Human Resources Manager from 2007 to January 2009. Ms.&nbsp;Rothman joined Penumbra with over 20
years of experience in finance and marketing of medical and emerging growth companies. Ms.&nbsp;Rothman served as Director of Corporate Marketing at Confer Software, Inc., a disease management company, from 1997 to 2000. Prior to that time,
Ms.&nbsp;Rothman worked at Robertson Stephens&nbsp;&amp; Company, a financial services firm, where she worked in both health care research and venture capital focused on potential medical device, service and software investment opportunities. She
received an M.B.A. from The Wharton School, University of Pennsylvania and a B.A. from Stanford University. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Robert Evans</I> joined Penumbra as
Executive Vice President, General Counsel and Secretary in 2008. Prior to joining Penumbra, Mr.&nbsp;Evans was Executive Vice President, General Counsel and Secretary of Waste Connections, Inc., a publicly traded waste services company, from 2002 to
2008, and a partner in the law firm Shartsis Friese LLP from 1978 to 2002. Mr.&nbsp;Evans received a B.A. and J.D. from the University of California, Berkeley. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><I></I><B><I>Nonemployee Directors</I></B><I> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Don
Kassing</I> has served on our board of directors since 2008. Mr.&nbsp;Kassing is President Emeritus of San Jose State University. Mr.&nbsp;Kassing served as President of San Jose State University from 2004 to 2008, Interim President from 2010 to
2011, and Vice President, Administration and Finance and Chief Financial Officer from 1993 to 2004. Prior to his tenure at San Jose State University, Mr.&nbsp;Kassing spent 18 years in higher education and 11 years in private industry, including
eight years in corporate finance and operations management at Brown Group, Inc., a retail real estate developer, and General Motors Corporation. Mr.&nbsp;Kassing received a B.A. and M.B.A. from Saint Louis University. Mr.&nbsp;Kassing is qualified
to serve on our board of directors based on his extensive business and leadership experience, including valuable skills related to strategic planning, based on his long tenure leading a major educational institution, including overseeing the
development and construction of two high-profile campus facilities and having primary responsibility for university business and financial affairs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Walter Wang</I> has served on our board of directors since January 2015. Mr.&nbsp;Wang has served as the Chief Executive Officer of Orlucent, Inc., an
early stage diagnostics company, since 2012. From 1999 to the present, Mr.&nbsp;Wang has researched, advised and invested in medical device, financial and technology start-up companies through Wang Ventures, a family investment partnership and other
related entities. In addition, Mr.&nbsp;Wang invests, develops and manages real estate through W5 Investments, a real estate company. Mr.&nbsp;Wang began his career in 1989 with U-Jin Enterprises, Inc., a food processing and import/export company.
Mr.&nbsp;Wang received a B.S. from the University of Southern California. Mr.&nbsp;Wang is qualified to serve on our board of directors based on his extensive experience in analyzing, investing in and advising medical device and emerging growth
companies and his strong financial background. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">95 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Harpreet Grewal</I> has served on our board of directors since April 2015. Since 2010, Mr.&nbsp;Grewal
has served as Executive Vice President and Chief Financial Officer of Constant Contact, Inc., a publicly-traded technology company primarily focused on marketing tools. From 2008 to 2009, Mr.&nbsp;Grewal worked as an independent consultant to small
businesses and early-stage entrepreneurs. From 2006 through 2008, Mr.&nbsp;Grewal was Executive Vice President and Chief Financial Officer of VistaPrint, Ltd., a publicly-traded online printing and marketing services company. Prior to VistaPrint,
Mr.&nbsp;Grewal was Senior Vice President and Chief Financial Officer of GoldenSource Corporation, a data management company, from 2002 to 2006, Chief Financial Officer of eGain Communications Corporation, a customer engagement services company,
from 1999 to 2002, and held various financial and strategic planning positions with PepsiCo, Inc., a publicly-traded food and beverage company, from 1996 to 1999. Mr.&nbsp;Grewal received a B.A. from the University of California, Berkeley and a M.A.
from Johns Hopkins University. Mr.&nbsp;Grewal is qualified to serve on our board of directors because of his extensive business and leadership experience, including financial expertise and strategic planning skills, based on his tenure as Chief
Financial Officer at numerous companies, including several publicly-traded corporations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Board Structure and Compensation of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Upon completion of the offering, our board of directors will consist of five members. In accordance with our amended and restated certificate of
incorporation and our amended and restated bylaws, immediately after the completion of this offering, our directors will be divided into three classes serving staggered three-year terms. At each annual meeting of stockholders, directors will be
elected to succeed the class of directors whose terms have expired. Our current directors will be divided among the three classes as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Class I directors will consist of Mr.&nbsp;Kassing, and his term will expire at the annual meeting of stockholders to be held in 2016; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Class II directors will consist of Dr. Bose and Mr. Wang, and their terms will expire at the annual meeting of stockholders to be held in 2017; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the Class III directors will consist of Messrs. Elsesser and Grewal, and their terms will expire at the annual meeting of stockholders to be held in 2018. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">This classification of our board of directors could have the effect of increasing the length of time necessary to change the composition of a majority of
the board of directors. In general, at least two annual meetings of stockholders will be necessary for stockholders to effect a change in a majority of the members of the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Director Independence </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our board of directors has
undertaken a review of the independence of each director. Based on information provided by each director concerning his background, employment and affiliations, our board of directors has determined that each of Don Kassing, Walter Wang and Harpreet
Grewal do not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and is independent under applicable
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rules. In making these determinations, our board of directors considered the current and prior relationships that each non-employee director has with our company and all other
facts and circumstances our board of directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director, and the transactions involving them described in the section
titled &#147;Certain Relationships and Related Party Transactions.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Director Compensation Policy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Directors who are also full-time officers or employees of our company will receive no additional compensation for serving as directors. All other
directors will receive an annual retainer of $25,000. The chairman of the audit committee will receive an additional annual fee of $25,000. Each non-employee director also will receive an annual grant of 2,000 shares of restricted stock under our
2014 Equity Incentive Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">96 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Board Committees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Audit
Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The members of our audit committee are Don Kassing, Walter Wang and Harpreet Grewal. Harpreet Grewal is the chair of our audit
committee. The composition of our audit committee meets the requirements for independence under the current &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; listing standards and SEC rules and regulations. Each member of our
audit committee is financially literate. In addition, our board of directors has determined that each of Mr.&nbsp;Grewal and Mr.&nbsp;Kassing is an &#147;audit committee financial expert&#148; as defined in Item&nbsp;407(d)(5)(ii) of Regulation S-K
promulgated under the Securities Act. This designation does not impose on either any duties, obligations or liabilities that are greater than are generally imposed on members of our audit committee and our board of directors. Our audit committee is
directly responsible for, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">selecting a firm to serve as the independent registered public accounting firm to audit our financial statements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">ensuring the independence of the independent registered public accounting firm; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">discussing the scope and results of the audit with the independent registered public accounting firm and reviewing, with management and that firm, our interim and year-end operating results; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">establishing procedures for employees to anonymously submit concerns about questionable accounting or audit matters; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">considering the adequacy of our internal controls and internal audit function; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing material related party transactions or those that require disclosure; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">approving or, as permitted, pre-approving all audit and non-audit services to be performed by the independent registered public accounting firm. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our audit committee will operate under a written charter, to be effective prior to the completion of this offering, that satisfies the applicable rules
of the SEC and the listing standards of the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The members of our compensation committee are Don Kassing, Walter Wang and Harpreet Grewal. Walter Wang is the chair of our compensation committee. Each
member of this committee is a non-employee director, as defined by Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended (Exchange Act), and an outside director, as defined pursuant to Section&nbsp;162(m) of the Code, and
meets the requirements for independence under the current &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; listing standards and SEC rules and regulations. Our compensation committee is responsible for, among other things:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and approving, or recommending that our board of directors approve, the compensation of our executive officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and recommending to our board of directors the compensation of our directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">administering our stock and equity incentive plans; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and approving, or making recommendations to our board of directors with respect to, incentive compensation and equity plans; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing our overall compensation philosophy. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our compensation committee will operate under a written
charter, to be effective prior to the completion of this offering, that satisfies the applicable rules of the SEC and the listing standards of the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Nominating and Governance Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The members of
our nominating and governance committee are Don Kassing, Walter Wang and Harpreet Grewal. Don Kassing is the chair of our nominating and governance committee. Messrs. Kassing, Wang and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">97 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Grewal all meet the requirements for independence under the current &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; listing standards. Our nominating and governance
committee is responsible for, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">identifying and recommending candidates for membership on our board of directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing and recommending our corporate governance guidelines and policies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">reviewing proposed waivers of the code of conduct for directors and executive officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">overseeing the process of evaluating the performance of our board of directors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">assisting our board of directors on corporate governance matters. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our nominating and governance
committee will operate under a written charter, to be effective prior to the completion of this offering, that satisfies the applicable rules of the SEC and the listing standards of the
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Code of Ethics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In connection with this offering, our board of directors will adopt a code of ethics that applies to all of our employees, officers and directors,
including our Chief Executive Officer, Chief Financial Officer and other executive and senior financial officers. Upon completion of this offering, the full text of our code of business conduct and ethics will be posted on the investor relations
section of our website. We intend to disclose future amendments to our code of business conduct and ethics, or any waivers of such code, on our website or in public filings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Limitation of Liability and Indemnification </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our amended and
restated certificate of incorporation, which will be in effect immediately prior to the completion of this offering, contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law.
Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any breach of the director&#146;s duty of loyalty to us or our stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of the Delaware General Corporation Law; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction from which the director derived an improper personal benefit. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our amended and restated
certificate of incorporation to be in effect immediately prior to the completion of this offering will provide that we may indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. Our amended and restated
bylaws to be in effect immediately prior to the completion of this offering will also provide that we are obligated to indemnify our directors and officers to the fullest extent permitted by Delaware law and advance expenses incurred by a director
or officer in advance of the final disposition of any action or proceeding and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless
of whether we would otherwise be permitted to indemnify him or her under the provisions of Delaware law. We have entered into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors. With
specified exceptions, these agreements will provide for indemnification for related expenses including, among other things, attorneys&#146; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or
proceeding. We believe these limitations of liability provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. We also maintain directors&#146; and officers&#146; liability insurance.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation, amended and restated bylaws and
indemnification agreements may discourage stockholders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">98 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. Our amended and restated certificate of incorporation will provide that any such lawsuit must be
brought in the Court of Chancery of the State of Delaware. The foregoing provisions may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and other
stockholders. Further, a stockholder&#146;s investment may be adversely affected to the extent that we pay the costs of settlement and damage awards against directors and officers as required by these indemnification provisions. Insofar as
indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such
indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. At present, there is no pending litigation or proceeding involving any of our directors, officers or employees for which indemnification
is sought, and we are not aware of any threatened litigation that may result in claims for indemnification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Compensation Committee Interlocks and Insider
Participation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our compensation committee has historically consisted solely of Adam Elsesser, our Chairman, Chief Executive Officer and
President. As a result, Mr.&nbsp;Elsesser determined the compensation of our executive officers. Prior to the completion of this offering, we will appoint a compensation committee consisting solely of independent directors. None of our executive
officers has served as a member of a compensation committee (or if no committee performs that function, the board of directors) of any other entity that has an executive officer serving as a member of our board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">99 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_12"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table sets forth
information concerning the compensation paid to our principal executive officer, and our two most highly compensated executive officers other than the principal executive officer during our fiscal year ended December&nbsp;31, 2014. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>2014 SUMMARY COMPENSATION TABLE </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:94.40pt; font-size:8pt; font-family:arial"><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Salary ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Stock&nbsp;Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Option&nbsp;Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>All Other<BR>Compensation<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total <BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Adam Elsesser,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">511,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,162,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,673,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; font-size:10pt; font-family:arial">Chairman, Chief Executive Officer and President</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Daniel Davis,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">387,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; font-size:10pt; font-family:arial">President, North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Lynn Rothman,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">387,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; font-size:10pt; font-family:arial">Executive Vice President and Chief Business Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect the aggregate grant date fair value for awards granted during 2014. The grant date fair value was computed in accordance with FASB ASC Topic 718, Compensation&#151;Stock Compensation. Unlike the
calculations contained in our financial statements, this calculation does not give effect to any estimate of forfeitures related to service-based vesting, but assumes that the executive will perform the requisite service for the award to vest in
full. The assumptions we used in valuing options and stock awards are described in Note 12 to our Consolidated Financial Statements included in this prospectus. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Executive Officer Arrangements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our executive officers are
employed on an at-will basis. Mr.&nbsp;Elsesser, Mr.&nbsp;Davis and Ms.&nbsp;Rothman have entered into at will employment agreements with us that set forth the general terms of their employment. We do not have agreements or policies that would
require us to provide severance benefits or change-in-control benefits to our executive officers, other than the provisions under our equity plans described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Outstanding Equity Awards at Fiscal Year End </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following
table sets forth information concerning unexercised options, stock that has not vested and equity incentive plan awards for the named executive officers named in the Summary Compensation Table as of the end of our fiscal year ended December&nbsp;31,
2014. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">100 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>OUTSTANDING EQUITY AWARDS AT 2014 FISCAL YEAR END </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Stock&nbsp;Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:19.25pt; font-size:8pt; font-family:arial"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Numbers<BR>of&nbsp;
Securities<BR>Underlying<BR>Unexercised<BR>Options</B><br><B>(#)<BR>Exercisable<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Numbers<BR>of&nbsp;Securities<BR>Underlying<BR>Unexercised<BR>Options</B><br><B>(#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Option<BR>Exercise<BR>Price <BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Option<BR>Expiration Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number<BR>of&nbsp;Shares&nbsp;or<BR>Units of<BR>Stock That<BR>Have Not<BR>Vested <BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Market&nbsp;Value<BR>of&nbsp;Shares&nbsp;or</B><br><B>Units&nbsp;of<BR>Stock That<BR>Have Not<BR>Vested <BR>($)<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Adam&nbsp;Elsesser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/01/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">05/01/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/01/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/21/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/20/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Daniel&nbsp;Davis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">09/30/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">02/07/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">618,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Lynn&nbsp;Rothman</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">06/13/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000<SUP STYLE="font-size:85%; vertical-align:top"></SUP></TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">618,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Options may be exercised prior to vesting, subject to repurchase rights that expire over the vesting periods indicated in the footnotes below. Accordingly, all options outstanding as of December&nbsp;31, 2014, were
exercisable in full. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>There was no public market for our common stock as of December&nbsp;31, 2014. The fair value of our common stock as of December&nbsp;31, 2014, was $12.36 per share.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>The shares subject to this option were granted under the Penumbra 2005 Stock Plan and are fully vested as of December&nbsp;31, 2014. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Options were granted under the Penumbra 2005 Stock Plan and vest with respect to 1/4th of the shares subject to the option on March&nbsp;21, 2015, and as to 1/48th of
the total shares subject to the option on each month thereafter, subject to the executive continuing to provide services to us through each applicable vesting date. In the event of a Change in Control, as defined under the 2005 Stock Plan, the
issued options will fully vest, subject to the executive continuing to provide services to us through the occurrence of the Change in Control. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Options were granted under the Penumbra 2011 Equity Incentive Plan and vest with respect to 1/4th of the shares subject to the option on March&nbsp;21, 2015, and as
to 1/48th of the total shares subject to the option on each month thereafter, subject to the executive continuing to provide services to us through each applicable vesting date. In the event of a Change in Control, as defined under the 2011 Equity
Incentive Plan, the issued options will fully vest, subject to the executive continuing to provide services to us through the occurrence of the Change in Control. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>The shares were issued upon the early exercise of options to purchase 1,500 shares of common stock. The original grant of options to purchase 1,500 shares of common
stock was made under the Penumbra 2005 Stock Plan to vest as to 1/4th of the shares subject to the option on January&nbsp;14, 2012, and as to 1/48th of the total shares subject to the option on each month thereafter, subject to the executive
continuing to provide services to us through each applicable vesting date. Our repurchase rights with respect to issued restricted shares lapse over the vesting period. In the event of a Change in Control, as defined under the 2005 Stock Plan, the
issued restricted shares will fully vest, subject to the executive continuing to provide services to us through the occurrence of the Change in Control. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Options were granted under the Penumbra 2005 Stock Plan and vest with respect to 1/4th of the shares subject to the option on September&nbsp;30, 2012, and as to
1/48th of the total shares subject to the option on each month thereafter, subject to the executive continuing to provide services to us through each applicable vesting date. In the event of a Change in Control, as defined under the 2005 Stock Plan,
the issued options will fully vest, subject to the executive continuing to provide services to us through the occurrence of the Change in Control. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Options were granted under the Penumbra 2005 Stock Plan and vest with respect to 1/4th of the shares subject to the option on January&nbsp;1, 2013, and as to 1/4th of
the total shares subject to the option on each January&nbsp;2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> thereafter, subject to the executive continuing to provide services to us through each applicable vesting date. In the event of a
Change in Control, as defined under the 2005 Stock Plan, the issued options will fully vest, subject to the executive continuing to provide services to us through the occurrence of the Change in Control. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">101 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></TD>
<TD ALIGN="left" VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top"></SUP>Mr.&nbsp;Davis and Ms.&nbsp;Rothman were each granted 50,000 restricted shares under the Penumbra 2011 Equity Incentive Plan on February&nbsp;3, 2014. Our repurchase
rights with respect to the issued restricted shares lapses as to 1/4th of the shares subject to the stock award on January&nbsp;2, 2015, and as to 1/48th of the total shares subject to the award on each month thereafter, subject to the executive
continuing to provide services to us through each applicable vesting date. In the event of a Change in Control, as defined under the 2011 Equity Incentive Plan, the issued restricted shares will fully vest, subject to the executive continuing to
provide services to us through the occurrence of the Change in Control. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Options were granted under the Penumbra 2005 Stock Plan and vest with respect to 1/4th of the shares subject to the option on February&nbsp;1, 2012, and as to 1/48th of the total shares subject to the option on each
month thereafter, subject to the executive continuing to provide services to us through each applicable vesting date. In the event of a Change in Control, as defined under the 2005 Stock Plan, the issued options will fully vest, subject to the
executive continuing to provide services to us through the occurrence of the Change in Control. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Employee Benefit Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our officers are entitled to participate in our equity incentive plans. All officers are eligible to participate in our 401(k) plan on the same terms as
all other employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>2014 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our board of directors and our stockholders approved our 2014 Equity Incentive Plan (the 2014 plan) and it became effective in May, 2014. Our 2014 plan
replaced our 2011 Equity Incentive Plan (the 2011 plan) and our 2005 Stock Plan (the 2005 plan). No further equity awards may be granted under our 2011 and 2005 plans. We expect that our board of directors will approve an amendment to the 2014 plan
prior to this offering, effective as of the date of the effectiveness of the registration statement of which this prospectus is a part. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of
March&nbsp;31, 2015, there were 2,199,713 shares remaining available for the grant of equity awards under our 2014 plan. As of March&nbsp;31, 2015, we had granted options to purchase 487,300 shares of our common stock under our 2014 plan, all of
which were outstanding. We had also granted 50,000 shares of restricted stock under our 2014 plan, of which 50,000 shares were unvested and were subject to forfeiture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Stock awards</I>. The 2014 plan provides for the grant of incentive stock options (ISOs), nonstatutory stock options (NSOs), stock appreciation
rights, restricted stock awards and restricted stock unit awards (collectively, &#147;stock awards&#148;). ISOs may be granted only to employees. All other awards may be granted to employees, directors and consultants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Share reserve</I>. The aggregate number of shares of our common stock initially reserved for issuance pursuant to stock awards under the 2014 plan was
2,700,000, plus (i)&nbsp;the shares reserved for issuance under the 2005 plan and 2011 plan which were not issued or subject to awards granted under those plans and (ii)&nbsp;any shares subject to stock options or other stock awards granted under
our 2011 and 2005 plans that expire or terminate for any reason, are forfeited or repurchased by us or are reacquired, withheld or not issued to satisfy a tax withholding obligation, up to a maximum of 3,007,276 shares added through clauses
(i)&nbsp;or (ii). The maximum number of shares that may be issued upon the exercise of incentive stock options will equal this aggregate maximum number of shares plus other shares that become available upon lapsed awards or certain other conditions,
to the extent allowed by section 422 of the Internal Revenue Code of 1986, as amended to the date hereof, and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If a stock award granted under the 2014 plan is forfeited back to us because of the failure to meet a contingency or condition required to vest, such
shares will become available for subsequent issuance under the 2014 plan. In addition, shares withheld to satisfy income or employment withholding taxes and shares used to pay the exercise price of a stock option will become available for the grant
of new stock awards under the 2014 plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Administration</I>. Our board of directors, or one or more duly authorized committees thereof, have the
authority to administer the 2014 plan. Subject to the terms of the 2014 plan, our board of directors or the authorized committee, referred to herein as the plan administrator, determines recipients, dates of grant, the numbers and types of stock
awards to be granted and the terms and conditions of the stock awards, including </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">102 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
the period of their exercisability and vesting schedule applicable to a stock award. Subject to the limitations set forth below, the plan administrator will also determine the exercise price,
strike price or purchase price of awards granted and the types of consideration to be paid for the award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The plan administrator has the authority
to modify outstanding awards under our 2014 plan. Subject to the terms of our 2014 plan, the plan administrator has the authority to extend the post-termination exercisability period of awards and to extend the maximum term of an option. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Stock Options</I>. Incentive and nonstatutory stock options are granted pursuant to stock option agreements adopted by the plan administrator. The
plan administrator determines the exercise price for a stock option, within the terms and conditions of the 2014 plan, provided that the exercise price of a stock option cannot be less than 100% of the fair market value of our common stock on the
date of grant. In the case of an incentive stock option granted to an employee who owns stock representing more than 10% of the voting power of all classes of our stock or any parent or subsidiary of us, the exercise price will be no less 110% of
the fair market value on the date of the grant. Options vest at the rate specified by the plan administrator. At the time an option is granted, the plan administrator will fix the period within which the option may be exercised and will determine
any conditions that must be satisfied before the option may be exercised. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The plan administrator determines the term of stock options granted under
the 2014 plan, up to a maximum of 10 years. In the case of an incentive stock option granted to an employee who owns stock representing more than 10% of the voting power of all classes of our stock or the stock of any of our parents or subsidiaries,
the maximum term will be 5 years. Unless the terms of an option holder&#146;s stock option agreement provide otherwise, if an option holder&#146;s service relationship with us ceases for any reason other than disability or death, the option holder
may generally exercise any vested options for a period of thirty days following the cessation of service. If an optionholder&#146;s service relationship with us ceases due to disability or death, the optionholder or a beneficiary may generally
exercise any vested options for a period of 6 months, or within such longer period of time as is specified in the award agreement. In no event may an option be exercised beyond the expiration of its term. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the plan administrator and may
include (1)&nbsp;cash, (2)&nbsp;check, (3)&nbsp;promissory note, (4)&nbsp;other shares, (5)&nbsp;a broker-assisted cashless exercise, (6)&nbsp;by net exercise, or (5)&nbsp;combination of the foregoing methods of payment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Unless the plan administrator provides otherwise, options generally are not transferable except by will or by the laws of descent and distribution. An
optionholder may designate a beneficiary, however, who may exercise the option following the optionholder&#146;s death. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Stock Appreciation
Rights</I>. The 2014 plan permits the grant of stock appreciation rights. Stock appreciation rights give recipients the right to acquire a specified number of shares of stock at a predetermined price. The terms of the stock appreciation rights
granted under the 2014 plan are determined by the plan administrator in the award agreement evidencing the award, including the number of shares, exercise price, expiration date and other terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Restricted Stock and Restricted Stock Units. The 2014 plan permits the grant of restricted stock and/or restricted stock units. Restricted stock awards
are grants of shares of our common stock. Restricted stock units represent the right to receive shares of our common stock (or a cash amount equal to the value of our common stock) on future specified dates. The terms of the restricted stock and/or
restricted stock units granted under the 2014 plan are determined by the plan administrator in the award agreement evidencing the award, including the number of shares, period of restriction or vesting schedule, and other terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Tax Limitations on Incentive Stock Options</I>. The aggregate fair market value, determined at the time of grant, of our common stock with respect to
ISOs that are exercisable for the first time by an optionholder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be
granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">103 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
that of any of our affiliates unless (1)&nbsp;the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant, and (2)&nbsp;the option
is not exercisable after the expiration of five years from the date of grant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Adjustments; Corporate Transactions</I>. In the event of certain
changes in our corporate structure, including any dividend or other distribution, recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of shares of the
Company the administrator will make appropriate adjustments to outstanding awards to prevent diminution or enlargement of the benefits or potential benefits available under the plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Merger or Change of Control</I>. In the event of certain corporate transactions specified in the plan, including a merger or change of control, as
defined in the plan, each outstanding award will be treated as the administrator determines, without a participant&#146;s consent, including that (i)&nbsp;awards will be assumed or substituted by the succeeding corporation; (ii)&nbsp;the awards will
terminate; (iii)&nbsp;outstanding awards will vest and become exercisable, (iv)&nbsp;the awards will terminate in exchange for an amount of cash and/or property, if any, equal to the amount that would have been attained upon the exercise of the
award or realization of the rights under the award as of the date of the transaction, (v)&nbsp;the replacement of any award with rights or property selected by the plan administrator or (vi)&nbsp;any combination of the above. In the event that the
successor corporation does not assume or substitute the award, the participant will fully vest in and have the right to exercise all of his or her outstanding options and stock appreciation rights and all restrictions on restricted stock and
restricted stock units will lapse and performance goals will be deemed achieved at 100% of the target levels. Our plan administrator is not obligated to treat all stock awards, even those that are of the same type, in the same manner. Under the 2014
plan, a change of control is generally (i)&nbsp;the acquisition by a person or entity of more than 50% of our combined voting power other than by private financing that is approved by the board, (ii)&nbsp;if we are public, the date on which a
majority of the board has been replaced during any twelve month period by directors whose appointment or election is not endorsed by a majority of the members of the board prior to the date of appointment or election; or (iii)&nbsp;change in
ownership of a substantial portion of our assets. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Amendment and Termination</I>. The 2014 plan will terminate in 2024. However, our Board of
Directors has the authority to amend, alter, or terminate our 2014 plan, provided that such action does not materially impair the existing rights of any participant without such participant&#146;s written consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Penumbra 2011 Equity Incentive Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our board of
directors approved our 2011 plan and it became effective in October 2011. As of March&nbsp;31, 2015, we had granted options to purchase 145,000 shares of our common stock under our 2011 plan, all of which were outstanding. We had also granted
505,000 shares of restricted stock under our 2011 plan, of which 266,501 shares were unvested and were subject to forfeiture and 1,667 shares had been forfeited. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Stock awards</I>. The 2011 plan provides for the grant of ISOs, NSOs, stock appreciation rights, restricted stock awards and restricted stock unit
awards (collectively, stock awards). ISOs may be granted only to employees. All other awards may be granted to employees, directors and consultants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Stock Options</I>. No ISOs were issued under the 2011 plan. Nonstatutory stock options have been granted pursuant to stock option agreements adopted
by the plan administrator. The terms of stock options granted under the 2011 plan are determined by the plan administrator in the award agreement evidencing the award, including the term of the option, exercise price of the option, vesting rate of
the option, period within which the option may be exercised and any conditions that must be satisfied before the option may be exercised, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value
of our common stock on the date of grant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The plan administrator determines the term of stock options granted under the 2011 plan, up to a maximum
of 10 years. Unless the terms of an option holder&#146;s stock option agreement provide otherwise, if an option holder&#146;s service relationship with us ceases for any reason other than termination for cause, disability or death, the option holder
may generally exercise any vested options for a period of three months following the cessation of service. If an optionholder&#146;s service relationship with us ceases due to termination for cause, the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">104 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
option terminates and ceases to be exercisable on termination of service. If an optionholder&#146;s service relationship with us ceases due to disability or death, the optionholder or a
beneficiary may generally exercise any vested options for a period of 12 months, or within such longer period of time as is specified in the award agreement. In no event may an option be exercised beyond the expiration of its term. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Unless the plan administrator provides otherwise, options generally are not transferable except by will or by the laws of descent and distribution. An
optionholder may designate a beneficiary, however, who may exercise the option following the optionholder&#146;s death. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Stock Appreciation
Rights</I>. The 2011 plan permits the grant of stock appreciation rights. The terms of the stock appreciation rights granted under the 2011 plan are determined by the plan administrator in the award agreement evidencing the award, including the
number of shares, exercise price, expiration date and other terms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Restricted Stock and Restricted Stock Units</I>. The 2011 plan permits the
grant of restricted stock and/or restricted stock units. The terms of the restricted stock and/or restricted stock units granted under the 2011 plan are determined by the plan administrator in the award agreement evidencing the award, including the
number of shares, period of restriction or vesting schedule and other terms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Adjustments;</I> Corporate Transactions. In the event of certain
changes in our corporate structure, including any dividend or other distribution, recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of shares the
administrator will make appropriate adjustments to outstanding awards to prevent diminution or enlargement of the benefits or potential benefits available under the plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Merger or Change of Control</I>. In the event of certain corporate transactions specified in the plan, including a merger or change of control, as
defined in the plan, each outstanding award will be treated as the plan administrator determines, without a participant&#146;s consent, including that (i)&nbsp;awards will be assumed or substituted by the succeeding corporation; (ii)&nbsp;the awards
will terminate; (iii)&nbsp;outstanding awards will vest and become exercisable, (iv)&nbsp;the awards will terminate in exchange for an amount of cash and/or property, if any, equal to the amount that would have been attained upon the exercise of the
award or realization of the rights under the award as of the date of the transaction, (v)&nbsp;the replacement of any award with rights or property selected by the plan administrator or (vi)&nbsp;any combination of the above. In the event that the
successor corporation does not assume or substitute the award, the participant will fully vest in and have the right to exercise all of his or her outstanding options and stock appreciation rights and all restrictions on restricted stock and
restricted stock units will lapse and performance goals will be deemed achieved at 100% of the target levels. Our plan administrator is not obligated to treat all stock awards, even those that are of the same type, in the same manner. Under the 2011
plan, a change of control is generally (i)&nbsp;the acquisition by a person or entity of more than 50% of our combined voting power other than by private financing that is approved by the board, (ii)&nbsp;if we are public, the date on which a
majority of the board has been replaced during any twelve month period by directors whose appointment or election is not endorsed by a majority of the members of the board prior to the date of appointment or election; or (iii)&nbsp;change in
ownership of a substantial portion of our assets. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Amendment and Termination</I>. The 2011 plan will terminate in October 2021. However, our board
of directors has the authority to amend, alter, or terminate our 2011 plan, provided that such action does not materially impair the existing rights of any participant without such participant&#146;s written consent. Termination of the 2011 plan
will not affect the plan administrator&#146;s ability to exercise its powers under the plan with respect to awards granted prior to termination of the plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Penumbra 2005 Stock Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our board of directors and
our stockholders approved our 2005 plan and it became effective in January 2005 and was subsequently amended and restated in 2006, 2007, 2008 and 2010. As of March&nbsp;31, 2015, we had granted options to purchase 5,431,017 shares of our common
stock under our 2005 plan, of which options to purchase 2,633,291 shares of our common stock were outstanding, and options to purchase 23,176 shares of our common stock had been early exercised and were unvested and subject to repurchase. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">105 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Stock awards</I>. The 2005 plan provides for the grant of ISOs, NSOs, and stock purchase rights
(collectively, stock awards). ISOs may be granted only to employees. All other awards may be granted to employees, directors and consultants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Stock Options.</I> Incentive and/or nonstatutory stock options have been granted pursuant to stock option agreements adopted by the plan
administrator. The terms of stock options granted under the 2005 plan are determined by the board in the award agreement evidencing the award, including the term of the option, exercise price of the option, vesting schedule of the option, period
within which the option may be exercised and any conditions that must be satisfied before the option may be exercised, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of our common stock
on the date of grant. In the case of an incentive stock option granted to an employee who owns stock representing more than 10% of the voting power of all classes of our stock or any parent or subsidiary of us, the exercise price will be no less
110% of the fair market value on the date of the grant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The board determines the term of stock options granted under the 2005 plan, up to a maximum
of 10 years. In the case of an incentive stock option granted to an employee who owns stock representing more than 10% of the voting power of all classes of our stock or the stock of any of our parents or subsidiaries, the maximum term will be 5
years. Unless the terms of an option holder&#146;s stock option agreement provide otherwise, if an option holder&#146;s service relationship with us ceases for any reason other than termination for cause, disability or death, the option holder may
generally exercise any vested options for a period of three months following the cessation of service. If an optionholder&#146;s service relationship with us ceases due to termination for cause, the option terminates and ceases to be exercisable on
termination of service. If an optionholder&#146;s service relationship with us ceases due to disability or death, the optionholder or a beneficiary may generally exercise any vested options for a period of 12 months, or within such longer period of
time as is specified in the award agreement. In no event may an option be exercised beyond the expiration of its term. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Options generally are not
transferable except by will or by the laws of descent and distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Stock Purchase Rights</I>. The 2005 plan permits the grant of stock
purchase rights. The terms of the stock purchase rights granted under the 2005 plan are determined by the board in the award agreement evidencing the award, including the number of shares, purchase price, purchase period and other terms, provided
that the purchase period is no longer than 30 days from the date of grant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Adjustments; Corporate Transactions</I>. In the event of certain
changes in our corporate structure, including any dividend or other distribution, recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of shares of the
Company the administrator will make appropriate adjustments to outstanding awards to prevent diminution or enlargement of the benefits or potential benefits available under the plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Merger or Change of Control</I>. In the event of certain corporate transactions specified in the plan, including a merger or change of control, as
defined in the plan, the surviving or purchasing corporation may, without the consent of the participants, either (i)&nbsp;assume our rights and obligations under the options or (ii)&nbsp;substitute for outstanding options substantially equivalent
options of that company&#146;s stock. Any unexercised options which are neither assumed by the surviving corporation nor substituted shall terminate as of the date of the change of control. In the event of a change of control, the board of directors
may also cancel each or any option outstanding prior to the change of control in exchange for cash, equity or other property of the same value. In the event of a change in control, our board of directors may provide for the acceleration and vesting
of any or all outstanding options and shares acquired upon the exercise of those options. Under the 2005 plan, a change of control is generally (i)&nbsp;the sale by our stockholders of more than 50% of the combined voting power of our outstanding
shares, (ii)&nbsp;a merger or consolidation in which we are a party, (iii)&nbsp;the sale, exchange or transfer of substantially all of our assets, or (iv)&nbsp;our liquidation and dissolution, in each case where our stockholders after the
transaction no longer beneficially own at least 50% of the combined voting power of our outstanding shares, or, in the case of an asset sale, beneficially own at least 50% of the combined voting power of the corporation to which our assets were
transferred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">106 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Amendment and Termination</I>. The 2005 plan will continue in effect until the earlier of its
termination by the board or all shares of stock available for issuance under the plan have been issued. All awards under the plan must be granted, if at all, within 10 years of its adoption. Termination or amendment of the 2005 plan will not affect
any then outstanding award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Pension Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We do not
maintain any defined benefit pension plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Nonqualified Deferred Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We do not maintain any nonqualified deferred compensation plans. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">107 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>2014 DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">None of our non-employee directors received any cash or equity compensation during fiscal 2014, or held any outstanding options or stock awards at the
end of fiscal 2014. Mr.&nbsp;Elsesser, our Chairman, Chief Executive Officer and President, Dr.&nbsp;Bose, our Chief Innovator, and Mr.&nbsp;Krebs, our Treasurer and a director in 2014, did not receive additional compensation for their services as
directors. For more information on Mr.&nbsp;Elsesser&#146;s compensation as an officer, see the section titled &#147;Executive Compensation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Benefit Plans
for Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our directors are entitled to participate in our equity incentive plans, described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">108 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_13"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We describe below transactions and series of similar transactions, during our last three fiscal years or currently proposed, to which we were a party or
will be a party, in which: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the amounts involved exceeds $120,000; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any of our directors, executive officers or beneficial holders of more than 5% of any class of our capital stock had or will have a direct or indirect material interest. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Other than as described below, there have not been, nor are there any currently proposed, transactions or series of similar transactions meeting this
criteria to which we have been or will be a party other than compensation arrangements, which are described where required under the sections titled &#147;Management&#151;Board Structure and Compensation of Directors&#148; and &#147;Executive
Compensation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Preferred Stock Financing and Tender Offer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">On May&nbsp;16, 2014, we sold a total of 4,545,455 shares of Series F preferred stock at a purchase price of $13.20 per share. Entities affiliated with
Fidelity Investments, who currently beneficially own more than 5% of our outstanding capital stock, purchased 3,030,303 shares of Series F preferred stock in this offering. Prior to this investment, entities affiliated with Fidelity Investments were
not affiliated with us. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In connection with our sale of Series F preferred stock in May 2014, we conducted a tender offer for up to 1,359,541 shares
of our then-outstanding preferred stock at a price of $13.20 per share. Pursuant to the tender offer, a total of 584,052 shares of preferred stock were tendered by our stockholders. One of our executive officers, James Pray, and his immediate family
or affiliated entities participated in the tender offer, tendering a total of 11,710 shares of preferred stock for aggregate consideration of $154,572. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Promissory Notes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In 2005, we made a loan to one of our
executive officers, James Pray, in the form of a full-recourse secured promissory note in the amount of $85,000, to permit him to exercise stock options granted to him. This note was secured by a stock pledge agreement covering 500,000 shares of our
common stock held by Mr.&nbsp;Pray. This note accrued interest at the rate of 2.92%&nbsp;per annum, with principal and interest due and payable on January&nbsp;31, 2015, provided that upon the occurrence of a change of control of Penumbra,
Mr.&nbsp;Pray would be required to pre pay principal in an amount equal to the product of the number of shares of our common stock that vested as a result of such change of control and $0.01. On April&nbsp;14, 2015, our board of directors forgave
this loan to Mr.&nbsp;Pray in its entirety, including accrued and unpaid interest thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Investor Rights Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have entered into an agreement with our two founders, Adam Elsesser and Arani Bose, and the holders of our preferred stock, that provides for certain
rights relating to the registration of their shares. See the section titled &#147;Description of Capital Stock&#151;Registration Rights&#148; for additional information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Director and Officer Indemnification </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have entered into an
indemnification agreement with each of our directors and executive officers. These indemnification agreements and our amended and restated certificate of incorporation and amended and restated bylaws indemnify each of our directors and officers to
the fullest extent permitted by the Delaware General Corporation Law. For information regarding these indemnification arrangements, please refer to the section titled &#147;Management&#151;Limitations on Liability and Indemnification of Directors
and Officers.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Policies and Procedures for Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our board of directors plans to adopt a written related party transaction policy setting forth the policies and procedures for the review and approval or
ratification of related party transactions. This policy covers any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">109 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
in which we were or are to be a participant and a related party had or will have a direct or indirect material interest, as determined by the audit committee of our board of directors, including,
without limitation, purchases of goods or services by or from the related party or entities in which the related party has a material interest, and indebtedness, guarantees of indebtedness or employment by us of a related party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">All related party transactions described in this section occurred prior to adoption of this policy and as such, these transactions were not subject to
the approval and review procedures set forth in the policy. However, these transactions were reviewed and approved by our board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">110 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_14"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table sets forth information regarding beneficial ownership of our common stock as of March&nbsp;31, 2015, by: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each person whom we know to own beneficially more than 5% of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each of our directors and named executive officers individually; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all of our directors and executive officers as a group. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In accordance with the rules of the SEC,
beneficial ownership includes voting or investment power with respect to securities and includes the shares issuable pursuant to stock options that are exercisable within 60 days of March&nbsp;31, 2015. Shares issuable pursuant to stock options are
deemed outstanding for computing the percentage of the person holding such options but are not outstanding for computing the percentage of any other person. The number of shares of common stock outstanding after this offering includes
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock being offered for sale by us in this offering. The percentage of beneficial ownership for the following table is based on 24,771,191 shares of common
stock outstanding as of March&nbsp;31, 2015, assuming the automatic conversion of all outstanding shares of our preferred stock as of March&nbsp;31, 2015 into common stock, and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
shares of common stock outstanding after the completion of this offering assuming no exercise of the underwriters&#146; option to purchase additional shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Unless otherwise indicated, the address for each listed stockholder is: c/o Penumbra, Inc., One Penumbra Place, 1351 Harbor Bay Parkway, Alameda,
California 94502. To our knowledge, except as indicated in the footnotes to this table and pursuant to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of common
stock. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares Beneficially<BR>Owned Before the<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares&nbsp;Beneficially<BR>Owned After the<BR>Offering</B></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:129.30pt; font-size:8pt; font-family:arial"><B>Name and Address of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Percent</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Greater than 5% Stockholders:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Entities affiliated with FMR LLC<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,030,303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Directors and Named Executive Officers:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Adam Elsesser<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,765,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.9</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Daniel Davis<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,444</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Lynn Rothman<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">273,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Arani Bose, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,614,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Don Kassing<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Walter Wang<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,480,931</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Harpreet Grewal<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Directors and Officers as a Group<BR>(10 persons)<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,264,293</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Represents beneficial ownership of less than one percent (1%)&nbsp;of the outstanding common stock. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE="font-family:arial; font-size:9pt">Consists of (i)&nbsp;1,250,000 shares held by Fidelity Select Portfolios: Health Care Portfolio (&#147;Fidelity Health&#148;), (ii)&nbsp;265,152 shares held by
Fidelity Select Portfolios: Medical Equipment and Systems Portfolio (&#147;Fidelity Medical Equipment&#148;), (iii)&nbsp;1,128,787 shares held by Fidelity Mt. Vernon Street Trust: Fidelity Growth Company Fund (&#147;Fidelity Growth&#148;),
(iv)&nbsp;257,576 shares held by Fidelity Mt. Vernon Street Trust: Fidelity Series Growth Company Fund (&#147;Fidelity Series Growth&#148;) and (v)&nbsp;128,788 shares held by Fidelity Group Trust for Employee Benefit Plans: Fidelity Growth Company
Commingled Pool (&#147;Fidelity Group Trust&#148;). Fidelity Health, Fidelity Medical Equipment, Fidelity Growth, Fidelity Series Growth and Fidelity Group Trust are managed by direct or indirect subsidiaries of FMR LLC. Edward C. Johnson 3d is a
Director and the Chairman of FMR LLC and Abigail P. Johnson is a Director, the Vice Chairman and the President of FMR LLC. Members of the family of Edward C. Johnson 3d, including Abigail P. Johnson, are the predominant owners, directly or through
trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders&#146; voting agreement under which all Series B
voting common shares will be voted in accordance with the majority vote of Series B voting </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">111 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders&#146; voting agreement, members of the Johnson family may be deemed, under the
Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Edward C. Johnson 3d nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various
investment companies registered under the Investment Company Act (Fidelity Funds) advised by Fidelity Management&nbsp;&amp; Research Company (FMR Co), a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds&#146; Boards of
Trustees. Fidelity Management&nbsp;&amp; Research Company carries out the voting of the shares under written guidelines established by the Fidelity Funds&#146; Boards of Trustees. The address for FMR LLC is 200 Seaport Blvd. V12G, Boston,
Massachusetts 02210. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;1,001,000 shares held by Mr.&nbsp;Elsesser, (ii)&nbsp;14,144 shares held by the Siegel/Elsesser Revocable Trust and (iii)&nbsp;750,000 shares issuable pursuant to options that are exercisable within
60 days of March&nbsp;31, 2015 (of which 643,750 would be vested). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;83,444 shares held by Mr.&nbsp;Davis, of which 37,500 shares are subject to our right of repurchase as of March&nbsp;31, 2015, and (ii)&nbsp;67,000 shares issuable pursuant to options that are
exercisable within 60 days of March&nbsp;31, 2015 (of which 61,250 would be vested). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;200,000 shares held by Ms.&nbsp;Rothman, of which 37,500 shares are subject to our right of repurchase as of March&nbsp;31, 2015, (ii)&nbsp;23,458 shares held by Richard Koch&nbsp;&amp; Lynn Rothman
and (iii)&nbsp;50,000 shares issuable pursuant to options that are exercisable within 60 days of March&nbsp;31, 2015 (all of which would be vested). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;500,000 shares held by Dr.&nbsp;Bose, (ii)&nbsp;14,144 shares held by Arani&nbsp;&amp; Shumita Bose, (iii)&nbsp;250,000 shares held by the Arani Bose 2009 Family Trust, (iv)&nbsp;250,000 shares held
by the Shumita Bose 2009 Family Trust and (v)&nbsp;600,000 shares issuable pursuant to options that are exercisable within 60 days of March&nbsp;31, 2015 (all of which would be vested). </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;8,000 shares held by The Kassing Family Trust and (ii)&nbsp;8,000 shares issuable pursuant to options that are exercisable within 60 days of March&nbsp;31, 2015 (all of which would be vested).
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;517,071 shares held by Mr.&nbsp;Wang and (ii)&nbsp;963,860 shares held by Wang Ventures LLC. Mr.&nbsp;Wang is the owner of a 25% interest in Wang Ventures LLC as a Member. Mr.&nbsp;Wang disclaims
beneficial ownership of all shares held by Wang Ventures LLC. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of 14,139 shares held by Mr.&nbsp;Grewal. Mr.&nbsp;Grewal joined our board of directors on April&nbsp;14, 2015. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;4,639,293 shares held by all current executive officers and directors as a group, of which 78,125 shares are subject to our right of repurchase as of March&nbsp;31, 2015 and (ii)&nbsp;1,625,000
shares issuable pursuant to options that are exercisable within 60 days of March&nbsp;31, 2015 (of which 1,513,000 would be vested). </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">112 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_15"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following descriptions are summaries of the material terms of our amended and restated certificate of incorporation and amended and restated bylaws
that will be in effect upon the completion of this offering. Reference is made to the more detailed provisions of, and the descriptions are qualified in their entirety by reference to, these documents, copies of which will be filed with the SEC as
exhibits to the registration statement of which this prospectus is a part, and applicable law. We refer in this section to our amended and restated certificate of incorporation as our certificate of incorporation, and we refer to our amended and
restated bylaws as our bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Following this
offering, our authorized capital stock will consist of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of common stock, par value $0.001 per share, and
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of preferred stock, par value $0.001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><B><I>Common stock outstanding.</I></B> As of March&nbsp;31, 2015, there were 24,771,191 shares of common stock outstanding (including preferred stock on
an as-converted basis) which were held of record by 280 stockholders. There will be &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock outstanding, assuming no exercise of the
underwriters&#146; option to purchase additional shares and no exercise of outstanding options, after giving effect to the sale of the shares of common stock offered hereby. All outstanding shares of common stock are fully paid and non-assessable,
and the shares of common stock to be issued upon completion of this offering will be fully paid and non-assessable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><B><I></I></B><I></I><B><I>Voting rights.</I></B><I></I><B><I></I></B> The holders of common stock are entitled to one vote per share on all matters to
be voted upon by the stockholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I></I><B><I>Dividend rights.</I></B><I></I> Subject to preferences that may be applicable to any outstanding
preferred stock, the holders of common stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by the board of directors out of funds legally available therefor. See the section titled &#147;Dividend
Policy.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I></I><B><I>Rights upon liquidation.</I></B><I></I> In the event of liquidation, dissolution or winding-up of Penumbra, the holders
of common stock are entitled to share ratably in all assets remaining after payment of liabilities, subject to prior distribution rights of preferred stock, if any, then outstanding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I></I><B><I>Other rights.</I></B><I></I> The holders of our common stock have no preemptive or conversion rights or other subscription rights. There are
no redemption or sinking fund provisions applicable to the common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Effective immediately prior to the completion of this offering, there will be no shares of preferred stock outstanding because all of our outstanding
shares of preferred stock will have been automatically converted into an aggregate of 19,510,410 shares of common stock. Our board of directors has the authority to issue the preferred stock in one or more series and to fix the rights, preferences,
privileges and restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any series or the designation of
such series, without further vote or action by the stockholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The issuance of preferred stock may have the effect of delaying, deferring or
preventing a change in control of Penumbra without further action by the stockholders and may adversely affect the voting and other rights of the holders of common stock. At present, we have no plans to issue any of the preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Registration Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">After the closing of this offering,
certain holders of our common stock will be entitled to rights with respect to the registration of their shares under the Securities Act. These registration rights are contained in our Fourth Amended and Restated Investors&#146; Rights Agreement,
dated as of May&nbsp;16, 2014, and are described in additional </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">113 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
detail below. With respect to any particular stockholder, when such stockholder is able to sell all of its shares pursuant to Rule 144 of the Securities Act without restriction (including any
volume limitations), these registration rights will expire. We will pay the registration expenses (other than underwriting discounts and selling commissions) of the holders of the shares registered pursuant to the registrations describe below. In an
underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions, to limit the number of shares such holders may include. In connection with this offering, each stockholder that has registration rights agreed
not to sell or otherwise dispose of any securities without the prior written consent of the underwriters for a period of 180 days after the date of this prospectus, subject to certain terms and conditions. For more information regarding such
restrictions, see the section titled &#147;Underwriting.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Demand Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Beginning 180 days following this offering through the date that is three years following this offering, the holders of approximately 19,641,495 shares
of our common stock will be entitled to certain demand registration rights. The holders of at least 66 2/3% of these securities have the right to require us, on not more than two occasions, to file a registration statement under the Securities Act
in order to register the resale of their shares of common stock. We may, in certain circumstances, defer such registrations and the underwriters have the right, subject to certain limitations, to limit the number of shares included in such
registrations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>Piggyback Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">After the closing of this offering, if we propose to register the offer and sale of any of our securities under the Securities Act, in connection with
the public offering of such securities the holders of approximately 21,641,495 shares of our common stock will be entitled to certain &#147;piggyback&#148; registration rights allowing the holders to include their shares in such registration,
subject to certain marketing and other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to a registration related to a company stock plan or on any form which does not
include substantially the same information as would be required to be included in a registration statement covering the sale of the registrable securities or a registration that would not customarily provide for the sale of secondary equity shares
for cash, the holders of these shares are entitled to notice of the registration and have the right, subject to limitations that the underwriters may impose on the number of shares included in the registration, to include their shares in the
registration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>S-3 Registration Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">After the
closing of this offering, the holders of approximately 19,641,495 shares of our common stock may make a written request that we register the offer and sale of their shares on Form S-3 if we are eligible to file a registration statement on Form S-3
so long as the request covers at least that number of shares with an anticipated aggregate offering price of at least $1.0 million. These stockholders may make an unlimited number of requests for registration on Form S-3; however, we will not be
required to effect a registration on Form S-3 if we have effected two such registrations in a given 12-month period. Additionally, if we determine that it would be seriously detrimental to us and our stockholders to effect such a registration, we
have the right to defer such registration, not more than once in any 12-month period, for a period of up to 180 days. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Election and Removal of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Immediately prior to the completion of this offering, our board of directors will consist of between five and nine directors. The exact number of
directors will be fixed from time to time by resolution of the board. No director may be removed except for cause, and directors may be removed for cause by an affirmative vote of shares representing a majority of the shares then entitled to vote at
an election of directors. Any vacancy occurring on the board of directors and any newly created directorship may be filled only by a majority of the remaining directors in office. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">114 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Staggered Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Upon the closing of this offering, our board of directors will be will be divided into three classes serving staggered three-year terms. Class I, Class
II and Class III directors will serve until our annual meetings of stockholders in 2016, 2017 and 2018, respectively. At each annual meeting of stockholders, directors will be elected to succeed the class of directors whose terms have expired. This
classification of our board of directors could have the effect of increasing the length of time necessary to change the composition of a majority of the board of directors. In general, at least two annual meetings of stockholders will be necessary
for stockholders to effect a change in a majority of the members of the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Limits on Written Consents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our certificate of incorporation and our bylaws will provide that holders of our common stock will not be able to act by written consent without a
meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Stockholder Meetings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our certificate of
incorporation and our bylaws will provide that special meetings of our stockholders may be called only by our board of directors acting pursuant to a resolution adopted by a majority of the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Amendment of Certificate of Incorporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The provisions of
our certificate of incorporation described under the sections titled &#147;Common Stock&#151;Voting rights,&#148; &#147;Amendment of Bylaws,&#148; &#147;Election and Removal of Directors,&#148; &#147;Stockholder Meetings&#148; and &#147;Limits on
Written Consents&#148; may be amended only by the affirmative vote of holders of at least 66<SUP STYLE="font-size:85%; vertical-align:top">2</SUP>/<SUB STYLE="font-size:85%; vertical-align:bottom">3</SUB>% of the voting power of our outstanding
shares of voting stock, voting together as a single class. The affirmative vote of holders of at least a majority of the voting power of our outstanding shares of stock will generally be required to amend other provisions of our certificate of
incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Amendment of Bylaws </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our bylaws may
generally be altered, amended or repealed, and new bylaws may be adopted, with: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the affirmative vote of a majority of directors present at any regular or special meeting of the board of directors called for that purpose, or without a meeting if all members of the board of directors consent to the
taking of the action; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the affirmative vote of holders of 66<SUP STYLE="vertical-align:top">&nbsp;2</SUP>&#8260;<SUB STYLE="vertical-align:bottom">3</SUB>% of the voting power of our outstanding shares of voting stock, voting together as a
single class. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Other Limitations on Stockholder Actions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our bylaws will also impose some procedural requirements on stockholders who wish to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">make nominations in the election of directors; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">propose any amendment to our bylaws; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">propose any other business to be brought before an annual or special meeting of stockholders. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Under
these procedural requirements, in order to bring a proposal before a meeting of stockholders, a stockholder must deliver timely notice of a proposal pertaining to a proper subject for presentation at the meeting to our corporate secretary along with
the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a brief description of any business to be brought before the meeting and the reasons for conducting such business at the meeting; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the text of any proposed amendments to our bylaws; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">115 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the stockholder&#146;s name and address; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the number and type of shares beneficially owned by the stockholder and evidence of such ownership; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a description of any arrangement between the stockholder and other beneficial owners of our stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any hedging arrangements with respect to our securities entered into by the stockholder; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">representations as to whether the stockholder intends to appear at the meeting, distribute a proxy statement or otherwise solicit proxies; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any other information required to be disclosed under the Exchange Act or that we may reasonably require to determine that the proposed business is proper. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In order to submit a nomination for our board of directors, a stockholder must also timely submit any information with respect to the nominee that we
would be required to include in a proxy statement, as well as some other information. If a stockholder fails to follow the required procedures, the stockholder&#146;s proposal or nominee will be ineligible and will not be voted on by our
stockholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">To be timely, a stockholder must generally deliver notice: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in connection with an annual meeting of stockholders, not less than 120 nor more than 150 days prior to the date on which the annual meeting of stockholders was held in the immediately preceding year, but in the event
that the date of the annual meeting is more than 30 days before or more than 70 days after the anniversary date of the preceding annual meeting of stockholders, a stockholder notice will be timely if received by us not later than the close of
business on the later of (1)&nbsp;the 70th day prior to the annual meeting and (2)&nbsp;the 10th day following the day on which we first publicly announce the date of the annual meeting; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">in connection with the election of a director at a special meeting of stockholders, not less than 90 nor more than the later of (1)120 days prior to the date of the special meeting, and (2)&nbsp;the close of business on
the 10th day following the day on which a notice of the date of the special meeting was mailed to the stockholders or the public disclosure of that date was made. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Limitation of Liability of Directors and Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our
certificate of incorporation will provide that no director will be personally liable to us or our stockholders for monetary damages for breach of fiduciary duty as a director, except as required by applicable law, as in effect from time to time.
Currently, Delaware law requires that liability be imposed for the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any breach of the director&#146;s duty of loyalty to our company or our stockholders; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any act or omission not in good faith or which involved intentional misconduct or a knowing violation of law; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of the Delaware General Corporation Law; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">any transaction from which the director derived an improper personal benefit. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As a result, neither we
nor our stockholders have the right, through stockholders&#146; derivative suits on our behalf, to recover monetary damages against a director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior,
except in the situations described above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our bylaws provide that, to the fullest extent permitted by law, we will indemnify any officer or director
of our company against all damages, claims and liabilities arising out of the fact that the person is or was our director or officer, or served any other enterprise at our request as a director, officer, employee, agent or fiduciary. We will
reimburse the expenses, including attorneys&#146; fees, incurred by a person indemnified by this provision when we receive an undertaking to repay such amounts if it is ultimately determined that the person is not entitled to be indemnified by us.
Amending this provision will not reduce our indemnification obligations relating to actions taken before an amendment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">116 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Forum Selection </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Court of Chancery of the State of Delaware will be the sole and exclusive forum for (i)&nbsp;any derivative action or proceeding brought on behalf of
Penumbra, (ii)&nbsp;any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee of Penumbra to Penumbra or Penumbra&#146;s stockholders, (iii)&nbsp;any action asserting a claim arising pursuant to any
provision of the Delaware General Corporation Law, or (iv)&nbsp;any action asserting a claim governed by the internal affairs doctrine. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of Penumbra shall
be deemed to have notice of and consented to the foregoing forum selection provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Delaware Business Combination Statute </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We elect to be subject to Section&nbsp;203 of the Delaware General Corporation Law, which regulates corporate acquisitions. Section&nbsp;203 prevents an
&#147;interested stockholder,&#148; which is defined generally as a person owning 15% or more of a corporation&#146;s voting stock, or any affiliate or associate of that person, from engaging in a broad range of &#147;business combinations&#148;
with the corporation for three years after becoming an interested stockholder unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the board of directors of the corporation had previously approved either the business combination or the transaction that resulted in the stockholder&#146;s becoming an interested stockholder; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">upon completion of the transaction that resulted in the stockholder&#146;s becoming an interested stockholder, that person owned at least 85% of the voting stock of the corporation outstanding at the time the
transaction commenced, other than statutorily excluded shares; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">following the transaction in which that person became an interested stockholder, the business combination is approved by the board of directors of the corporation and holders of at least two-thirds of the outstanding
voting stock not owned by the interested stockholder. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Under Section&nbsp;203, the restrictions described above also do not apply to
specific business combinations proposed by an interested stockholder following the announcement or notification of designated extraordinary transactions involving the corporation and a person who had not been an interested stockholder during the
previous three years or who became an interested stockholder with the approval of a majority of the corporation&#146;s directors, if such extraordinary transaction is approved or not opposed by a majority of the directors who were directors prior to
any person becoming an interested stockholder during the previous three years or were recommended for election or elected to succeed such directors by a majority of such directors. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Section&nbsp;203 may make it more difficult for a person who would be an interested stockholder to effect various business combinations with a
corporation for a three-year period. Section&nbsp;203 also may have the effect of preventing changes in our management and could make it more difficult to accomplish transactions that our stockholders may otherwise deem to be in their best
interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Anti-Takeover Effects of Some Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Some provisions of our certificate of incorporation and bylaws could make an acquisition of control of us by means of a proxy contest or otherwise more
difficult, including our classified board and ability to issue preferred stock. These provisions are designed to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to
acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection give us the potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or
restructure us, and that the benefits of this increased protection outweigh the disadvantages of discouraging those proposals, because negotiation of those proposals could result in an improvement of their terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Listing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We expect to apply to list our common stock on
the&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;under the symbol &#147;PEN.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The transfer agent and registrar for our common stock is
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">117 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_16"></A>MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSEQUENCES FOR </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>NON-U.S. HOLDERS OF COMMON STOCK </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following
are the material U.S. federal income and estate tax consequences of the ownership and disposition of our common stock acquired in this offering by a &#147;Non-U.S. Holder&#148; that does not own, and has not owned, actually or constructively, more
than 5% of our common stock. You are a Non-U.S. Holder if for U.S. federal income tax purposes you are a beneficial owner of our common stock that is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a nonresident alien individual; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a foreign corporation; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">a foreign estate or trust. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">You are not a Non-U.S. Holder if you are a nonresident alien individual
present in the United States for 183&nbsp;days or more in the taxable year of disposition, or if you are a former citizen or former resident of the United States for U.S. federal income tax purposes. If you are such a person, you should consult your
tax adviser regarding the U.S. federal income tax consequences of the ownership and disposition of our common stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If you are a partnership for
U.S. federal income tax purposes, the U.S. federal income tax treatment of a partner will generally depend on the status of the partner and your activities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">This discussion is based on the Internal Revenue Code of 1986, as amended to the date hereof (the Code), administrative pronouncements, judicial
decisions and final, temporary and proposed Treasury regulations, changes to any of which subsequent to the date of this prospectus may affect the tax consequences described herein, possibly with retroactive effect. This discussion does not describe
all of the tax consequences that may be relevant to you in light of your particular circumstances, including alternative minimum tax and Medicare contribution tax consequences, and does not address any aspect of state, local or non-U.S. taxation, or
any taxes other than income and estate taxes. You should consult your tax adviser with regard to the application of the U.S. federal tax laws to your particular situation, as well as any tax consequences arising under the laws of any state, local or
non-U.S. taxing jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Dividends </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As discussed
under &#147;Dividend Policy&#148; above, we do not currently expect to make distributions on our common stock. In the event that we do make distributions of cash or other property, those distributions will constitute dividends for U.S. federal
income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. To the extent those distributions exceed our current and accumulated earnings and profits, they will
constitute a return of capital, which will first reduce your basis in our common stock, but not below zero, and then will be treated as gain from the sale of our common stock, as described below under the section titled &#147;&#151;Gain on
Disposition of Our Common Stock.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Dividends paid to you generally will be subject to U.S. federal withholding tax at a 30% rate or a reduced
rate specified by an applicable income tax treaty. In order to obtain a reduced rate of withholding, you will be required to provide a properly executed applicable Internal Revenue Service (IRS) Form W-8 certifying your entitlement to benefits under
a treaty. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If dividends paid to you are effectively connected with your conduct of a trade or business in the United States (and, if required by an
applicable income tax treaty, are attributable to a permanent establishment or fixed base maintained by you in the United States), you will generally be taxed on the dividends in the same manner as a U.S. person. In this case, you will be exempt
from the withholding tax discussed in the preceding paragraph, although you will be required to provide a properly executed IRS Form W-8ECI in order to claim an exemption from withholding. You should consult your tax adviser with respect to other
U.S. tax consequences of the ownership and disposition of our common stock, including the possible imposition of a branch profits tax at a rate of 30% (or a lower treaty rate) if you are a corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">118 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Gain on Disposition of Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Subject to the discussions below under the sections titled &#147;&#151;Information Reporting and Backup Withholding&#148; and &#147;&#151;FATCA,&#148;
you generally will not be subject to U.S. federal income or withholding tax on gain realized on a sale or other taxable disposition of our common stock unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the gain is effectively connected with your conduct of a trade or business in the United States (and, if required by an applicable income tax treaty, is attributable to a permanent establishment or fixed base maintained
by you in the United States), or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">we are or have been a &#147;United States real property holding corporation,&#148; as defined in the Code, at any time within the five-year period preceding the disposition or your holding period, whichever period is
shorter, and our common stock is not regularly traded on an established securities market during the calendar year in which the sale or disposition occurs. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We believe that we are not, and do not anticipate becoming, a United States real property holding corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If you recognize gain on a sale or other disposition of our common stock that is effectively connected with your conduct of a trade or business in the
United States (and, if required by an applicable income tax treaty, is attributable to a permanent establishment or fixed base maintained by you in the United States), you will generally be taxed on such gain in the same manner as a U.S. person. You
should consult your tax adviser with respect to other U.S. tax consequences of the ownership and disposition of our common stock, including the possible imposition of a branch profits tax at a rate of 30% (or a lower treaty rate) if you are a
corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Information returns are required to be filed with the IRS in connection with payments of dividends on our common stock. Unless you comply with
certification procedures to establish that you are not a U.S. person, information returns may also be filed with the IRS in connection with the payment of proceeds from a sale or other disposition of our common stock. You may be subject to backup
withholding on payments on our common stock or on the proceeds from a sale or other disposition of our common stock unless you comply with certification procedures to establish that you are not a U.S. person or otherwise establish an exemption. Your
provision of a properly executed applicable IRS Form W-8 (usually IRS Form W-8BEN or W-8BEN-E) certifying your non-U.S. status will permit you to avoid backup withholding. Amounts withheld under the backup withholding rules are not additional taxes
and may be refunded or credited against your U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>FATCA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Provisions of the Code commonly referred to as &#147;FATCA&#148; currently require withholding of 30% on payments of dividends on our common stock, and
will require 30% withholding on payments of gross proceeds of dispositions of our common stock occurring after December&nbsp;31, 2016, to &#147;foreign financial institutions&#148; (which is broadly defined for this purpose and in general includes
investment vehicles) and certain other non-U.S. entities unless various U.S. information reporting and due diligence requirements (generally relating to ownership by U.S. persons of interests in or accounts with those entities) have been satisfied,
or an exemption applies. An intergovernmental agreement between the United States and an applicable foreign country may modify these requirements. If FATCA withholding is imposed, a beneficial owner that is not a foreign financial institution
generally may obtain a refund of any amounts withheld by filing a U.S. federal income tax return (which may entail significant administrative burden). You should consult your tax adviser regarding the effects of FATCA on your investment in our
common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Federal Estate Tax </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Individual Non-U.S.
Holders and entities the property of which is potentially includible in such an individual&#146;s gross estate for U.S. federal estate tax purposes (for example, a trust funded by such an individual and with respect to which the individual has
retained certain interests or powers), should note that, absent an applicable treaty exemption, our common stock will be treated as U.S. situs property subject to U.S. federal estate tax. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">119 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_17"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Prior to this offering, there has been no market for our common stock. Future sales of substantial amounts of our common stock in the public market could
adversely affect market prices prevailing from time to time. Furthermore, because only a limited number of shares will be available for sale shortly after this offering due to existing contractual and legal restrictions on resale as described below,
there may be sales of substantial amounts of our common stock in the public market after the restrictions lapse. This may adversely affect the prevailing market price and our ability to raise equity capital in the future. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Upon the completion of this offering, we will have &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock
outstanding assuming the exercise of the underwriters&#146; option to purchase additional shares, the automatic conversion of all outstanding shares of preferred stock and no exercise of any options outstanding as of March&nbsp;31, 2015. Of these
shares, the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares, or &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares if the underwriters exercise their option to purchase additional shares
in full, sold in this offering will be freely transferable without restriction or registration under the Securities Act, except for any shares purchased by one of our existing &#147;affiliates,&#148; as that term is defined in Rule 144 under the
Securities Act. The remaining &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock existing are &#147;restricted shares&#148; as defined in Rule 144. Restricted shares may be sold in the public market only
if registered or if they qualify for an exemption from registration under Rules 144 or 701 of the Securities Act. As a result of the contractual 180-day lock-up period described below and the provisions of Rules 144 and 701, these shares will be
available for sale in the public market as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:59.85pt; font-size:8pt; font-family:arial"><B>Number of Shares</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">On the date of this prospectus.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">After 90 days from the date of this prospectus.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">After 180 days from the date of this prospectus (subject, in some cases, to volume limitations).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">At various times after 180 days from the date of this prospectus (subject, in some cases, to volume limitations).</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Rule 144 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In general, a
person who has beneficially owned restricted shares of our common stock for at least six months would be entitled to sell such securities, provided that (i)&nbsp;such person is not deemed to have been one of our affiliates at the time of, or at any
time during the 90 days preceding, a sale and (ii)&nbsp;we are subject to the Exchange Act periodic reporting requirements for at least 90 days before the sale. Persons who have beneficially owned restricted shares of our common stock for at least
six months but who are our affiliates at the time of, or any time during the 90 days preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three month period only a number of
securities that does not exceed the greater of either of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">1% of the number of shares of our common stock then outstanding, which will equal approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares immediately after this offering, assuming
no exercise of the underwriters&#146; option to purchase additional shares; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the average weekly trading volume of our common stock on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; during the four calendar weeks preceding the filing of a notice on Form 144 with
respect to the sale; </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial">provided, in each case, that we are subject to the Exchange Act periodic reporting requirements for at least 90 days before the
sale. Such sales both by affiliates and by non-affiliates must also comply with the manner of sale, current public information and notice provisions of Rule 144 to the extent applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Rule 701 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In general, under Rule 701, any of our employees,
directors, officers, consultants or advisors who purchases shares from us in connection with a compensatory stock or option plan or other written agreement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">120 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
before the effective date of this offering is entitled to resell such shares 90 days after the effective date of this offering in reliance on Rule 144, without having to comply with the holding
period requirements or other restrictions contained in Rule 701. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The SEC has indicated that Rule 701 will apply to typical stock options granted by
an issuer before it becomes subject to the reporting requirements of the Exchange Act, along with the shares acquired upon exercise of such options, including exercises after the date of this prospectus. Securities issued in reliance on Rule 701 are
restricted securities and, subject to the contractual restrictions described above, beginning 90 days after the date of this prospectus, may be sold by persons other than &#147;affiliates,&#148; as defined in Rule 144, subject only to the manner of
sale provisions of Rule 144 and by &#147;affiliates&#148; under Rule 144 without compliance with its one-year minimum holding period requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Registration
Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Upon the completion of this offering, the holders of 21,641,495 shares of common stock will be entitled to various rights with respect to
the registration of these shares under the Securities Act. Registration of these shares under the Securities Act would result in these shares becoming freely tradable without restriction under the Securities Act immediately upon the effectiveness of
the registration, except for shares purchased by affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Stock Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of March&nbsp;31, 2015, options to purchase a total of 3,265,591 shares of common stock were outstanding. An additional 2,199,713 shares of common
stock were available for future grants under our stock plans. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Upon the completion of this offering, we intend to file a registration statement under
the Securities Act covering all shares of common stock subject to outstanding options or issuable pursuant to our 2014 Equity Incentive Plan. Subject to Rule 144 volume limitations applicable to affiliates, shares registered under any registration
statements will be available for sale in the open market, beginning 90 days after the date of the prospectus, except to the extent that the shares are subject to vesting restrictions with us or the contractual restrictions described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Lock-up Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We expect that all of our directors,
executive officers and substantially all of the other holders of our equity securities will agree, subject to certain exceptions, not to offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, or enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of
ownership of any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock for a period of 180 days after the date of this prospectus, without the prior written consent of the representatives
of the underwriters. See the section titled &#147;Underwriting.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">121 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_18"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We are offering the shares of common stock described in this prospectus through a number of underwriters. J.P. Morgan Securities LLC and Merrill Lynch,
Pierce, Fenner&nbsp;&amp; Smith Incorporated are acting as joint <FONT STYLE="white-space:nowrap">book-running</FONT> managers of the offering and as representatives of the underwriters. We will enter into an underwriting agreement with the
underwriters. Subject to the terms and conditions of the underwriting agreement, we will agree to sell to the underwriters, and each underwriter will severally agree to purchase, at the public offering price less the underwriting discounts and
commissions set forth on the cover page of this prospectus, the number of shares of common stock listed next to its name in the following table: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:19.25pt; font-size:8pt; font-family:arial"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number&nbsp;of<BR>Shares</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Merrill Lynch, Pierce, Fenner&nbsp;&amp; Smith</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Incorporated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Canaccord Genuity Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The underwriters will be committed to purchase all the common shares offered by us if they purchase any shares. The
underwriting agreement will also provide that if an underwriter defaults, the purchase commitments of non-defaulting underwriters may also be increased or the offering may be terminated. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The underwriters propose to offer the common shares directly to the public at the initial public offering price set forth on the cover page of this
prospectus and to certain dealers at that price less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. Any such dealers may resell shares to certain other brokers or dealers at a discount of up to
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share from the initial public offering price. After the initial offering of the shares to the public, the offering price and other selling terms may be changed by the underwriters. Sales of shares
made outside of the United States may be made by affiliates of the underwriters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The underwriters will have an option to buy up
to&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock from us. The underwriters will have 30 days from the date of this prospectus to exercise this option to purchase additional shares. If any
shares are purchased with this option to purchase additional shares, the underwriters will purchase shares in approximately the same proportion as shown in the table above. If any additional shares of common stock are purchased, the underwriters
will offer the additional shares on the same terms as those on which the shares are being offered. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The underwriters do not expect to sell more than
5% of the common shares in the aggregate to accounts over which they exercise discretionary authority. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The underwriting fee is equal to the public
offering price per share of common stock less the amount paid by the underwriters to us per share of common stock. The underwriting fee is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. The following table shows the per share and total
underwriting discounts and commissions to be paid to the underwriters assuming both no exercise and full exercise of the underwriters&#146; option to purchase additional shares. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Without<BR>exercise&nbsp;of&nbsp;option<BR>to purchase<BR>additional&nbsp;shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>With&nbsp;full<BR>exercise&nbsp;of&nbsp;option<BR>to purchase<BR>additional shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Per Share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Perella Weinberg Partners LLP (Perella Weinberg), a Financial Industry Regulatory Association, Inc. (FINRA) member, is
acting as our financial advisor in connection with the offering. We expect to pay Perella Weinberg, upon the successful completion of this offering, a fee of $1,250,000 for its services. The services provided by Perella Weinberg include business and
financial analysis, assistance in preparing information materials regarding the offering and advising us with respect to the marketing and structuring of this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">122 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Perella Weinberg is not acting as an underwriter and will not sell or offer to sell any securities and will not identify, solicit or engage directly with potential investors. In addition, Perella
Weinberg will not underwrite or purchase any of the offered securities or otherwise participate in any such undertaking. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We estimate that the total
expenses of this offering, including the fees of Perella Weinberg, registration, filing and listing fees, printing fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will be approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. We have agreed to reimburse the underwriters for certain FINRA-related and other expenses incurred by them in connection with this offering in an amount up to
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The underwriters have agreed to reimburse us for certain expenses we incur in connection with this offering up to $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">A prospectus in electronic format may be made available on the web sites maintained by one or more underwriters, or selling group members, if any,
participating in the offering. The underwriters may agree to allocate a number of shares to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to
underwriters and selling group members that may make Internet distributions on the same basis as other allocations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We will agree that, subject to
limited exceptions, we will not (i)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise dispose of, directly or
indirectly, or file with the Securities and Exchange Commission a registration statement under the Securities Act relating to, any shares of our common stock or securities convertible into or exchangeable or exercisable for any shares of our common
stock, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing, or (ii)&nbsp;enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with the ownership of any
shares of common stock or any such other securities (regardless of whether any of these transactions are to be settled by the delivery of shares of common stock or such other securities, in cash or otherwise), in each case without the prior written
consent of J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner&nbsp;&amp; Smith Incorporated for a period of 180 days after the date of this prospectus, other than the shares of our common stock to be sold hereunder and any shares of our
common stock issued upon the exercise of options granted under our existing equity incentive plans. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Our directors and executive officers, and
holders of substantially all of our outstanding shares have entered into or will enter into <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the underwriters prior to the commencement of this offering pursuant to which each of these
persons or entities, with limited exceptions, for a period of 180&nbsp;days after the date of this prospectus, may not, without the prior written consent of J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner&nbsp;&amp; Smith Incorporated,
(1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares
of our common stock or any securities convertible into or exercisable or exchangeable for our common stock (including, without limitation, common stock or such other securities which may be deemed to be beneficially owned by such directors,
executive officers, or other stockholders in accordance with the rules and regulations of the SEC and securities which may be issued upon exercise of a stock option or warrant) or (2)&nbsp;enter into any swap or other agreement that transfers, in
whole or in part, any of the economic consequences of ownership of the common stock or such other securities, whether any such transaction described in clause&nbsp;(1) or&nbsp;(2) above is to be settled by delivery of common stock or such other
securities, in cash or otherwise, or (3)&nbsp;make any demand for or exercise any right with respect to the registration of any shares of our common stock or any security convertible into or exercisable or exchangeable for our common stock. The
restrictions described above are subject to exceptions, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">open market transactions after the completion of this offering, provided that no filing under Section&nbsp;16(a) of the Exchange Act, or other public announcement, shall be required or shall be made voluntarily in
connection with any such transaction (other than a filing on a Form 5 made after the expiration of the restricted period); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE="font-family:arial; font-size:10pt">transfers that occur by operation of law pursuant to a qualified domestic order or in connection with a divorce settlement, provided that any filing required to
be made under Section&nbsp;16(a) of the Exchange Act shall clearly indicate the purpose of the transfer in the footnotes thereto, no other public announcement shall be required or shall be made voluntarily in connection with such transfer and each
transferee, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">123 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="6%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-family:arial; font-size:10pt">
donee or distributee shall execute and deliver to the underwriters a lock-up agreement substantially in the form of the lock-up agreement entered into by the party subject to the lockup
restrictions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">transfers to us pursuant to agreements under which we have the option to repurchase such shares or securities upon termination of service of the party subject to the lockup restrictions, provided that any public report
or filing required to be made under Section&nbsp;16(a) of the Exchange Act shall clearly indicate in the footnotes thereto the circumstances of such transfer and no other public announcement shall be required or shall be made voluntarily in
connection with such transfer; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the exercise of stock options granted under a stock incentive plan or stock purchase plan described in this prospectus, provided that the shares received upon exercise shall continue to be subject to the restrictions on
transfer set forth in the lock-up agreement and that any public report or filing required to be made under Section&nbsp;16(a) of the Exchange Act shall clearly indicate in the footnotes thereto that the filing relates to the exercise of a stock
option, that no shares were sold by the reporting person and that the shares received upon exercise of the stock option are subject to a lock-up agreement with the underwriters; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">transfers to us upon the exercise of options to purchase our securities outstanding as of the date the party subject to the lockup restrictions entered into the lock-up agreement or pursuant to a stock incentive plan or
stock purchase plan described in this prospectus, on a &#147;cashless&#148; or &#147;net exercise&#148; basis, provided that the shares received upon exercise shall continue to be subject to the restrictions on transfer set forth in the lock-up
agreement and that any public report or filing required to be made under Section&nbsp;16(a) of the Exchange Act shall clearly indicate in the footnotes thereto that the filing relates to the &#147;cashless&#148; or &#147;net&#148; exercise of a
stock option, that no shares were sold by the reporting person and that the shares received upon exercise of the stock option are subject to a lock-up letter agreement with the underwriters; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of common stock, provided that (i)&nbsp;such plan does not provide for the transfer of common stock during
the restricted period and (ii)&nbsp;no public announcement or filing shall be required or shall be made voluntarily in connection with the establishment of such plan during the restricted period. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We will agree to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We will apply to have our common stock approved for listing on the
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; under the symbol &#147;PEN.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In connection
with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for, purchasing and selling shares of common stock in the open market for the purpose of preventing or retarding a decline in the market price of
the common stock while this offering is in progress. These stabilizing transactions may include making short sales of the common stock, which involves the sale by the underwriters of a greater number of shares of common stock than they are required
to purchase in this offering, and purchasing shares of common stock on the open market to cover positions created by short sales. Short sales may be &#147;covered&#148; shorts, which are short positions in an amount not greater than the
underwriters&#146; option to purchase additional shares referred to above, or may be &#147;naked&#148; shorts, which are short positions in excess of that amount. The underwriters may close out any covered short position either by exercising their
option to purchase additional shares, in whole or in part, or by purchasing shares in the open market. In making this determination, the underwriters will consider, among other things, the price of shares available for purchase in the open market
compared to the price at which the underwriters may purchase shares through the option to purchase additional shares. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the
price of the common stock in the open market that could adversely affect investors who purchase in this offering. To the extent that the underwriters create a naked short position, they will purchase shares in the open market to cover the position.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The underwriters have advised us that, pursuant to Regulation&nbsp;M of the Securities Act, they may also engage in other activities that stabilize,
maintain or otherwise affect the price of the common stock, including the imposition of penalty bids. This means that if the representatives of the underwriters purchase common stock in the open market in stabilizing transactions or to cover short
sales, the representatives can require the underwriters that sold those shares as part of this offering to repay the underwriting discount received by them. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">124 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">These activities may have the effect of raising or maintaining the market price of the common stock or
preventing or retarding a decline in the market price of the common stock, and, as a result, the price of the common stock may be higher than the price that otherwise might exist in the open market. If the underwriters commence these activities,
they may discontinue them at any time. The underwriters may carry out these transactions on the &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Prior to this offering, there has been no public market for our common stock. The initial public offering price will be determined by negotiations
between us and the representatives of the underwriters. In determining the initial public offering price, we and the representatives of the underwriters expect to consider a number of factors including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the information set forth in this prospectus and otherwise available to the representatives; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our prospects and the history and prospects for the industry in which we compete; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an assessment of our management; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">our prospects for future earnings; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the general condition of the securities markets at the time of this offering; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the recent market prices of, and demand for, publicly traded common stock of generally comparable companies; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">other factors deemed relevant by the underwriters and us. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Neither we nor the underwriters can assure
investors that an active trading market will develop for our common shares, or that the shares will trade in the public market at or above the initial public offering price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Selling Restrictions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>General </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this
prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in
connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose
possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an
offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>European Economic Area
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In relation to each Member State of the European Economic Area (each, a Relevant Member State), no offer of shares may be made to the public
in that Relevant Member State other than: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top">to any legal entity which is a qualified investor as defined in the Prospectus Directive;</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top">to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive, 150, natural or legal persons (other than qualified investors as defined in the Prospectus
Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the representatives; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top">in any other circumstances falling within Article 3(2) of the Prospectus Directive, </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:arial">provided that no
such offer of shares shall require the Company or the representatives to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the Prospectus Directive. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">125 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Each person in a Relevant Member State who initially acquires any shares or to whom any offer is made will
be deemed to have represented, acknowledged and agreed that it is a &#147;qualified investor&#148; within the meaning of the law in that Relevant Member State implementing Article 2(1)(e) of the Prospectus Directive.&nbsp;In the case of any shares
being offered to a financial intermediary as that term is used in Article 3(2) of the Prospectus Directive, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares acquired by it in the offer have
not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer of any shares&nbsp;to the public other than their offer or
resale in a Relevant Member State to qualified investors as so defined or in circumstances in which the prior consent of the representatives has been obtained to each such proposed offer or resale. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company, the representatives and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and
agreements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">This prospectus has been prepared on the basis that any offer of shares in any Relevant Member State will be made pursuant to an
exemption under the Prospectus Directive from the requirement to publish a prospectus for offers of shares. Accordingly any person making or intending to make an offer in that Relevant Member State of shares which are the subject of the offering
contemplated in this prospectus may only do so in circumstances in which no obligation arises for the Company or any of the underwriters to publish a prospectus pursuant to Article 3 of the Prospectus Directive in relation to such
offer.&nbsp;Neither the Company nor the underwriters have authorized, nor do they authorize, the making of any offer of shares in circumstances in which an obligation arises for the Company or the underwriters to publish a prospectus for such offer.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">For the purpose of the above provisions, the expression &#147;an offer to the public&#148; in relation to any shares in any Relevant Member State
means the communication in any form and by any means of sufficient information on the terms of the offer and the shares to be offered so as to enable an investor to decide to purchase or subscribe the shares, as the same may be varied in the
Relevant Member State by any measure implementing the Prospectus Directive in the Relevant Member State and the expression &#147;Prospectus Directive&#148; means Directive 2003/71/EC (including the 2010 PD Amending Directive, to the extent
implemented in the Relevant Member States) and includes any relevant implementing measure in the Relevant Member State and the expression &#147;2010 PD Amending Directive&#148; means Directive 2010/73/EU. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B><I>United Kingdom </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In addition, in the United Kingdom,
this document is being distributed only to, and is directed only at, and any offer subsequently made may only be directed at persons who are &#147;qualified investors&#148; (as defined in the Prospectus Directive) (i)&nbsp;who have professional
experience in matters relating to investments falling within Article 19 (5)&nbsp;of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the &#147;Order&#148;) and/or (ii)&nbsp;who are high net worth companies
(or persons to whom it may otherwise be lawfully communicated) falling within Article 49(2)(a) to (d)&nbsp;of the Order (all such persons together being referred to as &#147;relevant persons&#148;).</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Any person in the United Kingdom that is not a relevant person should not act or rely on the information included in this document or use it as basis for
taking any action. In the United Kingdom, any investment or investment activity that this document relates to may be made or taken exclusively by relevant persons. Any person in the United Kingdom that is not a relevant person should not act or rely
on this document or any of its contents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Certain of the underwriters and their affiliates have provided in the past to us and our affiliates and may
provide from time to time in the future certain commercial banking, financial advisory, investment banking and other services for us and such affiliates in the ordinary course of their business, for which they have received and may continue to
receive customary fees and commissions. In addition, from time to time, certain of the underwriters and their affiliates may effect transactions for their own account or the account of customers, and hold on behalf of themselves or their customers,
long or short positions in our debt or equity securities or loans, and may do so in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">126 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_19"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The validity of the issuance of the shares of common stock offered hereby will be passed upon for us by Davis Polk&nbsp;&amp; Wardwell LLP. Goodwin
Procter LLP is representing the underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_20"></A>EXPERTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The consolidated financial statements of Penumbra, Inc. and its subsidiaries as of December&nbsp;31, 2013 and 2014, and for each of the two years ended
December&nbsp;31, 2014, included in this prospectus have been audited by Deloitte&nbsp;&amp; Touche LLP, an independent registered public accounting firm, as stated in their report appearing herein. Such financial statements have been so included in
reliance upon the report of such firm given upon their authority as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">127 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="toc923792_21"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the common stock offered hereby. This prospectus
does not contain all of the information set forth in the registration statement and the exhibits and schedules thereto. For further information with respect to the Company and its common stock, reference is made to the registration statement and the
exhibits and any schedules filed therewith. Statements contained in this prospectus as to the contents of any contract or other document referred to are not necessarily complete and in each instance, if such contract or document is filed as an
exhibit, reference is made to the copy of such contract or other document filed as an exhibit to the registration statement, each statement being qualified in all respects by such reference. A copy of the registration statement, including the
exhibits and schedules thereto, may be read and copied at the SEC&#146;s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. Information on the operation of the Public Reference Room may be obtained by calling the SEC at
1-800-SEC-0330. In addition, the SEC maintains an Internet site at www.sec.gov, from which interested persons can electronically access the registration statement, including the exhibits and any schedules thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As a result of the offering, we will be required to file periodic reports and other information with the SEC. We also maintain an Internet site at
www.penumbrainc.com. Our website and the information contained therein or accessible therefrom shall not be deemed to be incorporated into this prospectus or the registration statement of which it forms a part. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">128 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="index"></A><A NAME="toc923792_22"></A>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="95%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin923792_1">Report of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin923792_2">Consolidated Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin923792_3">Consolidated Statements of Operations and Comprehensive Income</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin923792_4">Consolidated Statements of Preferred Stock and Stockholders&#146; Deficit</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin923792_5">Consolidated Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><A HREF="#fin923792_6">Notes to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="fin923792_1"></A>Report of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">To the Board of Directors and Stockholders of </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Penumbra, Inc. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial">Alameda, California </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We have audited the accompanying consolidated
balance sheets of Penumbra, Inc. and subsidiaries (the &#147;Company&#148;) as of December&nbsp;31, 2013 and 2014, and the related consolidated statements of operations and comprehensive income, preferred stock and stockholders&#146; deficit, and
cash flows for each of the two years in the period ended December&nbsp;31, 2014. These consolidated financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the financial statements
based on our audits. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its
internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the Company&#146;s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the
consolidated financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for
our opinion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In our opinion, such consolidated financial statements present fairly, in all material respects, the consolidated financial position of
the Company as of December&nbsp;31, 2013 and 2014, and the consolidated results of its operations and its cash flows for each of the two years in the period ended December&nbsp;31, 2014, in conformity with accounting principles generally accepted in
the United States of America. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">/s/ DELOITTE&nbsp;&amp; TOUCHE LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">San
Francisco, California </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">June 9, 2015 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="fin923792_2"></A>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>CONSOLIDATED BALANCE SHEETS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>(in thousands,
except share and per share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,<BR>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,<BR>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March&nbsp;31,<BR>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Pro Forma<BR>Stockholders&#146;<BR>Equity at<BR>March&nbsp;31,<BR>2015</B><br><B>(See&nbsp;Note&nbsp;2)</B></TD></TR>
<TR STYLE="font-family:arial; font-size:7.5pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="5" NOWRAP ALIGN="center"><B>(unaudited)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Marketable investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Accounts receivable, net of doubtful accounts of $471, $602 and $429 at December 31, 2013 and 2014 and March 31, 2015 (unaudited),
respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Deferred taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">119,471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Restricted investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Deferred taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Other non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">328</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">504</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">121,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">127,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial"><B>Liabilities, Preferred Stock and Stockholders&#146; Deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,837</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,823</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Credit facility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Other non-current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,577</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Commitments and contingencies (Note 7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Preferred stock, $0.001 par value&#151;25,000,000, 25,000,000 and 25,000,000 shares authorized at December 31, 2013 and 2014 and March 31, 2015
(unaudited) respectively; 15,594,618, 19,510,410 and 19,510,410 shares issued and outstanding at December 31, 2013 and 2014 and March 31, 2015 (unaudited), respectively; aggregate liquidation value $85,218, $149,361, and $151,499 at
December&nbsp;31, 2013 and 2014 and March 31, 2015 (unaudited), respectively; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares authorized, no shares issued or
outstanding, pro forma (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Stockholders&#146; deficit:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Common stock, $0.001 par value&#151;40,000,000, 40,000,000 and 40,000,000 shares authorized at December 31, 2013, 2014 and March 31, 2015
(unaudited), respectively; 4,391,591, 4,736,689 and 4,921,104 shares issued and outstanding at December 31, 2013, 2014 and March 31, 2015 (unaudited), respectively;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares authorized, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares issued and outstanding pro
forma (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Notes receivable from stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Accumulated other comprehensive income/(loss)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(864</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,993</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,840</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,338</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,062</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,370</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,991</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:8pt; font-family:arial">Total liabilities, preferred stock and stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">121,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">127,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">The accompanying notes are an integral part of these financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="fin923792_3"></A>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>(in thousands, except share and per share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cost of revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Gross profit</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,454</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Operating expenses:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,084</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sales, general and administrative</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,918</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total operating expenses</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,613</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income (loss) from operations</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,126</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Interest income (expense), net</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">345</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">439</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other income (expense), net</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(474</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(309</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(37</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income (loss) before provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,255</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net income</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Foreign currency translation adjustments, net of tax</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(522</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(424</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(916</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unrealized gains on available-for-sale securities, net of tax</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(84</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(237</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Comprehensive income</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,493</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,613</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net income (loss) attributable to common stockholders (Note&nbsp;16)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(833</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net income (loss) per share attributable to common stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.18</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.18</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average shares used to compute net income (loss) per share attributable to common stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,304,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,609,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,430,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,903,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,500,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,609,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,705,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,193,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma net income per share (unaudited) (Note 16)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average shares used to compute pro forma net income per share (unaudited) (Note 16)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">The accompanying notes are an integral part of these financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="fin923792_4"></A>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF PREFERRED STOCK AND STOCKHOLDERS&#146; DEFICIT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>(in thousands, except share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Additional</B><br><B>Paid-in</B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Notes<BR>Receivable</B><br><B>from</B><br><B>Stockholders</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Accumulated<BR>Other</B><br><B>Comprehensive</B><br><B>Income/ (Loss)</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total</B><br><B>Stockholders&#146;</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Preferred Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>Balance at December&nbsp;31, 2012</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,594,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">56,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,192,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(138</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19,092</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(12,751</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Issuance of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">198,843</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Foreign currency translation adjustment, net of tax of $213</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(522</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(522</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Unrealized loss on investments, net of tax of $10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(84</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(84</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Net Income</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>Balance at December&nbsp;31, 2013</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,594,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,391,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">796</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,993</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,062</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Issuance of Series F preferred stock, net of issuance cost of $2,788</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,545,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Repurchase of preferred stock</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(629,663</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,967</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,344</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,344</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Repurchase of common stock</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(115,612</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(292</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(748</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,040</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Issuance of common stock</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">460,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,036</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Stock-based compensation</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Forgiven notes receivable from stockholders</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Foreign currency translation adjustment, net of tax of $245</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Unrealized loss on investments, net of tax of $168</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(237</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(237</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Net Income</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>Balance at December&nbsp;31, 2014</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,510,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,736,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(864</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,840</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12,370</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Issuance of common stock (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">184,415</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Stock-based compensation (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Forgiven notes receivable from stockholders (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Foreign currency translation adjustment, net of tax of $112 (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(916</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(916</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Unrealized gain on investments, net of tax of $20 (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Net Income (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>Balance at March&nbsp;31, 2015 (unaudited)</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,510,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,921,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,753</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(17,338</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9,991</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">The accompanying notes are an integral part of these financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="fin923792_5"></A>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF CASH FLOWS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>(in
thousands) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:9pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three Months<BR>Ended March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>CASH FLOWS FROM OPERATING ACTIVITIES:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Net Income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Adjustments to reconcile net income to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">751</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Provision for doubtful accounts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(151</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Inventory write downs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,852</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">285</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Write off of note receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Provision for sales returns</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(212</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Loss on minority investment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Loss on disposal of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Realized loss on marketable investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Provision for product warranty</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Release of valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,962</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(321</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Deferred taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(335</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(571</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Issuance of common stock to third parties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,550</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,426</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,394</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,933</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,779</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,444</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,340</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,057</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Prepaid expenses and other current and non-current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(961</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,906</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(451</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Accrued expenses and other non-current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,396</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,389</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(132</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,662</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>CASH FLOWS FROM INVESTING ACTIVITIES:</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Purchase of marketable investments</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,858</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,342</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(93</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,411</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Proceeds from sales of marketable investments</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,405</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(798</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,888</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(549</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,298</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Net cash provided by (used in) investing activities</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,251</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(37,001</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(642</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>CASH FLOWS FROM FINANCING ACTIVITIES:</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Proceeds from issuance of preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151; </TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Proceeds from exercises of stock options</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,036</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Repurchase of preferred stock</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,311</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Proceeds from credit facility</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Repayment of credit facility</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Net repurchase of common stock and stock options</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,040</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Effect of foreign exchange rate changes on cash and cash equivalents</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(835</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(348</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(45</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(362</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>Net Increase (Decrease) In Cash And Cash Equivalents</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,304</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(841</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,842</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">CASH AND CASH EQUIVALENTS&#151;Beginning of period</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">CASH AND CASH EQUIVALENTS&#151;End of period</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Cash paid for interest</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Cash paid for income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:arial"><B>NONCASH INVESTING AND FINANCING ACTIVITIES:</B></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:arial">Purchase of property and equipment funded through accounts payable</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">The accompanying notes are an integral part of these financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B><A NAME="fin923792_6"></A>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>1. Organization
and Description of Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Penumbra, Inc. (the &#147;Company&#148;) is a global interventional therapies company that designs, develops,
manufactures and markets innovative medical devices. The Company has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. The conditions
that the Company&#146;s products address include, among others, ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2. Summary of Significant Accounting Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Basis of Presentation and
Consolidation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted
in the United States (U.S. GAAP). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Subsequent events were
evaluated from the balance sheet dates of December&nbsp;31, 2014 and March&nbsp;31, 2015 (unaudited) through June&nbsp;9, 2015. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Use of Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets, liabilities and equity accounts; disclosure of contingent assets and liabilities at the date of the financial statements; and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, the
Company evaluates its estimates, including those related to provisions for doubtful accounts, sales return reserve, warranty reserves, valuation of inventories, useful lives of property and equipment, income taxes, the valuation of equity
instruments and contingencies, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities that are not readily apparent from other data. Actual results could differ from those estimates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Unaudited Interim Financial Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The accompanying
interim consolidated financial statements as of March&nbsp;31, 2015 and for the three months ended March&nbsp;31, 2014 and 2015 and the related interim information contained within the notes to the financial statements are unaudited. The unaudited
interim consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and on the same basis as the audited financial statements. In the opinion of management, the accompanying unaudited interim
consolidated financial statements contain all adjustments which are necessary to present fairly the Company&#146;s financial position as of March&nbsp;31, 2015, and the results of its operations and cash flows for the three months ended
March&nbsp;31, 2014 and 2015. Such adjustments are of a normal and recurring nature. The results for the three months ended March&nbsp;31, 2015 are not necessarily indicative of the results to be expected for the year ending December&nbsp;31, 2015
or for any future period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Unaudited Pro Forma Stockholders&#146; Equity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The unaudited pro forma stockholders&#146; equity information in the accompanying consolidated balance sheet reflects that there are 24,431,514 shares of
common stock outstanding and assumes the automatic conversion of all outstanding shares of preferred stock into shares of common stock in connection with the Company&#146;s proposed initial public offering (IPO). The unaudited pro forma
stockholders&#146; equity does not assume any proceeds from the proposed IPO. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2. Summary of Significant Accounting Policies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Segments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company determined its operating segment on the same basis that it uses to evaluate its performance internally. The Company has one business
activity: the design, development, manufacturing and marketing of innovative medical devices, and operates as one operating segment. The Company&#146;s chief operating decision-maker, its Chief Executive Officer, reviews its operating results for
the purpose of allocating resources and evaluating financial performance. The Company determines revenue by geographic area, based on the destination to which it ships its products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Foreign Currency Translation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s consolidated
financial statements are prepared in United States Dollars (USD). Its foreign subsidiaries use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these
subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the average exchange rates in
effect. The resulting foreign currency translation adjustments are recorded in other comprehensive income in the consolidated balance sheets. Transactions denominated in foreign currency are translated at exchange rates at the date of transaction
with foreign currency gains (losses) recorded in other income (expense), net in the consolidated statements of operations and other comprehensive income. The Company recognized net foreign currency transaction gains (losses) of $(0.3) million,
$(0.3) million, $(38,000) (unaudited) and $0.1 million (unaudited) during the year ended December&nbsp;31, 2013 and 2014 and the three months ended March&nbsp;31, 2014 and 2015, respectively. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As the Company&#146;s international operations grow, its risks associated with fluctuation in currency rates will become greater, and the Company will
continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening USD can increase the costs of the Company&#146;s international expansion. To date, the Company has not entered into any foreign currency
hedging contracts, since exchange rate fluctuations have not had a material impact on its operating results and cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Concentration of Credit Risk
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, marketable
investments and accounts receivable. The majority of the Company&#146;s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not
federally insured during the year ended December&nbsp;31, 2014 and held cash in foreign banks of approximately $0.6 million, $0.8 million and $2.5 million (unaudited) at December&nbsp;31, 2013 and 2014 and March&nbsp;31, 2015, respectively, that was
not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">All of the Company&#146;s revenue
has been derived from sales of its products in the United States and international markets. The Company uses both its own salesforce and independent distributors to sell its products. Concentrations of credit risk with respect to accounts receivable
are limited due to the large number of entities comprising the Company&#146;s customer base. The Company performs ongoing credit evaluations of its customers, including its distributors, does not require collateral, and maintains allowances for
potential credit losses on customer accounts when deemed necessary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">During the years ended December&nbsp;31, 2013 and 2014 and the three months
ended March&nbsp;31, 2014 (unaudited) and 2015 (unaudited), one customer (a distributor) accounted for 14%, 12%, 13% and 11%, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2. Summary of Significant Accounting Policies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
respectively, of the Company&#146;s revenue. No customer accounted for greater than 10% of the Company&#146;s accounts receivable balance as of December&nbsp;31, 2013, 2014 or March&nbsp;31, 2015
(unaudited). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Significant Risks and Uncertainties </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The
Company is subject to risks common to medical device companies including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product
liability, uncertainty of market acceptance of products and the potential need to obtain additional financing. The Company is dependent on third party suppliers, in some cases single-source suppliers. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">There can be no assurance that the Company&#146;s products will continue to be accepted in the marketplace, nor can there be any assurance that any
future products can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products will be successfully marketed, if at all. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s products require approval or clearance from the U.S. Food and Drug Administration prior to commencing commercial sales in the United
States. There can be no assurance that the Company&#146;s products will receive all of the required approvals or clearances. Approvals or clearances are also required in foreign jurisdictions in which the Company sells its products. If the Company
is denied such approvals or clearances or such approvals or clearances are delayed, it may have a material adverse impact on the Company&#146;s results of operations, financial position and liquidity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Fair Value of Financial Instruments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Carrying amounts of
certain of the Company&#146;s financial instruments, including cash equivalents, accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Cash, Cash Equivalents and Marketable Investments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The
Company invests its cash primarily in money market funds and in highly liquid debt instruments of U.S. federal and municipal governments and their agencies and corporate debt securities. All highly liquid investments with stated maturities of three
months or less from the date of purchase are classified as cash equivalents; all highly liquid investments with stated maturities of greater than three months are classified as marketable investments. The majority of the Company&#146;s cash and
investments are held in U.S. banks and its foreign subsidiaries maintain a limited amount of cash in their local banks to cover their short term operating expenses. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company determines the appropriate classification of its investments in marketable investments at the time of purchase and re-evaluates such
designation at each balance sheet date. The Company&#146;s marketable investments have been classified and accounted for as available-for-sale. Investments with remaining maturities of more than one year are viewed by the Company as available to
support current operations and are classified as current assets under the caption marketable investments in the accompanying consolidated balance sheets. Investments in marketable investments are carried at fair value, with the unrealized gains and
losses reported as a component of accumulated other comprehensive income. Any realized gains or losses on the sale of marketable investments are determined on a specific identification method, and such gains and losses are reflected as a component
of other income (expense), net. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Impairment of Marketable Investments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">After determining the fair value of available-for-sales debt instruments, gains or losses on these securities are recorded to accumulated other
comprehensive income until either the security is sold or the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2. Summary of Significant Accounting Policies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
determines that the decline in value is other-than-temporary. The primary differentiating factors that the Company considers in classifying impairments as either temporary or other-than-temporary
impairments is the intent and ability to retain the investment in the issuer for a period of time sufficient to allow for any anticipated recovery in market value, the length of the time and the extent to which the market value of the investment has
been less than cost, the financial condition and near-term prospects of the issuer. There were no other-than-temporary impairments for the years ended December 31, 2013 and 2014 and for the three months ended March 31, 2014 (unaudited) and 2015
(unaudited). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Accounts Receivable </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Accounts receivable
are stated at invoice value less estimated allowances for doubtful accounts. The Company continually monitors customer payments and maintains a reserve for estimated losses resulting from its customers&#146; inability to make required payments. The
Company considers factors such as historical experience, credit quality, age of the accounts receivable balances, geographic related risks and economic conditions that may affect a customer&#146;s ability to pay. In cases where there are
circumstances that may impair a specific customer&#146;s ability to meet its financial obligations, a specific allowance is recorded against amounts due, and thereby reduces the net recognized receivable to the amount reasonably believed to be
collectible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Restricted Investments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Restricted
investments of $6.0 million as of December&nbsp;31, 2013, classified as available-for-sale investments in money market funds, are held with a major financial institution as security for the Company&#146;s credit facility. Refer to Note 5. There are
no restricted investments as of December&nbsp;31, 2014 or March&nbsp;31, 2015 (unaudited). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Inventories </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Inventories are stated at the lower of cost (determined under the first-in first-out method) or market. Write downs are provided for raw materials,
components or finished goods that are determined to be excessive or obsolete. Market value is determined as the lower of replacement cost or net realizable value. The Company regularly reviews inventory quantities in consideration of actual loss
experience, projected future demand and remaining shelf life to record a provision for excess and obsolete inventory when appropriate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The estimate
of excess quantities is subjective and primarily dependent on the Company&#146;s estimates of future demand for a particular product or components or raw materials used in the manufacturing of such product. If the estimate of future demand is
inaccurate based on actual sales, the Company may increase the write down for excess inventory and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive income. The Company periodically
evaluates the carrying value of inventory on hand for potential excess amounts over demand using the same lower of cost or market approach as that has been used to value the inventory. The Company also periodically evaluates inventory quantities in
consideration of actual loss experience. As a result of these evaluations, the Company recognized total write downs of $0.9 million and $1.9 million for the years ended December&nbsp;31, 2013 and 2014, respectively, and $0.3 million for the three
months ended March&nbsp;31, 2014 (unaudited). No such write down was recorded in the three months ended March&nbsp;31, 2015. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Property and Equipment, net
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over five
years, which is the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the lease term or estimated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2. Summary of Significant Accounting Policies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
useful life. Upon retirement or sale, the cost and the related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations.
Maintenance and repairs are charged to operations as incurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Impairment of Long-Lived Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be
recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group&#146;s carrying value. If an asset is considered impaired, the
asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There was no impairment of long-lived assets during the year ended December&nbsp;31, 2013 and
2014 and for the three months ended March&nbsp;31, 2014 (unaudited) and 2015 (unaudited). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company has classified the preferred stock as temporary equity in the consolidated balance sheets due to the existence of certain change in control
events that are not solely within the Company&#146;s control, including liquidation, sale or transfer of the Company, that trigger the ability of the holders of the preferred stock to call for redemption of shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Revenue Recognition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Revenue is comprised of product revenue
net of returns, discounts, administration fees and sales rebates. The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable and collectability is reasonably
assured. Evidence of an arrangement consists of customer orders and the Company typically considers delivery to have occurred once title and risk of loss has been transferred and the product has been delivered to the customer. The Company typically
recognizes revenue when products are delivered to hospital customers or distributors. However, with respect to products that the Company consigns to hospitals, which primarily consist of coils, the Company recognizes revenue at the time hospitals
utilize products in a procedure. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Deferred revenue represents amounts that the Company has already invoiced its customers and are ultimately expected
to be recognized as revenue, but for which not all revenue recognition criteria have been met. The Company had a deferred revenue balance of $1.1 million, $1.6 million and $1.2 million, as of December 31, 2013, 2014 and March 31, 2015 (unaudited),
respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s terms and conditions permit product returns and exchanges, and it records returns reserves in the period when
revenue is recognized. Estimates are based on actual historical returns over the prior three years and are recorded as reductions in revenue at the time of sale. Upon recognition, the Company reduces revenue and cost of revenue for the estimated
return. Return rates can fluctuate over time, but are sufficiently predictable to allow the Company to estimate expected future product returns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Cost of Revenue
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Cost of revenue includes direct and indirect costs associated with the manufacture of the Company&#146;s products. Direct costs include material
and labor, while indirect costs include inbound freight charges, receiving costs, inspection and testing costs, warehousing costs, royalty expense and other labor and overhead costs incurred in the manufacturing of products. Cost of revenue also
includes stock-based compensation, warranty </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2. Summary of Significant Accounting Policies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
replacement costs, cost of revenue related to product return reserves and excess and obsolete inventory write-downs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Shipping Costs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Shipping and handling costs charged to
customers are recorded as revenue. Shipping and handling costs are included in cost of revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Research and Development (R&amp;D) Expenses </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">R&amp;D costs primarily consist of product development, clinical and regulatory expenses, materials, depreciation and other costs associated with the
development of the Company&#146;s products. R&amp;D costs also include related personnel and consultants&#146; salaries, benefits and related costs, including stock-based compensation. The Company expenses R&amp;D costs as they are incurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s clinical trial accruals are based on estimates of patient enrollment and related costs at clinical investigator sites. The Company
estimates preclinical and clinical trial expenses based on the services performed pursuant to contracts with research institutions and clinical research organizations that conduct and manage preclinical studies and clinical trials on its behalf. In
accruing service fees, the Company estimates the time period over which services will be performed and the level of patient enrollment and activity expended in each period. If the actual timing of the performance of services or the level of effort
varies from the estimate, the Company will adjust the accrual accordingly. Payments made to third parties under these arrangements in advance of the receipt of the related services are recorded as prepaid expenses until the services are rendered.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Advertising Costs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Advertising costs are included in
selling, general and administrative expenses and are expensed as incurred. Advertising costs consist primarily of trade show and booth costs, product demonstration, and marketing materials. Advertising costs for the years ended December&nbsp;31,
2013 and 2014 and the three months ended March&nbsp;31, 2014 (unaudited) and 2015 (unaudited) were $0.1 million, $0.3 million, $40,000, and $0.1 million, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company accounts for
stock-based compensation arrangements with employees in accordance with ASC 718, Compensation&#151;Stock Compensation. ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based
payments including stock options. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s determination of the fair value of stock options on the date of grant utilizes the
Black-Scholes option-pricing model and is impacted by its common stock price as well as changes in assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, expected term that options
will remain outstanding, expected common stock price volatility over the term of the option awards, risk-free interest rates and expected dividends. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The fair value is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the
requisite service period (usually the vesting period) on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated forfeitures. The Company estimates future forfeitures at the date of grant and
revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates. To the extent actual forfeiture results differ from the estimates, the difference is recorded as a cumulative adjustment in the period
forfeiture estimates are revised. No compensation cost is recorded for options that do not vest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2. Summary of Significant Accounting Policies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Equity instruments issued to non-employees are recorded at their fair value on the measurement date and
are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed over the service period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Estimating the fair value of equity-settled awards as of the grant date using valuation models, such as the Black-Scholes option pricing model, is
affected by assumptions regarding a number of complex variables. Changes in the assumptions can materially affect the fair value and ultimately how much stock-based compensation expense is recognized. These inputs are subjective and generally
require significant analysis and judgment to develop. For all stock options granted to date, the Company estimated the volatility data based on a study of publicly traded industry peer companies. For purposes of identifying these peer companies, the
Company considered the industry, stage of development, size and financial leverage of potential comparable companies. The risk-free interest rate is based on the yield available on U.S. Treasury zero-coupon issues similar in duration to the expected
term of the equity-settled award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Income Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The
Company accounts for income taxes using the asset and liability method, whereby deferred tax asset and liability account balances are determined based on differences between the financial reporting and tax bases of assets and liabilities, and are
measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance to reduce the net deferred tax assets to their estimated realizable value. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The calculation of the Company&#146;s current provision for income taxes involves the use of estimates, assumptions and judgments while taking into
account current tax laws, interpretation of current tax laws and possible outcomes of future tax audits. The Company has established reserves to address potential exposures related to tax positions that could be challenged by tax authorities.
Although the Company believes its estimates, assumptions and judgments to be reasonable, any changes in tax law or its interpretation of tax laws and the resolutions of potential tax audits could significantly impact the amounts provided for income
taxes in the Company&#146;s consolidated financial statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The calculation of the Company&#146;s deferred tax asset balance involves the use of
estimates, assumptions and judgments while taking into account estimates of the amounts and type of future taxable income. Actual future operating results and the underlying amount and type of income could differ materially from the Company&#146;s
estimates, assumptions and judgments thereby impacting the Company&#146;s financial position and results of operations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company follows ASC
740-10 &#147;Accounting for Uncertainty in Income Taxes,&#148; which prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of uncertain tax positions taken or expected to be taken in the
Company&#146;s income tax return, and also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company includes interest and penalties related to unrecognized tax benefits within income tax expense in the accompanying consolidated statements of
operations. The Company has not incurred any interest or penalties related to unrecognized tax benefits in any of the periods presented. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Comprehensive Income
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company is required to display comprehensive income and its components as part of the Company&#146;s consolidated financial statements.
Comprehensive income consists of net income, unrealized gains on available-for-sale investments and the effects of foreign currency translation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2. Summary of Significant Accounting Policies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Deferred Offering Costs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Deferred offering costs, which primarily consist of direct incremental legal and accounting fees relating to the proposed IPO, are capitalized. The
deferred offering costs will be offset against IPO proceeds upon the consummation of the offering. In the event the offering is terminated, deferred offering costs will be expensed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Net Income Per Share and Unaudited Pro Forma Net Income Per Share of Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company calculates its basic and diluted net income per share attributable to common stockholders in conformity with the two-class method required
for companies with participating securities. Under the two-class method, the Company determines whether it has net income attributable to common stockholders, which includes the results of operations less current period preferred stock
non-cumulative dividends. If it is determined that the Company does have net income attributable to common stockholders during a period, the related undistributed earnings are then allocated between common stock and the preferred stock based on the
weighted average number of shares outstanding during the period to determine the numerator for the basic net income per share attributable to common stockholders. In computing diluted net income attributable to common stockholders, undistributed
earnings are re-allocated to reflect the potential impact of dilutive securities to determine the numerator for the diluted net income per share attributable to common stockholders. The Company&#146;s basic net income per share attributable to
common stockholders is calculated by dividing the net income by the weighted average number of shares of common stock outstanding for the period. The diluted net income per share attributable to common stockholders is computed by giving effect to
all potential dilutive common stock equivalents outstanding for the period. For purposes of this calculation, options to purchase common stock and common stock warrants are considered common stock equivalents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The unaudited pro forma basic and diluted net income per share reflects the automatic conversion of all outstanding shares of preferred stock as if the
conversion had occurred at the earlier of the beginning of the period or the date of issuance, if later. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The unaudited pro forma basic and diluted
net income per share amounts do not give effect to the issuance of shares from the planned initial public offering nor do they give effect to potential dilutive securities where the impact would be anti-dilutive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Recently Issued Accounting Standards </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In May 2014, the FASB
issued ASU No.&nbsp;2014-09, <I>Revenue from Contracts with Customers</I>, which outlines a comprehensive new revenue recognition model designed to depict the transfer of promised goods or services to customers in an amount that reflects the
consideration to which the entity expects to be entitled in exchange for those goods or services. The accounting standard is effective for annual reporting periods (including interim reporting periods within those periods) beginning after
December&nbsp;15, 2016. Early adoption is not permitted. The Company is currently evaluating the impact of this accounting standard. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In April 2015,
the FASB proposed deferring the effective date by one year to December&nbsp;15, 2017 for annual reporting periods beginning after that date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date
of December&nbsp;15, 2016. Presently, the FASB&#146;s proposed deferral is not a final decision. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In November 2014, the FASB issued ASU
No.&nbsp;2014-17, <I>Pushdown Accounting</I>, which provides an acquired entity to elect the option to apply pushdown accounting in the reporting period in which the change-in-control event occurs and allows the acquired entity to determine whether
to elect to apply pushdown accounting for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2. Summary of Significant Accounting Policies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
each individual change-in-control event in which the acquirer obtains control of the acquired entity. This accounting standard is effective as of November&nbsp;18, 2014 and the Company will apply
the guidance to future change-in control events. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>3. Fair Value of Financial Instruments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction
between market participants at the reporting date. The accounting guidance establishes a three-tiered hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Level 1&#151;Quoted prices in active markets for identical assets or liabilities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Level 2&#151;Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in markets that are not active; or other
inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Level
3&#151;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The categorization of a financial instrument within the valuation hierarchy is based on the lowest level of input that is significant to the fair value
measurement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company classifies its cash equivalents and marketable investments within Level 1 and Level 2, as it uses quoted market prices or
alternative pricing sources and models utilizing market observable inputs. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company determined the fair value of its Level 1 financial
instruments, which are traded in active markets, using quoted market prices for identical instruments. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Marketable investments classified within
Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations or alternative pricing sources. When quoted prices in active markets for identical assets or liabilities are not available, the
Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar
instruments, historical pricing trends of a security as relative to its peers and&nbsp;internal assumptions of the independent pricing services. To validate the fair value determination provided by its investment managers, the Company reviews the
pricing movement in the context of overall market trends and trading information from its investment managers. In addition, the Company assesses the inputs and methods used in determining the fair value in order to determine the classification of
securities in the fair value hierarchy. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company did not own any Level 3 financial assets or liabilities as of December 31, 2013 or 2014 or March
31, 2015 (unaudited). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">During the years ended December&nbsp;31, 2013 and 2014, and the three months ended March 31, 2105 (unaudited), the Company did
not record impairment charges related to its marketable investments, and the Company did not have any transfers between Level 1, Level 2 and Level 3 of the fair value hierarchy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>3. Fair Value of Financial Instruments&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following tables set forth the fair value of the Company&#146;s financial assets and liabilities by
level within the fair value hierarchy (in thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of December 31, 2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Financial Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Marketable investments:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Mutual funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s marketable investments as of December&nbsp;31, 2013 of $15.5 million included $6.0 million of
restricted investments, which were held with a major financial institution as a security for the Company&#146;s credit facility. Refer to Note 5. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of December 31, 2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Financial Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Cash equivalents:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">155</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">155</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Marketable investments:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Mutual funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,783</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of March 31, 2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Financial Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Cash equivalents:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Marketable investments:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Mutual funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">32,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,710</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">During the years ended December&nbsp;31, 2013 and 2014 and the three months ended March&nbsp;31, 2015 (unaudited), the
Company did not have any transfers of financial assets measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3. The Company did not hold any Level 3 assets or liabilities as of December&nbsp;31, 2013 and 2014 and
March&nbsp;31, 2015 (unaudited). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The carrying amounts of cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts
payable and accrued liabilities approximate fair value due to their relatively short maturities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>4. Balance Sheet Components </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Accounts Receivable, Net </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s allowance for
doubtful accounts comprised of the following (in thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Balance&nbsp;At<BR>Beginning<BR>Of Year </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Charged&nbsp;To<BR>Costs And<BR>Expenses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Deductions</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Balance&nbsp;At<BR>End Of<BR>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Allowance for Doubtful Accounts</B> <B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">For year ended:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B></B>December 31, 2013<B></B> <B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B></B>December 31, 2014<B></B> <B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B></B>March 31, 2015 (unaudited)<B></B> <B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">602</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(151</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">429</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Prepaid Expenses and Other Current Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s prepaid expenses and other current assets comprised of the following (in thousands): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March&nbsp;31,</B><br><B>2015</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Prepaid expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,130</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,304</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income tax receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">273</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Marketable Investments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The
Company&#146;s marketable investments as of December&nbsp;31, 2013 were as follows (in thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:81.20pt; font-size:8pt; font-family:arial"><B>Marketable Investments</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Gross<BR>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Gross<BR>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Mutual funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(99</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(99</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,545</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s marketable investments as of December&nbsp;31, 2013 of $15.5 million included $6.0 million of
restricted investments, which were held with a major financial institution as a security for the Company&#146;s credit facility. Refer to Note 5. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s marketable investments as of December&nbsp;31, 2014 were as follows (in thousands): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:81.20pt; font-size:8pt; font-family:arial"><B>Marketable Investments</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Gross<BR>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Gross<BR>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,834</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(219</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Mutual funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(149</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48,625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(379</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>4. Balance Sheet Components&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s marketable investments as of March&nbsp;31, 2015 were as follows (in thousands):
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:81.20pt; font-size:8pt; font-family:arial"><B>Marketable Investments</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Gross<BR>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Gross<BR>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">U.S. Treasury</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,409</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Corporate bonds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,810</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(182</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Mutual funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(246</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,595</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">For the years ended December&nbsp;31, 2013 and 2014 and the three months ended March&nbsp;31, 2014 (unaudited) and 2015
(unaudited), gains or losses realized on the sale of investments were insignificant. As of December&nbsp;31, 2014, there are no securities that have been in a loss position for more than twelve months. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The contractual maturities of the Company&#146;s marketable investments as of December 31, 2014 and March&nbsp;31, 2015 (unaudited) were as follows (in
thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,<BR>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March 31,<BR>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Due in one year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,442</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Due in one to five years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,295</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,464</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Inventories </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The components
of inventories consisted of the following (in thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March&nbsp;31,</B><br><B>2015</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Raw materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,778</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,081</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Work in process</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Finished goods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,803</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Inventories</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">33,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>4. Balance Sheet Components&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Property and Equipment, Net </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Property and equipment, net comprised of the following (in thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March&nbsp;31,</B><br><B>2015</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Machinery and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,089</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,225</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">387</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">379</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Computers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Construction in progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,931</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">794</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total property and equipment</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,902</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: Accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,871</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,489</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,824</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Property and equipment, net</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,775</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Depreciation and amortization expense for the years ended December&nbsp;31, 2013 and 2014 and the three months ended
March&nbsp;31, 2014 (unaudited) and 2015 (unaudited) was $0.7 million, $0.8 million, $0.2 million and $0.3 million, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Accrued Liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table shows the components of accrued liabilities (in thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March&nbsp;31,</B><br><B>2015</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Payroll and employee-related expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sales return reserve</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,164</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Preclinical and clinical trial cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,584</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Product warranty</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sales tax payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income tax payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">332</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total accrued liabilities</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The estimated product warranty accrual was as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>March&nbsp;31,</B><br><B>2015</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Balance at the beginning of the period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accruals of warranties issued</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">155</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Settlements of warranty claims</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(100</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(158</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(94</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Balance at the end of the period</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>5. Credit Facility </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In May 2012, the Company entered into a revolving credit facility of $15.0 million with Wells Fargo Bank, National Association. The credit facility was
collateralized by the Company&#146;s investment balances. The interest on the credit facility was based on the daily one-month London Inter-Bank Offered Rate, plus 1.75% and was payable monthly. Any outstanding balance on the credit facility was due
in full on June&nbsp;1, 2015. The credit facility contained customary covenants for credit facilities of this type, including limitations on disposition of assets and changes in control. In May 2014, in conjunction with its Series F financing, the
Company paid the then outstanding balance on the credit facility and terminated the credit facility. The Company was in compliance with the covenants as of December&nbsp;31, 2013. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>6. Related Party Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Notes Receivable from Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In March 2005, options to purchase 875,000 shares of common stock, subject to repurchase by the Company, were exercised in exchange for full recourse
promissory notes totaling $0.1 million. The notes bear interest at 2.92%&nbsp;per year, compounded annually with interest and principal due on the earlier to occur of January&nbsp;31, 2015, or the date the employee ceases to be an employee, director
or consultant of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In July 2011, options to purchase 5,000 shares of common stock were exercised in exchange for a full recourse
promissory note totaling $10,250. The note is noninterest bearing and is due in full on December&nbsp;31, 2016. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of December&nbsp;31, 2013 and
2014 and March&nbsp;31, 2015 (unaudited), outstanding promissory notes were $0.1 million, $0.1 million and $31,500, respectively. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>7. Commitments and
Contingencies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Lease Commitments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company leases
its offices and other equipment under non-cancelable operating leases that expire at various dates in 2029. Rent expense for the years ended December&nbsp;31, 2013 and 2014 and the three months ended March&nbsp;31, 2014 (unaudited) and 2015
(unaudited) was $1.7 million, $1.8 million, $0.4 million and $0.6 million, respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Future minimum lease payments under the non-cancelable
operating leases as of December 31, 2014 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">are as follows (in thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:86.80pt; font-size:8pt; font-family:arial"><B>Year Ending December 31:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Lease&nbsp;Payments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2015</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,148</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total future minimum lease payments</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">36,044</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>7. Commitments and Contingencies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Future minimum lease payments under the non-cancelable operating leases as of March&nbsp;31, 2015
(unaudited) are as follows (in thousands): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:84.65pt; font-size:8pt; font-family:arial"><B>Quarter Ending March&nbsp;31:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Lease&nbsp;Payments</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2015</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,594</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total future minimum lease payments</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Purchase Commitments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The
Company had non-cancellable purchase obligations to suppliers for the year ended December&nbsp;31, 2014 and the three months ended March 31, 2015 (unaudited) of $9.9&nbsp;million and $5.5 million, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Royalty Obligations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In March 2005, the Company entered into
a license agreement that requires the Company to make minimum royalty payments to the licensor, on a quarterly basis.&nbsp;As of December 31, 2014 and March 31, 2015, the license agreement requires minimum annual royalty payments of $0.1 million and
$0.1 million in equal quarterly installments, respectively. On each January 1, the quarterly calendar year minimum royalty shall be adjusted to equal the prior year&#146;s minimum royalty adjusted by a percentage equal to the percentage change in
the &#147;consumer price index for all urban consumers&#148; for the prior calendar year as reported by the U.S. Department of Labor. Unless terminated earlier, the term of the license agreement shall continue until the expiration of the last to
expire patent that covers that licensed product or for the period of 15 years following the first commercial sale of such licensed product, whichever is longer. The first commercial sale occurred in June 2007. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In April 2012, the Company entered into an agreement that requires the Company to pay a 5% royalty on sales of products covered under applicable patents,
on a quarterly basis.&nbsp;The first commercial sale occurred in April 2014.&nbsp;Unless terminated earlier, the royalty term for each applicable product shall continue for fifteen years following the first commercial sale of such patented product,
or when the applicable patent covering such product has expired, whichever is sooner.</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In April 2015, the Company entered into a royalty agreement
that requires the Company to pay a 2% royalty on sales of certain products covered by the agreement, on a quarterly basis. The Company anticipates that the first commercial sale of the covered products will occur in June 2015. Unless terminated
earlier, the royalty term for each covered product shall continue for twenty years following the first commercial sale of the covered products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Royalty expense included in cost of sales for the years ended December 31, 2013 and 2014 and the three months ended March 31, 2014 (unaudited) and 2015
(unaudited), was $0.7 million, $1.1 million, $0.2 million and $0.4 million, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>7. Commitments and Contingencies&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business. The Company accrues a liability for
such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been no contingent liabilities requiring accrual or disclosure at December&nbsp;31, 2013 and 2014 or March&nbsp;31,
2015 (unaudited). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Indemnification </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company enters
into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the
indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#146;s technology. The term of these indemnification agreements is generally
perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and
officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such
indemnifications has been recorded to date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Litigation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">From time to time, the Company is subject to claims and assessments in the ordinary course of business. The Company is not currently a party to any
litigation matter that, individually or in the aggregate, is expected to have a material adverse effect on the Company&#146;s business, financial condition, results of operations or cash flows. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>8. Preferred Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The preferred stock at December&nbsp;31,
2014 consisted of the following (in thousands, except shares): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:20.40pt; font-size:8pt; font-family:arial"><B>Series</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares Issued<BR>and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Proceeds,<BR>Net&nbsp;of&nbsp;Issuance<BR>Costs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Aggregate<BR>Liquidation<BR>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series A Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series B Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,287,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,005,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series C Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,388,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,168,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series D Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,944,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,881,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,976</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series E Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,973,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,909,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,609</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series F Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,303,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,545,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Undesignated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,102,351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total preferred stock</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,510,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">149,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>8. Preferred Stock&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The preferred stock at March&nbsp;31, 2015 (unaudited) consisted of the following (in thousands, except
shares): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:20.40pt; font-size:8pt; font-family:arial"><B>Series</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares Issued<BR>and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Proceeds,<BR>Net&nbsp;of&nbsp;Issuance<BR>Costs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Aggregate<BR>Liquidation<BR>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series A Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series B Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,287,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,005,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series C Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,388,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,168,218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series D Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,944,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,881,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series E Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,973,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,909,940</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,919</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Series F Preferred Stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,303,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,545,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Undesignated</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,102,351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total preferred stock</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,510,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">111,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">151,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The rights, preferences and privileges of the Series&nbsp;A Preferred Stock (Series A), Series&nbsp;B Preferred Stock
(Series B), Series&nbsp;C Preferred Stock (Series C), Series&nbsp;D Preferred Stock (Series D), Series&nbsp;E Preferred Stock (Series E) and Series&nbsp;F Preferred Stock (Series F) are as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Voting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The holders of each share of Series A, Series B,
Series C, Series D, Series E and Series F preferred stock are entitled to the number of votes equal to the number of shares of common stock into which each share of preferred stock could be converted, and have voting rights and powers equal to the
voting rights and powers of the holders of common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Dividends </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The holders of Series A, Series B, Series C, Series D, Series E and Series F preferred stock are entitled to receive dividends out of any assets legally
available, prior, and in preference to, any declaration or payment of any dividend on the common stock of the Company, at the rate of 6% of the original purchase price (adjusted for any stock dividends, stock splits, or recapitalization) per share
per annum. For any future dividends per annum, the preferred stock would participate with common stock on an as-converted basis. Such dividends are payable when, as, and if declared by the Board of Directors and are not cumulative. No dividends have
been declared or paid since the issuance of preferred stock through December&nbsp;31, 2014 or March&nbsp;31, 2015 (unaudited). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Conversion </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Each share of Series A, Series B, Series C, Series D, Series E and Series F preferred stock, at the option of the holder, is convertible into the number
of fully paid and nonassessable shares of common stock, which results from dividing the original purchase price of the Series A, Series B, Series C, Series D, Series E and Series F preferred stock by the conversion price applicable to such shares.
The initial per-share conversion price of the Series A, Series B, Series C, Series D, Series E and Series F preferred stock is $0.30, $1.63, $3.19, $5.07, $7.60 and $13.20 per share, respectively. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Conversion is automatic at the then-effective conversion rate either (a)&nbsp;immediately upon the closing of a firm commitment underwritten public
offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, covering the offer and sale of common stock in which the aggregate proceeds raised, equal, or exceed $15,000,000 or (b)&nbsp;at the election of
the holders of two-thirds of the outstanding Series A, Series B, Series C, Series D, Series E and Series F preferred stock voting together as a single class on an as-converted basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>8. Preferred Stock&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Liquidation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In the event of any liquidation, dissolution, or winding-up of the Company, either voluntary or involuntary, the holders of Series A, Series B, Series C,
Series D, Series E and Series F preferred stock shall be entitled to receive, prior and in preference to any distribution of any of the assets of the Company to the holders of common stock by reason of their ownership, an amount per share equal to
the original purchase price, plus 6%&nbsp;per annum compounded annually from original issuance date for each outstanding share of Series A, Series B, Series C, Series D, Series E and Series F preferred stock (as adjusted for any stock dividends,
stock splits, or recapitalization), plus any declared, but unpaid, dividends on such share, respectively. As of December&nbsp;31, 2014, the holders of Series A, Series B, Series C, Series D, Series E and Series F preferred stock are entitled to
receive an amount per share equal to $0.55, $2.93, $5.34, $7.98, $11.31 and $13.70, respectively. As of March&nbsp;31, 2015, the holders of Series&nbsp;A, Series&nbsp;B, Series&nbsp;C, Series&nbsp;D, Series&nbsp;E and Series&nbsp;F preferred stock
are entitled to receive an amount per share equal to $0.56, $2.97, $5.41, $8.09, $11.48 and $13.89, respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">If upon the occurrence of such
event, the assets and funds distributed among the holders of Series A, Series B, Series C, Series D, Series E and Series F preferred stock are insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then,
subject to the rights of series of preferred stock that may from time to time come into existence, the entire assets and funds of the Company legally available for distribution will be distributed ratably among the holders of Series A, Series B,
Series C, Series D, Series E and Series F preferred stock, and holders of such series of preferred stock in proportion to the preferential amount each such holder is entitled to receive. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">After payment has been made to the holders of Series A, Series B, Series C, Series D, Series E and Series F preferred stock, any remaining assets and
funds are to be distributed among the holders of common stock ratably, based on the number of shares of common stock held by each stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Mergers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">A merger, reorganization or sale of all or substantially all of the assets of the Company in which more than 50% of the voting power of the Company is
disposed of shall be deemed to be a liquidation, dissolution or winding-up. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>9. Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally
available and when declared by the board of directors, subject to the prior rights of holders of all classes of stock outstanding. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>10. Common Stock Liability
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of December&nbsp;31, 2013 and 2014 and March&nbsp;31, 2015 (unaudited), the Company had outstanding options to purchase 3,092,176, 2,900,676
and 3,265,591&nbsp;shares, respectively, of common stock. Proceeds from the exercise of unvested stock options are accounted for as a liability. The liability as of December&nbsp;31, 2013 and 2014 and March&nbsp;31, 2015 (unaudited), were
$0.1&nbsp;million, $0.2&nbsp;million and $0.1&nbsp;million, respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The options are not considered exercised and the underlying shares are not
considered issued until the Company&#146;s right to repurchase lapses, when the employee vests in the award. Employees who have exercised shares prior to vesting are current employees of the Company. There were 16,305, 33,081 and 23,176&nbsp;shares
subject to repurchase as of December&nbsp;31, 2013, 2014 and March&nbsp;31, 2015 (unaudited), respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>11. Warrants</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In connection with the sale of Series B preferred stock in 2004, the Company issued warrants to purchase 211,138 shares of common stock at a purchase
price of $0.01 per share. The warrants were exercisable upon grant and had a term of 10 years from the date of grant, which expired on December 31, 2014. The value of the warrants was calculated using Black-Scholes option pricing model and was
deemed to be immaterial. As of December 31, 2013, warrants to purchase 79,645 shares of common stock were outstanding. No warrants were outstanding as of December 31, 2014. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>12. Stock Option Plans </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2005 Stock Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s board of directors and stockholders approved the Company&#146;s 2005 Stock Plan (the 2005&nbsp;Plan) and it became effective in
January 2005. The 2005 Plan was subsequently amended and restated in 2006, 2007, 2008 and 2010. As of December 31, 2014 and March 31, 2015 (unaudited), the Company had granted options to purchase 5,431,017 and 5,431,017&nbsp;shares of common stock,
respectively, under the 2005&nbsp;Plan, of which options to purchase 2,707,176 and 2,633,291&nbsp;shares of common stock were outstanding, and options to purchase 33,081 and 23,176 shares of common stock had been early exercised and were unvested
and subject to repurchase, as of December&nbsp;31, 2014 and March&nbsp;31, 2015 (unaudited), respectively. Under the 2005 Plan, the board of directors could grant incentive stock options (ISO), nonqualified stock options (NSO), or stock awards to
eligible persons, including employees, nonemployees, directors, consultants and other independent advisors who provide services to the Company. Stock purchase rights could also be granted under the Plan. The board of directors had the authority to
determine to whom options would be granted, the number of options, the term and the exercise price. ISOs could only be granted to Company employees, which include officers and directors of the Company. NSOs and stock purchase rights could be granted
to employees and consultants. For individuals holding more than 10% of the voting rights of all classes of stock, the exercise price for an ISO could not be less than 110% of fair market value. Options are exercisable immediately upon the optionee
entering into a restricted stock purchase agreement with respect to any unvested options. Options generally vest annually at a rate of 1/4 after the first year and 1/48&nbsp;per month thereafter. The term of the options is no longer than five years
for ISOs, for which the grantee owns greater than 10% of the voting power of all classes of stock and no longer than 10 years for all other options. Stock options granted under the 2005 Plan generally have a contractual life of ten years, and
generally vest over a period of four years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2011 Equity Incentive Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s board of directors approved the Company&#146;s 2011 Equity Incentive Plan (the 2011 Plan) and it became effective in October 2011. As
of December&nbsp;31, 2014 and of March 31, 2015 (unaudited), the Company had granted options to purchase 145,000 and 145,000&nbsp;shares of common stock, respectively, under the 2011 Plan, of which options to purchase 145,000 and 145,000&nbsp;shares
of common stock were outstanding at December&nbsp;31, 2014 and March 31, 2015 (unaudited), respectively. The Company had also granted 505,000 and 505,000&nbsp;shares of restricted stock under the 2011 Plan, of which 367,126 and 266,501&nbsp;shares
were unvested and subject to forfeiture and 1,667 and 1,667&nbsp;shares had been forfeited as of December&nbsp;31, 2014 and March&nbsp;31, 2015 (unaudited), respectively. Under the 2011 Plan, the board of directors could grant ISOs, NSOs, restricted
stock, or restricted stock units (RSU) to eligible persons, including employees, directors and consultants who provide services to the Company. Stock Appreciation Rights (SAR) could also be granted under the 2011 Plan. The board of directors had the
authority to determine to whom options would be granted, the number of options, the term and the exercise price. ISOs could only be granted to Company employees, which include </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>12. Stock Option Plans&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
officers and directors of the Company. NSOs, SARs, restricted stock and RSUs could be granted to employees and consultants. For individuals holding more than 10% of the voting rights of all
classes of stock, the exercise price for an ISO could not be less than 110% of fair market value. Stock options granted under the 2011 Plan generally have a contractual life of ten years, and generally vest over a period of four years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>2014 Equity Incentive Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s board of
directors and stockholders approved the Company&#146;s 2014 Equity Incentive Plan (the 2014 Plan) and it became effective in May, 2014. The 2014 Plan replaced the 2011 Plan and the 2005 Plan. No further equity awards may be granted under the 2011
Plan or the 2005 Plan. As of December&nbsp;31, 2014 and March&nbsp;31, 2015 (unaudited), respectively there were 2,688,513 and 2,199,713&nbsp;shares remaining available for the grant of equity awards under our 2014 Plan. As of December 31, 2014 and
March 31, 2015 (unaudited), the Company had granted options to purchase 48,500 and 487,300&nbsp;shares of common stock under the 2014 Plan, 48,500 and 487,300 of which were outstanding as of December 31, 2014 and March 31, 2015 (unaudited),
respectively. The Company had also granted 0 and 50,000&nbsp;shares of restricted stock under the 2014 Plan, as of December&nbsp;31, 2014 and March&nbsp;31, 2015 (unaudited), respectively, of which 0 and 50,000&nbsp;shares were unvested and subject
to forfeiture as of such dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>Early Exercises </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Stock
options granted under the 2005 Plan, 2011 Plan and 2014 Plan allow the board of directors to grant awards to provide employee option holders the right to elect to exercise unvested options in exchange for restricted common stock. Unvested shares,
which amounted to 16,305, 33,081 and 23,176 as of December&nbsp;31, 2013 and 2014 and March&nbsp;31, 2015 (unaudited), respectively, were subject to a repurchase right held by the Company at the original issue price in the event the optionees&#146;
employment was terminated either voluntarily or involuntarily. For exercises of employee options, this right lapses according to the vesting schedule designated on the associated option grant. The repurchase terms are considered to be a forfeiture
provision. The shares purchased by the employees pursuant to the early exercise of stock options are not deemed to be issued or outstanding for accounting purposes until those shares vest, though they are legally issued and outstanding. In addition,
cash received from employees for exercise of unvested options is treated as a refundable deposit shown as a liability on the consolidated balance sheets. As of December&nbsp;31, 2013 and 2014 and March&nbsp;31, 2015 (unaudited), cash received
related to unvested shares totaled $0.1 million, $0.2 million and $0.1&nbsp;million, respectively. Amounts recorded are transferred into common stock and additional paid-in-capital as the shares vest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>12. Stock Option Plans&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Activity of stock options under 2005 Plan, 2011 Plan and 2014 Plan is set forth below: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Shares<BR>Available for<BR>Grant</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Number<BR>of&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Weighted-<BR>Average<BR>Exercise<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Weighted<BR>Average<BR>Remaining<BR>Contractual<BR>Life<BR>(in&nbsp;Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Aggregate<BR>Intrinsic<BR>Value </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="6" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Balance, December&nbsp;31, 2013</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500,963</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,092,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Additional shares authorized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Restricted stock granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(286,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Restricted stock cancelled</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(268,050</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">268,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Options exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(421,159</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Options cancelled</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(38,391</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Balance, December&nbsp;31, 2014</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,688,513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,900,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Restricted stock granted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Options granted (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(438,800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">438,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Options exercised (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(73,885</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Options cancelled (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#150;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Balance, March&nbsp;31, 2015 (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,199,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,265,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Vested and expected to vest&#151;December&nbsp;31, 2014</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,890,852</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2.63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Exercisable&#151;December&nbsp;31, 2014</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,852,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Vested and expected to vest&#151;March&nbsp;31, 2015 (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,222,838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34,153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Exercisable&#151;March&nbsp;31, 2015 (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,778,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">33,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table summarizes information about stock options outstanding at December&nbsp;31, 2014: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Options Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:46.65pt; font-size:8pt; font-family:arial"><B>Exercise Price</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Stock<BR>Options<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Weighted<BR>Average<BR>Remaining<BR>Contractual<BR>Life (Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Options<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$0.17&#151;$1.54</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,562,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,562,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$2.05&#151;$3.98</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">885,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">885,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$4.49&#151;$5.99</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">192,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">192,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$7.75&#151;$9.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">259,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">211,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$12.36&#151;$12.36</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$0.17&#151;$12.36</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,900,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,852,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>12. Stock Option Plans&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table summarizes information about stock options outstanding at March&nbsp;31, 2015
(unaudited): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Options Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00px solid #000000; width:46.65pt; font-size:8pt; font-family:arial"><B>Exercise Price</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Stock&nbsp;Options<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Weighted</B><br><B>Average<BR>Remaining<BR>Contractual<BR>Life&nbsp;(in&nbsp;Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Options<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$0.17&#151;$1.54</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,537,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,537,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$2.05&#151;$3.98</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">845,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">845,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$4.49&#151;$5.99</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$7.75&#151;$9.06</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">257,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">208,675</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">$12.36&#151;$12.36</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">438,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,265,591</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,778,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company uses the Black-Scholes option pricing model to determine the fair value of stock options. The valuation model
for stock compensation expense requires the Company to make assumptions and judgments about the variables used in the calculation including the expected term (weighted average period of time that the options granted are expected to be outstanding);
volatility of the Company&#146;s common stock and an assumed-risk-free interest rate. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.63&#150;0.90</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.76&#150;2.02</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.76&#150;2.02</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.56</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Expected dividend rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Fair Value of Common Stock.</I> The fair value of
the shares of common stock underlying our stock options has historically been determined by the Company&#146;s board of directors. Because there has been no public market for their common stock and in the absence of recent arm&#146;s-length cash
sales transactions of their common stock with independent third parties, the Company&#146;s board of directors has determined the fair value of their common stock by considering at the time of grant a number of objective and subjective factors. The
Company&#146;s board of directors intends all options granted to be exercisable at a price per share not less than the per share fair value of their common stock underlying those options on the date of grant. The estimated fair value of their common
stock was determined at each valuation date in accordance with the guidelines outlined in the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. Their board
of directors, with the assistance of management, developed these valuations using significant judgement and taking into account numerous factors, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">independent third party valuations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">progress of research and development activities; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">their operating and financial performance, including levels of available capital resources; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">rights and preferences of their common stock compared to the rights and preferences of their other outstanding equity securities; </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>12. Stock Option Plans&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">equity market conditions affecting comparable public companies, as reflected in comparable companies; market multiples, IPO valuations and other metrics; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the achievement of enterprise milestones, including progress in clinical trials; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the likelihood of achieving a liquidity event for the shares of common stock, such as an IPO given prevailing market and medical device sector conditions; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">sales of their preferred stock in arms-length transactions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the illiquidity of their securities by virtue of being a private company; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">business risks; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">management and board experience. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">The Company considered the following approaches in the preparation of their
valuations: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Market Approach.</I> The market approach values a business by reference to guideline companies, for which enterprise values are known. This approach has two principal methodologies. The guideline public company
methodology derives valuation multiples from the operating data and share prices of similar publicly traded companies. The guideline acquisition methodology focuses on comparisons between the subject company and guideline acquired public or private
companies. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Option-Pricing Method Backsolve, or OPM backsolve.</I> The OPM backsolve method derives the implied equity value for a company from a recent transaction involving the company&#146;s own securities issued on an
arm&#146;s-length basis. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Probability Weighted Expected Return Method.</I> Using the probability weighted expected return, or PWERM, method, the value of a company&#146;s common stock is estimated based upon the analysis of future values for
the company assuming various possible future liquidity events like an initial public offering, or IPO, sale or merger. Share value is based upon the probability-weighted present value of expected future net cash flows, considering each of the
possible future events, as well as the rights and preferences of each share class. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial">In addition, the Company also considered an enterprise value
allocation method: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>Option-Pricing Method, or OPM. </I>Under this method, each class of stock is modeled as a call option with a distinct claim on the enterprise value of the company. The option&#146;s exercise prices would be based on
a comparison with the enterprise value. The method assumes that a formula, such as the Black-Scholes model, would calculate the fair value when provided with certain values, including share price, expiration date, volatility and risk free interest
rate. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The per share common stock value was estimated by allocating their enterprise value using the OPM method in October 1, 2013,
May 16, 2014, and September 30, 2014, which determined the common value to be $7.75, $9.06 and $10.92, respectively. The per share common stock value was estimated in December 31, 2014 and March 31, 2015, which utilized the PWERM method, which
determined the common stock value to be $12.36 and $14.46, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">In determining the estimated fair value of their common stock, the
Company&#146;s board of directors also considered the fact that their stockholders could not freely trade their common stock in the public markets. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>12. Stock Option Plans&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
Accordingly, the Company applied discounts to reflect the lack of marketability of their common stock based on the expected time to liquidity. The estimated fair value of their common stock at
each grant date reflected a non-marketability discount partially based on the anticipated likelihood and timing of a future liquidity event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The
key subjective factors and assumptions used in their valuations primarily consisted of: (i) the selection of the appropriate market comparable transactions, (ii) the selection of the appropriate comparable publicly traded companies, (iii) the
financial forecasts utilized to determine future cash balances and necessary capital requirements, (iv) the probability and timing of the various possible liquidity events, (v) the estimated weighted-average cost of capital and (vi) the discount for
lack of marketability of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">At each grant date the board of directors reviewed any recent events and their potential impact on the
estimated fair value per share of the common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Weighted Average Expected Term.</I> The Company derived the expected term using the
&#147;simplified&#148; method (the expected term is determined as the average of the time-to-vesting and the contractual life of the options), as the Company had limited historical information to develop expectations about future exercise patterns
and post vesting employment termination behavior. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Volatility.</I> Since there has been no public market for the Company&#146;s common stock and
lack of company-specific historical volatility, it has determined the share price volatility for options granted based on an analysis of the volatility used by a peer group of publicly traded medical device companies. In evaluating similarity, the
Company considers factors such as industry, stage of life cycle and size. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Risk-Free Interest Rate. The risk-free interest rate is based upon U.S.
Treasury zero-coupon issues with remaining terms similar to the expected term of the options. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Dividend Yield.</I> The Company has never paid
any dividends and does not plan to pay dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial"><I>Forfeitures.</I> The Company is required to estimate forfeitures at the time of grant, and revise those estimates in subsequent periods if actual
forfeitures differ from those estimates. The Company uses historical data to estimate pre-vesting option forfeitures and record stock based compensation expense only for those awards that are expected to vest. To the extent actual forfeitures differ
from the estimates, the difference will be recorded as a cumulative adjustment in the period that the estimates are revised. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The total intrinsic
value of stock options exercised during the year ended December&nbsp;31, 2014 and the three months ended March&nbsp;31, 2015 (unaudited) was $3.8 million and $0.9 million, respectively. The intrinsic value is calculated as the difference between the
estimated fair value of the Company&#146;s common stock at the exercise date and the exercise price of the stock option. As of December&nbsp;31, 2014 and March&nbsp;31, 2015 (unaudited), the Company&#146;s common stock valuation was at $12.36 and
$14.46 per share, respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The weighted average grant date fair value of the employee stock options granted during the years ended
December&nbsp;31, 2013 and 2014 and the three months ended March&nbsp;31, 2014 (unaudited) and 2015 (unaudited) was $2.63, $3.69, $3.58 and $5.61 per share, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>12. Stock Option Plans&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table summarizes the activity of unvested restricted stock: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Weighted&nbsp;Average</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>of Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Fair Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unvested at December&nbsp;31, 2013</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">286,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(52,668</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cancelled/Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,667</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unvested at December&nbsp;31, 2014</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">367,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Granted (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Vested (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(100,625</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cancelled/Forfeited (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Unvested and expected to vest at March&nbsp;31, 2015 (unaudited)</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">316,501</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of December&nbsp;31, 2014 and March&nbsp;31, 2015 (unaudited), total unrecognized compensation cost was
$2.9&nbsp;million and $5.5 million related to unvested share-based compensation arrangements which is expected to be recognized over a weighted average period of 2.8 years and 3.2 years, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table sets forth the stock-based compensation expense included in the consolidated statements of operations (in thousands): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three Months Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;2013&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;2014&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;2014&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;2015&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Cost of sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Sales, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>13. Common and Preferred Stock Repurchase </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s board of directors approved the repurchase of 70,612 shares of common stock, 45,000 stock options and 45,611 of preferred stock from
shareholders in May 2014 for $13.20 per share for a total purchase price of $2.0 million. For the repurchased shares of common stock and stock options, the Company charged the difference between the purchase and market prices of $0.5 million to
expense. For the repurchased preferred shares, the excess between the purchase and the issuance price of $0.5 million was treated as a deemed dividend. In addition, the Company commenced a tender offer in July 2014 to repurchase shares of preferred
stock from existing shareholders at a purchase price of $13.20 per share. The Company repurchased 584,052 shares of preferred stock for a total purchase price of $7.7 million. The excess between the purchase and the issuance price of $5.8 million
was treated as a deemed dividend. The repurchased shares of common and preferred stock were retired and remained as authorized but unissued. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>14.&nbsp;Employee Benefit Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company offers a retirement savings plan under Section&nbsp;401(k) of the Internal Revenue Code (the IRC) to its eligible U.S. employees whereby they
may contribute up to the maximum amount permitted by IRC. The retirement savings plan provides for employer contributions to be made at the discretion of the Company&#146;s board of directors. The Company has not provided any such matching
contributions through March&nbsp;31, 2015. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>15. Income Taxes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company is incorporated in the United States and operates in various countries with differing tax laws and rates. A portion of the Company&#146;s
income or (loss) before taxes and the provision for income taxes are generated from international operations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Income or (loss) before income taxes
for the fiscal years ended December&nbsp;31, 2013 and 2014 is summarized as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:arial" ALIGN="center"><B>Year Ended<BR>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;2013&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;2014&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">United States</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,142</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Foreign</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(113</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total income (loss) before provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1,255</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Income tax provision in 2013 and 2014 is comprised of federal, state, and foreign taxes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The components of the provision for (benefit from) income taxes are summarized as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;2013&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;2014&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Current:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Federal</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(155</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,155</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">State</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Foreign</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total current</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(68</TD>
<TD NOWRAP VALIGN="bottom">)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,752</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Federal</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,087</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(625</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">State</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(199</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(116</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Foreign</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(117</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total deferred</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,286</TD>
<TD NOWRAP VALIGN="bottom">)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(858</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Provision for (benefit from) income taxes</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(5,354</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>15. Income Taxes&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s actual provision for tax differed from the amounts computed by applying the U.S.
federal income tax rate of 34% to pretax income as a result of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended</B><br><B>December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Income tax at federal statutory rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">State income taxes, net of federal benefit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Foreign taxes differential</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">APB 51 prepaid tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8.9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Foreign exchange gains and losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">IRC 199 deduction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">-</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Meals and entertainment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10.7</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Tax credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Change in valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">378.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7.1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Effective tax rate</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">426.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Deferred income tax assets and liabilities consist of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2013</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net operating loss carryforwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,626</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Tax credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,890</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,779</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Accruals and reserves</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,759</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">416</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Translation adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">271</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">UNICAP adjustments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,729</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,227</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Gross deferred tax assets</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Valuation allowance</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,860</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,945</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total deferred tax assets</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,038</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred tax liabilities</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Depreciation and amortization</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(480</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(685</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total deferred tax liabilities</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(480</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(685</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net deferred tax assets</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Deferred income taxes, net - Balance Sheet Classification</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Current deferred income tax assets</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Long-term deferred income tax assets</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net deferred tax assets</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company assesses the realizability of its net deferred tax assets by evaluating all available evidence, both positive
and negative, including (1)&nbsp;cumulative results of operations in recent years, (2)&nbsp;sources of recent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>15. Income Taxes&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial">
losses, (3)&nbsp;estimates of future taxable income and (4)&nbsp;the length of net operating loss carryforward periods. From inception through 2012, the Company had determined that it was more
likely than not that all of the net deferred tax assets would not be realized. As a result, the Company had recorded a full valuation allowance against those net deferred tax assets to reduce them to their estimated net realizable value as of
December&nbsp;31, 2012. As of December&nbsp;31, 2013, the Company determined that it is more likely than not that a portion of the net deferred tax assets will be realized for federal and U.S. states except California and released the valuation
allowance of $5.0&nbsp;million. The Company continued establishing a full valuation allowance against the net deferred tax assets of California, Germany, Australia and Canada. As of December&nbsp;31, 2014, the Company determined that it is more
likely than not that German net deferred tax assets will be realized and released the German valuation allowance of $0.3&nbsp;million. As a result, the Company has continued establishing a full valuation allowance against the net deferred tax assets
of California, Australia and Canada. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The valuation allowance against net deferred tax assets changed as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="91%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Balance at December 31, 2012</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Release of valuation allowance</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,962</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other reserves and deferrals</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Balance at December 31, 2013</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Release of valuation allowance</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(321</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other reserves and deferrals</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(594</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Balance at December 31, 2014</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Release of valuation allowance</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other reserves and deferrals</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom" ALIGN="right">&#151;<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;<BR></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Balance at March 31, 2015</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,945</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">At December&nbsp;31, 2014, the Company had approximately $17.8 million and $2.0 million of state and foreign net
operating loss carryforwards, respectively, available to offset future taxable income. The state net operating loss carryforwards will begin to expire in 2017. At December&nbsp;31, 2014, the Company had research credits available to offset federal
and state tax liabilities in the amount of $0.7 million and $2.8 million, respectively. Federal credits will begin to expire in 2027 and California state tax credits have no expiration. As of December 31, 2014, the Company had fully used $22.6
million of federal net operating losses, which the Company had accumulated in its first six years of operations, from 2004 through 2009. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Internal
Revenue Code sections 382 and 383 limit the use of net operating losses and business credits if there is a change in ownership. In 2009, the Company determined there were changes in ownership in 2004 and 2008. As of December&nbsp;31, 2014, the
section 382 limitation has no impact on the Company&#146;s deferred tax assets prior to the valuation allowance. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">As of December&nbsp;31, 2014, the
Company has $1.7 million in unrecognized tax benefits, of which $0.7&nbsp;million would affect the Company&#146;s effective tax rate if recognized. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>15. Income Taxes&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">A reconciliation of the change in the gross unrecognized tax benefits from January&nbsp;1, 2013 to
December&nbsp;31, 2014, is as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Beginning Balance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">838</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Gross increase for tax positions of current year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">401</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Gross increase for tax positions of prior years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Settlements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Lapse of statute of limitations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Ending Balance</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company recognizes interest and penalties related to uncertain tax positions in income tax expense. As of
December&nbsp;31, 2014, the Company had $69,000 accrued interest and penalties related to uncertain tax positions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company files U.S., state and
foreign income tax returns in jurisdictions with varying statutes of limitations. Due to net operating loss and credit carryovers, the tax years ending December&nbsp;31, 2004 through December 31, 2014 remain subject to examination by federal and
state tax authorities. In Australia and Canada, tax years ending December&nbsp;31, 2008 through December 31, 2014 generally remain subject to examination by tax authorities. In Germany, tax years ending December&nbsp;31, 2013 through December 31,
2014 remain subject to examination by tax authorities. As of December&nbsp;31, 2014, the Company is under examination by the German tax authority for tax years ending December 31, 2010 through December 31, 2012. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company classifies its unrecognized tax benefits as non-current income taxes payable, as no amounts are expected to be payable within the next 12
months. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>16. Net Income per Share of Common Stock attributable to Common Stockholders and Unaudited Pro Forma Net Income per
Share of Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">A reconciliation of the numerator and denominator used in the calculation of the basic and diluted net income per share
attributable to common stockholders is as follows (in thousands except share and per share amounts): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Net income per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>Numerator</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: Deemed dividend paid to preferred stockholders upon repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,344</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Less: Undistributed income attributable to preferred stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,212</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(986</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,999</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Add: Undistributed loss attributable to preferred stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net income (loss) attributable to common stockholders&#151;basic and diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(833</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>Denominator</I></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average shares used to compute net income (loss) attributable to common stockholders<BR>&#151;Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,304,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,609,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,430,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,903,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Potential dilutive options, as calculated using treasury stock method</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,021,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,156,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,198,734</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Potential dilutive common stock warrants, as calculated using treasury stock method</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,985</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,098</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Potential dilutive restricted stock, as calculated using treasury stock method</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,852</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91,183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average shares used to compute net income (loss) attributable to common stockholders &#151;Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,500,835</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,609,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,705,066</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,193,452</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net income (loss) per share attributable to common stockholders<BR>&#151;Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.18</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">&#151;Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.18</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.07</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net
income per share of common stock for the periods presented, because the effect of including them would have been anti-dilutive: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Options to purchase common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,933,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">219,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">438,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Restricted stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">367,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">286,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,300,883</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">505,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">488,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>16. Net Income per Share of Common Stock attributable to Common Stockholders and Unaudited Pro Forma Net Income per Share of Common Stock&nbsp;(Continued) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">Unaudited pro forma basic and diluted income (loss) per share is computed as follows (in thousands,
except per share data): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2014</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Pro&nbsp;Forma<BR>Three&nbsp;Months&nbsp;Ended<BR>March&nbsp;31, 2015</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><B>Unaudited pro forma net income per share:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>Numerator</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Net income used in computing pro forma net income per share attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial"><I>Denominator</I></P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Weighted average shares used to compute the pro forma net income attributable to common stockholders&#151;basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma adjustments to reflect weighted average effect of assumed automatic conversion of preferred stock</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Denominator for pro forma basic net income per share of common stock</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Potential dilutive options, as calculated using treasury stock method</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Potential dilutive common stock warrants, as calculated using treasury stock method</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Potential dilutive restricted stock, as calculated using treasury stock method</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Denominator for pro forma diluted net income per share of common stock</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma net income per share&#151;Basic</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Pro forma net income per share&#151;Diluted</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>17. Geographic Areas and Product Sales </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company&#146;s revenue by geographic area, based on the destination to which the Company ships its products, was as follows (in thousands): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" NOWRAP ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">United States</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,894</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Japan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Other International</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,846</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,983</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center"><B>Notes to Consolidated Financial Statements&nbsp;(Continued) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>17. Geographic Areas and Product Sales&nbsp;(Continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The following table sets forth revenue by product category (in thousands): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Three&nbsp;Months&nbsp;Ended&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2013&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2014&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2015&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Neuro</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">81,343</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">106,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">31,654</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Peripheral Vascular</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:arial; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:arial">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">88,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">125,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">38,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company does not have significant long-lived assets outside the U.S. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:arial"><B>18. Subsequent Events </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:arial">The Company has evaluated subsequent
events that occurred after December&nbsp;31, 2014 through June&nbsp;9, 2015, the date that the audited annual consolidated financial statements were issued, and determined that no additional subsequent events had occurred that would require
recognition in these consolidated financial statements and all material subsequent events that require disclosure have been disclosed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">F-38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:60pt; margin-bottom:0pt; font-size:14pt; font-family:arial" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares </B></P>
<P STYLE="margin-top:50pt; margin-bottom:0pt; font-size:14pt; font-family:arial" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:50pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923792g60a08.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:50pt; margin-bottom:0pt; font-size:12pt; font-family:arial" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:70pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:arial; font-size:16pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:arial; font-size:16pt">
<TD VALIGN="top"><B>J.P. Morgan</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right"><B>BofA Merrill Lynch</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:arial; font-size:12pt">
<TD VALIGN="top"><B>Wells Fargo Securities</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right"><B>Canaccord Genuity</B></TD></TR>
</TABLE> <P STYLE="margin-top:60pt; margin-bottom:0pt; font-size:10pt; font-family:arial" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
2015 </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;13. Other Expenses of Issuance and Distribution </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;to&nbsp;Be&nbsp;Paid</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;listing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent&#146;s fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and engraving expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Blue Sky fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">*&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">To be completed by amendment. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the amounts set forth above, other than the SEC
registration fee and the FINRA filing fee, is an estimate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;14. Indemnification of Directors and Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145 of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers as well as other
employees and individuals against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed actions, suits or
proceedings in which such person is made a party by reason of such person being or having been a director, officer, employee or agent to the registrant. The Delaware General Corporation Law provides that Section&nbsp;145 is not exclusive of other
rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise. Article VIII of the registrant&#146;s certificate of incorporation provides for indemnification
by the registrant of its directors, officers and employees to the fullest extent permitted by the Delaware General Corporation Law. The registrant has entered into indemnification agreements with each of its current directors and executive officers
to provide these directors and executive officers additional contractual assurances regarding the scope of the indemnification set forth in the registrant&#146;s amended and restated certificate of incorporation and amended and restated bylaws and
to provide additional procedural protections. There is no pending litigation or proceeding involving a director or executive officer of the registrant for which indemnification is sought. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a
director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i)&nbsp;for any breach of the director&#146;s duty of loyalty to
the corporation or its stockholders, (ii)&nbsp;for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii)&nbsp;for unlawful payments of dividends or unlawful stock repurchases, redemptions or
other distributions, or (iv)&nbsp;for any transaction from which the director derived an improper personal benefit. The registrant&#146;s certificate of incorporation provides for such limitation of liability. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The registrant maintains standard policies of insurance under which coverage is provided (a)&nbsp;to its directors and officers against loss
rising from claims made by reason of breach of duty or other wrongful act, and (b)&nbsp;to the registrant with respect to payments which may be made by the registrant to such officers and directors pursuant to the above indemnification provision or
otherwise as a matter of law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proposed form of underwriting agreement filed as Exhibit 1 to this registration statement provides for
indemnification of directors and officers of the registrant by the underwriters against certain liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;15. Recent Sales of Unregistered Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2012, the registrant has sold the following securities without registration under the Securities Act of 1933: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preferred Stock Issuances </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
May&nbsp;16, 2014, we issued and sold an aggregate of 4,545,455 shares of our Series F preferred stock at a price of $13.20 per share to a total of 38 accredited investors for aggregate consideration of $60,000,006. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Option Grants and Common Stock and Restricted Stock Issuances </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2012, we granted to our directors, officers, employees and consultants options to purchase an aggregate of 995,300 shares
of common stock under our equity compensation plans, at exercise prices ranging from $4.49 to $14.46 per share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1,
2012, we issued and sold to our directors, officers, employees and consultants an aggregate of 650,396 shares of common stock upon the exercise of options under our equity compensation plans at exercise prices ranging from $0.17 to $7.75 per share,
for an aggregate amount of approximately $1,708,375. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2012, we granted to our officers and employees an aggregate of
1,159,861 shares of restricted stock under our equity compensation plans at a fair market value ranging from $4.49 to $14.46 per share, for an aggregate amount of approximately $12,693,850. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2012, we issued to our consultants an aggregate of 55,000 shares of common stock at a fair market value ranging from
$4.49 to $5.99 per share, for an aggregate amount of approximately $288,950. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2012, we issued and sold an aggregate
of 25,568 shares of common stock upon the exercise of warrants at an exercise price of $0.01 per share, for an aggregate amount of approximately $256. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;6, 2015, we issued 7,500 shares of restricted stock in connection with the acquisition of a privately held company at a fair market
value of $14.46 per share, for an aggregate amount of approximately $108,450. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the foregoing transactions involved any
underwriters, underwriting discounts or commissions, or any public offering. Unless otherwise stated, the sales of the above securities were deemed to be exempt from registration under the Securities Act in reliance upon Section&nbsp;4(2) of the
Securities Act (or Regulation D or Regulation S promulgated thereunder) or Rule 701 promulgated under Section&nbsp;3(b) of the Securities Act as transactions by an issuer not involving any public offering or pursuant to benefit plans and contracts
relating to compensation as provided under Rule 701. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any
distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;16. Exhibits and Financial Statement Schedules </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The following exhibits are filed as part of this registration statement: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>1.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Underwriting Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Certificate of Incorporation of Penumbra, Inc., as currently in effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Amended and Restated Certificate of Incorporation of Penumbra, Inc., to be in effect upon completion of this offering</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Bylaws of Penumbra, Inc., as currently in effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.4*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Amended and Restated Bylaws of Penumbra, Inc., to be in effect upon completion of this offering</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Common Stock Certificate</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fourth Amended and Restated Investors&#146; Rights Agreement, by and among Penumbra, Inc., Adam Elsesser and Arani Bose and the investors listed on Exhibit A thereto, dated May&nbsp;16, 2014</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Davis Polk &amp; Wardwell LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lease for facilities at 1351 Harbor Bay Parkway, Alameda, California, dated November&nbsp;28, 2007 and amended on May&nbsp;7, 2008 and June&nbsp;23, 2011</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lease for facilities at 1411 Harbor Bay Parkway, Alameda, California, dated September&nbsp;11, 2014</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lease for facilities at 1321 Harbor Bay Parkway, Alameda, California, dated September&nbsp;11, 2014</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Distribution Agreement between Penumbra, Inc. and Medico&#146;s Hirata, dated August&nbsp;2, 2009, as amended</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.5&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2014 Equity Incentive Plan, and forms of Restricted Stock Agreement, Stock Option Agreement and Early Exercise Stock Option Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.6&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2011 Equity Incentive Plan, and forms of Restricted Stock Agreement, Stock Grant Agreement, Stock Option Agreement and Early Exercise Stock Option Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.7&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2005 Stock Plan, and forms of Notice of Grant and Early Exercise Stock Option Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.8&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Indemnification Agreement by and between Penumbra, Inc. and each of its directors and executive officers, as currently in effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.9&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Indemnification Agreement by and between Penumbra, Inc. and each of its directors and executive officers, to be in effect immediately prior to the consummation of the offering</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.10&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Adam Elsesser</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.11&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Arani Bose</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.12&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Sri Kosaraju</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.13&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Daniel Davis</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.14&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with James Pray</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.15&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Lynn Rothman</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.16&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Robert Evans</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>21.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subsidiaries of the registrant</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Independent Registered Public Accounting Firm</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Davis Polk &amp; Wardwell LLP (included in Exhibit 5)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Power of Attorney (included on signature page)</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">To be filed by amendment. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top">Indicates management contract or compensatory plan. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">#</TD>
<TD ALIGN="left" VALIGN="top">Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment and this exhibit has been filed separately with the SEC. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Financial Statement Schedules. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All financial statement schedules are omitted because the information called for is not required or is shown either in the consolidated
financial statements or in the notes thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;17. Undertakings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The undersigned registrant hereby undertakes to provide to the underwriter at the closing specified in the underwriting agreement
certificates in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the provisions referenced in Item&nbsp;14 of this registration statement, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is
against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer, or
controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered hereunder, the registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Act and will be
governed by the final adjudication of such issue. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The undersigned registrant hereby undertakes that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">For purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a
form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">For the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Alameda, State of California, on the &nbsp;&nbsp;&nbsp;&nbsp; day of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>PENUMBRA, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Adam Elsesser</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chairman, Chief Executive Officer and President</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints
Adam Elsesser, Sri Kosaraju and Robert Evans, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all
capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and any and all additional registration statements pursuant to Rule 462(b) of the Securities Act of 1933, and to file the same, with all
exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agents full power and authority to do and perform each and every act in person, hereby
ratifying and confirming all that said attorneys-in-fact and agents or either of them or their or his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:15.95pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:16.00pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Adam Elsesser</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chairman, Chief Executive Officer and President (Principal Executive Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Sri Kosaraju</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer and Head of Strategy (Principal Financial and Accounting Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Arani Bose, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Innovator and Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Don Kassing</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Walter Wang</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Harpreet Grewal</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2015</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>1.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Underwriting Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Certificate of Incorporation of Penumbra, Inc., as currently in effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Amended and Restated Certificate of Incorporation of Penumbra, Inc., to be in effect upon completion of this offering</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Bylaws of Penumbra, Inc., as currently in effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>3.4*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Amended and Restated Bylaws of Penumbra, Inc., to be in effect upon completion of this offering</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Common Stock Certificate</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>4.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fourth Amended and Restated Investors&#146; Rights Agreement, by and among Penumbra, Inc., Adam Elsesser and Arani Bose and the investors listed on Exhibit A thereto, dated May&nbsp;16, 2014</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Davis Polk &amp; Wardwell LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lease for facilities at 1351 Harbor Bay Parkway, Alameda, California, dated November&nbsp;28, 2007 and amended on May&nbsp;7, 2008 and June&nbsp;23, 2011</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lease for facilities at 1411 Harbor Bay Parkway, Alameda, California, dated September&nbsp;11, 2014</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lease for facilities at 1321 Harbor Bay Parkway, Alameda, California, dated September&nbsp;11, 2014</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4#</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Distribution Agreement between Penumbra, Inc. and Medico&#146;s Hirata, dated August&nbsp;2, 2009, as amended</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.5&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2014 Equity Incentive Plan, and forms of Restricted Stock Agreement, Stock Option Agreement and Early Exercise Stock Option Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.6&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2011 Equity Incentive Plan, and forms of Restricted Stock Agreement, Stock Grant Agreement, Stock Option Agreement and Early Exercise Stock Option Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.7&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2005 Stock Plan, and forms of Notice of Grant and Early Exercise Stock Option Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.8&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Indemnification Agreement by and between Penumbra, Inc. and each of its directors and executive officers, as currently in effect</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.9&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Indemnification Agreement by and between Penumbra, Inc. and each of its directors and executive officers, to be in effect immediately prior to the consummation of the offering</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.10&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Adam Elsesser</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.11&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Arani Bose</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.12&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Sri Kosaraju</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.13&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Daniel Davis</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.14&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with James Pray</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.15&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Lynn Rothman</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.16&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer Letter with Robert Evans</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>21.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subsidiaries of the registrant</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Independent Registered Public Accounting Firm</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Davis Polk &amp; Wardwell LLP (included in Exhibit 5)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Power of Attorney (included on signature page)</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">To be filed by amendment. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top">Indicates management contract or compensatory plan. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">#</TD>
<TD ALIGN="left" VALIGN="top">Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment and this exhibit has been filed separately with the SEC. </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3
<SEQUENCE>2
<FILENAME>filename2.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit&nbsp;3.1</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIXTH AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned, Robert D. Evans, Executive Vice President, General Counsel and Secretary, hereby certifies that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. He is the duly elected and acting Executive Vice President, General Counsel and Secretary of Penumbra, Inc., a corporation (the
&#147;<U>Corporation</U>&#148;) organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware (the &#147;<U>General Corporation Law</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. The Corporation was originally incorporated pursuant to the General Corporation Law on June&nbsp;21, 2004. An Amended and Restated
Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on July&nbsp;20, 2004. A Second Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on
December&nbsp;16, 2004. A Third Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on March&nbsp;8, 2006. A Fourth Amended and Restated Certificate of Incorporation was filed with the
Secretary of State of the State of Delaware on March&nbsp;23, 2007. A Fifth Amended and Restated Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on March&nbsp;6, 2008 (the &#147;<U>Fifth Amended and
Restated Certificate of Incorporation</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. The Board of Directors of the Corporation (the &#147;<U>Board of
Directors</U>&#148;) duly adopted resolutions proposing to amend and restate the Fifth Amended and Restated Certificate of Incorporation of this Corporation, declaring said amendment and restatement to be advisable and in the best interests of this
Corporation and its stockholders, which resolution setting forth the proposed amendment and restatement is as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Resolved that
the Fifth Amended and Restated Certificate of Incorporation of this Corporation shall be amended and restated in its entirety to read in full as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of
this corporation is Penumbra, Inc. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The address of the registered office of the Corporation in the State of Delaware is: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3500 South DuPont Highway, Dover, Kent County, Delaware 19901. The Registered Agent in charge thereof is Incorporating Services, Ltd. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the General
Corporation Law of Delaware. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. <U>Classes of Stock</U>. The Corporation is authorized to issue two classes of stock to be designated, respectively, &#147;<U>Common
Stock</U>&#148; and &#147;<U>Preferred Stock</U>.&#148; The total number of shares which the Corporation is authorized to issue is 65,000,000 shares, each with a par value of $0.001 per share. 40,000,000 shares shall be Common Stock and 25,000,000
shares shall be Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. <U>Rights and Restrictions of Common Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1. <U>General</U>. The voting, dividend and liquidation rights of the holders of the Common Stock are subject to and qualified by the rights,
powers and preferences of the holders of the Preferred Stock set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2. <U>Voting</U>. The holders of the Common Stock are
entitled to one vote for each share of Common Stock held at all meetings of the stockholders (and written actions in lieu of meetings); provided, however, that, except as otherwise required by applicable law, holders of Common Stock, as such, shall
not be entitled to vote on any amendment to the Corporation&#146;s Certificate of Incorporation (as the same may be amended, restated or modified from time to time, the &#147;<U>Certificate of Incorporation</U>&#148;) that relates solely to the
terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Certificate of
Incorporation or pursuant to the General Corporation Law. The number of authorized Common Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by (in addition to any vote of the holders of one or more
series of Preferred Stock that may be required by the terms of the Certificate of Incorporation) the affirmative vote of the holders of shares of capital stock of the Corporation representing a majority of the votes represented by all outstanding
shares of capital stock of the Corporation entitled to vote, irrespective of the provisions of Section&nbsp;242(b)(2) of the General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. <U>Rights, Preferences and Restrictions of Preferred Stock</U>. The Preferred Stock authorized by this Sixth Amended and Restated
Certificate of Incorporation may be issued from time to time in one or more series. The first series of Preferred Stock shall be designated &#147;Series A Preferred Stock&#148; and shall consist of 1,000,000 shares. The second series of Preferred
Stock shall be designated &#147;Series B Preferred Stock&#148; and shall consist of 4,287,486 shares. The third series of Preferred Stock shall be designated &#147;Series C Preferred Stock&#148; and shall consist of 4,388,715 shares. The fourth
series of Preferred Stock shall be designated &#147;Series D Preferred Stock&#148; and shall consist of 3,944,733 shares. The fifth Series of Preferred Stock shall be designated &#147;Series E Preferred Stock&#148; and shall consist of 1,973,684
shares. The sixth Series of Preferred Stock shall be designated &#147;Series F Preferred Stock&#148; and shall consist of 5,303,031 shares. (The Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock,
Series E Preferred Stock and Series F Preferred Stock is sometimes hereinafter referred to collectively as the &#147;<U>Preferred Stock</U>&#148;.) The rights, preferences, privileges, and restrictions granted to and imposed on the Preferred Stock
are as set forth below in this Article IV(C). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Preferred Stock authorized by this Sixth Amended and Restated Certificate of Incorporation
may be issued from time to time in one or more series. The Board of Directors of the Corporation is expressly authorized to increase or decrease (but not below the number of shares of such series then outstanding), subject to and qualified by the
rights, powers and preferences of the holders of the Preferred Stock, as applicable, set forth herein, the number of shares of any series prior to or subsequent to the issue of shares in that series. In case the number of shares of any such series
shall be so decreased, the shares constituting such decrease shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series. The Board of Directors is expressly authorized to
provide for the issuance of all or any of the remaining shares of the Preferred Stock in one or more series, and to fix the number of shares and to determine or alter for each such series, such voting power, full or limited, or no voting powers, and
such designations, preferences, and relative, participating, optional, or other rights and qualifications, limitations, or restrictions thereof, as shall be stated and expressed in the resolution or resolutions adopted by the Board of Directors
providing for the issuance of such shares (a &#147;<U>Preferred Stock Designation</U>&#148;) and as may be permitted by the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1. <U>Dividend Provisions</U>. The holders of shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D
Preferred Stock, Series E Preferred Stock and Series F Preferred Stock shall be entitled to receive dividends out of any assets legally available therefor, prior and in preference to any declaration or payment of any dividend (payable other than in
Common Stock or other securities and rights convertible into or entitling the holder thereof to receive, directly or indirectly, additional shares of Common Stock of the Corporation) on the Common Stock of the Corporation, at the rate of six percent
(6.0%)&nbsp;of the Original Purchase Price (as defined below) per share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock or Series F Preferred Stock, as applicable
(appropriately adjusted to reflect subsequent stock splits, stock dividends, combinations or other recapitalizations), per annum on each outstanding share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D
Preferred Stock, Series E Preferred Stock or Series F Preferred Stock, as applicable, payable when, as and if declared by the Board of Directors. Such dividends shall not be cumulative. No dividend shall be paid on the Common Stock in any fiscal
year unless a dividend shall first have been paid in full on the Preferred Stock in an amount for each such share of Preferred Stock equal to or greater than the aggregate amount of dividends for all Common Stock into which each such share of
Preferred Stock could then be converted. The holders of outstanding Preferred Stock can waive any dividend preference that such holders shall be entitled to receive under this Section I upon the affirmative vote or written consent of (A)&nbsp;with
respect to Series A Preferred Stock, Series&nbsp;B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock, the holders of at least a majority of the applicable series of Preferred Stock then outstanding, and
(B)&nbsp;with respect to Series F Preferred Stock, the holders of at least a two-thirds majority of the Series F Preferred Stock then outstanding. &#147;<U>Original Purchase Price</U>&#148; shall mean (i)&nbsp;with respect to Series A Preferred
Stock, $0.30, (ii)&nbsp;with respect to Series B Preferred Stock, $1.63, (iii)&nbsp;with respect to Series C Preferred Stock, $3.19, (iv)&nbsp;with respect to Series D Preferred Stock, $5.07, (v)&nbsp;with respect to the Series E Preferred Stock,
$7.60 and (vi)&nbsp;with respect to the Series F Preferred Stock, $13.20. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2. <U>Liquidation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Preference</U>. In the event of any liquidation, dissolution or winding up of the Corporation, whether voluntary or involuntary: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) The holders of Series F Preferred Stock shall be entitled to receive, prior and in preference to any distribution of any of the assets of
the Corporation to the holders of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock, or Common Stock by reason of their ownership thereof, an amount per share equal to
the Original Purchase Price plus six percent (6.0%)&nbsp;per annum, compounded annually from the Purchase Date (as defined in Section&nbsp;4(d)) (as adjusted to reflect subsequent stock splits, stock dividends, combinations or other
recapitalizations), for each share of Series F Preferred Stock then held by them. If upon the occurrence of such event, the assets and funds thus distributed among the holders of Series F Preferred Stock shall be insufficient to permit the payment
to such holders of the full preferential amounts, then, subject to the rights of any series of Preferred Stock that may from time to time come into existence, the entire assets and funds of this Corporation legally available for distribution shall
be distributed ratably among the holders of Series F Preferred Stock in proportion to the preferential amount each such holder is entitled to receive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) Upon completion of the foregoing distribution, the holders of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred
Stock, Series D Preferred Stock and Series E Preferred Stock shall be entitled to receive, prior and in preference to any distribution of any of the assets of the Corporation to the holders of Common Stock by reason of their ownership thereof, an
amount per share equal to the applicable Original Purchase Price plus six percent (6.0%)&nbsp;per annum, compounded annually from the Purchase Date (as defined in Section&nbsp;4(d)) (as adjusted to reflect subsequent stock splits, stock dividends,
combinations or other recapitalizations), for each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock or Series E Preferred Stock, as applicable, then held by them. If upon the occurrence
of such event, the assets and funds thus distributed among the holders of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock shall be insufficient to permit the payment
to such holders of the full preferential amounts, then, subject to the rights of any series of Preferred Stock that may from time to time come into existence, the entire assets and funds of this Corporation legally available for distribution shall
be distributed ratably among the holders of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock and Series E Preferred Stock and holders of such other series of Preferred Stock in proportion to the
preferential amount each such holder is entitled to receive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Remaining Assets</U>. Upon the completion of the distribution
required by Section&nbsp;2(a) above and any other distribution that may be required with respect to any series of Preferred Stock that may from time to time come into existence, the remaining assets of the Corporation available for distribution to
stockholders shall be distributed among the holders of the Common Stock pro rata based on the number of shares of Common Stock held by each. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Certain Acquisitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) <U>Deemed Liquidation</U>. For purposes of this Section&nbsp;2, a liquidation, dissolution, or winding up of the Corporation shall be
deemed to occur if the Corporation shall sell, convey, or otherwise dispose of all or substantially all of its property, assets or business, merge into or consolidate with any other corporation (other than a wholly-owned subsidiary corporation) or
effect any other transaction, including but not limited to a stock sale, or series of any such related transactions in which more than a majority of the voting power of the Corporation is disposed of (each, a &#147;<U>Corporate Sale</U>&#148;),
<U>provided</U> that, this Section&nbsp;2(c)(i) shall not apply to a merger effected solely for the purpose of changing the domicile of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) <U>Valuation of Consideration</U>. The value of assets or securities distributed pursuant to this Article IV, Section&nbsp;2 shall be
computed at their fair market value at the time of payment to the Corporation or at the time made available to its stockholders, all as determined by the Board of Directors in the good faith exercise of its reasonable business judgment,
<U>provided</U> that (i)&nbsp;if such securities are listed on any established stock exchange or a national market system, their fair market value shall be the closing sales price for such securities as quoted on such system or exchange for the date
the value is to be determined (or if there are no sales for such date, then for the last preceding business day on which there were sales), as reported in the Wall Street Journal or similar publication, and, (ii)&nbsp;if such securities are
regularly quoted by a recognized securities dealer but selling prices are not reported, their fair market value shall be the mean between the high bid and low asked prices for such securities on the date the value is to be determined (or if there
are no quoted prices for such date, then for the last preceding business day on which there were quoted prices). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iii) <U>Consent for
Certain Repurchases</U>. Each holder of an outstanding share of Preferred Stock shall be deemed to have consented, to distributions made by the Corporation in connection with the repurchase of shares of Common Stock issued to or held by directors,
employees or consultants (i)&nbsp;upon termination of their employment or services, (ii)&nbsp;in connection with other repurchases from employees and consultants at the then deemed fair market value of the Common Stock, if approved by the Board of
Directors, or (iii)&nbsp;in connection with the exercise by the Corporation of contractual rights of first refusal or first offer pursuant to agreements providing for the right of said repurchase between the Corporation and such persons, provided
the terms of such repurchase shall have been approved by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3. <U>Redemption</U>. The Preferred Stock is not
redeemable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4. <U>Conversion</U>. The holders of the Preferred Stock shall have conversion rights as follows (the &#147;<U>Conversion
Rights</U>&#148;): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Right to Convert</U>. Subject to Section&nbsp;4(c), each share of Preferred Stock shall be convertible, at the
option of the holder thereof, at any time after the date of issuance of such share, at the office of the Corporation or any transfer agent for such stock, into such number of fully paid and nonassessable shares of Common Stock as is determined by
dividing (x)&nbsp;the Original Purchase Price of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock. Series E Preferred Stock or Series F Preferred Stock, as applicable, by (y)&nbsp;the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Conversion Price (as defined below) applicable to such share, determined as hereafter provided, in effect on the date the certificate is surrendered for conversion or, in the case of an automatic
conversion pursuant to Section&nbsp;4(b), on the effective date of such conversion. The initial conversion price per share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred
Stock and Series F Preferred Stock shall be the Original Purchase Price, which initial conversion price shall be subject to adjustment as set forth in Section&nbsp;4(d) (the &#147;<U>Conversion Price</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Automatic Conversion</U>. Each share of Preferred Stock shall automatically be converted into shares of Common Stock at the applicable
Conversion Price immediately upon the earlier of (i)&nbsp;the closing of a fine commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended (the &#147;<U>Securities
Act</U>&#148;), covering the offer and sale of Common Stock (other than a registration on Form S-8, Form S-4 or comparable or successor forms), with aggregate gross proceeds (prior to underwriters&#146; commissions and offering expenses) to the
Corporation of not less than $15,000,000 and following which the Common Stock is quoted on NASDAQ or on the New York Stock Exchange (a &#147;<U>Qualified IPO</U>&#148;), or (ii)&nbsp;the date specified by written consent or agreement of (A)&nbsp;the
holders of at least a two-thirds majority of the then outstanding shares of the Series F Preferred Stock voting as a separate class and (B)&nbsp;the holders of at least a majority of the then outstanding shares of the Preferred Stock voting together
as a single class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Mechanics of Conversion</U>. Before any holder of Preferred Stock shall be entitled to convert the same into
shares of Common Stock, the holder shall surrender the certificate or certificates therefore, duly endorsed, at the office of the Corporation or of any transfer agent for such series of Preferred Stock, and shall give written notice to the
Corporation at its principal corporate office, of the election to convert the same and shall state therein the name or names in which the certificate or certificates for shares of Common Stock are to be issued. The Corporation shall, as soon as
practicable thereafter, issue and deliver at such office to such holder of Preferred Stock, or to the nominee or nominees of such holder, a certificate or certificates for the number of shares of Common Stock to which such holder shall be entitled
as aforesaid. Such conversion shall be deemed to have been made immediately prior to the close of business on the date of such surrender of the shares of such series of Preferred Stock to be converted, and the person or persons entitled to receive
the shares of Common Stock issuable upon such conversion shall be treated for all purposes as the record holder or holders of such shares of Common Stock as of such date. If the conversion is in connection with a Qualified IPO pursuant to
Section&nbsp;4(b)(i) above, such conversion shall be deemed to have been made immediately prior to the closing of such offering, and the person or persons entitled to receive the shares of Common Stock issuable upon such conversion shall be treated
for all purposes as the record holder or holders of such shares of Common Stock on such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Conversion Price Adjustments of
Preferred Stock for Certain Dilutive Issuances, Splits and Combinations</U>. The applicable Conversion Price of each series of Preferred Stock shall be subject to adjustment from time to time as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) (A) If this Corporation shall issue, after the date on which any shares of Series A Preferred Stock, Series B Preferred Stock, Series C
Preferred Stock, Series D Preferred Stock, Series E Preferred Stock or Series F Preferred </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock were first issued (the &#147;<U>Purchase Date</U>&#148; with respect to such series), any Additional Stock (as defined below in Section&nbsp;4(d)(ii)) without consideration or for a
consideration per share less than the Conversion Price for such Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock or Series F Preferred Stock in effect immediately prior
to the issuance of such Additional Stock, the Conversion Price for such Preferred Stock in effect immediately prior to each such issuance shall forthwith (except as otherwise provided in this Section&nbsp;4(d)(i)) be adjusted to a price determined
in accordance with the following formula: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CP2 = CPl * ((A+ B)+ (A+ C))</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing formula, the following definitions shall apply: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CP2</U>&#146;&#146; shall mean the applicable Conversion Price for such series of Preferred Stock in effect
immediately after such issue of additional shares of Common Stock; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>CP1</U>&#148; shall mean the applicable
Conversion Price for such series of Preferred Stock in effect immediately prior to such issue of additional shares of Common Stock; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>A</U>&#148; shall mean the number of shares of Common Stock outstanding immediately prior to such issue of additional
shares of Common Stock (treating for this purpose as outstanding all shares of Common Stock issuable upon exercise of options outstanding immediately prior to such issue or upon conversion or exchange of Convertible Securities (including the
Preferred Stock) outstanding (assuming exercise of any outstanding options therefor) immediately prior to such issue); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>B</U>&#148; shall mean the number of shares of Common Stock that would have been issued if such additional shares of
Common Stock had been issued at a price per share equal to CP1 (determined by dividing the aggregate consideration received by the Corporation in respect of such issue by CP1); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<U>C</U>&#148; shall mean the number of such additional shares of Common Stock issued in such transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(B) No adjustment of the applicable Conversion Price for each series of Preferred Stock shall be made in an amount less than one hundredth of
one cent per share. Except to the limited extent provided for in Sections 4(d)(i)(E)(3) and 4(d)(i)(E)(4), no adjustment of such Conversion Price pursuant to this section 4(d)(i) shall have the effect of increasing the Conversion Price above the
applicable Conversion Price in effect immediately prior to such adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(C) In the case of the issuance of shares of Common Stock
for cash, the consideration shall be deemed to be the amount of cash paid therefor before deducting any reasonable discounts, commissions or other expenses allowed, paid or incurred by this Corporation for any underwriting or otherwise in connection
with the issuance and sale thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(D) In the case of the issuance of shares of Common Stock for a consideration in whole or in
part other than cash, the consideration other than cash shall be deemed to be the fair value thereof as determined by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(E) In the case of the issuance (whether before, on or after the applicable Purchase Date) of options, warrants or other rights to purchase
or subscribe for shares of Common Stock, securities by their terms convertible into or exchangeable for shares of Common Stock or options, warrants or other rights to purchase or subscribe for such convertible or exchangeable securities, the
following provisions shall apply for all purposes of this Section&nbsp;4(d)(i) and Section&nbsp;4(d)(ii): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(1) The aggregate maximum
number of shares of Common Stock deliverable on exercise (assuming the satisfaction of any conditions to exercisability, including, without limitation, the passage of time, but without taking into account potential antidilution adjustments) of such
options, warrants or other rights to purchase or subscribe for shares of Common Stock shall be deemed to have been issued at the time such options, warrants or other rights were issued and for a consideration equal to the consideration (determined
in the manner provided in Sections 4(d)(i)(C) and 4(d)(i)(D)), if any, received by this Corporation on the issuance of such options, warrants or other rights plus the minimum exercise price provided in such options, warrants or other rights (without
taking into account potential antidilution adjustments) for the Common Stock covered thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(2) The aggregate maximum number of shares
of Common Stock deliverable on conversion of, or in exchange for (assuming the satisfaction of any conditions to convertibility or exchangeability, including, without limitation, the passage of time, but without taking into account potential
antidilution adjustments), any such convertible or exchangeable securities or on the exercise of options, warrants or other rights to purchase or subscribe for such convertible or exchangeable securities and subsequent conversion or exchange thereof
shall be deemed to have been issued at the time such securities were issued or such options, warrants or other rights were issued and for a consideration equal to the consideration, if any, received by this Corporation for any such securities and
related options, warrants or other rights (excluding any cash received on account of accrued interest or accrued dividends), plus the minimum additional consideration, if any, to be received by this Corporation (without taking into account potential
antidilution adjustments) on the conversion or exchange of such securities or the exercise in full of any related options, warrants or other rights (the consideration in each case to be determined in the manner provided in Sections 4(d)(i)(C) and
4(d)(i)(D)). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(3) In the event of any change in the number of shares of Common Stock deliverable or in the consideration payable to this
Corporation on exercise of such options, warrants or other rights or on conversion of, or in exchange for, such convertible or exchangeable securities, including, but not limited to, a change resulting from the antidilution provisions thereof, the
applicable Conversion Price of each series of Preferred Stock shall be recomputed to reflect any applicable change, but no further adjustment shall be made for the actual issuance of Common Stock or any payment of such consideration on the exercise
of any such options, warrants or other rights or the conversion or exchange of such securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(4) On the expiration of any such options, warrants or other rights, the termination of any such
rights to convert or exchange or the expiration of any options, warrants or other rights related to such convertible or exchangeable securities, the applicable Conversion Price of each series of Preferred Stock, to the extent in any way affected by
or computed using such options, warrants or other rights or securities or options, warrants or other rights related to such securities, shall be recomputed to reflect the issuance of only the number of shares of Common Stock (and convertible or
exchangeable securities which remain in effect) actually issued on the exercise of such options, warrants or other rights, on the conversion or exchange of such securities or on the exercise of the options, warrants or other rights related to such
securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(5) The number of shares of Common Stock deemed issued and the consideration deemed paid therefor pursuant to Sections
4(d)(i)(E)(l) and (2)&nbsp;shall be appropriately adjusted to reflect any change, termination or expiration of the type described in either Section&nbsp;4(d)(i)(E)(3) or (4). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Additional Stock</U>&#148; shall mean any shares of Common Stock issued (or deemed to have been issued pursuant to section
4(d)(i)(E)) by this Corporation after the Purchase Date other than the Excluded Stock. &#147;<U>Excluded Stock</U>&#148; means the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(A) shares of Common Stock issuable (1)&nbsp;on conversion of Preferred Stock, (2)&nbsp;pursuant to a transaction described in
Section&nbsp;4(d)(ii) hereof, or (3)&nbsp;on exercise of warrants to purchase Common Stock issued to holders of Series B Preferred Stock prior to the date hereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(B) shares of Common Stock issued or issuable (1)&nbsp;in a public offering, before or in connection with which all outstanding shares of
Preferred Stock will be converted to Common Stock or (2)&nbsp;on exercise of warrants or rights granted to underwriters in connection with such a public offering; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(C) shares of Common Stock or other securities issued or issuable in connection with the acquisition by the Corporation of all or part of
another business entity by merger, purchase of assets or capital stock or other reorganization that in each case has been approved by the Board of Directors; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(D) shares of Common Stock or other securities issued or issuable (1)&nbsp;to financial institutions or lessors in connection with commercial
credit arrangements, leases, equipment financings or similar transactions, or (2)&nbsp;to any entity that creates strategic advantage for the Corporation, in each case as approved by the Board of Directors of the Corporation; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:21%; font-size:10pt; font-family:Times New Roman">(E) shares of Common Stock, options, warrants and other rights to purchase capital stock approved by the Board of Directors and issued to
employees, consultants, advisors or directors of the Corporation directly or pursuant to a stock option plan, restricted stock plan or other equity incentive plan approved by the Board of Directors of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iii) <U>Subdivisions, Combinations, or Consolidations of Common Stock</U>. In the event the outstanding shares of Common Stock shall be
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subdivided, combined or consolidated, by stock split, stock dividend, combination or like event, into a greater or lesser number of shares of Common Stock after the Purchase Date, the applicable
Conversion Price for each series of Preferred Stock in effect immediately prior to such subdivision, combination, consolidation or stock dividend shall, concurrently with the effectiveness of such subdivision, combination or consolidation, be
proportionately adjusted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Other Distributions</U>. In the event the Corporation shall declare a distribution payable in
securities of other persons, evidences of indebtedness issued by the Corporation or other persons, assets (excluding cash dividends) or options or rights not referred to in Section&nbsp;4(d)(ii), then, in each such case for the purpose of this
Section&nbsp;4(e), the holders of Preferred Stock shall be entitled to a proportionate share of any such distribution as though they were the holders of the number of shares of Common Stock of the Corporation into which their shares of Preferred
Stock are convertible as of the record date fixed for the determination of the holders of Common Stock of the Corporation entitled to receive such distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>Recapitalizations</U>. If at any time or from time to time there shall be a recapitalization of the Common Stock (other than a
subdivision, combination or merger or sale of assets transaction provided for elsewhere in this Section&nbsp;4 or Section&nbsp;2), provision shall be made so that the holders of Preferred Stock shall thereafter be entitled to receive upon conversion
of such Preferred Stock the number of shares of stock or other securities or property of the Corporation or otherwise, to which a holder of Common Stock deliverable upon conversion would have been entitled on such recapitalization. In any such case,
appropriate adjustment shall be made in the application of the provisions of this Section&nbsp;4 with respect to the rights of the holders of such Preferred Stock after the recapitalization to the end that the provisions of this Section&nbsp;4
(including adjustment of the Conversion Price then in effect and the number of shares purchasable upon conversion of such Preferred Stock) shall be applicable after that event and be as nearly equivalent as practicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>No Impairment</U>. The Corporation will not, without (i)&nbsp;the consent of the holders of at least a majority of shares of the
Preferred Stock, voting together as a single class, and (ii)&nbsp;the consent of the holders of at least a two-thirds majority of the then outstanding shares of the Series F Preferred Stock, voting as a separate class, by amendment of its Sixth
Amended and Restated Certificate of Incorporation or through any reorganization, recapitalization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, alter, avoid or seek to avoid the
observance or performance of any of the terms to be observed or performed hereunder by the Corporation, but will at all times in good faith assist in the carrying out of all the provisions of this Section&nbsp;4 and in the taking of all such action
as may be necessary or appropriate in order to protect the Conversion Rights of the holders of Preferred Stock against impairment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h)
<U>No Fractional Shares; Certificate as to Adjustments</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) No fractional shares shall be issued on the conversion of any share or
shares of Preferred Stock. All shares of Common Stock (including fractions thereof) issuable upon conversion of more than one share of Preferred Stock by a holder thereof shall be aggregated for purposes of determining whether the conversion would
result in the issuance of any fractional share. If, after such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
aggregation, the conversion would result in the issuance of any fractional share, the Corporation shall, in lieu of issuing any fractional share, pay cash equal to the product of such fraction
multiplied by the Common Stock&#146;s fair market value (as determined by the Corporation&#146;s Board of Directors) on the date of conversion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) On the occurrence of each adjustment or readjustment of the applicable Conversion Price of each series of Preferred Stock pursuant to
this Section&nbsp;4, the Corporation, at its expense, shall promptly compute such adjustment or readjustment in accordance with the terms hereof and prepare and furnish to each holder of Preferred Stock a certificate setting forth such adjustment or
readjustment and showing in detail the facts on which such adjustment or readjustment is based. This Corporation shall, on the written request at any time of any holder of Preferred Stock, furnish or cause to be furnished to such holder a like
certificate setting forth (A)&nbsp;such adjustment and readjustment, (B)&nbsp;the Conversion Price for such series of Preferred Stock at the time in effect, and (C)&nbsp;the number of shares of Common Stock and the amount, if any, of other property
which at the time would be received on the conversion of a share of Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Record Date; Notices</U>. In the event of
any taking by this Corporation of a record of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend (other than a cash dividend) or other distribution, any right to
subscribe for, purchase or otherwise acquire any shares of stock of any class or any other securities or property, or to receive any other right, this Corporation shall mail to each holder of Preferred Stock, at least ten (10)&nbsp;days prior to the
date on which any such record is to be taken for the purpose of such dividend, distribution or right (the &#147;<U>Record Date</U>&#148;), a notice specifying the Record Date and the amount and character of such dividend, distribution or right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any notice required by the provisions of this Section&nbsp;4 shall be in writing and shall be deemed effectively given: (i)&nbsp;upon personal
delivery to the party to be notified, (ii)&nbsp;when sent by confirmed facsimile if sent during normal business hours of the recipient, if not, then on the next business day, (iii)&nbsp;five (5)&nbsp;days after having been sent by registered or
certified mail, return receipt requested, postage prepaid or (iv)&nbsp;one (1)&nbsp;day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All notices shall be addressed
to the each holder of record at the address of such holder appearing on the books of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) <U>Reservation of Stock
Issuable Upon Conversion</U>. This Corporation shall at all times reserve and keep available out of its authorized but unissued shares of Common Stock, solely, for the purpose of effecting the conversion of the shares of Preferred Stock, such number
of its shares of Common Stock as shall from time to time be sufficient to effect the conversion of all outstanding shares of such Preferred Stock; and, if at any time the number of authorized but unissued shares of Common Stock shall not be
sufficient to effect the conversion of all then outstanding shares of such Preferred Stock, in addition to such other remedies as shall be available to the holder of such Preferred Stock, the Corporation will take such corporate action as may, in
the opinion of its counsel, be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">5. <U>Voting Rights</U>. Except as otherwise required by law, the holder of each share of Series A Preferred Stock, Series B Preferred Stock,
Series C Preferred </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock shall have the right to one vote for each share of Common Stock into which such Preferred Stock could then
be converted, and with respect to such vote, such holder shall have full voting rights and powers equal to the voting rights and powers of the holders of Common Stock, and shall be entitled, notwithstanding any provision hereof, to notice of any
stockholders&#146; meeting in accordance with the Bylaws of the Corporation, and shall be entitled to vote, together with holders of Common Stock, with respect to any question upon which holders of Common Stock have the right to vote. Fractional
votes shall not, however, be permitted and any fractional voting rights available on an as-converted basis (after aggregating all shares into which shares of Preferred Stock held by each holder could be converted) shall be rounded down to the
nearest whole number. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">6. <U>Protective Provisions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Subject to the rights of series of Preferred Stock which may from time to time come into existence, so long as at least fifty percent
(50%)&nbsp;of the originally issued shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock or Series E Preferred Stock or ten (10%)&nbsp;of the originally issued shares of Series F Preferred
Stock are outstanding, this Corporation shall not without first obtaining the approval (by vote or written consent, as provided by law) of the holders of at least a majority of the then outstanding shares of Preferred Stock, voting together as a
single class: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) amend or repeal any provision of, or add any provision to, this Corporation&#146;s Sixth Amended and Restated
Certificate of Incorporation or Bylaws to materially alter or change the rights, preferences or privileges of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock or Series
F Preferred Stock so as to adversely affect such Preferred Stock or increase or decrease the number of authorized shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred
Stock or Series F Preferred Stock; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) authorize or issue, or obligate itself to issue, any other equity security, or shares or
other securities convertible into or exchangeable for Common Stock having a preference or being superior or having a priority over, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E
Preferred Stock or Series F Preferred Stock with respect to voting, dividends, redemption or on liquidation, including any such security convertible into or exercisable for any equity security; <U>provided</U> that equity securities or convertible
securities issued in connection with a debt or equity financing may have rights senior to Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock or Series F Preferred Stock if
the holders of such Preferred Stock have been given the opportunity to approve an amendment to the terms of such Preferred Stock that would give such Preferred Stock the same rights, preferences and privileges as the equity securities or convertible
securities issued in connection with such financing; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iii) effect a Corporate Sale, liquidation or dissolution of the Corporation.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><I></I>(b) Notwithstanding the foregoing, the consent of the holders of at least a two-thirds
majority of the Series F Preferred Stock shall be required for: (i)&nbsp;any action that adversely changes the rights, preferences or privileges of the Series F Preferred Stock, <U>provided</U>; <U>that</U> for the avoidance of doubt the
authorization or issuance of any other series or class of capital stock ranking junior, <I>pari passu</I> or senior to the Series F Preferred Stock with respect to one or more powers, preferences or special rights shall not, in and of itself, be
deemed to constitute an amendment, alteration or change of the powers, preferences or special rights of the Series F Preferred Stock that adversely affects the Series F Preferred Stock; (ii)&nbsp;any action that creates or authorizes the creation of
additional shares of Series F Preferred Stock or increases the authorized number of shares of Series F Preferred Stock; (iii)&nbsp;any action that reclassifies, alters or amends any existing security of the Corporation that is junior to or on parity
with the Series F Preferred Stock, if such reclassification, alteration or amendment would render such other security senior to or on parity with the Series F Preferred Stock or (iv)&nbsp;any action that results in the purchase, redemption, payment
or declaration of dividends, or distribution on, any shares of capital stock other than the Series F Preferred Stock, other than repurchases of stock issued to or held by directors, employees or consultants (x)&nbsp;upon termination of their
employment or services, (y)&nbsp;in connection with other repurchases from employees and consultants at the then deemed fair market value of the Common Stock, if approved by the Board of Directors, or (z)&nbsp;in connection with the exercise by the
Corporation of contractual rights of first refusal or first offer pursuant to agreements providing for the right of said repurchase between the Corporation and such persons, provided the terms of such repurchase shall have been approved by the Board
of Directors.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">7. <U>Status of Converted Stock</U>. In the event any shares of Preferred Stock shall be converted pursuant to
Section&nbsp;4 hereof, such shares so converted shall be cancelled and shall not be issuable by this Corporation. This Sixth Amended and Restated Certificate of Incorporation of this Corporation shall be appropriately amended to effect the
corresponding reductions in this Corporation&#146;s authorized capital stock. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. To the fullest extent permitted by Delaware statutory or decisional law, as amended or interpreted, no director of the Corporation shall be
personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director. This Article V does not affect the availability of equitable remedies for breach of fiduciary duties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. The Corporation shall, to the fullest extent legally permissible under the provisions of the Delaware General Corporation Law, as amended
or interpreted, indemnify and hold harmless any and all persons whom it shall have power to indemnify under said provisions from and against any and all liabilities (including expenses) imposed on or reasonably incurred by him in connection with any
action, suit or other proceeding in which he may be involved or with which he may be threatened, or other matters referred to in or covered by said provisions both as to action in his official capacity and as to action in another capacity while
holding such office, and shall continue as to a person who has ceased to be a director or officer of the corporation. Such indemnification provided shall not be deemed exclusive of any other rights to which those indemnified may be entitled under
any bylaw, agreement or resolution adopted by the shareholders entitled to vote thereon after notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. Any repeal or modification of
this Article V shall be prospective and shall not affect the rights under this Article V in effect at the time of the alleged occurrence of any act or omission to act giving rise to liability or indemnification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the management of the business and for the conduct of the affairs of the Corporation, and in further definition, limitation and regulation
of the powers of the Corporation, of its directors and of its stockholders or any class thereof, as the case may be, it is further <U>provided</U> that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1. The management of the business and the conduct of the affairs of the Corporation shall be vested in its Board of Directors. The number of
directors which shall constitute the whole Board of Directors shall be fixed by the Bylaws of this Corporation, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2. The Board
of Directors may from time to time make, amend, supplement or repeal the Bylaws, <U>provided</U> that such action does not conflict with this Sixth Amended and Restated Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3. The directors of the Corporation need not be elected by written ballot unless the Bylaws so provide. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Corporation reserves the right to amend, alter, change or repeal any provision contained in this Sixth Amended and Restated Certificate of Incorporation, in the manner now or hereafter prescribed by statute, and all rights conferred upon the
stockholders herein are granted subject to this right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever a compromise or arrangement is proposed between the Corporation and its
creditors or any class of them and/or between the Corporation and its stockholders or any class of them, any court of equitable jurisdiction within the State of Delaware may, on the application in a summary way of the Corporation or of any creditor
or stockholder thereof, or on the application of any receiver or receivers appointed for the Corporation under the provision of Section&nbsp;291 of Title 8 of the Delaware Code or on the application of trustees in dissolution or of any receiver or
receivers appointed for the Corporation under the provisions of Section&nbsp;279 of Title 8 of the Delaware Code order a meeting of the creditors or class of creditors, and/or of the stockholders or class of stockholders of the Corporation, as the
case may be, to be summoned in such manner as the said court directs. If a majority-in-number representing three-fourths in value of the creditors or class of creditors, and/or of the stockholders or class of stockholders of the Corporation, as the
case may be, agree to any compromise or arrangement and to any reorganization of this corporation as a consequence of such compromise or arrangement, the said compromise or arrangement and the said reorganization shall, if sanctioned by the court to
which the said application has been made, be binding on all the creditors or class of creditors, and/or on all the stockholders or class of stockholders, of the Corporation, as the case may be, and also on the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">5. All amendments to the Fifth Amended and Restated Certificate of Incorporation reflected herein have been duly authorized and adopted by the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Corporation&#146;s Board of Directors in accordance with the provisions of Sections 141, 242 and 245 of the Delaware General Corporation Law, and the stockholders of the Corporation, acting in
accordance with Sections 228 and 242 of the Delaware General Corporation Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned has executed this Sixth
Amended and Restated Certificate of Incorporation as of the date set forth below and certifies under penalty of perjury that he has read the foregoing Sixth Amended and Restated Certificate of Incorporation and knows the contents thereof and that
the statements therein are true. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Executed this 16 day of May, 2014. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert D. Evans</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert D. Evans</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Executive Vice President, General Counsel and Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3
<SEQUENCE>3
<FILENAME>filename3.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED BYLAWS OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE
I </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Place of Meetings</U>. All meetings of stockholders shall be held at such place within or outside the State of Delaware as may be
designated from time to time by the Board of Directors, the Chairman of the Board or the Chief Executive Officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Annual
Meeting</U>. The annual meeting of stockholders for the election of directors and for the transaction of such other business as may properly be brought before the meeting shall be held on a date to be fixed by the Board of Directors at the time and
place to be fixed by the Board of Directors and stated in the notice of the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3 <U>Special Meetings</U>. Special meetings of
stockholders may be called at any time by the Board of Directors, the Chairman of the Board, the Chief Executive Officer or the holders of record of not less than 10% of all shares entitled to cast votes at the meeting, for any purpose or purposes
prescribed in the notice of the meeting and shall be held at such place, on such date and at such time as the Board may fix. Business transacted at any special meeting of stockholders shall be confined to the purpose or purposes stated in the notice
of meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4 <U>Notice of Meetings</U>. Written notice of each meeting of stockholders, whether annual or special, shall be given not
less than 10 nor more than 60 days before the date on which the meeting is to be held, to each stockholder entitled to vote at such meeting, except as otherwise provided herein or as required by law (meaning here and hereafter, as required from time
to time by the Delaware General Corporation Law or the Certificate of Incorporation). The notices of all meetings shall state the place, date and hour of the meeting. The notice of a special meeting shall state, in addition, the purpose or purposes
for which the meeting is called. If mailed, notice is given when deposited in the United States mail, postage prepaid, directed to the stockholder at his address as it appears on the records of the corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5 <U>Voting List</U>. The officer who has charge of the stock ledger of the corporation shall prepare, at least 10 days before each meeting
of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. Such list shall be
open to the examination of any stockholder, for any purpose germane to the meeting, during ordinary business hours, for a period of at least 10 days prior to the meeting, at a place within the city where the meeting is to be held, which place shall
be specified in the notice of the meeting, or if not so specified, at the place where the meeting is to be held. The list shall also be produced and kept at the time and place of the meeting during the whole time of the meeting, and may be inspected
by any stockholder who is present. This list shall determine the identity of the stockholders entitled to vote at the meeting and the number of shares held by each of them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6 <U>Quorum</U>. Except as otherwise provided by law or these Bylaws, the holders of a majority of the shares of the capital stock of the
corporation entitled to vote at the meeting, </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
present in person or represented by proxy, shall constitute a quorum for the transaction of business. If a quorum shall fail to attend any meeting, the chairman of the meeting or the holders of a
majority of the shares of stock entitled to vote who are present, in person or by proxy, may adjourn the meeting to another place, date or time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a notice of any adjourned special meeting of stockholders is sent to all stockholders entitled to vote thereat, stating that it will be
held with those present constituting a quorum, then except as otherwise required by law, those present at such adjourned meeting shall constitute a quorum, and all matters shall be determined by a majority of the votes cast at such meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.7 <U>Adjournments</U>. Any meeting of stockholders may be adjourned to any other time and to any other place at which a meeting of
stockholders may be held under these Bylaws by the Chairman of the meeting or, in the absence of such person, by any officer entitled to preside at or to act as Secretary of such meeting, or by the holders of a majority of the shares of stock
present or represented at the meeting and entitled to vote, although less than a quorum. When a meeting is adjourned to another place, date or time, written notice need not be given of the adjourned meeting if the place, date and time thereof are
announced at the meeting at which the adjournment is taken; provided, however, that if the date of any adjourned meeting is more than 30 days after the date for which the meeting was originally noticed, or if a new record date is fixed for the
adjourned meeting, written notice of the place, date, and time of the adjourned meeting shall be given in conformity herewith. At the adjourned meeting, the corporation may transact any business which might have been transacted at the original
meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.8 <U>Voting and Proxies</U>. Each stockholder shall have one vote for each share of stock entitled to vote held of record by
such stockholder and a proportionate vote for each fractional share so held, unless otherwise provided by law or in the Certificate of Incorporation. Each stockholder of record entitled to vote at a meeting of stockholders may vote in person or may
authorize any other person or persons to vote or act for him by written proxy executed by the stockholder or his authorized agent or by a transmission permitted by law and delivered to the Secretary of the corporation. No stockholder may authorize
more than one proxy for his shares. Any copy, facsimile transmission or other reliable reproduction of the writing or transmission created pursuant to this Section may be substituted or used in lieu of the original writing or transmission for any
and all purposes for which the original writing or transmission could be used, provided that such copy, facsimile transmission or other reproduction shall be a complete reproduction of the entire original writing or transmission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.9 <U>Action at Meeting</U>. When a quorum is present at any meeting, any election shall be determined by a plurality of the votes cast by
the stockholders entitled to vote at the election, and all other matters shall be determined by a majority of the votes cast affirmatively or negatively on the matter (or if there are two or more classes of stock entitled to vote as separate
classes, then in the case of each such class, a majority of each such class present or represented and voting affirmatively or negatively on the matter) shall decide such matter, except when a different vote is required by express provision of law,
the Certificate of Incorporation or these Bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All voting, including on the election of directors, but excepting where otherwise
required by law, may be by a voice vote; provided, however, that upon demand therefor by a stockholder </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
entitled to vote or his or her proxy, a stock vote shall be taken. Every stock vote shall be taken by ballot, each of which shall state the name of the stockholder or proxy voting and such other
information as may be required under the procedure established for the meeting. Every vote taken by ballot shall be counted by an inspector or inspectors appointed by the chairman of the meeting. The corporation may, and to the extent required by
law, shall, in advance of any meeting of stockholders, appoint one or more inspectors to act at the meeting and make a written report thereof. The corporation may designate one or more persons as an alternate inspector to replace any inspector who
fails to act. If no inspector or alternate is able to act at a meeting of stockholders, the person presiding at the meeting may, and to the extent required by law, shall, appoint one or more inspectors to act at the meeting. Each inspector, before
entering upon the discharge of his duties, shall take and sign an oath to faithfully execute the duties of inspector with strict impartiality and according to the best of his or her ability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.10 <U>Stockholder Action Without Meeting</U>. Any action which may be taken at any annual or special meeting of stockholders may be taken
without a meeting and without prior notice, if a consent in writing, setting forth the actions so taken, is signed by the holders of outstanding shares having not less than the minimum number of votes which would be necessary to authorize or take
such action at a meeting at which all shares entitled to vote thereon were present and voted. All such consents shall be filed with the Secretary of the corporation and shall be maintained in the corporate records. Prompt notice of the taking of a
corporate action without a meeting by less than unanimous written consent shall be given to those stockholders who have not consented in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An electronic transmission consenting to an action to be taken and transmitted by a stockholder, or by a proxy holder or other person
authorized to act for a stockholder, shall be deemed to be written, signed and dated for the purpose of this Section 1.10, provided that such electronic transmission sets forth or is delivered with information from which the corporation can
determine (i)&nbsp;that the electronic transmission was transmitted by the stockholder or by a person authorized to act for the stockholder and (ii)&nbsp;the date on which such stockholder or authorized person transmitted such electronic
transmission. The date on which such electronic transmission is transmitted shall be deemed to be the date on which such consent was signed. No consent given by electronic transmission shall be deemed to have been delivered until such consent is
reproduced in paper form and until such paper form shall be delivered to the corporation by delivery to its principal place of business or an officer or agent of the corporation having custody of the books in which proceedings of meetings of
stockholders are recorded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.11 <U>Meetings by Remote Communication</U>. If authorized by the Board of Directors, and subject to such
guidelines and procedures as the Board may adopt, stockholders and proxy holders not physically present at a meeting of stockholders may, by means of remote communication, participate in the meeting and be deemed present in person and vote at the
meeting, whether such meeting is to be held at a designated place or solely by means of remote communication, provided that (i)&nbsp;the corporation shall implement reasonable measures to verify that each person deemed present and permitted to vote
at the meeting by means of remote communication is a stockholder or proxy holder, (ii)&nbsp;the corporation shall implement reasonable measures to provide such stockholders and proxy holders a reasonable opportunity to participate in the meeting and
to vote on matters submitted to the stockholders, including an opportunity to read or hear the proceedings of the meeting substantially concurrently with such proceedings, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and (iii)&nbsp;if any stockholder or proxy holder votes or takes other action at the meeting by means of remote communication, a record of such vote or other action shall be maintained by the
corporation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BOARD OF DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1
<U>General Powers</U>. The business and affairs of the corporation shall be managed by or under the direction of a Board of Directors, who may exercise all of the powers of the corporation except as otherwise provided by law or the Certificate of
Incorporation. In the event of a vacancy in the Board of Directors, the remaining directors, except as otherwise provided by law, may exercise the powers of the full Board until the vacancy is filled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Number and Term of Office</U>. The number of directors shall initially be three (3)&nbsp;and, thereafter, shall be fixed from time to
time exclusively by the Board of Directors pursuant to a resolution adopted by a majority of the total number of authorized directors (whether or not there exist any vacancies in previously authorized directorships at the time any such resolution is
presented to the Board for adoption). All directors shall hold office until the expiration of the term for which elected and until their respective successors are elected, except in the case of the death, resignation or removal of any director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Vacancies and Newly Created Directorships</U>. Subject to the rights of the holders of any series of Preferred Stock then outstanding,
newly created directorships resulting from any increase in the authorized number of directors or any vacancies in the Board of Directors resulting from death, resignation, retirement, disqualification or other cause (other than removal from office
by a vote of the stockholders) may be filled only by a majority vote of the directors then in office, though less than a quorum, or by the sole remaining director, and directors so chosen shall hold office for a term expiring at the next annual
meeting of stockholders. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <U>Resignation</U>. Any director may resign by delivering notice in writing or by electronic transmission to the Chief Executive Officer,
Chairman of the Board or Secretary. Such resignation shall be effective upon receipt unless it is specified to be effective at some other time or upon the happening of some other event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 <U>Removal</U>. Subject to the rights of the holders of any series of Preferred Stock then outstanding, any directors, or the entire Board
of Directors, may be removed from office at any time, with or without cause, by the affirmative vote of the holders of at least a majority of the voting power of all of the outstanding shares of capital stock entitled to vote generally in the
election of directors, voting together as a single class. Vacancies in the Board of Directors resulting from such removal may be filled by a majority of the directors then in office, though less than a quorum, by the sole remaining director, or by
the stockholders at the next annual meeting or at a special meeting called in accordance with Section 1.3 above. Directors so chosen shall hold office until the next annual meeting of stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 <U>Regular Meetings</U>. Regular meetings of the Board of Directors may be held without
notice at such time and place, either within or without the State of Delaware, as shall be determined from time to time by the Board of Directors; provided that any director who is absent when such a determination is made shall be given notice of
the determination. A regular meeting of the Board of Directors may be held without notice immediately after and at the same place as the annual meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 <U>Special Meetings</U>. Special meetings of the Board of Directors may be called by the Chairman of the Board, the Chief Executive
Officer or two or more directors and may be held at any time and place, within or without the State of Delaware. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 <U>Notice of Special
Meetings</U>. Notice of any special meeting of directors shall be given to each director by the Secretary or by the officer or one of the directors calling the meeting. Notice shall be duly given to each director by (i)&nbsp;giving notice to such
director in person or by telephone, electronic transmission or voice message system at least 24 hours in advance of the meeting, (ii)&nbsp;sending a facsimile, or delivering written notice by hand, to his last known business or home address at least
24 hours in advance of the meeting, or (iii)&nbsp;mailing written notice to his last known business or home address at least three days in advance of the meeting. A notice or waiver of notice of a meeting of the Board of Directors need not specify
the purposes of the meeting. Unless otherwise indicated in the notice thereof, any and all business may be transacted at a special meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 <U>Participation in Meetings by Telephone Conference Calls or Other Methods of Communication</U>. Directors or any members of any
committee designated by the directors may participate in a meeting of the Board of Directors or such committee by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear
each other, and participation by such means shall constitute presence in person at such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10 <U>Quorum</U>. A majority of the
total number of authorized directors shall constitute a quorum at any meeting of the Board of Directors. In the event one or more of the directors shall be disqualified to vote at any meeting, then the required quorum shall be reduced by one for
each such director so disqualified; provided, however, that in no case shall less than 1/3 of the number so fixed constitute a quorum. In the absence of a quorum at any such meeting, a majority of the directors present may adjourn the meeting from
time to time without further notice other than announcement at the meeting, until a quorum shall be present. Interested directors may be counted in determining the presence of a quorum at a meeting of the Board of Directors or at a meeting of a
committee which authorizes a particular contract or transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11 <U>Action at Meeting</U>. At any meeting of the Board of Directors
at which a quorum is present, the vote of a majority of those present shall be sufficient to take any action, unless a different vote is specified by law, the Certificate of Incorporation or these Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.12 <U>Action by Written Consent</U>. Any action required or permitted to be taken at any meeting of the Board of Directors or of any
committee of the Board of Directors may be taken without a meeting if all members of the Board or committee, as the case may be, consent to the action in writing or by electronic transmission, and the writings or electronic transmissions are
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
filed with the minutes of proceedings of the Board or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are
maintained in electronic form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.13 <U>Committees</U>. The Board of Directors may designate one or more committees, each committee to
consist of one or more of the directors of the corporation, with such lawfully delegated powers and duties as it therefor confers, to serve at the pleasure of the Board. The Board may designate one or more directors as alternate members of any
committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of a committee, the member or members of the committee present at any meeting and not disqualified from
voting, whether or not he or they constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting in the place of any such absent or disqualified member. Any such committee, to the extent provided in the
resolution of the Board of Directors and subject to the provisions of the Delaware General Corporation Law, shall have and may exercise all the powers and authority of the Board of Directors in the management of the business and affairs of the
corporation and may authorize the seal of the corporation to be affixed to all papers which may require it. Each such committee shall keep minutes and make such reports as the Board of Directors may from time to time request. Except as the Board of
Directors may otherwise determine, any committee may make rules for the conduct of its business, but unless otherwise provided by such rules, its business shall be conducted as nearly as possible in the same manner as is provided in these Bylaws for
the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.14 <U>Compensation of Directors</U>. Directors may be paid such compensation for their services and such
reimbursement for expenses of attendance at meetings as the Board of Directors may from time to time determine. No such payment shall preclude any director from serving the corporation or any of its parent or subsidiary corporations in any other
capacity and receiving compensation for such service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.15 <U>Nomination of Director Candidates</U>. Subject to the rights of holders of
any class or series of Preferred Stock then outstanding, nominations for the election of Directors may be made by (i)&nbsp;the Board of Directors or a duly authorized committee thereof or (ii)&nbsp;any stockholder entitled to vote in the election of
Directors. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OFFICERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1
<U>Enumeration</U>. The officers of the corporation shall consist of a Chief Executive Officer, a President, a Secretary, a Chief Financial Officer and such other officers with such other titles as the Board of Directors shall determine, including,
at the discretion of the Board of Directors, a Chairman of the Board and one or more Vice Presidents and Assistant Secretaries. The Board of Directors may appoint such other officers as it may deem appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Election</U>. Officers shall be elected annually by the Board of Directors at its first meeting following the annual meeting of
stockholders. Officers may be appointed by the Board of Directors at any other meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Qualification</U>. No officer need be a stockholder. Any two or more offices may be held
by the same person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <U>Tenure</U>. Except as otherwise provided by law, by the Certificate of Incorporation or by these Bylaws, each
officer shall hold office until his successor is elected and qualified, unless a different term is specified in the vote appointing him, or until his earlier death, resignation or removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.5 <U>Resignation and Removal</U>. Any officer may resign by delivering his written resignation to the corporation at its principal office or
to the President or Secretary. Such resignation shall be effective upon receipt unless it is specified to be effective at some other time or upon the happening of some other event. Any officer elected by the Board of Directors may be removed at any
time, with or without cause, by the Board of Directors or, in the case of any officer other than the Chief Executive Officer, by the Chief Executive Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6 <U>Chairman of the Board</U>. The Board of Directors may appoint a Chairman of the Board. If the Board of Directors appoints a Chairman of
the Board, he shall perform such duties and possess such powers as are assigned to him by the Board of Directors. Unless otherwise provided by the Board of Directors, he shall preside at all meetings of the stockholders, and, if he is a director, at
all meetings of the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7 <U>Chief Executive Officer</U>. The Chief Executive Officer shall, subject to the direction
of the Board of Directors, have responsibility for the general management and control of the business and affairs of the corporation and shall perform all duties and have all powers which are commonly incident to the office of Chief Executive
Officer or which are delegated to him or her by the Board of Directors. The Chief Executive Officer shall, in the absence of or because of the inability to act of the Chairman of the Board, perform all duties of the Chairman of the Board and preside
at all meetings of the Board of Directors and of stockholders. The Chief Executive Officer shall perform such other duties and shall have such other powers as the Board of Directors may from time to time prescribe. He or she shall have power to sign
stock certificates, contracts and other instruments of the corporation which are authorized and shall have general supervision and direction of all of the other officers, employees and agents of the corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.8 <U>President</U>. The President shall perform such duties and possess such powers as the Board of Directors or the Chief Executive Officer
may from time to time prescribe. In the event of the absence, inability or refusal to act of the Chief Executive Officer, the President shall perform the duties of the Chief Executive Officer and when so performing shall have all the powers of and
be subject to all the restrictions upon the Chief Executive Officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.9 <U>Vice Presidents</U>. Any Vice President shall perform such
duties and possess such powers as the Board of Directors, the Chief Executive Officer or the President may from time to time prescribe. In the event of the absence, inability or refusal to act of the Chief Executive Officer and the President, the
Vice President (or if there shall be more than one, the Vice Presidents in the order determined by the Board of Directors) shall perform the duties of the Chief Executive Officer and the President and when so performing shall have at the powers of
and be subject to all the restrictions upon the Chief Executive Officer and the President. The Board of Directors may assign to any Vice President the title of Executive Vice President, Senior Vice President or any other title selected by the Board
of Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.10 <U>Secretary and Assistant Secretaries</U>. The Secretary shall perform such duties and
shall have such powers as the Board of Directors or the Chief Executive Officer may from time to time prescribe. In addition, the Secretary shall perform such duties and have such powers as are incident to the office of the Secretary, including,
without limitation, the duty and power to give notices of all meetings of stockholders and special meetings of the Board of Directors, to keep a record of the proceedings of all meetings of stockholders and the Board of Directors, to maintain a
stock ledger and prepare lists of stockholders and their addresses as required, to be custodian of corporate records and the corporate seal and to affix and attest to the same on documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Assistant Secretary shall perform such duties and possess such powers as the Board of Directors, the Chief Executive Officer, the
President or the Secretary may from time to time prescribe. In the event of the absence, inability or refusal to act of the Secretary, the Assistant Secretary (or if there shall be more than one, the Assistant Secretaries in the order determined by
the Board of Directors) shall perform the duties and exercise the powers of the Secretary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the absence of the Secretary or any
Assistant Secretary at any meeting of stockholders or directors, the person presiding at the meeting shall designate a temporary secretary to keep a record of the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.11 <U>Chief Financial Officer</U>. Unless otherwise designated by the Board of Directors, the Chief Financial Officer shall be the
Treasurer. The Chief Financial Officer shall perform such duties and shall have such powers as may from time to time be assigned to him by the Board of Directors, the Chief Executive Officer or the President. In addition, the Chief Financial Officer
shall perform such duties and have such powers as are incident to the office of chief financial officer, including without limitation, the duty and power to keep and be responsible for all funds and securities of the corporation, to maintain the
financial records of the corporation, to deposit funds of the corporation in depositories as authorized, to disburse such funds as authorized, to make proper accounts of such funds, and to render as required by the Board of Directors accounts of all
such transactions and of the financial condition of the corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.12 <U>Salaries</U>. Officers of the corporation shall be entitled
to such salaries, compensation or reimbursement as shall be fixed or allowed from time to time by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.13
<U>Delegation of Authority</U>. The Board of Directors may from time to time delegate the powers or duties of any officer to any other officers or agents, notwithstanding any provision hereof. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CAPITAL
STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Issuance of Stock</U>. Unless otherwise voted by the stockholders and subject to the provisions of the Certificate of
Incorporation, the whole or any part of any unissued balance of the authorized capital stock of the corporation or the whole or any part of any unissued balance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the authorized capital stock of the corporation held in its treasury may be issued, sold, transferred or otherwise disposed of by vote of the Board of Directors in such manner, for such
consideration and on such terms as the Board of Directors may determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Certificates of Stock</U>. Every holder of stock of the
corporation shall be entitled to have a certificate, in such form as may be prescribed by law and by the Board of Directors, certifying the number and class of shares owned by him in the corporation. Each such certificate shall be signed by, or in
the name of the corporation by, the Chairman or Vice Chairman, if any, of the Board of Directors, or the Chief Executive Officer, the President or a Vice President, and the Treasurer or an Assistant Treasurer, or the Secretary or an Assistant
Secretary of the corporation. Any or all of the signatures on the certificate may be a facsimile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each certificate for shares of stock
which are subject to any restriction on transfer pursuant to the Certificate of Incorporation, the Bylaws, applicable securities laws or any agreement among any number of shareholders or among such holders and the corporation shall have
conspicuously noted on the face or back of the certificate either the full text of the restriction or a statement of the existence of such restriction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Transfers</U>. Except as otherwise established by rules and regulations adopted by the Board of Directors, and subject to applicable
law, shares of stock may be transferred on the books of the corporation by the surrender to the corporation or its transfer agent of the certificate representing such shares properly endorsed or accompanied by a written assignment or power of
attorney properly executed, and with such proof of authority or authenticity of signature as the corporation or its transfer agent may reasonably require. Except as may be otherwise required by law, the Certificate of Incorporation or the Bylaws,
the corporation shall be entitled to treat the record holder of stock as shown on its books as the owner of such stock for all purposes, including the payment of dividends and the right to vote with respect to such stock, regardless of any transfer,
pledge or other disposition of such stock until the shares have been transferred on the books of the corporation in accordance with the requirements of these Bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Lost, Stolen or Destroyed Certificates</U>. The corporation may issue a new certificate of stock in place of any previously issued
certificate alleged to have been lost, stolen, or destroyed, upon such terms and conditions as the Board of Directors may prescribe, including the presentation of reasonable evidence of such loss, theft or destruction and the giving of such
indemnity as the Board of Directors may require for the protection of the corporation or any transfer agent or registrar. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U>Record
Date</U>. The Board of Directors may fix in advance a record date for the determination of the stockholders entitled to notice of or to vote at any meeting of stockholders or to express consent (or dissent) to corporate action in writing without a
meeting, or entitled to receive payment of any dividend or other distribution or allotment of any rights in respect of any change, concession or exchange of stock, or for the purpose of any other lawful action. Such record date shall not be more
than 60 nor less than 10 days before the date of such meeting, nor more than 60 days prior to any other action to which such record date relates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If no record date is fixed, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall
be at the close of business on the day before the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
day on which notice is given, or, if notice is waived, at the close of business on the day before the day on which the meeting is held. The record date for determining stockholders entitled to
express consent to corporate action in writing without a meeting when no prior action by the Board of Directors is necessary, shall be the day on which the first written consent is expressed. The record date for determining stockholders for any
other purpose shall be at the close of business on the day on which the Board of Directors adopts the resolution relating to such purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the
meeting; provided, however, that the Board of Directors may fix a new record date for the adjourned meeting. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1
<U>Fiscal Year</U>. The fiscal year of the corporation shall be as fixed by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Corporate Seal</U>. The
corporate seal shall be in such form as shall be approved by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Waiver of Notice</U>. Whenever any notice
whatsoever is required to be given by law, by the Certificate of Incorporation or by these Bylaws, a waiver of such notice either in writing signed by the person entitled to such notice or such person&#146;s duly authorized attorney, or by
electronic transmission or any other method permitted under the Delaware General Corporation Law, whether before, at or after the time stated in such waiver, or the appearance of such person or persons at such meeting in person or by proxy, shall be
deemed equivalent to such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Actions with Respect to Securities of Other Corporations</U>. Except as the Board of Directors
may otherwise designate, the Chief Executive Officer or President or any officer of the corporation authorized by the Chief Executive Officer or President shall have the power to vote and otherwise act on behalf of the corporation, in person or
proxy, and may waive notice of, and act as, or appoint any person or persons to act as, proxy or attorney-in-fact to this corporation (with or without power of substitution) at any meeting of stockholders or shareholders (or with respect to any
action of stockholders) of any other corporation or organization, the securities of which may be held by this corporation and otherwise to exercise any and all rights and powers which this corporation may possess by reason of this corporation&#146;s
ownership of securities in such other corporation or other organization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>Evidence of Authority</U>. A certificate by the
Secretary, or an Assistant Secretary, or a temporary Secretary, as to any action taken by the stockholders, directors, a committee or any officer or representative of the corporation shall as to all persons who rely on the certificate in good faith
be conclusive evidence of such action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>Certificate of Incorporation</U>. All references in these Bylaws to the Certificate of
Incorporation shall be deemed to refer to the Certificate of Incorporation of the corporation, as amended and in effect from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U>Severability</U>. Any determination that any provision of these Bylaws is for any reason
inapplicable, illegal or ineffective shall not affect or invalidate any other provision of these Bylaws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <U>Pronouns</U>. All
pronouns used in these Bylaws shall be deemed to refer to the masculine, feminine or neuter, singular or plural, as the identity of the person or persons may require. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <U>Notices</U>. Except as otherwise specifically provided herein or required by law, all notices required to be given to any stockholder,
director, officer, employee or agent shall be in writing and may in every instance be effectively given by hand delivery to the recipient thereof, by depositing such notice in the mails, postage paid, or by sending such notice by facsimile or other
electronic transmission in the manner provided in Section&nbsp;232 of the Delaware General Corporation Law, or by commercial courier service. Any such notice shall be addressed to such stockholder, director, officer, employee or agent at his or her
last known address as the same appears on the books of the corporation. The time when such notice shall be deemed to be given shall be the time such notice is received by such stockholder, director, officer, employee or agent, or by any person
accepting such notice on behalf of such person, if delivered by hand, facsimile, other electronic transmission or commercial courier service, or the time such notice is dispatched, if delivered through the mails. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10 <U>Reliance Upon Books, Reports and Records</U>. Each director, each member of any committee designated by the Board of Directors, and
each officer of the corporation shall, in the performance of his duties, be fully protected in relying in good faith upon the books of account or other records of the corporation, including reports made to the corporation by any of its officers, by
an independent certified public accountant, or by an appraiser selected with reasonable care. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11 <U>Time Periods</U>. In applying any
provision of these Bylaws which require that an act be done or not done a specified number of days prior to an event or that an act be done during a period of a specified number of days prior to an event, calendar days shall be used, the day of the
doing of the act shall be excluded, and the day of the event shall be included. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.12 <U>Facsimile Signatures</U>. In addition to the
provisions for use of facsimile signatures elsewhere specifically authorized in these Bylaws, facsimile signatures of any officer or officers of the corporation may be used whenever and as authorized by the Board of Directors or a committee thereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.13 <U>Annual Report</U>. For so long as the corporation has fewer than 100 holders of record of its shares, the mandatory requirement
of an annual report under Section&nbsp;1501 of the California Corporations Code, if otherwise applicable to the corporation, is hereby expressly waived. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENTS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <U>By the Board of Directors</U>. Except as is otherwise set forth in these Bylaws, these Bylaws may be altered, amended or
repealed or new Bylaws may be adopted by the affirmative vote of a majority of the directors present at any regular or special meeting of the Board of Directors at which a quorum is present. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <U>By the Stockholders</U>. Except as otherwise set forth in these Bylaws, these Bylaws may be altered, amended or repealed or new Bylaws
may be adopted by the affirmative vote of the holders of at least a majority of the shares of the capital stock of the corporation issued and outstanding and entitled to vote at any annual meeting of stockholders, or at any special meeting of
stockholders, provided notice of such alteration, amendment, repeal or adoption of new Bylaws shall have been stated in the notice of such special meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INDEMNIFICATION OF DIRECTORS AND OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <U>Right to Indemnification</U>. Each person who was or is made a party or is threatened to be made a party to or is involved in any
action, suit or proceeding, whether civil, criminal, administrative or investigative (&#147;proceeding&#148;), by reason of the fact that he or she or a person of whom he or she is the legal representative, is or was a director or officer of the
corporation or is or was serving at the request of the corporation as a director or officer of another corporation, or as a controlling person of a partnership, joint venture, trust or other enterprise, including service with respect to employee
benefit plans, whether the basis of such proceeding is alleged action in an official capacity as a director or officer, or in any other capacity while serving as a director or officer, shall be indemnified and held harmless by the corporation to the
fullest extent authorized by the Delaware General Corporation Law, as the same exists or may hereafter be amended (but, in the case of any such amendment, only to the extent that such amendment permits the corporation to provide broader
indemnification rights than said Law permitted the corporation to provide prior to such amendment) against all expenses, liability and loss reasonably incurred or suffered by such person in connection therewith and such indemnification shall
continue as to a person who has ceased to be a director or officer and shall inure to the benefit of his or her heirs, executors and administrators; <U>provided</U>, <U>however</U>, that except as provided in Section 7.2 of this Article VII, the
corporation shall indemnify any such person seeking indemnity in connection with a proceeding (or part thereof) initiated by such person only if (a)&nbsp;such indemnification is expressly required to be made by law, (b)&nbsp;the proceeding (or part
thereof) was authorized by the Board of Directors of the corporation, (c)&nbsp;such indemnification is provided by the corporation, in its sole discretion, pursuant to the powers vested in the corporation under the Delaware General Corporation Law,
or (d)&nbsp;the proceeding (or part thereof) is brought to establish or enforce a right to indemnification under an indemnity agreement or any other statute or law or otherwise as required under Section&nbsp;145 of the Delaware General Corporation
Law. The rights hereunder shall be contract rights and shall include the right to be paid expenses incurred in defending any such proceeding in advance of its final disposition; <U>provided</U>, <U>however</U>, that, unless the Delaware General
Corporation Law then so prohibits, the payment of such expenses incurred by a director or officer of the corporation in his or her capacity as a director or officer (and not in any other capacity in which service was or is tendered by such person
while a director or officer, including, without limitation, service to an employee benefit plan) in advance of the final disposition of such proceeding, shall be made only upon delivery to the corporation of an undertaking, by or on behalf of such
director or officer, to repay all amounts so advanced if it should be determined ultimately that such director or officer is not entitled to be indemnified under this Section or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Right of Claimant to Bring Suit</U>. If a claim under Section 7.1 is not paid in full by
the corporation within 90 days after a written claim has been received by the corporation, the claimant may at any time thereafter bring suit against the corporation to recover the unpaid amount of the claim and, if such suit is not frivolous or
brought in bad faith, the claimant shall be entitled to be paid also the expense of prosecuting such claim. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in defending any proceeding
in advance of its final disposition where the required undertaking, if any, has been tendered to this corporation) that the claimant has not met the standards of conduct which make it permissible under the Delaware General Corporation Law for the
corporation to indemnify the claimant for the amount claimed. Neither the failure of the corporation (including its Board of Directors, independent legal counsel, or its stockholders) to have made a determination prior to the commencement of such
action that indemnification of the claimant is proper in the circumstances because he or she has met the applicable standard of conduct set forth in the Delaware General Corporation Law, nor an actual determination by the corporation (including its
Board of Directors, independent legal counsel or its stockholders) that the claimant has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that claimant has not met the applicable standard of
conduct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>Indemnification of Employees and Agents</U>. The corporation may, to the extent authorized from time to time by the Board
of Directors, grant rights to indemnification, and to the advancement of related expenses, to any employee or agent of the corporation to the fullest extent of the provisions of this Article with respect to the indemnification of and advancement of
expenses to directors and officers of the corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <U>Non-Exclusivity of Rights</U>. The rights conferred on any person in
Section 7.1 and 7.2 shall not be exclusive of any other right which such persons may have or hereafter acquire under any statute, provision of the Certificate of Incorporation, bylaw, agreement, vote of stockholders or disinterested directors or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5 <U>Indemnification Contracts</U>. The Board of Directors is authorized to enter into a contract with any director,
officer, employee or agent of the corporation, or any person serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, including employee
benefit plans, providing for indemnification rights equivalent to or, if the Board of Directors so determines, greater than, those provided for in this Article VII. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6 <U>Insurance</U>. The corporation may maintain insurance to the extent reasonably available, at its expense, to protect itself and any
such director, officer, employee or agent of the corporation or another corporation, partnership, joint venture, trust or other enterprise against any such expense, liability or loss, whether or not the corporation would have the power to indemnify
such person against such expense, liability or loss under the Delaware General Corporation Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.7 <U>Effect of Amendment</U>. Any
amendment, repeal or modification of any provision of this Article VII by the stockholders and the directors of the corporation shall not adversely affect any right or protection of a director or officer of the corporation existing at the time of
such amendment, repeal or modification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CERTIFICATE OF SECRETARY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PENUMBRA, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(a Delaware corporation) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I,
Robert Evans, the Secretary of Penumbra, Inc., a Delaware corporation (the &#147;Corporation&#148;), hereby certify that the Bylaws to which this Certificate is attached are the Bylaws of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Executed effective on the 11<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of June 2008. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert Evans</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert Evans, Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>4
<FILENAME>filename4.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">E<SMALL>XECUTION</SMALL> V<SMALL>ERSION</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOURTH
AMENDED AND RESTATED INVESTORS&#146; RIGHTS AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of May&nbsp;16, 2014 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOURTH AMENDED AND RESTATED INVESTORS&#146; RIGHTS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS FOURTH AMENDED AND RESTATED INVESTORS&#146; RIGHTS AGREEMENT (this &#147;<U>Agreement</U>&#148;) is made as of May&nbsp;16, 2014, by and
among Penumbra, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), Adam Elsesser and Arani Bose (collectively, the &#147;<U>Founders</U>,&#148; and each individually, a &#147;<U>Founder</U>&#148;), and the investors (the
&#147;<U>Investors</U>,&#148; and individually, an &#147;<U>Investor</U>&#148;) listed on Exhibit A hereto with reference to the following facts: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company and certain Investors listed on Exhibit A thereto (the &#147;<U>Existing Investors</U>&#148;) are parties to that certain
Third Amended and Restated Investors&#146; Rights Agreement dated February&nbsp;1, 2008 (the &#147;<U>Investors&#146; Rights Agreements</U>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, certain of the Investors are parties to the Series F Stock Purchase Agreement (the &#147;<U>Series F Agreement</U>&#148;) of even
date herewith by and among the Company and such Investors (the &#147;<U>Series F Investors</U>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in order to induce
the Company to enter into the Series F Agreement and to induce the Series F Investors to invest funds in the Company pursuant to the Series F Agreement, the Existing Investors desire to amend and restate the Investors&#146; Rights Agreements by
entering into this Agreement and the Company and the Existing Investors executing this Agreement together represent sufficient signatory authority to amend and restate the Investors&#146; Rights Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW THEREFORE, the parties hereby agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Registration Rights</U>. The Company covenants and agrees as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.1 <U>Definitions</U>. For purposes of this Agreement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The term &#147;<U>Act</U>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The term &#147;<U>Fidelity</U>&#148; means Holders affiliated with Fidelity Management&nbsp;&amp; Research Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) The term &#147;<U>Form S-3</U>&#148; means such form under the Act as in effect on the date hereof or any registration form under the Act
subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The term &#147;<U>Holder</U>&#148; means any person owning or having the right to acquire Registrable Securities or any assignee thereof
in accordance with Section&nbsp;1.12, <U>provided</U> <U>that</U> a Founder shall not be deemed to be a Holder with respect to Founders&#146; Stock (as defined below) only for purposes of Sections&nbsp;1.2 and 1.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) The term &#147;<U>1934 Act</U>&#148; means the Securities Exchange Act of 1934, as amended. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) The term &#147;<U>Qualified IPO</U>&#148; shall mean a firm commitment underwritten public
offering by the Company of shares of its common stock pursuant to a registration statement under the Act, in which at least $15,000,000 is raised by the Company (prior to underwriters&#146; commissions and offering expenses) and following which the
Common Stock is quoted on NASDAQ or the New York Stock Exchange. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) The term &#147;<U>Redmile</U>&#148; means Holders affiliated with
Redmile Group LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) The terms &#147;<U>register</U>,&#148; &#147;<U>registered</U>&#148; and &#147;<U>registration</U>&#148; refer to
a registration effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or document. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The term &#147;<U>Registrable Securities</U>&#148; means (i)&nbsp;the shares of Common Stock issuable or issued upon conversion of the
Series A Preferred Stock, (ii)&nbsp;the shares of Common Stock issuable or issued upon exercise of Warrants issued to certain Holders of Series B Preferred Stock in connection with the issuance and sale of the Series B Preferred Stock,
(iii)&nbsp;the shares of Common Stock issuable or issued upon conversion of the Series B Preferred Stock, (iv)&nbsp;the shares of Common Stock issuable or issued upon conversion of the Series C Preferred Stock, (v)&nbsp;the shares of Common Stock
issuable or issued upon conversion of the Series D Preferred Stock, (vi)&nbsp;the shares of Common Stock issuable or issued upon conversion of the Series E Preferred Stock, (vii)&nbsp;the shares of Common Stock issuable or issued upon conversion of
the Series F Preferred Stock, (viii)&nbsp;any shares of Common Stock acquired by Fidelity or Redmile; (ix)&nbsp;the shares of Common Stock issued to the Founders (the &#147;<U>Founders&#146; Stock</U>&#148;) prior to the date of this Agreement
<U>provided,</U> <U>however</U>, that for the purposes of Sections&nbsp;1.2, 1.4, 2, 3.1 and 4.10, the Founders&#146; Stock shall not be deemed Registrable Securities and the Founders shall not be deemed a Holder, (x)&nbsp;Common Stock issued in
connection with any stock dividend, stock split or other reclassification of Common Stock that is otherwise a Registrable Security hereunder and (xi)&nbsp;any other securities issued by the Company from time to time after the date of this Agreement
that the Company&#146;s Board of Directors determines should be included in the definition of &#147;Registrable Securities,&#148; excluding in all cases, however, any Registrable Securities sold by a person in a transaction in which his rights under
this Section&nbsp;1 are not assigned; provided, however, that shares of Common Stock or other securities then held by any Holder shall not be treated as Registrable Securities for the purposes of any registration if and so long as at the time of
such registration all transfer restrictions and restrictive legends with respect thereto have been or, in the opinion of the Company&#146;s counsel, may be removed, and all the Registrable Securities held by such Holder may be sold without
restriction (including any volume limitations) under Rule 144 under the Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) The number of shares of &#147;<U>Registrable Securities
then outstanding</U>&#148; shall be determined by the number of shares of Common Stock outstanding which are, and the number of shares of Common Stock issuable pursuant to then exercisable or convertible securities which are, Registrable Securities.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) The term &#147;<U>SEC</U>&#148; shall mean the Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) The term &#147;<U>Underwritten Offering</U>&#148; means an offering of Common Stock to the public pursuant to an effective Registration
Statement that is firmly underwritten by a United States nationally recognized underwriter or underwriters that are selected or approved by the Company in accordance with this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.2 <U>Request for Registration</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Subject to the conditions of this Section&nbsp;1.2(a), if the Company shall receive at any time after-the earlier of (i)&nbsp;180 days
following a Qualified IPO or (ii)&nbsp;3 years after May&nbsp;16, 2014, a written request from Holders holding at least 66 2/3% of the Registrable Securities then outstanding (the &#147;<U>Initiating Holders</U>&#148;) that the Company file a
registration statement under the Act covering the registration of at least 25% of the Registrable Securities then outstanding (or a lesser percent if the anticipated aggregate offering price would exceed $25,000,000), then the Company shall, within
10 days after the receipt thereof, give written notice of such request to all Holders and shall, subject to the limitations and pursuant to the provisions of this Section&nbsp;1.2, use reasonable efforts to file a registration statement under the
Act covering all Registrable Securities which the Holders request to be registered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, the Company shall
not be obligated to take any action to effect any such registration pursuant to this Section&nbsp;1.2: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) if the Initiating Holders
propose to dispose of shares of Registrable Securities which may be immediately registered on Form S-3 pursuant to a request made under Section&nbsp;1.4; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) during the period starting with the date 60 days prior to the Company&#146;s good faith estimate of the date of filing of, and ending on
a date 180 days after the effective date of, a registration subject to Section&nbsp;1.3 hereof; provided that the Company is actively employing in good faith all reasonable efforts to cause such registration statement to become effective; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iii) if the Holders shall have initiated two (2)&nbsp;registrations pursuant to this Section&nbsp;1.2, which have been declared or ordered
effective and pursuant to which securities have been sold or have been withdrawn by the Holders other than as a result of a material adverse change to the Company; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iv) if the Company shall furnish to the Holders requesting a registration statement pursuant to this Section&nbsp;1.2, a certificate signed
by the Company&#146;s Chief Executive Officer stating that in the good faith judgment of the Board of Directors of the Company, it would be seriously and materially detrimental to the Company and its stockholders for such registration statement to
be effected at such time, in which event the Company shall have the right to defer such filing for a period not more than 180 days after receipt of the request of the Initiating Holders, provided that such right to delay a request shall be exercised
by the Company not more than once in any 12-month period; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(v) 3 years after a Qualified IPO. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Subject to the provisions of this Agreement, including, but not limited to, the foregoing
Section&nbsp;1.2(b) and Section&nbsp;1.5(a), the Company shall file a registration statement as soon as practicable after receipt of the request or requests of the Initiating Holders under this Section&nbsp;1.2, but in any event within 90 days after
receipt of such request or requests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) If the Initiating Holders intend to distribute the Registrable Securities covered by their
request by means of an Underwritten Offering, they shall so advise the Company as a part of their request made pursuant to this Section&nbsp;1.2 and the Company shall include such information in the written notice referred to in subsection 1.2(a).
The underwriter will be selected by the Initiating Holders and shall be reasonably acceptable to the Company. In such event, the right of any Holder to include his, her or its Registrable Securities in such registration shall be conditioned upon
such Holder&#146;s participation in such underwriting and the inclusion of such Holder&#146;s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority-in-interest of the Initiating Holders and such Holder) to the
extent provided herein. All Holders proposing to distribute their securities through such underwriting shall (together with the Company) enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such
underwriting. Notwithstanding any other provision of this Section&nbsp;1.2, if the managing underwriter advises the Initiating Holders and the Company in writing that marketing factors require a limitation of the number of shares to be underwritten,
then the Company shall so advise all Holders of Registrable Securities which would otherwise be underwritten pursuant hereto, and the number of shares of Registrable Securities that may be included in the underwriting shall be allocated among all
Holders thereof, including the Initiating Holders, in proportion (as nearly as practicable) to the amount of Registrable Securities of the Company owned by each Holder, or in such other proportion as shall mutually be agreed to by all such selling
Holders; provided, however, that the number of Registrable Securities held by the Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the
allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest 100. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Holder does not agree to the terms of any such underwriting, such Holder shall be excluded therefrom by written notice from the Company
or the underwriter. Any Registrable Securities or other securities excluded or withdrawn from such underwriting shall be withdrawn from such registration. If shares are so withdrawn from the registration and the number of shares of Registrable
Securities to be included in such registration was previously reduced as a result of marketing factors, the Company shall then offer to all persons who have retained the right to include securities in the registration the right to include additional
securities in the registration in an aggregate amount equal to the number of shares so withdrawn, with such shares to be allocated among the persons requesting additional inclusion pro rata according to the total amount of securities entitled to be
included in such registration owned by each such person or in such other proportions as shall be mutually agreed by such selling stockholders. For purposes of the preceding sentence concerning apportionment, for any selling stockholder that is a
holder of Registrable Securities and that is a partnership, limited liability company or corporation, the partners, retired partners, members, retired members and shareholders of such holder, or the estates and family members of any such partners,
retired partners, members, retired members and shareholders and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single &#147;selling stockholder,&#148; and any pro-rata reduction with respect to such &#147;selling
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholder&#148; shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals included in such &#147;selling stockholder,&#148; as
defined in this sentence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.3 <U>Company Registration</U>. If (but without any obligation to do so) the Company proposes to register
(including for this purpose a registration effected by the Company for any stockholders) any of its stock or other securities under the Act in connection with the public offering (other than the Company&#146;s initial public offering) of such
securities by the Company solely for cash (other than a registration relating solely to the sale of securities to participants in a Company stock plan or similar benefit plan, or a registration on any form which does not include substantially the
same information as would be required to be included in a registration statement covering the sale of the Registrable Securities or a registration that would not customarily provide for the sale of secondary equity shares for cash, each an
&#147;<U>Exempt Registration</U>&#148;), the Company shall, at such time, promptly give each Holder written notice of such registration. Registrations effected pursuant to Section&nbsp;1.4 hereof shall not require notice to the Holders pursuant to
this Section&nbsp;1.3. Upon the written request of each Holder given within 20 days after such notice is given by the Company in accordance with Section&nbsp;4.8, the Company shall, subject to the provisions of Section&nbsp;1.8, cause to be
registered under the Act all of the Registrable Securities that each such Holder has requested to be registered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.4 <U>Form S-3
Registration</U>. In case the Company shall receive from any Holder or Holders of not less than a majority of the Registrable Securities then outstanding a written request or requests that the Company effect a registration on Form S-3 and any
related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder, the Company will: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) within 10 days give written notice of the proposed registration, and any related qualification or compliance, to all other Holders; and
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) as soon as practicable but in any event within 60 days after such request is given, effect such registration and all such
qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of such portion of such Holder&#146;s or Holders&#146; Registrable Securities as are specified in such request, together with all or
such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within 20 days after effectiveness of such written notice from the Company pursuant to Section&nbsp;4.8;
<U>provided,</U> <U>however</U>, that the Company shall not be obligated to effect any such registration, qualification or compliance pursuant to this Section&nbsp;1.4: (i)&nbsp;if Form S-3 is not available for such offering by the Holders;
(ii)&nbsp;if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at any aggregate price to the public
less than $1,000,000; (iii)&nbsp;if the Company shall furnish to the Holders a certificate signed by the Chief Executive Officer of the Company stating that in the good faith judgment of the Board of Directors of the Company, it would be seriously
detrimental to the Company and its stockholders for such Form S-3 Registration to be effected at such time, in which event the Company shall have the right to defer the filing of the Form S-3 registration statement for a period of not more than 180
days after receipt of the request of the Holder or Holders under this Section&nbsp;1.4; <U>provided</U> that the Company shall not utilize this right more than </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
once in any 12-month period; (iv)&nbsp;if the Company has, within the 12-month period preceding the date of such request, already effected two (2)&nbsp;registrations on Form S-3 for the Holders
pursuant to this Section&nbsp;1.4; (v)&nbsp;in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or
compliance; or (vi)&nbsp;during the period starting with the date 60 days prior to the Company&#146;s good faith estimate of the date of filing of, and ending on a date 180 days after the effective date of, a registration statement subject to
Section&nbsp;1.3 hereof; provided that the Company is actively employing in good faith all reasonable efforts to cause such registration statement to become effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Subject to the foregoing, the Company shall file a registration statement covering the Registrable Securities and other securities so
requested to be registered as soon as practicable after receipt of the request or requests of the Holders. Registrations effected pursuant to this Section&nbsp;1.4 shall not be counted as demands for registration effected pursuant to
Section&nbsp;1.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.5 <U>Obligations of the Company</U>. Whenever required under this Section&nbsp;1 to effect the registration of any
Registrable Securities, the Company shall, as promptly as reasonably possible: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) prepare and file with the SEC a registration
statement with respect to such Registrable Securities and use its best efforts to cause such registration statement to become effective, and, upon the request of the Holders of at least a majority of the Registrable Securities registered thereunder,
keep such registration statement effective for a period of up to 120 days; <U>provided,</U> <U>however</U>, that in the case of any registration of Registrable Securities on Form S-3 that are intended to be offered on a continuous or delayed basis,
subject to compliance with applicable SEC rules, such 120-day period shall be extended for up to 180 days, if necessary, to keep the registration statement effective until all such Registrable Securities are sold; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with
such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement for up to 120 days; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary prospectus, in conformity with the
requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) use its best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue
Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of
process in any such states or jurisdictions, <U>unless</U> the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) in the event of any underwritten public offering, enter into and perform its obligations
under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) notify each Holder of
Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Act of the happening of any event as a result of which the prospectus included in such registration
statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing,
such obligation to continue for 120 days; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) cause all such Registrable Securities registered pursuant to such registration statement
to be listed on each securities exchange and trading system (if any) on which similar securities issued by the Company are then listed; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) provide a transfer agent and registrar for all Registrable Securities registered pursuant to such registration statement and a CUSIP
number for all such Registrable Securities, in each case not later than the effective date of such registration; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) promptly make
available for inspection by the selling Holders all financial and other records, pertinent corporate documents, and properties of the Company reasonably requested by such selling Holder to verify the accuracy of the information in such registration
statement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration
statement has been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) use reasonable efforts to furnish, at the request of any Holder requesting registration of Registrable Securities pursuant to this
Section&nbsp;1, on the date that such Registrable Securities are delivered to the underwriters for sale in connection with a registration pursuant to this Section&nbsp;1, if such securities are being sold through underwriters, or, if such securities
are not being sold through underwriters, on the date that the registration statement with respect to such securities becomes effective, (i)&nbsp;an opinion, dated such date, of the counsel representing the Company for the purposes of such
registration, in form and substance as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities and (ii)&nbsp;a letter dated
such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters,
if any, and to the Holders requesting registration of Registrable Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.6 <U>Furnish Information</U>. It shall be a condition
precedent to the obligations of the Company to take any action pursuant to this Section&nbsp;1 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding such Holder, the
Registrable Securities held by such Holder, and the intended method of disposition of such securities as shall be required to effect the registration of such Holder&#146;s Registrable Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.7 <U>Expenses of Company Registration</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Demand Registration</U>. All expenses other than underwriting discounts and commissions incurred in connection with registrations,
filings or qualifications pursuant to Sections 1.2 or 1.4, including (without limitation) all registration, filing and qualification fees, printers&#146; and accounting fees, fees and disbursements of counsel for the Company shall be borne by the
Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section&nbsp;1.2 if the registration request is subsequently withdrawn at the request of the Holders of a
majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be requested in the withdrawn registration), unless the
Holders of a majority of the Registrable Securities then outstanding agree to forfeit their right to one (1)&nbsp;demand registration pursuant to Section&nbsp;1.2; provided, further, however, that if at the time of such withdrawal, the Holders have
learned of a material adverse change in the condition, business or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness following disclosure by the Company of
such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section&nbsp;1.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Company Registration</U>. The Company shall bear all expenses other than underwriting discounts and commissions incurred in connection
with registrations, filings or qualifications of Registrable Securities pursuant to Section&nbsp;1.3 for each Holder (which right may be assigned as provided in Section&nbsp;1.12), including (without limitation) all registration, filing and
qualification fees, printers&#146; and accounting fees, fees and disbursements of counsel for the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Registration on Form
S-3</U>. The Company shall bear all expenses incurred in connection with a registration requested pursuant to Section&nbsp;1.4, including (without limitation) all registration, filing, qualification, printers&#146; and accounting fees, but excluding
any underwriters&#146; discounts or commissions associated with Registrable Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.8 <U>Underwriting Requirements</U>. In
connection with any offering involving an underwriting of shares of the Company&#146;s capital stock, the Company shall not be required under Section&nbsp;1.3 to include any of the Holders&#146; securities in such underwriting unless they accept the
terms of the underwriting as agreed upon between the Company and the underwriters selected by it (or by other persons entitled to select the underwriters), and then only in such quantity as the underwriters determine in their sole discretion will
not jeopardize the success of the offering by the Company. If the total amount of securities, including Registrable Securities, requested by stockholders to be included in such offering exceeds the amount of securities sold other than by the Company
that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the
underwriters determine in their sole discretion will not jeopardize the success of the offering (the securities so included to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be apportioned pro rata among the selling stockholders according to the total amount of securities entitled to be included therein owned by each selling stockholder or in such other proportions
as shall mutually be agreed to by such selling stockholders) but in no event shall the amount of securities of the selling Holders included in the offering be reduced below 30% of the total amount of securities included in such offering, unless such
offering is the initial public offering of the Company&#146;s securities, in which case, the selling stockholders may be excluded if the underwriters make the determination described above and no other stockholder&#146;s securities are included. For
purposes of the preceding parenthetical concerning apportionment, for any selling stockholder that is a holder of Registrable Securities and which is a partnership or corporation, the partners, retired partners and stockholders of such holder, or
the estates and family members of any such partners and retired partners and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single &#147;selling stockholder,&#148; and any pro-rata reduction with respect to such
&#147;selling stockholder&#148; shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals included in such &#147;selling stockholder,&#148; as defined in this sentence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any Holder does not agree to the terms of any such underwriting, the Holder shall be excluded therefrom by written notice from the Company
or the underwriter. Any Registrable Securities or other securities excluded or withdrawn from such underwriting shall be withdrawn from such registration. If shares are so withdrawn from the registration and if the number of shares of Registrable
Securities to be included in such registration was previously reduced as a result of marketing factors, the Company shall then offer to all persons who have retained the right to include securities in the registration the right to include additional
securities in the registration in an aggregate amount equal to the number of shares so withdrawn, with such shares to be allocated among the persons requesting additional inclusion pro rata according to the total amount of securities entitled to be
included in such registration owned by each such person or in such other proportions as shall be mutually agreed by such selling stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.9 <U>Delay of Registration</U>. No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such
registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section&nbsp;1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.10 <U>Indemnification</U>. In the event any Registrable Securities are included in a registration statement under this Section&nbsp;1: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, any underwriter (as defined in the Act) for
such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Act or the 1934 Act, against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Act, the
1934 Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a
&#147;<U>Violation</U>&#148;): (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or
supplements thereto, (ii)&nbsp;the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii)&nbsp;any violation or alleged violation by the
Company of the Act, the 1934 Act, any state securities law </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or any rule or regulation promulgated under the Act, the 1934 Act or any state securities law; and the Company will pay to each such Holder, underwriter or controlling person, as incurred, any
legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in this subsection 1.10(a) shall not apply
to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case
for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such
registration by any such Holder, underwriter or controlling person of such Holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) To the extent permitted by law, each selling
Holder will indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, any underwriter, any other
Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons may become
subject, under the Act, the 1934 Act or other federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the
extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration: and each such Holder will pay, as incurred, any legal or other expenses
reasonably incurred by any person intended to be indemnified pursuant to this subsection 1.10(b), in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement
contained in this subsection 1.10(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably
withheld; provided that in no event shall any indemnity under this subsection 1.10(b) exceed the net proceeds from the offering received by such Holder, except in the case of willful fraud by such Holder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) Promptly after receipt by an indemnified party under this Section&nbsp;1.10 of notice of the commencement of any action (including any
governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section&nbsp;1.10, deliver to the indemnifying party a written notice of the commencement thereof and the
indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the
parties; provided, however, that an indemnified party (together with all other indemnified parties which may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the reasonable fees and expenses
to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other
party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve
such indemnifying party of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
liability to the indemnified party under this Section&nbsp;1.10, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to
any indemnified party otherwise than under this Section&nbsp;1.10. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) If the indemnification provided for in this Section&nbsp;1.10 is
held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to therein, then the indemnifying party, in lieu of indemnifying such indemnified party
hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one
hand and of the indemnified party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense as well as any other relevant equitable considerations. The relative fault of the
indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by
the indemnifying party or by the indemnified party and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) The obligations of the Company and Holders under this Section&nbsp;1.10 shall survive the completion of any offering of Registrable
Securities in a registration statement under this Section&nbsp;1, and otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.11 <U>Reports Under Securities Exchange Act of
1934</U>. With a view to making available to the Holders the benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without
registration or pursuant to a registration on Form S-3, the Company shall: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) make and keep adequate current public information
available, as those terms are understood and defined in SEC Rule 144, at all times after the effective date of the first registration statement filed by the Company for the offering of its securities to the general public; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) take such action, including the voluntary registration of its Common Stock under Section&nbsp;12 of the Exchange Act, as is necessary to
enable the Holders to utilize Form S-3 for the sale of their Registrable Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the first registration statement filed by the Company for the offering of
its securities to the general public is declared effective; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) file with the SEC in a timely manner all reports and other documents
required of the Company under the Act and the 1934 Act; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) furnish to any Holder, so long as the Holder owns any Registrable
Securities, forthwith upon request (i)&nbsp;a written statement by the Company that it has complied </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with the reporting requirements of SEC Rule 144, or that it qualifies as a registrant whose securities may be resold pursuant to <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (at any time
after it so qualifies), (ii)&nbsp;a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii)&nbsp;such other information as may be reasonably requested in availing any
Holder of any rule or regulation of the SEC which permits the selling of any such securities without registration or pursuant to such form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.12 <U>Assignment of Registration Rights</U>. The rights to cause the Company to register Registrable Securities pursuant to this
Section&nbsp;1 may be assigned to a transferee or assignee (other than a competitor of the Company, as determined in the good faith discretion of the Board of Directors of the Company) who acquires at least a majority of the shares held by a Holder
(or, in the case of Fidelity or Redmile, any shares held by such Holder), <U>provided</U> <U>that</U>: (a)&nbsp;the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee or
assignee and the securities with respect to which such registration rights are being assigned; (b)&nbsp;such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) such assignment shall be effective only if immediately following such transfer the further disposition of such securities by the
transferee or assignee is restricted under the Act; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) transfer of registration rights to a limited or general partner of any
Holder that is a partnership will be without restriction as to minimum shareholding. For the purposes of determining the number of shares of Registrable Securities held by a transferee or assignee, the holdings of transferees and assignees of a
partnership or limited liability company who are partners or retired partners of such partnership or members or retired members of such limited liability company (including spouses and ancestors, lineal descendants and siblings of such partners,
members or spouses who acquire Registrable Securities by gift will or intestate succession) shall be aggregated together and with the partnership or limited liability company; provided that all assignees and transferees who would not qualify
individually for assignment of registration rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices or taking any action under this Section&nbsp;1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.13 <U>Market-Standoff Agreement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Market-Standoff</U>. In connection with the initial public offering of the Company&#146;s securities and upon request of the Company
or the underwriters managing such offering of the Company&#146;s securities, each Holder agrees not to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any Registrable Securities of the Company held
immediately prior to the Company&#146;s initial public offering (other than those included in the registration) without the prior written consent of the Company or such underwriters, as the case may be, for such period of time from the effective
date of such registration as may be requested by the Company or such managing underwriters (such period not to exceed 180 days) and to execute an agreement reflecting the foregoing as may be requested by the underwriters at the time of the
Company&#146;s initial public offering. The Company agrees to use its reasonable efforts to obtain the agreement of the managing underwriter to periodic early releases of portions of the securities subject to such lock-up agreements upon the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
request of a Holder to such early release, provided that in the event of any early release, all Holders will be released on a pro rata basis from such agreements. Any discretionary waiver or
termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all Holders subject to such agreements, based on the number of shares subject to such agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Limitations</U>. The foregoing provisions of this Section&nbsp;1.13 shall apply only to the initial public offering of the
Company&#146;s securities, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall be applicable to the Holders only if all officers, directors, and stockholders individually owning more than 2%
of the Company&#146;s outstanding Common Stock (after giving effect to conversion into Common Stock of all outstanding Preferred Stock) are subject to the same restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Stop-Transfer Instructions</U>. In order to enforce the foregoing covenants, the Company may impose stop-transfer instructions with
respect to the securities of each Holder (and the securities of every other person subject to the restrictions in Section&nbsp;1.13(a)) until the end of such period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Transferees Bound</U>. Each Holder agrees that it will not transfer securities of the Company unless each transferee agrees in writing
to be bound by all of the provisions of this Section&nbsp;1.13, provided that this Section&nbsp;1.13(d) shall not apply to transfers pursuant to a registration statement or transfers after the six-month anniversary of the effective date of the
Company&#146;s initial registration statement subject to this Section&nbsp;1.13. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.14 <U>Termination of Registration Rights</U>. No
Holder shall be entitled to exercise any right provided for in this Section&nbsp;1 after the earlier of (i)&nbsp;3 years after a Qualified IPO or (ii)&nbsp;such time as Rule 144 or a similar exemption under the Act is available for the sale of all
of such Holder&#146;s shares during a 90-day period. The Registrable Securities held by such holder immediately prior to such date shall cease to be Registrable Securities on such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.15 <U>Registration of Common Stock</U>. For purposes of Section&nbsp;1 of this Agreement, the only securities which the Company shall be
required to register pursuant hereto shall be shares of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Co-Sale Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.1 <U>Co-Sale Right</U>. Should a Founder (or a Permitted Transferee, as defined in Section&nbsp;2.4 below) propose to accept one or more
bona fide offers (collectively, a &#147;<U>Purchase Offer</U>&#148;) from any person or persons to purchase shares of the Company&#146;s Common Stock now or hereafter owned or held by such Founder (the &#147;<U>Shares</U>&#148;) from such Founder
(other than as set forth in Section&nbsp;2.4 of this Agreement), such Founder (the &#147;<U>Selling Founder</U>&#148;) shall promptly deliver a notice (the &#147;<U>Notice</U>&#148;) to the Company and the Investors stating the terms and conditions
of such Purchase Offer including, without limitation, the number of Shares proposed to be sold or transferred, the nature of such sale or transfer, the consideration to be paid and the name and address of each prospective purchaser or transferee.
The Notice shall certify that the Selling Founder has received a firm offer from the prospective transferee(s) and in good faith believes a binding agreement for the transfer is obtainable on the terms set forth in the Notice. The Notice
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall also include a copy of any written proposal, term sheet, letter of intent or other agreement relating to the proposed transfer. The Investors shall have the right (the &#147;<U>Co-Sale
Right</U>&#148;), exercisable upon written notice to the Company within 10 business days after receipt of the Notice, to participate in such sale on the terms and conditions specified in the Purchase Offer. To the extent an Investor exercises its
Co-Sale Right in accordance with the terms and conditions set forth below, the number of Shares that the Selling Founder may sell pursuant to such Purchase Offer shall be correspondingly reduced. The Co-Sale Right of each Investor shall be subject
to the following terms and conditions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Each Investor may sell all or any part of that number of shares of Capital Stock (as defined
in Section&nbsp;3.1 below) equal to the product obtained by multiplying (i)&nbsp;the aggregate number of shares of Capital Stock covered by the Purchase Offer by (ii)&nbsp;a fraction, the numerator of which is the number of shares of Capital Stock
at the time owned by the Investor and the denominator of which is the sum of (A)&nbsp;the total number of shares of Capital Stock at the time owned by all Investors participating in such sale plus (B)&nbsp;the total number of shares of Capital Stock
at the time owned by the Selling Founder, including shares transferred by such Founder to Permitted Transferees in accordance with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) Each Investor may effect its participation in the sale by delivering to the Selling Founder for transfer to the prospective purchaser one
or more certificates, properly endorsed for transfer, which represent the Conversion Shares that the Investor elects to sell. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.2
<U>Transfer</U>. The stock certificate or certificates that the Investors deliver to the Selling Founder pursuant to Section&nbsp;2.1 shall be delivered by such Selling Founder to the prospective purchaser in consummation of the sale pursuant to the
terms and conditions specified in the Notice, and the Selling Founder shall promptly thereafter remit to the Investors that portion of the sale proceeds to which such Investor is entitled by reason of its participation in such sale. To the extent
that any prospective purchaser or purchasers prohibits such assignment or otherwise refuses to purchase Conversion Shares from such Investor&#146;s exercise of its Co-Sale Right hereunder, the Selling Founder shall not sell to such prospective
purchaser or purchasers any Shares unless and until, simultaneously with such sale, the Selling Founder shall purchase such Conversion Shares from such Investor for the same consideration and on the same terms and conditions as the proposed transfer
described in the Notice (which terms and conditions shall be no less favorable than those governing the sale to the purchaser by the Selling Founder). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.3 <U>Non-Exercise of Rights</U>. To the extent that the Company, the other Founders and the Investors have not exercised their Co-Sale Right
within the time period specified in Section&nbsp;2.1, the Selling Founder shall have a period of 90 days from the expiration of such rights in which to sell the Shares upon terms and conditions (including the purchase price) no more favorable than
those specified in the Notice to the third-party transferees(s) identified in the Notice. The third-party transferees(s) shall acquire the Shares free and clear of subsequent rights of co-sale under this Agreement. In the event the Selling Founder
does not consummate the sale or disposition of the Shares within the 90-day period from the expiration of these rights, the Company&#146;s and the Investors&#146; co-sale right shall continue to be applicable to any subsequent disposition of the
Shares by such Selling Founder until such right lapses in accordance with the terms of this Agreement. Furthermore, the exercise or non-exercise of the rights of the Company, the other Founders and the Investors under this Section&nbsp;2.3 to
participate in the sale of Shares by the Selling Founder shall not adversely affect the Investors&#146; rights to participate in subsequent sales of Shares by such Selling Founder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.4 <U>Permitted Transactions</U>. The provisions of Section&nbsp;2 of this Agreement shall not
pertain or apply to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) any repurchase of Common Stock by the Company at a price no greater than that originally paid for such Common
Stock and pursuant to an agreement containing vesting and/or repurchase provisions approved by a majority of the Board; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) any transfer
made for bona fide estate planning purposes by a Founder, either during his or her lifetime or on death by will or intestacy to his or her spouse, child (natural or adopted), or any other direct lineal descendant <U>provided</U>, <U>that</U>
(i)&nbsp;the Founder shall inform the Investors of such pledge, transfer or gift and (ii)&nbsp;the pledgee transferee, donee or purchaser (each a &#147;<U>Permitted Transferee</U>&#148;) shall furnish the Investors with a written agreement that
binds such Permitted Transferee to comply with all provisions of this Agreement applicable to such selling Founder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) any pledge of
Common Stock made by a Founder pursuant to a bona fide loan transaction which creates a mere security interest; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) any sale or transfer
of Common Stock by a Founder which does not, in the aggregate, exceed 25% of the Common Stock initially subject to this Agreement held by such Founder; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) any sale or transfer of Common Stock among the Founders, provided, in each case, that (i)&nbsp;the Selling Founder shall inform the
Investors of such pledge, transfer or gift prior to effecting it and (ii)&nbsp;the Permitted Transferee shall furnish the Investors with a written agreement that binds such Permitted Transferee to comply with all provisions of this Agreement
applicable to such selling Founder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.5 <U>Assignment of Rights</U>. The rights of the Investors set forth in this Section&nbsp;2 may be
assigned (but only with all related obligations) by the Investors to (i)&nbsp;a transferee or assignee that is a current or former constituent partner, affiliate or member of such Investor, (ii)&nbsp;an entity controlling, controlled by or under
common control with such Investor, including without limitation, a corporation or limited liability company that is a parent or wholly-owned subsidiary of such Investor, or (iii)&nbsp;a transferee or assignee of at least a majority of an
Investor&#146;s Conversion Shares set forth in <U>Exhibit A</U> (as may be updated from time to time). Within a reasonable time after such transfer, the Investor shall furnish the Company written notice of the name and address of such transferee or
assignee, and provide the Company with written acceptance from such transferee whereby the transferee agrees to be bound by the provisions of this Agreement. Any assignment of rights under this Section&nbsp;2.5 is subject to the further condition
that the transferee is not an actual or potential competitor of the Company, to be determined in good faith by the Company&#146;s Board of Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.6 <U>Prohibited Transfers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) In the event a Founder should sell any Shares in contravention of the Co-Sale Right (a &#147;<U>Prohibited Transfer</U>&#148;), the
Investors, in addition to such other remedies as may be available at law, in equity or hereunder, shall have the put option provided below, and such Founder (the &#147;<U>Violating Founder</U>&#148;) shall be bound by the applicable provisions of
such put option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) In the event of a Prohibited Transfer, each Investor shall have the right to sell to the Violating Founder a number
of Conversion Shares equal to the number of Conversion Shares such Investor would have been entitled to transfer to the third-party transferee(s) under Section&nbsp;2.1 hereof had the Prohibited Transfer been effected pursuant to and in compliance
with the terms hereof. Such sale shall be made on the following terms and conditions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) the price per share at which the shares are to
be sold to the Violating Founder shall be equal to the price per share paid by the third-party transferee(s) to such Founder in the Prohibited Transfer. The Violating Founder shall also reimburse each Investor for any and all reasonable fees and
expenses, including reasonable legal fees and expenses, incurred pursuant to the exercise or the attempted exercise of the Investor&#146;s right under Section&nbsp;2.1 and this Section&nbsp;2.6; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) within 30 days after the later of the dates on which the Investor (A)&nbsp;received notice of the Prohibited Transfer or
(B)&nbsp;otherwise became aware of the Prohibited Transfer, each Investor shall, if exercising the option created hereby, deliver to the Violating Founder the certificate or certificates representing shares to be sold, each certificate to be
properly endorsed for transfer; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iii) the Violating Founder shall, upon receipt of the certificate or certificates for the shares to
be sold by an Investor pursuant to this Section&nbsp;2.6, pay the aggregate purchase price therefor and the amount of reimbursable fees and expenses, as specified in Section&nbsp;2.6(b)(i) above, in cash or by other means acceptable to the Investor.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, any attempt by the Violating Founder to transfer Shares in violation of Section&nbsp;2 hereof shall be void and the
Company agrees it will not effect such a transfer nor will it treat any alleged transferees(s) as the owner of such shares without the written consent of the Investors in accordance with Section&nbsp;4.10 of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Covenants of the Company</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3.1 <U>Right of First Offer</U>. Subject to the terms and conditions specified in this Section&nbsp;3.1, the Company hereby grants to each
Investor a right of first offer with respect to future sales by the Company of its Shares (as hereinafter defined). For the avoidance of doubt and for purposes of this Section&nbsp;3.1, a Founder shall be considered an Investor only with respect to
the Preferred Stock, as applicable, held by him, her or it, and his, her or its pro rata share (in Section&nbsp;3.1(b) below) shall be calculated based exclusively on the shares of Preferred Stock, as applicable, then held by him, her or it. An
Investor who chooses to exercise the right of first offer may designate as purchasers under such right a current or former constituent partner, affiliate or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
member of itself or an entity controlling, controlled by or under common control with itself, including without limitation a corporation or limited liability company that is a parent or
subsidiary, in such proportions as it deems appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each time the Company proposes to offer any shares of, or securities convertible
into or exercisable for any shares of, any class of its capital stock (&#147;<U>Capital Stock</U>&#148;), the Company shall first make an offering of such Capital Stock to each Investor in accordance with the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company shall deliver a notice (&#147;<U>Offer Notice</U>&#148;) to the Investors stating (i)&nbsp;its bona fide intention to offer
such Shares, (ii)&nbsp;the number and type of such Shares to be offered, and (iii)&nbsp;the price and terms, if any, upon which it proposes to offer such Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) By notification to the Company within 10 days after delivery of the Offer Notice, the Investor may elect to purchase or obtain, at the
price and on the terms specified in the Offer Notice, up to that portion of such Shares which equals the proportion that the number of shares of Common Stock issued and held, or issuable upon conversion and exercise of all convertible or exercisable
securities then held, by such Investor bears to the fully diluted total number of shares of Common Stock then outstanding (assuming full conversion and exercise of all outstanding convertible or exercisable securities). Such purchase shall be
completed at the same closing as that of any third party purchasers or at an additional closing thereunder subject to any applicable regulatory requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) At the expiration of such twenty (20)&nbsp;day period, the Company shall promptly notify each Investor that elects to purchase or acquire
all the shares available to it (each, a &#147;<U>Fully Exercising Investor</U>&#148;) of any other Investor&#146;s failure to do likewise. During the ten (10)&nbsp;day period commencing after the Company has given such notice, each Fully Exercising
Investor may, by giving notice to the Company, elect to purchase or acquire, in addition to the number of shares specified above, up to that portion of the Shares for which Investors were entitled to subscribe but that were not subscribed for by the
Investors, which is equal to the proportion that the number of shares of Common Stock issued and held, or issuable upon conversion and exercise of all convertible or exercisable securities then held, by such Investor bears to the fully diluted total
number of shares of Common Stock then outstanding (assuming full conversion and exercise of all outstanding convertible or exercisable securities) then held, by all Fully Exercising Investors who wish to purchase such unsubscribed shares. The
closing of any sale pursuant to this Section&nbsp;3.1(c) shall occur within the later of 120 days of the date that the Offer Notice is given and the date of initial sale of the Shares pursuant to Section&nbsp;3.1(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The Company may, during the 45-day period following the expiration of the period provided in subsection 3.1(c) hereof, offer the
remaining unsubscribed portion of the Shares to any person or persons at a price not less than, and upon terms no more favorable to the offeree than those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of
the Shares within such period, or if such agreement is not consummated within thirty (30)&nbsp;days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be offered unless first reoffered to
the Investors in accordance with this Section&nbsp;3.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) The right of first offer in this Section&nbsp;3.1 shall not be applicable to
(i)&nbsp;Excluded Stock (as defined in the Company&#146;s Certificate of Incorporation), and (ii)&nbsp;shares of Common Stock issued in the Qualified IPO. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3.2 <U>Information Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The Company shall deliver the following financial information to the Series F Investors at the times herein set forth: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) as soon as practicable but in any event within 60 days after the end of each of the first three (3)&nbsp;quarters of each fiscal year of
the Company, unaudited statements of income and of cash flows for such fiscal quarter, and an unaudited balance sheet and a statement of stockholders&#146; equity as of the end of such fiscal quarter, all prepared in accordance with GAAP (except
that such financial statements may (i)&nbsp;be subject to normal year-end audit adjustments and (ii)&nbsp;not contain all notes thereto that may be required in accordance with GAAP); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) as soon as practicable, but in any event within 180 days after the end of each fiscal year of the Company (i)&nbsp;a balance sheet as of
the end of such year, (ii)&nbsp;statements of income and of cash flows for such year, and (iii)&nbsp;a statement of stockholders&#146; equity as of the end of such year, all such financial statements audited and certified by independent public
accountants of nationally or regionally recognized standing selected by the Company and approved by the Board of Directors; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iii) such
other information relating to the financial condition, business, prospects, or corporate affairs of the Company as any Series F Investor may from time to time reasonably request; <U>provided,</U> <U>however</U>, that the Company shall not be
obligated under this Section&nbsp;3.2 to provide information (i)&nbsp;that the Company reasonably determines in good faith to be a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in form
acceptable to the Company) or (ii)&nbsp;the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iv) if, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such
period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Inspection</U>. The Company shall permit each Series F Investor, at such Investor&#146;s expense, to visit and inspect the
Company&#146;s properties; examine its books of account and records; and discuss the Company&#146;s affairs, finances, and accounts with its officers, during normal business hours of the Company as may be reasonably requested by the Investor;
<U>provided,</U> <U>however</U>, that the Company shall not be obligated pursuant to this Section&nbsp;3.2 to provide access to any information that it reasonably considers to be a trade secret or confidential information (unless covered by an
enforceable confidentiality agreement, in form acceptable to the Company) or the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Confidentiality</U>. Any Series F Investor who receives any information pursuant to Section&nbsp;3.2(a) shall, and shall direct any
person who receives any information pursuant to Section&nbsp;3.2(a) to, maintain the confidentiality of any information to delivered to it except as otherwise required by applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.1 <U>Termination of Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) The covenants set forth in Sections 2 and 3 shall terminate as to each Investor and be of no further force or effect (i)&nbsp;immediately
prior to the consummation of a Qualified IPO, or (ii)&nbsp;upon termination of the entire Agreement as provided in Section&nbsp;4.16. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The covenants set forth in Section&nbsp;2 shall terminate as to each Holder and be of no further force or effect when the Company first
becomes subject to the periodic reporting requirements of Sections 13 or 15(d) of the Exchange Act, if this occurs earlier than the events described in Section&nbsp;4.1(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.2 <U>Restrictive Legend</U>. Each certificate representing Common Stock shall, except as otherwise provided in Section&nbsp;4.3, be stamped
or otherwise imprinted with a legend substantially in the following form: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933 OR ANY STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS IT HAS BEEN REGISTERED UNDER SUCH ACT AND ALL SUCH OTHER APPLICABLE LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A certificate shall not bear such legend if in the opinion of counsel satisfactory to the Company the securities being sold thereby may be publicly sold
without registration under the Act and any applicable state securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.3 <U>Notice of Proposed Transfer</U>. Prior to any
proposed transfer of any Common Stock, the holder thereof shall give written notice to the Company of his or her intention to effect such transfer. Each such notice shall describe the manner of the proposed transfer and, if reasonably requested by
the Company, shall be accompanied by an opinion of counsel satisfactory to the Company to the effect that the proposed transfer may be effected without registration under the Act and any applicable state securities laws, whereupon the holder of such
stock shall be entitled to transfer such stock in accordance with the terms of the notice; provided, however, that no such opinion of counsel shall be required for a transfer to one or more partners or members of the transferor (in the case of a
transferor that is a partnership or limited liability company) or to an affiliated corporation (in the case of a transferor that is a corporation). Each certificate for Common Stock transferred as above provided shall bear the legend set forth in
Section&nbsp;4.2, except that such certificate shall not bear such legend if (i)&nbsp;such transfer is in accordance with the provisions of Rule 144 (or any other rule permitting public sale without registration under the Act) or (ii)&nbsp;the
opinion of counsel referred to above is to the further effect that the transferee and any subsequent transferee (other than an affiliate of the Company) would be entitled to transfer such securities in a public sale without registration under the
Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Promptly after effecting any such transfer, the Holder shall give written notice to the Company of the number of shares transferred. The restrictions provided for in this Section&nbsp;4.3 shall
not apply to securities which are not required to bear the legend prescribed by Section&nbsp;4.2 in accordance with the provisions of that Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.4 <U>Successors and Assigns</U>. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit
of and be binding upon the respective successors and assigns of the parties (including transferees of any shares of Registrable Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.5 <U>Governing Law</U>. This Agreement shall be governed by and construed and interpreted in accordance with the laws of the State of
Delaware, without regard to that state&#146;s conflict of laws principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.6 <U>Counterparts</U>. This Agreement may be executed in any
number of counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.7 <U>Titles and Subtitles</U>. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.8 <U>Notices</U>. Any notice, consent, authorization or other communication to be given
hereunder shall be in writing and shall be deemed duly given and received when delivered personally or transmitted by facsimile transmission with receipt acknowledged by the addressee or three days after being mailed by first class mail, or the next
business day after being deposited for next-day delivery with a nationally recognized overnight delivery service, charges and postage prepaid, properly addressed to the party to receive such notice at the following address for such pony (or at such
other address as shall be specified by like notice): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) If to the Company, to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="71%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;Penumbra, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;1351 Harbor Bay Parkway</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;Alameda, CA 94502</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Attention:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Telephone:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;(510) 748-3200</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Facsimile:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;(510) 814-8303</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="71%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;with copies to:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;Shartsis Friese LLP</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;One Maritime Plaza, 18<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;San Francisco, CA 94111</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Attention:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;Derek H. Wilson</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Telephone:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;(415) 421-6500</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Facsimile:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;(415) 421-2922</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;with copies to:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;Shearman&nbsp;&amp; Sterling LLP</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;599 Lexington Avenue</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;New York, NY 10022</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Attention:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;Robert Katz</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Telephone:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;(212) 848-8008</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;Facsimile:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;(646) 848-8008</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) if to the Investors, to the addresses on file with the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise provided, any notice required or permitted under this Agreement shall be given in writing and shall be deemed effectively given upon personal
delivery to the party to be notified or upon deposit with the United States Post Office, by registered or certified mail, postage prepaid and addressed to the party to be notified at the address indicated for such part on the signature page hereof,
or at such other address as such party may designate by 10 days&#146; advance written notice to the other parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.9 <U>Expenses</U>.
If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys&#146; fees, costs and necessary disbursements in addition to any other relief to which
such party may be entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.10 <U>Amendments and Waivers</U>. Any term of this Agreement may be amended and the observance of any term
of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the holders of at least a majority of the Registrable Securities then
outstanding, or in the case of waiver, by the holders of at least a majority of the Registrable Securities entitled to exercise the right being waived. Any amendment or waiver effected in accordance with this Section shall be binding upon each
holder of any Registrable Securities then outstanding, each future holder of all such Registrable Securities, and the Company. Notwithstanding the foregoing, Sections 1.13, 2.1, 3.1 and 3.2 and this sentence of this Section&nbsp;4.10 may not be
amended to reduce or terminate the rights of Fidelity or Redmile or their affiliates thereunder, and the observance of any term of Section&nbsp;3.2 may not be waived with respect to Fidelity or Redmile or their respective affiliates, in each case,
without the prior written consent of Fidelity or Redmile, as applicable; and provided further that any provision hereof may be waived by any waiving party on such party&#146;s own behalf, without the consent of any other party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.11 <U>Severability</U>. If any provision of this Agreement, or the application of such
provision to any person or circumstance, shall be held invalid or unenforceable, the remainder of this Agreement, or the application of such provision to persons or circumstances other than those to which it is held to be invalid or unenforceable,
shall not be affected thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.12 <U>Aggregation of Stock</U>. All shares of Registrable Securities held or acquired by affiliated
entities or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.13
<U>Entire Agreement</U>. This Agreement contains the entire agreement of the parties and supersede all prior negotiations, correspondence, agreements and understandings, written and oral, between or among the parties, regarding the subject matter
hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.14 <U>Further Assurances</U>. Each party shall execute such other and further certificates, instruments and other documents as
may be necessary and proper to implement, complete and perfect the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.15
<U>Interpretation</U>. All parties have been assisted by counsel in the preparation and negotiation of this Agreement and the transactions contemplated hereby, and this Agreement shall be construed according to its fair language. The rule of
construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.16 <U>Termination</U>. This Agreement shall terminate in its entirety 3 years after a Qualified IPO. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF. the parties have executed this Agreement as of the date first above written.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="68%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">COMPANY:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">PENUMBRA. INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert D. Evans</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Robert D. Evans</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Executive Vice President, General Counsel and Secretary</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FOUNDERS:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Adam Elsesser</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-bottom:1pt; margin-top:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Arani Bose</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="73%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FOUNDERS:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Adam Elsesser</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Arani Bose</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Arani Bose</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Fourth
Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Philip J. Arnautou</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Arnautou Family 1996 Trust dated 2/27/96</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Philip J. Arnautou</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,312 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">14,792 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Arani Bose &nbsp;&nbsp;&nbsp;&nbsp;/s/ Shumita Bose</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Arani&nbsp;&amp; Shumita Bose</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,471 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 10</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ann E. Carmel</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Ann Carmel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">45,937 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 19</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ann E. Carmel</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Trust l/11/65 FBO Ann E. Carmel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Ann E. Carmel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">beneficiary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">47,022 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">29,585 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">12,487 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 19</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nicolas Cazaux</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Nicolas Cazaux</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9.000 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>13/05/2014</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">/s/ James L. Cederholm</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jean Pray Cederholm</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">James L.&nbsp;&amp; Jean Pray Cederholm</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">12,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13th</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John David Chin</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">John David Chin and Carole Lam-Chin</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">John David Chin</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,289 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 17</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Smita Conjeevaram</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Smita Conjeevaram</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">146,285 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Smita Conjeevaram</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TD Ameritrade Clearing Custodian FBO Smita Conjeevaram</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Smita Conjeevaram</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">76,923 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Srini Conjeevaram</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">TD Ameritrade Clearing Custodian FBO Srini Conjeevaram</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Srini Conjeevaram</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">90,729 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Srini Conjeevaram</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">SC Capital (P), LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Srini Conjeevaram</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Managing Director, SC Capital (P), LP General Partner</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">838,264 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">197,368 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Shilpa Ghatalia</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Shilpa Ghatalia</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,420 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,420 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Alain Cornil</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Alain Cornil</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,000 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May, 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steven M. Cramer</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MLPF&amp;S Custodian FBO Steven M. Cramer RRA</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Steven M. Cramer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,350 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,962 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">29,781 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/19</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stanley Dahlin</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Stanley Dahlin</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">30,625 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,837 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">11,834 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,947 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>14 May</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sherman Little</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The Dante Cianciarulo Irrevocable Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Sherman Little</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">31,348 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,579 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12/14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel Davis</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel Davis</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">301 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">7,895 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">248 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>13 May</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael DeFilippo</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael DeFilippo</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2,000 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>10 May</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Diana Michener</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Diana Michener</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">78,370 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James L. Dine</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">James L. Dine</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">78,370 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">256,410 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">131,579 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David B. Dollinger</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Dollinger Harbor Bay Associates</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">David B. Dollinger</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">General Partner</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">32,895 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Siegel/Elsesser Revocable Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Adam Elsesser</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,471 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael A. Evans</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Michael A. Evans</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">12,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,837 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,972 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,289 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert D. Evans&nbsp;&nbsp;&nbsp;&nbsp;/s/ Norma J. Evans</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The 2010 Robert D. Evans and Norma J. Evans</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Revocable Trust u/d/t dated November&nbsp;11, 2010</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Robert D. Evans</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">45,937 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">47,022 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">27,041 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>9&nbsp;May</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert L. Feldman</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Feldman Interests, Ltd.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Robert L. Feldman</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">General Partner</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">235,110 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel Feldman</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Daniel Feldman</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">15,789 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"><U>May 15</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel Feldman</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Feldman Med Investments LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Daniel E. Feldman</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">47,022 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;15</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Weylin Fong</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Weylin Fong and Betty Fong Family</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Revocable Trust of 2001</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Weylin Fong</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">61,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">47,022 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">19,723 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">19,737 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Andrew Friedman</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Andrew&nbsp;&amp; Cynthia Friedman</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">24,500 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;17</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Andrew Friedman, Trustee</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Cynthia&nbsp;&amp; Andrew Friedman 1995 Revocable Trust (12/96)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Andrew Friedman</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">29,781&nbsp;Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,903&nbsp;Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,895&nbsp;Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 17</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Holger Friedrich</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Holger Friedrich</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,125 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 16th</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Rosemary Garcia</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Rosemary Garcia</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,125&nbsp;Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,135&nbsp;Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,316&nbsp;Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edward E. Grammens</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">National Financial Services LLC CUST FBO</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Edward E. Grammens SEP IRA</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">104,125&nbsp;Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edward E. Grammens</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Prudential Investment Management Services</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">FBO Edward Grammens Acct. No. F62-161454</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">21,944&nbsp;Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">32,895&nbsp;Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">44,378&nbsp;Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">29,250&nbsp;Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Edward E. Grammens</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Edward E. Grammens Revocable Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">79,625&nbsp;Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">56,426&nbsp;Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">4,930&nbsp;Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,645&nbsp;Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Paul Grammens</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Paul Grammens</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">30,625 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,674 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">19,723 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,579 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>12 May</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Hasselbach</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">David Hasselbach</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,800 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">300 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">4,118 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">4,000 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,200 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">249 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,579 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 11</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bertrand S. Irissou</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bertrand S. Irissou and Cynthia L. Irissou</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Revocable Living Trust dated August&nbsp;4, 2000</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Bertrand Irrisou</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">19,723 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,158 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12<SUP STYLE="font-size:85%; vertical-align:top">th</SUP></U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Pierre R. Irissou</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Irissou Family Living Trust, Pierre R. Irrissou&nbsp;&amp; Elizabeth M. Irissou</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Pierre R. Irissou</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">19,723 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,158 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>05/12/</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lia Jones</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Lia Jones</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">301 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">248 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5 - 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jonathan M. Kennedy</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Jonathan M. Kennedy&nbsp;&amp; Sherry Hope-Kennedy</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">76,562 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">62,696 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">19,723 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,868 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5 - 11</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Aaron E. Kilberg</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Aaron E. Kilberg</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">18,899 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/11</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Young C. Kim</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Young C. Kim</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,187 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,270 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,944 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,632 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/16/2014</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Richard Koch&nbsp;&nbsp;&nbsp;&nbsp; /s/ Lynn Rothman</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Richard Koch&nbsp;&amp; Lynn Rothman</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,187 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">5,917 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,895 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>11 May</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas R. Krebs</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Thomas R. Krebs Survivor&#146;s Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Thomas R. Krebs</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">810,320 Shares of Series A Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,471 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">173,102 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,317 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">11,882 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 9</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas R. Krebs</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The Fawn P. Krebs Bypass Trust for Barron David Krebs</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Thomas R. Krebs</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">94,840 Shares of Series A Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 9</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas R. Krebs</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The Fawn P. Krebs Bypass Trust for Walker Franz Krebs</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Thomas R. Krebs</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">94,840 Shares of Series A Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 9</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas R. Krebs</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Equity Trust Company d.b.a. Sterling Trust, Custodian FBO: Thomas Richard Krebs a/c#403105</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Thomas R. Krebs</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">40,556&nbsp;Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 9</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David H. Kremer, Trustee</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Kremer Miller Family Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">David H. Kremer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">107,187 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">94,044 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">59,171 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">23,026 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Hugh M. Laumeister</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Hugh M. Laumeister</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,500 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,500 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 11</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher G. Luck</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Christopher G. Luck 2012 IDG Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Christopher G. Luck</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">27,562 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">25,079 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/11</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kathryn E. Luck</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Kathryn E. Luck 2012 IDG Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Kathryn E. Luck</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">as Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">27,563 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">25,078 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 15</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John G. Manalili</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">John G. Manalili and Karen A. Cross</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Revocable Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">John G. Manalili</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,944 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">658 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Tom McGovern</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Tom McGovern</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">5,818 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Diana Meckfessel</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Diana Meckfessel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">24,500 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">23,511 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steven R. Meckfessel</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The Steven R. Meckfessel Revocable Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">24,500 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">23,511 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Murphy</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Christopher Murphy</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">301 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,000 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">248 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,000 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Anilesh Ahuja</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Anilesh Ahuja</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">612,500 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">235,110 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">98,620 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">32,895 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Artlyn Fong</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Artlyn Fong and Lena Fong Revocable Trust dated 08/26/1993</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Artlyn Fong</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">61,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">47,022 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,868 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Park / /s/ Jane Park</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">James and Jane Park Family Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">James Park / Jane Park</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Co-trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">30,625 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">39,185 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">88,757 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">26,316 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kyle K. Pond</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Kyle K. Pond</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">31,348 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,158 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James R. Pray</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Pray Revocable Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">James R. Pray</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,125&nbsp;Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>10 May</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert H. Pray</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Robert H. Pray</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,125&nbsp;Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,135&nbsp;Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 10</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Barry Reder</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Barry Reder</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,447 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carolyn Reiser, Trustee</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The Carolyn Shealy Reiser 2011 Revocable Trust u/d/t October&nbsp;26, 2011</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">45,937 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">23,511 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Karren Shorofsky</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The Karren Mia Shorofsky 2011 Revocable Trust u/d/t October&nbsp;26, 2011</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Karren Shorofsky</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">11,842 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>12/5 [May]</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mark Rettstatt</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Mark Rettstatt</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">300 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">249 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,000 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph Z. Rong &nbsp;&nbsp;&nbsp;&nbsp;/s/ Mei Xu Rong</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Joseph Z.&nbsp;&amp; Mei Xu Rong</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">12,260 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,500 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 11</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher J. Rupright</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Christopher J. Rupright</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">45,937 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,674 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,158 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5-12-14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert N. Sacks</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Robert N. Sacks</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">10,000 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">8,000 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12/14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ George E. Salah</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">George Salah</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">313,480 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">197,238 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael G. Schrantz</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Michael G. Schrantz</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,312 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,837 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">4,930 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Chandranath Sen</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Chandranath Sen</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">30,625 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">31,348 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,158 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/14/14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Arthur Shartsis&nbsp;&nbsp;&nbsp;&nbsp;/s/ Mary Jo Shartsis</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Arthur&nbsp;&amp; Mary Jo Shartsis</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">62,696 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,158 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/20/</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel Shore</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Daniel and Pamela Shore</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">122,500 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">62,696 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">19,723 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Trevor M. Smith</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Trevor M. Smith</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,944 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher Speck</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Christopher Speck</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">301 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">248 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,579 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Harry A. Kopelman</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Swartz Family Limited Partnership #4</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Harry A. Kopelman</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Managing Partner,</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Swartz Family Limited Partnership #4</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">153,125 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">78,370 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">49,310 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">32,895 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 10</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">/s/ David R. Tipton</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cynthia E. G. Tipton</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">David R. Tipton and Cynthia E. G. Tipton, as Trustees of the Tipton Family Revocable Trust dated March&nbsp;12, 2002</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,268 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,674 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,959 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12th</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="58%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/&nbsp;Ben&nbsp;H.&nbsp;Tompkins&nbsp;&nbsp;&nbsp;&nbsp;/s/&nbsp;Erica&nbsp;Tompkins,&nbsp;Trustee</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The Ben and Erica Tompkins 2013 Family Trust</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,750 Shares of Series C Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bryan Uhl</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Bryan Uhl</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">301 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">248 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">600 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/9</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Inja Kim Wang</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Jung T. Wang Family Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Inja Kim Wang</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">61,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">62,696 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">98,619 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">52,632 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Inja Kim Wang</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Wang Ventures LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Inja Kim Wang</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Managing Member</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">306,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">313,480 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">197,239 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">131,579 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Victor Wang</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Victor Wang</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">45,937 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">39,185 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">78,895 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">19,737 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Walter C. Wang</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Walter C. Wang</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">122,500 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">125,392 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">157,791 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">105,263 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Darryl L. Webster</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Darryl L. Webster</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,674 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,600 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 20</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Melissa J. Welk</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Melissa Welk</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">300 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,000 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">249 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Derek H. Wilson</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Derek H. Wilson</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">20,376 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,000 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Warren Wixen&nbsp;&nbsp;&nbsp;&nbsp;/s/ Rhonda Wixen</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Warren Wixen and Rhonda Wixen</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">76,562 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">62,696 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">78,895 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">39,474 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">/s/ Craig Wurm</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Denise Wurm</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Craig and Denise Wurm</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,125 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 11</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joel Zelden</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Zelden Living Trust Dated 8-10-04</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Joel Zelden</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,447 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 10</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="62%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carol M. Sands</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The Angels&#146; Forum 72, LLC</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Carol M. Sands</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Managing Member</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">168,437 Shares of Series B Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">192,192 Shares of Series C Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">148,324 Shares of Series D Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">84,215 Shares of Series E Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 21</U>, 2014</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Cohan</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">James Cohan</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">47,335 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>6/5</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">UBS Financial Services Inc. Custodian FBO</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Lisa Cracknell IRA</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lisa Cracknell</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">12,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June 5</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">UBS as Custodian FBO Lisa Cracknell</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">SEP Account 7144-3605</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lisa Cracknell</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">5,917 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,105 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June 5</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lisa Cracknell</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Peter&nbsp;&amp; Lisa Cracknell</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">18,375 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,944 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,105 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June 5</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Quyen Dang</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Quyen Dang</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">8,000 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,000 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June 10</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="62%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel W. Aljoe</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Daniel W. Aljoe and Audrey A. Aljoe Revocable Trust</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Daniel W. Aljoe</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">61,250 Shares of Series B Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">47,022 Shares of Series C Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,862 Shares of Series D Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,868 Shares of Series E Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5 June</U>, 2014</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Satyendra K. Deb&nbsp;&nbsp;&nbsp;&nbsp;/s/ Sima Deb</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Satyendra K.&nbsp;&amp; Sima Deb</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">30,625 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June&nbsp;5</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert Friese</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Robert Friese</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">61,612 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June&nbsp;8</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Douglas Godshall</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Douglas Godshall</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,837 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">4,930 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,632 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June&nbsp;5</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Margaret M. Gonzalez&nbsp;&nbsp;&nbsp;&nbsp;/s/ John Gonzalez</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Margaret M. Gonzalez and John Gonzalez</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,000 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">145 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5&#149;17&#149;14</U> , 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Hemant Jaiswal</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Hemant Jaiswal</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">10,000 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">10,000 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>6/5</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Aaron Katz</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Aaron Katz IRA Sterling Trust, Custodian</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Aaron Katz</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Owner</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,674 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June&nbsp;6</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Aaron Katz</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Aaron Katz</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,674 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">8,164 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,627 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,579 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,367 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June&nbsp;6</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marcia Katz</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Marcia Katz, Custodian for Evan Maximilian</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Katz under the Uniform Gift to Minors Act</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">(District of Columbia)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Marcia Katz</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,579 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>6/6</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael L. Meyers</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Michael L. Meyers</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">[&#9679;] Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>6/13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian Norton</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Brian Norton</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">301 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">248 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>6/1</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="58%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeffrey A. O&#146;Connell&nbsp;&nbsp;&nbsp;&nbsp;/s/ Catherine K. O&#146;Connell</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Jeffrey A. O&#146;Connell and Catherine K. O&#146;Connell, as Community Property</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">24,500 Shares of Series B Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,837 Shares of Series C Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,903 Shares of Series D Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,579 Shares of Series E Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;15</U>, 2014</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ JoAnne Powell</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">National Financial Services LLC CUST FBO</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">JoAnne Powell SEP IRA</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">30,625 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">14,792 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,870 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ JoAnne Powell</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Prudential Investment Management Services</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">FBO JoAnne Powell</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">13,158 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jahan P. Raissi</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Jahan P. Raissi</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,447 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>6/9</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric M. Ruttenberg</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Tinicum Investors</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Eric M. Ruttenberg</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">49,310 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">4,932 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>June&nbsp;9</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Artlyn Fong</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Artlyn Fong and Lena Fong Revocable Trust dated 08/26/1993</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Artlyn Fong</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">61,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">47,022 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,868 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew Friedman</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Matthew Friedman</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,312 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,674 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,889 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5-24-14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Margaret M. Gonzalez</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Margaret M. Gonzalez</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,000 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/17/14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="62%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Please sign and date below and if applicable, include name and title.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carol M. Sands</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Halo Fund II, LP</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Carol M. Sands</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Managing Member</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">80,407 Shares of Series C Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">98,619 Shares of Series D Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">40,132 Shares of Series E Preferred Stock</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;21</U>, 2014</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">The Kim P. Norman, M.D. Profit Sharing Plan</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kimberlie L. Cerrone</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Administrator</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">12,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Date: <U>5/23/14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ C. Louise LeCoque</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">C. Louise LeCoque, as Trustee of the C. Louise</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LeCoque Revocable Trust</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">C. Louise LeCoque</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Trustee of C. Louise LeCoque</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Revocable Trust</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">30,625 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">31,348 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">9,861 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,579 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Date: <U>May&nbsp;28</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Charles A. Strickler</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Charles A. Strickler</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">6,125 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">6,270 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>6-2</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Grant Weenig</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Grant Weenig</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">7,388 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">301 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">8,000 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">6,579 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">248 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">6,579 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>May&nbsp;12th</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joe Willson</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joe Willson</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">61,250 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">47,022 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">19,724 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">19,737 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>5-14-14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Harpeet Grewal</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Harpeet Grewal</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">9,404 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2,761 Shares of Series D Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1,974 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>6/10</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Fidelity Select Portfolios: Health Care Portfolio</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stacie M. Smith</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Stacie Smith</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Deputy Treasurer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,250,000 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Fidelity Select Portfolios: Medical Equipment and Systems Portfolio</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stacie M. Smith</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Stacie Smith</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Deputy Treasurer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">265,152&nbsp;Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Fidelity Mt. Vernon Street Trust: Fidelity Growth Company Fund</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stacie M. Smith</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Stacie Smith</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Deputy Treasurer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,128,787 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Fidelity Mt. Vernon Street Trust: Fidelity Series Growth Company Fund</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stacie M. Smith</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Stacie Smith</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Deputy Treasurer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">257,576 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><B>&nbsp;</B></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Fidelity Group Trust for Employee Benefit Plans: Fidelity Growth Company Commingled Pool</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Fidelity Management &amp; Trust Co.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kenneth Robins</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Kenneth Robins</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Authorized Signatory</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">128,788 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeremy Green</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Redmile Capital Offshore Fund II, Ltd.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Jeremy Green</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Managing Member of the Investment Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">757,576 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeremy Green</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Redmile Private Investments I, LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Jeremy Green/Redmile Group, LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Managing Member of the GP and/or Management Company</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">231,850 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeremy Green</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Redmile Private Investments I Affiliates, LP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Jeremy Green, Redmile Group, LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Managing Member of the GP and/or Management Company</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">172,596 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Kramer</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PWP EIV LLC &#150; Series C</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Michael Kramer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Member of the Board of Managers</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">243,561 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May&nbsp;15</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Elizabeth K. Becker</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Equity Trust Company, Custodian FBO Elizabeth K. Becker Traditional IRA</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Custodian</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,000 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michelle R. Bruce</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Michelle R. Bruce</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,515 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeremy W. Crawford</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Jeremy W. Crawford</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,030 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>13 May 2014</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bobby Douglas</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Bobby Douglas</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,000 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/14/2014</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lisa Fallon</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Lisa Fallon</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,894 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13th</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Hasselbach</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">David Hasselbach</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Southeast Regional Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,576 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thomas Hohman</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Thomas Hohman</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">758 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>15-May</U>, 2014 </TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lia Jones</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Lia Jones</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,061 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5-14-14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael L. Jones</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Michael L. Jones</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">American IRA, LLC FBO Michael L. Jones Traditional IRA</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,893 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 15</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael L. Jones</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Michael L. Jones</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">American IRA, LLC FBO Michael L. Jones Traditional IRA</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,516 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 15</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael Liguori</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Michael Liguori</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,200 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/10/2014</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Geoffrey Matthew MacIntyre</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,787 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 14th</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Cynthia Maskeny</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Cynthia Maskeny</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">3,788 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13th</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Eric Masterson</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Eric Masterson</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">568 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bradley Moore</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Bradley Moore</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Sales</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,894 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 9</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Christopher D. Murphy</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Christopher D. Murphy</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,500 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 16</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Bradley Parker</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Bradley Parker</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">758 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian Reinhard</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Brian Reinhard</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Sales Representative</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">12,879 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Roberts Jr.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">David Roberts Jr.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Sales Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">6,818 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Johanna Roberts</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Johanna Roberts</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">576 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 15</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Stan Schafeitel</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Stan Schafeitel</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Penumbra Territory Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">379 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Chris Speck</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Chris Speck</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">NW Regional Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,273 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Billy Stone</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Billy Stone</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Manager/Sales</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,576 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5/13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sara N. Thompson</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Sara N. Thompson</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">7,576 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>5-14-14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian Uhl</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brian Uhl</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">301 Shares of Series B Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">248 Shares of Series C Preferred Stock</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">600 Shares of Series E Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: <U>5/9/</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John C. Warnick II</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">John C. Warnick II</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Territory Manager</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">1,894 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 13</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Grant S. Weenig</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Grant S. Weenig</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Regional Manager &#150; Southcentral</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">15,000 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 12th</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COUNTERPART SIGNATURE PAGE TO </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INVESTORS&#146; RIGHTS AGREEMENT </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>HOLDERS OF PREFERRED STOCK</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Melissa J. Welk</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Melissa J. Welk</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Regional Manager &#150; Penumbra</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">2,273 Shares of Series F Preferred Stock</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: </TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>May 14</U>, 2014</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to
Fourth Amended and Restated Investors&#146; Rights Agreement] </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INVESTORS SUBJECT TO THIS AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LAST UPDATED ON MAY 16, 2014 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SERIES A FINANCING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas R. Krebs Survivor&#146;s Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series A Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Fawn P. Krebs Bypass Trust for Barron David Krebs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series A Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Fawn P. Krebs Bypass Trust for Walker Franz Krebs</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series A Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SERIES B FINANCING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Anilesh Ahuja</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ashish Ahuja</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel W. Aljoe and Audrey A. Aljoe Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Syed Naved Ameen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Angels&#146; Forum 72, LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arnautou Family 1996 Trust dated 2/27/96</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arani&nbsp;&amp; Shumita Bose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ann Carmel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jonathan Carmel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James L.&nbsp;&amp; Jean Pray Cederholm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark Chimenti</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael A. Chisek</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Technology Credit Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Smita Conjeevaram&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alain Cornil</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Peter and Lisa Cracknell</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">UBS Financial Services Inc. Custodian FBO Lisa Cracknell IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Steven M. Cramer&nbsp;&amp; Susan Cramer Tenants in the Entirety</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MLPF&amp;S Custodian FBO Steven M. Cramer RRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stanley Dahlin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel Davis</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Satyendra K.&nbsp;&amp; Sima Deb</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael DeFilippo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Demeter Holdings LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Siegel/Elsesser Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Peter J. Essex III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael A. Evans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The 2010 Robert D. Evans and Norma J. Evans Revocable Trust u/d/t dated November&nbsp;11, 2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Paul Feasby</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Artlyn Fong and Lena Fong Revocable Trust dated 08/26/1993</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Weylin Fong and Betty Fong Family Revocable Trust of 2001</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Andrew&nbsp;&amp; Cynthia Friedman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Matthew Friedman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Holger Friedrich</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert Friese</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Rosemary Garcia&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Shilpa Ghatalia</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Margaret M. Gonzalez</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Margaret M. Gonzalez and John Gonzalez</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Edward E. Grammens Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">National Financial Services LLC CUST FBO Edward E. Grammens SEP IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Paul Grammens</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vikas Gupta</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David Hasselbach</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lia Jones</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jonathan M. Kennedy&nbsp;&amp; Sherry Hope-Kennedy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Aaron E. Kilberg</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Young C. Kim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Richard Koch&nbsp;&amp; Lynn Rothman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas R. Krebs Survivor&#146;s Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kremer Miller Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Krishnan-Shah Family Limited Partnership</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alain G. LeCoque</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">C. Louise LeCoque, as Trustee of the C. Louise LeCoque Revocable Trust U/A/S 5/8/1990</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Nicholas J. Lembo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher G. Luck 2012 IDG Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kathryn E. Luck 2012 IDG Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Laura M. Lynch&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael Madison</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael G. Manasse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tom McGovern</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Diana Meckfessel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Steven R. Meckfessel Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sunit Mehra</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael L.&nbsp;&amp; Judith Brown Meyers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael L. Meyers, Trustee of the Meyers Family Trust u/a/d October&nbsp;10, 2000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael W. Meyers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Nicholas J. Mourlas</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher Murphy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James Nabers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Kim P. Norman, M.D. Profit Sharing Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brian Norton</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jeffrey A. O&#146;Connell and Catherine K. O&#146;Connell, as Community Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James and Jane Park Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Steven V. Pacia</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ramesh Babu Pitti</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">National Financial Services LLC CUST FBO JoAnne Powell SEP IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Pray Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert H. Pray</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Carolyn Shealy Reiser 2011 Revocable Trust u/d/t October&nbsp;26, 2011&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark Rettstatt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">RJC 1993 Living Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alan Robin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joseph Z.&nbsp;&amp; Mei Xu Rong</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher J. Rupright</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael G. Schrantz</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chandranath Sen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel&nbsp;&amp; Pamela Shore</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Angelica Sigalos</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher Speck</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Charles A. Strickler</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Swartz Family Limited Partnership #4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David R. Tipton and Cynthia E.G. Tipton, as Trustees of the Tipton Family Revocable Trust dated March&nbsp;12, 2002</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bryan Uhl</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jung T. Wang Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Victor Wang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Walter C. Wang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Wang Ventures LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Grant Weenig</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Melissa Welk</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joe Willson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Warren Wixen&nbsp;&amp; Rhonda Wixen&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Craig &amp; Denise Wurm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series B Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SERIES C FINANCING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Anilesh Ahuja</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel W. Aljoe and Audrey A. Aljoe Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Syed Naved Ameen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Angels&#146; Forum 72, LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Halo Fund II, LP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James Berman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trust 1/11/65 FBO Ann E. Carmel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark Chimenti</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael A. Chisek</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Dante Cianciarulo Irrevocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lawrence M. Clark</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James Cohan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MLPF&amp;S Custodian FPO Steven M. Cramer RRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Steven M. Cramer DMD Beneficiary Helen Cramer WfBNA Custodian Beneficiary Roth IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Oppenheimer&nbsp;&amp; Co., Inc. Custodian Helen Cramer (Deceased) Roth IRA FBO Steven M. Cramer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stanley Dahlin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Quyen Dang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel Davis</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Demeter Holdings LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Douglas L. Dethy&nbsp;&amp; Marianne E. Kozlowski&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James L. Dine</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael A. Evans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The 2010 Robert D. Evans and Norma J. Evans Revocable Trust u/d/t dated November&nbsp;11, 2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Paul Feasby</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Feldman Interests, Ltd.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Feldman Med Investments LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Artlyn Fong and Lena Fong Revocable Trust dated 08/26/1993</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Weylin Fong and Betty Fong Family Revocable Trust of 2001</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Andrew&nbsp;&amp; Cynthia Friedman 1996 Revocable Trust (12/96)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Matthew Friedman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Gaurav Gandhi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Rosemary Garcia</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Douglas Godshall</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Edward E. Grammens Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Prudential Investment Management Services FBO Edward Grammens Acct. No: F62-161454</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Paul Grammens</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Harpreet Grewal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David Hasselbach</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Gupta Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Hemant Jaiswal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lia Jones</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Aaron Katz&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Aaron Katz IRA Sterling Trust, Custodian</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Marcia Katz Custodian for Evan Maximilian Katz under the Uniform Gift to Minors Act (District of Columbia)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jonathan M. Kennedy&nbsp;&amp; Sherry Hope-Kennedy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Young C. Kim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Thomas R. Krebs Survivor&#146;s Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kremer Miller Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Krishnan-Shah Family Limited Partnership</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ruben Kuzniecky</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alain G. LeCoque</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alain G. LeCoque SEP IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">C. Louise LeCoque, as Trustee of the C. Louise LeCoque Revocable Trust U/A/S 5/8/1990</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Nicholas J. Lembo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher G. Luck 2012 IDG Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kathryn E. Luck 2012 IDG Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael Madison</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael G. Manasse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Diana Meckfessel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Steven R. Meckfessel Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael L.&nbsp;&amp; Judith Brown Meyers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Diana Michener</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Nicholas J. Mourlas</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher Murphy&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James Nabers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brian Norton</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jeffrey A. O&#146;Connell and Catherine K. O&#146;Connell, as Community Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James and Jane Park Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kyle K. Pond</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Prudential Investment Management Services FBO JoAnne Powell</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert H. Pray</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Carolyn Shealy Reiser 2011 Revocable Trust u/d/t October&nbsp;26, 2011</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark Rettstatt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">RJC 1993 Living Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John L. Roach</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alan Robin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher J. Rupright</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert N. Sacks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">George Salah</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael G. Schrantz</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chandranath Sen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arthur&nbsp;&amp; Mary Jo Shartsis</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel&nbsp;&amp; Pamela Shore</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benjamin Sorci</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher Speck</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Charles A. Strickler</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Swartz Family Limited Partnership #4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David R. Tipton and Cynthia E.G. Tipton, as Trustees of the Tipton Family Revocable Trust dated March&nbsp;12, 2002</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Ben and Erica Tompkins 2013 Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bryan Uhl</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jung T. Wang Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Wang Ventures LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Victor Wang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Walter C. Wang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Darryl L. Webster</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Grant Weenig</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joe Willson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Derek H. Wilson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Warren Wixen&nbsp;&amp; Rhonda Wixen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series C Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SERIES D FINANCING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Anilesh Ahuja</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel W. Aljoe and Audrey A. Aljoe Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Angels&#146; Forum 72, LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Halo Fund II, LP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arnautou Family 1996 Trust dated 2/27/96</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trust 1/11/65 FBO Ann E. Carmel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jonathan Carmel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael A. Chisek</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Eugene Chow</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">George C. Chow</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Margaux Chow</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael Chow</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michelle Chow</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Scott Chow</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">William Chow</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">TD Ameritrade Clearing Custodian FBO Smita Conjeevaram</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">TD Ameritrade Clearing Custodian FBO Srini Conjeevaram</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Peter&nbsp;&amp; Lisa Cracknell</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">UBS as Custodian FBO Lisa Cracknell SEP Account No.&nbsp;7144-3605</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stanley Dahlin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Satyendra K.&nbsp;&amp; Sima Deb</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Douglas L. Dethy&nbsp;&amp; Marianne E. Kozlowski</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James Dine</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Peter J. Essex III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael A. Evans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The 2010 Robert D. Evans and Norma J. Evans Revocable Trust u/d/t dated November&nbsp;11, 2010</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Paul Feasby</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Artlyn Fong and Lena Fong Revocable Trust dated 08/26/1993</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Weylin Fong and Betty Fong Family Revocable Trust of 2001</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cynthia&nbsp;&amp; Andrew Friedman 1996 Revocable Trust (12/96)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Matthew Friedman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Douglas Godshall</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Golden Eagle LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Edward E. Grammens Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Prudential Investment Management Services FBO Edward Grammens Acct. No: F62-161454</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Paul Grammens</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Harpreet Grewal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">HB Family Limited Partnership</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David Hasselbach</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bertrand S. Irissou and Cynthia L. Irissou Revocable Living Trust dated August&nbsp;4th, 2000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Irissou Family Living Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Hemant Jaiswal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Aaron Katz</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jonathan M. Kennedy&nbsp;&amp; Sherry Hope-Kennedy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Young C. Kim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Richard Koch&nbsp;&amp; Lynn Rothman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas R. Krebs Survivor&#146;s Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kremer Miller Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Krishnan-Shah Family Partners, LP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ruben Kuzniecky</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">C. Louise LeCoque, as Trustee of the C. Louise LeCoque Revocable Trust U/A/S 5/8/1990</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Amy C.M. Lo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Betty Lo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Falguni &amp; Vikram Malkani</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John G. Manalili and Karen A. Cross Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael L.&nbsp;&amp; Judith Brown Meyers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James Nabers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jeffrey A. O&#146;Connell and Catherine K. O&#146;Connell, as Community Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James and Jane Park Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Hyung Myung Peak</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kyle K. Pond</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">National Financial Services LLC CUST FBO JoAnne Powell SEP IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jahan P. Raissi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Barry Reder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher J. Rupright</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert N. Sacks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">George Salah</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SC Capital (P), LP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael G. Schrantz</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chandranath Sen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel&nbsp;&amp; Pamela Shore</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Karren Mia Shorofsky 2011 Revocable Trust u/d/t October&nbsp;26, 2011</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trevor M. Smith</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benjamin Sorci</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher Speck</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Swartz Family Limited Partnership #4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tinicum Investors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David R. Tipton and Cynthia E.G. Tipton, as Trustees of the Tipton Family Revocable Trust dated March&nbsp;12, 2002</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jung T. Wang Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Wang Ventures LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Victor Wang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Walter C. Wang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joe Willson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Derek H. Wilson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Warren Wixen&nbsp;&amp; Rhonda Wixen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Zeldin Living Trust Dated 8-10-04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series D Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SERIES E FINANCING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Anilesh Ahuja</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel W. Aljoe and Audrey A. Aljoe Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Angels&#146; Forum 72, LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Halo Fund II, LP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lawrence C. Best</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trust 1/11/65 FBO Ann E. Carmel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jonathan Carmel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark Chimenti</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John David Chin and Carole Lam-Chin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael A. Chisek</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Eugene Chow</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Dante Cianciarulo Irrevocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Peter&nbsp;&amp; Lisa Cracknell</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">UBS as Custodian FBO Lisa Cracknell SEP Account No.&nbsp;7144-3605</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Steven M. Cramer&nbsp;&amp; Susan Cramer Tenants in the Entirety</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Steven M. Cramer DMD Beneficiary Helen Cramer WfBNA Custodian Beneficiary Roth IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stanley Dahlin</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Quyen Dang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Douglas L. Dethy&nbsp;&amp; Marianne E. Kozlowski</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James Dine</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dollinger Harbor Bay Associates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael A. Evans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Paul Feasby</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Daniel E. Feldman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Artlyn Fong and Lena Fong Revocable Trust dated 08/26/1993</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Weylin Fong and Betty Fong Family Revocable Trust of 2001</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cynthia&nbsp;&amp; Andrew Friedman 1996 Revocable Trust (12/96)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Friedman Family 1996 Living Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Rosemary Garcia</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Douglas Godshall</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Golden Eagle II LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Margaret M. Gonzalez and John Gonzalez</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Edward E. Grammens Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Prudential Investment Management Services FBO Edward Grammens Acct. No: F62-161454</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Paul Grammens</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Harpreet Grewal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vanguard Ventures Retirement Plan, John Harrington Trustee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bertrand S. Irissou and Cythia L. Irissou Revocable Living Trust dated August&nbsp;4, 2000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Irissou Family Living Trust, Pierre R. Irissou&nbsp;&amp; Elisabeth M. Irissou</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jonathan M. Kennedy&nbsp;&amp; Sherry Hope-Kennedy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Young C. Kim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Richard Koch&nbsp;&amp; Lynn Rothman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas R. Krebs Survivor&#146;s Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Equity Trust Company d.b.a. Sterling Trust, Custodian FBO: Thomas Richard Krebs a/c #403105</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kremer Miller Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ruben Kuzniecky</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Hugh M. Laumeister</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alain G. LeCoque SEP IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">C. Louise LeCoque, as Trustee of the C. Louise LeCoque Revocable Trust U/A/S 5/8/1990</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Amy C.M. Lo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Betty Lo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Luck Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Falguni&nbsp;&amp; Vikram Malkani</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John G. Manalili and Karen A. Cross Revocable Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael G. Manasse</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PENSCO Trust Company Custodian FBO Michael L. Meyers IRA Account Number ME1CCU</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher D. Murphy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jeffrey A. O&#146;Connell and Catherine K. O&#146;Connell, as Community Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Steven V. Pacia</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">James and Jane Park Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kyle K. Pond</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">National Financial Services LLC CUST FBO JoAnne Powell SEP IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jahan P. Raissi</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Barry Reder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark Rettstatt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">RJC 1993 Living Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alan Robin&nbsp;&amp; Constance Levi JTWROS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joseph Z. Rong&nbsp;&amp; Mei Xu</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher J. Rupright</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SC Capital (P), LP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chandranath Sen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Arthur&nbsp;&amp; Mary Jo Shartsis</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David M. Shaw</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">The Karren Mia Shorofsky 2011 Revocable Trust u/d/t October&nbsp;26, 2011</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benjamin Sorci</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Swartz Family Limited Partnership #4</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tinicum Investors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bryan Uhl</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jung T. Wang Family Trust</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Wang Ventures LLC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Victor Wang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Walter C. Wang</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Grant Weenig</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joe Willson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Warren Wixen&nbsp;&amp; Rhonda Wixen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Zeldin Living Trust Dated 8-10-04</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series E Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SERIES F FINANCING</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fidelity Select Portfolios: Health Care Portfolio</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fidelity Select Portfolios: Medical Equipment and Systems Portfolio</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fidelity Mt. Vernon Street Trust: Fidelity Growth Company Fund</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fidelity Mt. Vernon Street Trust: Fidelity Series Growth Company Fund</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fidelity Group Trust for Employee Benefit Plans: Fidelity Growth Company Commingled Pool</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Redmile Capital Offshore Fund II, Ltd.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Redmile Private Investments I, LP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Redmile Private Investments I Affiliates, LP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PWP EIV LLC &#150; Series C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Equity Trust Company Custodian FBO Elizabeth K. Becker Traditional IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michelle Bruce</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jeremy W. Crawford</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robert M. Douglas</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lisa Fallon</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David Hasselbach</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas Hohman</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Lia Jones</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">American IRA, LLC FBO Michael L. Jones Traditional IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">American IRA, LLC FBO Michael L. Jones ROTH IRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael Liguori</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Geoffrey Matthew MacIntyre</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Cynthia Maskeny</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Eric Masterson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bradley D. Moore</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher D. Murphy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bradley E. Parker</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brian Reinhard</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jon Mark Rettstatt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David Roberts Jr.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Johanna Roberts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christopher Speck</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:64.90pt; font-size:8pt; font-family:Times New Roman"><B>Name and Address</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:63.85pt; font-size:8pt; font-family:Times New Roman"><B>Origin of Holdings</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stan Schafeitel</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Billy Stone</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sara Thompson</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bryan Uhl</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">John Charles Warnick II</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Grant S. Weenig</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Melissa J. Welk</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Series F Financing</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-20 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>5
<FILENAME>filename5.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LEASE MODIFIED NET </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Basic Provisions
(&#147;Basic Provision&#148;)</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.1 <B>Parties: </B>This Lease (&#147;<B>Lease</B>&#148;), dated, November&nbsp;28,
2007, is made by and between Dollinger Harbor Bay Associates, LP (&#147;<B>Landlord</B>&#148;) and Penumbra, Inc. (&#147;<B>Tenant</B>&#148;), (collectively the &#147;<B>Parties</B>,&#148; or individually a &#147;<B>Party</B>&#148;).<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2(a) <B>Premises: </B>A portion of that certain building containing approximately 72,788 rentable square feet, including all improvements
therein or to be provided by Landlord under the terms of this Lease, commonly known by the street address of <U>1351 Harbor Bay Parkway, Suite 100A&nbsp;&amp; 202</U>, located in the City of <U>Alameda</U>, County of <U>Alameda</U>, State of
<U>California</U>, with zip code <U>94502</U> as outlined on Exhibit <U>A</U> attached hereto (&#147;<B>Premises</B>&#148;). The &#147;<B>Building</B>&#148; is that certain building containing the Premises and generally described as (describe
briefly the nature of the Building): <U>a multi-tenant R&amp;D Office building. </U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to Tenant&#146;s rights to use and occupy the Premises
as hereinafter specified, Tenant shall have non-exclusive rights to the Common Areas (as defined in Paragraph 2.7 below) as hereinafter specified, but shall not have any rights to the roof, exterior walls or utility raceways of the Building or to
any other buildings in the Industrial Center. The Premises, the Building, the Common Areas, the land upon which they are located, along with all other buildings and improvements thereon, are herein collectively referred to as the &#147;<B>Industrial
Center.</B>&#148; (Also see Paragraph 2.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.2(b) <B>Parking: </B>240 unreserved vehicle parking spaces (&#147;<B>Unreserved
Parking Spaces</B>&#148;); and <U>no</U> reserved vehicle parking spaces (&#147;<B>Reserved Parking Spaces</B>&#148;)<B>. </B>(Also, see Paragraph 2.6)<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.3 <B>Term: </B>Six (6)&nbsp;years and 0 months (&#147;<B>Original Term</B>&#148;) commencing thirty (30)&nbsp;days after the
Landlord&#146;s substantial completion of Tenant Improvements (&#147;<B>Commencement Date</B>&#148;) and ending six (6)&nbsp;years thereafter. (&#147;<B>Expiration Date</B>&#148;)<B>.</B> (Also Paragraph 3.)<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.4 <B>Early Possession: </B>Tenant shall be allowed access to the Premises during Tenant Improvement Period; however Landlord shall
not be responsible for any delays caused by Tenant&#146;s work (&#147;<B>Early Possession</B>&#148;)<B>. </B>(Also Paragraphs 3.2 and 3.3.)<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.5 <B>Base rent: </B>$59,673.75 per month (which is for Suite 100A, although Tenant will be entitled to occupy Suite 202 during this
period) (&#147;<B>Base Rent</B>&#148;)<B>, </B>payable on the first day of each month commencing on the Commencement Date (Also see Paragraph 4.). Base Rent is not payable for suite 202 during the initial twelve (12)&nbsp;months of the Term. Base
Rent shall be adjusted on an annual basis as follows:<B> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="28%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="54%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Months 13-24</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,624.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">per month (which is for both Suite 100A &amp; 202)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Months 25-36</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">98,263.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">per month (which is for both Suite 100A &amp; 202)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Months 37-48</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">101,903.20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">per month (which is for both Suite 100A &amp; 202)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Months 49-60</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">105,542.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">per month (which is for both Suite 100A &amp; 202)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Months 61-72</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">109,182.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">per month (which is for both Suite 100A &amp; 202)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6(a) <B>Base Rent Paid Upon Execution</B>: $59,673.75 as Base Rent for the first month of the Lease Term.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.6(b) <B>Tenant&#146;s Share of Common Area Operating Expenses</B>: <U>48.72</U>% of the building for Months 1-12 of the Lease
Term and <U>74.29</U>% of the Building for Months 13-72 of the Lease Term (&#147;<B>Tenant&#146;s Share</B>&#148;) as determined by prorata square footage of the Premises as compared to the total square footage of the Building.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.7 <B>Security Deposit</B>: $1,000,000.00 Letter of Credit. The Letter of Credit shall be returned to Tenant and replaced by a cash
Security Deposit in the amount of $109,182.00 upon the completion of the conditions specified in Section&nbsp;53 (&#147;<B>Security Deposit</B>&#148;). (Also see Paragraph 5)<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.8 <B>Permitted Use</B>: General Office and R&amp;D Use (&#147;<B>Permitted Use</B>&#148;) (Also see Paragraph 5.) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.9 <B>Insuring Party</B>. Landlord is the &#147;<B>Insuring Party</B>.&#148; (Also see Paragraph
8) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.10(a) <B>Real Estate Brokers</B>. The following real estate broker(s) (collectively, the &#147;<B>Brokers</B>&#148;) and
brokerage relationships exist in this transaction and are consented to by the Parties (check applicable boxes):<B> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">[&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
<TD ALIGN="left" VALIGN="top">represents Landlord exclusively (&#147;<B>Landlord&#146;s Broker</B>&#148;); </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">[&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
<TD ALIGN="left" VALIGN="top">represents Tenant exclusively (&#147;<B>Tenant&#146;s Broker</B>&#148;); or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">[&nbsp;x&nbsp;]</TD>
<TD ALIGN="left" VALIGN="top">Cushman Wakefield represents both Landlord and Tenant (&#147;<B>Dual Agency</B>&#148;). (/also see Par. 15.) </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.10(b) <B>Payment to Brokers</B>. Upon the execution of this Lease by both Parties, Landlord shall pay to said Broker(s) according to
separate written agreement between Landlord and said Broker(s).<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1.11 <B>Guarantor</B>. The obligations of the Tenant under
this Lease are to be guaranteed by NONE (&#147;<B>Guarantor</B>&#148;). (Also see Paragraph 37.)<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.12 <B>Addenda and Exhibits</B>.
Attached hereto is Exhibit A through C, all of which constitute a part of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Premises, Parking and Common Areas</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.1 <B>Letting</B>. Landlord hereby leases to Tenant, and Tenant hereby leases from Landlord, the Premises, for the term, at the
rental, and upon all of the terms, covenants and conditions set forth in this Lease. The leaseable area is measured to the outside edge of the outside walls and drip lines to the centerline of any demising walls, including a pro rata share of the
electrical room, corridors, lobbies and other common spaces. Unless otherwise provided herein, any statement of square footage set forth in this Lease, or that may have been used in calculating rental and/or Common Area Operating Expenses, is an
approximation which Landlord and Tenant agree is reasonable and the rental and Tenant&#146;s Share (as defined in Paragraph 1.6(b) based thereon is not subject to revision whether or not the actual square footage is more or less.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.2 <B>Condition</B>. Landlord shall deliver the Premises to Tenant clean and free of debris on the Commencement Date and warrants to
Tenant that the existing plumbing, electrical systems, fire sprinkler system, lighting, air conditioning and heating systems and loading doors, if any, in the Premises, other than those constructed by Tenant, shall be in good operating condition on
the Commencement Date. If a non-compliance with said warranty exists as of the Commencement Date, Landlord shall, except as otherwise provided in this Lease, promptly after receipt of written notice from Tenant setting forth with specificity the
nature and extent of such noncompliance, rectify same at Landlord&#146;s expense. If Tenant does not give Landlord written notice of a non-compliance with this warranty within six (6)&nbsp;months after the Commencement Date, correction of that
non-compliance shall be the obligation of Tenant at Tenant&#146;s sole cost and expense.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.3 <B>Warranties</B>. Tenant
acknowledges that neither landlord nor any of its agents made any representations or warranties respecting the project, the buildings, or the leased premises, upon which tenant relied in entering into this lease, which are not expressly set forth in
this lease. Tenant further acknowledges that neither Landlord nor any of its agents made any representations as to (i)&nbsp;whether the leased premises may be used for tenant&#146;s intended use under existing law or; (ii)&nbsp;the suitability of
the leased premises for the conduct of tenant&#146;s business or; (iii)&nbsp;the exact square footage of the leased premises; that tenant relied solely upon its own investigations respecting said premises (including but not limited to the electrical
and fire sprinkler systems, security, environmental aspects, seismic and earthquake requirements, and compliance with the American with Disabilities Act and applicable zoning, municipal, county, state and federal laws, ordinances and regulations and
any covenants or restrictions of record (collectively, &#147;<B>Applicable Laws</B>&#148;) and that upon its execution of this lease, accepts the leaseable area as specified herein. Tenant expressly waives any and all claims for damage by reason of
any statement, representation, warranty, promise or other agreement of landlord or landlord&#146;s agent(s), if any, not contained in this lease or in any addenda hereto.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.4 <B>Tenant as Prior Owner/Occupant</B>. The warranties made by Landlord in this Paragraph 2.2 shall be of no force or effect if
immediately prior to the date set forth in Paragraph 1.1 Tenant was the owner or occupant of the Premises. In such event, Tenant shall, at Tenant&#146;s sole cost and expense, correct any non-compliance of the Premises with said warranties.<B>
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.5 <B>Vehicle Parking</B>. Tenant shall be entitled to use the number of Unreserved
Parking Spaces and Reserved Parking Spaces specified in Paragraph 1.2(b) on those portions of the Common Areas designated from time to time by Landlord for parking. Tenant shall not use more parking spaces than said number. Said parking spaces shall
be used for parking by vehicles no larger than full-size passenger automobiles or pick-up trucks, herein called &#147;<B>Permitted Size Vehicles.</B>&#148; Vehicles other than Permitted Size Vehicles shall be parked and loaded or unloaded as
directed by Landlord in the Rules and Regulations (as defined in Paragraph 40) issued by Landlord. (Also see Paragraph 2.9.)<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)
Tenant shall not permit or allow any vehicles that belong to or are controlled by Tenant or Tenant&#146;s employees, suppliers, shippers, customers, contractors or invitees to be loaded, unloaded, or parked in areas other than those designated by
Landlord for such activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) If Tenant permits or allows any of the prohibited activities described in this Paragraph 2.6, then
Landlord shall have the right, without notice, in addition to such other rights and remedies that it may have, to remove or tow away the vehicle involved and charge the cost to Tenant, which cost shall be immediately payable upon demand by Landlord.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Landlord shall at the Commencement Date of this Lease, provide the parking facilities required by Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.6 <B>Common Areas - Definition</B>. The term &#147;<B>Common Areas</B>&#148; is defined as all areas and facilities outside the
Premises and within the exterior boundary line of the Industrial Center and Interior utility raceways within the Premises that are provided and designated by the Landlord from time to time for the general non-exclusive use of Landlord, Tenant and
other tenants of the Industrial Center and their respective employees, suppliers, shippers, customers, contractors and invitees, including parking areas, loading and unloading areas, trash areas, roadways, sidewalks, walkways, parkways, driveways
and landscaped areas.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.7 <B>Common Areas - Tenant&#146;s Rights</B>. Landlord hereby grants to Tenant, for the benefit of
Tenant and its employees, suppliers, shippers, contractors, customers and invitees, during the term of this Lease, the non-exclusive right to use, in common with others entitled to such use, the Common Areas as they exist from time to time, subject
to any rights, powers, and privileges reserved by Landlord under the terms hereof or under the terms of any rules and regulations or restrictions governing the use of the Industrial Center. Under no circumstances shall the right herein granted to
use the Common Areas be deemed to include the right to store any property, temporarily or permanently, in the Common Areas. Any such storage shall be permitted only by the prior written consent of Landlord or Landlord&#146;s designated agent, which
consent may be revoked at any time. In the event that any unauthorized storage shall occur then Landlord shall have the right, without notice, in addition to such other rights and remedies that it may have, to remove the property and charge the cost
to Tenant, which cost shall be immediately payable upon demand by Landlord.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.8 <B>Common Areas - Rules and
Regulations</B>. Landlord or such other person(s) as Landlord may appoint shall have the exclusive control and management of the Common Areas and shall have the right, from time to time, to establish, modify, amend and enforce reasonable Rules and
Regulations with respect thereto in accordance with Paragraph 40. Tenant agrees to abide by and conform to all such Rules and Regulations and to cause its employees, suppliers, shippers, customers, contractors and invitees to so abide and conform.
Landlord shall not be responsible to Tenant for the non-compliance with said rules and regulations by other tenants of the Industrial Center.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 <B>Common Areas - Changes</B>. Landlord shall have the right, in Landlord&#146;s sole discretion, from time to time: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) To make changes to the Common Areas, including, without limitation, changes in the location, size, shape and number of driveways,
entrances, parking spaces, parking areas, loading and unloading areas, ingress, egress, direction of traffic, landscaped areas, walkways and utility raceways; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) To close temporarily any of the Common Areas for maintenance purposes so long as reasonable access to the Premises remains available; </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) To designate other land outside the boundaries of the Industrial Center to be a part of the
Common Areas; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) To add additional buildings and improvements to the Common Areas; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) To use the Common Areas while engaged in making additional improvements, repairs or alterations to the Industrial Center, or any portion
thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) To do and perform such other acts and make such other changes in, to or with respect to the Common Areas and Industrial
Center as Landlord may, in the exercise of sound business judgment, deem to be appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord shall use best efforts to ensure
that the performance of any such work of repairs or alterations shall not interfere with Tenant&#146;s use of the Premises (or any portion thereof) for Tenant&#146;s business purposes (such efforts to include limiting the performance of any such
work which might be disruptive to weekends or the evening and the cleaning of any work area prior to the commencement of the next business day); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Term</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <B>Term</B>. The
Commencement Date, Expiration Date and Original Term of this Lease are as specified in Paragraph 1.3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>3.2 <B>Early Possession</B>.
If Tenant totally or partially occupies the Premises after the Early Possession Date but prior to the Commencement Date, the obligation to pay Base Rent shall be abated for the period of such early occupancy. All other terms of this Lease, however,
(including but not limited to the obligations to pay Tenant&#146;s Share of Common Area Operating Expenses and to carry the insurance required by Paragraph 8) shall be in effect during such period. Any such early possession shall not affect nor
advance the Expiration Date of the Original Term.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>3.3 <B>Delay in Possession</B>. If for any reason Landlord cannot deliver
possession of the Premises to Tenant by the Early Possession Date, Landlord shall not be subject to any liability therefor, nor shall such failure affect the validity of this Lease, or the obligations of Tenant hereunder, or extend the term hereof,
but in such case, Tenant shall not, except as otherwise provided herein, be obligated to pay rent or perform any other obligation of Tenant under the terms of this Lease until Landlord delivers possession of the Premises to Tenant. If possession of
the Premises is not delivered to Tenant within sixty (60)&nbsp;days after the Commencement Date, Tenant may, at its option, by notice in writing to Landlord within ten (10)&nbsp;days after the end of sixty (60)&nbsp;day period, cancel this Lease, in
which event the parties shall be discharged from all obligations hereunder; provided further, however, that if such written notice of Tenant is not received by Landlord within said ten (10)&nbsp;day period, Tenant&#146;s right to cancel this Lease
hereunder shall terminate and be of no further force or effect.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Rent</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>4.1 <B>Base Rent</B>. Tenant shall pay Base Rent and other rent or charges, as the same may be adjusted from time to time, to Landlord
in lawful money of the United States, without offset or deduction, on or before the 1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> day of each month. Base Rent and all other rent and charges for any period during the term hereof which is
for less than one full month shall be prorated based upon the actual number of days of the month involved. Payment of Base Rent and other charges shall be made to Landlord at its address stated herein or to such other persons or at such other
addresses as Landlord may from time to time designate in writing to Tenant.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>4.2 <B>Common Area Operating Expenses</B>. Tenant shall pay to Landlord during the term
hereof, in addition to the Base Rent, Tenant&#146;s Share (as specified in Paragraph 1.6(b)) of all Common Area Operating Expenses, as hereinafter defined, during each calendar year of the term of this Lease, in accordance with the following
provisions:<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(a) &#147;<B>Common Area Operating Expenses</B>&#148; are defined, for purposes of this Lease, as all costs
incurred by Landlord relating to the ownership and operation of the Industrial Center, including, but not limited to, the following:<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The operation, repair and maintenance, in neat, clean, good order and condition, of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(aa) The Common Areas, including parking areas, loading and unloading areas, trash areas, roadways, sidewalks, walkways, parkways, driveways,
landscaped areas, striping, bumpers, irrigation systems, Common Area lighting facilities, fences and gates, elevators and roof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(bb)
Exterior signs and any tenant directories. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(cc) Fire detection and sprinkler systems. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The cost of water, gas, electricity and telephone to service the Common Areas. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Trash disposal, property management fees of 4% of the gross monthly rental and security services and the costs of any regularly
scheduled environmental inspections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) <B>[INTENTIONALLY OMITTED]</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) Real Property Taxes (as defined in Paragraph 10.2) to be paid by Landlord for the Building and the Common Areas under Paragraph 10
hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) The cost of the premiums for the insurance policies maintained by Landlord under Paragraph 8 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) Any deductible portion of an insured loss concerning the building or the Common Areas. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) Any other services to be provided by Landlord that are stated elsewhere in this Lease to be a Common Area Operating Expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The cost of any capital improvements or other capital items included in Common Area Operating Expenses shall be amortized by Landlord on a
straight line basis over the economic useful life of the capital item for accounting purposes, as determined by Landlord using generally accepted accounting principles, consistently applied, and Internal Revenue Service asset classification
regulations, if any. The amortized cost of capital improvements may include interest at the rate paid by Landlord on any funds borrowed for such expenditures from an unaffiliated third-party financial institution, but in no event in excess of the
market rate of interest customarily paid on such borrowed funds for such purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, Common Area Operating
Expenses will not include: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) repairs or other work occasioned by fire, windstorm or other insured casualty or hazard, to the extent
that Landlord shall receive proceeds of such insurance or would have received such proceeds had Landlord maintained the insurance coverage required under this Lease and diligently attempted to procure the maximum possible insurance coverage; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) marketing and promotional costs; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) debt service payments on or related to any indebtedness; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any amounts paid to any person, firm or corporation related or otherwise affiliated with Landlord or any general partner, officer or
director of Landlord or any of its general partners, to the extent same materially exceeds arms-length competitive prices paid in the Alameda, California metropolitan area for the services or goods provided; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) costs relating to maintaining Landlord&#146;s existence, either as a corporation, partnership, or other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Any common Area Operating Expenses and Real Property Taxes that are specifically attributable to the Building or to any other building in
the industrial Center or to the operation, repair and maintenance thereof, shall be allocated entirely to the Building or to such other building. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
However, any Common Area Operating Expenses and Real Property Taxes that are not specifically attributable to the Building or to any other building or to the operation, repair and maintenance
thereof, shall be equitably allocated by Landlord to all buildings in the Industrial Center. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) The inclusion of the improvements,
facilities and services set forth in subparagraph 4.2(a) shall not be deemed to impose an obligation upon Landlord to either have said improvements or facilities or to provide those services unless the Industrial Center already has the same,
Landlord already provides the services, or Landlord has agreed elsewhere in this Lease to provide the same or some of them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)
Tenant&#146;s Share of Common Area Operating Expenses shall be payable by Tenant within thirty (30)&nbsp;days after a reasonably detailed statement of actual expenses is presented to Tenant by Landlord. At Landlord&#146;s option, however, an amount
may be reasonably estimated by Landlord from time to time of Tenant&#146;s Share of annual Common Area Operating Expenses and the same shall be payable monthly or quarterly, as Landlord shall designate, during each 12-month period of the Lease term,
on the same day as the Base Rent is due hereunder. Landlord shall deliver to Tenant within sixty (60)&nbsp;days after the expiration of each calendar year a reasonably detailed statement showing Tenant&#146;s Share of the actual Common Area
Operating Expenses incurred during the preceding year. If Tenant&#146;s payments under this Paragraph 4.2(d) during said preceding year exceed Tenant&#146;s Share as indicated on said statement, Landlord shall be credited the amount of such
over-payment against Tenant&#146;s Share of Common Area Operating Expenses next becoming due. If Tenant&#146;s payments under this Paragraph 4.2(d) during said preceding year were less than Tenant&#146;s Share as indicated on said statement, Tenant
shall pay to Landlord the amount of the deficiency within ten (10)&nbsp;days after delivery by Landlord to Tenant of said statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)
Landlord shall maintain at all times during the term of this Lease, full, complete and accurate books of account and records prepared in accordance with generally accepted accounting principles with respect to Common Area Operating Expenses, and
shall retain such books and records, as well as contracts, bills, vouchers, and checks, and such other documents as are reasonably necessary to properly audit Common Area Operating Expenses. Upon reasonable notice from Tenant, Landlord shall make
available for Tenant&#146;s inspection (or inspection performed by Tenant&#146;s accountant and/or consultants) during normal business hours, Landlord&#146;s books and records relating to the Common Area Operating Expenses. If an audit, review or
inspection by a Tenant or Tenant&#146;s accountant or consultant alleges an overbilling, Tenant may submit a claim for the overbilled amount to Landlord, detailing the nature of the overbilling, and Landlord shall have thirty (30)&nbsp;days to pay
such amount or contest the claim by giving notice thereof to Tenant, detailing the nature of Landlord&#146;s contest of Tenant&#146;s claims. If, Landlord&#146;s statement is ultimately determined to be in error, Landlord will promptly reimburse to
Tenant, or Tenant will promptly pay to Landlord, any amount which may be determined to have been due as a result of Tenant&#146;s audit; additionally, if Landlord is determined to have overcharged Tenant for Common Area Operating Expenses by 3% or
more, Landlord shall reimburse Tenant within thirty (30)&nbsp;days following such determination for the reasonable cost of Tenant&#146;s review of Landlord&#146;s books and records not to exceed $500 (which cost may not be included as a Common Area
Operating Expense). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Security Deposit</B>. Tenant shall deposit with Landlord upon Tenant&#146;s execution hereof the Security Deposit set forth in
Paragraph&nbsp;1.7 as security for Tenant&#146;s faithful performance of Tenant&#146;s obligations under this Lease. If Tenant fails to pay Base Rent or other rent or charges due hereunder, or otherwise Defaults under this Lease (as defined in
Paragraph 13.1), Landlord may use, apply or retain all or any portion of said Security Deposit, Tenant shall within ten (10)&nbsp;days after written request therefore deposit monies with Landlord sufficient to restore said Security Deposit to the
full amount required by this Lease. Landlord shall not be required to keep all or any part of the Security Deposit separate from its general accounts. Landlord shall, at the expiration or earlier termination of the term hereof and after Tenant has
vacated the Premises, return to Tenant (or, at Landlord&#146;s option, to the last assignee, if any, of Tenant&#146;s interest herein), that portion of the Security Deposit not used or applied by Landlord. Unless otherwise expressly agreed in
writing by Landlord, no part of the Security Deposit shall be considered to be held in trust, to bear interest or other increment for its use, or to be prepayment for any monies to be paid by Tenant under this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Use</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <B>Permitted
Use</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall use and occupy the Premises only for the Permitted Use set forth in Paragraph 1.8, or any other legal use which
is reasonably comparable thereto, and for no other purpose. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Tenant shall not use or permit the use of the Premises in a manner that is unlawful, creates waste or a nuisance, or that disturbs owners and/or occupants of, or causes damage to the Premises or
neighboring premises or properties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Landlord hereby agrees to not unreasonably withhold, condition or delay its consent to any
written request by Tenant, Tenant&#146;s assignees or subtenants, and by prospective assignees and subtenants of Tenant, its assignees and subtenants, for a modification of said Permitted Use, so long as the same will not impair the structural
integrity of the improvements on the Premises or in the Building or the mechanical or electrical systems therein, does not conflict with uses by other Tenants, is not significantly more burdensome to the Premises or the Building and the improvements
thereon, and is otherwise permissible pursuant to this Paragraph 6. If Landlord elects to withhold such consent, Landlord shall within five (5)&nbsp;business days after such request give a written notification of same, which notice shall include an
explanation of Landlord&#146;s reasonable objections to the change in use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <B>Hazardous Substances</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(a) <B>Reportable Uses Require Consent</B>. The term &#147;<B>Hazardous Substance</B>&#148; as used in this Lease shall mean any
product, substance, chemical, material or waste whose presence, nature, quantity and/or intensity of existence, use, manufacture, disposal, transportation, spill, release or effect, either by itself or in combination with other materials expected to
be on the Premises, is either: (i)&nbsp;potentially injurious to the public health, safety or welfare, the environment, or the Premises; (ii)&nbsp;regulated or monitored by any governmental authority; or (iii)&nbsp;a basis for potential liability of
Landlord to any governmental agency or third party under any applicable statute or common law theory. Hazardous Substance shall include, but not be limited to, hydrocarbons, petroleum, gasoline, crude oil or any products or by-products thereof.
Tenant shall not engage in any activity in or about the Premises which constitutes a Reportable Use (as hereinafter defined) of Hazardous Substances without the express prior written consent of Landlord and compliance in a timely manner (at
Tenant&#146;s sole cost and expense) with all Applicable Requirements (as defined in Paragraph&nbsp;6.3). &#147;<B>Reportable Use</B>&#148; shall mean (i)&nbsp;the installation or use of any above or below ground storage tank, (ii)&nbsp;the
generation, possession, storage, use, transportation, or disposal of a Hazardous Substance that requires a permit from, or with respect to which a report, notice, registration or business plan is required to be filed with, any governmental
authority, and (iii)&nbsp;the presence in, on or about the Premises of a Hazardous Substance with respect to which any Applicable Laws require that a notice be given to persons entering or occupying the Premises or neighboring properties.
Notwithstanding the foregoing, Tenant may, without Landlord&#146;s prior consent, but upon notice to Landlord and in compliance with all Applicable requirements, use any ordinary and customary materials reasonably required to be used by Tenant in
the normal course of the Permitted Use, so long as such use is not a Reportable Use and does not expose the Premises or neighboring properties to any meaningful risk of contamination or damage or expose Landlord to any liability therefor. In
addition, Landlord may (but without any obligation to do so) condition its consent to any Reportable Use of any Hazardous Substance by Tenant upon Tenant&#146;s giving Landlord such additional assurances as Landlord, in its reasonable discretion,
deems necessary to protect itself, the public, the Premises and the environment against damage, contamination or injury and/or liability therefor, including but not limited to the installation (and, at Landlord&#146;s option, removal on or before
Lease expiration or earlier termination) of reasonably necessary protective modifications to the Premises (such as concrete encasements) and/or the deposit of an additional Security Deposit under Paragraph 5 hereof.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(b) <B>Duty to Inform Landlord</B>. If Tenant knows, or has reasonable cause to believe, that a Hazardous Substance has come to be
located in, on, under or about the Premises or the Building, other than as previously consented to by Landlord, Tenant shall immediately give Landlord written notice thereof, together with a copy of any statement, report, notice, registration,
application, permit, business plan, license, claim, action, or proceeding given to, or received from, any governmental authority or private party concerning the presence, spill, release, discharge of, or exposure to, such Hazardous Substance
including but not limited to all such documents as may be involved in any Reportable Use involving the Premises. Tenant shall not cause or permit any Hazardous Substance to be spilled or released in, on, under or about the Premises (including,
without limitation, through the prompting or sanitary sewer system).<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <B>Indemnification</B>. Tenant shall indemnify, protect,
defend and hold Landlord, its agents, employees, lenders and ground lessor, if any, and the Premises, harmless from and against any and all damages, liabilities, judgments, costs, claims, liens, expenses, penalties, loss of permits and
attorneys&#146; and consultants&#146; fees arising out of or involving any Hazardous Substance brought onto the Premises by or for Tenant or by anyone under Tenant&#146;s control. Tenant&#146;s obligations under this paragraph 6.2(c) shall include,
but not be limited to, the effects of any contamination or injury to person, property or the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
environment created or suffered by Tenant, and the cost of investigation (including consultants&#146; and attorneys&#146; fees and testing), removal, remediation, restoration and/or abatement
thereof, or of any contamination therein involved, and shall survive the expiration or earlier termination of this Lease. No termination, cancellation or release agreement entered into by Landlord and Tenant shall release Tenant from its obligations
under this Lease with respect to Hazardous Substances, unless specifically so agreed by Landlord in writing at the time of such agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>6.3 <B>Tenant&#146;s Compliance with Requirements</B>. Tenant shall, at Tenant&#146;s sole cost and expense, fully, diligently and in a
timely manner, comply with all &#147;<B>Applicable Requirements,</B>&#148; which term is used in this Lease to mean all laws, rules, regulations, ordinances, directives, covenants, easements and restrictions of record, permits, the requirements of
any applicable fire insurance underwriter or rating bureau, and the recommendations of Landlord&#146;s engineers and/or consultants, relating in any manner to the Premises (including but not limited to matters pertaining to (i)&nbsp;industrial
hygiene, (ii)&nbsp;environmental conditions on, in, under or about the Premises, including soil and ground water conditions, and (iii)&nbsp;the use, generation, manufacture, production, installation, maintenance, removal, transportation, storage,
spill, or release of any Hazardous Substance), now in effect or which may hereafter come into effect. Tenant shall, within five (5)&nbsp;days after receipt of Landlord&#146;s written request, provide Landlord with copies of all documents and
information, including but not limited to permits, registrations, manifests, applications, reports and certificates, evidencing Tenant&#146;s compliance with any applicable Requirements specified by Landlord, and shall immediately upon receipt,
notify Landlord in writing (with copies of any documents involved) of any threatened or actual claim, notice, citation, warning, complaint or report pertaining to or involving failure by Tenant or the Premises to comply with any Applicable
Requirements.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>6.3 <B>Inspection; Compliance with Law</B>. Landlord, Landlord&#146;s agents, employees, contractors and
designated representatives, and the holders of any mortgages, deeds of trust or ground leases on the Premises (&#147;<B>Lenders</B>&#148;) shall have the right to enter the Premises at any time in the case of an emergency, and otherwise at
reasonable times upon reasonable advance notice to Tenant, for the purpose of inspecting the condition of the Premises and for verifying compliance by Tenant with this Lease and all Applicable Requirements (as defined in Paragraph 6.3), and Landlord
shall be entitled to employ experts and/or consultants in connection therewith to advise Landlord with respect to Tenant&#146;s activities, including but not limited to Tenant&#146;s installation, operation, use, monitoring, maintenance, or removal
of any Hazardous Substance on or from the Premises. The costs and expenses of any such inspections shall be paid by the party requesting same (and if paid by Landlord, such cost will not be included in Common Area Operating Expenses), unless a
Default or Breach of this Lease by Tenant or a violation of Applicable Requirements or a contamination, caused or materially contributed to by Tenant, is found to exist or to be imminent, or unless the inspection is requested or ordered by a
governmental authority as the result of any such existing or imminent violation or contamination. In such case, Tenant shall upon request reimburse Landlord or Landlord&#146;s Lender, as the case may be, for the costs and expenses of such
inspections.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Maintenance, Repairs, Utility Installations, Trade Fixtures and Alterations</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <B>Tenant&#146;s Obligations</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Subject to the provision of Paragraphs 2.2 (Condition), 7.2 (Landlord&#146;s Obligations), 9 (Damage or Destruction), and 14
(Condemnation), Tenant shall, at Tenant&#146;s sole cost and expense and at all times, keep the Premises and every part thereof in good order, condition and repair (whether or not such portion of the Premises requiring repair, or the means of
repairing the same, are reasonably or readily accessible to Tenant, and whether or not the need for such repairs occurs as a result of Tenant&#146;s use, any prior use, the elements or the age of such portion of the Premises), including, without
limiting the generality of the foregoing, all equipment or facilities specifically serving the Premises, such as plumbing, heating, air conditioning, ventilating, electrical, lighting facilities, boilers, fired or unfired pressure vessels, fire hose
connections if within the Premises, fixtures, interior walls, interior surfaces of exterior walls, ceilings, floors, windows, doors, plate glass, and skylights, but excluding any items which are the responsibility of Landlord pursuant to Paragraph
7.2 below. Tenant, in keeping the Premises in good order, condition and repair, shall exercise and perform good maintenance practices. Tenant&#146;s obligations shall include restorations, replacements or renewals when necessary to keep the Premises
and all improvements thereon or a part thereof in good order, condition and state of repair. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Tenant shall, at Tenant&#146;s sole cost
and expense, procure and maintain a contract, with copies to Landlord, in customary form and substance for and with a contractor specializing and experienced in the inspection, maintenance and service of the heating, air conditioning and ventilation
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
system for the Premises. However, Landlord reserves the right, upon notice to Tenant, to procure and maintain the contract for the heating, air conditioning and ventilating systems, and if
Landlord so elects, Tenant shall reimburse Landlord, upon demand, for the cost thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If Tenant fails to perform Tenant&#146;s
obligations under this Paragraph 7.1, Landlord may enter upon the Premises after ten (10)&nbsp;days&#146; prior written notice to Tenant (except in the case of an emergency, in which case no notice shall be required), perform such obligations on
Tenant&#146;s behalf, and put the Premises in good order, condition and repair, in accordance with Paragraph 13.2 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>7.2
<B>Landlord&#146;s Obligations</B>. Subject to the provisions of Paragraphs 2.2 (Condition), 4.2 (Common Area Operating Expenses to the extent applicable), 7 (Use), 7.1 (Tenant&#146;s Obligations), 9 (Damage or Destruction) and 14 (Condemnation),
Landlord, subject to reimbursement pursuant to Paragraph 4.2 to the extent applicable, shall keep in good order, condition and repair the foundations, exterior walls, structural condition of interior bearing walls, roof, fire sprinkler and/or
standpipe and hose (if located in the Common Areas) or other automatic fire extinguishing system including fire alarm and/or smoke detection systems and equipment, fire hydrants, parking lots, walkways, parkways, driveways, landscaping, fences,
signs and utility systems serving the Common Areas and all parts thereof, as well as providing the services for which there is a Common Area Operating Expense pursuant to Paragraph 4.2. Landlord shall not be obligated to paint the exterior or
interior surfaces of exterior walls nor shall Landlord be obligated to maintain, repair or replace windows, doors or plate glass of the Premises. Tenant expressly waives the benefit of any statute now or hereafter in effect which would otherwise
afford Tenant the right to make repairs at Landlord&#146;s expense or terminate this Lease because of Landlord&#146;s failure to keep the Building, Industrial Center or Common Areas in good order, condition and repair.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <B>Utility Installations, Trade Fixtures, Alterations</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(a) <B>Definitions; Consent Required</B>. The term &#147;<B>Utility Installations</B>&#148; is used in this Lease to refer to all air
lines, power panels, electrical distribution, security, fire protections systems, lighting fixtures, heating, ventilating and air conditioning equipment, plumbing, and fencing in, on or about the Premises. The term &#147;<B>Trade Fixtures</B>&#148;
shall mean Tenant&#146;s machinery and equipment which can be removed without doing material damage to the Premises. The term &#147;<B>Alterations</B>&#148; shall mean any modification of the improvements on the Premises under the terms of this
Lease, other than Utility Installations or Trade Fixtures. &#147;<B>Tenant-Owned Alterations and/or Utility Installations</B>&#148; are defined as Alterations and/or Utility Installations made by Tenant that are not yet owned by Landlord pursuant to
Paragraph 7.4(a). Tenant shall not make nor cause to be made any Alterations or Utility Installations in, on, under or about the Premises without Landlord&#146;s prior written consent. Tenant may, however, make non-structural Utility Installations
to the interior of the Premises (excluding the roof) without Landlord&#146;s consent but upon notice to Landlord, so long as they are not visible from the outside of the Premises, do not involve puncturing, relocating or removing the roof or any
existing walls, or changing or interfering with the fire sprinkler or fire detection systems and the cost thereof does not exceed $25,000.00.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(b) <B>Consent</B>. Any Alterations or Utility Installations that Tenant shall desire to make and which require the consent of the
Landlord shall be presented to Landlord in written form with detailed plans. All consents given by Landlord, whether by virtue of Paragraph 7.3(a) or by subsequent specific consent, shall be deemed conditioned upon: (i)&nbsp;Tenant&#146;s acquiring
all applicable permits required by governmental authorities; (ii)&nbsp;the furnishing of copies of such permits together with a copy of the plans and specifications for the Alteration or Utility Installation to Landlord prior to commencement of the
work thereon; and (iii)&nbsp;the compliance by Tenant with all conditions of said permits in a prompt and expeditious manner. Any Alterations of Utility Installations by Tenant during the term of this Lease shall be done in a good and workmanlike
manner, with good and sufficient materials, and be in compliance with all Applicable Requirements. Tenant shall promptly upon completion thereof furnish Landlord with as-built plans and specifications therefor. Landlord may (but without obligation
to do so) condition its consent to any requested Alteration or Utility Installation that costs $25,000.00 or more upon Tenant&#146;s providing Landlord with a lien and completion bond in an amount equal to one and one-half times the estimated cost
of such Alteration or Utility Installation.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <B>Lien Protection</B>. Tenant shall pay when due all claims for labor or
materials furnished or alleged to have been furnished to or for Tenant at or for use on the Premises, which claims are or may be secured by any mechanic&#146;s or materialmen&#146;s lien against the Premises or any interest therein. Tenant shall
give Landlord not less than ten (10)&nbsp;days&#146; notice prior to the commencement of any work in, on, or about the Premises, and Landlord shall have the right to post notices of non-responsibility in or on the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Premises as provided by law. If Tenant shall, in good faith, contest the validity of any such lien, claim or demand, then Tenant shall, at its sole expense, defend and protect itself, Landlord
and the Premises against the same and shall pay and satisfy any such adverse judgment that may be rendered thereon before the enforcement thereof against the Landlord or the Premises. If Landlord shall require, Tenant shall furnish to Landlord a
surety bond satisfactory to Landlord in an amount equal to one and one-half times the amount of such contested lien claim or demand, indemnifying Landlord against liability for the same, as required by law for the holding of the Premises free from
the effect of such lien or claim. In addition, Landlord may require Tenant to pay Landlord&#146;s attorneys&#146; fees and costs in participating in such action if Landlord shall decide it is to its best interest to do so. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <B>Ownership, Removal, Surrender, and Restoration</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(a) <B>Ownership</B>. Subject to Landlord&#146;s right to require their removal as expressly set forth below, and to cause Tenant to
become the owner thereof as hereinafter provided in this Paragraph 7.4, all Alterations and Utility Installations made to the Premises by Tenant shall be the property of and owned by Tenant, but considered a part of the Premises. Landlord may, at
any time and at its option, elect in writing to Tenant to be the owner of all or any specified part of the Tenant-Owned Alterations and Utility Installations. Unless otherwise instructed per Subparagraph 7.4(b) hereof, all Tenant-Owned Alterations
and Utility Installations shall, at the expiration or earlier termination of this Lease, become the property of Landlord and remain upon the Premises and be surrendered with the Premises by Tenant.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(b) <B>Removal</B>. Landlord may, by notice delivered to Tenant concurrently with Landlord&#146;s consent to the installation of any
Tenant-Owned Alterations or Utility Installations (but not the Tenant Improvements or initial Alterations) require that any or all of such Tenant-Owned Alterations or Utility Installations be removed by the expiration or earlier termination of this
Lease, notwithstanding that their installation may have been consented to by Landlord. Landlord may require the removal at any time of all or any part of any Alterations or Utility Installations made without the required consent of Landlord.<B>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(c) <B>Surrender/Restoration</B>. The voluntary or other surrender of this Lease by Tenant, or a mutual cancellation thereof,
shall not work a merger, and shall, at the option of Landlord, terminate all or any existing subleases or subtenancies, or may, at the option of Landlord, operate as an assignment to Landlord of any or all such subleases or subtenancies. Immediately
prior to the expiration or sooner termination of this Lease, Tenant shall remove all of Tenant&#146;s signs from the exterior of the Building and shall remove all of Tenant&#146;s equipment, trade fixtures, furniture, supplies, wall decorations and
other personal property from the Leased Premises, and shall vacate and surrender the Leased Premises to Landlord in the same condition, broom clean, as existed at the Lease Commencement Date, subject to Tenant-Owned Alterations and Utility
Installations the removal of which is not required hereunder. Tenant shall repair all damage to the Leased Premises caused by Tenant or by Tenant&#146;s removal of Tenant&#146;s property and all damage to the exterior of the Building caused by
Tenant&#146;s removal of Tenant&#146;s signs. Tenant shall replace all stained or damaged ceiling tiles and shall repair or replace, as necessary, all burned out light bulbs and damaged or stained light lenses and shall touch up any painted walls if
needed. Tenant shall patch and refinish, to Landlord&#146;s reasonable satisfaction, all penetrations made by Tenant or its employees to the floor, walls or ceiling of the Leased Premises, whether such penetrations were made with Landlord&#146;s
approval or not. Additionally, Tenant shall, prior to the expiration or sooner termination of this Lease, remove any improvements, constructed or installed by Tenant which Landlord pursuant to the provisions of Section&nbsp;7.4(b) above, previously
requested be so removed by Tenant and repair all damage caused by such removal. If the Leased Premises are not surrendered to Landlord in the condition required by this Article at the expiration or sooner termination of this Lease, Landlord may, at
Tenant&#146;s expense, so remove Tenant&#146;s signs, property and/or improvements not so removed and make such repairs and replacements not so made or hire, at Tenant&#146;s expenses, independent contractors to perform such work. Tenant shall be
liable to Landlord for all costs incurred by Landlord in returning the Leased Premises to the required condition and Tenant shall be deemed to have impermissibly held over until such time as such required work is completed. Tenant shall pay Base
Monthly Rent and Additional Rent at the rate payable immediately preceding the Expiration Date until such work is completed.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Insurance;
Indemnity</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.1 <B>Payment of Premiums</B>. The cost of the premiums for the insurance policies maintained by Landlord
under this Paragraph B shall be a Common Area Operating Expense pursuant to Paragraph 4.2 hereof. Premiums for policy periods commencing prior to, or extending beyond, the term of this Lease shall be prorated to coincide with the corresponding
Commencement Date or Expiration Date.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <B>Liability Insurance</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <B>Carried by Tenant</B>. Tenant shall obtain and keep in force during the term of this Lease a Commercial General Liability policy of
insurance protecting Tenant, Landlord and any Lender(s) whose names have been provided to Tenant in writing (as additional insureds) against claims for bodily injury, personal injury and property damage based upon, involving or arising out of the
ownership, use, occupancy or maintenance of the Premises and all areas appurtenant thereto. Such insurance shall be on an occurrence basis providing single limit coverage in an amount not less than $1,000,000 per occurrence with an &#147;Additional
Insured-Managers or Landlords of Premises&#148; endorsement and contain the &#147;Amendment of the Pollution Exclusion&#148; endorsement for damage caused by heat, smoke or fumes from a hostile fire. Tenant must either cause their liability policy
to be endorsed to include pollution liability coverage, onsite and off site, including release of any pollutants, toxins, or contaminants, whether such release is sudden or prolonged or willful or accidental OR Tenant must procure a separate policy
which provides coverage for pollution, liability, premises pollution, on site and off site, including release of any pollutants, toxins, or contaminants, whether such release is sudden or prolonged or willful or accidental. The policy shall not
contain any intra-insured exclusions as between insured persons or organizations, but shall include coverage for liability assumed under this Lease as an &#147;<B>insured contract</B>&#148; for the performance of Tenant&#146;s indemnity obligations
under this Lease. The limits of said insurance required by this Lease or as carried by Tenant shall not, however, limit the liability of Tenant nor relieve Tenant of any obligation hereunder. All insurance to be required by this Lease or as carried
by Tenant shall not, however, limit the liability of Tenant nor relieve Tenant of any obligation hereunder. All insurance to be carried by Tenant shall be primary to and not contributory with any similar insurance carried by Landlord, whose
insurance shall be considered excess insurance only. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(b) <B>Carried by Landlord</B>. Landlord shall also maintain liability
insurance described in Paragraph 8.2(a) above, in addition to and not in lieu of, the insurance required to be maintained by Tenant except coverage for pollution liability, premises pollution, on site and off site, including release of any
pollutants, toxins, or contaminants, whether such release is sudden or prolonged or willful or accidental, shall only be carried solely by Tenant. Tenant shall not be named as an additional insured therein.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <B>Property Insurance-Building, Improvements and Rental Value</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(a) <B>Building and Improvements</B>. Landlord shall obtain and keep in force during the term of this Lease a policy or policies in the
name of Landlord, with loss payable to Landlord and to any Lender(s), insuring against loss or damage to the Building and Premises. Such insurance shall be for full replacement cost, as the same shall exist from time to time, or the amount required
by any Lender(s), but in no event more than the commercially reasonable and available insurable value thereof if, by reason of the unique nature or age of the improvements involved, such latter amount is less than full replacement cost. Tenant-Owned
Alterations and Utility Installations, Trade Fixtures and Tenant&#146;s personal property shall be insured by Tenant pursuant to Paragraph 8.4. Landlord&#146;s policy or policies shall insure against all risks of direct physical loss or damage (and
at Landlord&#146;s option the perils of flood and/or earthquake), including coverage for any additional costs resulting from debris removal and reasonable amounts of coverage for the enforcement of any ordinance or law regulating the reconstruction
or replacement of any undamaged sections of the Building required to be demolished or removed by reason of the enforcement of any building, zoning, safety or land use laws as the result of a covered loss, but not including plate glass insurance.
Said policy or policies shall also contain an agreed valuation provision in lieu of any co-insurance clause, waiver of subrogation, and inflation guard protection causing an increase in the annual property insurance coverage amount by a factor of
not less than the adjusted U.S. Department of Labor Consumer Price Index for All Urban Consumers for the city nearest to where the Premises are located.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(b) <B>Rental Value</B>. Landlord shall also obtain and keep in force during the term of this Lease a policy or policies in the name of
Landlord, with loss payable to Landlord and any Lender(s), insuring the loss of the full rental and other charges payable by all tenants of the Building to Landlord for at least one year (including all Real Property Taxes, insurance costs, all
Common Area Operating Expenses and any scheduled rental increases). Said insurance may provide that in the event the Lease is terminated by reason of an insured loss, the period of indemnity for such coverage shall be extended beyond the date of the
completion of repairs or replacement of the Premises, to provide for one full year&#146;s loss of rental revenues from the date of any such loss. Said insurance shall contain an agreed valuation provision in lieu of any co-insurance clause, and the
amount of coverage shall be adjusted annually to reflect the projected rental income, Real Property Taxes, insurance premium costs and other expenses, if any, otherwise payable, for the next 12-month period. Common Area Operating Expenses shall
include any deductible amount in the event of such loss.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(c) <B>Adjacent Premises</B>. Tenant shall pay for any increase in the premiums for the
property insurance of the Building and for the Common Areas or other buildings in the Industrial Center if said increase is caused solely by Tenant&#146;s acts, omissions, use or occupancy of the Premises.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(d) <B>Tenant&#146;s Improvements</B>. Since Landlord is the Insuring Party, Landlord shall not be required to insure Tenant-Owned
Alterations and Utility Installations unless the item in question has become the property of Landlord under the terms of this Lease.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.4 <B>Tenant&#146;s Property Insurance</B>. Subject to the requirements of Paragraph 8.5, Tenant at its cost shall either by separate
policy or by endorsement to a policy already carried, maintain insurance coverage on all of Tenant&#146;s personal property, Trade Fixtures and Tenant-Owned Alterations and Utility Installations in, on, or about the Premises similar in coverage to
that carried by Landlord as the Insuring Party under Paragraph 8.3(a). Such insurance shall be full replacement cost coverage with a deductible not to exceed $10,000.00 per occurrence. Upon request from Landlord, Tenant shall provide Landlord with
written evidence that such insurance is in force.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5 <B>Insurance Policies</B>. Insurance required hereunder shall be in
companies duly licensed to transact business in the state where the Premises are located, and maintaining during the policy term a &#147;General Policyholders Rating&#148; of at least A-VII, or such other rating as may be required by a Lender, as
set forth in the most current issue of &#147;Best&#146;s Insurance Guide.&#148; Tenant shall not do or permit to be done anything which shall invalidate the insurance policies referred to in this Paragraph 8. Tenant shall cause to be delivered to
Landlord, within seven (7)&nbsp;days after the earlier of the Early Possession Date or the Commencement Date, certificates evidencing the existence and amounts of, the insurance required under Paragraph 8.2(a) and 8.4. No such policy shall be
cancelable or subject to material modification except after ten (10)&nbsp;days&#146; prior written notice to Landlord. Tenant shall at least thirty (30)&nbsp;days prior to the expiration of such policies, furnish Landlord with evidence of renewals
or &#147;insurance binders&#148; evidencing renewal thereof, or Landlord may following notice to order such insurance and charge the cost thereof to Tenant, which amount shall be payable by Tenant to Landlord upon demand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.6 <B>Waiver of Subrogation</B>. Notwithstanding any other provision of this Lease to the contrary, Tenant and Landlord each hereby
release and relieve the other, and waive their entire right to recover damages (whether in contract or in tort) against the other, for loss or damage to their property arising out of or incident to the perils required to be insured against under
Paragraph 8. The effect of such releases and waivers of the right to recover damages shall not be limited by the amount of insurance carried or required or by any deductibles applicable thereto. Landlord and Tenant agree to have their respective
insurance companies issuing property damage insurance waive any right to subrogation that such companies may have against Landlord or Tenant, as the case may be, so long as the insurance is not invalidated thereby.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.7 <B>Indemnity</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)
<U>By Tenant</U>. Subject to the provisions of Section&nbsp;8.6 above, Tenant, shall, during the term of this lease, indemnify and save harmless Landlord from any and all loss, damage, claims of damage, obligations, cause or causes of action, or
liabilities of any kind or nature (including reasonable costs of attorney&#146;s fees if Landlord is made a party to any action which Tenant&#146;s indemnity runs hereunder) by reason of injury or death of any person or persons or damage to any
property of any kind and to whomsoever belonging, including injury or death to the person or damage to the property of Tenant, Tenant&#146;s officers, directors, employees, agents, guests, subtenants and assignees, concessionaires and licensees, and
any other person, firm or corporation selling or manufacturing merchandise or services upon or from the demised premises, or any part thereof, from any cause or cause whatsoever which result from Tenant&#146;s use of the Premises or from any other
activity done, permitted or suffered by Tenant. As a material part of the consideration to Landlord, Tenant hereby assumes all risk of damage to property or injury to persons in or about the Premises from any cause whatsoever (except that which is
caused by the negligence or willful misconduct by Landlord or its Agents or by the failure of Landlord to observe any of the terms and conditions of this Lease after prior written notice from Tenant). Tenant&#146;s obligations under this paragraph
shall survive the termination of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>By Landlord</U>. Subject to the provisions of Section&nbsp;8.6, Landlord shall
indemnify, defend, protect and hold harmless Tenant and Tenant&#146;s agents, employees, officers, directors, shareholders </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and partners from and against all liabilities, obligations, damages, penalties, claims, causes of action, costs, charges and expenses, including reasonable attorneys&#146; fees, court costs,
administrative costs and costs of appeals which may be imposed upon or incurred by, or asserted by reason of any of the following which shall occur during the Term of this Lease, or during any period of time prior to the Lease Commencement Date:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Any work or act done in or about the Premises or the Building by Landlord or its agents, contractors or employees; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Any negligence or other wrongful act or omission on the part of the Landlord or any of its agents, contractors, subcontractors,
servants, employees, subtenants, licensees or invitees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Any accident, injury or damage to any persons or property occurring in, on
or about the common area, unless caused by the negligence or willful misconduct of Tenant, its employees, contractors or agents, as well as any accident, injury or damage to any persons or property occurring in or about the common area, unless
caused by the negligence or willful misconduct of Tenant, its employees, contractors or agents; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Any failure on the part of
Landlord to perform or comply with any of the covenants, agreements, terms, provisions, conditions or limitations contained in this Lease on its part to be performed or complied with as long as Landlord was given prior written notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8.8 <B>Exemption of Landlord from Liability</B>. Landlord shall not be liable for injury or damage which may be sustained by Tenant or
to the person or goods, wares, merchandise or other property of Tenant, Tenant&#146;s employees, contractors, invitees, customers, or any other person in or about the Premises, whether such damage or injury is caused by or results from fire,
earthquake, steam, electricity, gas, water or rain, which may leak or from or into any part of the premises or from the breakage, leakage, obstruction or other defects of pipes, fire sprinklers, wires, appliances, plumbing, HVAC or lighting
fixtures, or from any other cause, whether said injury or damage results from conditions arising upon the Premises or upon other portions of the Building of which the Premises are a part, from other sources or places, and regardless of whether the
cause of such damage or injury or the means of preparing the same is accessible or not. Landlord shall not be liable for any damages arising from any act or neglect of any other tenant of Landlord nor from the failure by Landlord to enforce the
provisions of any other lease in the Industrial Center. Notwithstanding Landlord&#146;s negligence or breach of this Lease, Landlord shall under no circumstances be liable for injury to Tenant&#146;s business or for any loss of income or profit
therefrom.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Damage or Destruction</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <B>Definitions</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(a) &#147;<B>Premises Partial Damage</B>&#148; shall mean damage or destruction to the Premises, other than Tenant-Owned Alterations
and Utility Installations, the repair cost of which damage or destruction is less than fifty percent (50%)&nbsp;of the then Replacement Cost (as defined in Paragraph 9.1(d)) of the Premises (excluding the Tenant-Owned Alterations and Utility
Installations and Trade Fixtures) immediately prior to such damage or destruction.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(b) &#147;<B>Premises Total
Destruction</B>&#148; shall mean damage or destruction to the Premises, other than Tenant-Owned Alterations and Utility Installations, the repair cost of which damage or destruction is fifty percent (50%)&nbsp;or more of the then Replacement Cost of
the Premises (excluding Tenant-Owned Alterations and Utility Installations and Trade Fixtures) immediately prior to such damage or destruction. In addition, damage or destruction to the Building, other than Tenant-Owned Alterations and Utility
Installations and Trade Fixtures of any tenants of the Building, the cost of which damage or destruction is fifty percent (50%)&nbsp;or more of the then Replacement Cost (excluding Tenant-Owned Alterations and Utility Installations and Trade
Fixtures of any Tenants of the Building) of the Building shall, at the option of Landlord, be deemed to be Premises total Destruction.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(c) &#147;<B>Industrial Center Total Destruction</B>&#148; shall mean damage or destruction to the Industrial Center or the Building in
which the premises are located, regardless of the damage to the premises. The cost of which damage or destruction is fifty percent (50%)&nbsp;or more of the then Replacement Cost of the Industrial Center or the Building (excluding Tenant-Owned
Alterations and Utility Installations and Trade Fixtures) immediately prior to such damage or destruction.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(d) &#147;<B>Insured Loss</B>&#148; shall mean damage or destruction to the Premises,
other than Tenant-Owned Alterations and Utility Installations and Trade Fixtures, which was caused by an event required to be covered by the insurance described in Paragraph 8.3(a) irrespective of any deductible amounts or coverage limits
involved.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(e) &#147;<B>Replacement Cost</B>&#148; shall mean the cost to repair or rebuild the improvements owned by
Landlord at the time of the occurrence to their condition existing immediately prior thereto, including demolition, debris removal and upgrading required by the operation of applicable building codes, ordinances or laws, and without deduction for
depreciation.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(f) &#147;<B>Hazardous Substance Condition</B>&#148; shall mean the occurrence or discovery of a condition
involving the presence of, or a contamination by, a Hazardous Substance as defined in Paragraph 6.2(a), in, on, or under the Premises.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>9.2 <B>Premises Partial or Total Damage - Insured or Uninsured Loss</B>. If Premises Partial or Total Damage that is an Insured or
Uninsured Loss occurs, then Landlord shall, at Landlord&#146;s expense, repair such damage (but not Tenant&#146;s Trade Fixtures or Tenant-Owned Alterations and Utility Installations) as soon as reasonably possible, but only to the extent of the
available insurance proceeds, if any (provided Landlord has maintained the insurance coverage required hereunder), and this Lease shall continue in full force and effect. In the event, however, that there is a shortage of insurance proceeds and such
shortage is due to any reason (other than Landlord&#146;s failure to maintain the insurance required hereunder) including the fact that some but not all of which may include the fact that, by reason of the unique nature of the improvements in the
Premises, full replacement cost insurance coverage was not commercially reasonable and available, then Landlord shall have no obligation to pay for the shortage in insurance proceeds or to fully restore the unique aspects of the Premises unless
Tenant provides Landlord with the funds to cover same, or adequate assurance thereof, within ten (10)&nbsp;days following receipt of written notice of such shortage and request therefore [no deductible payment will be included in any such
&#147;shortage&#148;]. If Landlord receives said funds or adequate assurance thereof within said thirty (30)&nbsp;day period, Landlord shall complete the repairs as soon as reasonably possible and this Lease shall remain in full force and effect. If
Landlord does not receive such funds or assurance within said period, Landlord may nevertheless elect by written notice to Tenant within ten (10)&nbsp;days thereafter to make such restoration and repair as is commercially reasonable with Landlord
paying any shortage in proceeds, in which case this Lease shall remain in full force and effect. If Landlord does not receive such funds or assurance within such thirty (30)&nbsp;day period, and if Landlord does not so elect to restore and repair,
then this Lease shall terminate sixty (60)&nbsp;days following the occurrence of the damage or destruction. Unless otherwise agreed, Tenant shall in no event have any right to reimbursement from Landlord for any funds contributed by Tenant to repair
any such damage or destruction.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <B>Intentionally Deleted</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>9.4 <B>Industrial Center Destruction</B>. Notwithstanding any other provision hereof, if the Industrial Center in which the Premises
are located suffers Total Destruction (including any destruction required by any authorized public authority), this Lease at Landlord&#146;s option shall terminate sixty (60)&nbsp;days following the date of such Total Destruction, whether or not the
damage or destruction affected the premises. In the event, however, that the damage or destruction was caused by Tenant, Landlord shall have the right to recover Landlord&#146;s damages from Tenant except as released and waived in Paragraph 9.7.<B>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <B>Damage Near End of Term</B>. If at any time during the last six (6)&nbsp;months of the term of this Lease there is damage to
the Premises for which the cost to repair (other than the repair of Tenant&#146;s Trade Fixtures or Tenant-Owned Alterations and Utility Installations) exceeds three (3)&nbsp;months&#146; Base Rent, whether or not an Insured Loss, Landlord may, at
Landlord&#146;s option, terminate this Lease effective sixty (60)&nbsp;days following the date of occurrence of such damage by giving written notice to Tenant of Landlord&#146;s election to do so within thirty (30)&nbsp;days after the date of
occurrence of such damage. Provided, however, if Tenant at that time has an exercisable option to extend this Lease, then Tenant may preserve this Lease by (a)&nbsp;exercising such option, and (b)&nbsp;providing Landlord with any shortage in
insurance proceeds (or adequate assurance thereof) needed to make the repairs on or before the earlier of (i)&nbsp;the date which is ten (10)&nbsp;days after Tenant&#146;s receipt of Landlord&#146;s written notice purporting to terminate this Lease,
or (ii)&nbsp;the day prior to the date upon which such option expires. If Tenant duly exercises such option during such period and provides Landlord with funds (or adequate assurance thereof) to cover any shortage in insurance proceeds,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Landlord shall, at Landlord&#146;s expense repair such damage as soon as reasonably possible and this Lease shall continue in full force and effect. If Tenant fails to exercise such option and
provide such funds or assurance during such period, then this Lease shall terminate as of the date set forth in the first sentence of this Paragraph 9.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6 <B>Abatement of Rent; Tenant&#146;s Remedies</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) In the event of (i)&nbsp;Premises Partial Damage or (ii)&nbsp;Hazardous Substance Condition for which Tenant is not legally responsible,
the Base Rent, Common Area Operating Expenses and other charges, <B>if </B>any, payable by Tenant hereunder for the period during which such damage or condition, its repair, remediation or restoration continues, shall be abated in proportion to the
degree to which Tenant&#146;s use of the Premises is impaired, but not in excess of proceeds from insurance required to be carried under Paragraph&nbsp;8.3(b). Except for abatement of Base Rent, Common Area Operating Expenses and other charges, if
any, as aforesaid, all other obligations of Tenant hereunder shall be performed by Tenant, and Tenant shall have no claim against Landlord for any damage suffered by reason of any such damage, destruction, repair, remediation or restoration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(b) If Landlord shall be obligated to repair or restore the Premises under the provisions of this Paragraph 9 and shall not commence,
in a substantial and meaningful way, the repair or restoration of the Premises within ninety (90)&nbsp;days after such obligation shall accrue, Tenant may, at any time prior to the commencement of such repair or restoration, give written notice to
Landlord and to any Lenders of which Tenant has actual notice of Tenant&#146;s election to terminate this Lease on a date not less than sixty (60)&nbsp;days following the giving of such notice. If Tenant gives such notice to Landlord and such
Lenders and such repair or restoration is not commenced within thirty (30)&nbsp;days after receipt of such notice, this Lease shall terminate as of the date specified in said notice. If Landlord or a Lender commences the repair or restoration of the
Premises within thirty (30)&nbsp;days after the receipt of such notice, this Lease shall continue in full force and effect (subject to the remaining rights of that set forth herein). &#147;<B>Commence</B>&#148; as used in this Paragraph&nbsp;9.6
shall mean either the unconditional authorization of the preparation of the required plans, or the beginning of the actual work on the Premises, whichever occurs first.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(c) In the event of any damage which affects the Building, Landlord will, within thirty (30)&nbsp;days following the date of the
damage, deliver to Tenant an estimate of the time necessary to repair the damage in question such that the Premises may be used by and accessible to Tenant and the Building; such notice will be based upon the review and opinions of Landlord&#146;s
architect and contractor (&#147;<B>Landlord&#146;s Repair Notice</B>&#148;). If the Premises are damaged by fire or other casualty and are rendered not reasonably usable for Tenant&#146;s business purposes thereby, or if the Building shall be so
damaged that Tenant shall be deprived of reasonable access to the Premises, and if, pursuant to Landlord&#146;s Repair Notice, the restoration shall not be substantially completed on or before the date which shall be nine (9)&nbsp;months following
the date of such damage or destruction, Tenant shall have the right to terminate this Lease (with respect to the affected Floors only, or the entire Premises, at Tenant&#146;s option) by giving written notice (the &#147;<B>Termination
Notice</B>&#148;) to Landlord not later than thirty (30)&nbsp;days following receipt of Landlord&#146;s Repair Notice. If Tenant gives a Termination Notice, this Lease shall be deemed cancelled and terminated as of the date of the damage as if such
date were the Expiration Date, and Rent shall be apportioned and shall be paid or refunded, as the case may be up to and including the date of such damage or destruction. Notwithstanding the foregoing, if Tenant was entitled to but elected not to
exercise its right to terminate this Lease and Landlord does not substantially complete the repair and restoration of the Premises within two (2)&nbsp;months after the expiration of the estimated period of time set forth in Landlord&#146;s Repair
Notice, which period shall be extended to the extent of any delays caused by Tenant, then Tenant may terminate this Lease by written notice to Landlord within thirty (30)&nbsp;days after the expiration of such period, as the same may be so
extended.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.7 <B>Hazardous Substance Conditions</B>. If a Hazardous Substance Condition occurs, unless Tenant is legally
responsible therefor (in which case Tenant shall make the investigation and remediation thereof required by Applicable Requirements and this Lease shall continue in full force and effect, but subject to Landlord&#146;s rights under Paragraph 6.2(c)
and Paragraph 13), Landlord may at Landlord&#146;s option either (i)&nbsp;investigate and remediate such Hazardous Substance Condition, if required, as soon as reasonably possible at Landlord&#146;s expense, in which event this Lease shall continue
in full force and effect, or (ii)&nbsp;if the estimated cost to investigate and remediate such condition exceeds twelve (12)&nbsp;times the then monthly Base Rent or $50,000, whichever is greater, give written notice to Tenant within thirty
(30)&nbsp;days after receipt by Landlord of knowledge of the occurrence of such Hazardous Substance Condition of Landlord&#146;s desire to terminate this Lease as of the date sixty (60)&nbsp;days following the date of such notice. In the event
Landlord </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
elects to give such notice of Landlord&#146;s intention to terminate this Lease, Tenant shall have the right within ten (10)&nbsp;days after receipt of such notice to give written notice to
Landlord of Tenant&#146;s commitment to pay for the excess costs of (a)&nbsp;investigation and remediation of such Hazardous Substance Condition to the extent required by Applicable Requirements, over (B)&nbsp;an amount equal to twelve
(12)&nbsp;times the then monthly Base Rent or $50,000 whichever is greater. Tenant shall provide Landlord with the funds required of Tenant or satisfactory assurance thereof within thirty (30)&nbsp;days following said commitment by Tenant. In such
event this Lease shall continue in full force and effect, and Landlord shall proceed to make such investigation and remediation as soon as reasonably possible after the required funds are available. If Tenant does not give such notice and provide
the required funds or assurance thereof within the time period specified above, this Lease shall terminate as of the date specified in Landlord&#146;s notice of termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>9.8 <B>Termination - Advance Payments</B>. Upon termination of this Lease pursuant to this Paragraph 9, Landlord shall return to Tenant
any advance payment made by Tenant to Landlord and so much of Tenant&#146;s Security Deposit as has not been, or is not then required to be, used by Landlord under the terms of this Lease.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>9.9 <B>Waiver of Statutes</B>. Landlord and Tenant agree that the terms of this Lease shall govern the effect of any damage to or
destruction of the Premises and the Building with respect to the termination of this Lease and hereby waive the provisions of any present or future statute to the extent it is inconsistent herewith.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Real Property Taxes</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>10.1 <B>Payment of Taxes</B>. Landlord shall pay the Real Property Taxes, as defined in Paragraph 10.2, applicable to the Industrial
Center, and except as otherwise provided in Paragraph 10.3, any such amounts shall be included in the calculation of Common Area Operating Expenses in accordance with the provisions of Paragraph 4.2.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>10.2 <B>Real Property Tax Definition</B>. As used herein, the term &#147;<B>Real Property Taxes</B>&#148; shall include any form of
real estate tax or assessment, general, special, ordinary or extraordinary, and any license fee, commercial rental tax, improvement bond or bonds, levy or tax (other than inheritance, personal income or estate taxes) imposed upon the Industrial
Center by any authority having the direct or indirect power to tax, including any city, state or federal government, or any school, agricultural, sanitary, fire, street, drainage, or other improvement district thereof, levied against any legal or
equitable interest of Landlord in the Industrial Center or any portion thereof, Landlord&#146;s right to rent or other income therefrom, and/or Landlord&#146;s business of leasing the Premises. The term &#147;<B>Real Property Taxes</B>&#148; shall
also include any tax, fee, levy, assessment or charge, or any increase therein, imposed by reason of events occurring, or changes in Applicable Law taking effect, during the term of this Lease, including but not limited to a change in the ownership
of the Industrial Center or in the improvements thereon, the execution of this Lease, or any modification, amendment or transfer thereof, and whether or not contemplated by the Parties. In calculating Real Property Taxes for any calendar year, the
Real Property Taxes for any real estate tax year shall be included in the calculation of Real Property Taxes for such calendar year based upon the number of days which such calendar year and tax year have in common.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>10.3 <B>Additional Improvements</B>. Tenant shall pay to Landlord the Common Area Operating Expenses as payable under Paragraph 4.2,
the entirety of any increase in Real Property Taxes if assessed solely by reason of Alterations, Trade Fixtures or Utility Installations placed upon the Premises by Tenant or at Tenant&#146;s request.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>10.4 <B>Joint Assessment</B>. If the Building is not separately assessed, Real Property Taxes allocated to the Building shall be an
equitable proportion of the Real Property Taxes for all of the land and improvements included within the tax parcel assessed or the industrial center, such proportion to be determined by Landlord from the respective valuations assigned in the
assessor&#146;s work sheets or such other information as may be reasonably available. Landlord&#146;s reasonable determination thereof, in good faith, shall be conclusive.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.5 <B>Tenant&#146;s Property Taxes</B>. Tenant shall pay prior to delinquency all taxes assessed against and levied upon Tenant-Owned
Alterations and Utility Installations, Trade Fixtures, furnishings, equipment and all personal property of Tenant contained in the Premises or stored within the Industrial Center. When possible, Tenant shall cause its Tenant-Owned Alterations and
Utility Installations, Trade Fixtures, furnishings, equipment and all other personal property to be assessed and billed separately from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the real property of Landlord. If any of Tenant&#146;s said property shall be assessed with Landlord&#146;s real property, Tenant shall pay Landlord the taxes attributable to Tenant&#146;s
property within ten (10)&nbsp;days after receipt of a written statement setting forth the taxes applicable to Tenant&#146;s property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11.
Utilities</B>. Tenant shall pay directly for all utilities and services supplied to the Premises, including but not limited to electricity, water, telephone, security, gas, sewer, trash removal and cleaning of the Premises, together with any taxes
thereon. If any such utilities or services are not separately metered to the Premises or separately billed to the Premises, Tenant shall pay to Landlord a reasonable proportion to be determined by Landlord of all such charges jointly metered or
billed with other premises in the Building, in the manner and within the time periods set forth in Paragraph 4.2(d). Landlord shall not be liable to Tenant for injury, damage, loss of Tenant&#146;s business or profits, from any failure,
interruption, rationing or other curtailment in the supply of electric, gas, water or other utilities from whatever cause. Tenant shall not consume water in excess of that usually furnished or supplied for reasonable and normal drinking and lavatory
use in connection with an office environment (as determined by Landlord), without first procuring the written consent of Landlord, which Landlord may refuse, and in the event of consent, Landlord may have installed a water meter in the Premises to
measure the amount of water consumed. The cost of any such meter and of its installation, maintenance and repair shall be paid for by the Tenant, and Tenant agrees to pay to Landlord promptly upon demand for all such water consumed as shown by said
meters, at the rates charged for such services by the local public utility plus any additional expense incurred in keeping account of the water so consumed. If a separate meter is not installed, the excess cost for such water shall be established by
an estimate made by a utility company or electrical engineer hired by Landlord at Tenant&#146;s expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Assignment and Subletting</B>.<B>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1 <B>Landlord&#146;s Consent Required</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall not assign this lease, nor any right hereunder, nor sublet the premises, nor any part thereof, without the prior written
consent of Landlord which will not be unreasonably withheld, conditioned or delayed. In exercising its reasonable discretion Landlord may consider all commercially relevant factors involved in the leasing of the Premises including but not limited to
the a) the creditworthiness and financial stability of the prospective assignee or subtenant (as compared to the obligations of such entity under the sublease or assignment, as the case may be); b) references of prior landlords; c) the past history
of such subtenant, with respect to involvement in litigation and bankruptcy proceedings; d) the impact of said subtenant or assignee and proposed use of the premises on pedestrian and vehicular traffic, other tenants, and parking; e) the use,
generation or disposal of hazardous materials. The presence of one negative factor enumerated above if material, shall be deemed reasonable justification for Landlord&#146;s withholding consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) A change in the control of Tenant shall constitute an assignment requiring Landlord&#146;s consent. The transfer of forty-nine percent
(49%)&nbsp;or more of the voting control of Tenant shall constitute a change in control for this purpose. An initial public offering of Tenant&#146;s stock on a recognized exchange, as well as the subsequent transfer of shares of Tenant&#146;s stock
on a public exchange, will not, however, be deemed an assignment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(c) So long as Tenant is not entering into the Permitted
Transfer for the purpose of avoiding or otherwise circumventing the remaining terms of this Article 12, Tenant may assign its entire interest under this Lease, without the consent of Landlord, to (i)&nbsp;an affiliate, subsidiary, or parent of
Tenant, or a corporation, partnership or other legal entity wholly owned by Tenant (collectively, an &#147;<B>Affiliated Party</B>&#148;), or (ii)&nbsp;a successor to Tenant by purchase, merger, consolidation or reorganization, provided that all of
the following conditions are satisfied (each such Transfer a &#147;<B>Permitted Transfer</B>&#148;): (1)&nbsp;Tenant is not in default under this Lease; (2)&nbsp;Tenant shall give Landlord written notice prior to the effective date of the proposed
Permitted Transfer; and (3)&nbsp;with respect to a purchase, merger, consolidation or reorganization or any Permitted Transfer which results in Tenant ceasing to exist as a separate legal entity, (a)&nbsp;Tenant&#146;s successor shall own all or
substantially all of the assets of Tenant, and (b)&nbsp;Tenant&#146;s successor shall have a net worth which is at least equal to the greater of Tenant&#146;s net worth at the date of this Lease or Tenant&#146;s net worth as of the day prior to the
proposed purchase, merger, consolidation or reorganization. If requested by Landlord, Tenant&#146;s successor shall sign a commercially reasonable form of assumption agreement. As used herein, (A)&nbsp;&#147;<B>parent</B>&#148; shall mean a company
which owns a majority of Tenant&#146;s voting equity; (B)&nbsp;&#147;<B>subsidiary</B>&#148; shall mean an entity wholly owned by Tenant or at least 51% of whose voting equity is owned by Tenant; and (C)&nbsp;&#147;<B>affiliate</B>&#148; shall mean
an entity controlled by, controlling or under common control with Tenant.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(d) An assignment or subletting of Tenant&#146;s interest in this Lease without
Landlord&#146;s specific prior written consent shall, at Landlord&#146;s option, be a Default curable after notice per Paragraph 13.1, or a non-curable Breach without the necessity of any notice and grace period. If Landlord elects to treat such
unconsented to assignment or subletting as a non-curable Breach, Landlord shall have the right to either: (i)&nbsp;terminate this Lease, or (ii)&nbsp;upon thirty (30)&nbsp;days&#146; written notice (&#147;<B>Landlord&#146;s Notice</B>&#148;),
increase the monthly Base Rent for the Premises to the greater of the then fair market rental value of the Premises, as reasonably determined by Landlord, or one hundred ten percent (110%)&nbsp;of the Base Rent then in effect. Pending determination
of the new fair market rental value, if disputed by Tenant, Tenant shall pay the amount set forth in Landlord&#146;s Notice, with any overpayment credited against the next installment(s) of Base Rent coming due, and any underpayment for the period
retroactively to the effective date of the adjustment being due and payable immediately upon the determination thereof. Further, in the event of such Breach and rental adjustment, (i)&nbsp;the purchase price of any option to purchase the Premises
held by Tenant shall be subject to similar adjustment to the then fair market value as reasonably determined by Landlord (without the Lease being considered an encumbrance or any deduction for depreciation or obsolescence, and considering the
Premises at its highest and best use and in good condition) or one hundred ten percent (110%)&nbsp;of the price previously in effect, (ii)&nbsp;any index-oriented rental or price adjustment formulas contained in this Lease shall be adjusted to
require that the base index be determined with reference to the index applicable to the time of such adjustment, and (iii)&nbsp;any fixed rental adjustments scheduled during the remainder of the Lease term shall be increased in the same ratio as the
new rental bears to the Base Rent in effect immediately prior to the adjustment specified in Landlord&#146;s Notice.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)
Tenant&#146;s remedy for any breach of this Paragraph 12.1 by Landlord shall be limited to compensatory damages and/or injunctive relief. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.2 <B>Terms and Conditions Applicable to Assignment and Subletting</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(a) Landlord will respond to any request for consent to an assignment or sublease within fifteen (15)&nbsp;days following receipt of
such request. If Landlord fails to timely deliver to Tenant notice of Landlord&#146;s consent, or the withholding of consent, to a proposed Transfer, Tenant may send a second (2nd)&nbsp;notice to Landlord, which notice must contain the following
inscription, in bold faced lettering: &#147;<B>SECOND NOTICE DELIVERED PURSUANT TO ARTICLE 12 OF LEASE - - FAILURE TO TIMELY RESPOND WITHIN FIVE </B>(<B>5</B>)<B>&nbsp;BUSINESS DAYS SHALL RESULT IN DEEMED APPROVAL OF ASSIGNMENT OR
SUBLEASE.</B>&#148; If Landlord fails to deliver notice of Landlord&#146;s consent to, or the withholding of Landlord&#146;s consent, to the proposed assignment or sublease within such five (5)&nbsp;business day period, Landlord shall be deemed to
have approved the assignment or sublease in question. If Landlord at any time timely delivers notice to Tenant or Landlord&#146;s withholding of consent to a proposed assignment or sublease, Landlord shall specify in reasonable detail in such
notice, the basis for such withholding of consent. Regardless of Landlord&#146;s consent, any assignment or subletting shall not (i)&nbsp;be effective without the express written assumption by such assignee or subtenant of the obligations of Tenant
under this Lease, (ii)&nbsp;release Tenant of any obligations hereunder, nor (iii)&nbsp;alter the primary liability of Tenant for the payment of Base Rent and other sums due Landlord hereunder or for the performance of any other obligations to be
performed by Tenant under this Lease.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Landlord may accept any rent or performance of Tenant&#146;s obligations from any person
other than Tenant pending approval or disapproval of an assignment. Neither a delay in the approval or disapproval of such assignment nor the acceptance of any rent for performance shall constitute a waiver or estoppel of Landlord&#146;s right to
exercise its remedies for the Default or Breach by Tenant of any of the terms, covenants or conditions of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) The consent of
Landlord to any assignment or subletting shall not constitute consent to any subsequent assignment or subletting by Tenant or to any subsequent or successive assignment or subletting by the assignee or subtenant. However, Landlord may consent to
subsequent or successive assignment or subletting by the assignee or subtenant. However, Landlord may consent to subsequent sublettings and assignments of the sublease or any amendments or modifications thereto without notifying Tenant or anyone
else liable under this Lease or the sublease and without obtaining their consent; provided, however, that if Landlord consents to a subsequent amendment of this Lease with an assignee of Tenant, which amendment increases the obligations or liability
of the &#147;tenant&#148; hereunder, the original Tenant shall not be liable for such increased obligations unless the original Tenant consented to such amendment in writing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) In the event of any Default or Breach of Tenant&#146;s obligation under this Lease, Landlord
may proceed directly against Tenant, any guarantors or anyone else responsible for the performance of the Tenant&#146;s obligations under this Lease, including any subtenant, without first exhausting Landlord&#146;s remedies against any other person
or entity responsible therefor to Landlord, or any security held by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Each request for consent to an assignment or subletting
shall be in writing, accompanied by information relevant to Landlord&#146;s determination as to the financial and operational responsibility and appropriateness of the proposed assignee or subtenant, including but not limited to the intended use
and/or required modification of the Premises, if any, together with a non-refundable deposit of $1,000, as reasonable consideration for Landlord&#146;s considering and processing the request for consent. Tenant agrees to provide Landlord with such
other or additional information and/or documentation as may be reasonably requested by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) Any assignee of, or subtenant under,
this Lease shall, by reason of accepting such assignment or entering into such sublease, be deemed, for the benefit of Landlord, to have assumed and agreed to conform and comply with each and every term, covenant, condition and obligation herein to
be observed or performed by Tenant during the term of said assignment or sublease, other than such obligations as are contrary to or inconsistent with provisions of an assignment or sublease to which Landlord has specifically consented in writing.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) If Tenant desires to Sublet substantially the entire Premises for substantially the remainder of the term (other than pursuant to the
Permitted Transfer) or assign the Premises (other than pursuant to a Permitted Transfer) prior to the expiration of the term of this lease and obtains an acceptable subtenant or assignee, then the Landlord shall have the option prior to the
execution of the sublease or assignment agreement to cancel this Lease with respect to the portion of the Premises that is the subject of such proposed assignment or sublease. Landlord, in Landlord&#146;s sole discretion, may then enter into a new
lease with any prospective subtenant as the substitute Tenant. If Landlord exercises this option, then this present lease shall be terminated by mutual agreement as of that time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>12.3 <B>Additional Terms and Conditions Applicable to Assignment and Subletting</B>. The following terms and conditions shall apply to
any subletting or assignment by Tenant of all or any part of the Premises and shall be deemed included in all subleases and assignments under this Lease whether or not expressly incorporated therein:<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Tenant hereby assigns and transfers to Landlord all of Tenant&#146;s interest in all rentals, income or other consideration arising from
any sublease or assignment of all or a portion of the Premises heretofore or hereafter made by Tenant, and Landlord may collect such sums and apply same toward Tenant&#146;s obligations under this Lease. Landlord shall not, by reason of the
foregoing provision or any other assignment of such sublease to Landlord, nor by reason of the collection of the rents from a subtenant, be deemed liable to the subtenant for any failure of Tenant to perform and comply with any of Tenant&#146;s
obligations to such subtenant under such Sublease. Tenant hereby irrevocably authorizes and directs any such subtenant, upon receipt of a written notice from Landlord, to pay to Landlord the rents and other charges due and to become due under the
sublease. Subtenant shall rely upon any such statement and request from Landlord and shall pay such rents and other charges to Landlord without any obligation or right to inquire as to whether any Breach exists and notwithstanding any notice from or
claim from Tenant to the contrary. Tenant shall have no right or claim against such subtenant, or, until the Breach has been cured, against Landlord, for any such rents and other charges so paid by said subtenant to Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) In the event of a Breach by Tenant in the performance of its obligations under this Lease, Landlord, at its option and without any
obligation to do so, may require any subtenant to attorn to Landlord, in which event Landlord shall undertake the obligations of the sub landlord under such sublease from the time of the exercise of said option to the expiration of such sublease;
provided, however, Landlord shall not be liable for any prepaid rents or security deposit paid by such subtenant to such sub landlord or for any other prior defaults or breaches of such sub landlord under such sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Any matter or thing requiring the consent of the sub landlord under a sublease shall also require the consent of Landlord herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) No subtenant under a sublease or assignee approved by Landlord shall further assign or sublet
all or any part of the Premises without Landlord&#146;s prior written consent, not to be unreasonably withheld, conditioned or delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Landlord shall deliver a copy of any notice of Default or Breach by Tenant to the subtenant, who shall have the right to cure the Default
of Tenant within the grace period, if any, specified in such notice. The subtenant shall have a right of reimbursement and offset from and against Tenant for any such Defaults cured by the subtenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Default; Breach; Remedies</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>13.1 <B>Default; Breach</B>. Landlord and Tenant agree that if any attorney is consulted by Landlord in connection with a Tenant
Default or Breach (as hereinafter defined), $350.00 is a reasonable minimum sum per such occurrence for legal services and costs in the preparation and service of a notice of Default, and that Landlord may include the cost of such services and costs
in said notice as rent due and payable to cure said default. A &#147;<B>Default</B>&#148; by Tenant is defined as a failure by Tenant to observe, comply with or perform any of the terms, covenants, conditions or rules applicable to Tenant under this
Lease. A &#147;<B>Breach</B>&#148; by Tenant is defined as the occurrence of any one or more of the following Defaults, and, where a grace period for cure after notice is specified herein, the failure by Tenant to cure such Default prior to the
expiration of the applicable grace period, and shall entitle Landlord to pursue the remedies set forth in Paragraphs 13.2 and/or 13.3.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The vacating of the Premises or the abandonment of the Premises without paying the Rent due hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Except as expressly otherwise provided in this Lease, the failure by Tenant to make any payment of Base Rent, Tenant&#146;s Share of
Common Area Operating Expenses, or any other monetary payment required to be made by Tenant hereunder as and when due, the failure by Tenant to provide Landlord with reasonable evidence of insurance or surety bond required under this Lease, or the
failure of Tenant to fulfill any obligation under this Lease which endangers or threatens life or property, where such failure continues for a period of five (5)&nbsp;days following written notice thereof by or on behalf of Landlord to Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Except as expressly otherwise provided in this Lease, the failure by Tenant to provide Landlord with reasonable written evidence (in duly
executed original form, if applicable) of (i)&nbsp;compliance with Applicable Requirements per Paragraph 6.3, (ii)&nbsp;the inspection, maintenance and service contracts required under Paragraph 7.1(b), (iii)&nbsp;the rescission of an unauthorized
assignment or subletting per Paragraph 12.1, (iv)&nbsp;a Tenancy Statement per Paragraphs 16 or 37, (v)&nbsp;the subordination or non-subordination of this Lease per Paragraph 30, (vi)&nbsp;the guaranty of the performance of Tenant&#146;s
obligations under this Lease if required under Paragraphs&nbsp;1.11 and 37, (vii)&nbsp;the execution of any document requested under Paragraph 42 (easements), or (viii)&nbsp;any other documentation or information which Landlord may reasonably
require of Tenant under the terms of this lease, where any such failure continues for a period of ten (10)&nbsp;days following written notice by or on behalf of Landlord to Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) A Default by Tenant as to the terms covenants, conditions or provisions of this Lease, or of the rules adopted under Paragraph 40 hereof
that are to be observed, complied with or performed by Tenant, other than those described in Subparagraphs&nbsp;13.1(a), (b), or (c), above, where such Default continues for a period of thirty (30)&nbsp;days after written notice thereof by or on
behalf of Landlord to Tenant; provided however, that if the nature of Tenant&#146;s Default is such that more than thirty (30)&nbsp;days are reasonably required for its cure, then it shall not be deemed to be a Breach of this Lease by Tenant if
Tenant commences such cure within said thirty (30)&nbsp;day period and thereafter diligently prosecutes such cure to completion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) The
occurrence of any of the following events: (i)&nbsp;the making by Tenant of any general arrangement or assignment for the benefit of creditors; (ii)&nbsp;Tenant&#146;s becoming a &#147;debtor&#148; as defined in 11 U.S. Code Section&nbsp;101 or any
successor statute thereto (unless, in the case of a petition filed against Tenant, the same is dismissed within sixty (60)&nbsp;days); (iii)&nbsp;the appointment of a trustee or receiver to take possession of substantially all of Tenant&#146;s
assets located at the Premises or of Tenant&#146;s interest in this Lease, where possession is not restored to Tenant within thirty (30)&nbsp;days; or (iv)&nbsp;the attachment, execution or other judicial seizure of substantially all of
Tenant&#146;s assets located at the Premises or of Tenant&#146;s interest in this Lease, where such seizure is not discharged within thirty (30)&nbsp;days; provided, however, in the event that any provision of this Subparagraph 13.1(e) is contrary
to any applicable law, such provision shall be of no force or effect, and shall not affect the validity of the remaining provisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) The discovery by Landlord that any financial statement of Tenant or of any Guarantor, given
to Landlord by Tenant or any Guarantor, was materially false. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) If the performance of Tenant&#146;s obligations under this Lease is
guaranteed: (i)&nbsp;the death of a Guarantor, (ii)&nbsp;the termination of a Guarantor&#146;s liability with respect to this Lease other than in accordance with the terms of such guaranty, (iii)&nbsp;a Guarantor&#146;s becoming insolvent or the
subject of a bankruptcy filing, (iv)&nbsp;a Guarantor&#146;s refusal to honor the guaranty, or (v)&nbsp;a Guarantor&#146;s breach of its guaranty obligation on an anticipatory breach basis, and Tenant&#146;s failure, within sixty (60)&nbsp;days
following written notice by or on behalf of Landlord to Tenant of any such event, to provide Landlord with written alternative assurances of security, which, when coupled with the then existing resources of Tenant, equals or exceeds the combined
financial resources of Tenant and the Guarantors that existed at the time of the execution of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>13.2 <B>Remedies</B>. If
Tenant fails to commence to perform any affirmative duty or obligation of Tenant under this Lease, within ten (10)&nbsp;business days after written notice to Tenant (or in case of an emergency, without notice), Landlord may at its option (but
without obligation to do so), perform such duty or obligation on Tenant&#146;s behalf, including but not limited to the obtaining of reasonably required bonds, insurance policies, or governmental licenses, permits or approvals. The costs and
expenses of any such performance by Landlord shall be due and payable by Tenant to Landlord upon invoice therefor. If any check given to Landlord by Tenant shall not be honored by the bank upon which it is drawn, Landlord, at its own option, may
require all future payments to be made under this Lease by Tenant to be made only by cashier&#146;s check. In the event of a Breach of this Lease by Tenant (as defined in Paragraph&nbsp;13.1), with or without further notice or demand, and without
limiting Landlord in the exercise of any right or remedy which Landlord may have by reason of such Breach, Landlord may:<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)
Terminate Tenant&#146;s right to possession of the Premises by any lawful means, in which case this Lease and the term hereof shall terminate and Tenant shall immediately surrender possession of the Premises to Landlord. In such event Landlord shall
be entitled to recover from Tenant: (i)&nbsp;the worth at the time of the award of the unpaid rent which had been earned at the time of termination; (ii)&nbsp;the worth at the time of award of the amount by which the unpaid rent which would have
been earned after termination until the time of award exceeds the amount of such rental loss that the Tenant proves could have been reasonably avoided; (iii)&nbsp;the worth at the time of award of the amount by which the unpaid rent for the balance
of the term after the time of award exceeds the amount of such rental loss that the Tenant proves could be reasonably avoided; and (iv)&nbsp;any other amount necessary to compensate Landlord for all the detriment proximately caused by the
Tenant&#146;s failure to perform its obligations under this Lease or which in the ordinary course of things would be likely to result therefrom, including but not limited to the cost of recovering possession of the Premises, expenses of reletting,
including necessary renovation and alteration of the Premises, reasonable attorneys&#146; fees, and that portion of any leasing commission paid by Landlord in connection with this Lease applicable to the unexpired term of this Lease. The worth at
the time of award of the amount referred to in provision (iii)&nbsp;of the immediately preceding sentence shall be computed by discounting such amount at the discount rate of the Federal Reserve Bank of San Francisco or the Federal Reserve Bank
District in which the Premises are located at the time of award plus one percent (1%). Efforts by Landlord to mitigate damages caused by Tenant&#146;s Default or Breach of this Lease shall not waive Landlord&#146;s right to recover damages under
this Paragraph 13.2. If termination of this Lease is obtained through the provisional remedy of unlawful detainer, Landlord shall have the right to recover in such proceeding the unpaid rent and damages as are recoverable therein, or Landlord may
reserve the right to recover all or any part thereof in a separate suit for such rent and/or damages. If a notice and grace period required under Subparagraph 13.1 (b), (c)&nbsp;or (d)&nbsp;was not previously given, a notice to pay rent or quit, or
to perform or quit, as the case may be, given to Tenant under any statute authorizing the forfeiture of leases for unlawful detainer shall also constitute the applicable notice for grace period purposes required by Subparagraph 13.1 (b), (c)&nbsp;or
(d). In such case, the applicable grace period under the unlawful detainer statue shall run concurrently after the one such statutory notice, and the failure of Tenant to cure the Default within the greater of the two (2)&nbsp;such grace periods
shall constitute both an unlawful detainer and a Breach of this Lease entitling Landlord to the remedies provided for in this Lease and/or by said statute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Continue the Lease and Tenant&#146;s right to possession in effect (in California under California Civil Code Section&nbsp;1951.4) after
Tenant&#146;s Breach and recover the rent as it becomes due, provided Tenant has the right to sublet or assign, subject only to reasonably limitations. Landlord and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Tenant agree that the limitations on assignment and subletting in this Lease are reasonable. Acts of maintenance or preservation, efforts to relet the Premises, or the appointment of a receiver
to protect the Landlord&#146;s interest under this Lease, shall not constitute a termination of the Tenant&#146;s right to possession. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Pursue any other remedy now or hereafter available to Landlord under the laws or judicial decisions of the state wherein the Premises are
located. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The expiration or termination of this Lease and/or the termination of Tenant&#146;s right to possession shall not relieve
Tenant from liability under any indemnity provisions of this Lease as to matters occurring or accruing during the term hereof or by reason of Tenant&#146;s occupancy of the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.3 <B>[INTENTIONALLY OMITTED]</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>13.4 <B>Late Charges</B>. Tenant hereby acknowledges that late payment by Tenant to Landlord of rent and other sums due hereunder will
cause Landlord to incur costs not contemplated by this Lease, the exact amount of which will be extremely difficult to ascertain. Such costs include, but are not limited to, processing and accounting charges, and late charges which may be imposed
upon Landlord by the terms of any ground lease, mortgage or deed of trust covering the Premises. Accordingly, if any installment of rent or other sum due from Tenant shall not be received by Landlord or Landlord&#146;s designee within five
(5)&nbsp;days after such amount shall be due (that provided, however that Tenant shall be entitled to notice, prior to the commencement of such five (5)&nbsp;day period, on the first (1st)&nbsp;occasion in any calendar year on which Tenant fails to
timely pay an amount due hereunder), then, without any requirement for notice to Tenant, Tenant shall pay to Landlord a late charge equal to ten percent (10%)&nbsp;of such overdue amount. The parties hereby agree that such late charge represents a
fair and reasonable estimate of the costs Landlord will incur by reason of late payment by Tenant. Acceptance of such late charge be Landlord shall in no event constitute a waiver of Tenant&#146;s Default or Breach with respect to such overdue
amount, nor prevent Landlord from exercising any of the other rights and remedies granted hereunder. In the event that a late charge is payable hereunder, whether or not collected, for three (3)&nbsp;consecutive installments of Base Rent, then
notwithstanding Paragraph 4.1 or any other provision of this Lease to the contrary, Base Rent shall, at Landlord&#146;s option, become due and payable quarterly in advance; provided, however, that if Tenant subsequently pays such quarterly Base Rent
in a timely fashion for four (4)&nbsp;consecutive calendar quarters, Rent shall thereafter be payable on a monthly basis.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>13.5 <B>Breach by Landlord</B>. Landlord shall not be deemed in breach of this Lease unless Landlord fails within a reasonable time to
perform an obligation required to be performed by Landlord. For purposes of this Paragraph 13.5, a reasonable time shall in no event be less than thirty (30)&nbsp;days after receipt by Landlord, and by any Lender(s) whose name and address shall have
been furnished to Tenant in writing for such purpose, of written notice specifying wherein such obligation of Landlord has not been performed; provided, however, that if the nature of Landlord&#146;s obligation is such that more than thirty
(30)&nbsp;days after such notice are reasonably required for its performance, then Landlord shall not be in breach of this Lease if performance is commenced within such thirty (30)&nbsp;day period and thereafter diligently pursued to completion.<B>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Condemnation</B>. If the Premises or any portion thereof are taken under the power of eminent domain or sold under the threat of the exercise
of said power (all of which are herein called &#147;condemnation&#148;), this Lease shall terminate as to the part so taken as of the date the condemning authority takes title or possession, whichever first occurs. If more than twenty five percent
(25%)&nbsp;of the floor area of the Premises, or more than twenty-five percent (25%)&nbsp;of the portion of the Common Areas designated for Tenant&#146;s parking, is taken by condemnation, Tenant may, at Tenant&#146;s option, to be exercised in
writing within ten (10)&nbsp;days after Landlord shall have given Tenant written notice of such taking (or in the absence of such notice, within ten (10)&nbsp;days after the condemning authority shall have taken possession) terminate this Lease as
of the date the condemning authority takes such possession. If Tenant does not terminate this Lease in accordance with the foregoing, this Lease shall remain in full force and effect as to the portion of the Premises remaining, except that the Base
Rent shall be reduced in the same proportion as the rentable floor area of the Premises taken bears to the total rentable floor area of the Premises. No reduction of the Base Rent shall occur if the condemnation does not apply to any portion of the
Premises. Any award for the taking of all or any part of the Premises under the power of eminent domain or any payment made under threat of the exercise of such power shall be the property of Landlord, whether such award shall be made as
compensation for diminution of value of the leasehold or for the taking of the fee, or as severance damages; provided, however, that Tenant shall be entitled to any compensation, separately awarded to Tenant for Tenant&#146;s relocation expenses
and/or loss of Tenant&#146;s Trade Fixtures. In the event that this Lease is not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terminated by reason of such condemnation, Landlord shall to the extent of its net severance damages received, over and above Tenant&#146;s Share of the legal and other expenses incurred by
Landlord in the condemnation matter, repair any damage to the Premises caused by such condemnation authority. Tenant shall be responsible for the payment of any amount in excess of such net severance damages required to complete such repair. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Broker&#146;s Fees</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.1
<B>Procuring Cause</B>. The Broker(s) named in Paragraph 1.10 is/are the procuring cause of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>15.2 <B>Additional
Terms</B>. Unless Landlord and Broker(s) have otherwise agreed in writing, Landlord agrees that: (a)&nbsp;if Tenant exercises any Option (as defined in Paragraph 39.1) granted under this Lease or any Option subsequently granted, or (b)&nbsp;if
Tenant acquires any rights to the Premises or other premises in which Landlord has an interest, or (c)&nbsp;if Tenant remains in possession of the Premises with the consent of Landlord after the expiration of the term of this Lease after having
failed to exercise an Option, or (d)&nbsp;if said Brokers are the procuring cause of any other lease or sale entered into between the Parties pertaining to the Premises and/or any adjacent property in which Landlord has an interest, or (e)&nbsp;if
Base Rent is increased, whether by agreement or operation of an escalation clause herein, then as to any of said transactions, Landlord shall not be liable to said Broker(s) to pay a fee.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>15.3 <B>Assumption of Obligations</B>. Any buyer or transferee of Landlord&#146;s interest in this Lease, whether such transfer is by
agreement or by operation of law, shall be deemed to have assumed Landlord&#146;s obligation under this Paragraph 15.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>15.4
<B>Representations and Warranties</B>. Tenant and Landlord each represent and warrant to the other that it has had no dealings with any person, firm, broker or finder other than as named in Paragraph 1.10(a) in connection with the negotiation of
this Lease and/or the consummation of the transaction contemplated hereby, and that no broker or other person, firm or entity other than said named Broker(s) is entitled to any commission or finder&#146;s fee in connection with said transaction.
Tenant and Landlord do each hereby agree to indemnify, protect, defend and hold the other harmless from and against liability for compensation or charges which may be claimed by any such unnamed broker, finder or other similar party by reason of any
dealings or actions of the indemnifying Party, including any costs, expenses, and/or attorneys&#146; fees reasonably incurred with respect thereto.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Tenancy and Financial Statements</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>16.1 <B>Tenancy Statement</B>. Each Party (as &#147;<B>Responding Party</B>&#148;) shall within ten (10)&nbsp;business days after
written notice from the other Party (the &#147;<B>Requesting Party</B>&#148;) execute, acknowledge and deliver to the Requesting Party a statement in writing in a form similar to the then most current &#147;<B>Tenancy Statement</B>&#148; form
published by the American Industrial Real Estate Association, plus such additional information, confirmation and/or statements as may be reasonably requested by the Requesting Party.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>16.2 <B>Financial Statement</B>. If Landlord desires to finance, refinance, or sell the Premises or the Building, or any part thereof,
Tenant and all the Guarantors shall deliver to any potential lender or purchaser designated by Landlord such financial statements of Tenant and such Guarantors as may be reasonably required by such lender or purchaser, including but not limited to
Tenant&#146;s financial statements for the past three (3)&nbsp;years. All such financial statements shall be received by Landlord and such lender or purchaser in confidence and shall be used only for the purposes herein set forth.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Landlord&#146;s Liability</B>. The term &#147;<B>Landlord</B>&#148; as used herein shall mean the owner or owners at the time in question of the fee
title to the Premises. In the event of a transfer of Landlord&#146;s title or interest in the Premises or in this Lease, Landlord shall deliver to the transferee or assignee (in cash or by credit) any unused Security Deposit held by Landlord at the
time of such transfer or assignment. Except as provided in Paragraph 15.3, upon such transfer or assignment and delivery of the Security Deposit, as aforesaid, the prior Landlord shall be relieved of all liability with respect to the obligations
and/or covenants under this Lease thereafter to be performed by Landlord. Subject to the foregoing, the obligations and/or covenants in this Lease to be performed by the Landlord shall be binding only upon the Landlord as herein above defined.
Notwithstanding any other terms or provisions of this lease, Tenant agrees that in the event of any default or breach by Landlord with respect to any of the terms of the Lease to be observed and performed by Landlord (a)&nbsp;Tenant shall look
solely to the estate and property (which is the subject of this lease) of Landlord or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
successor in interest in the property (which shall be deemed to include the rental income, the proceeds of any sale by Landlord as well as any insurance or condemnation proceeds), for the
satisfaction of Tenant&#146;s remedies for the collection of a judgment (or other judicial process) requiring the payment of money by Landlord; (b)&nbsp;no other property or assets of Landlord, its partners, members, shareholders, officers or any
successor in interest shall be subject to levy, execution or other enforcement procedure for the satisfaction if Tenant&#146;s remedies; (c)&nbsp;no personal liability shall at any time be asserted or enforceable against Landlord, it&#146;s
partner&#146;s, members or successors in interest (except to the extent permitted in (a)&nbsp;above), and no judgment will be taken against any partner, member, shareholder, officer or director of Landlord. The provisions of this section shall apply
only to the Landlord and the parties herein described, and shall not be for the benefit of any insurer nor any other third party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18.
Severability</B>. The invalidity of any provision of this Lease, as determined by a court of competent jurisdiction, shall in no way affect the validity of any other provision hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19. Interest on Past-Due Obligations</B>. Any monetary payment due Landlord hereunder, other than late charges, not received by Landlord within ten
(10)&nbsp;days following the date on which it was due, shall bear interest from the date due at the prime rate charged by the largest state chartered bank in the state in which the Premises are located plus four percent (4%)&nbsp;per annum, but not
exceeding the maximum rate allowed by law, in addition to the potential late charge provided for in Paragraph 13.4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20. Time of Essence</B>. Time is
of the essence with respect to the performance of all obligations to be performed or observed by the Parties under this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>21. Rent Defined</B>.
All monetary obligations of Tenant to Landlord under the terms of this Lease are deemed to be rent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>22. No Prior or other Agreements; Broker
Disclaimer</B>. This Lease contains all agreements between the Parties with respect to any matter mentioned herein, and no other prior or contemporaneous agreement or understanding shall be effective. Landlord and Tenant each represents and warrants
to the Brokers that it has made, and is relying solely upon, its own investigation as to the nature, quality, character and financial responsibility of the other Party to this Lease and as to the nature, quality and character of the Premises.
Brokers have no responsibility with respect thereto or with respect to any default or breach hereof by either Party. Each Broker shall be an intended third party beneficiary of the provisions of this Paragraph 22. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>23. Notices</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>23.1 <B>Notice
Requirements</B>. All notices required or permitted by this Lease shall be in writing and may be delivered in person (by hand or by messenger or courier service) or may be sent by regular, certified or registered mail or U.S. Postal Service Express
Mail, with postage prepaid, and shall be deemed sufficiently given if served in a manner specified in this Paragraph 23. The addresses noted adjacent to a Party&#146;s signature on this Lease shall be that Party&#146;s address for delivery or
mailing of notice purposes. Either Party may by written notice to the other specify a different address for notice purposes. A copy of all notices required or permitted to be given to Landlord hereunder shall be concurrently transmitted to such
party or parties at such addresses as Landlord may from time to time hereafter designate by written notice to Tenant.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>23.2
<B>Date of Notice</B>. Any notice sent by registered or certified mail, return receipt requested, shall be deemed given on the date of delivery shown on the receipt card, or if no delivery date is shown, the postmark thereon. If sent by regular
mail, the notice shall be deemed given three (3)&nbsp;business days after the same is addressed as required herein and mailed with postage prepaid. Notices delivered by United States Express Mail or overnight courier that guarantees next day
delivery shall be deemed given twenty-four (24)&nbsp;hours after delivery of the same to the United States Postal Service or courier. If notice is received or otherwise deemed delivered on a Saturday or a Sunday or a legal holiday, it shall be
deemed received on the next business day.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>24. Waivers</B>. No waiver by a party of the Default or Breach of any term covenant or condition
hereof by the other, shall be deemed a waiver of any other term, covenant or condition hereof, or of any subsequent Default or Breach by the other of the same or any other term, covenant or condition hereof. Landlord&#146;s consent to, or approval
of, any such act shall not be deemed to render unnecessary the obtaining of Landlord&#146;s consent to, or approval of, any subsequent or similar act by Tenant, or be construed as the basis of an estoppel to enforce the provision or provisions of
this Lease requiring such consent. Regardless of Landlord&#146;s knowledge of a Default or Breach at the time of accepting rent, the acceptance of rent by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Landlord shall not be a waiver of any Default or Breach by Tenant of any provision hereof. Any payment given Landlord by Tenant may be accepted by Landlord on account of moneys or damages due
Landlord, notwithstanding any qualifying statements or conditions made by Tenant in connection therewith, which such statements and/or conditions shall be of no force or effect whatsoever unless specifically agreed to in writing by Landlord at or
before the time of deposit of such payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>25. Recording</B>. Either Landlord or Tenant shall, upon request of the other, execute, acknowledge and
deliver to the other a short form memorandum of this Lease for recording purposes. The Party requesting recordation shall be responsible for payment of any fees or taxes applicable thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>26. No Right To Holdover</B>. Tenant has no right to retain possession of the Premises or any part thereof beyond the expiration or earlier termination of
this Lease. In the event that Tenant holds over in violation of this Paragraph 26 then the Base Rent payable from and after the time of the expiration or earlier termination of this Lease shall be increased to one hundred fifty percent
(150%)&nbsp;of the Base Rent applicable during the month immediately preceding such expiration or earlier termination. Nothing contained herein shall be construed as a consent by Landlord to any holding over by Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>27. Cumulative Remedies</B>. No remedy or election hereunder shall be deemed exclusive but shall, wherever possible, be cumulative with all other remedies
at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>28. Covenants and Conditions</B>. Al provisions of this Lease to be observed or performed by Tenant are both covenants and
conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>29. Binding Effect; Choice of Law</B>. This Lease shall be binding upon the Parties, their personal representatives, successors and
assigns and be governed by the laws of the State in which the Premises are located. Any litigation between the Parties hereto concerning this Lease shall be initiated in the county in which the Premises are located. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>30. Subordination; Attornment; Non-Disturbance</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>30.1 <B>Subordination. [PLEASE PROVIDE A SNDA FROM CURRENT LENDER]</B> This Lease and any Option granted hereby shall be subject and
subordinate to any ground lease, mortgage, deed of trust, or other hypothecation or security device (collectively, &#147;<B>Security Device</B>&#148;)<B>, </B>now or hereafter placed by Landlord upon the real property of which the Premises are a
part, to any and all advances made on the security thereof, and to all renewals, modifications, consolidations, replacements and extensions thereof. Tenant agrees that the Lenders holding any such Security Device shall have no duty, liability or
obligation to perform any of the obligations of Landlord under this Lease, but that in the event of Landlord&#146;s default with respect to any such obligation, Tenant will give any Lender whose name and address have been furnished Tenant in writing
for such purpose notice of Landlord&#146;s default pursuant to Paragraph 13.5. If any Lender shall elect to have this Lease and/or any Option granted hereby superior to the lien of its Security Device and shall give written notice thereof to Tenant,
this Lease and such Options shall be deemed prior to such Security Device, notwithstanding the relative dates of the documentation or recordation thereof.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>30.2 <B>Attornment</B>. Subject to the non-disturbance provisions of Paragraph 30.3, Tenant agrees to attorn to a Lender or any other
party who acquires ownership of the Premises by reason of a foreclosure of a Security Device, and that in the event of such foreclosure, such new owner shall not: (i)&nbsp;be liable for any act or omission of any prior Landlord or with respect to
events occurring prior to acquisition of ownership, (ii)&nbsp;be subject to any offsets or defenses which Tenant might have against any prior Landlord, or (iii)&nbsp;be bound by prepayment of more than one month&#146;s rent.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>30.3 <B>Non-Disturbance</B>. With respect to Security Devices entered into by Landlord after the execution of this lease, Tenant&#146;s
subordination of this Lease shall be subject to receiving assurance (a &#147;<B>non-disturbance agreement</B>&#148;) from the Lender that Tenant&#146;s possession and this Lease, including any options to extend the term hereof, will not be disturbed
so long as Tenant is not in Breach hereof and attorns to the record owner of the Premises.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>30.4 <B>Self-Executing</B>. The
agreements contained in this Paragraph 30 shall be effective without the execution of any further documents; provided, however, that upon written request from Landlord or a Lender in connection with a sale, financing or refinancing of Premises,
Tenant and Landlord shall execute such further writings as may be reasonably required to separately document any such subordination or non-subordination, attornment and/or non-disturbance agreement as is provided for herein.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>31. Attorneys&#146; Fees</B>. If any Party brings an action or proceeding to enforce the terms hereof or
declare rights hereunder, the Prevailing Party (as hereafter defined) in any such proceeding, action, or appeal thereon, shall be entitled to reasonable attorneys&#146; fees, costs and expenses. Such fees may be awarded in the same suit or recovered
in a separate suit, whether or not such action or proceeding is pursued to decision or judgment. The term &#147;<B>Prevailing Party</B>&#148; shall include, without limitation, a Party who substantially obtains or defeats the relief sought, as the
case may be whether by compromise, settlement, judgment, or the abandonment by the other Party or Broker of its claim or defense. The attorneys&#146; fee award shall not be computed in accordance with any court fee schedule, but shall be such as to
full reimburse all attorneys fees, cost and expenses reasonably incurred. Landlord shall be entitled to attorneys&#146; fees, costs and expenses incurred in preparation and service of notices of Default and consultations in connection therewith,
whether or not a legal action is subsequently commenced in connection with such Default or resulting Breach. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>32. Landlord&#146;s Access; Showing
Premises; Repairs</B>. Landlord and Landlord&#146;s agents shall have the right to enter the Premises at any time, in the case of an emergency, and otherwise at reasonable times upon reasonable advance notice to Tenant for the purpose of showing the
same to prospective purchasers, lenders, or (during the final six (6)&nbsp;months of the term) tenants, and make such alterations, repairs, improvements or additions to the Premises or to the Building, as Landlord may reasonably deem necessary
(provided that Tenant shall have the right to require that Landlord be accompanied by a representative of Tenant during any such entry). Landlord shall use best efforts to ensure that the performance of any such work of repairs or alterations shall
not interfere with Tenant&#146;s use of the Premises (or any portion thereof) for Tenant&#146;s business purposes (such efforts to include limiting the performance of any such work which might be disruptive to weekends or the evening and the
cleaning of any work area prior to the commencement of the next business day). Landlord may at any time place on or about the Premises or Building any ordinary &#147;For Sale&#148; signs and Landlord may at any time during the last one hundred
eighty (180)&nbsp;days of the term hereof place on or about the Premises any ordinary &#147;For Lease&#148; signs. All such activities of Landlord shall be without abatement of rent or liability to Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>33. Auctions</B>. Tenant shall not conduct, nor permit to be conducted, either voluntarily or involuntarily, any auction upon the Premises without first
having obtained Landlord&#146;s prior written consent. Notwithstanding anything to the contrary in this Lease, Landlord shall not be obligated to exercise any standard of reasonableness in determining whether to grant such consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>34. Signs</B>. Tenant shall not place any sign upon the exterior of the Premises or the Building, except that Tenant may, with Landlord&#146;s prior
written consent, install (but not on the roof) such signs as are reasonably required to advertise Tenant&#146;s own business so long as such signs are in a location designated by Landlord and comply with Applicable Requirements and the signage
criteria established for the Industrial Center by Landlord. The installation of any sign on the Premises by or for Tenant shall be subject to the provisions of Paragraph 7 (Maintenance, Repairs, Utility Installations, Trade Fixtures and
Alterations). Unless otherwise expressly agreed herein, Landlord reserves all rights to the use of the roof of the Building and the right to install advertising signs on the Building, including the roof, which do not unreasonably interfere with the
conduct of Tenant&#146;s business; Landlord shall be entitled to all revenues from such advertising signs. Landlord approves of Tenants reasonable signage as long as it does not conflict with the office park CC&amp;R&#146;s and does not interfere
with signage for other Tenant&#146;s in the building. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>35. Termination; Merger</B>. Unless specifically stated otherwise in writing by Landlord, the
voluntary or other surrender of this Lease by Tenant, the mutual termination or cancellation hereof, or a termination hereof by Landlord for Breach by Tenant, shall automatically terminate any sublease or lesser estate in the Premises; provided,
however, Landlord shall, in the event of any such surrender, termination or cancellation, have the option to continue any one or all of any existing subtenancies. Landlord&#146;s failure within ten (10)&nbsp;days of following any such event to make
a written election to the contrary by written notice to the holder of any such lesser interest, shall constitute Landlord&#146;s election to have such event constitute the termination of such interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>36. Consents</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Except for
Paragraph 33 (Auctions) or as otherwise provided herein, wherever in this Lease the consent of a Party is required to an act by or for the other Party, such consent shall not be unreasonably withheld or delayed. Landlord&#146;s actual reasonable
costs and expenses (including but not limited to architects&#146;, attorneys&#146;, engineers&#146; and other consultants&#146; fees) incurred in the consideration of, or response to, a request by Tenant for any Landlord consent pertaining to this
Lease or the Premises, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including but not limited to consents to an assignment a subletting or the presence or use of a Hazardous Substance, shall be paid by Tenant to Landlord upon receipt of an invoice and supporting
documentation therefor. In addition to the deposit described in Paragraph 12.2(e), Landlord may, as condition to considering any such request by Tenant, require that Tenant deposit with Landlord an amount of money (in addition to the Security
Deposit held under Paragraph 5) reasonably calculated by Landlord to represent the cost Landlord will incur in considering and responding to Tenant&#146;s request. Any unused portion of said deposit shall be refunded to Tenant without interest.
Landlord&#146;s consent to any act, assignment of this Lease or subletting of the Premises by Tenant shall not constitute an acknowledgment that no Default or Breach by Tenant of this Lease exists, nor shall such consent be deemed a waiver of any
then existing Default or Breach, except as may be otherwise specifically stated in writing by Landlord at the time of such consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
All conditions to Landlord&#146;s consent authorized by this Lease are acknowledged by Tenant as being reasonable. The failure to specify herein any particular condition to Landlord&#146;s consent shall not preclude the impositions by Landlord at
the time of consent of such further or other conditions as are then reasonable with reference to the particular matter for which consent is being given. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>37. [INTENTIONALLY OMITTED]</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>38. Quiet
Possession</B>. Upon payment by Tenant of the rent for the Premises and the performance of all of the covenants, conditions and provisions on Tenant&#146;s part to be observed and performed under this Lease, Tenant shall have quiet possession of the
Premises for the entire term hereof subject to all of the provisions of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>39. Options</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>39.1 <B>Definition</B>. As used in this Lease, the word &#147;<B>Option</B>&#148; has the following meaning: (a)&nbsp;the right to
extend the term of this Lease or to renew this Lease or to extend or renew any lease that Tenant has on other property of Landlord.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>39.2 <B>Options Personal to Original Tenant</B>. Each Option granted to Tenant in this Lease is personal to the original Tenant named
in Paragraph 1.1 hereof and any assignee pursuant to a Permitted Transfer, and cannot be voluntarily or involuntarily assigned or exercised by any person or entity other than said original Tenant while the original Tenant is in full and actual
possession of the Premises and without the intention of thereafter assigning or subletting. The Options, if any, herein granted to Tenant are not assignable (other than pursuant to a Permitted Transfer), either as a part of an assignment of this
Lease or separately or apart therefrom, and no Option may be separated from this Lease in any manner, by reservation or otherwise.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>39.3 <B>Multiple Options</B>. In the event that Tenant has any multiple Options to extend or renew this Lease, a later option cannot be
exercised unless the prior Options to extend or renew this Lease have been validly exercised.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39.4 <B>Effect of Default on
Options</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall have no right to exercise an Option, notwithstanding any provision in the grant of Option to the contrary:
(i)&nbsp;during the period commencing with the giving of any notice of Default under Paragraph 13.1 and continuing until the noticed Default is cured, or (ii)&nbsp;during the period of time any monetary obligation due Landlord from Tenant is unpaid
(without regard to whether notice thereof is given Tenant), or (iii)&nbsp;during the time Tenant is in Breach of this Lease, or (iv)&nbsp;in the event that Landlord has given to Tenant three (3)&nbsp;or more notices of separate Defaults under
Paragraph 13.1 during the twelve (12)&nbsp;month period immediately preceding the exercise of the Option, whether or not the Defaults are cured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The period of time within which an Option may be exercised shall not be extended or enlarged by reason of Tenant&#146;s inability to
exercise an Option because of the provisions of Paragraph 39.4(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) All rights of Tenant under the provisions of an Option shall
terminate and be of no further force or effect, notwithstanding Tenant&#146;s due and timely exercise of the Option, if, after such exercise and during the term of this Lease, (i)&nbsp;Tenant fails to pay to Landlord a monetary obligation of Tenant
for a period of thirty (30)&nbsp;days after such obligation becomes due (without any necessity of Landlord to give notice thereof to Tenant), or (ii)&nbsp;Landlord gives to Tenant three (3)&nbsp;or more notices of separate Defaults under Paragraph
13.1 during any twelve (12)&nbsp;month period, whether or not the Defaults are cured, or (iii)&nbsp;if Tenant commits a Breach of this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>40. Rules and Regulations</B>. Tenant agrees that it will abide by, and keep and observe all reasonable rules
and regulations (&#147;<B>Rules and Regulations</B>&#148;) which Landlord may make from time to time for the management, safety, care, and cleanliness of the grounds, the parking and unloading of vehicles and the preservation of good order, as well
as for the convenience of other occupants or tenants of the Building and the Industrial Center and their invitees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>41. Security Measures</B>. Tenant
hereby acknowledges that the rental payable to Landlord hereunder does not include the cost of guard service or other security measures, and that Landlord shall have no obligation whatsoever to provide same. Tenant assumes all responsibility for the
protection of the Premises, Tenant, its agents and invitees and their property from the acts of third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>42. Reservations</B>. Landlord reserves
the right, from time to time, to grant, without the consent or joinder of Tenant, such easements, rights of way, utility raceways, and dedications that Landlord reasonably deems necessary, and to cause the recordation of parcel maps and
restrictions, so long as such easements, rights of way, utility raceways, dedications, maps and restrictions do not reasonably interfere with the use of the Premises by Tenant. Tenant agrees to sign any documents reasonably requested by Landlord to
effectuate any such easement rights, dedication, map or restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>43. Performance Under Protest</B>. If at any time a dispute shall arise as to
any amount or sum of money to be paid by one Party to the other under the provisions hereof, the Party against whom the obligation to pay the money is asserted shall have the right to make payment &#147;under protest&#148; and such payment shall not
be regarded as a voluntary payment and there shall survive the right on the part of said Party to institute suit for recovery of such sum. If it shall be adjudged that there was no legal obligation on the part of said Party to pay such sum or any
part thereof, said Party shall be entitled to recover such sum or so much thereof as it was not legally required to pay under the provisions of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>44. Authority</B>. If either Party hereto is a corporation, trust, limited liability company, or general or limited partnership, each individual executing
this Lease on behalf of such entity represents and warrants that he or she is duly authorized to execute and deliver this Lease on it&#146;s behalf and that such entity is duly authorized and existing and qualified to do business in California and
that Tenant has the full right and legal authority to enter into this lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>45. Conflict</B>. Any conflict between the printed provisions of this
Lease and the typewritten or handwritten provisions shall be controlled by the typewritten or handwritten provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>46. Offer</B>. Preparation of
this Lease by either Landlord or Tenant or Landlord&#146;s agent or Tenant&#146;s agent and submission of same to Tenant or Landlord shall not be deemed an offer to lease. This Lease is not intended to be binding until executed and delivered by all
Parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>47. Amendments</B>. This Lease may be modified only in writing, signed by the parties in interest at the time of the modification. The
Parties shall amend this Lease from time to time to reflect any adjustments that are made to the Base Rent or other rent payable under this Lease. As long as they do not materially change Tenant&#146;s obligations hereunder, Tenant agrees to make
such reasonable non-monetary modification to this Lease as may be reasonably required by an institutional insurance company or pension plan Lender in connection with the obtaining of normal financing or refinancing of the property of which the
Premises are a part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>48. Multiple Parties</B>. Except as otherwise expressly provided herein, if more than one person or entity is named herein as
either Landlord or Tenant, the obligations of such multiple parties shall be the joint and several responsibility of all persons or entities named herein as such Landlord or Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>49. Tenant Improvements</B>. Turnkey by Landlord as specified further in Exhibit A and Exhibit &#147;A&#148; Notes. The buildout in this space shall
consist of at least 80% of dropped ceiling office/R&amp;D/lab spaces, the lunch room will have 8&#146; counter with 8&#146; of cabinets below and a sink, VCT flooring only. The entire dropped ceiling space will have 10 ft. high (if possible,
otherwise 9 ft. high) 2x4 T-bar ceiling grid with 2x4 lay in white armstrong tiles except for the clean room area in which Landlord shall install vinyl ceiling tiles. The lights where not existing will be standard 3 tube 2x4 lights with prismatic
lenses. The floor coverings where not existing will be either standard VCT or standard 26 ounce carpet. All office doors to be 9&#146; prefinished birch. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
All offices to have 3&#146; sidelights. All walls will be drywall on metal stud and will be straight and painted white. The entire space including warehouse will have HVAC, and fire sprinklers
(for ordinary hazard). The balance of the space will be open warehouse ceiling insulated with R-19, with no floor covering, 8&#146; chain hung florescent lights spaced 10&#146; apart. Any upgrades to these specs or to a normal office or warehouse
environment (whether or not shown or labeled on Exhibit &#147;A&#148; or Exhibit &#147;A&#148; notes) to be paid for by tenant (this includes any additional HVAC loads above 1 ton per 400, any increased fire ratings, any hard ceilings, any soffits,
any special lighting or a/v equipment, any signs, any security equipment, any phones or network wiring or communications equipment, any dark rooms and their affiliated walls, any non drywall walls, any item that is not straight in nature such as
curved walls or cornices, any appliances, any electrical hookups for equipment, any electrical drops, any piping for air or gases, any increased power loads, any power strips, any electric over a standard office environment, any soundproofing, any
office cubicles or furniture). All window coverings by tenant, approved by landlord. All construction shall be done in a good and workmanlike manner and in compliance with all applicable laws. Landlord shall separate the HVAC units and power from
the neighboring space if needed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>50. Right of First Offering</B>. The Tenant shall have the right of first offer to purchase the Building should
Landlord decide to sell the Building. At the time Landlord decides to sell the Building, Landlord shall give Tenant written notice of the price that Landlord intends to sell the Building for and Tenant shall have 10 business days to inform Landlord
by written notice that it intends to purchase the Building for all cash within ninety (90)&nbsp;days. Failure of Tenant to purchase the Building at that time will make this right of first offer null and void forever. If Tenant fails to inform
Landlord in writing within ten (10)&nbsp;business days that it intends to purchase the building then Landlord shall be free to sell the Building to any third party as long as the purchase price is within five percent (5%)&nbsp;of the price
previously offered to Tenant. If the price is lower by five percent (5%)&nbsp;or more, then Tenant shall have five (5)&nbsp;business days to match said offer. Tenant shall purchase the building &#147;AS IS&#148; and sign a 1542 waiver releasing
Landlord of all liability known or unknown upon the close of escrow. Said Right of First Offer shall be subordinate to the rights of a lender that is acquiring the property through a deed in lieu or a foreclosure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>51. Option to Extend</B>. Subject to the terms and conditions set forth below, Tenant may at its option extend the Term of this Lease for One
(1)&nbsp;period of Five (5)&nbsp;years. Such period is called the &#147;<B>Renewal Term.</B>&#148; The Renewal Term shall be upon the same terms contained in this Lease, except that (i)&nbsp;Landlord shall have no obligation to provide Tenant with
any Tenant Improvement Allowance or demolition in connection with the Renewal Term, (ii)&nbsp;the Base Rental during the Renewal Term shall be calculated as set forth below, and (iii)&nbsp;any reference in the Lease to the &#147;Term&#148; of the
Lease shall be deemed to include the Renewal Term and apply thereto, unless it is expressly provided otherwise. Tenant shall have no additional extension options. The Base Rent during the Renewal Term shall be at the then Fair Market Rate (defined
hereinafter) for such space for a term commencing of the first day of the Renewal Term. &#147;<B>Market Rate</B>&#148; shall mean the then prevailing market rate for a comparable term commencing on the first day of the Renewal Term for tenants of
comparable size and creditworthiness for comparable space in the Building and other Office buildings in the Alameda Area. In no event shall the Base Rent payable during the first (1st)&nbsp;year of the Renewal Term be less than the 36<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> Month&#146;s Rent. Base Rent during the Renewal Term shall increase at four percent (4%)&nbsp;per year. To exercise any option, Tenant must deliver a binding written notice to Landlord not sooner
than twelve (12)&nbsp;months nor later than six (6)&nbsp;months prior to the expiration of the initial Term of this Lease. Thereafter, the Market Rate for the Renewal Term shall be calculated by Landlord and Landlord shall inform Tenant of the
Market Rate. If the parties cannot agree on the Market Rate within thirty (30)&nbsp;days following Landlord&#146;s delivery of a statement of Fair Market Rent, the parties shall each, within ten (10)&nbsp;business days following the expiration of
such thirty (30)&nbsp;day period, appoint a real estate broker (with at least 10 years experience in office leasing in Alameda) to determine the Market Rate, and each such broker will deliver its determination within ten (10)&nbsp;additional
business days. If the lower of the two is within 90% of the higher of the two valuations, then the Market Rent shall be the average of the two. If a party fails to timely designate a broker, the broker designated by the other party will determine
the Market Rate. If the lower of the two valuations is less than 90% of the higher valuation, then the two brokers/appraisers originally selected by the parties shall, within five (5)&nbsp;business days, select a third broker/appraiser and shall
present their final determinations of Market Rate to the third broker/appraiser, and the third broker/appraiser shall pick one of those two as being the Market Rate. The determination of the third broker/appraiser shall be binding on the parties. If
Tenant fails to timely give its notice of exercise, Tenant will be deemed to have waived its option to extend. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>52. Deposits</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">52.1 <B>Amount</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>Concurrently with the execution of this Lease, Tenant shall deliver to Landlord (1)&nbsp;first month&#146;s Rent in the amount of
fifty-nine thousand six hundred seventy-three dollars and seventy-five cents ($59,673.75) (2)&nbsp;an unconditional irrevocable standby letter of credit (the &#147;<B>Letter of Credit</B>&#148;) in the amount of One Million Dollars ($1,000,000.00)
issued by Wells Fargo Bank or Bank of America (or another bank doing business in one of the nine counties comprising the San Francisco-Oakland-San Jose area (&#147;<B>Bay Area</B>&#148;) and reasonably acceptable to Landlord) and naming Landlord as
beneficiary thereunder, as security for the faithful performance by Tenant of all Tenant&#146;s obligations under this Lease.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If
Landlord notifies Tenant in writing that the bank which issued the Letter of Credit has become financially unacceptable (e.g., the bank is under investigation by governmental authorities, has filed bankruptcy or reorganization proceedings, or has
closed two or more of its branches in the Bay Area), then Tenant shall have thirty (30)&nbsp;days to provide Landlord with as substitute Letter of Credit complying with all of the requirements set forth in this paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">lf, pursuant to the terms of Paragraph 52, Landlord uses any portion of the Letter of Credit, Tenant shall within ten (2)&nbsp;days after
demand from Landlord, restore the Letter of Credit to its full amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">52.2 <B>Letter of Credit</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If Tenant Fails to pay when due any Rent or other sum due under this Lease and such failure continues after notice from Landlord and the
expiration of any applicable grace period, regardless of whether Tenant has filed a petition in bankruptcy under the federal bankruptcy laws, or if Tenant, following the filing of any such petition, rejects this Lease, then Landlord may (but shall
not be required to) use, apply or retain all or any part of the Cash Security Deposit for the payment of any Rent or other sum due under this Lease or for the payment of any other amount which Landlord may spend or become obligated to spend by
reason of Tenant&#146;s breach or to compensate Landlord for any other loss or damage which Landlord may suffer by reason of Tenant&#146;s breach of this Lease. Landlord shall thereupon be entitled to draw on the Letter of Credit to the extent
necessary to cure the default in question. The Letter of Credit, or so much thereof as remains after the curing of any default of Tenant hereunder, shall be returned to Tenant within (30)&nbsp;days following the expiration of the term of this Lease
(or earlier termination of the Lease) and surrender of the Premises by Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Letter of credit shall be issued for a term of at
least twelve (12)&nbsp;months and shall be renewed automatically for consecutive twelve (12)&nbsp;month periods for the entire term of this Lease (except that the Letter of Credit shall expire not less than sixty (60)&nbsp;days after the expiration
or sooner termination of the Lease) subject, however, to reduction as provided in Paragraph 53 below. If, at any time during the term of this Lease, Landlord does not receive written notice from the issuing bank, at least fifteen (15)&nbsp;business
days prior to the expiration of any twelve (12)&nbsp;month term of the Letter of Credit, that the Letter of Credit is being renewed for another twelve (12)&nbsp;months, then Landlord shall have the right to draw upon the Letter of Credit for the
full amount thereof. Drawing upon the Letter of Credit shall be conditioned only upon presentation of the original Letter of Credit to the issuer thereof accompanied by a certified statement from Landlord that Tenant is in default under this Lease
and the default is continuing after notice and the expiration of any applicable grace period or Tenant has failed to timely renew such Letter of Credit. The Letter of Credit shall not be mortgaged, assigned or encumbered in any manner whatsoever by
Tenant. The use, application or retention of the Letter of Credit, or any portion thereof, by Landlord shall not prevent Landlord from exercising any other right or remedy provided by this Lease or by law, it being intended that Landlord shall not
first be required to proceed against the Letter of Credit, and such use, application or retention shall not operate as a limitation on any recovery to which Landlord may otherwise be entitled. At Landlord&#146;s election, the Letter of Credit may
name the Landlord&#146;s lender as a beneficiary, or as a co-beneficiary with Landlord, and/or may require that Landlord&#146;s lender sign the certification required to be presented for any draw against the Letter of Credit. Landlord shall have the
right to pledge or assign the Letter of Credit (or the proceeds of such Letter of Credit) to its lender holding a security interest in the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a termination or transfer of Landlord&#146;s interest in this Lease, Landlord shall transfer its interest in the Letter of
Credit to the Landlord&#146;s successor. In addition, upon termination or transfer of Landlord&#146;s interest in this Lease, within ten (10)&nbsp;business days after request by Landlord or Landlord&#146;s successor, Tenant shall either cause the
Letter of Credit to be amended to name Landlord&#146;s successor as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the party entitled to draw down on the Letter of Credit and deliver such amendment to the requesting party, or shall obtain and deliver to the requesting party a new Letter of Credit meeting the
requirements of this Paragraph 52 naming Landlord&#146;s successor as the party entitled to draw down on the Letter of Credit. At Landlord&#146;s election, within ten (19)&nbsp;business days after request by Landlord, Tenant shall cause the Letter
of Credit to be amended to name Landlord&#146;s lender as the beneficiary, or as a co-beneficiary with Landlord, and/or as a co-signer of any certification presented for a draw down of the Letter of Credit. If Tenant fails to comply with the
requirements described in either or both of the prior two (2)&nbsp;sentences, Landlord or any lender designated in the Letter of Credit shall be entitled to draw down on the entire amount of the Letter of Credit, the proceeds of which shall be held
by Landlord as a cash Security Deposit to be utilized in the manner described in Paragraph 5. If a new Letter of Credit is delivered to Landlord as required by this paragraph above, the previously existing Letter of Credit shall be promptly returned
to Tenant. Any fee due in connection with the transfer of Landlord&#146;s rights as beneficiary under the Letter of Credit to a successor landlord (or to Landlord&#146;s lender), or in connection with an amendment or substitution of the Letter of
Credit shall be paid by Tenant to the financial institution owned such fee or if Landlord or any designated lender incurs any such fees, shall be paid by Tenant to the party incurring such fees upon demand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>53. Letter of Credit</B>. The Letter of Credit shall be returned to Tenant within thirty (30)&nbsp;days following Tenant&#146;s satisfaction of either of
the criteria set forth in subparagraph 53 (a)&nbsp;or 53 (b). </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top">Tenant shall not be in default under this Lease and Tenant has had two (2)&nbsp;consecutive quarters of increasing sales growth and net profitability. In all events net profits shall be greater than $500,000.00 per
quarter. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top">Tenant shall not be in default under this Lease and Tenant and Tenant has gone public with a market cap of at least $250,000,000.00 or been acquired and the Lease has been assumed by a company with at market cap of at
least $250,000,000.00. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">In order to validate Tenant&#146;s performance with respect to Section&nbsp;52 (a)&nbsp;or (b),
Tenant will provide the Landlord with a CPA reviewed or audited FYE financials, by using Generally Accepted Accounting Principles, following each fiscal year end. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LANDLORD AND TENANT HAVE CAREFULLY READ AND REVIEWED THIS LEASE AND EACH TERM AND PROVISION CONTAINED HEREIN, AND BY THE EXECUTION OF THIS LEASE SHOW THEIR
INFORMED AND VOLUNTARY CONSENT THERETO. THE PARTIES HEREBY AGREE THAT, AT THE TIME THIS LEASE IS EXECUTED, THE TERMS OF THIS LEASE ARE COMMERCIALLY REASONABLE AND EFFECTUATE THE INTENT AND PURPOSE OF LANDLORD AND TENANT WITH RESPECT TO THE PREMISES.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THIS LEASE PREPARED FOR YOUR ATTORNEY&#146;S REVIEW AND APPROVAL. FURTHER, EXPERTS SHOULD BE CONSULTED TO THE PRESENCE OF ASBESTOS,
UNDERGROUND STORAGE TANKS OR HAZARDOUS SUBSTANCES. NO REPRESENTATION OR RECOMMENDATION IS MADE BY THE AMERICAN INDUSTRIAL REAL ESTATE ASSOCIATION OR BY THE REAL ESTATE BROKERS OR THEIR CONTRACTORS, AGENTS OR EMPLOYEES AS TO THE LEGAL SUFFICIENCY,
LEGAL EFFECT, OR TAX CONSEQUENCES OF THIS LEASE OR THE TRANSACTION TO WHICH IT RELATES; THE PARTIES SHALL RELY SOLELY UPON THE ADVICE OF THEIR OWN COUNSEL AS TO THE LEGAL AND TAX CONSEQUENCES OF THIS LEASE. IF THE SUBJECT PROPERTY IS IN A STATE
OTHER THAN CALIFORNIA, AN ATTORNEY FROM THE STATE WHERE THE PROPERTY IS LOCATED SHOULD BE CONSULTED. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties hereto have executed this Lease at the place and on the dates specified above their respective
signatures. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Executed&nbsp;at:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">San Leandro, CA</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Executed&nbsp;at:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">San Leandro</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">On:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">12-7-07</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">On:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">12-7-07</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7">By&nbsp;Landlord:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By Tenant:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">DOLLINGER HARBOR BAY ASSOCIATES,</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">a California limited partnership</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">D&amp;M Investors Fund I LLC, a</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">California Limited Liability Company</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">General Partner</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">D&amp;M Ventures LP, a</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">California Limited Partnership</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Its</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Sole Member</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">David Dollinger Living Trust</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">PENUMBRA, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Its General Partner</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David B. Dollinger</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">David B. Dollinger, Trustee</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">CEO</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">555 Twin Dolphin Drive, Suite 600</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">Redwood City, CA 94065</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Telephone:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">(650) 508-8666</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Telephone:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(&nbsp;&nbsp;&nbsp;&nbsp;)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Facsimile:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">(650) 508-8686</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Facsimile:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(&nbsp;&nbsp;&nbsp;&nbsp;)</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A Notes </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway &#150; First Floor <U> </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>All items
by Landlord unless specified.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clean Room &#150; Approximately Class 10,000 </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring &#150; VCT (do not wax) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; T-Bar grid with Clean Room ceiling tiles </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling height &#150; 10&#146; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Door Height &#150; 9&#146; min </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls- Smooth with Epoxy paint </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on every support column by Landlord, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA, on every support column (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on perimeter walls per code by Landlord, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA and Data along perimeter walls (by Tenant) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Landlord to reuse existing HVAC system and run return air ducts surface mounted and painted on the perimeter walls. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Landlord to supply and install 67 hepafilters, <SUP STYLE="font-size:85%; vertical-align:top">1</SUP>/<SUB
STYLE="font-size:85%; vertical-align:bottom">2</SUB> lay in, <SUP STYLE="font-size:85%; vertical-align:top">1</SUP>/<SUB STYLE="font-size:85%; vertical-align:bottom">2</SUB> fan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">220V Power &#150; 4 locations TBD by Landlord </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Engineering Lab </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring &#150; VCT
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling height &#150; existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Door height &#150; 8&#146; min </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls &#150; partition, paint to match existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power &#150;110V and 220V availability (along perimeter walls by code) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA- drops along perimeter walls (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Data &#150; ports along perimeter walls (landlord to stall data pull boxes in newly built walls, Tenant to do data wiring) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1QC </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring &#150; VCT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling
height &#150; existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Door height &#150; 8&#146; min </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls &#150; partition, paint to match existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power &#150; 110V (along perimeter walls per code) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA- drops along perimeter walls (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Data &#150; ports along perimeter walls (landlord to install power and data pull boxes, Tenant to do data wiring) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equipment Shop </B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring &#150; VCT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling
height &#150; existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Door height &#150; 8&#146; min </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls &#150; partition, paint to match existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power &#150; 110V and 220V availability (along perimeter walls per code) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA- drops along perimeter walls (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Data &#150; ports along perimeter walls (landlord to install power and data pull boxes, Tenant to do data wiring) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IQC Quarantine/Stores/Finished Goods </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Floors &#150; Finished concrete </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power &#150; 110V along perimeter walls (Landlord to provide per code only) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Data &#150; along perimeter walls (landlord to install power and data pull boxes, Tenant to do data wiring) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Wet Processing </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring &#150; VCT </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling
&#150; existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling height - existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Up to 4 Fume hoods to be provided (by Tenant) &#150; exhausting of such hoods to be provided by Landlord </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power 110V and 220V (Qty 2) availability (locations TBD) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Emergency Shower and Eyewash Station (provided by Tenant, installed by Landlord) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Utility sink </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upgrade break area cabinets and counter tops (by Tenant) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway &#150; Second Floor </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Private offices
</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Doors &#150; Light Wood, standard with 3&#146; side light </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power and Data on perimeter walls (landlord to install power and data pull boxes, Tenant to do data wiring) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Paint &#150; to match existing </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>27x24 Rooms
</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Doors &#150; Light Wood, standard doors with no side lights </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power and data on perimeter walls (landlord to install power and data pull boxes, Tenant to do data wiring) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Paint &#150; to match existing </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19x14 Room
</B> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Doors &#150; Light Wood, standard with 3&#146; side light </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power and data along Perimeter walls (landlord to install power and data pull boxes, Tenant to do data wiring) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power and data in floor center (for polycom phone) (by Tenant) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls &#150; partition, paint to match existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring &#150; existing throughout </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upgrade kitchen cabinets and countertops (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power and data on all support columns (by Tenant) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMENCEMENT DATE LETTER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">May&nbsp;7, 2008 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Re: The Lease
Agreement dated November&nbsp;28, 2007, Dollinger Harbor Bay Associates, herein after called Landlord, and Penumbra, Inc., herein after call Tenant relating to certain premises located at 1351 Harbor Bay Parkway, Suite 100A&nbsp;&amp; 202, Alameda,
CA 94502. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter is to confirm that on or before April&nbsp;11, 2008, Landlord delivered the above referenced Premises to the Tenant per the terms
of the Lease Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Now, therefore: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top">The Tenant had Possession on April&nbsp;11, 2008. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top">The Lease Commencement Date shall be May&nbsp;11, 2008. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top">The Rent shall commence on May&nbsp;11, 2008. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top">The initial term of the Lease shall now expire on May&nbsp;10, 2014. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top">NNN Expenses are estimated to be $21,836.40 per month, and this shall be paid monthly through December 2008. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top">Tenant has paid Rent in the amount of $59,673.75 which is to be applied to June Rent. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7)</TD>
<TD ALIGN="left" VALIGN="top">Due on May&nbsp;11, 2008 will be pro-rated Base Rent for 21 days in the amount of $40,424.15 and pro-rated expenses for 21 days in the amount of $14,792.40. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8)</TD>
<TD ALIGN="left" VALIGN="top">Due on June&nbsp;1, 2008 are NNN expenses for June in the amount of $21,836.40. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9)</TD>
<TD ALIGN="left" VALIGN="top">Thereafter all Rents will be due on the first day of each month in the full amount as outlined in the Lease Agreement. Payments should be made payable and remitted to: </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dollinger Properties </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">555 Twin
Dolphin Drive, Suite #600 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Redwood City, CA 94065 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I><U>As a reminder, no invoices for Rent will be sent. </U></I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10)</TD>
<TD ALIGN="left" VALIGN="top">Rent Increases shall occur annually, each May&nbsp;11<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per the terms of the Lease, the Tenant is responsible for Public Liability and Property Damage per Section&nbsp;8 of your lease agreement with Landlord named
Additional Insured. Please have your insurance carrier forward a Certificate of Insurance showing evidence of this coverage as soon as possible. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Also, as a reminder, Tenants are responsible for the maintenance and repair of their HVAC mechanical system. It
is our recommendation that you retain a licensed contractor to service your air-conditioning equipment under a standard maintenance contract to avoid costly repairs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you have any questions or concerns with your Premises or your Lease, please do not hesitate to call either myself (<U>kim@dollingerproperties.com</U>) or
Cary Thompson (<U>cary@dollingerproperties.com</U>) at (650)&nbsp;508-8666. Remember, move-in punch lists must be completed with the first 30 days of occupancy. On behalf of Dollinger Properties, I would like to welcome you as a new tenant. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Agreed To:</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dollinger Properties</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Penumbra, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Kimberlee Grover</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Kimberlee Grover</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><I>Lease Administrator</I></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">5/7/08</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;23, 2011 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway, Suite 100A&nbsp;&amp;
202 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alameda, CA 94502 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Adam Elsesser </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Adam: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This letter when executed shall serve as an
agreement modifying that certain lease dated November&nbsp;28, 2007 and last modified May&nbsp;7, 2008, by and between Dollinger Harbor Bay Associates, as Landlord and Penumbra, Inc., as Tenant, relating to the Premises at 1341 Harbor Bay Parkway,
Suite 100A&nbsp;&amp; 202, Alameda, CA 94502. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>IT IS AGREED THAT: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top">Effective upon full execution of this Letter Agreement, the Term of the Lease shall be extended for seven (7)&nbsp;years and twenty-one (21)&nbsp;days, commencing May&nbsp;11, 2014 and expiring May&nbsp;31, 2021.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top">Effective upon completion of the work specified in Paragraph 5 below (estimated to be November&nbsp;1, 2011}, the Premises shall be adjusted to include an additional 25,430 square feet, and the Tenant shall occupy the
entire 1351 Harbor Bay Parkway building, for a total of 97,980 square feet. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top">Effective three (3} months from the date of completion of the Tenant Improvements, the Base Monthly Rent shall be $117,576.00 per month. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top">Effective each February&nbsp;1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>, the Base Monthly Rent shall increase 3%. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top">Landlord, and Landlord&#146;s sole cost and expense shall build the Tenant Improvements as per the attached Exhibit A, using the same building standards as when the Tenant originally moved in. Such Tenant Improvements
shall include minor work in the building lobby, including, installing a new floor, painting the walls, and moving one of the walls to increase the size of the lobby. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top">All other terms and conditions of said Lease shall remain unchanged and in full force and effect. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ David Dollinger</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">David Dollinger</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Acknowledged and Agreed To:</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Penumbra, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Adam Elsesser</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Adam Elsesser</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794ex10_1pg038.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794ex10_1pg039.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794ex10_1pg040.jpg" ALT="LOGO">

 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>6
<FILENAME>filename6.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LEASE MODIFIED NET </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Basic Provisions
(&#147;Basic Provision&#148;)</B>.<B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1. <B>Parties</B>: This Lease (&#147;<B>Lease</B>&#148;), dated, September&nbsp;11, 2014, is
made by and between Dollinger Harbor Bay Associates, LP (&#147;<B>Landlord</B>&#148;) and Penumbra, lnc. (&#147;<B>Tenant</B>&#148;), (collectively the &#147;<B>Parties,</B>&#148; or individually a &#147;<B>Party</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2. (a) <B>Premises</B>: A portion of that certain building containing approximately 28,317 rentable square feet, including all improvements
therein or to be provided by Landlord under the terms of this Lease, commonly known by the street address of <U>1411 Harbor Bay Parkway</U>, located in the City of <U>Alameda</U>, County of <U>Alameda</U>, State of <U>California</U>, with zip code
<U>94502</U> as outlined on Exhibit <U>B</U> attached hereto (&#147;<B>Premises</B>&#148;). The &#147;<B>Building</B>&#148; is that certain building containing the Premises and generally described as (describe briefly the nature of the Building):
<U>a multi-tenant R&amp;D Office building</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to Tenant&#146;s rights to use and occupy the Premises as hereinafter specified, Tenant shall
have nonexclusive rights to the Common Areas (as defined in Paragraph 2.7 below) as hereinafter specified, but shall not have any rights to the roof, exterior walls or utility raceways of the Building or to any other buildings in the Industrial
Center. The Premises, the Building, the Common Areas, the land upon which they are located, along with all other buildings and improvements thereon, are herein collectively referred to as the &#147;<B>Industrial Center</B>.&#148; (Also see Paragraph
2.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 (b) <B>Parking</B>: the parking ratio will be 3.30 unreserved parking stalls per 1,000 sq. ft. of leased office space. unreserved
vehicle parking spaces (&#147;<B>Unreserved Parking Spaces</B>&#148;); and <U>no</U> reserved vehicle parking spaces (&#147;<B>Reserved Parking Spaces</B>&#148;). (Also, see Paragraph 2.6.) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3. <B>Term</B>: (&#147;<B>Original Term</B>&#148;) Commencing upon the Landlord&#146;s substantial completion of Tenant Improvements at 1411
Harbor Bay Parkway (&#147;<B>Commencement Date</B>&#148;) and ending on November&nbsp;30, 2029. (&#147;<B>Expiration Date</B>&#148;). (Also Paragraph 3.) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4. <B>Early Possession</B>: Tenant shall be allowed access to the Premises during Tenant Improvement Period, however Landlord shall not be
responsible for any delays caused by Tenant&#146;s work (&#147;<B>Early Possession</B>&#148;). (Also Paragraphs 3.2 and 3.3.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5.
<B>Base rent</B>: $36,812.10 per month (&#147;<B>Base Rent</B>&#148;), payable commencing one month following (the &#147;<B>Rent Commencement Date</B>&#148;) the Commencement Date (Also see Paragraph 4). Tenant will receive a Rent Credit for
Prometric&#146;s occupancy of Suite 1001 in the amount of $4,187.00 per month until the earlier to occur of Prometric vacating Suite 1001 or August&nbsp;30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 2022 . Beginning on the on the 1st
day of the month following the first anniversary of the Rent Commencement Date and annually thereafter, Base Rent shall be increased 3% annually. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6. (b) <B>Tenant&#146;s Share of Common Area Operating Expenses</B>: <U>100</U>% of the building (&#147;<B>Tenant&#146;s Share</B>&#148;) as
determined by prorata square footage of the Premises as compared to the total square footage of the Building. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.7. <B>Security
Deposit</B>: $36,812.10 (&#147;<B>Security Deposit</B>&#148;). (Also see Paragraph 5.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.8. <B>Permitted Use</B>: General Office and
R&amp;D Use (&#147;<B>Permitted Use</B>&#148;) (Also see Paragraph 5.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.9. <B>Insuring Party</B>. Landlord is the &#147;<B>Insuring
Party</B>.&#148; (Also see Paragraph 8.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.10. (a) <B>Real Estate Brokers</B>. [ x ]NONE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant shall Indemnify and hold Landlord, its trustees, members, principals, beneficiaries, partners, officers, directors, employees, mortgagee(s) and agents,
and the respective principals and members of any such agents harmless from all claims of any brokers claiming to have represented Tenant in connection with this Lease. Landlord shall indemnify and hold Tenant, its trustees, members, principals,
beneficiaries, partners, officers, directors, employees, and agents, and the respective principals and members of any such agents harmless from all claims of any brokers claiming to have represented Landlord in connection with this Lease. Tenant
acknowledges that any assistance rendered by any agent or employee of any affiliate of Landlord in connection with this Lease has been made as an accommodation to Tenant solely in furtherance of consummating the transaction on behalf of Landlord,
and not as agent for Tenant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.10 (b) <B>Intentionally Omitted</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.11. <B>Guarantor</B>. The obligations of the Tenant under this Lease are to be guaranteed by NONE (&#147;<B>Guarantor</B>&#148;). (Also see
Paragraph&nbsp;37.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.12. <B>Addenda and Exhibits</B>. Attached hereto are Exhibit A and B, all of which constitute a part of this Lease.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Premises, Parking and Common Areas</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1. <B>Letting</B>. Landlord hereby leases to Tenant. and Tenant hereby leases from Landlord, the Premises, for the term, at the rental, and
upon all of the terms, covenants and conditions set forth in this Lease. The leasable area is measured to the outside edge of the outside walls and drip lines to the centerline of any demising walls, including a pro rata share of the electrical
room, corridors, lobbies and other common spaces. Unless otherwise provided herein, any statement of square footage set forth in this Lease, or that may have been used in calculating rental and/or Common Area Operating Expenses, Is an approximation
which Landlord and Tenant agree is reasonable and the rental and Tenant&#146;s Share (as defined in Paragraph 1.6(b) based thereon Is not subject to revision whether or not the actual square footage is more or less. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2. <B>Condition</B>. Landlord shall deliver the Premises to Tenant clean and free of debris on the Commencement Date and warrants to Tenant
that the existing plumbing, electrical systems, fire sprinkler system, lighting, air conditioning and heating systems and loading doors, if any, in the Premises, other than those constructed by Tenant, shall be In good operating condition on the
Commencement Date. If a non-compliance with said warranty exists as of the Commencement Date, Landlord shall, except as otherwise provided in this Lease, promptly after receipt of written notice from Tenant setting forth with specificity the nature
and extent of such non-compliance, rectify same at Landlord&#146;s expense. If Tenant does not give Landlord written notice of a non-compliance with this warranty within six (6)&nbsp;months after the Commencement Date, correction of that
non-compliance shall be the obligation of Tenant at Tenant&#146;s sole cost and expense. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3. <B>Warranties</B>. Tenant acknowledges that
neither landlord nor any of Its agents made any representations or warranties respecting the project, the buildings, or the leased premises, upon which tenant relied In entering into this lease, which are not expressly set forth in this lease.
Tenant further acknowledges that neither Landlord nor any of its agents made any representations as to (i)&nbsp;whether the leased premises may be used for tenants intended use under existing law or, (ii)&nbsp;the suitability of the leased premises
for the conduct of tenant&#146;s business or; (iii)&nbsp;the exact square footage of the leased premises; that tenant relied solely upon its own investigations respecting said premises (including but not limited to the electrical and fire sprinkler
systems, security, environmental aspects, seismic and earthquake requirements, and compliance with the American with Disabilities Act and applicable zoning, municipal, county, state and federal laws, ordinances and regulations and any covenants or
restrictions of record (collectively, &#147;<B>Applicable Laws</B>&#148;) and that upon its execution of this lease, accepts the leasable area as specified herein. Tenant expressly waives any and all claims for damage by reason of any statement,
representation, warranty, promise or other agreement of landlord or landlord&#146;s agent(s), if any, not contained in this lease or in any addenda hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4. <B>Tenant as Prior Owner/Occupant</B>. The warranties made by Landlord in this Paragraph 2.2 shall be of no force or effect if
immediately prior to the date set forth In Paragraph 1.1 Tenant was the owner or occupant of the Premises. In such event, Tenant shall, at Tenant&#146;s sole cost and expense, correct any non-compliance of the Premises with said warranties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5. <B>Vehicle Parking</B>. Tenant shall be entitled to use the number of Unreserved Parking Spaces and Reserved Parking Spaces specified in
Paragraph 1.2(b) on those portions of the Common Areas designated from time to time by Landlord for parking. Tenant shall not use more parking spaces than said number. Said parking spaces shall be used for parking by vehicles no larger than
full-size passenger automobiles or pick-up trucks, herein called &#147;<B>Permitted Size Vehicles</B>.&#148; Vehicles other than Permitted Size Vehicles shall be parked and loaded or unloaded as directed by Landlord in the Rules and Regulations (as
defined in Paragraph 40) issued by Landlord. (Also see Paragraph 2.9.) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall not permit or allow any vehicles that belong to or are controlled by Tenant or
Tenant&#146;s employees, suppliers, shippers, customers, contractors or invitees to be loaded, unloaded, or parked in areas other than those designated by Landlord for such activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) If Tenant permits or allows any of the prohibited activities described in this Paragraph 2.6, then Landlord shall have the right, without
notice, in addition to such other rights and remedies that it may have, to remove or tow away the vehicle involved and charge the cost to Tenant, which cost shall be immediately payable upon demand by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Landlord shall at the Commencement Date of this Lease, provide the parking facilities required by Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6. <B>Common Areas &#150; Definition</B>. The term &#147;<B>Common Areas</B>&#148; is defined as all areas and facilities outside the
Premises and within the exterior boundary line of the Industrial Center and Interior utility raceways within the Premises that are provided and designated by the Landlord from time to time for the general non-exclusive use of Landlord, Tenant and
other tenants of the Industrial Center and their respective employees, suppliers, shippers, customers, contractors and invitees, including parking areas, loading and unloading areas, trash areas, roadways, sidewalks, walkways, parkways, driveways
and landscaped areas. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7. <B>Common Areas &#150; Tenant&#146;s Rights</B>. Landlord hereby grants to Tenant, for the benefit of Tenant
and its employees, suppliers, shippers, contractors, customers and invitees, during the term of this Lease, the nonexclusive right to use, in common with others entitled to such use, the Common Areas as they exist from time to time, subject to any
rights, powers, and privileges reserved by Landlord under the terms hereof or under the terms of any rules and regulations or restrictions governing the use of the Industrial Center. Under no circumstances shall the right herein granted to use the
Common Areas be deemed to include the right to store any property, temporarily or permanently, in the Common Areas. Any such storage shall be permitted only by the prior written consent of Landlord or Landlord&#146;s designated agent, which consent
may be revoked at any time. In the event that any unauthorized storage shall occur then Landlord shall have the right, without notice, in addition to such other rights and remedies that it may have, to remove the property and charge the cost to
Tenant, which cost shall be immediately payable upon demand by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8. <B>Common Areas &#150; Rules and Regulations</B>. Landlord
or such other person(s) as Landlord may appoint shall have the exclusive control and management of the Common Areas and shall have the right, from time to time, to establish, modify, amend and enforce reasonable Rules and Regulations with respect
thereto in accordance with Paragraph 40. Tenant agrees to abide by and conform to all such Rules and Regulations and to cause its employees, suppliers, shippers, customers, contractors and invitees to so abide and conform. Landlord shall not be
responsible to Tenant for the non-compliance with said rules and regulations by other tenants of the Industrial Center. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9. <B>Common
Areas &#150; Changes</B>. Landlord shall have the right, in landlord&#146;s sole discretion, from time to time: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) To make changes to
the Common Areas, including, without limitation, changes in the location, size, shape and number of driveways, entrances, parking spaces, parking areas, loading and unloading areas, ingress, egress, direction of traffic, landscaped areas, walkways
and utility raceways; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) To close temporarily any of the Common Areas for maintenance purposes so long as reasonable access to the
Premises remains available; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) To designate other land outside the boundaries of the Industrial Center to be a part of the Common Areas;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) To add additional buildings and Improvements to the Common Areas; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) To use the Common Areas while engaged in making additional improvements, repairs or alterations to the Industrial Center, or any portion
thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) To do and perform such other acts and make such other changes In, to or with respect to the Common Areas and Industrial
Center as Landlord may, in the exercise of sound business judgment, deem to be appropriate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord shall use best efforts to ensure that the performance of any such work of repairs or
alterations shall not interfere with Tenant&#146;s use of the Premises (or any portion thereof) for Tenant&#146;s business purposes (such efforts to include limiting the performance of any such work which might be disruptive to weekends or the
evening and the cleaning of any work area prior to the commencement of the next business day); and </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Term</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1. <B>Term</B>. The Commencement Date, Expiration Date and Original Term of this Lease are as specified in Paragraph 1.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2. <B>Early Possession</B>. If Tenant totally or partially occupies the Premises after the Early Possession Date but prior to the
Commencement Date, the obligation to pay Base Rent shall be abated for the period of such early occupancy. All other terms of this Lease, however, (including but not limited to the obligations to pay Tenant&#146;s Share of Common Area Operating
Expenses and to carry the insurance required by Paragraph 8) shall be in effect during such period. Any such early possession shall not affect nor advance the Expiration Date of the Original Term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3. <B>Delay In Possession</B>. If for any reason Landlord cannot deliver possession of the Premises to Tenant by the Early Possession Date,
Landlord shall not be subject to any liability therefor, nor shall such failure affect the validity of this Lease, or the obligations of Tenant hereunder, or extend the term hereof, but in such case, Tenant shall not, except as otherwise provided
herein, be obligated to pay rent or perform any other obligation of Tenant under the terms of this Lease until Landlord delivers possession of the Premises to Tenant. If possession of the Premises is not delivered to Tenant within sixty
(60)&nbsp;days after the Commencement Date, Tenant may, at its option, by notice in writing to Landlord within ten (10)&nbsp;days after the end of sixty (60)&nbsp;day period, cancel this Lease, in which event the parties shall be discharged from all
obligations hereunder; provided further, however, that if such written notice of Tenant is not received by Landlord within said ten (10)&nbsp;day period, Tenants right to cancel this Lease hereunder shall terminate and be of no further force or
effect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Rent </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1. <B>Base
Rent</B>. Tenant shall pay Base Rent and other rent or charges, as the same may be adjusted from time to time, to Landlord in lawful money of the United States, without offset or deduction, on or before the 1<SUP
STYLE="font-size:85%; vertical-align:top">st</SUP> day of each month. Base Rent and all other rent and charges for any period during the term hereof which is for less than one full month shall be prorated based upon the actual number of days of the
month involved. Payment of Base Rent and other charges shall be made to Landlord at its address stated herein or to such other persons or at such other addresses as Landlord may from time to lime designate In writing to Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2. <B>Common Area Operating Expenses</B>. Tenant shall pay to Landlord during the term hereof, in addition to the Base Rent, Tenant&#146;s
Share (as specified in Paragraph 1.6(b)) of all Common Area Operating Expenses, as hereinafter defined, during each calendar year of the term of this Lease, in accordance with the following provisions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B>Common Area Operating Expenses</B>&#148; are defined, for purposes of this Lease, as all costs incurred by Landlord relating to
the ownership and operation of the Industrial Center, including, but not limited to, the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The operation, repair and
maintenance, in neat, clean, good order and condition, of the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(aa) The Common Areas, including parking areas, loading and
unloading areas, trash areas, roadways, sidewalks, walkways, parkways, driveways, landscaped areas, striping, bumpers, irrigation systems, Common Area lighting facilities, fences and gates, elevators and roof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(bb) Exterior signs and any tenant directories. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(cc) Fire detection and sprinkler systems. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The cost of water, gas, electricity and telephone to service the Common Areas. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Trash disposal, property management fees of 4% of the gross monthly rental and security services and the costs of any regularly
scheduled environmental inspections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) <B>[INTENTIONALLY OMITTED]</B>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) Real Property Taxes (as defined in Paragraph 10.2) to be paid by Landlord for the Building
and the Common Areas under Paragraph 10 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) The cost of the premiums for the insurance policies maintained by Landlord under
Paragraph 8 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) Any deductible portion of an insured loss concerning the building or the Common Areas. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) Any other services to be provided by Landlord that are stated elsewhere in this Lease to be a Common Area Operating Expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The cost of any capital improvements or other capital items included in Common Area Operating Expenses shall be amortized by Landlord on a
straight line basis over the economic useful life of the capital item for accounting purposes, as determined by Landlord using generally accepted accounting principles, consistently applied, and Internal Revenue Service asset classification
regulations, if any. The amortized cost of capital improvements may include interest at the rate paid by Landlord on any funds borrowed for such expenditures from an unaffiliated third-party financial institution, but in no event in excess of the
market rate of interest customarily paid on such borrowed funds for such purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, Common Area Operating
Expenses will not include: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) repairs or other work occasioned by fire, windstorm or other insured casualty or hazard, to the extent
that Landlord shall receive proceeds of such insurance or would have received such proceeds had Landlord maintained the insurance coverage required under this Lease and diligently attempted to procure the maximum possible insurance coverage; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) marketing and promotional costs; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) debt service payments on or related to any indebtedness; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) any amounts paid to any person, firm or corporation related or otherwise affiliated with Landlord or any general partner, officer or
director of Landlord or any of its general partners, to the extent same materially exceeds arms-length competitive prices paid in the Alameda, California metropolitan area for the services or goods provided; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) costs relating to maintaining Landlord&#146;s existence, either as a corporation, partnership, or other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Any common Area Operating Expenses and Real Property Taxes that are specifically attributable to the Building or to any other building in
the industrial Center or to the operation, repair and maintenance thereof, shall be allocated entirely to the Building or to such other building. However, any Common Area Operating Expenses and Real Property Taxes that are not specifically
attributable to the Building or to any other building or to the operation, repair and maintenance thereof, shall be equitably allocated by Landlord to all buildings in the Industrial Center. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) The inclusion of the improvements, facilities and services set forth in subparagraph 4.2(a) shall not be deemed to impose an obligation
upon Landlord to either have said improvements or facilities or to provide those services unless the Industrial Center already has the same, Landlord already provides the services, or Landlord has agreed elsewhere in this Lease to provide the same
or some of them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Tenant&#146;s Share of Common Area Operating Expenses shall be payable by Tenant within thirty (30)&nbsp;days after
a reasonably detailed statement of actual expenses is presented to Tenant by Landlord. At Landlord&#146;s option, however, an amount may be reasonably estimated by Landlord from time to time of Tenant&#146;s Share of annual Common Area Operating
Expenses and the same shall be payable monthly or quarterly, as Landlord shall designate, during each 12-month period of the Lease term, on the same day as the Base Rent is due hereunder. Landlord shall deliver to Tenant within sixty (60)&nbsp;days
after the expiration of each calendar year a reasonably detailed statement showing Tenant&#146;s Share of the actual Common Area Operating Expenses incurred during the preceding year. If Tenant&#146;s payments under this Paragraph 4.2(d) during said
preceding year exceed Tenant&#146;s Share as indicated on said statement, Landlord shall be credited the amount of such over-payment against Tenant&#146;s Share of Common Area Operating Expenses next becoming due. If Tenant&#146;s payments under
this Paragraph 4.2(d) during said preceding year were less than Tenant&#146;s Share as indicated on said statement, Tenant shall pay to Landlord the amount of the deficiency within ten (10)&nbsp;days after delivery by Landlord to Tenant of said
statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Landlord shall maintain at all times during the term of this Lease, full, complete and
accurate books of account and records prepared in accordance with generally accepted accounting principles with respect to Common Area Operating Expenses, and shall retain such books and records, as well as contracts, bills, vouchers, and checks,
and such other documents as are reasonably necessary to properly audit Common Area Operating Expenses. Upon reasonable notice from Tenant, Landlord shall make available for Tenant&#146;s inspection (or inspection performed by Tenant&#146;s
accountant and/or consultants) during normal business hours, Landlord&#146;s books and records relating to the Common Area Operating Expenses. If an audit, review or inspection by a Tenant or Tenant&#146;s accountant or consultant alleges an
overbilling, Tenant may submit a claim for the overbilled amount to Landlord, detailing the nature of the overbilling, and Landlord shall have thirty (30)&nbsp;days to pay such amount or contest the claim by giving notice thereof to Tenant,
detailing the nature of Landlord&#146;s contest of Tenant&#146;s claims. If, Landlord&#146;s statement is ultimately determined to be in error, Landlord will promptly reimburse to Tenant, or Tenant will promptly pay to Landlord, any amount which may
be determined to have been due as a result of Tenant&#146;s audit; additionally, if Landlord is determined to have overcharged Tenant for Common Area Operating Expenses by 3% or more, Landlord shall reimburse Tenant within thirty (30)&nbsp;days
following such determination for the reasonable cost of Tenant&#146;s review of Landlord&#146;s books and records not to exceed $500 (which cost may not be included as a Common Area Operating Expense). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Security Deposit</B>. Tenant shall deposit with Landlord upon Tenant&#146;s execution hereof the Security Deposit set forth in Paragraph&nbsp;1.7 as
security for Tenant&#146;s faithful performance of Tenant&#146;s obligations under this Lease. If Tenant fails to pay Base Rent or other rent or charges due hereunder, or otherwise Defaults under this Lease (as defined in Paragraph 13.1), Landlord
may use, apply or retain all or any portion of said Security Deposit, Tenant shall within ten (10)&nbsp;days after written request therefore deposit monies with Landlord sufficient to restore said Security Deposit to the full amount required by this
Lease. Landlord shall not be required to keep all or any part of the Security Deposit separate from its general accounts. Landlord shall, at the expiration or earlier termination of the term hereof and after Tenant has vacated the Premises, return
to Tenant (or, at Landlord&#146;s option, to the last assignee, if any, of Tenant&#146;s interest herein), that portion of the Security Deposit not used or applied by Landlord. Unless otherwise expressly agreed in writing by Landlord, no part of the
Security Deposit shall be considered to be held in trust, to bear interest or other increment for its use, or to be prepayment for any monies to be paid by Tenant under this Lease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Use</B>.<B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1. <B>Permitted
Use</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall use and occupy the Premises only for the Permitted Use set forth in Paragraph 1.8, or any other legal use which
is reasonably comparable thereto, and for no other purpose. Tenant shall not use or permit the use of the Premises in a manner that is unlawful, creates waste or a nuisance, or that disturbs owners and/or occupants of, or causes damage to the
Premises or neighboring premises or properties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Landlord hereby agrees to not unreasonably withhold, condition or delay its consent
to any written request by Tenant, Tenant&#146;s assignees or subtenants, and by prospective assignees and subtenants of Tenant, its assignees and subtenants, for a modification of said Permitted Use, so long as the same will not impair the
structural integrity of the improvements on the Premises or in the Building or the mechanical or electrical systems therein, does not conflict with uses by other Tenants, is not significantly more burdensome to the Premises or the Building and the
Improvements thereon, and is otherwise permissible pursuant to this Paragraph 6. If Landlord elects to withhold such consent, Landlord shall within five (5)&nbsp;business days after such request give a written notification of same, which notice
shall include an explanation of Landlord&#146;s reasonable objections to the change in use. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2. <B>Hazardous Substances</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <B>Reportable Uses Require Consent</B>. The term &#147;<B>Hazardous Substance</B>&#148; as used in this Lease shall mean any product,
substance, chemical, material or waste whose presence, nature, quantity and/or intensity of existence, use, manufacture, disposal, transportation, spill, release or effect, either by itself or in combination with other materials expected to be on
the Premises, is either: (i)&nbsp;potentially injurious to the public health, safety or welfare, the environment, or the Premises; (ii)&nbsp;regulated or monitored by any governmental authority; or (iii)&nbsp;a basis for potential liability of
Landlord to any governmental agency or third party under any applicable statute or common law theory. Hazardous Substance shall include, but not be limited to, hydrocarbons, petroleum, gasoline, crude oil or any products or by-products thereof.
Tenant shall not engage in any activity in or about the Premises which constitutes a Reportable Use (as hereinafter defined) of Hazardous Substances without the express prior written consent of Landlord and compliance in a timely manner (at
Tenant&#146;s sole cost and expense) with all Applicable Requirements (as defined in Paragraph&nbsp;6.3). &#147;<B>Reportable Use</B>&#148; shall mean (i)&nbsp;the installation or use of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any above or below ground storage tank, (ii)&nbsp;the generation, possession, storage, use, transportation, or disposal of a Hazardous Substance that requires a permit from, or with respect to
which a report, notice, registration or business plan is required to be filed with, any governmental authority, and (iii)&nbsp;the presence in, on or about the Premises of a Hazardous Substance with respect to which any Applicable Laws require that
a notice be given to persons entering or occupying the Premises or neighboring properties. Notwithstanding the foregoing, Tenant may, without Landlord&#146;s prior consent, but upon notice to Landlord and in compliance with all Applicable
requirements, use any ordinary and customary materials reasonably required to be used by Tenant in the normal course of the Permitted Use, so long as such use is not a Reportable Use and does not expose the Premises or neighboring properties to any
meaningful risk of contamination or damage or expose Landlord to any liability therefor. In addition, Landlord may (but without any obligation to do so) condition its consent to any Reportable Use of any Hazardous Substance by Tenant upon
Tenant&#146;s giving Landlord such additional assurances as Landlord, in its reasonable discretion, deems necessary to protect itself, the public, the Premises and the environment against damage, contamination or injury and/or liability therefor,
including but not limited to the installation (and, at Landlord&#146;s option, removal on or before Lease expiration or earlier termination) of reasonably necessary protective modifications to the Premises (such as concrete encasements) and/or the
deposit of an additional Security Deposit under Paragraph 5 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <B>Duty to Inform Landlord</B>. If Tenant knows, or has
reasonable cause to believe, that a Hazardous Substance has come to be located in, on, under or about the Premises or the Building, other than as previously consented to by Landlord, Tenant shall immediately give Landlord written notice thereof,
together with a copy of any statement, report, notice, registration, application, permit, business plan, license, claim, action, or proceeding given to, or received from, any governmental authority or private party concerning the presence, spill,
release, discharge of, or exposure to, such Hazardous Substance including but not limited to all such documents as may be involved in any Reportable Use involving the Premises. Tenant shall not cause or permit any Hazardous Substance to be spilled
or released in, on, under or about the Premises (including, without limitation, through the prompting or sanitary sewer system). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)
<B>Indemnification</B>. Tenant shall indemnify, protect, defend and hold Landlord, its agents, employees, lenders and ground lessor, if any, and the Premises, harmless from and against any and all damages, liabilities, judgments, costs, claims,
liens, expenses, penalties, loss of permits and attorneys&#146; and consultants&#146; fees arising out of or involving any Hazardous Substance brought onto the Premises by or for Tenant or by anyone under Tenant&#146;s control. Tenant&#146;s
obligations under this paragraph 6.2(c) shall include, but not be limited to, the effects of any contamination or injury to person, property or the environment created or suffered by Tenant, and the cost of investigation (including consultants&#146;
and attorneys&#146; fees and testing), removal, remediation, restoration and/or abatement thereof, or of any contamination therein involved, and shall survive the expiration or earlier termination of this Lease. No termination, cancellation or
release agreement entered into by Landlord and Tenant shall release Tenant from its obligations under this Lease with respect to Hazardous Substances, unless specifically so agreed by Landlord in writing at the time of such agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3. <B>Tenant&#146;s Compliance with Requirements</B>. Tenant shall, at Tenant&#146;s sole cost and expense, fully, diligently and in a
timely manner, comply with all &#147;<B>Applicable Requirements</B>&#148;&middot; which term is used in this Lease to mean all laws, rules, regulations, ordinances, directives, covenants, easements and restrictions of record, permits, the
requirements of any applicable fire insurance underwriter or rating bureau, and the recommendations of Landlord&#146;s engineers and/or consultants, relating in any manner to the Premises (including but not limited to matters pertaining to
(i)&nbsp;industrial hygiene, (ii)&nbsp;environmental conditions on, in, under or about the Premises, including soil and ground water conditions, and (iii)&nbsp;the use, generation, manufacture, production, installation, maintenance, removal,
transportation, storage, spill, or release of any Hazardous Substance), now in effect or which may hereafter come into effect. Tenant shall, within five (5)&nbsp;days after receipt of Landlord&#146;s written request, provide Landlord with copies of
all documents and information, including but not limited to permits, registrations, manifests, applications, reports and certificates, evidencing Tenant&#146;s compliance with any applicable Requirements specified by Landlord, and shall immediately
upon receipt, notify Landlord in writing (with copies of any documents involved) of any threatened or actual claim, notice, citation, warning, complaint or report pertaining to or involving failure by Tenant or the Premises to comply with any
Applicable Requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4. <B>Inspection; Compliance with Law</B>. Landlord, Landlord&#146;s agents, employees, contractors and
designated representatives, and the holders of any mortgages, deeds of trust or ground leases on the Premises (&#147;<B>Lenders</B>&#148;) shall have the right to enter the Premises at any time in the case of an emergency, and otherwise at
reasonable times upon reasonable advance notice to Tenant, for the purpose of inspecting the condition of the Premises and for verifying compliance by Tenant with this Lease and all Applicable Requirements (as defined in Paragraph 6.3), and Landlord
shall be entitled to employ experts and/or consultants in connection therewith to advise Landlord with respect to Tenant&#146;s activities, including but not limited to Tenant&#146;s installation, operation, use, monitoring, maintenance, or removal
of any Hazardous Substance on or from the Premises. The costs and expenses </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of any such inspections shall be paid by the party requesting same (and if paid by Landlord, such cost will not be included in Common Area Operating Expenses), unless a Default or Breach of this
Lease by Tenant or a violation of Applicable Requirements or a contamination, caused or materially contributed to by Tenant, is found to exist or to be imminent, or unless the inspection is requested or ordered by a governmental authority as the
result of any such existing or imminent violation or contamination. In such case, Tenant shall upon request reimburse Landlord or Landlord&#146;s Lender, as the case may be, for the costs and expenses of such inspections. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Maintenance, Repairs, Utility Installations, Trade Fixtures and Alterations</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1. <B>Tenant&#146;s Obligations</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Subject to the provision of Paragraphs 2.2 (Condition), 7.2 (Landlord&#146;s Obligations), 9 (Damage or Destruction), and 14
(Condemnation), Tenant shall, at Tenant&#146;s sole cost and expense and at all times, keep the Premises and every part thereof in good order, condition and repair (whether or not such portion of the Premises requiring repair, or the means of
repairing the same, are reasonably or readily accessible to Tenant, and whether or not the need for such repairs occurs as a result of Tenant&#146;s use, any prior use, the elements or the age of such portion of the Premises), including, without
limiting the generality of the foregoing, all equipment or facilities specifically serving the Premises, such as plumbing, heating, air conditioning, ventilating electrical, lighting facilities, boilers, fired or unfired pressure vessels, fire hose
connections if within the Premises, fixtures, interior walls, interior surfaces of exterior walls, ceilings, floors, windows, doors, plate glass, and skylights, but excluding any items which are the responsibility of Landlord pursuant to Paragraph
7.2 below. Tenant, in keeping the Premises in good order, condition and repair, shall exercise and perform good maintenance practices. Tenant&#146;s obligations shall include restorations, replacements or renewals when necessary to keep the Premises
and all improvements thereon or a part thereof in good order, condition and state of repair. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Tenant shall, at Tenant&#146;s sole cost
and expense, procure and maintain a contract, with copies to Landlord, in customary form and substance for and with a contractor specializing and experienced in the inspection, maintenance and service of the heating, air conditioning and ventilation
system for the Premises. However, Landlord reserves the right, upon notice to Tenant, to procure and maintain the contract for the heating, air conditioning and ventilating systems, and if Landlord so elects, Tenant shall reimburse Landlord, upon
demand, for the cost thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) If Tenant fails to perform Tenant&#146;s obligations under this Paragraph 7.1, Landlord may enter upon
the Premises after ten (10)&nbsp;days&#146; prior written notice to Tenant (except in the case of an emergency, in which case no notice shall be required), perform such obligations on Tenant&#146;s behalf, and put the Premises in good order,
condition and repair, in accordance with Paragraph 13.2 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2. <B>Landlord&#146;s Obligations</B>. Subject to the provisions of
Paragraphs 22 (Condition), 4.2 (Common Area Operating Expenses to the extent applicable), 7 (Use), 7.1 (Tenant&#146;s Obligations), 9 (Damage or Destruction) and 14 (Condemnation), Landlord, subject to reimbursement pursuant to Paragraph 4.2 to the
extent applicable, shall keep in good order, condition and repair the foundations, exterior walls, structural condition of interior bearing walls, roof, fire sprinkler and/or standpipe and hose (if located in the Common Areas) or other automatic
fire extinguishing system including fire alarm and/or smoke detection systems and equipment, fire hydrants, parking lots, walkways, parkways, driveways, landscaping, fences, signs and utility systems serving the Common Areas and all parts thereof,
as well as providing the services for which there is a Common Area Operating Expense pursuant to Paragraph 4.2. Landlord shall not be obligated to paint the exterior or interior surfaces of exterior walls nor shall Landlord be obligated to maintain,
repair or replace windows, doors or plate glass of the Premises. Tenant expressly waives the benefit of any statute now or hereafter in effect which would otherwise afford Tenant the right to make repairs at Landlord&#146;s expense or terminate this
Lease because of Landlord&#146;s failure to keep the Building, Industrial Center or Common Areas in good order, condition and repair. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3. <B>Utility Installations, Trade Fixtures, Alterations</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <B>Definitions; Consent Required</B>. The term &#147;<B>Utility Installations</B>&#148; is used in this Lease to refer to all air lines,
power panels, electrical distribution, security, fire protections systems, lighting fixtures, heating, ventilating and air conditioning equipment, plumbing, and fencing in, on or about the Premises. The term &#147;<B>Trade Fixtures</B>&#148; shall
mean Tenant&#146;s machinery and equipment which can be removed without doing material damage to the Premises. The term &#147;<B>Alterations</B>&#148; shall mean any modification of the improvements on the Premises under the terms of this Lease,
other than Utility Installations or Trade Fixtures. &#147;<B>Tenant-Owned Alterations and/or Utility Installations</B>&#148; are defined as Alterations and/or Utility Installations made by Tenant that are not yet owned by Landlord pursuant to
Paragraph 7.4(a). Tenant shall not make nor cause to be made any Alterations or Utility </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Installations in, on, under or about the Premises without Landlord&#146;s prior written consent. Tenant may, however, make non-structural Utility Installations to the interior of the Premises
(excluding the roof) without Landlord&#146;s consent but upon notice to Landlord, so long as they are not visible from the outside of the Premises, do not involve puncturing, relocating or removing the roof or any existing walls, or changing or
interfering with the fire sprinkler or fire detection systems and the cost thereof does not exceed $25,000.00. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <B>Consent</B>. Any
Alterations or Utility Installations that Tenant shall desire to make and which require the consent of the Landlord shall be presented to Landlord in written form with detailed plans. All consents given by Landlord, whether by virtue of Paragraph
7.3(a) or by subsequent specific consent, shall be deemed conditioned upon: (i)&nbsp;Tenant&#146;s acquiring all applicable permits required by governmental authorities; (ii)&nbsp;the furnishing of copies of such permits together with a copy of the
plans and specifications for the Alteration or Utility Installation to Landlord prior to commencement of the work thereon; and (iii)&nbsp;the compliance by Tenant with all conditions of said permits in a prompt and expeditious manner. Any
Alterations of Utility Installations by Tenant during the term of this Lease shall be done in a good and workmanlike manner, with good and sufficient materials, and be in compliance with all Applicable Requirements. Tenant shall promptly upon
completion thereof furnish Landlord with as-built plans and specifications therefor. Landlord may (but without obligation to do so) condition its consent to any requested Alteration or Utility Installation that costs $25,000.00 or more upon
Tenant&#146;s providing Landlord with a lien and completion bond in an amount equal to one and one-half times the estimated cost of such Alteration or Utility Installation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <B>Lien Protection</B>. Tenant shall pay when due all claims for labor or materials furnished or alleged to have been furnished to or for
Tenant at or for use on the Premises, which claims are or may be secured by any mechanic&#146;s or materialmen&#146;s lien against the Premises or any interest therein. Tenant shall give Landlord not less than ten (10)&nbsp;days&#146; notice prior
to the commencement of any work in, on, or about the Premises, and Landlord shall have the right to post notices of non-responsibility in or on the Premises as provided by law. If Tenant shall, in good faith, contest the validity of any such lien,
claim or demand. then Tenant shall, at its sole expense. defend and protect itself, Landlord and the Premises against the same and shall pay and satisfy any such adverse judgment that may be rendered thereon before the enforcement thereof against
the Landlord or the Premises. If Landlord shall require, Tenant shall furnish to Landlord a surety bond satisfactory to Landlord in an amount equal to one and one-half times the amount of such contested lien claim or demand, indemnifying Landlord
against liability for the same, as required by law for the holding of the Premises free from the effect of such lien or claim. In addition, Landlord may require Tenant to pay Landlord&#146;s attorneys&#146; fees and costs in participating in such
action if Landlord shall decide it is to its best interest to do so. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4. <B>Ownership, Removal, Surrender, and Restoration</B><B>.</B>
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <B>Ownership</B>. Subject to Landlord&#146;s right to require their removal as expressly set forth below, and to cause Tenant to
become the owner thereof as hereinafter provided in this Paragraph 7.4, all Alterations and Utility Installations made to the Premises by Tenant shall be the property of and owned by Tenant, but considered a part of the Premises. Landlord may, at
any time and at its option, elect in writing to Tenant to be the owner of all or any specified part of the Tenant-Owned Alterations and Utility Installations. Unless otherwise instructed per Subparagraph 7.4(b) hereof, all Tenant-Owned Alterations
and Utility Installations shall, at the expiration or earlier termination of this Lease, become the property of Landlord and remain upon the Premises and be surrendered with the Premises by Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <B>Removal</B>. Landlord may, by notice delivered to Tenant concurrently with Landlord&#146;s consent to the installation of any
Tenant-Owned Alterations or Utility Installations (but not the Tenant Improvements or Initial Alterations) require that any or all of such Tenant-Owned Alterations or Utility Installations be removed by the expiration or earlier termination of this
Lease, notwithstanding that their installation may have been consented to by Landlord. Landlord may require the removal at any time of all or any part of any Alterations or Utility Installations made without the required consent of Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <B>Surrender/Restoration</B>. The voluntary or other surrender of this Lease by Tenant, or a mutual cancellation thereof, shall not work a
merger, and shall, at the option of Landlord, terminate all or any existing subleases or subtenancies, or may, at the option of Landlord, operate as an assignment to Landlord of any or all such subleases or subtenancies. Immediately prior to the
expiration or sooner termination of this Lease, Tenant shall remove all of Tenant&#146;s signs from the exterior of the Building and shall remove all of Tenant&#146;s equipment, trade fixtures, furniture, supplies, wall decorations and other
personal property from the Leased Premises, and shall vacate and surrender the Leased Premises to Landlord in the same condition, broom clean, as existed at the Lease Commencement Date, subject to Tenant-Owned Alterations and Utility Installations
the removal of which is not required hereunder. Tenant shall repair all damage to the Leased Premises caused by Tenant or by Tenant&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
removal of Tenant&#146;s property and all damage to the exterior of the Building caused by Tenant&#146;s removal of Tenant&#146;s signs. Tenant shall replace all stained or damaged ceiling tiles
and shall repair or replace, as necessary, all burned out light bulbs and damaged or stained light lenses and shall repaint all painted walls. Tenant shall patch and refinish, to Landlord&#146;s reasonable satisfaction, all penetrations made by
Tenant or its employees to the floor, walls or ceiling of the Leased Premises, whether such penetrations were made with Landlord&#146;s approval or not. Additionally, Tenant shall, prior to the expiration or sooner termination of this Lease, remove
any improvements, constructed or installed by Tenant which Landlord pursuant to the provisions of Section 7.4(b) above, previously requested be so removed by Tenant and repair all damage caused by such removal. If the Leased Premises are not
surrendered to Landlord in the condition required by this Article at the expiration or sooner termination of this Lease, Landlord may, at Tenant&#146;s expense, so remove Tenant&#146;s signs, property and/or improvements not so removed and make such
repairs and replacements not so made or hire, at Tenant&#146;s expenses, independent contractors to perform such work. Tenant shall be liable to Landlord for all costs incurred by Landlord in returning the Leased Premises to the required condition
and Tenant shall be deemed to have impermissibly held over until such time as such required work is completed. Tenant shall pay Base Monthly Rent and Additional Rent at the rate payable immediately preceding the Expiration Date until such work is
completed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Insurance; Indemnity</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1. <B>Payment of Premiums</B>. The cost of the premiums for the insurance policies maintained by Landlord under this Paragraph 8 shall be a
Common Area Operating Expense pursuant to Paragraph 4.2 hereof. Premiums for policy periods commencing prior to, or extending beyond, the term of this Lease shall be prorated to coincide with the corresponding Commencement Date or Expiration Date.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2. <B>Liability Insurance</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <B>Carried by Tenant</B>. Tenant shall obtain and keep in force during the term of this Lease a Commercial General Liability policy of
insurance protecting Tenant, Landlord and any Lender(s) whose names have been provided to Tenant in writing (as additional insureds) against claims for bodily injury, personal injury and property damage based upon, involving or arising out of the
ownership, use, occupancy or maintenance of the Premises and all areas appurtenant thereto. Such insurance shall be on an occurrence basis providing single limit coverage in an amount not less than $1,000,000 per occurrence with an &#147;Additional
Insured-Managers or Landlords of Premises&middot; endorsement and contain the &#147;Amendment of the Pollution Exclusion&#148; endorsement for damage caused by heat, smoke or fumes from a hostile fire. Tenant must either cause their liability policy
to be endorsed to include pollution liability coverage, onsite and off site, including release of any pollutants, toxins, or contaminants, whether such release is sudden or prolonged or willful or accidental OR Tenant must procure a separate policy
which provides coverage for pollution, liability, premises pollution, on site and off site , including release of any pollutants, toxins, or contaminants, whether such release is sudden or prolonged or willful or accidental. The policy shall not
contain any intra-insured exclusions as between insured persons or organizations, but shall include coverage for liability assumed under this Lease as an &#147;<B>Insured contract</B>&#148; for the performance of Tenant&#146;s indemnity obligations
under this Lease. The limits of said insurance required by this Lease or as carried by Tenant shall not, however, limit the liability of Tenant nor relieve Tenant of any obligation hereunder. All insurance to be required by this Lease or as carried
by Tenant shall not, however, limit the liability of Tenant nor relieve Tenant of any obligation hereunder. All insurance to be carried by Tenant shall be primary to and not contributory with any similar insurance carried by Landlord, whose
insurance shall be considered excess insurance only. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <B>Carried by Landlord</B>. Landlord shall also maintain liability insurance
described in Paragraph 8.2(a) above, in addition to and not in lieu of, the insurance required to be maintained by Tenant except coverage for pollution liability, premises pollution, on site and off site, including release of any pollutants, toxins,
or contaminants, whether such release is sudden or prolonged or willful or accidental, shall only be carried solely by Tenant. Tenant shall not be named as an additional insured therein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3. <B>Property Insurance-Building, Improvements and Rental Value.</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <B>Building and Improvements</B>. Landlord shall obtain and keep in force during the term of this Lease a policy or policies in the name of
Landlord, with loss payable to Landlord and to any Lender(s), insuring against loss or damage to the Building and Premises. Such insurance shall be for full replacement cost, as the same shall exist from time to time, or the amount required by any
Lender(s), but in no event more than the commercially reasonable and available insurable value thereof if, by reason of the unique nature or age of the improvements involved, such latter amount is less than full replacement cost. Tenant-Owned
Alterations and Utility Installations, Trade Fixtures and Tenant&#146;s personal property shall be insured by Tenant pursuant to Paragraph 8.4. Landlord&#146;s policy or policies shall insure against all risks of direct physical loss or damage (and
at Landlord&#146;s option the perils of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
flood and/or earthquake), including coverage for any additional costs resulting from debris removal and reasonable amounts of coverage for the enforcement of any ordinance or law regulating the
reconstruction or replacement of any undamaged sections of the Building required to be demolished or removed by reason of the enforcement of any building, zoning, safety or land use laws as the result of a covered loss, but not including plate glass
insurance. Said policy or policies shall also contain an agreed valuation provision in lieu of any co-insurance clause, waiver of subrogation, and inflation guard protection causing an increase in the annual property insurance coverage amount by a
factor of not less than the adjusted U.S. Department of Labor Consumer Price Index for All Urban Consumers for the city nearest to where the Premises are located. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <B>Rental Value</B>. Landlord shall also obtain and keep in force during the term of this Lease a policy or policies in the name of
Landlord, with loss payable to Landlord and any Lender(s), insuring the loss of the full rental and other charges payable by all tenants of the Building to Landlord for at least one year (including all Real Property Taxes, insurance costs, all
Common Area Operating Expenses and any scheduled rental increases). Said insurance may provide that in the event the Lease is terminated by reason of an insured loss, the period of indemnity for such coverage shall be extended beyond the date of the
completion of repairs or replacement of the Premises, to provide for one full year&#146;s loss of rental revenues from the date of any such loss. Said insurance shall contain an agreed valuation provision in lieu of any co-insurance clause, and the
amount of coverage shall be adjusted annually to reflect the projected rental income, Real Property Taxes, insurance premium costs and other expenses, if any, otherwise payable, for the next 12-month period. Common Area Operating Expenses shall
include any deductible amount in the event of such loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <B>Adjacent Premises</B>. Tenant shall pay for any increase in the premiums
for the property insurance of the Building and for the Common Areas or other buildings in the Industrial Center If said increase is caused solely by Tenant&#146;s acts, omissions, use or occupancy of the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <B>Tenant&#146;s Improvements</B>. Since Landlord Is the Insuring Party, Landlord shall not be required to Insure Tenant-Owned Alterations
and Utility Installations unless the Item In question has become the property of Landlord under the terms of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4.
<B>Tenant&#146;s Property Insurance</B>. Subject to the requirements of Paragraph 8.5, Tenant at Its cost shall either by separate policy or by endorsement to a policy already carried, maintain insurance coverage on all of Tenant&#146;s personal
property, Trade Fixtures and Tenant-Owned Alterations and Utility Installations in, on, or about the Premises similar In coverage to that carried by Landlord as the Insuring Party under Paragraph 8.3(a). Such insurance shall be full replacement cost
coverage with a deductible not to exceed $10,000.00 per occurrence. Upon request from Landlord, Tenant shall provide Landlord with written evidence that such Insurance is in force. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5. <B>Insurance Policies</B>. Insurance required hereunder shall be In companies duly licensed to transact business In the state where the
Premises are located, and maintaining during the policy term a &#147;General Policyholders Rating&#148; of at least A-VII, or such other rating as may be required by a Lender, as set forth in the most current Issue of &#147;Best&#146;s Insurance
Guide.&#148; Tenant shall not do or permit to be done anything which shall invalidate the insurance policies referred to in this Paragraph 8. Tenant shall cause to be delivered to Landlord, within seven (7)&nbsp;days after the earlier of the Early
Possession Date or the Commencement Date, certificates evidencing the existence and amounts of, the insurance required under Paragraph 8.2(a) and 8.4. No such policy shall be cancelable or subject to material modification except after ten
(10)&nbsp;days&#146; prior written notice to Landlord. Tenant shall at least thirty (30)&nbsp;days prior to the expiration of such policies, furnish Landlord with evidence of renewals or &#147;insurance binders&#148; evidencing renewal thereof, or
Landlord may following notice to order such Insurance and charge the cost thereof to Tenant, which amount shall be payable by Tenant to Landlord upon demand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.6. <B>Waiver of Subrogation</B>. Notwithstanding any other provision of this Lease to the contrary, Tenant and Landlord each hereby release
and relieve the other, and waive their entire right to recover damages (whether in contract or in tort) against the other, for loss or damage to their property arising out of or incident to the perils required to be insured against under Paragraph
8. The effect of such releases and waivers of the right to recover damages shall not be limited by the amount of Insurance carried or required, or by any deductibles applicable thereto. Landlord and Tenant agree to have their respective insurance
companies issuing property damage insurance waive any right to subrogation that such companies may have against Landlord or Tenant, as the case may be, so long as the Insurance is not invalidated thereby. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.7. <B>Indemnity.</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)
<U>By Tenant</U>. Subject to the provisions of Section 8.6 above, Tenant, shall, during the term of this lease, indemnify and save harmless Landlord from any and all loss, damage, claims of damage, obligations, cause or causes of action, or
liabilities of any kind or nature (including reasonable costs of attorney&#146;s fees if Landlord </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
is made a party to any action which Tenant&#146;s indemnity runs hereunder) by reason of injury or death of any person or persons or damage to any property of any kind and to whomsoever
belonging, including injury or death to the person or damage to the property of Tenant, Tenant&#146;s officers, directors, employees, agents, guests, subtenants and assignees, concessionaires and licensees, and any other person, firm or corporation
selling or manufacturing merchandise or services upon or from the demised premises, or any part thereof, from any cause or cause whatsoever which result from Tenant&#146;s use of the Premises or from any other activity done, permitted or suffered by
Tenant. As a material part of the consideration to Landlord, Tenant hereby assumes all risk of damage to property or injury to persons in or about the Premises from any cause whatsoever (except that which is caused by the negligence or willful
misconduct by Landlord or its Agents or by the failure of Landlord to observe any of the terms and conditions of this Lease after prior written notice from Tenant). Tenant&#146;s obligations under this paragraph shall survive the termination of this
Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>By Landlord</U>. Subject to the provisions of Section 8.6, Landlord shall indemnify, defend, protect and hold harmless
Tenant and Tenant&#146;s agents, employees, officers, directors, shareholders and partners from and against all liabilities, obligations, damages, penalties, claims, causes of action, costs, charges and expenses, including reasonable attorneys&#146;
fees, court costs, administrative costs and costs of appeals which may be imposed upon or incurred by, or asserted by reason of any of the following which shall occur during the Term of this Lease, or during any period of time prior to the Lease
Commencement Date: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Any work or act done in or about the Premises or the Building by Landlord or its agents, contractors or
employees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Any negligence or other wrongful act or omission on the part of the Landlord or any of its agents, contractors,
subcontractors, servants, employees, subtenants, licensees or invitees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Any accident, injury or damage to any persons or property
occurring in, on or about the common area, unless caused by the negligence or willful misconduct of Tenant, its employees, contractors or agents, as well as any accident, injury or damage to any persons or property occurring in or about the common
area, unless caused by the negligence or willful misconduct of Tenant, its employees, contractors or agents; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) Any failure on the
part of Landlord to perform or comply with any of the covenants, agreements, terms, provisions, conditions or limitations contained in this Lease on its part to be performed or complied with as long as Landlord was given prior written notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.8. <B>Exemption of Landlord from Liability</B>. Landlord shall not be liable for injury or damage which may be sustained by Tenant or to the
person or goods, wares, merchandise or other property of Tenant, Tenant&#146;s employees, contractors, invitees, customers, or any other person in or about the Premises, whether such damage or injury is caused by or results from fire, earthquake,
steam, electricity, gas, water or rain, which may leak or from or into any part of the premises or from the breakage, leakage, obstruction or other defects of pipes, fire sprinklers, wires, appliances, plumbing, HVAC or lighting fixtures, or from
any other cause, whether said injury or damage results from conditions arising upon the Premises or upon other portions of the Building of which the Premises are a part, from other sources or places, and regardless of whether the cause of such
damage or injury or the means of preparing the same is accessible or not. Landlord shall not be liable for any damages arising from any act or neglect of any other tenant of Landlord nor from the failure by Landlord to enforce the provisions of any
other lease in the Industrial Center. Notwithstanding Landlord&#146;s negligence or breach of this Lease, Landlord shall under no circumstances be liable for injury to Tenant&#146;s business or for any loss of income or profit therefrom. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Damage or Destruction</B>.<B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1.
<B>Definitions</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B>Premises Partial Damage</B>&#148; shall mean damage or destruction to the Premises, other than
Tenant-Owned Alterations and Utility Installations, the repair cost of which damage or destruction is less than fifty percent (50%)&nbsp;of the then Replacement Cost (as defined in Paragraph 9.(d)) of the Premises (excluding the Tenant-Owned
Alterations and Utility Installations and Trade Fixtures) immediately prior to such damage or destruction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B>Premises Total
Destruction</B>&#148; shall mean damage or destruction to the Premises, other than Tenant-Owned Alterations and Utility Installations, the repair cost of which damage or destruction is fifty percent (50%)&nbsp;or more of the then Replacement Cost of
the Premises (excluding Tenant-Owned Alterations and Utility Installations and Trade Fixtures) immediately prior to such damage or destruction. In addition, damage or destruction to the Building, other than Tenant-Owned Alterations and Utility
Installations and Trade Fixtures of any tenants of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Building, the cost of which damage or destruction is fifty percent (50%)&nbsp;or more of the then Replacement Cost (excluding Tenant-Owned Alterations and Utility Installations and Trade Fixtures
of any Tenants of the Building) of the Building shall, at the option of Landlord, be deemed to be Premises total Destruction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)
&#147;<B>Industrial Center Total Destruction</B>&#148; shall mean damage or destruction to the Industrial Center or the Building in which the premises are located, regardless of the damage to the premises. The cost of which damage or destruction is
fifty percent (50%)&nbsp;or more of the then Replacement Cost of the Industrial Center or the Building (excluding Tenant-Owned Alterations and Utility Installations and Trade Fixtures) immediately prior to such damage or destruction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B>Insured Loss</B>&#148; shall mean damage or destruction to the Premises, other than Tenant-Owned Alterations and Utility
Installations and Trade Fixtures, which was caused by an event required to be covered by the insurance described in Paragraph 8.3(a) irrespective of any deductible amounts or coverage limits involved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B>Replacement Cost</B>&#148; shall mean the cost to repair or rebuild the improvements owned by Landlord at the time of the
occurrence to their condition existing immediately prior thereto, including demolition, debris removal and upgrading required by the operation of applicable building codes, ordinances or laws, and without deduction for depreciation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) &#147;<B>Hazardous Substance Condition</B>&#148; shall mean the occurrence or discovery of a condition&nbsp;involving the presence of, or
a contamination by, a Hazardous Substance as defined in Paragraph 6.2(a), in, on, or under the Premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2. <B>Premises Partial or
Total Damage-Insured or Uninsured Loss</B>. If Premises Partial or Total Damage that is an Insured or Uninsured Loss occurs, then Landlord shall, at Landlord&#146;s expense, repair such damage (but not Tenant&#146;s Trade Fixtures or Tenant-Owned
Alterations and Utility Installations) as soon as reasonably possible, but only to the extent of the available insurance proceeds, if any (provided Landlord has maintained the insurance coverage required hereunder), and this Lease shall continue in
full force and effect. In the event, however, that there is a shortage of insurance proceeds and such shortage is due to any reason (other than Landlord&#146;s failure to maintain the insurance required hereunder) including the fact that some but
not all of which may include the fact that, by reason of the unique nature of the improvements in the Premises, full replacement cost insurance coverage was not commercially reasonable and available, then Landlord shall have no obligation to pay for
the shortage in insurance proceeds or to fully restore the unique aspects of the Premises unless Tenant provides Landlord with the funds to cover same, or adequate assurance thereof, within ten (10)&nbsp;days following receipt of written notice of
such shortage and request therefore [no deductible payment will be included in any such &#147;shortage&#148;]. If Landlord receives said funds or adequate assurance thereof within said thirty (30)&nbsp;day period, Landlord shall complete the repairs
as soon as reasonably possible and this Lease shall remain in full force and effect. If Landlord does not receive such funds or assurance within said period, Landlord may nevertheless elect by written notice to Tenant within ten (10)&nbsp;days
thereafter to make such restoration and repair as is commercially reasonable with Landlord paying any shortage in proceeds, in which case this Lease shall remain in full force and effect if Landlord does not receive such funds or assurance within
such thirty (30)&nbsp;day period, and if Landlord does not so elect to restore and repair, then this Lease shall terminate sixty (60)&nbsp;days following the occurrence of the damage or destruction. Unless otherwise agreed, Tenant shall in no event
have any right to reimbursement from Landlord for any funds contributed by Tenant to repair any such damage or destruction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3.
<B>Intentionally Deleted</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4. <B>Industrial Center Destruction</B>. Notwithstanding any other provision hereof, if the Industrial
Center in which the Premises are located suffers Total Destruction (including any destruction required by any authorized public authority), this Lease at Landlord&#146;s option shall terminate sixty (60)&nbsp;days following the date of such Total
Destruction, whether or not the damage or destruction affected the premises. In the event, however, that the damage or destruction was caused by Tenant, Landlord shall have the right to recover Landlord&#146;s damages from Tenant except as released
and waived in Paragraph 9.7. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5. <B>Damage Near End of Term</B>. If at any time during the last six (6)&nbsp;months of the term of this
Lease there is damage to the Premises for which the cost to repair (other than the repair of Tenant&#146;s Trade Fixtures or Tenant-Owned Alterations and Utility Installations) exceeds three (3)&nbsp;months&#146; Base Rent, whether or not an Insured
Loss, Landlord may, at Landlord&#146;s option, terminate this Lease effective sixty (60)&nbsp;days following the date of occurrence of such damage by giving written notice to Tenant of Landlord&#146;s election to do so within thirty (30)&nbsp;days
after the date of occurrence of such damage. Provided, however, if Tenant at that time has an exercisable option to extend this Lease, then Tenant may preserve this Lease by (a)&nbsp;exercising such option, and (b)&nbsp;providing Landlord
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with any shortage in insurance proceeds (or adequate assurance thereof) needed to make the repairs on or before the earlier of (i)&nbsp;the date which is ten (10)&nbsp;days after Tenant&#146;s
receipt of Landlord&#146;s written notice purporting to terminate this Lease, or (ii)&nbsp;the day prior to the date upon which such option expires. If Tenant duly exercises such option during such period and provides Landlord with funds (or
adequate assurance thereof) to cover any shortage in insurance proceeds, Landlord shall, at Landlord&#146;s expense repair such damage as soon as reasonably possible and this Lease shall continue in full force and effect. If Tenant falls to exercise
such option and provide such funds or assurance during such period, then this Lease shall terminate as of the date set forth in the first sentence of this Paragraph 9.5. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6. <B>Abatement of Rent; Tenant&#146;s Remedies</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) In the event of (i)&nbsp;Premises Partial Damage or (ii)&nbsp;Hazardous Substance Condition for which Tenant is not legally responsible,
the Base Rent, Common Area Operating Expenses and other charges, if any, payable by Tenant hereunder for the period during which such damage or condition, its repair, remediation or restoration continues, shall be abated in proportion to the degree
to which Tenant&#146;s use of the Premises is impaired, but not in excess of proceeds from insurance required to be carried under Paragraph 8.3(b). Except for abatement of Base Rent, Common Area Operating Expenses and other charges, if any, as
aforesaid, all other obligations of Tenant hereunder shall be performed by Tenant, and Tenant shall have no claim against Landlord for any damage suffered by reason of any such damage, destruction, repair, remediation or restoration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) If Landlord shall be obligated to repair or restore the Premises under the provisions of this Paragraph 9 and shall not commence, in a
substantial and meaningful way, the repair or restoration of the Premises within ninety (90)&nbsp;days after such obligation shall accrue, Tenant may, at any time prior to the commencement of such repair or restoration, give written notice to
Landlord and to any Lenders of which Tenant has actual notice of Tenant&#146;s election to terminate this Lease on a date not less than sixty (60)&nbsp;days following the giving of such notice. If Tenant gives such notice to Landlord and such
Lenders and such repair or restoration is not commenced within thirty (30)&nbsp;days after receipt of such notice, this Lease shall terminate as of the date specified in said notice. If Landlord or a Lender commences the repair or restoration of the
Premises within thirty (30)&nbsp;days after the receipt of such notice, this Lease shall continue in full force and effect (subject to the remaining rights of that set forth herein) &#147;<B>commence</B>&#148; as used in this Paragraph 9.6 shall
mean either the unconditional authorization of the preparation of the required plans, or the beginning of the actual work on the Premises, whichever occurs first. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) In the event of any damage which affects the Premises or the Building outside the boundaries of the Premises, Landlord will, within thirty
(30)&nbsp;days following the date of the damage, deliver to Tenant an estimate of the time necessary to repair the damage in question such that the Premises may be used by and accessible to Tenant and the Building and Common Areas; such notice will
be based upon the review and opinions of Landlord&#146;s architect and contractor (&#147;Landlord&#146;s Repair Notice&#148;). If the Premises are damaged by fire or other casualty and are rendered not reasonably usable for Tenant&#146;s business
purposes thereby, or if the Building shall be so damaged that Tenant shall be deprived of reasonable access to the Premises, and if, pursuant to Landlord&#146;s Repair Notice, the restoration shall not be substantially completed on or before the
date which shall be nine (9)&nbsp;months following the date of such damage or destruction, Tenant shall have the right to terminate this Lease (with respect to the affected Floors only, or the entire Premises, at Tenant&#146;s option) by giving
written notice (the &#147;Termination Notice&#148;) to Landlord not later than thirty (30)&nbsp;days following receipt of Landlord&#146;s Repair Notice. If Tenant gives a Termination Notice, this Lease shall be deemed cancelled and terminated as of
the date of the damage as if such date were the Expiration Date, and Rent shall be apportioned and shall be paid or refunded, as the case may be up to and including the date of such damage or destruction. Notwithstanding the foregoing, if Tenant was
entitled to but elected not to exercise its right to terminate this Lease and Landlord does not substantially complete the repair and restoration of the Premises within two (2)&nbsp;months after the expiration of the estimated period of time set
forth in Landlord&#146;s Repair Notice, which period shall be extended to the extent of any delays caused by Tenant, then Tenant may terminate this Lease by written notice to Landlord within thirty (30)&nbsp;days after the expiration of such period,
as the same may be so extended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.7. <B>Hazardous Substance Conditions</B>. If a Hazardous Substance Condition occurs, unless Tenant is
legally responsible therefor (in which case Tenant shall make the investigation and remediation thereof required by Applicable Requirements and this Lease shall continue in full force and effect, but subject to Landlord&#146;s rights under Paragraph
6.2(c) and Paragraph 13), Landlord may at Landlord&#146;s option either (i)&nbsp;investigate and remediate such Hazardous Substance Condition, if required, as soon as reasonably possible at Landlord&#146;s expense, in which event this Lease shall
continue in full force and effect, or (ii)&nbsp;if the estimated cost to investigate and remediate such condition exceeds twelve (12)&nbsp;times the then monthly Base Rent or $50,000, whichever is greater, give written notice to Tenant within thirty
(30)&nbsp;days after receipt by Landlord of knowledge of the occurrence of such Hazardous Substance Condition of Landlord&#146;s desire to terminate this Lease as of the date sixty (60)&nbsp;days following the date of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such notice. In the event Landlord elects to give such notice of Landlord&#146;s intention to terminate this Lease, Tenant shall have the right within ten (10)&nbsp;days after receipt of such
notice to give written notice to Landlord of Tenant&#146;s commitment to pay for the excess costs of (a)&nbsp;investigation and remediation of such Hazardous Substance Condition to the extent required by Applicable Requirements, over (B)&nbsp;an
amount equal to twelve (12)&nbsp;times the then monthly Base Rent or $50,000 whichever is greater. Tenant shall provide Landlord with the funds required of Tenant or satisfactory assurance thereof within thirty (30)&nbsp;days following said
commitment by Tenant. In such event this Lease shall continue in full force and effect, and Landlord shall proceed to make such Investigation and remediation as soon as reasonably possible after the required funds are available. If Tenant does not
give such notice and provide the required funds or assurance thereof within the time period specified above, this Lease shall terminate as of the date specified in Landlord&#146;s notice of termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.8. <B>Termination &#150; Advance Payments</B>. Upon termination of this Lease pursuant to this Paragraph 9, Landlord shall return to Tenant
any advance payment made by Tenant to Landlord and so much of Tenant&#146;s Security Deposit as has not been, or is not then required to be, used by Landlord under the terms of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.9. <B>Waiver of Statutes</B>. Landlord and Tenant agree that the terms of this Lease shall govern the effect of any damage to or destruction
of the Premises and the Building with respect to the termination of this Lease and hereby waive the provisions of any present or future statute to the extent it is inconsistent herewith. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Real Property Taxes</B>.<B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1.
<B>Payment of Taxes</B>. Landlord shall pay the Real Property Taxes, as defined in Paragraph 10.2, applicable to the Industrial Center, and except as otherwise provided in Paragraph 10.3, any such amounts shall be included In the calculation of
Common Area Operating Expenses in accordance with the provisions of Paragraph 4.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2. <B>Real Property Tax Definition</B>. As used
herein, the term &#147;Real Property Taxes&#148; shall include any form of real estate tax or assessment, general, special, ordinary or extraordinary, and any license fee, commercial rental tax, improvement bond or bonds, levy or tax (other than
inheritance, personal income or estate taxes) imposed upon the Industrial Center by any authority having the direct or indirect power to tax, including any city, state or federal government, or any school, agricultural, sanitary, fire, street,
drainage, or other improvement district thereof, levied against any legal or equitable interest of Landlord in the Industrial Center or any portion thereof, Landlord&#146;s right to rent or other income therefrom, and/or Landlord&#146;s business of
leasing the Premises. The term &#147;Real Property Taxes&#148; shall also include any tax, fee, levy, assessment or charge, or any increase therein, imposed by reason of events occurring, or changes In Applicable Law taking effect, during the term
of this Lease, including but not limited to a change in the ownership of the Industrial Center or in the improvements thereon, the execution of this Lease, or any modification, amendment or transfer thereof, and whether or not contemplated by the
Parties. In calculating Real Property Taxes for any calendar year, the Real Property Taxes for any real estate tax year shall be included in the calculation of Real Property Taxes for such calendar year based upon the number of days which such
calendar year and tax year have in common. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3. <B>Additional Improvements</B>. Tenant shall pay to Landlord the Common Area Operating
Expenses as payable under Paragraph 4.2, the entirety of any increase in Real Property Taxes if assessed solely by reason of Alterations, Trade Fixtures or Utility Installations placed upon the Premises by Tenant or at Tenant&#146;s request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.4. <B>Joint Assessment</B>. If the Building is not separately assessed, Real Property Taxes allocated to the Building shall be an equitable
proportion of the Real Property Taxes for all of the land and improvements included within the tax parcel assessed or the industrial center, such proportion to be determined by Landlord from the respective valuations assigned in the assessor&#146;s
worksheets or such other information as may be reasonably available. Landlord&#146;s reasonable determination thereof, in good faith, shall be conclusive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.5. <B>Tenant&#146;s Property Taxes</B>. Tenant shall pay prior to delinquency all taxes assessed against and levied upon Tenant-Owned
Alterations and Utility Installations, Trade Fixtures, furnishings, equipment and all personal property of Tenant contained in the Premises or stored within the Industrial Center. When possible, Tenant shall cause Its Tenant-Owned Alterations and
Utility Installations, Trade Fixtures, furnishings, equipment and all other personal property to be assessed and billed separately from the real property of Landlord. If any of Tenant&#146;s said property shall be assessed with Landlord&#146;s real
property, Tenant shall pay Landlord the taxes attributable to Tenant&#146;s property within ten (10)&nbsp;days after receipt of a written statement setting forth the taxes applicable to Tenant&#146;s property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Utilities</B>. Tenant shall pay directly for all utilities and services supplied to the Premises, including but not limited to electricity, water,
telephone, security, gas, sewer, trash removal and cleaning of the Premises, together with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any taxes thereon. If any such utilities or services are not separately metered to the Premises or separately billed to the Premises, Tenant shall pay to Landlord a reasonable proportion to be
determined by Landlord of all such charges jointly metered or billed with other premises in the Building, in the manner and within the time periods set forth in Paragraph 4.2(d). Landlord shall not be liable to Tenant for injury, damage, loss of
Tenant&#146;s business or profits, from any failure, interruption, rationing or other curtailment in the supply of electric, gas, water or other utilities from whatever cause. Tenant shall not consume water in excess of that usually furnished or
supplied for reasonable and normal drinking and lavatory use in connection with an office environment (as determined by Landlord), without first procuring the written consent of Landlord, which Landlord may refuse, and in the event of consent,
Landlord may have installed a water meter in the Premises to measure the amount of water consumed. The cost of any such meter and of its installation, maintenance and repair shall be paid for by the Tenant, and Tenant agrees to pay to Landlord
promptly upon demand for all such water consumed as shown by said meters, at the rates charged for such services by the local public utility plus any additional expense incurred in keeping account of the water so consumed. If a separate meter is not
installed, the excess cost for such water shall be established by an estimate made by a utility company or electrical engineer hired by Landlord at Tenant&#146;s expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Assignment and Subletting</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1. <B>Landlord&#146;s Consent Required</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall not assign this lease, nor any right hereunder, nor sublet the premises, nor any part thereof, without the prior written
consent of Landlord which will not be unreasonably withheld, conditioned or delayed. In exercising its reasonable discretion Landlord may consider all commercially relevant factors involved in the leasing of the Premises including but not limited to
the a) the creditworthiness and financial stability of the prospective assignee or subtenant (as compared to the obligations of such entity under the sublease or assignment, as the case may be); b) references of prior landlords; c) the past history
of such subtenant, with respect to involvement in litigation and bankruptcy proceedings; d) the impact of said subtenant or assignee and proposed use of the premises on pedestrian and vehicular traffic, other tenants, and parking; e) the use,
generation or disposal of hazardous materials. The presence of one negative factor enumerated above if material, shall be deemed reasonable justification for Landlord&#146;s withholding consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) A change in the control of Tenant shall constitute an assignment requiring Landlord&#146;s consent. The transfer of forty-nine percent
(49%)&nbsp;or more of the voting control of Tenant shall constitute a change in control for this purpose. An initial public offering of Tenant&#146;s stock on a recognized exchange, as well as the subsequent transfer of shares of Tenant&#146;s stock
on a public exchange, will not, however, be deemed an assignment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) So long as Tenant is not entering into the Permitted Transfer for
the purpose of avoiding or otherwise circumventing the remaining terms of this Article 12, Tenant may assign its entire interest under this Lease, without the consent of Landlord, to (i)&nbsp;an affiliate, subsidiary, or parent of Tenant, or a
corporation, partnership or other legal entity wholly owned by Tenant (collectively, an &#147;Affiliated Party&#148;), or (ii)&nbsp;a successor to Tenant by purchase, merger, consolidation or reorganization, provided that all of the following
conditions are satisfied (each such Transfer a &#147;Permitted Transfer&#148;): (1)&nbsp;Tenant is not in default under this Lease; (2)&nbsp;Tenant shall give Landlord written notice prior to the effective date of the proposed Permitted Transfer;
and (3)&nbsp;with respect to a purchase, merger, consolidation or reorganization or any Permitted Transfer which results in Tenant ceasing to exist as a separate legal entity, (a)&nbsp;Tenant&#146;s successor shall own all or substantially all of
the assets of Tenant, and (b)&nbsp;Tenant&#146;s successor shall have a net worth which is at least equal to the greater of Tenant&#146;s net worth at the date of this Lease or Tenant&#146;s net worth as of the day prior to the proposed purchase,
merger, consolidation or reorganization. If requested by Landlord, Tenant&#146;s successor shall sign a commercially reasonable form of assumption agreement as used herein, (A)&nbsp;&#147;parent&#148; shall mean a company which owns a majority of
Tenant&#146;s voting equity; (B)&nbsp;&#147;subsidiary&#148; shall mean an entity wholly owned by Tenant or at least 51% of whose voting equity is owned by Tenant; and (C)&nbsp;&#147;affiliate&#148; shall mean an entity controlled by, controlling or
under common control with Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) An assignment or subletting of Tenant&#146;s interest in this Lease without Landlord&#146;s
specific prior written consent shall, at Landlord&#146;s option, be a Default curable after notice per Paragraph 13.1, or a non-curable Breach without the necessity of any notice and grace period. If Landlord elects to treat such unconsented to
assignment or subletting as a non-curable Breach, Landlord shall have the right to either: (i)&nbsp;terminate this Lease, or (ii)&nbsp;upon thirty (30)&nbsp;days&#146; written notice (&#147;<B>Landlord&#146;s Notice</B>&#148;), increase the monthly
Base Rent for the Premises to the greater of the then fair market rental value of the Premises, as reasonably determined by Landlord, or one hundred ten percent (110%)&nbsp;of the Base Rent then in effect Pending determination of the new fair market
rental value, if disputed by Tenant, Tenant shall pay the amount set forth in Landlord&#146;s Notice, with any overpayment credited against the next installment(s) of Base Rent coming due, and any underpayment for the period retroactively to the
effective date of the adjustment being due and payable immediately upon the determination thereof. Further, in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the event of such Breach and rental adjustment, (i)&nbsp;the purchase price of any option to purchase the Premises held by Tenant shall be subject to similar adjustment to the then fair market
value as reasonably determined by Landlord (without the Lease being considered an encumbrance or any deduction for depreciation or obsolescence, and considering the Premises at its highest and best use and in good condition) or one hundred ten
percent (110%)&nbsp;of the price previously in effect, (ii)&nbsp;any index-oriented rental or price adjustment formulas contained in this Lease shall be adjusted to require that the base index be determined with reference to the index applicable to
the time of such adjustment, and (iii)&nbsp;any fixed rental adjustments scheduled during the remainder of the Lease term shall be increased in the same ratio as the new rental bears to the Base Rent in effect immediately prior to the adjustment
specified in Landlord&#146;s Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Tenant&#146;s remedy for any breach of this Paragraph 12.1 by Landlord shall be limited to
compensatory damages and/or injunctive relief. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.2. <B>Terms and Conditions Applicable to Assignment and Subletting</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Landlord will respond to any request for consent to an assignment or sublease within fifteen (15)&nbsp;days following receipt of such
request. If Landlord fails to timely deliver to Tenant notice of Landlord&#146;s consent, or the withholding of consent, to a proposed Transfer, Tenant may send a second (2nd)&nbsp;notice to Landlord, which notice must contain the following
inscription, in bold faced lettering: &#147;<B>SECOND NOTICE DELIVERED PURSUANT TO ARTICLE 12 OF LEASE&#151;FAILURE TO TIMELY RESPOND WITHIN FIVE (5)&nbsp;BUSINESS DAYS SHALL RESULT IN DEEMED APPROVAL OF ASSIGNMENT OR SUBLEASE.</B>&#148; If Landlord
falls to deliver notice of Landlord&#146;s consent to, or the withholding of Landlord&#146;s consent, to the proposed assignment or sublease within such five (5)&nbsp;business day period, Landlord shall be deemed to have approved the assignment or
sublease in question. If Landlord at any time timely delivers notice to Tenant or Landlord&#146;s withholding of consent to a proposed assignment or sublease, Landlord shall specify in reasonable detail in such notice, the basis for such withholding
of consent. Regardless of Landlord&#146;s consent, any assignment or subletting shall not (i)&nbsp;be effective without the express written assumption by such assignee or subtenant of the obligations of Tenant under this Lease, (ii)&nbsp;release
Tenant of any obligations hereunder, nor (iii)&nbsp;alter the primary liability of Tenant for the payment of Base Rent and other sums due Landlord hereunder or for the performance of any other obligations to be performed by Tenant under this Lease.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Landlord may accept any rent or performance of Tenant&#146;s obligations from any person other than Tenant pending approval or
disapproval of an assignment. Neither a delay in the approval or disapproval of such assignment nor the acceptance of any rent for performance shall constitute a waiver or estoppel of Landlord&#146;s right to exercise its remedies for the Default or
Breach by Tenant of any of the terms, covenants or conditions of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) The consent of Landlord to any assignment or subletting
shall not constitute a consent to any subsequent assignment or subletting by Tenant or to any subsequent or successive assignment or subletting by the assignee or subtenant. However, Landlord may consent to subsequent or successive assignment or
subletting by the assignee or subtenant. However, Landlord may consent to subsequent sublettings and assignments of the sublease or any amendments or modifications thereto without notifying Tenant or anyone else liable under this Lease or the
sublease and without obtaining their consent; provided, however, that if Landlord consents to a subsequent amendment of this Lease with an assignee of Tenant, which amendment increases the obligations or liability of the &#147;tenant&#148;
hereunder, the original Tenant shall not be liable for such increased obligations unless the original Tenant consented to such amendment In writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) In the event of any Default or Breach of Tenant&#146;s obligation under this Lease, Landlord may proceed directly against Tenant, any
guarantors or anyone else responsible for the performance of the Tenant&#146;s obligations under this Lease, including any subtenant, without first exhausting Landlord&#146;s remedies against any other person or entity responsible therefor to
Landlord, or any security held by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Each request for consent to an assignment or subletting shall be in writing, accompanied
by information relevant to Landlord&#146;s determination as to the financial and operational responsibility and appropriateness of the proposed assignee or subtenant, including but not limited to the intended use and/or required modification of the
Premises, if any, together with a non-refundable deposit of $1,000, as reasonable consideration for Landlord&#146;s considering and processing the request for consent. Tenant agrees to provide Landlord with such other or additional information
and/or documentation as may be reasonably requested by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) Any assignee of, or subtenant under, this Lease shall, by reason of
accepting such assignment or entering Into such sublease, be deemed, for the benefit of Landlord, to have assumed and agreed to conform and comply with each and every term, covenant, condition and obligation herein to be observed or performed by
Tenant during the term of said assignment or sublease, other than such obligations as are contrary to or inconsistent with provisions of an assignment or sublease to which Landlord has specifically consented in writing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) If Tenant desires to Sublet substantially the entire Premises for substantially the remainder
of the term (other than pursuant to the Permitted Transfer) or assign the Premises (other than pursuant to a Permitted Transfer) prior to the expiration of the term of this lease and obtains an acceptable subtenant or assignee, then the Landlord
shall have the option prior to the execution of the sublease or assignment agreement to cancel this Lease with respect to the portion of the Premises that is the subject of such proposed assignment or sublease. Landlord, in Landlord&#146;s sole
discretion, may then enter into a new lease with any prospective subtenant as the substitute Tenant. If Landlord exercises this option, then this present lease shall be terminated by mutual agreement as of that time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.3. <B>Additional Terms and Conditions Applicable to Assignment and Subletting</B>. The following terms and conditions shall apply to any
subletting or assignment by Tenant of all or any part of the Premises and shall be deemed included in all subleases and assignments under this Lease whether or not expressly incorporated therein: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Tenant hereby assigns and transfers to Landlord all of Tenant&#146;s interest in all rentals, income or other consideration arising from
any sublease or assignment of all or a portion of the Premises heretofore or hereafter made by Tenant, and Landlord may collect such sums and apply same toward Tenant&#146;s obligations under this Lease. Landlord shall not, by reason of the
foregoing provision or any other assignment of such sublease to Landlord, nor by reason of the collection of the rents from a subtenant, be deemed liable to the subtenant for any failure of Tenant to perform and comply with any of Tenant&#146;s
obligations to such subtenant under such Sublease. Tenant hereby irrevocably authorizes and directs any such subtenant, upon receipt of a written notice from Landlord, to pay to Landlord the rents and other charges due and to become due under the
sublease. Subtenant shall rely upon any such statement and request from Landlord and shall pay such rents and other charges to Landlord without any obligation or right to inquire as to whether any Breach exists and notwithstanding any notice from or
claim from Tenant to the contrary. Tenant shall have no right or claim against such subtenant, or, until the Breach has been cured, against Landlord, for any such rents and other charges so paid by said subtenant to Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) In the event of a Breach by Tenant in the performance of its obligations under this Lease, Landlord, at its option and without any
obligation to do so, may require any subtenant to attorn to Landlord, in which event Landlord shall undertake the obligations of the sub landlord under such sublease from the time of the exercise of said option to the expiration of such sublease;
provided, however, Landlord shall not be liable for any prepaid rents or security deposit paid by such subtenant to such sub landlord or for any other prior defaults or breaches of such sub landlord under such sublease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Any matter or thing requiring the consent of the sub landlord under a sublease shall also require the consent of Landlord herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) No subtenant under a sublease or assignee approved by Landlord shall further assign or sublet all or any part of the Premises without
Landlord&#146;s prior written consent, not to be unreasonably withheld, conditioned or delayed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Landlord shall deliver a copy of any
notice of Default or Breach by Tenant to the subtenant, who shall have the right to cure the Default of Tenant within the grace period, if any, specified in such notice. The subtenant shall have a right of reimbursement and offset from and against
Tenant for any such Defaults cured by the subtenant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Default; Breach; Remedies</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.1. <B>Default; Breach</B>. Landlord and Tenant agree that if any attorney is consulted by Landlord in connection with a Tenant Default or
Breach (as hereinafter defined), $350.00 is a reasonable minimum sum per such occurrence for legal services and costs in the preparation and service of a notice of Default, and that Landlord may include the cost of such services and costs in said
notice as rent due and payable to cure said default. a &#147;<B>Default</B>&#148; by Tenant is defined as a failure by Tenant to observe, comply with or perform any of the terms, covenants, conditions or rules applicable to Tenant under this Lease.
A &#147;<B>Breach</B>&#148; by Tenant is defined as the occurrence of any one or more of the following Defaults, and, where a grace period for cure after notice is specified herein, the failure by Tenant to cure such Default prior to the expiration
of the applicable grace period, and shall entitle Landlord to pursue the remedies set forth in Paragraphs 13.2 and/or 13.3. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) The vacating of the Premises, or the abandonment of the Premises without paying the Rent due
hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Except as expressly otherwise provided in this Lease, the failure by Tenant to make any payment of Base Rent,
Tenant&#146;s Share of Common Area Operating Expenses, or any other monetary payment required to be made by Tenant hereunder as and when due, the failure by Tenant to provide Landlord with reasonable evidence of insurance or surety bond required
under this Lease, or the failure of Tenant to fulfill any obligation under this Lease which endangers or threatens life or property, where such failure continues for a period of five (5)&nbsp;days following written notice thereof by or on behalf of
Landlord to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Except as expressly otherwise provided in this Lease, the failure by Tenant to provide Landlord with reasonable
written evidence (in duly executed original form, if applicable) of (i)&nbsp;compliance with Applicable Requirements per Paragraph 6.3, (ii)&nbsp;the inspection, maintenance and service contracts required under Paragraph 7.1(b), (iii)&nbsp;the
rescission of an unauthorized assignment or subletting per Paragraph 12.1, (iv)&nbsp;a Tenancy Statement per Paragraphs 16 or 37, (v)&nbsp;the subordination or non-subordination of this Lease per Paragraph 30, (vi)&nbsp;the guaranty of the
performance of Tenant&#146;s obligations under this Lease if required under Paragraphs 1.11 and 37, (vii)&nbsp;the execution of any document requested under Paragraph 42 (easements), or (viii)&nbsp;any other documentation or information which
Landlord may reasonably require of Tenant under the terms of this Lease, where any such failure continues for a period often (10)&nbsp;days following written notice by or on behalf of Landlord to Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) A Default by Tenant as to the terms covenants, conditions or provisions of this Lease, or of the rules adopted under Paragraph 40 hereof
that are to be observed, complied with or performed by Tenant, other than those described in Subparagraphs 13.1(a), (b), or (c), above, where such Default continues for a period of thirty (30)&nbsp;days after written notice thereof by or on behalf
of Landlord to Tenant; provided however, that if the nature of Tenant&#146;s Default is such that more than thirty (30)&nbsp;days are reasonably required for its cure, then it shall not be deemed to be a Breach of this Lease by Tenant if Tenant
commences such cure within said thirty (30)&nbsp;day period and thereafter diligently prosecutes such cure to completion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) The
occurrence of any of the following events: (i)&nbsp;the making by Tenant of any general arrangement or assignment for the benefit of creditors; (ii)&nbsp;Tenant&#146;s becoming a &#147;debtor&#148; as defined in 11 U.S. Code Section&nbsp;101 or any
successor statute thereto (unless, in the case of a petition filed against Tenant, the same is dismissed within sixty (60)&nbsp;days); (iii)&nbsp;the appointment of a trustee or receiver to take possession of substantially all of Tenant&#146;s
assets located at the Premises or of Tenant&#146;s interest In this Lease, where possession is not restored to Tenant within thirty (30)&nbsp;days; or (iv)&nbsp;the attachment, execution or other judicial seizure of substantially all of
Tenant&#146;s assets located at the Premises or of Tenant&#146;s interest in this Lease, where such seizure is not discharged within thirty (30)&nbsp;days; provided, however, in the event that any provision of this Subparagraph 13.1(e) is contrary
to any applicable law, such provision shall be of no force or effect, and shall not affect the validity of the remaining provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)
The discovery by Landlord that any financial statement of Tenant or of any Guarantor, given to Landlord by Tenant or any Guarantor, was materially false. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) If the performance of Tenant&#146;s obligations under this Lease is guaranteed: (i)&nbsp;the death of a Guarantor, (ii)&nbsp;the
termination of a Guarantor&#146;s liability with respect to this Lease other than in accordance with the terms of such guaranty, (iii)&nbsp;a Guarantor&#146;s becoming insolvent or the subject of a bankruptcy filing, (iv)&nbsp;a Guarantor&#146;s
refusal to honor the guaranty, or (v)&nbsp;a Guarantor&#146;s breach of its guaranty obligation on an anticipatory breach basis, and Tenant&#146;s failure, within sixty (60)&nbsp;days following written notice by or on behalf of Landlord to Tenant of
any such event, to provide Landlord with written alternative assurances of security, which, when coupled with the then existing resources of Tenant, equals or exceeds the combined financial resources of Tenant and the Guarantors that existed at the
time of the execution of this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.2. <B>Remedies</B>. If Tenant fails to commence to perform any affirmative duty or obligation
of Tenant under this Lease, within ten (10)&nbsp;business days after written notice to Tenant (or in case of an emergency, without notice), Landlord may at its option (but without obligation to do so), perform such duty or obligation on
Tenant&#146;s behalf, including but not limited to the obtaining of reasonably required bonds, insurance policies, or governmental licenses, permits or approvals. The costs and expenses of any such performance by Landlord shall be due and payable by
Tenant to Landlord upon invoice therefor. If any check given to Landlord by Tenant shall not be honored by the bank upon which it is drawn, Landlord, at its own option, may require all future payments to be made under this Lease by Tenant to be made
only by cashier&#146;s check. In the event of a Breach of this Lease by Tenant (as defined in Paragraph 13.1), with or without further notice or demand, and without limiting Landlord in the exercise of any right or remedy which Landlord may have by
reason of such Breach, Landlord may: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Terminate Tenant&#146;s right to possession of the Premises by any lawful means, in which case
this Lease and the term hereof shall terminate and Tenant shall immediately surrender possession of the Premises to Landlord. In such event Landlord shall be entitled to recover from Tenant (i)&nbsp;the worth at the time of the award of the unpaid
rent which had been earned at the time of termination; (ii)&nbsp;the worth at the time of award of the amount by which the unpaid rent which would have been earned after termination until the time of award exceeds the amount of such rental loss that
the Tenant proves could have been reasonably avoided; (iii)&nbsp;the worth at the time of award of the amount by which the unpaid rent for the balance of the term after the time of award exceeds the amount of such rental loss that the Tenant proves
could be reasonably avoided; and (iv)&nbsp;any other amount necessary to compensate Landlord for all the detriment proximately caused by the Tenant&#146;s failure to perform its obligations under this Lease or which in the ordinary course of things
would be likely to result therefrom, including but not limited to the cost of recovering possession of the Premises, expenses of reletting, Including necessary renovation and alteration of the Premises, reasonable attorneys&#146; fees, and that
portion of any leasing commission paid by Landlord in connection with this Lease applicable to the unexpired term of this Lease. The worth at the time of award of the amount referred to in provision (iii)&nbsp;of the immediately preceding sentence
shall be computed by discounting such amount at the discount rate of the Federal Reserve Bank of San Francisco or the Federal Reserve Bank District in which the Premises are located at the time of award plus one percent (1%). Efforts by Landlord to
mitigate damages caused by Tenant&#146;s Default or Breach of this Lease shall not waive Landlord&#146;s right to recover damages under this Paragraph 13.2. If termination of this Lease is obtained through the provisional remedy of unlawful
detainer, Landlord shall have the right to recover in such proceeding the unpaid rent and damages as are recoverable therein, or Landlord may reserve the right to recover all or any part thereof in a separate suit for such rent and/or damages. If a
notice and grace period required under Subparagraph 13.1(b), (c) or (d) was not previously given, a notice to pay rent or quit, or to perform or quit, as the case may be, given to Tenant under any statute authorizing the forfeiture of leases for
unlawful detainer shall also constitute the applicable notice for grace period purposes required by Subparagraph 13.1(b), (c) or (d). In such case, the applicable grace period under the unlawful detainer statue shall run concurrently after the one
such statutory notice, and the failure of Tenant to cure the Default within the greater of the two (2)&nbsp;such grace periods shall constitute both an unlawful detainer and a Breach of this Lease entitling Landlord to the remedies provided for in
this Lease and/or by said statute. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Continue the Lease and Tenant&#146;s right to possession in effect (in California under California
Civil Code Section&nbsp;1951.4) after Tenant&#146;s Breach and recover the rent as it becomes due, provided Tenant has the right to sublet or assign, subject only to reasonably limitations. Landlord and Tenant agree that the limitations on
assignment and subletting in this Lease are reasonable. Acts of maintenance or preservation, efforts to relet the Premises, or the appointment of a receiver to protect the Landlord&#146;s Interest under this Lease, shall not constitute a termination
of the Tenant&#146;s right to possession. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Pursue any other remedy now or hereafter available to Landlord under the taws or judicial
decisions of the state wherein the Premises are located. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The expiration or termination of this Lease and/or the termination of
Tenant&#146;s right to possession shall not relieve Tenant from liability under any indemnity provisions of this Lease as to matters occurring or accruing during the term hereof or by reason of Tenant&#146;s occupancy of the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.3. <B>[INTENTIONALLY OMITTED]</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;13.4. <B>Late Charges</B>. Tenant hereby acknowledges that late payment by Tenant to Landlord of rent and
other sums due hereunder will cause Landlord to incur costs not contemplated by this Lease, the exact amount of which will be extremely difficult to ascertain. Such costs include, but are not limited to, processing and accounting charges, and late
charges which may be imposed upon Landlord by the terms of any ground lease, mortgage or deed of trust covering the Premises. Accordingly, if any installment of rent or other sum due from Tenant shall not be received by Landlord or Landlord&#146;s
designee within five (5)&nbsp;days after such amount shall be due (that provided, however that Tenant shall be entitled to notice, prior to the commencement of such five (5)&nbsp;day period, on the first (1st)&nbsp;occasion in any calendar year on
which Tenant falls to timely pay an amount due hereunder), then, without any requirement for notice to Tenant, Tenant shall pay to Landlord a late charge equal to ten percent (10%)&nbsp;of such overdue amount. The parties hereby agree that such late
charge represents a fair and reasonable estimate of the costs Landlord will incur by reason of late payment by Tenant. Acceptance of such late charge be Landlord shall in no event constitute a waiver of Tenant&#146;s Default or Breach with respect
to such overdue amount, nor prevent Landlord from exercising any of the other rights and remedies granted hereunder. In the event that a late charge is payable hereunder, whether or not collected, for three (3)&nbsp;consecutive installments of Base
Rent, then notwithstanding Paragraph 4.1 or any other provision of this Lease to the contrary, Base Rent shall, at Landlord&#146;s option, become due and payable quarterly in advance; provided, however, that if Tenant subsequently pays such
quarterly Base Rent in a timely fashion for four (4)&nbsp;consecutive calendar quarters, Rent shall thereafter be payable on a monthly basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.4 <B>Breach by Landlord</B>. Landlord shall not be deemed in breach of this Lease unless
Landlord fails within a reasonable time to perform an obligation required to be performed by Landlord. For purposes of this Paragraph 13.4, a reasonable time shall in no event be less than thirty (30)&nbsp;days after receipt by Landlord, and by any
lender(s) whose name and address shall have been furnished to Tenant in writing for such purpose, of written notice specifying wherein such obligation of Landlord has not been performed; provided, however, that if the nature of Landlord&#146;s
obligation Is such that more than thirty (30)&nbsp;days after such notice are reasonably required for its performance, then Landlord shall not be In breach of this Lease if performance is commenced within such thirty (30)&nbsp;day period and
thereafter diligently pursued to completion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Condemnation</B>. If the Premises or any portion thereof are taken under the power of eminent domain
or sold under the threat of the exercise of said power (all of which are herein called &#147;condemnation&#148;), this Lease shall terminate as to the part so taken as of the date the condemning authority takes title or possession, whichever first
occurs. If more than twenty five percent (25%)&nbsp;of the floor area of the Premises, or more than twenty-five percent (25%)&nbsp;of the portion of the Common Areas designated for Tenant&#146;s parking, is taken by condemnation, Tenant may, at
Tenant&#146;s option, to be exercised in writing within ten (10)&nbsp;days after Landlord shall have given Tenant written notice of such taking (or in the absence of such notice, within ten (10)&nbsp;days after the condemning authority shall have
taken possession) terminate this Lease as of the date the condemning authority takes such possession. If Tenant does not terminate this Lease in accordance with the foregoing, this Lease shall remain in full force and effect as to the portion of the
Premises remaining, except that the Base Rent shall be reduced in the same proportion as the rentable floor area of the Premises taken bears to the total rentable floor area of the Premises. No reduction of the Base Rent shall occur if the
condemnation does not apply to any portion of the Premises. Any award for the taking of all or any part of the Premises under the power of eminent domain or any payment made under threat of the exercise of such power shall be the property of
Landlord, whether such award shall be made as compensation for diminution of value of the leasehold or for the taking of the fee, or as severance damages; provided, however, that Tenant shall be entitled to any compensation, separately awarded to
Tenant for Tenant&#146;s relocation expenses and/or loss of Tenant&#146;s Trade Fixtures. In the event that this Lease is not terminated by reason of such condemnation, Landlord shall to the extent of its net severance damages received, over and
above Tenant&#146;s Share of the legal and other expenses incurred by Landlord in the condemnation matter, repair any damage to the Premises caused by such condemnation authority. Tenant shall be responsible for the payment of any amount In excess
of such net severance damages required to complete such repair. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Broker&#146;s Fees</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.1. <B>Procuring Cause</B>. The Broker(s) named in Paragraph 1.10 is/are the procuring cause of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.2. <B>Additional Terms</B>. Unless Landlord and Broker(s) have otherwise agreed in writing, Landlord agrees that: (a)&nbsp;If Tenant
exercises any Option (as defined in Paragraph 39.1) granted under this Lease or any Option subsequently granted, or (b)&nbsp;if Tenant acquires any rights to the Premises or other premises in which Landlord has an Interest, or (c)&nbsp;if Tenant
remains in possession of the Premises with the consent of Landlord after the expiration of the term of this Lease after having failed to exercise an Option, or (d)&nbsp;if said Brokers are the procuring cause of any other lease or sale entered into
between the Parties pertaining to the Premises and/or any adjacent property in which Landlord has an interest, or (e)&nbsp;if Base Rent is increased, whether by agreement or operation of an escalation clause herein, then as to any of said
transactions, Landlord shall not be liable to said Broker(s) to pay a fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.3. <B>Assumption of Obligations</B>. Any buyer or
transferee of Landlord&#146;s interest in this Lease, whether such transfer is by agreement or by operation of law, shall be deemed to have assumed Landlord&#146;s obligation under this Paragraph 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.4. <B>Representations and Warranties</B>. Tenant and Landlord each represent and warrant to the other that it has had no dealings with any
person, firm, broker or finder other than as named in Paragraph 1.10(a) in connection with the negotiation of this Lease and/or the consummation of the transaction contemplated hereby, and that no broker or other person, firm or entity other than
said named Broker(s) is entitled to any commission or finder&#146;s fee in connection with said transaction. Tenant and Landlord do each hereby agree to indemnify, protect, defend and hold the other harmless from and against liability for
compensation or charges which may be claimed by any such unnamed broker, finder or other similar party by reason of any dealings or actions of the indemnifying Party, including any costs, expenses, and/or attorneys&#146; fees reasonably Incurred
with respect thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Tenancy and Financial Statements</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.1. <B>Tenancy Statement</B>. Each Party (as &#147;<B>Responding Party</B>&#148;) shall within ten (10)&nbsp;business days after written
notice from the other Party (the &#147;<B>Requesting Party</B>&#148;) execute, acknowledge and deliver to the Requesting Party a statement in writing in a form similar to the then most current &#147;<B>Tenancy Statement</B>&#148; form published by
the American Industrial Real Estate Association, plus such additional information, confirmation and/or statements as may be reasonably requested by the Requesting Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.2. <B>Financial Statement</B>. If Landlord desires to finance, refinance, or sell the Premises or the Building, or any part thereof, Tenant
and all the Guarantors shall deliver to any potential lender or purchaser designated by Landlord such financial statements of Tenant and such Guarantors as may be reasonably required by such lender or purchaser, including but not limited to
Tenant&#146;s financial statements for the past three (3)&nbsp;years. All such financial statements shall be received by Landlord and such lender or purchaser in confidence and shall be used only for the purposes herein set forth. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Landlord&#146;s Liability</B>.<B></B> The term &#147;Landlord&#148; as used herein shall mean the owner or owners at the time in question of the fee
title to the Premises. In the event of a transfer of Landlord&#146;s title or interest in the Premises or in this Lease, Landlord shall deliver to the transferee or assignee (in cash or by credit) any unused Security Deposit held by Landlord at the
time of such transfer or assignment. Except as provided In Paragraph 15.3, upon such transfer or assignment and delivery of the Security Deposit, as aforesaid, the prior Landlord shall be relieved of all liability with respect to the obligations
and/or covenants under this Lease thereafter to be performed by Landlord. Subject to the foregoing, the obligations and/or covenants in this Lease to be performed by the Landlord shall be binding only upon the Landlord as herein above defined.
Notwithstanding any other terms or provisions of this lease, Tenant agrees that in the event of any default or breach by Landlord with respect to any of the terms of the Lease to be observed and performed by Landlord (a)&nbsp;Tenant shall look
solely to the estate and property (which is the subject of this lease) of Landlord or any successor in interest in the property (which shall be deemed to include the rental income, the proceeds of any sale by Landlord as well as any insurance or
condemnation proceeds), for the satisfaction of Tenant&#146;s remedies for the collection of a judgment (or other judicial process) requiring the payment of money by Landlord; (b)&nbsp;no other property or assets of Landlord, its partners, members,
shareholders, officers or any successor in interest shall be subject to levy, execution or other enforcement procedure for the satisfaction if Tenant&#146;s remedies;(c) no personal liability shall at any time be asserted or enforceable against
Landlord, it&#146;s partner&#146;s, members or successors in interest (except to the extent permitted in (a) above), and no judgment will be taken against any partner, member, shareholder, officer or director of Landlord. The provisions of this
section shall apply only to the Landlord and the parties herein described, and shall not be for the benefit of any insurer nor any other third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18. Severability</B>. The invalidity of any provision of this Lease, as determined by a court of competent jurisdiction, shall in no way affect the
validity of any other provision hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19. Interest on Past-Due Obligations</B>. Any monetary payment due Landlord hereunder, other than late
charges, not received by Landlord within ten (10)&nbsp;days following the date on which it was due, shall bear interest from the date due at the prime rate charged by the largest state chartered bank in the state in which the Premises are located
plus four percent (4%)&nbsp;per annum, but not exceeding the maximum rate allowed by law, in addition to the potential late charge provided for in Paragraph 13.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20. Time of Essence</B>. Time is of the essence with respect to the performance of all obligations to be performed or observed by the Parties under this
Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>21. Rent Defined</B>. All monetary obligations of Tenant to Landlord under the terms of this Lease are deemed to be rent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>22. No Prior or other Agreements; Broker Disclaimer</B>. This Lease contains all agreements between the Parties with respect to any matter mentioned
herein, and no other prior or contemporaneous agreement or understanding shall be effective. Landlord and Tenant each represents and warrants to the Brokers that it has made, and is relying solely upon, its own investigation as to the nature,
quality, character and financial responsibility of the other Party to this Lease and as to the nature, quality and character of the Premises. Brokers have no responsibility with respect thereto or with respect to any default or breach hereof by
either Party. Each Broker shall be an intended third party beneficiary of the provisions of this Paragraph 22. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>23. Notices</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.1. <B>Notice Requirements</B>. All notices required or permitted by this Lease shall be in writing and may be delivered in person (by hand
or by messenger or courier service) or may be sent by regular, certified or registered mail or U.S. Postal Service Express Mall, with postage prepaid, and shall be deemed sufficiently given if served in a manner specified in this Paragraph 23. The
addresses noted adjacent to a Party&#146;s signature on this lease shall be that Party&#146;s address for delivery or mailing of notice purposes. Either Party may by written notice to the other specify a different address for notice purposes. A copy
of all notices required or permitted to be given to Landlord hereunder shall be concurrently transmitted to such party or parties at such addresses as Landlord may from time to time hereafter designate by written notice to Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.2. <B>Date of Notice</B>. Any notice sent by registered or certified mall, return receipt requested, shall be deemed given on the date of
delivery shown on the receipt card, or if no delivery date is shown, the postmark thereon. If sent by regular mall, the notice shall be deemed given three (3)&nbsp;business days after the same is addressed as required herein and mailed with postage
prepaid. Notices delivered by United States Express Mail or overnight courier that guarantees next day delivery shall be deemed given twenty-four (24)&nbsp;hours after delivery of the same to the United States Postal Service or courier. If notice is
received or otherwise deemed delivered on a Saturday or a Sunday or a legal holiday, it shall be deemed received on the next business day. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>24.
Waivers</B>. No waiver by a party of the Default or Breach of any term covenant or condition hereof by the other, shall be deemed a waiver of any other term, covenant or condition hereof, or of any subsequent Default or Breach by the other of the
same or any other term, covenant or condition hereof. Landlord&#146;s consent to, or approval of, any such act shall not be deemed to render unnecessary the obtaining of Landlord&#146;s consent to, or approval of, any subsequent or similar act by
Tenant, or be construed as the basis of an estoppel to enforce the provision or provisions of this Lease requiring such consent. Regardless of Landlord&#146;s knowledge of a Default or Breach at the time of accepting rent, the acceptance of rent by
Landlord shall not be a waiver of any Default or Breach by Tenant of any provision hereof. Any payment given Landlord by Tenant may be accepted by Landlord on account of moneys or damages due Landlord, notwithstanding any qualifying statements or
conditions made by Tenant in connection therewith, which such statements and/or conditions shall be of no force or effect whatsoever unless specifically agreed to In writing by Landlord at or before the time of deposit of such payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>25. Recording</B>. Either Landlord or Tenant shall, upon request of the other, execute, acknowledge and deliver to the other a short form memorandum of
this lease for recording purposes. The Party requesting recordation shall be responsible for payment of any fees or taxes applicable thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>26. No
Right To Holdover</B>. Tenant has no right to retain possession of the Premises or any part thereof beyond the expiration or earlier termination of this lease. In the event that Tenant holds over in violation of this Paragraph 26 then the Base Rent
payable from and after the time of the expiration or earlier termination of this lease shall be increased to one hundred fifty percent (150%)&nbsp;of the Base Rent applicable during the month immediately preceding such expiration or earlier
termination. Nothing contained herein shall be construed as a consent by Landlord to any holding over by Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>27. Cumulative Remedies</B>. No
remedy or election hereunder shall be deemed exclusive but shall, wherever possible, be cumulative with all other remedies at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>28.
Covenants and Conditions</B>. AI provisions of this lease to be observed or performed by Tenant are both covenants and conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>29. Binding Effect;
Choice of Law</B>. This Lease shall be binding upon the Parties, their personal representatives, successors and assigns and be governed by the laws of the State in which the Premises are located. Any litigation between the Parties hereto concerning
this Lease shall be initiated in the county in which the Premises are located. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>30. Subordination; Attornment; Non-Disturbance</B>.<B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.1. <B>Subordination</B>. This Lease and any Option granted hereby shall be subject and subordinate to any ground lease, mortgage, deed of
trust, or other hypothecation or security device (collectively, &#147;<B>Security Device</B>&#148;), now or hereafter placed by Landlord upon the real property of which the Premises are a part, to any and all advances made on the security thereof,
and to all renewals, modifications, consolidations, replacements and extensions thereof. Tenant agrees that the Lenders holding any such Security Device shall have no duty, liability or obligation to perform any of the obligations of Landlord under
this Lease, but that in the event of Landlord&#146;s default with respect to any such obligation, Tenant will give any Lender whose name and address have been furnished Tenant in writing for such purpose notice of Landlord&#146;s default pursuant to
Paragraph 13.5. If any Lender shall elect to have this Lease </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and/or any Option granted hereby superior to the lien of its Security Device and shall give written notice thereof to Tenant, this Lease and such Options shall be deemed prior to such Security
Device, notwithstanding the relative dates of the documentation or recordation thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.2. <B>Attornment</B>. Subject to the
non-disturbance provisions of Paragraph 30.3, Tenant agrees to attorn to a Lender or any other party who acquires ownership of the Premises by reason of a foreclosure of a Security Device. and that in the event of such foreclosure, such new owner
shall not: (i)&nbsp;be liable for any act or omission of any prior Landlord or with respect to events occurring prior to acquisition of ownership, (ii)&nbsp;be subject to any offsets or defenses which Tenant might have against any prior Landlord, or
(iii)&nbsp;be bound by prepayment of more than one month&#146;s rent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.3. <B>Non-Disturbance</B>. With respect to Security Devices
entered into by Landlord after the execution of this lease, Tenant&#146;s subordination of this Lease shall be subject to receiving assurance (a &#147;non-disturbance agreement&#148;) from the Lender that Tenant&#146;s possession and this Lease,
including any options to extend the term hereof, will not be disturbed so long as Tenant is not in Breach hereof and attorns to the record owner of the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.4. <B>Self-Executing</B>. The agreements contained in this Paragraph 30 shall be effective without the execution of any further documents;
provided, however, that upon written request from Landlord or a Lender in connection with a sale, financing or refinancing of Premises, Tenant and Landlord shall execute such further writings as may be reasonably required to separately document any
such subordination or non-subordination, attornment and/or non-disturbance agreement as is provided for herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>31. Attorneys&#146; Fees</B>. If any
Party brings an action or proceeding to enforce the terms hereof or declare rights hereunder, the Prevailing Party (as hereafter defined) in any such proceeding, action, or appeal thereon, shall be entitled to reasonable attorneys&#146; fees, costs
and expenses. Such fees may be awarded in the same suit or recovered in a separate suit, whether or not such action or proceeding is pursued to decision or judgment. The term &#147;<B>Prevailing Party</B>&#148; shall include, without limitation, a
Party who substantially obtains or defeats the relief sought, as the case may be whether by compromise, settlement, judgment, or the abandonment by the other Party or Broker of its claim or defense. The attorneys&#146; fee award shall not be
computed in accordance with any court fee schedule, but shall be such as to full reimburse all attorneys fees, cost and expenses reasonably incurred. Landlord shall be entitled to attorneys&#146; fees, costs and expenses incurred in preparation and
service of notices of Default and consultations in connection therewith, whether or not a legal action is subsequently commenced in connection with such Default or resulting Breach. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>32. Landlord&#146;s Access; Showing Premises; Repairs</B>. Landlord and Landlord&#146;s agents shall have the right to enter the Premises at any time, in
the case of an emergency, and otherwise at reasonable times upon reasonable advance notice to Tenant for the purpose of showing the same to prospective purchasers, lenders, or (during the final six (6)&nbsp;months of the term) tenants, and make such
alterations, repairs, improvements or additions to the Premises or to the Building, as Landlord may reasonably deem necessary (provided that Tenant shall have the right to require that Landlord be accompanied by a representative of Tenant during any
such entry). Landlord shall use best efforts to ensure that the performance of any such work of repairs or alterations shall not interfere with Tenant&#146;s use of the Premises (or any portion thereof) for Tenant&#146;s business purposes (such
efforts to include limiting the performance of any such work which might be disruptive to weekends or the evening and the cleaning of any work area prior to the commencement of the next business day). Landlord may at any time place on or about the
Premises or Building any ordinary &#147;For Sale&#148; signs and Landlord may at any time during the last one hundred eighty (180)&nbsp;days of the term hereof place on or about the Premises any ordinary &#147;For Lease&#148; signs. All such
activities of Landlord shall be without abatement of rent or liability to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>33. Auctions</B>. Tenant shall not conduct, nor permit to be
conducted, either voluntarily or involuntarily, any auction upon the Premises without first having obtained Landlord&#146;s prior written consent. Notwithstanding anything to the contrary in this Lease, Landlord shall not be obligated to exercise
any standard of reasonableness in determining whether to grant such consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>34. Signs</B>. Tenant shall not place any sign upon the exterior of the
Premises or the Building, except that Tenant may, with Landlord&#146;s prior written consent, install (but not on the roof) such signs as are reasonably required to advertise Tenant&#146;s own business so long as such signs are in a location
designated by Landlord and comply with Applicable Requirements and the signage criteria established for the Industrial Center by Landlord. The installation of any sign on the Premises by or for Tenant shall be subject to the provisions of Paragraph
7 (Maintenance, Repairs, Utility Installations, Trade Textures and Alterations). Unless otherwise expressly agreed herein, Landlord reserves all rights to the use of the roof of the Building and the right to install advertising signs on the
Building, including the roof, which do not unreasonably interfere with the conduct of Tenant&#146;s business; Landlord shall be entitled to all revenues from such advertising signs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>35. Termination; Merger</B>. Unless specifically stated otherwise in writing by Landlord, the voluntary or
other surrender of this Lease by Tenant, the mutual termination or cancellation hereof, or a termination hereof by Landlord for Breach by Tenant, shall automatically terminate any sublease or lesser estate in the Premises; provided, however,
Landlord shall, in the event of any such surrender, termination or cancellation, have the option to continue any one or all of any existing subtenancies. Landlord&#146;s failure within ten (10)&nbsp;days of following any such event to make a written
election to the contrary by written notice to the holder of any such lesser interest, shall constitute Landlord&#146;s election to have such event constitute the termination of such interest. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>36. Consents</B>.<B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Except for
Paragraph 33 (Auctions) or as otherwise provided herein, wherever in this Lease the consent of a Party Is required to an act by or for the other Party, such consent shall not be unreasonably withheld or delayed. Landlord&#146;s actual reasonable
costs and expenses (including but not limited to architects&#146;. attorneys&#146;, engineers&#146; and other consultants&#146; fees) incurred in the consideration of, or response to, a request by Tenant for any Landlord consent pertaining to this
Lease or the Premises, including but not limited to consents to an assignment a subletting or the presence or use of a Hazardous Substance, shall be paid by Tenant to Landlord upon receipt of an invoice and supporting documentation therefor. In
addition to the deposit described in Paragraph 12.2(e), Landlord may, as condition to considering any such request by Tenant, require that Tenant deposit with Landlord an amount of money (in addition to the Security Deposit held under Paragraph 5)
reasonably calculated by Landlord to represent the cost Landlord will incur in considering and responding to Tenant&#146;s request. Any unused portion of said deposit shall be refunded to Tenant without interest Landlord&#146;s consent to any act,
assignment of this Lease or subletting of the Premises by Tenant shall not constitute an acknowledgment that no Default or Breach by Tenant of this Lease exists, nor shall such consent be deemed a waiver of any then existing Default or Breach,
except as may be otherwise specifically stated in writing by Landlord at the time of such consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) All conditions to Landlord&#146;s
consent authorized by this Lease are acknowledged by Tenant as being reasonable. The failure to specify herein any particular condition to Landlord&#146;s consent shall not preclude the impositions by Landlord at the time of consent of such further
or other conditions as are then reasonable with reference to the particular matter for which consent is being given. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>37. [INTENTIONALLY
OMITTED]</B>.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>38. Quiet Possession</B>. Upon payment by Tenant of the rent for the Premises and the performance of all of the covenants,
conditions and provisions on Tenant&#146;s part to be observed and performed under this Lease, Tenant shall have quiet possession of the Premises for the entire term hereof subject to all of the provisions of this Lease. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>39. Options</B>.<B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39.1.
<B>Definition</B>. As used in this Lease, the word &#147;Option&#148; has the following meaning: (a)&nbsp;the right to extend the term of this Lease or to renew this Lease or to extend or renew any lease that Tenant has on other property of
Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39.2. <B>Options Personal to Original Tenant</B>. Each Option granted to Tenant in this lease is personal to the original
Tenant named in Paragraph 1.1 hereof and any assignee pursuant to a Permitted Transfer, and cannot be voluntarily or involuntarily assigned or exercised by any person or entity other than said original Tenant while the original Tenant is in full and
actual possession of the Premises and without the intention of thereafter assigning or subletting. The Options, if any, herein granted to Tenant are not assignable (other than pursuant to a Permitted Transfer), either as a part of an assignment of
this Lease or separately or apart therefrom, and no Option may be separated from this Lease in any manner, by reservation or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39.3. <B>Multiple Options</B>. In the event that Tenant has any multiple Options to extend or renew this Lease, a later option cannot be
exercised unless the prior Options to extend or renew this Lease have been validly exercised. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39.4. <B>Effect of Default on Options</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Tenant shall have no right to exercise an Option, notwithstanding any provision in the grant of Option to the contrary: (i)&nbsp;during the
period commencing with the giving of any notice of Default under Paragraph 13.1 and continuing until the noticed Default is cured, or (ii)&nbsp;during the period of time any monetary obligation due Landlord from Tenant is unpaid (without regard to
whether notice thereof is given Tenant), or (iii)&nbsp;during the time Tenant is in Breach of this Lease, or (iv)&nbsp;in the event that Landlord has given to Tenant three (3)&nbsp;or more notices of separate Defaults under Paragraph 13.1 during the
twelve (12)&nbsp;month period immediately preceding the exercise of the Option, whether or not the Defaults are cured. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The period of
time within which an Option may be exercised shall not be extended or enlarged by reason of Tenant&#146;s inability to exercise an Option because of the provisions of Paragraph 39.4(a) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) All rights of Tenant under the provisions of an Option shall terminate and be of no further force or effect, notwithstanding Tenant&#146;s
due and timely exercise of the Option, if, after such exercise and during the term of this Lease, (i)&nbsp;Tenant fails to pay to Landlord a monetary obligation of Tenant for a period of thirty (30)&nbsp;days after such obligation becomes due
(without any necessity of Landlord to give notice thereof to Tenant), or (ii)&nbsp;Landlord gives to Tenant three (3)&nbsp;or more notices of separate Defaults under Paragraph 13.1 during any twelve (12)&nbsp;month period, whether or not the
Defaults are cured, or (iii)&nbsp;if Tenant commits a Breach of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>40. Rules and Regulations</B>. Tenant agrees that it will abide by, and
keep and observe all reasonable rules and regulations (&#147;<B>Rules and Regulations</B>&#148;) which Landlord may make from time to time for the management, safety, care, and cleanliness of the grounds, the parking and unloading of vehicles and
the preservation of good order, as well as for the convenience of other occupants or tenants of the Building and the Industrial Center and their invitees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>41. Security Measures</B>. Tenant hereby acknowledges that the rental payable to Landlord hereunder does not include the cost of guard service or other
security measures, and that Landlord shall have no obligation whatsoever to provide same. Tenant assumes all responsibility for the protection of the Premises. Tenant, its agents and invitees and their property from the acts of third parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>42. Reservations</B>. Landlord reserves the right, from time to time, to grant, without the consent or joinder of Tenant, such easements, rights of way,
utility raceways, and dedications that Landlord reasonably deems necessary, and to cause the recordation of parcel maps and restrictions, so long as such easements, rights of way, utility raceways, dedications, maps and restrictions do not
reasonably interfere with the use of the Premises by Tenant. Tenant agrees to sign any documents reasonably requested by Landlord to effectuate any such easement rights, dedication, map or restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>43. Performance Under Protest</B>. If at any time a dispute shall arise as to any amount or sum of money to be paid by one Party to the other under the
provisions hereof, the Party against whom the obligation to pay the money is asserted shall have the right to make payment &#147;under protest&#148; and such payment shall not be regarded as a voluntary payment and there shall survive the right on
the part of said Party to institute suit for recovery of such sum. If it shall be adjudged that there was no legal obligation on the part of said Party to pay such sum or any part thereof, said Party shall be entitled to recover such sum or so much
thereof as it was not legally required to pay under the provisions of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>44. Authority</B>. If either Party hereto is a corporation, trust,
limited liability company, or general or limited partnership, each individual executing this Lease on behalf of such entity represents and warrants that he or she is duly authorized to execute and deliver this Lease on it&#146;s behalf and that such
entity is duly authorized and existing and qualified to do business in California and that Tenant has the full right and legal authority to enter into this lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>45. Conflict</B>. Any conflict between the printed provisions of this Lease and the typewritten or handwritten provisions shall be controlled by the
typewritten or handwritten provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>46. Offer</B>. Preparation of this Lease by either Landlord or Tenant or Landlord&#146;s agent or Tenant&#146;s
agent and submission of same to Tenant or Landlord shall not be deemed an offer to lease. This Lease is not intended to be binding until executed and delivered by all Parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>47. Amendments</B>. This Lease may be modified only in writing, signed by the parties in interest at the time of the modification. The Parties shall amend
this Lease from time to time to reflect any adjustments that are made to the Base Rent or other rent payable under this Lease. As long as they do not materially change Tenant&#146;s obligations hereunder, Tenant agrees to make such reasonable
non-monetary modification to this Lease as may be reasonably required by an institutional insurance company or pension plan Lender in connection with the obtaining of normal financing or refinancing of the property of which the Premises are a part.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>48.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Multiple Parties</B>. Except as otherwise expressly provided herein, if more than one person or entity is named herein as either Landlord or Tenant, the obligations of such multiple parties shall be the joint and
several responsibility of all persons or entities named herein as such Landlord or Tenant. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>49.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Option to Extend</B>. Subject to the terms and conditions set forth below, Tenant may at its option extend the Term of this Lease for One (1)&nbsp;period of TEN (10)&nbsp;years. Such period is called the
&#147;Renewal Term.&#148; The Renewal Term shall be upon the same terms contained in this Lease, except that (i)&nbsp;Landlord shall have no obligation to provide Tenant with any Tenant Improvement Allowance or demolition in connection with the
Renewal Term, (ii)&nbsp;the Base Rental during the Renewal Term shall be calculated as set forth below, and (iii)&nbsp;any reference in the Lease to the &#147;Term&#148; of the Lease shall be deemed to include the Renewal Term and apply thereto,
unless it is expressly provided otherwise. Tenant shall have no additional extension options. The Base Rent during the Renewal Term shall be at the then Fair Markel Rate (defined hereinafter) for such space for a term commencing of the first day of
the Renewal Term. &#147;Market Rate&#148; shall mean the then prevailing market rate for a comparable term commencing on the first day of the Renewal Term for tenants of comparable size and creditworthiness for comparable space in the Building and
other Office buildings in the Alameda Area. In no event shall the Base Rent payable during the first (1st)&nbsp;year of the Renewal Term be less than the Base Monthly Rent of January 2025. Base Rent during the Renewal Term shall increase at four
percent (4%)&nbsp;per year. To exercise any option, Tenant must deliver a binding written notice to Landlord not sooner than twelve (12)&nbsp;months nor later than six (6)&nbsp;months prior to the expiration of the Initial Term of this Lease.
Thereafter, the Market Rate for the Renewal Term shall be calculated by Landlord and Landlord shall inform Tenant of the Market Rate. If the parties cannot agree on the Market Rate within thirty (30)&nbsp;days following Landlord&#146;s delivery of a
statement of Fair Market Rent, the parties shall each, within ten (10)&nbsp;business days following the expiration of such thirty (30)&nbsp;day period, appoint a real estate broker (with at least 10 years experience in office leasing in Alameda) to
determine the Market Rate, and each such broker will deliver its determination within ten (10)&nbsp;additional business days. If the lower of the two is within 90% of the higher of the two valuations, then the Market Rent shall be the average of the
two. If a party fails to timely designate a broker, the broker designated by the other party will determine the Market Rate. If the lower of the two valuations Is less than 90% of the higher valuation, then the two brokers/appraisers originally
selected by the parties shall, within five (5)&nbsp;business days, select a third broker/appraiser and shall present their final determinations of Market Rate to the third broker/appraiser, and the third broker/appraiser shall pick one of those two
as being the Market Rate. The determination of the third broker/appraiser shall be binding on the parties. If Tenant falls to timely give its notice of exercise, Tenant will be deemed to have waived its option to extend. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>50.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Tenant Improvements</B>: Landlord shall complete specified tenant Improvements detailed in Exhibit A. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LANDLORD AND TENANT HAVE CAREFULLY READ AND REVIEWED THIS LEASE AND EACH TERM AND PROVISION CONTAINED HEREIN, AND BY THE EXECUTION OF THIS LEASE SHOW THEIR
INFORMED AND VOLUNTARY CONSENT THERETO. THE PARTIES HEREBY AGREE THAT, AT THE TIME THIS LEASE IS EXECUTED, THE TERMS OF THIS LEASE ARE COMMERCIALLY REASONABLE AND EFFECTUATE THE INTENT AND PURPOSE OF LANDLORD AND TENANT WITH RESPECT TO THE PREMISES.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THIS LEASE PREPARED FOR YOUR ATTORNEY&#146;S REVIEW AND APPROVAL. FURTHER, EXPERTS SHOULD BE CONSULTED TO THE PRESENCE OF ASBESTOS,
UNDERGROUND STORAGE TANKS OR HAZARDOUS SUBSTANCES. NO REPRESENTATION OR RECOMMENDATION IS MADE BY THE AMERICAN INDUSTRIAL REAL ESTATE ASSOCIATION OR BY THE REAL ESTATE BROKERS OR THEIR CONTRACTORS, AGENTS OR EMPLOYEES AS TO THE LEGAL SUFFICIENCY,
LEGAL EFFECT, OR TAX CONSEQUENCES OF THIS LEASE OR THE TRANSACTION TO WHICH IT RELATES; THE PARTIES SHALL RELY SOLELY UPON THE ADVICE OF THEIR OWN COUNSEL AS TO THE LEGAL AND TAX CONSEQUENCES OF THIS LEASE. IF THE SUBJECT PROPERTY IS IN A STATE
OTHER THAN CALIFORNIA, AN ATTORNEY FROM THE STATE WHERE THE PROPERTY IS LOCATED SHOULD BE CONSULTED. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties hereto have executed this Lease at the place and on the dates specified above their respective
signatures. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Executed&nbsp;at:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">555 Twin Dolphin Dr.</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Executed&nbsp;at:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">1351&nbsp;Harbor&nbsp;Bay&nbsp;Pkwy,&nbsp;Alameda,&nbsp;CA&nbsp;94502</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">on:&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">9/15/14</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">on:&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">17 September 2014</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By <B>Landlord</B>:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">By&nbsp;<B>Tenant</B>:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DOLLINGER HARBOR BAY ASSOCIATES,</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">a California limited partnership</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">D&amp;M Investors Fund I LLC, a</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">California Limited Liability Company</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">General Partner</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">D&amp;M Ventures LP,</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="3">PENUMBRA, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">a California Limited Partnership</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Its</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Sole Member</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="3">Adam Elsesser, CEO</TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">David Dollinger Living Trust</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="3">PENUMBRA, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="5">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Its General Partner</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David B. Dollinger</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lynn Rothman</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="6"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="5">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;David B. Dollinger, Trustee</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="3">Lynn Rothman, CFO</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">555 Twin Dolphin Drive, Suite 600</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Redwood City,
CA 94065</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Address:&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway,</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Alameda, CA
94502</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Telephone: (650)&nbsp;508-8666</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Telephone: (510) 748-3200</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Facsimile: (650)&nbsp;508-8686</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Facsimile: (510) 217-9422</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A Notes </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord, at Landlord&#146;s
sole cost and expense shall build the Tenant Improvements as per this attached Exhibit A, using the same building standards as when the Tenant originally moved in to 1351 Harbor Bay Parkway and as specified In Exhibit B attached hereto </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1411 Harbor Bay Parkway &#150; First Floor <U> </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>All items
by Landlord unless specified.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord will construct first floor as shown on Exhibit B </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compressor Room </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Flooring &#150; Exposed
finished concrete </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; none </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Walls &#150; painted </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Electrical
&#150; 460 V 3 phase power, 60 Amp fused disconnect box </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">CDA &#150; by Tenant </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Room will be supplied directly with HVAC air and have adequate ventilation </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Kitchen/Restaurant </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Floors &#150; New
VCT </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Counter tops/equipment &#150; by tenant </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Power &#150; Existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Ceiling
&#150; Existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Water &#150; Existing </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Break Room </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Flooring &#150; new VCT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Power &#150; add 200 amp panel in this area </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; Existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Break
room will have approximately 16&#146; of counter with cabinets above and below, double sink, and space for refrigerator / freezer </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restrooms </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Add 4 stalls in Women&#146;s Restroom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Add 3 urinals and 1 stall in Men&#146;s Restroom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Shower areas to expanded and converted to multiple shower open space (3&#150;4 shower heads per bathroom) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Partitions &#150; New </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Tile/grout
to match existing in expansion area </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Counter top/sinks &#150; need additional sinks (per code) / counter top &#150; new counter tops </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; Existing </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Server Room </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">VCT flooring </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Finish and paint
walls </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Room will be supplied directly with HVAC air and have adequate ventilation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Add pre-system fire sprinklers </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common
Area/Lobby </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Floors &#150; Existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Exterior
Doors &#150; Existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Elevator &#150; Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Stairs &#150; Existing </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A minimum of 1000 amps
of 110/208v of power required for 1411 1st floor &#150; distributed to 4-6 panels &#150; locations to be determined by Tenant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>1411 Harbor Bay &#150; Second Floor </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord will construct second floor as shown on Exhibit B </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Purpose Areas 1, 2 &amp; 3 </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; Match existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Flooring &#150; Carpet Tiles with small areas of VCT for break areas </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Sound System/Projectors/Screens &#150; By Tenant (work to be done during construction) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Power for projectors placed in ceilings &#150; Landlord </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rest rooms </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Plumbing/Toilets/Counters
&#150; Existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">These restrooms need to be remodeled - conference center must have upscale restrooms </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>1411 Harbor Bay &#150; GENERAL/BUILDING </U></B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Replace Roof </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Signage on building
to match 1351 (By tenant) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Repair any damage to exterior of building </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">All office doors to be 9&#146; clear birch with 3&#146; windows next to them </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">All windows to have matching blinds </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Entire
building to be converted from old T-12 lights I fixtures to new mandated TS lights / fixtures </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent air conditioning units removed during demolition
to be relocated to new locations determined by Tenant </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All new areas / Buildings: Penumbra will provide a drawing with colors of walls prior to paint being
purchased for job or all walls will be standard swiss coffee </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit B </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794001.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794002.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>7
<FILENAME>filename7.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LEASE MODIFIED NET </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1.&nbsp;&nbsp;&nbsp;&nbsp;Basic Provisions (&#147;Basic Provision&#148;). </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Parties</B>: This Lease (<B>&#147;Lease&#148;</B>), dated, September&nbsp;11, 2014, is made by and between
Dollinger Harbor Bay Associates, LP (<B>&#147;Landlord&#148;</B>) and Penumbra, Inc. (<B>&#147;Tenant&#148;</B>), (collectively the <B>&#147;Parties</B>,<B>&#148;</B> or individually a <B>&#147;Party&#148;</B>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2(a)&nbsp;&nbsp;&nbsp;&nbsp;<B>Premises</B>: A portion of that certain building containing approximately 50,177 rentable square feet,
including all improvements therein or to be provided by Landlord under the terms of this Lease, commonly known by the street address of <U>1321&nbsp;Harbor Bay Parkway</U>, located in the City of <U>Alameda</U>, County of <U>Alameda</U>, State of
<U>California</U>, with zip code <U>94502</U> as outlined on Exhibit <U>B</U> attached hereto (<B>&#147;Premises&#148;</B>). The <B>&#147;Building&#148;</B> is that certain building containing the Premises and generally described as (describe
briefly the nature of the Building): <U>a <FONT STYLE="white-space:nowrap">multi-tenant</FONT> R&amp;D Office building</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to Tenant&#146;s
rights to use and occupy the Premises as hereinafter specified, Tenant shall have <FONT STYLE="white-space:nowrap">non-exclusive</FONT> rights to the Common Areas (as defined in Paragraph 2.7 below) as hereinafter specified, but shall not have any
rights to the roof, exterior walls or utility raceways of the Building or to any other buildings in the Industrial Center. The Premises, the Building, the Common Areas, the land upon which they are located, along with all other buildings and
Improvements thereon, are herein collectively referred to as the &#147;<B>Industrial Center</B>.&#148; (Also see Paragraph 2.) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2(b)&nbsp;&nbsp;&nbsp;&nbsp;<B>Parking</B>: the parking ratio will be 3.30 unreserved parking stalls per 1,000 sq. ft. of leased office
space unreserved vehicle parking spaces (<B>&#147;Unreserved Parking Spaces&#148;</B>); and <U>no</U> reserved vehicle parking spaces (<B>&#147;Reserved Parking Spaces&#148;</B>). (Also, see Paragraph 2.6) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Term</B>: (<B>&#147;Original Term&#148;</B>) Commencing upon the Landlord&#146;s substantial completion of
Tenant Improvements at 1321 Harbor Bay Parkway (<B>&#147;Commencement Date&#148;</B>) and ending on November&nbsp;30, 2029. (<B>&#147;Expiration Date&#148;</B>). (Also Paragraph 3.) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Early Possession</B>: Tenant shall be allowed access to the
Premises during Tenant Improvement Period, however Landlord shall not be responsible for any delays caused by Tenant&#146;s work (<B>&#147;Early Possession&#148;</B>). (Also Paragraphs 3.2 and 3.3.) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.5&nbsp;&nbsp;&nbsp;&nbsp;<B>Base rent</B>: $65,230.00 per month (<B>&#147;Base Rent&#148;</B>), payable commencing one month following (the
&#147;Rent Commencement Date&#148;) the Commencement Date. (Also see Paragraph 4). Tenant will receive a Rent Credit for Boehm&#146;s occupancy of Suite 250 in the amount of $8,455.00 per month until the earlier of Boehm vacating Suite 250 or
December&nbsp;31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>, 2017. Beginning on the on the 1st day of the month following the first anniversary of the Rent Commencement Date and annually thereafter, Base Rent shall be Increased 3%
annually. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.6(b)&nbsp;&nbsp;&nbsp;&nbsp;<B>Tenant&#146;s Share of Common Area Operating Expenses</B>: <U>100</U>% of the building
(<B>&#147;</B><B>Tenants Share</B><B>&#148;</B>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.7<B>&nbsp;&nbsp;&nbsp;&nbsp;Security Deposit</B>: $65,230.10 (<B>&#147;Security
Deposit&#148;</B>). (Also see Paragraph 5) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.8&nbsp;&nbsp;&nbsp;&nbsp;<B>Permitted Use</B>: General Office and R&amp;D Use
(<B>&#147;Permitted Use&#148;</B>) (Also see Paragraph 5.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.9&nbsp;&nbsp;&nbsp;&nbsp;<B>Insuring Party</B>. Landlord is the
<B>&#147;Insuring Party</B>.<B>&#148;</B> (Also see Paragraph 8) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.10(a)&nbsp;&nbsp;&nbsp;&nbsp;<B>Real Estate Brokers</B>. [x] NONE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tenant shall indemnify and hold Landlord, its trustees, members, principals, beneficiaries, partners, officers, directors, employees, mortgagee(s) and agents,
and the respective principals and members of any such agents harmless from all claims of any brokers claiming to have represented Tenant in connection with this Lease. Landlord shall Indemnify and hold Tenant, its trustees, members, principals,
beneficiaries, partners, officers, directors, employees, and agents, and the respective principals and members of any such agents harmless from all claims of any brokers claiming to have represented Landlord in connection with this Lease. Tenant
acknowledges that any assistance rendered by any agent or employee of any affiliate of Landlord in connection with this Lease it has been made as an accommodation to Tenant solely in furtherance of consummating the transaction on behalf of Landlord,
and not as agent for Tenant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.10(b)&nbsp;&nbsp;&nbsp;&nbsp;<B>Intentionally Deleted</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.11&nbsp;&nbsp;&nbsp;&nbsp;<B>Guarantor</B>. The obligations of the Tenant under this lease are to be guaranteed by NONE
(<B>&#147;Guarantor&#148;</B>). (Also see Paragraph 37.) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.12&nbsp;&nbsp;&nbsp;&nbsp;<B>Addenda and Exhibits</B>. Attached hereto are
Exhibits A and B, all of which constitute a part of this lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2.&nbsp;&nbsp;&nbsp;&nbsp;Premises, Parking and Common Areas</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Letting</B>. Landlord hereby leases to Tenant, and Tenant hereby leases from Landlord, the Premises, for the
term, at the rental, and upon all of the terms, covenants and conditions set forth in this Lease. The leaseable area is measured to the outside edge of the outside walls and drip lines to the centerline of any demising walls, including a pro rata
share of the electrical room, corridors, lobbies and other common spaces. Unless otherwise provided herein, any statement of square footage set forth in this Lease, or that may have been used in calculating rental and/or Common Area Operating
Expenses, is an approximation which Landlord and Tenant agree is reasonable and the rental and Tenant&#146;s Share (as defined in Paragraph 1.6(b) based thereon is not subject to revision whether or not the actual square footage is more or less.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Condition</B>. Landlord shall deliver the Premises to Tenant clean and free of debris on the Commencement
Date and warrants to Tenant that the existing plumbing, electrical systems, fire sprinkler system, lighting, air conditioning and heating systems and loading doors, if any, in the Premises, other than those constructed by Tenant, shall be in good
operating condition on the Commencement Date. If a non-compliance with said warranty exists as of the Commencement Date, Landlord shall, except as otherwise provided in this Lease, promptly after receipt of written notice from Tenant setting forth
with specificity the nature and extent of such non-compliance, rectify same at Landlord&#146;s expense. If Tenant does not give Landlord written notice of a non-compliance with this warranty within six (6)&nbsp;months after the Commencement Date,
correction of that non-compliance shall be the obligation of Tenant at Tenant&#146;s sole cost and expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Warranties</B>. Tenant acknowledges that neither Landlord nor any of its agents made any representations or
warranties respecting the project, the buildings, or the leased premises, upon which tenant relied in entering into this lease, which are not expressly set forth in this lease. Tenant further acknowledges that neither Landlord nor any of its agents
made any representations as to (i)&nbsp;whether the leased premises may be used for tenant&#146;s intended use under existing law or; (ii)&nbsp;the suitability of the leased premises for the conduct of tenant&#146;s business or; (iii)&nbsp;the exact
square footage of the leased premises; that tenant relied solely upon its own investigations respecting said premises (including but not limited to the electrical and fire sprinkler systems, security, environmental aspects, seismic and earthquake
requirements, and compliance with the American with Disabilities Act and applicable zoning, municipal, county, state and federal laws, ordinances and regulations and any covenants or restrictions of record (collectively, <B>&#147;Applicable
Laws&#148;</B>) and that upon its execution of this lease, accepts the leaseable area as specified herein. Tenant expressly waives any and all claims for damage by reason of any statement, representation, warranty, promise or other agreement of
Landlord or Landlord&#146;s agent(s), if any, not contained in this lease or in any addenda hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Tenant
as Prior Owner/Occupant</B>. The warranties made by Landlord in this Paragraph 2.2 shall be of no force or effect if immediately prior to the date set forth in Paragraph 1.1 Tenant was the owner or occupant of the Premises. In such event, Tenant
shall at Tenant&#146;s sole cost and expense, correct any non-compliance of the Premises with said warranties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5&nbsp;&nbsp;&nbsp;&nbsp;<B>Vehicle Parking</B>. Tenant shall be entitled to use the number of
Unreserved Parking Spaces and Reserved Parking Spaces specified in Paragraph 1.2(b) on those portions of the Common Areas designated from time to time by Landlord for parking. Tenant shall not use more parking spaces than said number. Said parking
spaces shall be used for parking by vehicles no larger than full-size passenger automobiles or pick-up trucks, herein called <B>&#147;Permitted Size Vehicles</B>.<B>&#148;</B> Vehicles other than Permitted Size Vehicles shall be parked and loaded or
unloaded as directed by Landlord in the Rules and Regulations (as defined in Paragraph 40) Issued by Landlord. (Also see Paragraph 2.9.) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall not permit or allow any vehicles that belong to or are controlled by Tenant or Tenant&#146;s
employees, suppliers, shippers, customers, contractors or invitees to be loaded, unloaded, or parked in areas other than those designated by Landlord for such activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If Tenant permits or allows any of the prohibited activities described In this Paragraph 2.6, then Landlord shall
have the right, without notice, in addition to such other rights and remedies that it may have, to remove or tow away the vehicle involved and charge the cost to Tenant, which cost shall be immediately payable upon demand by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Landlord shall at the Commencement Date of this Lease, provide the parking facilities required by Applicable Law.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6&nbsp;&nbsp;&nbsp;&nbsp;<B>Common Areas - Definition</B>. The term <B>&#147;Common Areas&#148;</B> is defined as all areas and
facilities outside the Premises and within the exterior boundary line of the Industrial Center and Interior utility raceways within the Premises that are provided and designated by the Landlord from time to time for the general non-exclusive use of
Landlord, Tenant and other tenants of the Industrial Center and their respective employees, suppliers, shippers, customers, contractors and invitees, including parking areas, loading and unloading areas, trash areas, roadways, sidewalks, walkways,
parkways, driveways and landscaped areas. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.7&nbsp;&nbsp;&nbsp;&nbsp;<B>Common Areas - Tenant&#146;s Rights</B>. Landlord hereby
grants to Tenant, for the benefit of Tenant and Its employees, suppliers, shippers, contractors, customers and invitees, during the term of this lease, the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> right to use, in common with others
entitled to such use, the Common Areas as they exist from time to time, subject to any rights, powers, and privileges reserved by Landlord under the terms hereof or under the terms of any rules and regulations or restrictions governing the use of
the Industrial Center. Under no circumstances shall the right herein granted to use the Common Areas be deemed to include the right to store any property, temporarily or permanently, in the Common Areas. Any such storage shall be permitted only by
the prior written consent of Landlord or Landlord&#146;s designated agent, which consent may be revoked at any time. In the event that any unauthorized storage shall occur then Landlord shall have the right, without notice, in addition to such other
rights and remedies that it may have, to remove the property and charge the cost to Tenant, which cost shall be immediately payable upon demand by Landlord.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8&nbsp;&nbsp;&nbsp;&nbsp;<B>Common Areas - Rules and Regulations</B>. Landlord or such other person(s) as Landlord may appoint shall have
the exclusive control and management of the Common Areas and shall have the right, from time to time, to establish, modify, amend and enforce reasonable Rules and Regulations with respect thereto in accordance with Paragraph 40. Tenant agrees to
abide by and conform to all such Rules and Regulations and to cause its employees, suppliers, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shippers, customers, contractors and invitees to so abide and conform. Landlord shall not be responsible to Tenant for the non-compliance with said rules and regulations by other tenants of the
Industrial Center. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.09&nbsp;&nbsp;&nbsp;&nbsp;<B>Common Areas - Changes</B>. Landlord shall have the right, in Landlord&#146;s sole
discretion, from time to time: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;To make changes to the Common Areas, including, without limitation, changes in
the location, size, shape and number of driveways, entrances, parking spaces, parking areas, loading and unloading areas, ingress, egress, direction of traffic, landscaped areas, walkways and utility raceways; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;To close temporarily any of the Common Areas for maintenance purposes so long as reasonable access to the Premises
remains available; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;To designate other land outside the boundaries of the Industrial Center to be a part of the
Common Areas; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;To add additional buildings and improvements to the Common Areas; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;To use the Common Areas while engaged in making additional Improvements, repairs or alterations to the Industrial
Center, or any portion thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;To do and perform such other acts and make such other changes in, to or with
respect to the Common Areas and Industrial Center as Landlord may, in the exercise of sound business judgment, deem to be appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Landlord shall use best efforts to ensure that the performance of any such work of repairs or alterations shall not interfere with
Tenant&#146;s use of the Premises (or any portion thereof) for Tenant&#146;s business purposes (such efforts to include limiting the performance of any such work which might be disruptive to weekends or the evening and the cleaning of any work area
prior to the commencement of the next business day); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3.&nbsp;&nbsp;&nbsp;&nbsp;Term</B>.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Term</B>. The Commencement Date, Expiration Date and Original Term of this Lease are as specified in Paragraph
1.3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Early Possession</B>. If Tenant totally or partially occupies the Premises after the Early Possession
Date but prior to the Commencement Date, the obligation to pay Base Rent shall be abated for the period of such early occupancy. All other terms of this Lease, however, (including but not limited to the obligations to pay Tenant&#146;s Share of
Common Area Operating Expenses and to carry the insurance required by Paragraph 8} shall be in effect during such period. Any such early possession shall not affect nor advance the Expiration Date of the Original Term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Delay in Possession</B>. If for any reason Landlord cannot deliver possession of the Premises to Tenant by the
Early Possession Date, Landlord shall not be subject to any liability therefor, nor shall such failure affect the validity of this Lease, or the obligations of Tenant hereunder, or extend the term hereof, but in such case, Tenant shall not, except
as otherwise provided herein, be obligated to pay rent or perform any other obligation of Tenant under the terms of this Lease until Landlord delivers possession of the Premises to Tenant. If possession of the Premises is not delivered to Tenant
within sixty (60} days after the Commencement Date, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Tenant may, at its option, by notice in writing to Landlord within ten (10)&nbsp;days after the end of sixty (60)&nbsp;day period, cancel this Lease, in which event the parties shall be
discharged from all obligations hereunder; provided further, however, that if such written notice of Tenant is not received by Landlord within said ten (10)&nbsp;day period, Tenant&#146;s right to cancel this Lease hereunder shall terminate and be
of no further force or effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4.&nbsp;&nbsp;&nbsp;&nbsp;Rent </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Base Rent</B>. Tenant shall pay Base Rent and other rent or charges, as the same may be adjusted from time, to
time, to Landlord in lawful money of the United States, without offset or deduction, on or before the 1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> day of each month. Base Rent and all other rent and charges for any period during the term
hereof which is for less than one full month shall be prorated based upon the actual number of days of the month Involved. Payment of Base Rent and other charges shall be made to Landlord at its address stated herein or to such other persons or at
such other addresses as Landlord may from time to time designate in writing to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Common Area
Operating Expenses</B>. Tenant shall pay to Landlord during the term hereof, in addition to the Base Rent, Tenant&#146;s Share (as specified in Paragraph 1.6(b)) of all Common Area Operating Expenses, as hereinafter defined, during each calendar
year of the term of this Lease, in accordance with the following provisions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;</B><B>Common Area
Operating Expenses</B>&#148; are defined, for purposes of this Lease, as all costs incurred by Landlord relating to the ownership and operation of the Industrial Center, including, but not limited to, the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The operation, repair and maintenance, in neat, clean, good order and condition, of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(aa)&nbsp;&nbsp;&nbsp;&nbsp;The Common Areas, including parking areas, loading and unloading areas, trash areas, roadways, sidewalks,
walkways, parkways, driveways, landscaped areas, striping, bumpers, Irrigation systems, Common Area lighting facilities, fences and gates, elevators and roof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(bb)&nbsp;&nbsp;&nbsp;&nbsp;Exterior signs and any tenant directories </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(cc)&nbsp;&nbsp;&nbsp;&nbsp;Fire detection and sprinkler systems. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;The cost of water, gas, electricity and telephone to service the Common Areas. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Trash disposal, property management fees of 4% of the gross monthly rental and security services and the costs
of any regularly scheduled environmental inspections. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;<B>[INTENTIONALLY OMITTED]</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;Real Property Taxes (as defined in Paragraph 10.2) to be paid by Landlord for the Building and the Common Areas
under Paragraph 10 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;The cost of the premiums for the insurance policies maintained by Landlord under
Paragraph 8 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;Any deductible portion of an insured loss concerning the building or the Common Areas.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;Any other services to be provided by Landlord that are stated elsewhere in this Lease to be a Common Area
Operating Expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The cost of any capital improvements or other capital items included in Common Area Operating
Expenses shall be amortized by Landlord on a straight line basis over the economic useful life of the capital item for accounting purposes, as determined by Landlord using generally accepted accounting principles, consistently applied, and Internal
Revenue Service asset classification regulations, if any. The amortized cost of capital improvements may include interest at the rate paid by Landlord on any funds borrowed for such expenditures from an unaffiliated
<FONT STYLE="white-space:nowrap">third-party</FONT> financial institution, but in no event in excess of the market rate of Interest customarily paid on such borrowed funds for such purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, Common Area Operating Expenses will not include: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;repairs or other work occasioned by tire, windstorm or other insured casualty or hazard, to the extent that
Landlord shall receive proceeds of such insurance or would have received such proceeds had Landlord maintained the insurance coverage required under this Lease and diligently attempted to procure the maximum possible insurance coverage; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;marketing and promotional costs; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;debt service payments on or related to any indebtedness; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;any amounts paid to any person, firm or corporation related or otherwise affiliated with Landlord or any general
partner, officer or director of Landlord or any of its general partners, to the extent same materially exceeds arms-length competitive prices paid in the Alameda, California metropolitan area for the services or goods provided; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;costs relating to maintaining Landlord&#146;s existence, either as a corporation, partnership, or other entity.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Any common Area Operating Expenses and Real Property Taxes that are specifically attributable to the Building
or to any other building in the Industrial Center or to the operation, repair and maintenance thereof, shall be allocated entirety to the Building or to such other building. However, any Common Area Operating Expenses and Real Property Taxes that
are not specifically attributable to the Building or to any other building or to the operation, repair and maintenance thereof, shall be equitably allocated by Landlord to all buildings in the Industrial Center. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Inclusion of the Improvements, facilities and services set forth in subparagraph 4.2(a) shall not be deemed to
impose an obligation upon Landlord to either have said improvements or facilities or to provide those services unless the Industrial Center already has the same, Landlord already provides the services, or Landlord has agreed elsewhere in this lease
to provide the same or some of them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Tenant&#146;s Share of Common Area Operating Expenses shall be payable by
Tenant within thirty (30)&nbsp;days after a reasonably detailed statement of actual expenses is presented to Tenant by Landlord. At Landlord&#146;s option, however, an amount may be reasonably estimated by Landlord from time to time of Tenant&#146;s
Share of annual Common Area Operating Expenses and the same shall be payable monthly or quarterly, as Landlord shall designate, during each 12-month period of the lease term, on the same day as the Base Rent is due hereunder. Landlord shall deliver
to Tenant within sixty (60)&nbsp;days after the expiration of each calendar year a reasonably detailed statement showing Tenant&#146;s Share of the actual Common </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Area Operating Expenses incurred during the preceding year. If Tenant&#146;s payments under this Paragraph 42(d) during said preceding year exceed Tenant&#146;s Share as indicated on said
statement, Landlord shall be credited the amount of such over-payment against Tenant&#146;s Share of Common Area Operating Expenses next becoming due. If Tenant&#146;s payments under this Paragraph 4.2(d) during said preceding year were less than
Tenant&#146;s Share as Indicated on said statement, Tenant shall pay to Landlord the amount of the deficiency within ten (10)&nbsp;days after delivery by Landlord to Tenant of said statement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Landlord shall maintain at all times during the term of this Lease, full, complete and accurate books of account
and records prepared in accordance with generally accepted accounting principles with respect to Common Area Operating Expenses, and shall retain such books and records, as well as contracts, bills, vouchers, and checks, and such other documents as
are reasonably necessary to properly audit Common Area Operating Expenses. Upon reasonable notice from Tenant, Landlord shall make available for Tenant&#146;s Inspection (or Inspection performed by Tenant&#146;s accountant and/or consultants) during
normal business hours, Landlord&#146;s books and records relating to the Common Area Operating Expenses. If an audit, review or inspection by a Tenant or Tenant&#146;s accountant or consultant alleges an overbilling, Tenant may submit a claim for
the overbilled amount to Landlord, detailing the nature of the overbilling, and Landlord shall have thirty (30)&nbsp;days to pay such amount or contest the claim by giving notice thereof to Tenant, detailing the nature of Landlord&#146;s contest of
Tenant&#146;s claims. If, Landlord&#146;s statement is ultimately determined to be in error, Landlord will promptly reimburse to Tenant, or Tenant will promptly pay to Landlord, any amount which may be determined to have been due as a result of
Tenant&#146;s audit; additionally, if Landlord is determined to have overcharged Tenant for Common Area Operating Expenses by 3% or more, Landlord shall reimburse Tenant within thirty (30)&nbsp;days following such determination for the reasonable
cost of Tenant&#146;s review of Landlord&#146;s books and records not to exceed $500 (which cost may not be included as a Common Area Operating Expense). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<B>Security Deposit</B>. Tenant shall deposit with Landlord upon Tenant&#146;s execution hereof the Security Deposit set forth in
Paragraph 1.7 as security for Tenant&#146;s faithful performance of Tenant&#146;s obligations under this Lease. If Tenant fails to pay Base Rent or other rent or charges due hereunder, or otherwise Defaults under this Lease (as defined in Paragraph
13.1), Landlord may use, apply or retain all or any portion of said Security Deposit, Tenant shall within ten (10)&nbsp;days after written request therefore deposit monies with Landlord sufficient to restore said Security Deposit to the full amount
required by this Lease. Landlord shall not be required to keep all or any part of the Security Deposit separate from its general accounts. Landlord shall, at the expiration or earlier termination of the term hereof and after Tenant has vacated the
Premises, return to Tenant (or, at Landlord&#146;s option, to the last assignee, if any, of Tenant&#146;s interest herein), that portion of the Security Deposit not used or applied by Landlord. Unless otherwise expressly agreed in writing by
Landlord, no part of the Security Deposit shall be considered to be held in trust, to bear interest or other increment for its use, or to be prepayment for any monies to be paid by Tenant under this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<B>Use</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Permitted Use</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall use and occupy the Premises only for the Permitted Use set forth in Paragraph 1.8, or any other legal
use which is reasonably comparable thereto, and for no other purpose. Tenant shall not use or permit the use of the Premises in a manner that is unlawful, creates waste or a nuisance, or that disturbs owners and/or occupants of, or causes damage to
the Premises or neighboring premises or properties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Landlord hereby agrees to not unreasonably withhold, condition or
delay its consent to any written request by Tenant, Tenant&#146;s assignees or subtenants, and by prospective assignees and subtenants of Tenant, its assignees and subtenants, for a modification of said Permitted Use, so long as the same will not
impair the structural integrity of the improvements on the Premises or in the Building or the mechanical or electrical systems therein, does not conflict with uses by other Tenants, is not significantly more burdensome to the Premises or the
Building and the improvements thereon, and is otherwise permissible pursuant to this Paragraph 6. If Landlord elects to withhold such consent, Landlord shall within five (5)&nbsp;business days after such request give a written notification of same,
which notice shall include an explanation of Landlord&#146;s reasonable objections to the change in use. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Hazardous Substances</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<B>Reportable Uses Require Consent</B>. The term <B>&#147;Hazardous Substance&#148;</B> as used in this Lease shall
mean any product, substance, chemical, material or waste whose presence, nature, quantity and/or intensity of existence, use, manufacture, disposal, transportation, spill, release or effect, either by itself or in combination with other materials
expected to be on the Premises, is either: (i)&nbsp;potentially injurious to the public health, safety or welfare, the environment, or the Premises;(ii) regulated or monitored by any governmental authority; or (iii)&nbsp;a basis for potential
liability of Landlord to any governmental agency or third party under any applicable statute or common law theory. Hazardous Substance shall include, but not be limited to, hydrocarbons, petroleum, gasoline, crude oil or any products or by-products
thereof. Tenant shall not engage in any activity in or about the Premises which constitutes a Reportable Use (as herein after defined) of Hazardous Substances without the express prior written consent of Landlord and compliance in a timely manner
(at Tenant&#146;s sole cost and expense) with all Applicable Requirements (as defined in Paragraph 6.3). <B>&#147;Reportable Use&#148;</B> shall mean (i)&nbsp;the installation or use of any above or below ground storage tank, (ii)&nbsp;the
generation, possession, storage, use, transportation, or disposal of a Hazardous Substance that requires a permit from, or with respect to which a report, notice, registration or business plan is required to be filed with, any governmental
authority, and (iii)&nbsp;the presence in, on or about the Premises of a Hazardous Substance with respect to which any Applicable Laws require that a notice be given to persons entering or occupying the Premises or neighboring properties.
Notwithstanding the foregoing, Tenant may, without Landlord&#146;s prior consent, but upon notice to Landlord and in compliance with all Applicable requirements, use any ordinary and customary materials reasonably required to be used by Tenant in
the normal course of the Permitted Use, so long as such use is not a Reportable Use and does not expose the Premises or neighboring properties to any meaningful risk of contamination or damage or expose Landlord to any liability therefor. In
addition, Landlord may (but without any obligation to do so) condition its consent to any Reportable Use of any Hazardous Substance by Tenant upon Tenant&#146;s giving Landlord such additional assurances as Landlord, in its reasonable discretion,
deems necessary to protect itself, the public, the Premises and the environment against damage, contamination or injury and/or liability therefor, including but not limited to the installation (and, at Landlord&#146;s option, removal on or before
Lease expiration or earlier termination) of reasonably necessary protective modifications to the Premises (such as concrete encasements) and/or the deposit of an additional Security Deposit under Paragraph 5 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<B>Duty to Inform Landlord</B>. If Tenant knows, or has reasonable cause to believe, that a Hazardous Substance has
come to be located in, on, under or about the Premises or the Building, other than as previously consented to by Landlord, Tenant shall immediately give Landlord written notice thereof, together with a copy of any statement, report, notice,
registration, application, permit, business plan, license, claim, action, or proceeding given to, or received from, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any governmental authority or private party concerning the presence, spill, release, discharge of, or exposure to, such Hazardous Substance including but not limited to all such documents as may
be involved in any Reportable Use involving the Premises. Tenant shall not cause or permit any Hazardous Substance to be spilled or released in, on, under or about the Premises (including, without limitation, through the prompting or sanitary sewer
system). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<B>Indemnification</B>. Tenant shall indemnify, protect, defend and hold Landlord, its agents,
employees, lenders and ground lessor, if any, and the Premises, harmless from and against any and all damages, liabilities, judgments, costs, claims, liens, expenses, penalties, loss of permits and attorneys&#146; and consultants&#146; fees arising
out of or involving any Hazardous Substance brought onto the Premises by or for Tenant or by anyone under Tenant&#146;s control. Tenant&#146;s obligations under this paragraph 6.2(c) shall include, but not be limited to, the effects of any
contamination or injury to person, property or the environment created or suffered by Tenant, and the cost of investigation (including consultants&#146; and attorneys&#146; fees and testing), removal, remediation, restoration and/or abatement
thereof, or of any contamination therein involved, and shall survive the expiration or earlier termination of this Lease. No termination, cancellation or release agreement entered into by Landlord and Tenant shall release Tenant from its obligations
under this Lease with respect to Hazardous Substances, unless specifically so agreed by Landlord in writing at the time of such agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Tenant&#146;s Compliance with Requirements</B>. Tenant shall, at Tenant&#146;s sole cost and expense, fully,
diligently and in a timely manner, comply with all <B>&#147;Applicable Requirements</B>,<B>&#148;</B> which term is used In this Lease to mean all laws, rules, regulations, ordinances, directives, covenants, easements and restrictions of record,
permits, the requirements of any applicable fire insurance underwriter or rating bureau, and the recommendations of Landlord&#146;s engineers and/or consultants, relating in any manner to the Premises (including but not limited to matters pertaining
to (i)&nbsp;industrial hygiene, (ii)&nbsp;environmental conditions on, in, under or about the Premises, including soil and ground water conditions, and (iii)&nbsp;the use, generation, manufacture, production, installation, maintenance, removal
transportation, storage, spill, or release of any Hazardous Substance), now in effect or which may hereafter come into effect. Tenant shall, within five (5)&nbsp;days after receipt of Landlord&#146;s written request, provide Landlord with copies of
all documents and information, including but not limited to permits, registrations, manifests, applications, reports and certificates, evidencing Tenants compliance with any applicable Requirements specified by Landlord, and shall immediately upon
receipt, notify Landlord in writing (with copies of any documents involved) of any threatened or actual claim, notice, citation, warning, complaint or report pertaining to or involving failure by Tenant or the Premises to comply with any Applicable
Requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Inspection; Compliance with Law</B>. Landlord, Landlord&#146;s agents, employees, contractors
and designated representatives, and the holders of any mortgages, deeds of trust or ground leases on the Premises (<B>&#147;Lenders&#148;</B>) shall have the right to enter the Premises at any time in the case of an emergency, and otherwise at
reasonable times upon reasonable advance notice to Tenant, for the purpose of inspecting the condition of the Premises and for verifying compliance by Tenant with this Lease and all Applicable Requirements (as defined in Paragraph 6.3), and Landlord
shall be entitled to employ experts and/or consultants in connection therewith to advise Landlord with respect to Tenant&#146;s activities, including but not limited to Tenant&#146;s installation, operation, use, monitoring, maintenance, or removal
of any Hazardous Substance on or from the Premises. The costs and expenses of any such inspections shall be paid by the party requesting same (and if paid by Landlord, such cost will not be Included In Common Area Operating Expenses), unless a
Default or Breach of this Lease by Tenant or a violation of Applicable Requirements or a contamination, caused or materially contributed to by Tenant, is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
found to exist or to be imminent. or unless the inspection is requested or ordered by a governmental authority as the result of any such existing or imminent violation or contamination. In such
case, Tenant shall upon request reimburse Landlord or Landlord&#146;s Lender, as the case may be, for the costs and expenses of such inspections. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<B>Maintenance, Repairs, Utility Installations, Trade Fixtures and Alterations</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Tenant&#146;s Obligations</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provision of Paragraphs 2.2 (Condition), 7.2 (Landlord&#146;s Obligations), 9 (Damage or
Destruction), and 14 (Condemnation), Tenant shall, at Tenant&#146;s sole cost and expense and at all times, keep the Premises and every part thereof in good order, condition and repair (whether or not such portion of the Premises requiring repair,
or the means of repairing the same, are reasonably or readily accessible to Tenant, and whether or not the need for such repairs occurs as a result of Tenant&#146;s use, any prior use, the elements or the age of such portion of the Premises),
including, without limiting the generality of the foregoing, all equipment or facilities specifically serving the Premises, such as plumbing, heating, air conditioning, ventilating, electrical, lighting facilities, boilers, fired or unfired pressure
vessels, fire hose connections if within the Premises, fixtures, interior walls, interior surfaces of exterior walls, ceilings, floors, windows, doors, plate glass, and skylights, but excluding any items which are the responsibility of Landlord
pursuant to Paragraph 7.2 below. Tenant, in keeping the Premises in good order, condition and repair, shall exercise and perform good maintenance practices. Tenant&#146;s obligations shall include restorations, replacements or renewals when
necessary to keep the Premises and all improvements thereon or a part thereof in good order, condition and state of repair. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall, at Tenant&#146;s sole cost and expense, procure and maintain a contract, with copies to Landlord, in
customary form and substance for and with a contractor specializing and experienced in the inspection, maintenance and service of the heating, air conditioning and ventilation system for the Premises. However, Landlord reserves the right, upon
notice to Tenant, to procure and maintain the contract for the heating, air conditioning and ventilating systems, and if Landlord so elects, Tenant shall reimburse Landlord, upon demand, for the cost thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;If Tenant fails to perform Tenant&#146;s obligations under this Paragraph 7.1, Landlord may enter upon the Premises
after ten (10)&nbsp;days&#146; prior written notice to Tenant (except in the case of an emergency, in which case no notice shall be required), perform such obligations on Tenant&#146;s behalf, and put the Premises in good order, condition and
repair, in accordance with Paragraph 13.2 below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Landlord&#146;s Obligations</B>. Subject to the provisions
of Paragraphs 2.2 (Condition), 4.2 (Common Area Operating Expenses to the extent applicable), 7 (Use), 7.1 (Tenant&#146;s Obligations), 9 (Damage or Destruction) and 14 (Condemnation), Landlord, subject to reimbursement pursuant to Paragraph 4.2 to
the extent applicable, shall keep in good order, condition and repair the foundations, exterior walls, structural condition of interior bearing walls, roof, fire sprinkler and/or standpipe and hose (if located in the Common Areas) or other automatic
fire extinguishing system including fire alarm and/or smoke detection systems and equipment, fire hydrants, parking lots, walkways, parkways, driveways, landscaping, fences, signs and utility systems serving the Common Areas and all parts thereof,
as well as providing the services for which there is a Common Area Operating Expense pursuant to Paragraph 4.2. Landlord shall not be obligated to paint the exterior or interior surfaces of exterior walls nor shall Landlord be obligated to maintain,
repair or replace windows, doors or plate glass of the Premises. Tenant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expressly waives the benefit of any statute now or hereafter in effect which would otherwise afford Tenant the right to make repairs at Landlord&#146;s expense or terminate this Lease because of
Landlord&#146;s failure to keep the Building, Industrial Center or Common Areas in good order, condition and repair. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Utility Installations, Trade Fixtures, Alterations</B>.<B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<B>Definitions; Consent Required</B>. The term <B>&#147;Utility Installations&#148;</B> is used in this Lease to
refer to all air lines, power panels, electrical distribution, security, fire protections systems, lighting fixtures, heating, ventilating and air conditioning equipment, plumbing, and fencing in, on or about the Premises. The term <B>&#147;Trade
Fixtures&#148;</B> shall mean Tenant&#146;s machinery and equipment which can be removed without doing material damage to the Premises. The term <B>&#147;Alterations&#148;</B> shall mean any modification of the improvements on the Premises under the
terms of this Lease, other than Utility Installations or Trade Fixtures. <B>&#147;Tenant-Owned Alterations and/or Utility Installations&#148;</B> are defined as Alterations and/or Utility Installations made by Tenant that are not yet owned by
Landlord pursuant to Paragraph 7.4(a). Tenant shall not make nor cause to be made any Alterations or Utility Installations in, on, under or about the Premises without Landlord&#146;s prior written consent. Tenant may, however, make non-structural
Utility Installations to the interior of the Premises (excluding the roof) without Landlord&#146;s consent but upon notice to Landlord, so long as they are not visible from the outside of the Premises, do not involve puncturing, relocating or
removing the roof or any existing walls, or changing or interfering with the fire sprinkler or fire detection systems and the cost thereof does not exceed $25,000.00. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<B>Consent</B>.<B></B> Any Alterations or Utility Installations that Tenant shall desire to make and which require
the consent of the Landlord shall be presented to Landlord in written form with detailed plans. All consents given by Landlord, whether by virtue of Paragraph 7.3(a) or by subsequent specific consent, shall be deemed conditioned upon:
(i)&nbsp;Tenant&#146;s acquiring all applicable permits required by governmental authorities; (ii)&nbsp;the furnishing of copies of such permits together with a copy of the plans and specifications for the Alteration or Utility Installation to
Landlord prior to commencement of the work thereon; and (iii)&nbsp;the compliance by Tenant with all conditions of said permits in a prompt and expeditious manner. Any Alterations of Utility Installations by Tenant during the term of this Lease
shall be done in a good and workmanlike manner, with good and sufficient materials, and be in compliance with all Applicable Requirements. Tenant shall promptly upon completion thereof furnish Landlord with as-built plans and specifications
therefor. Landlord may (but without obligation to do so) condition its consent to any requested Alteration or Utility Installation that costs $25,000.00 or more upon Tenant&#146;s providing Landlord with a lien and completion bond in an amount equal
to one and one-half times the estimated cost of such Alteration or Utility Installation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<B>Lien
Protection</B>. Tenant shall pay when due all claims for labor or materials furnished or alleged to have been furnished to or for Tenant at or for use on the Premises, which claims are or may be secured by any mechanic&#146;s or materialmen&#146;s
lien against the Premises or any interest therein. Tenant shall give Landlord not less than ten (10)&nbsp;days&#146; notice prior to the commencement of any work in, on, or about the Premises, and Landlord shall have the right to post notices of
non-responsibility in or on the Premises as provided by law. If Tenant shall, in good faith, contest the validity of any such lien, claim or demand, then Tenant shall, at its sole expense, defend and protect itself, Landlord and the Premises against
the same and shall pay and satisfy any such adverse judgment that may be rendered thereon before the enforcement thereof against the Landlord or the Premises. If Landlord shall require, Tenant shall furnish to Landlord a surety bond satisfactory to
Landlord in an amount equal to one and <FONT STYLE="white-space:nowrap">one-half</FONT> times the amount of such contested fine claim or demand, indemnifying Landlord against liability </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for the same, as required by law for the holding of the Premises free from the effect of such lien or claim. In addition, Landlord may require Tenant to pay Landlord&#146;s attorneys&#146; fees
and costs in participating in such action if Landlord shall decide it is to its best interest to do so. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Ownership, Removal,
Surrender, and Restoration</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<B>Ownership</B>. Subject to Landlord&#146;s right to require their removal as
expressly set forth below, and to cause Tenant to become the owner thereof as hereinafter provided in this Paragraph 7.4, all Alterations and Utility Installations made to the Premises by Tenant shall be the property of and owned by Tenant, but
considered a part of the Premises. Landlord may, at any time and at its option, elect in writing to Tenant to be the owner of all or any specified part of the Tenant-Owned Alterations and Utility Installations. Unless otherwise instructed per
Subparagraph 7.4(b) hereof, all Tenant-Owned Alterations and Utility Installations shall, at the expiration or earlier termination of this Lease, become the property of Landlord and remain upon the Premises and be surrendered with the Premises by
Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<B>Removal</B>. Landlord may, by notice delivered to Tenant concurrently with Landlord&#146;s consent
to the installation of any Tenant-Owned Alterations or Utility Installations (but not the Tenant Improvements or initial Alterations) require that any or all of such Tenant-Owned Alterations or Utility Installations be removed by the expiration or
earlier termination of this Lease, notwithstanding that their installation may have been consented to by Landlord. Landlord may require the removal at any time of all or any part of any Alterations or Utility Installations made without the required
consent of Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<B>Surrender/Restoration</B>. The voluntary or other surrender of this Lease by Tenant,
or a mutual cancellation thereof, shall not work a merger, and shall, at the option of Landlord, terminate all or any existing subleases or subtenancies, or may, at the option of Landlord, operate as an assignment to Landlord of any or all such
subleases or subtenancies. Immediately prior to the expiration or sooner termination of this Lease, Tenant shall remove all of Tenants signs from the exterior of the Building and shall remove all of Tenant&#146;s equipment, trade fixtures,
furniture, supplies, wall decorations and other personal property from the Leased Premises, and shall vacate and surrender the Leased Premises to Landlord in the same condition, broom clean, as existed at the Lease Commencement Date, subject to
Tenant-Owned Alterations and Utility Installations the removal of which is not required hereunder. Tenant shall repair all damage to the Leased Premises caused by Tenant or by Tenant&#146;s removal of Tenant&#146;s property and all damage to the
exterior of the Building caused by Tenant&#146;s removal of Tenants signs. Tenant shall replace all stained or damaged ceiling tiles and shall repair or replace, as necessary, all burned out light bulbs and damaged or stained light lenses and shall
repaint all painted walls. Tenant shall patch and refinish, to Landlord&#146;s reasonable satisfaction, all penetrations made by Tenant or its employees to the floor, walls or ceiling of the Leased Premises, whether such penetrations were made with
Landlord&#146;s approval or not. Additionally, Tenant shall, prior to the expiration or sooner termination of this Lease, remove any Improvements, constructed or installed by Tenant which Landlord pursuant to the provisions of Section&nbsp;7.4(b)
above, previously requested be so removed by Tenant and repair all damage caused by such removal. If the Leased Premises are not surrendered to Landlord in the condition required by this Article at the expiration or sooner termination of this Lease,
Landlord may, at Tenant&#146;s expense, so remove Tenant&#146;s signs, property and/or improvements not so removed and make such repairs and replacements not so made or hire, at Tenant&#146;s expenses, independent contractors to perform such work.
Tenant shall be liable to Landlord for all costs incurred by Landlord in returning the Leased Premises to the required condition and Tenant shall be deemed to have impermissibly held over until such time as such required work is completed. Tenant
shall pay Base Monthly Rent and Additional Rent at the rate payable immediately preceding the Expiration Date until such work is completed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<B>Insurance; Indemnity</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Payment of Premiums</B>. The cost of the premiums for the insurance policies maintained by Landlord under this
Paragraph 8 shall be a Common Area Operating Expense pursuant to Paragraph 4.2 hereof. Premiums for policy periods commencing prior to, or extending beyond, the term of this Lease shall be prorated to coincide with the corresponding Commencement
Date or Expiration Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Liability Insurance</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<B>Carried by Tenant</B>. Tenant shall obtain and keep in force during the term of this Lease a Commercial General
Liability policy of insurance protecting Tenant, Landlord and any Lender(s) whose names have been provided to Tenant in writing (as additional insureds) against claims for bodily injury, personal injury and property damage based upon, Involving or
arising out of the ownership, use, occupancy or maintenance of the Premises and all areas appurtenant thereto. Such insurance shall be on an occurrence basis providing single limit coverage in an amount not less than $1,000,000 per occurrence with
an &#147;Additional Insured-Managers or Landlords of Premises&#148; endorsement and contain the &#147;Amendment of the Pollution Exclusion&#148; endorsement for damage caused by heat, smoke or fumes from a hostile fire. Tenant must either cause
their liability policy to be endorsed to include pollution liability coverage, onsite and off site, including release of any pollutants, toxins, or contaminants, whether such release is sudden or prolonged or willful or accidental OR Tenant must
procure a separate policy which provides coverage for pollution, liability, premises pollution, on site and off site, including release of any pollutants, toxins, or contaminants, whether such release is sudden or prolonged or willful or accidental.
The policy shall not contain any intra-insured exclusions as between insured persons or organizations, but shall include coverage for liability assumed under this Lease as an &#147;insured contract&#148; for the performance of Tenant&#146;s
indemnity obligations under this Lease. The limits of said insurance required by this Lease or as carried by Tenant shall not, however, limit the liability of Tenant nor relieve Tenant of any obligation hereunder. All insurance to be required by
this Lease or as carried by Tenant shall not, however, limit the liability of Tenant nor relieve Tenant of any obligation hereunder. All insurance to be carried by Tenant shall be primary to and not contributory with any similar insurance carried by
Landlord, whose insurance shall be considered excess insurance only. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<B>Carried by Landlord</B>. Landlord
shall also maintain liability insurance described in Paragraph 8.2(a) above, in addition to and not in lieu of, the insurance required to be maintained by Tenant except coverage for pollution liability, premises pollution, on site and off site,
including release of any pollutants, toxins, or contaminants, whether such release is sudden or prolonged or willful or accidental, shall only be carried solely by Tenant. Tenant shall not be named as an additional insured therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Property Insurance-Building, Improvements and Rental Value</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<B>Building and Improvements</B>. Landlord shall obtain and keep in force during the term of this Lease a policy or
policies in the name of Landlord, with loss payable to Landlord and to any Lender(s), insuring against loss or damage to the Building and Premises. Such insurance shall be for full replacement cost, as the same shall exist from time to time, or the
amount required by any Lender(s), but in no event more than the commercially reasonable and available insurable value thereof if, by reason of the unique nature or age of the improvements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
involved, such latter amount is less than full replacement cost. Tenant-Owned Alterations and Utility Installations, Trade Fixtures and Tenant&#146;s personal property shall be insured by Tenant
pursuant to Paragraph 8.4. Landlord&#146;s policy or policies shall insure against all risks of direct physical loss or damage (and at Landlord&#146;s option the perils of flood and/or earthquake), including coverage for any additional costs
resulting from debris removal and reasonable amounts of coverage for the enforcement of any ordinance or law regulating the reconstruction or replacement of any undamaged sections of the Building required to be demolished or removed by reason of the
enforcement of any building, zoning, safety or land use laws as the result of a covered loss, but not including plate glass insurance. Said policy or policies shall also contain an agreed valuation provision in lieu of any co-insurance clause,
waiver of subrogation, and inflation guard protection causing an increase in the annual property insurance coverage amount by a factor of not less than the adjusted U.S. Department of Labor Consumer Price Index for All Urban Consumers for the city
nearest to where the Premises are located. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<B>Rental Value</B>. Landlord shall also obtain and keep in force
during the term of this Lease a policy or policies in the name of Landlord, with loss payable to Landlord and any Lender(s), insuring the loss of the full rental and other charges payable by all tenants of the Building to Landlord for at least one
year (including all Real Property Taxes, insurance costs, all Common Area Operating Expenses and any scheduled rental increases). Said insurance may provide that in the event the Lease is terminated by reason of an insured loss, the period of
indemnity for such coverage shall be extended beyond the date of the completion of repairs or replacement of the Premises, to provide for one full year&#146;s loss of rental revenues from the date of any such loss. Said insurance shall contain an
agreed valuation provision in lieu of any co-insurance clause, and the amount of coverage shall be adjusted annually to reflect the projected rental income, Real Property Taxes, insurance premium costs and other expenses, if any, otherwise payable,
for the next 12-month period. Common Area Operating Expenses shall include any deductible amount in the event of such loss. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<B>Adjacent Premises</B>. Tenant shall pay for any increase in the premiums for the property insurance of the
Building and for the Common Areas or other buildings in the Industrial Center if said increase is caused solely by Tenant&#146;s acts, omissions, use or occupancy of the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<B>Tenant&#146;s Improvements</B>. Since Landlord is the Insuring Party, Landlord shall not be required to Insure
Tenant-Owned Alterations and Utility Installations unless the item in question has become the property of Landlord under the terms of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Tenant&#146;s Property Insurance</B>. Subject to the requirements of Paragraph 8.5, Tenant at Its cost shall
either by separate policy or by endorsement to a policy already carried, maintain insurance coverage on all of Tenant&#146;s personal property, Trade Fixtures and Tenant-Owned Alterations and Utility Installations in, on, or about the Premises
similar in coverage to that carried by Landlord as the Insuring Party under Paragraph 8.3(a). Such insurance shall be full replacement cost coverage with a deductible not to exceed $10,000.00 per occurrence. Upon request from Landlord, Tenant shall
provide Landlord with written evidence that such insurance is in force. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5&nbsp;&nbsp;&nbsp;&nbsp;<B>Insurance Policies</B>. Insurance
required hereunder shall be in companies duly licensed to transact business in the state where the Premises are located, and maintaining during the policy term a &#147;General Policyholders Rating&#148; of at least A-VII, or such other rating as may
be required by a Lender, as set forth in the most current issue of &#147;Best&#146;s Insurance Guide.&#148; Tenant shall not do or permit to be done anything which shall invalidate the insurance policies referred to in this Paragraph 8. Tenant shall
cause to be delivered to Landlord, within seven (7)&nbsp;days after </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the earlier of the Early Possession Date or the Commencement Date, certificates evidencing the existence and amounts of, the Insurance required under Paragraph 8.2(a) and 8.4. No such policy
shall be cancelable or subject to material modification except after ten (10)&nbsp;days&#146; prior written notice to Landlord. Tenant shall at least thirty (30)&nbsp;days prior to the expiration of such policies, furnish Landlord with evidence of
renewals or &#147;insurance binders&#148; evidencing renewal thereof, or Landlord may following notice to order such insurance and charge the cost thereof to Tenant, which amount shall be payable by Tenant to Landlord upon demand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.6&nbsp;&nbsp;&nbsp;&nbsp;<B>Waiver of Subrogation</B>. Notwithstanding any other provision of this Lease to the contrary, Tenant and
Landlord each hereby release and relieve the other, and waive their entire right to recover damages (whether in contract or in tort) against the other, for loss or damage to their property arising out of or incident to the perils required to be
insured against under Paragraph 8. The effect of such releases and waivers of the right to recover damages shall not be limited by the amount of insurance carried or required, or by any deductibles applicable thereto. Landlord and Tenant agree to
have their respective insurance companies issuing property damage insurance waive any right to subrogation that such companies may have against Landlord or Tenant, as the case may be, so long as the insurance is not invalidated thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.7&nbsp;&nbsp;&nbsp;&nbsp;<B>Indemnity</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>By Tenant</U>. Subject to the provisions of Section&nbsp;8.6 above, Tenant, shall, during the term of this
Lease, indemnify and save harmless Landlord from any and all loss, damage, claims of damage, obligations, cause or causes of action, or liabilities of any kind or nature (including reasonable costs of attorney&#146;s fees if Landlord is made a party
to any action which Tenant&#146;s indemnity runs hereunder) by reason of injury or death of any person or persons or damage to any property of any kind and to whomsoever belonging, including injury or death to the person or damage to the property of
Tenant, Tenant&#146;s officers, directors, employees, agents, guests, subtenants and assignees, concessionaires and licensees, and any other person, firm or corporation selling or manufacturing merchandise or services upon or from the demised
premises, or any part thereof, from any cause or cause whatsoever which result from Tenant&#146;s use of the Premises or from any other activity done, permitted or suffered by Tenant. As a material part of the consideration to Landlord, Tenant
hereby assumes all risk of damage to property or injury to persons in or about the Premises from any cause whatsoever (except that which is caused by the negligence or willful misconduct by Landlord or its Agents or by the failure of Landlord to
observe any of the terms and conditions of this Lease after prior written notice from Tenant). Tenant&#146;s obligations under this paragraph shall survive the termination of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>By Landlord</U>. Subject to the provisions of Section&nbsp;8.6, Landlord shall indemnify, defend, protect and
hold harmless Tenant and Tenant&#146;s agents, employees, officers, directors, shareholders and partners from and against all liabilities, obligations, damages, penalties. claims, causes of action, costs, charges and expenses, including reasonable
attorneys&#146; fees, court costs, administrative costs and costs of appeals which may be imposed upon or incurred by, or asserted by reason of any of the following which shall occur during the Term of this Lease, or during any period of time prior
to the Lease Commencement Date: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Any work or act done in or about the Premises or the Building by Landlord or
its agents, contractors or employees; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Any negligence or other wrongful act or omission on the part of the
Landlord or any of its agents, contractors, subcontractors, servants, employees, subtenants. licensees or invitees; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Any accident, injury or damage to any persons or property occurring
in, on or about the common area, unless caused by the negligence or willful misconduct of Tenant, its employees, contractors or agents, as well as any accident, injury or damage to any persons or property occurring in or about the common area,
unless caused by the negligence or willful misconduct of Tenant, its employees, contractors or agents; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;Any failure on the part of Landlord to perform or comply with any of the covenants, agreements, terms,
provisions, conditions or limitations contained in this Lease on its part to be performed or complied with as long as Landlord was given prior written notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.8&nbsp;&nbsp;&nbsp;&nbsp;<B>Exemption of Landlord from Liability</B>.<B></B> Landlord shall not be liable for injury or damage which may be
sustained by Tenant or to the person or goods, wares, merchandise or other property of Tenant, Tenant&#146;s employees, contractors, invitees, customers, or any other person in or about the Premises, whether such damage or injury is caused by or
results from fire, earthquake, steam, electricity, gas, water or rain, which may leak or from or into any part of the premises or from the breakage, leakage, obstruction or other defects of pipes, fire sprinklers, wires, appliances, plumbing, HVAC
or lighting fixtures, or from any other cause, whether said injury or damage results from conditions arising upon the Premises or upon other portions of the Building of which the Premises are a part, from other sources or places, and regardless of
whether the cause of such damage or injury or the means of preparing the same is accessible or not. Landlord shall not be liable for any damages arising from any act or neglect of any other tenant of Landlord nor from the failure by Landlord to
enforce the provisions of any other lease in the Industrial Center. Notwithstanding Landlord&#146;s negligence or breach of this Lease, Landlord shall under no circumstances be liable for injury to Tenant&#146;s business or for any loss of income or
profit therefrom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<B>Damage or Destruction</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Definitions</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;Premises Partial Damage&#148;</B> shall mean damage or destruction to the Premises, other than
Tenant-Owned Alterations and Utility Installations, the repair cost of which damage or destruction is less than fifty percent (50%)&nbsp;of the then Replacement Cost (as defined in Paragraph 9.1(d)) of the Premises (excluding the Tenant-Owned
Alterations and Utility Installations and Trade Fixtures) immediately prior to such damage or destruction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;Premises Total Destruction&#148;</B> shall mean damage or destruction to the Premises, other than
Tenant-Owned Alterations and Utility Installations, the repair cost of which damage or destruction is fifty percent (50%)&nbsp;or more of the then Replacement Cost of the Premises (excluding Tenant-Owned Alterations and Utility Installations and
Trade Fixtures) immediately prior to such damage or destruction. In addition, damage or destruction to the Building, other than Tenant-Owned Alterations and Utility Installations and Trade Fixtures of any tenants of the Building, the cost of which
damage or destruction is fifty percent (50%)&nbsp;or more of the then Replacement Cost (excluding Tenant-Owned Alterations and Utility Installations and Trade Fixtures of any Tenants of the Building) of the Building shall, at the option of Landlord,
be deemed to be Premises total Destruction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;Industrial Center Total Destruction&#148;</B> shall mean
damage or destruction to the Industrial Center or the Building in which the premises are located, regardless of the damage to the premises. The cost of which damage or destruction is fifty percent (50%)&nbsp;or more of the then Replacement Cost of
the Industrial Center or the Building (excluding Tenant-Owned Alterations and Utility Installations and Trade Fixtures) immediately prior to such damage or destruction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;Insured Loss&#148;</B> shall mean damage or destruction to
the Premises, other than Tenant-Owned Alterations and Utility Installations and Trade Fixtures, which was caused by an event required to be covered by the insurance described in Paragraph 8.3(a) irrespective of any deductible amounts or coverage
limits involved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;Replacement Cost&#148;</B> shall mean the cost to repair or rebuild the improvements
owned by Landlord at the time of the occurrence to their condition existing immediately prior thereto, including demolition, debris removal and upgrading required by the operation of applicable building codes, ordinances or laws, and without
deduction for depreciation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<B>&#147;Hazardous Substance Condition&#148;</B> shall mean the occurrence or
discovery of a condition involving the presence of, or a contamination by, a Hazardous Substance as defined In Paragraph 6.2(a), in, on, or under the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Premises Partial or Total Damage - Insured or Uninsured Loss</B>. If Premises Partial or Total Damage that is an
Insured or Uninsured Loss occurs, then Landlord shall, at Landlord&#146;s expense, repair such damage (but not Tenant&#146;s Trade Fixtures or Tenant-Owned Alterations and Utility Installations) as soon as reasonably possible, but only to the extent
of the available insurance proceeds, if any (provided Landlord has maintained the insurance coverage required hereunder),and this Lease shall continue in full force and effect. In the event, however, that there is a shortage of insurance proceeds
and such shortage is due to any reason (other than Landlord&#146;s failure to maintain the insurance required hereunder) including the fact that some but not all of which may include the fact that, by reason of the unique nature of the improvements
In the Premises, full replacement cost insurance coverage was not commercially reasonable and available, then Landlord shall have no obligation to pay for the shortage in insurance proceeds or to fully restore the unique aspects of the Premises
unless Tenant provides Landlord with the funds to cover same, or adequate assurance thereof, within ten (10)&nbsp;days following receipt of written notice of such shortage and request therefore [no deductible payment will be included in any such
&#147;shortage&#148;]. If Landlord receives said funds or adequate assurance thereof within said thirty (30)&nbsp;day period, Landlord shall complete the repairs as soon as reasonably possible and this Lease shall remain in full force and effect. If
Landlord does not receive such funds or assurance within said period, Landlord may nevertheless elect by written notice to Tenant within ten (10)&nbsp;days thereafter to make such restoration and repair as is commercially reasonable with Landlord
paying any shortage in proceeds, in which case this Lease shall remain in full force and effect. If Landlord does not receive such funds or assurance within such thirty (30)&nbsp;day period, and if Landlord does not so elect to restore and repair,
then this Lease shall terminate sixty (60)&nbsp;days following the occurrence of the damage or destruction. Unless otherwise agreed, Tenant shall in no event have any right to reimbursement from Landlord for any funds contributed by Tenant to repair
any such damage or destruction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Intentionally Deleted</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Industrial Center Destruction</B>. Notwithstanding any other provision hereof, if the Industrial Center in which
the Premises are located suffers Total Destruction (including any destruction required by any authorized public authority), this Lease at Landlord&#146;s option shall terminate sixty (60)&nbsp;days following the date of such Total Destruction,
whether or not the damage or destruction affected the premises. In the event, however, that the damage or destruction was caused by Tenant, Landlord shall have the right to recover Landlord&#146;s damages from Tenant except as released and waived in
Paragraph 9.7. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5&nbsp;&nbsp;&nbsp;&nbsp;<B>Damage Near End of Term</B>. If at any time during the last six
(6)&nbsp;months of the term of this Lease there is damage to the Premises for which the cost to repair (other than the repair of Tenant&#146;s Trade Fixtures or Tenant-Owned Alterations and Utility Installations) exceeds three (3)&nbsp;months&#146;
Base Rent, whether or not an Insured Loss, Landlord may, at Landlord&#146;s option, terminate this Lease effective sixty (60)&nbsp;days following the date of occurrence of such damage by giving written notice to Tenant of Landlord&#146;s election to
do so within thirty (30)&nbsp;days after the date of occurrence of such damage. Provided, however, if Tenant at that time has an exercisable option to extend this Lease, then Tenant may preserve this Lease by (a)&nbsp;exercising such option, and
(b)&nbsp;providing Landlord with any shortage in insurance proceeds (or adequate assurance thereof) needed to make the repairs on or before the earlier of (i)&nbsp;the date which is ten (10)&nbsp;days after Tenant&#146;s receipt of Landlord&#146;s
written notice purporting to terminate this Lease, or (ii)&nbsp;the day prior to the date upon which such option expires. If Tenant duly exercises such option during such period and provides Landlord with funds (or adequate assurance thereof) to
cover any shortage in insurance proceeds, Landlord shall, at Landlord&#146;s expense repair such damage as soon as reasonably possible and this Lease shall continue in full force and effect. If Tenant fails to exercise such option and provide such
funds or assurance during such period, then this Lease shall terminate as of the date set forth in the first sentence of this Paragraph 9.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6&nbsp;&nbsp;&nbsp;&nbsp;<B>Abatement of Rent; Tenant&#146;s Remedies</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In the event of (i)&nbsp;Premises Partial Damage or (ii)&nbsp;Hazardous Substance Condition for which Tenant is not
legally responsible, the Base Rent, Common Area Operating Expenses and other charges, if any, payable by Tenant hereunder for the period during which such damage or condition, its repair, remediation or restoration continues shall be abated in
proportion to the degree to which Tenants use of the Premises is impaired, but not in excess of proceeds from insurance required to be carried under Paragraph 8.3(b). Except for abatement of Base Rent, Common Area Operating Expenses and other
charges, if any as aforesaid, all other obligations of Tenant hereunder shall be performed by Tenant, and Tenant shall have no claim against Landlord for any damage suffered by reason of any such damage, destruction, repair, remediation or
restoration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;If Landlord shall be obligated to repair or restore the Premises under the provisions of this
Paragraph 9 and shall not commence, in a substantial and meaningful way, the repair or restoration of the Premises within ninety (90)&nbsp;days after such obligation shall accrue, Tenant may, at any time prior to the commencement of such repair or
restoration, give written notice to Landlord and to any Lenders of which Tenant has actual notice of Tenant&#146;s election to terminate this Lease on a date not less than sixty (60)&nbsp;days following the giving of such notice. If Tenant gives
such notice to Landlord and such Lenders and such repair or restoration Is not commenced within thirty (30)&nbsp;days after receipt of such notice, this Lease shall terminate as of the date specified In said notice. If Landlord or a Lender commences
the repair or restoration of the Premises within thirty (30)&nbsp;days after the receipt of such notice, this Lease shall continue In full force and effect (subject to the remaining rights of that set forth herein). <B>&#147;Commence&#148;</B> as
used in this Paragraph 9.6 shall mean either the unconditional authorization of the preparation of the required plans, or the beginning of the actual work on the Premises, whichever occurs first. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;In the event of any damage which affects the Premises or the Building outside the boundaries of the Premises,
Landlord will, within thirty (30)&nbsp;days following the date of the damage, deliver to Tenant an estimate of the time necessary to repair the damage In question such that the Premises may be used by and accessible to Tenant and the Building and
Common </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Areas; such notice will be based upon the review and opinions of Landlord&#146;s architect and contractor (&#147;Landlord&#146;s Repair Notice&#148;). If the Premises are damaged by fire or other
casualty and are rendered not reasonably usable for Tenant&#146;s business purposes thereby, or if the Building shall be so damaged that Tenant shall be deprived of reasonable access to the Premises, and if, pursuant to Landlord&#146;s Repair
Notice, the restoration shall not be substantially completed on or before the date which shall be nine (9)&nbsp;months following the date of such damage or destruction, Tenant shall have the right to terminate this Lease (with respect to the
affected Floors only, or the entire Premises, at Tenant&#146;s option) by giving written notice (the &#147;Termination Notice&#148;) to Landlord not later than thirty (30)&nbsp;days following receipt of Landlord&#146;s Repair Notice. If Tenant gives
a Termination Notice, this Lease shall be deemed cancelled and terminated as of the date of the damage as if such date were the Expiration Date, and Rent shall be apportioned and shall be paid or refunded, as the case may be up to and including the
date of such damage or destruction. Notwithstanding the foregoing, if Tenant was entitled to but elected not to exercise its right to terminate this Lease and Landlord does not substantially complete the repair and restoration of the Premises within
two (2)&nbsp;months after the expiration of the estimated period of time set forth in Landlord&#146;s Repair Notice, which period shall be extended to the extent of any delays caused by Tenant, then Tenant may terminate this Lease by written notice
to Landlord within thirty (30)&nbsp;days after the expiration of such period, as the same may be so extended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.7&nbsp;&nbsp;&nbsp;&nbsp;<B>Hazardous Substance Conditions</B>. If a Hazardous Substance Condition occurs, unless Tenant is legally
responsible therefor (in which case Tenant shall make the investigation and remediation thereof required by Applicable Requirements and this Lease shall continue in full force and effect, but subject to Landlord&#146;s rights under Paragraph 6.2(c)
and Paragraph 13), Landlord may at Landlord&#146;s option either (i)&nbsp;investigate and remediate such Hazardous Substance Condition, if required, as soon as reasonably possible at Landlord&#146;s expense, in which event this Lease shall continue
in full force and effect, or (ii)&nbsp;if the estimated cost to investigate and remediate such condition exceeds twelve (12)&nbsp;times the then monthly Base Rent or $50,000, whichever is greater, give written notice to Tenant within thirty
(30)&nbsp;days after receipt by Landlord of knowledge of the occurrence of such Hazardous Substance Condition of Landlord&#146;s desire to terminate this Lease as of the date sixty (60)&nbsp;days following the date of such notice. In the event
Landlord elects to give such notice of Landlord&#146;s intention to terminate this Lease, Tenant shall have the right within ten (10)&nbsp;days after receipt of such notice to give written notice to Landlord of Tenant&#146;s commitment to pay for
the excess costs of (a)&nbsp;Investigation and remediation of such Hazardous Substance Condition to the extent required by Applicable Requirements, over (B)&nbsp;an amount equal to twelve (12)&nbsp;times the then monthly Base Rent or $50,000
whichever is greater. Tenant shall provide Landlord with the funds required of Tenant or satisfactory assurance thereof within thirty (30)&nbsp;days following said commitment by Tenant. In such event this Lease shall continue in full force and
effect, and Landlord shall proceed to make such investigation and remediation as soon as reasonably possible after the required funds are available. If Tenant does not give such notice and provide the required funds or assurance thereof within the
time period specified above, this Lease shall terminate as of the date specified in Landlord&#146;s notice of termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.8&nbsp;&nbsp;&nbsp;&nbsp;<B>Termination - Advance Payments</B>. Upon termination of this Lease pursuant to this Paragraph 9, Landlord shall
return to Tenant any advance payment made by Tenant to Landlord and so much of Tenant&#146;s Security Deposit as has not been, or is not then required to be, used by Landlord under the terms of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.9&nbsp;&nbsp;&nbsp;&nbsp;<B>Waiver of Statutes</B>. Landlord and Tenant agree that the terms of this Lease shall govern the effect of any
damage to or destruction of the Premises and the Building with respect to the termination of this Lease and hereby waive the provisions of any present or future statute to the extent it is inconsistent herewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<B>Real Property Taxes</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Payment of Taxes</B>. Landlord shall pay the Real Property Taxes, as defined in Paragraph 10.2, applicable to
the Industrial Center, and except as otherwise provided in Paragraph 10.3, any such amounts shall be included in the calculation of Common Area Operating Expenses in accordance with the provisions of Paragraph 4.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Real Property Tax Definition</B>. As used herein, the term &#147;<B>Real Property Taxes</B>&#148; shall include
any form of real estate tax or assessment, general, special, ordinary or extraordinary, and any license fee, commercial rental tax, improvement bond or bonds, levy or tax (other than inheritance, personal income or estate taxes) imposed upon the
Industrial Center by any authority having the direct or indirect power to tax, including any city, state or federal government, or any school, agricultural, sanitary, fire, street, drainage, or other improvement district thereof, levied against any
legal or equitable interest of Landlord in the Industrial Center or any portion thereof, Landlord&#146;s right to rent or other income therefrom, and/or Landlord&#146;s business of leasing the Premises. The term &#147;<B>Real Property
Taxes</B>&#148; shall also include any tax, fee, levy, assessment or charge, or any increase therein, imposed by reason of events occurring, or changes In Applicable Law taking effect, during the term of this Lease, including but not limited to a
change in the ownership of the Industrial Center or in the improvements thereon, the execution of this Lease, or any modification, amendment or transfer thereof, and whether or not contemplated by the Parties. In calculating Real Property Taxes for
any calendar year, the Real Property Taxes for any real estate tax year shall be included in the calculation of Real Property Taxes for such calendar year based upon the number of days which such calendar year and tax year have in common. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Additional Improvements</B>. Tenant shall pay to Landlord the Common Area Operating Expenses as payable under
Paragraph 4.2, the entirety of any increase in Real Property Taxes if assessed solely by reason of Alterations, Trade Fixtures or Utility Installations placed upon the Premises by Tenant or at Tenant&#146;s request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Joint Assessment</B>. If the Building is not separately assessed, Real Property Taxes allocated to the Building
shall be an equitable proportion of the Real Property Taxes for all of the land and improvements included within the tax parcel assessed or the industrial center, such proportion to be determined by Landlord from the respective valuations assigned
in the assessor&#146;s work sheets or such other information as may be reasonably available. Landlord&#146;s reasonable determination thereof, in good faith, shall be conclusive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.5&nbsp;&nbsp;&nbsp;&nbsp;<B>Tenant&#146;s Property Taxes</B>. Tenant shall pay prior to delinquency all taxes assessed against and levied
upon Tenant-Owned Alterations and Utility Installations, Trade Fixtures, furnishings, equipment and all personal property of Tenant contained in the Premises or stored within the Industrial Center. When possible, Tenant shall cause its Tenant-Owned
Alterations and Utility Installations, Trade Fixtures, furnishings, equipment and all other personal property to be assessed and billed separately from the real property of Landlord. If any of Tenant&#146;s said property shall be assessed with
Landlord&#146;s real property, Tenant shall pay Landlord the taxes attributable to Tenant&#146;s property within ten (10)&nbsp;days after receipt of a written statement setting forth the taxes applicable to Tenant&#146;s property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<B>Utilities</B>. Tenant shall pay directly for all utilities and services supplied to the Premises, including but not limited to
electricity, water, telephone, security, gas, sewer, trash removal and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cleaning of the Premises, together with any taxes thereon. If any such utilities or services are not separately metered to the Premises or separately billed to the Premises, Tenant shall pay to
Landlord a reasonable proportion to be determined by Landlord of all such charges jointly metered or billed with other premises in the Building, in the manner and within the time periods set forth in Paragraph 4.2(d). Landlord shall not be liable to
Tenant for injury, damage, loss of Tenant&#146;s business or profits, from any failure, interruption, rationing or other curtailment in the supply of electric, gas, water or other utilities from whatever cause. Tenant shall not consume water in
excess of that usually furnished or supplied for reasonable and normal drinking and lavatory use in connection with an office environment (as determined by Landlord), without first procuring the written consent of Landlord, which Landlord may
refuse, and in the event of consent, Landlord may have installed a water meter in the Premises to measure the amount of water consumed. The cost of any such meter and of its installation, maintenance and repair shall be paid for by the Tenant, and
Tenant agrees to pay to Landlord promptly upon demand for all such water consumed as shown by said meters, at the rates charged for such services by the local public utility plus any additional expense incurred in keeping account of the water so
consumed. If a separate meter is not installed, the excess cost for such water shall be established by an estimate made by a utility company or electrical engineer hired by Landlord at Tenant&#146;s expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12&nbsp;&nbsp;&nbsp;&nbsp;<B>Assignment and Subletting</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Landlord&#146;s Consent Required</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall not assign this lease, nor any right hereunder, nor sublet the premises, nor any part thereof, without
the prior written consent of Landlord which will not be unreasonably withheld, conditioned or delayed. In exercising its reasonable discretion Landlord may consider all commercially relevant factors involved in the leasing of the Premises including
but not limited to the a) the creditworthiness and financial stability of the prospective assignee or subtenant (as compared to the obligations of such entity under the sublease or assignment, as the case may be); b) references of prior Landlords;
c) the past history of such subtenant, with respect to involvement in litigation and bankruptcy proceedings; d) the impact of said subtenant or assignee and proposed use of the premises on pedestrian and vehicular traffic, other tenants, and
parking; e) the use, generation or disposal of hazardous materials. The presence of one negative factor enumerated above if material, shall be deemed reasonable justification for Landlord&#146;s withholding consent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;A change in the control of Tenant shall constitute an assignment requiring Landlord&#146;s consent. The transfer
of forty-nine percent (49%)&nbsp;or more of the voting control of Tenant shall constitute a change in control for this purpose. An initial public offering of Tenant&#146;s stock on a recognized exchange, as well as the subsequent transfer of shares
of Tenant&#146;s stock on a public exchange, will not, however, be deemed an assignment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;So long as Tenant is
not entering into the Permitted Transfer for the purpose of avoiding or otherwise circumventing the remaining terms of this Article 12, Tenant may assign its entire interest under this Lease, without the consent of Landlord, to (i)&nbsp;an
affiliate, subsidiary, or parent of Tenant, or a corporation, partnership or other legal entity wholly owned by Tenant (collectively, an &#147;Affiliated Party&#148;), or (ii)&nbsp;a successor to Tenant by purchase, merger, consolidation or
reorganization, provided that all of the following conditions are satisfied (each such Transfer a &#147;Permitted Transfer&#148;): (1)&nbsp;Tenant is not in default under this Lease; (2)&nbsp;Tenant shall give Landlord written notice prior to the
effective date of the proposed Permitted Transfer; and (3)&nbsp;with respect to a purchase, merger, consolidation or reorganization or any Permitted Transfer which results in Tenant ceasing to exist as a separate legal entity, (a)&nbsp;Tenant&#146;s
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
successor shall own all or substantially all of the assets of Tenant, and (b)&nbsp;Tenant&#146;s successor shall have a net worth which is at least equal to the greater of Tenant&#146;s net worth
at the date of this Lease or Tenant&#146;s net worth as of the day prior to the proposed purchase, merger, consolidation or reorganization. If requested by Landlord, Tenant&#146;s successor shall sign a commercially reasonable form of assumption
agreement. As used herein, (A)&nbsp;&#147;parent&#148; shall mean a company which owns a majority of Tenant&#146;s voting equity; (B)&nbsp;&#147;subsidiary&#148; shall mean an entity wholly owned by Tenant or at least 51% of whose voting equity is
owned by Tenant; and (C)&nbsp;&#147;affiliate&#148; shall mean an entity controlled by, controlling or under common control with Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;An assignment or subletting of Tenant&#146;s interest in this Lease without Landlord&#146;s specific prior written
consent shall, at Landlord&#146;s option, be a Default curable after notice per Paragraph 13.1, or a non-curable Breach without the necessity of any notice and grace period. If Landlord elects to treat such unconsented to assignment or subletting as
a non-curable Breach, Landlord shall have the right to either: (i)&nbsp;terminate this Lease, or (ii)&nbsp;upon thirty (30)&nbsp;days&#146; written notice (&#147;<B>Landlord&#146;s Notice</B>&#148;), increase the monthly Base Rent for the Premises
to the greater of the then fair market rental value of the Premises, as reasonably determined by Landlord, or one hundred ten percent (110%)&nbsp;of the Base Rent then in effect. Pending determination of the new fair market rental value, if disputed
by Tenant, Tenant shall pay the amount set forth in Landlord&#146;s Notice, with any overpayment credited against the next installment(s) of Base Rent coming due, and any underpayment for the period retroactively to the effective date of the
adjustment being due and payable immediately upon the determination thereof. Further, in the event of such Breach and rental adjustment, (i)&nbsp;the purchase price of any option to purchase the Premises held by Tenant shall be subject to similar
adjustment to the then fair market value as reasonably determined by Landlord (without the Lease being considered an encumbrance or any deduction for depreciation or obsolescence, and considering the Premises at its highest and best use and in good
condition) or one hundred ten percent (110%)&nbsp;of the price previously in effect,(ii) any Index-oriented rental or price adjustment formulas contained in this Lease shall be adjusted to require that the base index be determined with reference to
the index applicable to the time of such adjustment, and (iii)&nbsp;any fixed rental adjustments scheduled during the remainder of the Lease term shall be increased in the same ratio as the new rental bears to the Base Rent in effect immediately
prior to the adjustment specified in Landlord&#146;s Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Tenant&#146;s remedy for any breach of this
Paragraph 12.1 by Landlord shall be limited to compensatory damages and/or injunctive relief. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Terms and
Conditions Applicable to Assignment and Subletting</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Landlord will respond to any request for consent to an
assignment or sublease within fifteen (15)&nbsp;days following receipt of such request. If Landlord fails to timely deliver to Tenant notice of Landlord&#146;s consent, or the withholding of consent, to a proposed Transfer, Tenant may send a second
(2nd)&nbsp;notice to Landlord, which notice must contain the following inscription, in bold faced lettering: <B>&#147;SECOND NOTICE DELIVERED PURSUANT TO ARTICLE 12 OF LEASE&middot;&#151; FAILURE TO TIMELY RESPOND WITHIN FIVE (5)&nbsp;BUSINESS DAYS
SHALL RESULT IN DEEMED APPROVAL OF ASSIGNMENT OR SUBLEASE</B>.<B>&#148; </B>If Landlord falls to deliver notice of Landlord&#146;s consent to, or the withholding of Landlord&#146;s consent, to the proposed assignment or sublease within such five
(5)&nbsp;business day period, Landlord shall be deemed to have approved the assignment or sublease in question. If Landlord at any time timely delivers notice to Tenant or Landlord&#146;s withholding of consent to a proposed assignment or sublease,
Landlord shall specify in reasonable detail in such notice, the basis for such withholding of consent. Regardless of Landlord&#146;s consent, any assignment or subletting shall not (i)&nbsp;be effective without the express written assumption by such
assignee or subtenant of the obligations of Tenant under this Lease, (ii)&nbsp;release Tenant of any obligations hereunder, nor (iii)&nbsp;alter the primary liability of Tenant for the payment of Base Rent and other sums due Landlord hereunder or
for the performance of any other obligations to be performed by Tenant under this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Landlord may accept any rent or performance of Tenant&#146;s
obligations from any person other than Tenant pending approval or disapproval of an assignment. Neither a delay in the approval or disapproval of such assignment nor the acceptance of any rent for performance shall constitute a waiver or estoppel of
Landlord&#146;s right to exercise its remedies for the Default or Breach by Tenant of any of the terms, covenants or conditions of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;The consent of Landlord to any assignment or subletting shall not constitute a consent to any subsequent assignment
or subletting by Tenant or to any subsequent or successive assignment or subletting by the assignee or subtenant. However, Landlord may consent to subsequent or successive assignment or subletting by the assignee or subtenant. However, Landlord may
consent to subsequent sublettings and assignments of the sublease or any amendments or modifications thereto without notifying Tenant or anyone else liable under this Lease or the sublease and without obtaining their consent; provided, however, that
if Landlord consents to a subsequent amendment of this Lease with an assignee of Tenant, which amendment increases the obligations or liability of the &#147;tenant&#148; hereunder, the original Tenant shall not be liable for such increased
obligations unless the original Tenant consented to such amendment in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;In the event of any Default or
Breach of Tenant&#146;s obligation under this Lease, Landlord may proceed directly against Tenant, any guarantors or anyone else responsible for the performance of the Tenant&#146;s obligations under this Lease, including any subtenant, without
first exhausting Landlord&#146;s remedies against any other person or entity responsible therefor to Landlord, or any security held by Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Each request for consent to an assignment or subletting shall be in writing, accompanied by information relevant to
Landlord&#146;s determination as to the financial and operational responsibility and appropriateness of the proposed assignee or subtenant, including but not limited to the intended use and/or required modification of the Premises, if any, together
with a non-refundable deposit of $1,000, as reasonable consideration for Landlord&#146;s considering and processing the request for consent. Tenant agrees to provide Landlord with such other or additional information and/or documentation as may be
reasonably requested by Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;Any assignee of, or subtenant under, this Lease shall, by reason of
accepting such assignment or entering into such sublease, be deemed, for the benefit of Landlord, to have assumed and agreed to conform and comply with each and every term, covenant, condition and obligation herein to be observed or performed by
Tenant during the term of said assignment or sublease, other than such obligations as are contrary to or inconsistent with provisions of an assignment or sublease to which Landlord has specifically consented in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;If Tenant desires to Sublet substantially the entire Premises for substantially the remainder of the term (other
than pursuant to the Permitted Transfer) or assign the Premises (other than pursuant to a Permitted Transfer) prior to the expiration of the term of this lease and obtains an acceptable subtenant or assignee, then the Landlord shall have the option
prior to the execution of the sublease or assignment agreement to cancel this Lease with respect to the portion of the Premises that is the subject of such proposed assignment or sublease. Landlord, in Landlord&#146;s sole discretion, may then enter
into a new lease with any prospective subtenant as the substitute Tenant. If Landlord exercises this option, then this present lease shall be terminated by mutual agreement as of that time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Additional Terms and Conditions Applicable to Assignment and
Subletting</B>. The following terms and conditions shall apply to any subletting or assignment by Tenant of all or any part of the Premises and shall be deemed included in all subleases and assignments under this Lease whether or not expressly
incorporated therein: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Tenant hereby assigns and transfers to Landlord all of Tenant&#146;s interest in all
rentals, income or other consideration arising from any sublease or assignment of all or a portion of the Premises heretofore or hereafter made by Tenant, and Landlord may collect such sums and apply same toward Tenant&#146;s obligations under this
Lease. Landlord shall not, by reason of the foregoing provision or any other assignment of such sublease to Landlord, nor by reason of the collection of the rents from a subtenant, be deemed liable to the subtenant for any failure of Tenant to
perform and comply with any of Tenant&#146;s obligations to such subtenant under such Sublease. Tenant hereby irrevocably authorizes and directs any such subtenant, upon receipt of a written notice from Landlord, to pay to Landlord the rents and
other charges due and to become due under the sublease. Subtenant shall rely upon any such statement and request from Landlord and shall pay such rents and other charges to Landlord without any obligation or right to inquire as to whether any Breach
exists and notwithstanding any notice from or claim from Tenant to the contrary. Tenant shall have no right or claim against such subtenant, or, until the Breach has been cured, against Landlord, for any such rents and other charges so paid by said
subtenant to Landlord. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event of a Breach by Tenant in the performance of its obligations under this
Lease, Landlord, at its option and without any obligation to do so, may require any subtenant to attorn to Landlord, in which event Landlord shall undertake the obligations of the sub Landlord under such sublease from the time of the exercise of
said option to the expiration of such sublease; provided, however, Landlord shall not be liable for any prepaid rents or security deposit paid by such subtenant to such sub Landlord or for any other prior defaults or breaches of such sub Landlord
under such sublease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Any matter or thing requiring the consent of the sub Landlord under a sublease shall also
require the consent of Landlord herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;No subtenant under a sublease or assignee approved by Landlord shall
further assign or sublet all or any part of the Premises without Landlord&#146;s prior written consent, not to be unreasonably withheld, conditioned or delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Landlord shall deliver a copy of any notice of Default or Breach by Tenant to the subtenant, who shall have the
right to cure the Default of Tenant within the grace period, if any, specified in such notice. The subtenant shall have a right of reimbursement and offset from and against Tenant for any such Defaults cured by the subtenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<B>Default; Breach; Remedies</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Default; Breach</B>. Landlord and Tenant agree that if any attorney is consulted by Landlord in connection with
a Tenant Default or Breach (as hereinafter defined), $350.00 is a reasonable minimum sum per such occurrence for legal services and costs in the preparation and service of a notice of Default, and that Landlord may include the cost of such services
and costs in said notice as rent due and payable to cure said default. A &#147;<B>Default</B>&#148; by Tenant is defined as a failure by Tenant to observe, comply with or perform any of the terms, covenants, conditions or rules applicable to Tenant
under this Lease. A &#147;<B>Breach</B>&#148; by Tenant is defined as the occurrence of any one or more of the following Defaults, and, where a grace period for cure after notice is specified herein, the failure by Tenant to cure such Default prior
to the expiration of the applicable grace period, and shall entitle Landlord to pursue the remedies set forth in Paragraphs 13.2 and/or 13.3. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The vacating of the Premises, or the abandonment of the Premises
without paying the Rent due hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly otherwise provided in this Lease, the failure by
Tenant to make any payment of Base Rent, Tenant&#146;s Share of Common Area Operating Expenses, or any other monetary payment required to be made by Tenant hereunder as and when due, the failure by Tenant to provide Landlord with reasonable evidence
of insurance or surety bond required under this Lease, or the failure of Tenant to fulfill any obligation under this Lease which endangers or threatens life or property, where such failure continues for a period of five (5)&nbsp;days following
written notice thereof by or on behalf of Landlord to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as expressly otherwise provided In this
Lease, the failure by Tenant to provide Landlord with reasonable written evidence (in duly executed original form, if applicable) of (i)&nbsp;compliance with Applicable Requirements per Paragraph 6.3, (ii)&nbsp;the inspection, maintenance and
service contracts required under Paragraph 7.1(b), (iii)&nbsp;the rescission of an unauthorized assignment or subletting per Paragraph 12.1, (iv)&nbsp;a Tenancy Statement per Paragraphs 16 or 37, (v)&nbsp;the subordination or non-subordination of
this lease per Paragraph 30, (vi)&nbsp;the guaranty of the performance of Tenant&#146;s obligations under this Lease if required under Paragraphs 1.11 and 37, (vii)&nbsp;the execution of any document requested under Paragraph 42 (easements), or
(viii)&nbsp;any other documentation or information which Landlord may reasonably require of Tenant under the terms of this Lease, where any such failure continues for a period of ten (10)&nbsp;days following written notice by or on behalf of
Landlord to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;A Default by Tenant as to the terms covenants, conditions or provisions of this Lease, or
of the rules adopted under Paragraph 40 hereof that are to be observed, complied with or performed by Tenant, other than those described in Subparagraphs 13.1(a), (b), or (c),above, where such Default continues for a period of thirty (30)&nbsp;days
after written notice thereof by or on behalf of Landlord to Tenant; provided however, that if the nature of Tenant&#146;s Default is such that more than thirty (30)&nbsp;days are reasonably required for its cure, then it shall not be deemed to be a
Breach of this Lease by Tenant if Tenant commences such cure within said thirty (30)&nbsp;day period and thereafter diligently prosecutes such cure to completion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The occurrence of any of the following events: (i)&nbsp;the making by Tenant of any general arrangement or
assignment for the benefit of creditors;(ii) Tenant&#146;s becoming a &#147;debtor&#148; as defined in 11 U.S. Code Section&nbsp;101 or any successor statute thereto (unless, in the case of a petition filed against Tenant, the same is dismissed
within sixty (60)&nbsp;days); (iii)&nbsp;the appointment of a trustee or receiver to take possession of substantially all of Tenant&#146;s assets located at the Premises or of Tenant&#146;s interest in this Lease, where possession is not restored to
Tenant within thirty (30)&nbsp;days; or (iv)&nbsp;the attachment, execution or other judicial seizure of substantially all of Tenant&#146;s assets located at the Premises or of Tenant&#146;s interest in this Lease, where such seizure is not
discharged within thirty (30)&nbsp;days; provided, however, in the event that any provision of this Subparagraph 13.1(e} is contrary to any applicable law, such provision shall be of no force or effect, and shall not affect the validity of the
remaining provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;The discovery by Landlord that any financial statement of Tenant or of any Guarantor,
given to Landlord by Tenant or any Guarantor, was materially false. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;If the performance of Tenant&#146;s
obligations under this Lease is guaranteed: (i)&nbsp;the death of a Guarantor, (ii)&nbsp;the termination of a Guarantor&#146;s liability with respect </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to this Lease other than in accordance with the terms of such guaranty, (iii)&nbsp;a Guarantor&#146;s becoming insolvent or the subject of a bankruptcy filing, (iv)&nbsp;a Guarantor&#146;s
refusal to honor the guaranty, or (v)&nbsp;a Guarantor&#146;s breach of its guaranty obligation on an anticipatory breach basis, and Tenant&#146;s failure, within sixty (60)&nbsp;days following written notice by or on behalf of Landlord to Tenant of
any such event, to provide Landlord with written alternative assurances of security, which, when coupled with the then existing resources of Tenant, equals or exceeds the combined financial resources of Tenant and the Guarantors that existed at the
time of the execution of this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Remedies</B>. If Tenant falls to commence to perform any affirmative
duty or obligation of Tenant under this Lease, within ten (10)&nbsp;business days after written notice to Tenant (or in case of an emergency, without notice), Landlord may at its option (but without obligation to do so), perform such duty or
obligation on Tenant&#146;s behalf, including but not limited to the obtaining of reasonably required bonds, insurance policies, or governmental licenses, permits or approvals. The costs and expenses of any such performance by Landlord shall be due
and payable by Tenant to Landlord upon invoice therefor. If any check given to Landlord by Tenant shall not be honored by the bank upon which it is drawn, Landlord, at its own option, may require all future payments to be made under this Lease by
Tenant to be made only by cashier&#146;s check. In the event of a Breach of this Lease by Tenant (as defined in Paragraph 13.1), with or without further notice or demand, and without limiting Landlord in the exercise of any right or remedy which
Landlord may have by reason of such Breach, Landlord may: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Terminate Tenant&#146;s right to possession of the
Premises by any lawful means, in which case this Lease and the term hereof shall terminate and Tenant shall immediately surrender possession of the Premises to Landlord. In such event Landlord shall be entitled to recover from Tenant: (i)&nbsp;the
worth at the time of the award of the unpaid rent which had been earned at the time of termination; (ii)&nbsp;the worth at the time of award of the amount by which the unpaid rent which would have been earned after termination until the time of
award exceeds the amount of such rental loss that the Tenant proves could have been reasonably avoided; (iii)&nbsp;the worth at the time of award of the amount by which the unpaid rent for the balance of the term after the time of award exceeds the
amount of such rental loss that the Tenant proves could be reasonably avoided; and (iv)&nbsp;any other amount necessary to compensate Landlord for all the detriment proximately caused by the Tenant&#146;s failure to perform its obligations under
this Lease or which in the ordinary course of things would be likely to result therefrom, including but not limited to the cost of recovering possession of the Premises, expenses of reletting, including necessary renovation and alteration of the
Premises, reasonable attorneys&#146; fees, and that portion of any leasing commission paid by Landlord in connection with this Lease applicable to the unexpired term of this Lease. The worth at the time of award of the amount referred to in
provision (iii)&nbsp;of the immediately preceding sentence shall be computed by discounting such amount at the discount rate of the Federal Reserve Bank of San Francisco or the Federal Reserve Bank District in which the Premises are located at the
time of award plus one percent (1%). Efforts by Landlord to mitigate damages caused by Tenant&#146;s Default or Breach of this Lease shall not waive Landlord&#146;s right to recover damages under this Paragraph 13.2. If termination of this Lease is
obtained through the provisional remedy of unlawful detainer, Landlord shall have the right to recover in such proceeding the unpaid rent and damages as are recoverable therein, or Landlord may reserve the right to recover all or any part thereof in
a separate suit for such rent and/or damages. If a notice and grace period required under Subparagraph 13.1 (b), (c)&nbsp;or (d)&nbsp;was not previously given, a notice to pay rent or quit, or to perform or quit, as the case may be, given to Tenant
under any statute authorizing the forfeiture of leases for unlawful detainer shall also constitute the applicable notice for grace period purposes required by Subparagraph 13.1 (b), (c)&nbsp;or (d). In such case, the applicable grace period under
the unlawful detainer statue shall run concurrently after </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the one such statutory notice, and the failure of Tenant to cure the Default within the greater of the two (2)&nbsp;such grace periods shall constitute both an unlawful detainer and a Breach of
this Lease entitling Landlord to the remedies provided for in this Lease and/or by said statute. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Continue the
Lease and Tenant&#146;s right to possession in effect (in California under California Civil Code Section&nbsp;1951.4) after Tenant&#146;s Breach and recover the rent as It becomes due, provided Tenant has the right to sublet or assign, subject only
to reasonably limitations. Landlord and Tenant agree that the limitations on assignment and subletting in this Lease are reasonable. Acts of maintenance or preservation, efforts to relet the Premises, or the appointment of a receiver to protect the
Landlord&#146;s interest under this Lease, shall not constitute a termination of the Tenant&#146;s right to possession. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Pursue any other remedy now or hereafter available to Landlord under the laws or judicial decisions of the state
wherein the Premises are located. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The expiration or termination of this Lease and/or the termination of
Tenant&#146;s right to possession shall not relieve Tenant from liability under any indemnity provisions of this Lease as to matters occurring or accruing during the term hereof or by reason of Tenant&#146;s occupancy of the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.3&nbsp;&nbsp;&nbsp;&nbsp;<B>[INTENTIONALLY OMITTED]</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Late Charges</B>. Tenant hereby acknowledges that late payment by Tenant to Landlord of rent and other sums due
hereunder will cause Landlord to incur costs not contemplated by this Lease, the exact amount of which will be extremely difficult to ascertain. Such costs include, but are not limited to, processing and accounting charges, and late charges which
may be imposed upon Landlord by the terms of any ground lease, mortgage or deed of trust covering the Premises. Accordingly, if any installment of rent or other sum due from Tenant shall not be received by Landlord or Landlord&#146;s designee within
five (5)&nbsp;days after such amount shall be due (that provided, however that Tenant shall be entitled to notice, prior to the commencement of such five (5)&nbsp;day period, on the first (1st)&nbsp;occasion in any calendar year on which Tenant
fails to timely pay an amount due hereunder), then, without any requirement for notice to Tenant, Tenant shall pay to Landlord a late charge equal to ten percent (10%)&nbsp;of such overdue amount. The parties hereby agree that such late charge
represents a fair and reasonable estimate of the costs Landlord will incur by reason of late payment by Tenant. Acceptance of such late charge be Landlord shall in no event constitute a waiver of Tenant&#146;s Default or Breach with respect to such
overdue amount, nor prevent Landlord from exercising any of the other rights and remedies granted hereunder. In the event that a late charge is payable hereunder, whether or not collected, for three (3)&nbsp;consecutive installments of Base Rent,
then notwithstanding Paragraph 4.1 or any other provision of this Lease to the contrary, Base Rent shall, at Landlord&#146;s option, become due and payable quarterly in advance; provided, however, that if Tenant subsequently pays such quarterly Base
Rent in a timely fashion for four (4)&nbsp;consecutive calendar quarters, Rent shall thereafter be payable on a monthly basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Breach by Landlord</B>. Landlord shall not be deemed in breach of this Lease unless Landlord fails within a
reasonable time to perform an obligation required to be performed by Landlord. For purposes of this Paragraph 13.5, a reasonable time shall in no event be less than thirty (30)&nbsp;days after receipt by Landlord, and by any Lender(s) whose name and
address shall have been furnished to Tenant in writing for such purpose, of written notice specifying wherein such obligation of Landlord has not been performed; provided, however, that if the nature of Landlord&#146;s obligation is such that more
than thirty (30)&nbsp;days after such notice are reasonably required for its performance, then Landlord shall not be in breach of this Lease if performance is commenced within such thirty (30)&nbsp;day period and thereafter diligently pursued to
completion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14</B>.&nbsp;&nbsp;&nbsp;&nbsp;<B>Condemnation</B>. If the Premises or any portion thereof are taken under the
power of eminent domain or sold under the threat of the exercise of said power (all of which are herein called &#147;condemnation&#148;), this Lease shall terminate as to the part so taken as of the date the condemning authority takes title or
possession, whichever first occurs. If more than twenty five percent (25%)&nbsp;of the floor area of the Premises, or more than twenty-five percent (25%)&nbsp;of the portion of the Common Areas designated for Tenant&#146;s parking, is taken by
condemnation, Tenant may, at Tenant&#146;s option, to be exercised in writing within ten (10)&nbsp;days after Landlord shall have given Tenant written notice of such taking (or in the absence of such notice, within ten (10)&nbsp;days after the
condemning authority shall have taken possession) terminate this Lease as of the date the condemning authority takes such possession. If Tenant does not terminate this Lease In accordance with the foregoing, this Lease shall remain in full force and
effect as to the portion of the Premises remaining, except that the Base Rent shall be reduced in the same proportion as the rentable floor area of the Premises taken bears to the total rentable floor area of the Premises. No reduction of the Base
Rent shall occur if the condemnation does not apply to any portion of the Premises. Any award for the taking of all or any part of the Premises under the power of eminent domain or any payment made under threat of the exercise of such power shall be
the property of Landlord, whether such award shall be made as compensation for diminution of value of the leasehold or for the taking of the fee, or as severance damages; provided, however, that Tenant shall be entitled to any compensation,
separately awarded to Tenant for Tenant&#146;s relocation expenses and/or loss of Tenant&#146;s Trade Fixtures. In the event that this Lease is not terminated by reason of such condemnation, Landlord shall to the extent of its net severance damages
received, over and above Tenant&#146;s Share of the legal and other expenses incurred by Landlord in the condemnation matter, repair any damage to the Premises caused by such condemnation authority. Tenant shall be responsible for the payment of any
amount in excess of such net severance damages required to complete such repair. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15</B>.&nbsp;&nbsp;&nbsp;&nbsp;<B>Broker&#146;s Fees</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Procuring Cause</B>. The Broker(s) named in Paragraph 1.10 is/are the procuring cause of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Additional Terms</B>. Unless Landlord and Broker(s) have otherwise agreed in writing, Landlord agrees that:
(a)&nbsp;if Tenant exercises any Option (as defined in Paragraph 39.1) granted under this Lease or any Option subsequently granted, or (b)&nbsp;If Tenant acquires any rights to the Premises or other premises in which Landlord has an interest, or
(c)&nbsp;If Tenant remains in possession of the Premises with the consent of Landlord after the expiration of the term of this Lease after having failed to exercise an Option, or (d)&nbsp;if said Brokers are the procuring cause of any other lease or
sale entered into between the Parties pertaining to the Premises and/or any adjacent property in which Landlord has an interest, or (e)&nbsp;if Base Rent is increased, whether by agreement or operation of an escalation clause herein, then as to any
of said transactions, Landlord shall not be liable to said Broker(s) to pay a fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Assumption of
Obligations</B>. Any buyer or transferee of Landlord&#146;s interest in this Lease, whether such transfer is by agreement or by operation of law, shall be deemed to have assumed Landlord&#146;s obligation under this Paragraph 15. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Representations and Warranties</B>. Tenant and Landlord each represent and warrant to the other that it has had
no dealings with any person, firm, broker or finder other than as named in Paragraph 1.10(a) in connection with the negotiation of this Lease and/or the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consummation of the transaction contemplated hereby, and that no broker or other person, firm or entity other than said named Broker(s) is entitled to any commission or finder&#146;s fee in
connection with said transaction. Tenant and Landlord do each hereby agree to indemnify, protect, defend and hold the other harmless from and against liability for compensation or charges which may be claimed by any such unnamed broker, finder or
other similar party by reason of any dealings or actions of the indemnifying Party, including any costs, expenses, and/or attorneys&#146; fees reasonably incurred with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16.&nbsp;&nbsp;&nbsp;&nbsp;Tenancy and Financial Statements</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Tenancy Statement</B>. Each Party (as &#147;<B>Responding Party</B>&#148;) shall within ten (10)&nbsp;business
days after written notice from the other Party (the &#147;<B>Requesting Party</B>&#148;) execute, acknowledge and deliver to the Requesting Party a statement In writing in a form similar to the then most current &#147;<B>Tenancy Statement</B>&#148;
form published by the American Industrial Real Estate Association, plus such additional information, confirmation and/or statements as may be reasonably requested by the Requesting Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Financial Statement</B>. If Landlord desires to finance, refinance, or sell the Premises or the Building, or
any part thereof, Tenant and all the Guarantors shall deliver to any potential lender or purchaser designated by Landlord such financial statements of Tenant and such Guarantors as may be reasonably required by such lender or purchaser, including
but not limited to Tenant&#146;s financial statements for the past three (3)&nbsp;years. All such financial statements shall be received by Landlord and such lender or purchaser in confidence and shall be used only for the purposes herein set forth.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17.&nbsp;&nbsp;&nbsp;&nbsp;Landlord&#146;s Liability</B>. The term &#147;<B>Landlord</B>&#148; as used herein shall mean the owner or owners at the
time in question of the fee title to the Premises. In the event of a transfer of Landlord&#146;s title or interest in the Premises or in this Lease, Landlord shall deliver to the transferee or assignee (in cash or by credit) any unused Security
Deposit held by Landlord at the time of such transfer or assignment. Except as provided in Paragraph 15.3, upon such transfer or assignment and delivery of the Security Deposit, as aforesaid, the prior Landlord shall be relieved of all liability
with respect to the obligations and/or covenants under this Lease thereafter to be performed by Landlord. Subject to the foregoing, the obligations and/or covenants in this Lease to be performed by the Landlord shall be binding only upon the
Landlord as herein above defined. Notwithstanding any other terms or provisions of this lease, Tenant agrees that in the event of any default or breach by Landlord with respect to any of the terms of the Lease to be observed and performed by
Landlord (a)&nbsp;Tenant shall look solely to the estate and property (which is the subject of this lease) of Landlord or any successor in interest in the property (which shall be deemed to include the rental income, the proceeds of any sale by
Landlord as well as any insurance or condemnation proceeds), for the satisfaction of Tenant&#146;s remedies for the collection of a judgment (or other judicial process) requiring the payment of money by Landlord; (b)&nbsp;no other property or assets
of Landlord, its partners, members, shareholders, officers or any successor in interest shall be subject to levy, execution or other enforcement procedure for the satisfaction if Tenant&#146;s remedies; (c)&nbsp;no personal liability shall at any
time be asserted or enforceable against Landlord, it&#146;s partner&#146;s, members or successors in interest (except to the extent permitted in (a)&nbsp;above), and no judgment will be taken against any partner, member, shareholder, officer or
director of Landlord. The provisions of this section shall apply only to the Landlord and the parties herein described, and shall not be for the benefit of any insurer nor any other third party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18.&nbsp;&nbsp;&nbsp;&nbsp;Severability</B>. The invalidity of any provision of this Lease, as determined by a court of competent jurisdiction, shall in no
way affect the validity of any other provision hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19.&nbsp;&nbsp;&nbsp;&nbsp;Interest on Past-Due Obligations</B>. Any monetary payment due Landlord hereunder,
other than late charges, not received by Landlord within ten (10)&nbsp;days following the date on which it was due, shall bear interest from the date due at the prime rate charged by the largest state chartered bank in the state in which the
Premises are located plus four percent (4%)&nbsp;per annum, but not exceeding the maximum rate allowed by law, in addition to the potential late charge provided for in Paragraph 13.4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20.&nbsp;&nbsp;&nbsp;&nbsp;Time of Essence</B>. Time is of the essence with respect to the performance of all obligations to be performed or observed by
the Parties under this Lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>21.&nbsp;&nbsp;&nbsp;&nbsp;Rent Defined</B>. All monetary obligations of Tenant to Landlord under the terms of this
Lease are deemed to be rent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>22.&nbsp;&nbsp;&nbsp;&nbsp;No Prior or other Agreements; Broker Disclaimer</B>. This Lease contains all agreements
between the Parties with respect to any matter mentioned herein, and no other prior or contemporaneous agreement or understanding shall be effective. Landlord and Tenant each represents and warrants to the Brokers that it has made, and is relying
solely upon, its own investigation as to the nature, quality, character and financial responsibility of the other Party to this Lease and as to the nature, quality and character of the Premises. Brokers have no responsibility with respect thereto or
with respect to any default or breach hereof by either Party. Each Broker shall be an intended third party beneficiary of the provisions of this Paragraph 22. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>23.&nbsp;&nbsp;&nbsp;&nbsp;Notices</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Notice Requirements</B>. All notices required or permitted by this Lease shall be in writing and may be
delivered in person (by hand or by messenger or courier service) or may be sent by regular, certified or registered mail or U.S. Postal Service Express Mail, with postage prepaid, and shall be deemed sufficiently given if served in a manner
specified in this Paragraph 23. The addresses noted adjacent to a Party&#146;s signature on this Lease shall be that Party&#146;s address for delivery or mailing of notice purposes. Either Party may by written notice to the other specify a different
address for notice purposes. A copy of all notices required or permitted to be given to Landlord hereunder shall be concurrently transmitted to such party or parties at such addresses as Landlord may from time to time hereafter designate by written
notice to Tenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Date of Notice</B>. Any notice sent by registered or certified mall, return receipt
requested, shall be deemed given on the date of delivery shown on the receipt card, or if no delivery date is shown, the postmark thereon. If sent by regular mail the notice shall be deemed given three (3)&nbsp;business days after the same is
addressed as required herein and mailed with postage prepaid. Notices delivered by United States Express Mail or overnight courier that guarantees next day delivery shall be deemed given twenty-four (24)&nbsp;hours after delivery of the same to the
United States Postal Service or courier. If notice is received or otherwise deemed delivered on a Saturday or a Sunday or a legal holiday, it shall be deemed received on the next business day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>24.&nbsp;&nbsp;&nbsp;&nbsp;Waivers</B>. No waiver by a party of the Default or Breach of any term covenant or condition hereof by the other, shall be
deemed a waiver of any other term, covenant or condition hereof, or of any subsequent Default or Breach by the other of the same or any other term, covenant or condition hereof. Landlord&#146;s consent to, or approval of, any such act shall not be
deemed to render unnecessary the obtaining of Landlord&#146;s consent to, or approval of, any subsequent or similar act by Tenant, or be construed as the basis of an estoppel to enforce the provision or provisions of this Lease requiring such
consent. Regardless of Landlord&#146;s knowledge of a Default or Breach at the time of accepting rent, the acceptance of rent by Landlord shall not be a waiver </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of any Default or Breach by Tenant of any provision hereof. Any payment given Landlord by Tenant may be accepted by Landlord on account of moneys or damages due Landlord, notwithstanding any
qualifying statements or conditions made by Tenant in connection therewith, which such statements and/or conditions shall be of no force or effect whatsoever unless specifically agreed to in writing by Landlord at or before the time of deposit of
such payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>25.&nbsp;&nbsp;&nbsp;&nbsp;Recording</B>. Either Landlord or Tenant shall, upon request of the other, execute, acknowledge and deliver
to the other a short form memorandum of this Lease for recording purposes. The Party requesting recordation shall be responsible for payment of any fees or taxes applicable thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>26.&nbsp;&nbsp;&nbsp;&nbsp;No Right To Holdover</B>. Tenant has no right to retain possession of the Premises or any part thereof beyond the expiration or
earlier termination of this Lease. In the event that Tenant holds over in violation of this Paragraph 26 then the Base Rent payable from and after the time of the expiration or earlier termination of this Lease shall be increased to one hundred
fifty percent (150%)&nbsp;of the Base Rent applicable during the month immediately preceding such expiration or earlier termination. Nothing contained herein shall be construed as a consent by Landlord to any holding over by Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>27.&nbsp;&nbsp;&nbsp;&nbsp;Cumulative Remedies</B>. No remedy or election hereunder shall be deemed exclusive but shall, wherever possible, be cumulative
with all other remedies at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>28.&nbsp;&nbsp;&nbsp;&nbsp;Covenants and Conditions</B>. All provisions of this Lease to be observed or
performed by Tenant are both covenants and conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>29.&nbsp;&nbsp;&nbsp;&nbsp;Binding Effect; Choice of Law</B>. This Lease shall be binding upon
the Parties, their personal representatives, successors and assigns and be governed by the laws of the State in which the Premises are located. Any litigation between the Parties hereto concerning this Lease shall be initiated in the county in which
the Premises are located. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>30.&nbsp;&nbsp;&nbsp;&nbsp;Subordination; Attornment; Non-Disturbance</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Subordination</B>. This Lease and any Option granted hereby shall be subject and subordinate to any ground
lease, mortgage, deed of trust, or other hypothecation or security device (collectively, &#147;<B>Security Device</B>&#148;), now or hereafter placed by Landlord upon the real property of which the Premises are a part, to any and all advances made
on the security thereof, and to all renewals, modifications, consolidations, replacements and extensions thereof. Tenant agrees that the Lenders holding any such Security Device shall have no duty, liability or obligation to perform any of the
obligations of Landlord under this Lease, but that in the event of Landlord&#146;s default with respect to any such obligation, Tenant will give any Lender whose name and address have been furnished Tenant in writing for such purpose notice of
Landlord&#146;s default pursuant to Paragraph 13.5. If any Lender shall elect to have this Lease and/or any Option granted hereby superior to the lien of its Security Device and shall give written notice thereof to Tenant, this Lease and such
Options shall be deemed prior to such Security Device, notwithstanding the relative dates of the documentation or recordation thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Attornment</B>. Subject to the non-disturbance provisions of Paragraph 30.3, Tenant agrees to attorn to a
Lender or any other party who acquires ownership of the Premises by reason of a foreclosure of a Security Device, and that in the event of such foreclosure, such new owner shall not: (i)&nbsp;be liable for any act or omission of any prior Landlord
or with respect to events occurring prior to acquisition of ownership, (ii)&nbsp;be subject to any offsets or defenses which Tenant might have against any prior Landlord, or (iii)&nbsp;be bound by prepayment of more than one month&#146;s rent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Non-Disturbance</B>. With respect to Security Devices entered into
by Landlord after the execution of this lease, Tenant&#146;s subordination of this Lease shall be subject to receiving assurance (a &#147;non-disturbance agreement&#148;) from the Lender that Tenant&#146;s possession and this Lease, including any
options to extend the term hereof, will not be disturbed so long as Tenant is not in Breach hereof and attorns to the record owner of the Premises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">30.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Self-Executing</B>. The agreements contained in this Paragraph 30 shall be effective without the execution of
any further documents; provided, however, that upon written request from Landlord or a Lender in connection with a sale, financing or refinancing of Premises, Tenant and Landlord shall execute such further writings as may be reasonably required to
separately document any such subordination or non-subordination, attornment and/or non-disturbance agreement as is provided for herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>31.&nbsp;&nbsp;&nbsp;&nbsp;Attorneys&#146; Fees</B>. If any Party brings an action or proceeding to enforce the terms hereof or declare rights hereunder,
the Prevailing Party (as hereafter defined) in any such proceeding, action, or appeal thereon, shall be entitled to reasonable attorneys&#146; fees, costs and expenses. Such fees may be awarded in the same suit or recovered in a separate suit,
whether or not such action or proceeding is pursued to decision or judgment. The term &#147;Prevailing Party&#148; shall include, without limitation, a Party who substantially obtains or defeats the relief sought, as the case may be whether by
compromise, settlement, judgment, or the abandonment by the other Party or Broker of its claim or defense. The attorneys&#146; fee award shall not be computed in accordance with any court fee schedule, but shall be such as to full reimburse all
attorneys&#146; fees, cost and expenses reasonably incurred. Landlord shall be entitled to attorneys&#146; fees, costs and expenses incurred in preparation and service of notices of Default and consultations in connection therewith, whether or not a
legal action is subsequently commenced in connection with such Default or resulting Breach. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>32.&nbsp;&nbsp;&nbsp;&nbsp;Landlord&#146;s Access; Showing
Premises; Repairs</B>. Landlord and Landlord&#146;s agents shall have the right to enter the Premises at any time, in the case of an emergency, and otherwise at reasonable times upon reasonable advance notice to Tenant for the purpose of showing the
same to prospective purchasers, lenders, or (during the final six (6)&nbsp;months of the term) tenants, and make such alterations, repairs, improvements or additions to the Premises or to the Building, as Landlord may reasonably deem necessary
(provided that Tenant shall have the right to require that Landlord be accompanied by a representative of Tenant during any such entry). Landlord shall use best efforts to ensure that the performance of any such work of repairs or alterations shall
not interfere with Tenant&#146;s use of the Premises (or any portion thereof) for Tenant&#146;s business purposes (such efforts to include limiting the performance of any such work which might be disruptive to weekends or the evening and the
cleaning of any work area prior to the commencement of the next business day). Landlord may at any time place on or about the Premises or Building any ordinary &#147;For Sale&#148; signs and Landlord may at any time during the last one hundred
eighty (180)&nbsp;days of the term hereof place on or about the Premises any ordinary &#147;For Lease&#148; signs. All such activities of Landlord shall be without abatement of rent or liability to Tenant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>33.&nbsp;&nbsp;&nbsp;&nbsp;Auctions</B>. Tenant shall not conduct, nor permit to be conducted, either voluntarily or involuntarily, any auction upon the
Premises without first having obtained Landlord&#146;s prior written consent. Notwithstanding anything to the contrary in this Lease, Landlord shall not be obligated to exercise any standard of reasonableness in determining whether to grant such
consent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>34.&nbsp;&nbsp;&nbsp;&nbsp;Signs</B>. Tenant shall not place any sign upon the exterior of the Premises or the
Building, except that Tenant may, with Landlord&#146;s prior written consent, install (but not on the roof) such signs as are reasonably required to advertise Tenant&#146;s own business so long as such signs are in a location designated by Landlord
and comply with Applicable Requirements and the signage criteria established for the Industrial Center by Landlord. The installation of any sign on the Premises by or for Tenant shall be subject to the provisions of Paragraph 7 (Maintenance,
Repairs, Utility Installations, Trade Fixtures and Alterations). Unless otherwise expressly agreed herein, Landlord reserves all rights to the use of the roof of the Building and the right to install advertising signs on the Building, including the
roof, which do not unreasonably interfere with the conduct of Tenant&#146;s business; Landlord shall be entitled to all revenues from such advertising signs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>35.&nbsp;&nbsp;&nbsp;&nbsp;Termination; Merger</B>. Unless specifically stated otherwise in writing by Landlord, the voluntary or other surrender of this
Lease by Tenant, the mutual termination or cancellation hereof, or a termination hereof by Landlord for Breach by Tenant, shall automatically terminate any sublease or lesser estate in the Premises; provided, however, Landlord shall, in the event of
any such surrender, termination or cancellation, have the option to continue any one or all of any existing subtenancies. Landlord&#146;s failure within ten (10)&nbsp;days of following any such event to make a written election to the contrary by
written notice to the holder of any such lesser interest, shall constitute Landlord&#146;s election to have such event constitute the termination of such interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>36.&nbsp;&nbsp;&nbsp;&nbsp;Consents</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except for Paragraph 33 (Auctions) or as otherwise provided herein, wherever in this Lease the consent of a Party
is required to an act by or for the other Party, such consent shall not be unreasonably withheld or delayed. Landlord&#146;s actual reasonable costs and expenses (including but not limited to architects&#146;, attorneys&#146;, engineers&#146; and
other consultants&#146; fees) incurred in the consideration of, or response to, a request by Tenant for any Landlord consent pertaining to this Lease or the Premises, including but not limited to consents to an assignment a subletting or the
presence or use of a Hazardous Substance, shall be paid by Tenant to Landlord upon receipt of an invoice and supporting documentation therefor. In addition to the deposit described in Paragraph 12.2(e), Landlord may, as condition to considering any
such request by Tenant, require that Tenant deposit with Landlord an amount of money (in addition to the Security Deposit held under Paragraph 5) reasonably calculated by Landlord to represent the cost Landlord will incur in considering and
responding to Tenant&#146;s request. Any unused portion of said deposit shall be refunded to Tenant without interest. Landlord&#146;s consent to any act, assignment of this Lease or subletting of the Premises by Tenant shall not constitute an
acknowledgment that no Default or Breach by Tenant of this Lease exists, nor shall such consent be deemed a waiver of any then existing Default or Breach, except as may be otherwise specifically stated In writing by Landlord at the time of such
consent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;All conditions to Landlord&#146;s consent authorized by this Lease are acknowledged by Tenant as
being reasonable. The failure to specify herein any particular condition to Landlord&#146;s consent shall not preclude the impositions by Landlord at the time of consent of such further or other conditions as are then reasonable with reference to
the particular matter for which consent is being given. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>37.&nbsp;&nbsp;&nbsp;&nbsp;[INTENTIONALLY OMITTED]</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>38.&nbsp;&nbsp;&nbsp;&nbsp;Quiet Possession</B>. Upon payment by Tenant of the rent for the Premises and the performance of all of the covenants,
conditions and provisions on Tenant&#146;s part to be observed and performed under this Lease, Tenant shall have quiet possession of the Premises for the entire term hereof subject to all of the provisions of this Lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>39.&nbsp;&nbsp;&nbsp;&nbsp;Options</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39.1&nbsp;&nbsp;&nbsp;&nbsp;<B>Definition</B>. As used in this Lease, the word Option&#148; has the following meaning: (a)&nbsp;the right to
extend the term of this Lease or to renew this Lease or to extend or renew any lease that Tenant has on other property of Landlord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39.2&nbsp;&nbsp;&nbsp;&nbsp;<B>Options Personal to Original Tenant</B>. Each Option granted to Tenant in this Lease is personal to the
original Tenant named in Paragraph 1.1 hereof and any assignee pursuant to a Permitted Transfer, and cannot be voluntarily or involuntarily assigned or exercised by any person or entity other than said original Tenant while the original Tenant is in
full and actual possession of the Premises and without the intention of thereafter assigning or subletting. The Options, if any, herein granted to Tenant are not assignable (other than pursuant to a Permitted Transfer), either as a part of an
assignment of this Lease or separately or apart therefrom, and no Option may be separated from this Lease In any manner, by reservation or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39.3&nbsp;&nbsp;&nbsp;&nbsp;<B>Multiple Options</B>. In the event that Tenant has any multiple Options to extend or renew this Lease, a later
option cannot be exercised unless the prior Options to extend or renew this Lease have been validly exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">39.4&nbsp;&nbsp;&nbsp;&nbsp;<B>Effect of Default on Options</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Tenant shall have no right to exercise an Option, notwithstanding any provision in the grant of Option to the
contrary: (i)&nbsp;during the period commencing with the giving of any notice of Default under Paragraph 13.1 and continuing until the noticed Default is cured, or (ii)&nbsp;during the period of time any monetary obligation due Landlord from Tenant
is unpaid (without regard to whether notice thereof is given Tenant), or (iii)&nbsp;during the time Tenant is in Breach of this Lease, or (iv)&nbsp;in the event that Landlord has given to Tenant three (3)&nbsp;or more notices of separate Defaults
under Paragraph 13.1 during the twelve (12)&nbsp;month period immediately preceding the exercise of the Option, whether or not the Defaults are cured. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The period of time within which an Option may be exercised shall not be extended or enlarged by reason of
Tenant&#146;s inability to exercise an Option because of the provisions of Paragraph 39.4(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;All rights of
Tenant under the provisions of an Option shall terminate and be of no further force or effect, notwithstanding Tenant&#146;s due and timely exercise of the Option, if, after such exercise and during the term of this Lease, (i)&nbsp;Tenant fails to
pay to Landlord a monetary obligation of Tenant for a period of thirty (30)&nbsp;days after such obligation becomes due (without any necessity of Landlord to give notice thereof to Tenant), or (ii)&nbsp;Landlord gives to Tenant three (3)&nbsp;or
more notices of separate Defaults under Paragraph 13.1 during any twelve (12)&nbsp;month period, whether or not the Defaults are cured, or (ii)&nbsp;if Tenant commits a Breach of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>40.&nbsp;&nbsp;&nbsp;&nbsp;Rules and Regulations</B>. Tenant agrees that it will abide by, and keep and observe all reasonable rules and regulations
(&#147;Rules and Regulations) which Landlord may make from time to time for the management, safety, care, and cleanliness of the grounds, the parking and unloading of vehicles and the preservation of good order, as well as for the convenience of
other occupants or tenants of the Building and the Industrial Center and their invitees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>41.&nbsp;&nbsp;&nbsp;&nbsp;Security Measures</B>. Tenant hereby acknowledges that the rental payable to
Landlord hereunder does not include the cost of guard service or other security measures, and that Landlord shall have no obligation whatsoever to provide same. Tenant assumes all responsibility for the protection of the Premises, Tenant, its agents
and invitees and their property from the acts of third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>42.&nbsp;&nbsp;&nbsp;&nbsp;Reservations</B>. Landlord reserves the right, from time to
time, to grant, without the consent or joinder of Tenant, such easements, rights of way, utility raceways, and dedications that Landlord reasonably deems necessary, and to cause the recordation of parcel maps and restrictions, so long as such
easements, rights of way, utility raceways, dedications, maps and restrictions do not reasonably interfere with the use of the Premises by Tenant. Tenant agrees to sign any documents reasonably requested by Landlord to effectuate any such easement
rights, dedication, map or restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>43.&nbsp;&nbsp;&nbsp;&nbsp;Performance Under Protest</B>. If at any time a dispute shall arise as to any
amount or sum of money to be paid by one Party to the other under the provisions hereof, the Party against whom the obligation to pay the money is asserted shall have the right to make payment &#147;under protest&#148; and such payment shall not be
regarded as a voluntary payment and there shall survive the right on the part of said Party to institute suit for recovery of such sum. If it shall be adjudged that there was no legal obligation on the part of said Party to pay such sum or any part
thereof, said Party shall be entitled to recover such sum or so much thereof as it was not legally required to pay under the provisions of this Lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>44.&nbsp;&nbsp;&nbsp;&nbsp;Authority</B>. If either Party hereto is a corporation, trust, limited liability company, or general or limited partnership,
each individual executing this Lease on behalf of such entity represents and warrants that he or she is duly authorized to execute and deliver this Lease on it&#146;s behalf and that such entity is duly authorized and existing and qualified to do
business in California and that Tenant has the full right and legal authority to enter into this lease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>45.&nbsp;&nbsp;&nbsp;&nbsp;Conflict</B>. Any
conflict between the printed provisions of this Lease and the typewritten or handwritten provisions shall be controlled by the typewritten or handwritten provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>46.&nbsp;&nbsp;&nbsp;&nbsp;Offer</B>. Preparation of this Lease by either Landlord or Tenant or Landlord&#146;s agent or Tenant&#146;s agent and submission
of same to Tenant or Landlord shall not be deemed an offer to lease. This Lease is not intended to be binding until executed and delivered by all Parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>47.&nbsp;&nbsp;&nbsp;&nbsp;Amendments</B>. This Lease may be modified only in writing, signed by the parties in interest at the time of the modification.
The Parties shall amend this Lease from time to time to reflect any adjustments that are made to the Base Rent or other rent payable under this Lease. As long as they do not materially change Tenants obligations hereunder, Tenant agrees to make such
reasonable non-monetary modification to this Lease as may be reasonably required by an institutional insurance company or pension plan Lender in connection with the obtaining of normal financing or refinancing of the property of which the Premises
are a part. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>48.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Multiple Parties</B>. Except as otherwise expressly provided herein, if more than one person or entity is named herein as either Landlord or Tenant, the obligations of such multiple parties shall be the joint and
several responsibility of all persons or entities named herein as such Landlord or Tenant. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>49.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE="font-family:Times New Roman; font-size:10pt"><B>Option to Extend</B>. Subject to the terms and conditions set forth below, Tenant may at its option extend the Term of this Lease for One
(1)&nbsp;period of TEN (10)&nbsp;years. Such period is called the &#147;Renewal Term.&#148; The Renewal Term shall be upon the same terms contained </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
in this Lease, except that (i)&nbsp;Landlord shall have no obligation to provide Tenant with any Tenant Improvement Allowance or demolition in connection with the Renewal Term, (ii)&nbsp;the Base
Rental during the Renewal Term shall be calculated as set forth below, and (iii)&nbsp;any reference in the Lease to the &#147;Term&#148; of the Lease shall be deemed to include the Renewal Term and apply thereto, unless it is expressly provided
otherwise. Tenant shall have no additional extension options. The Base Rent during the Renewal Term shall be at the then Fair Market Rate (defined hereinafter) for such space for a term commencing of the first day of the Renewal Term. &#147;Market
Rate&#148; shall mean the then prevailing market rate for a comparable term commencing on the first day of the Renewal Term for tenants of comparable size and creditworthiness for comparable space in the Building and other Office buildings in the
Alameda Area. In no event shall the Base Rent payable during the first (1st)&nbsp;year of the Renewal Term be less than the Base Monthly Rent of January 2025. Base Rent during the Renewal Term shall increase at four percent (4%)&nbsp;per year. To
exercise any option, Tenant must deliver a binding written notice to Landlord not sooner than twelve (12)&nbsp;months nor later than six (6)&nbsp;months prior to the expiration of the Initial Term of this Lease. Thereafter, the Market Rate for the
Renewal Term shall be calculated by Landlord and Landlord shall inform Tenant of the Market Rate. If the parties cannot agree on the Market Rate within thirty (30)&nbsp;days following Landlord&#146;s delivery of a statement of Fair Market Rent, the
parties shall each, within ten (10)&nbsp;business days following the expiration of such thirty (30)&nbsp;day period, appoint a real estate broker (with at least 10 years experience in office leasing in Alameda) to determine the Market Rate, and each
such broker will deliver its determination within ten (10)&nbsp;additional business days. If the lower of the two is within 90% of the higher of the two valuations, then the Market Rent shall be the average of the two. If a party fails to timely
designate a broker, the broker designated by the other party will determine the Market Rate. If the lower of the two valuations is less than 90% of the higher valuation, then the two brokers/appraisers originally selected by the parties shall,
within five (5)&nbsp;business days, select a third broker/appraiser and shall present their final determinations of Market Rate to the third broker/appraiser, and the third broker/appraiser shall pick one of those two as being the Market Rate. The
determination of the third broker/appraiser shall be binding on the parties. If Tenant fails to timely give its notice of exercise, Tenant will be deemed to have waived its option to extend. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">50.</TD>
<TD ALIGN="left" VALIGN="top"><B>Tenant Improvements</B>: Landlord shall complete specified tenant improvements detailed in Exhibit A. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LANDLORD AND TENANT HAVE CAREFULLY READ AND REVIEWED THIS LEASE AND EACH TERM AND PROVISION CONTAINED HEREIN, AND BY THE EXECUTION OF THIS LEASE SHOW THEIR
INFORMED AND VOLUNTARY CONSENT THERETO. THE PARTIES HEREBY AGREE THAT, AT THE TIME THIS LEASE IS EXECUTED, THE TERMS OF THIS LEASE ARE COMMERCIALLY REASONABLE AND EFFECTUATE THE INTENT AND PURPOSE OF LANDLORD AND TENANT WITH RESPECT TO THE PREMISES.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THIS LEASE PREPARED FOR YOUR ATTORNEY&#146;S REVIEW AND APPROVAL. FURTHER, EXPERTS SHOULD BE CONSULTED TO THE PRESENCE OF ASBESTOS,
UNDERGROUND STORAGE TANKS OR HAZARDOUS SUBSTANCES. NO REPRESENTATION OR RECOMMENDATION IS MADE BY THE AMERICAN INDUSTRIAL REAL ESTATE ASSOCIATION OR BY THE REAL ESTATE BROKERS OR THEIR CONTRACTORS, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">
AGENTS OR EMPLOYEES AS TO THE LEGAL SUFFICIENCY, LEGAL EFFECT, OR TAX CONSEQUENCES OF THIS LEASE OR THE TRANSACTION TO WHICH IT RELATES; THE PARTIES SHALL RELY SOLELY UPON THE ADVICE OF THEIR OWN
COUNSEL AS TO THE LEGAL AND TAX CONSEQUENCES OF THIS LEASE. IF THE SUBJECT PROPERTY IS IN A STATE OTHER THAN CALIFORNIA, AN ATTORNEY FROM THE STATE WHERE THE PROPERTY IS LOCATED SHOULD BE CONSULTED. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The parties hereto have executed this Lease at the place and on the dates specified above their respective
signatures. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="30%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Executed&nbsp;at:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">555 Twin Dolphin Dr.</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Executed&nbsp;at:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway, Alameda, CA 94802</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">on:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">9/18/14</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">on:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">17 September 2014</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="7"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7">By&nbsp;<B>Landlord</B>:<B></B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">By&nbsp;<B>Tenant</B>:<B></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">DOLLINGER HARBOR BAY ASSOCIATES,</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">a California limited partnership</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">D&amp;M Investors Fund I LLC, a</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">PENUMBRA, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">California Limited Liability Company</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">BY:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="5">General Partner</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Adam Elsesser, CEO</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">D&amp;M Ventures LP, a</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">PENUMBRA, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">California Limited Partnership</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">BY:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lynn Rothman</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Its</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Sole Member</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Lynn Rothman, CFO</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">David Dollinger Living Trust</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">Its General Partner</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David B. Dollinger</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">David B. Dollinger, Trustee</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">555 Twin Dolphin Drive, Suite 600</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Redwood City,
CA 94065</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">1351 Harbor Bay Parkway Alameda, CA 94502</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Telephone:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(650) 508-8666</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Telephone:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(510) 748-3200</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Facsimile:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(650) 508-8686</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Facsimile:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">(510) 217-9422</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit A Notes </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Landlord, at Landlord&#146;s sole cost and expense shall build the Tenant Improvements as per this attached Exhibit A, using the same building standards as
when the Tenant originally moved in to 1351 Harbor Bay Parkway and as specified in Exhibit B attached hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1321 Harbor Bay Parkway &#150; First Floor
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>All items by Landlord unless specified</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clean
Room</B> <B>&#150;</B> Approximately Class 10,000 (same as current clean room in 1351) </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Size <B>&#150;</B> approximately 8,281 square foot
of cleanroom </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling<B> &#150;</B> T-Bar grid with Clean Room ceiling tiles </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling height<B> &#150;</B> 10&#146; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Door height<B> &#150;</B> 9&#146; min. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> Smooth with Epoxy Paint </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on every Support Column by Landlord </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA on every Support column (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on perimeter walls per code by Landlord </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Junction boxes to be placed approximately every 200 sq. ft. above ceiling<B> &#150;</B> 1 dedicated 20 amp circuit per j-box by Landlord
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA and Data along perimeter walls (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> VCT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Slab<B> &#150;</B> Seal slab as necessary to prevent ground water from seeping up </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Pre-action system fire sprinklers </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Landlord to reuse existing HVAC system and run return air ducts surface mounted and painted on the perimeter walls. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Landlord to supply and install approximately 83 fan powered hepa-filters with pre-filter option </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">220V Power<B> &#150;</B> 8 locations TBD by tenant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gowning room 1 and 2 (approximately 460 sq ft and 410 sq ft) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling<B> &#150;</B> T-Bar grid with Clean Room ceiling tiles </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling height<B> &#150;</B> 10&#146; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Doors (each room):Three single 3.0x 7.0, 20 min rated door with metal frame and hardware (gowning room/exit with windows) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> Smooth with Epoxy Paint </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on every Support Column by Landlord </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA on every Support column (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on perimeter walls per code by Landlord </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> VCT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Slab<B> &#150;</B> Seal slab as necessary to prevent ground water from seeping up </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Landlord to reuse existing HVAC system and run return air ducts surface mounted and painted on the perimeter walls. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Landlord to supply and install approximately 4 fan powered hepa-filters with pre-filter option (each room) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">pre-action system fire sprinklers </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Materials pass-through Room </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling-T-Bar grid with Clean Room ceiling tiles </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling height- 10&#146; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Three
Double Doors 3.0x 7.0, 20 min rated doors with metal frame and hardware (gowning room/exit with windows). </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> Smooth with
Epoxy Paint </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on every Support Column by Landlord </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA on every Support column (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on perimeter walls per code by Landlord </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> VCT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Slab<B> &#150;</B> Seal slab as necessary to prevent ground water from seeping up </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Landlord to reuse existing HVAC system and run return air ducts surface mounted and painted on the perimeter walls. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Landlord to supply and install approximately 2 fan powered hepa-filters with pre-filter option </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">pre-action system fire sprinklers </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Eng, QC,
R&amp;D, and mfg labs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling<B> &#150;</B> T-Bar grid with Clean Room ceiling tiles </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling height<B> &#150;</B> 10&#146; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Door height<B> &#150;</B> 9&#146; min. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> white paint </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on every Support Column by Landlord </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Junction boxes to be placed approximately every 200 sq ft above ceiling<B> &#150;</B> 1 dedicated 20 amp circuit per j-box by Landlord
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA on every Support column (by Tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Power on perimeter walls per code by Landlord </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> VCT </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Shipping
Receiving </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> Exposed finished concrete </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling<B> &#150;</B> None </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> Finished/painted </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Roll up door 12&#146; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Hydraulic
lift equivalent to the one at 1351 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compressor room </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> Exposed finished concrete </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling<B> &#150;</B> none </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> painted </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Electrical<B> &#150;</B> 460 V 3 phase power, 60 Amp fused disconnect box </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA<B> &#150;</B> By Tenant </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Room
will be supplied directly with HVAC air and have adequate ventilation </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Break Room </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring-new VCT </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power
<B>&#150;</B> add 200 amp panel in this area </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Break room will have approximately 16&#146; of counter with cabinets above and below, double sink, and space for refrigerator / freezer </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restrooms </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Add 4 stalls in Women&#146;s Restroom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Add 3 urinals and 1 stall in Men&#146;s Restroom </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Partitions<B> &#150;</B> New </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Tile/grout to match existing in expansion area </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Counter top/sinks<B> &#150;</B> need additional sinks (per code)<B> &#150;</B> new counter tops </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling<B> &#150;</B> Existing </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equip maint,
and Storage rooms </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> Exposed finished concrete </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power<B> &#150;</B> 110V spaced per code </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">110V Junction boxes to be placed approximately every 250 sq ft above ceiling<B> &#150;</B> 1 dedicated 20 amp circuit per j-box by Landlord
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Data<B> &#150;</B> Per Tenant </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling<B> &#150;</B> Existing </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Boxing/
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> VCT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling<B> &#150;</B> Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> painted </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power<B> &#150;</B> 110V spaced per code </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">CDA<B> &#150;</B> By Tenant </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Offices /
conference room </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> carpet </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power<B> &#150;</B> provided per code. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling <B>&#150;</B> Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Data<B> &#150;</B> Provided by Tenant </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Doors<B> &#150;</B> 9&#146; doors and 36&#148; wide sidelight provided at each entrance to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> Painted </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cubicle
area</B>:<B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power<B> &#150;</B> Junction boxes provided above grid for cubes, power/ring and string boxes provided in conf. rooms and
offices per code. Electrical Panels moved to noninvasive locations </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Area/Lobby </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling<B> &#150;</B> Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Floors<B> &#150;</B> Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Exterior Doors<B> &#150;</B> Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Elevator<B> &#150;</B> Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Stairs<B> &#150;</B> Existing </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A minimum of 2000
amps of 110/208V power required for 1321 1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> floor<B> &#150;</B> distributed to 10 - 14 panels <B>&#150;</B> locations to be determined by Tenant </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>1321 Harbor Bay &#150; Second Floor </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Open
Office Area </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring <B>&#150;</B> carpet (match existing on second floor at 1351) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power <B>&#150;</B> Junction boxes provided above grid for cubes, power/ring and string boxes provided in conf. rooms and offices per code.
Electrical Panels moved to noninvasive locations Power placed in ceilings where projectors will be mounted in auditorium </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling <B>&#150;</B> Existing </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Data <B>&#150;</B> Provided by Tenant </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Doors-9&#146; doors and 36&#148; wide sidelight provided at each entrance to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls-Painted </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Auditorium (approximately 8400 sq
ft) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Flooring<B> &#150;</B> carpet (match existing on second floor at 1351) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power<B> &#150;</B> Junction boxes provided above grid for cubes, power/ring and string boxes provided in conf. rooms and offices per code.
Electrical Panels moved to noninvasive locations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power placed in ceilings where projectors will be mounted in auditorium </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Sound System/Projectors/Screens<B> &#150;</B> By Tenant (work to be done during construction) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; Existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Data<B>
&#150;</B> Provided by Tenant </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> Painted (one red, one grey, others white) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Storage rooms / conference room </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring<B>
&#150;</B> carpet </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Power<B> &#150;</B> provided per code. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ceiling &#150; Existing </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Data<B>
&#150;</B> Provided by Tenant </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Doors<B> &#150;</B> 9&#146; doors and 36&#148; wide sidelight provided at each entrance to </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Walls<B> &#150;</B> Painted </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Server Room</B>
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">VCT flooring </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Finish and
paint walls </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Room will be supplied directly with HVAC air and have adequate ventilation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Add pre-system fire sprinklers </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Break
Room</B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Flooring &#150; VCT </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">16&#146; lower Counter with cabinets above and below, double Sink, space for refrigerator and freezer </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restrooms </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Plumbing/flooring/electrical/partitions &#150; Existing </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1321 Harbor Bay Parkway &#150; Building </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New Roof </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Signage on building to
match 1351(by Tenant) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Repair any damage to exterior of building </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Key Card Access (By tenant) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Direct IT connection between 1351, 1321, and 1411 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Core drill 4&#148; tubing between all three buildings mains or equivalent-system to be pre-approved by Tenant </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All office doors to be 9&#146; clear birch with 3&#146; windows next to them </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All windows to have matching blinds </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Entire building to be converted from old T-12 lights / fixtures to new mandated T8 lights / fixtures </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All new areas / Buildings: Penumbra will provide a drawing with colors of walls prior to paint being purchased
for job or all walls will be standard swiss coffee </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Independent air conditioning units removed during demolition to be relocated to new locations
determined by Tenant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794ex10_3pg045.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794ex10_3pg046.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>8
<FILENAME>filename8.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [***]. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE
SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT UNDER RULE 406 OF THE SECURITIES ACT OF 1933. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DISTRIBUTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><SMALL>AND</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDICO&#146;S HIRATA INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIS</SMALL> D<SMALL>ISTRIBUTION</SMALL> A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> (&#147;Agreement&#148;) is made and entered
into this 2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> day of August 2009 (the &#147;Effective Date&#148;), by and between <B>Penumbra,</B> <B>Inc.</B>, a corporation organized under the laws of Delaware, USA, with offices at 1351 Harbor
Bay Parkway, Alameda, California, USA (&#147;<B>Penumbra</B>&#148;), and Medico&#146;s Hirata Inc. (&#147;<B>D<SMALL>ISTRIBUTOR</SMALL></B><SMALL></SMALL>&#148;), a corporation organized under the laws of Japan, with a registered office at 3-3-18
Dojima, Kita-Ku, Osaka, Japan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL></SMALL>, PENUMBRA is a medical device company that desires to engage
a marketing and distribution associate in Distribution Countries (as defined below), on the terms and conditions below; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><SMALL>WHEREAS</SMALL></B><SMALL></SMALL>, DISTRIBUTOR desires to be PENUMBRA&#146;s exclusive marketing and distribution partner in
Distribution Countries for the products described in Exhibit &#147;A&#148; and, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><SMALL>WHEREAS</SMALL></B><SMALL></SMALL>, the
relationship between DISTRIBUTOR and PENUMBRA is that of buyer and seller, respectively; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><SMALL>NOW</SMALL>
<SMALL>THEREFORE</SMALL></B><SMALL></SMALL>, in consideration of the mutual covenants and conditions herein contained, and intending to be legally bound hereby, the parties mutually agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. P<SMALL>RODUCTS</SMALL>, S<SMALL>COPE</SMALL> <SMALL>AND</SMALL> T<SMALL>ERRITORY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> PENUMBRA hereby appoints DISTRIBUTOR on an exclusive basis as its distributor for the sale to purchasers in the territory comprised
of Distribution Countries of all products (collectively, the &#147;Product&#148; or &#147;Products&#148;) described on Exhibit A. The Products will also include updates, improvements, product line extensions and replacements for Products or any
components thereof. Products shall include future products only to the extent agreed upon by the parties. The parties shall amend Exhibit A from time to time to reflect additions to and deletions from the Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Distribution Countries shall mean Japan. PENUMBRA may from time to time appoint DISTRIBUTOR as distributor for other territories
acceptable to DISTRIBUTOR. In the event that PENUMBRA appoints DISTRIBUTOR as distributor for other territories, the parties shall document such appointment and any particular terms thereof by amending this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> DISTRIBUTOR shall not engage in any advertising or promotional activities relating to
the Products directed primarily to customers outside Distribution Countries. DISTRIBUTOR shall not solicit orders from any prospective purchaser located outside Distribution Countries. PENUMBRA shall not sell or supply Products to any end user in
Distribution Countries or to any person or entity (other than DISTRIBUTOR) who PENUMBRA has reason to believe intends to resell such Products in Distribution Countries without agreement of DISTRIBUTOR. Each party shall immediately notify the other
upon learning of any sales of Products by a third-party in Distribution Countries, other than DISTRIBUTOR&#146;s approved <FONT STYLE="white-space:nowrap">sub-distributors.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> DISTRIBUTOR may appoint sub-distributors in a fashion typical of industry practice in the Territory, as long as each
sub-distributor agrees to be bound by the terms of this Agreement. DISTRIBUTOR shall defend, indemnify and hold PENUMBRA harmless from and against all demands, actions, defense of actions, causes of action (whether judicial, administrative or
otherwise), losses, claims, damages, judgments, fees, expenses (including without limitation attorneys&#146; fees, interest, penalties, investigative expenses and court costs) and liabilities, which PENUMBRA may incur in connection with the acts or
omissions of any <FONT STYLE="white-space:nowrap">sub-distributor.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. M<SMALL>ARKETING</SMALL> A<SMALL>PPROVAL</SMALL> <SMALL>IN</SMALL>
D<SMALL>ISTRIBUTION</SMALL> C<SMALL>OUNTRIES</SMALL> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> DISTRIBUTOR acknowledges that prior to entering into this Agreement,
PENUMBRA engaged ADMIS, Inc. (&#147;ADMIS&#148;) to assist PENUMBRA in obtaining product registrations and required permits, licenses and other approvals to market Products in the Distribution Countries. Following execution of this Agreement,
PENUMBRA and DISTRIBUTOR may mutually agree that DISTRIBUTOR will assume from ADMIS the responsibility for obtaining product registrations and required permits, licenses and other approvals to market Products in Distribution Countries. PENUMBRA
shall notify DISTRIBUTOR in writing the contents of the services which shall have been done by ADMIS on behalf of PENUMBRA. Following such mutual agreement, PENUMBRA will terminate its arrangement with ADMIS and DISTRIBUTOR will assume
responsibility for obtaining, and will use all commercially reasonable efforts to obtain, in PENUMBRA&#146;s name all product registrations and required permits, licenses, and other approvals necessary to market the Products in the Distribution
Countries, and DISTRIBUTOR will use all commercially reasonable efforts to qualify as Designated Marketing Approval Holder (hereinafter called &#147;DMAH&#148;) and Sales Agent and to obtain and maintain all manufacturing and sales licenses
necessary to permit DISTRIBUTOR to import the Products into the Distribution Countries and to sell them there (collectively, the &#147;Approvals&#148;). Specifically, DISTRIBUTOR will perform the following actions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> cause its regulatory department/advisors/legal counsel to prepare all necessary applications for Approvals, including the
designation of DISTRIBUTOR as DMAH of PENUMBRA for the distribution of the Products; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> submit all such applications, including
supporting data and materials; </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> hire and retain employees satisfying the education and experience requirements
necessary for DISTRIBUTOR to act as DMAH and to obtain and maintain sales and manufacturing licenses for the Products; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B>
respond promptly to all inquiries and requests for information from the relevant governmental authorities; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> keep PENUMBRA
informed of the status of all applications for Approvals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Except as provided in Section&nbsp;2 (c), PENUMBRA shall bear the
out of pocket costs and expenses (including without limitation regulatory filing fees and amounts payable to third parties) that may be incurred by DISTRIBUTOR in connection with the actions to be performed by DISTRIBUTOR in order to (i)&nbsp;obtain
the Approvals in the name of and on behalf of PENUMBRA described in Section&nbsp;2(a) following termination of service by ADMIS, (ii)&nbsp;obtain the Approvals for commercialization and reimbursement, and (iii)&nbsp;conduct any <FONT
STYLE="white-space:nowrap">post-market</FONT> studies which may be required by regulatory authorities. PENUMBRA and DISTRIBUTOR shall each bear their respective internal costs for such matters; provided, however, that when the details of the
internal costs necessary to obtain the Approvals become reasonably clear, if it appears reasonably likely that one party&#146;s internal costs will result in a substantial and disproportionate financial burden on that party, the parties shall
mutually consult and conclude a memorandum of agreement regarding the appropriate sharing of such internal costs. As used in this section, &#147;internal costs&#148; means items such as salaries of management and other employees, communication
expenses and other overhead items normally included in &#147;General and Administrative Expenses&#148; in a financial statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> PENUMBRA shall be responsible for all payments and expenses incurred by or due ADMIS prior to the effective date of ADMIS&#146;s
termination. In addition, PENUMBRA, at its expense, will provide DISTRIBUTOR with all information, data, materials and Product samples necessary or useful to obtain Approvals including, without limitation, access to all information and materials
developed by PENUMBRA in the course of its applications for regulatory approval from regulatory authorities. PENUMBRA shall appoint DISTRIBUTOR as DMAH for the Products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> DISTRIBUTOR shall keep PENUMBRA informed regarding ongoing regulatory requirements in the Distribution Countries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. S<SMALL>UPPLY</SMALL> T<SMALL>ERMS</SMALL>: P<SMALL>RICES</SMALL> <SMALL>AND</SMALL> P<SMALL>AYMENT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Forecasts</B>. DISTRIBUTOR shall submit 90-day rolling, non-binding forecasts for PENUMBRA production planning purposes. Such forecasts
shall not constitute a binding obligation upon DISTRIBUTOR. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Purchase Orders.</B> DISTRIBUTOR shall order, and PENUMBRA shall supply Products pursuant
to written purchase orders submitted by DISTRIBUTOR identifying the Products ordered. PENUMBRA will use commercially reasonable efforts to ship Products to DISTRIBUTOR on the date requested, but shall not be in breach of this Agreement in the event
that that date is not met, <I>provided</I> Products are delivered within sixty (60)&nbsp;days of the date of the purchase order. If at any time PENUMBRA determines that it will not be able to ship Products by the date requested by DISTRIBUTOR,
PENUMBRA shall immediately notify DISTRIBUTOR in writing of such delay. DISTRIBUTOR will use commercially reasonable efforts to place orders for Products in an even and regular fashion (e.g., monthly or quarterly) so as to allow for efficient
production and warehousing by PENUMBRA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c) Delivery and Risk of Loss.</B> Unless DISTRIBUTOR requests otherwise, PENUMBRA will
deliver all Products ordered by DISTRIBUTOR within the time period specified in Section&nbsp;3(b). PENUMBRA may choose the mode of shipment and carrier unless specified in the purchase order. DISTRIBUTOR shall purchase the Products from PENUMNBRA
Ex-Works Alameda, CA. The risk of loss and damage to Products shall pass to DISTRIBUTOR upon the delivery of such Products to the carrier. All Products shall be packed for shipment and storage in the standard manner suitable for exporting at
PENUMBRA&#146;s expense, unless DISTRIBUTOR notifies PENUMBRA of special packaging requirements, in which event PENUMBRA shall use commercially reasonable efforts to satisfy such requirements and shall be entitled to charge DISTRIBUTOR for any
additional costs incurred to satisfy such requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) Inspection.</B> DISTRIBUTOR will inspect all Products promptly upon
receipt thereof for conformance with the Products&#146; specifications, to the extent determinable by reasonable inspection upon delivery. PENUMBRA will, at its election, either repair or replace defective Products returned by DISTRIBUTOR within
thirty (30)&nbsp;days of receipt thereof by PENUMBRA, and its liability in this event shall be limited to such repair or replacement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e) Pricing.</B> The prices to be paid by DISTRIBUTOR for Products shall be determined in writing by the parties from time to time by means
of a fixed percentage of the current reimbursement prices, taking into account PENUMBRA&#146; s manufacturing costs, change of reimbursement prices, and competitive market situation in the Distribution Countries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PENUMBRA will provide DISTRIBUTOR with a reasonable number of field sales samples of Products for demonstration purposes, at PENUMBRA&#146;s
cost of goods sold. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f) Payments.</B> All amounts due and payable with respect to Products delivered by PENUMBRA, in accordance with
the preceding subsection, shall be paid in full by the end of the month following the month during shipment of product is made together with invoice. All such amounts shall be paid in US dollars (unless another currency is specified in Exhibit A
under the column &#147;Distribution Price&#148;) by wire transfer, to such bank or account as PENUMBRA may from time to time designate in writing. Whenever any amount hereunder is due on a day that is not a day on which banks in the United States or
Distribution Countries are open for business (a &#147;Business Day&#148;), such amount shall be paid on the next Business Day. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g) Taxes.</B> All taxes applicable to the import, distribution or sale of Products in
Distribution Countries will be paid by DISTRIBUTOR, with the exception of income or other taxes levied on PENUMBRA and measured by PENUMBRA&#146;s gross or net income. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h) Records.</B> DISTRIBUTOR shall maintain records of shipment for implantable devices manufactured by PENUMBRA, containing the production
lot/serial numbers, and the name and address of the consignee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. O<SMALL>THER</SMALL> O<SMALL>BLIGATIONS</SMALL> <SMALL>OF</SMALL>
D<SMALL>ISTRIBUTOR</SMALL></B><SMALL></SMALL>. Promptly upon receipt of all necessary Approvals from the authorities and throughout the term of this Agreement, DISTRIBUTOR will use all commercially reasonable efforts to promote the sale of the
Products in Distribution Countries. Specifically, DISTRIBUTOR shall: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> provide training and education to physicians, nurses and
sales force, as well as to all approved sub-distributors, to adequately support PENUMBRA&#146;s Products; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> maintain, at its own
expense, a sufficient inventory of the Products and of replacement parts as well as a sufficient non-operative inventory (sample, demo) to fulfill DISTRIBUTOR&#146;s forecasted demand for the Products in Distribution Countries; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> maintain adequate and experienced management and sales personnel meeting the educational and experience requirements of the
Ministry of Health; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> dedicate sufficient product and project management, marketing and financial resources to pursue the market
opportunities for the Products in Distribution Countries; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> in cooperation with PENUMBRA, translate into appropriate languages,
at its own expense and liability, any promotional materials, user and technical manuals, or advertising and marketing information supplied at the discretion of PENUMBRA, which DISTRIBUTOR determines may be useful in the marketing of Products in the
Distribution Countries. DISTRIBUTOR shall have a non-exclusive right to use all such materials during the term of this Agreement in connection with its activities pursuant to this Agreement; Distributor&#146;s right to use such material shall expire
on termination of this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> advertise the Products in trade and other relevant publications; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(g)</B> participate in appropriate trade shows; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(h)</B> make sales calls on physicians; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> promptly notify PENUMBRA upon learning of any complaints about Products which are reported to, or required to be reported to
applicable regulatory authorities using the PENUMBRA standard form; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(j)</B> comply in all respects with all laws applicable to
DISTRIBUTOR&#146;S business. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. P<SMALL>ENUMBRA</SMALL>&#146;<SMALL>S</SMALL> O<SMALL>BLIGATIONS</SMALL>.</B> In order to facilitate
DISTRIBUTOR&#146;S performance of its obligations under this Agreement, PENUMBRA at its own expense shall: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> provide DISTRIBUTOR
with such marketing and technical assistance, promotional materials (in English), and Product samples as PENUMBRA may in its reasonable discretion consider necessary to assist with the promotion of the Products; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b) </B>provide training to DISTRIBUTOR&#146;s personnel in connection with the marketing, sale, installation, maintenance and support of
the Products; <I>provided however</I>, that such training shall be reasonably available and necessary to assist DISTRIBUTOR to market and distribute the Products and to perform its obligations under the Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> provide to DISTRIBUTOR reasonable notification of any improvements to or replacements for Products, and use commercially reasonable
efforts to continue to supply the original Products until such time as such improvements or replacements are approved by the appropriate governmental authority and available for sale in Distribution Countries. PENUMBRA shall provide all information
and additional components necessary to permit DISTRIBUTOR to modify its inventory in the event PENUMBRA announces a revised version of any Product, or any component thereof, at the sole discretion of and under the direction of PENUMBRA; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d) </B>provide such access and availability to its maintenance and support personnel to assist DISTRIBUTOR&#146;s support personnel in
providing maintenance and support services; <I>provided however</I>, such access shall be reasonably available and necessary to assist DISTRIBUTOR to market and distribute the Products and to perform its obligations under the terms of this
Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> provide cooperation and assistance in the transfer of all Approvals held by the current distributor, if any; and,
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> provide such continued information, cooperation and assistance as may be necessary to maintain Approvals and comply with
applicable law in connection with the distribution of Products in Distribution Countries. Additionally, PENUMBRA shall notify DISTRIBUTOR in writing immediately upon learning of any adverse event or experience related to any Products and reportable
to regulatory authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. P<SMALL>ATENTS</SMALL>; T<SMALL>RADEMARKS</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The parties agree that the prosecution or maintenance of all PENUMBRA patents, trademarks and trade names relating to the Products
is entirely PENUMBRA&#146;s obligation. PENUMBRA shall, as appropriate, apply for or maintain patents for Products distributed, marketed or sold in Distribution Countries. DISTRIBUTOR acknowledges that PENUMBRA is the owner of the exclusive right,
title and interest in and to the patents, trademarks and trade names relating to the Products. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> During the term of this Agreement, PENUMBRA hereby grants DISTRIBUTOR a non-exclusive,
fully-paid license to use the name &#147;PENUMBRA&#148; and a non-exclusive, <FONT STYLE="white-space:nowrap">fully-paid</FONT> license to use other trade names, trademarks and service marks owned by PENUMBRA which are applicable to the Products
(the &#147;Marks&#148;) in Distribution Countries solely for display or advertising purposes in connection with selling and distributing the Products in accordance with this Agreement. DISTRIBUTOR acknowledges that PENUMBRA is the owner of the
exclusive right, title and interest in and to the Marks. DISTRIBUTOR has no permission to and will not adopt, use or register as trademark, trade name, business name, or corporate name or part thereof, whether during the term of this Agreement or
after its termination, any word or symbol confusingly similar to any of the Marks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In order to comply with PENUMBRA&#146;s quality
control standards, DISTRIBUTOR shall use the Marks in compliance with the laws of the Distribution Countries as the case may be, shall not modify any of the Marks and shall not use any Marks in connection with goods other than Products, except with
the prior written consent of PENUMBRA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> PENUMBRA shall, at its expense, indemnify, defend and hold DISTRIBUTOR, its
subsidiaries and affiliates harmless against all costs and liabilities incurred in connection with any claim, action, suit, or proceeding maintaining that any patent, trademark or other intellectual property rights of any third-party are infringed
or violated by the import, distribution or sale of Products in Distribution Countries, as provided in this Agreement. DISTRIBUTOR agrees to give PENUMBRA prompt written notice of any such claim, action, suit or proceeding of which DISTRIBUTOR
becomes aware and PENUMBRA shall have absolute control of any defense in such matter. PENUMBRA shall keep DISTRIBUTOR regularly informed regarding such action, including providing DISTRIBUTOR with copies of legal filings pertaining thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> If use, distribution or sale of any Product in Distribution Countries is enjoined, prohibited or prevented due to any third-party
rights or claim of infringement, then PENUMBRA shall, at its expense: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(i)</B></TD>
<TD ALIGN="left" VALIGN="top">procure a license for DISTRIBUTOR to continue selling the Products; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(ii)</B></TD>
<TD ALIGN="left" VALIGN="top">replace or modify the Products to render them non-infringing; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(iii)</B></TD>
<TD ALIGN="left" VALIGN="top">repurchase the Products purchased but not yet sold by DISTRIBUTOR and refund to DISTRIBUTOR the price it paid for the Products provided that the Products are in original package and not damaged. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. W<SMALL>ARRANTY</SMALL>; I<SMALL>NDEMNIFICATION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> PENUMBRA warrants that the Products, at the date of delivery to DISTRIBUTOR: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(i)</B></TD>
<TD ALIGN="left" VALIGN="top">will meet the specifications set forth in catalog numbers referred to in Exhibit A; </TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(ii)</B></TD>
<TD ALIGN="left" VALIGN="top">will be free from defects in design, manufacture, materials, and workmanship; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(iii)</B></TD>
<TD ALIGN="left" VALIGN="top">will be of merchantable quality and fit for the purpose for which they are intended; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(iv)</B></TD>
<TD ALIGN="left" VALIGN="top">will comply with all applicable laws in effect in the place of manufacture and in Distribution Countries, <I>provided however</I>, that DISTRIBUTOR notifies PENUMBRA upon becoming aware of any laws in Distribution
Countries which would have an adverse effect on the PENUMBRA warranty. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PENUMBRA&#146;S SOLE OBLIGATION UNDER THE FOREGOING
WARRANTY SHALL BE, AT PENUMBRA&#146;S SOLE ELECTION, TO EITHER REPLACE THE RELEVANT PRODUCT OR REFUND DISTRIBUTOR&#146;S FULLY-LANDED PURCHASE PRICE FOR THE PRODUCT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> PENUMBRA shall, at its expense, indemnify, defend and hold DISTRIBUTOR, its subsidiaries and affiliates harmless against all costs
and liabilities incurred in connection with any third-party claim, action, suit, or proceeding alleging bodily injury (including death) or damage to personal property to the extent such claim arises out of or relates to any breach of a warranty made
by PENUMBRA regarding the Products or any negligent or reckless act or omission or willful misconduct by PENUMBRA or any of its employees or agents. DISTRIBUTOR agrees to give PENUMBRA prompt written notice of any such claim, action, suit or
proceeding of which DISTRIBUTOR becomes aware and PENUMBRA shall have absolute control of any defense in such matter. PENUMBRA shall keep DISTRIBUTOR regularly informed regarding such action, including providing DISTRIBUTOR with copies of legal
filings pertaining thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> DISTRIBUTOR shall, at its expense, indemnify, defend and hold PENUMBRA harmless against all costs
and liabilities incurred in connection with any third-party claim, action, suit, or proceeding arising out of any negligent or reckless act or omission or willful misconduct by DISTRIBUTOR or any of its employees or any improper use, negligent
repair or alteration of a Product by DISTRIBUTOR. PENUMBRA agrees to give DISTRIBUTOR prompt written notice of any such claim, action, suit or proceeding of which PENUMBRA becomes aware and DISTRIBUTOR shall have absolute control of any defense in
such matter. DISTRIBUTOR shall keep PENUMBRA regularly informed regarding such action, including providing PENUMBRA with copies of legal filings pertaining thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. T<SMALL>ERMINATION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> The term of the Agreement will be five (5)&nbsp;years after the Approvals have been obtained. </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Upon the occurrence of a material breach or default of this Agreement by either party,
this Agreement may be terminated by the non-breaching party by giving ninety (90)&nbsp;days written notice of termination to the breaching party, unless the breaching party cures such material breach or default or, using commercially reasonable
efforts, commences a cure of any material breach or default which cannot be fully cured within such ninety (90)-day period and thereafter diligently pursues such cure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> PENUMBRA agrees to fill all purchase orders received by DISTRIBUTOR prior to the date of termination or expiration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> PENUMBRA shall have the right to terminate this Agreement immediately without notice on the bankruptcy, insolvency, dissolution,
assignment for the benefit of creditors, appointment of a trustee or receiver with respect to the assets of, liquidation of or similar event with respect to DISTRIBUTOR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(e)</B> Notwithstanding anything else in this Agreement to the contrary, the parties agree that Sections 6(b), 6(c), 7, 8(e), 9, 14 and 15
shall survive the termination or expiration of this Agreement, as the case may be, to the extent required thereby for the full observation and performance by any or all of the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(f)</B> Upon expiration or other termination of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> DISTRIBUTOR shall pay to PENUMBRA all amounts that are payable by DISTRIBUTOR to PENUMBRA under this Agreement less
any such amounts payable on the grounds of a dispute arising out of this Agreement against any claim or damages sought by DISTRIBUTOR; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> Each party shall return to the other all of the Proprietary Information of the other party in the possession or
under the control of the receiving party, together with a statement signed by an authorized representative of the party to the effect that all Proprietary Information has been returned to the party; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> DISTRIBUTOR shall cease using any of the Marks and shall return to PENUMBRA all materials supplied to DISTRIBUTOR
by PENUMBRA that contain any of the Marks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. R<SMALL>EPURCHASE</SMALL> <SMALL>OF</SMALL> I<SMALL>NVENTORY</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Within thirty (30)&nbsp;days after termination or expiration of this Agreement, PENUMBRA and DISTRIBUTOR shall mutually elect in
writing to either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(i)</B></TD>
<TD ALIGN="left" VALIGN="top">permit DISTRIBUTOR to sell off its remaining inventory of Products; <I>provided however</I>, that DISTRIBUTOR shall comply with all terms and conditions of this Agreement restricting such reselling activities in effect
immediately prior to termination or expiration; or </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(ii)</B></TD>
<TD ALIGN="left" VALIGN="top">permit PENUMBRA to repurchase DISTRIBUTOR&#146;s inventory of Products which are: salable; in the original packages; and, are unaltered from their original form and design (excluding the labels mounted on Products
following the regulatory requirements) (except as provided in section 5(c)); </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">and if the parties are unable to agree,
PENUMBRA shall make the election. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that this Agreement is terminated due to a material breach or default by either
PENUMBRA or DISTRIBUTOR then the repurchase options outlined in this section 9(a) will be at the sole discretion of the party not in breach of the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Any such repurchase of DISTRIBUTOR&#146;s inventory of Products shall be at the price paid by DISTRIBUTOR for such Products.
Repurchased inventory shall be shipped according to PENUMBRA&#146;S instructions, at PENUMBRA&#146;S expense. PENUMBRA shall pay DISTRIBUTOR for such repurchased Products within thirty (30)&nbsp;days after the date of shipment (B/L Date) thereof by
DISTRIBUTOR. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. M<SMALL>ODIFICATION</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No modification or change may be made in this Agreement except by written instrument duly signed by a duly authorized representative of
DISTRIBUTOR and by a duly authorized representative of PENUMBRA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. A<SMALL>SSIGNMENT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement and the rights and obligations hereunder may not be assigned, delegated or transferred by either party without the prior
written consent of the other party. Participation of a party in an Acquisition Transaction (as defined below) pursuant to which the owners of a majority of the outstanding voting stock or other ownership interests of such party immediately prior to
the consummation of the Acquisition Transaction do not own at least a majority of the outstanding voting stock or other ownership interests of such party immediately after the consummation of the Acquisition Transaction shall constitute an
assignment within the meaning of this Section. Notwithstanding the foregoing, PENUMBRA may assign its rights and obligations under the terms of this Agreement in connection with an Acquisition Transaction in which the successor entity assumes all
rights and obligations under this Agreement. This Agreement shall bind and inure to the benefit of all successors and permitted assigns of each party. Furthermore, any Acquisition Transaction involving PENUMBRA may only be consummated if the
surviving or resulting entity in such Acquisition Transaction shall effectively assume all of the rights and obligations of such party under this Agreement. For purposes of this </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
section, an &#147;Acquisition Transaction&#148; shall mean a merger or consolidation of a party with or into any other entity, including a reverse triangular merger involving such party, a sale
of all or substantially all of the assets or business of such party, or a similar transaction, or a sale of the business unit to which this Agreement relates, or sale of at least a majority of the outstanding voting stock or other ownership
interests of such party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. N<SMALL>OTICE</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All notices given under this Agreement shall be in writing and shall be addressed to the parties at their respective addresses set forth
below: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>F</SMALL> <SMALL>TO</SMALL></B><SMALL></SMALL> <B>DISTRIBUTOR,</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Y. Sato </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Medico&#146;s
Hirata Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">3-4-3 Edobori, Nishi-ku, Osaka, Japan </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Fax: 81-6-6445-2458 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>F</SMALL> <SMALL>TO</SMALL> </B><B>PENUMBRA:</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Robert Evans </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">PENUMBRA, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay
Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Alameda CA 94502 USA </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Fax: 510-814-8303 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Either party
may change its address or its telecopy number for purposes of this Agreement by giving the other party written notice of its new address or telecopy number. Any such notice if given or made by registered or recorded delivery international air mail
letter shall be deemed to have been received on the earlier of the date actually received and the date fifteen (15)&nbsp;calendar days after the same was posted (and in providing such it shall be sufficient to prove that the envelope containing the
same was properly addressed and posted as aforesaid), if given or made by telecopy transmission shall be deemed to have been received at the time of dispatch, unless such date of deemed receipt is not a Business Day, in which case the date of deemed
receipt shall be the next such succeeding Business Day, and if given by internationally recognized international package delivery service shall be deemed to have been received at the time of receipt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. W<SMALL>AIVER</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the
conditions or provisions of this Agreement shall be held to have been waived by any act or knowledge on the part of either party, except by an instrument in writing signed by a duly authorized officer or representative of the parties. Further, the
waiver by either party of </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any right hereunder or the failure to enforce at any time any of the provisions of this Agreement, or any rights with respect thereto, shall not be deemed to be a waiver of any other rights
hereunder or any breach or failure of performance of the other party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. R<SMALL>ESOLUTION</SMALL> <SMALL>OF</SMALL> D<SMALL>ISPUTES</SMALL>.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> In the event of any dispute, controversy or claim arising out of or relating to this Agreement or to a breach hereof,
including its interpretation, performance or termination, the parties agree to commence a good faith discussion toward the resolution of such issues. If, after ninety (90)&nbsp;days, the parties are unable to reach a resolution, such issues shall be
finally resolved by arbitration in San Francisco, California, U.S.A. in accordance with the Arbitration Rules of the American Arbitration Association if arbitration is invoked by DISTRIBUTOR, or in Tokyo, Japan in accordance with the Commercial
Arbitration Rules of the Japan Commercial Arbitration Association if arbitration is invoked by PENUMBRA. The arbitration shall be conducted by one arbitrator mutually selected by the parties. If the parties cannot agree on an arbitrator, then there
shall be three (3)&nbsp;arbitrators, one to be appointed by PENUMBRA, one to be appointed by DISTRIBUTOR and a third being nominated by the two arbitrators so selected or, if they cannot agree on a third arbitrator, by the Arbitration Association
concerned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> The decision of the arbitrators shall be binding upon the parties hereto, and the expense of the arbitration
(including without limitation the award of attorneys&#146; fees to the prevailing party) shall be paid as the arbitrators determine. The decision of the arbitrators shall be executory, and judgment thereon may be entered by any court of competent
jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. C<SMALL>ONFIDENTIALITY</SMALL> M<SMALL>AINTAINED</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> For purposes of this section, &#147;Proprietary Information&#148; shall mean any confidential or proprietary information provided
to one party by the other, orally or in written or electronic form, including but not limited to technical information concerning Products, customer lists, sales figures, cost or pricing information and marketing materials. (provided that
DISTRIBUTOR is not obligated to provide to PENUMBRA such information as its customer lists, sales, figures, cost or pricing information.) Each party shall disclose the other&#146;s Proprietary Information only to those of its agents and employees to
whom it is necessary in order properly to carry out their duties as limited by the terms and conditions hereof. Both during and for a three (3)&nbsp;year period after the term of this Agreement, all Proprietary Information of the other party shall
be held in strict confidence by the receiving party and shall not be used or disclosed for any purpose other than performing the terms of this Agreement. Each party shall return documents, computer disks and other media containing the other&#146;s
Proprietary Information as soon as practicable after the termination or expiration of this Agreement or on demand by the party furnishing the information. All such Proprietary Information shall remain the exclusive property of the disclosing party
during the term of this Agreement and thereafter. This section shall also apply to any agents, consultants or subcontractors that either party may engage in connection with its obligations under this Agreement, and to any authorized
sub-distributors. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> Notwithstanding anything contained in this Agreement to the contrary, neither party
shall have the above obligations with respect to Proprietary Information if it: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(i)</B></TD>
<TD ALIGN="left" VALIGN="top">was in the public domain at the time of disclosure without breach of this Agreement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(ii)</B></TD>
<TD ALIGN="left" VALIGN="top">was known to or contained in the records of the receiving party from a source other than the disclosing party at the time of disclosure and can be so demonstrated; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(iii)</B></TD>
<TD ALIGN="left" VALIGN="top">becomes known to the receiving party from a source other than disclosing party without breach of this Agreement and can be so demonstrated; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>(iv)</B></TD>
<TD ALIGN="left" VALIGN="top">was disclosed pursuant to court order or as otherwise compelled by law; <I>provided however</I>, the other party is notified of such proposed disclosure as soon as is reasonably possible and the disclosure is limited to
the maximum extent reasonably possible. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. E<SMALL>NTIRE</SMALL> A<SMALL>GREEMENT</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Agreement supersedes and cancels any previous agreements or understandings, whether oral, written or implied, heretofore in effect and
sets forth the entire agreement between PENUMBRA and DISTRIBUTOR with respect to the subject matter hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. I<SMALL>NDEPENDENT</SMALL>
C<SMALL>ONTRACTOR</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing herein contained shall be deemed to create an agency, joint venture or partnership relation
between the parties hereto; the parties are independent contractors. It is understood and agreed that neither party is, by reason of this Agreement or anything herein contained, constituted or appointed the agent or representative of the other for
any purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18. F<SMALL>ORCE</SMALL> M<SMALL>AJEURE</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(a)</B> Save in respect of payments due under this Agreement, neither party shall be liable in damages, or shall be subject to termination
of this Agreement by the other party, for any delay or default in performing any obligation hereunder if that delay or default is due to any cause beyond the reasonable control and without fault or negligence of that party; <I>provided that</I> in
order to excuse its delay or default hereunder, a party shall notify the other of the occurrence or the cause, specifying the nature and particulars thereof and the expected duration thereof; and <I>provided, further</I>, that within fifteen
(15)&nbsp;calendar days after the termination of such occurrence or cause, such party shall give notice to the other party specifying the date of termination thereof. All obligations of both parties shall return to being in full force and effect
upon the termination of such occurrence or cause. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(b)</B> In the event that any delay or default in performing any obligation hereunder, as
described in section 18(a), extends for ninety (90)&nbsp;days beyond the termination of the occurrence or cause then the parties shall meet to determine how to resolve such delay or default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(c)</B> If, after meeting for an additional ninety (90)&nbsp;days, the parties are unable to agree on how to resolve the delay or default
then the party not invoking <I>force majeure</I>, as provided above, shall have the right to terminate the Agreement upon ninety (90)&nbsp;days written notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>(d)</B> For the purposes of this Section, a &#147;cause beyond the reasonable control&#148; of a party shall include, without limiting the
generality of the phrase, any act of God, act of any government or other authority or statutory undertaking, act of terrorism, industrial dispute, fire, explosion, accident, power failure, flood, riot or war (declared or undeclared). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19. S<SMALL>EVERABILITY</SMALL>. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any
provision of this Agreement is declared invalid or unenforceable by a court having competent jurisdiction, it is mutually agreed that this Agreement shall endure except for the part declared invalid or unenforceable by order of such court. The
parties shall consult and use their best efforts to agree upon a valid and enforceable provision which shall be a reasonable substitute for such invalid or unenforceable provision in light of the intent of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20. D<SMALL>EFINITION</SMALL> <SMALL>OF</SMALL> A<SMALL>FFILIATES</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this Agreement, &#147;affiliates&#148; shall mean all companies, natural persons, partnerships and other business entities
controlled by, under common control with or controlling either party to this Agreement. Each party acknowledges that the other party may use affiliates to perform obligations under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>21. R<SMALL>EPRESENTATION</SMALL> <SMALL>BY</SMALL> P<SMALL>ARTIES</SMALL> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of PENUMBRA and DISTRIBUTOR represents and warrants to the other party that it and all of its employees and or agents are fully
authorized and able to enter into this Distribution Agreement and that the actions contemplated under this Distribution Agreement by each party and its employees or agents do not violate any existing agreement, employment contract, law, or other
understanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL><B></B></SMALL><B>,</B> the parties hereto have signed two
(2)&nbsp;originals of this Agreement, each party holding one original. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="7"><B>M<SMALL>EDICO</SMALL>&#146;<SMALL>S</SMALL> H<SMALL>IRATA</SMALL> I<SMALL>NC</SMALL>.</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Masataka Hirata</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Masataka Hirata</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">President</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">2009/Aug/07</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PENUMBRA, I<SMALL>NC</SMALL>.:</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James R. Pray</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Adam Elsesser</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">James R. Pray</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Chief Executive Officer</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">President</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">12 August 2009</TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>E<SMALL>XHIBIT</SMALL></B><SMALL></SMALL> A<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>P<SMALL>RODUCTS</SMALL> <SMALL>AND</SMALL> P<SMALL>RODUCT</SMALL> S<SMALL>PECIFICATION</SMALL>/P<SMALL>RICING</SMALL> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Catalog Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Description</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>Distribution&nbsp;Price<BR>(all&nbsp;prices&nbsp;in&nbsp;U.S.&nbsp;$)</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Reperfusion Catheters</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(OD/ID/TL/WL)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC026</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2.8F/.026in/154cm/150cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC032</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3.4F/.032in/154cm/150cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC041</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4.1F/.041in/141cm/137cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Separator&#153;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>(OD/TL/WL)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS026</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator 026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.022in/200cm/155cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS032</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator 032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.028in/200cm/155cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS041</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator 041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035in/200cm/142cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B>PST1<B></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Aspiration Tubing (Sterile)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PAPS1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>Non-Sterile Penumbra System Supplies</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Pump-Canister Tubing (Non-sterile)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Pump Canister and Lid</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Pump Filter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PAP220</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>Penumbra Aspiration Pump Starter Pack</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">220V/230V Penumbra Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PAP110</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Penumbra Aspiration Pump</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">110V Penumbra Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>Catalog Number</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Description</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Working</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Length</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Outer&nbsp;Diameter<BR>Proximal/</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Distal</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Inner</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Wire</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Compatibility</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Distributor&nbsp;Price</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(all&nbsp;prices&nbsp;in&nbsp;U.S.$))</B></P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"><B>$</B></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Neuron Deliver Catheter:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F11512</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Deliver Catheter, 115/12 Straight</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">115&nbsp;cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">12&nbsp;cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.053&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F11512M</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Deliver Catheter 115/12 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">115 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">12 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.053&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F1156</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">6F Neuron Deliver Catheter 115/6 Straight</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">115 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.053&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F1156M</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Deliver Catheter 115/6 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">115 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.053&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F10512</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">6F Neuron Deliver Catheter 105/12 Straight</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">105 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">12 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.053&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F10512M</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Deliver Catheter 105/12 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">105 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">12 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.053&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F1056</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">6F Neuron Deliver Catheter 105/6 Straight</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">105 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.053&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F1056M</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Deliver Catheter 105/6 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">105 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.053&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Neuron 6F 070 Delivery Catheter:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F070956</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Delivery Catheter, 95/6 Straight</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">95 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 6F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.070&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F0700956M</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Delivery Catheter, 95/6 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">95 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 6F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.070&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F0701058</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Deliver Catheter, 105/8 Straight</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">105 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">8 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 6F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.070&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PND6F0701058M</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Deliver Catheter, 105/8 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">105 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">8 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6F / 6F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.070&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>Neuron Select Catheter:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PNS35F137H1</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.5F Neuron Select Catheter, 137 H1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">137 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">42 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3.5F / 3.5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.022&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.018&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PNS35F137SIM</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.5F Neuron Select Catheter, 137 SIM</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">137 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">42 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3.5F / 3.5F</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.022&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">.018&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wiring Instructions </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">____ </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DISTRIBUTION
AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDICO&#146;S HIRATA INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIS</SMALL> A<SMALL>MENDMENT</SMALL> N<SMALL>O</SMALL>.&nbsp;1 T<SMALL>O</SMALL> D<SMALL>ISTRIBUTION</SMALL>
A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> (&#147;Agreement&#148;) is made and entered into this 17th day of June 2010, by and between <B>Penumbra, Inc.</B>, a corporation organized under the laws of Delaware, USA, with offices at 1351 Harbor Bay
Parkway, Alameda, California, USA (&#147;<B>Penumbra</B>&#148;), and Medico&#146;s Hirata Inc. (&#147;<B>D<SMALL>ISTRIBUTOR</SMALL></B><SMALL></SMALL>&#148;), a corporation organized under the laws of Japan, with a registered office at 3-3-18
Dojima, Kita-Ku, Osaka, Japan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL><B></B></SMALL><B>,</B> PENUMBRA and DISTRIBUTOR have
entered into a Distribution Agreement as of August&nbsp;2, 2009 (the &#147;Distribution Agreement&#148;); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL><B></B></SMALL><B>,</B> PENUMBRA and DISTRIBUTOR wish to amend the Distribution Agreement
as provided herein; and, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>W<SMALL>HEREAS</SMALL></B><SMALL><B></B></SMALL><B>,</B> capitalized terms used herein and not
defined herein shall have the respective meanings ascribed to them in the Distribution Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>N<SMALL>OW</SMALL>
T<SMALL>HEREFORE</SMALL></B><SMALL><B></B></SMALL><B>,</B> in consideration of the mutual covenants and conditions herein contained, and intending to be legally bound hereby, the parties mutually agree as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"><B>Amendment to Section 2(a).</B> Section 2(a) of the Distribution Agreement is hereby amended to read as follows: </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;DISTRIBUTOR acknowledges that prior to entering into this Agreement, PENUMBRA engaged ADMIS, Inc. (&#147;ADMIS&#148;) to assist PENUMBRA
in obtaining product registrations and required permits, licenses and other approvals to market Products in the Distribution Countries. Following execution of this Agreement, PENUMBRA terminated its arrangement with ADMIS and DISTRIBUTOR assumed
responsibility for obtaining, and will use all commercially reasonable efforts to obtain, in DISTRIBUTOR&#146;s name all product registrations and required permits, licenses, and other approvals necessary to market the Products in the Distribution
Countries (i.e., obtain a &#147;Shonin&#148; with respect to </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Products), and DISTRIBUTOR will use all commercially reasonable efforts to qualify as Marketing Approval Holder (hereinafter called &#147;MAH&#148;) and Sales Agent and to obtain and maintain
all manufacturing and sales licenses necessary to permit DISTRIBUTOR to import the Products into the Distribution Countries and to sell them there (collectively, the &#147;Approvals&#148;). Specifically, DISTRIBUTOR will perform the following
actions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> cause its regulatory department/advisors/legal counsel to prepare all necessary applications for
Approvals, including the designation of DISTRIBUTOR as holder of the Shonin and as MAH for the distribution of the Products; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> submit all such applications, including supporting data and materials; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> hire and retain employees satisfying the education and experience requirements necessary for DISTRIBUTOR to act as
MAH and to obtain and maintain sales and manufacturing licenses for the Products; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> respond promptly to all
inquiries and requests for information from the relevant governmental authorities; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(v)</B> keep PENUMBRA informed
of the status of all applications for Approvals.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"><B>Amendment to Section 2(b).</B> Section 2(b) of the Distribution Agreement is hereby amended to read as follows: </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;Except as provided in Section&nbsp;2(c), DISTRIBUTOR shall bear the out of pocket costs and expenses (including without limitation
regulatory filing fees and amounts payable to third parties) that may be incurred by DISTRIBUTOR in connection with the actions to be performed by DISTRIBUTOR in order to (i)&nbsp;obtain the Approvals in the name of and on behalf of DISTRIBUTOR
described in Section&nbsp;2(a), (ii)&nbsp;obtain the Approvals for commercialization and reimbursement, and (iii)&nbsp;conduct any post-market studies which may be required by regulatory authorities; provided, however, PENUMBRA shall bear one-half
of any monies paid under any name by DISTRIBUTOR to hospitals, clinic, or doctors who cooperated with DISTRIBUTOR in its post market studies which may be required by the regulatory authorities. PENUMBRA shall pay one-half of such monies within one
(1)&nbsp;month after PENUMBRA receives each invoice issued by DISTRIBUTOR. Each time DISTRIBUTOR issues an invoice, DISTRIBUTOR shall send to PENUMBRA the details of the payments made by DISTRIBUTOR, together with the pertinent evidence. DISTRIBUTOR
shall provide to PENUMBRA at such time copies of the data in Japanese which may be obtained by such post market studies each time such invoice is issued by DISTRIBUTOR. PENUMBRA and DISTRIBUTOR shall each bear their respective internal costs for
such matters enumerated in (i)&nbsp;(ii)&nbsp;(iii)&nbsp;above; provided, however, that when the details of the internal costs necessary to obtain the Approvals become reasonably clear, if it appears reasonably likely that one party&#146;s internal
costs will result in a substantial and disproportionate financial burden on that party, the parties shall mutually consult and conclude a memorandum of agreement </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
regarding the appropriate sharing of such internal costs. As used in this section, &#147;internal costs&#148; means items such as salaries of management and other employees, communication
expenses and other overhead items normally included in &#147;General and Administrative Expenses&#148; in a financial statement.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"><B>Amendment to Section&nbsp;8(a).</B> Section&nbsp;8(a) of the Distribution Agreement is hereby amended to read as follows: </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;The initial term (the &#147;Initial Term&#148;) of the Agreement will be five (5)&nbsp;years after the Approvals have been obtained. On
expiration of the Initial Term and of each successive Additional Term (as hereinafter defined), this Agreement shall be automatically extended for an additional term (each, an &#147;Additional Term&#148;) of one (1)&nbsp;year unless at least ninety
(90)&nbsp;days prior to expiration of the Initial Term or the Additional Term then in effect, as the case may be, one party gives the other written notice of its intention to terminate this Agreement on expiration of such Initial Term or Additional
Term.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"><B>Amendment to Section&nbsp;8(f).</B> Section&nbsp;8(f) of the Distribution Agreement is hereby amended to read as follows: </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Upon expiration or other termination of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(i)</B> DISTRIBUTOR shall pay to PENUMBRA all amounts that are payable by DISTRIBUTOR to PENUMBRA under this Agreement less
any such amounts payable on the grounds of a dispute arising out of this Agreement against any claim or damages sought by DISTRIBUTOR; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(ii)</B> Each party shall return to the other all of the Proprietary Information of the other party in the possession or
under the control of the receiving party, together with a statement signed by an authorized representative of the party to the effect that all Proprietary Information has been returned to the party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iii)</B> DISTRIBUTOR shall cease using any of the Marks and shall return to PENUMBRA all materials supplied to DISTRIBUTOR
by PENUMBRA that contain any of the Marks; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>(iv)</B> DISTRIBUTOR shall co-operate with PENUMBRA in obtaining
approvals to transfer, and transferring, the Approvals to such party as PENUMBRA shall designate.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"><B>Ratification and Approval.</B> In all other respects, the Agreement is ratified, confirmed and approved. </TD></TR></TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the parties have signed this Agreement effective as of
the date first set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>M<SMALL>EDICO</SMALL>&#146;<SMALL>S</SMALL> H<SMALL>ARATA</SMALL> I<SMALL>NC</SMALL>.</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="5"><B>PENUMBRA, I<SMALL>NC</SMALL>.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Masataka Hirata</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="6"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Masataka Hirata, President</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="5">Adam Elsesser, Chief Executive Officer</TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 2 TO DISTRIBUTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDICO&#146;S HIRATA INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIS</SMALL> A<SMALL>MENDMENT</SMALL> N<SMALL>O</SMALL>.&nbsp;2 <SMALL>TO</SMALL> D<SMALL>ISTRIBUTION</SMALL>
A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> (&#147;Agreement&#148;) is made and entered into this 16th day of September 2011 (the &#147;Effective Date&#148;), by and between <B>Penumbra, Inc.</B>, a corporation organized under the laws of Delaware,
USA, with offices at 1351 Harbor Bay Parkway, Alameda, California, USA (&#147;<B>Penumbra</B>&#148;), and <B>Medico&#146;s Hirata Inc.</B> (&#147;<B>D<SMALL>ISTRIBUTOR</SMALL></B><SMALL></SMALL>&#148;), a corporation organized under the laws of
Japan, with a registered office at 33-18 Dojima, Kita-Ku, Osaka, Japan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Penumbra and Distributor entered into a Distribution Agreement
dated August&nbsp;2, 2009, as amended by Amendment No.&nbsp;1 thereto dated June&nbsp;10, 2010 (the &#147;Distribution Agreement&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, Penumbra and Distributor wish to amend the Distribution Agreement as provided in this Amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the mutual covenants and conditions herein contained, and intending to be legally bound hereby, the parties
mutually agree as follows:<B> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">Exhibit A to this Agreement replaces Exhibit A to the Distribution Agreement. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">Section&nbsp;3(e) of the Distribution Agreement is hereby amended to read as follows: </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">&#147;<B>(e) Pricing.</B> Until such time as reimbursement prices are determined and effective for the Products by the Japanese government, the
prices to be paid by DISTRIBUTOR for the Penumbra Coil 400 Products shall be those set forth on Exhibit A. From and after the date that reimbursement prices are determined and effective for the Products by the Japanese government, the prices to be
paid by DISTRIBUTOR for Products shall be determined by the parties from time to time by means of a fixed percentage of the current reimbursement prices, taking into account PENUMBRA&#146;s manufacturing costs, change of reimbursement prices, and
competitive market situation in the Distribution Countries. Exhibit A shall be amended from time to time to reflect such agreed pricing. </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 1 of 7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">PENUMBRA will provide DISTRIBUTOR with a reasonable number of field sales samples of Products for
demonstration purposes, at PENUMBRA&#146;s cost of goods sold.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">In all other respects, the Agreement is ratified, confirmed and approved. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[Signature Page
Follows] </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 2 of 7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the parties
hereto have signed this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MEDICO&#146;S HIRATA, INC.: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Masataka Hirata</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Masataka Hirata, President</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PENUMBRA, I<SMALL>NC</SMALL>.: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Pray</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">James Pray, President</TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 3 of 7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A-Products and Pricing </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reperfusion Catheters </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/ID/Tl/WL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC026</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2.8F/.026in/154cm/150cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC032</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.4F/.032in/154cm/150cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC041</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.1F/.041in/141cm/137cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC054</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.0F/.054in/136cm/132cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Separator<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/TL/WL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS026</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.022in/200cm/155cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS032</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.028in/200cm/155cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS041</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035in/200cm/142cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS054</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.045in/175cm/135cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Aspiration Tubing </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PST1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Aspiration Tubing (Sterile)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Non-Sterile Penumbra System Supplies </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description Unit Price($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PAPS1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Pump Canister Tubing, Pump Canister and Lid, Pump Filter</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra Aspiration Pump </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PAP110</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">110V Penumbra Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PAP220</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">220V / 230V Penumbra Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 4 of 7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra Coil&#153;400 System </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Complex Standard </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Primary<BR>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Secondary<BR>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total<BR>Length</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Price</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0306</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 3 mm x 6 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0310</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 3 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0408</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 4 mm x 8 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0412</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 4 mm x 12 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0506</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 5 mm x 6 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0510</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 5mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0610</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 6mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0615</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 6mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0710</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 7mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0715</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 7 mm x 15 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0720</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 7mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0815</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 8 mm x 15 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0820</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 8mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0830</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 8mm x 30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0915</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 9 mm x 15 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0925</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 9mm x 25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C0935</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 9mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3Scm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 10 mm x 20 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1030</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 10mm x 30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1040</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 10mm x 40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1135</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 11mm x 3Scm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1145</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, llmm x 45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1235</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 12mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1245</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 12mm x 4Scm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4Scm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1335</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 13 mm x 35 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3Scm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1348</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 13mm x 48cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">48cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1450</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 14mm x 50cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">14mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">50cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1557</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 15mm x 57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">1Smm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1660</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 16mm x 60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">16mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C1857</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 18mm x 57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">18mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C2060</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 20mm x 60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C2260</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 22mm x 60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">22mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4002C2457</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 24mm x 57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">24mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 5 of 7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Complex Soft </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Primary<BR>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Secondary<BR>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total<BR>Length</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Price</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0303</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0304</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0306</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0310</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0404</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0406</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0408</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0412</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 12cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0509</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 5mm x 9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0513</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 5mm x 13cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0610</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 6mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0615</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 6mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0620</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 6 mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0710</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 7 mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0715</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 7mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0720</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 7mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0815</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 8mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0820</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 8mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0925</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 9mm x 25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C0935</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 9 mm x 35 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1020</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 10mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1030</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 10mm x 30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1040</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 10 mm x 40 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1135</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 11mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1145</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 11 mm x 45 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1235</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 12mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1245</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 12 mm x 45 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1335</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 13mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1348</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 13 mm x 48 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">48mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1440</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 14mm x 40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">14mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1545</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 15 mm x 45 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4004C1645</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 16mm x 45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">16mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 6 of 7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J Soft </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Primary</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total Length</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Price</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004J7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 J, 7cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004J10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 J, 10cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004J15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 J, 15cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Curve Extra Soft </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Primary<BR>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Secondary<BR>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Length</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Price</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0201</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x1lcm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">1cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0202</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 2cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0203</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 3cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0204</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0302</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 2cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">2cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0303</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 3cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0304</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0305</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 5cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0306</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0308</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 8cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0310</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0404</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0406</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0408</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4mm x 8cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>4006U0410</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Detachment Handle and Catheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DHl</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil Detachment Handle</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DHS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil Detachment Handle &#150; 5 Pack</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PX40045</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400,45&deg;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PX40090</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, 90&deg;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PX400J</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, J</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PX400STR</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 7 of 7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 3 TO DISTRIBUTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDICO&#146;S HIRATA INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>T<SMALL>HIS</SMALL> A<SMALL>MENDMENT</SMALL> N<SMALL>O</SMALL>.&nbsp;3 T<SMALL>O</SMALL> D<SMALL>ISTRIBUTION</SMALL>
A<SMALL>GREEMENT</SMALL></B><SMALL></SMALL> (&#147;Agreement&#148;) is made and entered into as of the 22nd day of August 2012 (the &#147;Effective Date&#148;), by and between <B>Penumbra, Inc.</B>, a corporation organized under the laws of
Delaware, USA, with offices at 1351 Harbor Bay Parkway, Alameda, California, USA (&#147;<B>Penumbra</B>&#148;), and <B>Medico&#146;s Hirata Inc.</B> (&#147;<B>D<SMALL>ISTRIBUTOR</SMALL></B><SMALL></SMALL>&#148;), a corporation organized under the
laws of Japan, with a registered office at 3-3-18 Dojima, Kita-Ku, Osaka, Japan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS,</B> Penumbra and Distributor entered into a Distribution
Agreement dated August&nbsp;2, 2009, as amended by Amendment No.&nbsp;1 thereto dated June&nbsp;10, 2010, and Amendment No.&nbsp;2 thereto dated September&nbsp;16,2011 (the &#147;Distribution Agreement&#148;); and<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS,</B> Penumbra and Distributor wish to amend the Distribution Agreement as provided in this Amendment. <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE,</B> in consideration of the mutual covenants and conditions herein contained, and intending to be legally bound hereby, the parties
mutually agree as follows:<B> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">Exhibit A to this Agreement replaces Exhibit A to the Distribution Agreement. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">Section&nbsp;3(e) of the Distribution Agreement is hereby amended to read as follows: </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">&#147;<B>(e) Pricing. [***</B>] <I><U>and provided further that</U></I> until such time as reimbursement prices are determined and effective
for the Detachment Handle and Catheter Products listed on Exhibit A by the Japanese government, the prices to be paid by DISTRIBUTOR for those Products shall be those set forth on Exhibit A, and from and after the date that reimbursement prices are
determined and effective for those Products by the Japanese government, the prices to be paid by DISTRIBUTOR for Products shall be determined by the parties from time to time by means of a fixed percentage of the current reimbursement prices, taking
into account PENUMBRA&#146;s manufacturing costs, change of reimbursement prices, and competitive market situation in the Distribution Countries. Exhibit A shall be amended from time to time to reflect such agreed pricing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">PENUMBRA will provide DISTRIBUTOR with a reasonable number of field sales samples of Products for demonstration purposes, at PENUMBRA&#146;s
cost of goods sold.&#148; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">Section&nbsp;3(g) of the Distribution Agreement is hereby amended to read as follows: </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(f)
Payments.</B> All amounts due and payable with respect to Products delivered by PENUMBRA, in accordance with the preceding subsection, shall be paid in full by the end of <B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 1 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the month following the month during shipment of product is made together with invoice. All such amounts shall be paid in US dollars (unless another currency is specified in Exhibit A under the
column &#147;Unit Price&#148;) by wire transfer, to such bank or account as PENUMBRA may from time to time designate in writing. Whenever any amount hereunder is due on a day that is not a day on which banks in the United States or Distribution
Countries are open for business (a &#147;Business Day&#148;), such amount shall be paid on the next Business Day. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">In all other respects, the Agreement is ratified, confirmed and approved. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[Signature Page
Follows] </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 2 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the parties
hereto have signed this Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PENUMBRA, INC.</B></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="3"><B>MEDICO&#146;S HIRATA, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Pray</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Masataka Hirata</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">James Pray</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Name:&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Masataka Hirata</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">President</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">President</TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 3 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A &#150; Products and Pricing </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reperfusion Catheters </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/ID/TL/WL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSC026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2.8F/.026in/154cm/150cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSC032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.4F/.032in/154cm/150cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSC041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.1F/.04in/141cm/137cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSC054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.0F/.054in/136cm/132cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Separator&#153; </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/TL/WL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSS026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator 026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.022in/200cm/155cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSS032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator 032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.028in/200cm/155cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSS041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator 041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035in/200cm/142cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSS054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator 054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.045in/175cm/135cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Separator Flex </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/Wl/TL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSF026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator Flex 026 (0.014in wire)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.022&#148;, 155cm, 190cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSF032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator Flex 032 (0.014in wire)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.028&#148;, 155cm, 190cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSF041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator Flex 041 (0.014in wire)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035&#148;, 142cm, 175cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSF054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Separator Flex 054 (0.014in wire)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.045&#148;, 135cm, 175cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Separator 3D </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Device<BR>Diameter<BR>(mm)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Device</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Length</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(mm)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Wire</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Length</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(cm)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Aspiration Catheters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit<BR>Price&nbsp;($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSS3D</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 3D</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4.5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">26</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">200</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheters 041 and 054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Aspiration Tubing </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PST1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Aspiration Tubing (Sterile)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Non-Sterile Penumbra System Supplies </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PAPS1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Pump Canister Tubing, Pump Canister and Lid, Pump Filter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra Aspiration Pump </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PAP110</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">110V Penumbra Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PAP220</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">220V/230V Penumbra Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 4 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Penumbra System&reg; MAX Intracranial Revascularization System </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra System&reg; MAX Reperfusion Catheters </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(00/ID/Tl/WL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3MAXC</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3MAX Reperfusion Catheter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.8/.035in/157cm/153cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4MAXC</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4MAX Reperfusion Catheter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.3F/.041in/143cm/139cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4MAXC130</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4MAX Reperfusion Catheter &#150; 130</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.3F/.04iln/134cm/130cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSC054</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5MAX Reperfusion Catheter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.0F/.054in/175cm/132cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSC054L125</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5MAX Reperfusion Catheter &#150; 125</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.0F/.054in/129cm/125cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra System&reg; MAX Separator </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="15%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/WL/TL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3MAXS</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">3MAX Separator</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.030&#148;, 158cm, 190cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSF041</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4MAX Separator (Separator Flex 041)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035&#148;, 142cm, 175cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSF054</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5MAX Separator (Separator Flex 054)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.045&#148;, 135cm, 175cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra System&reg; MAX Aspiration Tubing </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PST2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">MAX Aspiration Tubing (Sterile)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Non-Sterile Penumbra System&reg; MAX Supplies </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PAPS2</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Pump Canister Tubing, Pump Canister and Lid, Pump Filter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra System&reg; MAX Aspiration Pump Starter Pack </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit&nbsp;Price($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PMX220</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">220V/230V Penumbra MAX Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PMX110</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">110V Penumbra MAX Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Neuron&#153; </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron Delivery Catheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (WL/00/ID/WC)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit&nbsp;Price($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F11512</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 115/12 Straight</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">115cm/12cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F11512M</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 115/12 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">115cm/12cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F1156</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 115/6 Straight</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">115cm/6cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F1156M</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 115/6 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">115cm/6cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F10512</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 105/12 Straight</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">105cm/12cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PND6F10S12M</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 105/12 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">105cm/12cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PND6F1056</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 105/6 Straight</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">105cm/6cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PND6F1056M</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 105/6 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">105cm/6cm, 6F/5F, .053,, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 5 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron 6F 070 Delivery Catheter </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (WL/OD/ID/WC)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit&nbsp;Price&nbsp;($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PND6F070956</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Delivery Catheter 95/6 Straight</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">95cm/6cm, 6F/6F, .070&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PND6F0700956M</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Delivery Catheter, 95/6 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">95cm/6cm, 6F/6F, .070&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PND6F0701058</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Deliver Catheter ,105/8 Straight</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">105cm/8cm, 6F/6F, .070&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PND6F0701058M</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Deliver Catheter, 105/8 MP</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">105cm/8cm, 6F/6F, .070&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron Select Catheter </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (WL/00/ID/WCJ</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit&nbsp;Price&nbsp;($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS5F120H1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 120 H1</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">120cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS5F120SIM</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 120 SIM</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">120cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS5F120BER</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 120 BER</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">120cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS5F130H1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 130 Hl</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">130cm/9cm, 5F/5F, .040&#148;, .035&#148;/ .038 ..</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS5F130SIM</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 130 SIM</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">130cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS5F130BER</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 130 BER</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">130cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron MAX088 Select Catheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Working<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Distal<BR>Flexible<BR>Zone</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proximal/<BR>Mid/Distal<BR>Outer<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Inner<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Wire<BR>Compatibility</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NeuronMAX<BR>Compatibility</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Tip<BR>Shape</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit<BR>Price<BR>($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS6F105H1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="8">Both<BR> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">8F</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">Delivery</P>
<P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">Catheter and</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">Long Sheath</P>
<P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">Configurations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Hl</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS6F10SSIM</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS6F105BER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS6F105SIMV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SIM-V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS6F125H1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">125cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Hl</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS6F125SIM</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">125cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS6F125BER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">125cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNS6Fl25SIMV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">125cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SIM-V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron MAX088 Large Lumen catheter </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Working<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Distal<BR>Flexible<BR>Zone</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proximal<BR>and&nbsp;Distal<BR>OD</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Inner<BR>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Wire<BR>Compatibility</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Select catheter<BR>Compatibility</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Tip Shape</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price<BR>($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNMDSF088804</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">80cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F&nbsp;Neuron&nbsp;Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNMD8F088804M</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">80cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Multi-Purpose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNMDSF088904</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">90cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNMD8F088904M</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">90cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Multi-Purpose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNML6F088804</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">80cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>.088&#148;&nbsp;/&nbsp;6F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNML6F088804M</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">80cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>.088&#148;&nbsp;/&nbsp;6F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Multi-Purpose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNML6F088904</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">90cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>.088&#148;&nbsp;/&nbsp;6F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNML6F088904M</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">90cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>.088&#148;/&nbsp;6F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Multi-Purpose</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">00/10/Tl/Wl: Outer Diameter/Inner Diameter/Total length/Working length </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 6 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra Coil<SUP STYLE="font-size:85%; vertical-align:top">TM</SUP> 400 System </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Complex Standard </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Primary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Secondary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit</B><br><B>Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0306</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 3 mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0310</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 3 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0408</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 4 mm x 8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0412</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 4 mm x 12 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0506</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 5 mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0510</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 5mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0610</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 6mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0615</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 6mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0710</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 7mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0715</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 7 mm x 15 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0720</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 7mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0815</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 8 mm x 15 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0820</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 8mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0830</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 8mm x 30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0915</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 9 mm x 15 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0925</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 9mm x 25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C0935</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 9mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 10 mm x 20 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1030</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 10mm x 30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1040</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 10mm x 40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1135</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, llmm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1145</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, llmm x 45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1235</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 12mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1245</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 12mm x 45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1335</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 13 mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1348</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 13mm x 48cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">48cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1450</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 14mm x 50cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">14mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">50cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1557</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 15mm x 57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002Cl660</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coi1 400 Complex Standard, 16mm x 60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">16mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C1857</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 18mm x 57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">18mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C2060</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 20mm x 60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C2260</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 22mm x 60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">22mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4002C2457</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 24mm x 57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">24mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 7 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Complex Soft </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Primary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Secondary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit</B><br><B>Price</B><br><B>(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0303</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0304</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0306</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0310</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0404</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0406</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0408</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0412</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 12cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0509</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 5mm x 9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0513</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 5mm x 13cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0610</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 6mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">l0cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0615</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 6mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0620</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 6 mm x 20 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0710</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 7 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0715</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 7mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0720</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 7mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0815</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 8mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0820</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 8mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0925</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 9mm x 2Scm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C0935</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 9 mm x 35 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 10mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1030</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 10mm x 30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1040</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 10 mm x 40 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1135</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 11mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1145</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 11 mm x 45 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1235</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 12mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1245</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 12 mm x 45 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1335</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 13mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1348</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 13 mm x 48 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">48mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1440</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 14mm x 40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">14mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1545</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 15 mm x 45 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004C1645</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 16mm x 45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">16mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J Soft </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="7%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Primary</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total<BR>Length</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Price&nbsp;(&yen;)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004J7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 J, 7cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004J10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 J, 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4004Jl5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 J, 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 8 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Curve Extra Soft </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Primary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Secondary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit</B><br><B>Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0201</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 1cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">1cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0202</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 2cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0203</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0204</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0302</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 2cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0303</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0304</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0305</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 5cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0306</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0308</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0310</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3 mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0404</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0406</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0408</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4mm x 8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4006U0410</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4 mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Detachment Handle and Catheter </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DH1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil Detachment Handle</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DHS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil Detachment Handle &#150; 5 Pack</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Penumbra Delivery Microcatheters </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PX 400&#153; Delivery Microcatheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PX40045</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, 45&deg;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PX40090</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, 90&deg;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PX400J</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, J</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PX400STR</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PX SLIM&#153; Delivery Microcatheter </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PXSLIMSTR</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PXSLIM Delivery Catheter &#150; Straight (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PXSLIM045</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PXSLIM Delivery Catheter &#150; 45 (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PXSLIM090</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PXSLIM Delivery Catheter &#150; 90 (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PXSLIM130</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PXSLIM Delivery Catheter &#150; 130 (J) (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PXSLIM160STR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX SLIM Delivery Catheter &#150; Straight (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PXSLIM160045</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX SLIM Delivery Catheter &#150; 45 (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PXSLIM160090</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX SLIM Delivery Catheter &#150; 90&deg; (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PXSLIM160130</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX SLIM Delivery Catheter &#150; 130&deg; (J) (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 9 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Velocity&#153; Delivery Microcatheter </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="8%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit&nbsp;Price<BR>(&yen;)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VEL150STR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter&#150; Straight (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VEL150045</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 45 (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VEL150090</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; go (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VEL150130</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 130 (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VEL160STR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter&#150; Straight (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VEL160045</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 45 (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VEL160090</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 90 (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">VEL160130</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter&#150; 130 (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Page 10 of 10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 4 DISTRIBUTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BETWEEN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC.
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MEDICO&#146;S HIRATA INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS
AMENDMENT NO. 4 TO DISTRIBUTION AGREEMENT</B> (&#147;Amendment No.&nbsp;4&#148;) is made and entered into as of the 1st day of May 2013 (the &#147;Effective Date&#148;), by and between <B>Penumbra, Inc.,</B> a corporation organized under the laws of
Delaware, USA, with offices at 1351 Harbor Bay Parkway, Alameda, California, USA (&#147;<B>Penumbra</B>&#148;), and <B>Medico&#146;s Hirata Inc.</B> (<B>&#147;Distributor&#148;</B>), a corporation organized under the laws of Japan, with a registered
office at 3-3-18 Dojima, Kita-Ku, Osaka, Japan.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS,</B> Penumbra and Distributor entered into a Distribution Agreement dated
August&nbsp;2, 2009, as amended by Amendment No.&nbsp;1 thereto dated June&nbsp;17, 2010, Amendment No.&nbsp;2 thereto dated September&nbsp;16, 2011, and Amendment No.&nbsp;3 thereto dated August&nbsp;22, 2012 (the &#147;Amended Distribution
Agreement&#148;); and<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS,</B> Penumbra and Distributor wish to amend the Amended Distribution Agreement as provided in this Amendment.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the mutual covenants and conditions herein contained, and intending to be legally bound hereby the parties
mutually agree as follows:<B> </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">Exhibit A to this Amendment No.&nbsp;4 replaces Exhibit A to the Amended Distribution Agreement. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">The Amended Distribution Agreement is hereby amended by adding the following as Section&nbsp;2(e): </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">&#147;<B>(e) Liberty Stent Trial</B><B></B>.<B></B> Penumbra is conducting the clinical trial entitled: &#147;CLP 5038: The Penumbra Liberty
Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms&#148; (the &#147;Liberty Trial&#148;) in order to obtain approval of its Liberty Stent device from the United States Food and Drug Administration. The Liberty Trial
will include a limited number of sites in Japan to facilitate approval of the Liberty Stent device in Japan. Distributor agrees to provide its regulatory and clinical resources as necessary to cooperate with Penumbra as necessary to conduct the
clinical trial at the sites designated in Japan, and Penumbra agrees to bear certain costs related to enrolling and monitoring patients in the Liberty Trial. Distributor will conduct the clinical trial of the Liberty Stent device in Japan in order
to obtain the Shonin Approval of the Japan Pharmaceuticals and Medical Devices Agency (&#147;PMDA&#148;) and other necessary Approvals with respect to the Liberty Stent device, and Penumbra agrees to provide its regulatory and clinical <B> </B></P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">
resources as necessary to conduct the clinical trial at the sites in Japan and to support certain costs related to enrolling and monitoring patients enrolled in the Liberty Trial in Japan, as
follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">Penumbra will supply at no cost to Distributor all Liberty Stents, Penumbra coils, PX 400 catheters, and detachment handles necessary to conduct the procedures required by the Liberty Trial protocol for each patient
enrolled in the Liberty Trial in Japan; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">Penumbra will pay the per-patient research fee negotiated with each site in Japan, provided that Penumbra shall first have reviewed and approved the contract and fees for each such site; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top">Penumbra reserves the right to perform all clinical monitoring functions required by the Liberty Study. If Clinical Research Organization (&#147;CRO&#148;) is retained to perform such function, Penumbra will pay the
clinical monitoring costs for all patients enrolled in the Liberty Trial in Japan who are monitored by the CRO, provided that Penumbra shall first have reviewed and approved the contract with the fees and expenses payable to such CRO;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top">Penumbra will bear the consultation and filing fee payable to PMDA. Upon execution of this Amendment No.&nbsp;4, Penumbra will pay the amounts required for the consultation and filing fee to Distributor and Distributor
will in turn pay to PMDA the amount of the consultation in advance and the amount of the fee for filing the application for Shonin Approval. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top">Penumbra and Distributor will share equally all expenses payable to third parties in connection with any Post Market Surveillance Study that may be required by the Japanese regulatory authorities for the Liberty Stent
after it is approved in Japan. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top">The matters and contents of the cooperation to be made between Penumbra and Distributor and the support to be made by Distributor to Penumbra for conducting the clinical operations in Japan shall be consulted and agreed
between Penumbra and Distributor which agreement is set forth in Attachment 1 hereto. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">In all other respects, the Amended Distribution Agreement is ratified, confirmed and approved. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[Signature Page Follows] </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the
parties hereto have signed this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MEDICO&#146;S HIRATA, INC.: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Masataka Hirata</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Masataka Hirata, President</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PENUMBRA, I<SMALL>NC</SMALL>.: </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James Pray</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">James Pray, President</TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A &#150; Products and Pricing </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reperfusion Catheters </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/ID/TL/WL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC026</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2.8F/.026in/154cm/150cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC032</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.4F/.032in/154cm/150cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC041</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.1F/.041in/141cm/137cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSC054</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheter 054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.0F/.054in/136cm/132cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Separator&#153; </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/TL/WL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS026</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 026</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.022in/200cm/155cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS032</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 032</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.028in/200cm/155cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS041</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035in/200cm/142cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSS054</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.045in/175cm/135cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Separator Flex </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/WL/TL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSF026</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator Flex 026 (0.014in wire)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.022&#148;, 155cm, 190cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSF032</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator Flex 032 (0.014in wire)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.028&#148;, 155cm, 190cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSF041</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator Flex 041 (0.014in wire)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035&#148;, 142cm, 175cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PSF054</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator Flex 054 (0.014in wire)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.045&#148;, 135cm, 175cm</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Separator 3D </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Device<BR>Diameter<BR>(mm)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Device</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>length</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(mm)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Wire</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>length</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(cm)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Aspiration Catheters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit<BR>Price</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSS3D</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separator 3D</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">4.5</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">26</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">200</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reperfusion Catheters 041 and 054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Aspiration Tubing </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PST1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Aspiration Tubing (Sterile)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Non-Sterile Penumbra System Supplies </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit Price ($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PAPS1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Pump Canister Tubing, Pump Canister and Lid, Pump Filter</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra Aspiration Pump </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog&nbsp;Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PAP110</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">110V Penumbra Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PAP220</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">220V/230V Penumbra Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Penumbra System<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> MAX Intracranial Revascularization System
</U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra System<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> MAX Reperfusion Catheters </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Catalog<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(OD/ID/TL/WL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3MAXC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3MAX Reperfusion Catheter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.8/.035in/157cm/153cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4MAXC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4MAX Reperfusion Catheter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.3F/.041in/143cm/139cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">4MAXC130</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4MAX Reperfusion Catheter &#150; 130</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.3F/.041in/134cm/130cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSC054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5MAX Reperfusion Catheter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.0F/.054in/175cm/132cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSC054L125</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5MAX Reperfusion Catheter - 125</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.0F/.054in/129cm/125cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra System<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> MAX Separator </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Catalog<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (OD/WL/TL)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">3MAXS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3MAX Separator</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.030&#148;, 158cm, 190cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSF041</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4MAX Separator (Separator Flex 041)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035&#148;, 142cm, 175cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PSF054</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5MAX Separator (Separator Flex 054)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.045&#148;, 135cm, 175cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra System<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> MAX Aspiration Tubing </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Catalog<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PST2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">MAX Aspiration Tubing (Sterile)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">[***]</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Non-Sterile Penumbra System<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> MAX Supplies </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="85%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Catalog<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PAPS2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Pump Canister Tubing, Pump Canister and Lid, Pump Filter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra System<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> MAX Aspiration Pump Starter Pack </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="8%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:28.45pt; font-size:8pt; font-family:Times New Roman"><B>Catalog<BR>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Unit&nbsp;Price&nbsp;($)</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PMX220</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">220V/230V Penumbra MAX Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PMX110</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">110V Penumbra MAX Aspiration Pump</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Neuron&#153; </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron Delivery Catheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog&nbsp;Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (WL/OD/ID/WC)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F11512</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 115/12 Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">115cm/12cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F11512M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 115/12 MP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">115cm/12cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F1156</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 115/6 Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">115cm/6cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F1156M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 115/6 MP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">115cm/6cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F10512</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 105/12 Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm/12cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F10512M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 105/12 MP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm/12cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F1056</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 105/6 Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm/6cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F1056M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Delivery Catheter 105/6 MP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm/6cm, 6F/5F, .053&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron 6F 070 Delivery Catheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog&nbsp;Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (WL/OD/ID/WC)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F070956</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Delivery Catheter 95/6 Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">95cm/6cm, 6F/6F, .070&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F0700956M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Delivery Catheter, 95/6 MP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">95cm/6cm, 6F/6F, .070&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F0701058</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Deliver Catheter ,105/8 Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm/8cm, 6F/6F, .070&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PND6F0701058M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F 070 Neuron Deliver Catheter, 105/8 MP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105cm/8cm, 6F/6F, .070&#148;, .035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron Select Catheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog&nbsp;Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (WL/OD/ID/WC)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS5F120H1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 120 H1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">120cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS5F120SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 120 SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">120cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS5F120BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 120 BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">120cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS5F130H1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 130 H1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">130cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS5F130SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 130 SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">130cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS5F130BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5F Neuron Select Catheter, 130 BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">130cm/9cm, 5F/5F, .040&#148;, .035&#148;/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron MAX088 Select Catheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Working<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Distal<BR>Flexible<BR>Zone</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proximal/<BR>Mid/Distal&nbsp;Outer<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Inner<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Wire<BR>Compatibility</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>NeuronMAX<BR>Compatibility</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Tip&nbsp;Shape</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit<BR>Price<BR>($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS6F105H1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105&nbsp;cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9&nbsp;cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="8">Both 8F<BR>Delivery<BR>Catheter and<BR>6F&nbsp;Long&nbsp;Sheath<BR>Configurations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">H1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS6F105SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS6F105BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS6F105SIMV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">105 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SIM-V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS6F125H1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">125 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">H1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS6F125SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">125 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">SIM</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS6F125BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">125 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">BER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNS6F125SIMV</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">125 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.6F/6F/5F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.040&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">SIM-V</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuron MAX088 Large Lumen Catheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:57.10pt; font-size:8pt; font-family:Times New Roman"><B>Catalog&nbsp;Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Working<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Distal<BR>Flexible<BR>Zone</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proximal<BR>and&nbsp;Distal<BR>OD</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Inner<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Wire<BR>Compatibility</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Select Catheter<BR>Compatibility</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Tip Shape</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price<BR>($)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNMD8F088804</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">80&nbsp;cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4&nbsp;cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F&nbsp;Neuron&nbsp;Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNMD8F088804M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">80 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Multi-Purpose</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNMD8F088904</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">90 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNMD8F088904M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">90 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Multi-Purpose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNML6F088804</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">80 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;&nbsp;/&nbsp;6F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNML6F088804M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">80 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;&nbsp;/&nbsp;6F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Multi-Purpose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNML6F088904</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">90 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;&nbsp;/&nbsp;6F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PNML6F088904M</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">90 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.088&#148;&nbsp;/&nbsp;6F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.035/.038&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6F Neuron Select</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Multi-Purpose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OD/ID/TL/WL: Outer Diameter/Inner Diameter/Total Length/Working Length </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Penumbra Coil&#153; 400 System </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Complex Standard </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Primary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Secondary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit<BR>Price<BR>(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0306</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 3 mm x 6 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0310</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 3 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0408</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 4 mm x 8 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0412</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 4 mm x 12 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0506</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 5 mm x 6 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0510</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 5mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0610</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 6mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0615</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 6mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0710</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 7mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0715</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 7 mm x 15 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0720</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 7mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0815</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 8 mm x 15 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0820</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 8mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0830</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 8mm x 30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0915</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 9 mm x 15 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0925</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 9mm x 25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C0935</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 9mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1020</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 10 mm x 20 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1030</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 10mm x 30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1040</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 10mm x 40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1135</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 11mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1145</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 11mm x 45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1235</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 12mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1245</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 12mm x 45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1335</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 13 mm x 35 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1348</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 13mm x 48cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">48cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1450</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 14mm x 50cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">14mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">50cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1557</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 15mm x 57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1660</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 16mm x 60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">16mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C1857</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 18mm x 57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">18mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C2060</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 20mm x 60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C2260</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 22mm x 60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">22mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">60cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4002C2457</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Standard, 24mm x 57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">24mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">57cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Complex Soft </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Primary<BR>Diameter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Secondary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit<BR>Price<BR>(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0303</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 3 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0304</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0306</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 6 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0310</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 3 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0404</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 4 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0406</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 6 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0408</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 8 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0412</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 4 mm x 12 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0509</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 5mm x 9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0513</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 5mm x 13cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0610</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 6mm x 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0615</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 6mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0620</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 6 mm x 20 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0710</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 7 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0715</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 7mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0720</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 7mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0815</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 8mm x 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0820</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 8mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0925</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 9mm x 25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">25cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C0935</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 9 mm x 35 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">9mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1020</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 10mm x 20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">20cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1030</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 10mm x 30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">30cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1040</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 10 mm x 40 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1135</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 11mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1145</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 11 mm x 45 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">11mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1235</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 12mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1245</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 12 mm x 45 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">12mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1335</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 13mm x 35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">35cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1348</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 13 mm x 48 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">13mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">48mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1440</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 14mm x 40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">14mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">40cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1545</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 15 mm x 45 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004C1645</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Complex Soft, 16mm x 45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">16mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">45cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J Soft </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Primary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price<BR>(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004J7</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 J, 7cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">7cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004J10</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 J, 10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4004J15</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 J, 15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">15cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Curve Extra Soft </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Primary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Secondary<BR>Diameter</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Length</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit<BR>Price<BR>(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0201</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 1cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">1cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0202</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 2cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0203</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0204</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 2mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0302</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 2cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">2cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0303</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0304</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0305</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 5cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0306</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0308</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3mm x 8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0310</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 3 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0404</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4mm x 4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0406</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4mm x 6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">6cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0408</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4mm x 8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">8cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>4006U0410</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil 400 Curve Extra Soft, 4 mm x 10 cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">.020&#148;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4mm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">10cm</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Detachment Handle and Catheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DH1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil Detachment Handle</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DH5</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Coil Detachment Handle &#150; 5 Pack</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Penumbra Delivery Microcatheters </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PX 400&#153; Delivery Microcatheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="10%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PX40045</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, 45&deg;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PX40090</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, 90&deg;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PX400J</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, J</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PX400STR</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX400, Straight</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PX SLIM&#153; Delivery Microcatheter </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>PXSLIMSTR</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PXSLIM Delivery Catheter &#150; Straight (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>PXSLIM045</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PXSLIM Delivery Catheter - 45 (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>PXSLIM090</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PXSLIM Delivery Catheter - 90 (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>PXSLIM130</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PXSLIM Delivery Catheter &#150; 130 (J) (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>PXSLIM160STR</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX SLIM Delivery Catheter - Straight (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>PXSLIM160045</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX SLIM Delivery Catheter - 45 (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>PXSLIM160090</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX SLIM Delivery Catheter - 90&deg; (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>PXSLIM160130</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">PX SLIM Delivery Catheter - 130&deg; (J ) (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>[***]</B></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Velocity&#153; Delivery Microcatheter </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>VEL150STR</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; Straight (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>VEL150045</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 45 (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>VEL150090</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 90 (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>VEL150130</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 130 (150cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>VEL160STR</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; Straight (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>VEL160045</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 45 (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>VEL160090</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 90 (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>VEL160130</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Velocity Delivery Catheter &#150; 130 (160cm)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liberty&#153; Intracranial Stent System </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:26.65pt; font-size:8pt; font-family:Times New Roman"><B>Catalog</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Specifications (Expanded</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>O.D./Length/Twist)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unit&nbsp;Price&nbsp;(&yen;)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU3020PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 3.0 x 20 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.0mm/20mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU3035PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 3.0 x 35 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.0mm/35mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU3520PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 3.5 x 20 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.5mm/20mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU3535PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 3.5 x 35 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">3.5mm/35mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU4025PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 4.0 x 25 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.0mm/25mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU4045PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 4.0 x 45 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.0mm/45mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU4525PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 4.5 x 25 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.5mm/25mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU4545PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 4.5 x 45 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">4.5mm/45mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU5025PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 5.0 x 25 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.0mm/25mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>HU5045PRIM</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Liberty 5.0 x 45 mm, Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5.0mm/45mm/Primary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attachment I Task Responsibility </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra will appoint Medico&#146;s Hirata as an In-Country Care-taker prescribed in Article 15 of Ministerial Ordinance on Good Clinical Practice for Medical
Devices Ordinance of the MHLW No.36(March 23, 2005). Medico&#146;s Hirata, as the In-Country Care-taker, will take procedures related to request for clinical trial in Japan and submit the notification of clinical trial plan to the Minister of MHLW
according to the ordinance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Responsibility for each task is as follows (<FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT
STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT>: responsible) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MH bears the expenses for translation from English to Japanese and interpretation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PI bears the expenses for translation from Japanese to English (for FDA issues). </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="62%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:11.80pt; font-size:8pt; font-family:Times New Roman">No.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Necessary Tasks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Penumbra</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Medicos Hirata</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pre-trial preparation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Confirmation of non-clinical testing status</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Investigation of past shonin approval(s) and similar device(s)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Clinical Investigation Plan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Translation/Review)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CRF (Case Report Form)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Translation/Review)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Informed Consent Form</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Translation/Review)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Investigator&#146;s Brochure</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Translation/Review)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Pre-meeting with PMDA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Investigation of past trial(s) and similar device(s). Investigation of domestic and foreign results</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Investigation&nbsp;of&nbsp;foreign<BR>results</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Domestic&nbsp;investigation</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Preparation for SOP for GCP, other SOPs and system establishment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Translation)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Verification of protocol, SOP for JGCP and etc. (Acceptance to Japan)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Clinical trial consultation meeting with PMDA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Preliminary investigation of Principal Investigators</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Investigation of possible investigation sites (Selection and requirement exploration)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Discussion about the contents of Protocol, IC and CRF with Investigators.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Preparation and submission of the notification of clinical trial plan, Response to inquiries from PMDA.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Enrollment in insurance for investigational devices (establishment of compensation system)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Request to sites and contract</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Preparation and submission of a clinical trial request form and necessary documents for IRB</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Review by IRB and related tasks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Contract conclusion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Document&nbsp;preparation)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Explanation about Protocol and trial regulatory procedures, Obtaining agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Explanation of device usage and handling precautions (hospital workers concerned)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Support)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Provision of investigational devices to Investigational Device Administrator (including provision of related documents)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tasks during clinical investigation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">CRFs collection, initial check and status review</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">SDV (Source Data Verification)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Interpretation)</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Confirmation of documents that investigation sites and PIs must keep</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">26</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Investigation of Adverse Events</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">27</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Preparation of Adverse Event reports</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT> (FDA)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT> (PMDA)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">28</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Necessary tasks for compensation and recompense</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">29</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Auditing of the Clinical trial</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">(Interpretation)</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">30</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Contract termination procedures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">31</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Collection of investigational devices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DM/Analysis</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">32</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Data entry</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">33</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Coding and cleaning, Data-set creation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">34</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Preparation of Analysis Report</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">35</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Preparation of Clinical Investigation Report</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Translation</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Application submission for approval</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">39</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Preparation and submission of Shonin application, Response to inquiries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">40&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">GCP Audit and related tasks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT> (FDA)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:ARIAL"><SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#161;</FONT></SUP></FONT> (PMDA)</TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Confidential Information, indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission. </TD></TR></TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>9
<FILENAME>filename9.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014
EQUITY INCENTIVE PLAN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Purposes of the Plan</U>. The purposes of this Plan are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to attract and retain the best available personnel for positions of substantial responsibility, </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to provide additional incentive to Employees, Directors and Consultants, and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to promote the success of the Company&#146;s business. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Plan permits the grant of
Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock and Restricted Stock Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Definitions</U>. As used herein, the following definitions will apply: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Administrator</U>&#148; means the Board or any of its Committees as will be administering the Plan, in
accordance with Section&nbsp;4 of the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Applicable Laws</U>&#148; means the requirements relating
to the administration of equity-based awards under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of any
foreign country or jurisdiction where Awards are, or will be, granted under the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Award</U>&#148;
means, individually or collectively, a grant under the Plan of Options, Stock Appreciation Rights, Restricted Stock, or Restricted Stock Units. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Award Agreement</U>&#148; means the written or electronic agreement setting forth the terms and provisions
applicable to each Award granted under the Plan. The Award Agreement is subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Change in Control</U>&#148; means the occurrence of any of the following events: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Change in Ownership of the Company</U>. A change in the ownership of the Company which occurs on the date that
any one person, or more than one person acting as a group (&#147;Person&#148;), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than 50% of the total voting power of the stock of the
Company, except that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Board will not be considered a Change in Control; or </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Change in Effective Control of the Company</U>. If the Company
has a class of securities registered pursuant to Section&nbsp;12 of the Exchange Act, a change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12)&nbsp;month
period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this clause (ii), if any Person is considered to be in effective control of
the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Change in Ownership of a Substantial Portion of the Company&#146;s Assets</U>. A change in the ownership of a
substantial portion of the Company&#146;s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12)&nbsp;month period ending on the date of the most recent acquisition by such person or persons) assets from the
Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions. For purposes of this subsection (iii), gross
fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;2(f), persons will be considered to be acting as a group if they are owners of a corporation that enters
into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Notwithstanding the
foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning of Code Section&nbsp;409A, as it has been and may be amended from time to time, and any proposed or
final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (i)&nbsp;its sole purpose is to change the
jurisdiction of the Company&#146;s incorporation, or (ii)&nbsp;its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#146;s securities immediately before such
transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended. Any reference to a
section of the Code herein will be a reference to any successor or amended section of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Committee</U>&#148; means a committee of Directors or of other individuals satisfying Applicable Laws
appointed by the Board, or by the compensation committee of the Board, in accordance with Section&nbsp;4 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Common Stock</U>&#148; means the common stock of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company</U>&#148; means Penumbra, Inc. a Delaware
corporation, or any successor thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Consultant</U>&#148; means any natural person, including an
advisor, engaged by the Company or a Parent or Subsidiary to render bona fide services to such entity, provided the services (i)&nbsp;are not in connection with the offer or sale of securities in a
<FONT STYLE="white-space:nowrap">capital-raising</FONT> transaction, and (ii)&nbsp;do not directly promote or maintain a market for the Company&#146;s securities. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Director</U>&#148; means a member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disability</U>&#148; means total and permanent disability as defined in Code Section&nbsp;22(e)(3),
provided that in the case of Awards other than Incentive Stock Options, the Administrator in its discretion may determine whether a permanent and total disability exists in accordance with uniform and non-discriminatory standards adopted by the
Administrator from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Employee</U>&#148; means any person, including officers and
Directors, employed by the Company or any Parent or Subsidiary of the Company. Neither service as a Director nor payment of a director&#146;s fee by the Company will be sufficient to constitute &#147;employment&#148; by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Program</U>&#148; means a program under which (i)&nbsp;outstanding Awards are surrendered or
cancelled in exchange for Awards of the same type (which may have higher or lower exercise prices and different terms), Awards of a different type, and/or cash, (ii)&nbsp;Participants would have the opportunity to transfer any outstanding Awards to
a financial institution or other person or entity selected by the Administrator, and/or (iii)&nbsp;the exercise price of an outstanding Award is reduced or increased. The Administrator will determine the terms and conditions of any Exchange Program
in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Fair Market Value</U>&#148; means, as of any date, the value of Common Stock
determined as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;If the Common Stock is listed on any established stock exchange or a national market
system, including without limitation the Nasdaq Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market of The Nasdaq Stock Market, its Fair Market Value will be the closing sales price for such stock (or the closing bid, if no
sales were reported) as quoted on such exchange or system on the day of determination, as reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the
Fair Market Value of a Share will be the mean between the high bid and low asked prices for the Common Stock on the day of determination (or, if no bids and asks were reported on that date, as applicable, on the last trading date such bids and asks
were reported), as reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;In the absence of an established market for the Common Stock, the
Fair Market Value will be determined in good faith by the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(r)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Incentive Stock
Option</U>&#148; means an Option that by its terms qualifies and is otherwise intended to qualify as an incentive stock option within the meaning of Code Section&nbsp;422 and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(s)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Nonstatutory Stock Option</U>&#148; means an Option that by its terms does not qualify or is not intended
to qualify as an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(t)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Option</U>&#148; means a stock option granted pursuant to
the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(u)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent</U>&#148; means a &#147;parent corporation,&#148; whether now or hereafter existing,
as defined in Code Section&nbsp;424(e). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Participant</U>&#148; means the holder of an outstanding
Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(w)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Period of Restriction</U>&#148; means the period during which the transfer of Shares of
Restricted Stock are subject to restrictions and therefore, the Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the achievement of target levels of performance, or the occurrence of
other events as determined by the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Plan</U>&#148; means this 2014 Equity Incentive
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(y)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Restricted Stock</U>&#148; means Shares issued pursuant to an Award of Restricted Stock under
Section&nbsp;8 of the Plan, or issued pursuant to the early exercise of an Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(z)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Restricted Stock
Unit</U>&#148; means a bookkeeping entry representing an amount equal to the Fair Market Value of one Share, granted pursuant to Section&nbsp;9. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(aa)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Service Provider</U>&#148; means an Employee, Director or Consultant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(bb)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Share</U>&#148; means a share of the Common Stock, as adjusted in accordance with Section&nbsp;13 of the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(cc)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Stock Appreciation Right</U>&#148; means an Award, granted alone or in connection with an
Option, that pursuant to Section&nbsp;7 is designated as a Stock Appreciation Right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(dd)&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Subsidiary</U>&#148; means a &#147;subsidiary corporation,&#148; whether now or hereafter existing, as
defined in Code Section&nbsp;424(f). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock&nbsp;Subject&nbsp;to&nbsp;the&nbsp;Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Subject to the Plan</U>. Subject to the provisions of Section&nbsp;13 of the Plan, the maximum aggregate
number of Shares that may be subject to Awards and sold under the Plan is 2,700,000 Shares, plus (i)&nbsp;any Shares that, as of the date of stockholder approval of this Plan, have been reserved but not issued pursuant to any awards granted under
the Penumbra, Inc. 2005 Stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Plan (the &#147;2005 Plan&#148;) and the Penumbra, Inc. 2011 Equity Incentive Plan (the &#147;2011 Plan&#148;) and are not subject to any awards granted thereunder, and (ii)&nbsp;any Shares
subject to stock options or similar awards granted under the 2005 Plan or the 2011 Plan that expire or otherwise terminate without having been exercised in full and Shares issued pursuant to awards granted under the 2005 Plan or the 2011 Plan that
are forfeited to or repurchased by the Company, with the maximum number of Shares to be added to the Plan pursuant to clauses (i)&nbsp;and (ii)&nbsp;equal to 3,007,276 Shares. The Shares may be authorized but unissued, or reacquired Common Stock.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Lapsed Awards</U>. If an Award expires or becomes unexercisable without having been exercised in full, is
surrendered pursuant to an Exchange Program, or, with respect to Restricted Stock or Restricted Stock Units, is forfeited to or repurchased by the Company due to the failure to vest, the unpurchased Shares (or for Awards other than Options or Stock
Appreciation Rights the forfeited or repurchased Shares) which were subject thereto will become available for future grant or sale under the Plan (unless the Plan has terminated). With respect to Stock Appreciation Rights, only Shares actually
issued pursuant to a Stock Appreciation Right will cease to be available under the Plan; all remaining Shares under Stock Appreciation Rights will remain available for future grant or sale under the Plan (unless the Plan has terminated). Shares that
have actually been issued under the Plan under any Award will not be returned to the Plan and will not become available for future distribution under the Plan; provided, however, that if Shares issued pursuant to Awards of Restricted Stock or
Restricted Stock Units are repurchased by the Company or are forfeited to the Company due to the failure to vest, such Shares will become available for future grant under the Plan. Shares used to pay the exercise price of an Award or to satisfy the
tax withholding obligations related to an Award will become available for future grant or sale under the Plan. To the extent an Award under the Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of
Shares available for issuance under the Plan. Notwithstanding the foregoing and, subject to adjustment as provided in Section&nbsp;13, the maximum number of Shares that may be issued upon the exercise of Incentive Stock Options will equal the
aggregate Share number stated in Section&nbsp;3(a), plus, to the extent allowable under Code Section&nbsp;422 and the Treasury Regulations promulgated thereunder, any Shares that become available for issuance under the Plan pursuant to
Section&nbsp;3(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Share Reserve</U>. The Company, during the term of this Plan, will at all times reserve
and keep available such number of Shares as will be sufficient to satisfy the requirements of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Administration of the Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Procedure</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Multiple Administrative Bodies</U>. Different Committees with respect to different groups of Service Providers
may administer the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Other Administration</U>. Other than as provided above, the Plan will be
administered by (A)&nbsp;the Board or (B)&nbsp;a Committee, which Committee will be constituted to satisfy Applicable Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Powers of the Administrator</U>. Subject to the provisions of the
Plan, and in the case of a Committee, subject to the specific duties delegated by the Board to such Committee, the Administrator will have the authority, in its discretion: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;to determine the Fair Market Value; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;to select the Service Providers to whom Awards may be granted hereunder; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;to determine the number of Shares to be covered by each Award granted hereunder; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;to approve forms of Award Agreements for use under the Plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder.
Such terms and conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any
restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator will determine; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;to institute and determine the terms and conditions of an Exchange Program; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;to construe and interpret the terms of the Plan and Awards granted pursuant to the Plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations
relating to sub-plans established for the purpose of satisfying applicable foreign laws or for qualifying for favorable tax treatment under applicable foreign laws; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;to modify or amend each Award (subject to Section&nbsp;18(c) of the Plan), including but not limited to the
discretionary authority to extend the post-termination exercisability period of Awards and to extend the maximum term of an Option (subject to Section&nbsp;6(d)); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;to allow Participants to satisfy withholding tax obligations in a manner prescribed in Section&nbsp;14; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;to authorize any person to execute on behalf of the Company any instrument required to effect the grant of an
Award previously granted by the Administrator; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;to allow a Participant to defer the receipt of the payment of
cash or the delivery of Shares that otherwise would be due to such Participant under an Award; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;to make
all other determinations deemed necessary or advisable for administering the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Administrator&#146;s&nbsp;Decision</U>. The
Administrator&#146;s decisions, determinations and interpretations will be final and binding on all Participants and any other holders of Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Eligibility</U>. Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock, and Restricted Stock
Units may be granted to Service Providers. Incentive Stock Options may be granted only to Employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock
Options</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Options</U>. Subject to the terms and provisions of the Plan, the Administrator, at
any time and from time to time, may grant Options in such amounts as the Administrator, in its sole discretion, will determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Option Agreement</U>. Each Award of an Option will be evidenced by an Award Agreement that will specify the
exercise price, the term of the Option, the number of Shares subject to the Option, the exercise restrictions, if any, applicable to the Option, and such other terms and conditions as the Administrator, in its sole discretion, will determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Limitations</U>. Each Option will be designated in the Award Agreement as either an Incentive Stock Option or a
Nonstatutory Stock Option. Notwithstanding such designation, however, to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any
calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as Nonstatutory Stock Options. For purposes of this Section&nbsp;6(c), Incentive Stock Options
will be taken into account in the order in which they were granted, the Fair Market Value of the Shares will be determined as of the time the Option with respect to such Shares is granted, and calculation will be performed in accordance with Code
Section&nbsp;422 and Treasury Regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Option</U>. The term of each
Option will be stated in the Award Agreement; provided, however, that the term will be no more than ten (10)&nbsp;years from the date of grant thereof. In the case of an Incentive Stock Option granted to a Participant who, at the time the Incentive
Stock Option is granted, owns stock representing more than ten percent (10%)&nbsp;of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the term of the Incentive Stock Option will be five
(5)&nbsp;years from the date of grant or such shorter term as may be provided in the Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Option Exercise Price and Consideration</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise Price</U>. The per Share exercise price for the Shares to be issued pursuant to the exercise of an
Option will be determined by the Administrator, but will be no less than one hundred percent (100%)&nbsp;of the Fair Market Value per Share on the date of grant. In addition, in the case of an Incentive Stock Option granted to an Employee who owns
stock representing more than ten percent (10%)&nbsp;of the voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise price will be no less than one hundred ten percent (110%)&nbsp;of the Fair Market
Value per Share on the date of grant. Notwithstanding the foregoing provisions of this Section&nbsp;6(e)(i), Options may be granted with a per Share exercise price of less than one hundred percent (100%)&nbsp;of the Fair Market Value per Share on
the date of grant pursuant to a transaction described in, and in a manner consistent with, Code Section&nbsp;424(a). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Waiting Period and Exercise Dates</U>. At the time an Option is
granted, the Administrator will fix the period within which the Option may be exercised and will determine any conditions that must be satisfied before the Option may be exercised. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Form of Consideration</U>. The Administrator will determine the acceptable form of consideration for
exercising an Option, including the method of payment. In the case of an Incentive Stock Option, the Administrator will determine the acceptable form of consideration at the time of grant. Such consideration may consist entirely of: (1)&nbsp;cash;
(2)&nbsp;check; (3)&nbsp;promissory note, to the extent permitted by Applicable Laws, (4)&nbsp;other Shares, provided that such Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which
such Option will be exercised and provided further that accepting such Shares will not result in any adverse accounting consequences to the Company, as the Administrator determines in its sole discretion; (5)&nbsp;consideration received by the
Company under cashless exercise program (whether through a broker or otherwise) implemented by the Company in connection with the Plan; (6)&nbsp;by net exercise, (7)&nbsp;such other consideration and method of payment for the issuance of Shares to
the extent permitted by Applicable Laws, or (8)&nbsp;any combination of the foregoing methods of payment. In making its determination as to the type of consideration to accept, the Administrator will consider if acceptance of such consideration may
be reasonably expected to benefit the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Procedure for Exercise; Rights as a Stockholder</U>. Any Option granted hereunder will be exercisable according
to the terms of the Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement. An Option may not be exercised for a fraction of a Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">An Option will be deemed exercised when the Company receives: (i)&nbsp;notice of exercise (in such form as the Administrator may specify from
time to time) from the person entitled to exercise the Option, and (ii)&nbsp;full payment for the Shares with respect to which the Option is exercised (together with applicable tax withholding). Full payment may consist of any consideration and
method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan. Shares issued upon exercise of an Option will be issued in the name of the Participant or, if requested by the Participant, in the name of the
Participant and his or her spouse. Until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a
stockholder will exist with respect to the Shares subject to an Option, notwithstanding the exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a
dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section&nbsp;13 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">Exercising an Option in any manner will decrease the number of Shares thereafter available, both for purposes of the Plan and for sale under
the Option, by the number of Shares as to which the Option is exercised. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Relationship as a Service Provider</U>. If a
Participant ceases to be a Service Provider, other than upon the Participant&#146;s termination as the result of the Participant&#146;s death or Disability, the Participant may exercise his or her Option within thirty (30)&nbsp;days of termination,
or such longer period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement) to the extent that the Option is vested on the date of termination.
Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination the
Participant does not exercise his or her Option within the time specified by the Administrator, the Option will terminate, and the Shares covered by such Option will revert to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Disability of Participant</U>. If a Participant ceases to be a Service Provider as a result of the
Participant&#146;s Disability, the Participant may exercise his or her Option within six (6)&nbsp;months of termination, or such longer period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of
such Option as set forth in the Award Agreement) to the extent the Option is vested on the date of termination. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire
Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination the Participant does not exercise his or her Option within the time specified herein, the Option will terminate, and the Shares covered by
such Option will revert to the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;<U>Death of Participant</U>. If a Participant dies while a Service
Provider, the Option may be exercised within six (6)&nbsp;months following the Participant&#146;s death, or within such longer period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such
Option as set forth in the Award Agreement) to the extent that the Option is vested on the date of death, by the Participant&#146;s designated beneficiary, provided such beneficiary has been designated prior to the Participant&#146;s death in a form
acceptable to the Administrator. If no such beneficiary has been designated by the Participant, then such Option may be exercised by the personal representative of the Participant&#146;s estate or by the person(s) to whom the Option is transferred
pursuant to the Participant&#146;s will or in accordance with the laws of descent and distribution. Unless otherwise provided by the Administrator, if at the time of death Participant is not vested as to his or her entire Option, the Shares covered
by the unvested portion of the Option will immediately revert to the Plan. If the Option is not so exercised within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Appreciation Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Stock Appreciation Rights</U>. Subject to the terms and conditions of the Plan, a Stock Appreciation
Right may be granted to Service Providers at any time and from time to time as will be determined by the Administrator, in its sole discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Number of Shares</U>. The Administrator will have complete discretion to determine the number of Shares subject
to any Award of Stock Appreciation Rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise Price and Other Terms</U>. The per Share exercise price
for the Shares that will determine the amount of the payment to be received upon exercise of a Stock Appreciation Right as set forth in Section&nbsp;7(f) will be determined by the Administrator and will be no less than one hundred percent
(100%)&nbsp;of the Fair Market Value per Share on the date of grant. Otherwise, the Administrator, subject to the provisions of the Plan, will have complete discretion to determine the terms and conditions of Stock Appreciation Rights granted under
the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Appreciation Right Agreement</U>. Each Stock Appreciation Right grant will be evidenced by
an Award Agreement that will specify the exercise price, the term of the Stock Appreciation Right, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion, will determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Expiration of Stock Appreciation Rights</U>. A Stock Appreciation Right granted under the Plan will expire upon
the date determined by the Administrator, in its sole discretion, and set forth in the Award Agreement. Notwithstanding the foregoing, the rules of Section&nbsp;6(d) relating to the maximum term and Section&nbsp;6(f) relating to exercise also will
apply to Stock Appreciation Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment of Stock Appreciation Right Amount</U>. Upon exercise of a
Stock Appreciation Right, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;The difference between the Fair Market Value of a Share on the date of exercise over the exercise price; times </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;The number of Shares with respect to which the Stock Appreciation Right is exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the discretion of the Administrator, the payment upon Stock Appreciation Right exercise may be in cash, in Shares of equivalent value, or
in some combination thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Restricted Stock</U>. Subject to the terms and provisions of the Plan, the Administrator, at any time
and from time to time, may grant Shares of Restricted Stock to Service Providers in such amounts as the Administrator, in its sole discretion, will determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted Stock Agreement</U>. Each Award of Restricted Stock will be evidenced by an Award Agreement that will
specify the Period of Restriction, the number of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion, will determine. Unless the Administrator determines otherwise, the Company as escrow agent will hold
Shares of Restricted Stock until the restrictions on such Shares have lapsed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability</U>. Except
as provided in this Section&nbsp;8 or as the Administrator determines, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Other Restrictions</U>. The Administrator, in its sole discretion, may impose such other restrictions on Shares
of Restricted Stock as it may deem advisable or appropriate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Removal of Restrictions</U>. Except as otherwise provided in this
Section&nbsp;8, Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction or at such other time as the Administrator may
determine. The Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Voting Rights</U>. During the Period of Restriction, Service Providers holding Shares of Restricted Stock
granted hereunder may exercise full voting rights with respect to those Shares, unless the Administrator determines otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Dividends and Other Distributions</U>. During the Period of Restriction, Service Providers holding Shares of
Restricted Stock will be entitled to receive all dividends and other distributions paid with respect to such Shares, unless the Administrator provides otherwise. If any such dividends or distributions are paid in Shares, the Shares will be subject
to the same restrictions on transferability and forfeitability as the Shares of Restricted Stock with respect to which they were paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;<U>Return of Restricted Stock to Company</U>. On the date set forth in the Award Agreement, the Restricted Stock
for which restrictions have not lapsed will revert to the Company and again will become available for grant under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted Stock Units</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant</U>. Restricted Stock Units may be granted at any time and from time to time as determined by the
Administrator. After the Administrator determines that it will grant Restricted Stock Units, it will advise the Participant in an Award Agreement of the terms, conditions, and restrictions related to the grant, including the number of Restricted
Stock Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Vesting Criteria and Other Terms</U>. The Administrator will set vesting criteria in its
discretion, which, depending on the extent to which the criteria are met, will determine the number of Restricted Stock Units that will be paid out to the Participant. The Administrator may set vesting criteria based upon the achievement of
Company-wide, business unit, or individual goals (including, but not limited to, continued employment or service), or any other basis determined by the Administrator in its discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Earning Restricted Stock Units</U>. Upon meeting the applicable vesting criteria, the Participant will be
entitled to receive a payout as determined by the Administrator. Notwithstanding the foregoing, at any time after the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any vesting criteria that must be
met to receive a payout. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Form and Timing of Payment</U>. Payment of earned Restricted Stock Units will be
made as soon as practicable after the date(s) determined by the Administrator and set forth in the Award Agreement. The Administrator, in its sole discretion, may settle earned Restricted Stock Units in cash, Shares, or a combination of both. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Cancellation</U>. On the date set forth in the Award Agreement, all unearned Restricted Stock Units will be
forfeited to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance With Code Section&nbsp;409A</U>. Awards will be designed
and operated in such a manner that they are either exempt from the application of, or comply with, the requirements of Code Section&nbsp;409A, except as otherwise determined in the sole discretion of the Administrator. The Plan and each Award
Agreement under the Plan is intended to meet the&nbsp;requirements of Code Section&nbsp;409A and will be construed and interpreted in accordance with such intent, except as otherwise determined in the sole discretion of the Administrator. To the
extent that an Award or payment, or the settlement or deferral thereof, is subject to Code Section&nbsp;409A the Award will be granted, paid, settled or deferred in a manner that will meet the requirements of Code Section&nbsp;409A, such that the
grant, payment, settlement or deferral will not be subject to the additional tax or interest applicable under Code Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Leaves of Absence/Transfer Between Locations</U>. Unless the Administrator provides otherwise, vesting of Awards
granted hereunder will be suspended during any unpaid leave of absence. A Participant will not cease to be an Employee in the case of (i)&nbsp;any leave of absence approved by the Company or (ii)&nbsp;transfers between locations of the Company or
between the Company, its Parent, or any Subsidiary. For purposes of Incentive Stock Options, no such leave may exceed three (3)&nbsp;months, unless reemployment upon expiration of such leave is guaranteed by statute or contract. If reemployment upon
expiration of a leave of absence approved by the Company is not so guaranteed, then six (6)&nbsp;months following the first (1<SUP STYLE="font-size:85%; vertical-align:top">st</SUP>)&nbsp;day of such leave, any Incentive Stock Option held by the
Participant will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Nonstatutory Stock Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Limited Transferability of Awards</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Unless determined otherwise by the Administrator, Awards may not be sold, pledged, assigned, hypothecated, or
otherwise transferred in any manner other than by will or by the laws of descent and distribution, and may be exercised, during the lifetime of the Participant, only by the Participant. If the Administrator makes an Award transferable, such Award
may only be transferred (i)&nbsp;by will, (ii)&nbsp;by the laws of descent and distribution, or (iii)&nbsp;as permitted by Rule 701 of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Further, during the period the Company is relying upon the exemption from registration provided in Rule 12h-1(f)(1)
promulgated under the Exchange Act (the &#147;Rule 12h-1(f) Exemption&#148;) until the Company either (i)&nbsp;becomes subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act or (ii)&nbsp;is no longer relying upon the
Rule 12h-1(f) Exemption, an Option, or prior to exercise, the Shares subject to the Option, may not be pledged, hypothecated or otherwise transferred or disposed of, in any manner, including by entering into any short position, any &#147;put
equivalent position&#148; or any &#147;call equivalent position&#148; (as defined in Rule 16a-1(h) and Rule 16a-1(b) of the Exchange Act, respectively), other than to (x)&nbsp;persons who are &#147;family members&#148; (as defined in Rule 701(c)(3)
of the Securities Act) through gifts or domestic relations orders, or (y)&nbsp;to an executor or guardian of the Participant upon the death or disability of the Participant, in each case, to the extent required for continued reliance on the Rule
12h-1(f) Exemption. Notwithstanding the foregoing sentence, the Administrator, in its sole discretion, may determine to permit transfers to the Company or in connection with a Change in Control or other acquisition transactions involving the Company
to the extent permitted by Rule 12h-1(f) or, if the Company is not relying on the Rule 12h-1(f) Exemption, to the extent permitted by the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments; Dissolution or Liquidation; Merger or Change in
Control</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments</U>. In the event that any dividend or other distribution (whether in the form of
cash, Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Shares or other securities of the Company, or
other change in the corporate structure of the Company affecting the Shares occurs, the Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will adjust the
number and class of shares of stock that may be delivered under the Plan and/or the number, class, and price of shares of stock covered by each outstanding Award; provided, however, that the Administrator will make such adjustments to an Award
required by Section&nbsp;25102(o) of the California Corporations Code to the extent the Company is relying upon the exemption afforded thereby with respect to the Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Dissolution or Liquidation</U>. In the event of the proposed dissolution or liquidation of the Company, the
Administrator will notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been previously exercised, an Award will terminate immediately prior to the consummation of such
proposed action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Merger or Change in Control</U>. In the event of a merger of the Company with or into
another corporation or other entity or a Change in Control, each outstanding Award will be treated as the Administrator determines (subject to the provisions of the following paragraph) without a Participant&#146;s consent, including, without
limitation, that (i)&nbsp;Awards will be assumed, or substantially equivalent Awards will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof) with appropriate adjustments as to the number and kind of shares and
prices; (ii)&nbsp;upon written notice to a Participant, that the Participant&#146;s Awards will terminate upon or immediately prior to the consummation of such merger or Change in Control; (iii)&nbsp;outstanding Awards will vest and become
exercisable, realizable, or payable, or restrictions applicable to an Award will lapse, in whole or in part prior to or upon consummation of such merger or Change in Control, and, to the extent the Administrator determines, terminate upon or
immediately prior to the effectiveness of such merger or Change in Control; (iv)&nbsp;(A)&nbsp;the termination of an Award in exchange for an amount of cash and/or property, if any, equal to the amount that would have been attained upon the exercise
of such Award or realization of the Participant&#146;s rights as of the date of the occurrence of the transaction (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction the Administrator determines in good faith
that no amount would have been attained upon the exercise of such Award or realization of the Participant&#146;s rights, then such Award may be terminated by the Company without payment), or (B)&nbsp;the replacement of such Award with other rights
or property selected by the Administrator in its sole discretion; or (v)&nbsp;any combination of the foregoing. In taking any of the actions permitted under this subsection 13(c), the Administrator will not be obligated to treat all Awards, all
Awards held by a Participant, or all Awards of the same type, similarly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event that the successor corporation does not assume or
substitute for the Award (or portion thereof), the Participant will fully vest in and have the right to exercise all of his or her outstanding Options and Stock Appreciation Rights, including Shares as to which such Awards would not otherwise be
vested or exercisable, all restrictions on Restricted Stock and Restricted Stock Units will lapse, and, with respect to Awards with performance-based vesting, all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
performance goals or other vesting criteria will be deemed achieved at one hundred percent (100%)&nbsp;of target levels and all other terms and conditions met. In addition, if an Option or Stock
Appreciation Right is not assumed or substituted in the event of a merger or Change in Control, the Administrator will notify the Participant in writing or electronically that the Option or Stock Appreciation Right will be exercisable for a period
of time determined by the Administrator in its sole discretion, and the Option or Stock Appreciation Right will terminate upon the expiration of such period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For the purposes of this subsection 13(c), an Award will be considered assumed if, following the merger or Change in Control, the Award
confers the right to purchase or receive, for each Share subject to the Award immediately prior to the merger or Change in Control, the consideration (whether stock, cash, or other securities or property) received in the merger or Change in Control
by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided,
however, that if such consideration received in the merger or Change in Control is not solely common stock of the successor corporation or its Parent, the Administrator may, with the consent of the successor corporation, provide for the
consideration to be received upon the exercise of an Option or Stock Appreciation Right or upon the payout of a Restricted Stock Unit, for each Share subject to such Award, to be solely common stock of the successor corporation or its Parent equal
in fair market value to the per share consideration received by holders of Common Stock in the merger or Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section&nbsp;13(c) to the contrary, an Award that vests, is earned or paid-out upon the satisfaction of one
or more performance goals will not be considered assumed if the Company or its successor modifies any of such performance goals without the Participant&#146;s consent; provided, however, a modification to such performance goals only to reflect the
successor corporation&#146;s post-Change in Control corporate structure will not be deemed to invalidate an otherwise valid Award assumption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section&nbsp;13(c) to the contrary, if a payment under an Award Agreement is subject to Code
Section&nbsp;409A and if the change in control definition contained in the Award Agreement does not comply with the definition of &#147;change of control&#148; for purposes of a distribution under Code Section&nbsp;409A, then any payment of an
amount that is otherwise accelerated under this Section will be delayed until the earliest time that such payment would be permissible under Code Section&nbsp;409A without triggering any penalties applicable under Code Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Withholding</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding Requirements</U>. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise
thereof), the Company will have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy federal, state, local, foreign or other taxes (including the Participant&#146;s FICA
obligation) required to be withheld with respect to such Award (or exercise thereof). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Withholding Arrangements</U>. The Administrator, in its sole
discretion and pursuant to such procedures as it may specify from time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation) (i)&nbsp;paying cash, (ii)&nbsp;electing to have the
Company withhold otherwise deliverable Shares having a Fair Market Value equal to the minimum statutory amount required to be withheld, (iii)&nbsp;delivering to the Company already-owned Shares having a Fair Market Value equal to the statutory
amount required to be withheld, provided the delivery of such Shares will not result in any adverse accounting consequences, as the Administrator determines in its sole discretion, or (iv)&nbsp;selling a sufficient number of Shares otherwise
deliverable to the Participant through such means as the Administrator may determine in its sole discretion (whether through a broker or otherwise) equal to the amount required to be withheld. The amount of the withholding requirement will be deemed
to include any amount which the Administrator agrees may be withheld at the time the election is made, not to exceed the amount determined by using the maximum federal, state or local marginal income tax rates applicable to the Participant with
respect to the Award on the date that the amount of tax to be withheld is to be determined. The Fair Market Value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Effect on Employment or Service</U>. Neither the Plan nor any Award will confer upon a Participant any right
with respect to continuing the Participant&#146;s relationship as a Service Provider with the Company, nor will they interfere in any way with the Participant&#146;s right or the Company&#146;s right to terminate such relationship at any time, with
or without cause, to the extent permitted by Applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Date of Grant</U>. The date of grant of an
Award will be, for all purposes, the date on which the Administrator makes the determination granting such Award, or such other later date as is determined by the Administrator. Notice of the determination will be provided to each Participant within
a reasonable time after the date of such grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Plan</U>. Subject to Section&nbsp;21 of the Plan,
the Plan will become effective upon its adoption by the Board. Unless sooner terminated under Section&nbsp;18, it will continue in effect for a term of ten (10)&nbsp;years from the later of (a)&nbsp;the effective date of the Plan, or (b)&nbsp;the
earlier of the most recent Board or stockholder approval of an increase in the number of Shares reserved for issuance under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Termination of the Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Termination</U>. The Board may at any time amend, alter, suspend or terminate the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder Approval</U>. The Company will obtain stockholder approval of any Plan amendment to the extent
necessary and desirable to comply with Applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Amendment or Termination</U>. No
amendment, alteration, suspension or termination of the Plan will impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant
and the Company. Termination of the Plan will not affect the Administrator&#146;s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions Upon Issuance of Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Legal Compliance</U>. Shares will not be issued pursuant to the exercise of an Award unless the exercise of such
Award and the issuance and delivery of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect to such compliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Representations</U>. As a condition to the exercise of an Award, the Company may require the person
exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the
Company, such a representation is required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Inability to Obtain Authority</U>. The inability of the Company
to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company&#146;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, will relieve the Company of any liability in respect
of the failure to issue or sell such Shares as to which such requisite authority will not have been obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21.&nbsp;&nbsp;&nbsp;&nbsp;<U>Stockholder Approval</U>. The Plan will be subject to approval by the stockholders of the Company within twelve
(12)&nbsp;months after the date the Plan is adopted by the Board. Such stockholder approval will be obtained in the manner and to the degree required under Applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22.&nbsp;&nbsp;&nbsp;&nbsp;<U>Information to Participants</U>. If and as required (i)&nbsp;pursuant to Rule 701 of the Securities Act, if the
Company is relying on the exemption from registration provided pursuant to Rule 701 of the Securities Act with respect to the applicable Award, and/or (ii)&nbsp;pursuant to Rule 12h-1(f) of the Exchange Act, to the extent the Company is relying on
the Rule 12h-(1)(f)&nbsp;Exemption, then during the period of reliance on the applicable exemption and in each case of (i)&nbsp;and (ii)&nbsp;until such time as the Company becomes subject to the reporting requirements of Section&nbsp;13 or 15(d) of
the Exchange Act,, the Company shall provide to each Participant the information described in paragraphs (e)(3), (4), and (5)&nbsp;of Rule 701 under the Securities Act not less frequently than every six (6)&nbsp;months with the financial statements
being not more than 180 days old and with such information provided either by physical or electronic delivery to the Participants or by written notice to the Participants of the availability of the information on an Internet site that may be
password-protected and of any password needed to access the information. The Company may request that Participants agree to keep the information to be provided pursuant to this section confidential. If a Participant does not agree to keep the
information to be provided pursuant to this section confidential, then the Company will not be required to provide the information unless otherwise required pursuant to Rule 12h-1(f)(1) under the Exchange Act (if the Company is relying on the Rule
12h-1(f) Exemption) or Rule 701 of the Securities Act (if the Company is relying on the exemption pursuant to Rule 701 of the Securities Act). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTRICTED STOCK AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise defined herein, the terms defined in the 2014 Equity Incentive Plan (the &#147;Plan&#148;) shall have the same defined
meanings in this Restricted Stock Agreement (the &#147;Agreement&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>I.</B>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B><U>NOTICE OF GRANT OF RESTRICTED STOCK</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B>Name:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B>Address:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Participant has been granted a Restricted Stock Award, subject to the terms and conditions of
the Plan and this Agreement, as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date of Grant:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vesting Commencement Date:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total Number of Shares of:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Restricted
Stock:</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>Vesting Schedule</U>:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to any accelerated vesting provisions in the Plan, <B>[</B>twenty-five percent (25%)&nbsp;of the
Shares of Restricted Stock shall vest on the one (1)&nbsp;year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)&nbsp;of the Shares of Restricted Stock shall vest each
month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to Participant continuing to be a Service Provider through each such date.<B>]</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a Change in Control, and subject to Participant continuing to be a Service Provider through the date of such Change in
Control, the Participant will fully vest in all of the Shares of Restricted Stock granted under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of the Shares of
Restricted Stock granted under this Agreement which have not yet vested as of a given time are referred to herein as &#147;Unvested Shares of Restricted Stock.&#148; The Shares which have vested shall be delivered to Participant in accordance with
the terms of the escrow agreement (see Section&nbsp;10 of Part&nbsp;II of this Agreement). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>II.&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Restricted Stock</U>. The Company hereby grants to the person named in the Notice of Grant of Restricted
Stock in Part&nbsp;I of this Agreement (&#147;Participant&#148;) under the Plan for services performed and to be performed by Participant for the Company and as a separate incentive in connection with his or her services and not in lieu of any
salary or other compensation for his or her services, the number of Shares set forth in the Notice of Grant of Restricted Stock, subject to all of the terms and conditions in this Agreement and the Plan, which is incorporated herein by reference.
Subject to Section&nbsp;18(c) of the Plan, in the event of a conflict between the terms and conditions of the Plan and this Agreement, the terms and conditions of the Plan shall prevail. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Participant&#146;s Representations</U>. In the event the Shares have not been registered under the Securities Act
of 1933, as amended, at the time this Restricted Stock Award is granted, Participant shall, if required by the Company, concurrently with the grant of this Restricted Stock Award, deliver to the Company his or her Investment Representation Statement
in the form attached hereto as <U>Exhibit&nbsp;A</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Lock-Up Period</U>. Participant hereby agrees that
Participant shall not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or
indirectly, any Common Stock (or other securities) of the Company or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Common Stock (or other
securities) of the Company held by Participant (other than those included in the registration) for a period specified by the representative of the underwriters of Common Stock (or other securities) of the Company not to exceed one hundred and eighty
(180)&nbsp;days following the effective date of any registration statement of the Company filed under the Securities Act (or such other period as may be requested by the Company or the underwriters to accommodate regulatory restrictions on
(i)&nbsp;the publication or other distribution of research reports and (ii)&nbsp;analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule&nbsp;2711(f)(4) or NYSE Rule&nbsp;472(f)(4), or any
successor provisions or amendments thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participant agrees to execute and deliver such other agreements as may be reasonably
requested by the Company or the underwriter which are consistent with the foregoing or which are necessary to give further effect thereto. In addition, if requested by the Company or the representative of the underwriters of Common Stock (or other
securities) of the Company, Participant shall provide, within ten (10)&nbsp;days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the
Company&#146;s securities pursuant to a registration statement filed under the Securities Act. The obligations described in this Section&nbsp;3 shall not apply to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or
similar forms that may be promulgated in the future, or a registration relating solely to a Commission Rule 145 transaction on Form S-4 or similar forms that may be promulgated in the future. The Company may impose stop-transfer instructions with
respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of said one hundred and eighty (180)&nbsp;day (or other) period. Participant agrees that any transferee of the Restricted Stock Award or
Shares acquired pursuant to the Restricted Stock Award shall be bound by this Section&nbsp;3. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Transferability of Restricted Stock</U>. This Restricted Stock
Award may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised during the lifetime of Participant only by Participant. The terms of the Plan and this Agreement shall be binding upon
the executors, administrators, heirs, successors and assigns of Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Consequences</U>.
Participant has reviewed with Participant&#146;s own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. Participant is relying solely on such advisors and not
on any statements or representations of the Company or any of its agents. Participant understands that Participant (and not the Company) shall be responsible for Participant&#146;s own tax liability that may arise as a result of the transactions
contemplated by this Agreement. Participant understands that Section&nbsp;83 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), taxes as ordinary income the difference between the purchase price, if any, for the Shares and the
Fair Market Value of the Shares as of each vesting date. Participant understands that Participant may elect to be taxed at the time the Shares are granted rather than when such Shares vest by filing an election under Section&nbsp;83(b) of the Code
(the &#147;83(b) Election&#148;) with the IRS within thirty (30)&nbsp;days from the date of grant of the Restricted Stock Award. The form for making this election is attached as <U>Exhibit&nbsp;B-3</U> hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PARTICIPANT ACKNOWLEDGES THAT IT IS PARTICIPANT&#146;S SOLE RESPONSIBILITY AND NOT THE COMPANY&#146;S TO FILE TIMELY THE 83(b) ELECTION, EVEN
IF PARTICIPANT REQUESTS THE COMPANY OR ITS REPRESENTATIVES TO MAKE THIS FILING ON PARTICIPANT&#146;S BEHALF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Withholding</U>. Pursuant to such procedures as the Administrator may specify from time to time, the Company
shall withhold the minimum amount required to be withheld for the payment of income, employment and other taxes which the Company determines must be withheld (the &#147;Withholding Taxes&#148;) with respect to the filing of an 83(b) Election, or, if
an 83(b) Election is not filed or not timely filed, upon each vesting date, by, in the Administrator&#146;s discretion: (i)&nbsp;withholding otherwise deliverable Shares having a Fair Market Value equal to the amount of such Withholding Taxes,
(ii)&nbsp;withholding the amount of such Withholding Taxes from Participant&#146;s paycheck(s), (iii)&nbsp;requiring Participant to make appropriate arrangements with the Company (or the Parent or Subsidiary employing or retaining Participant) for
the satisfaction of all Withholding Taxes, or (iv)&nbsp;a combination of the foregoing. The Company shall not retain fractional Shares to satisfy any portion of the Withholding Taxes. Accordingly, if any withholding is done through the withholding
of Shares, Participant shall pay to the Company an amount in cash sufficient to satisfy the remaining Withholding Taxes due and payable as a result of the Company not retaining fractional Shares. Should the Company be unable to procure such cash
amounts from Participant, Participant agrees and acknowledges that Participant is giving the Company permission to withhold from Participant&#146;s paycheck(s) an amount equal to the remaining Withholding Taxes due and payable as a result of the
Company not retaining fractional Shares. Participant acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver the Shares if such withholding amounts are not delivered at the time they are due. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Guarantee of Continued Service</U>. PARTICIPANT ACKNOWLEDGES AND
AGREES THAT THE VESTING OF THE SHARES OF RESTRICTED STOCK PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) AND NOT
THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS RESTRICTED STOCK AWARD OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH
HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH PARTICIPANT&#146;S RIGHT OR THE RIGHT OF THE COMPANY (OR
THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT&#146;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Forfeiture Upon Termination as a Service Provider</U>. Notwithstanding any contrary provision of this Agreement
or the Notice of Grant of Restricted Stock, if Participant terminates service as a Service Provider for any or no reason prior to vesting, the then Unvested Shares of Restricted Stock awarded by this Agreement will thereupon be forfeited and
automatically transferred to and reacquired by the Company at no cost to the Company upon the date of such termination and Participant will have no further rights thereunder. Participant hereby appoints the Escrow Agent with full power of
substitution, as Participant&#146;s true and lawful attorney-in-fact with irrevocable power and authority in the name and on behalf of Participant to take any action and execute all documents and instruments, including, without limitation, stock
powers which may be necessary to transfer the certificate or certificates evidencing such Unvested Shares of Restricted Stock to the Company upon such termination of service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restriction on Transfer</U>. Except for the escrow described in Section&nbsp;10 or transfer of the Shares to the
Company or its assignees contemplated by this Agreement, none of the Shares or any beneficial interest therein shall be transferred, encumbered or otherwise disposed of in any way until such Shares shall have vested in accordance with the provisions
of this Agreement, other than by will or the laws of descent and distribution. Any distribution or delivery to be made to Participant under this Agreement shall, if Participant is then deceased, be made to Participant&#146;s designated beneficiary,
or if no beneficiary survives Participant, to the administrator or executor of Participant&#146;s estate. Any such transferee must furnish the Company with (a)&nbsp;written notice of his or her status as transferee, and (b)&nbsp;evidence
satisfactory to the Company to establish the validity of the transfer and compliance with any laws or regulations pertaining to said transfer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Escrow of Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;All Shares of Restricted Stock will, upon execution of this Agreement, be delivered and deposited with an escrow
holder designated by the Company (the &#147;Escrow Holder&#148;), together with the Assignment Separate from Certificate (the &#147;Stock Assignment&#148;) duly endorsed in blank, attached hereto as <U>Exhibit B-1</U>. The Shares of Restricted Stock
and the Stock Assignment will be held by the Escrow Holder, pursuant to the Joint Escrow Instructions of the Company and Participant attached as <U>Exhibit B-2</U> hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Escrow Holder shall not be liable for any act it may do or omit to
do with respect to holding the Shares of Restricted Stock in escrow and while acting in good faith and in the exercise of its judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Upon Participant&#146;s termination as a Service Provider for any reason, the Escrow Holder, upon receipt of
written notice of such termination, will take all steps necessary to accomplish the transfer of the Unvested Shares of Restricted Stock to the Company. Participant hereby appoints the Escrow Holder with full power of substitution, as
Participant&#146;s true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> with irrevocable power and authority in the name and on behalf of Participant to take any action and execute all
documents and instruments, including, without limitation, stock powers which may be necessary to transfer the certificate or certificates evidencing such Unvested Shares of Restricted Stock to the Company upon such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;The Escrow Holder will take all steps necessary to accomplish the transfer of Shares of Restricted Stock to
Participant after they vest following Participant&#146;s request that the Escrow Holder do so. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the
terms hereof, Participant shall have all the rights of a shareholder with respect to such Shares while they are held in escrow, including without limitation, the right to vote the Shares and receive any cash dividends declared thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;In the event of any merger, reorganization, consolidation, recapitalization, separation, liquidation, stock
dividend, split-up, share combination, or other change in the corporate structure of the Company affecting the Common Stock, the Shares shall be increased, reduced or otherwise changed, and by virtue of any such change Participant shall in his or
her capacity as owner of the Unvested Shares of Restricted Stock that have been awarded to him or her be entitled to new or additional or different shares of stock, cash or securities (other than rights or warrants to purchase securities); such new
or additional or different shares, cash or securities shall thereupon be considered to be &#147;Unvested Shares of Restricted Stock&#148; and shall be subject to all of the conditions and restrictions which were applicable to the Unvested Shares of
Restricted Stock pursuant to this Agreement. If Participant receives rights or warrants with respect to any Unvested Shares of Restricted Stock, such rights or warrants may be held or exercised by Participant, provided that until such exercise any
such rights or warrants and after such exercise any shares or other securities acquired by the exercise of such rights or warrants shall be considered to be Unvested Shares of Restricted Stock and shall be subject to all of the conditions and
restrictions which were applicable to the Unvested Shares of Restricted Stock pursuant to this Agreement. The Administrator in its absolute discretion at any time may accelerate the vesting of all or any portion of such new or additional shares of
stock, cash or securities, rights or warrants to purchase securities or shares or other securities acquired by the exercise of such rights or warrants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Company&#146;s Right of First Refusal</U>. Subject to
Section&nbsp;9, before any vested Shares held by Participant or any transferee (either being sometimes referred to herein as the &#147;Holder&#148;) may be sold or otherwise transferred (including transfer by gift or operation of law), the Company
or its assignee(s) shall have a right of first refusal to purchase the Shares on the terms and conditions set forth in this Section&nbsp;11 (the &#147;Right of First Refusal&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Proposed Transfer</U>. The Holder of the Shares shall deliver to the Company a written notice (the
&#147;Notice&#148;) stating: (i)&nbsp;the Holder&#146;s bona fide intention to sell or otherwise transfer such Shares; (ii)&nbsp;the name of each proposed purchaser or other transferee (&#147;Proposed Transferee&#148;); (iii)&nbsp;the number of
Shares to be transferred to each Proposed Transferee; and (iv)&nbsp;the bona fide cash price or other consideration for which the Holder proposes to transfer the Shares (the &#147;Offered Price&#148;), and the Holder shall offer the Shares at the
Offered Price to the Company or its assignee(s). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Right of First Refusal</U>. At any time within
thirty (30)&nbsp;days after receipt of the Notice, the Company and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the
Proposed Transferees, at the purchase price determined in accordance with subsection&nbsp;(c) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase Price</U>. The purchase price (&#147;Right of First Refusal Price&#148;) for the Shares purchased by
the Company or its assignee(s) under this Section&nbsp;11 shall be the Offered Price. If the Offered Price includes consideration other than cash, the cash equivalent value of the non-cash consideration shall be determined by the Board in good
faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment</U>. Payment of the Right of First Refusal Price shall be made, at the option of the Company
or its assignee(s), in cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company (or, in the case of repurchase by an assignee, to the assignee), or by any combination thereof within thirty
(30)&nbsp;days after receipt of the Notice or in the manner and at the times set forth in the Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Holder&#146;s Right to Transfer</U>. If all of the Shares proposed in the Notice to be transferred to a given
Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section&nbsp;11, then the Holder may sell or otherwise transfer such Shares to that Proposed Transferee at the Offered Price or at a higher price,
provided that such sale or other transfer is consummated within one hundred and twenty (120)&nbsp;days after the date of the Notice, that any such sale or other transfer is effected in accordance with any applicable securities laws and that the
Proposed Transferee agrees in writing that the provisions of this Section&nbsp;11 shall continue to apply to the Shares in the hands of such Proposed Transferee. If the Shares described in the Notice are not transferred to the Proposed Transferee
within such period, a new Notice shall be given to the Company, and the Company and/or its assignees shall again be offered the Right of First Refusal before any Shares held by the Holder may be sold or otherwise transferred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exception for Certain Family Transfers</U>. Anything to the contrary contained in this Section&nbsp;11
notwithstanding, the transfer of any or all of the Shares during Participant&#146;s lifetime or on Participant&#146;s death by will or intestacy to Participant&#146;s immediate family or a trust for the benefit of Participant or Participant&#146;s
immediate family shall be exempt from the provisions of this Section&nbsp;11. &#147;Immediate Family&#148; as used herein shall mean spouse, lineal descendant or antecedent, father, mother, brother or sister. In such case, the transferee or other
recipient shall receive and hold the Shares so transferred subject to the provisions of this Agreement, including but not limited to this Section&nbsp;11 and Section&nbsp;8, and there shall be no further transfer of such Shares except in accordance
with the terms of this Section&nbsp;11. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Right of First Refusal</U>. The Right of First
Refusal shall terminate as to any Shares upon the earlier of (i)&nbsp;the first sale of Common Stock of the Company to the general public, or (ii)&nbsp;a Change in Control in which the successor corporation has equity securities that are publicly
traded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictive Legends and Stop-Transfer Orders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Legends</U>. Participant understands and agrees that the Company shall cause the legends set forth below or
legends substantially equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE &#147;ACT&#148;) AND MAY NOT BE OFFERED, SOLD
OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE
THEREWITH. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER, A RIGHT OF FIRST REFUSAL AND
FORFEITURE RIGHTS IN FAVOR OF THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE RESTRICTED STOCK AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH
TRANSFER RESTRICTIONS, RIGHT OF FIRST REFUSAL AND FORFEITURE RIGHTS IN FAVOR OF THE ISSUER OR ITS ASSIGNEE(S) ARE BINDING ON TRANSFEREES OF THESE SHARES. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR A PERIOD OF TIME FOLLOWING THE EFFECTIVE DATE OF THE
UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY&#146;S SECURITIES SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER PRIOR TO THE EXPIRATION OF SUCH PERIOD
WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stop-Transfer Notices</U>. Participant
agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it
may make appropriate notations to&nbsp;the same effect in its own records. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Refusal to Transfer</U>. The Company shall not be required
(i)&nbsp;to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or (ii)&nbsp;to treat as owner of such Shares or to accord the right to vote or pay dividends to any
purchaser or other transferee to whom such Shares shall have been so transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Address for Notices</U>.
Any notice to be given to the Company under the terms of this Award Agreement will be addressed to the Company at 1351 Harbor Bay Parkway, Alameda, CA 94502, or at such other address as the Company may hereafter designate in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice to the Escrow Holder shall be sent to the Company&#146;s address with a copy to the other party not sending the notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;<U>Electronic Delivery</U>. The Company may, in its sole discretion, decide to deliver any documents related to the
Shares of Restricted Stock awarded under the Plan or future Restricted Stock that may be awarded under the Plan by electronic means or request Participant&#146;s consent to participate in the Plan by electronic means. Participant hereby consents to
receive such documents by electronic delivery and agrees to participate in the Plan through any on-line or electronic system established and maintained by the Company or another third party designated by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Waiver</U>. Either party&#146;s failure to enforce any provision or provisions of this Agreement shall not in
any way be construed as a waiver of any such provision or provisions, nor prevent that party from thereafter enforcing each and every other provision of this Agreement. The rights granted both parties herein are cumulative and shall not constitute a
waiver of either party&#146;s right to assert all other legal remedies available to it under the circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors and Assigns</U>. The Company may assign any of its rights under this Agreement to single or multiple
assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Agreement shall be binding upon Participant and his or her heirs, executors,
administrators, successors and assigns. The rights and obligations of Participant under this Agreement may only be assigned with the prior written consent of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Interpretation</U>. The Administrator will have the power to interpret the Plan and this Agreement and to adopt
such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any Shares of Restricted Stock
have vested). All actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon Participant, the Company and all other interested persons. Neither the Administrator nor any person
acting on behalf of the Administrator will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional Documents</U>. Participant agrees upon request to execute any further documents or instruments
necessary or desirable to carry out the purposes or intent of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law;
Severability</U>. This Agreement is governed by the internal substantive laws, but not the choice of law rules, of California. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal,
unenforceable or void, this Agreement shall continue in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement</U>. The Plan is incorporated herein by reference.
The Plan and this Agreement (including the exhibits referenced herein) constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and
Participant with respect to the subject matter hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participant acknowledges receipt of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and
hereby accepts this Agreement subject to all of the terms and provisions thereof. Participant has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and
fully understands all provisions of this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan or this Agreement. Participant
further agrees to notify the Company upon any change in the residence address indicated below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">PARTICIPANT</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Signature</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">By</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print Name</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Residence Address</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INVESTMENT REPRESENTATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PARTICIPANT</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COMPANY</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECURITY</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">COMMON STOCK</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AMOUNT</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DATE</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the purchase of the above-listed Securities, the undersigned Participant represents to the
Company the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Participant is aware of the Company&#146;s business affairs and financial condition and
has acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Securities. Participant is acquiring these Securities for investment for Participant&#146;s own account only and not with a view to,
or for resale in connection with, any &#147;distribution&#148; thereof within the meaning of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Participant acknowledges and understands that the Securities constitute &#147;restricted securities&#148; under the
Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Participant&#146;s investment intent as expressed herein.
In this connection, Participant understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if Participant&#146;s representation was predicated solely upon a present intention to
hold these Securities for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Securities, or for a period of one year or any other fixed period in the
future. Participant further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Participant further acknowledges and
understands that the Company is under no obligation to register the Securities. Participant understands that the certificate evidencing the Securities shall be imprinted with any legend required under applicable state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Participant is familiar with the provisions of Rule&nbsp;701 and Rule&nbsp;144, each promulgated under the
Securities Act, which, in substance, permit limited public resale of &#147;restricted securities&#148; acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions.
Rule&nbsp;701 provides that if the issuer qualifies under Rule&nbsp;701 at the time of the grant of the Restricted Stock Award to Participant, the exercise shall be exempt from registration under the Securities Act. In the event the Company becomes
subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934, ninety&nbsp;(90) days thereafter (or such longer period as any market stand-off agreement may require) the Securities
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exempt under Rule&nbsp;701 may be resold, subject to the satisfaction of the applicable conditions specified by Rule&nbsp;144, including in the case of affiliates (1)&nbsp;the availability of
certain public information about the Company, (2)&nbsp;the amount of Securities being sold during any three (3)&nbsp;month period not exceeding specified limitations, (3)&nbsp;the resale being made in an unsolicited &#147;broker&#146;s
transaction&#148;, transactions directly with a &#147;market maker&#148; or &#147;riskless principal transactions&#148; (as those terms are defined under the Securities Exchange Act of 1934) and (4)&nbsp;the timely filing of a Form&nbsp;144, if
applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event that the Company does not qualify under Rule&nbsp;701 at the time of grant of the Restricted Stock Award, then
the Securities may be resold in certain limited circumstances subject to the provisions of Rule&nbsp;144, which may require (i)&nbsp;the availability of current public information about the Company; (ii)&nbsp;the resale to occur more than a
specified period after the purchase and full payment (within the meaning of Rule&nbsp;144) for the Securities; and (iii)&nbsp;in the case of the sale of Securities by an affiliate, the satisfaction of the conditions set forth in sections&nbsp;(2),
(3)&nbsp;and (4)&nbsp;of the paragraph immediately above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Participant further understands that in the event
all of the applicable requirements of Rule&nbsp;701 or 144 are not satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption shall be required; and that, notwithstanding the fact that
Rules&nbsp;144 and 701 are not exclusive, the Staff of the Securities and Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to
Rules&nbsp;144 or 701 shall have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so
at their own risk. Participant understands that no assurances can be given that any such other registration exemption shall be available in such event. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PARTICIPANT</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Signature</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Date</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B-1 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT SEPARATE FROM CERTIFICATE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED I,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, hereby sell, assign and
transfer unto Penumbra, Inc. <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares of the Common Stock of Penumbra, Inc. standing in my name on the books of said
corporation represented by Certificate No.&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> herewith and do hereby irrevocably constitute and appoint
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> to transfer the said
stock on the books of the within named corporation with full power of substitution in the premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Stock Assignment may be used
only in accordance with the Restricted Stock Agreement between Penumbra, Inc. and the undersigned dated <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (the &#147;Agreement&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;</U></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Signature:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INSTRUCTIONS:</B> Please do not fill in any blanks other than the signature line. The purpose of this assignment is to
enable the Company to transfer the Unvested Shares of Restricted Stock to the Company upon Participant&#146;s termination as a Service Provider, without requiring additional signatures on the part of Participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B-2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JOINT ESCROW INSTRUCTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Corporate Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alameda, CA 94502 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
Escrow Agent for both Penumbra, Inc. (the &#147;Company&#148;), and the undersigned recipient of stock of the Company (the &#147;Participant&#148;), you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms
of that certain Restricted Stock Agreement (the &#147;Agreement&#148;) between the Company and the undersigned, in accordance with the following instructions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;At the closing, you are directed (a)&nbsp;to date the stock assignments necessary for the transfer in question,
(b)&nbsp;to fill in the number of shares being transferred, and (c)&nbsp;to deliver the stock assignments, together with the certificate evidencing the shares of stock to be transferred, to the Company or its assignee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;Participant irrevocably authorizes the Company to deposit with you any certificates evidencing shares of stock to be
held by you hereunder and any additions and substitutions to said shares as defined in the Agreement. Participant does hereby irrevocably constitute and appoint you as Participant&#146;s attorney-in-fact and agent for the term of this escrow to
execute with respect to such securities all documents necessary or appropriate to make such securities negotiable and to complete any transaction herein contemplated, including but not limited to the filing with any applicable state blue sky
authority of any required applications for consent to, or notice of transfer of, the securities. Subject to the provisions of this paragraph&nbsp;2, Participant shall exercise all rights and privileges of a stockholder of the Company while the stock
is held by you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;Upon written request of the Participant, but no more than once per calendar year, unless the
shares are forfeited, you shall deliver to Participant a certificate or certificates representing so many shares of stock that have vested. Within one hundred and twenty (120)&nbsp;days after cessation of Participant&#146;s continuous employment by
or services to the Company, or any parent or subsidiary of the Company, you shall deliver to Participant a certificate or certificates representing the aggregate number of shares held or issued pursuant to the Agreement that have vested. Upon any
forfeiture of such shares, you shall deliver or electronically transfer such shares to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;If at the
time of termination of this escrow you should have in your possession any documents, securities, or other property belonging to Participant, you shall deliver all of the same to Participant and shall be discharged of all further obligations
hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;Your duties hereunder may be altered, amended, modified or revoked only
by a writing signed by all of the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;You shall be obligated only for the performance of such
duties as are specifically set forth herein and may rely and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You
shall not be personally liable for any act you may do or omit to do hereunder as Escrow Agent or as attorney-in-fact for Participant while acting in good faith, and any act done or omitted by you pursuant to the advice of your own attorneys shall be
conclusive evidence of such good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;You are hereby expressly authorized to disregard any and all warnings
given by any of the parties hereto or by any other person or corporation, excepting only orders or process of courts of law and are hereby expressly authorized to comply with and obey orders, judgments or decrees of any court. In case you obey or
comply with any such order, judgment or decree, you shall not be liable to any of the parties hereto or to any other person, firm or corporation by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently
reversed, modified, annulled, set aside, vacated or found to have been entered without jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;You shall
not be liable in any respect on account of the identity, authorities or rights of the parties executing or delivering or purporting to execute or deliver the Agreement or any documents or papers deposited or called for hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;You shall not be liable for the outlawing of any rights under the Statute of Limitations with respect to these Joint
Escrow Instructions or any documents deposited with you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;You shall be entitled to employ such legal counsel
and other experts as you may deem necessary properly to advise you in connection with your obligations hereunder, may rely upon the advice of such counsel, and may pay such counsel reasonable compensation therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;Your responsibilities as Escrow Agent hereunder shall terminate if you shall cease to be an officer or agent of the
Company or if you shall resign by written notice to each party. In the event of any such termination, the Company shall appoint a successor Escrow Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;If you reasonably require other or further instruments in connection with these Joint Escrow Instructions or
obligations in respect hereto, the necessary parties hereto shall join in furnishing such instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;It is
understood and agreed that should any dispute arise with respect to the delivery and/or ownership or right of possession of the securities held by you hereunder, you are authorized and directed to retain in your possession without liability to
anyone all or any part of said securities until such disputes shall have been settled either by mutual written agreement of the parties concerned or by a final order, decree or judgment of a court of competent jurisdiction after the time for appeal
has expired and no appeal has been perfected, but you shall be under no duty whatsoever to institute or defend any such proceedings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;Any notice required or permitted hereunder shall be given in writing
and shall be deemed effectively given upon personal delivery or upon deposit in the United States Post Office, by registered or certified mail with postage and fees prepaid, addressed to each of the other parties thereunto entitled at the following
addresses or at such other addresses as a party may designate by ten (10)&nbsp;days advance written notice to each of the other parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;By signing these Joint Escrow Instructions, you become a party hereto only for the purpose of said Joint Escrow
Instructions; you do not become a party to the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;This instrument shall be binding upon and inure to
the benefit of the parties hereto, and their respective successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;These Joint Escrow
Instructions shall be governed by the internal substantive laws, but not the choice of law rules, of California. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">PARTICIPANT</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Signature</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">By</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print Name</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Residence Address</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">ESCROW AGENT</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Corporate Secretary</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B-3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION UNDER SECTION 83(b) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF THE INTERNAL REVENUE CODE OF 1986 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
undersigned taxpayer hereby elects, pursuant to Section&nbsp;83(b) of the Internal Revenue Code of 1986, as amended, to include in taxpayer&#146;s gross income or alternative minimum taxable income, as the case may be, for the current taxable year
the amount of any compensation taxable to taxpayer in connection with taxpayer&#146;s receipt of the property described below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7">The name, address, taxpayer identification number and taxable year of the undersigned are as follows:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">NAME:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">SPOUSE:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">ADDRESS:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">TAXPAYER IDENTIFICATION NO.:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">TAXABLE YEAR:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">The property with respect to which the election is made is described as follows: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares (the &#147;Shares&#148;) of the Common Stock of
Penumbra, Inc. (the &#147;Company&#148;). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">The date on which the property was transferred is:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
,<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">The property is subject to the following restrictions: </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Shares may not be transferred and
are subject to forfeiture under the terms of an agreement between the taxpayer and the Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">The Fair Market Value at the time of transfer, determined without regard to any restriction other than a restriction which by its terms shall never lapse, of such property is:
$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top">The amount (if any) paid for such property is: $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned has submitted a copy of this statement to the person for whom the services were performed in connection with the undersigned&#146;s receipt of
the above-described property. The transferee of such property is the person performing the services in connection with the transfer of said property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>The undersigned understands that the foregoing election may not be revoked except with the consent of the Commissioner</U>. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Taxpayer</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned spouse of taxpayer joins in this election. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Spouse of Taxpayer</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK OPTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise defined herein, the terms defined in the 2014 Equity Incentive Plan (the &#147;Plan&#148;) shall have the same defined
meanings in this Stock Option Agreement (the &#147;Option Agreement&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>I.</B>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B><U>NOTICE OF STOCK OPTION GRANT</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B>Name:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B>Address:</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Participant has been granted an Option to purchase Common Stock of the Company, subject to the
terms and conditions of the Plan and this Option Agreement, as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date of Grant:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vesting Commencement Date:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exercise Price per Share:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Number of Shares Granted:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Exercise Price:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Type of Option:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> &nbsp;&nbsp;&nbsp;&nbsp;Incentive Stock Option</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> &nbsp;&nbsp;&nbsp;&nbsp;Nonstatutory Stock Option</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Term/Expiration Date:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>Vesting Schedule</U>:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Option shall be exercisable, in whole or in part, according to the following vesting schedule: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[Twenty-five percent (25%)&nbsp;of the Shares subject to the Option shall vest on the one (1)&nbsp;year anniversary of the Vesting
Commencement Date, and one forty-eighth (1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)&nbsp;of the Shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if
there is no corresponding day, on the last day of the month), subject to Participant continuing to be a Service Provider through each such date.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a Change in Control, and subject to Participant continuing to be a Service
Provider through the date of such Change in Control, the Participant will fully vest in and have the right to exercise all of the Shares subject to this Option. The Administrator will notify the Participant in writing or electronically that this
Option will be exercisable for a period of time determined by the Administrator in its sole discretion, and, to the extent the Administrator determines, terminate upon or immediately prior to the effectiveness of the Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Termination Period</U>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Option shall be exercisable for three (3)&nbsp;months after Participant ceases to be a Service Provider, unless such termination is due
to Participant&#146;s death or Disability, in which case this Option shall be exercisable for twelve (12)&nbsp;months after Participant ceases to be a Service Provider. Notwithstanding the foregoing sentence, in no event may this Option be exercised
after the Term/Expiration Date as provided above and this Option may be subject to earlier termination as provided in Section&nbsp;13 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>II.&nbsp;&nbsp;&nbsp;&nbsp;<U>AGREEMENT</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Option</U>. The Administrator of the Company hereby grants to the Participant named in the Notice of
Stock Option Grant in Part I of this Agreement (&#147;Participant&#148;), an option (the &#147;Option&#148;) to purchase the number of Shares set forth in the Notice of Stock Option Grant, at the exercise price per Share set forth in the Notice of
Stock Option Grant (the &#147;Exercise Price&#148;), and subject to the terms and conditions of the Plan, which is incorporated herein by reference. Subject to Section&nbsp;18 of the Plan, in the event of a conflict between the terms and conditions
of the Plan and this Option Agreement, the terms and conditions of the Plan shall prevail. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If designated in the Notice of Stock Option
Grant as an Incentive Stock Option (&#147;ISO&#148;), this Option is intended to qualify as an Incentive Stock Option as defined in Section&nbsp;422 of the Code. Nevertheless, to the extent that it exceeds the $100,000 rule of Code
Section&nbsp;422(d), this Option shall be treated as a Nonstatutory Stock Option (&#147;NSO&#148;). Further, if for any reason this Option (or portion thereof) shall not qualify as an ISO, such as due to the stockholders of the Company not approving
the Plan within twelve (12)&nbsp;months after the date the Plan is adopted by the Board, then, to the extent of such nonqualification, such Option (or portion thereof) shall be regarded as a NSO granted under the Plan. In no event shall the
Administrator, the Company or any Parent or Subsidiary or any of their respective employees or directors have any liability to Participant (or any other person) due to the failure of the Option to qualify for any reason as an ISO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Right to Exercise</U>. This Option shall be exercisable during its term in accordance with the Vesting Schedule
set out in the Notice of Stock Option Grant and with the applicable provisions of the Plan and this Option Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Exercise</U>. This Option shall be exercisable by delivery of an exercise notice in the form attached
as <U>Exhibit&nbsp;A</U> (the &#147;Exercise Notice&#148;) or in a manner and pursuant to such procedures as the Administrator may determine, which shall state the election to exercise the Option, the number of Shares with respect to which the
Option is being exercised (the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
&#147;Exercised Shares&#148;), and such other representations and agreements as may be required by the Company. The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price
as to all Exercised Shares, together with any applicable tax withholding. This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the aggregate Exercise Price, together with any
applicable tax withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">No Shares shall be issued pursuant to the exercise of an Option unless such issuance and such exercise comply
with Applicable Laws. Assuming such compliance, for income tax purposes the Shares shall be considered transferred to Participant on the date on which the Option is exercised with respect to such Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Participant&#146;s Representations</U>. In the event the Shares have not been registered under the Securities Act
of 1933, as amended (the &#147;Securities Act&#148;), at the time this Option is exercised, Participant shall, if required by the Company, concurrently with the exercise of all or any portion of this Option, deliver to the Company his or her
Investment Representation Statement in the form attached hereto as <U>Exhibit&nbsp;B</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Lock-Up
Period</U>. Participant hereby agrees that Participant shall not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or
otherwise transfer or dispose of, directly or indirectly, any Common Stock (or other securities) of the Company or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of
ownership of any Common Stock (or other securities) of the Company held by Participant (other than those included in the registration) for a period specified by the representative of the underwriters of Common Stock (or other securities) of the
Company not to exceed one hundred and eighty (180)&nbsp;days following the effective date of any registration statement of the Company filed under the Securities Act (or such other period as may be requested by the Company or the underwriters to
accommodate regulatory restrictions on (i)&nbsp;the publication or other distribution of research reports and (ii)&nbsp;analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule&nbsp;2711(f)(4) or
NYSE Rule&nbsp;472(f)(4), or any successor provisions or amendments thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Participant agrees to execute and deliver such other
agreements as may be reasonably requested by the Company or the underwriter which are consistent with the foregoing or which are necessary to give further effect thereto. In addition, if requested by the Company or the representative of the
underwriters of Common Stock (or other securities) of the Company, Participant shall provide, within ten (10)&nbsp;days of such request, such information as may be required by the Company or such representative in connection with the completion of
any public offering of the Company&#146;s securities pursuant to a registration statement filed under the Securities Act. The obligations described in this Section&nbsp;4 shall not apply to a registration relating solely to employee benefit plans on
Form S-1 or Form S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a Commission Rule 145 transaction on Form S-4 or similar forms that may be promulgated in the future. The Company may impose
stop-transfer instructions with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of said one hundred and eighty (180)&nbsp;day (or other) period. Participant agrees that any transferee of
the Option or shares acquired pursuant to the Option shall be bound by this Section&nbsp;4. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Payment</U>. Payment of the aggregate Exercise Price shall
be by any of the following, or a combination thereof, at the election of the Participant: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;cash; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;check; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;consideration received by the Company under a formal cashless exercise program adopted by the Company in connection
with the Plan; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;surrender of other Shares which (i)&nbsp;shall be valued at its Fair Market Value on the
date of exercise, and (ii)&nbsp;must be owned free and clear of any liens, claims, encumbrances or security interests, if accepting such Shares, in the sole discretion of the Administrator, shall not result in any adverse accounting consequences to
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions on Exercise</U>. This Option may not be exercised if the issuance of such Shares
upon such exercise or the method of payment of consideration for such shares would constitute a violation of any Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Transferability of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution
and may be exercised during the lifetime of Participant only by Participant. The terms of the Plan and this Option Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Further, until the Company becomes subject to the reporting requirements of Section&nbsp;13 or 15(d) of the
Exchange Act, or after the Administrator determines that it is, will, or may no longer be relying upon the exemption from registration of Options under the Exchange Act as set forth in Rule 12h-1(f) promulgated under the Exchange Act (the
&#147;Reliance End Date&#148;), Participant shall not transfer this Option or, prior to exercise, the Shares subject to this Option, in any manner other than (i)&nbsp;to persons who are &#147;family members&#148; (as defined in Rule 701(c)(3) of the
Securities Act) through gifts or domestic relations orders, or (ii)&nbsp;to an executor or guardian of Participant upon the death or disability of Participant. Until the Reliance End Date, the Options and, prior to exercise, the Shares subject to
this Option, may not be pledged, hypothecated or otherwise transferred or disposed of, including by entering into any short position, any &#147;put equivalent position&#148; or any &#147;call equivalent position&#148; (as defined in Rule 16a-1(h)
and Rule 16a-1(b) of the Exchange Act, respectively), other than as permitted in clauses (i)&nbsp;and (ii)&nbsp;of this paragraph. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Option</U>. This Option may be exercised only within the term set out in the Notice of Stock Option
Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Option Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Obligations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Withholding</U>. Participant agrees to make appropriate arrangements with the Company (or the Parent or
Subsidiary employing or retaining Participant) for the satisfaction of all Federal, state, local and foreign income and employment tax withholding requirements applicable to the Option exercise. Participant acknowledges and agrees that the Company
may refuse to honor the exercise and refuse to deliver the Shares if such withholding amounts are not delivered at the time of exercise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Disqualifying Disposition of ISO Shares</U>. If the Option granted to Participant herein is an ISO,
and if Participant sells or otherwise disposes of any of the Shares acquired pursuant to the ISO on or before the later of (i)&nbsp;the date two (2)&nbsp;years after the Date of Grant, or (ii)&nbsp;the date one (1)&nbsp;year after the date of
exercise, Participant shall immediately notify the Company in writing of such disposition. Participant agrees that Participant may be subject to income tax withholding by the Company on the compensation income recognized by Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Code Section&nbsp;409A.</U> Under Code Section&nbsp;409A, an Option that vests after December&nbsp;31, 2004 (or
that vested on or prior to such date but which was materially modified after October&nbsp;3, 2004) that was granted with a per Share exercise price that is determined by the Internal Revenue Service (the &#147;IRS&#148;) to be less than the Fair
Market Value of a Share on the date of grant (a &#147;discount option&#148;) may be considered &#147;deferred compensation.&#148; An Option that is a &#147;discount option&#148; may result in (i)&nbsp;income recognition by Participant prior to the
exercise of the Option, (ii)&nbsp;an additional twenty percent (20%)&nbsp;federal income tax, and (iii)&nbsp;potential penalty and interest charges. The &#147;discount option&#148; may also result in additional state income, penalty and interest tax
to the Participant. Participant acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share exercise price of this Option equals or exceeds the Fair Market Value of a Share on the date of grant in a later
examination. Participant agrees that if the IRS determines that the Option was granted with a per Share exercise price that was less than the Fair Market Value of a Share on the date of grant, Participant shall be solely responsible for
Participant&#146;s costs related to such a determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement; Governing Law</U>. The Plan is
incorporated herein by reference. The Plan and this Option Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and
Participant with respect to the subject matter hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. This Option Agreement is governed by the internal
substantive laws but not the choice of law rules of California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Guarantee of Continued Service</U>.
PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) AND
NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT
CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH PARTICIPANT&#146;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR
SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT&#146;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participant acknowledges receipt of a copy of the Plan and represents that he or she is familiar
with the terms and provisions thereof, and hereby accepts this Option subject to all of the terms and provisions thereof. Participant has reviewed the Plan and this Option in their entirety, has had an opportunity to obtain the advice of counsel
prior to executing this Option and fully understands all provisions of the Option. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan
or this Option. Participant further agrees to notify the Company upon any change in the residence address indicated below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">PARTICIPANT</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Signature</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">By</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print Name</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Residence Address</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXERCISE NOTICE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alameda, CA 94502 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Treasurer </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Option</U>. Effective as of today,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, the undersigned
(&#147;Participant&#148;) hereby elects to exercise Participant&#146;s option (the &#147;Option&#148;) to purchase <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares of the Common Stock (the &#147;Shares&#148;) of
Penumbra, Inc. (the &#147;Company&#148;) under and pursuant to the 2014 Equity Incentive Plan (the &#147;Plan&#148;) and the Stock Option Agreement dated
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (the &#147;Option Agreement&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Payment</U>. Participant herewith delivers to the Company the full purchase price of the Shares, as
set forth in the Option Agreement, and any and all withholding taxes due in connection with the exercise of the Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations of Participant</U>. Participant acknowledges that Participant has received, read and understood
the Plan and the Option Agreement and agrees to abide by and be bound by their terms and conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
as Stockholder</U>. Until the issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a
stockholder shall exist with respect to the Common Stock subject to an Award, notwithstanding the exercise of the Option. The Shares shall be issued to Participant as soon as practicable after the Option is exercised in accordance with the Option
Agreement. No adjustment shall be made for a dividend or other right for which the record date is prior to the date of issuance except as provided in Section&nbsp;13 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Company&#146;s Right of First Refusal</U>. Before any Shares held by Participant or any transferee (either being
sometimes referred to herein as the &#147;Holder&#148;) may be sold or otherwise transferred (including transfer by gift or operation of law), the Company or its assignee(s) shall have a right of first refusal to purchase the Shares on the terms and
conditions set forth in this Section&nbsp;5 (the &#147;Right of First Refusal&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Proposed
Transfer</U>. The Holder of the Shares shall deliver to the Company a written notice (the &#147;Notice&#148;) stating: (i)&nbsp;the Holder&#146;s bona fide intention to sell or otherwise transfer such Shares; (ii)&nbsp;the name of each proposed
purchaser or other transferee (&#147;Proposed Transferee&#148;); (iii)&nbsp;the number of Shares to be transferred to each Proposed Transferee; and (iv)&nbsp;the bona fide cash price or other consideration for which the Holder proposes to transfer
the Shares (the &#147;Offered Price&#148;), and the Holder shall offer the Shares at the Offered Price to the Company or its assignee(s). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Right of First Refusal</U>. At any time within
thirty&nbsp;(30) days after receipt of the Notice, the Company and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the
Proposed Transferees, at the purchase price determined in accordance with subsection (c)&nbsp;below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase Price</U>. The purchase price (&#147;Purchase Price&#148;) for the Shares purchased by the Company or
its assignee(s) under this Section&nbsp;5 shall be the Offered Price. If the Offered Price includes consideration other than cash, the cash equivalent value of the non-cash consideration shall be determined by the Board of Directors of the Company
in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment</U>. Payment of the Purchase Price shall be made, at the option of the Company or
its assignee(s), in cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company (or, in the case of repurchase by an assignee, to the assignee), or by any combination thereof within
thirty&nbsp;(30) days after receipt of the Notice or in the manner and at the times set forth in the Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Holder&#146;s Right to Transfer</U>. If all of the Shares proposed in the Notice to be transferred to a given
Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section&nbsp;5, then the Holder may sell or otherwise transfer such Shares to that Proposed Transferee at the Offered Price or at a higher price,
<I>provided</I> that such sale or other transfer is consummated within one hundred and twenty (120)&nbsp;days after the date of the Notice, that any such sale or other transfer is effected in accordance with any applicable securities laws and that
the Proposed Transferee agrees in writing that the provisions of this Section&nbsp;5 shall continue to apply to the Shares in the hands of such Proposed Transferee. If the Shares described in the Notice are not transferred to the Proposed Transferee
within such period, a new Notice shall be given to the Company, and the Company and/or its assignees shall again be offered the Right of First Refusal before any Shares held by the Holder may be sold or otherwise transferred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exception for Certain Family Transfers</U>. Anything to the contrary contained in this Section&nbsp;5
notwithstanding, the transfer of any or all of the Shares during the Participant&#146;s lifetime or on the Participant&#146;s death by will or intestacy to the Participant&#146;s immediate family or a trust for the benefit of the Participant or the
Participant&#146;s immediate family shall be exempt from the provisions of this Section&nbsp;5. &#147;Immediate Family&#148; as used herein shall mean spouse, lineal descendant or antecedent, father, mother, brother or sister. In such case, the
transferee or other recipient shall receive and hold the Shares so transferred subject to the provisions of this Section&nbsp;5, and there shall be no further transfer of such Shares except in accordance with the terms of this Section&nbsp;5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Right of First Refusal</U>. The Right of First Refusal shall terminate as to any Shares upon the
earlier of (i)&nbsp;the first sale of Common Stock of the Company to the general public, or (ii)&nbsp;a Change in Control in which the successor corporation has equity securities that are publicly traded. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Consultation</U>. Participant understands that Participant may
suffer adverse tax consequences as a result of Participant&#146;s purchase or disposition of the Shares. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection with the purchase or
disposition of the Shares and that Participant is not relying on the Company for any tax advice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictive
Legends and Stop-Transfer Orders</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Legends</U>. Participant understands and agrees that the Company
shall cause the legends set forth below or legends substantially equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal
securities laws: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE &#147;ACT&#148;) AND MAY
NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS
IN COMPLIANCE THEREWITH. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND A RIGHT OF FIRST
REFUSAL HELD BY THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE EXERCISE NOTICE BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS AND RIGHT
OF FIRST REFUSAL ARE BINDING ON TRANSFEREES OF THESE SHARES. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON
TRANSFER FOR A PERIOD OF TIME FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY&#146;S SECURITIES SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE
DISPOSED OF BY THE HOLDER PRIOR TO THE EXPIRATION OF SUCH PERIOD WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stop-Transfer Notices</U>. Participant agrees that, in order to ensure compliance with the restrictions referred
to herein, the Company may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to&nbsp;the same effect in its own records.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Refusal to Transfer</U>. The Company shall not be required (i)&nbsp;to transfer on its books any Shares
that have been sold or otherwise transferred in violation of any of the provisions of this Exercise Notice or (ii)&nbsp;to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom
such Shares shall have been so transferred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors and Assigns</U>. The Company may assign any of its rights
under this Exercise Notice to single or multiple assignees, and this Exercise Notice shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Exercise Notice shall be
binding upon Participant and his or her heirs, executors, administrators, successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Interpretation</U>. Any dispute regarding the interpretation of this Exercise Notice shall be submitted by
Participant or by the Company forthwith to the Administrator, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Administrator shall be final and binding on all parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law; Severability</U>. This Exercise Notice is governed by the internal substantive laws, but not the
choice of law rules, of California. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Exercise Notice shall continue in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement</U>. The Plan and Option Agreement are incorporated herein by reference. This Exercise Notice,
the Plan, the Option Agreement and the Investment Representation Statement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company
and Participant with respect to the subject matter hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Submitted by:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">PARTICIPANT</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted by:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">PENUMBRA, INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Signature</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">By</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print Name</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title</FONT></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Address:</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Date Received</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INVESTMENT REPRESENTATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PARTICIPANT</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COMPANY</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECURITY</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">COMMON STOCK</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AMOUNT</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DATE</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the purchase of the above-listed Securities, the undersigned Participant represents to the
Company the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Participant is aware of the Company&#146;s business affairs and financial condition and
has acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Securities. Participant is acquiring these Securities for investment for Participant&#146;s own account only and not with a view to,
or for resale in connection with, any &#147;distribution&#148; thereof within the meaning of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Participant acknowledges and understands that the Securities constitute &#147;restricted securities&#148; under the
Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Participant&#146;s investment intent as expressed herein.
In this connection, Participant understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if Participant&#146;s representation was predicated solely upon a present intention to
hold these Securities for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Securities, or for a period of one (1)&nbsp;year or any other fixed period
in the future. Participant further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Participant further acknowledges and
understands that the Company is under no obligation to register the Securities. Participant understands that the certificate evidencing the Securities shall be imprinted with any legend required under applicable state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Participant is familiar with the provisions of Rule&nbsp;701 and Rule&nbsp;144, each promulgated under the
Securities Act, which, in substance, permit limited public resale of &#147;restricted securities&#148; acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions.
Rule&nbsp;701 provides that if the issuer qualifies under Rule&nbsp;701 at the time of the grant of the Option to Participant, the exercise shall be exempt from registration under the Securities Act. In the event the Company becomes subject to the
reporting requirements </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934, ninety&nbsp;(90) days thereafter (or such longer period as any market stand-off agreement may require) the Securities exempt
under Rule&nbsp;701 may be resold, subject to the satisfaction of the applicable conditions specified by Rule&nbsp;144, including in the case of affiliates (1)&nbsp;the availability of certain public information about the Company, (2)&nbsp;the
amount of Securities being sold during any three (3)&nbsp;month period not exceeding specified limitations, (3)&nbsp;the resale being made in an unsolicited &#147;broker&#146;s transaction&#148;, transactions directly with a &#147;market maker&#148;
or &#147;riskless principal transactions&#148; (as those terms are defined under the Securities Exchange Act of 1934) and (4)&nbsp;the timely filing of a Form&nbsp;144, if applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event that the Company does not qualify under Rule&nbsp;701 at the time of grant of the Option, then the Securities may be resold in
certain limited circumstances subject to the provisions of Rule&nbsp;144, which may require (i)&nbsp;the availability of current public information about the Company; (ii)&nbsp;the resale to occur more than a specified period after the purchase and
full payment (within the meaning of Rule&nbsp;144) for the Securities; and (iii)&nbsp;in the case of the sale of Securities by an affiliate, the satisfaction of the conditions set forth in sections&nbsp;(2), (3)&nbsp;and (4)&nbsp;of the paragraph
immediately above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Participant further understands that in the event all of the applicable requirements of
Rule&nbsp;701 or 144 are not satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption shall be required; and that, notwithstanding the fact that Rules&nbsp;144 and 701 are not exclusive,
the Staff of the Securities and Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules&nbsp;144 or 701 shall have a
substantial burden of proof in establishing that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. Participant
understands that no assurances can be given that any such other registration exemption shall be available in such event. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PARTICIPANT</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Signature</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Date</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK OPTION AGREEMENT &#151; EARLY EXERCISE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise defined herein, the terms defined in the 2014 Equity Incentive Plan (the &#147;Plan&#148;) shall have the same defined
meanings in this Stock Option Agreement &#150; Early Exercise (the &#147;Option Agreement&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>I.</B>&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B><U>NOTICE OF STOCK OPTION GRANT</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B>Name:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><B>Address:</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Participant has been granted an Option to purchase Common Stock of the Company, subject to the
terms and conditions of the Plan and this Option Agreement, as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date of Grant:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vesting Commencement Date:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exercise Price per Share:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Number of Shares Granted:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Exercise Price:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">$</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Type of Option:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> &nbsp;&nbsp;&nbsp;&nbsp;Incentive Stock Option</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> &nbsp;&nbsp;&nbsp;&nbsp;Nonstatutory Stock Option</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Term/Expiration Date:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>Vesting Schedule</U>:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Option shall be exercisable, in whole or in part, according to the following vesting schedule: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[Twenty-five percent (25%)&nbsp;of the Shares subject to the Option shall vest on the one (1)&nbsp;year anniversary of the Vesting
Commencement Date, and one forty-eighth (1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)&nbsp;of the Shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if
there is no corresponding day, on the last day of the month), subject to Participant continuing to be a Service Provider through each such date.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a Change in Control, and subject to Participant continuing to be a Service
Provider through the date of such Change in Control, the Participant will fully vest in and have the right to exercise all of the Shares subject to this Option. The Administrator will notify the Participant in writing or electronically that this
Option will be exercisable for a period of time determined by the Administrator in its sole discretion, and, to the extent the Administrator determines, terminate upon or immediately prior to the effectiveness of the Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Termination Period</U>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Option shall be exercisable for three (3)&nbsp;months after Participant ceases to be a Service Provider, unless such termination is due
to Participant&#146;s death or Disability, in which case this Option shall be exercisable for twelve (12)&nbsp;months after Participant ceases to be a Service Provider. Notwithstanding the foregoing sentence, in no event may this Option be exercised
after the Term/Expiration Date as provided above and this Option may be subject to earlier termination as provided in Section&nbsp;13 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>II.&nbsp;&nbsp;&nbsp;&nbsp;<U>AGREEMENT</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Grant of Option</U>. The Administrator of the Company hereby grants to the Participant named in the Notice of
Stock Option Grant in Part I of this Agreement (&#147;Participant&#148;), an option (the &#147;Option&#148;) to purchase the number of Shares set forth in the Notice of Stock Option Grant, at the exercise price per Share set forth in the Notice of
Stock Option Grant (the &#147;Exercise Price&#148;), and subject to the terms and conditions of the Plan, which is incorporated herein by reference. Subject to Section&nbsp;18 of the Plan, in the event of a conflict between the terms and conditions
of the Plan and this Option Agreement, the terms and conditions of the Plan shall prevail. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If designated in the Notice of Stock Option
Grant as an Incentive Stock Option (&#147;ISO&#148;), this Option is intended to qualify as an Incentive Stock Option as defined in Section&nbsp;422 of the Code. Nevertheless, to the extent that it exceeds the $100,000 rule of Code
Section&nbsp;422(d), this Option shall be treated as a Nonstatutory Stock Option (&#147;NSO&#148;). Further, if for any reason this Option (or portion thereof) shall not qualify as an ISO, such as due to the stockholders of the Company not approving
the Plan within twelve (12)&nbsp;months after the date the Plan is adopted by the Board, then, to the extent of such nonqualification, such Option (or portion thereof) shall be regarded as a NSO granted under the Plan. In no event shall the
Administrator, the Company or any Parent or Subsidiary or any of their respective employees or directors have any liability to Participant (or any other person) due to the failure of the Option to qualify for any reason as an ISO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Option</U>. This Option shall be exercisable during its term in accordance with the provisions of
Section&nbsp;6 of the Plan as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Right to Exercise</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;Subject to subsections&nbsp;2(a)(ii) and 2(a)(iii) below, this Option shall be exercisable cumulatively according
to the vesting schedule set forth in the Notice of Stock Option Grant. Alternatively, at the election of Participant, this Option may be exercised in whole or in part at any time as to Shares that have not yet vested. Vested Shares shall not be
subject to the Company&#146;s repurchase right (as set forth in the Restricted Stock Purchase Agreement, attached hereto as <U>Exhibit&nbsp;C-1</U>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;As a condition to exercising this Option for unvested Shares,
Participant shall execute the Restricted Stock Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;This Option may not be exercised for a
fraction of a Share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Exercise</U>. This Option shall be exercisable by delivery of an exercise
notice in the form attached as <U>Exhibit A</U> (the &#147;Exercise Notice&#148;) or in a manner and pursuant to such procedures as the Administrator may determine, which shall state the election to exercise the Option, the number of Shares with
respect to which the Option is being exercised (the &#147;Exercised Shares&#148;), and such other representations and agreements as may be required by the Company. The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price
as to all Exercised Shares, together with any applicable tax withholding. This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the aggregate Exercise Price, together with any
applicable tax withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">No Shares shall be issued pursuant to the exercise of an Option unless such issuance and such exercise comply
with Applicable Laws. Assuming such compliance, for income tax purposes the Shares shall be considered transferred to Participant on the date on which the Option is exercised with respect to such Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Participant&#146;s Representations</U>. In the event the Shares have not been registered under the Securities Act
of 1933, as amended (the &#147;Securities Act&#148;), at the time this Option is exercised, Participant shall, if required by the Company, concurrently with the exercise of all or any portion of this Option, deliver to the Company his or her
Investment Representation Statement in the form attached hereto as <U>Exhibit&nbsp;B</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Lock-Up
Period</U>. Participant hereby agrees that Participant shall not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or
otherwise transfer or dispose of, directly or indirectly, any Common Stock (or other securities) of the Company or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of
ownership of any Common Stock (or other securities) of the Company held by Participant (other than those included in the registration) for a period specified by the representative of the underwriters of Common Stock (or other securities) of the
Company not to exceed one hundred and eighty (180)&nbsp;days following the effective date of any registration statement of the Company filed under the Securities Act (or such other period as may be requested by the Company or the underwriters to
accommodate regulatory restrictions on (i)&nbsp;the publication or other distribution of research reports and (ii)&nbsp;analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule&nbsp;2711(f)(4) or
NYSE Rule&nbsp;472(f)(4), or any successor provisions or amendments thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Participant agrees to execute and deliver such other
agreements as may be reasonably requested by the Company or the underwriter which are consistent with the foregoing or which are necessary to give further effect thereto. In addition, if requested by the Company or the representative of the
underwriters of Common Stock (or other securities) of the Company, Participant shall provide, within ten (10)&nbsp;days of such request, such information as may be required by the Company or such representative in connection with the completion of
any public offering of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company&#146;s securities pursuant to a registration statement filed under the Securities Act. The obligations described in this Section&nbsp;4 shall not apply to a registration relating
solely to employee benefit plans on Form S-1 or Form S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a Commission Rule 145 transaction on Form S-4 or similar forms that may be promulgated in the
future. The Company may impose stop-transfer instructions with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of said one hundred and eighty (180)&nbsp;day (or other) period.
Participant agrees that any transferee of the Option or shares acquired pursuant to the Option shall be bound by this Section&nbsp;4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Method of Payment</U>. Payment of the aggregate Exercise Price shall be by any of the following, or a combination
thereof, at the election of the Participant: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;cash; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;check; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;consideration received by the Company under a formal cashless exercise program adopted by the Company in connection
with the Plan; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;surrender of other Shares which (i)&nbsp;shall be valued at its Fair Market Value on the date
of exercise, and (ii)&nbsp;must be owned free and clear of any liens, claims, encumbrances or security interests, if accepting such Shares, in the sole discretion of the Administrator, shall not result in any adverse accounting consequences to the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictions on Exercise</U>. This Option may not be exercised if the issuance of such Shares upon
such exercise or the method of payment of consideration for such shares would constitute a violation of any Applicable Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Transferability of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution
and may be exercised during the lifetime of Participant only by Participant. The terms of the Plan and this Option Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Further, until the Company becomes subject to the reporting requirements of Section&nbsp;13 or 15(d) of the
Exchange Act, or after the Administrator determines that it is, will, or may no longer be relying upon the exemption from registration of Options under the Exchange Act as set forth in Rule 12h-1(f) promulgated under the Exchange Act (the
&#147;Reliance End Date&#148;), Participant shall not transfer this Option or, prior to exercise, the Shares subject to this Option, in any manner other than (i)&nbsp;to persons who are &#147;family members&#148; (as defined in Rule 701(c)(3) of the
Securities Act) through gifts or domestic relations orders, or (ii)&nbsp;to an executor or guardian of Participant upon the death or disability of Participant. Until the Reliance End Date, the Options and, prior to exercise, the Shares subject to
this Option, may not be pledged, hypothecated or otherwise transferred or disposed of, including by entering into any short position, any &#147;put equivalent position&#148; or any &#147;call equivalent position&#148; (as defined in Rule 16a-1(h)
and Rule 16a-1(b) of the Exchange Act, respectively), other than as permitted in clauses (i)&nbsp;and (ii)&nbsp;of this paragraph. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Option</U>. This Option may be exercised only within the
term set out in the Notice of Stock Option Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Option Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Obligations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Withholding</U>. Participant agrees to make appropriate arrangements with the Company (or the Parent or
Subsidiary employing or retaining Participant) for the satisfaction of all Federal, state, local and foreign income and employment tax withholding requirements applicable to the Option exercise. Participant acknowledges and agrees that the Company
may refuse to honor the exercise and refuse to deliver the Shares if such withholding amounts are not delivered at the time of exercise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Disqualifying Disposition of ISO Shares</U>. If the Option granted to Participant herein is an ISO,
and if Participant sells or otherwise disposes of any of the Shares acquired pursuant to the ISO on or before the later of (i)&nbsp;the date two (2)&nbsp;years after the Date of Grant, or (ii)&nbsp;the date one (1)&nbsp;year after the date of
exercise, Participant shall immediately notify the Company in writing of such disposition. Participant agrees that Participant may be subject to income tax withholding by the Company on the compensation income recognized by Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Code Section&nbsp;409A</U>. Under Code Section&nbsp;409A, an Option that vests after December&nbsp;31, 2004 (or
that vested on or prior to such date but which was materially modified after October&nbsp;3, 2004) that was granted with a per Share exercise price that is determined by the Internal Revenue Service (the &#147;IRS&#148;) to be less than the Fair
Market Value of a Share on the date of grant (a &#147;discount option&#148;) may be considered &#147;deferred compensation.&#148; An Option that is a &#147;discount option&#148; may result in (i)&nbsp;income recognition by Participant prior to the
exercise of the Option, (ii)&nbsp;an additional twenty percent (20%)&nbsp;federal income tax, and (iii)&nbsp;potential penalty and interest charges. The &#147;discount option&#148; may also result in additional state income, penalty and interest tax
to the Participant. Participant acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share exercise price of this Option equals or exceeds the Fair Market Value of a Share on the date of grant in a later
examination. Participant agrees that if the IRS determines that the Option was granted with a per Share exercise price that was less than the Fair Market Value of a Share on the date of grant, Participant shall be solely responsible for
Participant&#146;s costs related to such a determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement; Governing Law</U>. The Plan is
incorporated herein by reference. The Plan and this Option Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and
Participant with respect to the subject matter hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. This Option Agreement is governed by the internal
substantive laws but not the choice of law rules of California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Guarantee of Continued Service</U>.
PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS
CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH
PARTICIPANT&#146;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT&#146;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participant acknowledges receipt of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and
hereby accepts this Option subject to all of the terms and provisions thereof. Participant has reviewed the Plan and this Option in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Option and fully
understands all provisions of the Option. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan or this Option. Participant further agrees
to notify the Company upon any change in the residence address indicated below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">PARTICIPANT</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Signature</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">By</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print Name</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Residence Address</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXERCISE NOTICE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alameda, CA 94502 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Treasurer </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Option</U>. Effective as of today,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, the undersigned
(&#147;Participant&#148;) hereby elects to exercise Participant&#146;s option (the &#147;Option&#148;) to purchase <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares of the Common Stock (the &#147;Shares&#148;) of
Penumbra, Inc. (the &#147;Company&#148;) under and pursuant to the 2014 Equity Incentive Plan (the &#147;Plan&#148;) and the Stock Option Agreement &#150; Early Exercise dated
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (the &#147;Option Agreement&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Delivery of Payment</U>. Participant herewith delivers to the Company the full purchase price of the Shares, as
set forth in the Option Agreement, and any and all withholding taxes due in connection with the exercise of the Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations of Participant</U>. Participant acknowledges that Participant has received, read and understood
the Plan and the Option Agreement and agrees to abide by and be bound by their terms and conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Rights
as Stockholder</U>. Until the issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a
stockholder shall exist with respect to the Common Stock subject to an Award, notwithstanding the exercise of the Option. The Shares shall be issued to Participant as soon as practicable after the Option is exercised in accordance with the Option
Agreement. No adjustment shall be made for a dividend or other right for which the record date is prior to the date of issuance except as provided in Section&nbsp;13 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Company&#146;s Right of First Refusal</U>. Before any Shares held by Participant or any transferee (either being
sometimes referred to herein as the &#147;Holder&#148;) may be sold or otherwise transferred (including transfer by gift or operation of law), the Company or its assignee(s) shall have a right of first refusal to purchase the Shares on the terms and
conditions set forth in this Section&nbsp;5 (the &#147;Right of First Refusal&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Notice of Proposed
Transfer</U>. The Holder of the Shares shall deliver to the Company a written notice (the &#147;Notice&#148;) stating: (i)&nbsp;the Holder&#146;s bona fide intention to sell or otherwise transfer such Shares; (ii)&nbsp;the name of each proposed
purchaser or other transferee (&#147;Proposed Transferee&#148;); (iii)&nbsp;the number of Shares to be transferred to each Proposed Transferee; and (iv)&nbsp;the bona fide cash price or other consideration for which the Holder proposes to transfer
the Shares (the &#147;Offered Price&#148;), and the Holder shall offer the Shares at the Offered Price to the Company or its assignee(s). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Right of First Refusal</U>. At any time within thirty
(30)&nbsp;days after receipt of the Notice, the Company and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the Proposed
Transferees, at the purchase price determined in accordance with subsection&nbsp;(c) below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Purchase
Price</U>. The purchase price (&#147;Purchase Price&#148;) for the Shares purchased by the Company or its assignee(s) under this Section&nbsp;5 shall be the Offered Price. If the Offered Price includes consideration other than cash, the cash
equivalent value of the non-cash consideration shall be determined by the Board of Directors of the Company in good faith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment</U>. Payment of the Purchase Price shall be made, at the option of the Company or its assignee(s), in
cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company (or, in the case of repurchase by an assignee, to the assignee), or by any combination thereof within thirty (30)&nbsp;days after
receipt of the Notice or in the manner and at the times set forth in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;<U>Holder&#146;s Right to
Transfer</U>. If all of the Shares proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section&nbsp;5, then the Holder may sell or otherwise transfer
such Shares to that Proposed Transferee at the Offered Price or at a higher price, provided that such sale or other transfer is consummated within one hundred and twenty (120)&nbsp;days after the date of the Notice, that any such sale or other
transfer is effected in accordance with any applicable securities laws and that the Proposed Transferee agrees in writing that the provisions of this Section&nbsp;5 shall continue to apply to the Shares in the hands of such Proposed Transferee. If
the Shares described in the Notice are not transferred to the Proposed Transferee within such period, a new Notice shall be given to the Company, and the Company and/or its assignees shall again be offered the Right of First Refusal before any
Shares held by the Holder may be sold or otherwise transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;<U>Exception for Certain Family Transfers</U>.
Anything to the contrary contained in this Section&nbsp;5 notwithstanding, the transfer of any or all of the Shares during the Participant&#146;s lifetime or on the Participant&#146;s death by will or intestacy to the Participant&#146;s immediate
family or a trust for the benefit of the Participant or the Participant&#146;s immediate family shall be exempt from the provisions of this Section&nbsp;5. &#147;Immediate Family&#148; as used herein shall mean spouse, lineal descendant or
antecedent, father, mother, brother or sister. In such case, the transferee or other recipient shall receive and hold the Shares so transferred subject to the provisions of this Section&nbsp;5, and there shall be no further transfer of such Shares
except in accordance with the terms of this Section&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Right of First Refusal</U>. The
Right of First Refusal shall terminate as to any Shares upon the earlier of (i)&nbsp;the first sale of Common Stock of the Company to the general public, or (ii)&nbsp;a Change in Control in which the successor corporation has equity securities that
are publicly traded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Tax Consultation</U>. Participant understands that Participant may suffer adverse tax
consequences as a result of Participant&#146;s purchase or disposition of the Shares. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection with the purchase or disposition of the
Shares and that Participant is not relying on the Company for any tax advice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Restrictive Legends and Stop-Transfer Orders.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<U>Legends</U>. Participant understands and agrees that the Company shall cause the legends set forth below or
legends substantially equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE &#147;ACT&#148;) AND MAY NOT BE OFFERED, SOLD
OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE
THEREWITH. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND A RIGHT OF FIRST REFUSAL HELD BY
THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE EXERCISE NOTICE BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS AND RIGHT OF FIRST
REFUSAL ARE BINDING ON TRANSFEREES OF THESE SHARES. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR
A PERIOD OF TIME FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY&#146;S SECURITIES SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY
THE HOLDER PRIOR TO THE EXPIRATION OF SUCH PERIOD WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<U>Stop-Transfer Notices</U>. Participant agrees that, in order to ensure compliance with the restrictions referred
to herein, the Company may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to&nbsp;the same effect in its own records.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;<U>Refusal to Transfer</U>. The Company shall not be required (i)&nbsp;to transfer on its books any Shares
that have been sold or otherwise transferred in violation of any of the provisions of this Exercise Notice or (ii)&nbsp;to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom
such Shares shall have been so transferred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Successors and Assigns</U>. The Company may assign any of its rights
under this Exercise Notice to single or multiple assignees, and this Exercise Notice shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Exercise Notice shall be
binding upon Participant and his or her heirs, executors, administrators, successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Interpretation</U>. Any dispute regarding the interpretation of this Exercise Notice shall be submitted by
Participant or by the Company forthwith to the Administrator, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Administrator shall be final and binding on all parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Governing Law; Severability</U>. This Exercise Notice is governed by the internal substantive laws, but not the
choice of law rules, of California. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Exercise Notice shall continue in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement</U>. The Plan and Option Agreement are incorporated herein by reference. This Exercise Notice,
the Plan, the Restricted Stock Purchase Agreement, the Option Agreement and the Investment Representation Statement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior
undertakings and agreements of the Company and Participant with respect to the subject matter hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Submitted by:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">PARTICIPANT</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted by:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">PENUMBRA, INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Signature</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">By</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print Name</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title</FONT></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Address:</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Date Received</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INVESTMENT REPRESENTATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="84%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PARTICIPANT</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COMPANY</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SECURITY</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">COMMON STOCK</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">AMOUNT</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DATE</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the purchase of the above-listed Securities, the undersigned Participant represents to the Company the
following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Participant is aware of the Company&#146;s business affairs and financial condition and has
acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Securities. Participant is acquiring these Securities for investment for Participant&#146;s own account only and not with a view to, or
for resale in connection with, any &#147;distribution&#148; thereof within the meaning of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Participant acknowledges and understands that the Securities constitute &#147;restricted securities&#148; under the
Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Participant&#146;s investment intent as expressed herein.
In this connection, Participant understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if Participant&#146;s representation was predicated solely upon a present intention to
hold these Securities for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Securities, or for a period of one (1)&nbsp;year or any other fixed period
in the future. Participant further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Participant further acknowledges and
understands that the Company is under no obligation to register the Securities. Participant understands that the certificate evidencing the Securities shall be imprinted with any legend required under applicable state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Participant is familiar with the provisions of Rule&nbsp;701 and Rule&nbsp;144, each promulgated under the
Securities Act, which, in substance, permit limited public resale of &#147;restricted securities&#148; acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions.
Rule&nbsp;701 provides that if the issuer qualifies under Rule&nbsp;701 at the time of the grant of the Option to Participant, the exercise shall be exempt from registration under the Securities Act. In the event the Company becomes subject to the
reporting requirements of Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934, ninety&nbsp;(90) days thereafter (or such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
longer period as any market stand-off agreement may require) the Securities exempt under Rule&nbsp;701 may be resold, subject to the satisfaction of the applicable conditions specified by
Rule&nbsp;144, including in the case of affiliates (1)&nbsp;the availability of certain public information about the Company, (2)&nbsp;the amount of Securities being sold during any three (3)&nbsp;month period not exceeding specified limitations,
(3)&nbsp;the resale being made in an unsolicited &#147;broker&#146;s transaction&#148;, transactions directly with a &#147;market maker&#148; or &#147;riskless principal transactions&#148; (as those terms are defined under the Securities Exchange
Act of 1934) and (4)&nbsp;the timely filing of a Form&nbsp;144, if applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event that the Company does not qualify under
Rule&nbsp;701 at the time of grant of the Option, then the Securities may be resold in certain limited circumstances subject to the provisions of Rule&nbsp;144, which may require (i)&nbsp;the availability of current public information about the
Company; (ii)&nbsp;the resale to occur more than a specified period after the purchase and full payment (within the meaning of Rule&nbsp;144) for the Securities; and (iii)&nbsp;in the case of the sale of Securities by an affiliate, the satisfaction
of the conditions set forth in sections&nbsp;(2), (3)&nbsp;and (4)&nbsp;of the paragraph immediately above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Participant further understands that in the event all of the applicable requirements of Rule&nbsp;701 or 144 are
not satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption shall be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and
Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules 144 or 701 shall have a substantial burden of proof in establishing
that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. Participant understands that no assurances can be given that
any such other registration exemption shall be available in such event. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PARTICIPANT</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Signature</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Date</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C-1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2014
EQUITY INCENTIVE PLAN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTRICTED STOCK PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS RESTRICTED STOCK PURCHASE AGREEMENT (the &#147;Agreement&#148;) is made between
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (the &#147;Purchaser&#148;) and Penumbra, Inc. (the &#147;Company&#148;) or its assignees of rights hereunder as of
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise defined herein, the terms defined in the 2014 Equity Incentive Plan shall have the same defined meanings in this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RECITALS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A.&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the exercise of the option (grant number
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>) granted to Purchaser under the Plan and pursuant to the Stock Option Agreement &#150; Early Exercise (the &#147;Option Agreement&#148;) dated
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>by and between the Company and Purchaser
with respect to such grant (the &#147;Option&#148;), which Plan and Option Agreement are hereby incorporated by reference, Purchaser has elected to purchase <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> of those
shares of Common Stock which have not become vested under the vesting schedule set forth in the Option Agreement (&#147;Unvested Shares&#148;). The Unvested Shares and the shares subject to the Option Agreement, which have become vested are
sometimes collectively referred to herein as the &#147;Shares.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B.&nbsp;&nbsp;&nbsp;&nbsp;As required by the Option Agreement, as a
condition to Purchaser&#146;s election to exercise the option, Purchaser must execute this Agreement, which sets forth the rights and obligations of the parties with respect to Shares acquired upon exercise of the Option. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Repurchase Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;If Purchaser&#146;s status as a Service Provider is terminated for any reason, including for death and Disability,
the Company shall have the right and option for ninety (90)&nbsp;days from such date to purchase from Purchaser, or Purchaser&#146;s personal representative, as the case may be, all of the Purchaser&#146;s Unvested Shares as of the date of such
termination at the price paid by the Purchaser for such Shares (the &#147;Repurchase Option&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Upon the
occurrence of such termination, the Company may exercise its Repurchase Option by delivering personally or by registered mail, to Purchaser (or his or her transferee or legal representative, as the case may be) with a copy to the escrow agent
described in Section&nbsp;2 below, a notice in writing indicating the Company&#146;s intention to exercise the Repurchase Option AND, at the Company&#146;s option, (i)&nbsp;by delivering to the Purchaser (or the Purchaser&#146;s transferee or legal
representative) a check in the amount of the aggregate repurchase price, or (ii)&nbsp;by the Company canceling an amount of the Purchaser&#146;s indebtedness to the Company equal to the aggregate repurchase price, or (iii)&nbsp;by a combination of
(i)&nbsp;and (ii)&nbsp;so that the combined payment and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cancellation of indebtedness equals such aggregate repurchase price. Upon delivery of such notice and payment of the aggregate repurchase price in any of the ways described above, the Company
shall become the legal and beneficial owner of the Unvested Shares being repurchased and the rights and interests therein or relating thereto, and the Company shall have the right to retain and transfer to its own name the number of Unvested Shares
being repurchased by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Whenever the Company shall have the right to repurchase Unvested Shares
hereunder, the Company may designate and assign one or more employees, officers, directors or stockholders of the Company or other persons or organizations to exercise all or a part of the Company&#146;s Repurchase Option under this Agreement and
purchase all or a part of such Unvested Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;If the Company does not elect to exercise the Repurchase
Option conferred above by giving the requisite notice within ninety (90)&nbsp;days following the termination, the Repurchase Option shall terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;The Repurchase Option shall terminate in accordance with the vesting schedule contained in Purchaser&#146;s Option
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Transferability of the Shares; Escrow</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;Purchaser hereby authorizes and directs the Secretary of the Company, or such other person designated by the
Company, to transfer the Unvested Shares as to which the Repurchase Option has been exercised from Purchaser to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;To insure the availability for delivery of Purchaser&#146;s Unvested Shares upon repurchase by the Company pursuant
to the Repurchase Option under Section&nbsp;1, Purchaser hereby appoints the Secretary, or any other person designated by the Company as escrow agent (the &#147;Escrow Agent&#148;), as its attorney-in-fact to sell, assign and transfer unto the
Company, such Unvested Shares, if any, repurchased by the Company pursuant to the Repurchase Option and shall, upon execution of this Agreement, deliver and deposit with the Escrow Agent, the share certificates representing the Unvested Shares,
together with the stock assignment duly endorsed in blank, attached hereto as <U>Exhibit C-2</U>. The Unvested Shares and stock assignment shall be held by the Escrow Agent in escrow, pursuant to the Joint Escrow Instructions of the Company and
Purchaser attached as <U>Exhibit C-3</U> hereto, until the Company exercises its Repurchase Option, until such Unvested Shares are vested, or until such time as this Agreement no longer is in effect. Upon vesting of the Unvested Shares, the Escrow
Agent shall promptly deliver to the Purchaser the certificate or certificates representing such Shares in the Escrow Agent&#146;s possession belonging to the Purchaser, and the Escrow Agent shall be discharged of all further obligations hereunder;
provided, however, that the Escrow Agent shall nevertheless retain such certificate or certificates as Escrow Agent if so required pursuant to other restrictions imposed pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor the Escrow Agent shall be liable for any act it may do or omit to do with respect to
holding the Shares in escrow and while acting in good faith and in the exercise of its judgment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Transfer or sale of the Shares is subject to restrictions on transfer
imposed by any applicable state and federal securities laws. Any transferee shall hold such Shares subject to all the provisions hereof and the Exercise Notice executed by the Purchaser with respect to any Unvested Shares purchased by Purchaser and
shall acknowledge the same by signing a copy of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Ownership, Voting Rights, Duties</U>. This
Agreement shall not affect in any way the ownership, voting rights or other rights or duties of Purchaser, except as specifically provided herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Legends</U>. The share certificate evidencing the Shares issued hereunder shall be endorsed with the following
legend (in addition to any legend required under applicable federal and state securities laws): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:6%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE
ARE SUBJECT TO CERTAIN RESTRICTIONS UPON TRANSFER AND RIGHTS OF REPURCHASE AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustment for Stock Split</U>. All references to the number of Shares and the purchase price of the Shares in
this Agreement shall be appropriately adjusted to reflect any stock split, stock dividend or other change in the Shares, which may be made by the Company pursuant to Section&nbsp;13 of the Plan after the date of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. Notices required hereunder shall be given in person or by registered mail to the address of
Purchaser shown on the records of the Company, and to the Company at their respective principal executive offices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Survival of Terms</U>. This Agreement shall apply to and bind Purchaser and the Company and their respective
permitted assignees and transferees, heirs, legatees, executors, administrators and legal successors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Section&nbsp;83(b) Election</U>. Purchaser hereby acknowledges that he or she has been informed that, with
respect to the exercise of an Option for Unvested Shares, an election (the &#147;Election&#148;) may be filed by the Purchaser with the Internal Revenue Service, within thirty (30)&nbsp;days of the purchase of the exercised Shares, electing pursuant
to Section&nbsp;83(b) of the Code to be taxed currently on any difference between the purchase price of the exercised Shares and their Fair Market Value on the date of purchase. In the case of a Nonstatutory Stock Option, this will result in the
recognition of taxable income to the Purchaser on the date of exercise, measured by the excess, if any, of the Fair Market Value of the exercised Shares, at the time the Option is exercised over the purchase price for the exercised Shares. Absent
such an Election, taxable income will be measured and recognized by Purchaser at the time or times on which the Company&#146;s Repurchase Option lapses. In the case of an Incentive Stock Option, such an Election will result in a recognition of
income to the Purchaser for alternative minimum tax purposes on the date of exercise, measured by the excess, if any, of the Fair Market Value of the exercised Shares, at the time the option is exercised, over the purchase price for the exercised
Shares. Absent such an Election, alternative minimum taxable income will be measured and recognized by Purchaser at the time or times on which the Company&#146;s Repurchase Option lapses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is intended only as a summary of the general United States income tax laws that
apply to exercising Options as to Shares that have not yet vested and is accurate only as of the date this form Agreement was approved by the Board. The federal, state and local tax consequences to any particular taxpayer will depend upon his or her
individual circumstances. Purchaser is strongly encouraged to seek the advice of his or her own tax consultants in connection with the purchase of the Shares and the advisability of filing of the Election under Section&nbsp;83(b) of the Code. A form
of Election under Section&nbsp;83(b) is attached hereto as <U>Exhibit C-4</U> for reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PURCHASER ACKNOWLEDGES THAT IT IS
PURCHASER&#146;S SOLE RESPONSIBILITY AND NOT THE COMPANY&#146;S TO FILE TIMELY THE ELECTION UNDER SECTION&nbsp;83(b) OF THE CODE, EVEN IF PURCHASER REQUESTS THE COMPANY OR ITS REPRESENTATIVE TO MAKE THIS FILING ON PURCHASER&#146;S BEHALF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations</U>. Purchaser has reviewed with his or her own tax advisors the federal, state, local and
foreign tax consequences of this investment and the transactions contemplated by this Agreement. Purchaser is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. Purchaser understands
that he or she (and not the Company) shall be responsible for his or her own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Entire Agreement; Governing Law</U>. The Plan and Option Agreement are incorporated herein by reference. The
Plan, the Option Agreement, the Exercise Notice, this Agreement, and the Investment Representation Statement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior
undertakings and agreements of the Company and Purchaser with respect to the subject matter hereof, and may not be modified adversely to the Purchaser&#146;s interest except by means of a writing signed by the Company and Purchaser. This Agreement
is governed by the internal substantive laws but not the choice of law rules of California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchaser represents that he or she has read
this Agreement and is familiar with its terms and provisions. Purchaser hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board upon any questions arising under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, this Agreement is deemed made as of the date first set forth above. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">PARTICIPANT</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Signature</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">By</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print Name</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Residence Address</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C-2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT SEPARATE FROM CERTIFICATE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED I,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, hereby sell, assign and transfer unto Penumbra, Inc.
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares of the Common Stock of Penumbra, Inc. standing in my name of the books of said corporation represented by Certificate
No.&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> herewith and do hereby irrevocably constitute and appoint&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> to transfer the
said stock on the books of the within named corporation with full power of substitution in the premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Stock Assignment may be
used only in accordance with the Restricted Stock Purchase Agreement between Penumbra, Inc. and the undersigned dated <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> (the &#147;Agreement&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;</U></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Signature:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">INSTRUCTIONS: Please do not fill in any blanks other than the signature line. The purpose of this assignment
is to enable the Company to exercise its &#147;repurchase option,&#148; as set forth in the Agreement, without requiring additional signatures on the part of the Purchaser. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C-3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JOINT ESCROW INSTRUCTIONS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Corporate Secretary Penumbra, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alameda, CA 94502 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As Escrow Agent for both Penumbra, Inc. (the &#147;Company&#148;), and the undersigned purchaser of stock of the Company (the
&#147;Purchaser&#148;), you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms of that certain Restricted Stock Purchase Agreement (the &#147;Agreement&#148;) between the Company and the undersigned, in
accordance with the following instructions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;In the event the Company and/or any assignee of the Company
(referred to collectively for convenience herein as the &#147;Company&#148;) exercises the Company&#146;s repurchase option set forth in the Agreement, the Company shall give to Purchaser and you a written notice specifying the number of shares of
stock to be purchased, the purchase price, and the time for a closing hereunder at the principal office of the Company. Purchaser and the Company hereby irrevocably authorize and direct you to close the transaction contemplated by such notice in
accordance with the terms of said notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;At the closing, you are directed (a)&nbsp;to date the stock
assignments necessary for the transfer in question, (b)&nbsp;to fill in the number of shares being transferred, and (c)&nbsp;to deliver the stock assignments, together with the certificate evidencing the shares of stock to be transferred, to the
Company or its assignee, against the simultaneous delivery to you of the purchase price (by cash, a check, or some combination thereof) for the number of shares of stock being purchased pursuant to the exercise of the Company&#146;s repurchase
option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;Purchaser irrevocably authorizes the Company to deposit with you any certificates evidencing shares of
stock to be held by you hereunder and any additions and substitutions to said shares as defined in the Agreement. Purchaser does hereby irrevocably constitute and appoint you as Purchaser&#146;s attorney-in-fact and agent for the term of this escrow
to execute with respect to such securities all documents necessary or appropriate to make such securities negotiable and to complete any transaction herein contemplated, including but not limited to the filing with any applicable state blue sky
authority of any required applications for consent to, or notice of transfer of, the securities. Subject to the provisions of this paragraph&nbsp;3, Purchaser shall exercise all rights and privileges of a stockholder of the Company while the stock
is held by you. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;Upon written request of the Purchaser, but no more than once per
calendar year, unless the Company&#146;s repurchase option has been exercised, you shall deliver to Purchaser a certificate or certificates representing so many shares of stock as are not then subject to the Company&#146;s repurchase option. Within
one hundred and twenty (120)&nbsp;days after cessation of Purchaser&#146;s continuous employment by or services to the Company, or any parent or subsidiary of the Company, you shall deliver to Purchaser a certificate or certificates representing the
aggregate number of shares held or issued pursuant to the Agreement and not purchased by the Company or its assignees pursuant to exercise of the Company&#146;s repurchase option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.&nbsp;&nbsp;&nbsp;&nbsp;If at the time of termination of this escrow you should have in your possession any documents, securities, or other
property belonging to Purchaser, you shall deliver all of the same to Purchaser and shall be discharged of all further obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.&nbsp;&nbsp;&nbsp;&nbsp;Your duties hereunder may be altered, amended, modified or revoked only by a writing signed by all of the parties
hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.&nbsp;&nbsp;&nbsp;&nbsp;You shall be obligated only for the performance of such duties as are specifically set forth herein and
may rely and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You shall not be personally liable for any act you
may do or omit to do hereunder as Escrow Agent or as attorney-in-fact for Purchaser while acting in good faith, and any act done or omitted by you pursuant to the advice of your own attorneys shall be conclusive evidence of such good faith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.&nbsp;&nbsp;&nbsp;&nbsp;You are hereby expressly authorized to disregard any and all warnings given by any of the parties hereto or by any
other person or corporation, excepting only orders or process of courts of law and are hereby expressly authorized to comply with and obey orders, judgments or decrees of any court. In case you obey or comply with any such order, judgment or decree,
you shall not be liable to any of the parties hereto or to any other person, firm or corporation by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently reversed, modified, annulled, set aside, vacated or
found to have been entered without jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.&nbsp;&nbsp;&nbsp;&nbsp;You shall not be liable in any respect on account of the
identity, authorities or rights of the parties executing or delivering or purporting to execute or deliver the Agreement or any documents or papers deposited or called for hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.&nbsp;&nbsp;&nbsp;&nbsp;You shall not be liable for the outlawing of any rights under the Statute of Limitations with respect to these
Joint Escrow Instructions or any documents deposited with you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.&nbsp;&nbsp;&nbsp;&nbsp;You shall be entitled to employ such legal
counsel and other experts as you may deem necessary properly to advise you in connection with your obligations hereunder, may rely upon the advice of such counsel, and may pay such counsel reasonable compensation therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.&nbsp;&nbsp;&nbsp;&nbsp;Your responsibilities as Escrow Agent hereunder shall terminate if you shall cease to be an officer or agent of the
Company or if you shall resign by written notice to each party. In the event of any such termination, the Company shall appoint a successor Escrow Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.&nbsp;&nbsp;&nbsp;&nbsp;If you reasonably require other or further instruments in connection with these Joint Escrow Instructions or
obligations in respect hereto, the necessary parties hereto shall join in furnishing such instruments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.&nbsp;&nbsp;&nbsp;&nbsp;It is understood and agreed that should any dispute arise with respect
to the delivery and/or ownership or right of possession of the securities held by you hereunder, you are authorized and directed to retain in your possession without liability to anyone all or any part of said securities until such disputes shall
have been settled either by mutual written agreement of the parties concerned or by a final order, decree or judgment of a court of competent jurisdiction after the time for appeal has expired and no appeal has been perfected, but you shall be under
no duty whatsoever to institute or defend any such proceedings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.&nbsp;&nbsp;&nbsp;&nbsp;Any notice required or permitted hereunder
shall be given in writing and shall be deemed effectively given upon personal delivery or upon deposit in the United States Post Office, by registered or certified mail with postage and fees prepaid, addressed to each of the other parties thereunto
entitled at the following addresses or at such other addresses as a party may designate by ten (10)&nbsp;days&#146; advance written notice to each of the other parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.&nbsp;&nbsp;&nbsp;&nbsp;By signing these Joint Escrow Instructions, you become a party hereto only for the purpose of said Joint Escrow
Instructions; you do not become a party to the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17.&nbsp;&nbsp;&nbsp;&nbsp;This instrument shall be binding upon and inure to
the benefit of the parties hereto, and their respective successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.&nbsp;&nbsp;&nbsp;&nbsp;These Joint Escrow
Instructions shall be governed by the internal substantive laws, but not the choice of law rules, of California. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">PURCHASER</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Signature</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">By</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print Name</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Print Name</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Title</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Residence Address</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">ESCROW AGENT</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT> <P STYLE="font-size:3pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Corporate Secretary</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:3pt">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C-4 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION UNDER SECTION 83(b) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF THE INTERNAL REVENUE CODE OF 1986 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
undersigned taxpayer hereby elects, pursuant to Sections 55 and 83(b) of the Internal Revenue Code of 1986, as amended, to include in taxpayer&#146;s gross income or alternative minimum taxable income, as the case may be, for the current taxable
year the amount of any compensation taxable to taxpayer in connection with taxpayer&#146;s receipt of the property described below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7">The name, address, taxpayer identification number and taxable year of the undersigned are as follows:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">TAXPAYER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SPOUSE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">NAME:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">ADDRESS:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>TAX&nbsp;ID&nbsp;NO.:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>TAXABLE&nbsp;YEAR:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">The property with respect to which the election is made is described as follows: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> shares (the &#147;Shares&#148;) of the Common Stock of
Penumbra, Inc. (the &#147;Company&#148;). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">The date on which the property was transferred
is:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">The property is subject to the following restrictions: </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Shares may not be transferred and
are subject to forfeiture under the terms of an agreement between the taxpayer and the Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">The Fair Market Value at the time of transfer, determined without regard to any restriction other than a restriction which by its terms shall never lapse, of such property is:
$<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top">The amount (if any) paid for such property is: $<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned has submitted a copy of this statement to the person for whom the services were performed in connection with the undersigned&#146;s receipt of
the above-described property. The transferee of such property is the person performing the services in connection with the transfer of said property. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>The undersigned understands that the foregoing election may not be revoked except with the consent of the Commissioner</U>. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Taxpayer</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned spouse of taxpayer joins in this election. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Dated:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>,
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:10pt">Spouse of Taxpayer</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>10
<FILENAME>filename10.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.6</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.6 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2011
EQUITY INCENTIVE PLAN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Purposes of the Plan</U>. The purposes of this Plan are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to attract and retain the best available personnel for positions of substantial responsibility, </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to provide additional incentive to Employees, Directors and Consultants, and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">to promote the success of the Company&#146;s business. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Plan permits the grant of
Incentive Stock Options (subject to Section 21), Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock and Restricted Stock Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Definitions</U>. As used herein, the following definitions will apply: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) &#147;<U>Administrator</U>&#148; means the Board or any of its Committees as will be administering the Plan, in accordance with
Section&nbsp;4 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) &#147;<U>Applicable Laws</U>&#148; means the requirements relating to the administration of equity-based
awards under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which the Common Stock is listed or quoted and the applicable laws of any foreign country or jurisdiction where
Awards are, or will be, granted under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) &#147;<U>Award</U>&#148; means, individually or collectively, a grant under the Plan
of Options, Stock Appreciation Rights, Restricted Stock, or Restricted Stock Units. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Award Agreement</U>&#148; means the
written or electronic agreement setting forth the terms and provisions applicable to each Award granted under the Plan. The Award Agreement is subject to the terms and conditions of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) &#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) &#147;<U>Change in Control</U>&#148; means the occurrence of any of the following events: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Change in Ownership of the Company</U>. A change in the ownership of the Company which occurs on the date that any one person, or more
than one person acting as a group (&#147;Person&#148;), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than 50% of the total voting power of the stock of the
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company, except that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Board will not be considered a Change in
Control; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Change in Effective Control of the Company</U>. If the Company has a class of securities registered pursuant to
Section&nbsp;12 of the Exchange Act, a change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12)&nbsp;month period by Directors whose appointment or election is
not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this clause (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control
of the Company by the same Person will not be considered a Change in Control; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) <U>Change in Ownership of a Substantial Portion
of the Company&#146;s Assets</U>. A change in the ownership of a substantial portion of the Company&#146;s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12)&nbsp;month period ending on the date of the
most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such
acquisition or acquisitions. For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such
assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">For purposes of this Section 2(f), persons will be considered to be acting as a group if they are owners of a corporation that
enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Notwithstanding
the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning of Code Section&nbsp;409A, as it has been and may be amended from time to time, and any proposed or
final Treasury Regulations and Internal Revenue Service guidance that has been promulgated or may be promulgated thereunder from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (i)&nbsp;its sole purpose is to change the
jurisdiction of the Company&#146;s incorporation, or (ii)&nbsp;its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#146;s securities immediately before such
transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) &#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended. Any reference to a section of the Code
herein will be a reference to any successor or amended section of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h) &#147;<U>Committee</U>&#148; means a committee of
Directors or of other individuals satisfying Applicable Laws appointed by the Board, or by the compensation committee of the Board, in accordance with Section 4 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Common Stock</U>&#148; means the common stock of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(j) &#147;<U>Company</U>&#148; means Penumbra, Inc., a Delaware corporation, or any successor
thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(k) &#147;<U>Consultant</U>&#148; means any individual, including an advisor, engaged by the Company or a Parent or Subsidiary
to render services to such entity. For the avoidance of doubt, the term &#147;Consultant&#148; shall not include any entity or any non-natural person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(l) &#147;<U>Director</U>&#148; means a member of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(m) &#147;<U>Disability</U>&#148; means total and permanent disability as defined in Code Section&nbsp;22(e)(3), provided that in the case of
Awards other than Incentive Stock Options, the Administrator in its discretion may determine whether a permanent and total disability exists in accordance with uniform and non-discriminatory standards adopted by the Administrator from time to time.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(n) &#147;<U>Employee</U>&#148; means any person, including officers and Directors, employed by the Company or any Parent or Subsidiary
of the Company. Neither service as a Director nor payment of a director&#146;s fee by the Company will be sufficient to constitute &#147;employment&#148; by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(o) &#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(p) &#147;<U>Exchange Program</U>&#148; means a program under which (i)&nbsp;outstanding Awards are surrendered or cancelled in exchange for
Awards of the same type (which may have higher or lower exercise prices and different terms), Awards of a different type, and/or cash, (ii)&nbsp;Participants would have the opportunity to transfer any outstanding Awards to a financial institution or
other person or entity selected by the Administrator, and/or (iii)&nbsp;the exercise price of an outstanding Award is reduced or increased. The Administrator will determine the terms and conditions of any Exchange Program in its sole discretion.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(q) &#147;<U>Fair Market Value</U>&#148; means, as of any date, the value of Common Stock determined as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) If the Common Stock is listed on any established stock exchange or a national market system, including without limitation the Nasdaq
Global Select Market, the Nasdaq Global Market or the Nasdaq Capital Market of The Nasdaq Stock Market, its Fair Market Value will be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such exchange
or system on the day of determination, as reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) If the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value of
a Share will be the mean between the high bid and low asked prices for the Common Stock on the day of determination (or, if no bids and asks were reported on that date, as applicable, on the last trading date such bids and asks were reported), as
reported in <I>The Wall Street Journal</I> or such other source as the Administrator deems reliable; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) In the absence of an
established market for the Common Stock, the Fair Market Value will be determined in good faith by the Administrator. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(r) &#147;<U>Incentive Stock Option</U>&#148; means an Option that by its terms qualifies and is
otherwise intended to qualify as an incentive stock option within the meaning of Code Section&nbsp;422 and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(s) &#147;<U>Nonstatutory Stock Option</U>&#148; means an Option that by its terms does not qualify or is not intended to qualify as an
Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(t) &#147;<U>Option</U>&#148; means a stock option granted pursuant to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(u) &#147;<U>Parent</U>&#148; means a &#147;<U>parent corporation,</U>&#148; whether now or hereafter existing, as defined in Code
Section&nbsp;424(e). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(v) &#147;<U>Participant</U>&#148; means the holder of an outstanding Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(w) &#147;<U>Period of Restriction</U>&#148; means the period during which the transfer of Shares of Restricted Stock are subject to
restrictions and therefore, the Shares are subject to a substantial risk of forfeiture. Such restrictions may be based on the passage of time, the achievement of target levels of performance, or the occurrence of other events as determined by the
Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(x) &#147;<U>Plan</U>&#148; means this 2011 Equity Incentive Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(y) &#147;<U>Restricted Stock</U>&#148; means Shares issued pursuant to an Award of Restricted Stock under Section 8 of the Plan, or issued
pursuant to the early exercise of an Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(z) &#147;<U>Restricted Stock Unit</U>&#148; means a bookkeeping entry representing an
amount equal to the Fair Market Value of one Share, granted pursuant to Section 9. Each Restricted Stock Unit represents an unfunded and unsecured obligation of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(aa) &#147;<U>Service Provider</U>&#148; means an Employee, Director or Consultant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(bb) &#147;<U>Share</U>&#148; means a share of the Common Stock, as adjusted in accordance with Section 13 of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(cc) &#147;<U>Stock Appreciation Right</U>&#148; means an Award, granted alone or in connection with an Option, that pursuant to
Section&nbsp;7 is designated as a Stock Appreciation Right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(dd) &#147;<U>Subsidiary</U>&#148; means a &#147;subsidiary
corporation,&#148; whether now or hereafter existing, as defined in Code Section&nbsp;424(f). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Stock Subject to the Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Stock Subject to the Plan</U>. Subject to the provisions of Section 13 of the Plan, the maximum aggregate number of Shares that may be
subject to Awards and sold under the Plan is 650,000 Shares. The Shares may be authorized but unissued, or reacquired Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b)
<U>Lapsed Awards</U>. If an Award expires or becomes unexercisable without having been exercised in full, is surrendered pursuant to an Exchange Program, or, with respect to Restricted Stock or Restricted Stock Units, is forfeited to or repurchased
by the Company due to the failure to vest, the unpurchased Shares (or for Awards other than Options or Stock Appreciation Rights the forfeited or repurchased Shares) which were subject thereto will become available for future grant or sale under the
Plan (unless the Plan has terminated). With respect to Stock Appreciation Rights, only Shares actually issued pursuant to a Stock Appreciation Right will cease to be available under the Plan; all remaining Shares under Stock Appreciation Rights will
remain available for future grant or sale under the Plan (unless the Plan has terminated). Shares that have actually been issued under the Plan under any Award will not be returned to the Plan and will not become available for future distribution
under the Plan; provided, however, that if Shares issued pursuant to Awards of Restricted Stock or Restricted Stock Units are repurchased by the Company or are forfeited to the Company due to the failure to vest, such Shares will become available
for future grant under the Plan. Shares used to pay the exercise price of an Award or to satisfy the tax withholding obligations related to an Award will become available for future grant or sale under the Plan. To the extent an Award under the Plan
is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under the Plan. Notwithstanding the foregoing and, subject to adjustment as provided in Section 13, the maximum number
of Shares that may be issued upon the exercise of Incentive Stock Options will equal the aggregate Share number stated in Section 3(a), plus, to the extent allowable under Code Section&nbsp;422 and the Treasury Regulations promulgated thereunder,
any Shares that become available for issuance under the Plan pursuant to Section 3(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Share Reserve</U>. The Company, during the
term of this Plan, will at all times reserve and keep available such number of Shares as will be sufficient to satisfy the requirements of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Administration of the Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Procedure</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i)
<U>Multiple Administrative Bodies</U>. Different Committees with respect to different groups of Service Providers may administer the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Other Administration</U>. Other than as provided above, the Plan will be administered by (A)&nbsp;the Board or (B)&nbsp;a Committee,
which Committee will be constituted to satisfy Applicable Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Powers of the Administrator</U>. Subject to the provisions of the Plan, and in the case of
a Committee, subject to the specific duties delegated by the Board to such Committee, the Administrator will have the authority, in its discretion: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) to determine the Fair Market Value; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) to select the Service Providers to whom Awards may be granted hereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) to determine the number of Shares to be covered by each Award granted hereunder; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) to approve forms of Award Agreements for use under the Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder. Such terms and
conditions include, but are not limited to, the exercise price, the time or times when Awards may be exercised (which may be based on performance criteria), any vesting acceleration or waiver of forfeiture restrictions, and any restriction or
limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator will determine; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) to institute and determine the terms and conditions of an Exchange Program; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vii) to construe and interpret the terms of the Plan and Awards granted pursuant to the Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(viii) to prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating to sub-plans
established for the purpose of satisfying applicable foreign laws or for qualifying for favorable tax treatment under applicable foreign laws; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ix) to modify or amend each Award (subject to Section 18(c) of the Plan), including but not limited to the discretionary authority to extend
the post-termination exercisability period of Awards and to extend the maximum term of an Option (subject to Section 6(d)); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) to allow
Participants to satisfy withholding tax obligations in a manner prescribed in Section 14; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xi) to authorize any person to execute on
behalf of the Company any instrument required to effect the grant of an Award previously granted by the Administrator; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xii) to allow a
Participant to defer the receipt of the payment of cash or the delivery of Shares that otherwise would be due to such Participant under an Award; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(xiii) to make all other determinations deemed necessary or advisable for administering the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Effect of Administrator&#146;s Decision</U>. The Administrator&#146;s decisions, determinations and interpretations will be final and
binding on all Participants and any other holders of Awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Eligibility</U>. Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock,
and Restricted Stock Units may be granted to Service Providers. Incentive Stock Options may be granted only to Employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Stock
Options</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Grant of Options</U>. Subject to the terms and provisions of the Plan, the Administrator, at any time and from time
to time, may grant Options in such amounts as the Administrator, in its sole discretion, will determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Option Agreement</U>.
Each Award of an Option will be evidenced by an Award Agreement that will specify the exercise price, the term of the Option, the number of Shares subject to the Option, the exercise restrictions, if any, applicable to the Option, and such other
terms and conditions as the Administrator, in its sole discretion, will determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Limitations</U>. Each Option will be designated
in the Award Agreement as either an Incentive Stock Option or a Nonstatutory Stock Option. The Administrator&#146;s ability to grant Incentive Stock Options is subject to the approval of the Plan by the stockholders of the Company within twelve
(12)&nbsp;months after the date the Plan is adopted by the Board, as set forth in Section 21. To the extent that stockholder approval of the Plan is not obtained within twelve (12)&nbsp;months after the date the Plan is adopted by the Board, the
Administrator will be unable to make grants of Incentive Stock Options under the Plan, and any Option previously designated as an Incentive Stock Option in the Award Agreement will be treated as a Nonstatutory Stock Option. Notwithstanding the
designation of an Option as an Incentive Stock Option, however, to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable for the first time by the Participant during any calendar
year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as Nonstatutory Stock Options. For purposes of this Section 6(c), Incentive Stock Options will be taken
into account in the order in which they were granted, the Fair Market Value of the Shares will be determined as of the time the Option with respect to such Shares is granted, and calculation will be performed in accordance with Code Section&nbsp;422
and Treasury Regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U>Term of Option</U>. The term of each Option will be stated in the Award
Agreement; provided, however, that the term will be no more than ten (10)&nbsp;years from the date of grant thereof. In the case of an Incentive Stock Option granted to a Participant who, at the time the Incentive Stock Option is granted, owns stock
representing more than ten percent (10%)&nbsp;of the total combined voting power of all classes of stock of the Company or any Parent or Subsidiary, the term of the Incentive Stock Option will be five (5)&nbsp;years from the date of grant or such
shorter term as may be provided in the Award Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <U>Option Exercise Price and Consideration</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Exercise Price</U>. The per Share exercise price for the Shares to be issued pursuant to the exercise of an Option will be determined
by the Administrator, but will be no less than one hundred percent (100%)&nbsp;of the Fair Market Value per Share on the date of grant. In addition, in the case of an Incentive Stock Option granted to an Employee who owns stock representing more
than ten percent (10%)&nbsp;of the voting power of all classes of stock of the Company or any Parent or Subsidiary, the per Share exercise price will be no less than one hundred ten percent (110%)&nbsp;of the Fair Market Value per Share on the date
of grant. Notwithstanding the foregoing provisions of this Section 6(e)(i), Options may be granted with a per Share exercise price of less than one hundred percent (100%)&nbsp;of the Fair Market Value per Share on the date of grant pursuant to a
transaction described in, and in a manner consistent with, Code Section&nbsp;424(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Waiting Period and Exercise Dates</U>. At
the time an Option is granted, the Administrator will fix the period within which the Option may be exercised and will determine any conditions that must be satisfied before the Option may be exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) <U>Form of Consideration</U>. The Administrator will determine the acceptable form of consideration for exercising an Option, including
the method of payment. In the case of an Incentive Stock Option, the Administrator will determine the acceptable form of consideration at the time of grant. Such consideration may consist entirely of: (1)&nbsp;cash; (2)&nbsp;check;
(3)&nbsp;promissory note, to the extent permitted by Applicable Laws, (4)&nbsp;other Shares, provided that such Shares have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which such Option will
be exercised and provided further that accepting such Shares will not result in any adverse accounting consequences to the Company, as the Administrator determines in its sole discretion; (5)&nbsp;consideration received by the Company under cashless
exercise program (whether through a broker or otherwise) implemented by the Company in connection with the Plan; (6)&nbsp;by net exercise, (7)&nbsp;such other consideration and method of payment for the issuance of Shares to the extent permitted by
Applicable Laws, or (8)&nbsp;any combination of the foregoing methods of payment. In making its determination as to the type of consideration to accept, the Administrator will consider if acceptance of such consideration may be reasonably expected
to benefit the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <U>Exercise of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Procedure for Exercise; Rights as a Stockholder</U>. Any Option granted hereunder will be exercisable according to the terms of the
Plan and at such times and under such conditions as determined by the Administrator and set forth in the Award Agreement. An Option may not be exercised for a fraction of a Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">An Option will be deemed exercised when the Company receives: (i)&nbsp;notice of exercise (in such form as the Administrator may specify from
time to time) from the person entitled to exercise the Option, and (ii)&nbsp;full payment for the Shares with respect to which the Option is exercised (together with applicable tax withholding). Full payment may consist of any consideration and
method of payment authorized by the Administrator and permitted by the Award Agreement and the Plan. Shares issued upon exercise of an Option will be issued in the name of the Participant or, if requested by the Participant, in the name of the
Participant and his or her spouse. Until the Shares are issued (as evidenced by the appropriate entry on the books of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares subject to an
Option, notwithstanding the exercise of the Option. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the
date the Shares are issued, except as provided in Section 13 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">Exercising an Option in any manner will decrease the number of
Shares thereafter available, both for purposes of the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) <U>Termination of Relationship as a Service Provider</U>. If a Participant ceases to be a Service Provider, other than upon the
Participant&#146;s termination as the result of the Participant&#146;s death or Disability, the Participant may exercise his or her Option within such period of time as is specified in the Award Agreement (but in no event later than the expiration
of the term of such Option as set forth in the Award Agreement) to the extent that the Option is vested on the date of termination. In the absence of a specified time in the Award Agreement, the Option shall remain exercisable for three
(3)&nbsp;months following the Participant&#146;s termination. Unless otherwise provided by the Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of
the Option will revert to the Plan. If after termination the Participant does not exercise his or her Option within the time specified by the Administrator, the Option will terminate, and the Shares covered by such Option will revert to the Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) <U>Disability of Participant</U>. If a Participant ceases to be a Service Provider as a result of the Participant&#146;s
Disability, the Participant may exercise his or her Option within such period of time as is specified in the Award Agreement (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement) to the extent the
Option is vested on the date of termination. In the absence of a specified time in the Award Agreement, the Option shall remain exercisable for twelve (12)&nbsp;months following the Participant&#146;s termination. Unless otherwise provided by the
Administrator, if on the date of termination the Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will revert to the Plan. If after termination the Participant does not exercise his
or her Option within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) <U>Death of Participant</U>. If a Participant dies while a Service Provider, the Option may be exercised within such period of time as
is specified in the Award Agreement (but in no event later than the expiration of the term of such Option as set forth in the Award Agreement) to the extent that the Option is vested on the date of death, by the Participant&#146;s designated
beneficiary, provided such beneficiary has been designated prior to the Participant&#146;s death in a form acceptable to the Administrator. If no such beneficiary has been designated by the Participant, then such Option may be exercised by the
personal representative of the Participant&#146;s estate or by the person(s) to whom the Option is transferred pursuant to the Participant&#146;s will or in accordance with the laws of descent and distribution. In the absence of a specified time in
the Award Agreement, the Option shall remain exercisable for twelve (12)&nbsp;months following the Participant&#146;s termination. Unless otherwise provided by the Administrator, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
if at the time of death Participant is not vested as to his or her entire Option, the Shares covered by the unvested portion of the Option will immediately revert to the Plan. If the Option is
not so exercised within the time specified herein, the Option will terminate, and the Shares covered by such Option will revert to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Stock Appreciation Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Grant of Stock Appreciation Rights</U>. Subject to the terms and conditions of the Plan, a Stock Appreciation Right may be granted to
Service Providers at any time and from time to time as will be determined by the Administrator, in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Number of
Shares</U>. The Administrator will have complete discretion to determine the number of Shares subject to any Award of Stock Appreciation Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Exercise Price and Other Terms</U>. The per Share exercise price for the Shares that will determine the amount of the payment to be
received upon exercise of a Stock Appreciation Right as set forth in Section 7(f) will be determined by the Administrator and will be no less than one hundred percent (100%)&nbsp;of the Fair Market Value per Share on the date of grant. Otherwise,
the Administrator, subject to the provisions of the Plan, will have complete discretion to determine the terms and conditions of Stock Appreciation Rights granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U>Stock Appreciation Right Agreement</U>. Each Stock Appreciation Right grant will be evidenced by an Award Agreement that will specify
the exercise price, the term of the Stock Appreciation Right, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion, will determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <U>Expiration of Stock Appreciation Rights</U>. A Stock Appreciation Right granted under the Plan will expire upon the date determined by
the Administrator, in its sole discretion, and set forth in the Award Agreement. Notwithstanding the foregoing, the rules of Section 6(d) relating to the maximum term and Section 6(f) relating to exercise also will apply to Stock Appreciation
Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <U>Payment of Stock Appreciation Right Amount</U>. Upon exercise of a Stock Appreciation Right, a Participant will be
entitled to receive payment from the Company in an amount determined by multiplying: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The difference between the Fair Market Value of
a Share on the date of exercise over the exercise price; times </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The number of Shares with respect to which the Stock Appreciation
Right is exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the discretion of the Administrator, the payment upon Stock Appreciation Right exercise may be in cash, in Shares
of equivalent value, or in some combination thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Restricted Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Grant of Restricted Stock</U>. Subject to the terms and provisions of the Plan, the Administrator, at any time and from time to time,
may grant Shares of Restricted Stock to Service Providers in such amounts as the Administrator, in its sole discretion, will determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Restricted Stock Agreement</U>. Each Award of Restricted Stock will be evidenced by an Award Agreement that will specify the Period of
Restriction, the number of Shares granted, and such other terms and conditions as the Administrator, in its sole discretion, will determine. Unless the Administrator determines otherwise, the Company as escrow agent will hold Shares of Restricted
Stock until the restrictions on such Shares have lapsed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Transferability</U>. Except as provided in this Section 8 or as the
Administrator determines, Shares of Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated until the end of the applicable Period of Restriction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U>Other Restrictions</U>. The Administrator, in its sole discretion, may impose such other restrictions on Shares of Restricted Stock as
it may deem advisable or appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <U>Removal of Restrictions</U>. Except as otherwise provided in this Section 8, Shares of
Restricted Stock covered by each Restricted Stock grant made under the Plan will be released from escrow as soon as practicable after the last day of the Period of Restriction or at such other time as the Administrator may determine. The
Administrator, in its discretion, may accelerate the time at which any restrictions will lapse or be removed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <U>Voting Rights</U>.
During the Period of Restriction, Service Providers holding Shares of Restricted Stock granted hereunder may exercise full voting rights with respect to those Shares, unless the Administrator determines otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) <U>Dividends and Other Distributions</U>. During the Period of Restriction, Service Providers holding Shares of Restricted Stock will be
entitled to receive all dividends and other distributions paid with respect to such Shares, unless the Administrator provides otherwise. If any such dividends or distributions are paid in Shares, the Shares will be subject to the same restrictions
on transferability and forfeitability as the Shares of Restricted Stock with respect to which they were paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(h) <U>Return of Restricted
Stock to Company</U>. On the date set forth in the Award Agreement, the Restricted Stock for which restrictions have not lapsed will revert to the Company and again will become available for grant under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Restricted Stock Units</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Grant</U>. Restricted Stock Units may be granted at any time and from time to time as determined by the Administrator. After the
Administrator determines that it will grant Restricted Stock Units, it will advise the Participant in an Award Agreement of the terms, conditions, and restrictions related to the grant, including the number of Restricted Stock Units. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Vesting Criteria and Other Terms</U>. The Administrator will set vesting criteria in its
discretion, which, depending on the extent to which the criteria are met, will determine the number of Restricted Stock Units that will be paid out to the Participant. The Administrator may set vesting criteria based upon the achievement of
Company-wide, business unit, or individual goals (including, but not limited to, continued employment or service), or any other basis determined by the Administrator in its discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Earning Restricted Stock Units</U>. Upon meeting the applicable vesting criteria, the Participant will be entitled to receive a payout
as determined by the Administrator. Notwithstanding the foregoing, at any time after the grant of Restricted Stock Units, the Administrator, in its sole discretion, may reduce or waive any vesting criteria that must be met to receive a payout. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U>Form and Timing of Payment</U>. Payment of earned Restricted Stock Units will be made as soon as practicable after the date(s)
determined by the Administrator and set forth in the Award Agreement. The Administrator, in its sole discretion, may settle earned Restricted Stock Units in cash, Shares, or a combination of both. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <U>Cancellation</U>. On the date set forth in the Award Agreement, all unearned Restricted Stock Units will be forfeited to the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Compliance With Code Section&nbsp;409A</U>. Awards will be designed and operated in such a manner that they are either exempt from
the application of, or comply with, the requirements of Code Section&nbsp;409A, except as otherwise determined in the sole discretion of the Administrator. The Plan and each Award Agreement under the Plan is intended to meet the requirements of Code
Section&nbsp;409A and will be construed and interpreted in accordance with such intent, except as otherwise determined in the sole discretion of the Administrator. To the extent that an Award or payment, or the settlement or deferral thereof, is
subject to Code Section&nbsp;409A the Award will be granted, paid, settled or deferred in a manner that will meet the requirements of Code Section&nbsp;409A, such that the grant, payment, settlement or deferral will not be subject to the additional
tax or interest applicable under Code Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Leaves of Absence/Transfer Between Locations</U>. Unless the
Administrator provides otherwise, vesting of Awards granted hereunder will be suspended during any unpaid leave of absence. A Participant will not cease to be an Employee in the case of (i)&nbsp;any leave of absence approved by the Company or
(ii)&nbsp;transfers between locations of the Company or between the Company, its Parent, or any Subsidiary. For purposes of Incentive Stock Options, no such leave may exceed three (3)&nbsp;months, unless reemployment upon expiration of such leave is
guaranteed by statute or contract. If reemployment upon expiration of a leave of absence approved by the Company is not so guaranteed, then six (6)&nbsp;months following the first (1st)&nbsp;day of such leave, any Incentive Stock Option held by the
Participant will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Nonstatutory Stock Option. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Limited Transferability of Awards</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Unless determined otherwise by the Administrator, Awards may not be sold, pledged, assigned, hypothecated, or otherwise transferred in any
manner other than by will or by the laws of descent and distribution, and may be exercised, during the lifetime of the Participant, only by the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Further, until the Company becomes subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act, or after the
Administrator determines that it is, will, or may no longer be relying upon the exemption from registration under the Exchange Act as set forth in Rule 12h-1(f) promulgated under the Exchange Act, an Option, or prior to exercise, the Shares subject
to the Option, may not be pledged, hypothecated or otherwise transferred or disposed of, in any manner, including by entering into any short position, any &#147;put equivalent position&#148; or any &#147;call equivalent position&#148; (as defined in
Rule 16a-1(h) and Rule 16a-1(b) of the Exchange Act, respectively), other than to (i)&nbsp;persons who are &#147;family members&#148; (as defined in Rule 701(c)(3) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;)) through
gifts or domestic relations orders, or (ii)&nbsp;to an executor or guardian of the Participant upon the death or disability of the Participant. Notwithstanding the foregoing sentence, the Administrator, in its sole discretion, may determine to
permit transfers to the Company or in connection with a Change in Control or other acquisition transactions involving the Company to the extent permitted by Rule 12h-1(f). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Adjustments; Dissolution or Liquidation; Merger or Change in Control</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Adjustments</U>. In the event that any dividend or other distribution (whether in the form of cash, Shares, other securities, or other
property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase, or exchange of Shares or other securities of the Company, or other change in the corporate structure
of the Company affecting the Shares occurs, the Administrator, in order to prevent diminution or enlargement of the benefits or potential benefits intended to be made available under the Plan, will adjust the number and class of Shares that may be
delivered under the Plan and/or the number, class, and price of Shares covered by each outstanding Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Dissolution or
Liquidation</U>. In the event of the proposed dissolution or liquidation of the Company, the Administrator will notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it has not been
previously exercised, an Award will terminate immediately prior to the consummation of such proposed action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Merger or Change in
Control</U>. In the event of a merger or Change in Control, each outstanding Award will be treated as the Administrator determines (subject to the provisions of the following paragraph) without a Participant&#146;s consent, including, without
limitation, that (i)&nbsp;Awards will be assumed, or substantially equivalent Awards will be substituted, by the acquiring or succeeding corporation (or an affiliate thereof) with appropriate adjustments as to the number and kind of shares and
prices; (ii)&nbsp;upon written notice to a Participant, that the Participant&#146;s Awards will terminate upon or immediately prior to the consummation of such merger or Change in Control; (iii)&nbsp;outstanding Awards will vest and become
exercisable, realizable, or payable, or restrictions applicable to an Award will lapse, in whole or in part prior to or upon consummation of such merger or Change in Control, and, to the extent the Administrator determines, terminate upon or
immediately prior to the effectiveness of such merger or Change in Control; (iv)&nbsp;(A)&nbsp;the termination of an Award in exchange for an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amount of cash and/or property, if any, equal to the amount that would have been attained upon the exercise of such Award or realization of the Participant&#146;s rights as of the date of the
occurrence of the transaction (and, for the avoidance of doubt, if as of the date of the occurrence of the transaction the Administrator determines in good faith that no amount would have been attained upon the exercise of such Award or realization
of the Participant&#146;s rights, then such Award may be terminated by the Company without payment), or (B)&nbsp;the replacement of such Award with other rights or property selected by the Administrator in its sole discretion; or (v)&nbsp;any
combination of the foregoing. In taking any of the actions permitted under this subsection 13(c), the Administrator will not be obligated to treat all Awards, all Awards held by a Participant, or all Awards of the same type, similarly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event that the successor corporation does not assume or substitute for the Award (or portion thereof), the Participant will fully vest
in and have the right to exercise all of his or her outstanding Options and Stock Appreciation Rights, including Shares as to which such Awards would not otherwise be vested or exercisable, all restrictions on Restricted Stock and Restricted Stock
Units will lapse, and, with respect to Awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at one hundred percent (100%)&nbsp;of target levels and all other terms and conditions met. In
addition, if an Option or Stock Appreciation Right is not assumed or substituted in the event of a merger or Change in Control, the Administrator will notify the Participant in writing or electronically that the Option or Stock Appreciation Right
will be exercisable for a period of time determined by the Administrator in its sole discretion, and the Option or Stock Appreciation Right will terminate upon the expiration of such period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For the purposes of this subsection 13(c), an Award will be considered assumed if, following the merger or Change in Control, the Award
confers the right to purchase or receive, for each Share subject to the Award immediately prior to the merger or Change in Control, the consideration (whether stock, cash, or other securities or property) received in the merger or Change in Control
by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided,
however, that if such consideration received in the merger or Change in Control is not solely common stock of the successor corporation or its Parent, the Administrator may, with the consent of the successor corporation, provide for the
consideration to be received upon the exercise of an Option or Stock Appreciation Right or upon the payout of a Restricted Stock Unit, for each Share subject to such Award, to be solely common stock of the successor corporation or its Parent equal
in fair market value to the per share consideration received by holders of Common Stock in the merger or Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section 13(c) to the contrary, an Award that vests, is earned or paid-out upon the satisfaction of one or
more performance goals will not be considered assumed if the Company or its successor modifies any of such performance goals without the Participant&#146;s consent; provided, however, a modification to such performance goals only to reflect the
successor corporation&#146;s post-Change in Control corporate structure will not be deemed to invalidate an otherwise valid Award assumption. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in this Section 13(c) to the contrary, if a payment under an Award
Agreement is subject to Code Section&nbsp;409A and if the change in control definition contained in the Award Agreement does not comply with the definition of &#147;change of control&#148; for purposes of a distribution under Code Section&nbsp;409A,
then any payment of an amount that is otherwise accelerated under this Section will be delayed until the earliest time that such payment would be permissible under Code Section&nbsp;409A without triggering any penalties applicable under Code
Section&nbsp;409A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Tax Withholding</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Withholding Requirements</U>. Prior to the delivery of any Shares or cash pursuant to an Award (or exercise thereof), the Company will
have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy federal, state, local, foreign or other taxes (including the Participant&#146;s FICA obligation) required to be
withheld with respect to such Award (or exercise thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Withholding Arrangements</U>. The Administrator, in its sole discretion
and pursuant to such procedures as it may specify from time to time, may permit a Participant to satisfy such tax withholding obligation, in whole or in part by (without limitation) (i)&nbsp;paying cash, (ii)&nbsp;electing to have the Company
withhold otherwise deliverable Shares having a Fair Market Value equal to the minimum statutory amount required to be withheld, (iii)&nbsp;delivering to the Company already-owned Shares having a Fair Market Value equal to the statutory amount
required to be withheld, provided the delivery of such Shares will not result in any adverse accounting consequences, as the Administrator determines in its sole discretion, or (iv)&nbsp;selling a sufficient number of Shares otherwise deliverable to
the Participant through such means as the Administrator may determine in its sole discretion (whether through a broker or otherwise) equal to the amount required to be withheld. The amount of the withholding requirement will be deemed to include any
amount which the Administrator agrees may be withheld at the time the election is made, not to exceed the amount determined by using the maximum federal, state or local marginal income tax rates applicable to the Participant with respect to the
Award on the date that the amount of tax to be withheld is to be determined. The Fair Market Value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>No Effect on Employment or Service</U>. Neither the Plan nor any Award will confer upon a Participant any right with respect to
continuing the Participant&#146;s relationship as a Service Provider with the Company, nor will they interfere in any way with the Participant&#146;s right or the Company&#146;s right to terminate such relationship at any time, with or without
cause, to the extent permitted by Applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Date of Grant</U>. The date of grant of an Award will be, for all purposes, the
date on which the Administrator makes the determination granting such Award, or such other later date as is determined by the Administrator. Notice of the determination will be provided to each Participant within a reasonable time after the date of
such grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Term of Plan</U>. Subject to Section 21 of the Plan, the Plan will become effective upon its adoption by the Board.
Unless sooner terminated under Section 18, it will continue in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effect for a term of ten (10)&nbsp;years from the later of (a)&nbsp;the effective date of the Plan, or (b)&nbsp;the earlier of the most recent Board or stockholder approval of an increase in the
number of Shares reserved for issuance under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Amendment and Termination of the Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Amendment and Termination</U>. The Board may at any time amend, alter, suspend or terminate the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Stockholder Approval</U>. The Company will obtain stockholder approval of any Plan amendment to the extent necessary and/or desirable
(as determined by the Administrator) to comply with Applicable Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Effect of Amendment or Termination</U>. No amendment,
alteration, suspension or termination of the Plan will impair the rights of any Participant, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing and signed by the Participant and the
Company. Termination of the Plan will not affect the Administrator&#146;s ability to exercise the powers granted to it hereunder with respect to Awards granted under the Plan prior to the date of such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Conditions Upon Issuance of Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Legal Compliance</U>. Shares will not be issued pursuant to the exercise of an Award unless the exercise of such Award and the issuance
and delivery of such Shares will comply with Applicable Laws and will be further subject to the approval of counsel for the Company with respect to such compliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Investment Representations</U>. As a condition to the exercise of an Award, the Company may require the person exercising such Award to
represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation
is required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Inability to Obtain Authority</U>. The inability of the Company to obtain authority from any regulatory body having
jurisdiction, which authority is deemed by the Company&#146;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, will relieve the Company of any liability in respect of the failure to issue or sell such Shares as to
which such requisite authority will not have been obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Stockholder Approval</U>. The Administrator&#146;s ability to grant
Incentive Stock Options is subject to the approval of the Plan by the stockholders of the Company within twelve (12)&nbsp;months after the date the Plan is adopted by the Board, as set forth in Section 21. To the extent that stockholder approval of
the Plan is not obtained within twelve (12)&nbsp;months after the date the Plan is adopted by the Board, the Plan will remain in effect, but the Administrator will be unable to make grants of Incentive Stock Options under the Plan and any Option
previously designated as an Incentive Stock Option in the Award Agreement will be treated as a Nonstatutory Stock Option. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Information to Participants</U>. Beginning on the earlier of (i)&nbsp;the date that the
aggregate number of Participants under this Plan is five hundred (500)&nbsp;or more and the Company is relying on the exemption provided by Rule 12h-1(f)(1) under the Exchange Act and (ii)&nbsp;the date that the Company is required to deliver
information to Participants pursuant to Rule 701 under the Securities Act, and until such time as the Company becomes subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act, is no longer relying on the exemption
provided by Rule 12h-1(f)(1) under the Exchange Act or is no longer required to deliver information to Participants pursuant to Rule 701 under the Securities Act, the Company shall provide to each Participant the information described in paragraphs
(e)(3), (4), and (5)&nbsp;of Rule 701 under the Securities Act not less frequently than every six (6)&nbsp;months with the financial statements being not more than 180 days old and with such information provided either by physical or electronic
delivery to the Participants or by written notice to the Participants of the availability of the information on an Internet site that may be password-protected and of any password needed to access the information. The Company may request that
Participants agree to keep the information to be provided pursuant to this section confidential. If a Participant does not agree to keep the information to be provided pursuant to this section confidential, then the Company will not be required to
provide the information unless otherwise required pursuant to Rule 12h-1(f)(1) under the Exchange Act or Rule 701 of the Securities Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2011 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTRICTED STOCK AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise defined herein, the terms defined in the 2011 Equity Incentive Plan (the &#147;Plan&#148;) shall have the same defined
meanings in this Restricted Stock Agreement (the &#147;Agreement&#148;). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>NOTICE OF GRANT OF RESTRICTED STOCK</U> </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Name: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Address: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned Participant has been granted a Restricted Stock Award, subject to the terms and conditions of the Plan and this Agreement, as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date of Grant:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vesting Commencement Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Number of Shares of:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Restricted Stock:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Vesting Schedule</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to any accelerated vesting provisions in the Plan, [all of the Shares of Restricted Stock shall vest on the first anniversary of the
Vesting Commencement Date]or[one-half of the Shares of Restricted Stock shall vest on each of the first and second anniversaries of the Vesting Commencement Date]or[one-third of the Shares of Restricted Stock shall vest on each of the first, second
and third anniversaries of the Vesting Commencement Date]or[one-fourth of the Shares of Restricted Stock shall vest on each of the first, second, third and fourth anniversaries of the Vesting Commencement Date], subject to Participant continuing to
be a Service Provider through each such date.] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a Change in Control, and subject to Participant continuing to be a Service
Provider through the date of such Change in Control, the Participant will fully vest in all of the Shares of Restricted Stock granted under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of the Shares of Restricted Stock granted under this Agreement which have not yet vested as of a given time are referred to herein as
&#147;Unvested Shares of Restricted Stock.&#148; The Shares which have vested shall be delivered to Participant in accordance with the terms of the escrow agreement (see Section&nbsp;10 of Part 0 of this Agreement). </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>AGREEMENT </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Grant of Restricted Stock</U>. The Company hereby grants to the person
named in the Notice of Grant of Restricted Stock in Part I of this Agreement (&#147;Participant&#148;) under the Plan for services performed and to be performed by Participant for the Company and as a separate incentive in connection with his or her
services and not in lieu of any salary or other compensation for his or her services, the number of Shares set forth in the Notice of Grant of Restricted Stock, subject to all of the terms and conditions in this Agreement and the Plan, which is
incorporated herein by reference. Subject to Section&nbsp;18(c) of the Plan, in the event of a conflict between the terms and conditions of the Plan and this Agreement, the terms and conditions of the Plan shall prevail. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Participant&#146;s Representations</U>. In the event the Shares have not been registered under the Securities Act of 1933, as amended,
at the time this Restricted Stock Award is granted, Participant shall, if required by the Company, concurrently with the grant of this Restricted Stock Award, deliver to the Company his or her Investment Representation Statement in the form attached
hereto as <U>Exhibit&nbsp;A</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Lock-Up Period</U>. Participant hereby agrees that Participant shall not offer, pledge, sell,
contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Common Stock (or other
securities) of the Company or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Common Stock (or other securities) of the Company held by
Participant (other than those included in the registration) for a period specified by the representative of the underwriters of Common Stock (or other securities) of the Company not to exceed one hundred and eighty (180)&nbsp;days following the
effective date of any registration statement of the Company filed under the Securities Act (or such other period as may be requested by the Company or the underwriters to accommodate regulatory restrictions on (i)&nbsp;the publication or other
distribution of research reports and (ii)&nbsp;analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participant agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter which are
consistent with the foregoing or which are necessary to give further effect thereto. In addition, if requested by the Company or the representative of the underwriters of Common Stock (or other securities) of the Company, Participant shall provide,
within ten (10)&nbsp;days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the Company&#146;s securities pursuant to a registration statement filed
under the Securities Act. The obligations described in this Section&nbsp;3 shall not apply to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or similar forms that may be promulgated in the future, or a registration
relating solely to a Commission Rule 145 transaction on Form S-4 or similar forms that may be promulgated in the future. The Company may impose </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stop-transfer instructions with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of said one hundred and eighty (180)&nbsp;day (or
other) period. Participant agrees that any transferee of the Restricted Stock Award or Shares acquired pursuant to the Restricted Stock Award shall be bound by this Section&nbsp;3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Non-Transferability of Restricted Stock</U>. This Restricted Stock Award may not be transferred in any manner otherwise than by will or
by the laws of descent or distribution and may be exercised during the lifetime of Participant only by Participant. The terms of the Plan and this Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of
Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Tax Consequences</U>. Participant has reviewed with Participant&#146;s own tax advisors the federal, state, local and
foreign tax consequences of this investment and the transactions contemplated by this Agreement. Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. Participant understands
that Participant (and not the Company) shall be responsible for Participant&#146;s own tax liability that may arise as a result of the transactions contemplated by this Agreement. Participant understands that Section&nbsp;83 of the Internal Revenue
Code of 1986, as amended (the &#147;Code&#148;), taxes as ordinary income the difference between the purchase price, if any, for the Shares and the Fair Market Value of the Shares as of each vesting date. Participant understands that Participant may
elect to be taxed at the time the Shares are granted rather than when such Shares vest by filing an election under Section&nbsp;83(b) of the Code (the &#147;83(b) Election&#148;) with the IRS within thirty (30)&nbsp;days from the date of grant of
the Restricted Stock Award. The form for making this election is attached as <U>Exhibit B-3</U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PARTICIPANT ACKNOWLEDGES THAT IT
IS PARTICIPANT&#146;S SOLE RESPONSIBILITY AND NOT THE COMPANY&#146;S TO FILE TIMELY THE 83(b) ELECTION, EVEN IF PARTICIPANT REQUESTS THE COMPANY OR ITS REPRESENTATIVES TO MAKE THIS FILING ON PARTICIPANT&#146;S BEHALF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Tax Withholding</U>. Pursuant to such procedures as the Administrator may specify from time to time, the Company shall withhold the
minimum amount required to be withheld for the payment of income, employment and other taxes which the Company determines must be withheld (the &#147;Withholding Taxes&#148;) with respect to the filing of an 83(b) Election, or, if an 83(b) Election
is not filed or not timely filed, upon each vesting date, by, in the Administrator&#146;s discretion: (i)&nbsp;withholding otherwise deliverable Shares having a Fair Market Value equal to the amount of such Withholding Taxes, (ii)&nbsp;withholding
the amount of such Withholding Taxes from Participant&#146;s paycheck(s), (iii)&nbsp;requiring Participant to make appropriate arrangements with the Company (or the Parent or Subsidiary employing or retaining Participant) for the satisfaction of all
Withholding Taxes, or (iv)&nbsp;a combination of the foregoing. The Company shall not retain fractional Shares to satisfy any portion of the Withholding Taxes. Accordingly, if any withholding is done through the withholding of Shares, Participant
shall pay to the Company an amount in cash sufficient to satisfy the remaining Withholding Taxes due and payable as a result of the Company not retaining fractional Shares. Should the Company be unable to procure such cash amounts from Participant,
Participant agrees and acknowledges that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Participant is giving the Company permission to withhold from Participant&#146;s paycheck(s) an amount equal to the remaining Withholding Taxes due and payable as a result of the Company not
retaining fractional Shares. Participant acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver the Shares if such withholding amounts are not delivered at the time they are due. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>No Guarantee of Continued Service</U>. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF THE SHARES OF RESTRICTED STOCK PURSUANT
TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS RESTRICTED STOCK
AWARD OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED
ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH PARTICIPANT&#146;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO
TERMINATE PARTICIPANT&#146;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Forfeiture Upon Termination as
a Service Provider</U>. Notwithstanding any contrary provision of this Agreement or the Notice of Grant of Restricted Stock, if Participant terminates service as a Service Provider for any or no reason prior to vesting, the then Unvested Shares of
Restricted Stock awarded by this Agreement will thereupon be forfeited and automatically transferred to and reacquired by the Company at no cost to the Company upon the date of such termination and Participant will have no further rights thereunder.
Participant hereby appoints the Escrow Agent with full power of substitution, as Participant&#146;s true and lawful attorney-in-fact with irrevocable power and authority in the name and on behalf of Participant to take any action and execute all
documents and instruments, including, without limitation, stock powers which may be necessary to transfer the certificate or certificates evidencing such Unvested Shares of Restricted Stock to the Company upon such termination of service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Restriction on Transfer</U>. Except for the escrow described in Section&nbsp;10 or transfer of the Shares to the Company or its
assignees contemplated by this Agreement, none of the Shares or any beneficial interest therein shall be transferred, encumbered or otherwise disposed of in any way until such Shares shall have vested in accordance with the provisions of this
Agreement, other than by will or the laws of descent and distribution. Any distribution or delivery to be made to Participant under this Agreement shall, if Participant is then deceased, be made to Participant&#146;s designated beneficiary, or if no
beneficiary survives Participant, to the administrator or executor of Participant&#146;s estate. Any such transferee must furnish the Company with (a)&nbsp;written notice of his or her status as transferee, and (b)&nbsp;evidence satisfactory to the
Company to establish the validity of the transfer and compliance with any laws or regulations pertaining to said transfer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Escrow of Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) All Shares of Restricted Stock will, upon execution of this Agreement, be delivered and deposited with an escrow holder designated by the
Company (the &#147;Escrow Holder&#148;), together with the Assignment Separate from Certificate (the &#147;Stock Assignment&#148;) duly endorsed in blank, attached hereto as <U>Exhibit B-1</U>. The Shares of Restricted Stock and the Stock Assignment
will be held by the Escrow Holder, pursuant to the Joint Escrow Instructions of the Company and Participant attached as <U>Exhibit B-2</U> hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) The Escrow Holder shall not be liable for any act it may do or omit to do with respect to holding the Shares of Restricted Stock in escrow
and while acting in good faith and in the exercise of its judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Upon Participant&#146;s termination as a Service Provider for any
reason, the Escrow Holder, upon receipt of written notice of such termination, will take all steps necessary to accomplish the transfer of the Unvested Shares of Restricted Stock to the Company. Participant hereby appoints the Escrow Holder with
full power of substitution, as Participant&#146;s true and lawful attorney-in-fact with irrevocable power and authority in the name and on behalf of Participant to take any action and execute all documents and instruments, including, without
limitation, stock powers which may be necessary to transfer the certificate or certificates evidencing such Unvested Shares of Restricted Stock to the Company upon such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) The Escrow Holder will take all steps necessary to accomplish the transfer of Shares of Restricted Stock to Participant after they vest
following Participant&#146;s request that the Escrow Holder do so. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) Subject to the terms hereof, Participant shall have all the rights
of a shareholder with respect to such Shares while they are held in escrow, including without limitation, the right to vote the Shares and receive any cash dividends declared thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) In the event of any merger, reorganization, consolidation, recapitalization, separation, liquidation, stock dividend, split-up, share
combination, or other change in the corporate structure of the Company affecting the Common Stock, the Shares shall be increased, reduced or otherwise changed, and by virtue of any such change Participant shall in his or her capacity as owner of the
Unvested Shares of Restricted Stock that have been awarded to him or her be entitled to new or additional or different shares of stock, cash or securities (other than rights or warrants to purchase securities); such new or additional or different
shares, cash or securities shall thereupon be considered to be &#147;Unvested Shares of Restricted Stock&#148; and shall be subject to all of the conditions and restrictions which were applicable to the Unvested Shares of Restricted Stock pursuant
to this Agreement. If Participant receives rights or warrants with respect to any Unvested Shares of Restricted Stock, such rights or warrants may be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
held or exercised by Participant, provided that until such exercise any such rights or warrants and after such exercise any shares or other securities acquired by the exercise of such rights or
warrants shall be considered to be Unvested Shares of Restricted Stock and shall be subject to all of the conditions and restrictions which were applicable to the Unvested Shares of Restricted Stock pursuant to this Agreement. The Administrator in
its absolute discretion at any time may accelerate the vesting of all or any portion of such new or additional shares of stock, cash or securities, rights or warrants to purchase securities or shares or other securities acquired by the exercise of
such rights or warrants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Company&#146;s Right of First Refusal</U>. Subject to Section&nbsp;9, before any vested Shares held by
Participant or any transferee (either being sometimes referred to herein as the &#147;Holder&#148;) may be sold or otherwise transferred (including transfer by gift or operation of law), the Company or its assignee(s) shall have a right of first
refusal to purchase the Shares on the terms and conditions set forth in this Section&nbsp;11 (the &#147;Right of First Refusal&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Notice of Proposed Transfer</U>. The Holder of the Shares shall deliver to the Company a written notice (the &#147;Notice&#148;)
stating: (i)&nbsp;the Holder&#146;s bona fide intention to sell or otherwise transfer such Shares; (ii)&nbsp;the name of each proposed purchaser or other transferee (&#147;Proposed Transferee&#148;); (iii)&nbsp;the number of Shares to be transferred
to each Proposed Transferee; and (iv)&nbsp;the bona fide cash price or other consideration for which the Holder proposes to transfer the Shares (the &#147;Offered Price&#148;), and the Holder shall offer the Shares at the Offered Price to the
Company or its assignee(s). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Exercise of Right of First Refusal</U>. At any time within thirty (30)&nbsp;days after receipt of the
Notice, the Company and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the Proposed Transferees, at the purchase price
determined in accordance with subsection (c)&nbsp;below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Purchase Price</U>. The purchase price (&#147;Right of First Refusal
Price&#148;) for the Shares purchased by the Company or its assignee(s) under this Section&nbsp;11 shall be the Offered Price. If the Offered Price includes consideration other than cash, the cash equivalent value of the non-cash consideration shall
be determined by the Board in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U>Payment</U>. Payment of the Right of First Refusal Price shall be made, at the option of
the Company or its assignee(s), in cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company (or, in the case of repurchase by an assignee, to the assignee), or by any combination thereof
within thirty (30)&nbsp;days after receipt of the Notice or in the manner and at the times set forth in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <U>Holder&#146;s
Right to Transfer</U>. If all of the Shares proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section&nbsp;11, then the Holder may sell
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or otherwise transfer such Shares to that Proposed Transferee at the Offered Price or at a higher price, provided that such sale or other transfer is consummated within one hundred and twenty
(120)&nbsp;days after the date of the Notice, that any such sale or other transfer is effected in accordance with any applicable securities laws and that the Proposed Transferee agrees in writing that the provisions of this Section&nbsp;11 shall
continue to apply to the Shares in the hands of such Proposed Transferee. If the Shares described in the Notice are not transferred to the Proposed Transferee within such period, a new Notice shall be given to the Company, and the Company and/or its
assignees shall again be offered the Right of First Refusal before any Shares held by the Holder may be sold or otherwise transferred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <U>Exception for Certain Family Transfers</U>. Anything to the contrary contained in this Section&nbsp;11 notwithstanding, the transfer of
any or all of the Shares during Participant&#146;s lifetime or on Participant&#146;s death by will or intestacy to Participant&#146;s immediate family or a trust for the benefit of Participant or Participant&#146;s immediate family shall be exempt
from the provisions of this Section&nbsp;11. &#147;Immediate Family&#148; as used herein shall mean spouse, lineal descendant or antecedent, father, mother, brother or sister. In such case, the transferee or other recipient shall receive and hold
the Shares so transferred subject to the provisions of this Agreement, including but not limited to this Section&nbsp;11 and Section&nbsp;8, and there shall be no further transfer of such Shares except in accordance with the terms of this
Section&nbsp;11. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) <U>Termination of Right of First Refusal</U>. The Right of First Refusal shall terminate as to any Shares upon the
earlier of (i)&nbsp;the first sale of Common Stock of the Company to the general public, or (ii)&nbsp;a Change in Control in which the successor corporation has equity securities that are publicly traded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Restrictive Legends and Stop-Transfer Orders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Legends</U>. Participant understands and agrees that the Company shall cause the legends set forth below or legends substantially
equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE &#147;ACT&#148;) AND MAY NOT BE OFFERED, SOLD
OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE
THEREWITH. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER, A RIGHT OF FIRST REFUSAL AND
FORFEITURE RIGHTS IN FAVOR OF THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">
RESTRICTED STOCK AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS, RIGHT OF
FIRST REFUSAL AND FORFEITURE RIGHTS IN FAVOR OF THE ISSUER OR ITS ASSIGNEE(S) ARE BINDING ON TRANSFEREES OF THESE SHARES. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES
REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR A PERIOD OF TIME FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY&#146;S SECURITIES SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE
ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER PRIOR TO THE EXPIRATION OF SUCH PERIOD WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Stop-Transfer Notices</U>. Participant agrees that, in order to ensure compliance with the restrictions referred to herein, the Company
may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Refusal to Transfer</U>. The Company shall not be required (i)&nbsp;to transfer on its books any Shares that have been sold or
otherwise transferred in violation of any of the provisions of this Agreement or (ii)&nbsp;to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so
transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Address for Notices</U>. Any notice to be given to the Company under the terms of this Award Agreement will be
addressed to the Company at 1351 Harbor Bay Parkway, Alameda, CA 94502, or at such other address as the Company may hereafter designate in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice to the Escrow Holder shall be sent to the Company&#146;s address with a copy to the other party not sending the notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Electronic Delivery</U>. The Company may, in its sole discretion, decide to deliver any documents related to the Shares of Restricted
Stock awarded under the Plan or future Restricted Stock that may be awarded under the Plan by electronic means or request Participant&#146;s consent to participate in the Plan by electronic means. Participant hereby consents to receive such
documents by electronic delivery and agrees to participate in the Plan through any on-line or electronic system established and maintained by the Company or another third party designated by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>No Waiver</U>. Either party&#146;s failure to enforce any provision or provisions of this
Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party from thereafter enforcing each and every other provision of this Agreement. The rights granted both parties herein are cumulative and
shall not constitute a waiver of either party&#146;s right to assert all other legal remedies available to it under the circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Successors and Assigns</U>. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this
Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors
and assigns. The rights and obligations of Participant under this Agreement may only be assigned with the prior written consent of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Interpretation</U>. The Administrator will have the power to interpret the Plan and this Agreement and to adopt such rules for the
administration, interpretation and application of the Plan as are consistent therewith and to interpret or revoke any such rules (including, but not limited to, the determination of whether or not any Shares of Restricted Stock have vested). All
actions taken and all interpretations and determinations made by the Administrator in good faith will be final and binding upon Participant, the Company and all other interested persons. Neither the Administrator nor any person acting on behalf of
the Administrator will be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Additional Documents</U>. Participant agrees upon request to execute any further documents or instruments necessary or desirable to
carry out the purposes or intent of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Governing Law; Severability</U>. This Agreement is governed by the internal
substantive laws, but not the choice of law rules, of California. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force
and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Entire Agreement</U>. The Plan is incorporated herein by reference. The Plan and this Agreement (including the
exhibits referenced herein) constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject
matter hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participant acknowledges receipt of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and
hereby accepts this Agreement subject to all of the terms and provisions thereof. Participant has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prior to executing this Agreement and fully understands all provisions of this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of
the Administrator upon any questions arising under the Plan or this Agreement. Participant further agrees to notify the Company upon any change in the residence address indicated below. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Title</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Residence Address</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INVESTMENT REPRESENTATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">COMPANY</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECURITY</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">COMMON STOCK</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AMOUNT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the purchase of the above-listed Securities, the undersigned Participant represents to the
Company the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Participant is aware of the Company&#146;s business affairs and financial condition and has acquired
sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Securities. Participant is acquiring these Securities for investment for Participant&#146;s own account only and not with a view to, or for
resale in connection with, any &#147;distribution&#148; thereof within the meaning of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Participant acknowledges and understands that the Securities constitute &#147;restricted securities&#148; under the Securities Act and
have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Participant&#146;s investment intent as expressed herein. In this
connection, Participant understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if Participant&#146;s representation was predicated solely upon a present intention to hold
these Securities for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Securities, or for a period of one year or any other fixed period in the future.
Participant further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Participant further acknowledges and understands that
the Company is under no obligation to register the Securities. Participant understands that the certificate evidencing the Securities shall be imprinted with any legend required under applicable state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Participant is familiar with the provisions of Rule 701 and Rule 144, each promulgated under the Securities Act, which, in substance,
permit limited public resale of &#147;restricted securities&#148; acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions. Rule 701 provides that if the issuer qualifies
under Rule 701 at the time of the grant of the Restricted Stock Award to Participant, the exercise shall be exempt from registration under the Securities Act. In the event the Company becomes subject to the reporting requirements of Section&nbsp;13
or 15(d) of the Securities Exchange Act of 1934, ninety (90)&nbsp;days thereafter (or such longer period as any market stand-off agreement may require) the Securities exempt </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under Rule 701 may be resold, subject to the satisfaction of the applicable conditions specified by Rule 144, including in the case of affiliates (1)&nbsp;the availability of certain public
information about the Company, (2)&nbsp;the amount of Securities being sold during any three (3)&nbsp;month period not exceeding specified limitations, (3)&nbsp;the resale being made in an unsolicited &#147;broker&#146;s transaction&#148;,
transactions directly with a &#147;market maker&#148; or &#147;riskless principal transactions&#148; (as those terms are defined under the Securities Exchange Act of 1934) and (4)&nbsp;the timely filing of a Form 144, if applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the Company does not qualify under Rule 701 at the time of grant of the Restricted Stock Award, then the Securities may be
resold in certain limited circumstances subject to the provisions of Rule 144, which may require (i)&nbsp;the availability of current public information about the Company; (ii)&nbsp;the resale to occur more than a specified period after the purchase
and full payment (within the meaning of Rule 144) for the Securities; and (iii)&nbsp;in the case of the sale of Securities by an affiliate, the satisfaction of the conditions set forth in sections (2), (3)&nbsp;and (4)&nbsp;of the paragraph
immediately above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Participant further understands that in the event all of the applicable requirements of Rule 701 or 144 are not
satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption shall be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and
Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules 144 or 701 shall have a substantial burden of proof in establishing
that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. Participant understands that no assurances can be given that
any such other registration exemption shall be available in such event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>(e) To allow the Company to determine whether the
Participant is an excluded purchaser under Section&nbsp;25102(f) of the California Corporate Securities Law of 1968, Participant makes the following representations <B><U>(check all that apply)</U></B>:<B> </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top">I reasonably expect my own income from all sources during the current year to exceed $200,000.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top">My yearly income from all sources during each of the last two years exceeded $200,000.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top">I reasonably expect the joint income of my spouse (if married) and I from all sources during the current year to exceed $300,000.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top">The joint income of my spouse (if then married) and I from all sources during the last two years exceeded $300,000.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top">My net worth (<I>i.e</I>., the excess of assets over liabilities) as of the date below, together with the net worth of my spouse (if married), exceeds
$1,000,000.&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>When determining your net worth, the value of your primary residence must be excluded. The related amount of indebtedness secured by the primary residence up to its fair market value may also be excluded. However,
indebtedness secured by the residence in excess of the value of the home should be considered a liability and deducted from net worth.</I> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><I>The value of vested employee stock options may be included in net worth.</I> </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B-1 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT SEPARATE FROM CERTIFICATE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED I,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, hereby
sell, assign and transfer unto Penumbra, Inc. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of the Common Stock of Penumbra, Inc. standing in my name on the books of said corporation
represented by Certificate No. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; herewith and do hereby irrevocably constitute and appoint
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to
transfer the said stock on the books of the within named corporation with full power of substitution in the premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Stock
Assignment may be used only in accordance with the Restricted Stock Agreement between Penumbra, Inc. and the undersigned dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(the &#147;Agreement&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Signature:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>INSTRUCTIONS:</B> Please do not fill in any blanks other than the signature line. The purpose of this assignment is to
enable the Company to transfer the Unvested Shares of Restricted Stock to the Company upon Participant&#146;s termination as a Service Provider, without requiring additional signatures on the part of Participant.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B-2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JOINT ESCROW INSTRUCTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Corporate Secretary </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alameda, CA 94502 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As Escrow Agent for both Penumbra, Inc. (the &#147;Company&#148;), and the undersigned recipient of stock of the Company (the
&#147;Participant&#148;), you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms of that certain Restricted Stock Agreement (the &#147;Agreement&#148;) between the Company and the undersigned, in
accordance with the following instructions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. At the closing, you are directed (a)&nbsp;to date the stock assignments necessary for the
transfer in question, (b)&nbsp;to fill in the number of shares being transferred, and (c)&nbsp;to deliver the stock assignments, together with the certificate evidencing the shares of stock to be transferred, to the Company or its assignee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Participant irrevocably authorizes the Company to deposit with you any certificates evidencing shares of stock to be held by you hereunder
and any additions and substitutions to said shares as defined in the Agreement. Participant does hereby irrevocably constitute and appoint you as Participant&#146;s attorney-in-fact and agent for the term of this escrow to execute with respect to
such securities all documents necessary or appropriate to make such securities negotiable and to complete any transaction herein contemplated, including but not limited to the filing with any applicable state blue sky authority of any required
applications for consent to, or notice of transfer of, the securities. Subject to the provisions of this paragraph 2, Participant shall exercise all rights and privileges of a stockholder of the Company while the stock is held by you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Upon written request of the Participant, but no more than once per calendar year, unless the shares are forfeited, you shall deliver to
Participant a certificate or certificates representing so many shares of stock that have vested. Within one hundred and twenty (120)&nbsp;days after cessation of Participant&#146;s continuous employment by or services to the Company, or any parent
or subsidiary of the Company, you shall deliver to Participant a certificate or certificates representing the aggregate number of shares held or issued pursuant to the Agreement that have vested. Upon any forfeiture of such shares, you shall deliver
or electronically transfer such shares to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. If at the time of termination of this escrow you should have in your possession
any documents, securities, or other property belonging to Participant, you shall deliver all of the same to Participant and shall be discharged of all further obligations hereunder. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. Your duties hereunder may be altered, amended, modified or revoked only by a writing signed by
all of the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. You shall be obligated only for the performance of such duties as are specifically set forth herein and may
rely and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You shall not be personally liable for any act you may
do or omit to do hereunder as Escrow Agent or as attorney-in-fact for Participant while acting in good faith, and any act done or omitted by you pursuant to the advice of your own attorneys shall be conclusive evidence of such good faith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. You are hereby expressly authorized to disregard any and all warnings given by any of the parties hereto or by any other person or
corporation, excepting only orders or process of courts of law and are hereby expressly authorized to comply with and obey orders, judgments or decrees of any court. In case you obey or comply with any such order, judgment or decree, you shall not
be liable to any of the parties hereto or to any other person, firm or corporation by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently reversed, modified, annulled, set aside, vacated or found to have
been entered without jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. You shall not be liable in any respect on account of the identity, authorities or rights of the
parties executing or delivering or purporting to execute or deliver the Agreement or any documents or papers deposited or called for hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. You shall not be liable for the outlawing of any rights under the Statute of Limitations with respect to these Joint Escrow Instructions or
any documents deposited with you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. You shall be entitled to employ such legal counsel and other experts as you may deem necessary
properly to advise you in connection with your obligations hereunder, may rely upon the advice of such counsel, and may pay such counsel reasonable compensation therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. Your responsibilities as Escrow Agent hereunder shall terminate if you shall cease to be an officer or agent of the Company or if you
shall resign by written notice to each party. In the event of any such termination, the Company shall appoint a successor Escrow Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. If you reasonably require other or further instruments in connection with these Joint Escrow Instructions or obligations in respect
hereto, the necessary parties hereto shall join in furnishing such instruments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. It is understood and agreed that should any dispute
arise with respect to the delivery and/or ownership or right of possession of the securities held by you hereunder, you are authorized and directed to retain in your possession without liability to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
anyone all or any part of said securities until such disputes shall have been settled either by mutual written agreement of the parties concerned or by a final order, decree or judgment of a
court of competent jurisdiction after the time for appeal has expired and no appeal has been perfected, but you shall be under no duty whatsoever to institute or defend any such proceedings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery or upon
deposit in the United States Post Office, by registered or certified mail with postage and fees prepaid, addressed to each of the other parties thereunto entitled at the following addresses or at such other addresses as a party may designate by ten
(10)&nbsp;days advance written notice to each of the other parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. By signing these Joint Escrow Instructions, you become a
party hereto only for the purpose of said Joint Escrow Instructions; you do not become a party to the Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. This instrument
shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. These
Joint Escrow Instructions shall be governed by the internal substantive laws, but not the choice of law rules, of California. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Signature</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Print Name</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Title</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Residence Address</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ESCROW AGENT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Corporate Secretary</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B-3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION UNDER SECTION 83(b) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF THE INTERNAL REVENUE CODE OF 1986 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
undersigned taxpayer hereby elects, pursuant to Section&nbsp;83(b) of the Internal Revenue Code of 1986, as amended, to include in taxpayer&#146;s gross income or alternative minimum taxable income, as the case may be, for the current taxable year
the amount of any compensation taxable to taxpayer in connection with taxpayer&#146;s receipt of the property described below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">The name, address, taxpayer identification number and taxable year of the undersigned are as follows: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="8%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">NAME:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">SPOUSE:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">ADDRESS:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR></TABLE></DIV> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="24%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="24%"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">TAXPAYER&nbsp;IDENTIFICATION&nbsp;NO.:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">TAXABLE&nbsp;YEAR:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">The property with respect to which the election is made is described as follows: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares (the &#147;Shares&#148;) of the
Common Stock of Penumbra, Inc. (the &#147;Company&#148;). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">The date on which the property was transferred is:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">The property is subject to the following restrictions: </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Shares may not be transferred and
are subject to forfeiture under the terms of an agreement between the taxpayer and the Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">The Fair Market Value at the time of transfer, determined without regard to any restriction other than a restriction which by its terms shall never lapse, of such property is: $
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top">The amount (if any) paid for such property is: $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned has submitted a copy of this statement to the person for whom the services were performed in connection with the undersigned&#146;s receipt of
the above-described property. The transferee of such property is the person performing the services in connection with the transfer of said property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>The undersigned understands that the foregoing election may not be revoked except with the consent of the Commissioner. </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Taxpayer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned spouse of taxpayer joins in this election. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Spouse of Taxpayer</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2011 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK GRANT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The person named below in Section I (&#147;Participant&#148;) has been granted shares of Common Stock of Penumbra, Inc., a Delaware
corporation (the &#147;Company&#148;), subject to the terms and conditions of the Company&#146;s 2011 Equity Incentive Plan (the &#147;Plan&#148;) and this Stock Grant Agreement (the &#147;Agreement&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Agreement. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>NOTICE OF GRANT OF COMMON STOCK</U> </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Name: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Address: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned Participant has been granted shares of Common Stock of the Company, subject to the terms and conditions of the Plan and this Agreement, as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date of Grant:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Number of Shares Granted:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>AGREEMENT</U> </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Grant of Stock</U>. The Administrator hereby grants to
Participant the number of Shares set forth in Section I above pursuant to a fully vested Restricted Stock Award under the Plan for past services and as a separate incentive in connection with his or her services and not in lieu of any salary or
other compensation for his or her services, and subject to the terms and conditions of this Agreement and the Plan, which is incorporated herein by reference. Subject to Section&nbsp;18 of the Plan, in the event of a conflict between the terms and
conditions of the Plan and this Agreement, the terms and conditions of the Plan shall prevail. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Participant&#146;s
Representations</U>. In the event the Shares have not been registered under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), Participant shall, if required by the Company, concurrently with the execution of this Agreement by
Participant, deliver to the Company his or her Investment Representation Statement in the form attached hereto as <U>Exhibit A</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.
<U>Lock-Up Period</U>. Participant hereby agrees that Participant shall not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase,
lend, or otherwise transfer or dispose of, directly or indirectly, any Common Stock (or other securities) of the Company or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of any Common Stock (or other securities) of the Company held by Participant (other than those included in the registration) for a period specified by the representative of the underwriters of Common Stock (or other
securities) of the Company not to </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exceed one hundred and eighty (180)&nbsp;days following the effective date of any registration statement of the Company filed under the Securities Act (or such other period as may be requested by
the Company or the underwriters to accommodate regulatory restrictions on (i)&nbsp;the publication or other distribution of research reports and (ii)&nbsp;analyst recommendations and opinions, including, but not limited to, the restrictions
contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Participant agrees to
execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter which are consistent with the foregoing or which are necessary to give further effect thereto. In addition, if requested by the Company or the
representative of the underwriters of Common Stock (or other securities) of the Company, Participant shall provide, within ten (10)&nbsp;days of such request, such information as may be required by the Company or such representative in connection
with the completion of any public offering of the Company&#146;s securities pursuant to a registration statement filed under the Securities Act. The obligations described in this Section 3 shall not apply to a registration relating solely to
employee benefit plans on Form S-1 or Form S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a Commission Rule 145 transaction on Form S-4 or similar forms that may be promulgated in the future. The
Company may impose stop-transfer instructions with respect to the shares of Common Stock (or other securities) subject to the foregoing restriction until the end of said one hundred and eighty (180)&nbsp;day (or other) period. Participant agrees
that any transferee of the Award or Shares pursuant to this Agreement shall be bound by this Section 3. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Tax Withholding</U>.
Pursuant to such procedures as the Administrator may specify from time to time, the Company shall withhold the minimum amount required to be withheld for the payment of income, employment and other taxes which the Company determines must be withheld
(the &#147;Withholding Taxes&#148;) with respect to the Shares by, in the Administrator&#146;s discretion: (i)&nbsp;withholding otherwise deliverable Shares having a Fair Market Value equal to the amount of such Withholding Taxes,
(ii)&nbsp;withholding the amount of such Withholding Taxes from Participant&#146;s paycheck(s), (iii)&nbsp;requiring Participant to make appropriate arrangements with the Company (or the Parent or Subsidiary employing or retaining Participant) for
the satisfaction of all Withholding Taxes, or (iv)&nbsp;a combination of the foregoing. The Company shall not retain fractional Shares to satisfy any portion of the Withholding Taxes. Accordingly, if any withholding is done through the withholding
of Shares, Participant shall pay to the Company an amount in cash sufficient to satisfy the remaining Withholding Taxes due and payable as a result of the Company not retaining fractional Shares. Should the Company be unable to procure such cash
amounts from Participant, Participant agrees and acknowledges that Participant is giving the Company permission to withhold from Participant&#146;s paycheck(s) an amount equal to the remaining Withholding Taxes due and payable as a result of the
Company not retaining fractional Shares. Participant acknowledges and agrees that the Company may refuse to deliver the Shares unless and until satisfactory arrangements (as determined by the Administrator) will have been made by Participant with
respect to the Withholding Taxes that the Company determines must be withheld with respect to such Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Tax Consequences</U>.
Participant has reviewed with Participant&#146;s own tax advisors the federal, state, local and foreign tax consequences of this investment and the transactions contemplated by this Agreement. Participant is relying solely on such advisors and not
on any statements or representations of the Company or any of its agents. Participant understands that Participant (and not the Company) shall be responsible for Participant&#146;s own tax liability that may arise as a result of the transactions
contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Company&#146;s Right of First Refusal</U>. Before any Shares held by Participant or any
transferee (either being sometimes referred to herein as the &#147;Holder&#148;) may be sold or otherwise transferred (including transfer by gift or operation of law), the Company or its assignee(s) shall have a right of first refusal to purchase
the Shares on the terms and conditions set forth in this Section 6 (the &#147;Right of First Refusal&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Notice of Proposed
Transfer</U>. The Holder of the Shares shall deliver to the Company a written notice (the &#147;Notice&#148;) stating: (i)&nbsp;the Holder&#146;s bona fide intention to sell or otherwise transfer such Shares; (ii)&nbsp;the name of each proposed
purchaser or other transferee (&#147;Proposed Transferee&#148;); (iii)&nbsp;the number of Shares to be transferred to each Proposed Transferee; and (iv)&nbsp;the bona fide cash price or other consideration for which the Holder proposes to transfer
the Shares (the &#147;Offered Price&#148;), and the Holder shall offer the Shares at the Offered Price to the Company or its assignee(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Exercise of Right of First Refusal</U>. At any time within thirty (30)&nbsp;days after receipt of the Notice, the Company and/or its
assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the Proposed Transferees, at the purchase price determined in accordance with
subsection (c) below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Purchase Price</U>. The purchase price (the &#147;Right of First Refusal Price&#148;) for the Shares
purchased by the Company or its assignee(s) under this Section 6 shall be the Offered Price. If the Offered Price includes consideration other than cash, the cash equivalent value of the non-cash consideration shall be determined by the Board in
good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U>Payment</U>. Payment of the Right of First Refusal Price shall be made, at the option of the Company or its
assignee(s), in cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company (or, in the case of repurchase by an assignee, to the assignee), or by any combination thereof within thirty
(30)&nbsp;days after receipt of the Notice or in the manner and at the times set forth in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <U>Holder&#146;s Right to
Transfer</U>. If all of the Shares proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section 6, then the Holder may sell or otherwise transfer such
Shares to that Proposed Transferee at the Offered Price or at a higher price, provided that such sale or other transfer is consummated within one hundred and twenty (120)&nbsp;days after the date of the Notice, that any such sale or other transfer
is effected in accordance with any applicable securities laws and that the Proposed Transferee agrees in writing that the provisions of this Section 6 shall continue to apply to the Shares in the hands of such Proposed Transferee. If the Shares
described in the Notice are not transferred to the Proposed Transferee within such period, a new Notice shall be given to the Company, and the Company and/or its assignees shall again be offered the Right of First Refusal before any Shares held by
the Holder may be sold or otherwise transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <U>Exception for Certain Family Transfers</U>. Anything to the contrary contained in
this Section 6 notwithstanding, the transfer of any or all of the Shares during Participant&#146;s lifetime or on Participant&#146;s death by will or intestacy to Participant&#146;s immediate family or a trust for the benefit of Participant or the
Participant&#146;s immediate family shall be exempt from the provisions of this Section 6. &#147;Immediate Family&#148; as used herein shall mean spouse, lineal descendant or antecedent, father, mother, brother or sister. In such case, the
transferee or other recipient shall receive and hold the Shares so transferred subject to the provisions of this Agreement, including but not limited to this Section 6 and Section 3, and there shall be no further transfer of such Shares except in
accordance with the terms of this Section 6. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) <U>Termination of Right of First Refusal</U>. The Right of First Refusal shall terminate
as to any Shares upon the earlier of (i)&nbsp;the first sale of Common Stock to the general public, or (ii)&nbsp;a Change in Control of the Company in which the successor corporation has equity securities that are publicly traded. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Restrictive Legends; Stop-Transfer Orders; Refusal to Transfer</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Legends</U>. Participant understands and agrees that the Company shall cause the legends set forth below or legends substantially
equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by applicable state or federal securities laws: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT AND MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED,
PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE SECURITIES ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE THEREWITH. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND A RIGHT OF FIRST REFUSAL HELD BY THE ISSUER OR
ITS ASSIGNEE(S) AS SET FORTH IN THE STOCK AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS AND RIGHT OF FIRST REFUSAL ARE BINDING
ON TRANSFEREES OF THESE SHARES. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR A PERIOD OF TIME
FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY&#146;S SECURITIES SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY THE HOLDER PRIOR
TO THE EXPIRATION OF SUCH PERIOD WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Stop-Transfer Notices</U>.
Participant agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent, if any, and that, if the Company transfers its own
securities, it may make appropriate notations to the same effect in its own records. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Refusal to Transfer</U>. The Company shall
not be required (i)&nbsp;to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement, or (ii)&nbsp;to treat as owner of such Shares or to accord the right to vote or pay
dividends to any purchaser or other transferee to whom such Shares shall have been so transferred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>No Guarantee of Continued Service</U>. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THIS
AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREUNDER DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER AND SHALL NOT INTERFERE IN ANY WAY WITH PARTICIPANT&#146;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE
PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT&#146;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Notices</U>. Any notice, demand or request required or permitted to be given by either the Company or Participant pursuant to the terms
of this Agreement shall be in writing and shall be deemed given when delivered personally or deposited in the U.S. mail, First Class with postage prepaid, and addressed to the parties at the addresses of the parties set forth at the end of this
Agreement or such other address as a party may request by notifying the other in writing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>No Waiver</U>. Either party&#146;s
failure to enforce any provision or provisions of this Agreement shall not in any way be construed as a waiver of any such provision or provisions, nor prevent that party from thereafter enforcing each and every other provision of this Agreement.
The rights granted both parties herein are cumulative and shall not constitute a waiver of either party&#146;s right to assert all other legal remedies available to it under the circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Successors and Assigns</U>. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this
Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors
and assigns. The rights and obligations of Participant under this Agreement may only be assigned with the prior written consent of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Interpretation</U>. Any dispute regarding the interpretation of this Agreement shall be submitted by Participant or by the Company
forthwith to the Administrator which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Administrator shall be final and binding on all parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Governing Law; Severability</U>. This Agreement is governed by the internal substantive laws but not the choice of law rules, of
California. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Entire Agreement</U>. The Plan is incorporated herein by reference. The Plan, this Agreement and the Investment Representation
Statement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof, and
may not be modified adversely to Participant&#146;s interest except by means of a writing signed by the Company and Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participant acknowledges receipt of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and
hereby accepts the grant of Common Stock hereunder subject to all of the terms and provisions of the Plan and this Agreement. Participant </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has reviewed the Plan and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all provisions of this
Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan or this Agreement. Participant further agrees to notify the Company upon
any change in the residence address indicated below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Participant and the Company have executed this Agreement and
agree that the grant of Common Stock hereunder is to be governed by the terms and conditions of the Plan and this Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Title</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Residence Address</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2011 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK OPTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise defined herein, the terms defined in the 2011 Equity Incentive Plan (the &#147;Plan&#148;) shall have the same defined
meanings in this Stock Option Agreement (the &#147;Option Agreement&#148;). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>NOTICE OF STOCK OPTION GRANT</U> </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Name: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Address: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned Participant has been granted an Option to purchase Common Stock of the Company, subject to the terms and conditions of the Plan and this Option Agreement, as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date of Grant:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vesting Commencement Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exercise Price per Share:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Number of Shares Granted:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Exercise Price:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Type of Option:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive&nbsp;Stock&nbsp;Option*</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonstatutory&nbsp;Stock&nbsp;Option</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Term/Expiration Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">If stockholder approval of the Plan is not obtained in a manner required by Applicable Law, as determined by the Administrator, within twelve (12)&nbsp;months after the date the Plan is adopted by the Board, then to the
extent this is Option designated as an Incentive Stock Option, it will be treated in whole as a Nonstatutory Stock Option. In addition, if this Option is designated as an Incentive Stock Option, it may be treated in part as a Nonstatutory Stock
Option, as described in Section&nbsp;1 below. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Vesting Schedule</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Option shall be exercisable, in whole or in part, according to the following vesting schedule: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[Twenty-five percent (25%)&nbsp;of the Shares subject to the Option shall vest on the one (1)&nbsp;year anniversary of the Vesting
Commencement Date, and one forty-eighth (1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)&nbsp;of the Shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if
there is no corresponding day, on the last day of the month), subject to Participant continuing to be a Service Provider through each such date.] </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a Change in Control, and subject to Participant continuing to be a Service
Provider through the date of such Change in Control, the Participant will fully vest in and have the right to exercise all of the Shares subject to this Option. The Administrator will notify the Participant in writing or electronically that this
Option will be exercisable for a period of time determined by the Administrator in its sole discretion, and, to the extent the Administrator determines, terminate upon or immediately prior to the effectiveness of the Change in Control. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Termination Period</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
Option shall be exercisable for three (3)&nbsp;months after Participant ceases to be a Service Provider, unless such termination is due to Participant&#146;s death or Disability, in which case this Option shall be exercisable for twelve
(12)&nbsp;months after Participant ceases to be a Service Provider. Notwithstanding the foregoing sentence, in no event may this Option be exercised after the Term/Expiration Date as provided above and this Option may be subject to earlier
termination as provided in Section&nbsp;13 of the Plan. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>AGREEMENT</U> </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Grant of Option</U>. The Administrator of the Company hereby
grants to the Participant named in the Notice of Stock Option Grant in Part I of this Agreement (&#147;Participant&#148;), an option (the &#147;Option&#148;) to purchase the number of Shares set forth in the Notice of Stock Option Grant, at the
exercise price per Share set forth in the Notice of Stock Option Grant (the &#147;Exercise Price&#148;), and subject to the terms and conditions of the Plan, which is incorporated herein by reference. Subject to Section&nbsp;18 of the Plan, in the
event of a conflict between the terms and conditions of the Plan and this Option Agreement, the terms and conditions of the Plan shall prevail. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If designated in the Notice of Stock Option Grant as an Incentive Stock Option (&#147;ISO&#148;), this Option is intended to qualify as an
Incentive Stock Option as defined in Section&nbsp;422 of the Code. Nevertheless, to the extent that it exceeds the $100,000 rule of Code Section&nbsp;422(d), this Option shall be treated as a Nonstatutory Stock Option (&#147;NSO&#148;). Further, if
for any reason this Option (or portion thereof) shall not qualify as an ISO, such as due to the stockholders of the Company not approving the Plan within twelve (12)&nbsp;months after the date the Plan is adopted by the Board, then, to the extent of
such nonqualification, such Option (or portion thereof) shall be regarded as a NSO granted under the Plan. In no event shall the Administrator, the Company or any Parent or Subsidiary or any of their respective employees or directors have any
liability to Participant (or any other person) due to the failure of the Option to qualify for any reason as an ISO. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Exercise of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Right to Exercise</U>. This Option shall be exercisable during its term in accordance with the Vesting Schedule set out in the Notice
of Stock Option Grant and with the applicable provisions of the Plan and this Option Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Method of Exercise</U>. This
Option shall be exercisable by delivery of an exercise notice in the form attached as <U>Exhibit&nbsp;A</U> (the &#147;Exercise Notice&#148;) or in a manner and pursuant to such procedures as the Administrator may determine, which shall state the
election to exercise the Option, the number of Shares with respect to which the Option is being exercised (the &#147;Exercised Shares&#148;), and such other representations and agreements as may be required by the Company. The Exercise Notice shall
be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares, together with any applicable tax withholding. This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice
accompanied by the aggregate Exercise Price, together with any applicable tax withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">No Shares shall be issued pursuant to the
exercise of an Option unless such issuance and such exercise comply with Applicable Laws. Assuming such compliance, for income tax purposes the Shares shall be considered transferred to Participant on the date on which the Option is exercised with
respect to such Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Participant&#146;s Representations</U>. In the event the Shares have not been registered under the
Securities Act of 1933, as amended (the &#147;Securities Act&#148;), at the time this Option is exercised, Participant shall, if required by the Company, concurrently with the exercise of all or any portion of this Option, deliver to the Company his
or her Investment Representation Statement in the form attached hereto as <U>Exhibit&nbsp;B</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Lock-Up Period</U>. Participant
hereby agrees that Participant shall not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose
of, directly or indirectly, any Common Stock (or other securities) of the Company or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Common Stock
(or other securities) of the Company held by Participant (other than those included in the registration) for a period specified by the representative of the underwriters of Common Stock (or other securities) of the Company not to exceed one hundred
and eighty (180)&nbsp;days following the effective date of any registration statement of the Company filed under the Securities Act (or such other period as may be requested by the Company or the underwriters to accommodate regulatory restrictions
on (i)&nbsp;the publication or other distribution of research reports and (ii)&nbsp;analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule&nbsp;2711(f)(4) or NYSE Rule&nbsp;472(f)(4), or any
successor provisions or amendments thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Participant agrees to execute and deliver such other agreements as may be reasonably
requested by the Company or the underwriter which are consistent with the foregoing or which are necessary to give further effect thereto. In addition, if requested by the Company or the representative of the underwriters of Common Stock (or other
securities) of the Company, Participant shall provide, within ten (10)&nbsp;days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the
Company&#146;s securities pursuant to a registration statement filed under the Securities Act. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligations described in this Section&nbsp;4 shall not apply to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or similar forms that may be promulgated in the
future, or a registration relating solely to a Commission Rule 145 transaction on Form S-4 or similar forms that may be promulgated in the future. The Company may impose stop-transfer instructions with respect to the shares of Common Stock (or other
securities) subject to the foregoing restriction until the end of said one hundred and eighty (180)&nbsp;day (or other) period. Participant agrees that any transferee of the Option or shares acquired pursuant to the Option shall be bound by this
Section&nbsp;4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Method of Payment</U>. Payment of the aggregate Exercise Price shall be by any of the following, or a combination
thereof, at the election of the Participant: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) cash; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) check; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) consideration
received by the Company under a formal cashless exercise program adopted by the Company in connection with the Plan; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) surrender of
other Shares which (i)&nbsp;shall be valued at its Fair Market Value on the date of exercise, and (ii)&nbsp;must be owned free and clear of any liens, claims, encumbrances or security interests, if accepting such Shares, in the sole discretion of
the Administrator, shall not result in any adverse accounting consequences to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Restrictions on Exercise</U>. This
Option may not be exercised if the issuance of such Shares upon such exercise or the method of payment of consideration for such shares would constitute a violation of any Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Non-Transferability of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised
during the lifetime of Participant only by Participant. The terms of the Plan and this Option Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Further, until the Company becomes subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act, or after the
Administrator determines that it is, will, or may no longer be relying upon the exemption from registration of Options under the Exchange Act as set forth in Rule 12h-1(f) promulgated under the Exchange Act (the &#147;Reliance End Date&#148;),
Participant shall not transfer this Option or, prior to exercise, the Shares subject to this Option, in any manner other than (i)&nbsp;to persons who are &#147;family members&#148; (as defined in Rule 701(c)(3) of the Securities Act) through gifts
or domestic relations orders, or (ii)&nbsp;to an executor or guardian of Participant upon the death or disability of Participant. Until the Reliance End Date, the Options and, prior to exercise, the Shares subject to this Option, may not be pledged,
hypothecated or otherwise transferred or disposed of, including by entering into any short position, any &#147;put equivalent position&#148; or any &#147;call equivalent position&#148; (as defined in Rule 16a-1(h) and Rule 16a-1(b) of the Exchange
Act, respectively), other than as permitted in clauses (i)&nbsp;and (ii)&nbsp;of this paragraph. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Term of Option</U>. This Option may be exercised only within the term set out in the Notice
of Stock Option Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Option Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.
<U>Tax Obligations</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Tax Withholding</U>. Participant agrees to make appropriate arrangements with the Company (or the Parent
or Subsidiary employing or retaining Participant) for the satisfaction of all Federal, state, local and foreign income and employment tax withholding requirements applicable to the Option exercise. Participant acknowledges and agrees that the
Company may refuse to honor the exercise and refuse to deliver the Shares if such withholding amounts are not delivered at the time of exercise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Notice of Disqualifying Disposition of ISO Shares</U>. If the Option granted to Participant herein is an ISO, and if Participant sells
or otherwise disposes of any of the Shares acquired pursuant to the ISO on or before the later of (i)&nbsp;the date two (2)&nbsp;years after the Date of Grant, or (ii)&nbsp;the date one (1)&nbsp;year after the date of exercise, Participant shall
immediately notify the Company in writing of such disposition. Participant agrees that Participant may be subject to income tax withholding by the Company on the compensation income recognized by Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Code Section&nbsp;409A.</U> Under Code Section&nbsp;409A, an Option that vests after December&nbsp;31, 2004 (or that vested on or prior
to such date but which was materially modified after October&nbsp;3, 2004) that was granted with a per Share exercise price that is determined by the Internal Revenue Service (the &#147;IRS&#148;) to be less than the Fair Market Value of a Share on
the date of grant (a &#147;discount option&#148;) may be considered &#147;deferred compensation.&#148; An Option that is a &#147;discount option&#148; may result in (i)&nbsp;income recognition by Participant prior to the exercise of the Option,
(ii)&nbsp;an additional twenty percent (20%)&nbsp;federal income tax, and (iii)&nbsp;potential penalty and interest charges. The &#147;discount option&#148; may also result in additional state income, penalty and interest tax to the Participant.
Participant acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share exercise price of this Option equals or exceeds the Fair Market Value of a Share on the date of grant in a later examination.
Participant agrees that if the IRS determines that the Option was granted with a per Share exercise price that was less than the Fair Market Value of a Share on the date of grant, Participant shall be solely responsible for Participant&#146;s costs
related to such a determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Entire Agreement; Governing Law</U>. The Plan is incorporated herein by reference. The Plan and
this Option Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter
hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. This Option Agreement is governed by the internal substantive laws but not the choice of law rules of
California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>No Guarantee of Continued Service</U>. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE
VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS
CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH
PARTICIPANT&#146;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) TO TERMINATE PARTICIPANT&#146;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participant acknowledges receipt of a copy of the Plan and represents that he or she is familiar with the terms and provisions thereof, and
hereby accepts this Option subject to all of the terms and provisions thereof. Participant has reviewed the Plan and this Option in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Option and fully
understands all provisions of the Option. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan or this Option. Participant further agrees
to notify the Company upon any change in the residence address indicated below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Title</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Residence Address</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2011 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXERCISE NOTICE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alameda, CA 94502 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Treasurer </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Exercise of
Option</U>. Effective as of today, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, the undersigned (&#147;Participant&#148;) hereby elects to exercise Participant&#146;s
option (the &#147;Option&#148;) to purchase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of the Common Stock (the &#147;Shares&#148;) of Penumbra, Inc. (the &#147;Company&#148;) under and
pursuant to the 2011 Equity Incentive Plan (the &#147;Plan&#148;) and the Stock Option Agreement dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (the &#147;Option
Agreement&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Delivery of Payment</U>. Participant herewith delivers to the Company the full purchase price of the Shares, as
set forth in the Option Agreement, and any and all withholding taxes due in connection with the exercise of the Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.
<U>Representations of Participant</U>. Participant acknowledges that Participant has received, read and understood the Plan and the Option Agreement and agrees to abide by and be bound by their terms and conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Rights as Stockholder</U>. Until the issuance of the Shares (as evidenced by the appropriate entry on the books of the Company or of a
duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to the Common Stock subject to an Award, notwithstanding the exercise of the Option. The Shares shall
be issued to Participant as soon as practicable after the Option is exercised in accordance with the Option Agreement. No adjustment shall be made for a dividend or other right for which the record date is prior to the date of issuance except as
provided in Section&nbsp;13 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Company&#146;s Right of First Refusal</U>. Before any Shares held by Participant or any
transferee (either being sometimes referred to herein as the &#147;Holder&#148;) may be sold or otherwise transferred (including transfer by gift or operation of law), the Company or its assignee(s) shall have a right of first refusal to purchase
the Shares on the terms and conditions set forth in this Section&nbsp;5 (the &#147;Right of First Refusal&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Notice of
Proposed Transfer</U>. The Holder of the Shares shall deliver to the Company a written notice (the &#147;Notice&#148;) stating: (i)&nbsp;the Holder&#146;s bona fide intention to sell or otherwise transfer such Shares; (ii)&nbsp;the name of each
proposed purchaser or other transferee (&#147;Proposed Transferee&#148;); (iii)&nbsp;the number of Shares to be transferred to each Proposed Transferee; and (iv)&nbsp;the bona fide cash price or other consideration for which the Holder proposes to
transfer the Shares (the &#147;Offered Price&#148;), and the Holder shall offer the Shares at the Offered Price to the Company or its assignee(s). </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Exercise of Right of First Refusal</U>. At any time within thirty&nbsp;(30) days after
receipt of the Notice, the Company and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the Proposed Transferees, at the
purchase price determined in accordance with subsection (c)&nbsp;below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Purchase Price</U>. The purchase price (&#147;Purchase
Price&#148;) for the Shares purchased by the Company or its assignee(s) under this Section&nbsp;5 shall be the Offered Price. If the Offered Price includes consideration other than cash, the cash equivalent value of the non-cash consideration shall
be determined by the Board of Directors of the Company in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U>Payment</U>. Payment of the Purchase Price shall be made, at
the option of the Company or its assignee(s), in cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company (or, in the case of repurchase by an assignee, to the assignee), or by any combination
thereof within thirty&nbsp;(30) days after receipt of the Notice or in the manner and at the times set forth in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)
<U>Holder&#146;s Right to Transfer</U>. If all of the Shares proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section&nbsp;5, then the Holder may sell
or otherwise transfer such Shares to that Proposed Transferee at the Offered Price or at a higher price, <I>provided</I> that such sale or other transfer is consummated within one hundred and twenty (120)&nbsp;days after the date of the Notice, that
any such sale or other transfer is effected in accordance with any applicable securities laws and that the Proposed Transferee agrees in writing that the provisions of this Section&nbsp;5 shall continue to apply to the Shares in the hands of such
Proposed Transferee. If the Shares described in the Notice are not transferred to the Proposed Transferee within such period, a new Notice shall be given to the Company, and the Company and/or its assignees shall again be offered the Right of First
Refusal before any Shares held by the Holder may be sold or otherwise transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <U>Exception for Certain Family Transfers</U>.
Anything to the contrary contained in this Section&nbsp;5 notwithstanding, the transfer of any or all of the Shares during the Participant&#146;s lifetime or on the Participant&#146;s death by will or intestacy to the Participant&#146;s immediate
family or a trust for the benefit of the Participant or the Participant&#146;s immediate family shall be exempt from the provisions of this Section&nbsp;5. &#147;Immediate Family&#148; as used herein shall mean spouse, lineal descendant or
antecedent, father, mother, brother or sister. In such case, the transferee or other recipient shall receive and hold the Shares so transferred subject to the provisions of this Section&nbsp;5, and there shall be no further transfer of such Shares
except in accordance with the terms of this Section&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) <U>Termination of Right of First Refusal</U>. The Right of First Refusal
shall terminate as to any Shares upon the earlier of (i)&nbsp;the first sale of Common Stock of the Company to the general public, or (ii)&nbsp;a Change in Control in which the successor corporation has equity securities that are publicly traded.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Tax Consultation</U>. Participant understands that Participant may suffer adverse tax
consequences as a result of Participant&#146;s purchase or disposition of the Shares. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection with the purchase or disposition of the
Shares and that Participant is not relying on the Company for any tax advice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Restrictive Legends and Stop-Transfer Orders</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Legends</U>. Participant understands and agrees that the Company shall cause the legends set forth below or legends substantially
equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE &#147;ACT&#148;) AND MAY NOT BE OFFERED, SOLD
OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE
THEREWITH. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND A RIGHT OF FIRST REFUSAL HELD BY
THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE EXERCISE NOTICE BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS AND RIGHT OF FIRST
REFUSAL ARE BINDING ON TRANSFEREES OF THESE SHARES. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR
A PERIOD OF TIME FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY&#146;S SECURITIES SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY
THE HOLDER PRIOR TO THE EXPIRATION OF SUCH PERIOD WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Stop-Transfer
Notices</U>. Participant agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent, if any, and that, if the Company transfers
its own securities, it may make appropriate notations to&nbsp;the same effect in its own records. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Refusal to Transfer</U>. The
Company shall not be required (i)&nbsp;to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Exercise Notice or (ii)&nbsp;to treat as owner of such Shares or to accord the
right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Successors and Assigns</U>. The Company may assign any of its rights under this Exercise
Notice to single or multiple assignees, and this Exercise Notice shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Exercise Notice shall be binding upon
Participant and his or her heirs, executors, administrators, successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Interpretation</U>. Any dispute regarding the
interpretation of this Exercise Notice shall be submitted by Participant or by the Company forthwith to the Administrator, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Administrator shall be
final and binding on all parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Governing Law; Severability</U>. This Exercise Notice is governed by the internal substantive
laws, but not the choice of law rules, of California. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Exercise Notice shall continue in full force and
effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Entire Agreement</U>. The Plan and Option Agreement are incorporated herein by reference. This Exercise Notice, the Plan,
the Option Agreement and the Investment Representation Statement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and
Participant with respect to the subject matter hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Submitted by:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Accepted by:</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Title</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Address:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Date Received</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INVESTMENT REPRESENTATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">COMPANY</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECURITY</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">COMMON STOCK</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AMOUNT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DATE</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the purchase of the above-listed Securities, the undersigned Participant represents to the
Company the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Participant is aware of the Company&#146;s business affairs and financial condition and has acquired
sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Securities. Participant is acquiring these Securities for investment for Participant&#146;s own account only and not with a view to, or for
resale in connection with, any &#147;distribution&#148; thereof within the meaning of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Participant acknowledges and understands that the Securities constitute &#147;restricted securities&#148; under the Securities Act and
have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Participant&#146;s investment intent as expressed herein. In this
connection, Participant understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if Participant&#146;s representation was predicated solely upon a present intention to hold
these Securities for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Securities, or for a period of one (1)&nbsp;year or any other fixed period in
the future. Participant further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Participant further acknowledges and
understands that the Company is under no obligation to register the Securities. Participant understands that the certificate evidencing the Securities shall be imprinted with any legend required under applicable state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Participant is familiar with the provisions of Rule&nbsp;701 and Rule&nbsp;144, each promulgated under the Securities Act, which, in
substance, permit limited public resale of &#147;restricted securities&#148; acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions. Rule&nbsp;701 provides that if the
issuer qualifies under Rule&nbsp;701 at the time of the grant of the Option to Participant, the exercise shall be exempt from registration under the Securities Act. In the event the Company becomes subject to the reporting requirements
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934, ninety&nbsp;(90) days thereafter (or such longer period as any market stand-off agreement may require) the Securities exempt
under Rule&nbsp;701 may be resold, subject to the satisfaction of the applicable conditions specified by Rule&nbsp;144, including in the case of affiliates (1)&nbsp;the availability of certain public information about the Company, (2)&nbsp;the
amount of Securities being sold during any three (3)&nbsp;month period not exceeding specified limitations, (3)&nbsp;the resale being made in an unsolicited &#147;broker&#146;s transaction&#148;, transactions directly with a &#147;market maker&#148;
or &#147;riskless principal transactions&#148; (as those terms are defined under the Securities Exchange Act of 1934) and (4)&nbsp;the timely filing of a Form&nbsp;144, if applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event that the Company does not qualify under Rule&nbsp;701 at the time of grant of the Option, then the Securities may be resold in
certain limited circumstances subject to the provisions of Rule&nbsp;144, which may require (i)&nbsp;the availability of current public information about the Company; (ii)&nbsp;the resale to occur more than a specified period after the purchase and
full payment (within the meaning of Rule&nbsp;144) for the Securities; and (iii)&nbsp;in the case of the sale of Securities by an affiliate, the satisfaction of the conditions set forth in sections&nbsp;(2), (3)&nbsp;and (4)&nbsp;of the paragraph
immediately above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Participant further understands that in the event all of the applicable requirements of Rule&nbsp;701 or 144 are
not satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption shall be required; and that, notwithstanding the fact that Rules&nbsp;144 and 701 are not exclusive, the Staff of the Securities
and Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules&nbsp;144 or 701 shall have a substantial burden of proof in
establishing that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. Participant understands that no assurances can
be given that any such other registration exemption shall be available in such event. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2011 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK OPTION AGREEMENT &#151; EARLY EXERCISE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise defined herein, the terms defined in the 2011 Equity Incentive Plan (the &#147;Plan&#148;) shall have the same defined
meanings in this Stock Option Agreement &#150; Early Exercise (the &#147;Option Agreement&#148;). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>NOTICE OF STOCK OPTION GRANT</U> </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Name: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Address: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned Participant has been granted an Option to purchase Common Stock of the Company, subject to the terms and conditions of the Plan and this Option Agreement, as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date of Grant:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vesting Commencement Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exercise Price per Share:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Number of Shares Granted:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Total Exercise Price:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Type of Option:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive&nbsp;Stock&nbsp;Option*</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nonstatutory&nbsp;Stock&nbsp;Option</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Term/Expiration Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">If stockholder approval of the Plan is not obtained in a manner required by Applicable Law, as determined by the Administrator, within twelve (12)&nbsp;months after the date the Plan is adopted by the Board, then to the
extent this is Option designated as an Incentive Stock Option, it will be treated in whole as a Nonstatutory Stock Option. In addition, if this Option is designated as an Incentive Stock Option, it may be treated in part as a Nonstatutory Stock
Option, as described in Section&nbsp;1 below. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Vesting Schedule:</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Option shall be exercisable, in whole or in part, according to the following vesting schedule: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[Twenty-five percent (25%)&nbsp;of the Shares subject to the Option shall vest on the one (1)&nbsp;year anniversary of the Vesting
Commencement Date, and one forty-eighth (1/48<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)&nbsp;of the Shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if
there is no corresponding day, on the last day of the month), subject to Participant continuing to be a Service Provider through each such date.] </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a Change in Control, and subject to Participant continuing to be a Service
Provider through the date of such Change in Control, the Participant will fully vest in and have the right to exercise all of the Shares subject to this Option. The Administrator will notify the Participant in writing or electronically that this
Option will be exercisable for a period of time determined by the Administrator in its sole discretion, and, to the extent the Administrator determines, terminate upon or immediately prior to the effectiveness of the Change in Control. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Termination Period</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
Option shall be exercisable for three (3)&nbsp;months after Participant ceases to be a Service Provider, unless such termination is due to Participant&#146;s death or Disability, in which case this Option shall be exercisable for twelve
(12)&nbsp;months after Participant ceases to be a Service Provider. Notwithstanding the foregoing sentence, in no event may this Option be exercised after the Term/Expiration Date as provided above and this Option may be subject to earlier
termination as provided in Section&nbsp;13 of the Plan. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"><B><U>AGREEMENT</U> </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Grant of Option</U>. The Administrator of the Company hereby
grants to the Participant named in the Notice of Stock Option Grant in Part I of this Agreement (&#147;Participant&#148;), an option (the &#147;Option&#148;) to purchase the number of Shares set forth in the Notice of Stock Option Grant, at the
exercise price per Share set forth in the Notice of Stock Option Grant (the &#147;Exercise Price&#148;), and subject to the terms and conditions of the Plan, which is incorporated herein by reference. Subject to Section&nbsp;18 of the Plan, in the
event of a conflict between the terms and conditions of the Plan and this Option Agreement, the terms and conditions of the Plan shall prevail. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If designated in the Notice of Stock Option Grant as an Incentive Stock Option (&#147;ISO&#148;), this Option is intended to qualify as an
Incentive Stock Option as defined in Section&nbsp;422 of the Code. Nevertheless, to the extent that it exceeds the $100,000 rule of Code Section&nbsp;422(d), this Option shall be treated as a Nonstatutory Stock Option (&#147;NSO&#148;). Further, if
for any reason this Option (or portion thereof) shall not qualify as an ISO, such as due to the stockholders of the Company not approving the Plan within twelve (12)&nbsp;months after the date the Plan is adopted by the Board, then, to the extent of
such nonqualification, such Option (or portion thereof) shall be regarded as a NSO granted under the Plan. In no event shall the Administrator, the Company or any Parent or Subsidiary or any of their respective employees or directors have any
liability to Participant (or any other person) due to the failure of the Option to qualify for any reason as an ISO. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Exercise of
Option</U>. This Option shall be exercisable during its term in accordance with the provisions of Section&nbsp;6 of the Plan as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Right to Exercise</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Subject to subsections 2(a)(ii) and 2(a)(iii) below, this Option shall be exercisable cumulatively according to the vesting schedule set
forth in the Notice of Stock Option Grant. Alternatively, at the election of Participant, this Option may be exercised in whole or in part at any time as to Shares that have not yet vested. Vested Shares shall not be subject to the Company&#146;s
repurchase right (as set forth in the Restricted Stock Purchase Agreement, attached hereto as <U>Exhibit C-1</U>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) As a condition to exercising this Option for unvested Shares, Participant shall execute the
Restricted Stock Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) This Option may not be exercised for a fraction of a Share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Method of Exercise</U>. This Option shall be exercisable by delivery of an exercise notice in the form attached as <U>Exhibit A</U>
(the &#147;Exercise Notice&#148;) or in a manner and pursuant to such procedures as the Administrator may determine, which shall state the election to exercise the Option, the number of Shares with respect to which the Option is being exercised (the
&#147;Exercised Shares&#148;), and such other representations and agreements as may be required by the Company. The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares, together with any
applicable tax withholding. This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the aggregate Exercise Price, together with any applicable tax withholding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No Shares shall be issued pursuant to the exercise of an Option unless such issuance and such exercise comply with Applicable Laws. Assuming
such compliance, for income tax purposes the Shares shall be considered transferred to Participant on the date on which the Option is exercised with respect to such Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Participant&#146;s Representations</U>. In the event the Shares have not been registered under the Securities Act of 1933, as amended
(the &#147;Securities Act&#148;), at the time this Option is exercised, Participant shall, if required by the Company, concurrently with the exercise of all or any portion of this Option, deliver to the Company his or her Investment Representation
Statement in the form attached hereto as <U>Exhibit B</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Lock-Up Period</U>. Participant hereby agrees that Participant shall not
offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Common
Stock (or other securities) of the Company or enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any Common Stock (or other securities) of the Company
held by Participant (other than those included in the registration) for a period specified by the representative of the underwriters of Common Stock (or other securities) of the Company not to exceed one hundred and eighty (180)&nbsp;days following
the effective date of any registration statement of the Company filed under the Securities Act (or such other period as may be requested by the Company or the underwriters to accommodate regulatory restrictions on (i)&nbsp;the publication or other
distribution of research reports and (ii)&nbsp;analyst recommendations and opinions, including, but not limited to, the restrictions contained in NASD Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Participant agrees to execute and deliver such other agreements as may be reasonably requested by
the Company or the underwriter which are consistent with the foregoing or which are necessary to give further effect thereto. In addition, if requested by the Company or the representative of the underwriters of Common Stock (or other securities) of
the Company, Participant shall provide, within ten (10)&nbsp;days of such request, such information as may be required by the Company or such representative in connection with the completion of any public offering of the Company&#146;s securities
pursuant to a registration statement filed under the Securities Act. The obligations described in this Section&nbsp;4 shall not apply to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or similar forms that may be
promulgated in the future, or a registration relating solely to a Commission Rule 145 transaction on Form S-4 or similar forms that may be promulgated in the future. The Company may impose stop-transfer instructions with respect to the shares of
Common Stock (or other securities) subject to the foregoing restriction until the end of said one hundred and eighty (180)&nbsp;day (or other) period. Participant agrees that any transferee of the Option or shares acquired pursuant to the Option
shall be bound by this Section&nbsp;4. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Method of Payment</U>. Payment of the aggregate Exercise Price shall be by any of the
following, or a combination thereof, at the election of the Participant: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) cash; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) check; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) consideration
received by the Company under a formal cashless exercise program adopted by the Company in connection with the Plan; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) surrender of
other Shares which (i)&nbsp;shall be valued at its Fair Market Value on the date of exercise, and (ii)&nbsp;must be owned free and clear of any liens, claims, encumbrances or security interests, if accepting such Shares, in the sole discretion of
the Administrator, shall not result in any adverse accounting consequences to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Restrictions on Exercise</U>. This
Option may not be exercised if the issuance of such Shares upon such exercise or the method of payment of consideration for such shares would constitute a violation of any Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Non-Transferability of Option</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may be exercised
during the lifetime of Participant only by Participant. The terms of the Plan and this Option Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Further, until the Company becomes subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act, or after the
Administrator determines that it is, will, or may no longer be relying upon the exemption from registration of Options under the Exchange Act as set forth in Rule 12h-1(f) promulgated under the Exchange Act (the &#147;Reliance End Date&#148;),
Participant shall not transfer this Option or, prior to exercise, the Shares subject to this Option, in any manner other than (i)&nbsp;to persons who are &#147;family members&#148; (as defined in Rule 701(c)(3) of the Securities Act) through gifts
or domestic relations orders, or (ii)&nbsp;to an executor or guardian of Participant upon </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the death or disability of Participant. Until the Reliance End Date, the Options and, prior to exercise, the Shares subject to this Option, may not be pledged, hypothecated or otherwise
transferred or disposed of, including by entering into any short position, any &#147;put equivalent position&#148; or any &#147;call equivalent position&#148; (as defined in Rule 16a-1(h) and Rule 16a-1(b) of the Exchange Act, respectively), other
than as permitted in clauses (i)&nbsp;and (ii)&nbsp;of this paragraph. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Term of Option</U>. This Option may be exercised only within
the term set out in the Notice of Stock Option Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Option Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Tax Obligations</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a)
<U>Tax Withholding</U>. Participant agrees to make appropriate arrangements with the Company (or the Parent or Subsidiary employing or retaining Participant) for the satisfaction of all Federal, state, local and foreign income and employment tax
withholding requirements applicable to the Option exercise. Participant acknowledges and agrees that the Company may refuse to honor the exercise and refuse to deliver the Shares if such withholding amounts are not delivered at the time of exercise.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Notice of Disqualifying Disposition of ISO Shares</U>. If the Option granted to Participant herein is an ISO, and if Participant
sells or otherwise disposes of any of the Shares acquired pursuant to the ISO on or before the later of (i)&nbsp;the date two (2)&nbsp;years after the Date of Grant, or (ii)&nbsp;the date one (1)&nbsp;year after the date of exercise, Participant
shall immediately notify the Company in writing of such disposition. Participant agrees that Participant may be subject to income tax withholding by the Company on the compensation income recognized by Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Code Section&nbsp;409A</U>. Under Code Section&nbsp;409A, an Option that vests after December&nbsp;31, 2004 (or that vested on or prior
to such date but which was materially modified after October&nbsp;3, 2004) that was granted with a per Share exercise price that is determined by the Internal Revenue Service (the &#147;IRS&#148;) to be less than the Fair Market Value of a Share on
the date of grant (a &#147;discount option&#148;) may be considered &#147;deferred compensation.&#148; An Option that is a &#147;discount option&#148; may result in (i)&nbsp;income recognition by Participant prior to the exercise of the Option,
(ii)&nbsp;an additional twenty percent (20%)&nbsp;federal income tax, and (iii)&nbsp;potential penalty and interest charges. The &#147;discount option&#148; may also result in additional state income, penalty and interest tax to the Participant.
Participant acknowledges that the Company cannot and has not guaranteed that the IRS will agree that the per Share exercise price of this Option equals or exceeds the Fair Market Value of a Share on the date of grant in a later examination.
Participant agrees that if the IRS determines that the Option was granted with a per Share exercise price that was less than the Fair Market Value of a Share on the date of grant, Participant shall be solely responsible for Participant&#146;s costs
related to such a determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Entire Agreement; Governing Law</U>. The Plan is incorporated herein by reference. The Plan and
this Option Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter
hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. This Option Agreement is governed by the internal substantive laws but not the choice of law rules of
California. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>No Guarantee of Continued Service</U>. PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE
VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING PARTICIPANT) AND NOT THROUGH THE ACT OF BEING HIRED, BEING
GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF
CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH PARTICIPANT&#146;S RIGHT OR THE RIGHT OF THE COMPANY (OR THE PARENT OR SUBSIDIARY EMPLOYING OR RETAINING
PARTICIPANT) TO TERMINATE PARTICIPANT&#146;S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participant acknowledges receipt of a copy of the Plan and represents that he or she is familiar
with the terms and provisions thereof, and hereby accepts this Option subject to all of the terms and provisions thereof. Participant has reviewed the Plan and this Option in their entirety, has had an opportunity to obtain the advice of counsel
prior to executing this Option and fully understands all provisions of the Option. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan
or this Option. Participant further agrees to notify the Company upon any change in the residence address indicated below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Title</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Residence Address</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2011 EQUITY INCENTIVE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXERCISE NOTICE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alameda, CA 94502 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Treasurer </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Exercise of
Option</U>. Effective as of today, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, the undersigned (&#147;Participant&#148;) hereby elects to exercise Participant&#146;s
option (the &#147;Option&#148;) to purchase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of the Common Stock (the &#147;Shares&#148;) of Penumbra, Inc. (the &#147;Company&#148;) under and
pursuant to the 2011 Equity Incentive Plan (the &#147;Plan&#148;) and the Stock Option Agreement &#150; Early Exercise dated, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
(the &#147;Option Agreement&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Delivery of Payment</U>. Participant herewith delivers to the Company the full purchase price
of the Shares, as set forth in the Option Agreement, and any and all withholding taxes due in connection with the exercise of the Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations of Participant</U>. Participant acknowledges that Participant has received, read and understood the Plan and the Option
Agreement and agrees to abide by and be bound by their terms and conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Rights as Stockholder</U>. Until the issuance of the
Shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to the Common Stock
subject to an Award, notwithstanding the exercise of the Option. The Shares shall be issued to Participant as soon as practicable after the Option is exercised in accordance with the Option Agreement. No adjustment shall be made for a dividend or
other right for which the record date is prior to the date of issuance except as provided in Section&nbsp;13 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.
<U>Company&#146;s Right of First Refusal</U>. Before any Shares held by Participant or any transferee (either being sometimes referred to herein as the &#147;Holder&#148;) may be sold or otherwise transferred (including transfer by gift or operation
of law), the Company or its assignee(s) shall have a right of first refusal to purchase the Shares on the terms and conditions set forth in this Section&nbsp;5 (the &#147;Right of First Refusal&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Notice of Proposed Transfer</U>. The Holder of the Shares shall deliver to the Company a written notice (the &#147;Notice&#148;)
stating: (i)&nbsp;the Holder&#146;s bona fide intention to sell or otherwise transfer such Shares; (ii)&nbsp;the name of each proposed purchaser or other transferee (&#147;Proposed Transferee&#148;); (iii)&nbsp;the number of Shares to be transferred
to each Proposed Transferee; and (iv)&nbsp;the bona fide cash price or other consideration for which the Holder proposes to transfer the Shares (the &#147;Offered Price&#148;), and the Holder shall offer the Shares at the Offered Price to the
Company or its assignee(s). </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Exercise of Right of First Refusal</U>. At any time within thirty (30)&nbsp;days after
receipt of the Notice, the Company and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the Proposed Transferees, at the
purchase price determined in accordance with subsection&nbsp;(c) below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Purchase Price</U>. The purchase price (&#147;Purchase
Price&#148;) for the Shares purchased by the Company or its assignee(s) under this Section&nbsp;5 shall be the Offered Price. If the Offered Price includes consideration other than cash, the cash equivalent value of the non-cash consideration shall
be determined by the Board of Directors of the Company in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U>Payment</U>. Payment of the Purchase Price shall be made, at
the option of the Company or its assignee(s), in cash (by check), by cancellation of all or a portion of any outstanding indebtedness of the Holder to the Company (or, in the case of repurchase by an assignee, to the assignee), or by any combination
thereof within thirty (30)&nbsp;days after receipt of the Notice or in the manner and at the times set forth in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e)
<U>Holder&#146;s Right to Transfer</U>. If all of the Shares proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section&nbsp;5, then the Holder may sell
or otherwise transfer such Shares to that Proposed Transferee at the Offered Price or at a higher price, provided that such sale or other transfer is consummated within one hundred and twenty (120)&nbsp;days after the date of the Notice, that any
such sale or other transfer is effected in accordance with any applicable securities laws and that the Proposed Transferee agrees in writing that the provisions of this Section&nbsp;5 shall continue to apply to the Shares in the hands of such
Proposed Transferee. If the Shares described in the Notice are not transferred to the Proposed Transferee within such period, a new Notice shall be given to the Company, and the Company and/or its assignees shall again be offered the Right of First
Refusal before any Shares held by the Holder may be sold or otherwise transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <U>Exception for Certain Family Transfers</U>.
Anything to the contrary contained in this Section&nbsp;5 notwithstanding, the transfer of any or all of the Shares during the Participant&#146;s lifetime or on the Participant&#146;s death by will or intestacy to the Participant&#146;s immediate
family or a trust for the benefit of the Participant or the Participant&#146;s immediate family shall be exempt from the provisions of this Section&nbsp;5. &#147;Immediate Family&#148; as used herein shall mean spouse, lineal descendant or
antecedent, father, mother, brother or sister. In such case, the transferee or other recipient shall receive and hold the Shares so transferred subject to the provisions of this Section&nbsp;5, and there shall be no further transfer of such Shares
except in accordance with the terms of this Section&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) <U>Termination of Right of First Refusal</U>. The Right of First Refusal
shall terminate as to any Shares upon the earlier of (i)&nbsp;the first sale of Common Stock of the Company to the general public, or (ii)&nbsp;a Change in Control in which the successor corporation has equity securities that are publicly traded.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Tax Consultation</U>. Participant understands that Participant may suffer adverse tax consequences as a result of
Participant&#146;s purchase or disposition of the Shares. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection with the purchase or disposition of the Shares and that Participant is
not relying on the Company for any tax advice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Restrictive Legends and Stop-Transfer Orders</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U>Legends</U>. Participant understands and agrees that the Company shall cause the legends set forth below or legends substantially
equivalent thereto, to be placed upon any certificate(s) evidencing ownership of the Shares together with any other legends that may be required by the Company or by state or federal securities laws: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE &#147;ACT&#148;) AND MAY NOT BE OFFERED, SOLD
OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER THE ACT OR, IN THE OPINION OF COUNSEL SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE
THEREWITH. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON TRANSFER AND A RIGHT OF FIRST REFUSAL HELD BY
THE ISSUER OR ITS ASSIGNEE(S) AS SET FORTH IN THE EXERCISE NOTICE BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH TRANSFER RESTRICTIONS AND RIGHT OF FIRST
REFUSAL ARE BINDING ON TRANSFEREES OF THESE SHARES. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO RESTRICTIONS ON TRANSFER FOR
A PERIOD OF TIME FOLLOWING THE EFFECTIVE DATE OF THE UNDERWRITTEN PUBLIC OFFERING OF THE COMPANY&#146;S SECURITIES SET FORTH IN AN AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES AND MAY NOT BE SOLD OR OTHERWISE DISPOSED OF BY
THE HOLDER PRIOR TO THE EXPIRATION OF SUCH PERIOD WITHOUT THE CONSENT OF THE COMPANY OR THE MANAGING UNDERWRITER. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U>Stop-Transfer
Notices</U>. Participant agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate &#147;stop transfer&#148; instructions to its transfer agent, if any, and that, if the Company transfers
its own securities, it may make appropriate notations to the same effect in its own records. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U>Refusal to Transfer</U>. The Company
shall not be required (i)&nbsp;to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Exercise Notice or (ii)&nbsp;to treat as owner of such Shares or to accord the right to
vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Successors and
Assigns</U>. The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and this Exercise Notice shall inure to the benefit of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Exercise Notice shall be binding upon Participant and his or her heirs, executors,
administrators, successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Interpretation</U>. Any dispute regarding the interpretation of this Exercise Notice shall
be submitted by Participant or by the Company forthwith to the Administrator, which shall review such dispute at its next regular meeting. The resolution of such a dispute by the Administrator shall be final and binding on all parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Governing Law; Severability</U>. This Exercise Notice is governed by the internal substantive laws, but not the choice of law rules, of
California. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Exercise Notice shall continue in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Entire Agreement</U>. The Plan and Option Agreement are incorporated herein by reference. This Exercise Notice, the Plan, the
Restricted Stock Purchase Agreement, the Option Agreement and the Investment Representation Statement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and
agreements of the Company and Participant with respect to the subject matter hereof, and may not be modified adversely to the Participant&#146;s interest except by means of a writing signed by the Company and Participant. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Submitted by:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">PARTICIPANT</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted by:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">PENUMBRA, INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Title</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Address:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Date Received</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INVESTMENT REPRESENTATION STATEMENT </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="81%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">COMPANY</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SECURITY</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">COMMON STOCK</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">AMOUNT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DATE</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the purchase of the above-listed Securities, the undersigned Participant represents to the Company the
following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Participant is aware of the Company&#146;s business affairs and financial condition and has acquired sufficient
information about the Company to reach an informed and knowledgeable decision to acquire the Securities. Participant is acquiring these Securities for investment for Participant&#146;s own account only and not with a view to, or for resale in
connection with, any &#147;distribution&#148; thereof within the meaning of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Participant acknowledges and understands that the Securities constitute &#147;restricted securities&#148; under the Securities Act and
have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Participant&#146;s investment intent as expressed herein. In this
connection, Participant understands that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if Participant&#146;s representation was predicated solely upon a present intention to hold
these Securities for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Securities, or for a period of one (1)&nbsp;year or any other fixed period in
the future. Participant further understands that the Securities must be held indefinitely unless they are subsequently registered under the Securities Act or an exemption from such registration is available. Participant further acknowledges and
understands that the Company is under no obligation to register the Securities. Participant understands that the certificate evidencing the Securities shall be imprinted with any legend required under applicable state securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Participant is familiar with the provisions of Rule 701 and Rule 144, each promulgated under the Securities Act, which, in substance,
permit limited public resale of &#147;restricted securities&#148; acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions. Rule 701 provides that if the issuer qualifies
under Rule 701 at the time of the grant of the Option to Participant, the exercise shall be exempt from registration under the Securities Act. In the event the Company becomes subject to the reporting requirements of Section&nbsp;13 or 15(d) of the
Securities Exchange Act of 1934, ninety (90)&nbsp;days thereafter (or such longer period as any market stand-off agreement may require) the Securities exempt under Rule 701 may be resold, subject to the satisfaction of the applicable conditions
specified by Rule 144, </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including in the case of affiliates (1)&nbsp;the availability of certain public information about the Company, (2)&nbsp;the amount of Securities being sold during any three (3)&nbsp;month period
not exceeding specified limitations, (3)&nbsp;the resale being made in an unsolicited &#147;broker&#146;s transaction&#148;, transactions directly with a &#147;market maker&#148; or &#147;riskless principal transactions&#148; (as those terms are
defined under the Securities Exchange Act of 1934) and (4)&nbsp;the timely filing of a Form 144, if applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event that the
Company does not qualify under Rule 701 at the time of grant of the Option, then the Securities may be resold in certain limited circumstances subject to the provisions of Rule 144, which may require (i)&nbsp;the availability of current public
information about the Company; (ii)&nbsp;the resale to occur more than a specified period after the purchase and full payment (within the meaning of Rule 144) for the Securities; and (iii)&nbsp;in the case of the sale of Securities by an affiliate,
the satisfaction of the conditions set forth in sections (2), (3)&nbsp;and (4)&nbsp;of the paragraph immediately above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Participant
further understands that in the event all of the applicable requirements of Rule 701 or 144 are not satisfied, registration under the Securities Act, compliance with Regulation A, or some other registration exemption shall be required; and that,
notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and Exchange Commission has expressed its opinion that persons proposing to sell private placement securities other than in a registered offering and
otherwise than pursuant to Rules 144 or 701 shall have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales, and that such persons and their respective brokers who participate in
such transactions do so at their own risk. Participant understands that no assurances can be given that any such other registration exemption shall be available in such event. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C-1 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2011
EQUITY INCENTIVE PLAN </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTRICTED STOCK PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS RESTRICTED STOCK PURCHASE AGREEMENT (the &#147;Agreement&#148;) is made between
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (the
&#147;Purchaser&#148;) and Penumbra, Inc. (the &#147;Company&#148;) or its assignees of rights hereunder as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise defined herein, the terms defined in the 2011 Equity Incentive Plan shall have the same defined meanings in this Agreement.
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>RECITALS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A.
Pursuant to the exercise of the option (grant number &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;) granted to Purchaser under the Plan and pursuant to the Stock Option Agreement &#150; Early Exercise (the &#147;Option Agreement&#148;) dated
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; by and between the Company and Purchaser with respect to such grant (the &#147;Option&#148;), which Plan and Option Agreement
are hereby incorporated by reference, Purchaser has elected to purchase &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of those shares of Common Stock which have not become vested under the vesting
schedule set forth in the Option Agreement (&#147;Unvested Shares&#148;). The Unvested Shares and the shares subject to the Option Agreement, which have become vested are sometimes collectively referred to herein as the &#147;Shares.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. As required by the Option Agreement, as a condition to Purchaser&#146;s election to exercise the option, Purchaser must execute this
Agreement, which sets forth the rights and obligations of the parties with respect to Shares acquired upon exercise of the Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.
<U>Repurchase Option</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) If Purchaser&#146;s status as a Service Provider is terminated for any reason, including for death and
Disability, the Company shall have the right and option for ninety (90)&nbsp;days from such date to purchase from Purchaser, or Purchaser&#146;s personal representative, as the case may be, all of the Purchaser&#146;s Unvested Shares as of the date
of such termination at the price paid by the Purchaser for such Shares (the &#147;Repurchase Option&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Upon the occurrence of
such termination, the Company may exercise its Repurchase Option by delivering personally or by registered mail, to Purchaser (or his or her transferee or legal representative, as the case may be) with a copy to the escrow agent described in
Section&nbsp;2 below, a notice in writing indicating the Company&#146;s intention to exercise the Repurchase Option AND, at the Company&#146;s option, (i)&nbsp;by delivering to the Purchaser (or the Purchaser&#146;s transferee or legal
representative) a check in the amount of the aggregate repurchase price, or (ii)&nbsp;by the Company canceling an amount of the Purchaser&#146;s indebtedness to the Company equal to the aggregate repurchase price, or (iii)&nbsp;by a combination of
(i)&nbsp;and (ii)&nbsp;so that the combined payment and cancellation of indebtedness equals such aggregate repurchase price. Upon delivery of such notice and payment of the aggregate repurchase price in any of the ways described above, the Company
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall become the legal and beneficial owner of the Unvested Shares being repurchased and the rights and interests therein or relating thereto, and the Company shall have the right to retain and
transfer to its own name the number of Unvested Shares being repurchased by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Whenever the Company shall have the right to
repurchase Unvested Shares hereunder, the Company may designate and assign one or more employees, officers, directors or stockholders of the Company or other persons or organizations to exercise all or a part of the Company&#146;s Repurchase Option
under this Agreement and purchase all or a part of such Unvested Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) If the Company does not elect to exercise the Repurchase
Option conferred above by giving the requisite notice within ninety (90)&nbsp;days following the termination, the Repurchase Option shall terminate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) The Repurchase Option shall terminate in accordance with the vesting schedule contained in Purchaser&#146;s Option Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Transferability of the Shares; Escrow</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Purchaser hereby authorizes and directs the Secretary of the Company, or such other person designated by the Company, to transfer the
Unvested Shares as to which the Repurchase Option has been exercised from Purchaser to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) To insure the availability for
delivery of Purchaser&#146;s Unvested Shares upon repurchase by the Company pursuant to the Repurchase Option under Section&nbsp;1, Purchaser hereby appoints the Secretary, or any other person designated by the Company as escrow agent (the
&#147;Escrow Agent&#148;), as its attorney-in-fact to sell, assign and transfer unto the Company, such Unvested Shares, if any, repurchased by the Company pursuant to the Repurchase Option and shall, upon execution of this Agreement, deliver and
deposit with the Escrow Agent, the share certificates representing the Unvested Shares, together with the stock assignment duly endorsed in blank, attached hereto as <U>Exhibit C-2</U>. The Unvested Shares and stock assignment shall be held by the
Escrow Agent in escrow, pursuant to the Joint Escrow Instructions of the Company and Purchaser attached as <U>Exhibit C-3</U> hereto, until the Company exercises its Repurchase Option, until such Unvested Shares are vested, or until such time as
this Agreement no longer is in effect. Upon vesting of the Unvested Shares, the Escrow Agent shall promptly deliver to the Purchaser the certificate or certificates representing such Shares in the Escrow Agent&#146;s possession belonging to the
Purchaser, and the Escrow Agent shall be discharged of all further obligations hereunder; provided, however, that the Escrow Agent shall nevertheless retain such certificate or certificates as Escrow Agent if so required pursuant to other
restrictions imposed pursuant to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) Neither the Company nor the Escrow Agent shall be liable for any act it may do or
omit to do with respect to holding the Shares in escrow and while acting in good faith and in the exercise of its judgment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) Transfer
or sale of the Shares is subject to restrictions on transfer imposed by any applicable state and federal securities laws. Any transferee shall hold such Shares subject to all the provisions hereof and the Exercise Notice executed by the Purchaser
with respect to any Unvested Shares purchased by Purchaser and shall acknowledge the same by signing a copy of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Ownership, Voting Rights, Duties</U>. This Agreement shall not affect in any way the
ownership, voting rights or other rights or duties of Purchaser, except as specifically provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Legends</U>. The share
certificate evidencing the Shares issued hereunder shall be endorsed with the following legend (in addition to any legend required under applicable federal and state securities laws): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS UPON TRANSFER AND RIGHTS OF REPURCHASE AS SET FORTH IN AN
AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Adjustment for
Stock Split</U>. All references to the number of Shares and the purchase price of the Shares in this Agreement shall be appropriately adjusted to reflect any stock split, stock dividend or other change in the Shares, which may be made by the Company
pursuant to Section&nbsp;13 of the Plan after the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Notices</U>. Notices required hereunder shall be given in
person or by registered mail to the address of Purchaser shown on the records of the Company, and to the Company at their respective principal executive offices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Survival of Terms</U>. This Agreement shall apply to and bind Purchaser and the Company and their respective permitted assignees and
transferees, heirs, legatees, executors, administrators and legal successors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Section&nbsp;83(b) Election</U>. Purchaser hereby
acknowledges that he or she has been informed that, with respect to the exercise of an Option for Unvested Shares, an election (the &#147;Election&#148;) may be filed by the Purchaser with the Internal Revenue Service, within thirty (30)&nbsp;days
of the purchase of the exercised Shares, electing pursuant to Section&nbsp;83(b) of the Code to be taxed currently on any difference between the purchase price of the exercised Shares and their Fair Market Value on the date of purchase. In the case
of a Nonstatutory Stock Option, this will result in the recognition of taxable income to the Purchaser on the date of exercise, measured by the excess, if any, of the Fair Market Value of the exercised Shares, at the time the Option is exercised
over the purchase price for the exercised Shares. Absent such an Election, taxable income will be measured and recognized by Purchaser at the time or times on which the Company&#146;s Repurchase Option lapses. In the case of an Incentive Stock
Option, such an Election will result in a recognition of income to the Purchaser for alternative minimum tax purposes on the date of exercise, measured by the excess, if any, of the Fair Market Value of the exercised Shares, at the time the option
is exercised, over the purchase price for the exercised Shares. Absent such an Election, alternative minimum taxable income will be measured and recognized by Purchaser at the time or times on which the Company&#146;s Repurchase Option lapses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This discussion is intended only as a summary of the general United States income tax laws that
apply to exercising Options as to Shares that have not yet vested and is accurate only as of the date this form Agreement was approved by the Board. The federal, state and local tax consequences to any particular taxpayer will depend upon his or her
individual circumstances. Purchaser is strongly encouraged to seek the advice of his or her own tax consultants in connection with the purchase of the Shares and the advisability of filing of the Election under Section&nbsp;83(b) of the Code. A form
of Election under Section&nbsp;83(b) is attached hereto as <U>Exhibit C-4</U> for reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">PURCHASER ACKNOWLEDGES THAT IT IS
PURCHASER&#146;S SOLE RESPONSIBILITY AND NOT THE COMPANY&#146;S TO FILE TIMELY THE ELECTION UNDER SECTION 83(b) OF THE CODE, EVEN IF PURCHASER REQUESTS THE COMPANY OR ITS REPRESENTATIVE TO MAKE THIS FILING ON PURCHASER&#146;S BEHALF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Representations</U>. Purchaser has reviewed with his or her own tax advisors the federal, state, local and foreign tax consequences of
this investment and the transactions contemplated by this Agreement. Purchaser is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. Purchaser understands that he or she (and not the
Company) shall be responsible for his or her own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Entire Agreement; Governing Law</U>. The Plan and Option Agreement are incorporated herein by reference. The Plan, the Option
Agreement, the Exercise Notice, this Agreement, and the Investment Representation Statement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and
agreements of the Company and Purchaser with respect to the subject matter hereof, and may not be modified adversely to the Purchaser&#146;s interest except by means of a writing signed by the Company and Purchaser. This Agreement is governed by the
internal substantive laws but not the choice of law rules of California. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Purchaser represents that he or she has read this Agreement and
is familiar with its terms and provisions. Purchaser hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Board upon any questions arising under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, this Agreement is deemed made as of the date first set forth above. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PARTICIPANT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print Name</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Title</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Residence Address</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C-2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT SEPARATE FROM CERTIFICATE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED I,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, hereby sell, assign and
transfer unto Penumbra, Inc. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of the Common Stock of Penumbra, Inc. standing in my name of the books of said corporation represented by
Certificate No. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; herewith and do hereby irrevocably constitute and appoint
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to
transfer the said stock on the books of the within named corporation with full power of substitution in the premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Stock
Assignment may be used only in accordance with the Restricted Stock Purchase Agreement between Penumbra, Inc. and the undersigned dated &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (the &#147;Agreement&#148;). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Signature:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">INSTRUCTIONS: Please do not fill in any blanks other than the signature line. The purpose of this assignment
is to enable the Company to exercise its &#147;repurchase option,&#148; as set forth in the Agreement, without requiring additional signatures on the part of the Purchaser. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C-3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>JOINT ESCROW INSTRUCTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Corporate Secretary </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alameda, CA 94502 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; : </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As Escrow Agent for both Penumbra, Inc. (the &#147;Company&#148;), and the undersigned purchaser of stock of the Company (the
&#147;Purchaser&#148;), you are hereby authorized and directed to hold the documents delivered to you pursuant to the terms of that certain Restricted Stock Purchase Agreement (the &#147;Agreement&#148;) between the Company and the undersigned, in
accordance with the following instructions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. In the event the Company and/or any assignee of the Company (referred to collectively for
convenience herein as the &#147;Company&#148;) exercises the Company&#146;s repurchase option set forth in the Agreement, the Company shall give to Purchaser and you a written notice specifying the number of shares of stock to be purchased, the
purchase price, and the time for a closing hereunder at the principal office of the Company. Purchaser and the Company hereby irrevocably authorize and direct you to close the transaction contemplated by such notice in accordance with the terms of
said notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. At the closing, you are directed (a)&nbsp;to date the stock assignments necessary for the transfer in question,
(b)&nbsp;to fill in the number of shares being transferred, and (c)&nbsp;to deliver the stock assignments, together with the certificate evidencing the shares of stock to be transferred, to the Company or its assignee, against the simultaneous
delivery to you of the purchase price (by cash, a check, or some combination thereof) for the number of shares of stock being purchased pursuant to the exercise of the Company&#146;s repurchase option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Purchaser irrevocably authorizes the Company to deposit with you any certificates evidencing shares of stock to be held by you hereunder
and any additions and substitutions to said shares as defined in the Agreement. Purchaser does hereby irrevocably constitute and appoint you as Purchaser&#146;s attorney-in-fact and agent for the term of this escrow to execute with respect to such
securities all documents necessary or appropriate to make such securities negotiable and to complete any transaction herein contemplated, including but not limited to the filing with any applicable state blue sky authority of any required
applications for consent to, or notice of transfer of, the securities. Subject to the provisions of this paragraph 3, Purchaser shall exercise all rights and privileges of a stockholder of the Company while the stock is held by you. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Upon written request of the Purchaser, but no more than once per calendar year, unless the Company&#146;s repurchase option has been
exercised, you shall deliver to Purchaser a </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certificate or certificates representing so many shares of stock as are not then subject to the Company&#146;s repurchase option. Within one hundred and twenty (120)&nbsp;days after cessation of
Purchaser&#146;s continuous employment by or services to the Company, or any parent or subsidiary of the Company, you shall deliver to Purchaser a certificate or certificates representing the aggregate number of shares held or issued pursuant to the
Agreement and not purchased by the Company or its assignees pursuant to exercise of the Company&#146;s repurchase option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. If at the
time of termination of this escrow you should have in your possession any documents, securities, or other property belonging to Purchaser, you shall deliver all of the same to Purchaser and shall be discharged of all further obligations hereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. Your duties hereunder may be altered, amended, modified or revoked only by a writing signed by all of the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. You shall be obligated only for the performance of such duties as are specifically set forth herein and may rely and shall be protected in
relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You shall not be personally liable for any act you may do or omit to do hereunder as
Escrow Agent or as attorney-in-fact for Purchaser while acting in good faith, and any act done or omitted by you pursuant to the advice of your own attorneys shall be conclusive evidence of such good faith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. You are hereby expressly authorized to disregard any and all warnings given by any of the parties hereto or by any other person or
corporation, excepting only orders or process of courts of law and are hereby expressly authorized to comply with and obey orders, judgments or decrees of any court. In case you obey or comply with any such order, judgment or decree, you shall not
be liable to any of the parties hereto or to any other person, firm or corporation by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently reversed, modified, annulled, set aside, vacated or found to have
been entered without jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. You shall not be liable in any respect on account of the identity, authorities or rights of the
parties executing or delivering or purporting to execute or deliver the Agreement or any documents or papers deposited or called for hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. You shall not be liable for the outlawing of any rights under the Statute of Limitations with respect to these Joint Escrow Instructions
or any documents deposited with you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. You shall be entitled to employ such legal counsel and other experts as you may deem necessary
properly to advise you in connection with your obligations hereunder, may rely upon the advice of such counsel, and may pay such counsel reasonable compensation therefor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. Your responsibilities as Escrow Agent hereunder shall terminate if you shall cease to be an officer or agent of the Company or if you
shall resign by written notice to each party. In the event of any such termination, the Company shall appoint a successor Escrow Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. If you reasonably require other or further instruments in connection with these Joint Escrow Instructions or obligations in respect
hereto, the necessary parties hereto shall join in furnishing such instruments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. It is understood and agreed that should any dispute arise with respect to the delivery and/or
ownership or right of possession of the securities held by you hereunder, you are authorized and directed to retain in your possession without liability to anyone all or any part of said securities until such disputes shall have been settled either
by mutual written agreement of the parties concerned or by a final order, decree or judgment of a court of competent jurisdiction after the time for appeal has expired and no appeal has been perfected, but you shall be under no duty whatsoever to
institute or defend any such proceedings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. Any notice required or permitted hereunder shall be given in writing and shall be deemed
effectively given upon personal delivery or upon deposit in the United States Post Office, by registered or certified mail with postage and fees prepaid, addressed to each of the other parties thereunto entitled at the following addresses or at such
other addresses as a party may designate by ten (10)&nbsp;days&#146; advance written notice to each of the other parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. By
signing these Joint Escrow Instructions, you become a party hereto only for the purpose of said Joint Escrow Instructions; you do not become a party to the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. This instrument shall be binding upon and inure to the benefit of the parties hereto, and their respective successors and permitted
assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. These Joint Escrow Instructions shall be governed by the internal substantive laws, but not the choice of law rules, of
California. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PURCHASER</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Signature</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">By</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Print Name</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Print Name</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Title</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Residence Address:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ESCROW AGENT</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Corporate Secretary</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT C-4 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELECTION UNDER SECTION 83(b) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF THE INTERNAL REVENUE CODE OF 1986 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
undersigned taxpayer hereby elects, pursuant to Sections 55 and 83(b) of the Internal Revenue Code of 1986, as amended, to include in taxpayer&#146;s gross income or alternative minimum taxable income, as the case may be, for the current taxable
year the amount of any compensation taxable to taxpayer in connection with taxpayer&#146;s receipt of the property described below. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top">The name, address, taxpayer identification number and taxable year of the undersigned are as follows: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="38%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">TAXPAYER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">SPOUSE</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NAME:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ADDRESS:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TAX&nbsp;ID&nbsp;NO.:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TAXABLE&nbsp;YEAR:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><U> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top">The property with respect to which the election is made is described as follows: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares (the &#147;Shares&#148;) of the
Common Stock of Penumbra, Inc. (the &#147;Company&#148;). </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top">The date on which the property was transferred is: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top">The property is subject to the following restrictions: </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Shares may not be transferred and
are subject to forfeiture under the terms of an agreement between the taxpayer and the Company. These restrictions lapse upon the satisfaction of certain conditions contained in such agreement. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top">The Fair Market Value at the time of transfer, determined without regard to any restriction other than a restriction which by its terms shall never lapse, of such property is:
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top">The amount (if any) paid for such property is: $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
undersigned has submitted a copy of this statement to the person for whom the services were performed in connection with the undersigned&#146;s receipt of the above-described property. The transferee of such property is the person performing the
services in connection with the transfer of said property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>The undersigned understands that the foregoing election may not be revoked except with the
consent of the Commissioner</U>. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Taxpayer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned spouse of taxpayer joins in this election. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Spouse of Taxpayer</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>11
<FILENAME>filename11.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.7</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.7 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2005
STOCK PLAN </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(As Amended and Restated Through December&nbsp;20, 2010) </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>E<SMALL>STABLISHMENT</SMALL>, P<SMALL>URPOSE</SMALL> <SMALL>AND</SMALL> T<SMALL>ERM</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL></B><SMALL></SMALL></U><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.1 <B>Establishment</B>. Penumbra, Inc. 2005 Stock Plan (the &#147;<B><I>Plan</I></B>&#148;) is hereby established effective as of
January&nbsp;1, 2005. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.2 <B>Purpose</B>. The purpose of the Plan is to advance the interests of the Participating Company Group and its
stockholders by providing an incentive to attract, retain and reward persons performing services for the Participating Company Group and by motivating such persons to contribute to the growth and profitability of the Participating Company Group.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">1.3 <B>Term of Plan</B>. The Plan shall continue in effect until the earlier of its termination by the Board or the date on which all of
the shares of Stock available for issuance under the Plan have been issued and all restrictions on such shares under the terms of the Plan and the agreements evidencing Awards granted under the Plan have lapsed. However, all Awards&nbsp;shall be
granted, if at all, within ten (10)&nbsp;years from the earlier of the date the Plan is adopted by the Board or the date the Plan is duly approved by the stockholders of the Company. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>D<SMALL>EFINITIONS</SMALL> <SMALL>AND</SMALL> C<SMALL>ONSTRUCTION</SMALL></B><SMALL></SMALL></U><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.1 <B>Definitions</B>. Whenever used herein, the following terms shall have their respective meanings set forth below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B><I>Affiliate</I></B>&#148; means (i)&nbsp;an entity, other than a Parent Corporation, that directly, or indirectly through one
or more intermediary entities, controls the Company or (ii)&nbsp;an entity, other than a Subsidiary Corporation, that is controlled by the Company directly, or indirectly through one or more intermediary entities. For this purpose, the term
&#147;control&#148; (including the term &#147;controlled by&#148;) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of the relevant entity, whether through the ownership of voting
securities, by contract or otherwise; or shall have such other meaning assigned such term for the purposes of registration on Form S-8 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B><I>Award</I></B>&#148; means an Option or Stock Purchase Right granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. If one or more Committees have been appointed by the Board
to administer the Plan, &#147;<B><I>Board</I></B>&#148; also means such Committee(s). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B><I>Code</I></B>&#148; means the
Internal Revenue Code of 1986, as amended, and any applicable regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B><I>Committee</I></B>&#148; means the compensation committee or other committee of
the Board duly appointed to administer the Plan and having such powers as shall be specified by the Board. Unless the powers of the Committee have been specifically limited, the Committee shall have all of the powers of the Board granted herein,
including, without limitation, the power to amend or terminate the Plan at any time, subject to the terms of the Plan and any applicable limitations imposed by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) &#147;<B><I>Company</I></B>&#148; means Penumbra, Inc., a Delaware corporation, or any successor corporation thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) &#147;<B><I>Consultant</I></B>&#148; means a person engaged to provide consulting or advisory services (other than as an Employee or a
Director) to a Participating Company, provided that the identity of such person, the nature of such services or the entity to which such services are provided would not preclude the Company from offering or selling securities to such person pursuant
to the Plan in reliance on either the exemption from registration provided by Rule 701 under the Securities Act or, if the Company is required to file reports pursuant to Section&nbsp;13 or 15(d) of the Exchange Act, registration on a Form S-8
Registration Statement under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) &#147;<B><I>Director</I></B>&#148; means a member of the Board or of the board of
directors of any other Participating Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) &#147;<B><I>Disability</I></B>&#148; means the inability of the Participant, in the
opinion of a qualified physician acceptable to the Company, to perform the major duties of the Participant&#146;s position with the Participating Company Group because of the sickness or injury of the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) &#147;<B><I>Employee</I></B>&#148; means any person treated as an employee (including an Officer or a Director who is also treated as an
employee) in the records of a Participating Company and, with respect to any Incentive Stock Option granted to such person, who is an employee for purposes of Section&nbsp;422 of the Code; provided, however, that neither service as a Director nor
payment of a director&#146;s fee shall be sufficient to constitute employment for purposes of the Plan. The Company shall determine in good faith and in the exercise of its discretion whether an individual has become or has ceased to be an Employee
and the effective date of such individual&#146;s employment or termination of employment, as the case may be. For purposes of an individual&#146;s rights, if any, under the terms of the Plan as of the time of the Company&#146;s determination of
whether or not the individual is an Employee, all such determinations by the Company shall be final, binding and conclusive as to such rights, if any, notwithstanding that the Company or any court of law or governmental agency subsequently makes a
contrary determination as to such individual&#146;s status as an Employee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(k) &#147;<B><I>Exchange Act</I></B>&#148; means the
Securities Exchange Act of 1934, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(l) &#147;<B><I>Fair Market Value</I></B>&#148; means, as of any date, the value of a share of
Stock or other property as determined by the Board, in its discretion, or by the Company, in its discretion, if such determination is expressly allocated to the Company herein, subject to the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) If, on such date, the Stock is listed on a national or regional securities exchange or market system, the Fair Market Value of a share of
Stock shall be the closing price of a share of Stock (or the mean of the closing bid and asked prices of a share of Stock if the Stock is so quoted instead) as quoted on the Nasdaq Stock Market or such other national or regional securities exchange
or market system constituting the primary market for the Stock, as reported in <U>The Wall Street Journal</U> or such other source as the Company deems reliable. If the relevant date does not fall on a day on which the Stock has traded on such
securities exchange or market system, the date on which the Fair Market Value shall be established shall be the last day on which the Stock was so traded prior to the relevant date, or such other appropriate day as shall be determined by the Board,
in its discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) If, on such date, the Stock is not listed on a national or regional securities exchange or market system, the
Fair Market Value of a share of Stock shall be as determined by the Board in good faith without regard to any restriction other than a restriction which, by its terms, will never lapse. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(m) &#147;<B><I>Incentive Stock Option</I></B>&#148; means an Option intended to be (as set forth in the Option Agreement) and which
qualifies as an incentive stock option within the meaning of Section&nbsp;422(b) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(n) &#147;<B><I>Insider</I></B>&#148;
means an Officer, a Director of the Company or other person whose transactions in Stock are subject to Section&nbsp;16 of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(o) &#147;<B><I>Nonstatutory Stock Option</I></B>&#148; means an Option not intended to be (as set forth in the Option Agreement) or which
does not qualify as an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(p) &#147;<B><I>Officer</I></B>&#148; means any person designated by the Board as an
officer of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(q) &#147;<B><I>Option</I></B>&#148; means a right granted under Section&nbsp;6 to purchase Stock pursuant to
the terms and conditions of the Plan. An Option may be either an Incentive Stock Option or a Nonstatutory Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(r)
&#147;<B><I>Option Agreement</I></B>&#148; means a written agreement between the Company and a Participant setting forth the terms, conditions and restrictions of the Option granted to the Participant and any shares acquired upon the exercise
thereof. An Option Agreement may consist of a form of &#147;Notice of Grant of Stock Option&#148; and a form of &#147;Stock Option Agreement&#148; incorporated therein by reference, or such other form or forms as the Board may approve from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(s) &#147;<B><I>Parent Corporation</I></B>&#148; means any present or future &#147;parent corporation&#148; of the Company, as
defined in Section&nbsp;424(e) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(t) &#147;<B><I>Participant</I></B>&#148; means any eligible person who has been granted one
or more Awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(u) &#147;<B><I>Participating Company</I></B>&#148; means the Company or any Parent Corporation,
Subsidiary Corporation or Affiliate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) &#147;<B><I>Participating Company Group</I></B>&#148; means, at any point in time, all entities
collectively which are then Participating Companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(w) &#147;<B><I>Rule 16b-3</I></B>&#148; means Rule 16b-3 under the Exchange Act,
as amended from time to time, or any successor rule or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) &#147;<B><I>Securities Act</I></B>&#148; means the Securities Act
of 1933, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(y) &#147;<B><I>Service</I></B>&#148; means a Participant&#146;s employment or service with the Participating
Company Group, whether in the capacity of an Employee, a Director or a Consultant. A Participant&#146;s Service shall not be deemed to have terminated merely because of a change in the capacity in which the Participant renders Service to the
Participating Company Group or a change in the Participating Company for which the Participant renders such Service, provided that there is no interruption or termination of the Participant&#146;s Service. Furthermore, a Participant&#146;s Service
shall not be deemed to have terminated if the Participant takes any military leave, sick leave, or other bona fide leave of absence approved by the Company; provided, however, that if any such leave exceeds ninety (90)&nbsp;days, on the one hundred
eighty-first (18lst)&nbsp;day following the commencement of such leave any Incentive Stock Option held by the Participant shall cease to be treated as an Incentive Stock Option and instead shall be treated thereafter as a Nonstatutory Stock Option
unless the Participant&#146;s right to return to Service is guaranteed by statute or contract. Notwithstanding the foregoing, unless otherwise designated by the Company or required by law, a leave of absence shall not be treated as Service for
purposes of determining vesting under the Participant&#146;s Option Agreement or Stock Purchase Agreement. Except as otherwise provided by the Board, in its discretion, the Participant&#146;s Service shall be deemed to have terminated either upon an
actual termination of Service or upon the corporation for which the Participant performs Service ceasing to be a Participating Company. Subject to the foregoing, the Company, in its discretion, shall determine whether the Participant&#146;s Service
has terminated and the effective date of and reason for such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(z) &#147;<B><I>Stock</I></B>&#148; means the common stock of
the Company, as adjusted from time to time in accordance with Section&nbsp;4.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(aa) &#147;<B><I>Stock Purchase Agreement</I></B>&#148;
means a written agreement between the Company and a Participant setting forth the terms, conditions and restrictions of the Stock Purchase Right granted to the Participant and any shares acquired upon the exercise thereof. A Stock Purchase Agreement
may consist of a form of &#147;Notice of Grant of Stock Purchase Right&#148; and a form of &#147;Stock Purchase Agreement&#148; incorporated therein by reference, or such other form or forms as the Board may approve from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(bb) &#147;<B><I>Stock Purchase Right</I></B>&#148; means a right granted under Section&nbsp;7 to purchase Stock pursuant to the terms and
conditions of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(cc) &#147;<B><I>Subsidiary Corporation</I></B>&#148; means any present or future &#147;subsidiary
corporation&#148; of the Company, as defined in Section&nbsp;424(t) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(dd) &#147;<B><I>Ten Percent Stockholder</I></B>&#148;
means a person who, at the time an Award is granted to such person, owns stock possessing more than ten percent (10%)&nbsp;of the total combined voting power (as defined in Section&nbsp;194.5 of the California Corporations Code) of all classes of
stock of a Participating Company (other than an Affiliate) within the meaning of Section&nbsp;422(b)(6) of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.2 <B>Construction</B>. Captions and titles contained herein are for convenience only and shall
not affect the meaning or interpretation of any provision of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term &#147;or&#148; is not intended to
be exclusive, unless the context clearly requires otherwise. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>A<SMALL>DMINISTRATION</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3.1
<B>Administration by the Board</B>. The Plan shall be administered by the Board. All questions of interpretation of the Plan or of any Award shall be determined by the Board, and such determinations shall be final and binding upon all persons having
an interest in the Plan or such Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3.2 <B>Authority of Officers</B>. Any Officer shall have the authority to act on behalf of the
Company with respect to any matter, right, obligation, determination or election which is the responsibility of or which is allocated to the Company herein, provided the Officer has apparent authority with respect to such matter, right, obligation,
determination or election. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3.3 <B>Powers of the Board</B>. In addition to any other powers set forth in the Plan and subject to the
provisions of the Plan, the Board shall have the full and final power and authority, in its discretion: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) to determine the persons to
whom, and the time or times at which, Awards shall be granted and the number of shares of Stock to be subject to each Award; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) to
designate Options as Incentive Stock Options or Nonstatutory Stock Options; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) to determine the Fair Market Value of shares of Stock or
other property; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) to determine the terms, conditions and restrictions applicable to each Award (which need not be identical) and any
shares acquired upon the exercise thereof, including, without limitation, (i)&nbsp;the exercise price of the Award, (ii)&nbsp;the method of payment for shares purchased upon the exercise of the Award, (iii)&nbsp;the method for satisfaction of any
tax withholding obligation arising in connection with the Award or such shares, including by the withholding or delivery of shares of stock, (iv)&nbsp;the timing, terms and conditions of the exercisability of the Award or the vesting of any shares
acquired upon the exercise thereof, (v)&nbsp;the time of the expiration of the Award, (vi)&nbsp;the effect of the Participant&#146;s termination of Service on any of the foregoing, and (vii)&nbsp;all other terms, conditions and restrictions
applicable to the Award or such shares not inconsistent with the terms of the Plan; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) to approve one or more forms of Option Agreement and Stock Purchase Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) to amend, modify, extend, cancel or renew any Award or to waive any restrictions or conditions applicable to any Award or any shares
acquired upon the exercise thereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) to accelerate, continue, extend or defer the exercisability of any Award or the vesting of any
shares acquired upon the exercise thereof, including with respect to the period following a Participant&#146;s termination of Service; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) to prescribe, amend or rescind rules, guidelines and policies relating to the Plan, or to adopt supplements to, or alternative versions
of, the Plan, including, without limitation, as the Board deems necessary or desirable to comply with the laws of, or to accommodate the tax policy or custom of, foreign jurisdictions whose citizens may be granted Awards; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) to correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Option Agreement or Stock Purchase Agreement
and to make all other determinations and take such other actions with respect to the Plan or any Award as the Board may deem advisable to the extent not inconsistent with the provisions of the Plan or applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3.4 <B>Administration with Respect to Insiders</B>. With respect to participation by Insiders in the Plan, at any time that any class of
equity security of the Company is registered pursuant to Section&nbsp;12 of the Exchange Act, the Plan shall be administered in compliance with the requirements, if any, of Rule 16b-3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">3.5 <B>Indemnification</B>. In addition to such other rights of indemnification as they may have as members of the Board or officers or
employees of the Participating Company Group, members of the Board and any officers or employees of the Participating Company Group to whom authority to act for the Board or the Company is delegated shall be indemnified by the Company against all
reasonable expenses, including attorneys&#146; fees, actually and necessarily incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason
of any action taken or failure to act under or in connection with the Plan, or any right granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by independent legal counsel selected by the
Company) or paid by them in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such person is liable for gross negligence, bad
faith or intentional misconduct in duties; provided, however, that within sixty (60)&nbsp;days after the institution of such action, suit or proceeding, such person shall offer to the Company, in writing, the opportunity at its own expense to handle
and defend the same. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>S<SMALL>HARES</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> P<SMALL>LAN</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.1 <B>Maximum Number of Shares Issuable</B>. Subject to adjustment as provided&nbsp;in Section&nbsp;4.2, the maximum aggregate number of
shares of Stock that may be issued </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under the Plan shall be Five Million Three Hundred Thousand (5,300,000)&nbsp;shall consist of authorized but unissued or reacquired shares of Stock or any combination thereof. If an outstanding
Award for any reason expires or is terminated or canceled or if shares of Stock are acquired upon the exercise of an Award subject to a Company repurchase option and are repurchased by the Company at the Participant&#146;s exercise or purchase
price, the shares of Stock allocable to the unexercised portion of such Award or such repurchased shares of Stock shall again be available for issuance under the Plan. However, except as adjusted pursuant to Section&nbsp;4.2, in no event shall more
than Five Million Three Hundred Thousand (5,300,000)&nbsp;shares of Stock be available for issuance pursuant to the exercise of Incentive Stock Options (the &#147;<B><I>ISO Share Limit</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>4.2 <B>Adjustments for Changes in Capital Structure</B>. Subject to any required action by the stockholders of the Company, in the
event of any change in the Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split,
split-up, split-off, spin-off, combination of shares, exchange of shares, or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than
Stock (excepting normal cash dividends) that has a material effect on the Fair Market Value of shares of Stock, appropriate and proportionate adjustments shall be made in the number and class of shares subject to the Plan and to any outstanding
Awards, in the ISO Share Limit set forth in Section&nbsp;4.1, and in the exercise or purchase price per share of any outstanding Awards in order to prevent dilution or enlargement of Participants&#146; rights under the Plan. For purposes of the
foregoing, conversion of any convertible securities of the Company shall not be treated as &#147;effected without receipt of consideration by the Company.&#148; Any fractional share resulting from an adjustment pursuant to this Section&nbsp;4.2
shall be rounded down to the nearest whole number, and in no event may the exercise price of any Award be decreased to an amount less than the par value, if any, of the stock subject to the Award. Such adjustments shall be determined by the Board,
and its determination shall be final, binding and conclusive.<B> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>E<SMALL>LIGIBILITY</SMALL> <SMALL>AND</SMALL> O<SMALL>PTION</SMALL> L<SMALL>IMITATIONS</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>5.1 <B>Persons Eligible for Awards</B>. Awards may be granted only to Employees,&nbsp;Consultants, and Directors of a Participating
Company. Eligible persons may be granted more than one (1)&nbsp;Award. However, eligibility in accordance with this Section shall not entitle any person to be granted an Award, or, having been granted an Award, to be granted an additional Award.<B>
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>5.2 <B>Option Grant Restrictions</B>. An Incentive Stock Option may be granted only to a person who is an Employee on the
effective date of grant of the Option to such person. Any person who is not an Employee on the effective date of the grant of an Option to such person may be granted only a Nonstatutory Stock Option.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">5.3 <B>Fair Market Value Limitation</B>. To the extent that options designated as Incentive Stock Options (granted under all stock plans of
the Participating Company Group, including the Plan) become exercisable by a Participant for the first time during any calendar year for stock having a Fair Market Value greater than One Hundred Thousand Dollars
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
($100,000), the portions of such options which exceed such amount shall be treated as Nonstatutory Stock Options. For purposes of this Section&nbsp;5.3, options designated as Incentive Stock
Options shall be taken into account in the order in which they were granted, and the Fair Market Value of stock shall be determined as of the time the option with respect to such stock is granted. If the Code is amended to provide for a different
limitation from that set forth in this Section&nbsp;5.3, such different limitation shall be deemed incorporated herein effective as of the date and with respect to such Options as required or permitted by such amendment to the Code. If an Option is
treated as an Incentive Stock Option in part and as a Nonstatutory Stock Option in part by reason of the limitation set forth in this Section&nbsp;5.3, the Participant may designate which portion of such Option the Participant is exercising. In the
absence of such designation, the Participant shall be deemed to have exercised the Incentive Stock Option portion of the Option first. Separate certificates representing each such portion shall be issued upon the exercise of the Option. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>T<SMALL>ERMS</SMALL> <SMALL>AND</SMALL> C<SMALL>ONDITIONS</SMALL> <SMALL>OF</SMALL> O<SMALL>PTIONS</SMALL></B><SMALL></SMALL></U><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Options shall be evidenced by Option Agreements specifying the number of shares of Stock covered thereby, in such form as the Board shall from
time to time establish. No Option or purported Option shall be a valid and binding obligation of the Company unless evidenced by a fully executed Option Agreement. Option Agreements may incorporate all or any of the terms of the Plan by reference
and shall comply with and be subject to the following terms and conditions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>6.1 <B>Exercise Price</B>. The exercise price for each
Option shall be established in the discretion of the Board; provided, however, that (a)&nbsp;the exercise price per share for an Option shall be not less than the Fair Market Value of a share of Stock on the effective date of grant of the Option and
(b)&nbsp;no Incentive Stock Option granted to a Ten Percent Stockholder shall have an exercise price per share less than one hundred ten percent (110%)&nbsp;of the Fair Market Value of a share of Stock on the effective date of grant of the Option.
Notwithstanding the foregoing, an Option (whether an Incentive Stock Option or a Nonstatutory Stock Option) may be granted with an exercise price lower than the minimum exercise price set forth above if such Option is granted pursuant to an
assumption or substitution for another option in a manner qualifying under the provisions of Section&nbsp;424(a) of the Code.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>6.2 <B>Exercisability and Term of Options</B>. Options shall be exercisable at such time or times, or upon such event or events, and
subject to such terms, conditions, performance criteria and restrictions as shall be determined by the Board and set forth in the Option Agreement evidencing such Option; provided, however, that (a)&nbsp;no Option shall be exercisable after the
expiration of ten (10)&nbsp;years after the effective date of grant of such Option and (b)&nbsp;no Incentive Stock Option granted to a Ten Percent Stockholder shall be exercisable after the expiration of five (5)&nbsp;years after the effective date
of grant of such Option. Subject to the foregoing, unless otherwise specified by the Board in the grant of an Option, any Option granted hereunder shall terminate ten (10)&nbsp;years after the effective date of grant of the Option, unless earlier
terminated in accordance with its provisions.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">6.3 <B>Payment of Exercise Price</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B><I>Forms of Consideration Authorized</I></B>. Except as otherwise provided below, payment of the exercise price for the number of
shares of Stock being purchased pursuant to any Option shall be made (i)&nbsp;in cash, by check or cash equivalent, (ii)&nbsp;by tender to the Company, or attestation to the ownership, of shares of Stock owned by the Participant having a Fair Market
Value not less than the exercise price, (iii)&nbsp;by delivery of a properly executed notice together with irrevocable instructions to a broker providing for the assignment to the Company of the proceeds of a sale or loan with respect to some or all
of the shares being acquired upon the exercise of the Option (including, without limitation, through an exercise complying with the provisions of Regulation T as promulgated from time to time by the Board of Governors of the Federal Reserve System)
(a &#147;<B><I>Cashless Exercise</I></B>&#148;), (iv)&nbsp;provided that the Participant is an Employee (unless otherwise not prohibited by law, including, without limitation, any regulation promulgated by the Board of Governors of the Federal
Reserve System) and in the Company&#146;s sole discretion at the time the Option is exercised, by delivery of the Participant&#146;s full recourse promissory note bearing interest (at no less than such rate as is a market rate of interest and which
then precludes the imputation of interest under the Code), in a form approved by the Company for the aggregate exercise price, provided that, if the Company is incorporated in the State of Delaware, the Participant shall pay in cash that portion of
the aggregate exercise price not less than the par value of the shares being acquired (v)&nbsp;by such other consideration as may be approved by the Board from time to time to the extent permitted by applicable law, or (vi)&nbsp;by any combination
thereof. The Board may at any time or from time to time, by approval of or by amendment to the standard forms of Option Agreement described in Section&nbsp;8, or by other means, grant Options which do not permit all of the foregoing forms of
consideration to be used in payment of the exercise price or which otherwise restrict one or more forms of consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b)
<B><I>Limitations on Forms of Consideration</I></B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(i) <B>Tender of Stock</B>. Notwithstanding the foregoing, an Option may not be
exercised by tender to the Company, or attestation to the ownership, of shares of Stock to the extent such tender or attestation would constitute a violation of the provisions of any law, regulation or agreement restricting the redemption of the
Company&#146;s stock. Unless otherwise provided by the Board, an Option may not be exercised by tender to the Company, or attestation to the ownership, of shares of Stock unless such shares either have been owned by the Participant for more than the
amount of time as to not result in any adverse accounting consequences to the Company by accepting such shares (and were not used for another Option exercise by attestation during such period) or were not acquired, directly or indirectly, from the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(ii) <B>Cashless Exercise</B>. The Company reserves, at any and all times, the right, in the Company&#146;s sole and absolute
discretion, to establish, decline to approve or terminate any program or procedures for the exercise of Options by means of a Cashless Exercise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iii) <B>Payment by Promissory Note</B>. No promissory note shall be permitted if the exercise of an Option using a promissory note would be
a violation of any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
law. Any permitted promissory note shall be on such terms as the Board shall determine. The Board shall have the authority to permit or require the Participant to secure any promissory note used
to exercise an Option with the shares of Stock acquired upon the exercise of the Option or with other collateral acceptable to the Company. Unless otherwise provided by the Board, if the Company at any time is subject to the regulations promulgated
by the Board of Governors of the Federal Reserve System or any other governmental entity affecting the extension of credit in connection with the Company&#146;s securities, any promissory note shall comply with such applicable regulations, and the
Participant shall pay the unpaid principal and accrued interest, if any, to the extent necessary to comply with such applicable regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">6.4 <B>Effect of Termination of Service</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(a) <B><I>Option Exercisability</I></B>. Subject to earlier termination of the Option as otherwise provided herein and unless
otherwise provided by the Board in the grant of an Option and set forth in the Option Agreement, an Option shall be exercisable after a Participant&#146;s termination of Service only during the applicable time period determined in accordance with
this Section&nbsp;6.4 and thereafter shall terminate:<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(i) <B><I></I></B><B>Disability</B><B><I></I></B>. If
the Participant&#146;s Service terminates because of the Disability of the Participant, the Option, to the extent unexercised and exercisable on the date on which the Participant&#146;s Service terminated, may be exercised by the Participant (or the
Participant&#146;s guardian or legal representative) at any time prior to the expiration of twelve (12)&nbsp;months (or such longer period of time as determined by the Board, in its discretion) after the date on which the Participant&#146;s Service
terminated, but in any event no later than the date of expiration of the Option&#146;s term as set forth in the Option Agreement evidencing such Option (the &#147;<B><I>Option Expiration Date</I></B>&#148;).<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B></B>(ii) <B>Death</B>. If the Participant&#146;s Service terminates because of the death of the Participant, the Option, to the extent
unexercised and exercisable on the date on which the Participant&#146;s Service terminated, may be exercised by the Participant&#146;s legal representative or other person who acquired the right to exercise the Option by reason of the
Participant&#146;s death at any time prior to the expiration of twelve (12)&nbsp;months (or such longer period of time as determined by the Board, in its discretion) after the date on which the Participant&#146;s Service terminated, but in any event
no later than the Option Expiration Date. The Participant&#146;s Service shall be deemed to have terminated on account of death if the Participant dies within three (3)&nbsp;months (or such longer period of time as determined by the Board, in its
discretion) after the Participant&#146;s termination of Service.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman">(iii) <B><I>Termination for Cause</I></B>. Notwithstanding any
other provision of the Plan to the contrary, if the Participant&#146;s Service with the Participating Company Group is terminated for Cause, as defined by the Participant&#146;s Option Agreement or contract of employment or service (or, if not
defined in any of the foregoing, as defined below), the Option shall terminate and cease to be exercisable immediately upon such termination of Service. Unless&nbsp;otherwise defined by the Participant&#146;s Option Agreement or contract of
employment or service, for purposes of this Section&nbsp;6.4(a)(iii) &#147;<B><I>Cause</I></B>&#148; (1)&nbsp;the Participant&#146;s theft, dishonesty, willful misconduct, breach of fiduciary duty for personal profit, or falsification of any
Participating Company documents or records; (2)&nbsp;the Participant&#146;s material failure to abide by a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Participating Company&#146;s code of conduct or other policies (including, without limitation, policies relating to confidentiality and reasonable workplace conduct); (3)&nbsp;the
Participant&#146;s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible asset or corporate opportunity of a Participating Company (including, without limitation, the Participant&#146;s improper use or disclosure
of a Participating Company&#146;s confidential or proprietary information); (4)&nbsp;any intentional act by the Participant which has a material detrimental effect on a Participating Company&#146;s reputation or business; (5)&nbsp;the
Participant&#146;s repeated failure or inability to perform any reasonable assigned duties after written notice from a Participating Company of, and a reasonable opportunity to cure, such failure or inability; (6)&nbsp;any material breach by the
Participant of any employment or service agreement between the Participant and a Participating Company, which breach is not cured pursuant to the terms of such agreement; or (7)&nbsp;the Participant&#146;s conviction (including any plea of guilty or
nolo contendere) of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or which impairs the Participant&#146;s ability to perform his or her duties with a Participating Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B></B>(iv) <B>Other Termination of Service</B>. If the Participant&#146;s Service terminates for any reason, except Disability, death or
Cause, the Option, to the extent unexercised and exercisable by the Participant on the date on which the Participant&#146;s Service terminated, may be exercised by the Participant at any time prior to the expiration of three (3)&nbsp;months (or such
longer period of time as determined by the Board, in its discretion) after the date on which the Participant&#146;s Service terminated, but in any event no later than the Option Expiration Date.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(b) <B><I>Extension if Exercise Prevented by Law</I></B>. Notwithstanding the foregoing other than termination for Cause, if
the exercise of an Option within the applicable time periods set forth in Section&nbsp;6.4(a) is prevented by the provisions of Section&nbsp;11 below, the Option shall remain exercisable until three (3)&nbsp;months (or such longer period of time as
determined by the Board, in its discretion) after the date the Participant is notified by the Company that the Option is exercisable, but in any event no later than the Option Expiration Date.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>6.5 <B>Transferability of Options</B>. During the lifetime of the Participant, an Option shall be exercisable only by the Participant
or the Participant&#146;s guardian or legal representative. No Option shall be assignable or transferable by the Participant, except by will or by the laws of descent and distribution. Notwithstanding the foregoing, to the extent permitted by the
Board, in its discretion, and set forth in the Option Agreement evidencing such Option, a Nonstatutory Stock Option shall be assignable or transferable subject to the applicable limitations, if any, described in Section&nbsp;260.140.41 of Title 10
of the California Code of Regulations, Rule 701 under the Securities Act, and the General Instructions to Form S&middot;8 Registration Statement under the Securities Act.<B> </B></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>T<SMALL>ERMS</SMALL> <SMALL>AND</SMALL> C<SMALL>ONDITIONS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCK</SMALL> P<SMALL>URCHASE</SMALL> R<SMALL>IGHTS</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Stock Purchase Rights shall be evidenced by Stock Purchase Agreements, specifying the number of shares of Stock covered thereby, in such form
as the Board shall from time to time establish. No Stock Purchase Right or purported Stock Purchase Right shall be a valid and binding obligation of the Company unless evidenced by a fully executed Stock Purchase Agreement. Stock Purchase Agreements
may incorporate all or any of the terms of the Plan by reference and shall comply with and be subject to the following terms and conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">7.1 <B>Purchase Price</B>. The purchase price under each Stock Purchase Right shall be established by the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">7.2 <B>Purchase Period</B>. A Stock Purchase Right shall be exercisable within a period
established by the Board, which shall in no event exceed thirty (30)&nbsp;days from the effective date of the grant of the Stock Purchase Right. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">7.3 <B>Payment of Purchase Price</B>. Except as otherwise provided below, payment of the purchase price for the number of shares of Stock
being purchased pursuant to any Stock Purchase Right shall be made (a)&nbsp;in cash, by check, or cash equivalent, (b)&nbsp;in the form of the Participant&#146;s past service rendered to a Participating Company or for its benefit having a value not
less than the aggregate purchase price of the shares being acquired, (c)&nbsp;by such other consideration as may be approved by the Board from time to time to the extent permitted by applicable law, or (d)&nbsp;by any combination thereof. The Board
may at any time or from time to time, by adoption of or by amendment to the standard form of Stock Purchase Agreement described in Section&nbsp;8, or by other means, grant Stock Purchase Rights which do not permit all of the foregoing forms of
consideration to be used in payment of the purchase price or which otherwise restrict one or more forms of consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">7.4 <B>Vesting
and Restrictions on Transfer</B>. Shares issued pursuant to any Stock Purchase Right may or may not be made subject to vesting conditioned upon the satisfaction of such Service requirements, conditions, restrictions or performance criteria (the
&#147;Vesting Conditions&#148;) as shall be established by the Board and set forth in the Stock Purchase Agreement evidencing such Award. During any period (the &#147;<B><I>Restriction Period</I></B>&#148;) in which shares acquired pursuant to a
Stock Purchase Right remain subject to Vesting Conditions, such shares may not be sold, exchanged, transferred, pledged, assigned or otherwise disposed of other than pursuant to an Ownership Change Event, as demined in Section&nbsp;9.1, or as
provided in Section&nbsp;7.5. Upon request by the Company, each Participant shall execute any agreement evidencing such transfer restrictions prior to the receipt of shares of Stock hereunder and shall promptly present to the Company any and all
certificates representing shares of Stock acquired hereunder for the placement on such certificates of appropriate legends evidencing any such transfer restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>7.5 <B>Effect of Termination of Service</B>. Unless otherwise provided by the Board in the grant of a Stock Purchase Right and set
forth in the Stock Purchase Agreement, if a Participant&#146;s Service terminates for any reason, whether voluntary or involuntary (including the Participant&#146;s death or disability), then the Company shall have the option to repurchase for the
purchase price paid by the Participant any shares acquired by the Participant pursuant to a Stock Purchase Right which remain subject to Vesting Conditions as of the date of the Participant&#146;s termination of Service. The Company shall have the
right to assign at any time any repurchase right it may have, whether or not such right is then exercisable, to one or more persons as may be selected by the Company.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">7.6 <B>Nontransferability of Stock Purchase Rights</B>. Rights to acquire shares of Stock
pursuant to a Stock Purchase Right may not be assigned or transferred in any manner except by will or the laws of descent and distribution, and, during the lifetime of the Participant, shall be exercisable only by the Participant. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>S<SMALL>TANDARD</SMALL> F<SMALL>ORMS</SMALL> <SMALL>OF</SMALL> A<SMALL>GREEMENTS</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">8.1 <B>Option Agreement</B>. Unless otherwise provided by the Board at the time the Option is granted, an Option shall comply with and be
subject to the terms and conditions set forth in the form of Option Agreement approved by the Board concurrently with its adoption of the Plan and as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">8.2 <B>Stock Purchase Agreement</B>. Unless otherwise provided by the Board at the time the Stock Purchase Right is granted, a Stock Purchase
Right shall be subject to the terms and conditions set forth in the form of Stock Purchase Agreement approved by the Board concurrently with its adoption of the Plan and as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">8.3 <B>Authority to Vary Terms</B>. The Board shall have the authority from time to time to vary the terms of any standard form of agreement
described in this Section&nbsp;8 either in connection with the grant or amendment of an individual Award or in connection with the authorization of a new standard form or forms; provided, however, that the terms and conditions of any such new,
revised or amended standard form or forms of agreement are not inconsistent with the terms of the Plan. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>C<SMALL>HANGE</SMALL> <SMALL>IN</SMALL> C<SMALL>ONTROL</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.1 Definitions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) An
&#147;<B><I>Ownership Change Event</I></B>&#148; shall be deemed to have occurred if any of the following occurs with respect to the Company: (i)&nbsp;the direct or indirect sale or exchange in a single or series of related transactions by the
stockholders of the Company of more than fifty percent (50%)&nbsp;of the voting stock of the Company; (ii)&nbsp;a merger or consolidation in which the Company is a party; (iii)&nbsp;the sale, exchange, or transfer of all or substantially all of the
assets of the Company; or (iv)&nbsp;a liquidation or dissolution of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) A &#147;<B><I>Change in Control</I></B>&#148; shall
mean an Ownership Change Event or&nbsp;a series of related Ownership Change Events (collectively, a &#147;<B><I>Transaction</I></B>&#148;) wherein the stockholders of the Company immediately before the Transaction do not retain immediately after the
Transaction, in substantially the same proportions as their ownership of shares of the Company&#146;s voting stock immediately before the Transaction, direct or indirect beneficial ownership of more than fifty percent (50%)&nbsp;of the total
combined voting power of the outstanding voting securities of the Company or, in the case of a Transaction described in Section&nbsp;9.1(a)(iii), the corporation or other business entity to which the assets of the Company were transferred (the
&#147;<B><I>Transferee</I></B>&#148;), as the case may be. For purposes of the preceding sentence,&nbsp;indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities of one or more
corporations or other business entities which own the Company or the Transferee, as the case may be, either directly or through one or more subsidiary corporations or other business entities. The Board shall have the right to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
determine whether multiple sales or exchanges of the voting securities of the Company or multiple Ownership Change Events are related, and its determination shall be final, binding and
conclusive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.2 <B>Effect of Change in Control on Options</B>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <B><I>Accelerated Vesting</I></B>. Notwithstanding any other provision of the Plan to the contrary, the Board, in its sole discretion,
may provide in any Award Agreement or, in the event of a Change in Control, may take such actions as it deems appropriate to provide for the acceleration of the exercisability and vesting in connection with such Change in Control of any or all
outstanding Options and shares acquired upon the exercise of such Options </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B><I>Assumption or Substitution of Options</I></B>. In
the event of a Change in Control, the surviving, continuing, successor, or purchasing corporation or other business entity or parent thereof, as the case may be (the &#147;<B><I>Acquiror</I></B>&#148;), may, without the consent of any Participant,
either assume the Company&#146;s rights and obligations under outstanding Options or substitute for outstanding Options substantially equivalent options for the Acquiror&#146;s stock. Any Options which are neither assumed by the Acquiror in
connection with the Change in Control nor exercised as of the date of the Change in Control shall terminate and cease to be outstanding effective as of the date of the Change in Control. Notwithstanding the foregoing, shares acquired upon exercise
of an Option prior to the Change in Control and any consideration received pursuant to the Change in Control with respect to such shares shall continue to be subject to all applicable provisions of the Award Agreement evidencing such Option except
as otherwise provided in such Award Agreement. Furthermore, notwithstanding the foregoing, if the corporation the stock of which is subject to the outstanding Options immediately prior to an Ownership Change Event described in Section&nbsp;9.1(a)(i)
constituting a Change in Control is the surviving or continuing corporation and immediately after such Ownership Change Event less than fifty percent (50%)&nbsp;of the total combined voting power of its voting stock is held by another corporation or
by other corporations that are members of an affiliated group within the meaning of Section&nbsp;1504(a) of the Code without regard to the provisions of Section&nbsp;1504(b) of the Code, the outstanding Options shall not terminate unless the Board
otherwise provides in its discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <B><I>Cash-Out of Options</I></B>. The Board may, in its sole discretion and without the
consent of any Participant, determine that, upon the occurrence of a Change in Control, each or any Option outstanding immediately prior to the Change in Control shall be canceled in exchange for a payment with respect to each vested share of Stock
subject to such canceled Option in (i)&nbsp;cash, (ii)&nbsp;stock of the Company or of a corporation or other business entity a party to the Change in Control, or (iii)&nbsp;other property which, in any such case, shall be in an amount having a Fair
Market Value equal to the Fair Market Value of the consideration to be paid per share of Stock in the Change in Control over the exercise price per share under such Option (the &#147;<B><I>Spread</I></B>&#148;). In the event such determination is
made by the Board, the Spread (reduced by applicable withholding taxes, if any) shall be paid to Participants in respect of their canceled Options as soon as practicable following the date of the Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.3 <B>Effect of Change in Control on Stock Purchase Right</B>. In the event of a Change in Control, the Acquiror, may, without the consent of
any Participant, either assume the Company&#146;s rights and obligations under outstanding Stock Purchase Rights or substitute for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
outstanding Stock Purchase Rights substantially equivalent purchase rights for the Acquiror&#146;s stock. Any Stock Purchase Rights which are neither assumed or substituted for by the Acquiror in
connection with the Change in Control nor exercised as of the date of the Change in Control shall terminate and cease to be outstanding effective as of the date of the Change in Control. Notwithstanding the foregoing, shares acquired upon exercise
of a Stock Purchase Right prior to the Change in Control and any consideration received pursuant to the Change in Control with respect to such shares shall continue to be subject to all applicable provisions of the Stock Purchase Agreement
evidencing such Stock Purchase Right except as otherwise provided in such Stock Purchase Agreement. Furthermore, notwithstanding the foregoing, if the corporation the stock of which is subject to the outstanding Stock Purchase Rights immediately
prior to an Ownership Change Event described in Section&nbsp;9.1(a)(i) constituting a Change in Control is the surviving or continuing corporation and immediately after such Ownership Change Event less than fifty percent (50%)&nbsp;of the total
combined voting power of its voting stock is held by another corporation or by other corporations that are members of an affiliated group within the meaning of Section&nbsp;1504(a) of the Code without regard to the provisions of Section&nbsp;1504(b)
of the Code, the outstanding Stock Purchase Rights shall not terminate unless the Board otherwise provides in its discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">9.4
<B>Federal Excise Tax Under Section&nbsp;4999 of the Code</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(a) <B><I>Excess Parachute Payment</I></B>. In the event
that any acceleration of vesting pursuant to an Award and any other payment or benefit received or to be received by a Participant would subject the Participant to any excise tax pursuant to Section&nbsp;4999 of the Code due to the characterization
of such acceleration of vesting, payment or benefit as an &#147;excess parachute payment&#148; under Section&nbsp;280G of the Code, the Participant may elect, in his or her sole discretion, to reduce the amount of any acceleration of vesting called
for under the Award in order to avoid such characterization.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(b) <B><I>Determination by Independent
Accountants</I></B>. To aid the Participant in making any election called for under Section&nbsp;9.4(a), no later than the date of the occurrence of any event that might reasonably be anticipated to result in an &#147;excess parachute payment&#148;
to the Participant as described in Section&nbsp;9.4(a), the Company shall request a determination in writing by independent public accountants selected by the Company (the &#147;<B><I>Accountants</I></B>&#148;). As soon as practicable thereafter,
the Accountants shall determine and report to the Company and the Participant the amount of such acceleration of vesting, payments and benefits which would produce the greatest after-tax benefit to the Participant. For the purposes of such
determination, the Accountants may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and the Participant shall furnish to the Accountants such information and documents as
the Accountants may reasonably request in order to make their required determination. The Company shall bear all fees and expenses the Accountants may reasonably charge in connection with their services contemplated by this
Section&nbsp;9.4(b).<B><I> </I></B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>T<SMALL>AX</SMALL> W<SMALL>ITHHOLDING</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">10.1 <B>Tax Withholding in General</B>. The Company shall have the right to deduct from any and all payments made under the Plan, or to require
the Participant, through </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
payroll withholding, cash payment or otherwise, including by means of a Cashless Exercise of an Option, to make adequate provision for, the federal, state, local and foreign taxes, if any,
required by law to be withheld by the Participating Company Group with respect to an Award or the shares acquired pursuant thereto. The Company shall have no obligation to deliver shares of Stock or to release shares of Stock from an escrow
established pursuant to an Option Agreement or Stock Purchase Agreement until the Participating Company Group&#146;s tax withholding obligations have been satisfied by the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>10.2 <B>Withholding in Shares</B>. The Company shall have the right, but not the obligation, to deduct from the shares of Stock
issuable to a Participant upon the exercise of an Award, or to accept from the Participant the tender of, a number of whole shares of Stock having a Fair Market Value, as determined by the Company, equal to all or any part of the tax withholding
obligations of the Participating Company Group. The Fair Market Value of any shares of Stock withheld or tendered to satisfy any such tax withholding obligations shall not exceed the amount determined by the applicable minimum statutory withholding
rates.<B> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>C<SMALL>OMPLIANCE</SMALL> <SMALL>WITH</SMALL> S<SMALL>ECURITIES</SMALL> L<SMALL>AW</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The grant of Awards and the issuance of shares of Stock upon exercise of Awards shall be subject to compliance with all applicable requirements
of federal, state and foreign law with respect to such securities. Awards may not be exercised if the issuance of shares of Stock upon exercise would constitute a violation of any applicable federal, state or foreign securities laws or other law or
regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. In addition, no Award may be exercised unless (a)&nbsp;a registration statement under the Securities Act shall at the time of exercise of
the Award be in effect with respect to the shares issuable upon exercise of the Award or (b)&nbsp;in the opinion of legal counsel to the Company, the shares issuable upon exercise of the Award may be issued in accordance with the terms of an
applicable exemption from the registration requirements of the Securities Act. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company&#146;s legal counsel to be necessary to
the lawful issuance and sale of any shares hereunder shall relieve the Company of any liability in respect of the failure to issue or sell such shares as to which such requisite authority shall not have been obtained. As a condition to the exercise
of any Award, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as
may be requested by the Company. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>T<SMALL>ERMINATION</SMALL> <SMALL>OR</SMALL> A<SMALL>MENDMENT</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Board may terminate or amend the Plan at any time. However, subject to changes in applicable law, regulations or rules that would permit
otherwise, without the approval of the Company&#146;s stockholders, there shall be (a)&nbsp;no increase in the maximum aggregate number of shares of Stock that may be issued under the Plan (except by operation of the provisions of Section&nbsp;4.2),
(b)&nbsp;no change in the class of persons eligible to receive Incentive Stock Options, and (c)&nbsp;no other amendment of the Plan that would require approval of the Company&#146;s stockholders under any applicable law, regulation or rule. No
termination or amendment of the Plan shall affect any then outstanding Award unless expressly provided by the Board. In any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
event, no termination or amendment of the Plan may adversely affect any then outstanding Award without the consent of the Participant, unless such termination or amendment is required to enable
an Option designated as an Incentive Stock Option to qualify as an Incentive Stock Option or is necessary to comply with any applicable law, regulation or rule. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>M<SMALL>ISCELLANEOUS</SMALL> P<SMALL>ROVISIONS</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">13.1 <B>Repurchase Rights</B>. Shares issued under the Plan may be subject to a right of first refusal, one or more repurchase options, or
other conditions and restrictions as determined by the Board in its discretion at the time the Award is granted. The Company shall have the right to assign at any time any repurchase right it may have, whether or not such right is then exercisable,
to one or more persons as may be selected by the Company. Upon request by the Company, each Participant shall execute any agreement evidencing such transfer restrictions prior to the receipt of shares of Stock hereunder and shall promptly present to
the Company any and all certificates representing shares of Stock acquired hereunder for the placement on such certificates of appropriate legends evidencing any such transfer restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">13.2 <B>Provision of Information</B>. The Company shall deliver to each Participant such disclosures as are required in accordance with Rule
701 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">13.3 <B>Stockholder Approval</B>. The Plan or any increase in the maximum aggregate number of shares of
Stock issuable thereunder as provided in Section&nbsp;4.1 (the &#147;<B><I>Authorized Shares</I></B>&#148;) shall be approved by a majority of the outstanding securities of the Company entitled to vote within twelve (12)&nbsp;months before or after
the date of adoption thereof by the Board. Awards granted prior to security holder approval of the Plan or in excess of the Authorized Shares previously approved by the security holders shall become exercisable no earlier than the date of security
holder approval of the Plan or such increase in the Authorized Shares, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">13.4 <B>Section&nbsp;409A</B>. To the extent
that the Board determines that any Option or Stock Purchase Right granted or awarded under the Plan is subject to Section&nbsp;409A of the Code, the agreement evidencing such Option or Stock Purchase Right shall be interpreted consistent with the
requirements of Section&nbsp;409A of the Code and the Department of Treasury regulations and other interpretive guidance issued thereunder. Notwithstanding any provision of the Plan to the contrary, in the event that the Board determines that any
Option or Stock Purchase Right may be subject to Section&nbsp;409A of the Code and the Department of Treasury regulations and other interpretive guidance issued thereunder, the Board may, with the written consent of the affected Participant, adopt
such amendments to the Plan and the applicable agreement or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Board determines are necessary or
appropriate to (a)&nbsp;exempt the Option or Stock Purchase Right from Section&nbsp;409A of the Code and/or preserve the intended tax treatment of the benefits provided with respect to the Option or Stock Purchase Right, or (b)&nbsp;comply with the
requirements of Section&nbsp;409A of the Code and the Department of Treasury regulations and other interpretive guidance thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAVE NOT BEEN QUALIFIED WITH THE COMMISSIONER OF
CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY
SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR
DISTRIBUTION THEREOF. NO SUCH SALE OR DISPOSITION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF
1933. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PENUMBRA, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK OPTION AGREEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Immediately Exercisable) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Penumbra, Inc. has granted to the individual (the &#147;<I></I><B><I>Participant</I></B><I></I>&#148;) named in the <I>Notice of Grant
of Stock Option</I> (the &#147;<I></I><B><I>Notice&#146;</I></B><I></I>) to which this Stock Option Agreement (the &#147;<I></I><B><I>Option Agreement</I></B><I></I>&#146;) is attached an option (the &#147;<I></I><B><I>Option</I></B><I></I>&#148;)
to purchase certain shares of Stock upon the terms and conditions set forth in the Notice and this Option Agreement. The Option has been granted pursuant to and shall in all respects be subject to the terms and conditions of the Penumbra, Inc. 2005
Stock Plan (the &#147;<I></I><B><I>Plan</I></B><I></I>&#148;), as amended to the Date of Option Grant, the provisions of which are incorporated herein by reference. By signing the Notice, the Participant: (a)&nbsp;represents that the Participant has
received copies of, and has read and is familiar with the terms and conditions of, the Notice, the Plan and this Option Agreement, (b)&nbsp;accepts the Option subject to all of the terms and conditions of the Notice, the Plan and this Option
Agreement, and (c)&nbsp;agrees to accept as binding, conclusive and final all decisions or interpretations of the Board upon any questions arising under the Notice, the Plan or this Option Agreement.<I> </I></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>D<SMALL>EFINITIONS</SMALL> <SMALL>AND</SMALL> C<SMALL>ONSTRUCTION</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>1.1 <B>Definitions.</B> Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Notice
or the Plan.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>1.2 <B>Construction.</B> Captions and titles contained herein are for convenience only and shall not affect
the meaning or interpretation of any provision of this Option Agreement. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term &#147;or&#148; is not intended
to be exclusive, unless the context clearly requires otherwise.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>T<SMALL>AX</SMALL> C<SMALL>ONSEQUENCES</SMALL>.</U></B> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.1 <B>Tax Status of
Option</B><B>.</B> This Option is intended to have the tax status designated in the Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(a) <B><I>Incentive Stock
Option.</I></B> If the Notice so designates, this Option is intended to be an Incentive Stock Option within the meaning of Section&nbsp;422(b) of the Code, but the Company does not represent or warrant that this Option qualifies as such. The
Participant should consult with the Participant&#146;s own tax advisor regarding the tax effects of this Option and the requirements necessary to obtain favorable income tax treatment under Section&nbsp;422 of the Code, including, but not limited
to, holding period requirements. (NOTE TO PARTICIPANT: If the Option is exercised more than three (3)&nbsp;months after the date on which you cease to be an Employee (other than by reason of your death or permanent and total disability as defined in
Section&nbsp;22(e)(3) of the Code), the Option will be treated as a Nonstatutory Stock Option and not as an Incentive Stock Option to the extent required by Section&nbsp;422 of the Code.)<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(b) <B><I>Nonstatutory Stock Option.</I></B> If the Notice so designates, this Option is intended to be a Nonstatutory Stock
Option and shall not be treated as an Incentive Stock Option within the meaning of Section&nbsp;422(b) of the Code.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I></I>2.2 <I></I><B>ISO Fair Market Value Limitation.</B><I> If the Notice designates this Option as an Incentive Stock Option</I>, then to
the extent that the Option (together with all Incentive Stock Options granted to the Participant under all stock option plans of the Participating Company Group, including the Plan) becomes exercisable for the first time during any calendar year for
shares having a Fair Market Value greater than One Hundred Thousand Dollars ($100,000), the portion of such options which exceeds such amount will be treated as Nonstatutory Stock Options. For purposes of this Section&nbsp;2.2, options designated as
Incentive Stock Options are taken into account in the order in which they were granted, and the Fair Market Value of stock is determined as of the time the option with respect to such stock is granted. If the Code is amended to provide for a
different limitation from that set forth in this Section&nbsp;2.2, such different limitation shall be deemed incorporated herein effective as of the date required or permitted by such amendment to the Code. If the Option is treated as an Incentive
Stock Option in part and as a Nonstatutory Stock Option in part by reason of the limitation set forth in this Section&nbsp;2.2, the Participant may designate which portion of such Option the Participant is exercising. In the absence of such
designation, the Participant shall be deemed to have exercised the Incentive Stock Option portion of the Option first. Separate certificates representing each such portion shall be issued upon the exercise of the Option. (NOTE TO PARTICIPANT: If the
aggregate Exercise Price of the Option (that is, the Exercise Price multiplied by the Number of Option Shares) plus the aggregate exercise price of any other Incentive Stock Options you hold (whether granted pursuant to the Plan or any other stock
option plan of the Participating Company Group) is greater than $100,000, you should contact the Chief Financial Officer of the Company to ascertain whether the entire Option qualifies as an Incentive Stock Option.)<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">2.3 <B>Election Under Section&nbsp;83(b) of the Code.</B> If the Participant exercises this Option to purchase shares of stock that are both
nontransferable and subject to a substantial risk of forfeiture, the Participant understands that the Participant should consult with the Participant&#146;s tax advisor regarding the advisability of filing with the Internal Revenue Service an
election under Section&nbsp;83(b) of the Code, which must be filed no later than thirty (30)&nbsp;days after </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the date on which the Participant exercises the Option. Shares acquired upon exercise of the Option are nontransferable and subject to a substantial risk of forfeiture if, for example, they are
unvested and are subject to a right of the Company to repurchase such shares at the Participant&#146;s original purchase price if the Participant&#146;s Service terminates. Failure to file an election under Section&nbsp;83(b), if appropriate, may
result in adverse tax consequences to the Participant. The Participant acknowledges that the Participant has been advised to consult with a tax advisor prior to the exercise of the Option regarding the tax consequences to the Participant of the
exercise of the Option. AN ELECTION UNDER SECTION 83(b) MUST BE FILED WITHIN 30 DAYS AFTER THE DATE ON WHICH THE PARTICIPANT PURCHASES SHARES. THIS TIME PERIOD CANNOT BE EXTENDED. THE PARTICIPANT ACKNOWLEDGES THAT TIMELY FILING OF A SECTION 83(b)
ELECTION IS THE PARTICIPANT&#146;S SOLE RESPONSIBILITY, EVEN IF THE PARTICIPANT REQUESTS THE COMPANY OR ITS REPRESENTATIVE TO FILE SUCH ELECTION ON HIS OR HER BEHALF. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>A<SMALL>DMINISTRATION</SMALL></B><SMALL><B></B></SMALL><B>.</B></U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">All questions of
interpretation concerning this Option Agreement shall be determined by the Board. All determinations by the Board shall be final and binding upon all persons having an interest in the Option. Any Officer shall have the authority to act on behalf of
the Company with respect to any matter, right, obligation, or election which is the responsibility of or which is allocated to the Company herein, provided the Officer has apparent authority with respect to such matter, right, obligation, or
election. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>E<SMALL>XERCISE</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> O<SMALL>PTION</SMALL>.</U></B> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>4.1 <B>Right to Exercise.</B> Except as otherwise provided herein, the Option shall be exercisable on and after the Initial Exercise
Date and prior to the termination of the Option (as provided in Section&nbsp;6) in an amount not to exceed the Number of Option Shares less the number of shares previously acquired upon exercise of the Option, subject to the Company&#146;s
repurchase rights set forth in Section&nbsp;11 and Section&nbsp;12. In no event shall the Option be exercisable for more shares than the Number of Option Shares, as adjusted pursuant to Section&nbsp;9.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>4.2 <B>Method of Exercise.</B> Exercise of the Option shall be by written notice to the Company which must state the election to
exercise the Option, the number of whole shares of Stock for which the Option is being exercised and such other representations and agreements as to the Participant&#146;s investment intent with respect to such shares as may be required pursuant to
the provisions of this Option Agreement. The written notice must be signed by the Participant and must be delivered in person, by certified or registered mail, return receipt requested, by confirmed facsimile transmission, or by such other means as
the Company may permit, to the Chief Financial Officer of the Company, or other authorized representative of the Participating Company Group, prior to the termination of the Option as set forth in Section&nbsp;6, accompanied by (i)&nbsp;full payment
of the aggregate Exercise Price for the number of shares of stock being purchased and (ii)&nbsp;an executed copy, if required herein, of the then current form of escrow agreement referenced below. The Option shall be deemed to be exercised upon
receipt by the Company of such written notice, the aggregate Exercise Price and if required by the Company, such executed agreement.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.3 <B>Payment of Exercise Price.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(a) <B><I>Forms of Consideration Authorized.</I></B> Except as otherwise provided below, payment of the aggregate Exercise
Price for the number of shares of stock for which the Option is being exercised shall be made (i)&nbsp;in cash, by check, or cash equivalent, (ii)&nbsp;by tender to the Company, or attestation to the ownership, of whole shares of stock owned by the
Participant having a Fair Market Value not less than the aggregate Exercise Price, (iii)&nbsp;by means of a Cashless Exercise, as defined in Section&nbsp;4.3(b), or (iv)&nbsp;by any combination of the foregoing.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <B><I>Limitations on Forms of Consideration.</I></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B></B>(i) <B>Tender of Stock.</B> Notwithstanding the foregoing, the Option may not be exercised by tender to the Company, or attestation to
the ownership, of shares of stock to the extent such tender or attestation would constitute a violation of the provisions of any law, regulation or agreement restricting the redemption of the Company&#146;s stock. The Option may not be exercised by
tender to the Company, or attestation to the ownership, of shares of Stock unless such shares either have been owned by the Participant for more than the amount of time as to not result in any adverse accounting consequences to the Company by
accepting such shares (and not used for another option exercise by attestation during such period) or were not acquired, directly or indirectly, from the Company.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:17%; font-size:10pt; font-family:Times New Roman"><B></B>(ii) <B>Cashless Exercise.</B> A &#147;<B></B><B><I>Cashless Exercise</I></B><B></B>&#148; means the delivery of a properly executed
notice together with irrevocable instructions to a broker in a form acceptable to the Company providing for the assignment to the Company of the proceeds of a sale or loan with respect to some or all of the shares of stock acquired upon the exercise
of the Option pursuant to a program or procedure approved by the Company (including, without limitation, through an exercise complying with the provisions of Regulation&nbsp;T as promulgated from time to time by the Board of Governors of the Federal
Reserve System). The Company reserves, at any and all times, the right, in the Company&#146;s sole and absolute discretion, to decline to approve or terminate any such program or procedure.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>4.4 <B>Tax Withholding.</B> At the time the Option is exercised, in whole or in part, or at any time thereafter as requested by the
Company, the Participant hereby authorizes withholding from payroll and any other amounts payable to the Participant, and otherwise agrees to make adequate provision for (including by means of a Cashless Exercise to the extent permitted by the
Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Participating Company Group, if any, which arise in connection with the Option, including, without limitation, obligations arising upon
(i)&nbsp;the exercise, in whole or in part, of the Option, (ii)&nbsp;the transfer, in whole or in part, of any shares acquired upon exercise of the Option, (iii)&nbsp;the operation of any law or regulation providing for the imputation of interest,
or (iv)&nbsp;the lapsing of any restriction with respect to any shares acquired upon exercise of the Option. The Option is not exercisable unless the tax withholding obligations of the Participating Company Group are satisfied. Accordingly, the
Company shall have no obligation to deliver shares of Stock or to release shares of Stock from an escrow established pursuant to this Option Agreement until the tax withholding obligations of the Participating Company Group have been satisfied by
the Participant.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>4.5 <B>Certificate Registration.</B> Except in the event the Exercise Price is paid by
means of a Cashless Exercise, the certificate for the shares as to which the Option is exercised shall be registered in the name of the Participant, or, if applicable, in the names of the heirs of the Participant.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>4.6 <B>Restrictions on Grant of the Option and Issuance of Shares.</B> The grant of the Option and the issuance of shares of Stock upon
exercise of the Option shall be subject to compliance with all applicable requirements of federal, state or foreign law with respect to such securities. The Option may not be exercised if the issuance of shares of Stock upon exercise would
constitute a violation of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange or market system upon which the Stock may then be listed. In addition, the Option may not be
exercised unless (i)&nbsp;a registration statement under the Securities Act shall at the time of exercise of the Option be in effect with respect to the shares issuable upon exercise of the Option or (ii)&nbsp;in the opinion of legal counsel to the
Company, the shares issuable upon exercise of the Option may be issued in accordance with the terms of an applicable exemption from the registration requirements of the Securities Act. THE PARTICIPANT IS CAUTIONED THAT THE OPTION MAY NOT BE
EXERCISED UNLESS THE FOREGOING CONDITIONS ARE SATISFIED. ACCORDINGLY, THE PARTICIPANT MAY NOT BE ABLE TO EXERCISE THE OPTION WHEN DESIRED EVEN THOUGH THE OPTION IS VESTED. The inability of the Company to obtain from any regulatory body having
jurisdiction the authority, if any, deemed by the Company&#146;s legal counsel to be necessary to the lawful issuance and sale of any shares subject to the Option shall relieve the Company of any liability in respect of the failure to issue or sell
such shares as to which such requisite authority shall not have been obtained. As a condition to the exercise of the Option, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence
compliance with any applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">4.7 <B>Fractional Shares</B><B>.</B> The Company shall not be required to issue fractional shares upon the exercise of the Option. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"><B></B><U><B>N<SMALL>ONTRANSFERABILITY</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> O<SMALL>PTION</SMALL></B><SMALL></SMALL></U><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Option may be exercised during the lifetime of the Participant only by the Participant or the Participant&#146;s guardian or legal
representative and may not be assigned or transferred in any manner except by will or by the laws of descent and distribution. Following the death of the Participant, the Option, to the extent provided in Section&nbsp;7, may be exercised by the
Participant&#146;s legal representative or by any person empowered to do so under the deceased Participant&#146;s will or under the then applicable laws of descent and distribution. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>T<SMALL>ERMINATION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> O<SMALL>PTION</SMALL>.</B></U> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Option shall terminate and may no longer be exercised after the first to occur of (a)&nbsp;the close of business on the Option Expiration
Date, (b)&nbsp;the close of business on the last date for exercising the Option following termination of the Participant&#146;s Service as described in Section&nbsp;7, or (c)&nbsp;a Change in Control to the extent provided in Section&nbsp;8. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>E<SMALL>FFECT</SMALL> <SMALL>OF</SMALL> T<SMALL>ERMINATION</SMALL> <SMALL>OF</SMALL> S<SMALL>ERVICE</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">7.1 <B>Option Exercisability.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(a) <B><I>Disability</I></B>. If the Participant&#146;s Service terminates because of the Disability of the Participant, the
Option, to the extent unexercised and exercisable on the date on which the Participant&#146;s Service terminated, may be exercised by the Participant (or the Participant&#146;s guardian or legal representative) at any time prior to the expiration of
twelve (12)&nbsp;months after the date on which the Participant&#146;s Service terminated, but in any event no later than the Option Expiration Date.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(b) <B><I>Death</I></B>. If the Participant&#146;s Service terminates because of the death of the Participant, the Option, to
the extent unexercised and exercisable on the date on which the Participant&#146;s Service terminated, may be exercised by the Participant&#146;s legal representative or other person who acquired the right to exercise the Option by reason of the
Participant&#146;s death at any time prior to the expiration of twelve (12)&nbsp;months after the date on which the Participant&#146;s Service terminated, but in any event no later than the Option Expiration Date. The Participant&#146;s Service
shall be deemed to have terminated on account of death if the Participant dies within three (3)&nbsp;months after the Participant&#146;s termination of Service.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(c) <B><I>Termination for Cause</I></B>. Notwithstanding any other provision of this Option Agreement, if the
Participant&#146;s Service is terminated for Cause (as defined below), the Option shall terminate and cease to be exercisable on the effective date of such termination of Service. Unless otherwise defined in a contract of employment or service
between the Participant and a Participating Company, for purposes of this Option Agreement &#147;<B><I>Cause</I></B>&#148; shall mean any of the following: (i)&nbsp;the Participant&#146;s theft, dishonesty, willful misconduct, breach of fiduciary
duty for personal profit, or falsification of any Participating Company documents or records; (ii)&nbsp;the Participant&#146;s material failure to abide by a Participating Company&#146;s code of conduct or other policies (including, without
limitation, policies relating to confidentiality and reasonable workplace conduct); (iii)&nbsp;the Participant&#146;s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible asset or corporate opportunity of a
Participating Company (including, without limitation, the Participant&#146;s improper use or disclosure of a Participating Company&#146;s confidential or proprietary information); (iv)&nbsp;any intentional act by the Participant which has a material
detrimental effect on a Participating Company&#146;s reputation or business; (v)&nbsp;the Participant&#146;s repeated failure or inability to perform any reasonable assigned duties after written notice from a Participating Company of, and a
reasonable opportunity to cure, such failure or inability; (vi)&nbsp;any material breach by the Participant of any employment or service agreement between the Participant and a Participating Company, which breach is not cured pursuant to the terms
of such agreement; or (vii)&nbsp;the Participant&#146;s conviction (including any plea of guilty or nolo contendere) of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude, or which impairs the Participant&#146;s
ability to perform his or her duties with a Participating Company.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(d) <B><I>Other Termination of
Service</I></B>. If the Participant&#146;s Service with the Participating Company Group terminates for any reason, except Disability, death or Cause, the Option, to the extent unexercised and exercisable by the Participant on the date on which the
Participant&#146;s Service terminated, may be exercised by the Participant at any time prior to the expiration of three (3)&nbsp;months (or such other longer period of time as determined by the Board, in its discretion) after the date on which the
Participant&#146;s Service terminated, but in any event no later than the Option Expiration Date.<B><I> </I></B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>7.2 <B>Additional Limitation on Option Exercise.</B> Notwithstanding the provisions of
Section&nbsp;7.1, the Option may not be exercised after the Participant&#146;s termination of Service to the extent that the shares to be acquired upon exercise of the Option would be subject to the Unvested Share Repurchase Option as provided in
Section&nbsp;11.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>7.3 <B>Extension if Exercise Prevented by Law.</B> Notwithstanding the foregoing other than termination
for Cause, if the exercise of the Option within the applicable time periods set forth in Section&nbsp;7.1 is prevented by the provisions of Section&nbsp;4.6, the Option shall remain exercisable until thirty (30)&nbsp;days after the date the
Participant is notified by the Company that the Option is exercisable, but in any event no later than the Option Expiration Date.<B> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>C<SMALL>HANGE</SMALL> <SMALL>IN</SMALL> C<SMALL>ONTROL</SMALL>.</U></B> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">8.1
<B>Definitions.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(a) An &#147;<B><I>Ownership Change Event</I></B>&#148; shall be deemed to have occurred if any of the
following occurs with respect to the Company: (i)&nbsp;the direct or indirect sale or exchange in a single or series of related transactions by the stockholders of the Company of more than fifty percent (50%)&nbsp;of the voting stock of the Company;
(ii)&nbsp;a merger or consolidation in which the Company is a party; (iii)&nbsp;the sale, exchange, or transfer of all or substantially all of the assets of the Company; or (iv)&nbsp;a liquidation or dissolution of the Company.<B><I> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman"><B><I></I></B>(b) A &#147;<B><I>Change in Control</I></B>&#148; shall mean an Ownership Change Event or a series of related Ownership Change
Events (collectively, a &#147;<B><I>Transaction</I></B>&#148;) wherein the stockholders of the Company immediately before the Transaction do not retain immediately after the Transaction, in substantially the same proportions as their ownership of
shares of the Company&#146;s voting stock immediately before the Transaction, direct or indirect beneficial ownership of more than fifty percent (50%)&nbsp;of the total combined voting power of the outstanding voting securities of the Company or, in
the case of a Transaction described in Section&nbsp;8.1(a)(iii), the corporation or other business entity to which the assets of the Company were transferred (the &#147;<B><I>Transferee</I></B>&#148;), as the case may be. For purposes of the
preceding sentence, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company or the Transferee, as the
case may be, either directly or through one or more subsidiary corporations or other business entities. The Board shall have the right to determine whether multiple sales or exchanges of the voting securities of the Company or multiple Ownership
Change Events are related, and its determination shall be final, binding and conclusive.<B><I> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">8.2 <B>Effect of Change in Control
on Option.</B> In the event of a Change in Control, and provided that the Participant&#146;s Service has not terminated prior to such date, the Vested Ratio shall deemed to be 1/1 and all shares acquired upon exercise of the Option shall be Vested
Shares for purposes of Section&nbsp;11 as of the date ten (10)&nbsp;days prior to the date of the Change in Control. Any vesting of the Option that was permissible solely by reason of this Section&nbsp;8.2 shall be conditioned upon the consummation
of the Change in Control. In addition, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the surviving, continuing, successor, or purchasing corporation or other business entity or parent thereof, as the case may be (the &#147;<B><I>Acquiror</I></B>&#148;), may, without the consent
of the Participant, either assume the Company&#146;s rights and obligations under the Option or substitute for the Option a substantially equivalent option for the Acquiror&#146;s stock. The Option shall terminate and cease to be outstanding
effective as of the date of the Change in Control to the extent that the Option is neither assumed by the Acquiror in connection with the Change in Control nor exercised as of the date of the Change in Control. Notwithstanding the foregoing, shares
acquired upon exercise of the Option prior to the Change in Control and any consideration received pursuant to the Change in Control with respect to such shares shall continue to be subject to all applicable provisions of this Option Agreement
except as otherwise provided herein. Furthermore, notwithstanding the foregoing, if the corporation the stock of which is subject to the Option immediately prior to an Ownership Change Event described in Section&nbsp;8.1(a)(i) constituting a Change
in Control is the surviving or continuing corporation and immediately after such Ownership Change Event less than fifty percent (50%)&nbsp;of the total combined voting power of its voting stock is held by another corporation or by other corporations
that are members of an affiliated group within the meaning of Section&nbsp;1504(a) of the Code without regard to the provisions of Section&nbsp;1504(b) of the Code, the Option shall not terminate unless the Board otherwise provides in its
discretion. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>A<SMALL>DJUSTMENTS</SMALL> <SMALL>FOR</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> C<SMALL>APITAL</SMALL> S<SMALL>TRUCTURE</SMALL>.</B></U> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Subject to any required action by the stockholders of the Company, in the event of any change in the Stock effected without receipt of
consideration by the Company, whether through merger, consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares,
exchange of shares, or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (excepting normal cash dividends) that has a
material effect on the Fair Market Value of shares of stock, appropriate and proportionate adjustments shall be made in the number, Exercise Price and class of shares subject to the Option, in order to prevent dilution or enlargement of the
Participant&#146;s rights under the Option. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as &#147;effected without receipt of consideration by the Company.&#148; Any fractional share
resulting from an adjustment pursuant to this Section&nbsp;9 shall be rounded down to the nearest whole number, and in no event may the purchase price of the Option be decreased to an amount less than the par value, if any, of the stock subject to
the Option. Such adjustments shall be determined by the Board, and its determination shall be final, binding and conclusive. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>R<SMALL>IGHTS</SMALL> <SMALL>AS</SMALL> A S<SMALL>TOCKHOLDER</SMALL>, D<SMALL>IRECTOR</SMALL>, E<SMALL>MPLOYEE</SMALL> <SMALL>OR</SMALL> C<SMALL>ONSULTANT</SMALL></U><SMALL></SMALL></B><SMALL></SMALL>.
</TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Participant shall have no rights as a stockholder with respect to any shares covered by the Option until the date of the
issuance of a certificate for the shares for which the Option has been exercised (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for dividends,
distributions or other rights for which the record date is prior to the date such certificate is issued, except as provided in Section&nbsp;9. If the Participant is an Employee, the Participant understands and acknowledges that, except as otherwise
provided in a separate, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
written employment agreement between a Participating Company and the Participant, the Participant&#146;s employment is &#147;at will&#148; and is for no specified term. Nothing in this Option
Agreement shall confer upon the Participant any right to continue in the Service of a Participating Company or interfere in any way with any right of the Participating Company Group to terminate the Participant&#146;s Service as a Director, an
Employee or Consultant, as the case may be, at any time. Participant acknowledges and agrees that the vesting of shares pursuant to the Option is earned only by continuing service or employment at the will of the Company (not through the act of
being hired, being granted the Option or acquiring shares hereunder). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>U<SMALL>NVESTED</SMALL> S<SMALL>HARE</SMALL> R<SMALL>EPURCHASE</SMALL> O<SMALL>PTION</SMALL>.</B></U> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>11.1 <B>Grant of Unvested Share Repurchase Option.</B> In the event the Participant&#146;s Service with the Participating Company Group
is terminated for any reason or no reason, with or without cause, or, If the Participant, the Participant&#146;s legal representative, or other holder of shares acquired upon exercise of the Option attempts to sell, exchange, transfer, pledge, or
otherwise dispose of (other than pursuant to an Ownership Change Event) any Unvested Shares, as defined in Section&nbsp;11.2 below (the &#147;<B></B><B><I>Unvested Shares</I></B><B></B>&#146;), the Company shall have the right to repurchase the
Unvested Shares under the terms and subject to the conditions set forth in this Section&nbsp;11 (the &#147;<B></B><B><I>Unvested Share Repurchase Option</I></B><B></B>&#148;).<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>11.2 <B>Unvested Shares Defined.</B> The &#147;<B></B><B><I>Unvested Shares</I></B><B></B>&#148; shall mean, on any given date, the
number of shares of Stock acquired upon exercise of the Option which exceed the Vested Shares determined as of such date.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>11.3 <B>Exercise of Unvested Share Repurchase Option.</B> The Company may exercise the Unvested Share Repurchase Option by written
notice to the Participant within sixty (60)&nbsp;days after (a)&nbsp;termination of the Participant&#146;s Service (or exercise of the Option, if later) or (b)&nbsp;the Company has received notice of the attempted disposition of Unvested Shares. If
the Company fails to give notice within such sixty (60)&nbsp;day period, the Unvested Share Repurchase Option shall terminate unless the Company and the Participant have extended the time for the exercise of the Unvested Share Repurchase Option. The
Unvested Share Repurchase Option must be exercised, if at all, for all of the Unvested Shares, except as the Company and the Participant otherwise agree.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>11.4 <B>Payment for Shares and Return of Shares to Company.</B> The purchase price per share being repurchased by the Company shall be
an amount equal to the Participant&#146;s original cost per share, as adjusted pursuant to Section&nbsp;9 (the &#147;<B></B><B><I>Repurchase Price</I></B><B></B>&#148;). The Company shall pay the aggregate Repurchase Price to the Participant in cash
within thirty (30)&nbsp;days after the date of the written notice to the Participant of the Company&#146;s exercise of the Unvested Share Repurchase Option. For purposes of the foregoing, cancellation of any purchase money indebtedness of the
Participant to any Participating Company for the shares shall be treated as payment to the Participant in cash to the extent of the unpaid principal and any accrued interest canceled. The shares being repurchased shall be delivered to the Company by
the Participant at the same time as the delivery of the Repurchase Price to the Participant.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>11.5 <B>Assignment of Unvested
Share Repurchase Option.</B> The Company shall have the right to assign the Unvested Share Repurchase Option at any time, whether or not such option is then exercisable, to one or more persons as may be selected by the Company.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>11.6 <B>Ownership Change Event.</B> Upon the occurrence of an Ownership Change Event, any
and all new, substituted or additional securities or other property to which the Participant is entitled by reason of the Participant&#146;s ownership of Unvested Shares shall be immediately subject to the Unvested Share Repurchase Option and
included in the terms &#147;Stock&#148; and &#147;Unvested Shares&#148; for all purposes of the Unvested Share Repurchase Option with the same force and effect as the Unvested Shares immediately prior to the Ownership Change Event. While the
aggregate Repurchase Price shall remain the same after such Ownership Change Event, the Repurchase Price per Unvested Share upon exercise of the Unvested Share Repurchase Option following such Ownership Change Event shall be adjusted as appropriate.
For purposes of determining the Vested Shares following an Ownership Change Event, credited Service shall include all Service with any corporation which is a Participating Company at the time the Service is rendered, whether or not such corporation
is a Participating Company both before and after the Ownership Change Event.<B> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>R<SMALL>IGHT</SMALL> <SMALL>OF</SMALL> F<SMALL>IRST</SMALL> R<SMALL>EFUSAL</SMALL></B><SMALL></SMALL></U><SMALL></SMALL>. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>12.1 <B>Grant of Right of First Refusal.</B> Except as provided in Section&nbsp;12.7 below, in the event the Participant, the
Participant&#146;s legal representative, or other holder of shares acquired upon exercise of the Option proposes to sell, exchange, transfer, pledge, or otherwise dispose of any Vested Shares (the &#147;<B></B><B><I>Transfer
Shares</I></B><B></B>&#148;) to any person or entity, including, without limitation, any stockholder of a Participating Company, the Company shall have the right to repurchase the Transfer Shares under the terms and subject to the conditions set
forth in this Section&nbsp;12 (the &#147;<B></B><B><I>Right of First Refusal</I></B><B></B>&#148;).<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>12.2 <B>Notice of
Proposed Transfer.</B> Prior to any proposed transfer of the Transfer Shares, the Participant shall deliver written notice (the &#147;<B></B><B><I>Transfer Notice</I></B><B></B>&#148;) to the Company describing fully the proposed transfer, including
the number of Transfer Shares, the name and address of the proposed transferee (the &#147;<B></B><B><I>Proposed Transferee</I></B><B></B>&#148;) and, If the transfer is voluntary, the proposed transfer price, and containing such information
necessary to show the bona fide nature of the proposed transfer. In the event of a bona fide gift or involuntary transfer, the proposed transfer price shall be deemed to be the Fair Market Value of the Transfer Shares, as determined by the Board in
good faith. If the Participant proposes to transfer any Transfer Shares to more than one Proposed Transferee, the Participant shall provide a separate Transfer Notice for the proposed transfer to each Proposed Transferee. The Transfer Notice shall
be signed by both the Participant and the Proposed Transferee and must constitute a binding commitment of the Participant and the Proposed Transferee for the transfer of the Transfer Shares to the Proposed Transferee subject only to the Right of
First Refusal.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>12.3 <B>Bona Fide Transfer.</B> If the Company determines that the information provided by the Participant
in the Transfer Notice is insufficient to establish the bona fide nature of a proposed voluntary transfer, the Company shall give the Participant written notice of the Participant&#146;s failure to comply with the procedure described in this
Section&nbsp;12, and the Participant shall have no right to transfer the Transfer Shares without first complying with the procedure described in this Section&nbsp;12. The Participant shall not be permitted to transfer the Transfer Shares If the
proposed transfer is not bona fide.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">12.4 <B>Exercise of Right of First Refusal.</B> If the Company determines the proposed
transfer to be bona fide, the Company shall have the right to purchase all, but not less </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
than all, of the Transfer Shares (except as the Company and the Participant otherwise agree) at the purchase price and on the terms set forth in the Transfer Notice by delivery to the Participant
of a notice of exercise of the Right of First Refusal within thirty (30)&nbsp;days after the date the Transfer Notice is delivered to the Company. The Company&#146;s exercise or failure to exercise the Right of First Refusal with respect to any
proposed transfer described in a Transfer Notice shall not affect the Company&#146;s right to exercise the Right of First Refusal with respect to any proposed transfer described in any other Transfer Notice, whether or not such other Transfer Notice
is issued by the Participant or issued by a person other than the Participant with respect to a proposed transfer to the same Proposed Transferee. If the Company exercises the Right of First Refusal, the Company and the Participant shall thereupon
consummate the sale of the Transfer Shares to the Company on the terms set forth in the Transfer Notice within sixty (60)&nbsp;days after the date the Transfer Notice is delivered to the Company (unless a longer period is offered by the Proposed
Transferee); provided, however, that in the event the Transfer Notice provides for the payment for the Transfer Shares other than in cash, the Company shall have the option of paying for the Transfer Shares by the present value cash equivalent of
the consideration described in the Transfer Notice as reasonably determined by the Company. For purposes of the foregoing, cancellation of any indebtedness of the Participant to any Participating Company shall be treated as payment to the
Participant in cash to the extent of the unpaid principal and any accrued interest canceled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>12.5 <B>Failure to Exercise Right of
First Refusal.</B> If the Company fails to exercise the Right of First Refusal in full (or to such lesser extent as the Company and the Participant otherwise agree) within the period specified in Section&nbsp;12.4 above, the Participant may conclude
a transfer to the Proposed Transferee of the Transfer Shares on the terms and conditions described in the Transfer Notice, provided such transfer occurs not later than ninety (90)&nbsp;days following delivery to the Company of the Transfer Notice.
The Company shall have the right to demand further assurances from the Participant and the Proposed Transferee (in a form satisfactory to the Company) that the transfer of the Transfer Shares was actually carried out on the terms and conditions
described in the Transfer Notice. No Transfer Shares shall be transferred on the books of the Company until the Company has received such assurances, if so demanded, and has approved the proposed transfer as bona fide. Any proposed transfer on terms
and conditions different from those described in the Transfer Notice, as well as any subsequent proposed transfer by the Participant, shall again be subject to the Right of First Refusal and shall require compliance by the Participant with the
procedure described in this Section&nbsp;12.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>12.6 <B>Transferees of Transfer Shares.</B> All transferees of the Transfer
Shares or any interest therein, other than the Company, shall be required as a condition of such transfer to agree in writing (in a form satisfactory to the Company) that such transferee shall receive and hold such Transfer Shares or interest
therein subject to all of the terms and conditions of this Option Agreement, including this Section&nbsp;12 providing for the Right of First Refusal with respect to any subsequent transfer. Any sale or transfer of any shares acquired upon exercise
of the Option shall be void unless the provisions of this Section&nbsp;12 are met.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>12.7 <B>Transfers Not Subject to Right
of First Refusal.</B> The Right of First Refusal shall not apply to any transfer or exchange of the shares acquired upon exercise of the Option if such transfer or exchange is in connection with an Ownership Change Event. If the consideration
received pursuant to such transfer or exchange consists of stock of a Participating Company, such consideration shall remain subject to the Right of First Refusal unless the provisions of Section&nbsp;12.9 below result in a termination of the Right
of First Refusal.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>12.8 <B>Assignment of Right of First Refusal.</B> The Company shall have the right to
assign the Right of First Refusal at any time, whether or not there has been an attempted transfer, to one or more persons as may be selected by the Company.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>12.9 <B>Early Termination of Right of First Refusal.</B> The other provisions of this Option Agreement notwithstanding, the Right of
First Refusal shall terminate and be of no further force and effect upon (a)&nbsp;the occurrence of a Change in Control, unless the Acquiror assumes the Company&#146;s rights and obligations under the Option or substitutes a substantially equivalent
option for the Acquiror&#146;s stock for the Option, or (b)&nbsp;the existence of a public market for the class of shares subject to the Right of First Refusal. A &#147;<B></B><B><I>public market</I></B><B></B>&#148; shall be deemed to exist if
(i)&nbsp;such stock is listed on a national securities exchange (as that term is used in the Exchange Act) or (ii)&nbsp;such stock is traded on the over-the-counter market and prices therefor are published daily on business days in a recognized
financial journal.<B> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>E<SMALL>SCROW</SMALL>.</B></U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>13.1 <B>Establishment of Escrow.</B> To ensure
that shares subject to the Unvested Share Repurchase Option will be available for repurchase, the Company may require the Participant to deposit the certificate evidencing the shares which the Participant purchases upon exercise of the Option with
an agent designated by the Company under the terms and conditions of an escrow agreement approved by the Company. If the Company does not require such deposit as a condition of exercise of the Option, the Company reserves the right at any time to
require the Participant to so deposit the certificate in escrow. Upon the occurrence of an Ownership Change Event or a change, as described in Section&nbsp;9, in the character or amount of any of the outstanding stock of the corporation the stock of
which is subject to the provisions of this Option Agreement, any and all new, substituted or additional securities or other property to which the Participant is entitled by reason of the Participant&#146;s ownership of shares of stock acquired upon
exercise of the Option that remain, following such Ownership Change Event or change described in Section&nbsp;9, subject to the Unvested Share Repurchase Option shall be immediately subject to the escrow to the same extent as such shares of stock
immediately before such event. The Company shall bear the expenses of the escrow.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>13.2 <B>Delivery of Shares to
Participant.</B> As soon as practicable after the expiration of the Unvested Share Repurchase Option, but not more frequently than twice each calendar year, the escrow agent shall deliver to the Participant the shares and any other property no
longer subject to such restriction.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>13.3 <B>Notices and Payments.</B> In the event the shares and any other property held
in escrow are subject to the Company&#146;s exercise of the Unvested Share Repurchase Option or the Right of First Refusal, the notices required to be given to the Participant shall be given to the escrow agent, and any payment required to be given
to the Participant shall be given to the escrow agent. Within thirty (30)&nbsp;days after payment by the Company, the escrow agent shall deliver the shares and any other property which the Company has purchased to the Company and shall deliver the
payment received from the Company to the Participant.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"><B><U></U><U>S<SMALL>TOCK</SMALL> D<SMALL>ISTRIBUTIONS</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> O<SMALL>PTION</SMALL> A<SMALL>GREEMENT</SMALL>.</U></B> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If, from time to time, there is any stock dividend, stock split or other change, as described in Section&nbsp;9, in the character or amount of
any of the outstanding stock of the corporation the stock of which is subject to the provisions of this Option Agreement, then in such event any and all new, substituted or additional securities to which the Participant is entitled by reason of the
Participant&#146;s ownership of the shares acquired upon exercise of the Option shall be immediately subject to the Unvested Share Repurchase Option and the Right of First Refusal with the same force and effect as the shares subject to the Unvested
Share Repurchase Option and the Right of First Refusal immediately before such event. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>N<SMALL>OTICE</SMALL> <SMALL>OF</SMALL> S<SMALL>ALES</SMALL> U<SMALL>PON</SMALL> D<SMALL>ISQUALIFYING</SMALL> D<SMALL>ISPOSITION</SMALL>.</U></B> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I></I>The Participant shall dispose of the shares acquired pursuant to the Option only in accordance with the provisions of this Option
Agreement. In addition, <I>if the Notice designates this Option as an Incentive Stock Option</I>, the Participant shall (a)&nbsp;promptly notify the Chief Financial Officer of the Company if the Participant disposes of any of the shares acquired
pursuant to the Option within one (1)&nbsp;year after the date the Participant exercises all or part of the Option or within two (2)&nbsp;years after the Date of Option Grant and (b)&nbsp;provide the Company with a description of the circumstances
of such disposition. Until such time as the Participant disposes of such shares in a manner consistent with the provisions of this Option Agreement, unless otherwise expressly authorized by the Company, the Participant shall hold all shares acquired
pursuant to the Option in the Participant&#146;s name (and not in the name of any nominee) for the one-year period immediately after the exercise of the Option and the two-year period immediately after Date of Option Grant. At any time during the
one-year or two-year periods set forth above, the Company may place a legend on any certificate representing shares acquired pursuant to the Option requesting the transfer agent for the Company&#146;s stock to notify the Company of any such
transfers. The obligation of the Participant to notify the Company of any such transfer shall continue notwithstanding that a legend has been placed on the certificate pursuant to the preceding sentence.<I> </I></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>L<SMALL>EGENDS</SMALL>.</B></U> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company may at any time place legends referencing
the Unvested Share Repurchase Right, the Right of First Refusal and any applicable federal, state or foreign securities law restrictions on all certificates representing shares of stock subject to the provisions of this Option Agreement. The
Participant shall, at the request of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to the Option in the possession of the Participant in order to carry out the provisions of this Section.
Unless otherwise specified by the Company, legends placed on such certificates may include, but shall not be limited to, the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">16.1 &#147;THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE
SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE IS MADE IN ACCORDANCE WITH RULE 144 OR RULE 701 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SUCH
ACT.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">16.2 &#147;THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO AN UNVESTED SHARE REPURCHASE OPTION IN FAVOR OF THE
CORPORATION OR ITS ASSIGNEE SET FORTH IN AN AGREEMENT BETWEEN THE CORPORATION AND THE REGISTERED HOLDER, OR SUCH HOLDER&#146;S PREDECESSOR IN INTEREST, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THIS CORPORATION.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">16.3 &#147;THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A RIGHT OF FIRST REFUSAL OPTION IN FAVOR OF THE CORPORATION OR ITS
ASSIGNEE SET FORTH IN AN AGREEMENT BETWEEN THE CORPORATION AND THE REGISTERED HOLDER, OR SUCH HOLDER&#146;S PREDECESSOR IN INTEREST, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THIS CORPORATION.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I></I>16.4 &#147;THE SHARES EVIDENCED BY THIS CERTIFICATE WERE ISSUED BY THE CORPORATION TO THE REGISTERED HOLDER UPON EXERCISE OF AN
INCENTIVE STOCK OPTION AS DEFINED IN SECTION 422 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (&#147;ISO&#148;). IN ORDER TO OBTAIN THE PREFERENTIAL TAX TREATMENT AFFORDED TO ISOs, THE SHARES SHOULD NOT BE TRANSFERRED PRIOR TO [<I>INSERT
DISQUALIFYING DISPOSITION DATE HERE</I>]. SHOULD THE REGISTERED HOLDER ELECT TO TRANSFER ANY OF THE SHARES PRIOR TO THIS DATE AND FOREGO ISO TAX TREATMENT, THE TRANSFER AGENT FOR THE SHARES SHALL NOTIFY THE CORPORATION IMMEDIATELY. THE REGISTERED
HOLDER SHALL HOLD ALL SHARES PURCHASED UNDER THE INCENTIVE STOCK OPTION IN THE REGISTERED HOLDER&#146;S NAME (AND NOT IN THE NAME OF ANY NOMINEE) PRIOR TO THIS DATE OR UNTIL TRANSFERRED AS DESCRIBED ABOVE.&#148;<I> </I></P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>L<SMALL>OCK</SMALL>-U<SMALL>P</SMALL> A<SMALL>GREEMENT</SMALL>.</U></B> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Participant
hereby agrees that in the event of any underwritten public offering of stock, including an initial public offering of stock, made by the Company pursuant to an effective registration statement filed under the Securities Act, the Participant shall
not offer, sell, contract to sell, pledge, hypothecate, grant any option to purchase or make any short sale of, or otherwise dispose of any shares of stock of the Company or any rights to acquire stock of the Company for such period of time from and
after the effective date of such registration statement as may be established by the underwriter for such public offering; provided, however, that such period of time shall not exceed one hundred eighty (180)&nbsp;days from the effective date of the
registration statement to be filed in connection with such public offering. The foregoing limitation shall not apply to shares registered in the public offering under the Securities Act. The Participant hereby agrees to enter into any agreement
reasonably required by the underwriters to implement the foregoing within a reasonable timeframe if so requested by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"><U><B>R<SMALL>ESTRICTIONS</SMALL> <SMALL>ON</SMALL> T<SMALL>RANSFER</SMALL> <SMALL>OF</SMALL> S<SMALL>HARES</SMALL>.</B></U> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">No shares acquired upon exercise of the Option may be sold, exchanged, transferred (including, without limitation, any transfer to a nominee or
agent of the Participant), assigned, pledged, hypothecated or otherwise disposed of, including by operation of law, in any manner which violates any of the provisions of this Option Agreement and any such attempted disposition shall be void. The
Company shall not be required (a)&nbsp;to transfer on its books any shares which will have been transferred in violation of any of the provisions set forth in this Option Agreement or (b)&nbsp;to treat as owner of such shares or to accord the right
to vote as such owner or to pay dividends to any transferee to whom such shares will have been so transferred. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"><B><U>M<SMALL>ISCELLANEOUS</SMALL> P<SMALL>ROVISIONS</SMALL>.</U></B> </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>19.1 <B>Further
Instruments.</B> The parties hereto agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>19.2 <B>Binding Effect.</B> Subject to the restrictions on transfer set forth herein, this Option Agreement shall inure to the benefit
of and be binding upon the parties hereto and their respective heirs, executors, administrators, successors and assigns.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>19.3 <B>Termination or Amendment.</B> The Board may terminate or amend the Plan or the Option at any time; provided, however, that
except as provided in Section&nbsp;8.2 in connection with a Change in Control, no such termination or amendment may adversely affect the Option or any unexercised portion hereof without the consent of the Participant unless such termination or
amendment is necessary to comply with any applicable law or government regulation or is required to enable the Option, if designated an Incentive Stock Option in the Notice, to qualify as an Incentive Stock Option. No amendment or addition to this
Option Agreement shall be effective unless in writing.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>19.4 <B>Notices.</B> Any notice required or permitted hereunder
shall be given in writing and shall be deemed effectively given (except to the extent that this Option Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, upon deposit in the United States Post
Office, by registered or certified mail, or with an overnight courier service with postage and fees prepaid, addressed to the other party at the address shown below that party&#146;s signature or at such other address as such party may designate in
writing from time to time to the other party.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>19.5 <B>Integrated Agreement.</B> The Notice, this Option Agreement and the
Plan constitute the entire understanding and agreement of the Participant and the Participating Company Group with respect to the subject matter contained herein or therein and supersedes any prior agreements, understandings, restrictions,
representations, or warranties among the Participant and the Participating Company Group with respect to such subject matter other than those as set forth or provided for herein or therein. To the extent contemplated herein or therein, the
provisions of the Notice and the Option Agreement shall survive any exercise of the Option and shall remain in full force and effect.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>19.6 <B>Applicable Law.</B> This Option Agreement shall be governed by the laws of the
State of California as such laws are applied to agreements between California residents entered into and to be performed entirely within the State of California.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B></B>19.7 <B>Counterparts.</B> The Notice maybe executed in counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.<B> </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Incentive Stock Option</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">Participant: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nonstatutory Stock Option</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">Date: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK OPTION EXERCISE NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention: Chief Financial Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2401 Merced Street, Suite 200 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Leandro, CA 94577 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <B><U>Option</U>.</B>
I was granted an option (the &#147;<B><I>Option</I></B>&#148;) to purchase shares of the common stock (the &#147;<B><I>Shares</I></B>&#148;) of Penumbra, Inc. (the &#147;<B><I>Company</I></B>&#148;) pursuant to the Company&#146;s 2005 Stock Plan
(the &#147;<B><I>Plan</I></B>&#148;), my Notice of Grant of Stock Option (the &#147;<B><I>Notice</I></B>&#148;) and my Stock Option Agreement (the &#147;<B><I>Option Agreement</I></B>&#148;) as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Date of Option Grant:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Number of Option Shares:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise Price per Share:</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <B><U>Exercise of Option</U>.</B> I hereby elect to exercise the Option to purchase the following number of
Shares, in accordance with the Notice and the Option Agreement: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested Shares</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested Shares:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Shares Purchased:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Exercise Price (Total Shares X Price per Share)</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <B><U>Payments</U>.</B> I enclose payment in full of the total exercise price for the Shares in the
following form(s), as authorized by my Option Agreement: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="26%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">! Cash:</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">! Check:</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">! Tender of Company Stock:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Contact&nbsp;Plan&nbsp;Administrator</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <B><U>Tax Withholding</U>.</B> I authorize payroll withholding and otherwise will make
adequate provision for the federal, state, local and foreign tax withholding obligations of the Company, if any, in connection with the Option. If I am exercising a Nonstatutory Stock Option, I enclose payment in full of my withholding taxes, if
any, as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Contact Plan Administrator for amount of tax due.) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash:</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Check:</P></TD>
<TD VALIGN="bottom"></TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U><B>Participant Information</B></U>. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">My&nbsp;address&nbsp;is:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="87%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">My&nbsp;Social&nbsp;Security&nbsp;Number&nbsp;is:</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <B><U>Notice of Disqualifying Disposition</U>.</B> If the Option is an Incentive Stock Option, I agree that
I will promptly notify the Chief Financial Officer of the Company if I transfer any of the Shares within one (1)&nbsp;year from the date I exercise all or part of the Option or within two (2)&nbsp;years of the Date of Option Grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <B><U>Binding Effect</U>.</B> I agree that the Shares are being acquired in accordance with and subject to the terms, provisions and
conditions of the Option Agreement, including the Unvested Share Repurchase Option and the Right of First Refusal set forth therein, to all of which I hereby expressly assent. This Agreement shall inure to the benefit of and be binding upon my
heirs, executors, administrators, successors and assigns. If required by the Company, I agree to deposit the certificate(s) evidencing the Shares, along with a blank stock assignment separate from certificate executed by me, with an escrow agent
designated by the Company, to be held pursuant to the Company&#146;s standard Joint Escrow Instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <B><U>Transfer</U>.</B> I am
aware of the Company&#146;s business affairs and financial condition and have acquired sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Shares. I am acquiring these Shares for investment for my
own account only and not with a view to, or for resale in connection with, any &#147;distribution&#148; thereof within the meaning of the Securities Act of 1933, as amended (the &#147;<B><I>Securities Act</I></B>&#148;). I acknowledge and understand
that the Shares constitute &#147;restricted securities&#148; under the Securities Act and have not been registered under the Securities Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona
fide nature of my investment intent as expressed herein. I understand that, in the view of the Securities and Exchange Commission, the statutory basis for such exemption may be unavailable if my representation was predicated solely upon a present
intention to hold these Shares for the minimum capital gains period specified under tax statutes, for a deferred sale, for or until an increase or decrease in the market price of the Shares, or for a period of one year or any other fixed period in
the future. I understand and acknowledge that the Shares have not been registered under the Securities Act, and that consequently the Shares must be held indefinitely unless they are subsequently registered under the Securities Act, an exemption
from such registration is available, or they are sold in accordance with Rule 144 or Rule 701 under the Securities Act. I further understand and acknowledge that the Company is under no obligation to register the Shares: I understand that the
certificate or certificates evidencing the Shares will imprinted with legends which prohibit the transfer of the Shares unless they are registered or such registration is not required in the option of legal counsel satisfactory to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <B><U>Election Under Section&nbsp;83(b) of the Code</U>.</B> I understand and acknowledge that if I am exercising the Option to purchase
Unvested Shares (i.e., shares that remain subject to the Company&#146;s Unvested Share Repurchase Option), that I should consult with my tax advisor regarding the advisability of filing with the Internal Revenue Service an election under
Section&nbsp;83(b) of the Code, which must be filed no later than thirty (30)&nbsp;days after the date on which I exercise the Option. I acknowledge that I have been advised to consult with a tax advisor prior to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the exercise of the Option regarding the tax consequences to me of exercising the Option. AN ELECTION UNDER SECTION 83(b) MUST BE FILED WITHIN 30 DAYS AFTER THE DATE ON WHICH I PURCHASE SHARES.
THIS TIME PERIOD CANNOT BE EXTENDED. I ACKNOWLEDGE THAT TIMELY FILING OF A SECTION 83(b) ELECTION IS MY SOLE RESPONSIBILITY, EVEN IF I REQUEST THE COMPANY OR ITS REPRESENTATIVES TO FILE SUCH ELECTION ON MY BEHALF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I am familiar with the provisions of Rule 70 I and Rule 144, each promulgated under the Securities Act, which, in substance, permit limited
public resale of &#147;restricted securities&#148; acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions. Rule 701 provides that If the issuer qualifies under Rule 70 I
at the time of the grant of the Option to me, the exercise will be exempt from registration under the Securities Act. In the event the Company becomes subject to the reporting requirements of Section&nbsp;13 or 15( d) of the Securities Exchange Act
of 1934, as amended (the &#147;<B><I>Exchange Act</I></B>&#148;) ninety (90)&nbsp;days thereafter (or such longer period as any market stand-off agreement may require) the Shares exempt under Rule 701 may under present law be resold, subject to the
satisfaction of certain of the conditions specified by Rule 144, including: (1)&nbsp;the resale being made through a broker in an unsolicited &#147;broker&#146;s transaction&#148; or in transactions directly with a market maker (as this term is
defined under the Exchange Act); and, in the case of an affiliate, (2)&nbsp;the availability of certain public information about the Company, (3)&nbsp;the amount of Shares being sold during any three (3)&nbsp;month period not exceeding the
limitations specified in Rule 144(e), and (4)&nbsp;the timely filing of a Form 144, if applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that the Company does not
qualify under Rule 701 at the time of grant of the Option, then the Shares may be resold in certain limited circumstances subject to the provisions of Rule 144, which, effective as of February&nbsp;15, 2008, requires the resale to occur not less
than six months, or, in the event the Company is not subject to the reporting requirements of Section&nbsp;13 or 15(d) of the Exchange Act, not less than one year, after the later of the date the Shares were sold by the Company or the date the
Shares were sold by an affiliate of the Company, within the meaning of Rule 144; and, in the case of acquisition of the Shares by an affiliate, the satisfaction of the conditions set forth in sections (1), (2), (3)&nbsp;and (4)&nbsp;of the paragraph
immediately above or, in the case of a non-affiliate who subsequently holds the Shares less than one year, the satisfaction of the conditions set forth in section (2)&nbsp;of the paragraph immediately above. I understand that any sale of the Shares
that might be made in reliance upon Rule 144 may only be made in limited amounts in accordance with the terms and conditions of such rule and that a copy of Rule 144 will be delivered to me upon request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I further understand that in the event all of the applicable requirements of Rule 701 or 144 are not satisfied, registration under the
Securities Act, compliance with Regulation A, or some other registration exemption will be required; and that, notwithstanding the fact that Rules 144 and 701 are not exclusive, the Staff of the Securities and Exchange Commission has expressed its
opinion that persons proposing to sell private placement securities other than in a registered offering and otherwise than pursuant to Rules&nbsp;144 or 701 will have a substantial burden of proof in establishing that an exemption from registration
is available for such offers or sales, and that such persons and their respective brokers who participate in such transactions do so at their own risk. I understand that no assurances can be given that any such other registration exemption will be
available in such event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I understand that I am purchasing the Shares pursuant to the terms of the Plan, the Notice and my Option
Agreement, copies of which I have received and carefully read and understand. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">(Signature)</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Receipt of the above is hereby acknowledged. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Penumbra, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>12
<FILENAME>filename12.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.8</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.8 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INDEMNIFICATION AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Indemnification Agreement (the &#147;<U>Agreement</U>&#148;) is made as of November&nbsp;1, 2008, by and between Penumbra, Inc., a
Delaware corporation (the &#147;<U>Company</U>&#148;), and &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (the &#147;<U>Indemnitee</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>RECITALS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company and Indemnitee recognize the increasing difficulty in obtaining liability insurance for directors, officers and key employees, the significant increases in the cost of such insurance and the general reductions in the coverage of such
insurance. The Company and Indemnitee further recognize the substantial increase in corporate litigation in general, subjecting directors, officers and key employees to expensive litigation risks at the same time as the availability and coverage of
liability insurance has been severely limited. Indemnitee does not regard the current protection available as adequate under the present circumstances, and Indemnitee and agents of the Company may not be willing to continue to serve as agents of the
Company without additional protection. The Company desires to attract and retain the services of highly qualified individuals, such as Indemnitee, and to indemnify its directors, officers and key employees so as to provide them with the maximum
protection permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration of the mutual promises made in this Agreement, and for other good and valuable consideration, receipt of which is hereby
acknowledged, the Company and Indemnitee hereby agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>1. <B><U>Indemnification</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U><B>Third Party Proceedings</B>.</U> The Company shall indemnify Indemnitee if Indemnitee is or was a party or is threatened to be made
a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Company) by reason of the fact that Indemnitee is or was a director,
officer, employee or agent of the Company, or any subsidiary of the Company, by reason of any action or inaction on the part of Indemnitee while an officer or director or by reason of the fact that Indemnitee is or was serving at the request of the
Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement (if such settlement
is approved in advance by the Company, which approval shall not be unreasonably withheld) actually and reasonably incurred by Indemnitee in connection with such action, suit or proceeding if Indemnitee acted in good faith and in a manner Indemnitee
reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe Indemnitee&#146;s conduct was unlawful. The termination of any action, suit
or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed
to be in or not opposed to the best interests of the Company, or, with respect to any criminal action or proceeding, that Indemnitee had reasonable cause to believe that Indemnitee&#146;s conduct was unlawful. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U><B>Proceedings By or in the Right of the Company</B>.</U> The Company shall indemnify
Indemnitee if Indemnitee was or is a party or is threatened to be made a party to any threatened, pending or completed action or proceeding by or in the right of the Company or any subsidiary of the Company to procure a judgment in its favor by
reason of the fact that Indemnitee is or was a director, officer, employee or agent of the Company, or any subsidiary of the Company, by reason of any action or inaction on the part of Indemnitee while an officer or director or by reason of the fact
that Indemnitee is or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys&#146; fees) and, to the
fullest extent permitted by law, amounts paid in settlement (if such settlement is approved in advance by the Company, which approval shall not be unreasonably withheld), in each case to the extent actually and reasonably incurred by Indemnitee in
connection with the defense or settlement of such action or suit if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company and its stockholders, except that no
indemnification shall be made in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudicated by court order or judgment to be liable to the Company in the performance of Indemnitee&#146;s duty to the Company and
its stockholders unless and only to the extent that the court in which such action or proceeding is or was pending shall determine upon application that, in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to
indemnity for such expenses which such court shall deem proper. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U><B>Mandatory Payment of Expenses</B>.</U> To the extent that
Indemnitee has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in Section&nbsp;1(a) or Section&nbsp;1(b) or the defense of any claim, issue or matter therein, Indemnitee shall be indemnified
against expenses (including attorneys&#146; fees) actually and reasonably incurred by Indemnitee in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>2.
<B><U>No Employment Rights</U>.</B> Nothing contained in this Agreement is intended to create in Indemnitee any right to continued employment. <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>3. <B><U>Expenses; Indemnification Procedure</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U><B>Advancement of Expenses</B>.</U> The Company shall advance all expenses incurred by Indemnitee in connection with the investigation,
defense, settlement or appeal of any civil or criminal action, suit or proceeding referred to in Section l(a) or Section&nbsp;1(b) hereof (including amounts actually paid in settlement of any such action, suit or proceeding). Indemnitee hereby
undertakes to repay such amounts advanced only if, and to the extent that, it shall ultimately be determined that Indemnitee is not entitled to be indemnified by the Company as authorized hereby. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U><B>Notice/Cooperation by Indemnitee</B>.</U> Indemnitee shall, as a condition precedent to
his or her right to be indemnified under this Agreement, give the Company notice in writing as soon as practicable of any claim made against Indemnitee for which indemnification will or could be sought under this Agreement. Notice to the Company
shall be directed to the Chief Executive Officer of the Company and shall be given in accordance with the provisions of Section&nbsp;12(d) below. In addition, Indemnitee shall give the Company such information and cooperation as it may reasonably
require and as shall be within Indemnitee&#146;s power. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U><B>Procedure</B>.</U> Any indemnification and advances provided for in
Section&nbsp;1 and this Section&nbsp;3 shall be made no later than twenty (20)&nbsp;days after receipt of the written request of Indemnitee. If a claim under this Agreement, under any statute, or under any provision of the Company&#146;s Certificate
of Incorporation or Bylaws providing for indemnification, is not paid in full by the Company within twenty (20)&nbsp;days after a written request for payment thereof has first been received by the Company, Indemnitee may, but need not, at any time
thereafter bring an action against the Company to recover the unpaid amount of the claim and, subject to Section&nbsp;11 of this Agreement, Indemnitee shall also be entitled to be paid for the expenses (including attorneys&#146; fees) of bringing
such action. It shall be a defense to any such action (other than an action brought to enforce a claim for expenses incurred in connection with any action, suit or proceeding in advance of its final disposition) that Indemnitee has not met the
standards of conduct which make it permissible under applicable law for the Company to indemnify Indemnitee for the amount claimed, but the burden of proving such defense shall be on the Company and Indemnitee shall be entitled to receive interim
payments of expenses pursuant to Section&nbsp;3(a) unless and until such defense may be finally adjudicated by court order or judgment from which no further right of appeal exists. It is the parties&#146; intention that if the Company contests
Indemnitee&#146;s right to indemnification, the question of Indemnitee&#146;s right to indemnification shall be for the court to decide, and neither the failure of the Company (including its Board of Directors, any committee or subgroup of the Board
of Directors, independent legal counsel, or its stockholders) to have made a determination that indemnification of Indemnitee is proper in the circumstances because Indemnitee has met the applicable standard of conduct required by applicable law,
nor an actual determination by the Company (including its Board of Directors, any committee or subgroup of the Board of Directors, independent legal counsel, or its stockholders) that Indemnitee has not met such applicable standard of conduct, shall
create a presumption that Indemnitee has or has not met the applicable standard of conduct. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U><B>Notice to Insurers</B>.</U> If, at
the time of the receipt of a notice of a claim pursuant to Section&nbsp;3(b) hereof, the Company has director and officer liability insurance in effect, the Company shall give prompt notice of the commencement of such proceeding to the insurers in
accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such proceeding
in accordance with the terms of such policies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <U><B>Selection of Counsel</B>.</U> In the event the Company shall be obligated under
Section&nbsp;3(a) hereof to pay the expenses of any proceeding against Indemnitee, the Company, if appropriate, shall be entitled to assume the defense of such proceeding, with counsel approved by Indemnitee, upon the delivery to Indemnitee of
written notice of its election so to do. After delivery of such notice, approval of such counsel by Indemnitee and the retention of such </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">counsel by the Company, the Company will not be liable to Indemnitee under this Agreement for any fees of counsel
subsequently incurred by Indemnitee with respect to the same proceeding, provided that (i)&nbsp;Indemnitee shall have the right to employ counsel in any such proceeding at Indemnitee&#146;s expense; and (ii)&nbsp;if (A)&nbsp;the employment of
counsel by Indemnitee has been previously authorized by the Company, (B)&nbsp;Indemnitee shall have reasonably concluded that there may be a conflict of interest between the Company and Indemnitee in the conduct of any such defense or (C)&nbsp;the
Company shall not, in fact, have employed counsel to assume the defense of such proceeding, then the fees and expenses of Indemnitee&#146;s counsel shall be at the expense of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>4. <B><U>Additional Indemnification Rights; Nonexclusivity</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U><B>Scope</B>.</U> Notwithstanding any other provision of this Agreement, the Company hereby agrees to indemnify the Indemnitee to the
fullest extent permitted by law, notwithstanding that such indemnification is not specifically authorized by the other provisions of this Agreement, the Company&#146;s Certificate of Incorporation, the Company&#146;s Bylaws or by statute. In the
event of any change, after the date of this Agreement, in any applicable law, statute, or rule which expands the right of a Delaware corporation to indemnify a member of its board of directors or an officer, such changes shall be deemed to be within
the purview of Indemnitee&#146;s rights and the Company&#146;s obligations under this Agreement. In the event of any change in any applicable law, statute or rule which narrows the right of a Delaware corporation to indemnify a member of its board
of directors or an officer, such changes, to the extent not otherwise required by such law, statute or rule to be applied to this Agreement shall have no effect on this Agreement or the parties&#146; rights and obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U><B>Nonexclusivity</B>.</U> The indemnification provided by this Agreement shall not be deemed exclusive of any rights to which
Indemnitee may be entitled under the Company&#146;s Certificate of Incorporation, its Bylaws, any agreement, any vote of stockholders or disinterested members of the Company&#146;s Board of Directors, the General Corporation Law of the State of
Delaware, or otherwise, both as to action in Indemnitee&#146;s official capacity and as to action in another capacity while holding such office. The indemnification provided under this Agreement shall continue as to Indemnitee for any action taken
or not taken while serving in an indemnified capacity even though he or she may have ceased to serve in any such capacity at the time of any action, suit or other covered proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>5. <B><U>Partial Indemnification</U>.</B> If Indemnitee is entitled under any provision of this Agreement to indemnification by the
Company for some or a portion of the expenses, judgments, fines or penalties actually or reasonably incurred in the investigation, defense, appeal or settlement of any civil or criminal action, suit or proceeding, but not, however, for the total
amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion of such expenses, judgments, fines or penalties to which Indemnitee is entitled. <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>6. <B><U>Mutual Acknowledgment</U>.</B> Both the Company and Indemnitee acknowledge that in certain instances, Federal law or public
policy may override applicable state law and prohibit the Company from indemnifying its directors and officers under this Agreement or otherwise. For example, the Company and Indemnitee acknowledge that the Securities and Exchange <B>
</B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Commission (the &#147;<U>SEC</U>&#148;) has taken the position that indemnification is not permissible for liabilities arising under certain federal securities laws, and federal legislation
prohibits indemnification for certain ERISA violations. Indemnitee understands and acknowledges that the Company has undertaken or may be required in the future to undertake with the SEC to submit the question of indemnification to a court in
certain circumstances for a determination of the Company&#146;s right under public policy to indemnify Indemnitee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>7.
<B><U>Officer and Director Liability Insurance</U>.</B> The Company shall, from time to time, make the good faith determination whether or not it is practicable for the Company to obtain and maintain a policy or policies of insurance with reputable
insurance companies providing the officers and directors of the Company with coverage for losses from wrongful acts, or to ensure the Company&#146;s performance of its indemnification obligations under this Agreement. Among other considerations, the
Company will weigh the costs of obtaining such insurance coverage against the protection afforded by such coverage. In all policies of director and officer liability insurance, Indemnitee shall be named as an insured in such a manner as to provide
Indemnitee the same rights and benefits as are accorded to the most favorably insured of the Company&#146;s directors, if Indemnitee is a director; or of the Company&#146;s officers, if Indemnitee is not a director of the Company but is an officer;
or of the Company&#146;s key employees, if Indemnitee is not an officer or director but is a key employee. Notwithstanding the foregoing, the Company shall have no obligation to obtain or maintain such insurance if the Company determines in good
faith that such insurance is not reasonably available, if the premium costs for such insurance are disproportionate to the amount of coverage provided, if the coverage provided by such insurance is limited by exclusions so as to provide an
insufficient benefit, or if Indemnitee is covered by similar insurance maintained by a parent or subsidiary of the Company. <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>8. <B><U>Severability</U>.</B> Nothing in this Agreement is intended to require or shall be construed as requiring the Company to do or
fail to do any act in violation of applicable law. The Company&#146;s inability, pursuant to court order, to perform its obligations under this Agreement shall not constitute a breach of this Agreement. The provisions of this Agreement shall be
severable as provided in this Section&nbsp;8. If this Agreement or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the Company shall nevertheless indemnify Indemnitee to the full extent permitted by
any applicable portion of this Agreement that shall not have been invalidated, and the balance of this Agreement not so invalidated shall be enforceable in accordance with its terms. <B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>9. <B><U>Exceptions</U>.</B> Any other provision herein to the contrary notwithstanding, the Company shall not be obligated pursuant to
the terms of this Agreement: <B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U><B>Claims Initiated by Indemnitee</B>.</U> To indemnify or advance expenses to Indemnitee
with respect to proceedings or claims initiated or brought voluntarily by Indemnitee and not by way of defense, except with respect to proceedings brought to establish or enforce a right to indemnification under this Agreement or any other statute
or law or otherwise as required under Section&nbsp;145 of the Delaware General Corporation Law, but such indemnification or advancement of expenses may be provided by the Company in specific cases if the Board of Directors finds it to be
appropriate; </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U><B>Lack of Good Faith</B>.</U> To indemnify Indemnitee for any expenses incurred by
Indemnitee with respect to any proceeding instituted by Indemnitee to enforce or interpret this Agreement, if a court of competent jurisdiction determines that each of the material assertions made by Indemnitee in such proceeding was not made in
good faith or was frivolous; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U><B>Insured Claims</B>.</U> To indemnify Indemnitee for expenses or liabilities of any type whatsoever
(including, but not limited to, judgments, fines, ERISA excise taxes or penalties, and amounts paid in settlement) to the extent such expenses or liabilities have been paid directly to Indemnitee by an insurance carrier under a policy of
officers&#146; and directors&#146; liability insurance maintained by the Company; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U><B>Claims under Section&nbsp;16(b)</B>.</U>
To indemnify Indemnitee for expenses or the payment of profits arising from the purchase and sale by Indemnitee of securities in violation of Section&nbsp;16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor statute.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>10. <B><U>Construction of Certain Phrases</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) For purposes of this Agreement, references to the &#147;<U>Company</U>&#148; shall include, in addition to the resulting corporation, any
constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, and employees or
agents, so that if Indemnitee is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another corporation,
partnership, joint venture, trust or other enterprise, Indemnitee shall stand in the same position under the provisions of this Agreement with respect to the resulting or surviving corporation as Indemnitee would have with respect to such
constituent corporation if its separate existence had continued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) For purposes of this Agreement, references to &#147;<U>other
enterprises</U>&#148; shall include employee benefit plans; references to &#147;<U>fines</U>&#148; shall include any excise taxes assessed on Indemnitee with respect to an employee benefit plan; and references to &#147;<U>serving at the request of
the Company</U>&#148; shall include any service as a director, officer, employee or agent of the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its
participants, or beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the interest of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in
a manner &#147;<U>not opposed to the best interests of the Company</U>&#148; as referred to in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>11.
<B><U>Attorneys&#146; Fees</U>.</B> In the event that any action is instituted by Indemnitee under this Agreement to enforce or interpret any of the terms hereof, Indemnitee shall be entitled to be paid all court costs and expenses, including
reasonable attorneys&#146; fees, incurred by Indemnitee with respect to such action, unless as a part of such action, the court of competent jurisdiction determines that each of the material assertions made by Indemnitee as a basis for such action
were not made in good faith or were frivolous. In the event of an action instituted by or in the <B> </B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
name of the Company under this Agreement or to enforce or interpret any of the terms of this Agreement, Indemnitee shall be entitled to be paid all court costs and expenses, including
attorneys&#146; fees, incurred by Indemnitee in defense of such action (including with respect to Indemnitee&#146;s counterclaims and cross-claims made in such action), unless as a part of such action the court determines that each of
Indemnitee&#146;s material defenses to such action were made in bad faith or were frivolous. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>12. <B><U>Miscellaneous</U>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) <U><B>Governing Law</B>.</U> This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties
hereto shall be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflict of law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) <U><B>Entire Agreement; Enforcement of Rights</B>.</U> This Agreement sets forth the entire agreement and understanding of the parties
relating to the subject matter herein and merges all prior discussions between them. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to
this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(c) <U><B>Construction</B>.</U> This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and
their respective counsel, if any; accordingly, this Agreement shall be deemed to be the product of all of the parties hereto, and no ambiguity shall be construed in favor of or against any one of the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(d) <U><B>Notices</B>.</U> Any notice, demand or request required or permitted to be given under this Agreement shall be in writing and shall
be deemed sufficient when delivered personally or sent by telegram or forty-eight (48)&nbsp;hours after being deposited in the U.S. mail, as certified or registered mail, with postage prepaid, and addressed to the party to be notified at such
party&#146;s address as set forth below or as subsequently modified by written notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(e) <U><B>Counterparts</B>.</U> This Agreement may
be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(f) <U><B>Successors and Assigns</B>.</U> This Agreement shall be binding upon the Company and its successors and assigns, and inure to the
benefit of Indemnitee and Indemnitee&#146;s heirs, legal representatives and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(g) <B><U>Subrogation</U></B>.<B></B> In the event
of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all documents required and shall do all acts that may be necessary to secure such rights
and to enable the Company to effectively bring suit to enforce such rights. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The parties hereto have executed this Agreement as of the day and year set forth on the first
page of this Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Penumbra, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adam Elsesser</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Executive
Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1351 Harbor Bay Parkway</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Alameda, CA
94502</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AGREED TO AND ACCEPTED:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>13
<FILENAME>filename13.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.9</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.9 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF INDEMNIFICATION AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>This Indemnification Agreement (this &#147;<B>Agreement</B>&#148;), made and entered into as of the &nbsp;&nbsp;&nbsp;&nbsp; day of
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 20&nbsp;&nbsp;&nbsp;&nbsp;, by and between Penumbra, Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;) and
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(&#147;<B>Indemnitee</B>&#148;).<B> </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W&nbsp;I&nbsp;T&nbsp;N&nbsp;E&nbsp;S&nbsp;S&nbsp;E&nbsp;T&nbsp;H: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, highly competent persons have become more reluctant to serve publicly-held corporations as directors or officers or in other
capacities unless they are provided with adequate protection through insurance or adequate indemnification against risks of claims and actions against them arising out of their service to and activities on behalf of the corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>WHEREAS, the Board of Directors of the Company (the &#147;<B>Board</B>&#148;) has determined that, in order to attract and retain
qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance
has been a customary and widespread practice among United States-based corporations and other business enterprises, the Company believes that, given current market conditions and trends, such insurance may be available to it in the future only at
higher premiums and with more exclusions. At the same time, directors, officers, and other persons in service to corporations or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to, among
other things, matters that traditionally would have been brought only against the Company or business enterprise itself.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>WHEREAS, the Certificate of Incorporation of the Company provides that the Company shall indemnify and advance expenses to all
directors and officers of the Company in the manner set forth therein and to the fullest extent permitted by applicable law, and the Company&#146;s Certificate of Incorporation provides for limitation of liability for directors. In addition,
Indemnitee may be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (&#147;<B>DGCL</B>&#148;) . The Certificate of Incorporation and the DGCL expressly provide that the indemnification provisions set forth
therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the board of directors, officers and other persons with respect to indemnification.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such
persons. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board has determined that the increased difficulty in attracting and retaining such
persons is detrimental to the best interests of the Company&#146;s stockholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on
behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, this Agreement is a supplement to and in furtherance of the Company&#146;s Certificate of Incorporation and any resolutions adopted
pursuant thereto and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
Indemnitee does not regard the protection available under the Company&#146;s Certificate of Incorporation and insurance as adequate in the present circumstances, and may not be willing to serve as an officer or director of the Company without
adequate protection, and the Company desires Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that he be so indemnified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree
as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">A<SMALL>RTICLE</SMALL> 1 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C<SMALL>ERTAIN</SMALL> D<SMALL>EFINITIONS</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As used in this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Change of Control</B>&#148; means any one of the following circumstances occurring after the date hereof: (i)&nbsp;there shall
have occurred an event required to be reported with respect to the Company in response to Item&nbsp;6(e) of Schedule 14A of Regulation 14A (or in response to any similar item or any similar schedule or form) under the Exchange Act, regardless of
whether the Company is then subject to such reporting requirement; (ii)&nbsp;any &#147;person&#148; or &#147;group&#148; (as such terms are used in Sections 13(d) and 14(d) of the Exchange Act) shall have become, without prior approval of the
Company&#146;s Board by approval of at least a majority of the Continuing Directors, the &#147;beneficial owner&#148; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 15% or more of
the combined voting power of the Company&#146;s then outstanding voting securities (provided that, for purposes of this clause (ii), the term &#147;person&#148; shall exclude (x)&nbsp;the Company, (y)&nbsp;any trustee or other fiduciary holding <B>
</B></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities under an employee benefit plan of the Company, and (z)&nbsp;any corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as
their ownership of stock of the Company); (iii)&nbsp;there occurs a merger or consolidation of the Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately
prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 51% of the combined voting power of the voting securities of the surviving
entity outstanding immediately after such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body of such surviving entity; (iv)&nbsp;all or substantially all the assets of the
Company are sold or disposed of in a transaction or series of related transactions; (v)&nbsp;the approval by the stockholders of the Company of a complete liquidation of the Company; or (vi)&nbsp;the Continuing Directors cease for any reason to
constitute at least a majority of the members of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Continuing Director</B>&#148; means (i)&nbsp;each director on
the Board on the date hereof or (ii)&nbsp;any new director whose election or nomination for election by the Company&#146;s stockholders was approved by a vote of at least a majority of the directors then still in office who were directors on the
date hereof or whose election or nomination was so approved.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Corporate Status</B>&#148; means the status of a
person who is or was a director, officer, trustee, general partner, managing member, fiduciary, board of directors&#146; committee member, employee or agent of the Company or of any other Enterprise.<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Disinterested Director</B>&#148; means a director of the Company who is not and was not a party to the Proceeding in respect
of which indemnification is sought by Indemnitee.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Enterprise</B>&#148; means the Company and any other
corporation, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, trustee, general partner, managing
member, fiduciary, board of directors&#146; committee member, employee or agent.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>ERISA</B>&#148; means the
Employee Retirement Income Security Act of 1974, as amended.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Exchange Act</B>&#148; means the Securities Exchange
Act of 1934, as amended.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Expenses</B>&#148; means all direct and indirect costs (including attorneys&#146; fees,
retainers, court costs, transcripts, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses) reasonably incurred in
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with (i)&nbsp;prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding or
(ii)&nbsp;establishing or enforcing a right to indemnification under this Agreement, the Company&#146;s Certificate of Incorporation, applicable law or otherwise. Expenses also shall include Expenses incurred in connection with any appeal resulting
from any Proceeding, including the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent. For the avoidance of doubt, Expenses, however, shall not include any Liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Independent Counsel</B>&#148; means a law firm, or a member of a law firm, that is experienced in matters of corporate law and
neither currently is, nor in the five years previous to its selection or appointment has been, retained to represent (i)&nbsp;the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning
Indemnitee under this Agreement or of other indemnitees under similar indemnification agreements) or (ii)&nbsp;any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term
&#147;Independent Counsel&#148; shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine
Indemnitee&#146;s rights under this Agreement.<B> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Liabilities</B>&#148; means any losses or liabilities, including
any judgments, fines, ERISA excise taxes and penalties, penalties and amounts paid in settlement, arising out of or in connection with any Proceeding (including all interest, assessments and other charges paid or payable in connection with or in
respect of any such judgments, fines, ERISA excise taxes and penalties, penalties or amounts paid in settlement).<B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B></B>&#147;<B>Proceeding</B>&#148; means any threatened, pending or completed action, derivative action, suit, claim, counterclaim, cross
claim, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether civil (including intentional and unintentional tort claims), criminal,
administrative or investigative, including any appeal therefrom, and whether instituted by or on behalf of the Company or any other party, or any inquiry or investigation that Indemnitee in good faith believes might lead to the institution of any
such action, suit or other proceeding hereinabove listed in which Indemnitee was, is or will be involved as a party, potential party, non-party witness or otherwise by reason of any Corporate Status of Indemnitee, or by reason of any action taken
(or failure to act) by him or her or of any action (or failure to act) on his or her part while serving in any Corporate Status.<B> </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) For the purposes of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">References to &#147;Company&#148; shall include, in addition to the resulting or surviving corporation, any constituent corporation (including
any constituent of a </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, employees or agents, so
that if Indemnitee is or was a director, officer, employee, or agent of such constituent corporation or is or was serving at the request of such constituent corporation as a director, officer, employee, or agent of another corporation, partnership,
joint venture, trust or other enterprise, then Indemnitee shall stand in the same position under the provisions of this Agreement with respect to the resulting or surviving corporation as Indemnitee would have with respect to such constituent
corporation if its separate existence had continued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference to &#147;other enterprise&#148; shall include employee benefit plans;
references to &#147;fines&#148; shall include any excise tax assessed with respect to any employee benefit plan; references to &#147;serving at the request of the Company&#148; shall include any service as a director, officer, employee or agent of
the Company which imposes duties on, or involves services by, such director, officer, employee or agent with respect to an employee benefit plan, its participants or beneficiaries; and a person who acted in good faith and in a manner he reasonably
believed to be in the best interests of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &#147;not opposed to the best interests of the Company&#148; as referred to in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference to &#147;including&#148; shall mean &#147;including, without limitation,&#148; regardless of whether the words &#147;without
limitation&#148; actually appear, references to the words &#147;herein,&#148; &#147;hereof&#148; and &#147;hereunder&#148; and other words of similar import shall refer to this Agreement as a whole and not to any particular paragraph, subparagraph,
section, subsection or other subdivision. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 2 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S<SMALL>ERVICES</SMALL> B<SMALL>Y</SMALL> I<SMALL>NDEMNITEE</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;2.01<I>. Services By Indemnitee. </I>Indemnitee hereby agrees to serve or continue to serve as a director, officer or key
employee of the Company, for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders his or her resignation or is removed.<I> </I></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 3 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I<SMALL>NDEMNIFICATION</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.01<I>. General. </I>(a)&nbsp;The Company hereby agrees to and shall indemnify Indemnitee and hold Indemnitee harmless
from and against any and all Expenses and Liabilities, in either case, actually and reasonably incurred by Indemnitee or on Indemnitee&#146;s behalf by reason of Indemnitee&#146;s Corporate Status, to the fullest extent permitted by applicable law.
The Company&#146;s indemnification obligations set forth in this Section&nbsp;3.01 shall apply (i)&nbsp;in respect of Indemnitee&#146;s <I> </I></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
past, present and future service in any Corporate Status and (ii)&nbsp;regardless of whether Indemnitee is serving in any Corporate Status at the time any such Expense or Liability is incurred.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, the meaning of the phrase &#147;to the fullest extent permitted by applicable law&#148; shall include,
but not be limited to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) to the fullest extent permitted by any provision of the DGCL, or the corresponding provision of
any successor statute, and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) to the fullest extent authorized or permitted by any amendments to or replacements of the
DGCL adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(b) <I>Witness Expenses</I>. Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is, by reason of his
or her Corporate Status, a witness in any Proceeding to which Indemnitee is not a party, he shall be indemnified against all Expenses actually and reasonably incurred by Indemnitee or on his or her behalf in connection therewith.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(c) <I>Expenses as a Party Where Wholly or Partly Successful</I>. Notwithstanding any other provisions of this Agreement, to the
fullest extent permitted by applicable law, to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part,
the Company shall indemnify Indemnitee against all Expenses actually and reasonably incurred by him or her in connection therewith. If Indemnitee is not wholly successful in such Proceeding, but is successful, on the merits or otherwise, as to one
or more but less than all claims, issues or matters in such Proceeding, the Company shall, to the fullest extent permitted by applicable law, indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on his or her
behalf in connection with each successfully resolved claim, issue or matter. For purposes of this Section and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be
deemed to be a successful result as to such claim, issue or matter.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;3.02<I>. Exclusions. </I>Notwithstanding
any provision of this Agreement and unless Indemnitee ultimately is successful on the merits with respect to any such claim, the Company shall not be obligated under this Agreement to make any indemnity in connection with any claim made against
Indemnitee:<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) for (i)&nbsp;an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of
securities of the Company within the meaning of Section&nbsp;16(b) of the Exchange Act or similar provisions of state statutory law or common law or (ii)&nbsp;any reimbursement of the Company by </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Indemnitee of any bonus or other incentive-based or equity-based compensation or of any profits realized by Indemnitee from the sale of securities of the Company, as required in each case under
the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 (the &#147;<B>Sarbanes-Oxley Act</B>&#148;), or the payment to the Company of
profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act); or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)
except as otherwise provided in Sections 6.01(e), prior to a Change of Control, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee (other than any cross claim or counterclaim asserted by the Indemnitee),
including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i)&nbsp;the Board authorized the Proceeding (or any part of any Proceeding)
prior to its initiation or (ii)&nbsp;the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 4 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A<SMALL>DVANCEMENT</SMALL> O<SMALL>F</SMALL> E<SMALL>XPENSES</SMALL>; D<SMALL>EFENSE</SMALL> <SMALL>OF</SMALL> C<SMALL>LAIMS</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.01<I>. Advances. </I>Notwithstanding any provision of this Agreement to the contrary, the Company shall advance any
Expenses actually and reasonably incurred by Indemnitee in connection with any Proceeding within ten (10)&nbsp;days after the receipt by the Company of each statement requesting such advance from time to time, whether prior to or after final
disposition of any Proceeding. Advances shall be unsecured and interest free. Advances shall be made without regard to Indemnitee&#146;s ability to repay such amounts and without regard to Indemnitee&#146;s ultimate entitlement to indemnification
under the other provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to
support the advances claimed. <I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;4.02<I>. Repayment of Advances or Other Expenses. </I>Indemnitee agrees that
Indemnitee shall reimburse the Company for all Expenses advanced by the Company pursuant to Section&nbsp;4.01, in the event and only to the extent that it shall be determined by final judgment or other final adjudication under the provisions of any
applicable law (as to which all rights of appeal therefrom have been exhausted or lapsed) that Indemnitee is not entitled to be indemnified by the Company for such Expenses.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03. <I>Defense of Claims.</I> The Company will be entitled to participate in the Proceeding at its own expense. The Company
shall not settle any action, claim or Proceeding (in whole or in part) which would impose any </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Expense, judgment, fine, penalty or limitation on Indemnitee without Indemnitee&#146;s prior written consent, such consent not to be unreasonably withheld. Indemnitee shall not settle any action,
claim or Proceeding (in whole or in part) which would impose any Expense, judgment, fine, penalty or limitation on the Company without the Company&#146;s prior written consent, such consent not to be unreasonably withheld. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 5 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">P<SMALL>ROCEDURES</SMALL> F<SMALL>OR</SMALL> N<SMALL>OTIFICATION</SMALL> <SMALL>OF</SMALL> <SMALL>AND</SMALL> D<SMALL>ETERMINATION</SMALL>
<SMALL>OF</SMALL> E<SMALL>NTITLEMENT</SMALL> T<SMALL>O</SMALL> I<SMALL>NDEMNIFICATION</SMALL> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;5.01<I>. Notification;
Request For Indemnification. </I>(a)&nbsp;As soon as reasonably practicable after receipt by Indemnitee of written notice that he is a party to or a participant (as a witness or otherwise) in any Proceeding or of any other matter in respect of which
Indemnitee intends to seek indemnification or advancement of Expenses hereunder, Indemnitee shall provide to the Company written notice thereof, including the nature of and the facts underlying the Proceeding. The omission by Indemnitee to so notify
the Company will not relieve the Company from any liability which it may have to Indemnitee hereunder or otherwise.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) To obtain
indemnification under this Agreement, Indemnitee shall deliver to the Company a written request for indemnification, including therewith such information as is reasonably available to Indemnitee and reasonably necessary to determine
Indemnitee&#146;s entitlement to indemnification hereunder. Such request(s) may be delivered from time to time and at such time(s) as Indemnitee deems appropriate in his or her sole discretion. Indemnitee&#146;s entitlement to indemnification shall
be determined according to Section&nbsp;5.02 of this Agreement and applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02<I>. Determination of Entitlement.
</I>(a)&nbsp;Where there has been a written request by Indemnitee for indemnification pursuant to Section&nbsp;5.01(b), then as soon as is reasonably practicable (but in any event not later than 60 days) after final disposition of the relevant
Proceeding, a determination, if required by applicable law, with respect to Indemnitee&#146;s entitlement thereto shall be made in the specific case: (i)&nbsp;if a Change of Control shall not have occurred, (A)&nbsp;by a majority vote of the
Disinterested Directors, even though less than a quorum of the Board, (B)&nbsp;by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (C)&nbsp;if there are
no such Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee; or (ii)&nbsp;if a Change of Control shall have occurred, by
Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee. If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10)&nbsp;days after such
determination. Indemnitee shall reasonably cooperate with the </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
person, persons or entity making such determination with respect to Indemnitee&#146;s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance
request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or expenses (including attorneys&#146;
fees and disbursements) actually and reasonably incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee&#146;s
entitlement to indemnification). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If entitlement to indemnification is to be determined by Independent Counsel pursuant to
Section&nbsp;5.02(a)(ii), such Independent Counsel shall be selected by Indemnitee, and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected. If entitlement to indemnification is to
be determined by Independent Counsel pursuant to Section&nbsp;5.02(a)(i)(C) (or if Indemnitee requests that such selection be made by the Board), such Independent Counsel shall be selected by the Company in which case the Company shall give written
notice to Indemnitee advising him or her of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may be, may, within 10 days after such written notice of selection shall have been received,
deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of
&#147;Independent Counsel&#148; as defined in Section&nbsp;1 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as
Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined
that such objection is without merit. If, within 20 days after the later of submission by Indemnitee of a written request for indemnification pursuant to Section&nbsp;5.01(b) hereof and the final disposition of the Proceeding, no Independent Counsel
shall have been selected and not objected to, either the Company or Indemnitee may petition a court of competent jurisdiction for resolution of any objection which shall have been made by the Company or Indemnitee to the other&#146;s selection of
Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the court or by such other person as the court shall designate, and the person with respect to whom all objections are so resolved or the person so
appointed shall act as Independent Counsel under Section&nbsp;5.02(a) hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section&nbsp;6.01(a) of this Agreement, the Independent Counsel shall be discharged and
relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company agrees to pay the reasonable fees and expenses of any Independent Counsel serving under this Agreement. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;5.03<I>. Presumptions and Burdens of Proof; Effect of Certain Proceedings.
</I>(a)&nbsp;In making any determination with respect to entitlement to indemnification hereunder, the person or persons or entity making such determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to
indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section&nbsp;5.01(b) of this Agreement, and the Company shall, to the fullest extent not prohibited by law, have the burden of proof to
overcome that presumption in connection with the making by any person, persons or entity of any determination contrary to that presumption. Neither the failure of any person, persons or entity to have made a determination prior to the commencement
of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by any person, persons or entity that Indemnitee has not met such
applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If the person, persons or entity empowered or selected under Section&nbsp;5.02 of this Agreement to determine whether Indemnitee is
entitled to indemnification shall not have made a determination within the sixty (60)&nbsp;day period referred to in Section&nbsp;5.02(a), the requisite determination of entitlement to indemnification shall, to the fullest extent not prohibited by
law, be deemed to have been made and Indemnitee shall be entitled to such indemnification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The termination of any Proceeding or of
any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of
Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding,
that Indemnitee had reasonable cause to believe that his or her conduct was unlawful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) For purposes of any determination of good
faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee&#146;s action is in good faith reliance on the records or books of account of any Enterprise, including financial statements, or on information supplied to Indemnitee by the
officers of such Enterprise in the course of their duties, or on the advice of legal counsel for such Enterprise or on information or records given or reports made to such Enterprise by an independent certified public accountant or by an appraiser
or other expert selected by such Enterprise. The provisions of this Section&nbsp;5.03(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed or found to have met the applicable
standard of conduct set forth in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The knowledge and/or actions, or failure to act, of any other director, trustee,
partner, managing member, fiduciary, officer, agent or employee of any Enterprise shall not be imputed to Indemnitee for purposes of determining any right to indemnification under this Agreement. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 6 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R<SMALL>EMEDIES</SMALL> <SMALL>OF</SMALL> I<SMALL>NDEMNITEE</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;6.01. <I>Adjudication or Arbitration</I>. (a)&nbsp;In the event of any dispute between Indemnitee and the Company
hereunder as to entitlement to indemnification or advancement of Expenses (including where (i)&nbsp;a determination is made pursuant to Section&nbsp;5.02 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement,
(ii)&nbsp;advancement of Expenses is not timely made pursuant to Section&nbsp;4.01 of this Agreement, (iii)&nbsp;payment of indemnification pursuant to Section&nbsp;3.01 of this Agreement is not made within ten (10)&nbsp;days after a determination
has been made that Indemnitee is entitled to indemnification, (iv)&nbsp;no determination as to entitlement to indemnification is timely made pursuant to Section&nbsp;5.02 of this Agreement and no payment of indemnification is made within ten
(10)&nbsp;days after entitlement is deemed to have been determined pursuant to Section&nbsp;5.03(b)) or (v)&nbsp;a contribution payment is not made in a timely manner pursuant to Section&nbsp;8.04 of this Agreement, then Indemnitee shall be entitled
to an adjudication by a court of his or her entitlement to such indemnification, contribution or advancement. Alternatively, in such case, Indemnitee, at his or her option, may seek an award in arbitration to be conducted by a single arbitrator
pursuant to the Commercial Arbitration Rules of the American Arbitration Association. The Company shall not oppose Indemnitee&#146;s right to seek any such adjudication or award in arbitration.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>(b) In the event that a determination shall have been made pursuant to Section&nbsp;5.02(a) of this Agreement that Indemnitee is not
entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;6.01 shall be conducted in all respects as a <I>de novo</I> trial, or arbitration, on the merits, and Indemnitee shall not be prejudiced by
reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;6.01 the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as
the case may be, and the Company may not refer to or introduce into evidence any determination pursuant to Section&nbsp;5.02(a) of this Agreement adverse to Indemnitee for any purpose. If Indemnitee commences a judicial proceeding or arbitration
pursuant to this Section&nbsp;6.01, Indemnitee shall not be required to reimburse the Company for any advances pursuant to Section&nbsp;4.02 until a final determination is made with respect to Indemnitee&#146;s entitlement to indemnification (as to
which all rights of appeal have been exhausted or lapsed).<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If a determination shall have been made pursuant to
Section&nbsp;5.02(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;6.01. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company shall be precluded from asserting in any judicial proceeding or arbitration
commenced pursuant to this Section&nbsp;6.01 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the
provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Company shall indemnify Indemnitee to the fullest extent permitted by law against all Expenses and,
if requested by Indemnitee, shall (within ten (10)&nbsp;days after the Company&#146;s receipt of such written request) advance such Expenses to Indemnitee, which are reasonably incurred by Indemnitee in connection with any judicial proceeding or
arbitration brought by Indemnitee for (i)&nbsp;indemnification or advances of Expenses by the Company (or otherwise for the enforcement, interpretation or defense of his or her rights) under this Agreement or any other agreement, including any other
indemnification, contribution or advancement agreement, or any provision of the Company&#146;s Certificate of Incorporation or By-laws now or hereafter in effect or (ii)&nbsp;recovery or advances under any directors&#146; and officers&#146;
liability insurance policy maintained by the Company, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, contribution, advancement or insurance recovery, as the case may be. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 7 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">D<SMALL>IRECTORS</SMALL>&#146; <SMALL>AND</SMALL> O<SMALL>FFICERS</SMALL>&#146; L<SMALL>IABILITY</SMALL> I<SMALL>NSURANCE</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01<I>. D&amp;O Liability Insurance. </I>The Company shall obtain and maintain a policy or policies of insurance
(&#147;<B>D&amp;O Liability Insurance</B>&#148;) with reputable insurance companies providing liability insurance for directors and officers of the Company in their capacities as such (and for any capacity in which any director or officer of the
Company serves any other Enterprise at the request of the Company), in respect of acts or omissions occurring while serving in such capacity, on terms with respect to coverage and amount (including with respect to the payment of Expenses) no less
favorable than those of such policy in effect on the date hereof, except for any changes approved by the Board prior to a Change of Control; <I>provided</I> that such coverage and amounts are available on commercially reasonable terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;7.02<I>. Evidence of Coverage. </I>Upon request by Indemnitee, the Company shall provide copies of all policies of D&amp;O
Liability Insurance obtained and maintained in accordance with Section&nbsp;7.01 of this Agreement. The Company shall promptly notify Indemnitee of any changes in such insurance coverage.<I> </I></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE 8 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">M<SMALL>ISCELLANEOUS</SMALL> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.01<I>. Nonexclusivity of Rights. </I>The rights of indemnification, contribution and advancement of Expenses as provided
by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled to under applicable law, the Company&#146;s Certificate of Incorporation, the Company&#146;s Bylaws, any agreement, a vote of
stockholders or a resolution of directors, or otherwise. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and
remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or
remedy.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.02<I>. Insurance and Subrogation. </I>(a)&nbsp;Indemnitee shall be covered by the Company&#146;s
D&amp;O Liability Insurance in accordance with its or their terms to the maximum extent of the coverage available for any director or officer under such policy or policies. If, at the time the Company receives notice of a claim hereunder, the
Company has director and officer liability insurance in effect, the Company shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all
necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies. The failure or refusal of any such insurer to pay any such amount
shall not affect or impair the obligations of the Company under this Agreement.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event of any payment under this
Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents
as are necessary to enable the Company to bring suit to enforce such rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company shall not be liable under this Agreement to
make any payment of amounts otherwise indemnifiable (or for which advancement is provided) hereunder if and to the extent that Indemnitee has actually received such payment under any insurance policy or other indemnity provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.03 <I>Amounts Received from Non-Company Sources. </I>The Company&#146;s obligation to indemnify or advance Expenses
hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, fiduciary, board of directors&#146; committee member, employee or agent of any other Enterprise shall be reduced
by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such Enterprise.<I> </I></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.04<I>. Contribution. </I>To the fullest extent permissible under applicable
law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines,
penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the
circumstances of such Proceeding in order to reflect (i)&nbsp;the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving rise to such Proceeding; and/or (ii)&nbsp;the relative fault of the
Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s).<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.05<I>. Amendment. </I>This Agreement may not be modified or amended except by a written instrument executed by or on
behalf of each of the parties hereto. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit, restrict or reduce any right of Indemnitee under this Agreement in respect of any act or omission, or any event
occurring, prior to such amendment, alteration or repeal. To the extent that a change in applicable law, whether by statute or judicial decision, (i)&nbsp;permits greater indemnification, contribution or advancement of Expenses than would be
afforded currently under the Company&#146;s Certificate of Incorporation and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change or (ii)&nbsp;limits
rights with respect to indemnification, contribution or advancement of Expenses, it is the intent of the parties hereto that the rights with respect to indemnification, contribution or advancement of Expenses in effect prior to such change shall
remain in full force and effect to the extent permitted by applicable law. <I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.06<I>. Waivers. </I>The
observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) by the party entitled to enforce such term only by a writing signed by the party against which such
waiver is to be asserted. Unless otherwise expressly provided herein, no delay on the part of any party hereto in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any waiver on the part of any party
hereto of any right, power or privilege hereunder operate as a waiver of any other right, power or privilege hereunder nor shall any single or partial exercise of any right, power or privilege hereunder preclude any other or further exercise thereof
or the exercise of any other right, power or privilege hereunder.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.07<I>. Entire Agreement. </I>This
Agreement and the documents referred to herein constitute the entire agreement between the parties hereto with respect to the matters covered hereby, and any other prior or contemporaneous oral or written understandings or agreements with respect to
the matters covered hereby are superseded by this Agreement, provided that this Agreement is a supplement to and in furtherance of the Certificate of Incorporation and By-laws of the Company and applicable law, and shall not be deemed a substitute
therefor, nor to diminish or abrogate any rights of Indemnitee thereunder.<I> </I></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.08<I>. Severability. </I>If any provision or provisions of this Agreement
shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)&nbsp;the validity, legality and enforceability of the remaining provisions of this Agreement (including each portion of any Section of this Agreement containing any
such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by law;
(b)&nbsp;such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c)&nbsp;to the fullest extent possible, the provisions of
this Agreement (including each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the
intent manifested thereby.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.09<I>. Notices. </I>All notices, requests, demands and other communications under
this Agreement shall be in writing (which may be by facsimile transmission). All such notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. in the place of
receipt and such day is a business day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding business day in the place of receipt. The address for notice to
a party is as shown on the signature page of this Agreement, or such other address as any party shall have given by written notice to the other party as provided above. <I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.10<I>. Binding Effect. </I>(a)&nbsp;The Company expressly confirms and agrees that it has entered into this Agreement
and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of the
Company.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto and their
respective successors, assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company, spouses, heirs, and executors, administrators,
personal and legal representatives. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or substantially all, or a substantial part of the business or assets of the
Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the manner and to the same extent that the Company would be required to perform if no such succession had
taken place. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The indemnification, contribution and advancement of Expenses provided by, or granted
pursuant to this Agreement shall continue as to a person who has ceased to be a director or officer and shall inure to the benefit of the heirs, executors, administrators, legatees and assigns of such a person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.11<I>. Governing Law. </I>This Agreement and the legal relations among the parties shall be governed by, and construed
and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.12<I>. Consent To Jurisdiction. </I>Except with respect to any arbitration commenced by Indemnitee pursuant to
Section&nbsp;6.01(a) of this Agreement, the Company and Indemnitee hereby irrevocably and unconditionally (i)&nbsp;agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Chancery Court of
the State of Delaware (the &#147;<I></I><B>Delaware Court</B><I></I>&#148;), and not in any other state or federal court in the United States of America or any court in any other country, (ii)&nbsp;consent to submit to the exclusive jurisdiction of
the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement, (iii)&nbsp;waive any objection to the laying of venue of any such action or proceeding in the Delaware Court, and (iv)&nbsp;waive, and
agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.13<I>. Headings. </I>The Article and Section headings in this Agreement are for convenience of reference only, and shall
not be deemed to alter or affect the meaning or interpretation of any provisions hereof.<I> </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.14<I>.
Counterparts. </I>This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by
the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.<I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I>Section&nbsp;8.15<I>. Use of Certain Terms. </I>As used in this Agreement, the words &#147;herein,&#148; &#147;hereof,&#148; and
&#147;hereunder&#148; and other words of similar import refer to this Agreement as a whole and not to any particular paragraph, subparagraph, section, subsection, or other subdivision. Whenever the context may require, any pronoun used in this
Agreement shall include the corresponding masculine, feminine or neuter forms, and the singular form of nouns, pronouns and verbs shall include the plural and vice versa.<I> </I></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, this Agreement has been duly executed and delivered to be effective as of the
date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Facsimile:</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attention:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy to:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Facsimile:</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attention:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:10pt">INDEMNITEE</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Facsimile:</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">With a copy to:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Facsimile:</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attention:</P></TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>14
<FILENAME>filename14.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.10</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.10 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g923794ex10_10pg001.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2551 Merced
Street</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">San Leandro, CA 94577</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">December&nbsp;8, 2004 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Adam Elsesser </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Employment Agreement </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Adam: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Penumbra, Inc. (&#147;Company&#148;), I am pleased to offer you employment in the position of CEO, reporting to the Board of Directors. This
letter sets out the terms of your employment with the Company, which will start on February&nbsp;1, 2005. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be paid a starting base salary of
$11,538.46 every two weeks, which equals $300,000 per year, less applicable tax and other withholdings. This position is an exempt position, which means you are paid for the job and not by the hour. Accordingly, you will not receive overtime pay if
you work more than 8 hours in a workday or 40 hours in a workweek. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will also be eligible to participate in various Company fringe benefit plans, in
accordance with the Company&#146;s benefit plan requirements. You will also be eligible to participate in any incentive compensation plan that may be established by the Company during your employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the approval of the Company&#146;s Board of Directors, you will be granted an option to purchase 0 shares of Company common stock under the
Company&#146;s stock option plan at an exercise price equal to the fair market value of that stock on your option grant date. Your option will vest over a period of four years, and will be subject to the terms and conditions of the Company&#146;s
stock option plan and standard form of stock option agreement, which you will be required to sign as a condition of receiving the option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your employment
with the Company is &#147;at will.&#148; This means it is for no specified term and may be terminated by you or the Company at any time, with or without cause or advance notice. In addition, the Company reserves the right to modify your
compensation, positions, duties or reporting relationship to meet business needs and to decide on appropriate discipline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a condition of your
employment, you will be required to sign the Company&#146;s standard form of employee nondisclosure and assignment agreement (a copy of which is enclosed), and to provide the Company with documents establishing your identity and right to work in the
United States. Those documents must be provided to the Company within three business days of your employment start date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any dispute or
claim relating to or arising out of your employment relationship with the Company, this agreement, or the termination of your employment with the Company for any reason (including, but not limited to, any claims of breach of contract, wrongful
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
termination or age, sex, race, national origin, disability or other discrimination or harassment), all such disputes shall be fully, finally and exclusively resolved by binding arbitration
conducted by the American Arbitration Association (&#147;AAA&#148;) under AAA&#146;s National Rules for the Resolution of Employment Disputes then in effect, which are available online at the AAA&#146;s website at <U>www.adr.org</U> or by requesting
a copy from the Company. You and the Company hereby waive your respective rights to have any such disputes or claims tried before a judge or jury. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
agreement and the non-disclosure and stock option agreements referred to above constitute the entire agreement between you and the Company regarding the terms and conditions of your employment, and they supersede all prior or contemporaneous
negotiations, representations or agreements between you and the Company. The provisions of this agreement regarding &#147;at will&#148; employment and arbitration may only be modified by a document signed by you and an authorized representative of
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adam, we look forward to working with you at the Company. Please sign and date this letter on the spaces provided below to acknowledge your
acceptance of the terms of this agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely, </TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Adam Elsesser</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">CEO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree to and accept employment with Penumbra on the terms and conditions set forth in this agreement. I understand and
agree that my employment with the Company is at-will. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: 1/5, 2005 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Adam Elsesser</TD></TR>
</TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>15
<FILENAME>filename15.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.11</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.11 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g923794ex10_11pg001.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Penumbra, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2551 Merced
Street</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">San Leandro, CA 94577</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">December&nbsp;8, 2004 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Arani Bose </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Re: Employment Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Arani: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Penumbra, Inc. (&#147;Company&#148;),
I am pleased to offer you employment in the position of Chairman and Chief Medical Officer, reporting to the Board of Directors. This letter sets out the terms of your employment with the Company, which will start on March&nbsp;1, 2005. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be paid a starting base salary of $14,230.77 every two weeks, which equals $370,000 per year, less applicable tax and other withholdings. This
position is an exempt position, which means you are paid for the job and not by the hour. Accordingly, you will not receive overtime pay if you work more than 8 hours in a workday or 40 hours in a workweek. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will also be eligible to participate in various Company fringe benefit plans, in accordance with the Company&#146;s benefit plan requirements. You will
also be eligible to participate in any incentive compensation plan that may be established by the Company during your employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the approval
of the Company&#146;s Board of Directors, you will be granted an option to purchase 0 shares of Company common stock under the Company&#146;s stock option plan at an exercise price equal to the fair market value of that stock on your option grant
date. Your option will vest over a period of four years, and will be subject to the terms and conditions of the Company&#146;s stock option plan and standard form of stock option agreement, which you will be required to sign as a condition of
receiving the option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your employment with the Company is &#147;at will.&#148; This means it is for no specified term and may be terminated by you or the
Company at any time, with or without cause or advance notice. In addition, the Company reserves the right to modify your compensation, positions, duties or reporting relationship to meet business needs and to decide on appropriate discipline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a condition of your employment, you will be required to sign the Company&#146;s standard form of employee nondisclosure and assignment agreement (a copy of
which is enclosed), and to provide the Company with documents establishing your identity and right to work in the United States. Those documents must be provided to the Company within three business days of your employment start date. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any dispute or claim relating to or arising out of your employment relationship with the Company,
this agreement, or the termination of your employment with the Company for any reason (including, but not limited to, any claims of breach of contract, wrongful termination or age, sex, race, national origin, disability or other discrimination or
harassment), all such disputes hall be fully, finally and exclusively resolved by binding arbitration conducted by the American Arbitration Association (&#147;AAA&#148;) under AAA&#146;s National Rules for the Resolution of Employment Disputes then
in effect, which are available online at the AAA&#146;s website at <U>www.adr.org</U> or by requesting a copy from the Company. You and the Company hereby waive your respective rights to have any such disputes or claims tried before a judge or jury.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This agreement and the non-disclosure and stock option agreements referred to above constitute the entire agreement between you and the Company regarding
the terms and conditions of your employment, and they supersede all prior or contemporaneous negotiations, representations or agreements between you and the Company. The provisions of this agreement regarding &#147;at will&#148; employment and
arbitration may only be modified by a document signed by you and an authorized representative of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Arani, we look forward to working with you
at the Company. Please sign and date this letter on the spaces provided below to acknowledge your acceptance of the terms of this agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Sincerely,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Adam Elsesser</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">CEO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree to and accept employment with Penumbra on the terms and conditions set forth in this agreement. I understand and
agree that my employment with the Company is at-will. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">February&nbsp;4, 2005</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Arani Bose</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Arani Bose</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>16
<FILENAME>filename16.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.12</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.12 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794ex10_12logo.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;10, 2015 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Sri Kosaraju </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sri: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Penumbra, Inc. (&#147;Company&#148;), I am pleased to offer you employment in the position of Chief&nbsp;Financial Officer and Head of Strategy,
reporting to Adam Elsesser. This letter sets out the terms of&nbsp;your employment with the Company, which will start on April&nbsp;28, 2015. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be
paid a base salary of $19,230.77 every two weeks, which equals $500,000 per year, less applicable taxes and other withholdings. This is an exempt position, which means you are paid for the job&nbsp;and not by the hour. Accordingly, you will not
receive overtime pay if you work more than 8 hours in a&nbsp;workday or 40 hours in a work week. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will also be granted 604,861 shares of Restricted
Stock under the Company&#146;s stock option plan. Your&nbsp;stock will vest over a period of four years, and will be subject to the terms and conditions of the Company&#146;s stock option plan and standard form of stock option agreement, which you
will be required to sign as a condition of receiving the stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your employment with the Company is &#147;at will.&#148; This means it is for no
specified term and may be terminated by you or the Company at any time, with or without cause or advance notice. In addition, the Company reserves the right to modify your compensation, positions, duties or reporting relationship to
meet&nbsp;business needs and to decide on appropriate discipline. This &#147;at will&#148; employment relationship may not be modified by any oral or implied agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During and after your employment, you will not use any Company Property for any purpose other than for&nbsp;the benefit of the Company. Except for business
uses related to the performance of your job, you will not remove from the Company premises any Company Property without written consent of your supervisor.&nbsp;In the event of your termination of employment, or at any time at the request of the
Company, you will return all Company Property. You will also return all copies of Company Property, and any Work&nbsp;Product derived from Company Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a condition of your employment, you will be required to sign the Company&#146;s standard form of employee&nbsp;nondisclosure and assignment agreement (a
copy of which is enclosed), and to provide the Company with documents establishing your identity and right to work in the United States. Those documents must be provided to the Company three business days prior to your employment start date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also ask that, if you have not already done so, you disclose to the Company any and all agreements relating to your prior employment that may affect your
eligibility to be employed by the Company or limit the manner in which you may be employed. It is the Company&#146;s understanding that any such agreements will not prevent you from performing the duties of your position and you represent that such
is the case. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Alameda, CA
94502 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">T (510) 748-3200 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">F (510)
814-8303 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.penumbrainc.com </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any dispute or claim relating to or arising out of your employment relationship with the Company,
this agreement, or the termination of your employment with the Company for any reason (including, but not limited to, any claims of breach of contract, wrongful termination or age, sex, race, national origin, disability or other discrimination or
harassment), all such disputes shall be fully, finally and exclusively resolved by binding arbitration conducted by the American Arbitration Association (&#147;AAA&#148;) under AAA&#146;s National Rules for the Resolution of Employment Disputes then
in effect, which are available online at the AAA&#146;s website at <U>www.adr.org</U> or by requesting a copy from the Company. You and the Company hereby waive your respective rights to have any such disputes or claims tried before a judge or jury.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This agreement and the non-disclosure and stock option agreements referred to above constitute the entire agreement between you and the Company regarding
the terms and conditions of your employment, and they supersede all prior or contemporaneous negotiations, representations or agreements between you and the Company. The provisions of this agreement regarding &#147;at will&#148; employment and
arbitration may only be modified by a document signed by you and an authorized representative of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We look forward to working with you at
Penumbra. Please sign and date this letter on the spaces provided below to acknowledge your acceptance of the terms of this agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;&nbsp;&nbsp;Lynn
Rothman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center">Lynn Rothman</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center">Executive Vice President</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="center">Chief Business Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree to and accept employment with Penumbra on the terms and conditions set forth in this agreement. I understand and
agree that my employment with the Company is at-will. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/&nbsp;&nbsp;&nbsp;&nbsp;Sri
Kosaraju&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">2/10/15</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Sri Kosaraju</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Alameda, CA
94502 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">T (510) 748-3200 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">F (510)
814-8303 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.penumbrainc.com </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>17
<FILENAME>filename17.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.13</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="5" NOWRAP>


<IMG SRC="g923794ex10_13logo.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">Penumbra, Inc.</TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">2401 Merced Street</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">Suite 200</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">San Leandro, CA 94577</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">Phone: (510) 618-3200</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" ALIGN="right">Fax: (510) 618-3232</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.13 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">May&nbsp;14, 2007 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Daniel Davis </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Employment Agreement </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Daniel: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Penumbra, Inc. (&#147;Company&#148;), I am pleased to offer you employment in the position of Territory Manager, reporting to Greg Finch. This
letter sets out the terms of your employment with the Company, which will start on June&nbsp;11, 2007. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be paid a starting base salary of
$8,653.85 every two weeks, which equals $225,000 per year, less applicable tax and other withholdings. This position is an exempt position, which means you are paid for the job and not by the hour. Accordingly, you will not receive overtime pay if
you work more than 8 hours in a workday or 40 hours in a workweek. The base salary will be adjusted at the launch of the Penumbra Stroke System. At that time, you will be paid a starting base salary of $4,807.70 every two weeks, which equals
$125,000 per year, less applicable tax and other withholdings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will also be entitled to receive up to an additional $60,000 incentive bonus per year
(paid quarterly in equal installments) based upon agreed upon quarterly performance and Management by Objectives (MBO&#146;s). Additionally, you will participate in a sales incentive program based upon the approval process and commercialization.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be eligible to participate in various Company fringe benefit plans, in accordance with the Company&#146;s benefit plan requirements. You are
entitled to four weeks of vacation. You will also be eligible to participate in any incentive compensation plan that may be established by the Company during your employment. You will also be eligible for an $800.00 per month car allowance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the approval of the Company&#146;s Board of Directors, you will be granted an option to purchase 10,000 shares (0.92 per share) of Company common
stock under the Company&#146;s stock option plan at an exercise price equal to the fair market value of that stock on your option grant date. Your option will vest over a period of four years, and will be subject to the terms and conditions of the
Company&#146;s stock option plan and standard form of stock option agreement, which you will be required to sign as a condition of receiving the option. In addition, if you are responsible for selling Penumbra&#146;s first product into at least 20
accounts prior to the launch of the Penumbra Stroke System, subject to all the same terms and conditions above, you will be granted 10,000 additional shares of Company common stock. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your employment with the Company is &#147;at will.&#148; This means it is for no specified term and may be
terminated by you or the Company at any time, with or without cause or advance notice. Your base salary shall be paid during the first year, unless the termination is for cause. In addition, the Company reserves the right to modify your
compensation, positions, duties or reporting relationship to meet business needs and to decide on appropriate discipline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a condition of your
employment, you will be required to sign the Company&#146;s standard form of employee nondisclosure and assignment agreement (a copy of which is enclosed), and to provide the Company with documents establishing your identity and right to work in the
United States. Those documents must be provided to the Company within three business days of your employment start date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also ask that, if you have
not already done so, you disclose to the Company any and all agreements relating to your prior employment that may affect your eligibility to be employed by the Company or limit the manner in which you may be employed. It is the Company&#146;s
understanding that any such agreements will not prevent you from performing the duties of your position and you represent that such is the case. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the
event of any dispute or claim relating to or arising out of your employment relationship with the Company, this agreement, or the termination of your employment with the Company for any reason (including, but not limited to, any claims of breach of
contract, wrongful termination or age, sex, race, national origin, disability or other discrimination or harassment), all such disputes shall be fully, finally and exclusively resolved by binding arbitration conducted by the American Arbitration
Association (&#147;AAA&#148;) under AAA&#146;s National Rules for the Resolution of Employment Disputes then in effect, which are available online at the AAA&#146;s website at <U>www.adr.org</U> or by requesting a copy from the Company. You and the
Company hereby waive your respective rights to have any such disputes or claims tried before a judge or jury. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This agreement and the non-disclosure and
stock option agreements referred to above constitute the entire agreement between you and the Company regarding the terms and conditions of your employment, and they supersede all prior or contemporaneous negotiations, representations or agreements
between you and the Company. The provisions of this agreement regarding &#147;at will&#148; employment and arbitration may only be modified by a document signed by you and an authorized representative of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Daniel, we look forward to working with you at the Company. Please sign and date this letter on the spaces provided below to acknowledge your acceptance of
the terms of this agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Greg Finch</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Greg Finch</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Vice President of Sales</TD></TR>
</TABLE></DIV>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree to and accept employment with Penumbra on the terms and conditions set forth in this agreement. I
understand and agree that my employment with the Company is at-will. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: May 16, 2007</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel Davis</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Daniel Davis</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794ex10_13pg005.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December&nbsp;1, 2011 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Daniel Davis </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Territory Manager </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Daniel: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is my pleasure to congratulate you on your
transition to the Marketing Department as a Marketing Director at a salary of $250,000 per year. You will report to John Lockhart retroactive to October&nbsp;1, 2011 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We welcome and look forward to your continuing contributions to the company&#146;s achievement of its vision and mission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Best Wishes, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adam Elsesser </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Acknowledged</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">/s/ Daniel Davis</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">12-2-11</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Daniel Davis</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">date</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Alameda, CA
94502 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">T (510) 748-3200 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">F (510)
814-8303 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.penumbrainc.com </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g923794ex10_13pg006.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">December&nbsp;26, 2012 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Daniel Davis </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Daniel: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is my pleasure to congratulate you on your promotion to Vice President of Strategy at a salary of $300,000 per year. This change is effective
January&nbsp;1, 2013. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This change reflects the knowledge, skills, abilities, experience and expertise you&#146;ve brought to the team. We welcome and
look forward to your continuing contribution to the company&#146;s achievement of its vision and mission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Best Wishes, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adam Elsesser </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="11%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="29%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Acknowledged:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">/s/ Daniel Davis</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">8 Jan 13</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE="border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Daniel Davis</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Date</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Penumbra, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">1351 Harbor Bay Parkway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Alameda, CA
94502 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">T (510) 748-3200 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">F (510)
814-8303 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">www.penumbrainc.com </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>18
<FILENAME>filename18.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.14</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g923794ex10_14logo.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Penumbra, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">2551 Merced Street</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">San Leandro, CA
94577</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Phone: (510) 614-6491</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Fax:
(510) 614-4411</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.14 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">December&nbsp;10, 2004 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;James&nbsp;R.
Pray </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Employment Agreement </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Jim: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Penumbra, Inc. (&#147;Company&#148;), I am pleased to offer you employment in the position of President, reporting to Adam Elsesser. This letter
sets out the terms of your employment with the Company, which will start on January&nbsp;4, 2005. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be paid a starting base salary of $6,807.69
every two weeks, which equals $177,000 per year, less applicable tax and other withholdings. This position is an exempt position, which means you are paid for the job and not by the hour. Accordingly, you will not receive overtime pay if you work
more than 8 hours in a workday or 40 hours in a workweek. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will also be eligible to participate in various Company fringe benefit plans, in accordance
with the Company&#146;s benefit plan requirements. You will also be eligible to participate in any incentive compensation plan that may be established by the Company during your employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the approval of the Company&#146;s Board of Directors, you will be granted an option to purchase 500,000 shares of Company common stock under the
Company&#146;s stock option plan at an exercise price equal to the fair market value of that stock on your option grant date. Your option will vest over a period of four years, and will be subject to the terms and conditions of the Company&#146;s
stock option plan and standard form of stock option agreement, which you will be required to sign as a condition of receiving the option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your employment
with the Company is &#147;at will.&#148; This means it is for no specified term and may be terminated by you or the Company at any time, with or without cause or advance notice. In addition, the Company reserves the right to modify your
compensation, positions, duties or reporting relationship to meet business needs and to decide on appropriate discipline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a condition of your
employment, you will be required to sign the Company&#146;s standard form of employee nondisclosure and assignment agreement (a copy of which is enclosed), and to provide the Company with documents establishing your identity and right to work in the
United States. Those documents must be provided to the Company within three business days of your employment start date. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any dispute or claim relating to or arising out of your employment relationship with the Company,
this agreement, or the termination of your employment with the Company for any reason (including, but not limited to, any claims of breach of contract, wrongful termination or age, sex, race, national origin, disability or other discrimination or
harassment), all such disputes shall be fully, finally and exclusively resolved by binding arbitration conducted by the American Arbitration Association (&#147;AAA&#148;) under AAA&#146;s National Rules for the Resolution of Employment Disputes then
in effect, which are available online at the AAA&#146;s website at <U>www.adr.org</U> or by requesting a copy from the Company. You and the Company hereby waive your respective rights to have any such disputes or claims tried before a judge or jury.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This agreement and the non-disclosure and stock option agreements referred to above constitute the entire agreement between you and the Company regarding
the terms and conditions of your employment, and they supersede all prior or contemporaneous negotiations, representations or agreements between you and the Company. The provisions of this agreement regarding &#147;at will&#148; employment and
arbitration may only be modified by a document signed by you and an authorized representative of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jim, we look forward to working with you at
the Company. Please sign and date this letter on the spaces provided below to acknowledge your acceptance of the terms of this agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Adam Elsesser</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">CEO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree to and accept employment with Penumbra on the terms and conditions set forth in this agreement. I understand and
agree that my employment with the Company is at-will. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: 27&nbsp;December, 2004</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James R. Pray</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">James R. Pray</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>19
<FILENAME>filename19.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.15</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" ROWSPAN="6">


<IMG SRC="g923794ex10_15logo.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">Penumbra, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">2401 Merced Street</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">Suite 200</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">San Leandro, CA 94577</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">Phone: (510) 618-3200</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">Fax: (510) 618-3232</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.15 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">December&nbsp;18, 2007 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Lynn Rothman
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Employment Agreement </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Lynn: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Penumbra, Inc. (&#147;Company&#148;), I am pleased to offer you employment in the position of Director of Human Resources, reporting to Adam
Elsesser. This letter sets out the terms of your employment with the Company, which will start on January&nbsp;2, 2008. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Initially, you will work
part-time, approximately 20 hours per week. Upon mutual agreement at any time after your start date, your part-time status will change permanently to full-time status. During the part-time portion of your employment, you will be paid $3,365.38 every
two weeks, which equals $87,500 per year, less applicable tax and other withholdings. When your status changes to full-time, you will be paid $6,730.77 every two weeks, which equals $175,000 per year, less applicable tax and other withholdings. This
position is an exempt position, which means you are paid for the job and not by the hour. Accordingly, you will not receive overtime pay if you work more than 4 hours in a workday or 20 hours in a workweek when you are part-time, or 8 hours in a
workday or 40 hours in a workweek when you are full-time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the part-time portion of your employment, you will not be eligible to participate in
Company fringe benefit plans. When your employment status becomes full-time, you will be eligible to participate in various Company fringe benefit plans, in accordance with the Company&#146;s benefit plan requirements. You will also be eligible to
participate in any incentive compensation plan that may be established by the Company during your employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the approval of the
Company&#146;s Board of Directors, you will be granted an option to purchase 50,000 shares of Company common stock under the Company&#146;s stock option plan at an exercise price equal to the fair market value of that stock on your option grant
date. Your option will vest over a period of four years, and will be subject to the terms and conditions of the Company&#146;s stock option plan and standard form of stock option agreement, which you will be required to sign as a condition of
receiving the option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your employment with the Company is &#147;at will.&#148; This means it is for no specified term and may be terminated by you or the
Company at any time, with or without cause or advance notice. In addition, the Company reserves the right to modify your compensation, positions, duties or reporting relationship to meet business needs and to decide on appropriate discipline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a condition of your employment, you will be required to sign the Company&#146;s standard form of employee nondisclosure and assignment agreement (a copy of
which is enclosed), and to </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provide the Company with documents establishing your identity and right to work in the United States. Those documents must be provided to the Company within three business days of your employment
start date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also ask that, if you have not already done so, you disclose to the Company any and all agreements relating to your prior employment that
may affect your eligibility to be employed by the Company or limit the manner in which you may be employed. It is the Company&#146;s understanding that any such agreements will not prevent you from performing the duties of your position and you
represent that such is the case. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any dispute or claim relating to or arising out of your employment relationship with the Company, this
agreement, or the termination of your employment with the Company for any reason (including, but not limited to, any claims of breach of contract, wrongful termination or age, sex, race, national origin, disability or other discrimination or
harassment), all such disputes shall be fully, finally and exclusively resolved by binding arbitration conducted by the American Arbitration Association (&#147;AAA&#148;) under AAA&#146;s National Rules for the Resolution of Employment Disputes then
in effect, which are available online at the AAA&#146;s website at <U>www.adr.org</U> or by requesting a copy from the Company. You and the Company hereby waive your respective rights to have any such disputes or claims tried before a judge or jury.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This agreement and the non-disclosure and stock option agreements referred to above constitute the entire agreement between you and the Company regarding
the terms and conditions of your employment, and they supersede all prior or contemporaneous negotiations, representations or agreements between you and the Company. The provisions of this agreement regarding &#147;at will&#148; employment and
arbitration may only be modified by a document signed by you and an authorized representative of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lynn, we look forward to working with you
at the Company. Please sign and date this letter on the spaces provided below to acknowledge your acceptance of the terms of this agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Adam Elsesser</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">CEO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree to and accept employment with Penumbra on the terms and conditions set forth in this agreement. I understand and
agree that my employment with the Company is at-will. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: 12/19, 2007</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lynn Rothman</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Lynn Rothman</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>20
<FILENAME>filename20.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.16</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" ROWSPAN="6">


<IMG SRC="g923794ex10_16logo.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">Penumbra, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">2401 Merced Street</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">Suite 200</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">San Leandro, CA 94577</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">Phone: (510) 618-3200</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" ALIGN="right">Fax: (510) 618-3232</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.16 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">October&nbsp;18, 2007 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Robert&nbsp;D.
Evans </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Employment Agreement </B></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Bob: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of Penumbra, Inc. (&#147;Company&#148;), I am pleased to offer you employment in the position of Executive Vice President and General Counsel,
reporting to Adam Elsesser. This letter sets out the terms of your employment with the Company, which will start on December&nbsp;3, 2007 or such other date as you and Penumbra agree upon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will be paid a starting base salary of $7,692.31 every two weeks, which equals $200,000 per year, less applicable tax and other withholdings. This
position is an exempt position, which means you are paid for the job and not by the hour. Accordingly, you will not receive overtime pay if you work more than 8 hours in a workday or 40 hours in a workweek. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will also be eligible to participate in various Company fringe benefit plans, in accordance with the Company&#146;s benefit plan requirements. You will
also be eligible to participate in any incentive compensation plan that may be established by the Company during your employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the approval
of the Company&#146;s Board of Directors, you will be granted an option to purchase 150,000 shares of Company common stock under the Company&#146;s stock option plan at an exercise price equal to the fair market value of that stock on your option
grant date. Your option will vest over a period of four years, and will be subject to the terms and conditions of the Company&#146;s stock option plan and standard form of stock option agreement, which you will be required to sign as a condition of
receiving the option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your employment with the Company is &#147;at will.&#148; This means it is for no specified term and may be terminated by you or the
Company at any time, with or without cause or advance notice. In addition, the Company reserves the right to modify your compensation, positions, duties or reporting relationship to meet business needs and to decide on appropriate discipline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a condition of your employment, you will be required to sign the Company&#146;s standard form of employee nondisclosure and assignment agreement (a copy of
which is enclosed), and to provide the Company with documents establishing your identity and right to work in the United States. Those documents must be provided to the Company within three business days of your employment start date. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of any dispute or claim relating to or arising out of your employment relationship with the Company,
this agreement, or the termination of your employment with the Company for any reason (including, but not limited to, any claims of breach of contract, wrongful termination or age, sex, race, national origin, disability or other discrimination or
harassment), all such disputes shall be fully, finally and exclusively resolved by binding arbitration conducted by the American Arbitration Association (&#147;AAA&#148;) under AAA&#146;s National Rules for the Resolution of Employment Disputes then
in effect, which are available online at the AAA&#146;s website at <U>www.adr.org</U> or by requesting a copy from the Company. You and the Company hereby waive your respective rights to have any such disputes or claims tried before a judge or jury.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This agreement and the non-disclosure and stock option agreements referred to above constitute the entire agreement between you and the Company regarding
the terms and conditions of your employment, and they supersede all prior or contemporaneous negotiations, representations or agreements between you and the Company. The provisions of this agreement regarding &#147;at will&#148; employment and
arbitration may only be modified by a document signed by you and an authorized representative of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Bob, we look forward to working with you at
the Company. Please sign and date this letter on the spaces provided below to acknowledge your acceptance of the terms of this agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PENUMBRA, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam Elsesser</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Adam Elsesser</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">CEO</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I agree to and accept employment with Penumbra on the terms and conditions set forth in this agreement. I understand and
agree that my employment with the Company is at-will. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2007</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert D. Evans</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top">Robert D. Evans</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>21
<FILENAME>filename21.htm
<TEXT>
<HTML><HEAD>
<TITLE>EX21.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 21.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SUBSIDIARIES OF PENUMBRA, INC. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name of Subsidiary</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Jurisdiction of Organization</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Penumbra Europe GmbH</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Germany</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Penumbra Neuro Australia Pty. Ltd.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Australia</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">Penumbra Neuro Canada Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Montr&eacute;al (Qu&eacute;bec) Canada</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Penumbra Latin America Distribuidora de Equipamentos e</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Productos M&eacute;dicos LTDA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Brazil</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">ChemoFilter, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Delaware</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g923792g07k32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g07k32.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[2A^4&AO=&]S:&]P(#,N,  X0DE-! 0
M     $@< 5H  QLE1QP"   "JW8< E  "')R,C$R,C@V' (% "=-:6-R;W-O
M9G0@5V]R9" M(%!E;G5M8G)A($9O<FT@4RTQ+D1/0U@X0DE-!"4      ! >
MC6C!XC>[)500XE>]BD;^.$))300Z      #E    $     $       MP<FEN
M=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M    0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M
M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M  H  0         ".$))30/T       2 #4    ! "T    &       !.$))
M30/W       <  #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@             "$    <8          0
M       !              '&   "$                      !
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M;&]N9P   A      4F=H=&QO;F<   '&     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    #.$))300,     !Z1     0   (H
M  "@   !H  !!    !YU !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" "@ (H# 2(  A$! Q$!_]T !  )_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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MDK/0G@]>PM2276#Q_P %8^#^D?\ ]_4.K8EWJ4D>HSVN;%C7"?:YK>/6J?\
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M$_XOT]_ :&XE4&06@C6>?=R/S?=[4V7:YF.ZPM!#1+I=M @QR[9[6_2=[O\
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M@&*]K:Z"9W5V>A^DM<ZK\SU<FWW^_P#T7I]"DI__V0 X0DE-!"$      %4
M   ! 0    \ 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '     3 $$
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M     0   A          !@$#  ,    !  8   $:  4    !   !-@$;  4
M   !   !/@$H  ,    !  (   (!  0    !   !1@("  0    !
M      !(     0   $@    !.$))30/]       (          #_X0%(34T
M*@    @ " $2  ,    !      $:  4    !    ;@$;  4    !    =@$H
M  ,    !  (   $Q  (    >    ?@$R  (    4    G $[  (    )
ML(=I  0    !    O    .@   /      0   \     !061O8F4@4&AO=&]S
M:&]P($-3-B H5VEN9&]W<RD ,C Q-3HP-3HR,R P-SHT,SHR, !R<C(Q,C(X
M-@       Z !  ,    !__\  * "  0    !   !QJ #  0    !   "$
M       & 0,  P    $ !@   1H !0    $   $V 1L !0    $   $^ 2@
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MTM/7V.3Q_\0 % $!                     /_$ !01 0
M      #_V@ , P$  A$#$0 _ -_CT!Z ] >@/0'H#T!Z ] >@/0<5]U(U-Q!
M%D*:!ZK+K[K9<0KJIJAS.RRR<N>(QA7",I3ESSQQ&/'////VX]!5,SZFU?U"
M=)5H>QRN<=XW92RT)?@[A$#_ %C_ '8TU[3]@,02M9XT?/IQ;P5#>38/;6':
M,'4+5O(JB0!U 9KHOIR@U"MVO6WD?W[BNP"$E"Q5J*M&E25#DAL9'"7LJ^J\
M]U>V; CT7$BA9MDX-Q*\NR+GG('%$Z&C2!U>BO*#MOK+MFCQ=\T"5=VV<VIQ
MNI>ZU2F"?/=G'- C[ZLFZH6JU:*&GE!,Q)5:].FR67U9,#L]+(8C4*J43D+,
M_0'H#T!Z ] >@/0'H#T!Z ] >@/0'H#T'38@T-%YRPKW/C,0R@2/:GS7;[!=
M$Q[O;LX_OKL]NR7X3X_OC+[2X_OX]!5G]*U@ZQ>![4\<NPR5\>SNG^SG8!OV
MX$&<:Q("MS^7,W1XH0*X2ZUQK43LNPL4,65ZIEFVQ 0PS]44R"UCT"L^871F
M:[SZ.W"EDN#XUF?S;70]?ZJ"SDK19/3HY@:A69GF ?LOEUM[S-([2H(6 !A_
M( M,K9^W"'H,P\9NV#N[NC.O.RVZRM*\T"BZM^JI)Y+I#>IF)J-O&F^0XLIC
MD'+KC!N)45RB,15'G\N>/RD$[>@/0'H#T!Z ] >@/0'H#T!Z ] >@/0'H*K_
M #/"U/C=V9EO,3!)XLDB\X!?V8L",S^?G[;/]?G=!6S,8UUDZ,'M3.AY%&$G
M^93-5VQU;TJ:K]@-[M[B@LOR6KSVZR^>VF3;!/<QJDR[0('*TBLH!FH;"5&@
M&BD52E7;20/=79"4>>>/MS]N?MSQSQZ#(.?]/_[Q_P"S^_T%<7T^5'.>=^9B
M"50E$E'E3H1.:@R!)41^^)QET?P"## H71YC;QQQ14$-39+B=T*:ISLJ@%CW
MH#T!Z ] >@/058^4_P!6CQQ\8NQ=9U&S*K=[_ U+K=N*R:6YE!F_W: '0):K
M7,4SXAD46(T6RO"6*R+Q:B>;N>)\#D1J"I#L3^H\%9+*9]<86M$393SS>.70
M.R-'OF77.JVIM9>V!F&*./:*3"_)P)8V&_X7Z7D>!,@1/M?^HH[O(LX]B;1$
MMJ(GS475I$=50LB*AN/BE5X;-8Q\77]E;+F@DJ)- US+_>A&--=L0^^I_/WZ
MC/F8L9'^.V>[^[,4IF0B=L=USL^R25:XXU3<7R.X+)UIN9E)C0$SGQ0_"(30
M)XM## JOK#%I#\U@'ULZ5@C^70WEG>JK:5+! @E@+Y_%@6!RQY9F)*>OFNJM
M7^V-*R\EU,S.4-/;27DBD6A@3#MK,G]:HPA?,WI7R3+:FR7I(VQS8>95VWVS
ME,0TT'C)+D2<:4S.;&3!CS4'1.FR]XRG./ U(9R*M^M3UQ!P5/IOR="A6?$%
MJ9GMOI1Q#0J::;"85!8+1KJ^*>.+K+@M$A7?A7SQ71?;9< ?7>'C(?J>?4IZ
MQN,T>WGW0ASP,EZEH=H<O9+-4G,N:6*D&UKW%D]D.I*>""\<B3XHY<7@W%1#
MNINLE]@FY-_4+>0N4NJEK\9U^^&E[ETU[%?78RNIM(&I$^([SK['A4QI@,TX
M*D5F;.+";J?:G7\&T,L'+ZO_ *@GIOL&H;-=W=&E(%+V*X%BXR&T4ZU3$9I\
M*BTHI'J%6-.JK7DV&_/B :ZX!O!XH%+/(JNMH!JOIQ>;WC_J])OO'?+]B@RS
MDMA;K/&OG4W?H7.CQ.Y(?,6'6XBUC.N7#[KK3H]. O5#?C69E;5/"&DP90PM
MI"XELU7HE3-VW+H7JDZ\QJS/*MA2,$O7C6%FEDW62C750,-3;==;.485UPE*
M4N(\<\^@IO\ %Z[NM;I_,3N/QXS2O98?>=JI-VA2;V;-/'>V'AG0>K<2WK/F
M<DDC%L'9L7CC..^-(8;4&FH+L$G3P%F70?>V7\@,1/6(%[C.-%3<[.;+#:D7
M]=L,-I0.86V)=*IES[P!)2TA>[7\70KF4G: %2KIMLM'I";O0'H#T!Z ]!0K
M]8+Z?/CEI^F>_/+GG..E_<PZ?$V.&*?0G+U>GKKU&.R,[G2RNDNDIC7F)\*A
MRY47^V(./3$65@X=HH:6>]QV5R.@4!KJGT8GK)771OT7,(_>5Q_'^'7?EPY6
M1K]FJ<;!*K>8\WV5SMC&GBF(+!Y"#H!NL](314P@5.F%-=G+H4F4?<E/CB<H
MUJX66\\6<U4\53KNE/FR4H_:-?W@&WQ_1RY6Y7].KO/5D<71EKO+;75#?G;"
MV) "#K?K0>LSGCB4KJ[YGGL@[86QHC*L$>ZH:'NSN(#;=] >@/0([]22@&_P
ME[W_ &5'R QTV8-MC^<*O;Y WN4,@3S=8,551$6=$2++[JZZ*:ZIV$%!41L,
MH#1C[V19IQN;XP$M'@$I7BV54-UX\9\P8N9VV1K70ME&N5TK?<E97[MAOR[K
MK.+;9Q)!:.T=QB>C\99J6"5HUH^78$ #!NNJKG,:NNXOFVVY"3'@4")8T#:H
M<CVCR9"<S$A63.,@L/Z#\)<;VCK/I$:[I73]D9GM_P BEVF\R%PA79B<3-95
MOU<+O=CFL@GY#Z^%*,2.3<T1?H.3RABQ;;[?@39#\D5#!=?]1#RX\L_$[QY[
M'+\H'K\3"Z*FCK?AUC\#A"UFJ8]@(M(3:B2:> :>H(M0F5G6R^]-)%U()MW!
M\3OCK;0[7C/W;Y9F]::2SP\QW+3!R;E,KWEN05;X@C17JU$*@1V\-$J47VA(
MQ@[F"BDIF3<S(^?8WB0[G'T#C]+Z/RKZO[GP_<?DL.MS>,[X(RO3.E7PXI76
M4[AS$RWJYT;DEII8B5N1H;)8J\FN,+ZZM'Q!W^UB-2U0!<-Z ] >@/0'H*_O
MJHB7&?3U\JN*+XC2#ZUFXG?R;-=S6.B?)71?-1E=U%M-_(H%T1O9YNOG?S75
M0$PMG $@- WL=+IF3]47<L?\$S35QC :O6USMA&=MD9^U3D/<E*%/,1JY5@G
M4QJHC367&?%M-8)3Y%":>K /(G?LN5]=-?'/$[]#*'$^+ZK.9W#EQC*<>1JK
M(QD*%S7^7-<I774PESR&V_\ TLWD/T;U!],1T@[%[0S.1<%^3_:KI=G7)UT'
M<TAV4ZVI'9!)H1*8$*2S%S:RE@'3<!;8,QES=&\4^% ;&$_.[Q3A"BR7:L?Q
M)KNMJ^V*[$YESQ1P/*=<X<9'F=9$XDTSH$LC$HFKFRX>FVH<B=0>,9]03Q:!
MILNOVFD_"',OP]OK#LRR1/$.81ER+&.3^Y'WG9",(U_>=L>9$50F+79? /L3
MZA'B,3Q][NUN5D>+:ZI6N,1V$M$JE=?(6CY# G*07"^^5"0U/!)=4YD?C3Q'
M\[*HS"*/-;O7H_LSQ'[E387NSK)VS/2I[ :DF^S-S&WA9M<V0;8NX@SA; @2
M-$N/G5VA05D<TE7MDW%?#,4-*+R!::,3>G#B-2KJ(*$O-55SD@DFB%U9)L)7
M1EN&O%=%M9U%PLX +!?:OXLHJJ]Z/!X5^>5S-L1U*06>0YDMJMMKE?\ .TQ(
MW)-G!%E<?<C<2)7]HKBOQA9R!Q5(<C\*P[*IU6AM7^#R.&7[Y_ITL1"+&MHA
M^GMO]GI%GZYB/:OX[(\?=/H$]NA)')-C]QBCWP8=+VRM=86RLO60 9RY L#"
M_P"KQVK=/TOX@8\74&KT;S7]UZM[E*VQ JO0697/]?YU2X:*JSQ:&=F;EV$<
M.JOL&)) +T$HB6BQ,*]X'\_IR]%HWOB-V./H= 7IKT79616_N+VP[@8XV_H[
MJUJR/ ,#:/ [AFE[&#;@@9P<.9\Z)HG- ) @]06Q>;V":]@^+W;8.9&MNW&:
MS9&_Z](%-M6L%VYPG/&FSYJX^B==PY7R%TPY0A;5P:*62NMMKH,MGP$^]=[(
M#L;K_#=A*HQ@KW>/S.R6P@30;" &G2A.Q(1,&YD,7&(YU<>"1Y2IOXX]VKGF
M$H\^@S'T!Z##M7V#B<15*S5:92FGQ1\F 9!4;&9%'WLC[HBD?WF9L?O5;Q]Q
M!+O^I6?][G]@@\CR?2G2YCDL?IG$(5GV$&.AIY86B(A,!J[)5G47F5\6U_(-
MF.Q'5FQH&Y%J'N;6<+H N':SKLGOW(:3KEUILJIP^PS<U.T6XT6-[10M*NX%
M;@L=*21HTU3&C_5A7$Y4-%-?66)8;>(2O:A#>!^D;XQ2:JS-)G&.O!7UUD5,
M&!:ZE<]I+O()K$-5)@:U%\QKP;[CS"1SJFU;\=@O/C$BT 4)4V?C%X*](W"T
MLNM>HU.O/7V3M7 93EGI-2G#'<W!W$YY%>O8PXH=?!O$.N)'6%,QY!+YKBC)
M\U!-&*RW3N@J9\=99)"')M7$ZMGSGH'FR$L93JL>)07-KQ2*M#9Q."4C7"\
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M;Z""]\K%:,XL-")?$5X'6N>TO70VE8K0379[G@)+*(NA &4G'GITG,#;LF)
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MKE)#ME9<39$EF"5ENOU-U-17/#2XB_FNFEC:0U+2'OJ/Y&"&#-DUPC(DSBV
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g923792g09m51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g09m51.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1ZP4&AO=&]S:&]P(#,N,  X0DE-! 0
M     !<< 5H  QLE1QP!6@ #&R5'' (   (    X0DE-!"4      !#'71?E
M=+5N]=N^.93 Z7E<.$))300Z      #U    $     $       MP<FEN=$]U
M='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M04-L<@    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%
M6%0    ) $( :0!Z $@ =0!B #  ,@      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 \
M   !  $#P     $  3A"24T$)@      #@             _@   .$))300-
M       $    >#A"24T$&0      !    !XX0DE- _,       D
M  $ .$))300*       !   X0DE-)Q        H  0         !.$))30/T
M       2 #4    ! "T    &       !.$))30/W       <  #_________
M____________________ ^@  #A"24T$"       $     $   )    "0
M   X0DE-!!X       0     .$))300:      ,U    !@             "
M[@  !*,          0                         !              2C
M   "[@                     !                         !     !
M        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M!     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG
M   "[@    !29VAT;&]N9P  !*,    &<VQI8V5S5FQ,<P    %/8FIC
M 0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)
M1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U
M=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@
M    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M         $QE9G1L;VYG          !"=&]M;&]N9P   NX     4F=H=&QO
M;F<   2C     W5R;%1%6%0    !        ;G5L;%1%6%0    !
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M300H       ,     C_P        .$))3001       ! 0 X0DE-!!0
M  0   !5.$))300,     !3N     0   *    !E   !X   O6   !32 !@
M ?_8_^T #$%D;V)E7T--  /_[@ .061O8F4 9(     !_]L A  ," @("0@,
M"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,
M# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,
M# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !E * # 2(
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MEJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$ /P#U1K6L:&, :UH :T"
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M!C@;MS 6%Q>'6;6O])L/K;<]KMG]M)3U57UVL+R;,&ST1])S(.T^&_<YMO\
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M!;L?9[WL=N_G/SUN)*?_T_54DDDE*7*]2PL+"ZK:,G%&7TK+8<B_'<UCV57
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MVQ'&GT?^BOEA))3]4Z)U\JI)*?_9.$))300A      !5     0$    / $$
M9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4 ( !0
M &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X0DE-!"(      2Y-30 J
M    "  ' 1(  P    $  0   1H !0    $   !B 1L !0    $   !J 2@
M P    $  @   3$  @   !X   !R 3(  @   !0   "0AVD !     $   "D
M    T  MQL   "<0 "W&P   )Q!!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*0 R,#$U.C U.C(Y(#$U.C,P.C(Q   #H $  P    '__P  H ( !
M  $   2CH , !     $   +N          8! P #     0 &   !&@ %
M 0   1X!&P %     0   28!*  #     0 "   " 0 $     0   2X" @ $
M     0              2     $   !(     3A"24T#_0      "
M    _^$!,$U- "H    (  <!$@ #     0     !&@ %     0   &(!&P %
M     0   &H!*  #     0 "   !,0 "    '@   '(!,@ "    %    )"'
M:0 $     0   *0   #0   #P     $   /      4%D;V)E(%!H;W1O<VAO
M<"!#4S8@*%=I;F1O=W,I #(P,34Z,#4Z,CD@,34Z,S Z,C$   .@ 0 #
M ?__  "@ @ $     0  !*.@ P $     0   NX         !@$#  ,    !
M  8   $:  4    !   !'@$;  4    !   !)@$H  ,    !  (   (!  0
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ \ %\ P$1  (1 0,1 ?_$ !\
M 0 " P # 0$!           ("08'"@,$!0(!"__$ #\0  $% 0 !! (" 0,"
M P4%"0,! @0%!@<( !$2$PD4%2$B%B,Q,D$7)%$E,V%Q@0H80E*1H28T0U-B
M<Z+1_\0 %0$! 0                    '_Q  8$0$  P$
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MJH$=NC>3]=C:J;<2Y$*GJH@E>25(_P!TB?X^Z,8B*Y7G>OL@F,&JN7^D1?\
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MH_*;6[_N%:=\:'U75KPOQYCR&D"2BYQ3S)"V]]%<8B,#.O6QI]];?4![S&?
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M))08\5ZN2(_YA YC3.$X49PE#0_EG74GD[Q#+=NKYD6MVF<&3-ZR01/\!S8
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M%5C7Y&LB@C2;"SFL&!P/Y706"(]0-5S0D;3;+EGC-DVYC#FC3MB8;(L5T:,
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M/HJ0!U6K+[M?[Q[ZL-/I9#5:Y%9-1WQ56-5 Y!(@L_L 2L#:U[KD&7KK-:<
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MGDQAR(P(^HF H:>(!&F2(^-23'28\N,61""@FKG;*KN<G&S4FZ5O.='>G9:
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MA/M_&\%1K2]2Y7'2JOJ:1^]J,?&<1AXX8T@4A]I2".C3E%$DQ1RE"YJ%8@B
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MQ#&NG8.$W2XJSCN^ULDMIE4E0;>$Y[$13) J/U1M<YIVR%0ZH&H-]JO!O9*
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MK2QH& J+F,(,> .6TTR1H*^"]H[&4VH"LH<1S/U([HR.:V6CWG*'4^$0HXA
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-Z!Z!Z!Z!Z!Z!Z#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g923792g22q56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g22q56.jpg
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M20LM5MB,(),D<I=$N%T/2U$,<$S)64[GL,S:EM)&&R5($KYOGM$D4<6Q,_\
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M5*^:JST\(GA$\(GA$\(GA$\(GA$\(GA$\(I8A?\ Y\I?_P V+G^\0_.M6?\
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M )C>7[KTO^!BG\%QC\"J]S:C_&P_^*X;^+3U#.?_ *BIC_[A:'_F-X[KTO\
M@8I_!<8_ IW-J/\ &P_^*X;^+3U#.?\ ZBIC_P"X6A_YC>.Z]+_@8I_!<8_
MIW-J/\;#_P"*X;^+3U#.?_J*F/\ [A:'_F-X[KTO^!BG\%QC\"G<VH_QL/\
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M^4K?PR?DICW[#_,TOMT_H<?2:?X0+2_R OYOX_+7X,^$OY2M_#)^2F/?L/\
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M/Z''TFG^$"TO\@+^;^/RU^#/A+^4K?PR?DICW[#_ #-+[=/Z''TFG^$"TO\
M("_F_C\M?@SX2_E*W\,GY*8]^P_S-+[=/Z''TFG^$"TO\@+^;^/RU^#/A+^4
MK?PR?DICW[#_ #-+[=;>=+>@7</J[:1]_OVAG2L4XP@%$\:>8=8_"%+92#$J
MFH8C5S%GR=GQJ0+7S,W#CG7QA\% W^[GQEQCQE^5^%_PBP?%<-@IZ"KZ>9E=
M%,YG05,=HVT]2PNVI86--G2,%@2[.X%@2/T?P8P3$\-KYIZRFZ*)]')$UW2P
M/O(Z:G>&VCE<1=L;C<BV5KW(73WV2_M$7Q]<EF_C0UY^_P "[R81]64/W6)?
MBL6[ZXG]85OWF14KYJK/3PBNKKK^NNOOVQN_VV=YEXUWKK/W;?ZC%H85WPI?
MWG^ERI7S46>GA$\(GA$\(GA$\(GA$\(GA%ZH7=R;8$/J S:JM=V"MWPR4HM4
M O:MQ[X\K9.5R5FID2\#7SCEANYCB34_XQ'W8\QY$3+?HD<? ;-GGEE_SW?2
M=Z2O0\>YE]VR/_2NJ"%WW[D#L7",5CJ]=NI6Z[P3YN5I'T]>JQ9O&C>NW2X2
M(H04VVHSJ J#4MK6\XWH["B"SOG6,S)JU.8D(?LSEE9<>OO[^X7* /-UWL2<
M\@<QD-+K8%H[ZWIP:/)JH8K_ #=%=J[=+[8&S6_EPDD8('I(.O77N@=[8O0S
MD(D-Q9^N%HG'"-IG[Q.QYT[![H'D:!>K'9D46'DL#_Y"2.>74N#?7=7LI2;/
M>"H)<D]R=*C&VPOCZX*(D".U&D2O?1T&^SH?MZ3@ABL8ERJG^S(N'1<G2+AQ
MZVXS+8),.3JL2%NV["!H-L[ V\A+K6_Z<\_&NQ+JW8%FMQ/LJH6@;@,\^FK[
M%U^MLT)9U*>9I89>M_7F\L/C@N++F0LM@-AN)B584N-M]_O# !?!+9+-:R9"
M8U53;*W$>LCU+;#PH3PB>$3PB>$3PB>$3PB>$3PBJ&XOT>A?6]67XGB>2-_D
M/H*J[]'Z06EO?>RKUJZQ.LKA3,UA(C$GFY;.M6L@V$B1'MJM40*F<NRMR/CZ
M]FPBVC44XXL]7P=?'&V=9 9:'_UQYDK'F%R"UC?J .E_]L^JZT K'O3W#U5H
ME!8A94*N:GT7K2QHP9](IDI[NN9-]'K*NR?<*P"(M<2V[):MG9'7 2B4)54Y
MR3RMK-A_+,WYU;M$H'!ZM]MRL0VYTVCY/E6TR%M>KR[@UCV[M^][\U)E<OJ/
M,J7?:33%$NB@N"F^,V):%U7Z07'.! &K$SN7/C!NS;BMU-),FO I\DP].P+&
MB1SZWP0BRJVL+G?VEW9[A:\J_I$>S46M-MP98J5P@%2M^NE@6^M)Z;\0+H5O
M]B$CL8M&NI>C&&8E2(3K3=^+?6H86&,N.-@!5NRC>A^CZ=\]>FQE_?\ VTXJ
M=D7MNO< \,B,^O*^[>;64K<^[U]KMQ6%38.VZHY/J=-V+#9)]L::QJU?6+EJ
M61UNR)%ES?)=I9H2$?UBQ+6-I,BYA*^MLA<,!) -/-?KI\L?(&Y D97&[/(W
MW^*PW#CGG9?#?WZM$W7%X/"S:8I88Z[Z:,MNT)4EAI=><6+V4<15874P%WJ!
M&5V@H,<5M6;:^A1X>JCY)91+!@)1AY-$UYU7)(J#Q\62BV[CGGOL.K7CG?Q:
MK]/G<\[*N8_:,1^RE5-6HWN4M)#;6,8&U+!18C+'H^B:<WR.232'KAH^16&S
M'/?H<65C%*@ 'D7(%2L &,-R<I2V0URW_P#[>7@,M_E5S].NT%[]B7:OU\T]
M*.(!?#]CBCR07%E;,RW_ #J/M*[4F@:<V (>)*H+0VUKI4[ +3%+3*AGIL@<
M<3Y8M0+X0IA"VPOXO. ?,<O>ZJ2[_2$6@EW]<->H#<!VK8!8?1I+!X64K3-I
MEA0;GZJ(IZP< 8)VW.I))7ZGN:W;DD[[1&K,=S!U;FRJ.G0@!S18N4@#*_5Q
MM?(FV?&X RW>/=*;"[G62H<7MN1[_J^SB-3]9N;(H)4A!$<D0[=EMR7:IQBL
M=<S7F2+M:U^MBRAHB%ENH^8FG#E):]9TA%X:!&2\46'BN<[W^3NMSOO*CP'N
MO>\<Y3.TW;-),:/830Z)R//27>@79Q=2L@R.');+; %*?24/&LEF1+)#+%9.
MN^\\728P*:YN@@0MZ2W <I+1G;>,SD;>(9<K\.-U:R3VLMIOZ+V-:@NQJ_UV
MW6]BJZ0X6(YLM(AJBD9<G:KG6'G45F@VB;2S3!DI[F:!T^P-9N##U6ED,1;6
MA#3B^UP=9187MVWZKC?X^K,*M\NZ?95J]\O5P03P>)SJV.[DIUFWR"!(*["J
MDI3.A"B*%C$1AZ:EKKSSV6YW6+*-CS$Y-TU]EI$Q9L]?YP8=Y+#?UVL-;\/)
MEK=51QWJNC3IM:T%BS3)P=&ZQ=<RBBC/P6H86?RC/[M]@>O/8^]P<A1:.:\:
MERH413#V+O=UIMV52>3)*.Y,!8<F&@^SDIV1D.))W7_5!:..^YRL3P4^Q[:=
MO#NE<Q$6'6.B'A+ZD0];"I+B9:PQU7NS?I +CZJ:V>4TIC:21L6):I@&COYP
M:DD)2X.M>"7AY[OF?\97]Q+#.^CNJQ#=KB+[\L^'6K'ZW]P;H;;SHNOK<;E<
MA$LI9?%L4NU_#0.&>6XUD<OV*POESI)%AQLROU-D7ZI!2TMN2@9"M=CA/WI9
MV0,)LJKIY*",B1PL<^L#=PWGQ^=:W7-V^[!+]X-]@!6X:1.58K]XD6;1D$4/
MCQ:64%?MKU"JQ$N:Q(TIC'_*L@_1DED[&KQ.P9(-:X6Y!G()/'J&M@E;(_OQ
M\7JY*;"W+/7(DC=K89:<5+FGNA>40"M1'A]J]N6[/I3L%K11-.-E-OC:ZF5O
M=V:V+3?: U+?MQJ(DR*Z0*YB3W'KI)-!0%OCK2&,N*ZM9!=RY*;(\5B-X/&U
M[7&IW'A;RP\WWT[)+L^UAZZUI(+"GZ>;S:PDL*\O9"6\FM]6:YL5*"+O!=H]
M<;PY:FEC=66P!D8>( <)2A!S!-.WD:?ELHILCKS-K_\ [6W[MV[Q^)6&Z=T>
MV"39X^G>6&N]D@1:5Y*(:R7Z-7=8+UM'D1AZ[R$>M#$YP<%X,+F%U>VW2-N@
MUOH*V*QY@ 9Y8$[8RP[0S)  <[<-PN=1EY0-YLK8ZB7)9US=LF,PZV-%(2.:
M-MH67JH) CC8%&-*IV:FJ0]+8A^HC,WS7* IP TN>1:(T8T2SFS2P_7%538<
M6/*" !NXC/6X/OZ5KG7_ ':[!KM>4G$GW(KN3G/7AQG(4RKH"6U7];QCLY'K
M!^ZWAL!Q*!O7VJJ4J9'*3!(6#N:UZ8XK!E@A:TY3*A3)38$G2]O$+9'Q'T>1
M;?WUVHM)%[A0:;4'%-PAP,>C$@73DE>AD7:U1'9/L)<]57F?'D,B^DY&&TA6
M"!HMKXR!%YQ!.I>,[&S?)#D=.F,4 97/7GP! !\][>5:TDNZ_:16HSK79#$^
M)&ISNCJKH[,KZO.K>$(CV]<1+11>E>Z>(,?:>R(:RA?!T:I.K.'()V.7)FQ9
M83C$6DE@#$"DM%R!P=;R9_*\W]]Q$X)]E^Q;$X[%AF5!Y+BC>U-;T^:UP1!@
M)L=G@M9]U&09 ?(@%HVJ%JD=<H/7=VYA2,2@#DM<4W3/BR=86+CF46'_ )2>
M&@]=^O):E+_=OL(*)<65Q<*R?U72I=-8EC/W,9 5*[Z[G6:F>Y]BLR+A%L=X
M"URD%8%N)R75;!(L<_':L8LR"CF/C=H3%>=R5MD:;KZYYM'CW'AQSM:Z_P!#
MU8F&9BK:O6!TCKT1Q.HZF8;(JD2X,JD9F)@8$T]'63'&S=P67M)3?*UA27&[
M;Q.&XQI7&S/X7WW)<9ZMRG'A$\(GA%UX^DM_42I_6T"_!SYY=F_R>L*C]WE]
M17FO]DO[1%\?7)9OXT->>D,"[R81]64/W6)?"L6[ZXG]85OWF14KYJK/3PBN
MKKK^NNOOVQN_VV=YEXUWKK/W;?ZC%H85WPI?WG^ERI7S46>GA$\(GA$\(GA$
M\(GA$\(GA%ZT%SWJC]::(-7=9&)W-*1PZOM-XK(C8>.Y8'3 -7@\#@^G;IW$
M-O),W"]_'T9\R.=/PN6C5OW8X:=GEE_SW?2=Z2O0\8NU@_Y1Z%#L.ZG6K7BR
M[RMF@P(U;=]*-\M%M^K@.<D;*KK2Y=[2!G0-L_"17PM$ME,)'7N=P/6@',_G
M(R0@Q,X<N956L??QVYWX*:E^S?7\!%W3C=N)(F%'V6#JD2YYC3%C:,ZIM(!2
M=D?#[]O&.K3BF6PTKJ$?SV98X06(O"A[,O\ Q/?\$L=#_OF/-FL'GV^ZSZ)<
MN%-N-/%RQR1)L0EJ,R)87(6JPDCBS9T@KD6AP\19>!6_/%A3U6?E':H*/SPV
M2PND#_\ B'A+'W]_.OBR]MZ/ T;;_806S;GE HZ$R2'[6D0=A-C@SE8+ 8YX
M*."(9B=^9N6"+A#(:+)V0]!D,=!FA\K>(+CYT@EC<#7W_P!]%"N.^?7?:?L@
M'"/&26JJNLX#M@V, X1C*7L*L91D\Z*TCIN$SB1/;=R]%@G^5_"%ASR*85W=
MJF;=Q+X#24[)M?KMY??BOR2[VT:+5Z9;I&#MF*[!5Q$?J?QT+FK.6YER!E"7
MQU1Q-61/#7!N4@8LA=A0TDMN@?#<QV:1P3XB)[1($DV3GU&Q\^?BR]&JW-\*
MJ>$3PB>$3PB>$3PB>$50W%^CT+ZWJR_$\3R1O\A]!57?H_2"X]GWDD4^;6H3
M\7!K*\:6[#:RS:P,H4&-6@E<CPI$R2FQ24G3-FC]48SKV3Y\'7LBA-.KB05S
MT:)&G/F%:RJWCO/U>S8EQ=TV;#W;&1.NEYUEN!1K2$! NOTM9BVIRVSI0_1F
MJ35OAJ&S-T0Y'A9Y0..9>66O7,#\DRFQW]8'.]K:[BIR+[2]?S)M%71UF@]I
M2S?E'A!PW1R\*$U9#);/"V8"2TT='$[LYVY+:]@'#*=AFS0@) BNXE!^GXUR
M2QY>_P#OIQ6,7^WW6II^9WS<MM;,\V(:E@T#B!J+[N7B7!WI^B7.4>,1ONLB
M[HX?TR9FVA_CBM\E,(\SP9Y$Y[)NLECGENW]7C]^I8S?W7ZK1E>:XR;I4XX*
M R3%"7LD8%])/!D@*>+])%8+VP9BPR-V*'E\^-6R.+VQY*;AM:8V[<!T[I^!
M+&]K9KZ2>WU'!,G68X/"RL+BG8 9"B-7)V&?!E<S=3U?;L8\0F+W!'2FA=:]
M:@'?OG-NT7!T"=HUFWS=(,^)D[B;)TZ_.1ZBI&M]C$0PHVJ\&>""HMU):3I5
M3#-(QMI+9*+)IZ(N;)PR "U$B$R.9)SHL<3"T1-I.1MWZM/Q3X;/'#DECEUB
MZXNGMIUNDYK>,>XTO?@UH6VTA<K3/V;1\:NM,=@DY.C$3UZ,AZ>O98*39JTD
M6Z4#T2)JJS#]&6R>OEXT,ECI[Y=H7XA=M>N<_)%PU6J T;;+G8#TN.2C&0\H
MO(WL E2@;-L0L,A21,$RUGP"NOE#6H<-8F(\#!@Y9 H7'19)+'3=_OZ,_%FO
MP'[<=<V'2I2 -H"#.E]-R0*1F+&L,[YV[H>M>VRC"YQ&#[,C"9HU-JIMVO\
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MJVW,E<]"ZIL,#6UB&UKBPNP>W5T/.V[*<5N(5=8UUOS=(O80%09L=05"J]J
MKUBYGR?SIF0B"X4N VCIM'/@/E6TL!;/EY=_*ENIA:>U/6X+"[C)EV5D[]<^
MP1K7M3H->#E:T;*5W6FN=@T9DMDR.O>QHRTP$2? @9+D&P ""4Y+:O@R)V;N
M>_H52,CE;,:[L]5VE>%5/")X1/")X1/")X1/")X1/")X15#<7Z/0OK>K+\3Q
M/)&_R'T%5=^C](+4GOU>MX4V,A\4L9!@ID?K]VRN.=+,)GSRYG&Z 1U)T3UW
M7'S)CM4. RSYTX,=RQ^&GR!$J3K#;!AC"$6@PN0 '?J!SOU'1:BF._G8Z(Z7
M_+VR*Q65VI6.3&845C)(>IL0J[&7902L$MCYMZ7799TA*9ZG<;&>G)U=%0&D
M!(I6OYRV3T0@YG<S%(:,K\>(\1RW6O>P W[]1:5Z^Z'9AM"7 Z5K)5&T95]4
M=][D0UQ<2,V/&[N*![$7#5]"* H\/,[>=@%X3@2:5E%%:-+,-TOB$17",""4
MWQYQ-D99\6@WX7 )\5C?DL9AW3[':Y&V"A.*'?:$UW;NZI5)?*FG0=H)HM&S
MZXZX/U?V5(UK9N<N$DBHB+%V26["^0MW(R3M2ET"0EPFY=:\2CW";/C&5_("
M1SR'IW64,/\ I#[9F,?8N"G6G7D)01MB>S"Y=AS:(K:Q5P*-NNWZTMM&58K3
M9F:%BYQ("D@R%0#>I129L<3<J<SPP4EM5PP8IL,KC7=<@FP(X>/=<<BK+T=[
MG>0#M:PY-M)JKN2[)ZP#H%"O:B 47]<ZX6(_=2];]V0L0:2/_.L.-R0[<L*>
M7-<QH==H..8Z',D9%DD[.+O%U>_)5V=W'(YC47R\WODJOT=S7K:Y6%:1RQ)2
MP,/@S-8(;6N04^2@0Q@GTC7;BG*V<MV^R6Y>JD1%8:J1TO@I8QPUE$+ZY0^8
M&@')Y=< S"DMW :7/_2TGKR-\AFMN>BG9"[NS\U?:71A51:V+ZS];'IC55=1
MU:]1VT[?66[.P,-C',-E9(D>FLJ5NB#EB#KRF#),XF.8"Q/9&B8Q"@BW,CR"
MUO2M6AO>CLDS&I(1/L&MV.0SVIC6QW(/7\8OSUME\>D@2.HBU!8HL%IYVDSU
MC4VRM]@C83?N@[,3]<SSHZ+PIRMPC42PXWW7\?R2=/<+(6GWF[)UPVVVM"65
M&9V-&F6VJL2#.1=>3#3%?UP*J_A:[;/,4.?BE)J<UZ6HV\3Q,J,'52H<NO!5
M8B-VJ3,0/%(:,O(;\#_R^^>_+<I0R=TKR$7BM5U5EAU3>ZQ&K%)=$X[\N5 "
MB]H_ET[>8ZQ\4&6,=M)5G9Z]Q0E,,)7Z666+1!8=!GU@:XL-Q6\ )+"USESR
MW6X'??72QWJEJA[FV6M.<6QF6]4=_4;>=*+"NSM(ACP%<)^T]T2[16AK35W5
MPQ2PBB3U]A41!0?@)T[-B(D)41&.\$',A\<DE):+&PS -M3\H 7UROZE/X?=
M7M/)H1VO(L:718Y?=NF=7D8<5*6 <-*%WUU^Z;V_:EQF&=^:A:W$R73ET/BN
MOXL\X,@I_$T8:=<ST-<E0]Y1LBX&MSR+@!EXKGCI97AUO[77*V7_ %C6MQ.5
M8G>+(I_0RJHBB&&J'P1LW"@&XR6=+0X".YQZ4,&G1JCE$P^I1F.EI<<J.5<F
MOEIG!\RY"!8D:\;CR#AS-^K3M<\*B>$3PB>$3PB>$3PB>$3PB>$3PB>$3PB>
M$3PB>$77CZ2W]1*G];0+\'/GEV;_ ">L*C]WE]17FO\ 9+^T1?'UR6;^-#7G
MI# N\F$?5E#]UB7PK%N^N)_6%;]YD5*^:JST\(KJZZ_KKK[]L;O]MG>9>-=Z
MZS]VW^HQ:&%=\*7]Y_I<I7U M\#0G8VM;<9LS6H,F2F*7(VKVC7)-:9!!/80
MHW>/U;9<'#G=H)DH>W+/XWIRTZL-F[#G+/7CAER8K2OKL/J*6/8VY1& )#9A
M#9HWN#B [>UI&XW.2X\/J&TE9#4/VMF,O-V"[@3&]K2,QN<X'?EO7<R$]+!U
M]W,H%WAK!2N+"G40CQV-AY2F<HK@;RC=F[ [$W4)%A:LNJGFHK5UNM+O+:M8
M?8UQ0/QO2+0VY4+K.G>5T_DW_!FN$;X3(V>!M;,8X^EC;(^C.'4]!2.<^II*
MJ-M32QPB/;Z,OL7312MD(:?TK<?I"]DH8Z"8TL0>_HGNC;5"NEK*EH9!4TSW
M05#Y3)L](&7#8I(W,NX5U5GI$>L*CG1C.=C/>!A?+]+^'Q)!5R(TK:Z(ZP6[
M;+8S?-R=*>Y'):*SKMAC\E<'MA1\8/R?)%ERGO\ C3)W]BIP+$9?CD;##L/9
MBW0ROG>9)'XC2TL4>V!"-DQR0.$C[W=M!S6[PN&GQBBC%,]XEVF.PSI8VPMV
M&-H:FHD?L$RG:#V3#8;86L6N=Q-,5[Z1 >-ZTG ;Q8US&[LR W</)AR/,EH7
MK=L1_EU5LIF[79U,-OQKYU=?HM?ZM2WP86SQ,5BJI,%4(1(1,U\B=J? G.Q!
MCX:>D91[=(YKFVC?2P0"I^-T<,+(K=%7&<F39D8UW2S&1I<UFWUH<8#:)[99
MJEU3L50+23(RHFF,!IJJ61S[])2"+Y&VQ[F]'$(R 7;.QR!Z37K2 [-![<B<
MW-7*&M[DYOY2%/)E'+;@>L3L4P=@.TJRT+*/:*3BRQ)'#7$KRM(;F4/UJ06$
M$5\^T0KIVPQN'0G^#V(OPYU*?BD\\G2Q=-)L.DB9!0,H<-DCDFIYC&6]&9Z@
MQ-94"29_0S--RNY%C=$VN;4#XS#$SHY#$PO#)'S5CZNN9(R*>+I >D$,(E<^
M LB'2Q.&RU0!4[]T&$4*9 $G:U![A6Z3=-2HCW6P!U7E^DUUSIZP$%#M*!6)
MJY""C(N)9;F4*2X>*E%U<?EJG#"6-[BM@;(&[/GEP2M?+5R-AIG15$U)5305
M$D,DE6^&JAFFIG5+*1LHI9(HWMZ&J?4L$FPU@;#M <,>*TC(Z9AEG;)#%501
M2PLD8RF9+33113MA=4F,U+)'M=TU.V!YCVW/+I2"H\N=Y:%!U=I%LMA7-9=F
M#Z\;:EGL;$CZ,YC[F8](767<#.US[(6L<P6TSS:FL&PTL+.UF2^;5SCMG%_B
M<GB9E>3!JU]3M1P4E/3NJ(JIL<<QM!LX%485\69&VG8PM9+(QX>W8;T>09<6
M5&8I2,@V7RU,\PADIR]\0O*78O#B/QA[W3.==T;'-+3M/Z3,NL;JUPOI%^K@
M\4Q:=C#>,V&P=FPO8?A18X3*P!5L^N=]Y%Y;)J* WVKZLT_6P]?YT<=GR)0=
M+G)L3)ZA,#SO5C(6/GUG8#B)=&>CHP8\.=0]+&Z-CY&28(**T[Q3?&)>CK6E
MPVIC"(.A+(1*QY7.S&*%K7C;J2'UK*OHWM>]K'LQ4U1,334=!&'TA ^3#TIF
M,H?+T;FA=)EVV>PW':CK83(SL[;).FYGR44;RLXN:CJT+;E!4@F6^?+G;8H]
M?7(XP*)$Z)&4 .-@Q1@[#5"BZ->/Z^CIHZ2FA@CCCB#&#:;$T-89"+ROLT %
MSY"Y[G$7<XESLR5^:J9WU$\LSWOD+G'9=(XN=L#*-MW$D!C UK6WLUH#18 *
MJ_.RN!>M;:UPK="4S)M-M&L!D* CI(W(.JPQ\YA*E'%B74E?&BXQ4H%&92)S
M Q"XO.P@6'PX^K;LD296K5JSR\\LO^>[Z3O25Z'C%VL'_*/0J)"][D-H:4A!
M4JEO-GL-LVW1J+HH]?0X!RN/4 [UO7UH;'B6PV.$6\M 1AME(PB;DH\YZS4$
MGMFB<IFJ'(]Y56MOS&5O+<7%LEPM?I'>K>.BR99!H-AHE/V!V1KBRY),!MQX
M4C'5@ 1:K.(S8\.1,G2P,E<&;BJA/%12&YDXRX'Z8D<QHFC8A3LG++> 1U@Y
M#SY*>#.W*QQ-#!GJK;CJ-C8*]NJU0ZS8@--UF):'1.BJI#>;RQ3GQP@0\YWK
M@5] (3/GQ3><R&PPC8X%*%\:I)1;K!S RU-^Q4XQ^E%ZL*J!?ECF9[O&!=<:
M\H&S;!C<+&C(O(6^RBX(9JTQ68?)?'48([(9P=&88N<F'K 3=^'$N1S#V:)F
MTIV3D.)N.2O%U[A4NA6/:E5'"!S-PI_K\<[)MD6 '^,P]M?*^?\ ^4T(+.RE
M:=)!O7XLU7)%U[+XOLA#'M(F[)/P1_5SJ*+'+K-O?WX%5+']))UYA8#<'^)8
M=2$YC)$7YX:PUT5IF@8Q:@++[*+C,3E*;&V!):\TUK4KEP!Y7BQTW(:XD14E
M!(9>7AIQ*=D^_C X]96[ZH>S:5A>9=@(^L9L 489Y7&J%H&LP+Y3AZ9G EA'
M19D_0/-0.-W$8G!US9/$29KW1\MN66O+GPJK/^$3PB>$3PB>$3PB>$50W%^C
MT+ZWJR_$\3R1O\A]!57?H_2"M[R%9/")X1/")[G'_P"CPB>$3PB>$4:4DY80
MPO"ZGA82^#Q*L1S@8/PRUQN"[:Q%6UDG^]RRSY^,&&0V6,3,O?>YG,G[\\>,
M<<N,>"*2^$7\]SC^K^KC^K^KC_\ A_\ Z_\ T>$7]\(GA$]S_P!__O\ _+W?
M")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/"+KQ]);^HE3^MH%^#GSR
M[-_D]85'[O+ZBO-?[)?VB+X^N2S?QH:\](8%WDPCZLH?NL2^%8MWUQ/ZPK?O
M,BI7S56>GA%=777]==??MC=_ML[S+QKO76?NV_U&+0PKOA2_O/\ 2Y4KYJ+/
M3PBG=6UTQV]9E>U0GQOCC99;LK(2U&]S+G'<=;C<$"+PV>\XYRXU?'9^GG=G
MQQ[F&KC//GW.,>>?.&IGCI:>>IE-HJ>&2>0Z,B87N\S2N6"%]1/#3QB\D\L<
M3!_S2.#&^<BZ[5NROHYJEI^Q+:;I3I=%;]7U"F:@M51D&*N@NUWFM]E.FVG-
M@>6G,C72@B+&@V6JOQ6<1GFQNV"KQUV-''E)AN)+R_-8?CU5504L38J2HQ&:
MKJJ:79J'0T;!3PBK#A+'%5N)--+ P-:QUY3(2YH86K>K<'IZ::HD,M3#11TU
M//&74XEJGF:3XN6F-\E*T!LT<KB2YMF!@#27 JO%KT>2 9?2%:$;[."6FM>L
MJ7V<O61-0ZR7$U=7[*7*0/I2S6KQ8O8A#7G,M\+?"N-9B3U(J0*/R&%Y*_+:
M<\QD&=SR8[.R%M0VB8Z.HQ&;#J,-GJ))7OIY*QDTE1#!03/A9:BD=&V'XR]P
M<P/;'\HMX681"Z4P&K<U\-#'759,,+(XV3,I7Q,AEFK(F2NO5,$CIC3-&RXL
M,A+0<WI]&]567S6D:.W:>SK,JX+%K%\M1&TTT7J%!Q5#-S"D#299SG8Y9.!V
M2\]%6+Q:K"+LJ)E*&(-G@_A+LUY 3?/E#C]3^=OA<L<@I(*B"FF^-LJI^D92
M.G+(V4$C'QT9J7MJ6PR35;#3/_X2SV*PP:"T9&(1R,-1-!+/%\6=3Q=&ZI;$
M'2/K&.;)5"!KH#+'%3.$S?\ B?D.773=U9S:;ME]K A&9HDE+898?C4Y!P8!
MESC88Z]\&44%+#:^K<?9.A;X\W1L7W1H"RXDB/-%FR$*1HD9[U'4"KI8*AIC
M(FC#_P TY[X[[G!KI(H9#LD$$20QO!!#F-<"%D54!IJB: B0&)Y;:5K&/MO!
M<V.25@N""-B5[2""UQ!!56>=E==/")X1>K_V1H;#LUUN/TIL."%SAMC5[-Q*
ML*CP^KV.Q,<E)[U0#Z;R?5N&0$9VK. 8P*X81.4D;/D\8S,,N..,O++_ )[O
MI.])7H>,V:P_\H]"TM!^C'(J[?3+\)?>O1@Y4A3L(6%J#[U'S:J9395]V-2=
MCY;^OE;0KZ7)E%3$(M2^O8L3M;@]2,2;VZF<LM,@EAHUU]SES]\U?:W[\[;C
MH#ORSWK\.GHDJU>3S0;(V8P#.+%7NZBO9FD$O0X6YK']K[,O.QDXGHWR"\V*
M*::$Y[!/@,(>W#BW#M$S&<FH R$+'BXA-KJ'Z/\ Y0!X\["ZMBR>B$OLB42#
MO;EJI*\"E?5CV&K=<A1^M6D.IQ]UY1:3P&OG"T_VO;V,1Z1)E3F9,8N)(#=9
M.*\;!\".M8A-L@^0&VZ^\'?I?+=Q6M=E>AJ5K(#G!$N]"XS6RTXT5$PX:$"/
MO@']$[J'4W6%#.FX'+EHX(;JN9:OV72KC\I&K#Y>9I@#F7'PA8'I37K_ -E.
MW;AQOOW9DGGN/B5XV1Z.';8+I8-C9=AW48UV<6[#:FJ'L3U:>FYHM[4+C0.E
M0'B=.0QJC[E)>3:*.;2DMYGBV,]3^F5RKA,F?9F$* ZW </'D;]O-1$EZ)*H
M3(D D$FK+U8!+KA7IBMCE/4+:]+?'ZD/767'>'LF.P\L(R<N,S4&O>KV"5I+
MG:K=EK2'59VH)K5OF:3;._B1;R7OZ,CJ"NS>O@K4N(J<OO#?KL!Q!K(40T/6
ML!I5N'$Z.'QXA-GS7(Q K%";CDK3M)2!D0A)B1-\G9IB9XQ\=>O JJ8>$3PB
M>$3PB>$3PB>$50W%^CT+ZWJR_$\3R1O\A]!57?H_2"M[R%9/")X1/")X1/")
MX1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/"+
MKQ]);^HE3^MH%^#GSR[-_D]85'[O+ZBO-?[)?VB+X^N2S?QH:\](8%WDPCZL
MH?NL2^%8MWUQ/ZPK?O,BI7S56>GA%=777]==??MC=_ML[S+QKO76?NV_U&+0
MPKOA2_O/]+E2OFHL]/"*1*;:SHC",;4P\46&<+MV2!!X),W#RHR1MC[HN<B#
M-CY8;XN_XOOW:\=VG/#;AQGSSAGCE[F7''+%'-&Z*5C9(WBSF/ <UP!!L0<B
M+@'-7CD?$]LD;W,>W-KVFSFFUK@C,&QWC-6PF]H^Q=>QQ$1*NFQ5V&  &E8/
M"'LQ'&$/7&)BC.!@+'A[-NR-P.F-T.&U?%LM66N.RQ8QZ+QH*Z-4O'K2X=03
MEQFI()"^1DKG.C;M&1D9B:\NM?:$1,5[YQDL-VDA=B.NK(0T15,S QKF- D=
M9K'O$CF@7MLF0"2VX/ >+.%UDA/;OLZ"P2=8J\['B:ZY7IBBF:\6.9MP#*<X
M?%$R%?C#?EMQGKG F#!%1@9/B:+A#($$?#BQXD.-IU5=A>'/Z;:HX#\8>)9?
MD ;<K7%PDRMLR;1<XO;LN<YSG.)+B3+<0K6]%LU4P$+#'&-LV;&0&F/K9LM:
MT-==H: T   +XP^V/9*! @"XES/6H:.;"CUI@<ELMD/>VFM[/))G"<?;AGJ,
MS)6]U<-W/!?&=IU;&EART:M?)B?\8DX9A[G.<:2':=$V$NV+$1,$8:QI%BP
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M:];/%D*D)_;SY*=FPZ^7Z-_'<>G+K4NT^D\7N1&\H2J$HK:BHJHSR45<;"4
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MQN_VV=YEXUWKK/W;?ZC%H85WPI?WG^ERYU=]:KBMI%E/U;J<IQ'Q[63:9UA
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MVF3!A.DK:'W\DR@N9E\G%)L:%('P\I64.Q.G94STQ;,?BK.DJIQ$334P,)J
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M>$77CZ2W]1*G];0+\'/GEV;_ ">L*C]WE]17G<E0"LU]_IRN\M_-?)3)V^W
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MD1J4C85%V5HZMRU4IUD[,0+XIE5KVT%1(K[!?W616%BM26Z*HZC=T*27-S$
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MP?M&J;3B2':;#'LAI@<62 $@/:"TEFT^:+OI/EM,1#U*+W7P@0I$Y6U5TG*
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ME]V:L@0Y;JS3L16,_8,!+4?:6+E>(<&/QQS(YRX\M.)VG9GYQX]:]#, +6W
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M=2JOL&)##;C"Y-$!6]2K&1L(\G8LL<*!TBF\M!7]9P@NJBYU/G38%KV%O%U
M[[6SOEUK&QN\G2WE.46HUUFGI<NR1-(,]9 7N502EPW)]_U3:]QH3%(;2UK:
M4)1QW*-(63KEB&UH$FL3H\ "C09)%H&Z.&T=3S*=&-&Y7OD>%AIUA2Q,OZCK
MEN;KZJU!UN&9U%9KF45F6T'-45QNF5.YZF[NS M;506APX<A9T;#.I<,^184
MW:"YD1W!?BR-<Z"-)S6T=3S*; %\ARZ[:**0>P*0L/78L2^]38;1 1[>M95J
MM3KA5K2,Q2ZLZ^5TK.-MV,?8&JX(@PSLXVMJYD&!X"$\O\8;E@#&&E\];0:6
MVT=3S38;ED,P-XXF]@+#WZEM76#7UNMO5;9U4Z[\<UY4NO9JD6+.$(>D*XE=
M*:OV!M&J870RR6_CC%3:@,_@@RKZY!VR9FV#JV[-L7=EXN=3S*C8&0L+GJZ[
M:+6,5W-ZBY:XIARZCN==I&Z/A/DO#$%IPH,&BB?5QN[>K!&8*3K*96/G ]42
M"VY9Z8HB3N#LT* &(XZ]1+B?&;1U/,J>CZFGR=8&FI4MJ?LWU6N\^L)57]6Y
M3B]GB3AF17 ,ZA"X]<3$$#0["W/4IY%VE,0C4 )J[)56!F EAD,L^#A,8P/(
MGX)8(DO%SJ>90L X#EK?JZBH?4O92G32&R3[-ZM+(5R6PFYM@S."E'H-?O2E
M.O9\I863!,5A6Y#AK.T224XN)J \D@9<MLGQ]JH*+2I? 6(N=3S*; RL!G;A
MN-@=/1=2@#VEZD.658[5;K0<S7+24*/98SU+6:QV DR1V-37-JJL0R!]%AZV
M(M/WR$<N$/\ *G#,!1Q#.#MU,&\3*S+1ESJ>938&>3<K\--YW=:R%,W;1-E5
M?,>8/6G4U!*^J.K6BS[0VC:0J%+UV'8-#57?NI1TA+"NS=O5L\T.W4P^0F$&
M8XFK&TYBO<O[%+$D"'C:.IYJ"P#@W/A:_$C3J\?4LQUVLZD.R5F1(";2*'"K
MV73#HV_%I@I7*L^JQJW[%V%U^<A,5H56A@0SJIB<KPKROF04R;!.1,XAV,:Y
M'SM<72N=3S*DL &X7O;<.(OHM?5;M<AS-M3.+ATQ'!:SL&J=SVQQ1,:MRK2B
M8$NPRM2RZTD9FVPHL$LJ81VF)++AE\85;^9&F9,BC\=.B,.G+G4\RFPVQW9&
MV[07*N4QV1ZW# LX[$Z;.9N'KF=AY0>.,&TKB28T7JBP$%2^;$&0YUFP\8H1
M79HH\"##&MXMO;"+$#V#5[6*R*%!;:.IYJ-@:-X<-=PW?VZU$W3N-U-4_GB4
M@]0G)M1DI0O-^(/P(33,<+.3NML5$.6\=%BCMEB&K=I#J=BKAX%"D (I5EV<
MSQ4.!IE1<-F]M'4\RIZ,9?-N;6%M=W#J6-D]K>O=72[BQOWK:+ KR?95_JE<
M/2\'KO0K/NNGGE248*9SP;L3@J!="7+P$XY8G.$EH$C="8ILPPO"QL.247.I
MYE3T8X ;@=V>?'=U;LRK$1.QO6:UL2>FJNJ!"PIRBCM#Y8^*_OH_,*DB0CS:
MM;@,M33(LC2ON\>P&FFGK:H$T*<QCLUH=H-F]X:1-BB=K:.IYJI8!O#>7BZN
M%UP*Q[&]>&P32FQNZH25F=8:AUE)6 :@CZX*)U6.';&5/#TTL$=NMPY93FML
M.P86GB:N #."["<$S:R\P-TIBU+2YU/,J2P"_P TV)&[?;?P4<1.WO6A_P D
M/<,Z16+"&62NTTU*9&:,HK=S-#=BJW<;#H[+:.%6N1*:)[Y\PF1:R@?%,]BT
M7Q%[V7,:,(;)D. XGB==_P#=-@9_-RZCPM?APNMN>O)3JKV; &6VM*E#;543
MC7_&H\560L6&7D6%4=?W1!C"\-$N7)V; RG9BM$/9[],?3#8MA,+IV29(B?S
MIFYU/,J"P#>!QX#@2/4MA/4!2?LN2OL*%_#\7.IYE18:#D%HIZ0:KJZ2Z962
MBFEKJ\1D6<%'[IHH9'B2-L+:JNDC9%SV:L.,LM.>^+&VY8<\^YSGHUY?^>/'
MEV$DYD[NQ4> !D!O[5Y^I: 9*]_9XM<VL&AA)=OMT %O4E\&VM6DS,N3F.+V
MK*JSD@ZVS,&N=LT9A5]A+B@9DEQ&&EB4&!)D2M7H6@+&_!BC=((S&W H"\2O
M?%$6"@:7"26-KY(X]F^V^-CGL;=S6N< #\3JPYV/U09MAYQB8,Z-C))-HUK@
MW8CD+6/?>VRQ[FL<;-<0"2NP'M+>NBP^K-H 8[OV>O+ K#K1Q'F;?ZO==^MR
ME7Z_IM*4KZWT89J^RW)IL#%A8@1VMH@77!P6=!#(J6GR\BBY UZ\[#:,P8C3
MO,.'T>RZHA<REQ*OQ"2>3XL)#"YE13Q10]'&]E07[1D+=EK1LO=?0KZL34,[
M!+6U6T(9 ZHH:.ACA8)S'TS703223;;VN@#;=&"7.)VF!='7G[!?EU=777]=
M=??MC=_ML[S+QKO76?NV_P!1BT,*[X4O[S_2Y4KYJ+/3PB>$3PB>$3PB>$3P
MB>$3PB]=HZGP7Q U*Q(JV XI$:$SR*I#<QHS-#VP-D$C&V#F55)"C,/CF1%U
M83(VN7\2*0<I(LK&FBYDR'O\LO\ GN^D[TE>AF?-;]$>A:?L_1WI;7P'4V-X
M5@ J2LKPEIEQ)W1<6E:>A.=JMML:X-K M+UQ!N8DU7#9K:Q$(#Y!;9SZT.4L
M20AG."NH5MJN2[CERR&@&6660');O+30";QN\NNSN2 ^.;95S=OYBS8?.!E/
M8BBFQ0^=,^/%W\_)S %)P/C&.KF++^+?&H.^3"W1Y.TJJ0>$7!($QHC1KE%2
M$$9%W3A@S5)(2X\+1M)&B40,&'Z]TG9KUYSBQ>?!%#(F.7,B>2FQ(,77ME2-
M.K,BQRXT FV%,(K\[Y0AP#S*L2]WQ69$^".*# 25V*#\'.CQMNSY/.B"$'XS
MJUYPYGQ?XU!D2H>[1(VD61GDQHK7HW%"$$;JE3H(R+MGRX\/7))$Y6J$-'Z,
MY&S7CNG$)N[3$@Q-?.4B7*VZH^C7LV[,<.2+'+#0"<@^H^MSOE$3OF%H&J7\
M5F0_?2P1><!*ZOB\^/%E8_%2HV;%^$RT\:M_P/P\;/=&V:=VPBS_ (11H&XK
M#*5<@8$U!*EJ]88:FZP8FS+9O6V2>IK+W#"D^.<>,=,_>GN:JQ8:>,L^?DP\
M-WY<\?#\<>$7]6'!9=(A.<JFH1V&&9&1/)R8&>6W3#9D\U,76@+LV<XXX\S0
M1X=/$$<,.<\=$^')C99?":<\<2+ZEV@$"**P8K.^*DG0Q, K,;XK,W_*1: O
M&VN7$^&C1]T>%\$ 73,_X<AMB1MGQ/XKKW9S9$6-O(L_X18 4T C99H!BYWQ
MDHF$X(=DB_%9FCY-(D@0IEA1_AY$?3'F?#!#8R;\- W2M&OXS\6W;=<S1(CZ
MB+/^$50W%^CT+ZWJR_$\3R1O\A]!57?H_2"X5WT"@]A5O--LB2][%.<,/@&)
M;4K+?D$*YK#5"U#617=1Z6Q X[0#,#M7,#='*X;Y$2'*)1ADJ#I+EL)L*X)&
M[U*O)_2ZBI166<@0[ 5S4A^:[(B%DFV[.3"(-A?X&D?8,9;F+36-W@%UZQCZ
M)[.LB\XP2<<C#6#5"C' H,@,)<^:W#<%R&KIAUU<XC'"8$B9)UM4"\QYC9';
MW*#(SU=CSJFS6WNB2(1[1M'S#YY'5B8Z9"RT2%B0*PX6=@G5(F:Y!+G+JMYM
MRMO;4:++9$=P*#9AMFKQ!<JS7#!TT8+R<E"P=J'(<X)O"?.W1V28P2*U3]\X
ML>T$"GP@^3SIEZN"I7B84*IEKIW2ZF(JL&(XLGD;1[R(?:CTD[BM(WG7\T$C
M,%9#5U?WEVV;NU(VNOFI@4I:;)V2@)022V<%8DZ5HB2HY3<\^H>_E7PG]*NN
M1%-KM#W))#2OU+4@&DJV^(NKN/+IJ(J-%6.RGB%/PV'0;T-"JXTI6#0NN^<_
M:WB#:G#GPS6O;(G\RR7//^_:<E)I?5JEBYM 9FI;)/3-6R98"$N,+ZV-3D6D
M+5HQM<%WBL<@^9G8M.XH/^.BX4I@UD-ZZ',GPJSD'$'"D*42Y]&[+=XE_4+K
M#55=\UYF(Q>C.^J)9R174MYM&Q7^8IQCZE#19@<;*<68SNR!Z56!%&PA<O.3
M&C;^))KC',^0(E)9+DWZ]^0'H7$;NIM%O=DYVHTJI$FS2)X,R2@\M[?%339]
M;6#Z0%8SZ%#.:$TZ>AI3.:4<R94)+D35V1$&$,I>D.$^3B7-K*/?0PIC.NPM
M2S)UO%JX!$!DF*H'+WN$V)E!P>L#J")A; JZ2]Q9)$ZU@+C%7)^[?#S^ FYR
M^9.9U@R*DN;WX^(>_EWJE2'H^8(R\%6TJKMEBJE8!RT2443P$NTN#12.K758
MEXM*_@?%72OI)=5M)BLQJ".0>TZGM;= 5S9L6D$5+XT*V@BG:RL1??Z+#APM
MKXU;6OHGUMA"DP:!5F94DUPHTVD5\QJEDV( ;DQ?H-.L:O:ST &@>SZC$26+
M1+<LE1,$,Y6Z:V@6\I!:]YG#F-S'*+G/KW[N-CZ@IF'ZI4J"L^';X\*S?/6
MQY.D7?-L2P2@7AVWU7JI0DZ2%HFS2P$YK-UE&@K9TY/'RIQ;*!I.3-NUCWSR
M\PESN]0UOZ5A'OIAU^L2.<TGEIBA[V1P>'8X45K#L!/.$25G*8U&L89M-K#*
M**:U9V5 XL4>5(\K2 W;!HTQ%@13PL85ADVCKH.6Y6LJ4O6J.$?%Q46M04'9
M1@@=;A<2:1XB3"!-5!)4KF#JSEY8A(GS96@HR./"_$(,/"'QNBQ],C;OW;"B
M^[JW>E5+]"3K-E!&"Y-;:YXH5RM?%Q9)C:R([?J4:':NLX2(1AS#>[03A:J5
M=65.F0R&$B,4X)<FB6J4?CQ2>DIVCK[W!](!7(@]/ZD'X5]LTE;BVF:NWG=:
M8V2[XN*:Z#5QGTIT=B0=S;*=-IXA7IO77J/N)ILZ=(#3"JP,8M\?-EXDF)!+
MGJY#L6+G]'.N,S2!XCJC $GJNL=@KG%ZPGX(?7<Q5B,5IPY DQ 8],R-*X<6
MUDE[I'.S/;)'%Y0+?EL#<:8.HFT=?,-+>A?56Z/];4T.!! TDG@.6<:MUA,)
MSP\E-\*/2N#=IK"+\<(L4F7(CJL1X8H4?7*W;^2$23&TF,B' ^#S')<Y]=_/
MO6(T=">MT$#.5 P%X7E0DJULL3E=?MNT0Z_+WT\O)"G6#G*%0FW5$EV*EK=:
M5^(%/<K7N8]L5-6^24Z=N$0MNDFT?3P'&Y/#K*L:HNKU.T>9EL2 &/:#T^*Y
M0YI=@=7!NGRM-@V<QW*Y9;]S.;*\[9)^S6]F;IDO/C*5Q/-3-.G=J@\ZHFHA
M)._WL+>A0X=T?ZX#0?S<UJ!N4%U@Y"M"A$G]](X"E;?90:V]*V)V2V/;N'!A
M[ROB"0R)&V8<08L3D3ISX&29<7>2Y]_%;T+E-_2SKVZIPE%*J[!" ABEOD8N
M2U83^JF=L6_CIQCNA;G,2\RC3T]0L<HQ$=[ K2B.T-QEJ$;!D0?(75_>,)<^
MCS;D/])^M3,*;@9:O/?"7E5O9*8Q\)F;1<62L=E!*F"N(5#U#3D7$3I912.L
M0X>8KB'N6<!WOE?8'SE2\MY-HY9[K6\FY<$]T:ZW,Y=M,,"B?*[7+BP=\^%)
ML2PL10<W:;&#:WEN3AVAFTQTIU*G5=9G06Y5Q$GEG8#B\JLX)S)*<D"G:/HX
M#AP.68ZCD>*DVCJG56I@7&O=-L^>S@E?>DDCQ*X[0FDWY1V'S[3$6K/W[FKG
MBP@80\TL<Q;%L^,^$MQ3A4$#TP%TA+$;BBY]P/-IY%%5GHQUU4R-;DA2^W[<
MZL#5V"7(16T+',B",.GIS"1I_<YAB;1*&/)*JY307V(A1LBEB +G@-\%(SY5
ME7D*2Y]P/?/BLVJ=-.NR3I1-"TBR(&JM0M$+Z;CDV.$SY*$]:0#2L4S&SRFG
MI&1#E4"NC'$W;R7,N0P93\9#)M+28D/;')<Y]=_/O4LZXT*N=;ZQUUHLR,)T
M;-RLAY($,!V K"48LI_8WV?'C#\)4[B"( \L&M86AWQR3@)5@801'V<18&C7
M@0F^?B\PLKV\*%UX^DM_42I_6T"_!SYY=F_R>L*C]WE]17GA22[( ](5L.IN
M++FWA>X_!=5P3%> [N&3(-NGB8#Q5$LK+'BV]ER)Z8O )7)3X4 ^4YBB9DN-
M'E[-V'H6A9')\%J1DO1]$_ 862=+(Z&+HW4#0_I96ASHH]DG;D:"YC;N )%E
M\2JG/9\(*E\>WTC<8F='T3!+)MMK7%O1QN(;(_: V&$@/=9I(!7</Z32 W('
M4S<O-;)F'/L6Q'"[ZL!=">O=3[U51&NA!SB!'^]>O!%K04^+':R9$^.J\;81
MLY(;2I+8QJB_.DRY6[\_\'G13XF)(HMID?3.%3)C5?4])*Z%L1?!15XCGE)B
M:UCJAT#&")K>CD>  MS&Q)%0;$CME[S$TP,PJDIRR-LCI V6JHWR0Q@2.<\0
M-F>\R.=TD;"25_FK\^@+\6KJZZ_KKK[]L;O]MG>9>-=ZZS]VW^HQ:&%=\*7]
MY_I<J5\U%GIX1/")X1/")X1/")X1/")X1>P*%_0PG]F0/^UU>>67_/=])WI*
M]#,^8WZ+?0%K7V9365P8.JNT:'('TQ0[1K+K:8<=I^-Y[UP+5=OZD(E*A>^X
M^'A*]_SJ9;Y$CGCG6%X7\6*1EHC!]TG157''Q9<QZK^^2T$J?IQV/DG:#9+A
MTR_EE;-T!I>YVJR.2.2V+!TM?=FWD37L81G+7)V.?9:X(M/E<HNGDF=0!469
MLPV*,"-SP4W&>[CPU(L/(!<=9UWU..Z/]OS:)UX"7(9?#D\E5356=R>KMJ03
MY*K&Y<4:-J&@K3 ;["L--&9STY65+RN/ES6<W1W3KCN(I- J#'\ )G 'O[^_
M'E-P+[NKA?,FV6N[A<:*V8?5&U6"RQGSPHN>P4W*[V ;V8I-AD*>E7&1 [$?
MLJ9Y)-$U=M$^KNE:U1<CO4$>K-F_>+ML=6<,LLS$,E\SE^:7)<6.>>S86O;>
MW7/, WX7ZLAKL+K'LX$MNFDPFKD7^_X(^MK4E2Y3@V<*=0D%BNKMOZQT0TQ1
MX?(*.NVAVD842M6%P72I(4Y*D]979&V=JKO(.#)<6-CEY,Q>PRZ@+YY@]15P
M5OU)O/2R)AY_H7.<K .YG%_0J\^5*F$B X^!T5PKH,5X5HMONX05%V=F3[(>
M,Y0')M<-L]92VZ3J8=FTD9U$)&>>]MN._:OED.'4!P48T]1.[8%87XP\868+
MJKNKE3-,N2;:0+0!PBK?1<PAL5+P8VYM^<&ANM'NJQL#VZF9ZOJKV=7TD ?F
M/$UE2%1:&DNV^C2=W_[7O_T@#@;\.*Y=U=,>S4&O+TINK*[X:$RQF!O-HK=B
MX+4Y^2&U:ZT];*JKZQ!<MYM)3BKC,Z/L/L581MYCXM#J/<AZ!,R'B=YF<YB2
M C(DG++J.9-LN&X6\:VR:J$N;.H;0T9JA-A,VWWDE6U:Z$J-2R.87WKXN6@#
M5%U:A'#K,KK.W%PHNKZQX<%DXU!=1!-FM"$2SVRY&T1+*+B_B;EX[=I.[J6M
M-&]%+K7+'K<58PEI7*]'A!KD*D5J<KV<JU*YL]K]@+INI&V$"[V'>P^-A&;,
M"HC 9KBOVN&\I,)?"'380:N<?%BDD6.>?I&0'CUSM8\%B!?4+O-ZGJ\VM1@W
M/M7"A&Y?M&"K6G&&SN#0?CK-3::B(!_>QC(L,^S=?U+L<Y\M<DR+&@+OM660
MX;1D;9#+0"7;GX\LO'Z[>1; I?6-_P NUB8[8UV]U)2RF(KXU4J^ORJ;Y!U-
MH$A[&FV%6S1K$6N5-@BMAN;I,WNW-6K#RKNP?!*@&GG"*H1(P@HN+'B3OO?/
M=8[NK*Y%LU!+5ZB=E[49+7*%H\O7#<#UYYK>C78VN-H"2;"OCK<B5P_0(L0W
MJUP#=5];^O>VT5;C'7Q+"-3M-AC=&#MQOU:27'H\M@;B_638\+>)=S?A550W
M%^CT+ZWJR_$\3R1O\A]!57?H_2"M[R%9/")X1/")X1/")X1/")X1/")X1/")
MX1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/"+KQ]);^HE3^MH%^#
MGSR[-_D]85'[O+ZBO-I["3IHOLM=A,9,E#B(Z[K%G#R$&1NB38,V(\EY$29#
MEQ\]>^-*C;]>O?'D:-F&[3NPPV:\\<\<<N/1^"-#L#PEK@'-=A=$US7 $.!I
M8P00<B",B#D0OA>*DMQ;$G-)!&(UA!!L014R$$$9@@Y@C<H6PVQ:;:,V!6NR
M[ 9@^[9IW;1+"Y,9H9MW1\^-FC;L@$B4F+GLT;..,].S+5SEKSXXRPYQR_K\
M[\=+31.VXJ>"-XN Z.*-C@#O&TUH.?'-=1]1/(W9DGF>TY[+Y'N;ENR<XC)5
M_P"<ZX5=777]==??MC=_ML[S+QKO76?NV_U&+0PKOA2_O/\ 2Y4KYJ+/3PB>
M$3PB>$3PB>$3PB>$3PB]@4+^AA/[,@?]KJ\\LO\ GN^D[TE>AF?,;]%OH"I_
ML/=<&A:ZDNTC!2FD,IN(X&#;WN-7\0_.UCR)N= &E<PK+/GE(B^&-&\1(5=,
MD]\ 3/E_%=4"%.FQ*JP][9JMX?:B2U9=:15=U@5.MW8VHMM^8+K.Q0$[5754
MB(]7<LT]J*:H#)\8;8!.WT\&%5!L';K8"&)W;D;%# <PAP4VWW.[+QG/L.:U
M)JCOPZL)59TD ^3J6LJ.,E5RMP>5]05)T*Z7KN58=,R2CA)P)%!WS,ZR]9QY
MRPIF TEA)&'8+4)$$B,K8)R*=GK\?DV;^<V\F:E=:^D!+6XV)L.LZV/LARW*
MQI)E5:M93"ZGC$:6QTOK[#V68;'^../$OA0"1:=(*<H3' %<=C8Q+' Z/ $F
M64Z')L^:]SQWV&7C!X^I<QW[ZSBC18-5UD*6,VP!9G5)54W< VCK(5SJQ?W:
M"52!V>0CPAHJ(&9EU:2K-:?D*(39HVB,O2]<TK%,B"0702WCW.X<0V_GN%*;
M[[P'ZQ+=DTE1K4%/?::25DB@BWQWDJL^VVE]DUB#4B:DJZEB5+8:DCN5JAT,
M^^ V'?O@V(#-HL\.%DR@1HB0-W7W'2V0&^^>1XV/#-?QH](6LIG!*&;K)CF'
M1Y:W5N.(6S@HKBPLM/&*.K@N*7)Q#0$U2\3E^7THTN#FD]8?1P8QVFRW R#G
ME&T%%O?JS.?D%U D+OXX1WEH2K3K7#%G>;>L5'H-52V&$:B$<J?;^NE!6$K?
M.60)"RC_ "%MRQGBPC;9M7QW"]688WMGA<.5*5\*4VTX 7\MSZ+#?OLMR>L=
MHG[;KIB867XGM)+EZ=EZIU$!\7XI#,"*7[#6=4P$KCIXV;,.)LH(F#_EO/1\
M'$V']97.%IT0LH^K H(MR!Y@'_9;#>%">$3PB>$3PBJ&XOT>A?6]67XGB>2-
M_D/H*J[]'Z05O>0K)X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/
M")X1/")X1/")X1/")X1/")X1/")X1=>/I+?U$J?UM OP<^>79O\ )ZPJ/W>7
MU%>:_P!DO[1%\?7)9OXT->>D,"[R81]64/W6)?"L6[ZXG]85OWF14KYJK/3P
MBNKKK^NNOOVQN_VV=YEXUWKK/W;?ZC%H85WPI?WG^ERI7S46>GA$\(GA$\(G
MA$\(GA$\(GA%[ H7]#"?V9 _[75YY9?\]WTG>DKT,SYC?HM] 5;6[1577L-!
MB;/7IAV&N$B90-D-:6Y0G1)!Q7/)1V/D52SR\4EB3RFSGE\Z!FS) 0T+);XQ
M0?+PXU?!U5P2-RXL_K_59 M59[(,=@&Z7!;%:OBP%^L):(P%61L5=\M58)B\
MTC-[VKD)20IS2:X^YLP4I/ CYY"#)FZ^=^1+G/KW[E$PW4+K@O0UX>%JT2.B
M*8<&OK>J.48^.0HA9I\W02_#@;,C.6W1B(J%D84J#MXS^,:()LK.QV_+$^21
MV$N3?KW^4W]*_6GJ/U^A$ Y8,BRE<N!98#6,,)CM8"47UDQ]>U_5&J')**34
M%GD5>57=55PJETDE(EIAT>F <C8 A*@ZY'A+GW\I]).?6N E=-.M]?&1AY5K
MZ1$)!-R3M!\DGFQ&.$"U5KML??7PT$)9&TN)# TG9;EB?-=>&0HH('@R;=0X
M='U#Q&$ ESKKY[7YV"R3IU/HRQ#Y]I=EMF9#Q^..B_*!&U+9SS5M(MW0[*B\
M5IIUO&N-4FS-_JZN7"=OJ[2G[RC"D+),GLF21$//40$C=ZM",]<B1GJL9-Z9
M];B,MNGS*\W[IKK(:IA:3\^+$PW#I[N_*=K-1)+SU-N'-<DS%HHRG9,@G7WS
M8GZGX-'<(TC0P[91'>L/?W\OCS2Y]_?KMXLE\8W46JQ3I6CBM8$UG94*Y?\
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MO ;/S;QW)PKP9A_V*F]FG='$/VZL^TS?^]/7A=7M?M'[P&S\V\=R<*\&8?\
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MKFUZX8B/\A,+!OZW-:.<3=.TIBO-C0B1HC"?BFID@6VCJ?.IV!GD+BXM;B"
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MO;82]Q)1P;7E[:,[>65V*H+;V8<75F8&UE,KJH/%+0'YQFBL0.!" 1 Z+&@
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M04C_ %6!_P"?XL=#R*7&HYA/696_M!2/]5@?^?XL=#R*7&HYA/696_M!2/\
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M,9)G@B4TMQ9>Z-J'SS8"))RF;I?,X=\WXP]E* +^.X \MUL7U_=(=JSK@4K
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M-;]$>A8ISINKK#94YR=$< PM=?R-LA.8IT3W# 'XQ/$E9,2+/T9Z9&P7**@
M)64'DY[Q4HH##$=\/9,%P-\>JM<\_?MYG514KUCZ^&PV:^3I]#DB,QX87C#^
M08NCXO!77>390#5"WQL=,F!F$L"9*<A,B%NT21['OV%HF[5,R^%\)?W\>]9
M1UVHD!C P!U(@!]8K%%P&:ABR,@Z1^%8-#6ZUWKA:8T?7JBZDIM>7%A6M6G#
M#6(*LAB7#QU;)NWG(IN=3S]]!R6,@=7NO H^K- RG$& >2=0_2KD(8")'S$X
M!L3.(+G5IU8XQM^Q=Y9&+:M[I>F1M7)# <DA,X$@N0VR"7.I7'+]5.N1W17\
M4I3:+(C56NJBE7<? -JBZ%%:0B0@TB!1&J'E'PTP$<T!$&4S3GCLX53$#24
M\CY_OY&9+G7?GY??>I(Q4+3;<_A[29ZZ63S\OZ]6(9C*P?CDF!MC1"4").TQ
MMV>0_DM @&"L$<9V1,RPZ&1F184V/HW[->1+G=?)135U)ZQZ(I&%IH>KM,0N
M-V!BL?4GB->DB(W5P-J#>,FX81N,9(_?5P@:@[X>[C/1N5HN C;KSBY;->9+
MG4\_+Z<U/9]-U24=XUDD:]4YK[$(#2L9MDA8>XYI)B%%X01A#&=GJYV_'(21
M9;\IZ)///.[%?;38KW_,.;LU>%%SNO[[_2OHK5#5Z1M3=R@AK"YMKM!W58B;
M! J-#R4:WWR%Z7L1E_G5AC\EJ_,A26-F(:+\'!U_( G#7IPP@Q\<"7\^940/
M=8NO;0V-SPQ4\A&FA_"3EYZ)$@$.5BY"B:[J3R&MI'[<,AAZ7+4(\93WE"D*
M44V+$6*O<S/DB-HAZR7\VY?P;UAZ]B!8T/ I]$U#Q&@CH@Z]@*+*W8\&'I<L
MXQND397&^;/FE[$4%=V*D)\B3.(LP$88FR-\V+KW<$N5>WA$\(GA%4-Q?H]"
M^MZLOQ/$\D;_ "'T%5=^C](++.H&JSQU5@/PE1,,!>"Z*RE!8XD"=-(BV!?Y
MR?@HV),PV<R1Q5;&^\8XW&O.+)'Z->F;QEAGKPSA6SX*#P.KG6\9,$3!M.5Y
M"VAJ]A5&.C10,+2.]7 =7FI0U+E"-?' LH&$II DJ#HI*%,R'+<^>$B9:!LN
M3&V%-SKU^5?E4IKK;21!4S4T2O$(P292XI3EPX$*(9*-QY,#C#<>(0V\YD29
MXFAU4"@D,]TB1.WKB(.C[L^8031CI)<G4^_]U^A75CK:"769,%4I6L)7=2RV
M;9EO%8&9B3,U),Z&--PWC]VG9HQ&)QR/K+*H2/KU!5N;ENWAA\'*5)YVDN=2
ML&S=>>K'+OPTL=>H<-_M8TPKL0UQ\(*/M#"66-I]K'!Y,"7%D:S!A;K;YQL/
M GF-,*9(L$^2RD$5R!-ADN>7O_M_=<!4ZV]4&];56@+12A&"G:GS3!PUCKDJ
MFE)M6M8AATRU)V0V\2#/\:Y0U_<8Q4#8*_B=&R'-OCDHL,@P'L)9+G7C?RCK
M7*G]<.I8:&(22=5U;$U/,QL6 PN<*@Y$&8N>7 )ERT1I6_G,F08"*_3"V;,%
M/C.9G/U>"2VZ;Q.#1I.LESJ<O?U^=6-7=%TW5<CX_6U>*JE+^ 8(?,X) UZI
M7.EH8^6QIU92^<MF[+EA;N=S,>YYV<YE621,-D.=Y29+E;B$D[S=0AQJ'K8'
M;"+6UU>!V'[EGY!&H]J2S9@.8E+Z_P /&9FPYHD;.65:)H$U.)QV/KMF#@3B
M:VE*.;!).2D\),)GKD.OR>OAU\+K"B4GJ+:YL^JC$JMV\N&!XNIJ)DJ\;=&(
M3L:[#;HW'(Y"4.UCB&-E6!582Q"NP9,E2=K(HA313"--T#MF9,QJ/[9>:]O,
MOP[T=U#JA+T6:ZU?7@)2ZW@FZU-;%(6-I:2FB@9B5<+:V[]$&*2.,<_0WB=]
MG;]TF*=,S'^'K<(FN0XXZ"')+DY9F]AZAYLO%EN6/#TCTSN2,>BB:MKECT5D
MV#THQEPIR!&Q8:DB.VMPL;%E2(0O?QD TWZ\E84T5NW0-6RR6G#3+RWDBFK@
MER.)SZ_?3S+F1>L?4LXU6% XHQ8VG-J]-5G6640V" %.+=G 1<=B$"SI4?&6
M&B$T#EH%L>-:K/)\[#@0)-;LM;+!';]9,\L_/IZ.I2UBZK=:FH;N%---5X>'
M_+6AC(:C(2+/RG%M**M5GLEFY,KG9)+:R-=)JLE'(A?=+@L*NOBPYR.1@1-6
MG@ESJ588ZJJR",,=N&)"N-9M!1O+1CT45$CD]9>P\PV3M.U2\<,=N,QLS7@7
M)O;CE[\CD*@?#^_YCZ_<*%KLO5#TTM<U>B6!JQ7-S %GPI%O8_,9H"@-5M2H
M))OD30#-,%BUD@V<:K .DG.?6Y>5+C$WA@C.>[479RT><5KNRS.[+/A[^^2M
MN5UOZ]3H,B!OIZM<QA&/NB;8&M6#:1V^),JO&C]L/7#T1M<7")MI[#"M,8NC
M5AHQ2\, &O7B/QQT\%6YU]]_IS4;M'J=1=KI#JC$T\2OX.D=IT$V%7%+NIC@
MSG98$*#,3B\FPQX)*EGE,&%73<)@!F@C"NP=(%@$%0FW? W%()!!T[;^E8:I
M^GE.5-5#/3,>/+94YT=)#X:'SX2BE#]9W;%78FG4K*U/*]9I*,*A:U83)UC4
ME8 ZYICY69C>99H86(T5)<WOI[^7RWTW*10NK-(#6HVPQ52#%T&J,KCKI 4(
M.D<'556IZJ.NC"O+R9 "P1I$!IRG/&6$_&,4SBZ8ZTGX"(HC8)V[9Q+GSW\J
M<=3>LF4&0*QI:O/B,M+'U[,B:PL?'&<IK[M/L0./G>\RXSFR@%CERST(-RLM
MIT,[%RS/ )Q3Q.=.D$N=3S4I@4+2(W7 D0ZW3L>1L2N(T*?N&Z)<K"/4;.RN
MU8Y;"4OG?+D[$EO<FMG7I4F1ND03K&8)X;N99"1MV%%_?Q[U]BU#TL;3EJNB
MU:ITM,3R^+"HK.8B+K'+AG5@5T["8+3JXUYC)6^&PG1L_;"SU<SA# ;#SOC
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M0=K7-6K9CSIWKK(-%BHQP#,UR!!3@4*V38>[<,@[(Y1=?:LZEK6F@$A7JU+
MI *83VFI\ %#XC\$2^V"/%<DR4C/+9+)3M8@0'"QI,Z1(VQ @<.%BY:18H?$
MC$WJQ/"+KQ]);^HE3^MH%^#GSR[-_D]85'[O+ZBO-?[)?VB+X^N2S?QH:\](
M8%WDPCZLH?NL2^%8MWUQ/ZPK?O,BI7S56>GA%=777]==??MC=_ML[S+QKO76
M?NV_U&+0PKOA2_O/]+E(>IEP@Z"[!UW;K''/R@Z;O8I$G2KZX>T]\,44& #
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M-ZU8),D&8XQ%;*=H6.I)/C!M8;^&>O4H'47H_+N -E<.5A4W0\C!5[#4/?+
MCK>JL@:3I; U!7E3-O&ZZ652JU, #TPG9LK>PD_8=B$7@XHJX'AH;Y;XO1H4
M0A(SM?<<_*"!OT%CPN=%=-Q]:;=M'NL[O:76Z*-W*<[JDX)E^6!@3C3 .E'B
MW!OL)#1^(:E,FGA=B1)H)#LD>&<0>C6KL4O:;T2]D</ )%%\K>/+E;SYJJ:)
MZ V\E.]..CI3M,90$+MTHW_N4A7%6"1*E&*]-V#K\^ED!=1*L3$P!-7[D@I=
MH@QPX5H,&EX4N&B;/+L8%LTZ2%V_?NMY[YW.F7CRW*$IOHP[Y%"5$>W$XY=C
M7>H%?5.K,JZ[(<$(DN2ETS;NNS%7AK>>I<O;ANM6%Y92;G%B)UD*RL0F-,UE
M8572>5H>#04EPN2,AM7MU;5];;LO[;KB&>CH/+-FJ#1'JNHBZ8OWOD]15X'.
M'*9%7'./1BOJ%>G=4EZU7X-?<,[K3/GK,FA,HIPKLC"73"=FR1=>C24;61U(
M'I)Y>]E9"+U$NA8Z//U&@PU>JKZG60K6?UA@[XR$!D8DZ:-5;956Z[P-TW7R
M0B$V4S:->SQK,UJB-KS(5Q. XL,8PR8,/,PE\[^0^7?:YTW7XZ+750]%K<0%
M+%(K"T);S&7+,L=>$%60C.EX$^O)SI_WC2$^$PC]P+=JDG8/8;NRXQR ;C3(
MAX5Z/AE,)LJ=HQ#\E.UG?Q7\=QZ@/?-6I7?0)R#/5+V;S6=0(;%6>73>"-^1
MMHC:>3%VGENX5V[ JL<#K,3XB/=\7@3NV#16^%":=$HAJ.XZ\X__ +00NOK^
ME?RYCDL9VNZ3]B;KNF_'%45JF&0[!IOL)2RTX#]J6JFV%,MKJ#JKU4AV>6@U
MUNM%G)@KY'R.2NLJ^E$L0A>KD@KJ.\\$.[(#K1K@+7OD0>3KGC;=N\MUL0?Z
MELQVA>U]9M0W(]E<78$?;2L+3V!4B$9 L)S2I$-K(9V2FME?3-FH]6TO>:3'
M=3:$=Q!89JK1$EA&$CIU% .[J!'IZQKJM1VWH3?CLAZTVSZ;ZVV2&>)/6*/9
MJZ%V+RM$7E2G*J,K[JN5!&G5_N UY.=#.0="FL2D/ 20U<EG78BQUDO*7) (
MIVAGOXV\MMYOPM?CPO=?J9Z-I[(2>P))R%,C6><+!L=M79RTY]>(JT[AF_M'
M ORL1[:HO/7$QF]3J86Q .O88:_3UE)X)=T,R]6,,.'. \E<EQE;3=GI8YWX
MG/*W7N5X]F^HUZ7/3- +Q!0I!W<E'J[:=/."7KF;DRJ$/L!9E>U@!4>PE61-
MRN7VB8-'L*<ZC4K6+&"W9>3[#FR5'=I+0LQLQ[Z?[* 1<[QG?KL+Y;^.6JL1
M3ZG/%9TKW< *"M31VT.PUA/[@*F,ZX$D@+'BL:.K \/6M#DKLL<4GFBVASFR
MAK"/9U_ @P[I);03@DB\7>2_S;W^3U]9.7N%IB$]&K<$E2V!RJI6438FZKHG
MTI&+SE#?OKH^^=KZW[ (9A:T(]>+"@A'515A.0"3+KU< 0@K!\:AK&&X 7Q)
M[2G:%[ZVN/$"#O.>N:E*ET O1#--;Y'T_.VQQO8Q0M/=*FO]= E:[%,)VE8K
MGTRYN*Y2R^\QK#"I+#(&Q"%MN3[K%DY1=+7"^"GMAG<27&7B/ Y96UW>+SE9
MI;]'FSBZQN25:X-'GOT;IJAUQ4#LI#I-A/-8V\AOW:VQR;)6^V2KPF/1NXGV
M+3Q$9@"CQ23F45\!1,/[P7 T2"%P)%OUKD'($6:+'/J-^HJ%&.A]\MJ^E/H-
M24Q]SVYUKN ;?Y:QI245"*CWV!7^S+\Q+->XD*_+6T@."S;O8+4HZ6Q*>E]5
M8*EB;UYY6#&28FP.'OK[[TVK9< 1NZK#6QN!IOM8[U)9GHPY49AL<@(K^M@0
M1W?;/QG\5K/$5Z[3J9L7T;:!U\/(HEETILF*$R8.T(1HL66*GQ"BMF4)8689
M&EC\XB.V$VMV_=GQSVKWWZ6"O"7UCNLGTRK6AF"N*)8) VUF"0Y)&Q&HZ/ T
MT[*:+')ITL* DT^0Z\P+FCXED K8Y434$=0DR=EF;T@9I.3U\CD47%[W]/\
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MMLU-0-GH[6FD%NBC=%%:SLNBB>^..WS(WN8VS7$'.<=G.R'!%X+XW[<V!2S
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M:#D$^(PO_@XO_P!/J_<\)8:#D$^(PO\ X.+_ /3ZOW/"6&@Y!/B,+_X.+_\
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MY2PD]MDB"CG/8F%@:>&\K"FLL1M.FFR"4C,96>4D$N??E;Q6RMNMDON/ZD4
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MK/Y2I>.CB3KV%FY;!.$S;%VZ-NQO%Q6KW_#!AR1Y*;G4Y;EQ=75^H(#.CLX
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MWO)A<8RUL=H^R3AUU31IWX- 81X9&CL8P3*:&&/+)D5D#HEF82^SR9F0@:4
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MGA<VZO.OHS^DU+*2UO<B53JTA2BT%<=GPF?%LNT$"=[6IH7V )MO7A2)-W6
M!%7;14]=&8XOZ=<FVK+" \,1[);0W7U<F."Q3L\+\0.'&V>1W9[Q<+)VUZ2=
M@0WU]K-*ZX-5I.J2TO<"& 4I%B,Y5R6ZXZU=2+^.Y@A5;4S8I,>Z'"W;=7KE
M1#LD00BR)"_-8V:S%C$E" XE ;>V=MV^PWDCB1EEF?,NU3#/C9AAGQQECQGC
MCGQCGCSAGCQEQQS[F>&7'&6&7'N^YECEQQSCS[O'/''/'A57Z\(NO'TEOZB5
M/ZV@7X.?/+LW^3UA4?N\OJ*\U_LE_:(OCZY+-_&AKSTA@7>3"/JRA^ZQ+X5B
MW?7$_K"M^\R*E?-59Z>$5U==?UUU]^V-W^VSO,O&N]=9^[;_ %&+0PKOA2_O
M/]+E'*=WBHMN59).[A\<''L='WF9!?9&U"M K4S"]A'<3VS.<8FH?JB8[LYN
MR5EC&PC8[,M_/&KC+GSN58<:2J# XO-/,&!ERXN,;MD- S+B;6MG>ULUU:8M
M%1 7[(8)HBXNMLANVW:VKY;-KWOE;>O]&=D;/1S70S!CL4[24.4[6KW1<)M?
MZ3M=PQ$*\E.MJ^KM'WRH4FR:B!959;!-#DW=6FD[:"77#$YO$M)CGN8T0F+E
M?@J?N]21N:65A$5-A,+9RR<N-'+435$MG"GJG_&:9LXHZC8II:B.&$3%EW-<
M/V,QP>I>QP=2@RSXG(80Z$-%4R&&&(N!FIV&"H=":J .GBA?+*8@_)S3J,XU
M+T7G(]FNRJ.J91U!!O<0+%5#M\(!!S$6!".TR2HT:#"@+C<LG 1&"R+/CI9]
M/+OJL3@:=T HW,!J+HWYZL55C39J>&5U5+MNPMYE913MB? 65C:QSWOI(>B>
M7BE,S)602--BV)C"0L^6GPLQ3RQBGC#&XBP1OJHC*V8/IW4K6-942=*W8Z<1
M/B=-&X ATCW %3@2G>C[:[I[/!M:EUA#5=7G9X_5T0EA;ID3KA]. L2]Y>%Y
MT^5/W'EG;-K%&&/7\33+4]CKS-TPT46O(N 5G+\%.%TN.14F'.,N(OJ9\.CJ
M2WXJQQ.*O-&#15364O\ PU,R,SDB7HMDF9SYMN-@;R-CPB2IKF]'1-@AK7P!
MWQAS;8<T59^-4SGU/_$5#GB$ QF6X$09$&/=M09AI;J"VH(24KX4&C-[3T_=
M,DZMCMN5R/:0ETI17K+.^>K3:\3L:Y()SBP012ZIR0-=X-.-D*2)=ULA7&W@
M6I2,.:.KQ2*9XE^.S11XI#TM0REG=$ZDF;B Z&.F-!%.SH'LI&S.A-7&0^%X
MJ/E2A<;Z;#GQ-+/BD4DF'2=%"^HA$C*F)U"[I9*@5DD3NF8ZI,0E%.\%LC##
M\F,BQ"%9=$R?955JZK:^H=]0VN^N^!@V>%6"QL4U6J&C(CDWT?(U3(-K"UN!
M76U?AYL,T@T2UZ ^+"U\"8L]36]9EK'==M3C+</DJ:F>MAFCHL%:QCH(XVR5
M5:Z**L!#J9TAGZ0]&&QAYADD^33ROV8G<O086:R.""*EFBDJ\5<][9GO,=/2
MB22E((G:P0[(+R7E@FCCLZ>-@<]LP:J]ZKBI0I 95VK4O1M8F-\JFI6J[0@*
MI;3<9'0*(=JJRF,:K7RSI:O6MP]D-?/ H[NLG/@:(F!*L8[#C#8$Z+&XHI\2
M>'SQR5,MHXX:JJBI'OJJ:(8VYE33QNDHF2R5%)A_SV"G^4]KZF. N()Y7Q4#
M2V)[((OEOEIZ>2J:VGGE.$AT$TC65;XF0U%:,G]-\EI9 ^8-!"KJE*TZX+U<
M"K"L.;U&3KF!W)6=G!--<VHK82JZ(K'=5-2'I)F,I#M$[16X3 J#>7>Q8Q>K
M?).C(&Y::(-C,;%%/ZX_8JZFODJ'00-Q26D=25%.\U%-):H;)A$LT,PC&'0F
M)QJ@R%SI*CI3.)(S3QQNCOPTL-$R%LTQP^.I94P3MZ&HCO"68G%%+&7FOE$C
M!3ETK6MAZ,0[$@F>\/MTW=@B0XS?=W& \^$5$E;>LHD+*#96B<.)#ISF:E0I
M\";%V;8TR%,C;=4B+*C[=FB1HV:]VG9GKSQRY_5T#7,H:-CVN:]M+3M<UP+7
M-<V%@<US38AP((((N#D5^<JW!U54N:0YKJB9S7-((<#(X@@C(@C,$9$*H?.T
MNNO5V[/G;&!=6'_U0+[8R6FR)HFOZ^B)$'1.81;;9<P37P5NTXS98T7#'(<Q
MFUNQTL<+!E\."7R)0Z:$"8DLC&\LO^<[Z3O25Z'C^:R^[9;?AP\JZ>2]L=MZ
MVKA%Z]J^CM%65FUI1WI$1].INNO8-H.5K.5%V-U5XZ,<O+$+7KB!GD+.M+J$
M)EGO0]XBUY*;.6L8W6*/FB-^,"JY; W.1S;?,@"^UM;\[W'7XBI]:9CMY8QE
MV238B[&F)LM5RG6,C2:H)::Z2 U;^D:ZYX]1B=0-4) %_.W4U]7=#N_/^X(V
M.VG'@8:/._S-( HX?$H^3;*VX<<\V':R^ED-W5=?2N2_;BN3RVF Q5W*0W*Z
MXYBM5 =4Q&:B/VBS?2B=E^>U<NX62:@E\5(*N=4)==6%7A$RT(L>1!9-C4D;
MW,GMUCXT9^CTY^;W*9=6[71HMQUZE>U\)[[H[Q"BE?[6%M.VPKZ:UCFIE-7+
M\K]2M.RJ;.CXW55-W2HA#KD05>"TP5M<:P90V!8DYSXF?#*2*[PJAHE0#\GQ
M9[P+YC*V\^/L525W?'<2PAO5Z]6*;8.U=N&UMZ\RT!6B\7T2E8=%/432A%N]
M806D;'4"J0J-*I>%NEEQ]<JKB,U=V219%U^WYU\OB(9389C0',GQD<1O%AN.
M>5L[J&TPS=W .74FO]+'=(D-D$5LG9DM%!LO=O*6WI[$Y1[O2'W0#ZQN_,T)
MNJC7&&(YUC<*>3(>IM9K!'6"Q\)V9-0(=G/=YM.&8X^-3.M37?C$_7C.T./9
M,AAM%>CX8F52.UBLPUC<8M_LE=E7=HP96)#J887ACD*D%NNVTT,U&(4JO,B<
M*PF+?K^7M$_>0AO"WZ7$\&@CCQ)(\B[RO"HGA$\(GA$\(GA$\(JAN+]'H7UO
M5E^)XGDC?Y#Z"JN_1^D%+6='16R3 F."PN,$F&-8ET=N/C8)#+4)=(.D8TA=
M'$W7LQYA,HZ-I@F(/'&6HE$TXQY.O;JQ][Y"M=5E"ZP];AD\7,'TU6D*4O5S
M JR!IC+8K3$BUD,6R"4*3Y(O#5P/EKHQ0FEE,9$(1)&J N3B@*'SI&S)D7:4
MW.IU51+4_I)1Z 3N)(55%654.U#M6;SZ96;.39?6Z9>$SK*760X8"LD7AM:&
M1R4T&K=$@(,-9LNH"L1QTL@$A#Y.!,R;>7S7OINN5D$&@.D]I5\RZ46G:U*U
MX6L5Y76L5@CR5X:1=:@<'JFG-9+@B@X1(E U5G'6 EX+N^#FE28$HWB&@S%\
M]EO($N>)//R]B_A5(Z8@H<^Y62J$U<V6B^!ZO)G&>HCH)F8W&SKO0*]%AYJ\
M95HC-%@/5UB*WF[B^X/#7#D^&MV,1([@N,=G\)GKY]!V74>8?1\]?7B_6GL$
MVX$&XRW3SNUI43 &IYRX9U'J1W=>SRJ;:,*VPN(N@SJ]DS=,RK#-ISJYR/R]
MAO8J<RXX_B$3:-K=NM];>97<>ZK=<F8PSL!RFD.>;<B <PRE<PFC3.*&P&P3
MM%'LY$;G3LCL$;D"$UYGH?,<O*CB!D69-D1H,;5K*+GW]_>YU4B6:!I)-7#2
M>K52A@U1D3H%>'UN M"]8,P@BM3!'%I)$7S'RARU,9%:V2$/7MVG(3"@&B$"
M+$U0Y&>CPESKU^750P?U ZQBL1^$&DT33K&M0]XT:LA7._5O<!,-6@C64GJD
M;=NLR9A1T9*XCSS&,[?KW**S*XS^- QFZ,4W.ITWK@U-TYZZTTN0U]5K-7ER
M(Y@ PRVDX 7Y;@:/*388>% N:.0Q [9.G*;2?+&EW;SIU\"R4^:2CX\$9TZ9
M**+^_OU9+/G^JW7%H&HX<_2U>D15:KNA10A^U=A:XBHL0Y(:>/ !]$?#5KBB
MA1-= %PT+CCG0&- Q!H7A$*CH<S24W.I7-RZR]>\];)IW4U7<F.W^M#AEC2U
M@9+BE\+L+K[!;VJ5%DZ-L?X"R6!47#[GHUZ]>E@.AX9@CAO):^9.1+G4\/-N
MY<%]!G6N@0X;0O#:?K^,&CCI K"#PMCMF&V#,==%DSM<O9NT[-\[<1L*/I>"
M<N;MD3"39CRP3]\@IGG*R)<Z^^[T9>)9=UHNG;'+D3SY6J>VF#"9MKLN0.A8
MD^052-I':8P627.[#+&<*AEY$HJ+T2L=OR02F39PO*'*FRMNXHN=5&M75CKC
MIRK_ #UTG7&.=63-Y! V<JXW+:MD)33I>Y)"-LSTY;),_>^QX[]NFD,IDG8^
MQ]#MEMY:-.LMB4W)XG/K4]BU56L$,JKL-%5XP)&8OG<G"-(:%K'K+1\.5D_+
MX2+CJXU#BW$@Z9W?'8V.O?\ "$YV?O\ W9&SG(H4/6>M77]-G3B:K3E> "!%
MJ$NTJ8,5QD:1RT ))Z< *Z-F&CWT/,%/:FD@%C0_@(0D@SL<X?&CRSI7=+*;
MG4K.O5)5'9I30:L&NU-P*QU5G1L)QX1&G[]B:YZXVII5I7.['G&:!-XPXW,X
M5,QWP]FS3CNQTX[??9\E'OR6'/=<J(9S,%B.U.CD3XYJ+.T0WM!1-9;!H/ZU
MW4?*;"&C#5*D9'\%!3^7HDG;M@&LE==V%(LK8$&9127.JF)RLJZ9][E)9$=5
M/[K%28%;/N1H$.)XN5?"]K9O'I3-JFQ]VHTL1-KXZ9Z0I##>/QY:3O\ X'N$
MY7&PBA4#K90HT1$!QJF2<AD(7*"Q]$P-H);.!4UJ#.\N!MED?C4V3'WMZZ 8
MMF$F1M]\5"BY?N_"08W.LIN=2OR0ZT]?BIM=9"-.5W,.J;2>=E\IN5Q>4L:V
ML[MQ9AT_AL^ X^&)$;(QU6#MWRN-_P &\1H;;HXU'X<4AI)<Z[\O(/>WBR1@
MZT]?VL?.%,5.UZ5'$["+6N2AR5D9\ 1LA@"REIB<Y^.O1A\</,BU.GK;),D<
M[,F%>($09GB<+GS(FXHN=5FQ-&TZ#36JNQ=9I<=&>AL(.[*F0 ?)!. L?7ZU
M5,."T#Y>G?H/Q]-:IRJC\8%<97OUE?%"=GOXD/3KQ)<[U_4BCJ@K;8OR$2N%
M)7EJPQW# " H/&T$QPZRCZTU6''UD^<,R&[)X94U4/MDB3)W23Y=>$$">Z3*
M@Z-F!+G7W"Q4KKG14TDQ&)-5)>PHUECYX_/^1H^$J><:UK<GLYGX77QAE%*L
M"U(D"3)&%S'EDM$C?G+W;=^[9MR*;G7WWK QNI?6B)R"^#I"NMNI:$,X,+%F
MKL,A!B07;YX?/+/(?/QDP99)KXL)_P 6,W-CR31O!Y<=9(A)P9S>,XESK[^X
M')?#7U!ZP:@4!:TT76^D,-9N7.)&TKD/5NQ:=BT&3)1W=/UXXD99 BH+P%6+
M[I<O?\LKP<:&*\3!\/1'P)<ZE;'>%">$77CZ2W]1*G];0+\'/GEV;_)ZPJ/W
M>7U%>:_V2_M$7Q]<EF_C0UYZ0P+O)A'U90_=8E\*Q;OKB?UA6_>9%2OFJL]/
M"*ZNNOZZZ^_;&[_;9WF7C7>NL_=M_J,6AA7?"E_>?Z7*E?-19Z>$3PBWX$]'
M<7*E:*LFLK?$OC[V#L ]52+4&E+8%TCB_) ZN3%BC3#PPRH2<("IHFS A*2U
MDIL0#,A1"LKB5%BP=^_#$=C'0UE93U%*Z&"A@94S51F8]O03.J&0.9#&'2O?
M*^G>T1-!>"YHL2;+6;A?2TU+/!4-EEJYG4\5.(WL/2Q"%TP=*\B-K8VS-<9'
M$,(#C< $K#PO1X=GR<HCI%+B83B80%2:I&H5H5[L!6MN>5IG<%(-4!7)BPC6
M0PFUY+;)>H"M93"D.8"E B<:"P[QXF9<X]AS0TNDF:=J02L--.'TPADCBE?5
M-Z.].QDDL32^2S7!X>TNC#G"HP>N<3LLC(V8W1N$\.S/TK'R1MIW;=IGN9'(
M0QER"PM(#RUIS[QU$N'K\"6^P-?6-' +PNLJ!L0;87+L)JMQCOMT44FW3/0Z
M[BZFC%G/G4X([:HNP@$RC2"D'X&3IBQI4W(5JI#BE+7/DHIX"^1U370.@Z%U
M3$8*2MFI&SSDQ]&QDKX20U]PUUQ<ANTK2X?44C&5<4P8QL%),V7I&P2=+4TL
M528H0'[;WQMEL7-MM"QL"=D:1-C@VOK"2;7IH8G1K,[=>\PS-ALFQL)7=JTZ
MXVK<2-&),PE.VZX^G3HU[)4G;GAIU:]6//&&O''C7BBB@C;%#''#$S)L<3&Q
MQM!-[-8P!K<R3D!F;K,DDDE>Z25[Y)'&[GR.<][C:UW.<2XFP S.Y1WSD5$\
M(GA%[ H7]#"?V9 _[75YY9?\]WTG>DKT,SYC?HM] 7[VB!6XK".[A@_:<&CR
M8D<9VPHVPK %&I F89&0B.>KF7%'EI8 %*)P]&[7&GR HG?*U[=HZ'EIJK+(
M>$3PB>$6/$B10$9 "@Q@\*&%1-$ 6)$PHPX8-@QM>.J-#@0(>O3%AQ(^K''7
MHCQ]6O3JUXXX:\,<>../"+(>$3PB>$3PB>$3PB>$3PB>$50W%^CT+ZWJR_$\
M3R1O\A]!57?H_2"TU](YUKN3LNI+:Q5B]69;$8IVEOB&VO2FQ'5-MB1@D2:E
M8U-K;ZYL.6JK<;D4YX-T^O\ A3LG%BRKB>O-@D:*/[?(7(TVUO<>*V=^(SW6
MX;[K7%[]'1:9TVT-X$)4L<TXD>WI&PHF^?G!DVXK6KW9ZS]BZXJ5_-Q5.5N,
MK#!4]66G5S/\LZS Q3P?Y4$>-,AS)CGR.'/E?L4[0M8W_1MU6:0;9ZD'R*X8
MW1<J6ZCQZ#-UQ30W3N[TJ'9'16^&@<7KI8JO1WT6NQ; F0HW*C$$Y%-5,ZF5
M,S#P5^.!(DITI;XF_-XEO(Y2HOG?/<1UWV; \\U4Q'HEV(AFY^D+$K><%=+;
M>&LQ/WNA05FH+7'I7'#O2L[=(S!.G<GB!^JV70M;AL:0.TA'2)MA2)\D-G@8
MX)M"WO\ J[*Q$7T=EQZVY++'%NH''<'LWKHZKKD9.[MQ^DH5-^DBMOMC9/"%
MA-2ILS C<U16 J*\_, 27LYIQ-S"-DZ4!A+TGPFUE;Q^6[0,\^%KK=GH5U\=
M>M: ]5X> K:XF:W:)*K =%V)!9^Y68R8L!9LFT'5!KVM1E@'\C0J;'"N#(%,
M6485XHB98[>Q-&Z7MC$<;F_;ZR>R^[);V>%5/")X1/")X1/")X1/")X1/")X
M1/")X1/")X1/")X1/")X1/")X1/")X1/"+KQ]);^HE3^MH%^#GSR[-_D]85'
M[O+ZBO-?[)?VB+X^N2S?QH:\](8%WDPCZLH?NL2^%8MWUQ/ZPK?O,BI7S56>
MGA%=777]==??MC=_ML[S+QKO76?NV_U&+0PKOA2_O/\ 2Y4KYJ+/3PB>$6V%
M8]Q;1J8)U_ JXI+V0^NMN6A<"GL*C#$O>Q%;@7JY5'=8<O@3\71.4IR]6HT9
MHC!-"^;CZ33!LX/9R-PO<*S*G"::J?7/D=,#7TM-2R[+F 1MI9)Y89(KL)$K
M9*ASB7E["6,^18.#N_!B,].RD8QL1%'43U$>TUQ+W5#(8Y626> 8RR%H :&.
M&T_Y=RW9O@1Z3NV5_P"2882K:;@KM?ZT.10ZUS'LN5!H1CKA4>5%;;4J=)LK
M8;9#6<>Q6<Z7CV>3>P))HV#"6073"%Z16?2=\':5^V7U%6Z2?IA6R7IPZMCJ
M)(99(I0*<,C8#!&QAIFP/;&'#;+G%Z[;<;J&;(;!3AD(B-*RTQ%(^&.6-DD1
M,Q>]UIGN<)W2L+]D[(#0U0W7Z0FV-:'8"-PI).&FQ*#K3K@9G:#%M:!^5?U;
M5ZS4Z].F(.-G<U>P.FL KQB\-K9DDQ/7&HB2-J>(+G /&$<W<.FZ:";I9OS%
M;45[ 6TQ=T]34R54C1/\7^,,A+Y"PQ1S,$D36LE+_EEW%W7J.BFBZ.*TU)#1
M..U46Z*"!E.QQBZ?H'RAC X2/B<62.<^/8^2&Z$^;2RD\(GA$\(O8%"_H83^
MS('_ &NKSRR_Y[OI.])7H9GS&_1;Z LGY563PB>$3PB>$3PB>$3PB>$3PB>$
M3PB>$3PBJ&XOT>A?6]67XGB>2-_D/H*J[]'Z05O>0K)X1/")X1/")X1/")X1
M/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1/")X1=>/I+
M?U$J?UM OP<^>79O\GK"H_=Y?45YW?8!DI?1>]TZ"M5N1$IIM>P]1$A%MF(-
MC3IVMM+X2YD<=E6T_*!HDR.-F[5#RG3,HNO/'3S*D<X?"Y_?\&@Q-V$868\0
MIF1G#J(L8[#G/<QAIX]EKG_'6[9:+ NV6[1%]EM[#XSB<V'#$L0$E#4/>*ZK
M#WMKFL:YPJ)-IP9\4?L@FY#=IUMUSO51?.FB/8\\_?-#_E7YI?%\6\)TO\,=
M^/71Z?#/!]3_ !!OX)/G31'L>>?OFA_RK\?%\6\)TO\ #'?CTZ?#/!]3_$&_
M@E;E#LE,;[=1M0NJW(<0S*[>(LV5;,0C'CY_)\SGG/;"QK:#E(QYPXRQ]YQ+
MT>YSEQE[_GWOO><[%X,3&'51DQ"F>P1C::,.<PGY;-SOCKK9Y_-.EEWL-FPX
MUU,&4-0QQD^2XUS7@'9=O;\3;?\ Z@JC^=-$>QYY^^:'_*OS1^+XMX3I?X8[
M\>NCT^&>#ZG^(-_!)\Z:(]CSS]\T/^5?CXOBWA.E_ACOQZ=/AG@^I_B#?P2?
M.FB/8\\_?-#_ )5^/B^+>$Z7^&._'IT^&>#ZG^(-_!)\Z:(]CSS]\T/^5?CX
MOBWA.E_ACOQZ=/AG@^I_B#?P2?.FB/8\\_?-#_E7X^+XMX3I?X8[\>G3X9X/
MJ?X@W\$GSIHCV///WS0_Y5^/B^+>$Z7^&._'IT^&>#ZG^(-_!)\Z:(]CSS]\
MT/\ E7X^+XMX3I?X8[\>G3X9X/J?X@W\$GSIHCV///WS0_Y5^/B^+>$Z7^&.
M_'IT^&>#ZG^(-_!)\Z:(]CSS]\T/^5?CXOBWA.E_ACOQZ=/AG@^I_B#?P2?.
MFB/8\\_?-#_E7X^+XMX3I?X8[\>G3X9X/J?X@W\$O4.:3SC5==;+ L2_JT2$
M@ ,"["[$Q5ENABQ>LE('B1N$N;LLK##X263(01T;CC#C.3-E:-&K7SLW88<^
M;GVVG9'YQX]9ZE]U8"6MM^J+"Q)W>/U*(@[Q$LPJ*<7NWE#FA,Q4LEXT3QJ9
M%F:/FG3A-="VP;W<Z;3SYBQ*W,-JR*=N)6.G<MD3@Z$6U19,G#7S7+0\QV*U
MG>[3VK!;>RZ5':2Z1O[H=?M#<"$[#91=W)T?45CCM5<0[@V[-<3.T<=DN3KJ
MF?$L?8/A\2"&"1NX9LHO C'.7BRT/,=B6=[M/BUUR5IC6EF+_+G(OLA4<_4L
MK0%R8I,:O]6V$$5&@>1++S"4G8VGS#A""XD20*PITC?KT;1D;(AQGQ#SU[LV
M6AYCL46=U<CVK%U;81>[5W<VU/V3JQ\6=!;('F;7ZOERA^1/&! *X1M._*R=
M>,C&2+*#2D&1'^%BD!I"'/@[I$23IW9LM#S'8EG#B.1[5^ U@-9QYT5K$NH+
M$>98RPS<)?.]<7]:DSP56-RVBNAX?(8FL7 G@X;(WK<808AR]PYL@%HYQ2DG
M 6$@EI9:'F.Q+.U'+7_]E:/S:NOVL)GW1R_YE^,M#S'8F>HY'M3YM77[6$S[
MHY?\R_&6AYCL3/4<CVI\VKK]K"9]T<O^9?C+0\QV)GJ.1[4^;5U^UA,^Z.7_
M #+\9:'F.Q,]1R/:GS:NOVL)GW1R_P"9?C+0\QV)GJ.1[4^;5U^UA,^Z.7_,
MOQEH>8[$SU'(]J?-JZ_:PF?='+_F7XRT/,=B9ZCD>U/FU=?M83/NCE_S+\9:
M'F.Q,]1R/:GS:NOVL)GW1R_YE^,M#S'8F>HY'M56VJO6]J@I/,ZS5.9CG:5>
M:HV.BKY,/G1.V,47&)+V996%*^,:(V[G';MA\8Z.96/'.KB5']WX3B1;0[CQ
MZCU*KKY9CYPX?W4O)2K##L2TI%+VKB SN6!O:J I57[=)1@UK<6/./YBHF=F
M\;9F(>'+C22'.G'+B-IWZL]GN<9\>[&6AYCL5K.ZN1[5G^%^YN>=F/%N)'/.
MGGC'=QQ4TGGG5SECQGCQLX]9GNX<\X98Y\<9>YSSCEQEQ_5SQSXRT/,=B9ZC
MD>U?G@%<?.6.'%OHW.>6.&>.'%4;^<LL-F.S/7ECCQ9ON\XYX:=N>&7''N98
MZMF6///&&7/#+0\QV)GJ.1[5^\%VZ-F&&S"VTG/7LQQRUYX5+)RPV8Y<>^QR
MPRXLSGC+'+'_ *L><>>>.>/Z^/ZO&6AYCL3/4<CVK!-&RS$M<86UFNE(&+ZH
MOF&D_/YIXG+Y@  $'>2+D?B<&Q94^5KAPHV[=EIA19$G;SCQJT:=N[/7KR9:
M'F.Q+.U'+^ZY0*-:S*$#L82XTJ<&/BQYH3-XI\C'XEC"D/3/@2?@)5CZ)6CX
M>)(T[O@9.G3OU<9^]W:M>SC+'AEH>8[$SU'+^ZR. "Y=G/O==O(^>7N9\^]P
MJ>1ES[FO9SJV<^YC9O//N:]O'.K/_P#QV<<X9>YEQSQXRT/,=B9ZCD>U?K!=
MNC;ACLUVVD[->>/&6&>%2R<\,\>?Z^,L<L;,YQRQYX_KXYXYYXY\9:'F.Q,]
M1R/:H7K8G;:_E*NPO5&Y>@J:+L H#YIHUC\243)DROC2^TGE8.(?W)!=?+Q.
M8.)#(EHXB?&9,/3$D1=^YEH>8[$L[4<O[K-:N;*WG3"SJO*NMC OB I\X(QJ
M[=S.$A6.0=B B<_1ZS??1H962LL&F%NV^]QW9"9OO?ZM///C+0\QV)GJ.1[5
MB+$//-3H;K9M@7FCKR17:<SV XFLZ9-$N1"@FAY1]E,\# ]@D#!'6+$0I$O9
M$%#YT^1[S'1#B2).W3IV,M#S'8@#CE<9]7_V4O\ D&Y.>,,N+>1_>[-F6G7S
MZIY'N9[L><\<M6'/K-]S+9CEKV<988^[EQSAGQSQ[N.7N,M#S'8F>HY'M5/[
M;=F:4(W9VSL2CXHZY8)RJS1OBBVS+F"^KEOSJ%,@<QF+KD8V\P[9&3E+@G''
M[0\K9'S,0R$A>YP+9,M#S_LILZ]LK[]W5?717%BNW1GSGCC;:3EEKRXPV8XU
M+)YYUY\XXY\8Y\<69SSCESAGAGQCE[G/..6.7N>YEQSRRT/,=BC/4<CVK\\@
M;DXPRV<V\C\:\,LL,\^:GD>\QSPS^#SPRR]9OO<<L=G_ $98\\\<XY_]//'&
M7]7C+0\QV)GJ.1[5#S3 \+S8F(YB]$:&T6#RRXJ SFFC6[@ODH0XT]CPXG1K
M!W#8&P;%F1\^=9.9"SE;-GP$+&3(QSU8LM#S'8EG:C+J/:EAGGFJ$9SLE_O-
M(7TNOE@LY.!G*F#9/D,M H,DB4*9C ]@$"\S"-#AR=V,<? ES)'.G/5%C[]W
MN:^66AYCL2SM1R_NLF SM9DU$-P^U0D;$:Q&U??B>H!L5MT@JOSI \AF+CLS
MN)WF@^W=&W;1#&'USEY@@\8DP10B.V:Y63+0\QV)8ZCE_P#99_E>N?C/X/FW
M$GC9[SG;[SFII/&?P?'/&/.SWOK,]][SC+GCCG/W/>\<\\<<\^[XRT/,=B9Z
MCD>U5>]V$T5GN@ZW:[ 8:*1VIT6&:PZY/Q59V3[ L93J=-$Y-09K(+>DT>>W
MA9%10NXIK*:X,[>R2HD=8%EC,%EH>8[%-G'B.75?];J5H<KUS\9\:N;<2>-F
M6.6>.OFII/&?.&.6..6?&'-F>^YQQRSPQRRXX]SC++'CGGW<N/=9:'F.Q1GJ
M.1[5^-@&Y-/_ .^MY&U?].S/_P 2J)&'_1IQ]_MR_P"JS>/^G5A_U[,O_+#'
M_JRYXX_K\9:'F.Q,]1R/:L4OXV:U@P+,MW?7IH T!H#"NEA]6;Y$(R#*0XY
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M%]4R!=W.+]<FIT ,MPFM]Z1]=^OTEVQB2$0H+&'(]R(#P\G#,&#R?D"9&33
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MA8]X^KG-I<J.-=\7"J<N'+]@$V)G +B7SS-Y9-;)[@'8*XP_KDX%N>(66/\
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M8*3A!L53E91;2KPA)QT%XV?.B%"8HN^7*V>YE_TZ8^G'+9MSY_JPQXYYY\D
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M[+KAKGS=#PH[&4TC(>KWA,]=W6JOIS/IU<)0I;=85L)D[6G)?N/?9A:E'!*
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M57Q!KUBLE3G= )=M^%M]K?\ ,#;R#+?Z5:)"NNP1"_*1*5V6[0U1UR# ZCG
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M6M<;!SMAU@2=EUK'?7NE;3_='4+(82J*^:X6T195++C';1[ELUP:W00W=@K
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MC,Y)D1<*:RT/,=B6=J.7]U-N0-Q\;?@.;?2.-WP/,CX'FJ=W&WXOCEQAEO\
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M(KF4XWR8D(AOPV9B5^=KAXX1-F.V;E'T[,M.K9GOU^67_/=])WI*]#Q_-;]
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M4O*9VKMK"&;$HX3 *.G<4[0Z\B+>2V_,<!IOT7-,^CGM=D=BK+L!+*K#(41
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M9^,?%WUARNYU22> &9C4D#JIL=,UK(HX]LM;LD"6J>^KD9M-O?H.G;2[R (
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FK5!U2IL.-LE[-6.C#?+C:<MG&S?JQSNP$','=V*CR",B-_:O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g923792g36f76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g36f76.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1A44&AO=&]S:&]P(#,N,  X0DE-! 0
M     $@< 5H  QLE1QP"   "JW8< E  "')R,C$R,C@V' (% "=-:6-R;W-O
M9G0@5V]R9" M(%!E;G5M8G)A($9O<FT@4RTQ+D1/0U@X0DE-!"4      ! >
MC6C!XC>[)500XE>]BD;^.$))300Z      #E    $     $       MP<FEN
M=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M    0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M
M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M  H  0         ".$))30/T       2 #4    ! "T    &       !.$))
M30/W       <  #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@             #R@   X0          0
M       !              .$   #R@                     !
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M;&]N9P   \H     4F=H=&QO;F<   .$     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    #.$))300,      YG     0   )0
M  "@   !O  !%8    Y+ !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" "@ )0# 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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MQF1CU]3I+@#?265V-;R[8Y[L9K7[?H,=5LLL_P *MK]IMK#/7KLK:X?3<P@
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MV)TW%9B8C/3J9\W.)^E98\^ZRQ_YSW(.7U(LR/L.&T7YI:'N83[:V.,-MO\
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MK%Z?B8@_0LAQ^D\ZN/Q<5924I))))2DDDDE*22224__9 #A"24T$(0
M50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !,
M00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -@    $ .$))
M300B      %&34T *@    @ " $2  ,    !  $   $:  4    !    ;@$;
M  4    !    =@$H  ,    !  (   $Q  (    >    ?@$R  (    4
MG $[  (    )    L(=I  0    !    O    .@ +<;    G$  MQL   "<0
M061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q-3HP-3HR,R P-SHS
M-#HU,P!R<C(Q,C(X-@       Z !  ,    !__\  * "  0    !   #A* #
M  0    !   #R@         & 0,  P    $ !@   1H !0    $   $V 1L
M!0    $   $^ 2@  P    $  @   @$ !     $   %& @( !     $
M         $@    !    2     $X0DE- _T       @          /_A 4A-
M30 J    "  ( 1(  P    $      1H !0    $   !N 1L !0    $   !V
M 2@  P    $  @   3$  @   !X   !^ 3(  @   !0   "< 3L  @    D
M  "PAVD !     $   "\    Z    \     !   #P     %!9&]B92!0:&]T
M;W-H;W @0U,V("A7:6YD;W=S*0 R,#$U.C U.C(S(# W.C,T.C4S ')R,C$R
M,C@V       #H $  P    '__P  H ( !     $   .$H , !     $   /*
M          8! P #     0 &   !&@ %     0   38!&P %     0   3X!
M*  #     0 "   " 0 $     0   48" @ $     0             #P
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@!-@$@ P$1  (1 0,1 ?_$ !X
M 0 " @,! 0$            ("08'! 4* P(!_\0 ,Q   00#  $$ @(! P,#
M!0  ! (#!08  0<("1$3%!(5%B$B%R,Q&"1!,C-""B4F47'_Q  4 0$
M                _\0 %!$!                     /_:  P# 0 "$0,1
M #\ ]C4MX6!5IR3FO'?KO1N%6/50<K-<BQ)%-TYE'$MJT^#*S%+L&_VT\Z.4
MVPM2'+>+_M-;&:VT&3(BG!TTO=O.[C+4\7.<QYYY356,9JX%<?Y5*O<VZU89
M&0>;8G925IEO=-I$3$QKJW-_ +>SRF@TB%+)+_.14 ':5;U .'2$K8:WT0.]
M\1LE3EVZU.A]/JQ($,NU(^JD^"@+7".3=?GW@E&"NZ=',9^T"0@YAK;31J1
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MFG1E)>1O;>_RP)B8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M# 8# 8# 8# 8# 8&.6"H5:U#EBV.OQ,RV=%'P9*C@F'B%P\HW\<A'(+VC1;
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M^P:6EIX-H<IQO9CC3ZO@^0%10SKNMZ'?>3[*V&4X# 8# 8# 8# 8# 8# 8#
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MO>M[]E(5K:5)W_:5:WK>M;U@?K 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M0\R%*PT] 3<+&2T*8,D-]X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# ^) [!8[XA3+9 Q++HY##R-.-/L/(4VZTZA6MI6VXVI2%I5K>
ME)WO6]>V\#SZ]KC^D^G5Y-4NS<TL,M-\8L=.FWH*JW*>..?LK4!99Z_W/C+M
MC.&*67)N1\[<)SF5DL<JP='WNQ5Z.FR;)%2<PH0+[JA:X*]U.LW>K'-RE:N%
M?A[/7Y)K6]-GPL]'CRD86E*O\DZ("*9=_!6M*1M7XJUI6MZP,BP& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P&!H7R7X'7?)3C=RY/8"7(
MEVP19"*_9Q66'I*I6-MM2H>R1J"FB!72HLS31.A3AC(XQ*-CGA&#+<86%6GH
MJ]^N,GSBZ>)78#4_ZE<#DY)=8%-(CG)E7.]R;(,E!D*ARS8221SJV&_I&I:
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M='(J/U^;R![[;&T[U(NR>K-'"H*>6 \;-U2+%:(&>?4[J.4,<0%IN P& P&
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M-C6:4093&HP- + \<,S'(@-!:!BFUQ$?MC8,007&CBE/!,W 8# 8# 8# 8#
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)& P& P& P/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g923792g47d02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g47d02.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1%B4&AO=&]S:&]P(#,N,  X0DE-! 0
M     $@< 5H  QLE1QP"   "JW8< E  "')R,C$R,C@V' (% "=-:6-R;W-O
M9G0@5V]R9" M(%!E;G5M8G)A($9O<FT@4RTQ+D1/0U@X0DE-!"4      ! >
MC6C!XC>[)500XE>]BD;^.$))300Z      #E    $     $       MP<FEN
M=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M    0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M
M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+'C4
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M  H  0         ".$))30/T       2 #4    ! "T    &       !.$))
M30/W       <  #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@              V   !UP          0
M       !              =<    V                      !
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M;&]N9P   -@     4F=H=&QO;F<   =<     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
M  =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L
M;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U
M='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT
M3W5T<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M       ! 0 X0DE-!!0       0    #.$))300,      =U     0   *
M   2   !X   (<    =9 !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  2 * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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MR27SLKEH]S*JPYOJ-]OTK['[$"FK[:&7P]M4?HJFN=7IK[[W?H]FZ?YJNO\
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M5)+Y5224_P#_V0 X0DE-!"$      %4    ! 0    \ 00!D &\ 8@!E "
M4 !H &\ = !O ', : !O '     3 $$ 9 !O &( 90 @ %  : !O '0 ;P!S
M &@ ;P!P "  0P!3 #8    ! #A"24T$(@     !1DU- "H    (  @!$@ #
M     0 !   !&@ %     0   &X!&P %     0   '8!*  #     0 "   !
M,0 "    '@   'X!,@ "    %    )P!.P "    "0   +"':0 $     0
M +P   #H "W9,   )Q  +=DP   G$$%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I
M;F1O=W,I #(P,34Z,#4Z,C,@,#<Z,C,Z,S4 <G(R,3(R.#8       .@ 0 #
M     ?__  "@ @ $     0  !UR@ P $     0   -@         !@$#  ,
M   !  8   $:  4    !   !-@$;  4    !   !/@$H  ,    !  (   (!
M  0    !   !1@("  0    !              !(     0   $@    !.$))
M30/]       (          #_X0%(34T *@    @ " $2  ,    !      $:
M  4    !    ;@$;  4    !    =@$H  ,    !  (   $Q  (    >
M?@$R  (    4    G $[  (    )    L(=I  0    !    O    .@   /
M     0   \     !061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q
M-3HP-3HR,R P-SHR,SHS-0!R<C(Q,C(X-@       Z !  ,    !__\  * "
M  0    !   '7* #  0    !    V          & 0,  P    $ !@   1H
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( $4"6@,!$0 "$0$#$0'_Q  ?   " @,  P$!            " <)! 4&
M @,* 0O_Q  S$  !! ,  00" 00"  4%   $ @,%!@$'"  )$A,4$146"A<A
M(B,Q&!DE,D$D*#1"4?_$ !0! 0                    #_Q  4$0$
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MW;CV53HQYYPAXQ%YW)M/MTW5%3,4V,7EL6Y6IU]AQT8.,BORY&"^!8MK2O\
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MQI;=64_<C<T&0@W;H4B_69"MICY5J2B@I&.@+=_'Y]V1>AS(Z;/IUMC&F@3
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M4O2W/V^&<+T]N77.PR<-$NDP];M42998U(;_ -8Q$U5<DMV2"?$?_#9(TQ%
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MFS[O4=<T>OC*,G;A>;'$5.L0PJ,9RHB3GITP"+!:QC&?]R2FTYS_ (QG.?\
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M69-X0)HU9HCU$.:J=!UVN=*:HZVAH(0IAVO[QHUUUO;/UD>PE$%"U?:$;?\
M:DR](D)_*).:V4W<OE=:82+^J%=7]4-0SZI5:U&4U ]Y\^;LX?EDN(9)V%<:
M^_M7EUY3R6_J/"].:K#G=?PS9JU+PD78**-(@?AIN4$#>>2WX%AFLMQ:DW5
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M2B)*8G-$1>QZC%6*41&!Q0DG;J.JH2FN[8N,9CP_IYF*P^2XG!*&GELF2'R
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M;5VU]U[KML5(P[[P,I'Z_P"7JA=]7T.1$FG8MHF)V/M3+A\=B<';8C) %!"
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M8T?J.!KE=C 86"A(K751"C(F)C1FPP(X 1B(0R,((*TTPPRVE*&VT)3C'^/
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MA'0IN.P&L\DD<5LM4?\ 9<RZ^&_^<IR$.T:$ZDU1*$0]IMD#TKK5PQQ</9)
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MG]S] 7$9M-QO\\<ZT0^%'"X?,&H] C7666JOKFMOL5J &8:4VP0>H@]\&Z\
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MB1$<$/K%LQ%Q\A(P4M%OK,B\G1\BR]&6FNX*6YB4J5@9+AI0,DQG#8A3[9[
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MZ')(267&TNLPU9#--2TAC[QS$.&&@X]3+:&W#B\/%NI3CY'E9\#NO / / /
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MB<EH4.S)/.)4G -[X!X!X'YG.,8SG.<8QC&<YSG/XQC&/\YSG.?\8QC'_>?
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MU2$ZO[$@?==8;^VSIL&"VJK!"5,[6I!,M-X>3(QLX5.F$//Q0>'8_8G/,1_
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M2A"$)PE"$)QA*4I2G&$I2E.,82G&,8QC&,8Q^/ \O / / / / / / / / /
M/ / / / / / / / / / / / / / / / / / / / / / / / / / / / / /
3/ / / / / / / / / / / __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g923792g52i76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g52i76.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1?T4&AO=&]S:&]P(#,N,  X0DE-! 0
M     % < 5H  QLE1QP!6@ #&R5'' (   *K=AP"4  (<G(R,3(R.#8< @4
M)TUI8W)O<V]F="!7;W)D("T@4&5N=6UB<F$@1F]R;2!3+3$N1$]#6#A"24T$
M)0      $ %2RCII*@TH";(._BHX/[0X0DE-!#H      .4    0     0
M    "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M    26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R
M:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M# !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0
M  !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$
M.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P
M  !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#
M8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;
M    16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M  !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M          !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q
M<L>-0         IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0
M<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&
M(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R;W!7
M:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M#&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M      MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ /      0 !
M \     !  $X0DE-!"8       X             /X   #A"24T#\@
M"@  ________   X0DE-! T       0   !X.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-! H       $  #A"24TG$
M"@ !          (X0DE- _0      !( -0    $ +0    8       $X0DE-
M _<      !P  /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              )X   %CP         !
M      $             !8\   )X                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     4X0DE-! P     #=L    !    H
M $<   '@  "%(   #;\ &  !_]C_[0 ,061O8F5?0TT  __N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( $< H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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M+G_]MH63_C@^KU8<VG$R[;0V6M>VNH$^&ZV[U/\ ,JL79Y'3\#*(.5C57D:
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M    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\
M8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -@    $ .$))300B
M  %&34T *@    @ " $2  ,    !  $   $:  4    !    ;@$;  4    !
M    =@$H  ,    !  (   $Q  (    >    ?@$R  (    4    G $[  (
M   )    L(=I  0    !    O    .@ +=DP   G$  MV3   "<0061O8F4@
M4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q-3HP-3HR.2 Q.3HR,CHT. !R
M<C(Q,C(X-@       Z !  ,    !__\  * "  0    !   %CZ #  0    !
M   ">          & 0,  P    $ !@   1H !0    $   $V 1L !0    $
M  $^ 2@  P    $  @   @$ !     $   %& @( !     $
M $@    !    2     $X0DE- _T       @          /_A 4A-30 J
M"  ( 1(  P    $      1H !0    $   !N 1L !0    $   !V 2@  P
M  $  @   3$  @   !X   !^ 3(  @   !0   "< 3L  @    D   "PAVD
M!     $   "\    Z    \     !   #P     %!9&]B92!0:&]T;W-H;W @
M0U,V("A7:6YD;W=S*0 R,#$U.C U.C(Y(#$Y.C(R.C0X ')R,C$R,C@V
M   #H $  P    '__P  H ( !     $   6/H , !     $   )X
M  8! P #     0 &   !&@ %     0   38!&P %     0   3X!*  #
M 0 "   " 0 $     0   48" @ $     0             #P     $   /
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M  0" P4& 0< " D1$A,4%18*%R$B(R4Q&"0G,R89-C=Q@?_$ !0! 0
M              #_Q  4$0$                     _]H # ,!  (1 Q$
M/P#?XX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.!QVV6^IT*O2
MENO5HKM+J<&/]N:L]LFXVN5Z'%]Z6_LRDU,$AQL>/\BT-_,62RW[UI3[O<K&
M,A2]V7_D8>)#K,Z;&2':"(W5: <NX76.N$45N'*_@?4.1_\ G$*L;4XRAW&B
MU.M2&P@WDL1LP5AK(T-+/!A1)O+^:/1\.G1G6?I].$+1E2 K'OFX.1J_5S&4
MMK,HVNHN=4VH=U;."ATW_P"3WM2HZE#NQB<FA5')?R/O+QVALLH+5=QU#3T
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MK%HO<M-AK*XX*Q8-.]?WX") #6X2EIN1W3>=BGL0A:,O#M/2</.54E[,0>^
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M'D<=Q2?5QE>%+PH/ ;Z*]7G9U-HL.O)&_P!D2H5:IS:>Q=G[5.6L-I++.?\
MY#N5E&::]B$86(..R$OV-XR-[&6DH#,=7T3I*D.Q[].U!K&KE1/N_&F0-$K$
M6<"I<D=,N.#G!QC1;;SLQ)R4N\\E[Y7I21/D75K,,(><#*W <!P' <!P' <!
MP,4;TW?J_K9J#86]]TVP"D:NU=69"V7*S2/R+: BX]&/1D45A#IDI+R92QXJ
M#A8Y@F4G)HT"(BQ2I$T8=T/F =X^V5\[F7S='D&WM*S].JU\FF:5U^U7B=G)
M .HT.L)?*I=8&31.QM/PF6B(8>:V?:G3J,&+;+!!V^"&6$;L>#9<#<N_C6=&
M+3U5Z-KW5MH*0"W=W%EXW;4[%2\C*R\A3]7A NQ^G:@[(3<U89$A_-:)(MII
M#TJX^^NTC#R;?Y2/*>=#8HX#@. X#@. X#@. X#@. X#@. X#@. X#@. X'S
MP_(=MR_[U[]=H[Q':^M%UHE=WI.:N?#8#VF+#VBM:TS$]<QH""LP>D9R)C82
MUQLW+UINR5^=EHP7':F>V.$06QJ5Z1!"5APTQ<-<#.,UVY7;]GAD&8]-:[HK
M ]X79_R)SD@HC'4 1RJHV2[V )FSA\OBXHA??K8<>ZX&GI4<F#"O\F)G56!L
MIJ"ML>2W(?EE6%O7.ZS77G"#1;0Y:<P">O"U,$2#A;NT<5E24+'-F/Z]RPE4
M>XTT&T%X"] P$'K#='8V:J+D5L>X;0G]2094L-,HDJ_K'6T;5(EFOQB;)5J;
M-A"D3<8W%RQ1->"?MK='K5A,(D<*#(2&P=P' <#I4E*TJ0M*5(4G*5)5C"DJ
M2K'HI*DY]<93G&<XSC./3./\9X$3.Q?1KJ[VKK5?J>Z-7AS434S<R%9Q7INR
M40J#+<G(NQ$J#(I$O *<9-EX<$L\0W!09BDO)('<241AT*>-U?QYZ%,W:MS7
M6/>C_7BH1#OS(JDC1"=IOP!\:$](UB5@YBQ784B5;A;E2NOAGX*?2M!<-I_#
M)TT:9<+>Y.A2UN#Q\]X.KU?G+9LW0[T5J>HN.C@7"J7@':8\#&5^MTZ:C)MF
M'UMK>VW-Z!HL14M?!@R5WK=9>N<GU#CHLD!B;[(/0I@0Y'E?W&+ >CZM9)6.
M):/AP*\U5-T)CG&AB\U)56'M[?7E8I8J7$O:O=L;;[J&&73KHMW/XAY\</"(
M'O )/^U6K?*HE /K.@?H^Y16[B-:HXB/?C'"<]<%HKBMGB[SE8 @AS*54%[N
MV::Z@5?5F13&AS.B;IV-3K$+?*N-M^G7QTA!S>T-;,=@M93MF7+R<!95FR0%
M>ZVQV&X^_P WL-VQDP$TV5&UC'<,D$L3X>K"&(@+F^NGG([2T5MT7;]-8[3T
MD.,:*:GX;5.Z]0[B;%8RDTV8)_\ A$77]G;:J,?+61JO,U:G2Y$AAFOIFB)D
MV)C#0OFZZ^37J7V0.AZQ#7">U=LR69>]FI]Z5*:U5=<2(AM@CCX6*(L#":;=
M),,RIV;"V]>VVW,$!09\P$03#(;D' G_ (SC.,9QG&<9QC.,XSZXSC/^<9QG
M'^,XSC_K/ _> X#@. X#@. X#@. X#@. X'H;1::U2*Y-W"Y6"%JE4K489-6
M*RV*3#AH*#B(]E9!TG+2L@\.#'@",(6\044^TRRVG*EKQC' ^>KY8O)A:/+?
MN0O5.I%7*I>-;KJ1+7Z=NK](VH&G>DY3&!V2-B6 4+6<Z\/4 9&=A*[KFJEL
M9-%Q;F=C6D0(X)V(I0<*\0O06P>7'MC5-E;(IY$1X_\ I>6''N@R0!K41N>_
MM'BV-NAQ!$C3JB:>";,1=:DMAH=S)N05<JL? $. D76+>2'T>6FFF&FV&&VV
M666T-,LM(2VTTTVG"&VVVT8PA#:$8PE"$XPE*<82G&,8QC@=S@. X#@. X#@
M. X#@. X#@. X#@. X#@. X#@:$M T)'[YQMN;G*&/>S=F[*V=9%3FU],V2K
MSEG*N5KL[ZSMA2*/%+9GH%NVKOTD+L2<3:I]ZET3<';.W(L!A>D8N5!#+6K-
M O26NGZG):T;L,C7S"XJ1B[MUXL%:"DDS#E@?6S<EN^'5TJK1]S8VW-2%W6_
M]1VH_P#E!Y"74_C\];8=P$(C6O13=7V:AQ^B9#'D'5234NWH"R.6!U;T@+9!
MITR+7XCL,!6[)*UV^0KZ&&4Q^Q2)*GN-83&I;$#9O\%,\]$Z+W1H^0BEP9NK
MMQ&V",C$U2=J,:/4MDQK1D.Q  3F@>M?VX(&4KU@ C9&/UFR(>&./(_G9M1^
M"\A>5P' <!P' <!P(D=B.AW3[MB37#.Q'7[7>TS*D.:% %V*)5\X49)IE$2<
M.MP%X/)D-(XFY=944=]D%1,@^>AAN0^(ML*0-Y_QUZCA5SM6@MA0LD\1"6%,
M!IV]:GZV5>O3)!L#*-.UV=V2'UTO$DW%W0JT[;KEA.8IK)T9#;\O<M%%(-K]
M:!P%*^[O&=V.Z_ U4K>'7"K_ )"^S\Y&1A%0J])VP;*GJV'*4L#-H>T3XU=A
MUFN36SS;25<&(-J>5++JO9_=\C'QL>9J6#@:H$0I+K\*XZ*0Q4<BELCL'H=?
MT%9A)QIP04^=<D6XO'B<_P!V8$0#FU!QB6LI>O<%6JHVPAN;:&,#T3=&N-4$
M+:>I(JX\8=##8D1H*>,?C\1:8IYA,2^_XE\-GYK)NJJW)U!;R26IP_1/7@<H
M8F+V@4-,A/GKAY$^VW5]N(@:#L6^P%4AGG\M:EN]9[ [*U:!'AG3'R0%?B$>
M/*NSL#!  L3U>@1*M:*TN4CZ/I*5QER?W;<K"X%_^B?.G6I7V1?8[1]YK1#?
MUVR+UHK7?8'8M,3E\^,C'#9"OW+2] N<3&CE23+JGH@>YNN1:T32&_Q@D^1
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MNFW::(-]CJC&$V7KR0()D=XIHKU,,VU%NJ0%F*L6#EO BY$=JUF:>0G]?F%
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MMJ<:5.U],Q7EDCEB-RJBA"F& E[P' <!P' <!P' <!P' <!P' <!P' <!P'
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M]K+MQ8V:H1"V$_8^LH&R6AG3D9IR V"J!J<](PDQ#0\-)ST6Z]5H6S":UF
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M?^6IMHKMMBOD<9_)UF;C)Z/^9I:VG6ONQ1)0WR-NMN-N-_)[D+;6A6,*2K&
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M%)84MD@=]I:'67FEK;=;4E:%*2K&<AY/ <!P' <!P' <!P' <!P' <!P/$/
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M*J2#](A%1;RS<Z&M+FO;6_(%!-B1GZ51+%$?*!9J3I-T2SO0^L(J ?#7BO\
MJ,"@FM5[8.JWM)W8AN2;57=XT>G:^I1S*9N7KDE^!BISKH'/9H+-DB):%=<?
M9]S>L@;$,0[^0$?0.'IJU<9S51<%*5=<?&M!"LX? FL49JJRT2]&2R5!WL8/
M1XR7()\>0,"W&I.5.+J$SY'H\?#:'E*?#,.=]ZRV-6;;6MD4JIKL3[JW!+7,
M5W5B;<2W)I4,29;):5U"2\S.NK><F-GELB/$_MUJ\E,OEUOVP?R!'O8E5UO6
M=3H(H.0)'*XB*'>?G$ZP/L0.)'!*/LRF([1L>ZQ=&,M>T/*I5;PN[_T)/SD^
MCF7 SC"":QSJJ,J\.,Q!R)GZ]&$DU..U(.:B.4_$NR),$<%H4$_%I*R(Y_4[
MV<>TK8$/XR7B5Y5*FH6$XMH1=(H&K8/6]7M].$B[?].FRB]2&ZE2X56S<M-3
M 6O\5_3:OE;LX;( FH1R(UJ/G=<@^-ALK*'Y(]G(2:8["7;J#JUR6UK:J)/B
MUB+CHJO4NZS],=J2#WX@B#!3$UNG:ZKV'Z#&*)%F)%V/0$4!HJ.L-B$;8(C$
MC*"B39G:_H()MS.O=J04[MF0J1:5V_8L["==;F'?-A2Q[DK9S[);'->AGV2N
M*D3L&6:3(=!G7KK<>RTHZPR5*P$CD,G0&YO$78&A1X:F5R*6IP-(F+W0.MP$
M6I6%PJ8Q5T<#U^4Z@51+5!QL=P/T^.KS/?=^,4EQJCN!!DMG1WC&VX$&W6IR
M!@E/80@(EY?6RM3:$.C5Q$6]=EBZD=0Q(-#NU4O8BQ&<)'LP7?ET-"@:M4QH
M\/2*\<'7G*_O:]WM#1_J]ET88K:6EPK6U[3AGD-C"1>D'\IN+23<,1 C)"$_
MW #0(MHAI#HTFP'<ANIW:&A(!7JKL7%F@!Y87&L4K;\::/ET1BNJCT:X5%:-
M0P1-*-KE59TZX(*RX[:9WQ@F",-F2E:CH<+B/&OJ;N+?MEP\!N2X:7&U8PS
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M2L>@1H"8B==5G$R T ^Z4"T!+$1[\@"T(2^Z2,T(2RVR0M3[:4NY]_ ECP'
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MNXVP/S-D'E-L[!>D%/:\#9M@L'*ML>6"X(EX^$SU[DQMA*D*],,VYGI9W&9
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M8*3LMFM%NG?SUUN-7I&L]:5F(LMJ(<C[3=#8:K1L<Q:).WLO!AQ=?9E9,,Z
MR@Q[:7&T&#>]3*6VY$ V+?=4_'CR:4M#R# SSJFAB4I)PA"LBE,&!$?&8"6R
MR&-]S[7UMHZAV7;&RY2,B8BBUJ?L'S/X%=G2QPAF5$Q%6!6K$C+SDX5F-AXN
M#B$O'SDR=$1(HY!IH;#@4X>*?3E\WQN?='E%[ U0*$M^V"9S7G72+(B:JZ='
MZC27%?L^Q0K"-JS65X-B[Y(P,-1]?.7P$JU8TMK*AKDSY!,HV4Z%]' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
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6P' <!P' <!P' <!P' <!P' <!P/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g923792g52x14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g52x14.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1;^4&AO=&]S:&]P(#,N,  X0DE-! 0
M     %@< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<< @   JMV' )0  AR<C(Q
M,C(X-AP"!0 G36EC<F]S;V9T(%=O<F0@+2!096YU;6)R82!&;W)M(%,M,2Y$
M3T-8.$))300E       0UMXE57@?2!ZIE*=UKU:6 #A"24T$.@      Y0
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M;G,    7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
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M;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M   08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N
M9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H
M=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0
M \     !  $#P     $  3A"24T$)@      #@             _@   .$))
M300-       $    >#A"24T$&0      !    !XX0DE- _,       D
M      $ .$))300*       !   X0DE-)Q        H  0         ".$))
M30/T       2 #4    ! "T    &       !.$))30/W       <  #_____
M________________________ ^@  #A"24T$"       $     $   )    "
M0      X0DE-!!X       0     .$))300:      ,U    !@
M   "50  !?$          0                         !
M  7Q   "50                     !                         !
M   !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL
M;VYG   "50    !29VAT;&]N9P  !?$    &<VQI8V5S5FQ,<P    %/8FIC
M     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O
M=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M#6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !)
M;6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   E4     4F=H
M=&QO;F<   7Q     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M    37-G951%6%0    !       &86QT5&%G5$585     $       YC96QL
M5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z
M06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E
M<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +
M8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4
M   )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M#&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M.$))300H       ,     C_P        .$))3001       ! 0 X0DE-!!0
M      0    ..$))300,      SS     0   *     _   !X   =B    S7
M !@  ?_8_^T #$%D;V)E7T--  /_[@ .061O8F4 9(     !_]L A  ," @(
M"0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,
M# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1
M# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1"  _ * #
M 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$          P ! @0%!@<(
M"0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(
M!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/P
MX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6U
MQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U
M 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086
MHK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$ /P#U-C&5L:QC0QC
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M]3_!9.-CK$NQ_0RIH#LK;);>W=MH#M(R;"+6O8^/S_5MMJ_1Y]?\Y<DIZ/\
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M;/124__9 #A"24T$(0      50    $!    #P!! &0 ;P!B &4 ( !0 &@
M;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O
M '  ( !# %, -@    $ .$))300B      %&34T *@    @ " $2  ,    !
M  $   $:  4    !    ;@$;  4    !    =@$H  ,    !  (   $Q  (
M   >    ?@$R  (    4    G $[  (    )    L(=I  0    !    O
M .@ +<;    G$  MQL   "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W
M<RD ,C Q-3HP-3HR.2 Q.3HR,3HP,@!R<C(Q,C(X-@       Z !  ,    !
M__\  * "  0    !   %\: #  0    !   "50         & 0,  P    $
M!@   1H !0    $   $V 1L !0    $   $^ 2@  P    $  @   @$ !
M  $   %& @( !     $              $@    !    2     $X0DE- _T
M      @          /_A 4A-30 J    "  ( 1(  P    $      1H !0
M  $   !N 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^ 3(
M @   !0   "< 3L  @    D   "PAVD !     $   "\    Z    \     !
M   #P     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$U.C U
M.C(Y(#$Y.C(Q.C R ')R,C$R,C@V       #H $  P    '__P  H ( !
M  $   7QH , !     $   )5          8! P #     0 &   !&@ %
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
MOP'G P$1  (1 0,1 ?_$ !X  0 " @,! 0$            ("08'! 4* P$"
M_\0 ,Q   @(" P !!0$  @$"! < ! 4#!@('  $("1(3%!46$1<A(A@D"B,Q
M,ADE)C,V05'_Q  4 0$                     _\0 %1$! 0
M         !'_V@ , P$  A$#$0 _ /?QP' <!P' <!P' <!P' <!P' <!P'
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MA,"-$(PQE@*$*'SD@)'GCRQDAFADSCDPRQSPRRQ[Z[X'+X#@. X#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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MR00UGYS7[6 2=8:#VN<8ON,WI<J"K?B2ARQ/J6OIVJT9F$\<:+H:.R,J\@L
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MU9@RLB8L6#-!L7!0%+WV+"U[SE4/H\(8\ [&O(ES' %;JAL@MRX#@. X#@.
MX#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@. X#@.
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M)-2J^$E&[#6@)QR9H<>Y3V&*M5 ,N!S9L92V,PXD$<.$Y4GT]=_]Y=AL;@.
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M@ [4'9LPL62W$-D&3DP79==]XG@XPS9]EA9===]XE#]20=]==_Y)P.WX#@.
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MDW\BHJ,VW(YLC:OK"MK[Q+ >+5O]Z)77R]@GK"1S>1CT]& :!DR6RS:_VTZ
M#5F8GA"!8WD@R3*?4UEU,MUTLK6RV6'E'1P-@'L#CMM=F[45(^?SYLI3QF=;
M@VG?MJ2W"K@#$#=!ZWCZEF4?B6.$0)#BT>C=;?U+IU*NKHNI/$^JJ[=!UV<H
MY9-;N35*WUYJ"".'+&2=;'5-:UW8S(B3O/&>?M]6YL<?LXY=S!%.U:?USOS5
M,MIVYKNNV?=7O#8<!NI(;.O%+,U)3%5-?!:Q8@$1XCL,X]2Z4AL>X'"B,B 1
MYLRUVI*(U7#6-<R""KW;U:9>=-K=:K?7ND7O4M*!N%37E0T\,Z>E2V@TE?3T
MMA6S1J!)G;/:9-_M+G7;BQBK[;K6Q;>3T%C "W8@PAD#QZB8*; #9S:TXTUL
MFKGRYPS$TULUMZ.[DL5UVK@GYX\2NT[#66?6-GPACDFG;Y^B?)M3:GAKE._W
M"$(-0S%762KUR&V6J>;P[K&LJ;3<O/BRUU"=S2.EA:>MW-OJJ&])'>+VOU\&
MQ:ZW8JUQ<7L"Y34=MU8I2=$BP@,?!<#JE3I.R:D>>M=A.-?5/S&AK1Q&MP1+
M'4+FFS 8QHZ]>GMS8NEA*%;:V\M7KFHOYX,W%E'A7',MH9D6R[67/((&:+#M
M_HEQKFF:;JVK6^GMY6J\G>@=\CB5RQR78INJ,AO FDRV%?BJ^PZSK;6LN&I[
MCLHU,>M>;/OCZ:5+WV>DSR"S>IT+6NG]P[TL\9JK/17FK35B1M4CA13T*G_E
M3:"X?:^TE\TR*O5Y(5TMU2FU[-B*8&7(O#V*WAQCA")RBE#MZYK:82F>0O,-
MEB -=71\^]-[]!Q%R_#:PTYQ!M"S#%B,0OSF Q/H?8>L5V/;\,><Y N88L9X
MF<< 10=]?#=;6L/UYM[==5IFQ=:U;[&AJ)3W'2=C%9Q*5V@/M2<<]D/A$!8+
MOZ%<PZ^R2BE&Q0NM9THW*6*Q9S*E@4S>G/+EW\7Y:NL&%LI6R*0SGLM_N^C&
MZ"M(DZ)*BKDU7VN<P.;Y%N9M<'1;>L>NG6Q['8($*FOVZHI;([@9ODMHQ#GU
MRYC8I\]C5A[$KQ7V=I8>[7MFBA 'AB5?$*QK[U9_U>!;([&RTNXVR\[-%B:=
MBNZV)[@D63'#[,JCE &E\*[M%N&73=035'2NGK>MF26#S[U<0U-6W(<[*O92
MM*U!&%F5J-CDRU6RZ4[9J:8.CL5[H=08W0 TN_8I5X3\\DJM6>NZE/<H6E)I
MNH=%!D7QY4&MLKMOMN%P=)9V=/;[/>9*%/5$UK7M:?\ YU2B (@6E@Z>N+W6
MV]3! "B*"/O>[7S784L'GBC5JP]WZ[_RN6\F (4];U68P<R :UUH6P@PG%<[
M3["L=G]//:>X>(%5-</*^I/&&ZT^X!R"T2K>0-:I=M:GU%G1Z:^&U56I]VW#
M8PH6(;G*Q3]VG7.FJZ/7&+2TLD:];"5=+%76QSHF.8_70\(W;(H1U(.&49(7
M'>H[W?UI!T&WO7>SHZE0[/"HEBMM<UQ<L5.N*@PPD!R /[QJ&B:E-O%J$:0&
M$%:!7)N4<,PL&?0;3-HU;?;7U1YYK]>4 :3\X42L;#:UB%>*4B(?PY,*?HNE
MS R@RKX J@/7['L/H;N>-B,]1Z[:P#XP8?D2!41NCS*DLFN[?[$T 7K72'6S
M[DSU=K#5]6H:QD/N'7S\N?5:VO8P1Y=@SNMKN/Z:[#5]979:T%4W<!3=7&\
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M&N#4)5H"=2N@P%7JU88Z]<"+%U_D0P80D<(PL$?7_6$,$6$>'7_6./77 Y_
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MU 8U0$+!5]KC[RQ"$P![8.YNY>_O3AH?<VS[1I=(N2V6 =Q5[<JJ[VZ@)U&
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M?L.Y3JE:=5:FUU6+/LYW8*7"U:[*I,6OV6NR8=D7VXG+"T*LXN:"IZU-44"
MX&+(] IK9,<1T0+$/$0-1JP-DZTNK9/NBJTL:XL(%ZL$E9>Z('F\'&0H\2E#
MVT/G2*>OD6:ALQ;M6V$";+.CEU/7A@]:8 3-WM=#N7;\U+1Y5EG1Z%;ZQL2<
MZZ#2'V'4:53;>^Y&UOJ;L>OM&#62''8X%Q?5F4X&)8BJJK:4B HC.'S_ )RW
M8.MU(JV;6K]KS:7KF*?:/C:D;0MU?U;HQGLW45ELVMI6N4SRDD;'76&UURM
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M33P_>"Z32.U]:;)Q@]'JRJ#KK66@*?U2ZC7D5DUV.:W?O,FHUI@>(4)LHE'
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M*57+"E_;H,@$EBK)]GKE>0X&Y+T_?0;VJNQ!TE,K.13D-/L(60$Z[D8@O#W
M%\I=OK#)'>(.V0JA+>9K8;6*]M1]5P9,&=BN!'HFJG31@[Y-;3!N;7\,%9W*
M/?:^U IM]IM)CUGJU]066$@AVNJN.VL&MZA<+NXD)JM@KMB8,S]6"6ZWBRC$
M4QEY8V5!$"I?E*" G!JKT86*^JVQSZJXLGI3T6OQJR];9IE2=6N0?B*0Z-"C
M[B-9'4C5]=LJIG+>5/XQGVMGV^S"RDDV[/M+"'UL"=Z@UDE\?U^M9[*O?GW8
MZ_<EU_% ;HU=PUE5G &VR'S/,<EA]=CVY9K435QJG$S8$VP\2]YY1GKTM@'P
M#FM/25*HNZ/0^]ZJE4;"'V11$U%HJM,*U<V.Q.M<5QCE5C/U"-<U-*JNV+XZ
M=:MBF $(>'V"@5I<*M9_FKX0PCB-EC63/,-5^Q76)>KZH(S?TTM!@(E<VA'C
M?,1&-HN*^4R0Y0UV?=";AVB9Y8"JE% O=FGR*A<C'-PR8WVM::.SW-O$F-*-
M<]C2#4O06MF3,UGL2\5O4F31(-4T^M\P/Z.<DK;#NXYEDUXNV1R9W5I)B>4%
MK<4. *SQO ^]O2URJ#F*I@:YW/3*:%=W_GO9)5N!PNN%8Q@S"W#MMC94H]/:
MWS9UYD5J%5;AI+^M&AU]R^V!9LK"K-C?!N"L-J+9GDPUXK=1JUR;78:H6D-=
M7V0-)$C;@V1&[E=!K,R,JE5J2]NMEHUD(*=8KN]9[MNM6K3&2#56OOT0=Q8=
M>#,3$8.R +HPNE$LMLV#JV\"EW#+;U?V'9#W)E] KYOX*5NIV '(EQLUE4B.
M$L)FYM9.5"H;])Z97IW(3VTWZ1F(M"??.X<I]@-3Z=8M0H"5;.CU]6A<"OU+
M,F ,1]G2<4%PM2QXB9V5V*1B"[UO_&/U_<:^MV& ,,A@#L2'SCL74IC3-EZO
MV?<]GVBTUZN6IC8SU:=G0"%/;S)Y$3"T959;Y['JE306]E%&L[V$RIXBD<!I
M/7%PP9*TM.GYMSKZO- F;^98=<LGR492GCA$KVYMA:DBBPUL"R -7+J:TFT(
M(WO'0QF:G,*?92Z7LU;DY3R3A%OJY[,M.FA%AUPI^5"W!AM]82>PB'ENH^6W
MCW$W_([-X&A8&SVFH^?7AZ1J4"Z4BP-V]2IDJS(JT*01PF(AO]4;[HK%@PZ1
MU;3ODW3<Z)*WL)DQ2=;M.[5&&:Q'"NF$&,$ZO6FI408F=I7=AX2@7*[K,R)9
M)L@NPJ/]!W?87NI:T?ZVT[4GM@O6SU %7VG<2G2"T44M<O;!:=T]IV@MR:P^
MVT3'33;5M;=HCW S3ZL\R\6$2O6U%2?Z,T.EU!HL+Q\UHNO[M/5+!4['BW?)
MKM4ZV39; YC+9%2U&UEI>A8+';K'1-J4\-P]J]N4,[;6$9KS489!=#M%R#=A
M)?7K:O*Z<R=41\")9* FJ][J\PR.Q6E>B2T,N9#K=]V!"&0^=_\  9EC?:.M
M%D6B_B6SS7=:T\MS7*&G8LD@=ULS5-6L_P"\:5E(O0637IX&^:8#6S&RG9]1
MJR01]3=JZQAM@(A3$;'2EWP1;1I 8<L7=FU;8':I(DR!-[+R#8-*M^^J8U]0
M-+A7J[OVS[+O2[34=G9X%AR)Z1:Z'B^U5"GKM6K,_P"QHNP$E@[=DI54Z>0S
M8#(U+)-D<6"7P+ _)^]],]Z1U;0/^0Z^JLNNJG1-4/$EH;KT;C"UH:PG51@0
M8'QJ(6LS7N+&=9(I&RC.^J:""' L,X04)K\!P' <#1GJ C\7S3Z'*^F//\;1
MFVB/IF91IH<OLT&P2?3*WESCB51]_3_DC*7/",''OLK//'&+OOH*UO#2/)/Y
MTU53C>RX-;;SIU:MQY<N8=G.UQ7W"D5)1*K.6566"1*EN;_N.>H9,1<P \ [
M%) L1,VN,801/W17M4>2+>S8;GL.3F@7O]<H6J&TU/M8M-V$+5&TJ)]5FJBO
M+>J@;^2$43&&[&(IL1!T'1ZR1>OF?KP_:5<;9=ZQ;ZEL^TV([9YIK9456TG\
MVV[U]K)I^=!"IIIP@6<8RZ[5Z,IC:CU2J2;+M3U 0[(&#<Q#AL74VF-7'/\
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M)Q#,[>U',:CN3R <CF10:AW'\:..WK TO["PZY2WQP&R'DQI>OL:16E[ @:
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M0CN%:(UOK$RI;9_' ] 2!7!-<]F7W\[MQ&YM-"+L6N]6U16XB@;]#*Q+B=D
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MB;,MK=6"?[DJ2)O5S'CI$+TLM=-L/028IN9D,+CF,5*AA7YI)C+.'M!X#@.
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MKRDK:=VG5TS)UVZ?_L#*(OS&IC*?ICUA^Q0E88+DF&&*5>$P. X#@. X#@.
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M@. X#@. X#@. X#@. X#@?$B",D><:7_ 'N(B&6"3KKO_.^XY<,H\_\ ._\
MO_._IR[_ ,[_ ,[_ ,[X'C<^,O!@GUVGU_"JE+?[AO\ 8J9D0U;:]2L5E'53
MK:Y@3 B666-T0&_-1V@HHL92LGS1Y/E,3.KKL_\ ]7AZ7:0I4UFM#U:.F%F:
M-KI5B**M],(!-K%U CK\;']Y8J\*\FL]BK,XY>=7S75]=:@7E@5%]EH1:@*K
M.R#O5H59<@8;&JNPQ5FNT[L'%+663&Q/:OTW@9#+0XCD&5H%S#-*8_STE'I
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M($!$*TI2GHJ-2FC&SG8-\2LX1 >Y8RQV60TZDI1E"$'A_G9 7S<!P' <!P'
M<!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P' <!P'
M<!P' <!P' <!P' <!P' <#JWG6621QUAU_N?:MAUCU]7>/\ N78DW6/7U8_[
MEC_O?^=?5CU_O7_UZ_[X'D0^"_\ RH539^N*ZQ;N;+N%86._H;1A9V;I*LK@
M1'=PEI#JT/<4W1+I4;#%,PB'"[E,@KD9\<T\0,T8>F>B"T*\F9M]:DW+79-;
M@Q3A"X=,D2MQ .+F%^453F762BS@*(9^AE;$R$R(,J3$@;&/'L>8P.WL#*5
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M!P' <""/HWY&?-?EX[="[9#.V%D: UCKS9NSLJG7.G@R/K<-YEU[I_7V!<C
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M^L/8GFO/3^C=^8;35Y:A])V'4M4TA=>E%G_"O]@WJ:$NU.M7@?H_W*Z2XFL
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MF!3#(OP72'8LV"P,P/G9_26B:;O#6WFNR[0JJO?6W4-EM.N]4R&YD7*QUBH
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M[T%_R=$IU_ZVIFYK50\,ZS;S-!)G@>I1+?K^II*Y>X:A'79P:/\ O(5Q9F'
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M].T[7=P3'UNTTK6VW]O/6FO0[#6F@H+*M.[-5@UVP6]?8B#,DS*XE+VD$+*
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ENO\ .NNNNO\ KKKKK_KKKK_KKK_KK@?O <!P' <!P' <!P/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g923792g57t30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g57t30.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1C,4&AO=&]S:&]P(#,N,  X0DE-! 0
M     $@< 5H  QLE1QP"   "JW8< E  "')R,C$R,C@V' (% "=-:6-R;W-O
M9G0@5V]R9" M(%!E;G5M8G)A($9O<FT@4RTQ+D1/0U@X0DE-!"4      ! >
MC6C!XC>[)500XE>]BD;^.$))300Z      #E    $     $       MP<FEN
M=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M    0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M
M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M  H  0         ".$))30/T       2 #4    ! "T    &       !.$))
M30/W       <  #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@             #4P   68          0
M       !              %F   #4P                     !
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M;&]N9P   U,     4F=H=&QO;F<   %F     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    #.$))300,      [?     0   $,
M  "@    S   ?X    [# !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" "@ $,# 2(  A$! Q$!_]T !  %_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M^^IV+[/?^C6AUS=7TJJR7$49&'9:YQ$[*\C'??98[V_0J:^VQ)3J    " -
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MJYK_ */LM]B[=)2DDDDE/__9 #A"24T$(0      50    $!    #P!! &0
M;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H
M &\ = !O ', : !O '  ( !# %, -@    $ .$))300B      %&34T *@
M  @ " $2  ,    !  $   $:  4    !    ;@$;  4    !    =@$H  ,
M   !  (   $Q  (    >    ?@$R  (    4    G $[  (    )    L(=I
M  0    !    O    .@ +<;    G$  MQL   "<0061O8F4@4&AO=&]S:&]P
M($-3-B H5VEN9&]W<RD ,C Q-3HP-3HR,R P-SHS-#HQ,0!R<C(Q,C(X-@
M     Z !  ,    !__\  * "  0    !   !9J #  0    !   #4P
M   & 0,  P    $ !@   1H !0    $   $V 1L !0    $   $^ 2@  P
M  $  @   @$ !     $   %& @( !     $              $@    !
M2     $X0DE- _T       @          /_A 4A-30 J    "  ( 1(  P
M  $      1H !0    $   !N 1L !0    $   !V 2@  P    $  @   3$
M @   !X   !^ 3(  @   !0   "< 3L  @    D   "PAVD !     $   "\
M    Z    \     !   #P     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD
M;W=S*0 R,#$U.C U.C(S(# W.C,T.C$Q ')R,C$R,C@V       #H $  P
M  '__P  H ( !     $   %FH , !     $   -3          8! P #
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M 0$! 0$!_\  $0@!$ !S P$1  (1 0,1 ?_$ !\   $%  ,! 0$
M   &!P@)"@0%"P,! O_$ "T0  (" P " 00" @(" P$   0% P8! @< " D2
M$Q05$18*%R$B(R08&B4Q_\0 % $!                     /_$ !01 0
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M7.-5VM^B'15'?C.Q36)QNH[Y1]*&HY14!;5%L6XDNEPWEVLQ#!;7ASPZHVF
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M#&O4*X)RISR]XX=/YWG,8,2RV;1B7(0P:M##&3$HHXL@B0'"\ \ \ \ \ \
M\ \#/G[J\M!O_;/:L[V4Z:BH?KVLIM[N]8:[L+9JU1\JY_Z9$5SJ=NT>J##D
ML M0ZS<(9MN>0)5K@&/%I=L#[/GI*!(@"4'QF>W]R]DPVK%_F\.J!TY0UZSP
M6UWH%$$Z8<RKVU%II!DL5?05(0:OV9TYPYI 1]52V'5? Y8.,'PLE1LH6V>!
MDL]&RH2?\K/Y1X=1_HE7^I0H\A'U3_S+]_;TC+UUSKOC$/\ UUFQC&T/\_\
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M)=X:XY%WWK,&V J!(][/GV,CE(EL/N)D7!<!,^L'KX0*O_80L(WHADXHG+(
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M@"U:+ " "+#KC2$8,,6.(<8>+3&-8X88](]-<8UUUQC'\>!S? / / / / /
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MVMEJD'Y\@DQ=BTAUF 8A7)[*C=?L$O5BYP4@A32VUS^N5NM@[6]$X2;4Z-3
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MWY6?2;W@%K?.O:7UBD%Y:TXLQ9&6Q>?T:L<^06RN.3:XVU66X&T7?2CV3/\
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MYF$!6MEDB=J=L3KC04M;4-]7Z?=KI&I.&>(EF1=(&[<QJCC,,UC)!W,:R/\
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M5J4V>P2DSD1&AL9Y!#'#R^BXA"POBEK:XO07'W<_3J;#@S$N9)_H(GW)^_\
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M! 6!>@=O*,]<^8T6Z-7!'7JQ3Q6'0PK+3V5$;R.'K$YJQ,'2L6+N,H,8]AL
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M?NI>JQ6Y_IV_G-7]9>><R]4C1-9OXUC*CTZCQ?J3+[NNGU#$MR5DDDOZ_7.
MGQX!X!X#.=&U^Q;*.;MM!]F59=TD^A,$OX^(3A4C;>8DS## T8T6M?S'* 8C
M:0,\S::;E+]8-AV@9P/5P=:1\M7ML^#N!TCZ97ZXJ["H<JPQZZ(&J$MYB49+
M@F5)O]T>2S2C/BQ0]E@T+,54MKASD2P= 7AI)Y?F20[I4N"1Y@M;S$(OACC^
MDH2 6EU#6:)CMG_ON7(7N03]4V9)LP30[23D9VQ-L$/OEO6)G?QS>TR*QLXJ
M[7G]*2('UTG@V(BYLE>7NIJFO6-]-?IWC_U*"7/TK!.DHNX>U5P7J:#M!@R
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MZ;Q[Z9QMIOKG.NVN<;:YSC.,^!]/ / / / X3)DN3+CV[<\)4I5!%,FC1D5
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M;HS?0%)A-LB&"X$QD]JI8 JH%JL4B=.%*GS0]U_R%^/4#_>WK)8.;TCUR?\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g923792g60a08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g60a08.jpg
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MTFSR-G+"JB9([N'KXJ)+'K_(,ZB5AG&BI[F2GA1!43@O_M#5"%K\!XN.?15
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MD545/HNM<5G66--/EU5M!E5ME D.Q)T"='=BS(DEDE!Z/)COB#K+S9HHFVX
MD*IY36\>=K71U3;UM[BNZ?;U.XJZWZVZ]933Q^> 3N)H>G3<;]#/:"S)H K@
M+%GB'%;ZD6O3(I?$!P"?P5/?%+UH^Y3E;E^:6_>6MKJ^4D?M][@R0<.[S[>_
M<G!OR[9_P=]N/G;=-]K6?^E7TD]+EJAS[/\ .<;6\2:M4DJUAR/>)7+$2:K?
ML<+E</;K.B<N[V^7>'ARV+CT\;</\1^U*9RMH;A9=) !641)707,J1,/49,J
M+/9(7:IC@ E!-L KG$0*D G$ YZGQ?J.GE:*$J)Y5$;1=_V#8[K^SSJNTZ5^
M@=Q4;'K1EH$:H(FL_@@J7A"4G< [0HB^5)SY$3R7C?74/6]W*3>T.<9G4':C
M"PZ];/Q2<V$9%-23D? V:4K#)64LE67K%K%:STVTQL.V>3C1@^E)]E+Q$?)+
MEDF+ALS:2?J8YF)VDXZBTA?#[0.YQ%.8MN$TBDXTK3OZ5ET01302)P3 27D*
MH(E777STHP^G6'1.J73?+?SYZ=22AK(DNE#?FU\:Q="/7V06-9PKK:MD2G&H
M;K[$:$[%E/QP6.^VXZ[&GEY.]87:<::<::<::<::<::<::<::<::<::<::<:
M:<::T[L/=YO&6 ,YY(K(M LF/L.Y-N]?&0;B[8!-U2E3<]$B]:@HB+EH#]@W
M^2W!5(5D?6F"A/5Z@Z=@\<:!.D-;=R/#DO-\DW'FTR9ANGC=.0INF_E/&I5@
ME/#R'-\-H+'N_#[S*L>IYW8/M/>SL[>'"D]ESB7;=[+Y]L^)<#V+BNVVHZ^E
MS=3-.]VK%WR_G8]4/;X#/%JQVP&GP)Z[&!78>A8RL3,%F2C^1%1]]1M<L*KK
MWR@= 6R7M%]GU'CV&7,V]JGID[M=X)SL<>RWVQ[8,1G!W'D7S<G2W7?Z;)MX
MU?'JUZ28ET9ZD4^+88EDE7-PNMOGTM9J3I'OY5WD4!W@\C+""S[>LB\6^"['
MW"Y+SV27;DMUB[IQIIQIIQIIQIIQIIQIIQIIQIJJ[WV]DTOC=N36;$DV9E//
MO=+8I%BMX5:K-C F_?*"01$PPSD?I,&BH!4@LB$U**E47K<9ZJUSK)#@-)7Q
M#XR7D7<D^K8HNQ.?\9%W!K[.:&?U;36:'HY]/D;JYE4K*<JB*_@F'OL>YB."
MJ,Y#>F*/Q:8U\(4&,UPG7 HJD;+D*$0]NP-UJF8 /91\ >I=](R+L ]2AS+.
M7CUXM_2.HH83JKN%U/)CJ&$RBAQ,8PB(CRD_F,OJI&9?55W4B)?JJKY555?J
MOU76[$1CPHP@V#4:)$800;; 6F(\=AO80;;!$!MIIL4$0 4$ %!%$1$35K1+
MK9T U;Q[!L-DX?'=@LZ+M&M63)F9LQY&Q_&3V0D&!W5CAJ)#43(F/XTE<C5V
M[L(PCUC-3/TU)F\F)DJ\B1FC;08SCE5%:2U2.XZJHVY)ES)$<3D(G)QMAMA]
M@4;'9>/(3/AL1&BELFHB7ZI/4_U:RZ_#HM&F1:.N-QZ)346+45Y,C5"R%CP9
MMO+NZVS=6;*1!)Y(YQXR.D;;,?@TIK@KG#G3J'GXL7IR8?X>O9_/O]O_ $A"
M_P!@?_OZO&L+!M_"5*I_6<_Q_P#?>?M_;^&NY^?/Y0W_ 'EF7_5Y@W^S.O!;
M:G=:.753T_&E-P1-6!VFJ+=E@S::]NLKK%(F910U2KM_RQDEG.NVZ)%'"B#7
M'%I,@DF9=RU*W*IX#38C.7L11A*Z6_%(5H^LE?'^*;D27Q<5$W79&'=D15)-
MM=29UQ]<73YG\XLRJ+I^CB*ARRR#IY3M4C8(2>;"=CM352H39*J CIV,4554
M$3Y[:QC7FZ9(ZG-BL:&A;S)9 U3S3./X*K2TXD$4_JEF27CU)['5[8(+NXZ-
M<N"2<6X^IL5#5^91>Q=]ADXF6B;=6HKXKG)6(V<:.3Y2*>>X01G7-@)A[<>3
M+R>1'DI#NHKVR0AD!P(7FT]#/QQ;U>]-+SJ5B]&WCO6CIO!:?R^@C%WQR;'F
MVG323$<0&W9Y,,1I+M6X8%81RC/4,GW33]/,6[93K7#7JJU^XUYQ\J%LD4SE
MXY80 %/CO$2J@BN0#&]ITV.)F[M 1$[=RDJB?P=,P<N!LQ< 7 7<3%"3^9?O
M_%/HOXZUR*FR[:I^?AE<O8FQ8PW1+D[*&.\<&G'FO9H0M\NM:J!I@L:CFL)$
M8L+!)QPR ,!?L0>BT]X&HO&@+^W\A'UU!TSEQ(HW/N94>/S*OX=]YMGGQ2;R
MX]PAY<>0\MM]MTW^J:VN?E"L6R;)'NDJX[CE[?I#:SI):TM186OM?<'B'8]S
M[&._V.]V7NUW>/<[3G#?@6UIIWN)J.P;+O'NTNN;1HV2.LX<N<VXT10023 3
M'4554LQ2$(4H")C&$  .6B5Q4BBD5I7"*)NJK-C(B)]ZKW=:X&^E75!YP&FN
MG&>..N$@-MAB&0$9F2[((BE<JD2K]$1-]57ZUD"H;Q?B*Z+E'693\RXZQT6,
ME+7D:&:+I1$Y%8RQD]@[!:U%S))*JPTI-O8C',-**D]B9*I#+-3J1S]LJ-6M
M2&;OJ(Q*K/TD>/Q)Z0"*@.#&BDVX[OMNH$9!' U\'\BIN)(J[(K"DM.CWH0N
M<<ZA#\/OK[W,:MH9;@%*AR<BR%J9!K4!"(1EQX;,J_EQQ7G$490.H,AEP==9
M;0=ENZNW>WMIT/ZL6T'7QQ\\F(G)^P,LUBWI&Z]<?IPUNE6DK-QLY"5.AP$P
MO^7TIIG SUMM4P5%6GBB1=@E)>M:9+=6]N[18LC;?MU,95@: 6RMEP>(2,3!
MIALU[:&C9O.FGZ'9%'E673KT^](^EW2VMZS^I!R9.^.-1)6.X/%<DLJ83V2E
MU<5V-#D0YEI=3H@>^.([-A5=9$4PM4)0?*/^\_UZ=Z.-H1;(N-^S%3*&18IN
M:5-C:>EI\:],.D"^^I#P@7Z)G*0^<.3E%NR1L=?K40L8Q2O'L:B)CD_7,?SF
M,'N(V2^ZD G+VSA.=LU3RH!WP<9)5^@HX#8?>0ZXX77/T;Y!,&AO_3X..T,D
MTC)D$*+!]]$;-> RIGP63#MV6VT7F\<"=82@1%[3,@MA+M#J0[.[/NLTR3@W
M8.IM,>[9X#45;WV":,7$,SM<-'2YJS*V!&O/%5G5<L%:LA4(&\P(J'8-).1B
M7T29NVE%86#]G$LF=NDDP;!I(]M W20V@J N@)]LG$;7=6W&G-FWV]]D(A(=
MD)0"IO4]Z=Z[I&YC^98-9NWO3+-1$Z68Z\W+=K);\7XA&@E.:$6Y\&PKU.;3
M3>*/NQX\EF5W'(PRYD7%C[,^R-OVB[1:E8,>-<S+2%BO>,L!8WLU?I,53,8R
M[66KDI^DBTST97XFSRD%1*5&7!95O,V=5JX=OF:S].4%NE'.HLYDN1IE%I4P
M228I./QH$9UMD6(IH;9>Y=,&P=)MA@7EV-U44B%20MD%<C8'IZZ GZ<^G/4[
M,6G,3%B!2Y#FU_7SKB3;9%%<BSXWP"MA2)TFNC3;JWD50"Y$KA<!IET62C=P
MGV^C[IUT]XDU'NKXEVD-'.3!1/)#0X%Y;J1CY20*45QBHY:#KL? $0,IY;-1
M=8\8LCB*?RB-T144)Z;V.YN8J^F4"LG;EV 5UF/R^O 5!L6]M_";QQ'[]DU
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MT[9G9P!;<KN:2-F($WM*R/<[L[_\C;O]_P"4VPO_ .7L)_\  ?)U\'S_ /\
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M^&1TL_I.EO\ KC+UM+\,A(TQ;2;+47$'9!=F&QE@=W- !3&5^GR-!H"=2=N
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K.Z<?K(L\)<N6G?!F83KC<=QQ^#,>?=!-SD2">$'Y+CSD>+!BJQ!C_P#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g923792g65f54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g65f54.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[15.4&AO=&]S:&]P(#,N,  X0DE-! 0
M     $@< 5H  QLE1QP"   "JW8< E  "')R,C$R,C@V' (% "=-:6-R;W-O
M9G0@5V]R9" M(%!E;G5M8G)A($9O<FT@4RTQ+D1/0U@X0DE-!"4      ! >
MC6C!XC>[)500XE>]BD;^.$))300Z      #E    $     $       MP<FEN
M=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M    0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M
M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M  H  0         ".$))30/T       2 #4    ! "T    &       !.$))
M30/W       <  #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@             !H@   T\          0
M       !              -/   !H@                     !
M                 !     !        ;G5L;     (    &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG   !H@    !29VAT;&]N9P   T\    &<VQI
M8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$
M;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,
M15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *
M15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   :(     4F=H=&QO;F<   -/     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    #.$))300,      MA     0   *
M  !/   !X   E"    M% !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" !/ * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M)2DDDDE*22224I))))2DDDDE/__0]55',Z+TG..[*Q:WV'_"@;;/^WJ]MO\
MTU>224\QD_4FK5W3\RR@ZD5W 7,^'^#O_P#!GK$S>C_6C <2[#;FT_Z3%<'$
M"?SJ;?3O_P"VF7+T)))3X[U3.'4,.^B366,>S(8\$/K:X%GJ/J/Z3]"_Z;5G
M])S?\9G3+V=-JHORJGM]N/E5^K0YA =I?;[&U[?W;U[-F](Z9U!]=F9C5W6T
M'=3:YOO8?^#M'Z1G^<L_,Z3=1+\8&ZIQE]?)'\H5Z>I_UO\ 3?\ &)*<+ >&
M4,QZ\7%P7ALVX;&FH-M<9?Z45NKLIV_GM]-6;<(70W8#NT+3!!/[K7?0=N_,
M]3TD9S:K@-[!;$@!VKA&AV/_ #]O^C=^E8@W58%6/9D0:V5-<][VDZ-:-S_R
M)*:+:\S#8'=-O+*2);2X>I09_P" ?_-_]9]%ZLXWUC#?T>=BOQ7M$^OCA]],
M>+VU-^V8O_;=M7_#(V-+Z2;=KB\E\L,L!L<ZUS&6?1LKKW[/569=U #U+,>E
MV552YK0&N+6 V>ZK;72RV[/SLBIU>17CUL_1T78_OK_P:4]3C=7?Z;7L<W)I
M=]&UIW-(_P",9N_ZEZT*,ZBT#78X]G1!/\EX]CEP?4#;CNNS&V7N9C5"IY$;
M*RY_VJ]U#?6J=<Y_IMKJ]7*_XFFW'R%*KK.?B%]=SK,EE!++'V5^C;[/;=9L
M!?BY3*7[OM+\:W]!^D]3'_1I*?0TESG3^M'TQ942ZJ8=6> 1^8)_F_\ 7]$M
MG%ZACY.C3M?^X[GY)*;22222E))))*4DDDDI_]'U5))))2DDDDE*22224TLW
MIM63-C/T=Y_.[.C@6-_ZFS^<K6'E8MDOILFJX1+Q#OZCGRW9?7N_PNS_ (/(
MK_P"ZE!R<6O)9M=HYOT'CD3_ -]=^>S\])3Q;3E,J;C]6++::RUOH8U9J:\.
MTJK?2'VM]&[^:_1WUXO^#_X-4J.J5T8+!D/9@DWB]Y<2;2XN;]I]2K]&ZIM5
M[L>G,MW>CC;+,3^8Q[5T>9C9%8=2898UIV.+=[(<6[OT>YCK<:QS6>K7ZK+J
M;/S]_HW6\I=5?A]2<]\X1&*ZH68KH#,>JR_J-F1B6-K;?N^AOHKQK:[,C'NP
M>I8U3,W#SDE,RW[9C6?M6BS]EFX.;B"P/LO<\MOW31MJM93M_1].QG_IK<:S
M^D6?9/6;.]&EK,7%&.P?:&OKLO>36TAQP1U"U]8]6W+MV?9/2>ZJ^[T;_MGV
MGT?7R*^S#OQL?%9CM_9QJ/41+G45!NYUE+[**/29ATOR;K<BBG(ZG7C4?I_Y
MST<>E$K??:,;J=?ZWMMJ<^JL[?MN18/1I>VL[/3Q:/4K_9^&_P!']5]7,S/3
M^@DIJ4Y74\;JO5,/"=6/LV.S)Z=D"IM9=6_TO1QLJBMK*KJ;Z[/0L9;5ZV/;
M_,K?Z;UJO*JK&;4,#)>(,NW4%PT<QES_ .9LW?X/(]G^CM63T4NS.LY[:';L
M"CT<?U?I&U^+7Z,BW\ZCUW69'\N_]*M=V &U[!JV.'=Y24]#C]3R,=PKN:7-
M'+7?2'P6M1D57L#ZS,]NX7"49F9@;:RS[3B-T]!QAS!_W6N_,_XBS]#_ ,4M
M?#RZ[AZ^#87!GTVD$65GC;=2?<S^O_-?\(DIZE)96)U5YAMXW F-VFX?'\VS
M_7Z:TZ[*[6[JW!S>)'BDIDDDDDI__]+U5))))2DDDDE*22224I))))2'*Q:\
MFO8^01JUXY!7/Y>*YA-%WMV.%@VP2UP,,R:=^[V_F>[\S]5R%TR!EXK<FN)V
M6-UKLB8/FW\^M_\ A*TE/F75,&GI&<W.LZ;=ETVV5OKNQ+?:,AAG'^T-RM^5
MB^EL_5Z?MEN"_P#\!4F8GUBZE0,.JH],QS(LRWOK.26NW>I715AUTX6'OWO9
M^@KW[/\ C+%UM]3JB]EC/:?9;23N:0?C].FS_!O_ /1J#6T8S-S)./,23)83
M_@['?G-_T=B2D'3.DXO2\5F+CLV,K$ #\JM.9(U$HA?N (U![II\N4E-2S&8
MX$1"SLC#OJL;DXMCJ<BK^;M88='[O\MO\A_L6RX"8@H;FM(@@I*:6)URNYXQ
M^I,&'DNT;D#3'L/_  CO^TMCO^V?^$6PVW(Q+6[I#HTV\D?UOHVM_KK*R,.J
MQA&V0>Q57%RNH=)<&-9]LP.#BO.K!_W6>9V?\4[]%_Q22GLL7J;+!MNAKARX
M?1^+AKZ?_4?\(KRY7$RJ<IINP'EPK_G*SI;63])MM?TO[?Y_^#6ITW- >*GD
M@'1H[3\/S?["2G__T_4V%SF-<X;7$ EO@?!22224I))))2DDDDE*22224I))
M))37R\-F2V?HVM!#'_UOS7_O5N]NYBP+<7J&-<0UHL:-" TN$'\QVON73H&0
MS&?I<6@P>2 8/Q24\R:,VD>K4P_9W<L<UVZL^'_%H_I9KH(82/ZI6H<3 U-5
M[&B#N!<UPCSU^CM51N%BL,XUU3Z3J&[VZ>#6G_J4E-1]&?.C)_L%,:.H'_!_
M/:Y7'4-W !U>HGZ;?_)*!IK;+MU<#F' _@TE)31=C]1'-9']@H5F+F/&K=?Z
MA_O6AZ=)( <V#XF/^J43C4_OU?Y[/_))*<*[I_4:[6Y&,74Y+-&VL#@Z/W3^
M\S^LK_3NIY-]_H]3J^RY,C9DM8[T7_UI_F'N_P S_A%<.'C/ W6TMG]Y[ 1\
M?<K&%T_I5=C'W9-+RTRU@>T@D?124__9 #A"24T$(0      50    $!
M#P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E
M "  4 !H &\ = !O ', : !O '  ( !# %, -@    $ .$))300B      %&
M34T *@    @ " $2  ,    !  $   $:  4    !    ;@$;  4    !
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M 2@  P    $  @   @$ !     $   %& @( !     $              $@
M   !    2     $X0DE- _T       @          /_A 4A-30 J    "  (
M 1(  P    $      1H !0    $   !N 1L !0    $   !V 2@  P    $
M @   3$  @   !X   !^ 3(  @   !0   "< 3L  @    D   "PAVD !
M  $   "\    Z    \     !   #P     %!9&]B92!0:&]T;W-H;W @0U,V
M("A7:6YD;W=S*0 R,#$U.C U.C(S(# W.C0P.C(W ')R,C$R,C@V       #
MH $  P    '__P  H ( !     $   -/H , !     $   &B          8!
M P #     0 &   !&@ %     0   38!&P %     0   3X!*  #     0 "
M   " 0 $     0   48" @ $     0             #P     $   /
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M!P 1$A,(%!4)%B$B(Q<D,B4Q,S1!0A@F8?_$ !0! 0
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MS+E6OH;'>S6QJH][&A$58\%W:0$.:W9<'8CB/C'=_)W%[7)P!\U2L9P-Q!S
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M8I"-=#C!RTJG>USFMT5@=B>3D_PZ20HT;XO>[V"C7#$8/_S.<^;$1HE9(<=
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M'$BW]<7%0Z6T#&4Q'&_)S &8*0T\=X"J&T*&J=9.#95\.?'.&0*5'$9I@?\
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MRW+XRX_^F&>(V8U41OOCLC6UN_S3P7L^,RV4B-5S&$5A!Q0Y.>N[([[(BY9
M^:JK_P#2:&1 ]WJ1'.,E$L=H45RN5Y9E>YJ*PBHD=Z6Y Y*6SD<"C:I<N]O_
M "3U<2QW=O)GH1/6+$G?V[_XN[X8E\D^NU7'5*- ])/C<@R^[O/--<9J-]G^
MD0O C?9[E17/QL81U_JK_(<NP[M3VI[(['VP B^]HN2T5JBL\FY!^7DCN-<^
MB@1$5OCVDW-1]7LCD:OV!42#7M[0C>X<64$?)QQMM0Y(4\>.FD(K_!Q<#BBL
M17*HVN2,[<D<?LJ)_((-FY51!*CRL?7Q@UF_3Q^.%W@"VW(5N5M?"*+\=4Q*
MRAB9J->2"CD,L)AQ0Y$E+.IAL,%D C2OKB6*&-$?))!640-6.@= Z!T#H'0.
M@= Z!T#H'0.@= Z!T#H'0.@= Z#G9N0RUA(B2YN?J)$J IUAR"0(_MCK*]"2
M?6]!HY/>D8"&3OV(@F([NC43H(GV?QQXWV<>O:> ^NLJYX49>!CUEG:2X0G.
M(2LL2Z&ON!38<DJH4SRB^\,C5+$F1BD(]X<-_P#BAG(T@:5UE6CKF1U18TG(
M4/W/N)[50T>;!#!%$"KG#<X((*/\D*]IFD,YZ!Q\_P"+4QME-];,FVF<QOU)
MGN,VQDE4$?V,F5 <R&#'&BI)CM)^5LO,(8SG : ZP(0>#-^.+HY"+]FF1W]_
M-[?NHKU1WM14<, 2M[.3W+Y&(JF_R(YLOM/0(%Y6K,WP_*JP7[[*5(FP)<Z(
MM&*9*CB##EP:\C"CFZ>I&,BOL1(-(H!(H$(BD&)/J'"(V\C<9WZP0_B](XLU
M4"-3U-;X%_A[?]VIM-8(5B*!?%LL5EXM0:?V:@V@"?.-^(*3DRCDW]!#JXL6
M':RJDK+JLIA2/LQXE9:$>)D6CL?\+A7$9S7LFQ2_9;(_HPJ)/D*Z<'6M^)X3
M^Y&1\IZ0G4#H[XE7ZT<D4;O\3?V4036>LB1T1 -5!M\/YA=J] \ZN^&LTMLO
MWJOCZ)1E:1Z64*1%F7)4<B%"A:AW&%4%?8=&N-[]--]2HAT63*:,K D*-\.\
M^.7%]MW$_%A%(1\4-(44Q#JQC8;XDH-P"%""'N=) 8]4Q3M>-H"PV(9A@D_*
M_&OC+,NLED0).F99?8$Z+HW19=?&A2@! 6"&O!%BQCB5!D5)%@R;8(PY(WW%
FBM$$83\UK6M1K41K6HC6M:B(UK43LB(B?PB(G\(B?PB?PG0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g923792g69x68.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g69x68.jpg
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M 0$! 0$!_\  $0@!E )= P$1  (1 0,1 ?_$ !\  0 " @,! 0$!
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M7Z8\6'^\G[K?Y@Y_^U-N3R8_5[8_\!A_H(<M?UMY0_S3%?3*]N9TU<< < <
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MZ%"$L%5QC@L6Z5.=.6(JX?*JT9PEKJ!Z/JZ3>&W;ZTMF'6N:6+,:1CM^5^H
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M@MGX=XK$TXU*DX4JE%P5.DTISY]U%0<,SC&,U4<:DI0C3<I3BGHWG=,:. .
M. . . ?;%_T4;^Q[N%_ZE5=_PO*.>/?VF_GFROX;$?6P/H/^Q7\QV]_%X+ZF
ML?6=SS ]M' ' ' ' ' ' ' ' (9>(W_=\]Y_\H'9+_V=F/,OR?\ T[L7^:[/
M_P!W2,!RK_5?E'_(MK?["N?Y3G/ID^+AP!P#>!KLSV(D=7L*3/WA:IFH1;00
M.8UL2G4D>0Q 9'U\.8\*^ %R&XY43'G.-7  6L@H/"+ZZ+"VS1377;'2AL[
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MW4J.C&<:+G-THU9QJ5(T\SR1J3C"G&<U&RG.-.G&4KM0BGE7E<L4' ' ' '
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M)+],\LOYNOKL<>H\O?U<_L[_ )!+_;[+/GMYO9Y<. . . . . . . . . .
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M . . . . ;@HK^T<5_@RW[/7YC-K_F4_AT_I(R^P_P!(TO@5?JY$\.:D;R.
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M. . . . 57\] /+QP!P!P!P!P!P!P!P#<%%?VCBO\&6_9Z_,9M?\RG\.G])&
M7V'^D:7P*OU<B>'-2-Y' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M ' ' ' ' ' ' ' ' ' ' ' ' ' ' *K^>@'EXX X X X X X X X!N"BO[1Q
M7^#+?L]?F,VO^93^'3^DC+[#_2-+X%7ZN1/#FI&\C@#@#@#@#@#@#@#@#@#@
M#@#@#@#@#@#@#@#@#@#@$.K=\0KHO0Q!8+;O;CKW")&@ME!6)$K4B+B:ZK8V
MSIE+$+&%'TKWWPICT>== ^V<*^1+_K,XUR+*,GNBWX&:4^[ >'QOY-FESRXJ
MWV_T7P+KEV>/B]\?U^?H5"4R_&[IY_U*ZNLIY^;R;?/C@9)='E7WGO1KQ:O#
M;DQ9N!U[BTS$C3K.-6PJU#CNF7Z^^<XUU22;6X/A*NZV^^<)Z(XU]+NKG"6F
MFRF?-X&27L6^\K^8GK&I1&9F%92.'R(%*X\23]*./1HN/.A7Z7E\GI6106X=
M,72?E^;ST%U-?+\WEX*GN\ < < < < < < < < < < PZ?6' :IB1F?6?-HG
M74'CK;+P_,9Q(1,5C 9KC.-?6"ATX[8C&*6=\ZZ:;.7*>-U-M4]/.WVUUR%K
MZ+5E=^GB3/[ASLAT8ZG7SV[8*;9PUMUTR']<NLSG73[Q9P-N>[-0A.;,TE=M
M-</JFKJR63E+TB[-PXTU3],+9;>NDH_YGXE]MCN:!?%\L7R;D)[T(ZN#'?X7
M5C&Z_N[MA,A2>_SZ-U9!()IUHB+AXCIG.KC9*(.6F5]<>KK*(X\Y0.X7LI>*
M/]7G1S?)C\1];&57/BABT'&?GRD'Z-4\T&:[?^&C8M.CY'"?_AKN844^;YUL
M\"\?8_YF?C:IO%BA7])B_<KJ-=>N/](%<O3V;5PJKKC_ +J<PJ+L2Z2:K;_-
MCUC>!ODDL^7;U%;'DTP%X>QDN])>9K[3J*=N>[U+8\O9[P_3\PC#/RZ/[4Z*
M66/[%C=,>3.V'[JE)P!IV\V[3&FN^5VL1C=DO4?,QA/5QNHGIEZ>GI_RM%[I
M?&5O+JO#=$I^N_<+K5VL8EG-$6U')J4C:GH)A"5=2,8LV".\;ZI[,I]5LN9
MK#A#O"VWH<(RB-"LJJ8VPAE7&/.X(::WK[O'N9);@@< < < < < < < < <
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M1DP@4F;934PXCLO!A3"6-,J;,_19UWV$--.S-]<$#@#@#@#@%5_/0#R\< <
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MX@9:U1C+\*VJOO95<.M$21\OS*,=+JI4?3%K@L9US_1B9MO9.[;9-/988_\
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M%+S]-5D%M4W0\BR6PL/+B7R+<D'*M7HHFU:OV;ENF*M--I[T;(X(' ' ' '
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M3T>YB90AP&,TU:S]%';TLMAC*1O%MU)DVW4"6MI+COZI<5X;W7?MP++^"HX
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M-5=3&6.Y/9NRO$ E&/A2K*R+3SK3T/%N,87%-H?&C2L7[ =D!B:GGH[';NL
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MT:VED3B1@OOL'55"L3 G*_%:ZXJ__:%F][8A6EE3>(KUI8$B@%/36G:XO>Z
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M_!4< H1[27C)Z6!56P@D? 2"?W;=D-HZ$^US\D.B 0S*1<FD;J12=4.U=EG
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MV;/F[L[@NR7$:B>;EES6TX=+Z[=!,[Y;'37\[7K/_P#]VJ[[4\%;/H?B94]
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MCC^KS!D;[J7RB+;XU_JT3:#EFS-'37[W1!NGICYL>3@3]=_AC]%%F/!4< <
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MNZ:B&VF^NNVN<8%I*TI+K?G(B]:NO%&7Z/\ $RZ<]E:PB=H1F-]_[9GKV&S
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MQGDJDO9:%U3?5C^QLGH+Q$8TR@1F;5._F<5L/K>$8%("UAL!BE8!Y=6P*2#
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M26^F/.QZX1:S"]2#/*NFOFZQAPLW4](CMC@+2,GTVC_[/S+QEG/!4< JOYZ
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M?&VN!5Z:/>C*^ . . . . . . . 52G7>.ZWB"1J*BL_"77'PWSFTUGA-/\
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M5J2EB?X [W\O>#$1(5<0KY-%U^JE%RM 3*;?.+I;[[!['GX^*4^/6;J.VF+
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MK2OS-O42%VS]R9L\TT;-TQ[B(#-E0>0<N$59/?Q;[[^Q618UP5' ' ' ' '
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MD3PYJ1O(X X X X X X X X X X X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
MX X X X X X X X X!5?ST \O' ' ' ' ' ' ' ' -P45_:.*_P9;]GK\QFU
M_P RG\.G])&7V'^D:7P*OU<B>'-2-Y' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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M+]*K;^8G 'ML>_)387Z56W\Q. /;8]^2FPOTJMOYB< >VQ[\E-A?I5;?S$X
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MB4Q8#32(]SG?&S!]NUPW>IZ[[M]]]=<YX*^F^_F-I< < < < < < < JOYZ
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M)D60Q'\$-:/7J:[ELP2_!LT5=&^GWJ>.#C/>X X X X X X X X X X X X
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M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
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MAT_I(R^P_P!(TO@5?JY$\.:D;R. . . . . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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M . . . . . . . . . . . . . . . . . . . . . 53>N,_P#:VW^_2_\
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MECGT@">]6'\?@#VECGT@">]6'\?@#VECGT@">]6'\?@'3]B89]$8Q[@%?5.
M/8F&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3
M@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'N 5]
M4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%
M?5. /8F&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X
M!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'
MN 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8
MQ[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1
M&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AG
MT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B8
M9]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8
MF&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#
MV)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'N 5]4X
M ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5
M. /8F&?1&,>X!7U3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7
MU3@#V)AGT1C'N 5]4X ]B89]$8Q[@%?5. /8F&?1&,>X!7U3@#V)AGT1C'N
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MXTZ<7GIZQA%/URXI7,KL6M6GM"E&=6I*.2KI*<I+2#X-M$WN:J;J. . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
M. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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MMX=(SX)BNP.R05<R\9"+YJ:5F*AHJLZWB<JJCL;BMLV& ;5V)07#!96V<U%
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M$.Z>#*4';2UDT!J,GX3>+O(9 %H-'CCUX0E)+9&5&#1QV&737A&^EO9Y;?\
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M6':O:QIP_-W[J$]L[0H"7H]3[.@LGH^X2!V'$ZYI^DZU<W6[)]6A67C203*
M6+8)21#AR3'2'QD &]:9 BSTZ/3TW$IJ^NZ\4]5JN+;X]=C:%]4OV*?3KN5K
MUOKR4R]]>, DLP.VK.J,F%<W'$&NM@T*4?=?8?;QFPH>SO.N[,K =9 F%UG'
MV=?G*O6 I1XU/A;TXVRF(37<WX=>G'5JVCOQ\)XACJW,G\8BK(_6-AW#0$G
M]V=8K2H/KA+:.B--=@;)BO6\/UY=QWK_ "NQ)P>@T!$N8=V*?1Z>2 TQCM>S
MBV2YG;:(@2(PNT$IKO-9=;WNE>^O%[N^D3/MFOYLETHZ/5!(Z#&V./3#4U#K
MJ&RRJ9/>&:B3CG7F1H:'W%.0R8PHS+B7QC#H_7>SSX?W#P9>5;3DPR=#XZJN
MU%5OD[VWM:VOJM+OJU\!!NNZMOV% ^IT\E]<3VP+?:=+:ZJ.^DKQIB7O2M!N
M*UH:T@$ZLFJNS[J5,XY$CS^792'3R O0<U+7(L3$RL :19+MSF1;2[7#-I9J
MSNU96XJWB\AY'7VF;CEE74;/Z=JBSXC!Y5#O!1D]G*E-]ASFV[=@/;F#VAV&
MNE!G[0D'<@384DJF0LJRW>J6U@A5AHM5[(U(BY:" ;5W=W_^3O:Q:7EW*VG4
M2)UZ\22(]:H^A+^L;"P)I=7<2\M.PIZ?UC,NP!Z-U&)M?MM(:#FK^J8S-XS(
MYZ':#2];0:$C&I]$%78"RT)T]#*"XN[02$7N]^Z*M9VUTNK\./BL1<8=8;S<
M41/W\EH2T"7929^!@ZZVQ*:NXB3?3=MV>KZ)]C(?*8H5G&57;@'+CX\S7PR,
MR0J<U:V$T5%N8[(#R*.7F!;,M%?15,SUTRMKP/Q:$K'=*WDIVH<FDZRLCXWL
M]MRTX4O[#5YB!+='E>J#R+,JITF?PC\&[C<6.JSC>E)>K_"J5KHJ7/F.:,__
M +^4%;JW#UMK?O7W^+6^ZVE^!LWPV^O5FT;)*X>2> R6%(2SPU.DK.Z')==R
MKM(NV467LQO:SN8JN'[Q0K:3 :4",9,<=97?N!NH8>J_79#!Z#0)M/=[.=O@
M]S;P;RX;@H. . . . . . . . . . . . . . . . . . 57\] /+QP!P#4M
M\4W&>PM-651\S?G1<4M.(&(7(",8<CV<A9BS3;9JZ<!W148:&MWZ:>V<MU7H
MH@WUW\F5&JNOWO..K35:G.E)M1J1<&XVNDU;2Z:OWTSFP]:6'K4J\%%SHSC4
MBIIN+<7=*23BVNFS3ZR+<L\.FG)%F;JB);8\,6EUGUK>0MN"5@) #!+LK:+.
M(5\9T5BLK@,BCJYJP(NO@/9XN4CY)&)6DEAXF#%EEG1%?KRP5.6>TIQS3IU5
M;(U"K"+AGC&4&FYQ=IJ2<9;[)MG:AM*O'F[QISR4:N'DY<XI5*%6?.<U.<:D
M9*-.>M)P<)0W9FM#LGNF/PM=?3.P'<@:R<-U?$W)N?/R)J !S6='IPA&5(>@
MO&J[A$0KG 8-)&+^:K;L1D=P$/@8S@,(>8)G72<O#7JX:=U)4%4<FU%3G*5L
MO<PA&%E*\],MI*-EJQ'&VH8VFHN$L5*AEC%RE3IQIY\_=U:E2KFE%J"O*5XR
MEFDK11/7G;,>. . ;@HK^T<5_@RW[/7YC-K_ )E/X=/Z2,OL/](TO@5?JY$\
M.:D;R. . 8ZUF$2?'%(RRE$=>21%DZ)+1YJ;&.#B0YB36"/7Z@E)SN_T9,S+
M=P)=.MF^$&Y-!9@JIHZ2W2U X1$WA<@;,GH&7Q<VS)E7@(:[$'Q))L0.#F[Q
MV0#,EV3M9)V58M![]T\'(;J.VS=B\661T3;+;: -9Q"MW =GI+XON[D.4=0#
M760"=G!S9PD37;ZAT,.\JD\KHA3*R.&6J^54A)-33SM&#K*0'\$SF%'M$504
MPBQI-R:?1MNH)D DCHO(AC1R_) $=V;M;54T/8LGCQ\*TSL^:-&CEPN@FB@K
MOJ!QZSZ"[&!4=UFD2VD!W!'8("UD8?)@QJ'7=-BVPH9AYZZ0P+<L7S<CEH@M
MADNS=).?1*-UM= .#-D5WJC*G&T]A>$(*MZO-E\RD'A&'+^7?7T,J4R^\R/+
M><DIKZ,OLTW\J>^/-\NFWD"WEW&N[/A-%WR CC:;EV95E&)%')K#9+#K0D<
ME$6DLF&&H;&9#$+#K.61:81Q_+ LJD,2'NP,B8YE B1%X]KDBQ*NV:X(TY0.
MW3UY%Z<F%;B8]"T8A*NQ=4TZVF!G89*592I<9N&WLL*;GI$0(R^3SRRJ_(FB
M\L(KG)E)5"#PT_(ZO94=T?"SS<==$_!:Z[VC)?-I1&7AE:.,Y$"=2%NS6(N
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MD7( H<E+]@^L-UDSV/' DAQ$T3ZTF0CY@4<="4!1%F[6$V=D^G=Z> V;P0.
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MY>E_4PAJEK>#S23B>QDH<0JAY/"X*_A:,OE\9M:5LG\?B1:/AGZ2Y<>_&O\
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M1J>;$FHY\5'HM2CPOO\ .5?V+R*Q)K@@< < < < < < < < < < < < < <
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M1Q7^#+?L]?F,VO\ F4_AT_I(R^P_TC2^!5^KD3PYJ1O(X X X X X X X X
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MDAVKYL[ N$M)!J))859)"'&RO?HMITQ4EQZRS;@J. . . . . . . . . .
M. . . . . . . . . . 57\] /+QP!P!P!P!P!P!P!P#<%%?VCBO\&6_9Z_,
M9M?\RG\.G])&7V'^D:7P*OU<B>'-2-Y' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' /#81F-BRYF0#(\#''I'ZGF0FV
M E@S+G<CD<MQ^3))NW3>E/44-MD&?KRR_JR.<IH^9IG.O -2V7UFHVXC,D/V
M9 64N)2^E)EUVDFQ$K(4V16G+ *##,NAZXID7:BM,%2888[T/(,DI.-4:::B
MC3%/=7103=^6_A,=$=1J3 3]_8X=C/V)DZP8,I@$TN:X58!8KD97S*J69^T:
MV<3E:!V?*\5X,$1=[*I['I">+M <=>&'Y M&H\0%A=[NC=HM-;Z/?O-?#_#R
MZIC8H?AZ$+FBXR01BH(7Z\3NV[S4ECD6Z^3MW9M$A8+*S%B/I' &M0SQZO)H
M%M#"8-P$)^8MHLIC7S<AF?3T\%QT?C6\]-#H9UL8;1AT"!V1%CL4.6"?93.)
MWY?,:L,HYMHT DMH,I78H>R6DXF(:?R2*QR1R8+)SY4:^D 9@<U;(E4<.\B<
MS\W!<-W#K9ZF.D?7?U.V :D>FJ\+NEK-T)O6:UQW#O5*;JR9/B;3@]#JR]N\
M0>NY8>F>5I;B7P,''),%DCXP9CA4._/'%R(B[TZNI&=0+K745;QJTHK'0TA=
ML;M+.3UM$9;8-A3N3SPX\KR*U2Y*FI;-)0>DVKO>OH3%HTE\'E6*+1F&:J,D
M6SKTJZ@7>G5NZM;^<P,QT<ZRF1FPU2 DAJB<"H"MA9L!8=E1^51J,=6S,VD%
M!YB4J$2]G((M(:\+6+-'#67@2+"5GT#SH;+3,@%)MV*(9GT]+\=K^9',EU-H
ML\4KR>C"]KN)%"(\WBPFP '9.^$9--(BQE#J7-(U94T$V9H9MR.CY4[)$1PR
MP2<F9B<$C@88FS!&S0I^]-_I?PB[]$K>*VAS@>JO6^J)_M=H\*^C1\7(K&E
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M^D:7P*OU<B>'-2-Y' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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MNE\&@DG?2SLM][+1WXZ<+7OX#Z ^"@X X X X X X X X X X X X X X X
MX X X X X!5?ST \O' ' ' ' ' ' ' ' -P45_:.*_P9;]GK\QFU_P RG\.G
M])&7V'^D:7P*OU<B>'-2-Y' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
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M#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@%5_/0#R\< < < < < <
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MUJ?B"O\ W5(_M7P!\M:U/Q!7_NJ1_:O@#Y:UJ?B"O_=4C^U? 'RUK4_$%?\
MNJ1_:O@#Y:UJ?B"O_=4C^U? 'RUK4_$%?^ZI']J^ /EK6I^(*_\ =4C^U? '
MRUK4_$%?^ZI']J^ /EK6I^(*_P#=4C^U? 'RUK4_$%?^ZI']J^ /EK6I^(*_
M]U2/[5\ ?+6M3\05_P"ZI']J^ /EK6I^(*_]U2/[5\ ?+6M3\05_[JD?VKX
M^6M:GX@K_P!U2/[5\ ?+6M3\05_[JD?VKX ^6M:GX@K_ -U2/[5\ ?+6M3\0
M5_[JD?VKX ^6M:GX@K_W5(_M7P!\M:U/Q!7_ +JD?VKX ^6M:GX@K_W5(_M7
MP!\M:U/Q!7_NJ1_:O@#Y:UJ?B"O_ '5(_M7P!\M:U/Q!7_NJ1_:O@#Y:UJ?B
M"O\ W5(_M7P!\M:U/Q!7_NJ1_:O@#Y:UJ?B"O_=4C^U? 'RUK4_$%?\ NJ1_
>:O@#Y:UJ?B"O_=4C^U? 'RUK4_$%?^ZI']J^ ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g923792g84m45.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g84m45.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[16V4&AO=&]S:&]P(#,N,  X0DE-! 0
M     % < 5H  QLE1QP!6@ #&R5'' (   *K=AP"4  (<G(R,3(R.#8< @4
M)TUI8W)O<V]F="!7;W)D("T@4&5N=6UB<F$@1F]R;2!3+3$N1$]#6#A"24T$
M)0      $ %2RCII*@TH";(._BHX/[0X0DE-!#H      .4    0     0
M    "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M    26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R
M:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M# !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0
M  !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$
M.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P
M  !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#
M8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;
M    16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M  !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M          !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q
M<L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0
M<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&
M(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R;W!7
M:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M#&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M      MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ /      0 "
M \     !  (X0DE-!"8       X             /X   #A"24T#\@
M"@  ________   X0DE-! T       0   !X.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-! H       $  #A"24TG$
M"@ !          (X0DE- _0      !( -0    $ +0    8       $X0DE-
M _<      !P  /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              &:   #4P         !
M      $              U,   &:                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     ,X0DE-! P     "YT    !    H
M $T   '@  "08   "X$ &  !_]C_[0 ,061O8F5?0TT  __N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( $T H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MFW]&]_Z6BS9^D]/U*GI3TV-UJ]M0NK>W*Q3&VUA-C23^9ZOTZW-_.];U+/\
M@EHXO6L._1Q])W'N^B?A9]'_ #]BX-]+\7);]A<ZNVP:V-T ;&X>HQH?Z_\
MQ6Q67]3SFA@=15DW&0]M.^ASN\4LN]3'?8[_ $3+:?4_<24^AI+C^D=>=;CC
M)P;?5Q]0YA$ACAHZNZGZ=%C/W/T2W\3K6+?#;3Z+S^\?:?@_3_P38DIT4DDD
ME*22224I))))3__1]522224I))))2DDDDE.?U#I-.5-M<5WGET2U\:#U6_\
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M],NP^[7:NI/[I_.LQO\ 1V_X/Z%O[Z2G,Z)T"[&MLS^H6F_J&2=UUI_ZAO\
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M    $P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V
M 0 X0DE-!"(      49-30 J    "  ( 1(  P    $  0   1H !0    $
M  !N 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^ 3(  @
M !0   "< 3L  @    D   "PAVD !     $   "\    Z  MQL   "<0 "W&
MP   )Q!!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$U.C U.C(S
M(# W.C,Y.C0V ')R,C$R,C@V       #H $  P    '__P  H ( !     $
M  -3H , !     $   &:          8! P #     0 &   !&@ %     0
M 38!&P %     0   3X!*  #     0 "   " 0 $     0   48" @ $
M 0              2     $   !(     3A"24T#_0      "
M_^$!2$U- "H    (  @!$@ #     0     !&@ %     0   &X!&P %
M 0   '8!*  #     0 "   !,0 "    '@   'X!,@ "    %    )P!.P "
M    "0   +"':0 $     0   +P   #H   #P     $   /      4%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,34Z,#4Z,C,@,#<Z,SDZ-#8
M<G(R,3(R.#8       .@ 0 #     ?__  "@ @ $     0   U.@ P $
M 0   9H         !@$#  ,    !  8   $:  4    !   !-@$;  4    !
M   !/@$H  ,    !  (   (!  0    !   !1@("  0    !
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M4V%Q_\0 % $!                     /_$ !01 0
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M9,KYVCL/RC 1KFKD&&0E Z00 BB22)5K[7TS&SQ]BQ48+O(0*!M_4A^6%+;
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MH'058^1_PQ^/7RKC,3F+$_F+F)2R*&GU-=93JO0T<"00YE2N,(I*XCQ'DR#
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M\["AR^<-5<82]IKGC 4F*"LC\91,1G?\1I,G-@!B0+&+69B?:(D2#0W.H6-
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MI,8JQTHB#C_R$HF&C1V>#>SVC=%#RA0(WP5[G>EM$]HU>I4JX7N6PL@C,OA
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L&K&*T,E-8QB*C&M8BN<]4:U&HKWN5SW*B(G=SW*KG.7]W.55555>@^N@_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g923792g98k18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g98k18.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[14>4&AO=&]S:&]P(#,N,  X0DE-! 0
M     $@< 5H  QLE1QP"   "JW8< E  "')R,C$R,C@V' (% "=-:6-R;W-O
M9G0@5V]R9" M(%!E;G5M8G)A($9O<FT@4RTQ+D1/0U@X0DE-!"4      ! >
MC6C!XC>[)500XE>]BD;^.$))300Z      #E    $     $       MP<FEN
M=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M    0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M
M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M  H  0         ".$))30/T       2 #4    ! "T    &       !.$))
M30/W       <  #_____________________________ ^@  #A"24T$"
M    $     $   )    "0      X0DE-!!X       0     .$))300:
M  ,U    !@             !0    WH          0
M       !              -Z   !0                      !
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M;&]N9P   4      4F=H=&QO;F<   -Z     W5R;%1%6%0    !
M;G5L;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$58
M5     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$58
M5     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@
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M       ! 0 X0DE-!!0       0    #.$))300,      LR     0   *
M   Z   !X   ;,    L6 !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  Z * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "
M4 !H &\ = !O ', : !O '  ( !# %, -@    $ .$))300B      %&34T
M*@    @ " $2  ,    !  $   $:  4    !    ;@$;  4    !    =@$H
M  ,    !  (   $Q  (    >    ?@$R  (    4    G $[  (    )
ML(=I  0    !    O    .@ +<;    G$  MQL   "<0061O8F4@4&AO=&]S
M:&]P($-3-B H5VEN9&]W<RD ,C Q-3HP-3HR,R P-SHT,3HU,0!R<C(Q,C(X
M-@       Z !  ,    !__\  * "  0    !   #>J #  0    !   !0
M       & 0,  P    $ !@   1H !0    $   $V 1L !0    $   $^ 2@
M P    $  @   @$ !     $   %& @( !     $              $@    !
M    2     $X0DE- _T       @          /_A 4A-30 J    "  ( 1(
M P    $      1H !0    $   !N 1L !0    $   !V 2@  P    $  @
M 3$  @   !X   !^ 3(  @   !0   "< 3L  @    D   "PAVD !     $
M  "\    Z    \     !   #P     %!9&]B92!0:&]T;W-H;W @0U,V("A7
M:6YD;W=S*0 R,#$U.C U.C(S(# W.C0Q.C4Q ')R,C$R,C@V       #H $
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M 0$! 0$! 0$!_\  $0@ 9@$= P$1  (1 0,1 ?_$ !X  0 !! ,! 0
M       (!08'"0,$"@(!_\0 ,Q   @(#  (!! $#! (" 04  P0"!0$&!P (
M$PD1$A05"A8A%R(C)#$R&"4S&2<U04/_Q  4 0$
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MYGL@6=4Z96Z_.P:J87S.CWXT;XVN&L4V54]IKE']8LY0@:JN'5CKG*$A_ >
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M#]AM164F)9ZGBJT4;=F9FJLCHY 4H8;V[ZG?%=12B[=7O0JLE<NR%$Y=KK+
M58!X(BPJ&!T6W-6":I&0)_/GF<+30IQ2!#+F)X=&J$>;GZS?J,M>+ZL"_P"@
M-62N5G*6@'1[S96%%. <8_E)QU5=[%173#.,@V'(<N[!D1XR:A%ME\8PLJL^
MM)ZN;A.P'J^J]LW/&)&E8CU'F75;]EZP%*1#VZ7Z-83^2@/.(D)=[A!??O\
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M9;Y8!]PX*PJYN])SE.!\8D:8T6SA_P#08Y.?<N9P#IZSW)ZV48:VOBO7N8_
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M7]+KS#P(R._Z!JFXIE%@\&L#(ML538AG##0X,XC*&<88A V,8)&,L!KUZ/\
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M\"M> \!X#P'@/ > \!X#P'@/ > \!X#P'@/ > \!X#P'@/ > \!X#P'@/ >
M\!X&'.\^O?$?:#FM[Q_V#Y?IW7.:[(&0[74]UIEK>OD7XBA%8(3+'#=/<*0,
M7-?=U#*-O7$G(J+JY,_GX'D3]JO0#V%^AU>5GLGZ1>S-QM?IO;[2MIY_5+O>
MP[?L+',MFVE9B=!/G=]51R*UTQ(E4X(E4\UJEFFBSA2Q=W.)G)E#T^_3SYAT
M7D?I]QS5>M;/JFW]'L:V_P!]VRXT;75=5U"-AT[;+[H@JC7Z92OJH02H$=F4
;HR6;%>K8["Y7M;%;PE:VKI9A-+P'@/ >!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g923792g99m70.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923792g99m70.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( G<"8 ,!$0 "$0$#$0'_Q  ?  $  @(" P$!            !P@%!@D*
M P0+ @'_Q !0$  !! ("  $'" 0- @0% P4% P0&!P((  $)$Q05%QA7EA$2
M%E:7M=76.'9WU HA-#8W5%5TE;2VTM,B(QDD)3$F6'B3UR<R05&W,S5A_\0
M' $!  (" P$               $% @<#! 8(_\0 4A$  0(#! ,(#0H$!04
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M*OG+E52<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PBL%L)_+*?_\
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M!Y4*(PTF2;YOU6)D8[#INQS@&&PQ/R?HBFSPC@%PQ*%\VK8D/R=0;5LX1I2
M)R7=$GFN=*W(T)S8S6F@<QP?1P>[@0[M=T>"UM2UU)%G3QA3,;>L=K)1P;,7
MH41IA.(O%KFEM06-X;ZTN,(<Z@<*UGY8+I)PB<(G")PB<(K!L_T5)'_]0<*_
M_MQ/N4SO_P!A@?\ AIO\])JU;W$B_P#E9?\ *32KYRY54G"*=JJUNMVZX79L
MZK2-92@74[^K14G','":DC=%;EFZ->5^+C8##K,C(B)J5N$!W3,:DJNCVJFI
MGA\W+KG3F9^5E(LO!F(FYNF6S+H;G"D,-E()CQW1'_-AM9"!=5Q -%VH$E,3
M,*/%@,W1LNZ V( 1?+IF+N,%K&9O+HA#:-J14+)2'5.^PTTMJ#!*YDEF$:)5
M60MTO3X@K:<2@"S)%7,M]));"V)< .;!730D-)DUWV(E(@(*HH/W"3)1;F#+
M3DGPI6,^8AR[9T RK)I[9:+'#CP=SA1G->XO!:YK0+Q:]M0":+)\A-MBS$)L
M%\=TK43#I=KH\.%0&]?B0@YC0TAP<XFZ"UV)I51BXJ^S&B;M9W7<Z;),(0)L
MQ^JXB1]%-E7!]<6V!6 [S4'XXMH0:<FPK<3*UN\ )%<N+29OUE"#3%7LB8ER
M0!'@DNC.EV@16$NF&!Q? '"QC,#'ET(<-H8XEHNFG 8$<5)@Q0!";'),-^$%
MQ ;&.&$)Q<T-B?,)<*'$*V%4>'5LG==6PBU:\:UL4:V?G9*5700C;$$CMJV:
MXJ+'RMA,Z^KZ0F1AV7D(ZU[P>.!H1)X_6;JM^VK995RW25K)FWK/E)F-+1S,
M-,MO??,9LK'B2TN)K" 8\>&QS(38AP#GD-!!J10T[\"QYV9@0H\$07"/N^X0
MC,0F1XYE\8P@P7N:^(Y@Q+6@DBE 20%6QO0UY.PH"2M:8M=S'98<CL8BQ]O7
M4O6"R62R\>L6B<> %4P^3$R<E INX)QT2.7<OS0]!9X-;N6R6:F-@9V3#WPS
M-RPB0V1(D1ACP@^'#A.#(KWMOWFLAO(;$<X!K'$-<031=,2DT6L>):8+(CF,
MAO$&(6O?$%Z&QCKM'.>T$L:TDN JT$+*(ZU;&.+%(U A0-UKVT'%J'"]7(U7
M.E+%%!44$'*I@C"< .4E8BTFSELX4(.1B33!!P@KDMTFJGEEB;0D! ;-&=E!
M*N<&-F3,P=P<\D@-;&O[F7$@@-#JU!%%(DIPQC+B4F3,-;>= $"+NS6T!O&%
M<OAM"#4MI0A;_>FG%W4==4PI):*';#,Q*R!M1IR&NXK+CD;DUCEP ^2#X7&G
M.0)N[(RIV+(I+MXUBTQ.N$L%%T!ZC?YJN7!)VK)SDI"G!%9 9%EW35R/%A,B
M0Y=CW0W1H@OD-A!S:&)6X*@%P."YIJSIJ5F8DJ8;HSH<9LO?@PXCV/C.8'B&
MPW 71"UU0RE\Y@46A136G8R=@4I7"J$N>611:4LX,G*8[6$U,1GN:$"K4&QB
M>4A8!%PZ<C=FGS(2@%4>XD5"+MLRQ;]N%DT\N:):$A!>846=E(<40S&W)\Q!
M;$W)K2\Q=S+P_<PP%Q?2[=!-:+AAR4Y%8(D*4F8D,Q!"$1D"*YFZ%P:(=\-+
M;Y<0T-K6I I4K>EM,M@6FUC;3 G#% =[O[$4K08!D*JD?%%3?9)T-8%1IHRW
M9-G<3.]M<B$?E"6'8HR(7:DV*ZK1RDIWPBUI$V8;6;&#Y)L 3#GPZ1'-9=#G
M-<QA<1%96Z^'\YC@6N (7*;-FQ/BS70KLT8VX-8_@-<Z\6AS7. !ANI5C_FN
M:0X&A61MW2#8.G_H.Y<@(]9H.R&]@K0N44/,8W=T=,JU,FW<6>Q\^KA^?5'$
M( S>-2$J:EFS',6,6])*_*Q2<.$<96V)&:W8"(^7?+F (L.=A1).(P3)(EW4
MF&L#FQR"V$6%P<X7?G$ Y3%F3<ON1+&1FQA&,.)*Q&33';W ,<7H+GT,$$.B
M!P%UN)P!(CHCK!LL'"S>1EM>+S%QZLGBHZR#Q&I9\R"U\000;.EV$W*.8^DQ
MBCQ%L]9N%6IY=@NF@[;+9X=)KI99]AMHV>Y\&&V>DW1)@7I=C9J 7QVDD!T%
MH?6**@BK X5!&@KA=(SK6Q7NDYIK(!+8SW2\4-@N !(BN+*0R 02'D&A!TK7
MRM&78"@_5FFZ=M,/6W:H!#JP2M?2T?!^UY6'82&+H]2QV(1 ^5D@ J+. $_/
M_GF Y)@3'=.&3QNNIFV<DWQM[,FI9\Q1YW!L>$Z-2$]T.(=R#B^D.(US'\'@
M/:YKJ$$+!TK-,A;NZ6CM@< ;LZ#$$+^8T/9_,+0SAL<US,>$UP<*@@J>3NA.
MS<9J& VD?JNP Y>S[B(4W!*B*5U8 ZVI619P,#/VDHCD2>QE!T?BIH<<Z8AG
MP;)\N^(#26"3;M!OY?+I,MJSHDU'EF3,!S):5;-QIIL> Z5A-=&? ,.)%$0A
MD5CF5>U] &N;C4T7;?94\R7A1WR\9KH\P9:%+N@QA,1'"$V*'LAE@+X;@ZC2
MVI+FNPH*JKTW@DXK.4%H/9$-E=?34"HW2.0^;QXO%)0&5=LVY!JD6CYYFP+#
ME'+!VT?-\'C1')9FY;N4^LD5D\\K*#&@S$-L:7BPX\%]2R+!B-BPW@$M):]A
M<UU' @T)H01F%T8L*+!>Z%&AQ(,5E Z'%8Z&]M0"+S'@.%0014"H(.16J<Y%
MQIPB<(K!;"?RRG__ *?:D^XE.4]C_-M+_P Q:/\ 5"M+4^=(_P#BY'^DJ^\N
M%5IPB<(G")PB<(G")PB<(G")PB<(G")PBF77ZA[!V9MV(TC5C<.ZG4U]/=A4
MCYMC' W2<:C)J7F%R!LFHDP'H-08 FY[6<J8)]Y(XI?.ZR4QYU)Z=@6?*Q9R
M9+A!@W+Y8QT1_P#,B,A,#6-JYQ+WM%!KJNS*2L:=F(<M #3%B7[H>X,;_+AN
MB.JYV HQCCBI&L_2[8&L#]8@>HJ,M'"[4C&5-GZ#E$?O>,VBXCCW$;)14*,U
M:0DZ)B01HAFFT/QS#!,\)S6;*O!R;5XS77X)>UY&89,OW5TMO,MWVR=AODHD
MN(@O0W1F3+89;#B-Q9$^8ZA =4$#FCV;-P'P&;F(^^KV]G2CV33(Y8;KVPG0
M'1 Y[#@]GSVU%10@G0F&L^R!4M/P(S7Z[B1RIT>G-I!F%4SMX6K5ODV6>8KS
M\<W J/(:CDS;KNNE9$B.P[;(++]9>23SRQYG6A(-; >Z>DVLF326>Z9@ALP:
MTI <7TBFI I#+L33-<(DIQSHS!*3)?+BL=H@12Z *5K&:&5AB@)X8;@*KTFF
MO%_D(I%IXPHVX7L'G)/,)"IDTK.:.8I,#*:3Y?,1%I$B$S$2 G@B+)K9L!+Q
MVZQ2'/E.TNL&CCM/(STD(L2"9R5$:"V_&A&8@B+"94"]$AE]YC:N:+S@!5PQ
MQ"@2<V8<.*)68,**ZY"BB!%,.([$W8;[MU[J-<:-)/!.&!6[NM4;<'03*0EX
M?/P\]7M&#5F&ILE45MM)P>SL*"F9[&3XMVK"L8JLF7$BV^0.->GNIE(V1)&0
M P#Z.MW11/A%IRKHUQL6 Z ):-,/FVS4J8+-PC,@1&. C;J+CG&_$N;E#<W<
MWO$0AJY3(3 A7W0XS8QCPH#98R\P(KMVA.BL>#N=SA-:+D.]NCP;[&%@+ED8
M+I#MI8<P<0(%KY;S:6(U5)[J2"G*YF@9^_KF,QPM(L9 *9O06#PHUE&0GN.P
ME1BW71EDN)!XX'6<$22"?>,:V+,@0A'?/2IA&9AR9>R8@O:V8B1&0]S<0^C3
M#O[I&O$&%":Z(\!K2LH5F6A&B;DV3F!$WO$F0U\&*TN@L8Y]]H+*N#[MR%0$
M1(A:QI+G!85UJ]:#U*EV$ C4VM&=7+%)3)V-;0JJ;6>3 +E$9K*(:5%ILW<,
M:MYDHWRC#D@^)0)Q)1(?+-R(,/&18:]:X9"T9<&;,>)!EH,I%APW3$69EA"?
MNL&'%:XD128-=T#0V.(;G8.:"QP*P,C'.]A"9%CQ9F'$>(,*!,&(W<XL2&YM
M#" B4N%Q,(O:W%KB'-(6JQG7/82:ES4?AM$7++3T;+DH_(@D9J^;GBX$\&:K
MO2X0T-% W3T67%,FSEV2&OD4'C%JW7<.D4DDE,\>6)/R$%K'Q9V4A,B-:^&^
M),P6->QQ#6O8YSP'-<2 UP)!) !JL&2<Y$<YD.5F8CV.<Q[&0(KW,>T$N:YK
M6DM<T ES2 0 20H<SPS3SR34QRP4PRRPSPSQ[QSPSQ[[QRQRQRZZRQRQRZ[Z
MRQ[ZZ[Z[Z[Z[Z^7G;767YX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$5A]2OTF
M:,_:7%OO)+E+V1]PK6^XQ_8*M;#[L6=][@^TO'MA^DM>/[2Y5]YK<GL=[A63
M]PEOZ;5%M]U[2^^1_;*KYRY56G")PB<(G"+G3\.W=[5FE=9V= [&.BCV.&[^
MG]L3&.M(L:,HYM(PXTVL:K,T7;!HLCDYE4KU[F$!<X)*9=B64BR)%TT1:_2V
M7C+=L>TINT'3L@&MB-DH$M"B&(QM#$;:LO,U#B#2'#GH4<8<,PPUM7"B]18]
MIR$M)"5G"XL=-Q9B(QK'.!$,V;&@8@'&)$DXD$T-6M>7.X)QF+#?;42?7I'=
MBY_/WZ-GPZF?#^Z2R/BK\9PXK-JE:%"&S8YF"J8F!<2"S6AO(5C49&Q'#BHG
M2SJ2+&W..+ID]3ZO:6U(,G$D(,$;VBS=N5W-TB8S8,T6MLYQ?-->&2Y9>WTV
M !-"D,,R(/9[:V?%FF3D6*1'A2UDTO";$-T67#C/-:R7+2Z.'%N]W1B9<U?>
MS!%;-AMRZ?+H4U%:SM$V2C$7\0W:[8"=H@@\XCL<*U39]F4W+ZV).!!<4"5,
MNVXR,RGKT&Z%YD CMNJGBW3Q(-E7-A(63-,,U%F)9C8D2PK,D8-]\&)$9,RT
MO-PIAH<QSPP%T2$;X==>",>"0.E.6C+N$M#@1W.9#M:T)N*&MBL8Z!'CRT2
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MO?3>DUX-,?@Q/=3U:6/]0)M\*G?W#C?TEX9*^D0O?3>DUX-,?@Q/=3U:6/\
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M0]O7G?I08-Q)8&$)?_ZBY/O!'_H7,5G7 C6*;;WK47@_#<J.+BHN C-D7,%
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M3*@2K>J'58Q.86Y-"5B3HQ&S3>KFEQ)-W\U.R4^.CQ2U"D:#.).79L!& I
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M^KH7] Z@:_1FY%[X#0THWL!21RJ:LTUI[83Z!@IY/ V4=G-A1:J'\J<U=%+
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MG+I5:<(G"+E(\+!NT@ME6]M(]F==P![K94AA[6DDM B18Q%&\K84[K"N.G^
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M-Z_9:;_W<7>4WI2]R7=">O=I[J;U^RTW_NXN\IO2E[DNZ$]>[3W4WK]EIO\
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M$U;3PBJ+,FUF+0##7$Q,7\9D5SQT19T=F<#;Y2!X@\/.XB'*"T!Q%<B1ISQ
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M_P"@Y/RE[(>Y$UY4K^<EU:6-W2E_)F/RL96DT6E,7CU$>(ZQD)2.MW<DU@A
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MR)KRI7\Y+JTL;NE+^3,?E8RKYRZ56G")PB<(G")PB<(G")PB<(G")PB[;_\
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M:[L.H"X A.K++QOU3VDY9/9G60J-EID]!1ZOW9 >@3"0Z/CQ<>AQ11\3AH\
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M3"LO"TA<,N!Y8$HD5;RN+/"^P1&1 @E$CX5/;L'[%_31&6Q3:2Q$Y[( =WQ
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M'K/VQK.N,1J[-)^^9,5'23G-#!X\:MLL^EG"6&:HU#;UI0ZSLZE'ELRZ+T]
MS]AG]J+E.A(M-:P@,C;0UQ19\N#D-MV)#ZSBB)9EU7[7 :ET=G 5\2[?.&[A
ML"Z=D6[=YDDDV75&H;>M2&DZ3D3HR ).CB*D7,&,3C",W4W#G*<+<J8(MY=G
M(Z)QC"ZRCS(?@DB?RK?H4JIF_P ,F.&&#O++)YCDVZZ[6Z[PZ5&H;>M10Y5-
M>8=2AR:V$UAMC3JJ<+CVFE<UK^ 4%9AD=%A= J(.HIL3;T]IF'NA3X]$@#1R
MX!GZVE1V7MG"K3)C%6K=V%RD!AVD$XJ-0V]:FZ<#>-#75H )T<:E]$2&</3(
MYON3-5R$<;D'<A8(R>AE7H)J)6Q;%7)EKA7&2XMN,<98H$%GV"";);+%)SDG
MGWUCQ4:AMZU%#K.SJ6K'#L#CCJJ6A?=>;H9WA)B,/JA9(W2CQE-Y )C$DF!%
MF%(,ZP78KIM D3-9JOLG&#'HBFQ"].>S)<2Q>JC4-O6IH<<3AGEAC35K*]B)
M9922*"Y8:V(O.MD3<RE4%$"+&?:]!3!,[%YE((8FF/Q&PTT,??25Q'5S49:-
M"BY=X"?,%2 P84[>BF2HU#;UI0ZR=.%.I;JO#,FQMG&7.V-DMY&17=M1\?7+
MTBD;?N6 YH7?-V8I2L\7[I=D)?L2;M%!#-1N.>-'JV.#9PBKFJ-0V]:BAUG9
MU+]&X4I&5Q#:2;767'W,@?XB@+<V5I(4N;*9]==X#1"3^LD%"3_/K+'O%FSQ
M6<9=9=?(GW\O7%1J&WK2AUG9U+5Y>RSBL>LLRUV2NF9EZJB9>6R:!PU_01"=
M>0&!'IUL(1$$H*(:,#!]LRS0 X2(F"&NW*J.3@FS9^5=I*C4-O6IH<,3CS=2
MB0?:#8O-9+7XFV-L2,EAEB4Y6\N;("=>DT(\3NN ,;(CQIXY=QELFZCP$"1:
MH2M<5Z1*M"F63<,(.ML.WG%1J&WK2Z: WLZZM'_JI^81'$J_("A>VEC$B8EB
MU*%1K S2#Q^,&O<<\V1$@S;UHHX9L7>":F;5VY33;N,<,\DE,^L<N^E1J&WK
M44.L[.I>*,QAM-,5LX=MU8,LP;(H.7&<9.T:>Q;MW3E^S:KK9"ZU==)(N78H
MHU05S[QP6<C7Z">62K-QBFJ-0V]:4.L] ZE^ D<9257R$<V^GQ]?T@_$^1"2
M"BRJOI44EBN4&>38ULOGZ0&H98K/V?R><LTLL5'":>'?7?%1J&WK2AUG9U+P
MKA1+5ZS&N=QIPW(D1I$R/8+R6B$7KX0(\ZZ+%6;52N,5W0T7VQ>]$7R&&;5E
MYFZ\Y52\W6^8J-0V]:4.L[.I:K"C4&L.O(?:\2W5G)*O9]T+QB$I4,TJ.&G'
M)I'%<6-:9$JP:*>EWJ6>.: =5-,IE\OS>VG67R]<5&H;>M3=.53AS=2W(G&F
M@4AT(,;>6 )*]IDE>AA,]1C AVD&%-SIA3IDZK5)SVF*!NVIDEGTE\UB*<MR
M+KM)HLFMDJ-0V]:BAUG9U+,#ZY*%A#:0"]H+8) 7K+$DS-CWE,O!#L=FEY;!
M^V)-ZO49KLLT?^[BZ26S0R2_[G2G>/\ 'Q4:AMZTH=9V=2@V$6#!9\;NL4$V
MWMA(70IJ&@IO-B!*A&T!6<SF$1^>!7(&5IP)P.?L,!4E','SISDPZ0-XN1R>
M"_DL5E%1J&WK4W2*8G&NK1G7!2^ZB:;$C'Q#W;:Q69:6)Y*Q86Z-4>W(R5+!
M/!;-6/LE:TP<F4\$E$U<LQR3G'%-3#/OOK'/'OM4:AMZU%#K.SJ6B11^TD$+
MB$TD6R=TU;C-LBR82-V>6UUC\E56#OGK)VAT@/AYH0\7\DS[)8IB3)+M(<Y;
M+.O-ELEFZ*HU#;UJ:'*I/-3J6\,HNW(DV(0?MS83\R38KE!HAD=HYT3(#&N6
M&#DBQ8(5KFZ=L6V2J>*[MNDHW1R4PZ44Q[SQZ[5&H;>M10ZSLZD0BS=TUD;U
MMMS83AE#G#QI+G:!RCEFL5=#TNUR#:1N$ZUR2!N&*&.2SQ$GFU4;)==J+8X8
M==]\5&H;>M*'6=G4HQK&7Q>V %JRV-;37.TB=.V%*ZYE\J-K4<QC?9&&APAT
MP?%FT*]>#G41[&'V+IJ<7<-,%4L7"F:"*2>*BBHU#;UJ2TBF)QYNI;)#GL2G
ML(KJQHON78+Z'6TQ#/ZZ+KE*8&8RSH\R2?C& IH3JYF^5-*(+8XK@<FV)EDY
MP69O6*#M!9%-4:AMZU!!&!)J.;J4I^IZ6_\ S$W7_P#;J3_\4\5&H;>M*'6=
MG4GJ>EO_ ,Q-U_\ VZD__%/%1J&WK2AUG9U*'-A*NDPJD+2).KSMH\W90LVX
M6#%\*RZ%DTTVN663-_V+K<:1Z;+=?]*OF1!FX^;W_P!MPGE\F74@XC 9C7UJ
M' T.)RXNH+YH6V'Z2UX_M+E7WFMSZ-['>X5D_<);^FU:-MONO:7WR/[95?.7
M*JTX1.$5@]6/Z=89_=)G_H.3\I>R'N1->5*_G)=6EC=TI?R9C\K&5?.72JTX
M1.$3A$X1.$3A$X1.$3A$X1.$7;?_ (*3_/O=7]4J.^^+.YK#^)?T%D?:SGL2
MZV!V!?2VE]G*^U'789VIU[O&VMR=/9_5LWE52Q.N:5W,BT]MJ("ZTD!:.$K/
M*ZLJPV/( K)%25DJXDZ,"ECUH6:18ND)7C'6)%1LF^;MR&IELL$!K@<22V@Q
MQI6N7/K5#2WAP%JTV%BM=Q>-WJ1US#0'1"%4=.JZ"Z]S0W7'6K%@G),3:SZ=
M6P4"6+7*;:2]C++D!NK&.2<['RB6#!H]W)&#&..2F]4&N9+B<QB[FPYJT7CZ
MT%NA2*!>@E,@X]8<J[\;0%/I7BY@XXN2%;2VG:I76S&82-@1S)FP\K!$8._&
MMUERGT69MAK<XU".!735J2\->'\NF>;0 ?U7Y4UAV%N#,N4D&MDOC4<.(^![
M$RD1LQ_4[AP<":D[8V#+]G.R(4+/Y8,<QJ+P$\D1<LRRR:LQ$.U&P 6;R7Z:
MJD!  %<MTT'2T!NC6/,L@VT)LJ*G&QB#T!'HP[[V=\4@Z[(QIO7@)ZI3]ZU-
M=(JE6ZC@<0:.58W*9:;AN(R-_.R[!O5&#TP+$)CU'#6.?6?UIL4!V)J3DVF>
M8+:[ 5&C712W3E?-XG%M5?5D !4IX4]+6C!R+2HP@FZ)[KMNY +4NZ9IB(S*
M2@&5Q> 50-E3E24R3-J0F[23/P0!B:<M'#+DJ;PK4FIX=#CA5I '33UJPFU6
MO]Q&-DH!G6NL#,;7E*WCH[/*OE-,5IKZ'],5I"+:#E;U:S*?2$R-LH&ZAH5U
M(A\9K: ,XR/*QE\[667E+$[(!@TH! !QQ(-0:YD9Y4QXS6N.%,9T\1>KK$.%
M!-EZW03:]AMK'JIFL8I6Y=>9/4(R =FR3YJ9CM7[#QJV9PTC\DK!W-!8&0G%
M3E>EFPD)Z;4C4G&'W*K)P4-(&=*5Q!!/G%-/G'&J7VGH]MO*]N;SGC&&I?03
M:^UZT@%_F19Z/(!"=*P&C?#LE+J4"V#X\@<Q"D991.U&OC<:X'N3V.=JI&E!
M"0/YAQ4LKPH.2#3#35W6#JPUK2R>BV\\_P!5-::E'5Q!8C(]6O#1IB!0O*R)
MO@@0%;A8E*]L$F3AR,*2E8E](J<D^L]0CAYV0DP8%SG.Y(R!&G ]4R_2)>;>
M<:G%Y)PS;CY\:G7D*@J5[AU.VLN2S=A;@+0JP!]77%(/#O/VKJ@S/TN@SO.
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MLQ'0GQ-:/MJT%']8#6VX%O[)*BUJ?[ GA<O<&YCA,CPPM9I&0V@UC'4!)&4
M9%5H8,'FS$LKPJ#7"\PTH< !CT:A6OF"Y@=5JGL&OKOW.E<PCBP6/V?.-?BL
M$(J/A;K"0#X;JI3U>R5RD@P?.G3/$7,8T<"YX$D&2KA1AFZ9X.&"S9VM T\_
MZ!8'1S?J5>3DJ$X1.$3A%!5$?R2UOVZVE]]X\R=WODA8M[[RBN$;8[0390_;
M]W7Q5D.>KF[&WLJX=.(QU(HPUQM#4 4-TSG@2>,O2)M-DV+4K?-+2<@+&/\
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M.7X<>MHVB6B[U*;0:,8K$>A9Y\7C1 :4UM=>RSRP)KQ;5X2FG-\NY9;0E!M
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M9$NGBRK6HI2M,^?!9* ;W4;:YZM(Y6+.T9X0LB"0ZRE<H]5TN7:UO#9[+9E
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M6OJ7'UL[NKL%"K!V+@\6G#V)"(1OQI?KM&C,.J!"UYL K6[]<Z]L:?8A(0S
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MZA+QVN/^(4/J6RQC2&F8C; 2V@SRP$WD4MBT[MA4)6F+E6N899-X@IL&N,^
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M&,,L2[T:OD>T;BEHQLELBP<PJ,8A4F^I]@7M.W4=/'!KN#1(W;4YKAC! Y/
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MH])RNS<II=WMA([K&@;\E=VEX;HL>%N\+=(,-@#GOBLO7H;6-(<]S@ T$%U
M0NIO.;W.%%WK,;E'>V'!B;C$N17N-&LANNT>YQ!#0TDN((;4@T]!G0%ZD5V3
M8?3%K/W),K8((<W95]+'2Y W4HS$U:8=DB@)44=%*W#YX%9V/0Q4=Q(=EB]/
M),&V72G>1GI)H)=-RS0UL![B8\(!K)IUR6>278-F'\&"XX17<%A<<% E)HD
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M<_DU@FBQ>2R$7*JX3 +2&,VRS,PD63=SQ<9E'&V+N0@@XMR4-( &/UJC'$$
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M<EU:6-W2E_)F/RL95\Y=*K784HOQ/J&A=:P&F)W](WT-B.BSB*1PHVBV;QY
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MQ\H+*\(B^A3W^V3M-:/_ &8?I4I^^GLM7?\ 5@)]HM:?G#CY065X1%]"GO\
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M\!V%^5>+CM6T=:7VZ]AZD]I2G/K(7^ ["_*O%QVK:.M+[=>P]2>TI3GUD+_
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MUY]"K)'_  Q8#!'E7%*[M28 34 K;NG#QB2P6F+)=3^N6UG2^UPC4DTFU=%
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MK'E"6P@1IV0-']>A##IRQ9]O2B4W8-.G91\V%C&O;EV921Z<D2;QH.8H?/\
M*NWSILT;XJ.%TD\G Y6Q.'R=JR'D]F?ZY17^&S_\5XX'*V)P^3M3R>S/]<HK
M_#9_^*\<#E;$X?)VIY/9G^N45_AL_P#Q7C@<K8G#Y.U/)[,_URBO\-G_ .*\
M<#E;$X?)VK&N"NP+0F-".I#KPV,F42#D0(<839$F5;B>FO95<:P4-8NGR(SI
M\R[(*M4E<&73QKVYR3Z<)?/<#E;$X?)VK)>3V9_KE%?X;/\ \5XX'*V)P^3M
M3R>S/]<HK_#9_P#BO' Y6Q.'R=J>3V9_KE%?X;/_ ,5XX'*V)P^3M3R>S/\
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MRBO\-G_XKQP.5L3A\G:GD]F?ZY17^&S_ /%>.!RMB</D[4\GLS_7**_PV?\
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MMK5+ Z%AUG1(%+YR&K&15BRF86Q>Y>"57%0Y XXKG(#F6<YR(@H<Z(0*$TR
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M1D$AY!A->7/OM9\T.ONO 5O&M5V/X+<*T:FT1/W;M[X(!ZGPTE"$;.!55KB
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M[8N!D(HB#-BGN'E69,069K,"0]VE\O7E&SUDX6;+X?+U\])3/'Y?X^$7YCX
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MEUIP7',B9)I@*F6CG!5KY>*J3A$X1.$3A$X1.$3A$X1.$3A$X1=M_P#@I/\
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M27&ZMIZU#M-T!49AM9&1*(XN<AMQ6*'9=^G)(EY$<.+XHLVWR(&$NE/(I_\
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M\M!4VKLM+<1@UJNM@ONU[ FYC' U%,,=.7QIT+TR-G^%^(#M) 4O[6P<!(3
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M /UKQ56A6GJ%>PN%7);DVK86\"9X>*I;<BK8 7>SN3NX[LS0@ ?!(2U#0Q<
M7E4M(/PI:/'PL,.M''13_LQJ3NTW8TXJ4WA@/)%<*8'/']?.HJU_@]IW$1>G
M(H.'WK:-'V%HW=9R> ;]CUBU1;<+IE*XX8*UW"S5AJ5J+ XI;]7#CYNT?0[Z
M&2A160F80E.K(CR"X/$"0T'$#7"E"*TQS<:&E*5R!PU\I-0:ZRV/ZF; 0>WJ
MBB5CE;^M+9NVCFN#N6#LHHE'K[LN42]"IW<S5'9@^RW8(U@ZDIEBSP!XSTD;
M5$E%1^+61+EB3B",*717FICU<5 N.2T=8]H:VUDGLBAWK"KJ:Q7:^HW^@U6S
M^X)%LI/Z9;7-#P>I-@A35FN"<R,X0<IZY+(F["*93.6@($ $,C#TZ%9HN6\;
M+($$C(U!O&E*T-[+S#&F.K7=,'J=9=([(5"AJR"F%;4P-CM9P"]"!6P*_,4W
M9E2U32):M8>R2JY^')V: NB..AU>A@LEAC^&Q5[' 3EQ*7QK^((Z+&H(->.F
M>9/13GQT<:IV*T,VB9TUI+'Y'!YDY4HO1>>Z$W'7=6W34L7+R-B?9T8QSL"/
M2B<1N5QI[5TZ;5::'RL+EA&;*8LU(8_0&/5F)0(F65X5<=;@X5KAGA0:179Q
MJRJ.B]J";!D!$,-#*1+KQ!--[_C*I>4HDSGJAH332D**D;LH[59I*NI4UE\!
M.HMFV6";@NUZ3,8=H8OO)8E%X4'D$><N<?U5V]*Z@F5&44M7\\1'-S^5Z[:3
MU)$4^P(L\8S;^U]UV[!^^G*>">&+G.$SF/9OV?6/_IS[)R.[[SR:]YY%B2"<
M-31YPT [5:_A0G")PB<(G")PB<(G")PB@JB/Y):W[=;2^^\>9.[WR0L6]]Y1
M7&I9>FFX,EV-)[6@)13B9F-[GT[9D&K9[$#O=@N-?JYB"VN\FC#6\T[5:Q8
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MJD2;0*_"H6-C&HJ'Y8C]7_!MJ8BW4D37!NI*=)-V"]Y7BV[P[;=IKC6%>/\
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MJI@168S,^S8 WQ20QBJK3-U:!4D]?AK5C@F27&/AJ]5QR0&ZYD<;EPT";F#
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M [#K;M!SX,2_#$2#'AS)>V!":Z-,0F7(<:8(:#&>QE0+^&+B07.<3%H7=38
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MIF925;Y'K4G<I&])Q:0./+!CI3%T-<9]HL,^D5%4>OG9MU/FK)=_]*F&/?\
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G'K-!HUQ574PP[7<K)()_+\Y53##KO+J0UU1AIXE!>"",<OC2O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g923794ex10_1pg038.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_1pg038.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@#*@)J P$1  (1 0,1 ?_$ (\  0 !! ,! 0
M       (!08'"0$"! ,* 0$                     $   !00! P($ P4&
M P4%!0D! @,$!0 1!@<((1(3,0E!42(487$5@9$R(Q:AL4)2)!?!,QC18G)#
M)>&"DB<9\++"8S0V"G-4-2931'41 0                    #_V@ , P$
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M4'O;17(LQ/\ 5YUJ)0UK6::_RM(H_C<^?*G#K\J"FOHGE I9.-V!I)NL)@.
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MH?1S1%X3T%,ZYL75<)%'YIF*-!<TSJC?CI$P0?*W(XAV)BB!E]4:CD6PE
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M0$"C<H#U !Z]0#Y]:#@J1"^@#^5QL-AN B%["(4'(ID,-Q*%^G6WR]+VM>U
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M[@H%@^0?N"@6#Y!^X*!8/D'[@H%@^0?N"@6#\ORZ?W4"P?C^\?\ MH%@_/\
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M H% H% H% H% H% H% H% H% H% H/DNF"J1TS!<#%$!ZB'P^8=:#SL&Z+=
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M]?3\:"0% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M:X?C0?05!+?N(( 'Q#N$/7_PA0<E/WE 0#UO:X&#J'S 0 0"]!\045$![DC
M'6]P ?01  "QQO?H-_@ _,!H/H)U.ANTI2W#N[QL8 Z=QN@]M@O\Z#R"],-O
M& '%1,QTRI@*P 7ZC%6.H40*"9RA8 _S=+T'*+P5+$$R0+&)YBID$5!,AW6*
M<H7*8W0Y>ZP6*(VN/K0<K/4T0*8]@[@,8O</8-DR]R@F*8P"3M /C\_E<:#L
M=T*92G,GT-;_ !]0ZC\@$! ;=.OQ_.@^WD,!.\X 'R  .-AO\P 3" A_W0MZ
M4'8QP*6X_3<M^ZPB4!'T_P HB/X>HT%%'((M(B:CF7AT$SK&:@HI(-2$.Z*5
M01;E.9<H X+X#W3ZF#M-_E&@]B<FU.)0!TS.)BD/9-RB8Q2*]G:H8H*&_EF$
MW0U[#TMZT'D5R.%;V%S-PB!1#KYI1FD);")A$>]8H6\07_/\*"FJY_A+=?[9
M?,L22<"!1!!3)(=)>QA$I3>%1Z4_:8P6"U[C04X^T-?D*83Y[@I"D3NJL?+<
M?*D@<W@\?EO)]P$/]TF ?/O+_F"X?8=E8$5^_B39Y@X2T:W3=OXH^4PA7[%J
MX(J=JY>M1?\ W+5NN5 XE.HF4I@*:P_2-!Y VQK43^(=AX""XF*4J)LQQP%;
M^7Q&)V%DS&[_ "!V@'^?H-J"G*[NU&EW=^UM8IF(4YU2J9_B90222$#.%E!/
M,%$$FJ9@,?TL!@]*#Y?[[Z9441(CN#5!_.H+=+_YAXD)U7)BKG201(28,*JJ
MB;94P%#ZK(G^0V#H7?&FU0."6W=5',0Z*0"786)G!0S@C$43 ",PJ=,%323?
MM P -ETQ]#E$0]9MTZD(58RFU]9D(@@=VJL?.<6*DW:%*L<':YAF0[6PD;*C
MWC8 !,PB-@&@Y'=NG.\I2[;U@8PJ+)@7^O<4[C*MQ.5=,H?J]^]$2CWA:Y>P
M0&@[MMQ:LD2E/';4UH\3!,BRAFN:8TY J)_&4BMTI@P%35.X3L(]+& /4P4'
MS#=>HE <'2VQK Q6XB!^W/,64[!%-V;^<8LN!41_T*XV'X(*=?I-8/2.X-6D
M1,HILO7UDP(50_\ 66.)E*NHJ#=- 0-*"8%%' ^,H>HJ?1_%TH*$/(72'F.@
M&Y-0BJC(GBW*'^Y^% NV?ID;K'9JI_K0F*\11=)F41&RI04((%$# -!42;OT
M^J8HH;7UBL0Q0,(HYYB:W:!DEERB(EF@[NY)N<P6 ;@ B'0IAH/N;<FKKJ"G
MLO71R 9)-,?ZWQD>Y514Z12#V2AA 3JI*$#I_$D;Y#8.O^\NJSG50)M'6H/$
MDTE#H?USC"ATB+G2(BHJB27\A4U?.GVB-@$5"V'KU#U-]L:V<D(9/8VOE@.F
MHL!T,RQU5/L22*Z5$!))CWD;M# J<P= 3$#>G6@^">X]6K/$8U#9FMU95P?Q
M(1I,YQH[Q5<XOA023;DDCN%3+$C'-@*03704L @0_:'*&X-7K@?Q[,UVJ<@B
M4Y29CCP@!B+@@?ZPDS  >54B87_QC^-!\AW3J4MC&VIKGQF*4Y/_ .[H+J0Y
M6QB#Y DS%N<KM,0_\84%*<\@M,-2F.?9^$G(F8Y53-)I&1 HD!P4Y1,Q\W:)
M5FIP'\"#\:#U([RU>L[28%S6$^]4:JO2-A%Z"JC9-XA'&.4#-2A=-Z[2(8+W
MNH7X#>@H3SDUHE@'^LVMA;?N451()Y%0;JI"V(8A@*B(D.0[M.X?]\/SH.ZO
M)72**8K*;(QPZ/D(D06X2;E43F%X4@"BW8*JCY#QZUK!;^68+C;J'I2Y#:B6
M1(X2S>+404.KV'.RG6YC^-ZBQ%-,BL5W*'!RX(F'IW',  %NM!\G')#2[%**
M5>Y]$H$FS."QIBLIQ4CHS5DG(+@0P1@"F"3-4JES@4!+Z=>E!\?^I33 ().A
MV'CYVRZJR*2Y$9H4U3MUI!NH1+MC% 44*K&+!8!Z^,UK@ "(?%3D]H]'Q^78
M45_-=E8)"G&9&IWNSKM6I4$P3B%!45%9\D%@M_&'6UQ ,?QG.WBS-12T[#[@
MA)6&;/TXQ:18P&;KMU'JJKM!))F=#&%@>E569G+WH^1,HD-]0]*"ZC<M-$)_
M<"?/2E!BJ1)X)L/STH%.H1,Q0*8<9'O$W?<G8!@.'H(6&P>=YS#X\QY1,]V%
M]L4!M<^'9^ ^G<:X!BINU0@ (B3J-O6U!9Z'N"\1W"YFZ6V3*JE  %-+7VTC
MF$US ($MA-CA<OPO0<&]P/BH*QVS?/\ (GC@G:!D6NHMQJF*8_\ #<XX&1&P
M_P#BM^-!49CG9Q:@7T2PFMK,H9S/.XMA$$E\3V#'D6=R\@VBV*#MTYQ)-I&G
M<R+Q)$GG.F J' !$*"729A.F!C!8;F_B  ]#" #8#& .@?.@^E H% H% H%
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M]0.N9V9NXS=N*YR*$.KX-A96F(F!0YC"8IB6O>PVZ4$I1(00[1*%A^'Y#?\
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M=RRXW:J;Z]V'%XOL'$=JIRL?'\A-XL@ES0^*RLD@D8$L[$ZQVZC0I[B<HW*
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M[:.CW4@\>MHZ/CD%GLE(O%TVK6/8M4S+.GCIRX[6S=HV;D,=510Q")I@)A$
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MS:Z<Q=!@FU39H/LR30!D  W4$N:9 #A8GJ%UG('-T&PWO09W[P +F^GZK=1
M/4;!\?B(_OH.]! C@XRQ5VRY%YA"1R(2$ORKW?#OY9VT8#-G""R)M&N(QQ)H
M)B]4B47[0ZC9N<]D^^_:%QN$]Z!0<" #Z@ _F #0<T"@4"@4"P!Z!:@Z%(0O
M\)2EZ6Z% .EQ&W0 Z=:#O0<6#IT]/3\.EO[J ( /J #^87H%@M:P6^5NG[J
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M']T\_P#7<7":PW3@XL^/FP =/=PZHRG5JL@*.3L3,T\?)DC=F,PW(0Z@*'3
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MDHN,<&2QQS&,)A5; G+@^6,HEC,R"D<1\\0*BH^;B5,!(8IA#;>!0L4/\H
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M8EH]Q$Y;@F6MD$'#_%<P@G)"NH>6:)N$U! X>-1)0BB9C$,4PAF 54RA<3
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MAX'M'!-EGDBX7E4)DBD*9%*14A72CI%N9WYQ:K=RB2(.FCQ- XH+$[TC&3,
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M\**GF%%9%03F:ATZA]76UKA09?):PVO_ !&O?YB-QM\P^5!WH% H% H% H%
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M:<G H '_ )/:(_Q&3+<Y0R;O4IWNE-SM4D!<.'&HMAI(L2E_FNC+8K+D1;@
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M(0+K'0=%_P"9;H4H= M<+W ,RD]!_P#$:UB]O2X_G>WS^-!WH% H% H% H%
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MP]; 4F)RPB-PZW *"]\%.53"L0.01$AL7Q\Q##?ZRFB&9@-U !Z@-!=5 H%
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M% Q3%-Z" @/J'3]@WH+.QHS[]1R(KU5BN(S3L6YF*ACF;MBD;BFW>@( )7
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MC,<9M896Q?HKF45!2!V#L6*D63EJ*92)%.$V@=$_?<]CA8+7H)@J"!2&,-K
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M!5,/I;[JQ,[@0 1[43Q&2HB/0+_Q+E_?09J$?IO\;"(>G3IZ];!TO0>$'1C
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M!M\_G0 &WU"("'S*)A"_Y7$ "@\SHPD3^DPE*?NNIY#!V_3<  "B*AA/Z!V
M(AZT&F/E/ [+BO=5]MO)Y_9Z<UJ[(<FY#,,&UB7#F4<;$YMKH,K><E'&<$74
M>S)Y=1,RJ350B?;W" 7Z6#9MR 0%]J#+$/(LF*J^/&*=-PLQ7)V9ACZJ0%70
M,59,I@)UL/U -AZ"-!F]/ML(%M8#&+T+V@ @-A#\1O\ 'XT'TH% H% H% H%
M H/CX2"%K" ?@(E'H-P$! 0$/E^73TH/M0*!08BWZ;QZ.W(J!0,<NJ]@"4IK
MB!P+BLJ;LL%^AA#\Z"[=>G!7 L)5*7L*KB&-*$3M8$RGA6(@F'QL6@O"@4"@
M4"@4"@4&"=V'%)_I'M4,F"N],4(IVF$ 5 V/9@()F^91,4!M\P"@S:Y01<MU
MVZZ::S==%5!9)5--9)1%5,R:B:B*I3)*IJ$,("4P"4P#80$*")9>'VI$3OV1
M'NS$\"D9DLVZU0;9F6%U@D]4,0H1;/$T9 Z$=C %N(PR(DB#]XB9"@R-D[5T
M7;.E :J@E$(QFRT';9'L(B= 8&+*Q2\"(%;IHLQ 2D H=+6H*?@3$2<A]_2!
MEU#@IC^G6R* G$44B$B,G.HH1/H4IE3VN(!UM07CN!VR8XB*SOL @Y!B"-A,
M9.ZK[+H-B@8QRM'MQ!98+!X[F'IWI_Q@'JVDZ)'ZNV:^,;QIL=?YD[[R6*=(
MK;&Y!<RA1/8A! HB(7O8?41H(J>UL\;R?MR\*))LZ!ZWDN-VJY(CKN3/YOO\
M88O!,)DOY0B4ZP@-OB%!/8O4I1^90_NH.:!0<" &"PA<!]0'_C0?#[9N-KH)
M#]1C]4RFL<YBF,8.X!L)C$ 1_$ H/N  'H !<1$;?,1$1'\>HT'- H% H.!
M!]0^7]@W#^V@X$A!]2@(=>@]0Z^O0>G6@YL%[VZVM^SY4'- H% H.! ! 0$
M$/D/I01CT.B5KL/DXD)" =7<3=T8_=W&.5UA..*I@8/\/8'0 _&@DY8+WL%_
MG;K^^@"4!$!$+B%[?MM?^Z@6"_=8+^E[!>WROZT"P?(/W!0<"0@A82E$/E8+
M4' )IAZ$*'Y  ?"W]U!&/4J1$N0/*\@E(4SG)=/R)NG4X_[1X_'@8P_$P&CP
M !^0!02?H%!YG;5N\05;.D4W#=PDJW715*4Z:J"Z9DEDE"FZ&353,)3!\0&@
MP!BW$KC#@^1_U?AV@-18OE/B@D#9# X%CL5,G1QATJ^QQ%219L47*B4$\7.J
MT*8P@@H<3$L(B-!(<   ]+?/TN/XC;U&@ZB0AA 1*41 W< B%[' + /Y@%!P
M5-,O\)"%^HQNA0#ZC^HC;XF^/SH/I0*!0*!0?,Z2:@@)R%,(=P )@ ; 8O::
MU_2Y>E!W  *   6    #Y 'H'[*#5GB2Z0>\IO-F!D/(K[=NBU!(7M!Q9+?>
MXB!;_$*0 MZ>@"-!M&7 #)'*)A*!OH,(#8P%,( :PC8"F[1Z#\/6@_+/C7-3
MF+E'NZ0.G#[E8K<>T^3&RM>I8.G%.2Y&IC&#R4ZQ+&+NL>OC$!'(.WK=(XY
M8DM+(MBG9E,%C"'ZDTA!4>TQ0,4+B!3AU3%,W:0>TP"("<HWN-AH-2?-0\NI
M[E/M'1[9-F$,;)N6T@^773 SE%VQT[$ S39G&_C%RDNJ0UO4M!L"W^\%AJ/*
M7!/J5([QE$2J)+.2'.IF./MA$4&Z+A42@F7H/98/C\1 ,YDZE&XA?N/?M&X
M/</[A"@[T"@4"@4"@4"@4"@4"@4&+]UNV\?IW:KYX4JC1GKC-W+E,Y 4(HBA
MC4FLJ50A@$#$%-,0$!Z#>@K.M'*;S76!O$[^-UAN,N4[E[!!->%9*D#L_P
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M[0H.U H% H% H% H% H% H%!C#=8B&G]JB"1EO\ Y;9R'C "B![XU(_0('$
M$#>E!4-57'6.O!,3QB.$XO<G0/&/Z*SN6Q?I#M].E!?] H% H% H% H,+;:E
M#Q[_ % 5-,R@26Y\=BU_X0\15,;RQ;R=1"Y>YL3TN/6@S30?-4X)IG.:P%(7
MO,(^G:7J81_(H4&#\H'_ .<NGS@#/M59[);_ .H;'6?(>.!BE2IQ[D+$8 8O
M5<AK^0 "PT'WQ--FIN_;3DB:?WK;'M<,G"I5!,H5)=I-ND$3)_X2F$!, _&U
M!Y>0I%QURH9%06YDLNUHH=P199(R*9-CXN=6WA4(?L.D ]UAL(=#W)<*"Y-P
M%45U+MA$+I@IK7/2%5 ;B4Y\=ERE$H&MZ$$I@^%!#_VD4G"'MG\)4G2YG#DG
M'W! 76,  8R@L!,<! HV 2"/;^R@V(D_@+_X2_W!0=J!0*!0*!0*!0*!0*!0
M*!0*!0=3E Y#%&]A 0^D1 ?V"'4!H([Z<?*2&QN1*ZJ2*3AMLF)AS D8?J9Q
MN%Q ,E#@(?\ ..FM<WSO02*H% H% H%!@O7DP5]MK?\ $_:F05@\@UVFHL8Q
M+OD7^MH-Z1T%@Z@14YD!^(BD/PM09TH% H% H% H% H% H% H%!K_P"3WM_Z
M&Y2YW%[2W/(9N<N*X,]Q!O'067FQ''6T(M,*3LE+R"[$C&0(]2L(G4%V"12
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M0 O1(!H)5(L&>/128MH]!A%P3$YV["*9($(W8,VW<9HTC6+9)(ABD(8$DD"
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M  H'7\ _>/\ V4''< =!'K^0_P#MH W$![!"_P"__CTH!AL4PAU$ $;7L B
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MBT.F=ZS6/N!^FU>3*8%*=L1XBDH5J(B/F\"H!;LH)\+?RT5#7OXR]X=QBD
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MB+'FY1TVD129)@D4020#M +@)KB(3*+PVVLX23_4N;/(%Z<2 )S)_H<<!CF
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MU'U&@X$I1&X@ C:UQ"_0!O;]]!S8/D'[@H%@^0?N"@YH% H% H.+!\@_<%
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M"@4"@4"@4"@4"@4"@Q+OI9PAI#<BS0IS.4=4;%60 A@*;SI8C+'1 !$0L85
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M,( #=''I!57H4! >A/C\+T%#T"]+(Z0U,_(J"Y'NOL4<E6*%BJ%5AFAP, ?
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M891!8HV$>@T%5CO<?U1)O6S(NEN83(7(%.1VZXM;3,P*!K_2L\9P[M)'\Q$
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MXX[9\#(')R=H* NJ<P_48U!F  M\1'\QO0<T'Q5,)2V 1[C#]/0!]+";U"P
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MESD=E(JGW+_<-M98)]NH@?\ PBB+DXV'H'=TZT&:>=1W2^/:XA&Q1.,YDCI
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M.5K(MB$N?^,*#88B6QEKWN*@VN(#8@  E  +T*4!O:_6@]% H% H% H% H%
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MJY<I7>2<@Y;MF\00A7,.W6;N_*D=<X&33*4BGU@:@G5(\F>5C0_C:< -B2A
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MR9Q&&4%DH11N!4E&QS*&[T@ +@!KA8?G07'0*!0:GN5L\9K[IGM08\1LZ/\
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M(ABWC8YDFX7,HY53;,6J:8&.<QA MQ$1$1H+A2(5$@)@(6+Z  %(4H? I2%
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MF"@F^6]NH6&X]+W^(VZ_E0=J!0*!0*!0*!0*!0*!0*#'VU5/!K38ZYC@1-+
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M5)9%4! P#TH*QE//N0U_C\OF.R.*O(C7N'0*; 96>R.$@5DFKN4?(QD<S%M
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MMZA](B4+AZ#\:#DB92=PE"W>;O-]1AN80*%^HC;H'H'2@^E H% H% H% H%
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M%),>Z'B59*X"J I@:Z%[B%J#X<:M<0['BW@6)K3,WD47GVM49F7D9=5HG*.
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MDDU@,HV*JV.#@? !@,&=\YW#LG/=<Z-D]7: W]R2Q3$T(Q7(H'(87"<%)O\
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M,0V>R9%O&8$ ;W 2E,-J"C\T41><3.1!$@ _DU)F1D2**>%$ZI(E95$QU#@
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MC'$O./V\;)RKAK'-; X7)&1;5Y(NC%$X"!4DCF[;B/0!$ TOYYRMTIRLY?\
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M:WTW&8ME3>?@(C)6<UKMV"^3:UR9F_R""=R&L,\;NA!^=-0RX=G:0!+:@]'
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MY/(X;'FJ;W)9R)@&)UF;1-[-/VD2T5?/#@DV9INWZC9N=R[54*5),#"H<W0
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M<:W<F<2IV"PW$!H*9C44).3NT9N[8!<:QU['F*"9_O/Y4E-+_6MW>,Z  I8
M +]U!=V]Q7#74G]J\!@N,OA@$=^!5P=M;-<?N8B2)#J7. ]MP#Z;WH+GSPR*
M.NL[NF51!'#,H.JEV'[36A7YED3)F$%;'ZCVB(#8UJ#0=[7/&KD]GOM\<1LJ
MQ7W =K:KQ>1UN)X[ ,>U1J&9CXA@ADLZW1B&T]DT"^R$S=%- "@(J < L%Q
MH4&TIGQBWZPC6397G#N5^NW!=1[(NL.UT9V^.H;O(4B"<*1-(B8F$"D .@6"
M@@UQN;>Y%M[<^ZL7VAF7(S1FE<12<#J;9>68AH,TKL5\UR)W%*=N+,XV7EV,
M<O"HD>(_<BW,?O\ X:"].>VH=T:]XB[MV8YY5;7S$V 8TWRU3#9O']?M\9S
MD$_QQ;](F6D= ,GB#1V\:G.((KIF Y_B 6H-MN,*$<P4'_+$B:L%$.#-^HD3
M\K)!8I2B<PF[2&,(6"_H%!<!&K=,+$;HD"XW[4R@ B(W$1 "]1->XC\1]:#[
ME*4M^T+7&X_G8 _N"@[4"@4"@4'S!%( ,'86Q@ #!;H8 ]+AZ4')$R)E I"@
M4H%*4"AZ 4H=I2@'R *#O0*!0*!0*!0*!0*!0?$R")R]@D "AW6 MR6[K@80
M[1+:X4'/A2N ^,O0P&#H'\0!8#?B8 ^(]:#ZT"@4"@4' @ ]1#^__A0<T'
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MDL)A$3=R::H]M_@-!3,)G95]ROW9".UB_I$/K34KB'0\1"'\DJMD:DDJJ<
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M0*#J?^$?V?WA0>=LF8@' RXK )C" #_@ 1OV^HWM>@]5 H% H% H% H% H%
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MR+#,JSC5JNP<BUC";,0GF.4X?CR#[+&>+2D7+1V0*$,O(Q[AXV%,@-U2%
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MU1"0\5EK')B%A0P'8/*S1F$93AJ^(I8U*N)'(,T6ER((O >()I()K 8.[M$
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M9H% H% H/*JV164(HJBDH=$;I'4224,41"XF2$P"*1[_ !H/06_:%P$!^0B
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M7BZ2B28B8O;0?F=Y ;.Y!\DMG[WP3;^ZH#7FK-<YGN*3R3=^P\:BGVT]/O\
M3$;G\=J?CYA;3(9%I/RS+93U-X=\]9MW!5UG*9/)W%+WAM^]D"4W#L;;$IMJ
M6EIO*-2ON-N+P"N5?T=B&LHEQM!I(8N=;%YW7&)Y9),83,L/Q<$FBRI6BBBP
M%.9RLDX$Z-!L8YI(H+\]?:<;G23%TGM'DR^0<'<+)>(C71#@SE,B"9#$7.X!
M0H!W"  (?C03;Y#/58G4^6/TD#.ETW&+=K8$!=IJ%5S+'T%C*-CG*D8GC4$0
M P@ =1H,ZI%(4HE3OV@8P=OP*-^I0 ; 4I1Z  =*"PMB:]CMD8S(8M,.G+6.
MD5&1UQ8@D50WV3]!\F ^4!N90Z %$;A8!Z=>M!>Z+?P-4&R9K W;D;D'U^E,
MA$RCUO<P%)\?C08EE-,0LQN;"=V.Y64+D."8CE6&Q,4@+8D.M&Y:O&KOUG?>
M@H].Y2-%IBGVJ%( B/2@S+0*!0*!0*!0*!0*"ES(_P#I<@%A$/L'XFM\@9K@
M(?F(C08/XH*)J\;=**)$.FF;7N/"1-0.U0A?M"V*<+C80H)"4"@4"@4"@4"@
MC!RSEBPNK(ITH4%"J;?T@R[1 U@_4=KXBT[A\0E,()^83?C\:"3IS=I3&Z?2
M CU&P= OU'K:@\_G.) ,"0E$0$0[S ) L V$QR=W: _,?A01^V+'F>[RX\RA
M;@,2AN,+!X['!_A\:CWE QP.)/(F%A H@-^M@H/4DFO_ -4(K_;&!$=!@DH[
M#L\9UB[$,9)#H(F$Y4A,;Y6&@N7=B:"FMYU)RT!Z@LY@454#)M5"@4^11A17
M,F\(HW4!N ]_:8!#Z>G7J 7I-)@.,2Y0 1\T%(] ["B)S12P 4@]P)D^@.@W
M OXT'Y[O; YZZDU_[<_&;6^<ZTY1[4D8?7L[ Y#(X#Q-WAL_!IL@YCE +-&.
M21V&O\>R-DDS5*U5%%== 3IG)<>V@SU&<U_;^824H#3@UR+Q=T\$'DC)#[:&
MU6(N3&2.FL'W3+6ZBIG(E5. B!0,7R&MU,(T$*]\<[>(F;.>4FO<Q8;:@9C>
MS7#L3+)Y)H7<T'G>O=?8G#P4Q@>.)ZWR/6JC9BPBYQ->1<,U>Q*2(L518H'[
M1 )F>Q6S99]Q$UWR 0S"1R5H]8;/T[AK0^$)8+'L\+P_?6R9<LD,.L[D9O[Z
M>FI%9P NUB&0;B1+P)F U!O'H/@HKXSI)@43"J)^H?X2D +F$/B "8/V4&(=
M(;GA=Z8M-Y? 8UG&,1D/GF;X$5OGN-/<6DY-W@D^[QN2G8N/?E(X<XW)2#%4
M6+NP$=(E\A+E, B&9:!0*!0!&W4:!0*!0*!0*!0< (#Z4'- H% H% H% H%
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M?W?(W,F;7*)9_.0NH\<5D2L\)SA=-HU>Y*[.U9*+A#?;A(ONT'"2!2 <[?\
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MJ"8N@Y/:<MKUE);B@9?&,U<S60N"P$\\PY_.1>.FEW2&/-IE]@*[O#W<HC%
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M(W$!&_QO\:#@" !NZYAM>US&,'7K>PC8!#J 6^ T'TH% H% H/.=NF<P&'O
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M<QZ$!#Q_WQ)O*W+K(Y)J11OXB&<&[2=G:F )]M!MTH% H/B+=(1,;M^HUKF
M3 ;Z?2QKW#]EJ#@K=(@W(3M"XF[ $0(!Q$H]P$ >T!N6@[ B0I@.!;G + 81
M'NMU]?@/\0T$%/;HV+%[=XK8IL.-B7<(QEL\W:U0C7ZA%'+-.$W+G4$9NJ8H
M"!NY6/-8/6PVH/R5;PXZ<M,IV9R(Q?9^G>1S;1,]G.6GG]11C)!'*-V36/GV
MLQT?LG3DG/,)+%<?U?A*OV2DHB]<I2BI'7^G 3*" AM.]B[07);&MCY1O#=&
MLLUQB*=Z0BM1.Y;<,I RVUT,UQ.7@7XPZ,J9LXR*>PI6,5.1F_;NDXU8C4J0
MI=Z " ;*N4TBI_\ 41]L/&OT\%R/EN6,N+XX"JJQ" UE!_\ +5,/TJ.P=% X
M@4# 6X"/6@F9R6;$'3>9'(F8RAAQCHF4YW!_#F6/+ 4G:[9]P"*=^WR$O\_@
M(9\1,!TRG  #O^JP#Z";ZAO\A^84'UH%!1)V>B,:BW$U.R;*)C&QVR:\A(N$
MVC-N=Z\08-"K.%?Y:0KNW*:1+]!4. ?&@IK/*XQWE#[$2.Q/.1<8REG[(J/T
M-FTBHX(V[G)1,F*@"W$!)T-80-U*-!=M H% H% H% H%!0,G6%OCTXL0P%51
MA995(1*!@*=./<J%$0M80 2>GQH,&\/I )7B[H>2*(&*^UEBSH#!Z&\T>F<1
M  Z!<1H)(T"@4"@4"@4"@B!S2<'::A@U4C&-_P#/;CPFX3$1_F).-T84@9,_
M^8@^0O3TZ!02^$ $! 0N @("'S ?4/VT'S.0@AU(4W<8G< ];_4'7K_E]?V4
M&$<S*V/M_2GW":7W($V<#(YBE,N"08PR(\%N:W\LY[D WP$O2@Z,"K?]14R8
M6YP11U%#(%>"J)@54/E*ZAD3ICT*H4"WOZB T%R[@<BRU_.O .D0&BL(Y'S+
M-VZ?:E/Q9A[EG*+A!,OTC_$F:_PL/6@K64+@GA^3.3'*44<9GS"(=J:27AC7
MAC^1183)))V*%C&L%@];=*#\2RO,OD7J;VV_;AU_@S_=NC(0V$YFM'[)U_R
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MF,HTG,K:8_!(93+,T/M&<GDS:,;H3LJQ:E312:M'\@511-(J28$*8 L%!=M
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M9$+RDY$L$7C_ "[A;G&/Q#(3BL^1V1A\DDDU0#N</W"J!6K=BS0+?N,J<!L
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MQ^I,E2-R(70(2QA$#7N ;NMP&5:Z\FW!1'R-U8(2"!&XGN?)HHJGTK-W2)0
M@C<0+<0^-^H!EA("]MRVL)C&"P"%NXPCZ" 6'K\@H/I0845D&'^\S=@#TQI5
MSKYPX/'JL&A&7Z>6=C$A=IR(1Y7RSHBJH 9N9[XRE$! MZ",6PLRQ7:B[^2R
M+2V5WU[-[HP%YD+W$6V7G@FD.S8H.'\?&M3IOW">Q&(D&-2;J=ZW\*QBEH,I
M:,S,TWL7+\)0QM[C,#KO#<!:XM$R$$6-<L(^9A4G[Q!=P/D,60*91%-5H4YB
M-_'ZW-8 EM0*!0*!0*!0*!04/(RB> G2%"YCPDH4O3H(F9+@ =WS'Y4$4?;Q
M:.&'![BVR=IBDY::;P]NNF/;]"B3 I#%^GZ>@A\*"95 H% H% H% H(P\N(8
MD]I-^P,N=J(;+T4^*J511N(GB]YZYD!*!TRJ&$RB;,2E^ B(7L'6@D]0=3_P
M&MZ]H_A\*#"F9-45MOZ;=**J%69ALM-NF!@(0WW6,Q_F->UQ%,I.@_ 1H+0Q
MYSV<LM@L!*F/=IC"'7E H^4WCR*7;B"A[]HEN:X=/G07;R'CG<QJ#.HECVB]
MDHINR9E,94A3.5)!J8HG.@\8+$(4@=1*J0?S#I09!D407Q6205[1!3''K=7Z
M?X0/%&(JF)A-VCZ_,?3U^-!JQ]J+.<1TQ[0/&?8.PW\9AV%X#IC+,KS&8;D<
M+1./PD/F.82$U*+)MDW#I1-N@!UEO&10W?W6 >E!@MU[Z>EV&6:RB95QJ.-Q
M/><'FF<:DRYQL#+'T9(:^Q'+LJQ=">S9Y':X>1N"2>5)P3-[&L'ZR:RZ,B0H
M")B'$ S+D^MX#G_AFUM@\<LLD-?--AY!DG'WDEB6PL.?1S+8<SHS)'$)'S,#
M+"HX>8MD.-OT!+%S[5M*,I.)53(9L82%43#)OM>\?9S2FB<>;Y9EL?DTS N=
MI:SQUEC*!TL1QG"<7WCL15NP1>OV*$]D&22,RJNZD7[P]UESB"::28  AL^H
M% H% H% H%!U-_A_\04&M?W3,RRC >.N,93BV>0^MS0N^M/362Y-.LHN09AA
M6/Y$6>RJ);M99A)(+2LS%QID&A$DONE%SE*B8IQ 0"(V82&R^6G$CVX=OAE3
M:&V9+LY#D(>5R7&6\VUF\H7T;F4(ZQU[!8]+X$#*-F&&<.#(&1=M7+4$$BJ"
M)P4$0P%H;/\ )>&7)-EJ"9W$QC,1GN5>YAR'"RXF_;[!Y&O\IUOCF40<5K[$
MRPN31Y(O$\DR11PX<GR)L=NT\9%5ESB(4&YS'.5.N=G+R&&8Y!YU'3[[$\@=
MM#3V*%CHU(S;%4YX&#YVC(/4V3Q2-DT%RHJ  B4X=>@T'AX!9E*Y_P .] 97
M,0T+CDE-82(.H+'2'1C&9V,W,1GG;E567[U'*; %U@"XBNJ<; '2@@S@G*B!
MTES4YZPLS([TVY)RF?:2=&P=I"8G#X)IS'@PQOA\.7"W4OL(%YM'+9HZKA^(
M-F2WF1.<$3$L80V2\?>2N(\BV^7GQ>%R&$<87(0;*4;3AH90JB620X3D,^CI
M" EYABY1<1Y@\A/("J"ER'*!@$*"1GC*'9W6OW!?U'N-W=Q1$P6,(@)?CTH-
M>WMR2LW,\=YE[D:(EE3;WY"LU4TDD1(1DALZ>1;@4C<P@5N9NDD(CW ?NM?U
M&@U7^[;L'DSB.59QA^K-QS^18GMR?T+A+KCR$'(IX^6.>8[GL=ENN_\ <!GB
MIVVL?]T)EW$/'4ZN[=(MF[10%#D*84SAA?VSF6T,>Y1\6<+REI+P,+ X-L!I
M(X,_U]@Z[;6&08\?=19'&4-VQ$6SFMG,7QYGS,I("().TE?B5)(!#>QS)E2H
M37$&&,0Q4YOEKJ]<%SH&.D1:'6?OT&QC$25,BNJJ7N*82@7^6-Q#I03PH% H
M% H% H% H% H% H% H%!B;<VG\6WMJ_.M09R>5_H[8V-R>)Y+^B2!XR6&*E4
M547!H]^4BA63OM/_ ,SL. VMVT&J'@MP6>QFF8S!LCVWD$CH3%)R0UYC^GV[
M!FW?2>'Z;V=EZ>)8IFF;(^$\OB:B[A1TX9,V#!5V=7M<N'"0=@@Y&>\=IC2A
MMN.L/:87L!'2:$;&9=C,EE[[%MCN<F%SF">01N/8*CC<PZE8O"&N--CR3I$#
M DF\( @!2!<,Q<'?<TQ+F/M?+]3QV#FAI&)U]![3QO+L?FW4_AV2XC(_I$/*
MIJ&FX/%LDAYR#RUTO'F178@BNFW!5$YBCU#OS&.S9>X3[34DLW*=TIF_+2!:
M.!N!DAEM &45( ]P!94C"]AN/T^E!/W;CA)MK^?653^Z1(:'*+<ETCG-^O1)
M"@4PJ$#Z%"W&]OE?YAD] P&13, " &(40 1N(7"]A'N/U#T'KZT'UOZ]!Z?A
MZ_E\Z# ;2%?FWO-32<4FA$M<#9M3S#AB[']1D'LIY#,VTDH^%JB5HBWNH0C8
M#"!O7H T&),RV;E^%D:0^ F9;8DII7<@PYIA>/:S3S-<>$SB)UTPQUHG$I2"
M<6H8Z"S]PY:I(()$*H<YE"W#-6H,QF<F3E(W)6;.,RC'@@T,CB6;MVJA&R4I
MC[.6631:O$C?8)BNX43*W377!,J0W/UM09NH% H% H% H% H*9+B QL@02F&
M\>]&X>G5LJ @/6U[#08.XGMTVG&W2K9)'[=-'7\"F1"P!XBE;]"V#H%J"0E
MH% H% H% H(M\NY9K!Z:%X_ XI+;7T,R3(GW#W+26[M?1R)#"4>XI1%;N$;6
M^%!*$3@4#"/0 O;\;7$:"QWNQ\(C9X,8D,QP]CD1A; 6!>Y5!M)L1>"/VB0P
M[I\E)>9R0IA('BL>WTB/6@QEGCPZN[] ))@<&[IOM\3&*!A WCQ2,\9C%Z"4
MX&,8 +U'I^5!2XEBX;\M,ODC(F!D[T;BK<BXF*/<NVS"0 R8$ PJ7 BH"(B
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MSY=V\CVSIP"3&+:'0 KKP,&JK@JYU#'*0H!M65[RM5C& 3*'3/\ 0/I]0#]
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M@H>H.'?+'(M0ZMR,FZ-/X:]G]6Z^>.\1D](;'*]Q!T^QB(?N(9Z#7?;4B\O
MN3BV57!)'R*)"(D)_" 4/:.F-W:DVOQ F]L[-U7F,/+\M-9XQ"-<%UAGV,S7
MZDY:R;U-W(2$OLS.8]-J=K&+D6*H@0#**%-Y2V[3!O, +  "(B(!:X_&WQ&W
M2XT'- H% H% H% H% H% H% H%!T+Z%_,?[C4$"_;?AD<7XHXW$HNSNRH[%W
M>J"JQ#BH4SO<></!24L/_D$6[0_[H!01EE?9STZMD6S<N@=R[KQB>V))[.>H
M3K21A5LAUG&[?"?/G.'ZEG$XJ.7Q/$YN1R-TY6:F(X\BBEQ, "-!(?@[[=FC
M."\?)M=7.\_R*;F(^(BY7*M@Y5+9#*NHV B(?'HYF9-XZ60[D6\&0Y5![S%%
M50$Q(D8$RA8/+]HG(>X1[4+5T<09-<TY<S2:140/Y)B-X_F3CS?<&"Z!44WJ
MXB ?QWM037WRL[1U-E'@*8792PAT?&D[6*9<F40IRMP"/)]V(*DZ?3_< T&N
MOGSKB$VEO'C*K$"_-NK!96#SF$P)M@^.S9MG8NWS6 ')HHF9FE8K-\&1PQDT
M6D%7# X-E""!79%2V* ;<Y JJ[-TBB(>59!8J  HJ@450 1(;[E$IU$>MNH!
M?XA0:R4L+4=X\8N.[FPEWMJ8Q53$\_5B\\<S3%#&6VPU4<X61RF0^R:04BS?
M/6[$@N8ML[,LB9L01^HQ0D2&WL,4F8' <>RB0D&AIJ?P>;>LB%.G'R\!%,TI
M**_6CG17359I/DS'=MP=HHJ ;R"02] J?']5B.0Y0V0Q<\=)(8[@;B3S-THJ
M^?Y^1[#.PCY!U,("I#2QXAFT(V%=LJI=3R )2A:@E90*!0*!0*!0*!04B>()
MX:7 O0QHF1*!K]0$6BP!8/3U&@C3P9CW43P_XZQKU=5RZ8ZKQ=NNX7OY5E$V
M8 8ZG<(F[A^-Z"5M H% H% H% H(I\SP[M!R@E()C!L_CN;M HF'^7R)U4?O
M[;"%B 6][=+4$K*#J<2@0PF_A !$W2_TAU'I^5!@3-FT8?<NCWKLRR3IF&UO
MM$>T!16,XQ6/^\.)KB(E(V+](!\1'Y4'V+'M_P#J32E2A=S_ +&K1W>'4 ;!
MGR+E(AC!\14O8!'X#04KED\".XZ[>E#1DM-DC\*D'98: 3CUYJ6604050C8U
M&6=,XDSI^H0$BF<*IID[^X3!:@B%!\\=A9ICSHL)P/Y4O6*I)7'TY*/)K&7C
MEW;5X^QN4*FY:9MXWJ$4]9*]YT!,4R:7T"81 HA ;@;R4WS[?_MRZBUUR1X.
M\@,?<Z.:9/CF89J^FM1XUB#I?(MQY/\ T](LU\DV$@]8Q4U_4C$J?W*:?8"X
M!80 *#8+JGW"<AW=A4+L+77#SD/EF'S#J<8M9W')'5LI$KO<<FWN-S:!'B>:
MMTUEF&01CELJ7L AP2\A!,00$0QC&;-Y-8KL_;^P,,X=;H?RNSLAA921EYB%
MU&X=?H..X^C XY@8R(;G;+(,L67:N'71J43*2)PZG :"5? KD]*<M](NMKR\
M''0$A'[3V5K5RSBTI!!L#O7,\MC<R@JC*)HO$7L9D31XR< />F=PU.=(QTC$
M,(3? 0'T$!_(;T'-!P @( (" @/H(#<!_(?C0<T''<7_ #%];>H>OR_.@Z]Y
M._L[B]P^A;AW#8+CT]>EZ#GO+U^HO3UZAT_/KTH'>7M$W<7M"XB:X=H 'J(F
M] M0!,4 N)@ /F(@ ?VT'(V$.OI04Y2+BU% 65CV*RI;654:MU52@2XELHH0
M3@"?=TL/2]!ZDDT"%L1%)$.H=@)D):W4.@ '3I>@^H^M_HZ>@CZA\^OPH-1_
MNW<LLDXQZ7U[CVLL.FMC;CWEN3$,,P#6V/,<B*[RQACT@QR_/V#ASCL>\4^U
M/B;9<RY3';BNB<R93">@U*>VAR6V+GO-'3>)YM,8ZWR"<1DY[((K$)XL@Y81
M\A@.U ;XOE[,<YG'<.Z:2D'8T8X8$70,T345.F82E,'ZVK_P7&PB80'T >@&
M&W]@4'S6'N+V@8;@HF ^,Q@,!@,4Q0^@0-81 .X!$ [1&_2@U]2.L-Q\5,?S
MS/=-YXIM/ 5,XG=K99IG-\<8)23/'9>6_5<[1UEE^*-6#\LI%-#KO6;%^T?B
M_51!OY4Q5!0 FS@V88_L+#\=SC$Y5.:Q7,(>*R+'99(QRE?1<LT2>,UQ(ND@
MN@J8B@ 9(Y2J)' 2&*4Q1"@MO;>?LM9X%E^;O&[B03QZ'4<1T.Q$3/,BFW2A
M6$#C++PIJB1[D<XZ19HCVF$%%+F^D!H(X,]![AVL\T]GW(393F#EM>9= [1:
M:3U5&0[7!HS(XU-4T7!9'E<HE)Y!F9L<,],DJ[:K1K9T<@G*@!1*%!5^8G(#
M(>/6(ZLR6#?80S_K/D#JK5,ZIG#T6#48;/IXL&^'%RJN&3>0RIL8Y5FC4RH?
M<&(8A>XP@40F7W% .TI@$2F* @!KB'U!?NZW]/6@^@F#UN%@ZCU] #U&@X Y
M#% P'*)36[3 (" W]+#Z#0=K@/H-Z!0*!0*!0*!0*!0*#@1 /40#J ?M'H ?
MF(T'R Y?I+W$[A$0 HF !$1*)@"W41'M&_Y4&H#A5J[DQ)Z(;2^'\IVN/XY/
M97LL8?%GVH\<R$<261V;EI)G]/G3NXM[+%=ROD,51RB)$BC8 ,%J"3+?1O,D
M2LBN>:R0_;KG5>*H:(PPRKI ;B5 J9WQ"$$OIW>M!]$M!<N2LB-#\Y9=5<YG
M*AGQ] :_(X %7 *H)E(#_P )"-D1\?4HB;U&@P_FO K=VP]DZBVKF'-W8#S,
M]%RF5R^LW$5J;7$.UC'F;XRKB>2C(-$!4)*H/X9;M BHV3[1MZC06;N7'N3F
MH)#!XG8_+V:V#K_/Y>3C)1HVU)@6)349^@_ID[%K!,)IRR;AL_7;?9N2"W*H
M)%^Y,P&"X!3^=&1:0QGEKQ0'-^)[;<FWLA*ZB=9[A6R^/Q9341SY3!-'[=F1
MU(LIB24DV;DZPIL4G"B_B!!0I2*W -O3E CANJV6LHD=!1!<JO\ +*HFK<AA
M[D^T"7M\+6 :#5SGFCV6NVYGF/;6FG.9PX87#K-XMM%84@93+,UGWZ.43Q83
M'W^/24@[BGKIF<%F"K<X%!RX$%1 Y0R5,RV,Q\LUQ#*XN3B\2R1?*$(9ZZ.R
MS-K+SJDGC[I&>.P>1J,@U;^947)TF]T?Y8E,7M-:@R)QUTW):QV%GTNV>X2Z
MP'(<-UE$8>$ M-#DKJ3QJ*D4<LF\E92":D9'-Y5RZ;_9HLW+@I2)G,;L$X@(
M3(H% H% H% H% H*7+D [!\ @-A8/2B>_0H&:K /J-J#"G%>.1B>.>F8U!9)
MPDRP&"03706*X25(1L%CIK)F,14H_,!$!H,_T"@4"@4"@4"@C1RL$YM0.6Y$
MB&!QLG1B9A5'Z2C_ +X8 J(C:_0/"%OQ$*"2P>G[1_O&@ZJV\9^X;!V&N-[?
M ?C01LV2Z$>0/&IH10O8Z0W<4R?<'8K]OAT5VF[/4QBF/ZA>P"/SH(HYEM#8
M&+^[%JK6D9)1R6M=C\.\LF\I82S*9>O!R3&]F),<6)B+N/0&)B7[Q-VH=V,@
M<J:J)  GU@%!+?E!*QL/Q^V=)2Z2RK!M!M6[E-$@"L*KB78->\MA*F D<N $
M1*-N@T%5XTG05TMAIV[1)BF!\D(=LW-_**X)EDX1TH7M$P?S7)3G'KZF&@JV
MZ]'ZIY#8)+ZKWAKK%MK:UG5XUW+87FL2C/8Y(NHIXB^CCO(U<UE#LGR":Q!$
M!* E]*" V6XU&Z,YK\$-,Z6&-U/IA3!.0*BFE\*7/C>$S*[9&#D7$JOB48",
M')N8!P<JJ2JA!5;'=',6PF&@]'M;0,IBV)\P8V6CLB92"O/SDW,E/D4?,Q@O
M8F;R9L\A5(M&<CXM1Q&@R.4$ET 59+%-=)<X ($# _%C1GNH<1\'S/3N!:\X
M-YC@SS=V^MH8UEF9;EW3"Y&YB]L[4R;8,7'3&.0>H9E@T>QS?( 14,D_5)_+
M"WS$)&DR+WC5"JF5U#[;9!*!A034WOR5$5>M@*)$]"K)%.:_J)K!Z7H-7?N?
M\P?<=U+IMMIK<&N^+&+3'(1W'XW@&1\>-O\ (V6SO'96"R_$'CZ5*FUTBNHE
M&I-7!@<"H+<BK4CA.YKB6@W.ZF<^X 7&<?;[%PWB-'NVC1-N\+C6R-Q3BCQL
MBV0(QD#.I36448L@Z#N,Y(<I@\EQ PWH+[>N>:B+UZ2'QCBZM% V9#&FD\YV
MHU>$>AY1D/NDF6N7*(MKB7Q"4_?Z]U!K[]P?E1SDXOZ;=9$AB^G6TOE\=ET#
MBLUJ9IEVPLMA\VC<;?S\3'QL/G,;B$ X>SC&/=)-5UU#I-UR^0Z"R93$,$;6
M7N-<GM>:OT9.QF78!N7$<KQ[4C+)]B[,Q#(,;SEQLS9^-+/WF-,VV.QN/X-)
M8]AF01[EM(/VQONTA[2IMU^TYP#==R$V%E&$XOBL9KQ_C:>T=B;!PS L"2RA
MH[E(@KB4E&[K+9!Q%QSIG(.T\>P=E)/#AY4@ 4B )BB8*"@SV,<R$\=FU(#;
MNBCY0$6X+CS68U-D[?'C3 D$&HRSUML!S(),/);O\2)SVH,=.([W(CK.4H^?
MX7MVO>(QYEHW<"RYTOH[CNFR:+=))2YC?24YP].OK08<T)N3W =W-\OD8M#B
M]",,+S";P600GF&RVSJ5E\=E'T=(3,8>,_4$ AWYVO<@53M6* CWA>@DPT@>
M<4N^;_K6<\;<+8-R*&66QS"\]SI])',)2E;F1G)K#48Q$H?4*A%%S&'IV@'6
M@MS/,EY%ZBD-83^9[*U/DN 36U,;PW9*B&MI#$7</CV6-W\1$.XZ36SN9(#D
MV8.8] 3'3L!5AZ!U$ L#G1O[>FE,@T!C^GIS6V/H;5R_-L=R29V- RV1ECU(
MN(AWN+H0C*,DHA0#/G2KE)PJH*Q4@.0;6"@J_*Z'USL;7&D#9G@>J\[VCF^6
M8=CNHVV>8T.5)X_-Y]&LS9Y.X[CJ$M%2JZ<+AB+QT[,W>-A(U2N94.@&"Q-<
M^W/!:/R0F=:(P[AOJG8<?'2C6#S+&.)XLIYBO+D< _.M-H[0+*+(/C/#^8/+
MWG*<X=W4:#)$9J+W R21'DMRUU4LR/Y 6BX[0*#5H7ON!#,P=9*Y>(>"_< *
M+*B80ZC\:#W,]*\W2V)*\R,5=H@EV@"7'K'2',Y+]PH!E 7R+Q*)6,0/4G\/
MK?U".;C@WSI<R3Z1'W,LI DD\,Y?(HZ5!LW37=F5+($CF*&S$X]BU72%,J:9
M43)MQ)W%#J:@M7$]3<NN.>U^-_&MAS!92>O<\@-OJ1;.(X]X/CAL:'"(5I-L
M$2J+3LHK)-U9":,LX*)RK'$##W  @%!G787$?ESM7$9/"<RYIQ$ECDN_A944
M@X\PL=+Q<A!2367C743-P><1+MJ9O),DE2&L)R"7^(?6@\+/A)R0CY+'):,Y
MO9LR>XQ.QDXF"V)3$LRG2Q9%$!B<G8S6PGS26B7@'$ZJ0@4YC6&_0*"E\@N%
MO+K?..0,&3G:7"E8'(T,K05'C7KS(&ZL]$+M'N.ST<BYR%!Q$N81ZDH=L/F,
M?M5$JEQ* T&>V^F^9+%HFDCS"QV2=@T@F?W4WQW@%B]C(4/UJ0!.-R^. DO,
MI)J 4YKH-S*7!$U@"@Z[#Q3E?AVOLIRJ&W_&93.8S!O9U""#34,W3G!BDP>N
M(Y,K:9<.2*.VB*A" F!SB<0L C063S#Y S&/<,G.^^/N<DB%98,$G<0R(D0P
MF_U&&EY5LJ\B3P\Z7P)N'S0ZC=<ABE6:G[@$ ,F( $S=53;S)=<Z^R637*\E
M<@P'#9F2?@DF@+UY*X^PD7+@B"0 FBDLX=',!2_241$ Z!09#H% H% H% H%
M H%!B+=[R;9:FV*YQMT[CLA+B\JV@Y!JN9J\93#XGV<6Z:N4RF!(S=TN10!$
M#"6P7"@A3Q0W?/X-P7A]K;JS20SG*8N1V?')2V0O?NLCS&:C,]R2!PW$F8E0
M!Y*S<JLQ09MDT4CG,'7M$ &@S_PMTI*Z!XWZTUY.+/%,D*&09AE3=\\+(&A\
MIV)DLMG>38\V<H(-4AC827R!9HW#L H%2+^%!+2@^9E"$"YC  7 +];=?2_K
M8/Q]* 10AQ$"&[NSUL V]3%Z#:PC<H^E!KN]PDZ+:$U/(+ENDSRF6 QA$  O
MW#6-3 1'J/KT_;08.]PU-@ZY#<8ECPN)9 E O6KS*6$MF Q$NWBI'8>&,H-^
M.*-LBBI3+(EO)E45(5HT?*HO4D1.3PBI0;?' E!!8JA@*F"0W4'M .H" W /
MC</E016?Q365GI&6QS:<8P0F(O'66/HN&V)3S7&)F)GGOZAD,,Z=& 5T\ACW
MJL:NFIW FH)#)"!P$#!CK($F>)S,RYD7>\W+:4R;8L)&3SR/Q#(4L)>R^/1L
MFRF<<R"417DHJ&*]*$="IE."0NUSI*IB)2B 7_IB-QYGO/<AXJ0RJ3ET\<U<
ME._K, HQ@FO?CJZ486 FS)-64V[%!D<S\&:8IME5@*H:X@ !+F@4"@4"@4"@
M4"@H\\41AY<W3I$R(!?U WVBP@(7Z=*"./",5!XC<>15L"G^UN,=]@$ N#(
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MJZ:\*BT\=N@#99<AA'T[0^=!.5JB5NV;MR%(0K=%)$I" ($("292 4@#U[
M.GX4'W$ , @(7 >@@/QH/*9O<RAB&\1CWN9,"")QL  903)B(B6WIZ6Z4')D
M5!*( 8##_#_,L8HE$ N8 [?I-</0.E!V33.0>HV*%P"PB(F#J!>_Z0$Q@* =
M;WH/10*!0*!0*!0*!043(?(,++)I@ BK%2A"_P#\3[%<2!ZAU$0&@C5P4;2;
M/AUQP:S*0HRK?4^*(OTA$!$CDC I5 N%P'J%!+"@4"@4"@4"@4$=>3IG(:L6
M4:J-@,VV'I910'( 8O@/N#"D5; -K*%!6Y?Q"U!(8YR)E,<YBD*4ICF,<P%*
M!2@(F,81&P%* 7$?@%!"U?F?"OT\TG,.U1M#-=<Z_77)D.?PD4P!.39,E54W
MN0X!B+J02R_8F*LS-53&D(UJ=NLDBHH@94I0$P5K)9N%S'=7$#,<;EF<MCTW
M!;EG8&08+ Y:2L5-8%!.V#UNJ3N R!VRQ37*(V$P!07LR; '*"0>^,2F=:-9
M(K'M8HK,LZ6**9#= 4["*E$U@^D3 %!4>1CY!EI?/G#Q)<6BD6Q:* B0BBPF
M>33%D'8D8Q.XQ16 0 1 HT%H<1)1F[T!ASU@0AFS^:V,\(JD4Y$136V7F!U'
M)O* '3#O-]0& !"_I05?=/)7"M-+Q< I'9#L'9>2N2LL2U)KM@?(,[G5U *)
M7B[!,R;;'<>0 W<O)R*C9FD0##WF$HEH+%UYK+;N;;1QG?>]GD+C$MAD5FD5
MKO3.%*MYN)Q!KG'Z6VE)K,LX.B1WE.4OX>#;)^%FFA'LC&5!(5P-WT&LK)_9
M4*.5;HSW5W,/8NGLRW+MS/-KRV:X[@6,R&8XI";&CI:-SK6F/*3$D;'$L1R!
MI(I&=*KL%'Q5VA5"+$4N-!.?@KI_37"[2Q=-0W)>$W =7*Y?,GN9Y7DV!QT]
M(.I2(@X?PO6L$](W<BV8X\C_ #U"BL<1$3&^%!,T-MZS(H9);8NOT3(H@X<=
M^:8Z7PH'.8B:G::1*<$C&+V]X@!!, @ C:@L/.>5O'#7#**?YAO'540VG<E@
M,0B#+9UC:AW>0Y/(I14*Q!)&14. .7BP 8X@!$R@)C" !07<?>>ETR>17;^J
MTBE#ZA4V%B92E,(B4"F.,L!?4!#\PH/F??6CR% Y]SZE*F(6 Q]BXB4HF^(
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M@T%]7?TOD1L0A&[K?V79$51M*Q"DEX$$471A:H& H4&QIA[Y/MLI0>//,QY
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MV @9GQ1X[H',)3&,73>OP*((=J8F,88$P"!$[=M_\/X4%?+Q6XM%33)_TTZ
M[41*8I4]-:_LWM8PW ,=$Q#EN C05!OQTX[M7 D3X_Z3062 B@ VU5@J10$!
MNF8BGZ$0XG.4/IL 6$@A\*#[M.._'9BFL5AH?2Z**R@*"5GK##"@NH % 3G
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MF(L;@!1$0$0Z (#0?8NM]>(=GBU[@_:!%#$!'%,?(I_$7M\)09!](=UQ_,*
M[USKY\W%N\U]A#U/R6!-UB^/N4>_U+=([%4@' .EQ#IZT'0FL=:)%)]OKS D
MNPI"@F3#\?2[2#W@F!2_IY3)E!01L'YVH/23 \%0*';A>&$#NN DQN#1*%S
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M&KPV,8]$.I*1F'47"Q;!S*RZR3B5D7#5D@BL]D5T4D$57CE4ACJ&(0I!,(V
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M(AF&*H1D9#RRZ;QR0!$SOPE2[@*8;!D_4''++,<P1.#VSN3.]B9R"[O[G/\
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MC-EC<A#K[&V9F&GIG,-5Y_QJPSCVEG.18[F".:Y0MK>,>(!EVX<+@W3[,(W
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M2L:J==-*1CWC!51LJ1%RFF\;J-C';*J)JIIN"%5$2&,4P 8 N A0:O4]-Y+
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MZW0NF7_^9Y%[Q6&U[]3'SP3=1_&@OEOQ7U2U*D5%]LTH(-2,TQ'=&TSF!NF
M 4@G/EAC&$+?Q"(F_&@JK?C9JQ A$SES)^0A@,4LGLS/I(+CZW^]R):]PZ#\
MPH*^ST9JAB<#I8E'K'+Z&?O)&0&_PO\ >/%@, WZ@/K07?%X)BD(*AX. AXD
M5@$%3Q[,K<50L)1 XIB6X6H+C9,&K!'PMD"(IW&Z:0""8"(B8>U.XE( B-^G
MQ&@]] H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H.IB%,("8 $0 P!?Y&"Q@_&X!0<$(5,.TH6"XFM
M<1ZB(B-K_"XT'>@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
*4"@4"@4"@4'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g923794ex10_1pg039.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_1pg039.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@#*@)O P$1  (1 0,1 ?_$ )(  0 !! ,! 0
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ME9LH"X%@?TH/;5RWGDN,MIX.Y?[5K2%/)@Z>$-DD#N<OMW=[:1U-A_"@Z_\
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MMM\/7T^% ()'6UP01Z^H/_50#?T %A:U_P#</A:@#N/K8?IZ_P"\4 A7P/\
M;;_<*!\__=_OH*B_QM?\OPH*75^ 'ZF_^R@K:_\ ,!?_ *?C0+#\!_8*!\U_
M\-K_ )WM_P!= _&UK]/^A^- '=\;?PO0+ ^H%!6@H;_"W\;T%!<^H%O[;_F*
M"MC^)_N_ZJ 4A5K_  -Q05-_AZ_G04Z_$V_3_P"(H'7X&_Z__ 4%/G_[O]]
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M-KY'QD#+PY#4/+EB'DLICM=EO%L-1-DS.+A2\7@9+J70H(DNMJ" 5$=HO02
MA9?&Y&)$G0)D>7#R$1F?!EQW4/19<*0CW8\J/(;*F7&)#1[T*!LI)!H/G3L.
M&5EOV(Y.$C,F$,BC%KDM(R"H'OKB_6"(5%_Z7ZEM39<MVA0MZT'JJ>;00%+L
M2+@=25?^'IUO^7^\4'+W6^GS#K?\;]/7IZB@Y@_'U']_Z6M0=2GVD7[EIZ6O
M:YM<@ D"_3KZ^E!4O-@I'>"5%(%NM^X@#J 1UH.16D!1) "0>XGT  N2;VZ"
M@KW)MW=P[0.XGX=MK@W_  ^-!U^\W\W7T25*M?H !<W].@_V4!#S:PHI4?E)
M"R4E(!%@3\P'3\_2@YAQ!]% ] >G464; W]#_NH.!<2DH!*OZBK)%E$W/3TM
MT2/6YH.7N(N % FW0#K?X] /R]*"GNI^%[A7;;M5U)[;=+?RCO%S\*#EWIN1
M?KW!-NOJ0.E!7N2!<J%K$W)'PZG^P4'6A]IS^18/3NOU[>WN*;WZ#J105+J
M+E5NIM<$7ZBP%QUO<4'$/LJ (<!"E=@/7^>QZ"_IT!H*EY";=QM<@"]SZ] +
M@'YB?AZT'$2622.\#XB]_F'K=/\ VNA^'I0=GNMWMWIO\1?T]/7IT)N.E!P3
M(:62$J)('<4@*)  ZDBW3J+?K04$EDWLOT[NO8O_  V[B.GH+B@YAYLDV420
MD+L$K_E)(!].H/\ \:"I<2+]?0@>A)"B>WTM^=!13S:2E)58J) ^51OV_P U
MK"_3\?2@HAY#@NDJM974H4+=IL;W']GXT')+J%@*2H6)L+W!)!(([2 JXM0
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MD5YP.+2@77V 'I067J_(GEWLNJXC.:9A(W(6/E/OQW,YDW-!U5<@QW@AR<Q
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MFW?>? SPG_RAJF&G9O,2M>\E=IRN6CP,>Q]1*D8_#,:^9F56E 5VL-@/+(L
M20"%V1O(#[^63BXG*8?P7\%I>-R,.'D Y(\G-JB/+BST)>;2XRK7E.1W6F'
MM23<W/;Z@T'RYWR!_P#<)PYDB/@/MX>!V9A-!!:G_P#J\V6*)2E!/N-_1RM4
MBNL+;)-RHD$#H>M!Y.%\CO\ W#4O+S(61^WMX$16H<=*W&XOEYFY,IAU\7BA
MYAO#./LMOH!(*T("@D]MZ#(67YI^_1$A17,/X1> V6R#K;1G17O*'>L<H%94
M'%(*]->:<0%6 _J&Y506C)YW_P#<+O.378O@/X"1(\::AF'CI7E5MLG(9.
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M@L7-_P"7^2'L8S%6WEXFH[5A=F1D8KI<A,9/#R&I45EEY/\ 3E.)*KD7(O\
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MEKE=R%)*52(FD&3BFD>W'@K3BG_;=2E#GM%;Z/B$)/;\309MH% H% H% H%
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M]Q<0UC\TU@\AA,\C+09SD!R<^ &E,S&HCR9,25C)#L9:DI?9<2M/=TH+ET[
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M-@T?5N8^'\]H/[[BM>C2)>6D1ITYQ^(DQF(JR$*4%*MT!H)^I-QZ6].A]1<
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MH(Q6:+:R[&92XXE)2M2ATH--?A%M/$WC7OW%V.YQ\4O!C7>?N/=[U_0MO?\
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M/Z,-B'D'Y'0'N2EAT]M^E!E]I*I.G,,IN3+T\!'NA39NYADI%T]J"E1)'<"
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M2Y+BESO2/BFUQ\:#,45/9&CHL!VL,ILGJD=K:19/_=%NE!W'T/6W0]?P_/\
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M?*^*7G,]A1&9)]2/<4;"@D;0*!0*!0*"/7.>(AY+,\'O2U)2K&<SZOD(@/\
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MR192$7UM]-WE%+0)E14I+BPI"D@7/HH4%\OK]G27>_JMO4W""$] XW@E%00
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MF[A*TUB%-9V*'A(N<D+<Q+K<!..FRY4'MC9@,_2R9 E1%AQH+*TVN109"H%
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MD*2E&H66IQ9CM(=+A/3M6[8#J4^E!(*@4"@4"@4"@4"@4"@4"@XK%TD7 O\
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M7BTM=[7NE[V_</=8GK03PH% H% H% H% H% H% H% H% H% H% H% H% H%
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M,RC!S6I$>9C@C(2H3C4MB8TQ,C/H$4E;3J$.MD]JP% B@S8ZA!;</:2;+/\
M3/:Y<I-^T]"%D?QH(-8[!Y5K[@V>R"(C+6(_]-."S*\B):RY*>F[GD=<CX9,
M+^5I44X=4DO=2H/I1_AH)U"]T_'Y3U_.Z?S-!RH% H% H% H% H% H% H% H
M% H% H% H% H% H/+RLZ+C84G(SI[&,@8]AZ=.G3'1'AQ(D5LNR)$MY:FT-1
MV6@5**E)2 +GI08NXXYUXDY<G['!XLY)U/D!_4G6(>QM:UDVLFC%2WQ[C+<F
M5&2J,/<0H'^FM?3X4&7V7$NMH6E06%"X4+];="1W $B_3T%!W4"@4'4Z+H(2
MOV^HNOTL.X!=C_A*DW /P)O0:ZO +RKY.\G7N=SO>)Q[.+XVY)DZGK69QNJY
M3569L5 >*X+K>3RV6.;=@H0D_7L?3,O=_1I-J#8U0*##_.4Z#CN*.1LGE9[F
M.Q4+2]A5-EM)D%R.T<:\5/-)B1<A)=="1VA*6'2KNL$DF@@+Q_\ =3\*L!Q[
MQ_B)&\<A_48W4=<Q"F6^!^;%+3(Q.%A09+13_I^@J]M^.H7  -KCI8T&4L']
MS/Q%SRTM0,_R*T75H:0J=P;R]$;475=J25.:8A(0>_J3:P-S071,\^_&^'D$
M0&LOR'D7'$O=JL9PYR;*@,+AN66AZ6-7;C(=<7_PP5"XH/*W/[@7CEBL'EF,
MMD>1\/*G8#,KQS61X8Y26F46\5,>)1])JTALMA+?4J4A/XJ Z@([?8@SZMG^
MUIXNYU:W7%Y/$[G*+LDN>^\ES?MF4ETM/)0]&[T%)]I8[FQ\IZB@O'[<$+WM
MK\JMGCO*?Q.P[MH#6-45%24JP&M93%S4H/6UGT]?SH-IM H% H% H% H% H%
M H%!Q4+BUK]1TO:XN+_W4$?>1\@B!S7X^M%7S9)_D>&$]IZ]NNP7K]P-OAZ=
M?2@D @_,L'U*B?\ [D6 _.@[*!0*!0*!0*#!_D3D48OAS>9BT!0^A@1BH@*[
MA(RL%HBWI8=_7X4&;6_^&W_X$_\ YHH.1%P1UZ_A01.YOSDB+S%XK8%,:*MC
M(<IY>2N0ZHB0VJ/QCR">Q@$]2D]#;X&@]6(/9\Q=@ZW3/\;-)#:5'T5C.3>1
MEK4/P)_=DWM^ H,A<XMQ5\6;JF:B"J+^RK]U.0:2[#43+AAM$AM:VVW&U.6^
M1711M0>CL[:G.--I;]HI6[HN;:9:NDH 7KD@=C=B4(9)("4BP2#0:J/_ &^B
M9#7VE_%:-)CJC/0X7(\1;1(-O9Y2W)*5#M)':H>E!)KSR\4=T\L,)Q=CM#V_
M5=0RG&/(L?;LF=NUZ3F!G,(J(N)/Q^MY*')BS=2V0MD_299@EZ*X I/I022\
M?>+3POPYI/&+N5G9A.IL9<#)Y2?)RF3DMY/9,KG4IFY26I<S)2HC62#3S[I+
MCZT%2NI-!=_(G(6H<8ZCE-UWC/Q]<US&M6?G.K>==<DNN_\ )P<?!BA4S)93
M(.?(U'92IUPFR1ZF@CCQ'LFR\C^1FP<@IXNY&U+0D<':MJF)VG>86.UY&<SC
M6[['GI$&-K"7)&6C+A8R<PL//*2D!?9VA?<:":E H% H% H% H% H% H% H%
M H% H% H% H% H% H,2<ZPCD^'.6,6%/(5E>,-]QR%L,N/.MJEZUD(X<:0TA
M;KCS1=[D(2"5K  H/SI?^W1X8WWA-CR/UO?,/L<9_,2,!F\=F]@>FJDYV$S,
M>9C3YT:7C(#D3*/LE)(6MUTH2 2 D4'Z@VA\@/7J2>M_B?@"3VC\J#MH%!U/
M$AM5KWM8=M[W)L+6ZCU]?A00I\UN2>2>)-(XMV_C:9F$Y=SG[B_6]FP^)P[&
M:>V?2MGGR</L>+6T_!FMX]J)%EIEIE$)+!CDA0)H/G\+?$./XDP^3L7C\OKN
M1@<@[G)VT)U[6WM><D.O>X1E=G+LZ:WDMKF(>[93[/LLK[ 0VDDT$XZ!0=*V
M&70I#K3;B' 4K0XD+2M) !"T$%*@;#UO0?)^T8KI;&X\6]+0HO3]/Z72@[!C
MH"?2%$Z#T$6./]C8H*IAQDBR8D8)/4A+#*03;UZ)M>@M;?(++^E;<DQV/<&J
M[$AEU;3*E,E>(F)!05)^4"]!J]^Q7!@X[[6?B<Q "D,KUO:7EE9*U/R7]XV5
MR0]WF_\ Q';G]#0>Q]K?8$Y-CR:P@ ;5J?+K.(<92V&TM*7#R$OH/\7<';D_
MC0;7Z!0*!0*!0*!0*!0*!0*#BKX?^(4$5^;GUQ^<_%+L;=6A_;>08ZUH0M3;
M0<T]LI+BD@A"5%%A?H302F2I)/0]5#N_*P/;_#K\*#LH% H% H% H([>5"%.
M\#<C!*%*]J#BW0 /_IYK&K*A;U"0+T$@8ZPIAI1/53;1/PZJ:0?X4'S/93&L
MRVL<[D8+.0DI[XT)R9';F/IO;N8C..!YU-P>J4D=*"+W)9B+\C> 1D/V^7[3
MNQKQD5QU"9L++JU_8DN92*U?N64X\N,N&W3W*"_HL+%N>168RMD*RL3A?58;
M:P\A:FL?(WC=UNW1?O[7'XU@JUB4D?"@^CR)"'.%>0T.0U9!M6!)7$2Z6"]V
MSH5F_="VU(4;W!N/Y:"]IC;3NESFI#?<R-4>2MAQ1+9:7A'$.-%?JH*2HI)N
M?2]!H_\ M->5_&>@>!O%^"9U;/Q<+@=MY2UZ.O"PI,_&I?C<C;$/9AKCP3WM
ME;_2Q-E W-!,G)_='X"Q>=R.NMZ?S=F)^,[42'L1Q5M,Z&I[T6PQ-_;VVGW&
MR>MB1^=!R5]RC0%O0F\7PGY!Y!.22XIA]?'N1@QFW4+^2*\N6A/T[TCU2DB@
MPKY!^7N-?VOA+?D\<.9#7-,R&T9C+:3R%G,?J+B-MG8A,'4\VQ"GQ7/WN?AW
M3)0E"$K3%6ZE[HH T&:O%7S^>\DN:MBX=F<5N:9+PF@1-Y8S3.U1]DC2HTN:
MF&F(Y]/!CM1P\5=[:N]14D=10;)@4H[>_P"52C8>IN>I(%K]+#XT')*T*-DJ
M!-@; ]0#>Q(]0#:@YT"@4"@4'5[[7_U$#X]386)('4V'4B@Y!QLJ[ M)5VE5
M@>O:#8G^!H.= H%!UJ=;0;*4$FQ/7\!:_P#MH*EQ"4]Q4 G\3T_VT'$OLI6&
MRX@+5>R;]387/I^ H.V@7!]#>@4%"0/4@?J;4#N3>U^OX4%"I(]5 =;=2!U]
M+?VT%/<1>W<+V[ORM<"]_3U- ]Q%[=POZ].OQM\/SH.'OL]![B;D$CYNM@DJ
M)/X62">OX4%4NMK'RJ!M?KUL;&Q*3:RA?XB@YE:0+D]/B0"0/QN1<"U!Q)0L
M*0"A?^%:>B@ 1U!3?KT^%!TLQHL=3BH\5AA3EO<4RPAI3A3<#O*$ K 'IZT'
M>5I!L38_+\#_ (B0GX?$T'($$7'44"_Z_P!A_P"J@H5=#8$G\+'U_LH/G>9;
M>["XV%H2L+"5MA9]Q'5)[7$*L1UZBQ_.@[@0/_NCTL%'XV(Z"P(H.=QU_+UZ
M'\+_ (?A0=:GFD=G<JWN**4?*KJH DCTZ=!0<O<1\5 ?'KT]/CUH 6@]0H'_
M '?K^'\:#E<$7'7]*"M!:F\ N:3N"6PI:UZML"4)0"I:E*Q,M(2@#J5$FPM\
M:#6U]EG&)Q/VT_&#&MK26H>N[&AD@((<:_SEL)!';Z6[_P!?QH+0^UY@-@U[
MDGSQ8RK;",;D.<=4RNM+0\'''\1/U%]SWI 3U0ZI\*Z'X"@V_P! H% H% H%
M H% H% H%!UO EIP)]2DV_Z?C08=W932>3N&E2&T/-+>W5ICO2%%F:K!Q"Q)
M02#9:4I4!\>IH,P-W[E"]P@V!M8@6 [#_$7H.Z@4"@4"@4"@PMY#!ISAO?([
MP4I$G$M1T!""ZI3[N1AI91V $_.Y87]!09+S$F?C=<RLS&Q/K,I"PLR1CX2@
M?^:FQH"W(T903U_K2&PFPZ]:#59POH\KE77FIV]\78O<^-.7,+_F'DSGD\I3
M(&_:[R0W-R\O,X"'ADRHLW3]?XPS6.3B$?3.L$*82XMMQ)<-!C(<E\YY'E#P
MSDXWCG!\A9)V=R%&U;=\UR)&Q<[:]0Q.'WS&8_)Y=L0$M_NTJ)$:?4I/<'TV
M6+]UJ#,K6_>;+?E/MJL;XV\5B2CQZT!*1-YE0AB6D<E<HK81#=9Q"W&UQ4J)
MD=[=B74=JK"@]KFO>?,^;PYR+'WW@OB34M;<UU_]TS6'Y6D['D($=,AA:7HV
M*=P,5$Y[W $I05BY-!/E^6]#X^FY!U O#TV3+6RA14 &==+X)"NBW5]MNW^4
M"@U#?8-G<J9?[>7&BM^U34\1JCV9WW+<;YC$9!,_(;%ALCR+M4I^3G\<MI/[
M9D6Y)*>ERH 'X4&U;F7GSB7QZU)_<^6=OQFGX-$N/ BN2U R<IE9BPW#Q&(B
MMI#F0RTMP]K;* 5*/Y4%X:#O6N\HZ9@-\U-]Z;K>RPW)V+?F0U1)'8W)?B*]
M^)(!=9>9D1UH4D^A301O\EN*]@R6>XSYIT_1,+R9L'$+^=9RG&F68Q*_\[Z=
MML2+!V=C .91AV%'V_&L0VY>/+A2EYQE3!-G:#W."N9N%.1]BR>O:+J$W0>0
M<+K>,S6X:EG..5:7LF$Q<Z;+QD*!DW58^,RZ6IT%U*$-.N)4D!:190H*>;7-
MNV>.GC/R'S'HN&P^P;7J3VEL8?$9U;S6)F.[1OFL:@_]8Y'(=0B-$S[CR;'J
MIL#XT$D\&Y)DP,?.F!GZN9C,>_(^F"DQ@^[&;=>#(6._L]Q9[;]>WUH/: M\
M2?UH*T"@4'%:4N(4A0NE22DB]K@BQ%_A08BY0A\O/0=01Q#)U"),&_:V[N[F
MZ,S)#+W'"77SMD7#-0P5-['):2TF(M?]-%C>@RHRV0KN4T1>Z@HD7!6$@I(Z
MFX2 #\.G2@^N@4"@PKR!MVQX[<]!U;6DM-*V#*/2,K-DXZ;+@(QF'"7YT1Z>
MPV8V.DR6G+("S=9/2@NK88FS2\SKO^7\C$Q\!G*(F[4W(BJER,I@XD=\MXZ$
M2L(AN29+B4]_\UDWH/%V77N39VX<>936MQQF!TO#3,Z]R-K$O")R,_<X<O'!
MG 0\;E"X@X1S%S0E;KH!+H!%NM!E1(6IL>XFR_B+@W^'6W2]J!V$BWI^=_3_
M &^M "5H_EZW];GTM^H_.@^9Y$YQ;):>2PVA?<Z"A+A=2/1(O8IO0>7&B[ '
M9*I&18<8<D+<CI0R$+:CD?(RHCHI23ZF@[9<'+O!P,9!J/:,^B.HQTOEN6XV
M4LREA=NX,J-^WXT&/&]'WY[.ZCE9_)$Q&,P>&F1-@UV%B8GT6V9I]]MV/F9$
MEQ8D01$0E02T@6-^OI07/KF!V+%N; <SLLG/,Y+8$Y##-NQ6H:M?PIQ>-@'"
ML+;-Y8,V(](]Q8"KR+#^44%-:CYV/$R3&P2I$^8<UDEQI"V(\5Q6'>R*WL;'
M;#14EUJ)"6&>Y7SN%'_>H(.^+O+F][9Y*>6.F[7OBMCU?C[+1X^ QKS;$;'Z
M<YC<OG,1DXQ? 0H>^W 2XX%'L:MZT$,_*CF3R7U74N3_ "JXWYHFY?BO)>0&
M@\6\0\;XB&$8M&J_O6O:3M6VLY"*P\YF1*S4;*3(Z5$,O,J![K 4&R[R"W+<
M,+K.A:#QKL*\?RMROLN!P&)RC42/,R&'UY$42MHW-[%N*+8CXF(V"XHW2%K
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M(0%W(+3E_P +V-!?_P F1T]20MUSZ_5>PJCI44O?5X0A19<"4A]5C=/;U!Z
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MEX?5_$_CWC?.;CR7KV79E;WJ.);<>XCXXUS6W\IG-OR@7*;5BLL8RVX&+]Q
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M/;ME]GX-F\S;-H^&CPI@:CZ6K4,=L*OV2=%A8/"6B[*ZMJZ'WIUQ%N7%]P"
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MKY<\N<D<6<M>#>L:-G(N+U_F+R:;XZY'A/8MJ:]FM0D:'MVPJA1);A[L8_\
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M/4-@OCQX7<=>0&-WW)Y':_N!\5Q=8VM>KP'\_P"2F\QCM8C0XTB=D,0QE<-
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MW#S%WF7J.UXG(8[RA\)=TQ^ >R.O9#+N9/%<?X")C8$>3B\K.Q2$2(0)[7)
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M\XMP^X[MK_'^8GZKL9.1PVSQ<O@8,G(:^\C+XB;BY4I_&30%Q?>*TH-Q:RE
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MH:63[?O+1V?X30;G?&S;-\W_ ((XAW7E'7Y6J<B['H&LY3>-9GQ$PY>#VY^
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MKP\;HD;"_P"</'S3,1@!KV9_8&L!"S;C./Q_[/(S<28W%2JX<B.N$&ZZ#?\
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MH^(GC\KL22H=R^+M94NRCUZ.=U!/2@4"@4'2EA"7%.B_<JU^O3H !T_A0=U
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M$_4HV6XR8Y2V78^>^-L-QMC),O:L>-;WU>2#N$VGW-.RN&G28F.<9(?:D/\
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M30]?>3F7&)(^E5FL>\I<3(N12J,N8T2@)!(H)Y4'6XTV\GL<0%I!O90NF]B
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MX3WWR$SN+R.*Q\;C+C14)&VY89B6F"J7$_<'&XIC8XN)6_<W#=R/2@C1X?\
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M9YESYFWFGFBVZTHF_<E:%$'\J"'F)\=N3--AMZWH?*&LPM>Q+N68TC+;/QI
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M0W4+$A5[CI\.GZT'-E"FT)2I7<H) *K6[K=!TNH]!8>M!VT"@4"@ZW4%QM2
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MG&N_3.#99;P7)F!'<\M".X@B@W_4'R2W/:94XIX,)202X4]WKT2CL]5*4L@
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MNQ(0YEH#9!5\.X&WYT&7,E-_;,'/R(9?E)Q^'DS1&93W//\ TL5;X::1\7G
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M5QV88:DMY-(<UB%BF<EBX(QK.!E+4%K*U*<:0 ;F@V$-E01\W4B]CU'<!Z$
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MS%6UH_M-_1P?><<QC3S?4I4AOW574 0;T$G0;_ C]:"M H% H% H% H% H%
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MM6C;1IO*.8R&*TCDF'LKS^HK=QC_ +"W=\F8S"9.7QB)G:HPSF&F!+[;-FY
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M;&T3187^;=BA/16)<N#D9&?:^L+SJ>\#VE+(%^M!L[TO[>T[2-5U+3-?\O\
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M:T;DK;%:EC\ER!I#^,B)P<MG4M >=T;3X6";083</&)99LWW*;0JXH-GB?\
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MB</Y,/:QBCE>0>)H^QKPD%W+MIXQV!R!'RKD9#DEI##>_I46F9"E)L% D)N
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MWWD3C3RDP$'*Y3;L3G=C$OA+0VE[3ELBB/A%3<SF9[.8ENS68[# ;6I*@6V
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M*M5<FXS*Q9IB[ W%*7G<;(:94E:$GYKB@_.V?L;^5T;:N+6V]+\7]DBX+?\
M2N1^1^7-VQK.6Y4>5@X4R%-T?0IS,1IG%:_KTZ4B9AW'$&0VEHI4LJ[:#]@Z
M%A:>Y)OW *!L0""D6(OUL:#L]?[Q_N-!UK "20>WTN;G^6X[O_W;T$*O#S%,
MXG8?+M*)+<A^?Y9<E922&R/Z"I\7"R&6%B_1QN,I -_UH)LT"@H+_'_I_>:"
MM H% H!]#_T_ZZ#@%I[NT+NK\.A_#\!0<KW_ .G7^R@I>YM^5S^(OZ#IZ&@U
M^<.8U$#SK\I\G<#]_P!6X]CA)0NZEXG&-J</N$]A 2^.E!L";(+:"/0I!'4'
MH>OJ*#DHV!/7H">@N>@^ ^)H-'7B]]N'EO@K[COD7Y;YW;N)<OQARUN>_;/J
MV,Q&O+8Y2PD3;3$!Q&<SX8"LI$^I82X4E1]KM ZV%!)GQ8.KH\V_N##$:SDL
M?LR]IXAD;CM3^9RV7QFRO'1T1<)$PL6:XO'85K"82,RU+CPP$B45E?\ 4*A0
M;)7T!YM3*@?ZJ'&^G3^9M:2"KX=%=#^-!JI^UKGV\CK_ #/K3S"6<MIF>T_%
MY-P("7752H&>G0EN]+DIC+%K_"@VN@ 7M\:"M H% H% H% H% H% H*%(((M
MT/X=*##&YQ(<KEWAA<EA2G(+'(<N$X24I9D'"XUI?=8]5+:</0_A09D0D)[K
M7O<="2>ENGXT',^A_0_[*#BA14+G\2/[*#G0*!0*!01S\KH*)? ')%K=S&/Q
M\T] ;F%F<:]:WXA*302$0Z@,(7_*GV4J_)">P&Y/H$I!ZF@@ZYYAO3=GR^)T
M7B+=N1]5PK>24_M<#8=0Q.4SXPN4GP-B<TC0,I-:VK;86"=Q[S9D,-(:?4PM
M+941<A]NV9B#O_(?B/RCJDUZ7K6P;7E S)?"XLIR/D>/-Y?3 F8AWL5"FPWX
MZDR>[^JT\V6R/6@S>PF /('...&(F0GA[4&D.+D,)DAL[KO*W&FT*7[I:[P"
ML@6!M\;4%I^7.9:QOCCRM/:D-!4+ 0Y*?;D)+EFLYBBI2>U1(";VH/#\*<:O
M$^.6B-!"F4.NYV<VP%^[=K(9B9*;2B_PL[<?A07-R9Y'Z7H6P,\?XA4OD/F#
M+07Y6 XHTM2,CL<M# /=)S,M"5XO4<8AP?/*GK:2$7*4J-!96I\;\S;WM^J\
MI\\Y?#X27I\^;EM#X=T%YQW"ZY)FX]>.7-W+;) ^KVO-MQUDEII+<)I:CV ^
MM!!IO[-O%<+ESFCG[%^0?,^N<J<J<F/\E0=^Q2M<@YWB=B7C),+-:;H>2<@N
M1L5J.9B3'1,;?;<6Z5*^<7H,Q>'?%?BEX,:_N6L:]Y50=^>W78XL[*9?DCDC
M4LGF69F";R4/Z!N5CG&4.OM/Y-\.%8]SHE'HV*"9CGD[X\Q_><G<\<0XUJ.^
MEB4<KR%J^(2R\MOO:9;.3R,4O*<3\WRWZ=?2@Q9RI]PGPGX>TS+[_NOE)P?#
MUK7G,6,L[C.2=2SV41^[Y>#A88CXC$9:7D)0,_(M!SL;5[;7<M5DH) >HQYV
M>&TF/+G1/*;@V7"B!MZ4_"Y&UN:F.@LH=]IP1ICA1_36%#_%UZB]!<$?S(\4
M9*&U-^2?":$OH:>9#_)6JQ9"FGVPZTLQI>09>0TXVH*[R+"]J#RI7G+X<P5O
M&5Y3\"(2R2VXE/*&HN]CJ?YAW,Y18)%OA>@A3YS><OA?NGB]S+I^)\G.#-@R
MV6P,*.UA(^[X^>[);5EX!D-NQ\8Y(DK92QW*-@/E2;F@EI@?-7P^UO2]9"_(
M7BB%B\9K.":1]/L;#D6+#;Q,9N/VH;"W&6$LL_(%@$ =>O2@\G_\8_X$B-.F
MK\MN#?IH&05C9LI>ZXQ"(.0$8S!$>*EA*)*(S:G%!77M'6@Q=O'W?/ML<=XW
M7,UF?,+AV7!V;>-<XZQZM?V6-L$AC/;;+DL8N3DXL$O2L?AD/17ERIRT^RR@
M7)'2X0IT?[C?@Q$^YASCO3GE3PO&T#(>,W'..8VMS=8O[%D-@QFWYMF? C2B
MRF+^X0V%H]Q <)4D=P]:"?0^[-]M1U=D^:_C\OVU$@*W:"H]PZ#VU*3\R@?^
MS<T'GO\ W<OMEL+(D>:W!"R5>UV)V<O**E$60E#$996H]>H!H,#>0?W9OMP[
M3Q-OVH:KYG<,N;3EL.S!PL%R7FGDN2C*CEI!:&'/NM]"I?;Z =:"[^._O&?;
M'Q&DZ?A,[YM\'1\[#PF/QF2CJS.3CEO)PXP9EM>T]B6U,A+K:NT* ^6WJ+&@
MN9?WJ_M3(2M:O.O@KM2I3*U)S\]82XW<+"2WC#\P(_/TH+$VK[[GVJ]/RFA8
MQ_S'X[V%/(&Q*U^'D=6;S.:Q>O$P9LX97:IL;%K:P>$1],& ^YZO.)!'K8+T
M>^]9]JIMKW%><'#JA_.E;<C89'\G2Z4,8!9)H/-3][S[39"%#S7XG4AY96U:
M%NI[E"_<5$:K8&YZ7M01O\N?NX_;1Y"X6FZ[IWE5HFRSG=DUF<[CL+KV^928
M84&;[CD@,-:NA7:RI*;K)Z#I020Q7WIOM=8W%X&%D?,#0<2^YB\;'8&5PV]X
MY+[K<9IHLH7+U1#1?2H6*.XD'\:#[)7WL_M4QG7V7O,SC14B.HH=9;QN]//A
M:2/E"&]37W?E:X/PH/+'WOOM;NN%,7RCP62>#C;?; TSDF2XI1[G4*2&]022
M $W)_*@\S*_>\^W[A.1,5I,WE3.L8'*:O,V27RFYQ_NZ>/<#*B3H<2'K.7FJ
MP F0\SEV91<83[780CJ1>@R%,^\/]MZ!)E1)7E#KS;L!F1*EJ_RQO_MH;AML
M+?274ZG[94/JD_*/4FWPH+3?^^!]L!$>0ZUY5X!X-'VE"-I7(DEUIQ2NP7;3
MJ-U*0?4&@PCXD_=+\,QD/(N7DN3,7CQLODCO&<UB1C-$WQK);3J62_;8^$VG
M*I>P/MK^N<;4PTM(2 TT@$7H),[9]X;[=^@S$1-V\B(>KO.JD-M-9;3=\;2X
M[%<]N0TA;&L2$*>;41<7OUO06?-^]S]MAZ%*.!\F\%/R*H$UW'M)TGD9QE<Q
M##@AID.)U9M+3*I02%7]0?AZT&DYS[\'+\28LKY9Q$G68>;;9&</ .^AW;MG
MRF7<9QVM:ZW'P95#X_Q&(3WY#*NI]SWD@-_S&@V]:K]]CP-R>9V76=DWG=<-
MD-0Q6L27M@8XDY,D:EN\S+8Q+^:=T.4SK4B7-@X/+-N1W ^E#AZ$ BYH+W5]
MZSP)3*1#:W3E>;(+#<L?1\#\MOH<B/(#S<A"DZF$%I3:QU'7IZ7H/$R'WT_M
MX8AUI&6WOEC&(=LVAZ9X_<QLQN[N";J?_P GJ2FQ];_ T'SR/OQ_;:8-F^5.
M0IO46$'@?F.9WDGH$*;TRQ)H/.D??D^WLOW6(FS<[3Y#:?=#>-\9^:Y3RT)(
M*TM(&G)2X2@^E_3K007Y+^\QNN3Y+RJN%9',$O4I^WL86!%E>+7(SN#P7%;V
M-@S9.VMRI>*CY"=OT5Y;J!'6 WWW!':D4$D?&S[UG$\[C5+O.."\E9&Y?YHV
MR# DXGQ9Y3"'-8@Y14?6WLF86#<AKS$F(GW'%(LD]UK=+T&3].^^/XPYIK9#
MMW$_EUHCN"ST[&Q6\UXQ\H/_ +SA6 DX_/L.8_$RT-M9!!*O:-E(M8WOT#R_
M%/SY\=.<?,'DR'K,/F[!9WD5&$C\:Y#?N&=ST75MI@,X&'$S<6)E,_"BH3DL
M5E64!06$DMJN!ZV#=NT%!MOO[>X(2%!/\H5;Y@G\@>@_*@[:#I*4-CN#8'9<
MI* +B_\ -^E[=:#\@'./D#S)P-]Q'SSU[B+*<P+W[D#G[Q4@Q]/XK:U=;.Q:
MQF]5>1DW(1VE2Q&E.8%UEI;D4) RC<A3A))H-NGV>_*/DKR9XVYNSG)>7W[(
M2M Y"B:@EKD1_!S,[#R$+#%_86FW\!'8A-1FL@"@,W64%/\ -UH+P^VOB8>-
MWWRZ>QTLR\=DMGXCEQ'G+&04G3<LASWS\3[@('Y"@VPT"@4"@4"@4"@4"@4"
M@4'%7H.MNHH,%<@.26^9."4-*66'U\BHDMD_*L)U^ MM;B;=2VOTH,Z( !4;
MW5?K^(Z#Y3^E!SH.B.X'$K4  /<6!8W]+>O0=:#OH% H% H,(^1,B)$X6Y$>
MFM^_'5A$L.,C_&9$Z&PR%$]+)6L$_E094R&,;RF!F8=YQUAO)8E_&./1UEM]
ME,N&N*IQEU-E(<;2Y=*AU!%Z#29@>5X_%V3RF:F<&Y/DG*>*#$C0\5M7''%V
M<V7(;I-P>,S\'%9)7-4!2=6P.-QV)V-*,_%FJ_Y=Y,IUSN64T'H?Z':J]R'X
M4?O6:SV<R?)&X;5R+G]EX\Y)R[6ANY?.Z;R/GV86N0(KBHCF*ALS1',AGL3(
M[.[M"E&@\+F/C+A;7ON<^/W"&7X^W_9(G.OB]N<1O>&N3MRQJ=(G<>;ME<^E
M$MN/D$M3YFYMYEQI?<0XCZ!'8+=]!(GR)\-N#^,N!>6]TTS!;D=EQ6DRD8Q_
M*[]N6981]3DL9[RAC\KEWX+ILU\Q<;5VH%P 3<!!CQK\YMGU+.:!QES3Y <.
M<7<:;OO7).D\6Q<7.AN;WC<=JG<G'XK<$3$J,'9)RW265=OME(OZB@V>^$.K
M\&\-\&X,:UF]8A3-DS&T9O-;;E]O@Y[:=WE939,G+;RV<VC)R%93(_4)<"FF
M"OV8Z;(;2E(M03 <Y+XY946G=\TUMV]E(<V3$(7W'T%E2P;]:#7]E,WI7E)R
M=R7C^6.3L+K7C[QCLYT+6N-\5R%#UUWEG9H&+AY39MOW2?B<C%RS^FMQLPB#
M!QZ'&PZZTZ\M?RI2H,JZKXU> FE8+#M:OQ=X^XW66&1'Q<E;6"FQR6'2^"U.
MR3\M4J2)"RI;KCBG5$DJ4>M!JLT[Q?\ '7GCS:XZQ'(_#7''(NI1\%Y+.9/#
M;'KF(FX1.7PNR:UC=3?B06^YF0]CM66VEET]R#$D(6!W&]!M/@_;,^WOBG&G
M(/A=XX-N-'O"E\4:K)(!3V'M,C&O!;A!^-^E!D_7?#KQ*U**['UCQBX'P\-X
MI<7&QO$VDQTOJ18A3B1ARE=@?\7K0>5GO!GPWV[*_ONS>+?!F5S"XZ8ZI\KC
M35P^8P0$ICJ",<E/M)!MV=4B@IC_  2\+<5V#'^*'C[&]E(#0;XETD! !)%N
M[#K!/7UZF@O;'>+/C)BBHXSQTX,@*6GL6Y&XFT1EQ;:NBT+<3@0M23^!)%J#
MV&^ N#60^RSPIQ8VS))]]#>@:HVV[T(2%I&,"2V$DCMM87M:@\<^+WC;[<A'
M_IUX,4W+?,J4ROB;0UMR9"F?95(?0O"=CDA32B@K4"HIN.H-!\)\2O%<R ^?
M&;Q_,@L?3./CAGCX.&-8@,I6G7^ZR;V'X"]J#Z6O%#Q>8AMXYGQNX#1CVU=R
M(7^D&@*CI5?JOVSKY1[GS'K:_P"=!V)\5?&%/;__ ,W\"#VSW-A/#O'J>Q1M
M=2#_ )?(23^5C0?:SXT^.<52%,< \(,+0>YM3'%&B,J201U1VX0%)'X@B@]9
M?!7![WMK/#G$[Q9)+*CQWJ+GM*^/MJ_:5=BOTM0?$]XZ\ 27%/2."^&GW75%
M3CKW%^EN.+418J6MS#%:E$"USUM0=*?'#QV9':C@?A)L=U^U/%FC(^8]20!A
M1\U!W,^/GCW$;*(_!_#,9M8)*&>--(90H'^8E*,,E*@2K^^@[6>$N V /I^(
M^'FDI]/9T#2VPD$'J.S%@"XH/01Q/PLR"&^->+6@CU"-,U- 2;GITQZ0D]*#
M[6./>*HZBJ+I''C"D?*I<?6=;;4D*[3VDMPP4@].GQZ4%9?'_%4Y+;<[2>/)
M:6%=[*)>LZW(2RL$GO;2]$6&UI(O<=:#I_TSXD]PR?\ (/&_N] 9'^4]8]SY
M?2[OT'=T'IU]*#[6]-XSBJ]QG5=$C*%AWMX+7FEIZ&UE(BIM\I_LH/H=UOC^
M0'6'\#ITE$KM+L=W$X1T2"@GL]QM;2@\0IL]MP;=OY4'4K5N.'?<2O7-)<"O
ME=2O#X!845=O1Q)8-^X=OKZ]/RH/E;TWBM/<6M4X_'=\ZE-8+6AW7[?G)3'L
M;].IH/O;UWC^-V*9P.G,7/L(4UBL$U?L4K^BE26D ]BTGY1Z$4'7-U?CO(A*
MI^NZ3.2TXLI,W#X&4E#KA_J*"GV%=CJK?-;J;4'2WJ/&3?1K5]#;%CT;PNO)
M!%@HD=L=)L+WH/0_9M):;0XG%:JAA/:TV4X_#I:25'Y$)4EL(2E1'0?E0?0B
M#J# ;;1!UMGM(+:$1L4UVE:NA0E*18J4OX>I/YT'V)=PC1"D.XE@ANZ>TPD%
M+2+"Z2%#^FB_J.@N*!*D:^^CVYKN'?;[K);E.07$%=E* "7E%(40VH^E_E/X
M4'R-O:@S\K+FN,];V;7BVQ<+#?\ @L.CJ@G_ ,1M0=CFQ:O"4$O9[ Q"4*4$
M.9+',$H18*593R#VH[A<^G6@[W-BU]II#SF>P[32^K;RLG!2VYZ_RK+W:NY!
M]/PH/C5NFH-I"E[1KZ4^@6K+P E1([A97OA)^7K8?"@Z7-ZTIM3:'-PUIM3J
M@AI#N;QC:G5J!4E"$JD K44I)L.IM00,\G^4=&UGGOQRV[)Y9G/X34X>]YR5
M U^1&S4YM5\!#5D8V+B/%V4]#:E!5DFZ4];&@R,]YY\',O+9..Y86H.%*2SQ
MKL+C;I(]P%A26B'$J2;@CX4'<UYU<///(81K?-7N+%T!7%&T)"_0_*?8^:PH
M/<9\S>(7Q_4@\EP2BZC^X<?9V&+=UCW>^RD$#\+^E!K:YQ\8?MW<^\@[]RQR
M!F.=8VR<GNZXYLK>J[%D-<?<_P IY"1D,(_AWL7&&<PS$69)<4HQY"%J"^TG
MMZ4&8/$F+X4>$VC\D<>^/V!YS8U3+; G/[$YG<1MNY)DYZ?"_;4N8C+3TK=7
M[Z$CW$@D>X>Y1!-!F#P!P*,-(YID.LM1<AD9?&PR41"FEOPI$?7<FMF%/#*E
MH9G,PY39=:)[VU*(5UH-C2!9/ZDG^TT'.@4"@4"@4"@4"@4"@4'!P70L6O=)
M%O\ Y=:#!F^1W'N9^!EM* $5ODMUP%7\S2M>QC:@$WN2%6_2@S@V/F6;6"^U
M=O47(MZ^GPH.:NM@/B;'K;I8FQ^-!\D @H? _P $EU']@0;?PO0?=0*!0*!0
M8*\B\:_F>']UQ49;*7)K&,94MT+[&VE9>"I:G;=+)[!:@RSEX60FZ_DL="FC
M'929AY<*'D4MAT0I\B$XPQ+#2E(#B8\A06$DB]K=*#4[H_D%!X.>XMXHY)Y6
M=T/.:=KN1P&?\?G.)\OD^0.:=T1F,J9&U:MG677X4O![^]-1.:1%:<*'I*FU
MK':HT&5^,O#[9<E@>#]OS7(F^<99KC;*;/N&I\>8K&:FYB]0&[G;$G7,DEZ'
M*D3',9BMM=#C:G$AF0.U(LV!092<\9N5'^2LCR.ORDY#8D.:/C],QF*1I&@F
M/CT1,OD,Q,S"GUX]\RILM60#:/\ A^T@+%CW&@M+G/BC?-;X>Y6S&Z\_\@[]
MK1TG)PYFJ3,#I6%C/_7KC16)2,CC\2B6U)A/+#B.MB1U%J#K_P#2YJFA:EL_
M)*LGCMCV7$Z;*VIG*YKB[B^1EO<PNN.S4)8R USO9E2TQPE]Y/:ZZLE2E&]Z
M"O'?#DKFWCK0>3T;U%P,;==4PVQ(PR.'^(9XQ<F=%2Z0S+R6KR71[!40#8GI
M>]!?!\,M+G(0<YGV\N\/YI0XXXGA277.[JXMQK2U_,5&@MO+^ _!^7+8FO2X
MBW7DN.N1=2XJ8F35,I-DOR7- DK4U\;"P_2@[H_@;Q)#A38#&Q[U,Q4\-)1A
M<@GC_(X2"H$*6[CL4_H[<"(IU'0EM)(^%Z#U,?X4<?8W8L!M>*VOD77<OK.*
MR^%Q#^LSM9U9M479&<)&S,W)1\'K,!K)924Q@(S:''DDQVV[) O0>GR=Q+'T
M[1<]L^-Y&Y;>R6%0U)C#(;\^S#=<R$TXM;4LMX[L2PVSDU$* LA:$*'\MJ#W
M,KXUX+8&(!E\I<[LK8R<;--MXKDJ5C&G982IY,)?TV.;6O$CW/\ A*^0I O>
MU!Z&N>..!UN!/@Q^1N;IC>5,=;LC,<CSLI+B&.RTT&83[T/_ )5(,<=Q NM2
ME$GYJ#BWXZ8IIWW1R5SFZM*93W:[R0XI(^H]SO26TXXW" LAL6/:0/UH/*B>
M,.!C2?W$\K>0"BIN*"Q-Y1EKCA3#D=;5XJ<9T4][ +EK%04H6ZF@^E[Q;U>4
MIY<OD7G1[WOK$+CCE3,(9'UKV2>);,>-'*0R<@H-&]FTH; _D%!Z<'QXPT!]
M#[7(/,RTIDB>EJ3R/.D->XJ<G(.)6V[C^K++B?:""KM6RH@_C08JY7X"AX'
M9'8\-R=S8J?DMAT+%RX\SE3(1L7'Q.4SVJ:IDU0VTPTB-(E8B,M04@@_5R%N
M7NHT%Y'Q.T9M;C8WSG5Q10V"ASES9$H+:6LRR@H=4H)24ISKUB""7&F>O],&
M@NM?CUJC\]$EW:>60]$2PEMM'(N<^F_H>V6W"VA:?<6Z&_GO>Y*A0<)/CKHS
MK"4R<]R5*0R^M]MM7(F=3WGMZMJ>:>:6AI5[!)4+T',>/6AA$AK'9KDC "4U
M&:>1B^0-B8"5Q'A*[FURI,H-NK6?ZJDD!Q/3K0>?+\:]/RJI'UFW<O/>ZAQM
M0:Y,SS(6EU :5V*9$8)4D"Z;*L#U%!\SGB;Q6Y-3DGYG)CTL)E*NODW<%(6J
M2B4RM:F4Y1+1=")JR@A/R6!'\HH,/;[XX\1ZYE^'-9(Y%FPLYNJ]<49?*&]N
MN.Q',2C(.-2G6<VPZ\A;N%9!45?( M(_XAH,G0O"_P ?<=C7,<SIVSN1D_4K
M2B3R=R2ZX][QR*_9+R=M2XEIPY1VPN W< 6[4T%Q#Q<X,EJFN2=)F*<R,I,K
M(=^Z[^E4B6B6J4VZE#6T>W';+JROL0$H5>Q%A:@[\IXP\'SVWQ(TN9>8II+H
M@[AN\)]8:=B/(*C$V-(-EXYHWZ'Y+>A-P^&/XH<"0DK:8T*:H.N+==+V\<A2
M5*?>"D]79&UN+;[DJ/=T"!\/A0>GD?'#AK)8N9A\CI\C]JE(;8D1D;AO$-QU
M+*VUM!N5#V)$A':6P>YMQ)4/E4+4%K3?#?QSGM+8F<<3I4=Y+2'4'?\ DCYD
MML&(A2PG<4K4IB.XI)M91O\ $B]!BR;P;QEA?)#CG3\/H^.CZU*XXWC8\H7]
MDW=[)M9+&YF$UCI$>0]M#B TE>?EJ""A1(?)N.Q/:&;D>*G I4GLX_0MM+C,
MD+;V;=D.+D1517([JG?\S$N(28C9[5$]U@#?YKA;6,\*O&[ .NO8CB[Z:0]'
M:C*[]WY&F,?3L_3?T@F9N"VDE*8B " DW1?J+W"Y<AXS<*YF.J+FM#;<@MJ:
M_;F6]FW2(ZRXW];=2C$V%E2%^].>5WH65K[RHGHCM#X5^)?C_)@B$GCQ2HPF
MLSA&7N._ ^^&'65/.J;VOO4XIMY20%'MN;JN>M!]F,\4>!<1[IQ7'2(JY)4A
M_P"HV3=9*5)]I$<)")6SNAL!AM*24]#;IUH/7C>/'$D=I3+6D(BQW5*6Y'5G
MMK6V'"5-D=BL^ZW\S:CU2E/0]"#08*U7QIX(V#?>5VYO'GOSM3VO7&\7[FX<
M@!AIM>)QF7AN!A.VJ86W^Y04K[>Q""I-B.V]PD(YP-Q;)?C2Y6EQW9;&,D8I
M+K.4SS:6H$E$>.[!;2<REDH5'A-MW*2L%'<""22'!7CMPRZX9#FBQ'5_4JDK
M6[D]A<O* FI6\$NY<I0"B>^/2P#A%CT%!]\;@OB." 8FC8A"UK4XFZ\@X%O_
M %")16"[.7_++:0YZ&Q'2@KD.#N(,PE"<IQ[K64*(ZVNZ5CUOO*:?<;+B$K6
MM*BVXXA)5UZ=O6@[_P#1#B92([;F@:\XW&2E+#*F'UM,=JUK"6HZG76D)!6>
MH'Q/Z4'IQN*N.8:6F&="U+Z5#_>6'M;QDAM+G;[;:F/?87V!M/2]O2@C5P5Q
MYJ.Y)Y@.\Z9IVR2-<Y_W2'JCF1U?"+5AL3%A8E.*B1%1\='<0S$^I= '6P6>
MM!G*3P%PG-?@O3>&>,IYQR'_ *-[*:/KV1,5Q]EB,_\ 2";"?4R);#"6UGU*
M&T@WZ4'LHX3X:1[(/$7%R%MV+=M U0>S9)LACMQ(MV 6%OA0?=_I;Q9W(4WQ
MSQW[[*7#'6--UX*92D@.%LC']R4@D7[2.M!1[B3BR4$_6<8\=2^X7_JZ1KCH
M)L+?\7'+/]WI0>8O@GA%QVZ^&N)W%@IN5\=:DI0!'J'%8<]0!Z4&$O&/3=6V
M+A^#DMCT'CYW-9'/[5'R<ICCW4\:U,;Q^PY"/CUO1(&)8BOAB*TA'>I)5\OY
M= X^/L21BO(3S!P49O'0-7Q>T</JUK!XG%XS$0<2F=QNW*RRFX^-APTNN9">
MLN+6X7%J_&@F4#?_ '?F/QH*T"@4"@4"@4"@4"@4"@H?0_H?]E!@#?Y!C\Y<
M *[06I3/*<-2_@%+U_%N-I'ZJ;H,^I-U&PZ>A/YCI;U-J"IZV_(@G]/QH/DA
M)4E+]Q8F2Z1<?"R!<]?RH/MH% H% H,&^1>0CXWAG?I$IQUML8^(TTXR+N?4
MOY.$VR@!/S7]U0]>EOC09JCI4(K"5=Q6([8))LHJ]I())_[1/QH.#;!3V$I2
M5)3=/>?<+1(_E2M?<X0.MOF H.[L)6%>@N5$$GN[K% ]#V]O;0=M!"3[C;FY
M1_"7R+E<?1<3.W*-H#KN$@YV7.A8J:XWFL,[*B29.-ASIK!DQ&EMMK0TKM<4
M";"YH([<T^3/DMAH$?A' ^'>V[3#V?QYSN4VWF?![+-/%?&LV=H\EF)C,CG\
MSJF(C;'E(X<4X]'A.K4E"0"KN(H+X\0MF\HAXL^.R,-Q9P\_#_TIUIN1-S7+
M^P19(<8C*9#IB8[C3*QTHE(;2XD(D.]H7VE5Q09Z7E?--]Q:D:9XW8N,H_(H
M\@\@9E:4&UN]!T##-F_KT5:@B*[Y)?<=8YQR?$C7@_J^?TMW9L7K>+\B1R!-
MUG0<+C,CA)61R^W9'59F)RVQ;'@L!DFH\?V6S#D2EN'VT@ JH)=:]C_-"(IQ
M>T9?QHRK26#]/'P&&Y$PY#Z4J]M3LB=-R;8;[^T]&[CK:@K+'FFZMQ$-?C/&
M:<M].9LKD>4M O<A;;.-9#MT].BD_K01J\L6//*)X\\CS,?MGBNU+C1<$XVT
M_K/)DB.\A.S84.PUO?N[8;5*2?;2LM%*2JY2109QPV$\\E8UM4_D7Q93*=AX
MQ4<Q.->2@VPH1$B4AXO;T%/I==4"W8-E(Z6-!<SF$\S6<7'#'(?CE)S ;_YH
M2>.=]A8TK!NE<=;&]29!2E/P*:#QLE@_.I3,16*Y-\7(KUKY-4_B[D>4RT@D
M*0N(MCD2*IQ21Z!P(!H(S\=;C]V[/<KNZ_R'QCXT:;Q"C,YB WR-&5/RF>F8
MC&^V<5F5:?!Y)R#\)C:>]80VMU3T,('N)/?=(3,_8O+!( '(7!-[&W_[,=T0
MD 7L /\ 40A("?@2:#&V;UO[A"Y;J]?Y;\38&/[%^VK+\.<GY&6DD*[5.B'R
MKC&EH1:]@H7MZT&"N==8\_6]*P*\US;XG3X;_(O%<6?B6."^3\:SFE#?L ZR
MRUDT\L9Y_'KBS&DR4=S2D+#!;*D]_=02CQ6L>8K14G,<M\!9%J]D&'Q#MV/>
M4[[A4$O%WDJ:U9MGH+)!)%^GI0?9D<!Y>N+D''\J\"06/;"8P?XFW*4XVHW'
M<\?]3&4J2>GH *"U1H_F^Y#GA_GC@94IV-WX]<'@[8VDM2TK]Q)>$CE"2F0T
MZ@=G4#M-E=;6H,!<4O\ W<LSDX6,Y?C^'&FXEJ/G3*VK7L1R#M\S(R69SB-?
MCNZQ_FG"-8EF5CBA;KJ)DDATJ!;2 +AG65IOGJ\\X8O._C;C8B@DM-)X)W:8
MXV3?O2IUWEUD+2#Z&PZ4'.%Q[YS!"_W+R-X1<=4HE/T7 F>9:2V?Y>U+W*3B
MDD?@2JWXT$?N;]$\PXG('C!*=\C.-)$=/.$*#D8">#I*&9D"5JVQ"2Z9QWAU
MV)D6T)0IA(2$*=Z*-A03.A:/SLE"OW'G/#OI6.TJB\90&"A7=VGM]W.OI*BH
M6LH'U/2@XO\ 'O,B_EB>0:XB%=Q^3C;7'SWA0)(O/ 'Y@]:#PI'%7D*ZHK8\
MI9$9!*>Q/^CVJFZ@H+(6I>5N4*2"+@"U_P"%!]QX^YO,;+JA>1<E<Z4B.WBA
MD.,-=5"Q;D<I3+?=BQIS4J:F4D$H!=; /XT$0.1..?NS/;[G(_&/D!XS,<6)
MD:FC7<KM.D9Y6_KB)6/\ZO9G!Q\:O7F)91?]N2U.6D$ NT$LX'$G/+,EYW(>
M5.;G,EL)$5CBS1H"&3W ^[[BURW"I0!]3V_@!08>V7CCE9WRBX_E0/(#,-JC
M\.[W]1C<AQ]JLME,=>6P$892 ]#,-U>4,M;=T.J4P&KV3<T$C9O'O*[\7V(?
M/&8A/GL/U2-!U60$I18+2VTH! +GPN56H+37Q#S<N6V\?*K;FV$*[W8;?&W'
M;;;B"""VIQ_'N/('4&X-Q:@MCF'C[RT&C8^)P%S+K3_(2MCQ/UN:Y4US'L8"
M+K(<4C-R$0-<P\N3,RPBV3%;1[+)425J]*#P>+N)_-"1J,0\V>3>$@[ZUD\J
MF8GBOCC7G]3E8D37/V5]MS9X*,H)2\>$>^DI2E+EP"109FB\:<ML(*7/(G.S
M%].YU[0]*'7X )88;"2K\[_E0<Y'&W++S:4H\@]BC+"NY3K.@Z?\R?0(L]%<
M">M!@KBGC/F&/RCY$/O>1F7GXJ9M6I#'P!QUJ+&0PTV/JK2<@'IR5.-9")-"
MVE-I]AM3:DGJ4F@D.CCSDD!D.<Y[$LMW[R=2U!M3Q/<1WA,*P*;CTL#:@\6?
MQ=R[*6X8?D?L^/"TN)2E&B:*_P"VI:5!*D%Z!92V[@B]QTH(R\P\)_<"F937
MH_"'F+K>O8/]KS:-FR/(?$VK9?)G-2PPC7W,5"P\.)&,3'=CBI"7'4*=4M(3
M>Q!#(VC\&>4<?5L$SOOF/M.2V]&.C#89N'XMXRA8I[)!'=+&-85B5O,Q5._R
M]]U=H /6]PO5?"/*[P D>4_)I7_*I4?6>/(B56_F(;;P1"+_ )4'VQ>&=_@Y
M*-D%>2')TQ:5-)1$E8K3GX"^VR5EYAK"-(+:TWN"18F_Y4&!^ N ]^PN.YAQ
MK7D9R@AJ=SSN6=B3<CBM/DYAJ/*:QREP%Y%S%.IG0/<7_1^5):0D)]!09I@<
M%<D0I*Y#WE)RK-[PXDLR<5HOL@+)[5-H:P*>PM!5KF][4%W8[B_=X,%$-7/&
M[S5#W?\ G)>+U)<E7N%2KJ4C%I25)[OE[0  *"'/D=XL^=&\3L8KQS\^9'#F
M/&/AMYH;7Q9KN[3',C%SL66^_ADQ7\/&A1)V 2[#6VX'"AU27AW%/:0SQ)\6
M\]+^F7,\J/(I#K4>(W(&/V?48++[S+2&Y+P0=244"4L=UNX]I/2@NG#^.QQB
M8*7.?>?<F83_ +R#/W7".J=/=<(E^SJZ$R&NT$65=(H-?&K^(/DSF.*-!Q_C
MCYT\B<4X7'<@\CY#<'^0-4Q/)N;S6!R&Q2SBL%@G4.ZPQBOV=86I,EYI]3W=
M92 !02/\->+)'%7-_F/!E<N<H<JO9/;N(7Y\ODW(X3+2(.8'&[9R#F#DXK$8
MQ['X6:M7<S"<+J(@':A:@;T&Q1)!%@02 +B_I<?&@Y4"@4"@4"@4"@4"@4"@
MX+!*?E];IM_^4+_A\*#"F\05S>7.$G4-BV-5R#+6HD#M;7A(#'<FY%U*4H=!
M<V/6@S4B_K:P/4_J;7_6@YV^:_P[;?WT'!L$>Y?XN*(_2R:#LH% H% H(M^9
M#TAGQWW]^*HH7&7K[BE)2"4MIV/%%U0%^IL3^%!*%L6;0">XA"1W?CT'7^-!
MSH%!Q4H) )OU('3\S:_Z"@@+YY<BHG<2[[X]:-IV\<G<T\HZ%E&=;TS0</%R
M+^*BN26&&=@VO-Y29C=:U;#)E)'8N;+97)*"EH$@J2$4YWD-SMD.'\AB)G*.
M"C[XYKF:T*1X_I\=<O YE8V"-@#!E(RN)SW(+F)B:O#]]#CVPJ=&",98=#]B
M$T&5/#J3S1D] U7B39>6<WQOR)QSH^O#8-!>XBT=J,O$R M$+-:9LD+);'K&
MW:Z5687,@2W667QV.!*O4)R(X\Y/667$\\[ 6O:<"FSHV@W6I: &UA2<19OV
M'/FL!U/0FU!81X3Y_4I7=Y@[R$*7W!#?%7#22E/>5%L*=U)ZZ"FR?F!-OC>@
M^B-PISLR[WR/+S?Y;7<#[#G&/"S: D6NCN:TE"^TC\Z"\HW'G)T%A0F<_;7D
M56*4K7I/'++O<H%*.Q#.NH:*NX] 1UH(*>5,OG'.X;:O''B_:^2.5^1LY@,3
MF\[G)FM<0ZGQKQEC%9S'9'&-;[L^2Q4-MO([%&@/_00X:9,DEI*W$)96%J#+
M7#Z.7N46MAQRO(CE[CO<-)G,8/;>/=JXTX/=R> =<C-O8V;#R&,UK)XS,X'-
M0K/PID>0XEYE0)[5 @!GG$\3<Q1)29.0\G-UR[ 3;Z21Q[Q/%;/K<ER%J3#_
M '?_ '5!Z.2XNY2DXZ=$QOD-N.(F2E!<?)-Z7QM.<@G_ !!$:?K3\=Y)_!:2
M!06]&X:YM90RASRMWIXM_P#$6>-N'4%X_$J#>FA* 3\$A-!<3'%_*C3Z7G/(
MK<Y"0V$+9<TKC1+3G2Q44MZPBRC^7I0?)-XLY=="U,>2NZ1!VJ^1O0.+7_A_
MV7M563T^'J:""'-</FWD:;E^*N,>:MIV?(\9[_H6;VG?]N5Q+Q]HJ<_K^6B;
M=D>-,&N!K/[KFMRCZ]'1)>LQ]#'0Z@.O)/< $G.(XFV<N8$YYCF7ES4L]K6=
MDZSN6D[!B..U9?5MGPCB7LAK^97C\+*QT]F0Q,9D-.,.N,R(CK3B565:@RZO
MBGD9UN85<_;HB4^.V*_'UG1HS>/3\0U%:P@9=4?B5WN:"S7/'SE"2I"Y7E=S
M"2D*!1$Q''D!I7<;W*(^K"Y'PN30?9#\?=YC/>Z[Y,<S3!:WMOJU)+=OR2QK
MS20?SM>@N/\ T8V@Q#%<YTY565"WU*). :E#K>_N(Q 3W?F$T%K3O&K+3B"Y
MY%^04570J5!W.%$"U)ZW*48<H3?\$@"PH('<BZIN_(6SZWD-(Y9VK(:7Q;RL
MTQA]HY%YZQ&C.\E;)K\>7A=IP''B(&OOR#)UO*2CCI#TM20_.#C8'8"N@EGQ
M#@6N<],C[1&Y'\D- R&,SN8U?:='V?:XN-VK6]@UR2[C\IA,U])&=;<]X=DJ
M/)95_P Q%>:>0>U8H+VS/BLWE7.Z)S_Y,8,*2L.MX_E[++2LGHEQ!EQGU,$?
M@@I3^5!'WF3P4Y7S&B92'PAYF^26G<F/OQ?V79M_Y4VK:-4Q3'O).17(U?"R
M=>=R<ER,"E@.2?:;6>Y256M06GXV^"_DWHVV;IE_(_S>Y:YKPF1DE6B8K5]O
MWCCX:Q!]MM @Y>.SGLC%SSH/<KZE78Y<BX-J"7\7QDQK,5N.>8/(U78I:TK>
MYMVI^0.]95V&0X?<6A(-@%7L.E!X&;\6]<<,O)Y'G7RCQ\:)#<E2D0N>]N@0
MF8\5@N/2"B*II8[$(N5 ]2*"!7^G7+>TY;$\\:;E.;7^+-<U[9<)K&FY[RJW
M.%RQR7A\S+8$#>L.P[#DXS$Y#(IQ+J,7B9KA=FI6E9+2P!02LT_QPX^YCTO5
M^1]7\C?,AO6]TPL/,XH1/(C=\4XVQ.90IR/*B)7]1"R$"05LOMJ(4T^VI/P%
M!GC&^-N&QF#CX)'*WD',;C !.3R/-6XS,T^!_P#[.2<D^\[?XT'B9;Q2PV8:
M6TYS9Y/8Y*DA-\3SOM\!T6O\R7VE^ZE7Z*H+7A^%6OPYS4[_ -07F%)4TA;9
MC3/)?D!^&\' 1WNQO?2E2T7^4]+4%Z0_%["0B@-\P>23R4!(_P";YTW25W=M
MQ\P?E+)N#U-P:".W.'C9INC:;L&[9KGWS;<^DEP3 PFH>2F_09>6R^3EH@8C
M XYJ#8M,3ICR4JL%%";FYM8A%6-XS;3P\WLG(O(_(_DK.XZVC<<-'W;+Z#YS
M<O[1L7%R/^7UN0_ED2(>/C[-CL=+D)<GEI3,F"VE00ASMH)\8[P;X^@**D\O
M^54M75)7D?)3D^:M9^*E>[F5!:B?4GK^-!=^+\2=$Q*F7&=[YWD+C.^ZTO(<
MW;].(7_VU!_*K2KMO< BW3K0>H]XPZ7(AO17]LY>>2XPS&]Q7+&WB1VQY!E-
M/HD-S4.-R?=/\R2.G06H/6A^.6C0\;(QG[MR'+1*=4\]/G<C[?+RQ4I)24HR
M#F3]YM  '04'B0_%#BZ$Y[JLAR3/_J%WV\GRANTQKO5<&Z',L1V]?3TH,9\U
M\?\ '7&NNX/&Z[IF3VW<MTV.'KNI8/*[_N,#&NSU)<G3LQG\PU,F28&OZYCF
M%RY2T **$=@*>ZX""_#^CZEA=RR&$WKD3C;R U_>>0\ _F)O#VY<E:=G^+WN
M5LD]A]*<R.'R&]YJ/M6B3\OBUPXTJ.MIUEWO4I*@>@;/8'BYPNF*EE6L3G65
M-^TM+^W;9*4H-]S90ZZ]E_==4"#=1/6U![T;QPX:BQ(<1G2F$M0?^ DYC/K*
M0%*4.Y2LM=P$_P#:O0=K_CQQ'(4\7-21_6]ON;;S.PLH!1Z*2490%*C\;4'B
M9+Q6X$RB5*R/'L2<OH#]3G]K6+ BU_\ [<'H/A01QYLX\XTXY3@=!X5XOTV5
MS'O.'W39=1C;/.W"?B<5B>/\;&FYS.S,-C\XSFLT&Y.2B0FHD-UEUR3.;^8)
M!-!K"\9.3=TUOC+<#R]X;92&]-YKP_%/&ND9#"[QHF\.\H\@QOW]&1WC%/9#
M]N9XTA.NK4[EFT%3;2 $F0I0503'X<9W;QFWKFG<VMMX?Y&Q&4W32SY+\=:3
MKFT:?EN&)[>*9US%[!J>1V_9LB<_JN/@2&Y,P2$*DS4I*XI0+HH-O\-U;S7>
MHMGOLMM;2KH=;6E*D/H^912AT*N >H_.@^V@4"@4"@4"@4"@4"@4'%=^TV-B
M>@/0=3^O2@C?OTQUCR,\=XR%+#4W"<R(?27%!),?!X)]CN3_ "JL0JQ^'PH)
M'H5W#T^"3?IUN+]*#G04 M?\R3_;05H% H% H(W^6\1$[QRY;C*2HI&MMNCV
MR0YWQ\I D)*2 ;=JF_\ ;02)B_\ EH_K_P !GU]?^&GU_.@[Z!0=+O: DJ (
M"@;DD6*02#^-SZ4&M+F#CZ7'Y@YRPNX[)S-IVE>3T'C=&J<L\-3,A#SW'F5T
M76AKF;U*=E<''E9+!8;+"+]8'76W(<AV6XA0"DW(1_;1L&&S^5Y/8X1V+>.%
M'/'4^,$7?.2M!EYSE3*9C!Y";,B;UO'&V(7AL_E^)<YD)0B9%;*XTU]F.'K>
MVL=H9)\(-#V_-#@O/S-*P_'^.X.T#D77-B&JZKG=+T#=-\Y RS+LECC7"[5_
M^$Z="P&,BH=:DROYWW%(3W!/>0VR,)[66TD@D)ZVO:_^*U^MKGXT'=0*#YI*
MNUI75T$E(!: *TDJ2 JROE[$W^:_3MO>@UA>4/$\O<-BY0UCD;1N6L]PSRS(
MT+,0]UX'<Q;VUX#8M:TW-:?DL#MF"6XUF)>*G&6)3$J,V^VVZ&^XH4VE5!FO
MQ/XNV76,QM^ZYC7<]INNY#6-!T'C[6]MS+>8W56J:'AOV]O/[K(AO/PQF\U)
M<4XAHK<<C,]K95TL FT!86]:"M H%!UN_P B^I'R*ZA03;H?12@0D_F>@H-3
M&V^-LS%+W#3-CTSF;9=#SW-&Y<Y\?;WPUN.%QNSZUE.36/:W+C;9HV4FQ'T8
MH3$R6D2$!V-]#+]HJ;]NZPFGXX:;M>M8W;<YMVN1-2RF][3*VAC58>63F7=8
MP2,;B\#KV#S.58"8>9SK6.PR77Y".Y*5/*;2M:4!1"3% H% H.*@%)4#Z*20
M>MC8BQM^%!I\Y*\27LS+PVL;YPORQRY@>/=OW7,<:[/QCS'C-(@Y/5MVW)_D
M9[6N1,#+S&#<4O![*Z(ID1VY+TIAE*U&Y4E0; . M0W?6<'L.8Y'7A(N]\B;
MC.W[:,3K;JY.!U^1,Q>,U_$ZQCIDE#<C*JPFM:U!8DSUH;7,F)><2$((0 D+
M04(O_N/X?F*!8#TZ?I^7ZWH%OQZ_PH/ V'!QMCP^:P<QQY$7+XN=C)"FU%+J
M&I\9<=;C2@KU:"^Y(Z?,*#5_-X*Y+D;!J>4W'@)O?^9.)9&O8/C+F")RQ.P'
M%LW%:O,G?Y!WO<M+1*:?&TZLA\.RH @3&UN=4/V79(; ^$.*8_#'%.C<9QLU
M/SYU+$").S^2#1R.=RLJ0]D,OEI99;:;#D[)2G5@!/RH*4_"@R[0*!0*#"G.
MW'N1Y,T+*Z]@)C&-VN,_B=@U"?D6O?Q;.R:]/;RV)$]H-ON""]*8#;Z@@J2A
M5P#:Q"#F"\9M@=.[:]KO#^0XA1S;M4#8^><MFN6\KN^B_43,G&RFY?Z0:N)[
MBXF9SKT!*69#T7'LM!9*VED=I#:4WU3>X/<I1%K6LI1-NEP2!_;0=E H% /7
M^T?W&]!@SG#C[8=VPV(R.C9/%X;D?2\M_F31LCG8;\[ /STQEQ,EKFPQ(TJ)
M)<P6S8YQ<:2MI:76DJ"T=UBA01&XN\;-_;WO$OY+B/A7Q\XXP^:Q&Z;- XOV
MC,<A;ERAM6$R'[WA,4K-9;5M78T[CC"Y]Q<OZ-IM]R0[\J?8!4I0;)(_\@O\
M%+L>U* H=Q*5)2DD)%C;\?QH/HH% ]>AH(N>1_#^];U$Q&Y<0Y_ Z]R]IV(W
M'!:_)VK'2)>LYW6=\A18>S:OFG\6_#S&*1(7C8DJ+-C.]\:7$0M3;J244$(^
M-_!7GC,9S=\SRUR?$TUN?R'@>8=1Q>C956YR%<LZU@F<+BMFV3*Y35]9BKU:
M,RT;X1F(DRRM2WI*U]I 9&TOQXY]VK>]VD<N:%X^\=8+=)^+?Y1Y X=VC>\]
MO//$77'4.8:+DM?V'&8G#\>8V:64"9'2_F75(!;:?;3UH-E\5L--)2 E*0E"
M4M@ !I*$)0AOI<DH2 .I-!]5 H% H% H% H% H% H*$ ^HO084W3&QYG,_"L
MUQ(^HQ4'DIYA?^(B7AL7&=;O_P!FQ!_A09I0"!U-_E2 .G2P]+CUH.= H% H
M% H%!A3R&A(R'"G)4-;BFDRM=?96MM'NK0#(C]?;38J4 /QH,R1;_31QUN&&
M0;@I-_;3>Z3U!_*@[Z!04(O\?T]/P_/UH/E^D07"ZHJ4LI0DDA)Z)))2+@V0
MN_H.@_6@?2HZGN5W$!*E= 5-I!LV; #L_+TH!B(/: I2 E(2.PA(';_+9 '8
ME(/6P%J#ZD@@ $]Q^)L!<_$V'07H*T"@HI(4"#Z'H?S'X4'S-Q4-+<4A2D^Z
M>Y0!]7+64X5?S$K %QZ=*#DU'0R5]E[.$%5^I*AT))/4DB@^B@4"@4%" 1U
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M0/[J#OH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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I4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g923794ex10_1pg040.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_1pg040.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"%0-P P$1  (1 0,1 ?_$ (L  0 !! ,! 0
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M>?P]!_ ?Q >/Q# ^F P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P..
M '\,   'L'&!S@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<"(  B/L <C_(,#&#;'9V(
MTG:DVFP:)L-KKUPP9?1['K-,L]_8NY]XJH4T(%?HL18K(T^E13\U'"S4B'Z@
M #<^F!&I_N'Z . &CHK>,FF8@F(HCUWW>V X@'(% K^AM5"F,/I^HH8'K0^X
M%H 5/BD&VYXA8C5FNN@ZZ];P7^-1X!CD;?,QU^[14623X,IX&$"^0 /KS@9,
M:VV?7-LU>/NM.3FQKDD=RDW5L=8LE/E@6:+G:KD7@+5%P\RV*"R8@4RB!2G#
M@Q1$H@(A?RRXHI**F((E3(*AA*/ B!/42E#\3" <!_' U':B^ZTQW+LK_32D
M:!M-LGGT;MB;9P=-V)JJ?M$)$ZEN=8I3]S=X5&W%<5=Q:GMH(O%MG0(NE6[1
MR<4_%,Q@#)>6[DO:^[EV=CTQ,55>#9Q,A*)V[:^EJXO'Q\F=,32$DUD;TDO&
M1[-G\K@RS@J:2B2!Q(8P!@>B![AFM")G4#0XV1: =9M]0RVQJN11*Z5(Y7A@
M,K'VMP04YIFW^H0 !$YT#>90$ $<"C*]YJV9>/\ VR+IDLV.DFK+IMMVZ>;2
M3(%ADD" V:2%T:F<@+V/,0I__3,!%  W)# 4/JAW@@G:3)1O7*TBH[>.VZK9
M?=6G'BT:V;%3%&0?FB[J\03;NSF,!0*83%\1YP.4NW\L]3CEF%7K:J4@JA\9
MVUD2G$#MW!"+)':O*^I(-'HG04 Q3I'.FH40,01*("(58.U,FLFU(DPIB4A]
M)]5)13J9D$I)B4RB9$Q,P*E]8"8 <3'.8GB0H"(B&!<;'L_$>$4,RM6V_P!0
M\5;3(,)<[@T,4H%%LJL8X@40= (B' CX\?JXP*V3L[KQB+@DU9H1@#J8E6M;
M41;SD@E*QC(Q"-W2BK-BNFD[7.)N4@'GQ#DH<8%;B.QVKIIXX9-+C"F.TAG-
MC='73D(TC6!CP*,I(NC2C=J"!&!3>1RFX-X (\< .!9-\[)25)G6L&6CJV7Z
MMM%NF;V"E6RH+C*G>F;$!@=?]Q(J=FQ4722.F"CI)-4Z)3E06$@70S[(ZW=&
M1*XM]>C_ )GZ<9X/'X,%F[\6A7*K-PG("W.#A+]0"4 ]./7 \6L>P'^H3NZI
MJUWZ!O6[PZ@(<[:98R*LE7$$VA6EE?IMG*H-"22YU%$"!Z*-Q3,'/E@5R9W3
M.QLG$1S+5M@EC/\ ZE9^9O.U=N,1')CXM91P5W)H_,T?*<%3^/R'D?RP*78]
M\6V&69)1.AM@VLKI?XEU82<H/@P(!0$RSH'EG;G\"\^H% P_PP*9-]F4X*MN
M)B1HJL;-LI D;(T^9V!K.*G8YTJU!\V:O".K41!O(/69R*HMS&!91(Y3@42B
M X%ER/<5NT9N9!"HUU5F#1^M'N%MT:>;(2+IG#/94K!)RM<2-RKJ&9F(;DW"
M90,<W!"F$ M:9[[5ZN"C^[5*M +D"_ 1'L#U\:J#P'*YS$E]C1WDBB8Q"B8@
MFX,<.0]0P/$C]PBB.BJ+@AKF-9H<D=.7_8K03T&JOB40(X3A=@OCH"/F7^OC
MW#\PP*/?N_:%,HT/?"1VJY*%EK;7:JN[/NB@,(J"3L$@+$UAG)]Y8D(1A"Q!
M?\UR8ZY3 F43 '' X'.NN]B&U:(QO%;NW5F 15E;/$.(VU;QK@JJ*5Z8>Q#2
M0CGD5,KLG,7.@R^I:J^?"C94B@")3 .!)TAVWK<;7(%PYVIUA_NEZ\*62CD]
MR0"D4$?P<5EXM\65$RZ[?](&*?@!$WI@6\][GQ$<A&K/;WU\2(X43,[60V">
M1;?"X4,9FDP<1QG*3N1=-!*8J &%03CQXX%]O]\7J"CW3RRJZCAA1(T73.[E
M+<@W!LJ\:LESN#KQA#(J"Z<?3IE-P/U)R)FX$>,#PS&Y-P0C5O*R1-#!&&8K
MR4B[;V2X._IXQ-ZPC&CTA&\<H84QE)1N@H42@9,RY3" % P@%6B=L[@7AF\\
M[9:8/$RCH&L1(Q-CLSUDN?Y$T2HN' ,C)HK"=3CW  'T'UP+>O&Z-WU%&1?N
M5^LT#&PJT6WG'-RV#8(,(QQ87Z,77&[H54$R(+S4DX(@@0_B=550I2@(F+R$
MDR5PW9%.(I!PAHY@65<?MK8DE;IEFO(3IF:CX(V+362(+UP9LS<J_$3R5^)$
MQ_'@IA .6-_VLQL+5A<U-(0\6X9O5BE;75Z2<648$;+/%&C*1^G36:,6SU$Z
MYO=,%B";@#%$0NJ4V[4*P4[FY;$U;6(U9K'+1\C,7>$BDG1GK=-^<2*24DW0
M50/'.VZJ!BB/R$5 P<E$HB%G2?9/5S16N*-MR:(4C)9V=-^[>;;I;54&OTJO
MQ&A>9T$)!R,@4I!* F#PY'W],#JIVOZ^ D(I=B>NIS%.1-3C<E#-X&,/QB!O
M&P\%,540*//MZC@6Q)=L-<0M:CK-)[?ZZ'C$I5=E:)=IN>HIP4.AY@#3XI!S
M/)HB]$I@!1-0P 4PAQZ8$=2O=NJ)6B1AX;:G561CUB+NZRFOO:I(3[N-:-S/
M5W$DP"=\04^A3.H (>8<!Z^F!U6[;RSB$=SL1LOIHY9-XY4X.C[YBEF*,D+1
MRJR9O9!E)J,VQ'CM(B9!%0##^KCGC FK3.] OT))R=CM.G5W->A6$M9$];WU
MI;6,*5ZI* 160>$=+)-V"R$?YI+"/B;Q. CR4> N9CV4T9*3JE8B]J4.2L*4
MC$11H2/M$,]DQD+ P0DX1H#-J]57*M(LG '2 Q0\R@)@_3ZX$SL'[62:MGS)
MRU>L7S9%ZP>LG"3IF]8N4B+-GC5PB<Z3ALX24 Q%"")#E$!*(@.![#"( (@
MF'T] ]Q]>,#7)VZ^X51.M,=3I:-F-334;-S>V(6:?7C;]%U@U0EM.(MQMM2K
MJMUGX(MENZ3]86A8]I\RP./ HE_67D-A4/))S$9'RB1#)I2#%D^2(80$Q2/&
MR3DI3"')3"4%>.0Y >/3 J6 P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P.#!Y%$/3U_,.0'^ A^(#@8\*/--4S<002%9K%;V%)ZZL]X>V=K1G<(S"
MD0L[ 1MD7FM@MZX2IHG)*S+0XLWDH1\L7R631,BDN=,+2O%]TIM/4^]G]"G-
M=; D(*@WZ*E',,$'.*D>1E3=*)$%U\*I))BR(\+PLF99L F$@'Y P $<;U,X
MHG3=M9Z;,1.KI-&MZ:2>WB%I0S<I!LIJ9I=?DY*-BH&.<OCR(,)19%-<$C$:
M)JF5-PFF8P!7GG3EE+V>!MJ.^MVM6$<S2#^VX:8K32M3J2C?E)>79A73J.P\
MUCJD_44 .H(@'(B(A=+KJE"O8I]$J;'V>FB_6;BLNV?5YJY^C2</%EXX%4X(
MH_22"3SX5P]SI))AZ>.!/M'H-<HE2J].@XMFVB:C78*M0Z?TC7Y4H^ BFD0Q
M\U2(E^18&S,H&'^&!<PP\4*QG QL>+@Q1(=?Z)K\QR#Z"4RHI"<2B ^W/&!T
M&%AP W_Y5&\&']0?0-.#?Q-P@/.!B5O7M-5M.69/7U/T3MCL;LEG!C;9K7FB
MJ_07D]5*T;R(UG9U_L6ZZXJ;0)!0O@V:)2*LDN'ZB-A3_7@8J=E.PVL=NTUK
M%T!*SQ=I&I[Q1LM5MFJ;M1YZ/22ZY[<76092-PK]=KD^]@[.BS(L6,?OTUC$
M\T!51 RI0O':^TJ9J&]ZIN>Q5W$#7F-DZ\G/(Q-*N5ZL4X]?Z.[5H(0+2LZZ
MKMOM+]ZR.S,N0Q&8H)D%014+P(@$H-NYNJ9.8;O'>D]O1&I59(S!WV#N^MHB
ME:PBY94B1VB<LQN<O";3CB2";@G@\7KB;(IC FHN13]&!FY'-(L[9-RP9QR"
M;Q!JO\K!)I\+A,R*9T#D7;%^-=(J8AX& QBB7C@>.,#U"P;&'R.W:B($!,#
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M44D*I IHD3*'BF4A",?C\2)\%#@.. P/L;7U(X*4:A40*4P> #683])./4A
M%GXAR(?E@>DM*JQ" F6MULJ9#%.DF6OQ)4TU2?T+%*#4 !0GX"'M@5<T2S5(
M8CE!N[(?^L'39!?S_P PJWZ_D(8#?YY /_\ . &]PYP/J,<R$HE%HT$HE$@E
M^E0\1(8Q3F((>' D,8A1$/;DH#^ 8'5*+8HD^)-JV30#^ANFW13;D_4!Q,5$
MI/C XG#GGCW# \LA 1$DFJD]CX]RDN9$[@CN/9.RKJ-54UVJRP.D%2J*M5DB
MG3,8!$A@ 2\"'.!Z'$6S=';*+-VZQVBGSH'7;(+&3<"F9+ZI,RA!%)P"1SE
MY.#>)S!SP(A@8,]K$:RVV_U^-(IQR;U6H]@DF8R#E=%FJU&,UJO+%79M8Q\9
M\JHDS1 IQ,04B@( !_/@H9,:W@ZO8]9Z^=JP4$_C7-*ISIB5S#LG;4[56MQ9
MD#-P?- <%2*W\4R>9$SE(F "4. # NTVO:.H"9%J93U"(^/P%&L0P@B(<"(I
M =F8J?)N1] #C \Y=8:X()A)0*.03" B8M1@ ,/J(F\A!@ #S@?4==4<[4[)
M2E4Q5DJ83JM#U:&,V44'_P"\.A])\)S^WJ)1]L#K_IKKWY"K_P!ATGZ@A1*1
M;^TX/S( E\!*0_T7R%*)/T\ /M@?9/7E$114:I4JH)-%1*95JG6(4B!Q)R)3
M&2*R!,YBF'T$P#Q@05<>O478]O5RZ0UB5HC%AIK<.JYB$J$4UAWDN78DQJ^2
MAK*A+M/C;LY&EC3'I6I%&ZPF&5.)1(!3 <+2?]/FZ*[J5B=U[O9/U:XPB%6S
M.S1#9&9>0T(,2RDY-4D(5=:7<I% %''F0>1'CQ# E#JR9RVT%JB ?-?I)&FT
MN$H$FW\FRHM92@,$*A*,_J&CEVV=&:/X4Z9E"'$IC%YX#V ,@QYX]..>2^_Y
M<AS_ (B'M_' UO\ 2ZDZVOE;[*C+5R.NR,?WE[2&*-]JT!+MXJ=2OAFDNC7V
MST94&S-%PU GS?Y*JYB>8EX$!$-CJ2?Q)E3 " 4@>)2IE A"%#T*0I0]"E*'
MH >P!@?3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# PV[;QTW;&
MVHM<14I,5Z%V-MV(K][GX-JN[=EID3%R-MD:Z[1(S=)J0EO=P24:\\S)%!!<
MP@;G@HACCW^BM=]>=15;;E(CF%"DJA9!J:$%3(DD1_>U=NC1>NS-1=1L2S.W
MDFJ;=P5Z":J?"AV90%1,!$V!L1AH2)F=;0U;?))S$%(T^#AUDW[8A"2,8X@V
MC8YW+8@KD2,= WF)"FX*?@ .']6!:NE9/83>O(5G;4)4*[=H@KE)!C3)R3FX
M:1K35T=M"2B)Y.&BSQC@[$A"K-/E=F2.'/R"4Q<";$U 4YX_X"'^\?3G [\A
MR(?B''/O^/M_/VP.<#@1X#U 1#V] $?^'K@88[.ZRWN5VW+;IT=N5/35UN%5
MC*5L9&6HI]@5RV14,8X04XUC4K937<-<X5BH+9N\%RX;$1]#M3F_5@8<]C>K
MUHJKV@;"M?9K?^UYR"J.]H]I5;4^I;;7"DK-:(V>@K.)0<75V,M&OV:!CIMS
MJ/W8)I&\3%./J 7=N'1A]][DJM?6V'M34CNFJ]5KW6;]IJTUV"N,?/M=5]RZ
MHX16&SP=@C7$,YB[>NDX1!D91?S(<H "1\"89+J#MZX4>3TSLGM59]C:;EW0
MN)P\S0HI'=DL5!Q$O&,*ZV6A.)4XT FX8*"NB6I LL"P 5=/P$3AGTQ:I,6S
M=DW01;-FJ*35JW;)@DW;M6R946Z*28>B2::1 *!0]"@'&![,!@<"(![X%MV.
MT1%7C5967>HM&*1R)^1@,HNNJH7DB#-HF!G#UP)?U?&D4Q_ !$ 'CC I]9B$
MDU)"R+,4F\Y848\DB9-918WT<8+H8B.,Y52;BLFR_<5SE-\28@*Y@$/3 UUM
M(=KL?O-):[V *<W2JU"[7V&RHDD@L_K$Y.//]!(>!G).-?$.Q>RE23:R((?I
M.F0'_D! , F$)/LFIV54[84Q]2FI8:A[IK-[7WK!1A@CXNQ6:O140:GVUXW:
MF9E9S:9V94%7)!*==-,A! 0# SW3*!2    !R/H4HE !\AY "CZAP.!R<.0X
MYXY$ YXYP, Z+]P?4<LP*78L5<=:65QN'<6I(ZLMZQ<=E_5K:GVS;]7)V%U.
MT&I2<5#L[0>J_N"2#DR:C5%R1,YC"43B&LE__P#[!<)*I:%>:NZJ3]Z8;4D=
M<M+R2:VA(T:7UZVOE73LRCN ;NM/34'?2,U#A'-7#B2K\2YD%4?J'S%L91RB
M&S'M;W-N?6V\:CJT5I-A=H#:3=PB_O5BVL2@PU0L;V5A*_3ZJ>-B]?[&G)F2
MM$Y.IIBY*W;L&:*2AU%A-\:2@86QWWK86 G]<:VW3HN+UQN'9DGNZ.@JC7=W
M%OU6:_Z0SM:A8T)O8:^K*6PAGU]"8>KLT73-$I21IP34<B8?B#*3[:/W YC[
MA>N+WL=_I)/3;2D[ G*&W18;(>['CY=U!/EV#TCAY,:VU5+1DRS40 RZ!(YV
MQ JA!0?. $PE#9B/IZX&#7:EN]6V5HR3;-HU5E&UK?)9-P^?(MG;5!U7Z>FF
M>+9&8/G$JY.LF "DF*(>@"8X>F!DOI05/]'M5%6Y!4FMJ(50ID_B.53^UHH3
M@HGR)2'\A'D '@OM^&!)V P& P&!'SFRLD;_  E659R@2$O V>:9/B- /$$:
MUYW66SYN[> MYH/E3SJ)D2"F(*%*<0'](@ 7^( ;@?0?Q*/_  '\,#&R :+:
M6N,M%J."%UC<Y9[,0B*;'Z-C1[+,O5I2=3?/G<HM\K&PS3MP[%0"$^-=?Q !
M#UP,C_F3%,I_(IRB4IP,0?(I@'@0,00Y X?B''.!CEUOILO2&NXV$DBQ11G=
M^[/NT;](\CG:J[&XS!9H7+X(]-$&CM=PN<PHK%^=,. .8P^N!DG@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#J;R\1\1 #?@)@$P!Z^XE Q1$ _F
M&!@L]^X/HN/V$YI3M*](U:.V4?3<UO@:8[_]OL!M=.>&HCKV<VB9\2%C;2:Z
MF1A ;*^)OW9TBW'@YP# E.R.*1LC8)Z0G;[0JZL&LYV5:*4FP2,;'MXR-GZ^
MT=2T7.Q#XS4D\B^?($  *8WQ',4P"43 (0+M?KG9UM4WFP[BV_/;:)J_6FP)
M36D',0=)K-9BYME49XD/=+4I#UE&Q3=VBV3KZ?Y_W!&*$B8*#'_4"98P9FZB
M.J?5FM?E4!50-?4H5%@.*H+*&K,88ZA51X^0IC"(^7_-SS@>B\Z[K>Q(]K%V
M(LXDA'R*$PQ>5VT62IRK:1;$4(@<)6LRD4_<M %3R.S6449.!(7YD5 *  $7
MV5MOBE1+F3@KU1;% 5V-FI"03O=&?J6Z70;?4O6G-BJMKJ-98_1,@3;" 0IS
M+?%YB/D81P+ST1L97;NEM/[67:-8Y7:&J=>;'/'LW!G;9@>[5*(LBC)L[./+
MELT4DQ(F<?4Q  1]\"6N0'V'G 8# P3[LK+I,*$BF'#9\GN-%\I^X-V!4VZ'
M7?;[M10ZCIJZ*<A!;ASX?&).?(3<%$!"B+UUG(]AZ5*3=BD(!K$(]9Y:HHPZ
M,:H6XVMKK?MM$/:M/.%(]9RM!C 3RDB44U4SE=,$A(8I#*$5#8&B8#I@8 $
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M4@"("//ZL"K&55 /1(X\?P]1_CQQ@4TSV6 YRDB_,A0#A3ZQN!3"(\>(!QR
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MDH#P)0X] 'W /PP.V P,7NRB+EU&U=DBU17!5>WKB\5C32#EDJWJ3\J/[4(
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M]>?TAZ^GKZ>_IZ>N!VP& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M#?G5&KZADNM^OJ*E([&JFH*H:5>0&R+8,I-ITUGO;1$B]MLC)RJ;&(5AM?A
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M*4WPD;K@(E\_4,D"_P!)?Y![CS^'YAR X'. P& P& P& P& P& P& P& P&
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M-P.!^CGHS-REHZA];[1-2CF<E9_35&DW\T^!<C^37=P[=<KQZDY217*X73.
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M@1XKBEICM 89,%TR_MY36;K:06_TYE2G6,_.(?J*0WQ_"("(>7J&3:8\D(/
MAR0H\#[AZ!Z#_' [X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# QSW+V+8ZBM-(I#36VRMGVZ]Q=GG(J"UQ"LI9RTAJB
MK"-YB2E%9"2C&S1LFZL+5,GZQ$QE/;@!P(KZM]]]/]L-G=@=-4>%O=<V5UAL
MD14-Q5NYP24<->L<Q%,YAO$MY)B]D8N3=-V3Y/YP15-\*G)#<&*( &<& P&
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M=&PBD G.-H%FV9-7R\<HZ>&0=+II',J'R& QA#\L#,[ 8# 8# 8'4_\ 2/\
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MR<<D+<BX$$"X&UJ,53&/9B;@AC($'P-\@' 1]>!*N8ZW/(_\PB.!4.2>0%]
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M61]HVI,CT3 ?Z8RIUR&)XB43@!0'GC RBP& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MQ@995<"(*N%4R.CIJE1,<R*H$#(2B;$J4FE.+P5:V/&)1WTJSHEATIMNC*N
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M)@8!HFSCV+%DF"#5ND5,I5%"(HE I1.(FXP+O(BDG_00"_J$WI_XA 0$W\Q
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MMTA25, E#TX,.!1F^J==M'I9)I3:^UD4U2KI/D&"1'2*Y.?!=%7Q$4U2"(B
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MV-2+),&@8"VUB=EB1XRJC&$G8V5<$8 H1$71DV3E8P) JJ4HCQP'D'YA@7L
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M?(P!@4MIOO2D@Q=RK';VJWL0P-\3Z59['IKF.9+BW7=D0=O$9DZ#94[5LHJ
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MC%]*S#YG%1,4Q=R<K+2;I"/C(R.8H'<NWT@_=G2:,V;5NF91150Y2)D*)C"
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M=KR#M%-=04R^(!^J5$0,!CE'DIC&X#D! ! Y@-Z@(AR)N<#[8# 8# 8# 8#
M8%&FX&)L;!Q%3C!K*1CD6XKL'J15VRQFCI!\V.=,P<?(V>-DU4S!ZD4(4P"
M@&!8%)T9J#6\G^[4#6E(IL@*3Y([VMUV,B71TY)1JL^3.NS;(J'3>+-$U%0$
M1\SIE$?4,"6,!@,!@,!@,!@,!@,!@,!@,!@,#'_:O5W0VZK&QMFS-8UNV6..
MA?[=1F7Q'+>06@!=KO0@I!PP6:J2D*FY=+*%:N151*993Q*7Y#^03-7X&,K$
M+$UV#8,HF!@8J.A(2&C&Q&<9$1$2S0CXZ,CF:0 DU9,F;<B:29?TD(4"@
M!@5D  .>  .1$1X#CD1]1$>/Q$<#G 8# 8# 8# 8# 8# 8# 8# 8# ^2R8JI
M'(!O$3!P!O?CU]^/3GTP/SQ]]NN/;B+WSI[7G6B/HFS-5[DFV-IME.W)M@*P
MA_>&K9%6=F&$:Q?:OV,V(RL>OY:7*+I,J:B3Q%N3@0'R );B^I/9B<</(JWZ
M$@:]5W-A=3Z+6&[O*S+=(#)@W9QJL&XZGQS<S5JT(1(.' F $R@!A  P(0["
M4K>FA(^ 9(T2DLT)YY;#V^'<;KKLY?K]64:W*VM[(4N1>ZZA7IW=*8U,OJZ9
M(MRKJ)I@J;S\BA$)+#JW7^R(>5D;=VZL_56L-GE!W)V$E:#KNUZ^UOO791]:
MR= 1DB-7/^HK>'AHU0\>^FV===L&[N7:-_E.5=95L&XZ/Z,P148]Y$; !D*[
MPLT[E(FB4MH\G3*,$&[1R_=(1)3.U?C(!OD/R8W/X8$*!]JIHM8#VM7L]N!G
M83&)S*0L71XQV5)(1%%$BY:\HJ0J0?T\#Z8% ;_9SUVU=-'K;LKV$9.&8F$A
MHM36K$3B?]*@"<:&LH!5$Q$I@ P<E$0$<"=(C[<]0ASQ M=R[>,C&LG3)RDX
M&DF&8%PF!2O)!1O5&X'=(G#R*8 XYP/9;.@C:Q5V+A(7?.UJ.[CCB*LW6F]2
M:R4B3Q4$GUJAH(Y3JIN#%4\P !\R@.!<4[TG"8J4G40[%]@82(DXQG&N4(*P
M5V-1*5M\/R*MF@U]5F15^Y2^10#$.4QS"/'.!&\ST^KUHC8FGP.Q]QZ^JRK!
MK(VD(UC68J?L:\<A+PZ2[J0;QBC<3R3667+(>:0F4(5'C@/(,"!]O=;M)THE
MJI=C==A-D791"C;$0VE4*+2+?L*IZV;H/J-"4@MEFR-73N/7E(9XHHW;HJ*%
M;BB %\$Q' F#K/J1W>X+9D+<EME,FJ4U+UN@O+W5:U%6"M4V#4"OUE2*;I-)
M2/CDVD/&)-6XH.51621!44TB'*4 QOM^N(F%V4MUY2LI_P#]4[R@Z0G>'5?K
M3N^QU:L5)4FG4='2X1I"-R-GY?D(!DC\E$0'\\"_'_3:D=3;;J?84]==@;FE
M;+O.AU2NNK.ZIL*GKP'S=VT9IP2K>':/!8.?I?%RU35$RY0  * %P-T >W^(
M_P#$<"#NQ$Y#0FI[@2=5CR-+.UC=;L6\G'+2K21LVV9R*U?3HE:-206*_3E[
M;<&3;XS^*)A5 %3II>:A0@BT=%M5V  4K4!0:$BY3BE7K6OZOIA"J/H^0CGI
MG/\ FQIN%EV[99J<1\A!)R< ' @?9_VQE-BSSR01W-_;T&]5Y4K3#6U/%@1N
M")TB($$&Z8C\?F(E$P#Q^6!]HK[94Q'1]?8CVPW*!*I] G6$VC2K-FM=:1RO
MS-V$&W"+,6-:%5_4!4^! W(AZX&PC4.MWVK:/#5"3O-JV3(1JDFY>W.\.RR%
MGEW4H]4>K*/7:9$R&*F93P(''H0H!^&!*> P& P& P& P& P& P& P.!]A_D
M.!J*W_H.;W]W M=64>Z!K+)IIFE3U5D+IH^M;%O%Q4=3%MB[*V&8G!;+J152
M4A&AC-DQ6*4) HCX<\"%]LNH>Y*O7911_L;KQ9K@\F:FI'6RQ]<:NT95ROQ"
MC=O,-1:)/EU)#YXIN"#5,542H"(?J I<"%MN='[W=;IK6XWG?L"%5?V='7LM
M6=6ZK8U$DE6[B*!PB4Y=E,*@BVB).(3<LU#IJ$;G.?\ 2(F# VCNM&:CDU6#
MF>UE0+%(13(&#28L%1@967^ 5OJEO^O=L%%4Q<O3&74\1 #K'$XAY"(X$LI)
M)HI)HI)D2223(DFDD4")IIIE I$TR% "E(0H    <  8'TP& P& P& P& P&
M P& P& P& P.IBE.4Q#E Q#E$IBB'(&*8.!*(?B A[X'!4TRB(E(4!'U$0 .
M1X  #D??T ,#L  4.   #\@#@/7U'T#^.!S@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#J8Y"_U&* ^H\"
M( (\<<\ (^O'.!A=OXGQ]G>C<F54P$<7W<,&9( +XG%SI*XR9#&-P(_I&)'@
M $.<#,PRR)1$AC%Y ?8>/Q_G@:M_N")M]VS>MNG.M7<4AN;;]BA%;[>6L3^\
MV;2'7"(D@M.P+*U72*DG'N+PXK[2LI-EW305D)M5P3S%N4APDJX?;HT[>)24
M2>VW:L5JRSW.J["NNAH6PQ47J^ZVVFQ[5A"/[ 1O!A=19$&-9+K,&\R@P7<L
M$%%$3"3U#8 @BFW1201(5-%%,B2*90X*DDF0")IE#\"D(4 # ^N P& P/DNF
M*B8D*82B)B" AQS^@Y3_ /, @'/C_/\ +@?7 I"4"T29H,RF7 B!3)E.=915
M<R1E#*F2474,8YRF.8>1'UX_E@=$*U#H2SR<(T)^Z/XN/A7+H3*"<T7%N)!V
MP9@0RADB$;N95P8! H&$5!Y$> X"MD2(GP! X   OIP'(%#Q#G@/7@ P---O
MEH];O37C':-&CF/[.0<"50R:KMR\5>Z:4=E>_"8Z:*"8)C\('X.)!#R#@<#-
MOM[%H2,%I)1:LQ=H-'=E-6/$&\N_DF*,4H5W*D_?6AHY0AG$E&@;R126\D3B
M80,'L.!ERHLFDFH<ZJ1 (!C"*BA2$+[B'F81X*'\<""6TC7=USC10T0H_JNO
M+;%3L%.*F^KKEKL,80QFDA%BD=-*0:UB8,"B*I_(I)!LBN0/\L,"?,!R'YX#
M 8# 8# 8# 8# 8# 8# 8# 8# QUVQ0'HW&@[E@G?TT]K1O86<HQ;0B,HXLU'
MG5&+NQ0#8QUDUV;]4L80S=4GR"0_D/B(FP)%BK/6-@U:'L4:\3=04]'1LO'&
M'U<&:R35%\W0?LQ#S8O2IK 59NL *)' 2G#D!P(RW)(,V5=IBL*S</BLMNTE
M-2/BT?C=J*'6>)JI-$U3$0^4@&\@ ! H<#_+ O77S8\6YDX5N_G9&*06*^^O
MGWC60?\ [A*JB^<1AW+8WBB2+,I\()&(4Q #CD?? EW 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#D/SP&
M YY]L!@,!@,!@,!@,!@,!@,!@,!@,!@,#01W<[0V?0'W5.I='=RVZJ]JC=FN
MI2O7:PU*X4H*+79)SLK6E6HLG,Z]NVM[HXE6\Q?;)&PCI]%24&HT2E#?*9;R
M*7 S:[MWIUKC8'3JRP=:LVP;%%[,V[+0E7IE=D;=8)QXTZV;323^F@89RV<.
M6YW*Z8*BF8I4R*<@ <>@:M^O'W9.Y?9/==@ZXR_7W6/3;L;*MZD1:D=L]TUY
ME8Z=7DCSRCO9FK^MB&OJ+M383*QP@(.01?W!PW0=$*!"E336(N&\SKQUDJVA
M?[TL:MIMNT-N;4E$)_:^X;X];K6:[2S5,R3%-I#0[:+IM*K$0@I\3*'@8Z/C
M6Y/U?$=4QU3ADS@,!@,!@,!@,!@,#1U<SHI=XX_Q(=%\OW1HJ2CXJRIC%CQT
M<KXM/A54.@FDZ7#Q,)2E$?SYP-F79_45\W+1(*NZUV8RU/;Z[L&I7V+MDC4D
MKNQ%6LN73C]G>0"LG$$5:R0K 4Y_G*8I0'Q]1Y *E6];WBQ0L8AN6_\ ]R2)
M8U!G9H.CPC>C4N9?LQX;S+<A%9*^1BKDG!UFW[ZHT,<1#XP)P0 FF$@8JN1S
M2(A&+.+BV"!&[*-CF;2/8-$2!P5-LS9((-T$P_ I"@ 8%8P-/OW._N ;PZ6V
M+7#+2^M*#LLLSK;:VQKC'WA.RQ+%JSH3^DQ\2W?;'B)5.$UC&2:EF<<R$G&R
M::RS<J*:93"8P!AG,?>DVM6-5:QV?:7_ %(@$]C:CG-JLHV<?W2$!_858-=S
M!:)K#UU=%_W_ &5 2;;Y'ZY$RDDX]9NHW9M/F P!=.E?N7?< W#M2H4>@:BT
MEO&ORNN];VFVVW7VK]OTVKTJ3V,K'HNBSMRF]J72(BG&OT7"KMS#+("\ED$S
M DY:"0QQ"/T_O$]LJS7IM;85;ZGQ<XM.;U5KDG)-]CZ_K+.&T7N.TZ?_ +5E
M@GK_ #[J=O&U%ZPI)PJC9=DBW;@9$S=T8/EP,W?MT?= MG>C8<]1;#HF5TL]
MJ>K%KY8HZQDF2/\ ZV8V3/1E%+!/)!HP;3<+-:M)$2CM5-(#,Y5VNS$3?!Y"
M&XC 8# 8# C[9&T]?:A@4;5LRY5NC5I>7BX!*;L\FA%,#S<VX!I#Q:;AR<J:
MCV3<CX))\@)C!P'.![+)?*O4"1:UGL<' MYZQ0U3@UI1VBU3DK)8%#-H>$;'
M5<$*J_DW29BHE#@3\<  B X$'Z?[J=6]_6ZQT/3>\]=;"N%2KI;A8*[6K QD
MI:,J8N6S#^XUV;9PHK^T?N#M-'YN *"AP*/K[A;]][]=0]7UB@7/8'8'5U2J
MFSK/8*?2K)/6N,C8><GZLT=/)]BQ=+N/!=:+39G!8 -_EFX 1 1# BB$^[1]
MO6=/70;=KM.-0M2J2$"B_MT.W=2(O97]FAW**1G_ ) SGI !(R.(?]0(?IP,
MMM4[^U'NX)Q35&P:GL!O7%6K>9=567;2R#%=X"HH(N5&JBI4EC?";D@CR E$
M!P)FP&!P( /'/X>W\," );2\9!'LU@UO9+GK*=L\F:;L:E."*L;6:?&*!%1:
M4^^Q=MJ4*JZ5'YG!XMBQ6<*B=10YCG.80P#V_>^T>HFE.C+2IK6U0I+K/WBN
MN'=9M36XSC/6ZK.5D'%GD4K:%:CEK TF^&X,HULW;G2\2H^)@# VL5Z/8)M3
M2+1HU9*3GTLL^1:-6C<#.7#5%3E<S=!(SE8@" ?*?DYB@'(X%R8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M&]6MO2:A9;4Y9NY!.O0KV6%@
MQ^+ZMZ9JD8R;5 RQTT4SK*^)?,YBID ?(P@ ".!&-$W8K:[NK19&I&KTF%9<
M6INF6W5"QO"L6CJ"9K(RT97I:0D(1RHI/)"D#DB8*@FIX\^ X$]ASQZ^_K_L
MY] _#V# A+=^[HO1E>A;/,U6]7!E,7*NTLD7KRLOKC9"/[*_38,UT*W#HN)B
M311,IYJ%;)'.0@"(AZ#@0RGW<K2AVQ/_ &]]S4OG% !.MU2V^BBA\_\ S.E5
M*Z4J!$/=01$ ('O@0_K;[I?7K:)3.XB7KM;8HVZTT]RVV!LC7U)M35[4GPQ\
M@L[I4Y.-[*W(HY#])3-P.!>!,  (8$E0/?/4]B0,[BY_63UDDYD&:[]CO+5#
MYJ@YCE#I+I'%O9#*"<BQ!*<H%Y3'^K NN+[I:3<QJ\G+W_6\$DFFNNW*MM"C
M2)'K5HD=9ZZ3=1<JZ;(IM4DC"<%#%'@O/L&!2*IW2IEKV>]UNV-0T5$V<LK&
M2#?<NLY>0F'D6XA.6*%6C)Y>PM15CI51P91=$B:((E*<0,JGY!E8TM\*Z=+L
MBR,<+YNFBJLP2D&CETDDX(4R"BI&ZA_C*J(B!>??@1#TP*@E.,G*"JC)=!ZH
MDJLW\&ZR9O)R@;Q60_J#_,2'T$/P$.,"W5+7**"/[;!&D#%<$;?$22C&WZQ$
M?G.*CITF0XMR?J%,@BH( / #@6KKO<D/L>.+(Q$58&Z8S]KKYBOX=VU(=W4'
M2;*2.W543 AFZRZGBB<1X5$AO'VP.TYN*'@MET#63ED\_>MA-)Q]&**JLVK=
M!O )BJ]Y3<J)N'2@IEY J0'$!'U].,"7T#BHBF<W'D<A3#X@8 Y$/7@#@!@#
M^8<X%H;#M3BDTZ=M+:-++*0K)1Z+%25B8-)1)'@ZYE9:<<LXMDFDD F$ZRI"
M^G'/(X&.<+VC=.+]0J+;]?#4C;.(L-%DV^QM=6M>;(@T.\.]+ 5F?D)L(D2(
MJ%%V"(HE4+XF, CQ@9>IB)B%$P<"(>H?D(#QQ@6'M#8$-JJAVC8E@1>N8BIQ
M9Y1ZVC4?J'[DA5DD$T&B'("JX677(4I?Q$<#'D.XU?%91N72':UZ4L5 RQ)*
M)ZW[*EH1VC860/VZ,5-L(9:.EUF"1P*Y^ Y@1.( /N&!\:OW%HEINENJ+^"M
M^LTZ=(040_D]PQG^F"LG(3U8A[0V)7X2TBQFIA%NSF4DUU4$C)IK\D$>0XP+
MN4[?=;6SM%JZWGJALX6%!%)%2YQ8J*N%4R\I)ID5$PG\Q$ ]/7 ]X=N.M:R*
M9VN\]7N55E1;MDT;=%J"NZ!0$0;D*"HF^05C 7CCGR'C J+GLKIL&,DM#[%I
M-@D(LIBKQ;&U0J+OZDH%_P"E44=.$6R"IC& H>9@#D0P/!'=C:D\G8&N+NH%
MA*V!&8*P8.[G5?KW,C$E%7]I:M$I$RSQRL@'F91(#(I% 1,(8%Q$V;:5(\5T
M->_/*&<N@;09+W11=.V**[9%!\@Z"9^A KE)8ZOQF4 Y"IB!@ QB@(?$NRM@
M"W%573DZ1Z#YLV3C6UNHT@99JLB[4=/5'+.;5;MOI#MTBE2.8JJXK_H*8"'\
M0MI7=>RDK&VK9]#2B#Q^R%_')O=GZH9OG[= Q1D5&L,M:@EU4XM%9$RYBHB4
M@J@41Y > ]4GN>[PJ KS6H_V8IW"J+7]TVEJUB#HB!S%643.XLQ"#\12\G(
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MCR(^WIQ@=\!@:3ON"VOI9'=@*?.;HUWW"V%<M;TXKF^.NM==WE9-9P&N7,_
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MJ4SKB??H+QD<Z7E)6180Z=7:QQ8=E!R#;]HA)4]I;G>.'C<WBLS/\0B*@B7
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M&==[)<&TF_@(NOO://51ZLZ@:[79)9.QDL*BRC8IB? 57XT_$OJ0P &Q5/\
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MNKQ,$SBXQ-3A=5NS*X< +E98Y@G45B ( /E[B _I,/B/ #P;@!X$0' ZBY1
M1#R'T'@P@4P@4>/+@1 /01# ^I3@<.0YX]>!$..>!X].?7@?PP.V P&!\073
M$> $1'R,0."B/)B  F . ]>.<#CZA/Q$P^8  @ \D. @(@(^H<<_A@=BK)G$
M *(_JYXY 0 >..?7CCGUP.KENDZ14073(LBH0R:B"I2J(JD.'B8BJ1P,FH0Q
M1$! P" _E@0I+;$'6MB1@+2P<M:&>"DY5GL03+.8NO-ZW&.)*7:W=TM^ED<S
M9@L=NY#_ "SAX$-RH; ^.YK*DI38I:N3+$7)MAZJ;JJ$*V?&*SDKW )+E(@H
M;]"SABJ?P/QY$Y\P#TP,7M5Q$<E/U.3D)HB5I2?458Y74JW/&R)HQ?=;&.;M
M&[L$W"#DS"85%8R8\JF(3\"8&;<Y>8B%CW0MW 3,L@"[9M PYD%Y&0E2LUG3
M>)0Y$R*3ET*?!3'_ $@(^OIS@?6O-9=ZF6<LQ?\ -<@C(1L*NS:_45?ZM H*
ML/J4@$[AVD!Q(HKZ"(<\>@X%Y_,F40#]7ZO8? WCSQ[!^GW' Y%=(H<B?@.>
M/4#!ZCZ_E_' Y*LF8> -Z\B7@0,'ZBB("'(AQR AQ@=A*41Y$/4/Q_\ W>^!
MV ./0,!@,#@1  $1'@ ]Q' ^/U" D$_GR3@PB8 ,(>)1$IA] Y  $!#^88!1
M5!(HF4,!2^GJ8!_'VX'CW' $61,;Q(;D?3D0 W'//  (B''(X'WP&!\U$B*E
M IP$0 0'T$0]0'GW#CTP(,%G9];6N0DPD;!;:5<Y=N1*!,SAT6VK#H,9A[)R
M,6Z;()/7L#-'(@15NMR#51$IDA_SE<#W[4M4*]USM**B9B.=V)GJNT3!8T'(
M)ODFCRN2:D>\61#_ #D6[HZ(^)N ]AP(!JK%9[!=5Y2RC1T6W[1JM>/-89*2
M:3/[^.MXWX&=:(Q\&TM-"\4<&2(Y 4?C$1X 0P,XTO\ TR\^_'(_S'U'_?@=
M\!@,#\[OW7XB(LO:/6%?LTC!.F:E!TW+P\2_BVKA^R/$]W>N:[\R3UTW6$C>
M34%$ATB<%6*3@_/ 8&_-37U"6,8ZU(J"ISAXF,I6H8YC%]> ,8S(3"'K^.!\
MT=<Z];B(MZ'3$!$>1%&KP:0B(AP//@Q+SR \?RP+Q(0B9"IIE*1,A2D(0A0*
M0A"@!2D(4H 4I2E#@ #T ,#M@,!@,!@,!@, /\/?\.<#1IV>J^W9W[HW5C5,
M#OE_2M9; AKIO1>FL];4N=40V9INO)A$R"-DERFDUF#MF['Y$#AP0Q0$G'(X
M&PBQ:=[4R0)_LO<N2K'!G(F!OU_U/+BHFJMRU#F3.;P,U1  /P'!A' Q.[%N
MNX_5FG5;9#SN=([8<2^WM6ZYB=>RW7?4%<B+-*;&N<;66,/)3E=10FXMDH+P
M0.X:F%8@>H!SZ@&V] 53)$%8I2JB0@J%*/)"J"0/D*0?<2E/R <^N!]<#"KM
MGT6U'W&5@E-FSFS(3]DK-CIX)4"W%KC.7K]DGZ;:7S*P-%&+U&433GJ)'+H@
M8OZ#)&#U PX&-4W]GC0]FL&Q+18M[]QY"8VRZAGVQ#-]^O8EA9GM=0(U@7#F
M.BX)JW:FB&B94D"H?&0B90#C \.K/LT:$TA"+5K3G8GO?K& <SB]D=Q-2[6W
M%BQ=S;DY#+OUVRK)TF*JW@ & H 00#U# SIZJ]6]8=/-1M=+:C_NQ6IM[3=;
MLZD;S:9"YVR:M>P[/)7"W3DU8I,?JW[R6GY9=<PB  7SX*  '&!D?@,!@,!@
M,#5]]W+KKN?LUU28T70<8REMBP.X-=7QLR=KQ2!U86O*2Z%A38_OI%(5>1<Q
M,FHBDF[*9 XJ#YAQ@8":#ZX[@ZP,]JPFN>B>Y+G&7S5;"NP1=D[0Z\RL;4KE
M_>NX[L]>5Z"3A09U^%1D-G)E1:(BH@5%J4H@)@ ^!9W0WKOW%ZY;2V)*[G^W
MGKO8-,L&K>OU/HUH87+7J^P8%_JO4U UU/PDO%2#4*K_ &\[?UAP_0=MR@^5
M4,3Y1$3&$ W ?;^U-?M2:DO;'8E.;:]E[SV$W1M**H[5[%R"=5J]XLG[C!1)
MG$(FE$_,FV)YJ%0*5,#G'@ P,[<!@,#@?8>?4.!Y#_# U%]E:PDX[K4*2?6J
M)CAEK1T?<5ZN"Y*$Y+.=>[/[ R-@%%I_]ZR*TMC0#F#U <#;F3V_^T?_ ,QL
M#M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"(]]OABM+[0
MER'8$5BJ18)- TJ@FYB@<1S!5ZW"306*9)6/,N@4%P-^GXA-SZ8&#/6'4&L]
MW/\ =]AV[JZH62=HW8^X,:;)R44L)XYC-:WU:XDE8GY3)_ VD3% I@3Y3,5(
MOY8&R*#J]>K*1VU?@XF%;JD1(HE%1K./(H5N@DV1%P+9)-1R=-!$I"F.)C 4
M..>,#%3O02Y*:)58T:T;#IZ[Z\4=E8Y34-BBZKM,]1=3Z 61A0)>461(G:)%
MD)DVY$/)RH8P@F438&AYMH[[C-^H\+,[<[8]Q-93$SNL6[1/55YN\>ZJFAJ=
M4EY:#C;9'0\8^++7JZN4$6,O*I%.W*^.=03$+R(!6NS0_<T6IQ%:NOVTC[A?
MY'KW4T&^L=V4V)AIO2U?C7LUM"0I#)>:&Y5/=0O7*03,^Q2*J[0$B0F%,H!@
M?H]TG+1TSJRA.XE]99!FG589D=6ZS*T_=D7S!FBTD&=UE7*BCM[;F;M(R<@=
M806%T4_F &Y# E7 8'10PE((@!AX_ H<F_CP'X_\<#\\G>V1[_VS:6Q-;=<=
MPO*$XGMBUZ"<S0[VU'2*S4>O3N'J+BRJU: +:6&RJSNMJZ/*KHRBB!!(W.F8
M/T@0<"S+-2^WND7-RLT1W$V5;:H]9V^F1M-L/:2HVZTGUHK%0KBOWRC*VRQ#
M)/=M2KAB_-#+I L]6*;Q%,QQ#D)NZ/[3V78.VEU=[;OW:Q+72-(HE=Z^1VS[
M2R<:_M$;*56+EIZ2V3&0B 1I-LFGG"J*)GYF\A\"9N4N! <#?"40,4# (" ^
MH" @(#S^0A[A^6!YG;!F^15;/6Z3MJX+X+M7*9%VRZ8B F2604 R2J1A#D2F
M 0' A">ZV:'D[E_JK(:IISS8D>[93K.W+1A!F&\Q!,W"$/(I. .!2.XY)8Q4
M3^/)/+TP,0- T.D;?<2S#:.N:]9&9]=U%V="P'5G'JPL[SM)M%.R'7745'A)
M5R!C^ADP$I0$ '@0SLU]IK5FJ8HD-K>C5^F1902\6<$Q(T3#XE%5D_7DZG)5
M'!QYYY_4.!(YD4O$Y3)@)3\>9?4?+U#\/_A@?F&WVE]SZT]H?V:K;;MNK=%V
M6[NI?=FS8G>M1;Z[;TRMO9&#TI7.MD$QGW%OJ4]8EC336]-4T16?RD<T,! !
M'T#U?V+]U/456I@;#VSO*TPTY=Y^:W:6I; ;3VUHG4$9N6_M(!CK/]X=JL6D
MX33"$(YD7$64[D%ERG6\%A' RW^VG.=B+)O#L?L#L[8>Q:<K>IR=D=/UV];&
MAYC02&GYFUDE]7IT>GU9VYHT=L\U$%@=\K$J*$5(9P/ "<V!N\((&*40]A !
M#TX_W#ZA@=L!@,"G2BBR;!Z=K\8/"LW)V9E@Y1!RFB<R J_A\8*\<_PP/R\5
MZZ=X=I[MB&-T[&733W7FH/.P\KO.17W[38J]6#9</LVV1^HX+4Z-+L3B?C=9
M+45I$H*LCH W0=I.3.O%8RN!664_V[IE-Z]?W#V;W7MI@_Z^P=Z['R^H-\:U
MDKE$=CZS'-73^M59O+3SD5=>+6A-1I(ILDU8I\T*(E/X' <#/?[1=BVI(T+9
MZ?8S86_[+V!GKD[MMGJ&[+,:?B*=65'KB-KJ6KVK-'^VH6LNT2@*Z$<JJ@+@
M.0$,#<0'KZX# 8'S43(J7P.'D4?ZBC_28/Q*8/8Q3?B'XX%B36K==V ;*I-4
MV"DU+A7@JMG4<,4A7G:V1-VD2#?K$\%%H\B3Y8I4^>"@H/'O@8I[.FXBD[+T
M'K^K:R,[CX+8^O:LS=R<).-:U4*RZKLK'1R],E$D$XA[(P#6*30^'YE?ITS<
MG*'H.!G0G_0'\S?^8<#O@,!@?G!^Z^]:L>_'6=NY8)NTI'14.],=8Z:*9%X[
MO=U#C6Y3*J&(0PB:<Y*3D3"8 XP/T?8# 8# 8# 8# 8# #Z>N!16]C@7<D]A
MFLS%.)>-(DI)1*,BS4E(\C@YDVYWL<187C4C@Y>$S'(4#_\ +S@:C-^#)J_>
M6Z!?"(FAVFB>TB[_ -"@1-1>I,$FQ_+D!'R-Z<![8&X7ZA,1 I/,W(B0IBIJ
M'3$0#TX4*44Q /81YX 0X' U4V>Q->]W9RJT*B3"L[UGZF7>$O\ L+9=/FDU
MZSL+L/6%6TI6-7Q$ZQ67B+-%:_<K$5G#,CK SET5&#DR;A%5( VNEYX#D/$1
M]1#GG@1'D?7\<#G 8# 8# 8# 8# 8# <<_X#S@,!@,!@,!@<#[#P/'H/K^7\
M?7T],#5AV7<OF/=/0CME L7JHO-5Q8R[AH456;.9MMM1E5 =%#S K9%HD;DP
M\$$_IZB.!M/#V_Q-_P"8<#G 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MC]QMONECW1T/:>OYM=LMN0_63L\WJEDV?=9RDT^GNGE/2^:WR3FOTZZR$HA
M_"546A&R9E>>"J%' PCTQV<MO8G5%RC/N#;@G=;5F8V_7=<[QN?4O2>P(:EV
MFQ(59LYK4/L^RQQ/]?-5ZWMU37*9V^O- K%=>M>#)21V_"@A^G?5=8UW4:!4
M:QJN)K45KF$@8MG2&M0)'_VO_;J+5,(I>%7BA,P=M%V@$4!9,Q@5$WD(B(\X
M$CX# 8# 8 ?3UP+?E;1 PGC^[2\9%@8OD4\G(-&"8EYX$P*.EDB>(#^//'/(
M<\@( %GH;FU8Z5^!ILG7CMQ_T?#=M>JHNL(/UD4&AOC3EQ-XN%'!"I^G*AC
M4GD)B@(5M'8-1<,ADT+##KQ@*IH#)-7R3R.!=5=-N1$7S0RS7Y166( AY\AY
M<CZ<B 5].78K 4R;QF8I@\BB1ZU'R+R)?(.%O4O(>^!\EIID@4IE5TR$$Y$P
M.*I"E$ZA@(0OF8X%$QS" %#GDPB !R(X%9*8#!R "'MZ" @/K_ >! ?YX';
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M#GTY#D/\0P/Q,23/9X=Y+'MG1,VYC-NZ9H]VL6Q2V'<E*T;4YJC7'<_9%O\
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M1Z[XT4)R(/V^PMEKA\\D=ZD1-,4G11(F5$ZA1Y$#%YP-N >W^)O_ ##@<X#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# A7LE$R\_P!=M^0-
M?48)3\UI7:<3!JRIQ3BDI>1HTXSC5)-0J[8Q(\CU<@K""B?"8&_47W (XZMU
MJTU@VZ2VI%NF:=V\I-02K-LFW;N84=:ZWCBKIG3674=I*R+%QX*JJ**&*7U'
M@ P,L<"WK'4ZQ<H_]HN%<@;5$?4-W?[38XB/G8L73-4%V;L6$HV=-?JVJQ0,
MFIX^1#!R @.!%+WJSUCDE!5D>N>B'ZIB@0RCW4.OG2AB%+X 43KUY0PE GH
M>W'I@4Q;J!U+<I$1<=7>NJZ*8@*:2VD]:*I)B'L)$SUDQ""'X<!@335ZC5*/
M#-JY2ZS7JA7F9USLX&KPL;7X9H=RJ9PY.VBXELT9('<+G,<XE( G.(B/(C@7
M#@,!@1!:.OFA+M/+VNYZ0U!;K2Z(1)S9+1K6F3\\X322!%)->8E85W(K$31
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MD909)U+2=<92XIA'+S#11@U,Q(Z%0 *!Q^3R]!* @/ 97FDR(F$IVDD<P&(
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M0TJUVW*@])LB(@WD\H$\Y.BLW2-(-3)IM&#D3)("8G B&ZK 8# 8# 8# 8#
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MJ/<:OLFG6^L6VPU[:\FZD;A&/+U9$V;I)[;(RYNHQJV0>IH,HQY-1" KI)E
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MX# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8' ^P\^W&!'S=%L38RSH]I>
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M 8# 8# 8'4QRD*8YC 4I"B8YA]BE*'D(C^7 >N!\1=M2E,<SA I"_P!1S*D
MI>3%('D81 I1$QP .?<1P.QQ,8 $@ 8H\" AZ\@(<\^_M@?4 X  P.<!@,!@
M,!@,"T-@76&UO1+IL*Q*BC 46J6"X3:H#P*<36XIW,2!P$0$ $&K,_'OZX&,
M%0VI2>_O2F-VMHIZPEZGO_7(S^LY2XP\LP9-7;E<3UZ9E(Q9*.FVBD!.,4W9
M#)@DY35;E42,!P(.!IS^TM0]D6K>FXFTENRIW%;J7LQ+2F]:Y&6OLB\=S.V(
M"!G)B/OHP>R[;)4H[B:K^Q19F79M/ "1P$3$H_)Y!^E@@"!  ?</0?\ # Y-
MR #Q[X&+=N[=ZAI/:34G3V;EGZ6Z-UTV]7VBQ)(M\NP?5S7; LC95W,FBV%@
MR6;MS!\9%5"G4,/Z0-[8&491\BE'\P 1]./7\?0?4/7 [8' ^P\>_&!B[V4[
M8:PZL+:-_P!4Y%['-]_;Q@NOM'69QCV0(>_V.EWN\Q:,@+-JY%NP6B=>OB?*
M/@0JIB 8P<@ AE$'X_P'_M_NP.<!@=#B8 #QX\A$ #D.0]?<1 .!X /Y8&..
MD.S>N>Q;39Z^IY-2?<Z>VWL;2E^BCI"QDH6]ZUL<A79B,6*_3;I@1XHQ!=JJ
M'*:C=5,_D)3<B%-1W=MLL?'.YCK5<X%U)O4F;..>;"U8HZ6$R"SI110R,XHB
MB5%HV.JJ!A**9"F$>..,"B278_8T<]78+=:MBJ&2C$WIU_[JU\DU3="=,@QI
MG"THFBFN J>ISC\8A_2(X&-NB/N#--UWS?&N-::'V5*6_KY=H:M[H825PUPU
M0I=JN$$:=A8!E(NWR+:PIO86-%P QYW)4S' AC@<Q2X%=[&?<MH_5.&I=DWG
MI_;E1@MA[.K>G:>^1B4I@\IL&X/V497((S*)2<O&1I%\^*1-5<A$O0>38&2;
M/>5\?.731OU\V.=TR^L*Z0-+U5,$#-CI$; 951VFF)I'S,*8>0APF8?8.<"@
M2/8W9$4D5RKU6W>Y*9-V<$8TD!)J$^A%(JH&19N55@4<"X+\)1 ?F IA)_2?
M U0?<FW78(F@G[%6/3.Q]=U)K6V^N-E,K\QVK4R!#H2\G-U6=>6#3,E!S;EM
M!O+ ^4;MW3H[)%5505$O(QQ$,M-;3Z]/HE#B]^]<=K;-V1IJPRCB(V19BQ5\
MMTW(Q%OD305W!^W5>2C=T^3^&0*1?A1JH;D2E,7@ K.L?NJ:WW+>MKZRU%I+
ML#L.W:+LL73MK,HG7DX1.HV*8CEI2,CW[YS&-V2RCEBW.?S2,9,O' F <">T
M.UVQ5B+'/U&WLR!,2_%^Y(0,?\_D!A#@73M($2@(<")^..<")==_<CA-K[#V
MQJJA:6MTSL#15@;U';U97N>OXE_3+8[0^=I!J%E)EH674<D$/!9F*Z)O(.#8
M$T..T5\2AF<\AU;W6^:NY5:'!NQ2@73M)PAR8[I1DBY.]"*$$S 1WX? < ]#
M"(A@8[[C^YZQZ_U=Y?=P]:MRT>BQ\U7J\[L<BM6U2DF+3*%AH5L$2V=+S"B#
MA\LF51<B(HH H J&+@32KW&FDW!4!T;8#&\2+*@;9FITE&J0  J&51/8TU2I
ME$OJ(A^/N <8&CO7&G.RE5[,0FF0ZST&RZ]B>Q _<Q-NI9C19KLY:8Z;VU8K
M5'T.Q3SI_P#V]+3%8DKC_;<9)-B$7:U2/;))K%4("@AO%E.V6TXENH<G4;9:
MHI"!$T5;_JMBL<>?4#$>V1,R0@7U$3>G\<"LU'LMN*VI/))OU-O*-?9HN _>
M6^TM/2Y%Y%H8R;R*2CXRSKR(O6BQ/ P"0 $P\!R.!"3/[ED3-;OOG6ZK]=MU
MV3=VKJ-4-B;$H[&/CT?[4JU\;)O*F\<S[LR, Z<2;54#'01<G5;& 2*E(8HA
M@7V7N1MTR"SC_P!E^V4RM_@.=->_:F0741.X22<J((*6;Y5S-&YSK"F0!44!
M/Q* F$ P*N\[C6MBU,\-U@W(_!0C8S-G#F@9M^Z.L58QDD6,4NY<E61!$PJD
M-^HA>!$  >< 7MQM50JID^EO8$$TR(J_*_\ [6BT!25027$YEG\BW22^,%/$
MX'$!(<! >.,#47N7=&S;C]T3K?*6/J_LJD5J,V;H*FGO<W>=?.X: &X--@.8
MP30[&7<S7,X[2^G4(S((G$"_-R3QP/TN8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8' ^P_R' @&[:JOUEOR%PJN]-@:W8)U%"L/ZA"0-!G*U(KHS#N4"
MQ_\ ZNK$X]93AT7?TIC-E$BBBD7D!-ZX%W06IZE%S(6E^U>6.X':QK9>T65X
MYEI IHM@G'%6C472JK"#^L21 ZY622!%E#"<X"81$0DTB12% H"<0 ..3&$Y
MN.>?4QN3"/\ / MN6IU9FGK22EH./?R+$IR,I!9LG]<S2.LBY,BW=$*59-([
MA B@EYX,<@"/J 8$ 6;KS/6*#;5-_NC9K^IJV^,L\Q&2']N2DA(HQ%D96EC!
M!9W\0XM$?%)R<<B %;NTA*@44@$"&,40RD)SZCP(<^O _P >1$/3T].<#O@,
M!@,!@,!@<&_I-Z\?I'U]/3T]_7T],#\O7W8JU-.>Z[J_PFC;KNE.B]<^OA[
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M3.B@02E)R)E!X H#R&!6JSV>G9SZG]WZ[[YJ8-TD5"GFJ4^\7 +#QP0R#,X
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M1Y#JF_RT$BE#\@*&!1$OM ?:P1%04?MZ]0$Q6\?E\-"Z[+Y^!0(3GB"_Y2%
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M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#@Q@*43&$ *4!,(B(
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M.>127*;V,&!6$9%LL<R952F4*/ D*!_(! .1#@Q0$>,#WX# 8# 8# 8# 8#
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M]#Q%TKKE.:2*[=;"63CG;^!8K'2(@[.#20 WQ <%"@'J4!'C V4@(" "'L/
M_P"T.<#G 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M+ZU,FD&Q::5H+9K65CKUY-&$2(,*JHHV5.>,4*8%68F.T2'@A@#] ![8&0P
M!0X#V_[ '^P,#G 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# C;;9':FO;81C4_[Z=FBB?!4OF(@
M$XH#UL(-/F45133\0_7R)B_TX%?BH!G'1J!8QI^S"KP_<,T3F$@OW""7R X
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M\X%41.)TTS#Y")B@(B8H$'GCUY* F H_PY' ^N P&!QR >XA@.0_,/\ ;@<
M8H_CQ_ 1#G Y\B_F'^T,#CS#_?Q^'K^/(>OM@<@8!_'C^8A@.0_,/]H8#D/S
M#_:&!P)@#^/\N!P.V P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P.!]AX]^!]_0/\ 'C I8MWP*F4^
M81()0 $_D3*F0?+D3 'TQCF-X^G]8 /\,#L";HXD**@%* \F,42B8WY!ZD
M ,"I '  'Y  8'S6Y @B4 $X /AS[ ?CT'\?Q_G@1'*TNWR#QP[:[%O40#@Y
M%"Q\9(4DD6T*FY2<?$T)):XE7I2+)IBB8%%U3%3.80$3 !@"_:O&2L3%I,Y>
M9DIQT0ZAS2$LO&.7RH'\1*0ZL1"U]D)$N! OBV*/YB/X!<8\^G \?G@1 _M,
MJ\=3;*NVFO?ND'/?0/HY;X79D&Q$6SIPT<% 6JK)X5JX*<#C\A2^8<@/.!1)
M*.VDX4N[2*OB+59XSB92K.G#**67K:H.5D7T:ZB"1A/KX]R@7R!P=<%!4#Q
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M7S9?$<OK[\!S@7DU?-W0G(D81.D<R2I#?I4(H3^H#$']7 "'O^(X'MP& P&
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M' ^P[6E56J)6&OY]Q-++S2)*^JX1;N520R9Q6<?7'+]*W;K+% B9C@/R"<.
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MP+SUL,@9G*'7G6EBA_W-4]9E2%7"2<1JP%452E3*&!L*K9R82)?"1,OQ 'D
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MH@BF @/YAP0  ?3 ^PE >/?T]L#X@U;@4Q 2(!#G%4Y0*  901Y$X_\ UA'
M^W@ !P'H''  '   <\^GI@ * ?B/_;_# X43*H42G#DI@X,7\#!^0A^(8';Q
M#Q\0  +QQP'L 8'R*@0OEQS^L>3\^(^0_P#UOT\CQ@"-D$^032(0#")A I0*
M F'CDP\>YAX]1P ()\@;CDP<^)N  0Y'GD.  .>0P.3()',4QB@82^P"4H@!
MOP/P(#P<OX"'MR/YX R")RB11,BA3%\3%4*!P.7\0.!@$# (A^.!P1N@F4"I
MI)D(4  I"$*0A>/;@I0  XP.112$P&\ \@ 2@8/0W!AY$/+WX$?7CVYP.WQD
M'@!#D ]@'V ?S#\AP./B('L4 X_+ ?$GSY>(";_Q#[^W'O\ R'C Y^,G_A#
MC.^UQ],0\C'Q4Z]K$A+&:$9V")8H(OX99JN"ZKM)Z=J<J*KI GTYC'Y 4C"
M>O&![(^(32B7?RR3N0<*O)!Z19!T"S]H20D74D,:S<E\W!&+3ZD4$DS#P5$@
M%P+GB(T6HN72BSHQWRB:Y6RR@_"Q*"8!\#5N'";8HCZG H>IO7 KF P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P&!P(<^GK_ (8''B'_ -'X?S_G@=L!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@<"( '(B  'XCZ!@4]67C$7I8Q209$DCH&<DCC.VP/SMB"!3N",
MQ5!P= AA !,!1 !' ]Y#E.4IBCR!@ P?R$ $/]PX$$=C>R>I.J6MUMN;NGI.
MJZ[93U;K\M9F-4M%K9P;FTS;&OQ;^>3JL5+.(6 3D9!,'<BY(FR8HB95=1-,
MIC $\X'43%*( )@ 1YX 1XYX]\#J<Y? WB<OEXCX^H#Z\"(>W(X&)E5V?OJ1
M[7[-U;;M(+P6AJ]5JW,ZWWB@Y^N97R?DH]BZF(-PV;NEQAEJVX57;G%RD@"R
MB8"D)RCS@0AJW>A;M]T#M!I* F=@/(33W6C1$[<HV1G6\EK)C=+_ '+9*<&-
M7A_KE75<M18.L/"RG^2F1ZB9N(B/PE# V3 (#Z@/(?F'K@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@8'_<C[M5W[?_ %/O?8:9KO\ >$XQ>P%-US457[:%C+'L
MNZ2B$'36-@L<@=&+K-:;R:X.I%\X.4J+)NIX>2PID,&O[HAUNZC[%O5#[+;
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M& P& P& P& P& P& P& P& P& P& P& P& P&!U,7R_$Q?7GDH\"/'YC^(8
M"@  ')C?AR81'G^?X<X'; Z^)?\ PA_L_G_WX'(  >P '\@P.<!P'Y8# <![
M\>OYX# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
D 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g923794ex10_3pg045.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_3pg045.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"6 *L P$1  (1 0,1 ?_$ *\  0 ! P4!
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M !M^1U_+^;0?.A?YRMW]86W]E*QH*AT#0- T#0- T#0- T#0- T#0- T#0-
MT#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0-
MT#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T%/0O\Y6[^
ML+;^RE8T%0Z!H&@:!H-!,4NW<8I=QV#<0#<?78-_CL&@"8H!N)@ /M$0VT&@
MG('J8H;=1W,'^SH-=P^T.N@T Y3?DF*;<.X-A >GV]!]- $Q0#<3%  #<1$0
M   ?CN/PT&NX;;[AMZ[_  Z?AT&@G( =PG*!>GS"8-NOIUWVZZ#7N+OMN&X
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MT4,EMN<Q]QW 1V'?TT&QQXW:T,<WCW?++FH?Z=(44'BG(>SINR[F$2J&7(!
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M'Q3%4()-@(\BUB )=]]]O70?*)X^UO>(JOS!YD+@FX*X(3]<CM(FX;[D,";
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M-;!=8.)/8EZE+QDE5[&]K .0:$M$1$3[9@]E:^HY'L!T@0Z0#ZB&@];G.6^
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M"6W7NT%Y_%+F_A/F*^S8RQ O95UL!Y1F<0WS[\A'$6W+;H01^M)%++;ED&A
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M;BMQTR^A;)8'39O,GC6:ZH)H=GN"0.XQ3#WZ#)C  * %  *     !L   ;
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MRZYH\J)3"EV99)Q?3LXY2B9*DUV]1>XQ-E<PT%68Q60>1QS"9$IW );[;E$
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MBGE&FGV_'M+!MH- Y><6Q]>16#@_'E.F;_NA][AMTT&H<O.+0F @<BL(B(B
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MNHO'R$BW=H%63$#%[R%[BCN&@I[_ !6\9/\ YH'#7_634/\ Y+Z!_BMXR?\
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MD?ZL_BDBR0*_+.Q'WDSBVI2G?U%N4'J*9"'(S4>5I105G1C )B@<PB/0/38
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M4Z]V^@E/XL"!N,7'(Q3%.4<#XA$IRD!,I@''U>$#%3 1 A3!U /AZ:#WC0-
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MG_Z>>&7_ %+9+_[0= _0?RS_ /3SPR_ZELE_]H.@?H/Y9_\ IYX9?]2V2_\
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MRAUJ+Q[ M+7G+,=QC,6X)JTI]0C6Y3(,RFLY!Y;I5EW+0U3KT$T>24@X( J
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M</'1TVZ)2@.^YC%#\.@AZS]YSN'&*;RXPYB)ODGF%G$#%;H8TXM5(^3#HO'
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MJW<HG$IRB [E$0^.@[T/"QD!%QL-#LFL=%P[)M'1K%H@F@W9L&:!6S5JW23
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M\F&PF,;O,8/IQV[0 /30<:ED_:D4SI%+0N"BI3.%BG,$]);%2,(%2,;_ (,
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M/R3XT1]1Y&24+,R%<S-BJXO9:I#" ^!"(;2-<GW+>624/(BH9R=-N.X"7L
MW$+C^$=N\@ZO(K+>+>7>7.,V3H&@8YH\VJG@RKV2!E*_;;Q*6,T;$3OWT[>
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M1F*U3E9A4J?5)N2A2VJ790\=+V1NQ56@X4B[QTT]]Q(/TR$!),_N&+W;!TW
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M4IS('I6>V^75[5DBI+SL2E-KQS6OPA(MR^J;YFV<+=H"H2/1W$P]PZ"8'0-
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M_#?Q_P#^@_$7_5U4O_D1H-R?''C^F;N+A#$9#!Z&)CJH@8/Q#]S[AH-Y^.F
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MN(E_A++!P<'QZRW)9(LT=)1*D@\GF3F'3:M6$$[171%DL5RB43J'*J4X"':
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M<DR#Y0/!$J9) ?;Y/Y+_ #YW/8LF'Z#-Q$$VVX J40#<1^&WX=!D5%$! -A
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M.%PUY-?+>$_4<F65*PWGBP,>?'..[#=RM_9Q+,('+*F@FKC[O.)@ 0!381*
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M\8:#&M_9]A#];'FA 4S_ "^2Z]"*HA^;$#5:/#L*/J)B=NYOL P:#)4T#0-
MT#0- T#0- T#0-!XGGGD5AKC)0ELG9TO<+CJC(3$5 JV&>7]AD65FESMXQF
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M!H&@:"Q#DB@U'EIP'=**=CA*[9M22+\#$5PY-B81+Z")#$#8?AH+[] T#0-
MT&T_Y(_N?QAH,9[]GS$GZZO-7U$3_P"LAM70!#;M_1_H/I_G;Z#)CT#0- T#
M0- T#0- T#0-!:SS SV]X]X:>6ZOL&4S>;'9:ECK&L*_<-VK66OM]G&M>KZ#
ME5VJBB+5HLZ,[6*)R"=!N<I3 80T$4_,W@W@C'_&C(6>,D-&69^4S^PXG=67
M.5W%G(6IM+.<J5'Z^.H;%,?NW'M:9J*G1:QL4FBB@C\HB<1,80GQCP &340
M [FS<?W/83[0'\(%T'=T%@7,'QB\,N=MFIETY*8QD[9;J!#RE>JUFKM_OV.I
MV/@IATB]?Q"DIC^R5MX]CU7B!5037.H4I]Q#U'06>J_L[7BK<)^TYP[E1RB)
M!3%!QRBY*+("4P"!P%%3*9DOG >O3KH-&/[.SXJ8Q%NVC\-909MVB1$&B#?E
M!R420:HIA\J+=$F5"I))@(B/: ;;B(Z#J+_LY7B9<RJ,\[P9D-S--43MF\PY
MY+<BUY-LV5+V+-6T@KD\SMLV6  [TTSE(<0#<!VT'TS?L]/BR42!$<397$-C
M)"8.5/)CW3;B(&**GZU^[NW';IMMZ:#YS7]G2\43(I"LL-9.:)HE["IM.3W(
M]LFFF38 2*5#**?M(I[; 0O:0OP -![5@/PF^.3C7EJM9OQAA><+DBG*N'%3
MFKKEO*^1V]>?.$A15D8>'O5RGXAE) @8Q2KD0!4A3#L(#UT$K?ME%/V]Q O:
M  )1 H[!Z;"4  -!&#R0\-WCZY797E,W9BP].O,FSK)BQGK-2\L97QDK.IQH
M+E9K33+'ESK4=*/44G!DP772.K[6Q.[M*  %O\A^SJ>*261^GDL*Y,?MA617
M,V><G.2+IN95LL1PW4%%QE)0G>@X3*<AMNXIB@("&@#^SL^+("*E;XHRXS.J
M!_SS3E'R/263.;_TB9_UG&V.4>H;@(;AU =!>WPW\</$?@22\#QGQY*U)[D=
MW$O+G,V*]7?(<]-*030644DM-WR?L,DBU9MQ$"I)J$3 3";;<=]!?,([ /IZ
M#Z^F@AZYV*/"^0KQ-))F(+ ^3,_G7#=4J@."XM333.44U2%'8JYMNXI@#03"
MEZ%*'V%#^+0:Z!H&@:!H&@:!H&@^:ZB(Q\9([QBU=G1,)T3.6Z*XI'$O8)D_
M=(8"F$@  B'7H&@[8H$$  1/MN([ ;;<1]0'8 W+^#T_!H.JYBF#TZ2CMJ@Z
M.@H55 SE!!?V%2"4Q%$052.5)0IB (&* " @'7H&P=Y,@)AL F'<1$>[;U'\
MH>@  =P]?LWT&_0!$ ZB.P?:/30-!#IQ$>1L'Y,/+-*OW32.9I,.(3M^]>K$
M;-4$T*1DDAEW#@^R2*92%#N,80 -!+A&6*%F&+.2BY6.D&4@)RLG3)VBY;.C
MI"(* W<)',FL!>T?30?6^50ABF$H@8!*8 V$-C=.T0$3!U+H*=AJ?5JZDX0K
M\%$0:#MXYD':,-'L8Q)R_>+'=.WC@K%!#W7+I<YE%#&W%0PB)MQT%0+)HJ@)
M5>P0*41,!NWH0P" ]P&W#M, ?'04PG$T^D-)J9:L8*MMG;H9>PR*#>,AD7CD
MQ$6ZDI,NTTVJ;E<C<A0%58PG$I0W$1VT%I7&R1CY;D1S+DXMPT?,7=QQ2HVE
M6+QN^:.TAQDQ$AT5&RJJ0E H_;O\V@OCT#0- T#0- T&,5YY9N_53F?X8;;B
M^.J,Q>X+DSD-:MQE[DG\/47<BI1"=A9Z4BV[M^R9$3(8>])(X@?8-NN@M6\8
M?*_E;A*GV^QT/CKA^Q8IS'Y$9N@Y)L+3D!=;Y9'5YR1>$6UAE\;0\G"D;HUF
M!CS.5P9^Z(I%:'$_4VV@S'"CW% =P'</4/0?W^H?^+0;M T#0- T#0- T%/0
MO\Y6[^L+;^RE8T%0Z!H&@:!H+&.22(&Y3<#7 B4A6U^S,4QS=PA_PO#DZD1/
MH40 RIR;!U]=!?/H&@:!H&@VFZE']S^,-!C4> ! K7.GFQ;)B0Z1/)':3)J%
M+VG$IZV3Y=]Q^4HAT_#H,EG0- T#0-!2DW>:A6U?8L%E@85;8IO:DY>/8* 1
M0PD3.)';A W8H8! H[;"(" #N&@^.&6L8[D*.0*64R@@5/NM$&4#F,.Q2E$7
MWS&,(] #XZ#4,LXR,7O+D"F"7L]S<+1!;=FX@)O_ (_^ AH-A\NXM3V[\BT@
MF^VW?:H, '?T_P#SX=!N_6SC/M*H%^IIDC (E6+9X041 "]P@"GUP )@#KMZ
MZ#4,L8S,*0%O]+$5@W2VM,%\X;B'3_A_VAH 98QD)"J!?Z8)#B<"&"T0>PB0
MPD.'_P ?A^28-M!Y/F"O\7N0M7;4K+SK&-]J\98HFQMH>:LT>+=E9(,3N(>4
M1,TDVKA%_'F5$R9R*%$!,.@C)\@W'OB)4.*]SF\=UZBMK=&VO%"D$\96N1EY
M)-R.5:6HH9DT=6-_[IR)F,(B8AS% WV:"<..'_@30-NH-6NX_;^83T'=T%IV
M>><W$OB_9(BI<@<[4/$\_/QZDI!QEO?N8]S+L4#"5RYCR@S43=)-A[?<$AC"
M03!W &X;AXD?R[^-1/V._F/ADOU7>+?>><?G2I 05#%W8@/R@?06W\J/,3PK
M3PQ>8? //GB52LYS-;?H8WE\K6]ZTJD=*G$R(2<@FUBG3M4S,$U!2*5%0!5*
M'<4P;E$+':WY:,>+U9W6[KY8>$R#V!:8_F8.S5>^P*%AM<I]#(*Y.J4^YFZP
MYCF,*9ZZ3+"O$V)'1P22%<H" E.%"5GR\+XOPGCUM$^3CQ\9SS38KO-S.5#9
MBRHA"1- HCM)9S7:[CV5HU2B6MIG6"()INEI%LB11T8P"(% !$*5;>8V_35'
MHK=OY//&A7IA:)B'UC<R=S(E:&$LR;,@?0DRJ#"6@WC.<!-RJNX9)D73<&31
M)L0#B8/8<'>;=D&6ZFQSSSU\9I<*-4I9Y>YRM9.ESY&7!1H@$&S@X]FT0KZ4
MB6536!< 5.D1BHGW[K 8-!+<W\OWC1<,T'K;F1A5=HX AD72-B6.U5*L '1.
MFX%E[1DU2FW*;?8?AH*YQEY-N!.9;] XMQCRGQ#<,@VAV=A7JG$V4BDM,ODT
M%71V<>BH@F5RZ!L@<X)E-WB!1V#07N24K'0Z*;F4>LX]LJY;M".'KI!HB9T[
M5*BU;$47.0IW#A8P%(0![CF'8-QZ:"C,K99QS@['=GRSERX0>/\ '%+CTY6U
MW"S/2Q\' QZCINR(ZD'ABF*DF=V[32+T$3*'*4.HAH/G8HS9C+.-6;77%-KC
MKI5'C@&[2=BRO"L'8BW:NRG:+/&C4':1FKU(X'3[B& W0P]=@K&VR*D/6YZ8
M36;H'B(26E"*.B*J-BBQ8.' F<IH *QT$Q(!C 3<X@'3KH,82D\W)[FUR;\2
M&5K+4R4QXYY!<QJ6$0U!<C=TC3:.UCXJ?^[WYRR\:E-LA*Y2(Y33.=%0I^T
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MS.<V[61*:"F'\(\%5!'&+@A %W'*=OSCN78?CH.CQ]Y<9VY)X[#)F/N/E*)
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M.<A0$IE"@8=Q ! /7WOB_P#'L1M]0XXC86,2. 7J0_HR5/V3M0]TI@,5P80
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M7D_#\G/-$7">(\17V.=^1BQJV%QDO-%GQ>_B78UQJ5)&.85_#>4$Y1!2/_/
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M)H8G3Q17SUT[!PXBDZP$LK?R.@#VW!G'R>@EW$ FV3'=,@[[_*'7TWV#;?\
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M'-W&:M!,/01,V(81 ?7J([]=!J2-9D  (V;$*7T!-NF00Z[_ "B =-QT'>
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MWL&X]WP$)+_]<7GB,=19[IXE>=U K3F;@H62MMKB\=1D)"A/RK.'9NWSI:Y
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MR2J\8_8OT"*% HF2.JT.J0AR@8-P$0$-]!9!S/\ (+@_A%+X1K^2F%WLUIY
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ME*<JB2Q5$E .7H.Y1 0T&.=X)FB##DGYNF+-N@V9MO(S((-T&Q"I-T4RT5F
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M/K3//<049>8LDHJHO)3L@:#: ZE7ZRIU%5'CY4!44$QA,)S#N.@N:$=@$?L
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M=B5'$1'+-WDHM&MFS(SU?M*BW3W]T1$>F@RY@#8   V  V /L_!H-= T#0-
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M<1('D9<F G3;N-0VY3#OT'<W8 ?N:#(VT#0- T#0- T&PZ9#B43  B7?M$0
M=M]M]MP'[-!KV!]IO]^;_9T#M#[3?[\__G:!VA]IO]^?_P [0.T/M-_OS_\
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M=!OT#0- T 0W 0^WIH-@$ /B<?QG/_%OL&@U[0^TW^_/_P"=H':'VF_WY_\
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M\0^6\5-Y<E6L>3.553=)6%JU:23"5J=+)%3+)=JS?O2I*H24:/8<Q@[B#U*
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MR2XO-JG:9PMU4MC <0.WM;Q:QJL&I,42;A;"I=R,[Y)9D<HF1<Q@G;'@'!B
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MJ%DY:)L]@Y)SD<B]CG[11,\TK!J"['N4$FY@V#-+2 033 =MP(0![0$"[@4
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M3E J@\1H8$@4  $Z(6O*PF5;[]3$ _0VWH;UT$PV@:#8*:8[;ID'8! -REZ
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M+(8B8;9[S6(%$A=@,7#LCVB'38#%*'0?@&@F/#\'I\-M T#0- T#0- T#0-
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MDQ=9'"+>NV2WN!5%Q.2;D\$NY(JHT,Y]T"IAEMHAVI)%$A2"5,@"0@;$)L4
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MYI>P2DW .:XFWR*6UT99")*F@=B5%\J+H>X$P 0R%D@V33#<1V(0-QV 1V*
M;B   ;C^(-!OT#0-!L.3O+V[[;B41Z .X%,!A#K_ )P!M^#?0<7TX>XFIWF,
M)-P^<1,.P]WH/<40-\WJ._3X:#L:#YDPLU;1KQP]4!%H@W67<K"H*8(MT$CK
M+K=Q1 P DDF8P[?Y(#H,#O)F8J)>,2^4DM0R">\D;\N^/S: ?S"3U.??U(W*
M]K,%L17CNM1<?(-'";]) OTCE4Z@$]U8"G$V@SP8$W?#19M]P%@T ##ZF[4$
MR]PA\!';0?6T$0%B:D/YFZJ\$I"*M^*T*@0Y40!5=%Q.93.8BB_N;BDDHEN
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M@_@*=8>F@R-M T#0- T#0- T#0- T#0=-\"8M5?>,8J(D,"O:3OW3,0Q#;E
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MW7M]=OCMMU'\7QT&+QC&H83Y9WKRDW#GMD61QWDG$^;<A8XIZ4ADV2J#_ 6
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M(R^5. CZ@O1VWY._J)11'I^'09'W<4/4Q0_=#0.X/M#]\- W#[0_?#0.XO\
MG!^^&@ (#Z" ^OH(#Z=!_>'0-P^T.GKU]- [B_:'[X:!N'VA^^&@T$Q0]3%#
MKMU$/4?0/QZ#7N#[0_?#0-P^T/WPT ! ?00'\0[Z#C5(FJ0R9QW*8!*8 -MN
M!BB40'X" @/H/0=!CX^3;Q\<=L,<)N5=BXZT"N8CG,OYJP)F3+SB(&46;6F1
MIN7ZM)/5V\:Z?.V4.Y<IO7!RE9)MD176,82"(CN$_=?$HP<2)#B<HQ[00.("
M F[D"&WV'J'KH/L:#'&Y:-FJOGSX'.@(95XCCI=J<4R+=B;-:J\@C*@N*8@F
M)3'.4HB?</0/707[\W9>N<8,D83YMJ2SBH0<)<X'#G(9Q$03V<<7;$UT^\VE
M91E(V+:NGKMS3<AR+5VT<$(*S<BZY-_;5.70=$?,SP'VW#)=J[=M]QQ9D,.F
MVXB/_%_IH.J;S3^/I,RA%,L3Y#(D]Q8A\:WPATD]M^\X'@RB0OX1^&@B\\RO
MD?XO<GO'5R%P[@RUVB[Y%MT;4AJ\&PQ_;&WWH:-N$'*/A1?/F#-B'TK)J<3
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M@XCC\G2>6FZ9\:5ZI3M[O4_=D$TR+&=L(Q>PG181;%-8JKAR[%LW0 0$YMQ
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M#:=$YDS?XJ<F%,)=OF(?$<R0Y!$0'Y3 ;KH)O2]2E$>H]H;C]O30;M T#0-
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M=S7>,?WJYYIY;K-5%Z+5).I,6\=1<"S];;N';*2FYO=\^;*E4.1-0$B*=W8
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M/OML B 7=6BU0%+K,_<+1*-8:MU>(DIZP2[PXD:14/#M%G\F_=G*4YBMV+)
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M"M<XC(8PNQ AD<\<B):)>LU*A8$10.Q>X18(*O':BX=[=51-+=,_>H  .@F
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MA/\ 4GROQ.ZXQ>6)"Q\H[<:=/F:"P)'5')N.(ING3BQ]:J-@KKAFNBUC$JB
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M2XVN2J,G[)R1-PS=H&*<JB:A2G(<IBB "&V@R,$_]&3_ '!?_)#0;] T#0-
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M.$5%DT"BD1W./Y!XDB0B1>Q,#]A ] #?05[H&@:"GH7^<K=_6%M_92L:"H=
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M^<UO,N-8BQWW.%2:U^VDKU70I62JO&PM$;6YY7DZQ.-[G6)%XN^49JJ*,VY
M5 0!0-!*[P%Y;VOE7$WY6RQ],=DI9J(JTN^-1FCT:8=72C0]LD:XQ=3B39X[
MG*@YD1;/C)%,A\Q-C ;N* ?/\IB:2'%E!?Z<JPDS_P 7E%2AOWJ KR$QVB!M
M^\HB8ASE'XCL&WIH)($]@ 1W_+,)@#ITZ &WX?\ Z.@Y-] W#[?_  _\ T&F
MX>FX;^NV^@UT'"NB1<@IGW !^S;\0@(" E, _$! 0$-!:#QTBVT;FGF,=J9
MJ3O,-.#Z=$H%!J#7#E"0(@9, *FF78HF)VAL &'07B:!H(&?*VE'$YA^+]XL
MH*4G^N]PT8F[SI]Q%+MC(54P%,0$PF*41V'<H@7J'303P>V11$R8AN4WN$,
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M]@B;P]4X698Q-<>3%KB; XLCI=JH[EV"L:R*$I"R59.*:+LKHI 56./M )
MQ@\<@N5V6V_DA4P2_P O8QO&*I-Y8X%EC6I_=HY,QM+1=3:6--UD1FY@0DC1
M9B(F3(^(^,0ZKE,@&'<0$+SN.\^$CF_F5#_*8:_F*FH'4^G31-W2.&:#( 7W
M$^TSGHK^6)?0-M!>&80* F$0 "@(B(]   #<1$?L -!9;R5\B/##AY882I<E
M\_TC$5EL<2:<A(:S*R8O7\45RHS,]33C8Y_[;?ZE(2 8_: F#;00>\N><O$;
MF]S.\:T'Q8S36LW6FE9P<6">BZ2RL;]S!PY9BFN#2KX%(!-!-A](P7%50YTR
M(@7<Q@$ *8,I!$2BF':(" &. ["(@!@.8#EW$1$1*8! ?PAH.70-!'WR6R[=
MJ3S&X"8YK]@6C:IE:S9V;7J$0<-DPG6U5QHWEH,':*K95=1LQD%S*![9R")]
MM]P#0> \N_(3GS%N><@X6XY<>JCEI/ N 1Y&9WL%[R.O0TF-//\ I0LRKU&:
M-H*76G[(]8U-X?\ .^RW(;L#N_*T$1N)/,[R6B+_ ,Z>2R6-V^3N"E/R+QLL
M+AW8[\TA\E8?K&;,9X^!C!T2H,H1Z2>23F)\)!T+QTB!2B8J?7< #TSA-Y3N
M;@X;K=XR=B**S-1<O<M.1G'W"MV>WE.,R-,Y!CY&[RN)*Q*U9I7FT+'5!]+P
MJ5;2=&7]U$_:L?N#U"6/BYS_ )3D_F+&^.:KBUNV@G7&^.S!FJUDM)'JF)LC
MRED>U=CA99BV9G2D9UM-5Z5!Z?WDQ;E8@)B_G=M!*+H,?OS4Y>QO@G.GB6RG
MENVQ='H-5YG65Y/VB9%R$=&-AQ%="%4<?2-W3CM,?8/E(;J.@NS+YM?%B=/W
M2\S<3F3!(ZH]JMB%0 1(*BX"B, 50/:(41'< ]/MT'%)^;?Q71T:^D7G-3$C
M)BS$B#E^NXG$6[59P4/IP457@3)$,H)@$O<!BC\>F@@ZF_-JHI/U-N7RE\,6
M\!<,NY9B\G/X0K3NI& W[5ZIAV;QHV>T))ZI?X^0?*$DQDC. ]ADF(@)S=XA
M]G"WFWQXQ+G!WD7R58?&1@,-Q45@EG:KGCNQUG(68&%..FK+SZ55QA"3E?BI
MRV]@K)J+G$J:@C[@!VE*%OTUYT\ZP_U\M7_(UP*FWR\!C]>3KL\YA4:RQGGW
MZ2QU[945_'U5O-F;PC)I$OBC)&<D7>O3[A[!!2T'1JOGVY(OK#6V4KSB\;$3
M4G$Y Q]OLLM8Y&2L==K*(^W/3]<@J]5X.'FG:H+%<@W5$1!1%1,2"D<A0#(F
MJ'FW\6TQ!-7C3G!AZQ$0;((/9.--/D;+.D4P3<./8^XMVYUE $PI=P^V'3X:
M"H%?-=XM$3I$4YE8K(99,JB8F-82E,4X )0W&#Z&'N#IZZ ^\UOBZCC+)N.8
M.-?>1*)OIT4K(LNH'9WE!),D$(J'4#\D ZB.@O+X]<H\#\JZA(7OC_D6$R75
M8J5&#D)B#)()M6TN1FU?G9&^\63%8QP:/4C@8I!(8IP$!'07 :!H&@:!H&@:
M!H&@:!H.-53VR"<0W O4>NW^SH([H.=RAS&MUODJCD>;Q1QCJ%KL-!8OZ.1-
MCD/-%@J3H(6X.TK'),'2U,I$196S^*34CDTI%\LQ.LFZ32[0,% >+BNQ].C>
M9-2BI.<EXZL\W,TQC-W9+'8+9-&+]'45E2OIZS.GTN^4]Y8Q@$ZIP*!@ H[!
MH)5- T#0- T$5_.5VDVY?^+,IVQE5'G(W)S5-P54Q2H=V$+0)^Y(1 IQ-V_9
M^[H)34QW(4?M#?\ ?T$*GG!SUE3$.!L&4+%)JW$R_)+D_A_"+R[V6+6GFU"2
MFK(UF&5E;0)';)M-+MY&(2*9LX/[*J1C ;X:#LS7#+RKWF,8P%Z\DV(9NIB]
MB7LE%-N%U$9.)!&.D&;]-,C[](U5&+@I6_YM9$"G(IL;KZ:"9F.07:L&39TL
M1RY0:H(N'":0($7732*598B)1$J155 $P% 1[0';01MYYX[XBY3<F[UAG.-7
M_3+&\SQWQS.2U>+*3,-]3*5O,RT[ .3R=?>1\JB+23B$S^T18J9RE^<#%';0
M4-/>%KQJ(6&Z9);<9(.-N5J3ODI892O7;*5:5G'5V:LU;61XC7;K&MSMY0L6
M4"H@0"-_<6%$"&74$P>-M>;B?##A]QOMLA5&%V7S9DVQ4YH@:RO:[&5>QV>X
M23>#BI-^X:VB5:Q[5ZH#-R[5*;V3H^XML)AT'EW)7RVX9-@RY6O(''6D9KIN
M-G%U7RS7FN4(:QQE>F,1W2 IEC<0IE:FHC8DZY.VAF<RY2-Q,B<QTP5]L_:$
MQ/%5:EV;"./<BTC'=0Q?&9%K$#<QK5+2B#PY"S$:U>-%$Y"'91K:0[V9TMU?
M82.82[" [ (A<KH&@:"GH7^<K=_6%M_92L:"H= T#0- T%F7*Z0;QEYX@J+@
M8?KN2]?B4MAZ>^_J%P22$0 !V$HB.PCT#<=!>;H&@:!H+1.<R3]?C5D1O&2(
MQ#]S$/VC64]LZY8]1U%R*'U9FQ?D<F0*<3$(?8@J 7<0T%PV.%E5L>45PY/[
MBZU/K2JZGM@G[BJL.R.HI[1!$J?><PCVAN!=]@Z:"I32T<5P+/ZQ SL""J=L
MFH51PFD4"B951$@F433 I@'N$ #;0=L5TBB &/L([[;@8.H;CMN(?8 C^(-!
MM*Y1-OL?T#NZ@(;EZ !@W#J4>[H.@XU738.Q(ZI"G7,*2)3&]LRRG;WB1+NV
M[S 0!'IOT*8?@.P0.9N\6W,*5Y3Y[Y*<5><"?&Q_G25A7<ZTCL9M+)(N&474
MJ[7$F,J]DY<C=PBR>UM-TW,@BF8I5E"& P#MH+6N76!_+WP_XV9<Y*RWE2G<
M@,<1U1Q:G=/98=K<6M-HMOI$5VB;TZ[WZ7WG)^XI^PXI$WV -QT$VWCJR;<L
MZ\$>)>5\FR2MENF2,$8^M]PEY!)$KB6GYJOLGL@^>-TTD6Z:SIXHH<4TTRII
MCT*4I0  "[24H]*F5DW4S4:S*N$'"CQ)>1@HQ\LDZ42314<I*.&JIR.#H(E(
M)P'N$I0#?8 T"*;4TJ[^/AF4"DX9N4%I!HQ8LT3HN]A7;*KII(D_/@!A,0P_
M,&^X:#[C6.CV*CI5DQ9M%7RYG3Q1LV104=NCD33,X<F2(0RZYDTBE$YMS;%
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M1^Y,62]!&;D%"E09R4P[&$=+2\N_6]M,'3IP9990Q0%0XFW$0O*]Q(@!NH0
M'T$3E#<1'KUW !$1T'&9VT)OW.FY>T0 W<LF&PB.P .Y@V$1'0;_ *A#J'O)
M;AZA[A.F_P!OS:#0KAN<1 BZ)Q*&X@54AA -]MQ #"(!OTT&I%T5/]&LD?J(
M?(H0W4-]PZ"/4-M!R"(!U$0   1$1Z; 'J/X@T#<-M]PV^W?I^_H.+ZEO_\
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MW0:/5#++2"QS*'303[3!V  E >P-NH>EQWCF\Q;!L";GS&3DBN K;K*8:BA
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M'=W!^2/3;X@.@^LK^SAT<Q&!4O(/SW3%J5Z#DQLR2)_JC.>\J1@_.E]H$$S
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M$1_E124&JP3D#?F&U1G!7)N/S^YD3%()[%]#;&*/KZ:"6*,_FV/_ /L%I_\
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M@M=ZVCD,O8[6?O7C".9LTK;"J.7;^4=),8UDV1([$Z[I^]6(BB0@"914X$*
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M0I4ZXCOI_P P\*4PJK"78!(.@\EJ/F+A+%)UV5D\"W>&P_\ KSQ[Q<R%EO\
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M<"_9ZZ#GT#0- T#0- T#0- T#0-!YGF;(S#$.)<DY3E&+J2CL=TBS7-XP9
MNG:%;AWDL=NB(B $.L#3M[A$ +OO\-!CZ7KR2<VN,.'Y[)G(5IC2[S.<>(.3
MN1_'*EXVJ,XWD\<6*BFHWMT.[_5RL@I<ROF>2X\Y'+8$!,X:*D[>TY3 %<8'
MY[\C4>.^>[EE//&.,J9O8GPS5\9XP@\$7#"UHHEKR^])$P<A9JO=Y)U+V>JR
MCN2%=J]11(15K$N! HG$2E#X=>\HO)&KMJGR3R'&T&Y\8\JY2RGQ^H6+,8U>
M5_6TPO..*W;Y*.M3Z?DGC:(ED+E+4AXW^[FY"J-R*MQ(90YCD*''QH\L^2I=
MW0['FS)&!+_ <AN..6.1E!I>'V_T]DPBGBN&8V)[2<C/I:86-*/WS60*S!<4
M&O9(HJD$.PH"(3*<5,DY4O>,*BXRU5'45<'=&I5JF)\$F3*#E)2Z1WWZY@XQ
MDV66.W<5=NX3:+B8>PRQ?EZ#H+J] T#04]"_SE;OZPMO[*5C05#H&@:!H&@C
M8\A"+A6Y< #-R@84.=N)5%MQV[4AKE[ 3;;AW?N;CH))] T#0- T#0- T#0-
M T#0- T#0- T#0- T#0- T#0- T'A'(SC9ASE;CC]4V=J7'7Z@C:*I<3UV4.
MNFS5GZ5--K!6WR@MSD.88Z79IK 4=RF$NPAL.@]M:M$6;1NQ;IE0;-4DV[=%
M,?D3;H !$4B] V(5(H%V^ =.N@\<J7'C#]#RKDW-M0H5=@\HYE;UIMDVY,F2
M:4Q;4*@U6:5]*26 IO=(Q16, ?AZ]1T%*WKB-@3(^<L7\DK9C^*=YLPZC-,J
M%D-HJ[C;!%Q5B9F:3,(Z<QZK8LO!/ .)A9NP60!01/MOH++^1/A(\<G)S(;[
M+.0^/L1%9$FG9GUJLV.IVP8X=7=THL9=9>Y(TY]$-; Z<J',*B[E-18_>/<)
MOB%T*? ;B4UXS2'#J,P70HGC9+Q014IBR*CCQ<&\("Z+H'CE6/4;OGDG]8V3
M7,Y55,L=9,IA-N :"ZBM5V+J<##5J$:I,86 BF$-%LDO<.1LQC6R;-H@518Z
MBIR(MD2$#N$3;%ZCH+7.6_!'B]SEJ4=3N3&)Z_D%E!/RR=7F53.XRW5"1!0B
MAW]2ML2K'S]><N/; BHMUR@HD)BCN!N@4!Q'\8G"S@_(3$]QWPG7ZM;Y] &4
MM?)=W*6V]O(LBJ:R<0:VV1U)3:<20Y.C<JP)@(;]1T'C7(CPC^.'E#E.>S1E
M3 ;4<C6YS]==[!3K3::,I?'W:FD+^ZMJQ)QS:R/CMT2)'5<%,8Y"@ _A#V"_
M^+G@[DGC'3N'-DP)4@XY4*>CK/5L9PWUD#"QM@B_O 6\R/W6NW<.I-126<J+
M+J',HJHIW&$1] MEAOV?WQ50%EK=OB>+\.QG:G/0EEA%B6ZZK(-IBONR/XQS
M],XG#HG!L]2(H!3%,7<H;AH*MR]X,O&/G3+-SSEDKC+69S)^0)DUBMMB1F++
M%GFYPR::1Y-VVC99JU^L<E2*94Y4P[S;B.@O]X^<9L!\5*(AC/COB2B8?HZ"
MPN1K]%K\?"-G;PW<*DA*.&J!'LQ(K"<1.X=J+KF$1W..^@HGE9PKXV\VJ$UQ
MOR9Q;7\F5F,E2S<&60,[92U=F$2>VWEJ].1JK.5A9 B8B'N(*E'?KN.@\+XH
M>*'@]PPL,W=<'85AXO(%@;KLI#(UGDY>\Y$1C'30&+N%B[O;'4I/QD$\;!LL
MT15(DH/40T%VN ^/>)^,F.4<4X4JC.E49M.66R-X1BHY503FK;+NIZ>>]SE9
M4X'?2SU14P%$I0$W0 T'PIOBU@VP9WJO)R8QU7I3/%)J4C1ZKD5\FX5F("M3
M"XKR;"(!115DQ%R=0VZI$?>$!V[]A'0=7D3Q.P5RK@:;7,[X_A\@QF/<@5_*
M%+2E3.$5:[>:TLJI$S\:[9F2<(.6Q'!R&)N)%B&$I@V'06K<J/#YP!YD7HF4
M<W8(A9#)GT:4>]R!5)2=HMMFF34")LD+#,522BG,\#)N44TOJQ6$B9A(&Q>F
M@]2BO&SPG@^-4WQ!AN/..X?CM:#).+5CB+BE64;9I)-=FZ&:FW2#A.0D)==T
MR(HHNJL=0YO4?AH+.V?[/9XFV#QF]:<5:XBLQ=?5-^RPVLI .5=)=(IB$F$P
M,0ID@Z;[;@'0=!+?=,94?(>.+!B6Y5N-GL>VFL.Z;/U5^0ZT7(UE\R&-=1*Y
M ,14S<[$W9T,!O0=P'KH/C89PIC'CWBVJX7PY3HBBXUHT26%JM4B$SDC8Q@
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M 0T&B=DYJ"!!4Q9QZ+U#O N5[V?IOU[1'&:>W3\ Z#>2R<T3&/W8MX]E*!A
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MYRMW]86W]E*QH*AT#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0-
MT#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0-
MT#0- T#0- T#0- T#0- T#0- T#0- T#0- T'QHQHX;O;$LLGV)OYE!VT-W$
M-[K<E?@F)E-BF,8FSIFH78P ;Y=]MA 1#[.@:!H&@:!H&@:!H&@:!H&@:!H&
M@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&
L@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g923794ex10_3pg046.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_3pg046.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"<P)] P$1  (1 0,1 ?_$ *X   $$ @,!
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MLE_6ZP_T:J?V8T!]RR7];K#_ $:J?V8T!]RR7];K#_1JI_9C0'W+)?UNL/\
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M $:J?V8T!]RR7];K#_1JI_9C0'W+)?UNL/\ 1JI_9C0'W+)?UNL/]&JG]F-
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M/V__ )IUG0-#X5"517E$X^A5CU'7*O)ZRB"I1*900;5],%R[@ B4Y2AH'OZ
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M_P#-.LZ!J?#<S@Y>2(N52*G+R;R,0IB& P 0K2 ,!!VW #%$X@(:!Y^@- :
MT!H#0&@@!\L\8^5J?(5^U6[11:XG'V5!V]PB=6N^_LCT  **X[_#IH)J\')
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ME^=(K"4!%+_"1D3N^/QV H>GV_#0=!OS&?"P!$G]S'.DIR[[B;B)D<P#MZE
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M;1=9QE4[RTPI<)YOE3.-HN]:J]KBA1D&Y,<8]_";E))_?#O>QPD54IA* IF
M-NF@FLX+QR\=P[XV,'K6;9/F^&Z 5^WL:2J$\D_-76*CT)(KC_:/?%P<VPG
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M2Y@%$IA[E5C+*A[FXCW=YAZ[=/V:!]OTZ0>B*?\ *(?^\CH.8)%+L( ("'H
M#N ?H#H'305C/S"]Y7QR[X[3;*P6TKNPQV0Z4O5(2JA9X]Y"S/W*,_))%+9:
MNK&V!Q%I*1J:QES)"T>K%V P@.@E5\3N.YK&G!O"\%-Q4]7G#YM:;0A5+%!)
M5MY2XVV6Z<G8JGM(0K^54C(B#CGB9&J9G3@12,!N_KL 2(RW6.>A]K-S_P#
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MW ,'<4"F-Z"(^F@F4Q(04L8X]3'?<M)JVXB(B)C?<K,IAW$1Z_+H%$T'P1
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MS3\18I%VK5@<SP-G*AD2+?3E33,4-N@7%$1$4R[B(CUW_7OU /CL ^F_7[=
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M$N7H\I<9"S7:<EXR\V6Q6R4E5K<R9/(MXL1^V4??3)&4<+G.4B+=("F-L'0
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MN%B'C4SM,;@##,;=JNTI-LC\7T1E8JBQ[?HZU--JS&HR4(U*4ZO8A&N2&2*
MF,(=OJ.@:]--VBOE0QP[*<!=->#F4VPE^?<A'&;L;G,7K\NQA0 >G^CH)$=
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MQ66J1'K=!PH0035.@+9N)P2,.^P&W';;0(4'CH\Z?80IO,77R;$ H@7!'N$
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M='+Z!OU'8.O[-!]T!MH#0?   ]  /0.GZ/3^30':'V!U'?T#U^W]>@^@ !T
M-@^P.F@-O^/0?-@'U !^/\GIH/NP?9H#0&@- : T'S8/L#^0-!]V#TV_]GK_
M )= : T!MH#8!]0WT'S8/L#^30?=MO3IH#8!]0WT'S8/L#^30?=MO_9^S_)H
M#0&VWIH/FP?8'7UZ: V /0 T'W0&@-!\V ?@'IM^S[/U:   #T  _5H/NV@!
M !]0W_7H/@  >@ 'PZ!^W_+H/NP?9^C]GV:#YL'V!_(&@^[;= Z!H/FP!Z
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MF(_N[]-PT&.6\X?CT33,H3+JBP%,4IBHP<BLJ &4*0YRI)I&.H"93"80 -Q
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MZZ"9W(=_HN**?/WS(<U#56H56)6E9R?FG#=C&L6C5+N/[CIR=- JI]NU,@F
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M-MP73).S<(I":SID22H5?]BNW(D8R5B:C+6UV^D7BR@':BJTB%2D  .)C]H
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MY7-\I.)2RO<64!H\J+?'5=6F"&:1_P!W?[>>16$B8CWD["@(Z"2%'QW^31!
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M=(KU>.D"WYI5+A'HHDAIQJ_#[Q=)(_6)E_< P]-!OUGQIE;BMX3>1X7">O\
M2OQ1D"+LF/ZVI-NZ=9JI VW(]6;OJ^P?+OU%JG!/BG64;L3. ]AI\AS;F$-
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MT%Q/%ZIUL=T-4X]PJTJKJ";8-C&-#-!W#8-NH#H-+Y+F(7C[FT3G(0O]U-^
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M0+#LJEL4B5TC3G,814#M*4@"(CUVT$;/E249N^9GB!4!RU (_EI)N  JY%#
M8*?(* "_;\K9(Q2 !3B([B;;;0/DO,U'J>0?!;,J[ Q@P#E8PK%?(G/VFG*Z
MD)1;B<I?; 2B83;B/R[;:!\!G<4JF9 []AV D8#%^J9D*FFHF*8F+VJ"HG[A
M##O]N^W30-OQ%Q$XQ82R-><OXIQU4JWD;)*P!;+@Q64=RTL"CIR\!F*RZZX-
MVYW+I0W8GVA\V@=<FH)^T![>[M QNTW<4 -OVB4=@[@';0=AA H"8?0H"(_J
M -QT&I6)"MV>(E:W/&CG,7+Q[V(F8IZZ2 CI@^3%N[9NT 5+NDX0,)3 /42F
M$.F@;WQUXE\8.)32RH<?\>U/&[>X/4I*R'AW1S*RSQ(H%(NY6=+JB8>P-O4/
MUZ#S7A9BZY98*>?4HC]-C3+XH@FLW6!0#O:.8YSF36$4B$$Y0WV'?0,9I;I%
M'SAYV6[A.'^!C"JJA2=IC$(6]Y-5 I"IG.=14>OR]I1 -A^(:#5N&G/_ (]W
MSGGS<XZPTE-DNAK[5)UH1_7YUJWD4EJE&0KD@H.8I$S!)J]CC%%9<Q2*;[EZ
M  B$KF=L$8IY(XPG,.Y@K$9;L?6%2,5DX)XJLDBLK#R+:6CE040,FH4[=^S3
M.&P[#ML.X#MH.S"6$\4\=Z+'XPP_6H^GTN&.LLQ@HY9PJW9'<&,HI[7U"BJQ
MO>4.8PAOL&_V:!:M!7<P,Y,'Y@SF,S #['P+CUP)Q 2E+VP503["^H' 0'??
M</LVT%B/0,#\J7_Y.#FP/OD;=O'+)I_J%.\2H@2NNSBIVD35,<Q.W<I>T>XV
MP= '< JG<,,I6J XJ<=4(W+&*DV;FA,%U6UBYCY1Q2_4 73PAUGM)AJ?),HQ
M0ZB8]$G AMM^L07_ !UEFPN,U9:4E<FX\?E4Q3C9,)!MSGR*2$9$3DKT:-"/
ML9<?MY1PL*VXJ-%1V2  , F$V@1/D/DS[WH./Z\KD2FVR2&\RCT(V Y37O-+
MYJ0:])H'!2M6:GPS-N@!>[=T5R)B";M NV@NL8E$PXLQMW%[1_ =2W+ON(?]
M L/7H'70;!:JO#W.MSM3L#<7D'9(U_#RS4JJJ!G$=)-5&;Q JR!TUDA5;JF+
MW$,!@WZ" Z"*;R!8APIQA\47(S&%4A(JKXCJ^)[*V91$J$Q+Q$8E(/$WJRKT
M4G*DLY;B^4%0^RG</H AOOH&-^//@GPCYN^.3C\[K2$I RE7@+!5Y&_X^-(U
MM\I8)9>.D;6#9M.D=@^B'K@K55 %R* B*8>V)1 1$%@?>-+C3@G.G$? >-*S
M8HFER4?FZS6^::6Z;87*UV6090BSV?G[.R<HRCURNX#O$@G]OX != Q_!G#/
M$JWGEY7XR?A>EJG7^+>*'T$Y_O#MA)XKI5ZN[=*.9M&33DE"G%42E3,H)"@&
MX!H%:I/C+MU[R9RAR%Q5Y+7WC'DZ,S%/XLG[ =O_ 'CI9"QLUBX9T-9GC6&2
M;NVAFRR9Q;ND52KI>Z8 ,(;@(/AE^!,9QE\=7*/"^.(F0RY><L5"URMB2B(U
MC#NK/:Y&'1BVR,/%_5N46X,&K<IB$.=4ZIB"8QS&,.X:5XK^,3V?X.PV!^2_
M&]UC?\'W9G-",V1!I)9 D8B7";B+2_0C$8\R+M@HFDD&_<':3X^N@G2;H)MD
M4D$B@5-%)-%,H /1-(O:0O43&'M+TZCH,#=*E#7ZGVJC6-N9W7;G7)JJS[0I
MS)F=PEAC7,3*M04(('3%RP=J$[BB!B]VX==!&]Y N/#".\76=^-N(J5-6&*B
ML$A1J)18%,\E-JQL,>*0CF,810X'=/&#=H51/<>XYB>O7?01I<(/%Y7>17#Z
MIU+/^$K[Q4R)22M:\SN]<EF,5?<EU%P#>1^]K(DWCTT64B*B1DB[F46:B<3$
M. [[@J3[QW\=,=\SN*_&*FM;E6<>UGC9F*PD=5^ZST+:YJ>=W.+=O)>?L;!X
MC(2KYXX5,=0ZIC;C]F@1SC)X_P#!4OY.O(717$OF)*&J%2P2^8KM<Q7IO+NW
MTI6CNGCN0ETI4K]V<W[I0.H8"%Z!L'30(OQF\7&3K)D/F?8^)_+>_P" V8<I
M+SC'*F/K!'N,D5O+=&BF\.JBG-2\E8XZQQLP@P?.&Y%T'29C)' IN@=07OR6
M<$;9B/Q^8 XX<8L36+-"L%G!G9;6M7(Y@G*D=*0]@>NI1K%DCY..C6<O-/"L
MNJ!DF[=0>X1'J(2BX'XOXVS+C+A+EG-/'=+$V6^-\8\GL>X^5F3J!B6T3L2E
M"3J*?W0WCHZ566:QQ3!WHD(451$ ^&@D<<N2Q[9PX4^9-LW.Y5'8X=B*"9U%
M#%*FFJ<X@FD80  ,81  ^.@I;\WO(9C'E/YU/&)QRH%3L2;7">8$+"^ND\PF
M*\,Q(V&)F&SN);5^?AXR1!*)68='0&42< ?<O;MU"ZJ3J'=_I#W;?9OMT_FT
M'/0&@- : T#23()?XWV:_?NM_AHD2F)M^X4<ELMA[NX=]]OLT#MM : T&NPW
M_6-O^/\ V@;]/7_XDZQ\-!'#XI%U5\*YO]\!]Y'F+R>344$0,9<39)D%2K',
M CW&,4_Z]!*!H#0&@- : T!H#08.Q'*G"S)S=0+#21A ?00(U4,;?]&P:"N]
M^6$4!;@'D)4J92%-RUY#'()0#8R2EM[B' 0VW VV@L<+?ZE78=OX2G7TV^4>
MNX@8 V_4.@K)\*[S;[+Y/\K8VR'&W=K6?Q!EW(K.)O%>@XK&=BL=?EH2)JER
MPU&)0L?+(V&#A%UDYETH90CD[E-8G:)BZ"S:E_JR^GQ]/3]X=]OT;Z!D_/DX
M)X7KIQ,)0#,V'A$=Q]OM"]1 F]P ZB78-!Z_'L58G#+ ";@-EDZ8":A0]"F)
M.211*'ZMM ]'0:9$TBKU8;"[J]<AH-W9I!>:L"L-&M(]Q.3"Q.U22DE4$DQ>
M/U   %57O-]N^@@*X8<%.1];Y*<VZ]R9PKC*Q\8.25PE[H2;D9A:6LCB3).3
M"\0PCXTCIPSCF"#!Z14AR(ME 6$?]$!T"L\B^#O%GCG7>-&/\6XAJD-7K]RY
MQLZO:,@Q0EG5P<)MI I%;"\>)JKRQR=H"7WC& !T#:^8G&;CY$^8WQ>4V&PY
MC^/KDQ1^1;ZQ0R-6ADHJ8*RKK<6!%&16P).7#=4-RB<H]I?3KH'&\FO&1QZY
M*YLF,502,WQSD8G%=,N]3R?Q\&.HV0JY/L+;(-EA:OVS-1NJVDV*YD')%$S"
M=$QB@8 ,.X+=C[QO1?&;BAR*QMAN9D<D9>RS1K;$EO=Z;Q$/+RSI[#OVD%7Q
M+"-6T:P@V3AZJH4 3,=5TNHNH?O'< T+Q&\3>0>$.)$MQRYA8HQ7'5I*3<G@
M8.'FG]W/8(B45,O)-KBVGGDJR3%-P4!322V2$B@_* AH)E(B)C(**C82%CVD
M5$1#!I&1<8P;I-64=',4$VS-BS;(E(DW:M6Z92)D* %*4H  ;!H,@(;@(?:
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MV_\ Q)UG01X^+=LS:8ASDDR2413'E]R24.101,/NJ7]X)S 8?4##\/AH),-
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M8\DZ5!Y A9*?QE4)J,R1$UJR,T+!2'DE5GLDU:S*H+IC OG3#=5N982>@']
M'8(,?$SR'P%Q5X29/S98LD3]H=S>4U(0:.,_$7.PHSR8R/W+7(EPQ>.6OO3K
M5,S@RZS@B*0$4,<Q0(;8%TG_ "\X(Y!5E:E6.@Y<PGD&IWC'%\C:A?:;*K.\
MBX\;7:+9_C3%[F(9N27J+%V<Z0@Q*J<#I&]2]HB#6/(YS<PMDKE_XI[;7(O+
M8Q5 Y%6&?F2RF&,FQ,@JS"I2$>0(:-DJNV?3C@[@G1-J10_9\VW;UT"O<BO*
M)A>H<S,2Y2I-$S5DBQEP3?:'3<6LL27FK7R_76RV^N';5^K15R@H,\DLA'-U
MG*JB8F3121,8X@4-!*+P\\@^,>9S"SUN/KU@QODVJ0996ZXQMY2_B"#CE7:L
M8Y,*K, 17<,GA/8<)AL=%?<I@VZB$,/B$F^.-%Y=>2*_2\O(Q5RH5AE#RLV_
MEY]U ,<2MYJ:D/J):.41/'1DVW53$5 *)E@1 !-\-!9]H=[J^3*C6;[1Y9K/
MTVWPC&P5V=9B<S64BI%$J[-VU$Y2F%)5$P#U !V'0;2[<HLFKEXX.5-!HW6<
MKJ'-VD3103,JH<YAZ%*4A!$1^ :!HEWS5B?.W$_,]_QY8&=_Q\KCW*D0M)0"
MJ^SUW"1,S%RT<U4$J2I5TGK91N(@&_N@&WP'05>?#!SDXW<1^,>:V[>/FKMR
M7F<C.)>PX7I:LJ9VZKR3%NVA9=E]]A]UHM&I'2;=<Z:HJ*OER))D4,;;02JT
MGR685SER7P1D>*KV5JU(5/&^7Z1DC%\GC2UR63\?VQW)TAS'QMHJ4-&O9&-:
MR#=)55LZ.0$5TR[@._30(M5.9.)VWFKSA<W;#)J$6OPZQ+ -6;G$^04YPSJ.
MM-N<NU%*^2 4F2-B_4 (*BB"0CT[M]!MU@\NE!PME?-<3CK$>6L]WFU9#A[/
M,4JL526@IG&V,&=<@T'60K\REV)'T#76Q4Q,*RJ6XE'< $ '0;-Y->6V..17
MAXS=FNEF5:1J$A0!7CI<3E5C9"+RA5#N&\@ZBU5DQCG\8)CI.&YU"+-U>XFX
M;[ IWC4Y.\1<-^.+C[D5/( 5:AVQU'5DKRR??2J[K)LZHX%S L4G2"SX43.$
MU/9,)?:]L $3!N :";%%TB[;E60.!TU6Z;@@A\4ER"9,W[0 =!7AX]MUP_,#
M<S3%(041P=CA943*F!4@&KE8]LY4NW8R1C([;[AZZ"Q1H&->3/L_W?/,<J@F
M BG'O)21A*4#"4%JZ\2[MA*<-BB?<>G0-! #XZ,?7F3X2<?088!R-<XXE$1;
ML[1&X6XURT?.1QG;E5FX:R5I,A87B"8;;&= "NY=AZ;:!8VN9Z+)6TF/Z[7H
MMW>1D74"^I25.X)R%P6FV)OIW$>2!0G2RZ3QFKT4(5,1+\>N@1/F=5;A58O"
MAKAAZZ41!YE1FBE.7+'V#*I"NG9F"BX,63_&_N6!9XL*/<FBH8K8=MS;F -!
M;(J>XUZ!$=NL!#" %*!2E#Z%'H !H-C,4#%$H@ @8! 0$ $! >FP@/00T#6.
M4G(;"/$#&#W,F:2DCJ:S?M8UP]CJZA)//O!\591(HHH(^X<7'LF'<>@"'KUT
M&X8,R9C#D-BZG9?QVU:2--O,864BE7L2@@Y!(YE"B1TS41$6JR*J1BB4>@;>
MN@;WE6NQ(<W^,((QD<F4N.\QG.4L>R[%2@G7BF*J3V.PY@[@$AA#<@@.WKH(
MS<"PS(WY@GFRT/&M1B4>,&%CH,E(UDK&"HHFY,<Z:9D.Q!;N1#?M#Y@_5H)
MN#L='.[MS+3>QL:[!ER5LB"/O1S(P)HC"QP@DB!D3>TD7IL4-PT#H.0MWQ?Q
MWPWD/-URI;*5K..ZZ]LLVPA:W&/9=XV9$ QDV2!T.Q5PJ(@  .P;CN(@ :!!
M>!_++ _.S&I\Q8GQ?-4^.AIM2)#\8TF/KTB21;&4[CQJJ38I7C<NYME43B7Y
MO7<=!((!=MQ^([;CZ;B ;;[?J#0?%$RJD,F< ,4P;&*( )1#<!V,4>ABCMU
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M)_<$WZ1'021>.E/VN"_$T@D AB8&QR4Z8& Y450K; 3I$. %*8""80W   =
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M; @'W[#[[=-P8M2Z7Y?'/ERRL8V5>').14?Q1QND\E_PK=G%#<8\>6FS&8)
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MB&KEL<RV,VKL HJLZ(H[;-BHC[P[%%0I_P!&@>6T_,A8<>-W2R?"3G@BNU
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MCH.J[TR%R#4+/2+&BJX@;;#2<!,(MG2[)PK&2S-5@]31>-C$<-5C-UC 4Y!
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M+<Q1W'06).#$'-UGA[QDKME8+Q$_#X2QZRE(MXF9N\9/$JS&@NV7;* 51%5
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M^38/^#0=F@C<\B?-S)O"NKX^G<:\1\V<KWEVL$A$R$=AYFF]/4$&+9%=)[.
M(*'(B_,H)$P FPB4=QT$1$E^8ZR*TR.TPVGXLN8*>6G%9+<"X_<0S EE<5@C
MP[!>=817M"Z<1Y':9B&4 NVY?703N\*N35JY7X:9Y5MV \G\<Y)W+R$4&/\
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M'N\+V;,DQF1W&9MRU=GEZ=SN2[1&0L3*M)/Z$A$$(J(;1,VFV20333*F<@B
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M0  ]-!KMF\>N7KN5L2XTN!LA&RIU6X6#DMER:*S45$?<5;$>1:I$C&*.P]H
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M]_[6@^"AOZJ*[?H.8/\ A'0?2H@7_/5'KOL)Q$!_0(?$-!W: T!H#0&@- :
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M@-!K,9_SNZ?_  \2_P#-&M:!D?C='_T&7H/B7DGR++M\2E+E&<*4OZ *4
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M%, =-!*45$A!*)0$H$ 0 H#L7YO41 .@CMZ?9H.PP=Q3%].X!#<-AVW#;T,
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M+O?Y96!I%NFD%_I%XBLSTFB[^E7?BS481+MT5Y] V*=R^*U,EWBBF4QU0#M
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M[_\ ==1Z[_,)CF-^S<V@K:<V7"H^9_B"FB#-8JT1C4@"1T@9VW,E;K8LH!R
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MHBOU6#DX9M].=1@7Z5])J?7.Q540 PG4#<1W$=M [3_<^X]()Q5RG*  CW$
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M$5!.B;%M4%,QQ)W&(,8CVF^01#8X?,'Z!T#J5"%.42G_ '3%,40';80.42B
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M@]=!#],^(RB++N'\ORQY<)%4<.'RRQ\TS;=LD*ZRJPHE %R@FFGN(%W
M-]!]9>(O&\BDFJARLY</6IR=Z9T<X6 Y! ![>ITU-@, CZ;CH&2OO&C0V?D<
M@,/)\@>3X(O>(EHNQK,?+LZK8 %3)L'!_<@/U!.H$4/L^\9(! ICCU^.@;CP
M_P#&C0;SY(?)MC5[G?DS'M\7/< ,6EABLNSC"PV7[VQ['295;2_;>V>7!F!O
M:2(?Y4T^@;Z!P7CW\8N.[Y7.2YI'/'*&-6K'+_--+;+P69['$BZ95R4B12DW
MZ*!C)NYI\=;N6<&^83!\=M _%SXF,,0"!EIGDWRX*BY,9!%Q)\A;(U0365_=
M33444(07*H?N%WW$0Z:!>N-' 3'_ !VO+/(M4S'GZ^*IQ3^*3C<D98FKI7%6
M\CW;O$X]X<[51Z!QV*J41 "A\!T$A.@K<<LSG+YS.*I!.)2EIU ,)>T1*;WY
M+)6Q0-Z 8-M!9$3_ '"#]I2C_P#,AH.>@BX\H6.>:V6L;5+'W$?'G&G),38I
M*9:9?@^2;N40@OPZ+!$L6E#)1T',&,X=NC*>Z?8AR%*':/S#H*]N%(?F+XFN
M27'=#,/"?@MB;%_(#*\3C65S+@^2DUG<)+V-$Z3=BNK(PAI-FH][3"0Q"E3'
M80.)0T%U1 X*(HJ )1 Z29P$HB)1 Q , E$0 1+L/3< T' S<#+@X[C=Y4C)
M@7<0(.XB.YB_'KH&.*$7#R-Q1C( 1L'$.:(4_N'$3+_WLQACG H@!0*8FP?;
MH'UZ T!H-<B WD+@'7K/MPZ>O6IUGT_3H&*^--HBRPEDU)!^\D4S\J>32WU#
MTXG5*<^5IT#(%$?1-(Q=@T$AN@K@?F!:#&Y=M7B^PQ8[=>JK2\Q<V8V@W@V/
M+!*UBPOZ[)4*T**((RT2N@X2V<ID O[P!W".WIH(IDO#QQ__ -\8[X3+Y4Y6
MOL%M>+">8T__ %A[RWM#&V+6)*/3<_?R+H%"1Z)3=J20)[]VXF$0Z:"2K\N+
M"+4)GY-\2IVJZVFJ8<Y\W;'--6OEJD[E.,JQ6H=".9(+2\D<[A8RI&P*&V O
M<)MQ#?06;M : T!H,'90$:_.AMOO"R8 'Z19K!T_3H*]OY8=($?'+8"@0""?
ME7R-.< V#N-^,^T#&V]1[2@'Z@T%B[0&@- SOR$D[^"_+TO<0G=QPS&'>HG[
MQ2 -$FMS"EN'>!0#?;]&@:IX2A,T\5O%8!<_4*-J!+D%P5/VA,HG9YP $$NX
M>PQ3  ;;_#0-F\5E,G<T<C>4',._M6CET[NMFI6.'"I"N7T7&2$Q(MY1 SY8
M55_JHZ(BF;$AB]@&1[BAL'303X3DM'U^#DYR3< SC(:.=2;YP8-RMV3!N=RY
M5.'8IN5-!(PCL CL&@KN<O\ )/#7FM/TFY,,X-:[%PZ53<,K+&X'F;'=G#2!
MLHV Q:W?EGD<:"9O1**8>PW4[BF,.X@;8 RO-3F?@7*S.BH4.5M$XA%XXSG7
M'KL:#8#JIO['0UZ]7DA:N6K<#K/G@ 4QM]B"8!]-!&MS2R+1LY.(A*O5>8DT
MXC,^>K:UFGF.Y0Z,?6[1Q(/CF =E:=GN&%]<C$2*W$0 %42F^ #H,YQER)0\
M-5VFP%@>Y453@).A2?LOZM8YAK%*M^,&0J%+LTTG!1.G'IW68;$]HFY"F,"@
M#\N@U;^\B/+=J&\$MW518XEX5UF<E4,?R:19&:QEEW)=SOR':=+W00A(>69J
M*F$XBN*I2@(CH%WQ1GJN5BBNFC]I?4)9; M#IC6/)3)4R:-BA^0#RY/RF<B?
MM$[6LK L90=@*!NSJ/3065^,O)C$O*B@#D;#=B7L=69RRU6<O'+!]%*$EX]A
M'OE418OTTE2"=I))* ;;YB'#]@..T&HWRZ5['50L%ZMLBC#UBJQCJ;GI5P8Q
M6\=%L43K.WB_9\XHH)%$QM@$=OAH$IP!R<PGREK,O;L&WMG?*_ SHUJ:?QS=
M\Q^[YHC1O(BS43D&S1?O%D[34 >T2G3. @/70.$T"=7[+F,\6),E\BWFLTM.
M2,N2/4L4HVC"/#-B%5<%;F<'("@I)G 3;>@#H"D9;QGDDT@2AWFL6X\4!321
M:_+-),6)3B<I!<@U54%$%!3-V]VW=MTT$?7F7M]:J_CGY+IV!_%(C8:,M!14
M9)*MRC8'KIZQ,I$,T' @#MRNT*?Y"[FV = TWAAX??&/E'BA@*^6SAIARPS]
MLQE6)R9E'U=*+A[(2+%!TZ77%-P"9U%5=C&,'J.@=BGX6/%PB@5LGPLPP5N0
MXG*B%9-[8''U, ?4[==!Q;>%?Q;LQ5,UX5X71!5 &YDTJQV$,D4P'!,2BX$@
ME]P -L/3?09MOX??&NW*!$>(&)FY"]H%*G  4 [>I=@1<%V[=!Z77B.\=CCJ
M?BUC],-P$PHM'211V*4FXD*[ ?W"@'Z@T%=:Y5"H\0/*[R'QQQTET>,T#+UG
M -:3F:2VC&BL7#7:<K+>729IR#)ZT3.NLJJJ)UBG+W (F^.@DR\;^3,A6WR@
M\Y,=V_)DSFB"P;2ZA0*-D>QN(Q:>DJW(.F5H6;OU(%O'0[_Z.;E7!4E$FQ 3
M34$O41'06(- : T!H."A>XAB]!W#80$.X!#X@(?$!^.@J+8VMM)E/S"5V6<S
M60G=G@+/:Z(C$S+!@_8Q/WMCERLW/#2Q+"4\34FJ+-15,HLS![ZH_, CMH+=
M"0B*28F*!1%,@B4#=P%'M#<H&V#N !^/QT'9H#01T^6A=1OXX>8*J0#[@8?G
M>T2]! 1.P -A]0'09'Q2G.KXX>%ZJG<)SX HICB;J/>,?N;<?B.^@D 670;I
M*KKK)HH(%,=994Y4TDB$+W'.H<P@4A2EZB(CL :""'S_ .4+]2N!L'D/#&1[
M=45$,V8Y9R=FQI8?NQX[K\P[=Q;EJ>48R4<N:.4=N$C*"BN AV;_ *@6E'G;
M@W@?Q@XZ,.0&7YK*-XMF.(^=8O81@^G[';&1TRN9.P>PK(R*YV#)PX*V!59X
MJ<YP[0,<VX:!)$?)UPRR'G/CUR'C\T0T7C=YC+,]1=NIUF\C)*%M[*3IYWM8
MEHE1D:28R[4AMSI* &P#H&L8#YS\2H?RZ<R<K+9]H"M*NF"\.1D)*J+.?J5W
ML"!TG2 ]K4BV_<L)AW -Q'H ]=!Z,1>6GBQQNR-RCD7SVQWT^7.2EIF:PTQW
M!/I90M7B8"L1<E;Y<PMTT8Z&0EU"-BK.%"E,H;M+ZZ"2;D]G>E<F_&UR'R7A
M^ZR$;$2.)[2FQF$RK0LU!6%FT^9@^^K[1CGS=TF"9BB IB"@&'Y1T#-_!AD#
M#%(X11%JL6<Y&7NEIR2E7LE,KO>VEA2J>29&07AX*G,'*39%F@>8;"DM[2(B
M053@!>@:"PH0Y3E Q! Q1]!#T'](?:&@Q-AGHBJP4Q9I]\WBX*OQCV9F9-XH
M"+2.BHUNH[D'[I8WRI-F;5(ZBAAZ%(41T$97EBN4%+>,3DM?:U:5B0CG$[>P
MUBV5JPC$@[<KS4*M6U&DRBDZ(1C)OSHD,<2*%%(YOEZZ")WQK^0;BAPMX*P<
MO:\JY5RW?K%89BRY5J*4X]R;*XRG"_3-):,:N4V4:C$5A$RJ9F:"9#*+&.8$
MP'8VP./9>2/AA9N>.(>3;?.$(WQ+D'A!;8"K6=PV?M"N+!#9R;HV&O/6@LUG
M[*8B54A3614(F<IB[;[Z!MO"OR,\-JMY./*ID2<S;76%-R%/\<R4Z;,G*F:S
M(1&,&#*2!)%-H=V15LNF(']PI0W+\=!Y^(WF;XH8$DLZTMF2ZY44R3S(SO=V
M<QCV"<O(2 J]AG81C69&PRDHJT:,E+"\*H1HB8X*+B0"E+W#MH-Q\_67ZMFS
M@=QSO6*[ZJ:NY%SO"-V<E'V!Q4#.*PI6+.6V=TF=D^6BYF#;H&.3^$"S9RF
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M"4JR68J+$35 4SG2(N)@ P" B'4-!"U7/$18*=4(*EP.8,>O(FKQZ$+#JV3
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M#$!)'%EN^I$P)&[4QB')3EV6253-WE-VB E_=$= S/Q-Q/W3'<J120109O\
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M;@D0$1!01,)P]O;J(B(^N@].@-!&_P"78JA_&OS(32$P'/A:QF Q [CD$!:
M!B%W#N, AN ;]1T&0\2X'_W:W"?W!/WAQZH13@J7M4$P1P;F,7<=A'[- O\
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M'J(6 = P0$4#^3%!R"+KZA'AL\2.J9!7Z<I5\O-AV]X0[ ,/TX;!\=QT#^]
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M,C:(FK?=$:2/A_IWZK^5*<%Q.X3.0B9-Q#8PCL ]0F#X]UWD%>N3MKY!9GQ
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M*1-F^2,B6,K;QJ@^(=9.+402.;Z]/M*&VW=T#UV"-'CU?O)XAY=.=-TKG'?
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M(&:(XQ3%4*8Q#@;W!Z@.V@:WP4[_ />_>7Y051$ <<;A @[=I11QTV( ?;U
M= X/@'<:711Y61MFM4! 2-IYNYZ>0K.=F8^*<2QTG$(FY3C$GRC4' MR$$1
MHF]/7UV!-O-!S6S!PMPEA^\X>L-8KCB^Y@:XVDI^PQTE,MTE)VO2;R 18QT+
M&S;YR9Z^9"!E"H=B1/G,<I $=!)CQS<Y4?84QP]S0ZK[S);VMQKVW.:RHX6@
MU)!T@*X&C5'*+9<Z9T3IB/<F3YC#L'IH%QT%=CR=G /+7X6 '?O'*&6B[?#M
M-CV1W']8#H+$I?\ ._Y0Z#@LJ5%,RAAV H"(B.VQ0 !$3&$3% "E* B(B(
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MM^KH'\VW70?.POV?SC_QZ#YL0!#J #N&P";KN/ITW]1T'$Z21OF4*78/B([
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M\@+!DQQ"XLLE,;0T).T"N1L,[E7\C6XUK].N\9J@F(G#N, EZ^F@M0)[!W@
M; 4VP ._3Y2F$-Q]?F,/705R_)#&,Y+S/>'8SQN"WT,MFYXAOW%!)RE5ER-U
M! H@ CV'-L [@.@L;E]/_=&_\(=OYM!RT'A>/(YD4#/WK1F103  NG238J@E
M .\ %50@'[0,&_V;Z!&L@8GX]Y1DJW8<BU+'%NE:;+L[!6)B>0AGKR"F&!A^
MCD8]\L856[A Q! I@-\!T"T,W3%T@0[!RU<MP#VTSM%TETOX8 42%.D<Y1[
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MO!PS8D6 >U4-PEJ[0V$.NPB(^HAU$=Q]!^W0'83_ $0']?S?Y=] =A/] O\
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M^@4"]0W_ )1'_*(Z#EH.)B%/L!N[H.X=IC$'</TD$HCH/GMD_P"Z_P"_/_\
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M'2(0;K72B91/;O+N,EMN7?0>93E/QS1$06S?BQ#8>S=6]5L %7<?D#:2$=Q
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M'J.$A!W!,9R<$O< =#;?>6VX?#]6@\+OP8>--VHDJ/'YBD=$QCD[)Z=[2F.
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MB@82B7??H/KMOT']H:#EH#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
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M*)]P@L\S7L"<\\),U"/E)J <KM).&EH244B[;CZXQHI.&BB3AN8\A7[-7WP
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M06*] : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
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M]@$'! (;\(F[0 ?_ !?W@[]K?]/M[;_IT#]3_N&_Y)O\@Z"O#Y2<;1^6^??
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M9HT0F<K,L^LT B*[KL]U9-,@'$1+N(6G4_\ 5I_\@O\ X(:#BML)0 =_F'M
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M@@(_+&*++>.!998>X5\_9I6*<-^TV]K6(;;H&_4N_P"W06*= : T!H#0&@-
M: T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- SKR"*
MG:\)N53M+<%4,$9&6(8 $1 R-=>*!L ?$.W0)_XM'AG_  .XX.S&[S+8_8G4
M-MMNJ*BG=N ]0'02""&X"'V@(:"OIYEJMG2E9SX#\E,&#6IB<IV69.C2M0F8
MN1DWLTTGX9Q,*/HU!@LW%4\6V@5#>UW=RHFV#KMN"TAGZB<DHW%^*.45,;((
M954D%<3\AL;JO&E28W",$A$8=U../HK!B/)9'G<C]VK^\591'L!43 8@ Y?
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M?NMDR3K#9**4,FX:?5MU' F/\W<KMU#0/JT!H#0&@TO(I.^AW4-]N^I6%/\
M5W1CD-_V;Z"!3\L<0I/&>R, !W'SYG+N'TW_ .UZBG7]7N;?LT%A_0&@- :
MT!H#0:9D"^UK&50L5ZN,BA$UFK13B8F)!<X%(W9M2'.H( .W>H;M I2AU,8P
M!\= SRIY4Y@9>@HW(5"QWB>ATR=;!*U*%R;)V1Y=9Z >H ZA9*7:P(MXZLKR
M2"B:GL&%PLB0_P P;AVB"HX&SS:[W8;=B[+5%;8[S!1$(V1G(B)DU)NJS,',
MJ*IQD[59Q9!JK(,E%$#D5*=,BB*@ 4P=0T#I= : T!H#0&@- : T!H#0&@-
M: T!H#0&@- : T!H#0&@- : T#,/(H<Q."O+LQ![3EX[Y6.0WV')4Y$Q/Y3
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MVB78HD 0#M'J78/A\-!VZ!J409+_ !G6PI2!W#Q\K(B;KOTOD[OZ_;OH'6Z
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M]FR);,>#&TM6)C'B-1R-+P"3^ *Z030AD8".]IJ9%(" 94#"4-MM!;)3$1(
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MH.8FZS'HQ!Y=I(R))=X>4;LD6[=\Z5D1,?WE0.J&_P"]U'0.0*4"%*4/0H
M?J#0<M : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T#)O(\?
MV>"7+E?O,G[7'W)9N\G[Y!)7G9^\N_3N+V[A^G0)#X<S$/XXN,RA#JJ>]59E
M4RBW^L.8UMGMS#MN&PZ"3<>G705N?*(];L/,KX55EU&Z8+3'(!F45U"DW,YC
MJV0I2 /J)S]I?^4(!\=!)OF7"N2,,7&;Y)\6TW;N:E%@ELNX'3^D/4<P"D1)
MLO9HY-<4%:]DQO$) F5XW5(G(E122<E/V$, *(T_P^>0'![=PX0";@A=$(JD
M8SB+NN,,APO<7Y5DE$I&M76FRVXD$!#M5('<!R#L();AS.%[PMDN(XM\GY\9
M^>G%"LL"9M78MV">:6"#$72T!/-6)$8Z,R+7R;)K$[44I A2JI)E,8Q=!D\V
M87O^*[#+\D^*4,T4R*_405REB0SLC"JYLBDP*5>4=JF242AL@0:!C*,W:($(
MY3 R2W=N4= CW*6^5SG)XZ<^R&#8]2R7=K3YY"+K[J-23MM%RE6"$=&9)-)
M2*QMI@WB1E&IS?(8Y $.XIMA"OUQ%MN9<$<G.!E%K.5\E3$CDB;>1LW,Y<N4
M3)0=MQ6+1\YR!5IND/SK+8URM 7= A&Z<4+5%\U'N!,0Z:"RCE/!M^P3;K%R
M+XH0X.):>??>^9,!HF9-:IF YQ!!W<F:7:D6#RBR8 /8LW,DG(  )+D$P@<
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MW=BJ1Q#0('BK+>1^'618#C3R;GGEHQ18I-A5^,7(.8*9U-3AW2H_08[RF[1
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MB[+&JN4DTR_0QYC=B)=MRD  WT#E] U&*2.'-.TN#%* *<=JRB!@ 0,?LO\
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MBYF=4@A!,NS861S[ 8VV@M7!T /U!_D_6.@^Z T!H#0&@- : T!H#0&@- :
MT#'?)88B? 'F(H8#&]OCSDY02DW[Q E:>&V+_P!T.W3].@3/PZ/TY3QE\/)%
M$BB:3K$[51,BFX& GWW,@4P@8 $.\ W_ &Z"2TW[H_J'_)H*U7E4D&#'S"^%
M<SYTW:IEM&;RB=RJ1%,#KQ-520 3*&*3<[A( #?_ #@#02AYLPKD#$.1Y#E-
MQF;/)28=-?=RO@5HZ385G,:"?:0]D9BH50L9D.+CR[-UDRBF](4"J )MC:!7
MZ]8\&\W<..R"@QL5:?G,QEH!\F"5EI5HCS""B$@U<$(^K]G@WH"&Q@*HFH0!
M 1 0T".XMRC9^,]RAN.G(JS.[-7[ Z*SP9G2;2,F%R37 ZSBC7M= IHF'MD-
M[H)LU%%"$E$/F* ' 2Z#8,^X<O5,N!.3?&=LF\R##1KLM^Q&)RQ]5SI7EP2*
MJB_<)["QN\,G_&BWP%,43$,DL!BG#8&O\]\I8KY0^,'E'9(:ELLB.(/'$T68
MQY:X%XYGZ->8ML";D9BO>P$JSFJHLLHL02D %BI=R8B0P[A3W\8V1H?!WD2J
MG&N\2^/.45&O-GQ74XF6M&)*XPK:=$ON/GDU*S#"5)'_ %-=L%?F"(,3(/51
M*Z(KT ##H+O.9>-ELQ/8X[D#PWAV,;:JM#A%VO <:JSK6/\ ,E>23!!) Q$"
M@C$W>%8[&C7A0]M02@DJ!BCT!H[FL^(?RC7O(F/K'7Z#,\DP8UU;,-$G(]>M
MYCJ\A6$UQCV4ZU738KJO*T]=B0RK<5 ]PA?G$NV@VK@WRGPMAFY6#Q]K6V$D
MX;"4C'T7%N0FK (B/DBF!18V-[NS1;)1U4NT0H()-#KF(A-I_.B/N )= [;.
MF";I3[2OR.XN,H9AD]J@52^8Z. L*WFV"0[UC-)H4!*5M;V'>K]WR  (B)^U
M3N+H-ZIMXPCSFP].14E%"\9K*&KMYH%E14C;71+>P(BJJSD6"Y$Y.&F8ERL1
M5F\(4H'#M52-L8!T#?\ %=]NO#2WP_'3/L](7#$%@=*1O'K.DT9=9^'N.7"C
M7%>5I$>YHWFXHA@0C9,XIIOFY2%.'N@(Z#-9_P".=\I%V7Y7\26L>CF&,9."
M7'%+B2) X\Y"P[A8!<,[0HT131C[FU:]XQLN'>J18.U4IRG$0!9J_8L+<X\)
M/H^2A4Y.-E$7$/<*C,(E;W+'-N9BNR?M7;-P)'T/.UN2 PMW*?:<QB@HEN'J
M#6<'Y?N7#[)41P_Y03\U8JA-.$O\,/).=.JLRR/&*@X.[QGE*2% K*O9+J:A
MD4F:JYTT)ILJ0R0^ZFJ70*KGG#N0L57%SR=XI0B$M;2)%5RQA)!PC"U[-,3V
ME6<S*!R*-FS/(\.Q$QF;DW<1WN"2N^X"4(:.1N;:#R#\SOA[O>/)!=6.-6>0
M<=+1LLR>0UGK,\VAB)RE9L==DDD)&%D8Y<0 4U2@!B& Q-R&*80M4$Z%V#T*
M(E#]@[?Y=!ST$6?D=Y"^17!!\8K<#N(%6Y3HS:T[_>.6PWYM3W%9^D(Q+ -V
M#95VDH\3E#N%C*J[ "((E#KW:"$&J^:;S>VO/]ZXVQ?B[Q4^RUC:L0]SN%0_
MOA1;+Q->L#E=M%/32 R(M%2.#-50*4/G'LZ@ ;;A.SXI>:F2^>/%<F;LN8TA
M\2Y#C<LY5Q7;*%!3+F=8PDMC6T.JX^#[Q<ID]XX.FQBB!#*$Z?*80ZZ"3'0-
M,AUU%N:5M2V'VFG'ZMI=WP%12]31Q+^C8H[_ += [/0&@-!J\>.SB[#Z;31!
MW_\ [0K6@C(\,IP/PS5-WB;NS[R*'L^4")A_>Q9 V(   @7</B(Z"5_0&@-
M: T!H#0&@T[('_D1<A_T:C9!#]L0[+U_8.@@;_+)$.GXNZB0X;;9>R\!?M$O
MXI=;"/Z=@T%A70&@- : T!H#0&@- : T!H#0&@- : T!H#00A><'\8ML0X+E
MJ$WD8>VQ^83(0635X!Q<Z/C5_+U&?C EKU26=:MSFPQLFBL=HA_L.S=RH10%
MDA#N$'$>+]A.FX?UI:UQ;HEBE[/;I"POG;!6'9VB6^]W9'MFA(-S#UU6 A+
M='W&S0S1$J"9^O>'00CA\=9L<2'D#SLUL2$I'YNI-@S,C%4M>*?,:E3J1-6Q
M([P]-5?6)VBY_$$@BDN]4;-/9%4-@!, V$+*1?W2]-N@= ^'3TT'W0&@- :
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MU.Z8/YNXBGH*6@V-EAUA-6LB8YM;)9*9J%H12*+Z L,:;Z9[%ST5WB<BJ(E
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MXFRQ>N)F2(/B_P F+9,72D7>03BN-V?+&8KZ<MSAT G=47(BB)1;L[/& ?\
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M X& =PDESQ@6ZQUB4Y#<6E(N S9'H(-+16G)ONRG9HK2!R+K0%U:- 126L#
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MN+N!OW1F2 ;_ )(U"M;_ ,V@C]\3#5HSX;0*#),J:),IYS I2E OIEJVAU
M#<?TCU'025Z T!H#0&@- : T&G7_ *TVUA_]JMDW#] Q#K00B_EO $/&-1"C
M^Z3)V8"I[_Z(7B3Z /QT$]>@- : T!H#0&@C1\ADU)4V9XOY(=1#N<H./,Q?
MB&YL1DD(F%!V>NRS"FK34B\ [&/2_$KE(B;A8IDTCG[AVV#0:YQ*\DT;RCS)
MD+#$CA6<Q1,T!S864E)2E]K5K9/7M74C6S]O])"HHN$F2A)(IB.3![*Q"B)=
M JO&2:KEJY%\M[122JK5E2U46!>3K5LB2!L%M@*NFC8EXR0264^\_I <(I'4
M#IWIB7<=M [S)N2J?B2GR][O4^PKU;A6IU7;U^?M*=90R:;1LW3* K.GCE<P
M)I)$^90YP -!'XWY_P"8I01L,%P!Y-2F+DGS$IKH9U2&$Y(1KU$R@S4%1'4X
M$X_B69P RPF,DH"0@)"&'IH'XXER]2LR5)O;J=('5:F769248_ &\Y7Y=J82
M/H2=CA,96.DV*H"4Z9_LW 1#KH%2T!H#0&@-!T^V/N>YO_E]/LT'=H/.[]WZ
M=7V3%(H)=BG-OL41$ WZ /4/U#H*R.$I0<K^5^2HV37]MLEJCF]SM4M8#3<^
MVJ4DSQ/;!=XQ@$JU8*'%-31U5=6!T'_1K\Y3JG,=0QMR[!9T+T*4!VW[0W[0
MV#T^ ? -!]'T'J(=!ZAZAT]0_2&@9-R,ROEI]?JIQSP $?#WZXQ+JQVG)\RU
M),0F*JFR<@1-\M7RB129FK"=%5NQ0,=%+W0W.< T"76C'O,;#4 3)%=Y&_WS
M,JB/XAN>-;5CV(C%+5"LDU%9MC4YF(.X=PTN")!%H54#(%/^^?;KH'QXCR9!
M9BQU5,E5DK@D';H=I+L47@%*\:@X(/O,GA2'.4';18IB'VZ;AH%(T!H#0&@-
M : T$1O*3RF*\?.3!>+]/XU9%S=?%:<RN: T^>C&OU3!R9;WT6T4LP>OE#1Z
M:(F5-L!=C%$/0=!JD?Y4\SJEWE/'5R*CNNP%!_&JG,7M#YP]R*;B =PB'0!]
M/70,KYN\D,[<L*]C9O1\!<R^.=SQ9=_QQ7K?0H.F625=NR1#^,4:N8VR,3,0
M; 1_W%.)3& ?3019\C+CY&_\/>8AR1D_R&SE1)0+2M/1UPHN&6-.=Q/TJXNT
M;,$;#IRR,>LGM[AT5"G(EU((#MH+0?AI251\9/#P%E1545Q%$N#]QBBHF9=T
M]5%)4A1,!%"=VPAW"(:"3=3_ %9_^0;_ ,$=!59\P\W?:OY<O%):,<02%ILU
M?;9?ET:NJZ,S=6=LPAXMR[@(MP*"Z2<K)()"F@*@ 3W!#<0T$Z-/MF"_('Q]
ME8ZR59VXK\\*U;R#C>VHIMK=1K+'F]Q]"3K=!4RL3*QRIB*HJI#N(;'((@.@
M1W$61K_Q1NK/COR1M2-EQY+N2$X_YPD#"Q:NH<J_TL9BV\+.1V+<(ML9(J#S
MW#IOB$W$ /TT"AY\PK?JU>2<F^-?TR.2(TK-;)6/#;HQ^?JA$H !:ZL]^=*'
MMS)F<2QKXZ9P*8H)'^0VY0WB)E\,\Y,'S52ME=3>1TPV2C,@8UFS(GL5%L[5
M7WQCY5$O:#66B)%MW(KI[ 82@<@[#H(GN5EAM_'SC)GWA[RTODB3$-_Q;<V^
M&.6JT$1Y'U]F=J P6,;S$J.4E1O$>HW$L>N5447XIE[C$,.V@KN</,.YNAN3
M^*,XY*M_)R1M,E<ZS?\ &F/\U8@@<=XPY$6''-0)!QJ%1GJ_;ITK*\.:85,[
M$'#0B:Y2;',!A$=!>+KMDP/SHP=(1DM&,K35Y]LA%7FCS(E).TNQM3I*/("P
M,0."\19*W)E*&Y1Z*I HF82B Z!(\993MG&VTL^/O(:2?S%3<+*!A[/;Y K2
M%FHY1\BVAJ%<%5%#*-+G#$,1,')SBE($*!Q$IS=N@RG(C".0JS:C\FN+QV+/
M+$<C'CD3'ZQQ0KV>J?$]YAKLHX036".LC5FJJ:+D1(<Z2_:F;Y#"(!O-)NF&
M><V%Y^M6>L@9L^34KN3L66\J06.ESZ"9P6C9%!,3?3O&3L .V=I[ H!>\@@/
MH#>L:W7(W"B]P''_ #9)R%[P1<I8L=@W.[Y?9S3E54"IQV+,I^Z0/G(HD8(R
M4*J<JI#$24*42[Z!7<_\=[$^MD?R)XXOF%:S7 MT#3<<8Q$JWG"IL2D5_!-K
M<-_<,BLY:]R4?(>VJ=HJ<IA*8G30;-1KUACFWAZ<KL_6#'1>G-!9-QG;V14+
M!3K"U50-(14FS%45D'#-SL=H\3^1;VR*D]>W0(]CK*UPXMY 8<?<]OG#W&=A
M?&CL"9J?&,,:JW!9$([&5Z=+;KL[&T:&]IH[,)TG9$@[A*8=M!FL]8/N..K[
M*<K^,S,W]XXMF+G,>*8XZ;:,Y$P$.021J:WNE,T:WV#CO>+'/>W=0# BH<";
M" *75;5@KGG@]^PE8$LI7I=,(JX4FRI)H6FD6A@ &6BI9$AQ<PMGK[\_<DH4
M=@.0#$,(#H*\-_Q-E+&GG7\>5 RID-#*$-5:+F>2Q7='12IW16F?<[@\? 79
MI[ $7EJ^[5601?)K'*[;%(8Q"&Z:"W 3?YMQWW,.W7?IT_DT'/01H^1#"?/'
M.$)4:SPWRSQVQY!F2GVF5X;D-C22R+#W*/DB,@B&,8R8L7*2)(\Z"IEO=W _
M>&W4-!!33Z[Y+O&'RRXKT_)4QPBE<*\E<IC0[1,<;\"'J5Q(Y,Q4<]C]NM&1
M)TF7=V "ONG[>O[0N ICW)IFZCW$*.XAL([E >H? =!ST#3(LJ9.:5E*0I"F
M/@.'4,  '<(A<G)=_M -M [/0&@-!JS QB+W<Q  QRS)#$*/4#&"H5H2@(?8
M(Z"/?Q+.7SGAW"GD&7T+H<IYS]]N4XG(B<,LVL2D#Y";B*9P'TT$F.@- : T
M!H#0&@-!H^2U@;X]O"X_+[-0L2WN" ]I03BG1Q 1#<0WVT$*'Y<$NWC"QPIW
M]_O9&R^IN ;?O7B3'[>N^^@GGT!H#0&@- : T#3>;LE5HOC!FI>WU@MWB#42
M52/31=M&"]E<*(+@UBHYV[ X(R+E4-DQ(0ZO< "0!$-!73\//#/'F9++R%OR
MF6,E1L,H_JL*RK5(R9(R+)LSD*Z1S,5:6MLO7HJTOW\2)44': &,BD?Y>XWI
MH+45'QS3L:5IG4Z' QU:K\63L9144U3;H)B40,J80* F5<.C%_BJ'$QSF$1$
M=_0&-\^+!!5VR\5G>18=:;Q*.8W?XF8$1!=%Y:T*9.N,>,5D#[(+JN9Q)3V"
M*F*F=<I"B("(" 9/!?D.Q5F[*K/!D31,I4^WNB7ILQ-<JT2-AUGN-B0QK7$I
M/FSMQL^C"S[4>SL IB'W*([#H/)QVBXV/YE\S%*>@W"K+(XK^_R,/>*R+DI&
M)D/Q FH44B-/O48T[4SH4]S"=0 /L8.H2+AZ!^H/\F@^Z T!H#0&@-!UJI@J
M02#^Z(AW!Z@8H" B4>H=#!TT"(U;C?A>F9 E,J5N@0$9D*90=M9"V)-E%)=9
MH_<F=O6I'+E=<6Z#IP(&."79W;== N0:#B<3 0XD+WG IA(01[0,8 $2E$VP
M]O</3?;IH(-O(7<LC<3,H6?-F/;DUQT.:,7LJ6QR5;((MNJE>R+2I%:4K-7<
M1AY:%3C/QPW6.U2745%,BX[B ^@ADN,O/>TSO%.PV3D%88"Q90M\[*57#$%!
M0GX<LN46TG"HH5T[6G(S%B=LR/9Q95+WS'*@*)/<W -!(QPTQO9,2<;\7T*W
M-09V2(@0<3;4%_J!:RLL]>2KUEW@0I3$9'=@D AZB40V   1!T.@- : T!H#
M0&@KW3XNR_F#:H*8D^C_ ,+DE[Z9DN\3G'8"'*IWA[8E,/\ HCTT%@=-(#$*
M8NQ-P$1 O< ".X]>A@T$1WD^SK<,*J80=(9WN?'O&$_-V.,N=VQ[3:[>[<XG
MTVK5.HQ2,%.$<*J,'S]7L5.@@IV .Y^T-AT"1NYSDO/>%/D/-<L5G,AEY7$>
M>%ADY6%;P$Q,4U.9GAQ]*3<0T,+=A)2-+*R572*!=C&] ]- Z[P_J&5\;?$Q
M4P$ RF+HPX@0O:4.Y=R.P!N.@DF4W$AP#U$A@_F'05H?)C*L([S7^(0[XS%(
MH&R\F1215]EH19Q&PB"0BMOL1Q[BP>T @8#G^7ION 2H<@.-UZJM['E5Q>6=
M,,TP\49G;<5IOT8['_(".2[018W5+VR)L[3&-Q.G'2R9!51 W8H14O:!0WF@
MW[ W/O"\]#34&SDT&+M[3LB4&<:E_$..+]$D^FEHU9-PD1PQF:])"(MG:9=A
M,0JA#" Z!$<5Y3MO#[(U8XP<AK/*VC'-TD&<'QJS]9EE',S9Y=\H90N,LD2"
M)#,6ME9"!4XQZI[82:8@4P J'4%=SOA>VP=B0Y(<;V#1+,D"T,A/T!1P,=3<
MUUQ82@_B+*9$6YT9F/(?WXZ1*4ZJ:B?88AR'$ !O'*_//&[D=X[>3]BR)!/Y
M.GU/']BB<HT!RD2.NM-NK1A_ ARH/VIW$;)MY<2F:O!3[#@4JB8'(([!6W\>
M/+S+4SRAXM8,Y]4BQ0]!X\V9CCOCUD@^1496-ELCW.JM;726V3696(-Y.RQU
M#=D0:N6YVR([F _40#06FN0F <B4^YARDXILVZV5HIHJG<\,%=)PM$SS%F.(
M'+854BHJ,[W&I;G8R("?=0 24[R"!@!<:->,-\S,,R*;J.:S4+*D>U>[U&=:
MD+-4NUI(_0S$!)M%R%7C9V'D3'(FJ/:;W$RJ)B(;#H$/QW?+!Q*MM?X_9DDY
M^>QE85D&6$LW3YC/'0/G!Q_]'.1I<IS-&DPW.)48IVH5(C],03-LH7<P;]R"
MPA<&<RQS]QT!A%9HK:2YY&OJ)E95K,$ H3^)5;JFV4;'6<HE[E(]]N*K=<W7
M<FY1#.8VR7B?FGB2S5^=K8&6;K.J=E'&-I:J-+!3K&BR0%XP=,7) <(G2,N1
M5B]( %5*8JA# .@;U1+S:^#USA<(9@DWE@XYV291A,&9=E3.'DM4W;YR8S7&
M^2) XK)F;,G3@&\9**_3^ZD0J:G4 $05WD)QZL2UDCN1W']\6"SA4&KA5Q '
M539U',%=4:N>^HW9!$S4IUC"<IV$B43.&+@I#;*D**1@V^GV?%W-+#TQ$V*
M;&%4CFLY"HTTB5*?H=N:%,WE62P"FJO'RL8]$5&;@O[P%(J0W70-VQ3E&T<0
M,DQ'%G/\U-V/'MD=-F_&_D#8E%G2MC*JLN9]C+(TDF*C>,M, Y5128.5 13D
MVJA0#^(F83!O/('!V0J;=D.4'%A@T-DMA%_19!Q8JY3AZGFRN_4F<K*2B[9,
MAFETBVY3FCGX"<3B8$E2'*(" 0I94Y'8[Y$><KQN6;'JJRSN&QWG"I7:'D4U
MH^P4ZUL8UP,A69R)=(I.V[MEN4W<( 10I@$H_'06N '?X;=1#^01#?\ ;MH/
MN@-!K4S4:[8'46]FH6)E'<(X%[#.Y"-:/742^$O9]9&KN4U19N?;$0[R !MO
MCH-D*&P 'V  =.GH'V;CMH/N@:!%@H7F]8.Y)8I#\>HS910@$2.);PKT1-W"
M*@E_SN@;:!W^@- :#5F B5>[F*.QBS)!*/KL(4^M" [?'8=!'MXE912:X>Q4
MD9<%RK98SH3W 132]PZ.5K.D)S=@ )C!V=NX_9H),M : T!H#0&@- :!.LMJ
MG0QED)=/<%$Z/:C$,4=C (0;X>@]!#80#00N_EOS";Q?XW,81$1R-EX>H[[;
MWB4$0T$\^@- : T!H#0&@95Y#*/6\@\.\^U^T'K36/-CN<>-Y6UM1=14'*M&
MBZL;,' H@HBJQ<!W%4)L<H]0T$,WY<' "6(<99Y+, JI/IY)^J@PG'3YW;&E
M5L<0SE&CEXN]:M#C&3G:5PW3 !3(7J78!T%FPF^VXE[1$1Z; '[1V$>HZ!K7
M-*!Q_8.-65T,FQ3J5J,?4Y2:<DC&",C-,9"*1^JC)6#07$J02\:Z*"J!A$!*
MJ4I@$-M!7>\6_&6R98S=R&O*G("WQMMK3"GUI*Z%AJ%/9#?U')]39S\L5I?H
M5FI68:POVL:@@\49-@DT%4" Y.8Y2CH+..',.4W!].:TFE-7I(Y!=P]>2<W)
M.IZS6"7>KJN)&?LMAD3*2,U,R*RO<JLL<QN@ &P   "KZ T!H#0&@- : T!H
M#0<3[]IMA, ]H["7M[@'8=A+W@)>X!]-P$-! 9YW.1U;P_AB@4ZSQSEW6K+:
MFLU=#_W<P]V46J$<[3:OVM;E;5#S-2KMG.X73 BCI,I@2,<4C%. #H'0^+G%
MV!6G&/$4S4:3CUY=*M7(Z%FK?'51DC,I2AFJ#HR0RB[%)S]2#)X4#G1[4A$1
M[=@T$J8  ;[  ;^NP &_Z_Y=!]T!H#0&@- : T%:?/RF;$?.= K8(CJ*_N:?
M&=P@ 9'DI1E7",U>\XF]N(:N'RSH%"[@.Y0   -]NF@DML%Q\EU3BY6U255X
MI.ZY7H61F9-@RGK^G*NTH]FHY53CEU& MT5!.D.WN%$-A#IH(8,\<@Y;R.T2
M'J^5O[F<*R./[&1R]$;QB.2D9R-L=>:O?HH<V7,>6F1K:Y&BQB&=QHM'0+=A
M@, D*.@5SE3SCE7' [-F&X>*PT]@VN!;)1$) .0L?9;BX;M:X:,06;,"0;1Q
M/2!6R!#&#H!S_* ^F@E&\0!2%\;G$HR9C"0^*(8PE$IR>V?W'/N$[#E*("!O
MT;:"2<W[H[[[;#OMT'T^ _;H*M?E<HT'DKS,^*:D6]%D\K<_#9E9+MMRMWA%
M%F$21-=N^ H.6#]$0[F[EN=-T@L4ATSEV'<)8,:97MG$G(D;QNSY-3UIQS8I
M%T7C[G.8,ZDA3@4BI$2QKEFS.U#'"[QSLPBS?N# $DS.F B94AQ$%,SU@JX,
M)A//G%5>"K.8HO=2SPSE($JGEVL>X5Y)0D^Q: F@XL2A$]H^3-NJW.<0[A(8
M0T&7JEHPISVPA/P%KIBBS)TJXKM]QS;FP1ESH<^T,)=E$TS)R$#.LSE*NQ>M
MSD.F?M52/TWT#?\ %-_R/PXR1!<=.0EH<6K"UN?NH[CIFR>6+[\*SCT%%([&
M&5K6N9#ZVSJHB8C"1=F'ZU-+VSB)]MPV/FCPT@LKP=PR'CNO1RUYL-8/5\HU
M%155I4<[8K<HF"?I]J8,#(LWEE.S !AIGH^C5TB>VH5,QRF!EW#_ ,6'C'NZ
M-BRO3Z)D.8NC]@TJ5LH^5\N7&W2V*[#"Q:<"BJT@Y67.-=M,;&LB),I5(I7
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M=NEVIFUZ2K1X==9O7[:Z0[XV;?5XXF1*\2-WKD[14V,&@MGE#;N_281_X/\
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M+\J8DYB8RGH64KO>93W:EE'%5R8F^]:M+^V 2-?L4<Z AU?:6(8R#I, (L0
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MCX0#<0DS" #Z"(4RN" #O^G01N^&TSL_""NG>=H*#EC._:!2E#^&.6+09/\
M<Z;"4?UZ"5'0&@- : T!H.)_3?XAZ?MV =!%EBP%"\N,L$(4HI&Y4V BW;W
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M?Q]?'SVV\-K(LG%T_*\NNX7L^$++(G*A$42[BDB)WU$?F3V:S*GSL552IN!
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MUT#(_"LH"WCBXZJ%Z@$&[W'I\%O:_P#"#02M: T!H#0&@- : T!H#0&@- :
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MP3-JX[6-XY:8NY%V5R*;6@N3G3;5W#^0G9"F5,X.=$$8B45'9<"@FN;W![S
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M=<@H1THL?9L4R:*Q@#LT"L9[XSJ2]I:<E./ZJ%-Y&5V-]I>0BW9V41F*K,C
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MOOZ].H2Q: T!H/&^8M9)LHS>MV[MJL4R:[9V@1P@LF<AB&3514^0Z9P-L8!
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MY-!]]PH_ W_>B'^70 JE#UW_ )-!\!4-]C?* ^@B(_\ "4-!VZ T!H#0&@-
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M3[%*&^P:"1_0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
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M ? /A\/L]/Y-!]T!H#0?.T Z@  /V[!H/NW_ !: V#[/3H'Z ^S^;0&@- :
MT!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0
M&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#8/7;_ -GI_DT'S8/L
M#^3[?70?= : T!H#0:]"_P#65N_^Z%M_YJ5C0;#H#0&@- : T!H#0&@- : T
M!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&
M@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- :
MT!H,>R_YS+_]7?\ 6*7_ #+_ )S_ -4QG_6__P!4?]'_ /A/9T&0T!H#0&@-
M : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!
MH#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@
/- : T!H#0&@- : T'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g923794ex10_10pg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_10pg001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .@$6 P$1  (1 0,1 ?_$ -8  0 " P$  P$
M       )"@0'" 8" P4+ 0$  00# 0$             !P4&" D" P0!"A
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M]6^772IRH6?623R'^H"-Z-BL6G-%:?:L=@IZ>VZ9H6?*V@!#;;:$S4M9^D9
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M+&SA74:I>X!2<(8TJ[8O$7!8_P!/TA J6Z@CN&VOM]U&FR6=N[*94Z%Y/(%
M'S"?$X81PV>V'J-W-T:W;6FN3="[1IJ3UUM*<2KW9SIGR!22,W$35AP,<'6/
MSAY,S*2LT_Q[<-+MR;R:M6ZW,9(D%G3MOBK&%@FXXDHZH<C;8]NU;R\_'-E
M!18%VJ!5 $H <=^V@.ZYJ:TII].T3E55Y 5DF3:%$3R%0XF)HM_:!8-*&HNN
M^>JZ33FGA4.MTJ0 :RL;;64)J4,**E(:6H3 RK5+$D83U5BWS_90QAGQE@SR
M2\3W7%[ZRZ0;-[G#*6)>/K;=519J6>GHN<1<+SE54?$!(S^)67(WV,8Q3[;:
M\M)K^LI:\4.IJ3W4J/M))(3Z3/BF?-/"+HU'V1Z=U'HE>L]@-3(U&&4$JIW
MT%ND 'IMK;(#;P3,AMY*2O  B-HW'S-\G<XW";AO&CP0N')3'U7DY6+>YLNP
MRU8H%K7B% ;/34I9$8Y%T@BZ 0(95V958@@8$B;@ ^E_6EUKGE-Z8MZZIA!(
MZJR4H5+ Y?5]F+:M7:AMYH^ULU?<%K.DT]?*EM"TV]C(]4LA8S)]X'G*24XD
M! "3AF/+[^%?G0FLF<CXSB#S6XZR?%_.%FFAK]5724F#5IU8') /#5R:C;"@
ME-Q#F=(FH+-^!UF#@_:0#%W[M<K+KERIN0L]\IC2URS)/'*5<DD'$3Y'@8X[
MM]G-'I[0#FZFT5^;U'HVG:#CP(0'DMC]<=0IL]-8;F.HW)+B!,D&4HYA]TP)
M2T_@V<Y@(FEER_KK*&W[4D4(2K++JFV 1[4DDS&';<=@U2]T_P!9H?RROM")
M'^' ";KK%*<5&UTP \27'@!\IPC<EM\Z>5KR^&H>/'A#DSE-7:<JSK<GE]_%
MV1ACZ8?1L4B$BWA"0L<HY0]%P3\)1TX(9<G4$B[AKV.Z[JWU]#3M"[5-(P+A
M!""0,0)8_*>,6A;>SC35E9^M=]M86_35;5!3J*%*VEU2$K6<A<SJD9CB$((2
M<,QQC(P=[A9C$9*@L/<_N,-\XC6BP+@1K;GS2:/4FB3MXFRCG4K"S\>SLC.&
M,J8P+220N6Z8@&Y0#J'*AW"2BI31W^E<HW5?2(.7T3!&8#Q.(CCK'L9J*JP/
MZKV1U%0ZIMC \S"5-A\D)S+"%MJ4TIR6*6CD41S)PB;/EKR=AN+W%?*/*1&"
M'(T#CFF-KJVA868:L2V>->/(UNU-'31T7C0B#A"2*L14"*%.0.F^X:O:[W-%
MKM+UU">JAIO/($#,,.!X8SXQB'MEM[5[B[D6W;DO>XUUPJS3EQQ!5TEA*R<S
M<TJF"@I(F"#QX1!5;/<<P]AP[C-QQWXQVO)_)O)I+$Z/A=I(/;,RQY&0D^YB
M6+JV/JK%C+R3^Q,VAG39FU03,FB<ISJ;=!L1W<A#M&T;=2K<NCH4>E/,$ &7
MF*1B3Q '*,RK9V%UE#JNX-Z\U#2VW;RW%H>_J2EE54MQL+4EA+R\B4M%00M:
MU$%0(">8[ZX3>2')&2^*6=N2_-_#A>+3;!DS)?6H=6(N$<X<5AC$-GZ4@G&W
M!%M)KOW[U<&K<B?X:RIB% 0$1VK]BU)555I?N=]8]TZ"C,24/*!QDH S/ >F
M(4W>V$T_I[<JS;?[/W;\Y%WAI'3<"V%@/*<*<I6P2@)2D9U$XI2"<0(X4J_F
M@Y^<K'\S8> WC9D\BXAB%U625XR?97$$,RX2=N$/5CG+=W"P1SF32#U6B+AT
MNU/N50V^J"WK34-U)<T];"[2 ^TXK+/TB6'K'$1,MR[3=E-M&6J#>O7[5!JE
MT!1IZ1H.=,%(,E@I<<XGRK4E"5C%(C)+YQ^3O&7(U2J/DKX(37'ZHWE^S80^
M1J),.[!"QI%%>QZ^=%=JR+&<"/(<AUFK-X5TDEW*"00#;7T:YNMLJ$,ZGH#3
MM.&06@Y@/29\?2!B(ZSV>;>[AV&JNG;]K-F^72B;4IRDJ$!IQ<A-*4R"%-YL
M0E:VR@JDF8XQ9/AY>-GXF,G89XA(Q$S'LY6+D&IP5;/8^0;INV;M!0O0Z+AN
MJ4Y1#X@.I+0M+B M!F@B8/B#& 553/T52Y1U22BI:6I"TG I4DD*!](((,?H
MZY1T1KS+-S+CS&EXNPE.8U;KDE)(@F4AS Y30,1H;L4^X8I'*A!$!Z" #KJ?
M<Z3*G/ 1\49 F/Y>_+W,TSGCD1DN_2\@XD$C6&1AH<S@#%.G'1CQ9)4XI&.H
M"2KM_P"JHIVCL81 =8Q7ZO7<KJ]4J,TA12GU R^WQC]#7;AMQ3;7;-673J$)
M3<WZ9-75J&.>HJ4APG-($A*"E*9XI EPCR/&T 'DGQQW !#^/^&]P$-P$!R%
M7]P$!Z;#KQV_^D:;_B&_PQ$C:]_N%?O[$K_^5=BQUY\KQD'&5<XYCCV_7?'Z
ML]F+D<$RK1[7.U):728)5,\>G)K03Y@H^38F6.*)51,"?>;MVW'4E[A/U%.B
ME-.XXW-UZ>513/V93D1.7*-8_P .2PV*^?G6J]T-%6EIBW9/>&&WLF;K9LH<
M2H)S2$Y2G(3X17 _XBN1?_R(SW_?%D'^O]1K]8W'_>'_ -T7]V-G7YBZ%_J*
MR?S&E_@H]UCWF[ROP_86]TK>>LFS"T;^,^K]ZM\W>JI88Y/[[V$G("TO)1BO
M'R;<#(JF(5-<I3[D.4P .N^FOMWH7/>&*ATJ3R4HJ21X$*F)'GSBW-4;)[4:
MZM+FGK]8+6:1X90IFG:8=;4< XVXTE*DK0?,F<Q,8@B)Z/)C5XR5X6SUU:,B
M14KCVU<?<S8T43%4JM&E<I0+9[<82$<'.+A"-?JN$2I)F,( 1L0^W?N(R5J]
MI+^GTU@&5YM;3B"/HE8FH)/@8U=]F3CFF^Y"\[;A:G]+5E/<J*I:5(I?13.%
M#2W$\"H(S X">8CA';M%YP25D\&>;<HJ/UC67'-/J$:D[%NL1$KZS9 JU938
ME$%175;EL#I=,1$0V14#[ VU6F[^I>B'+G/\<AH#_P!14$_A&(H.PP3W6#8]
M8/U6J^8#,,WN$C62S2EG]U2H2E*?EB'G"&*.7^8?++SBK7"G,D5@_*C/(V9)
M28MDPHNDV>5,ET(@YAR"W82*AE5GJB9P_#V#MWW#5A45)>:S5=>U8WTL58<<
M)4>!3FX1L4UEJ7:K2_;+HRNW?M+MXTVNAH4-LMRFE_W>8<,UHP"01Q^2)=/^
M _W"'P_^Q*D=>@_TZ4^ ]!'_ ,)_8 ZNSZBW%_K)KYC]R,7_ /K%V,?X$K?L
M?P\>JXK^!W*2G(NO\H?(AR86Y*72E349.U>JL'%@EHJ0D(547T$>T3MK!)[]
M*@90060C62!&QCE*)C@ =H]]JT'5FXINFHZKWE]"@4I$R"1B,Q5C('$) E%/
MW'[S].)T$_MQL5IX:>L]6RMMYY0;0XE+@RN=)MF:<[B/*IUQ17(D <XB5\A&
M5;;;/.79)J2P--<K4\(R->AJ/QV2?O\ Y:>;4ZKA*MUV[=)G)]L4WGEAF'C8
M&ZB#HY!!0!*(ZM/4-4\[KE3BJ=59T"D)9GQRIGAZ)^8C@8R;V-T[:[7V;L4S
M-[9TR;PEU=1="E,VR\]D()*D><M#H(5F"D ^4@Q+"EYJ?(8BFFBCX?LJ(HHD
M(DDDE8+$FFDFF4"$33(2B@4A"%        U=0UIJ,"0LSTO7_P"$8RJ[3]AE
MJ*U[J6PJ)F26VB23S/\ &(B8Y;W;FGRNY:\?>6-)\;N8>-N7<86FK+6*WUJ*
MFK&>Y)15DCW,5)S"8UZ&23D(2-4=-S+J%6.NV4*F<>Q,NUIW=^^76[4]V8MC
M]-6-+3-0$\TE"1. Q2)X\QZHR:VPMNS^VNV-]VRO&X%JU!I:Y4SH:8=6AKH%
M;2@M+9ZBSE<7D5E!2$K!4D348[1]S2W1LEZX(,Y!%9)M8%IYH_;F 45R-Y:4
MKR3MN8H]4U027,00'X#N&JUN: X_0)5P43/Y2(BKX>CBZ"T:T>8(+K"&U)/$
M30ETI/I$P#%LK%U4K=%QM0Z=3X6-KE7K=2@(B#@XAHBQC8R.9QC9)NV:M6Y$
MTDB%*&X[!N8PB([B(CJ6*5IMBF;992$M)0  ,  !&LO4=RK[S?ZVZW1YQ^XU
M%4XMQQ:BI:U*622I1F2?_**K/NDJW MR\(;FA$LD+8\OMSK#JPHHE2EG%?:$
MJTLTB57A *L=DVDECKID$=B*',(;"(ZBO=-M 30O #JEQ29\Y>4RGX3QC9)\
M..X5JUZPM*W5FV)H:=X-$S0'5%Y!6$G#,4 ))EB  >$>W]SIN/##B.(B(C_%
M]GN(B(B(_P ,93J(CU$=>C<_^A*3\L/P#%)^'A_W:U1_92O^;1%E?!?_ *)8
M=_W5X]_V2B-250_R)G\DC\$1K\UE_>^Z_P!I5/[^N*[OND__ &AX+_WZ#_LE
M*ZCO=+^AV/R_Z4QG3\.3_NK=_P"QC^_(C$\ZB@H^'#CTL7]I*3X^*%W^&Y*
MY,&_ZPU]UUAHZG/I:_ CEV7I"^ZF])/ MW,?_9$2W>*#$M+P]X_.,<!3(EC'
M)SF,H*YV!\V8MVCV?LMK0&:E9B860("C^145=@EZR@F.*21"[[  !=>E*1BC
MT_2ML  *:"CAQ4K$D^)QXQC)W*:HN^K-[M15]V=6XIFXNL-I4HJ2VTP>FA"
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M=N@R;DL$3Q[-T[.W=J5NMIL53"W15!$Q7AB"43;!N&_P =?=U)EBA !)ZR^
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M  %#9-(A=NXYAV(0H '4QSB ?RCKS\!A%=Q<7YSQXD\AS/R#&+=.,N)MLA/
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<E_G_ +O]X'[/^C^W_P I_BU\CD>7'A_I\D?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g923794ex10_11pg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_11pg001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .@$6 P$1  (1 0,1 ?_$ -8  0 " P$  P$
M       )"@0'" 8" P4+ 0$  00# 0$             !P4&" D" P0!"A
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M]6^772IRH6?623R'^H"-Z-BL6G-%:?:L=@IZ>VZ9H6?*V@!#;;:$S4M9^D9
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M+&SA74:I>X!2<(8TJ[8O$7!8_P!/TA J6Z@CN&VOM]U&FR6=N[*94Z%Y/(%
M'S"?$X81PV>V'J-W-T:W;6FN3="[1IJ3UUM*<2KW9SIGR!22,W$35AP,<'6/
MSAY,S*2LT_Q[<-+MR;R:M6ZW,9(D%G3MOBK&%@FXXDHZH<C;8]NU;R\_'-E
M!18%VJ!5 $H <=^V@.ZYJ:TII].T3E55Y 5DF3:%$3R%0XF)HM_:!8-*&HNN
M^>JZ33FGA4.MTJ0 :RL;;64)J4,**E(:6H3 RK5+$D83U5BWS_90QAGQE@SR
M2\3W7%[ZRZ0;-[G#*6)>/K;=519J6>GHN<1<+SE54?$!(S^)67(WV,8Q3[;:
M\M)K^LI:\4.IJ3W4J/M))(3Z3/BF?-/"+HU'V1Z=U'HE>L]@-3(U&&4$JIW
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M*ZCO=+^AV/R_Z4QG3\.3_NK=_P"QC^_(C$\ZB@H^'#CTL7]I*3X^*%W^&Y*
MY,&_ZPU]UUAHZG/I:_ CEV7I"^ZF])/ MW,?_9$2W>*#$M+P]X_.,<!3(EC'
M)SF,H*YV!\V8MVCV?LMK0&:E9B860("C^145=@EZR@F.*21"[[  !=>E*1BC
MT_2ML  *:"CAQ4K$D^)QXQC)W*:HN^K-[M15]V=6XIFXNL-I4HJ2VTP>FA"
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M=N@R;DL$3Q[-T[.W=J5NMIL53"W15!$Q7AB"43;!N&_P =?=U)EBA !)ZR^
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M  %#9-(A=NXYAV(0H '4QSB ?RCKS\!A%=Q<7YSQXD\AS/R#&+=.,N)MLA/
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<E_G_ +O]X'[/^C^W_P I_BU\CD>7'A_I\D?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g923794ex10_12logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_12logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ -P#L P$1  (1 0,1 ?_$ +\   $%  (# 0
M       !!P@)"@(& P0+!0$!  $% 0$!              8!! 4'" D# A
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M4:'D:+6@/SUL;9_MV[R[Y@DN]OX.Y:RCD=#),T5O&SHS(ZQO,Z"7I=65C'U
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M0#'$QZ:*W&M?.@I3FP XG4=<:>5G@5F7D2RXKXHS]"9#S+(J6%!C"U2#M,K
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M)X:M<<\A/N4G;=9JAPDXDQRZZ9TD'YK[&+E9K'*().3HJY@,DH1)381 P;"
M=>FL@+_?E>-E;'Z'_P"$ZYS_ &/]DZ$/)N?<31A@2OHOYN(\O"Q!%>5:\.>N
M^>-OQS\C<"YJY"^2+GY=JU>>5V3ZO.-R5JD+IOX.CUI%NR=RC87[9JVC5)%:
M+J[",9,V!3M&#! 2 LL=01)>X?#7MO<RYG+LK9%U- IX* *<^1)  J/  :Q7
M>KO+M#=NU<+V2[/6T]KV^L+A#ZLXZ9+B9FHK%22P4.\DCLYK)(Y;I4 #6>_@
M9S#XEVKD1R(YK^07 F?>6.:;UD!<F-&=<PR7+N+\=UA(/J46XQDI+MX9*?BV
MJC=@Q:+(+$CX]OWD_N+F.$3Q=_8??)<CG(9KB[D:JA8FE1 >-.1%1P'AP'+C
MKL/N[VS[@XK9V%[5]H<OB-O[7M<>#=F2\:UNKN4^2K-&C,$8B1Y/,#*["O",
M5E'Y)N5GC6YCX'LD=BW@_P I,5<E*TW1G,*Y2J_%=ICYQ&6J-=).6L5:)6J2
MR;E[6I%,ADU!.BNJT5$BZ':<G6^S.2P>1LS#;6=REV*%&%LR4(Y>8+P&H#V1
M[?=ZNVV[X)\YNK Y#94[%+RUFR<EPK1.I4M''+'TB1*U'F4.*JW/@X_D1S?D
MCD#]N5Q]R)E]M/H9-_\ E/&%1O)K,P>Q,Y*S-%E,@5']^D6<BV:O"O)QK#HN
MU3F3*"JQS' 1 VOOF;F:ZVE;RW2GU_60-U @F@8 D'B*\#QUB.RVV<'L_P!Z
MF9PVVS$^WQ8W4L(B<,B).EM-Z:,M0!&795 Y=(4TU?KP(\>?%+"G&'%#%'"^
M.KS:[ICFG6S(^1\@U&"NUYO]LL]>8S$[)V"P69A)R"S4[M\=-LU X(-VQ")E
M+T$1E.+PN.MK&,&&-IV56=F 8LQ J:D5Y\!\!37)'=OO!W W1OW)32Y*[M<?
M;7T\5M;6\LD,%O#'(51$2-E6M%JSTZF:I)^%-=,Q#0.)WW+5+H& *Y'8SQ]F
MGCM8K'<:-5D?VJJJ/Y2D7"7?)L(5L8C)C'K6"C,Y K8A001==YDB$ P%#!06
ML-GO4"U4)&\!)4<!7I-> X<2*_(ZZ2R.XLQW ]C5UF-WSM?9?%YV.*WGE\\W
M2L\'1UR-5BP2XDC+DU*!0>6G6X! '_\ 0KY5>@=,:PX!T] &0Q%N ?GKXX@
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M<>1F0?%'3,/5M#(/*G-T-D7#;FWSM4IR;VTW62B8ZR!:;@%5J4<@UBXDT@Z
M2)(( FV1.F4PB("8;G=%G>R8.*WB62YNEECZBJCJ:@-6(% /XM83VK[RV7@^
M_MUN>_:TP.UY;&]$,<T](X5=HS% )IFJ[A12K'J?I+:O+P3'2$1A##<3+,74
M9*Q>*L>QTG&OD3MWL?(,JC$-GK%XW4 #H.FCE(R:A#=2G*(#Z:E4"E844\"%
M _)KF#=D\%UNK)W-LZR6TF0N&1E(*LK3.592.!!!!!' CCJA_)V#<T2'W%N!
M,\,,4W][A2!XX2%>F,KM:Q)K4".G3T7*[,L0[LY$!BV\B+N2;I>T=0#BHL0N
MVY@U&FMKG]L(Y_3;[MZ!'7^J#TD4)^=?AKJC";LVS![+<OL^:_M%W3+GTE2T
M,BB=X_7L_.L9/45HC&H')3J,?(AARK\87ECS5SYIW&;(O)WC'RCIL?#W0<5Q
MSV4M5+>%95A)XS<MV#*45BY2*G:D1TW^L0(PD&3H2 X25((DQ=W%?8+/R9>*
M![BRN%\P0%F'*HH.1X5^?+F-3?9MUV^[]^WK%]H\IF[3;^^\#<L\'WHA(IUZ
MI>EBSNE5>.4JP0]:R*"5*FC.;R1\@O,#R,\:<V84X8\"^26,XFSXQM[?(V9^
M0M:+4FS&I)PKUQ,TO&-4CC2CV]Y"OS9$(E@F@KNB9X904OT=Y+BZR^4R]H]M
MCK&:,-&>IY:"B^*JM26=O &@IX^&H_LWM#VZ[+;YQ6Y^YF[<-?W-OD(3;V..
ME]9C,9 (YKN1POH6]NQ6:3J6CA:!Q2A:)MQHY$D^VGD>/9\&Y2)G0\L)B8B-
M39D,A&3-R-:SQ52U;Z89;VAA2BZW]KHW_7_3UU9M8WIV:;<0O]YZZ]%/,*-7
MERY?/4J;?NRS[X?VQ&4L3M3I/^L$R&VK^&LE/5!Z*F0>F.-.H@:T-^/:L6.C
M\%>(M-N4%*U>VU3CGB*!LU;G&2T=,P,W%T>&:243*,'!2+LY!@[1.FJD< ,0
MY1 0U,\9&\6-@CD!$@B6H\1PY:X][Q7]CE>[&Y,CBYH[C'3YN\>*6,]4<B-.
MY5T8<&5AQ!','53[/!^9@^XT>Y[-BN^%PFIQ:"KDRL:M284(]B+2V;488EF]
MC]J-(_5$%/VO<[^\!#;<-1U;6Z_;(W0C8VGHTZ_U:A *?&OU:WVV[-LCV7Q[
M/_$+,[H&X?5-J)4-P(S,WG,5>L+2AK2G$:MG\@=6LMWX/<LJ?38&6M-KLV ,
MH0E=KD$R6DIJ<F)&IR39A%Q;!N4Z[Q\]<*%(DF0!,<P@ :D.51Y,;.D8+2&-
MJ <233D!\=:"[17]EB^Z6W\EDI8X+"#+VKR2.0J(BS*69F/  #B2>6LZT_QE
MY&+?;2P7'M'!N4SYU1FX11;$)*;,&R*DDER0-8U5%*H#8TJ1,L"/U8B*8;(#
MWCL'74.DLKP;*CMVBD%P&!*$4:GJ$TI]!UV+C]^;)B]\,V\9<M8)M3T#_J_6
MC]"OX:L=/4ZN@'U/)4F@8'CIP.+'D/YJ^.GCEB#!W-S@3R4R5 UJB5AIBW-&
M!8(EP,^IB\.U>UVDY%K[OZ%2KW>C,%BQ;Q-==%P!FH$.@82"LK]K'-93"VZ6
M>4LIY(D0=$D8#U%. 9:@AA7CSX<=8;N!V=[7]YMZ9/=?:S=^$LKJYO9FNK/(
M2>AT3"0K)/;2KU>M;RL#*K*A0AZA^/2&]O5.YF>=_DE@)>]<:\@\2?'Y@.XH
MWJ7',2"T1>\I2I3M3R";**>,&2TA)R\>P"-;%;(GCHEHZ=+J.EEU"(C\77)[
MLO(C+;O:XF)^KS4ZB?Y?T>GD%:M:\-9G#Y/MG[3MEY@8?-VFX>\N7MC;(;-B
M]O:1FO)PS  ,1*S%@\CQQH(T4,3+OFW@?,EG\XGC3RU4,4WF=Q'C:A24?=<B
M0E:DGE(IRQGF2?IV$W/-T#1T6J"4@W[2*G*/:J3YZOLI9W4FY[.>&)C:HHZF
M'):-X^.M>=L=X;:QWM5WMMO)Y"UBW->WH>&W>15FF%+2K1QD]3 T;E4#I:O+
M5[^8ZC*9 P]DVA04L,!.7?'MSJ,).E.<@PTM9*W)Q$=*@='^Z7]O=/"*[D_4
M';TZZEL\;O;R01GID9&4'X$@@?577)^W<E;X7/V&7O(O7M+2]@F>.E?42*57
M9:'AQ532O"M-9*?&SRRO7A_Q=:N)O*#QQ\H5\B1=_L\PRRU@7%K*_1^4VLPY
M0)'"\LBSN%0DFC K84H]PU>.T3,S$ R**H* > 8;)2;>MVQUY8W/JK(?.B!@
MU>=2#6GB#R(UZ$][.W^)]QVX(.XNP][8'\%>RB0VF0NFMVM"H\U(Z/T@U!DZ
MHU/J5\Y% .J>36U>3#R)5O$6=*QP*R]C7BUQYRS6+I7L7V-J9]R0R?/N71?J
M+LOCZ,;K2456(&+8"S(1)(Q4%)(RHJ.2B86_SS<F:S<:W*6<L=A"X*+P:1V/
MZY4$T4"O"M032G#60[#V'9#LO?Y/:N2W;C;_ '_F,9-!)<QL%QEJB@_Z=;DL
ML;R2M1S(6HX0*J1MP?69Q?SD]Y&8<K&69#$>4L'.;)^YD5QIF>")6\A0 Q4D
MYBP&8AB*K W0D2MOJ&QN[=5NH0P@7?M"?6-T+^U2Z].2/J_5< ,*?$ FE>?/
MEKSYWKMF/9^Y+C;\.0L<K%!TTN;-_4MY.I0WD<JM>FM&J.# CB..I"[!\O\
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A_P![U<_T^(Y#APU,L-O]NVV_PV]?CZ?'5]JQTNFFO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>g923794ex10_13logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_13logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00$0 P$1  (1 0,1 ?_$ ,X  0 " P # 0$!
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M)$3%,Z?.C_*FF7U$=Q'8H"(=<LL<$9ED-D KZ56=@B LY(  %R2>   XDD\
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M!">08M(+D>X$GZN'&KOZ46V=C^DC<^=OR$S;3@U3*DRD4#S)(XX,)Q$IM?\
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M>UZ]2NVFE:GZ>?1SN+7-[H,+<&O&8XN+."LE\B%,6"-XC\0D91).PL"D97S
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MD,LTD1!$A  '0"+<[F_(7XLN/N";>ZW%7A[0?4=_DSKD@O\ RV.L,_I%R?\
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M4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4H(;^@^H#Z"
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DI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>g923794ex10_13pg005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_13pg005.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 0P$F P$1  (1 0,1 ?_$ -\  0 " @(# 0$
M       )"@<(!08#! L! @$!  $$ P$               8$!0<) 0(( Q
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MC\.6W8& =X[]X>Q[!6L'<2OUHR;[:CBC=;FZ<O[+*%XW-9*0>&,=W)# _?\
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M.6\,(+NWAV-Y; &W+>YMW< E% X+\-]DA'_E?P5\_P#RTK8!]'R#4YTYF&!
M+?X)/[D5KGZP ?SL;F_V]G_^IEK:)_(R[<!%K$^KV^&RAP$?P F/CJK+N.Q:
MQP>%8%S7'/<FXWM^.[=495"I6J+&-G'T;-EA7B+'U*#@XHR;EHLW9"8Z!2F,
M<H@)1$/IU33EY8FC=#R$<>-OEK@@$6/95<.=[$?;=7D9!\JIEIT\>/'3MU_S
M18Y(;U+E=19<!*>IF4*8%3CN!A$WS\=1%]N:86+6EN23^N[SQKVU@><CS$8.
M#!A8>F87V.&%(TMIN6?<10J<1+8^Z!V</1PKI;WL8]NQ$#>1"Y?<!L(?5Y3X
MY#P^&_\ P>(:^;;<TPBW+-_#&JG]]/S(_P EX7^[<S_.UNQG7CK0\^XTO6!L
MFT&VK8V<(XK3>L(7(D949Z )C9%JUIAG=RE8I]&//O)%$OF;H%]28W4GMX:N
M&3B1YD3XTR-X1Y;@-RD<MK>]^%Z\X[ ZG;UV+U"FW]M>"*;=4OVGFC:"251]
MH;FFM"C*XY3V<?=[#>HX7/9>X-([^3BS-3CY;<JZ!X_UM+'81U;/V?T[_%S?
MPQKT?^^EYC_Y,PO]VYG^=K@''9SX6(#U)X3S8X*40,)3\KZ(0A@#Q$#F)2@,
M0@A\1 0V#Z=<?<&G_P"+F_AC7'[Z7F1(L-+P^;_9N9\'^%KIG)[D]@/@EAK]
MG>+'F.XS)M8I-JH/'_ F+[>VR*.*9*\(/FMIS+F2\,9"9:_K<U"67?-T'+M2
M7DI<&HF;M6#4 #C*R\;38/ @Y!,JD)&IYN7FO=W-SQ[3<GF9JJNDG1GJUY@.
MJL/5#JQ!DP;>BR(IYI<B(XYR1"08<7%@8*PANH#ORA%3F]YI&XQ3=E(9(O/O
M$OW:*@J?>U:ZQ)N)A']H%,%(1V^(BMMJV: "-10#MX?C%>F_/X(/YE\/Q+>-
M]_X_)[? R>:W]C>OI]:RQ6GBJ/G)+'N0'7NBJU<6M#NKJH%S[Q6<&M;:J3[B
MM%;M..F(6CQP:>1CSQ16[-T@=-4XJ]*1R&*80$H@&.\Q7.\4LCE?%CX\K<OZ
MH?I6Y?E[>';6U'9.MZ-'Y#)M+DR\9=2^Z-5'A&5!)=M1S&4<A;FNP((%KD$6
M[15X/61*U74TI6E?<)X<5WGGQ,RIQLG9)*OR%MCV<I2+4L@HY3J>0:T\2F*E
M.+H(B"RT<61;@W?$3_.*,'"Y";&, A;]3P$U+"?$8V+"X/H8<0?C^2LG]'.I
M>;TDZAZ?O?$0S0X[E)X@0#+CRJ4F0$\ W*>:,G@)%0G@#56KA_W+^7/93@OY
M&/<&XLY.LN(:-*2R>+LE4U--RI$PKZ5<O'#&KV*2!O2<B4==\NLZ8@618R$<
M"YD52B4"((0S"UG.V\/N[5()&@4^ZRBX ]1["OHXAAV6X7KWOU(Z'=.O-!F?
MSF='=?P8-QY<:?:L::X#NJ !I8UO/C3A0J/>-TDY0R\;N^P^=?<*Y.Y;UB4P
M%VMN+&?9[->0&IZZSR7/042HYQ^WDDCMWDY!05<>V>,0F6B2FZ$E,/V,?&G#
MSU"J@0"ZJLG=4V<OV718)FR'%@Q7@OY+^@D@5#=J>3C0NG6?'N[KWK^DQ;7P
MV\1L:-W R"IN(Y))5B8H2/>BAC>24>XI6]3K=OC!7*'!?%5*(YBYVMF>N0EL
M)*6NZ/YZ;+/Q=%,]BTFT=CNIO$6[<CYC!-FP&=.BE$'<BLN9,10!'4DTG&S<
M7!"ZA*TN6;EB2#:_Z(L +#LO;B>->3^L.Z]A[KW^<CIMI./I.SL?EBA6-/#>
M?E<ELB523RLY-D7AR1*@8!^:H)/:X4NZ5&;Y[&MU.MM4+)V;$RL::SUF;KQ9
M!-)WE45C,33#%F#OR 5)Y@)]0DZR]6W4&\=V<KJV5S*R^^.U2M_G=EP+CUCA
M7K+SZZII>I8VT1IV3CY!CAS WA2))RFV):_(QM>QL3P-C:]C5N?4WK73507L
M2TBZUWNN]SJ9L--ML!#S#K*QHB7G*S-Q$7*%5Y&*N41CI&08MF;WSFP^:3RC
MFZT_K!N7QU!=MJXUS-+*X%CQ*L ?K#V$@ _!>MCGFQU;2\[R^[%Q<+)QYLF)
M,3G1)$=EMIMCS*I)%CP-QP/ \:P7SHA>3?:2[PMJ[CU8PU.9AX\9B<R$G,R$
M4V?_ '1]V76O1L5?Z-.V".9R1*5:HF>B@DHEP\1]([2*@'YP <)IT^I_:]"U
MQM52)I,63CP!/: &4V!Y3PNI/ ]]2WI3E;%\Q'EMQ^BF=J46F[RTU55%8KS\
M\$C/CSQQL5\:)XV\*54;F0E_F_5EM]V'N=L&Y'CFM<X^\/N4^6LW39"LJ[C1
MG"5@6;B=<%%-JW=359F[7+&8 Z$ ,HC%J'$FXB4GB(7']LL:1>7%Q\F3)/ (
M%[_;<BL0S^17=>AS-F[QW'H.G;6B-Y,DO+S!!VD)+'"G-;N:8"_>>^,'A]CW
MF2'N&,69.Y<T*5BLHWAS:,@7D]=@YM_0Z$C=.,MJD:MC]*T)MG4&4U)KSMC#
MJ@5XN5-V@*(K*K 8QK3@)G_M.CYZ$9# LU@Q1;H;*&M;W18=OP5GCJ1K733]
MS;/T#IWEQR:%BK%CP>(Z+/D&'5(EER/#)#GQY%DF%T4E&YPBK8#;ON.TFZRG
MN*N =HBZ;;9.L1C;CF$E98ZLS;ZOQXM\E9!5<@^FVK%6,:>E24*=7S%2^40P
M&-L @.J_5E<[KPR%<K[G$*Q XMVL!8?":QQT5U72\?R8;OT_(R<=,^1M2Y8V
MD19&OBXX%D+!C<@@6'$\!<U;ZU.*UQU4#Y$4B[.O=!X#M[6F6US4FD=CDKJU
M-ZU-K5IN9/"5K;J>?/)L3127EN%"IF$RP 50>D=A\-07)#_ME&>5^7E7CRMR
M_,;]*W*/C_'6QW9FK:5'Y$-7TR3)QUU)FR+1&1!(?].B(LE^;B!<<.(X]E6_
M-3JM<55!:]2;J7W5%BN)J9;BT\T8]3+;35B<+5S&'AQ',PZ;"+ (<P"]#R-P
M6V\_\WOU_5U!E5_VU)Y7Y.3MY3R_JQ^E;EOZKWK8[F:KI9\@,&EC)Q_O(.#X
M/B)XO^NF/ZOFY_F^]:U^7WNSC6KW>MQ%RAOW>NQ+(\8*Q:1R@SH&$I+&-P;Q
M4DVK3&^59];;%$(N[2JQ/7F1A=QY$C Z6(W$RI2+"5,QA"BW!'EON%%PU?[0
M40HW*>4,.8B[6Y1V6XGOMWU/?*_N386C^5W4<??D\'W&^9G+DPEE,C02K%&Y
M$0/B'W6)]T%K"Z L!4AE=]RU5\/QGZ@\Z>&W(O"N?ZR@,9;(.NUZ)5KDQ-L=
MV[M_"M[M.5*8BF3Y9/S$TA!^B0I@Z'2Y=CC<X]WI"OA:GC3Q9:\" MP3;N/H
MK#.7Y'\_<L_WOTIW+HVI[0G/-$\DC^(B-Q"N8(YD<J#8GZMB1QC0W CQY!9/
MYJ^XQS#B_%.%L%6_ W"W'5G3GIF_W9!RK$I/7B!H^1N]HL -&4%/6B/@E'+>
M$KL0=V=,[E0RRXD4,LA:\G(U'=<Z08\3PZ>C<6;AZN8]Q-OF@7X\2>%9FV=H
M73#R6[;S]P;GU;'U;J?FP&-,>$@/93S+!%'=I$B9^5ILF8("% 5 RA'EE[]6
M"FV.^S[4<#8;J<_,06,KS@"E5>"@(A_/2Y:]4&,A$-W3AK$M'#A504&I3N%O
M+ HJG$1V$VKWN> 0Z$L$*L51XP  6-@;=@!/MX5YY\I&[7UCS(Y&[MS9$4>5
MG8N?/+)(ZHGB3,KD L0+7-E%^P>JI+NT[&2<+VVN%T3,QLA#RL?@2E-7\9*L
MG,=(L7*30Y5&[QB\21=-5R#\2'(4P?+5YT6XTK'N"#X0X$$'X0>(^&L'^87(
M@RNMVY\G%=),=]7F*LI#*P)%B&!((]AJ.'W(_#W-_*7B+CRS8.K4S?I; V19
M&ZVJ@5MJO)6.8J$U6G4-(3D%#-2J.IR0J[A-)0[5 AW!FBZZB93>6)1M&[,#
M(S,%'QE+M$]RH[2"""0.^U[V[;=E9K\DG4G:VP>HV9@[JGBP\?5\)8(LB0A8
MTF20.L<CFPC64$@,Q"\ZHI(Y@1KOQP]S!Q$H6$,?XYS7@K/6-LJXYI=9HLE1
MZ12:_,UIP^JT(R@R?JV>1L]9DH=@Z%D ILG;)-1H ^5U*@0%#4>+O' CQTBR
M8ITG50.4(2. MP[+#U$ BICO;R.]1=7W5F:UM?5=)S=OYN5+.L\\TJ2A99&?
MZSEAE5V'-Q='(?YUE)Y1'KW2^1?<![M& 97(F+.'.5<3\', R\;>5C6N->JY
M$RM9'YQK#.T-81NS36FXBFQLVX640B$GC./;K+N'+Q4P)D2MFKYNJ:YC--#C
M2QZ7%Q]X'F<\1<+VD*.-@.^]9DZ!;,Z/^7G=\>C:_N7 U#JGJ\3P?5,HQ\6-
M?K6B+DGD>9HU :8H\C!$CB7WBUASLJ\ZJ?RLXTT_$,)BW+..[3Q9PWA''MY>
MY KR$76K%,H5I_6?44>53=J+R[3KI2CA4JS=LLV3=(E,41$1U*MOZG%GX@A1
M)$:!$4\RE03:WNW[1P_)7C;S0=*-2V!OC)W)E9^GYNGZ_J>=D0+CR%I8T,JR
MVG0J I^O"@JS*Q1B#PJ9[5_KS)6-\Q4-'*&*<BX[6Z "YTVPUY$ZG@1%Y)1C
MANP<F'Z/3/3)J?U.OE/'XT+1?24BN&',I4]AKY/?+_$\KAWD3DZG3$:M&J?K
M+)2[9LN0R9DDI-ZX6=-@*/V1C94KAJ8/R3H"&L-YV.(<MT8 'FO\?]6];[O+
M+OJ#J!T4T/5 X;4,3%7"R1WK-B 1'F];QB.4>D.#6LYTR=!OJA]DWXAU1.B<
MAX#L-9Z/95U7NXM0+VK;(YV^JX8<*#!^&#BA#^=J;ZXO_P 2U^()@_&*T]>5
M6X\VN>#]+6/XTU2LZ"_+\?[^H7R+Z*W#4Z"_+\>G(OH%*_0*4H;%  #Y &VB
MJJBR@ >JE67/;9<<)3(/*,V67;!48"D[R179D1\H"5HGJ^L#F#I,5>TR$4D7
M;XBDK\1(.TKVKBF7+,]O=7\G]6U:O?Z0C?&//FZ%TYQ'#3XXDS\@ WY3(/!Q
ME([B5$SV/'E93V&OH"ZR16MFFE*:4II2FE*]-_'1\JU48RC!G),EO!5F_:H/
M&JH>/@HW<$42/\?I =<$!A8BXKZPS38\@E@=DE'85)!'L(L:].&KT!7$#M:_
M!P\$V5."BC>&C&46@HH&^QSHLD$$SG#J'Q$-_'7"JJBR@ >JOIDYN9FN),R6
M6:0#@79F(^%B:YC7:J:FE*:4II2O$LBBX240<))+H+$,FJBLF55)5,X;&(HF
M<#$.0P#L(" @.G;7969&#H2'!N".!'L-<+#U2K5Y1=:OUJ @UG6_J58>&CHQ
M1QN/4/GG9-D#*[F#?ZPCXZZJB)\T >P559.H9^: N9/-*J]@=V:WLYB;5S^N
MU4=-*4TI32E-*4TI32E<',UBMV,$2V&O0<Z5N;J;EF8EA* @;??J1!\W7!(V
M_P!)=M=61&^< ?:*JL;/SL(DX<TL);MY'9;^WE(O7+-VS=F@DU:((M6R! 31
M;MTB(((IA\")))%*FF0/H   -=@ . [*IW=Y',DA+.3Q)-R?:37FTKK32E-*
M5UIU2Z<^DBS+ZIUIY+D-UEE74%%N)(IP\0,5\LU.Z V_T]6^NAC0GF*@MZ;5
M71ZGJ44'V:+(G7&^@)'"_P!J#;Y*[*   ;!X '@ !\ #7>J&OP  /    ^0>
M'[NE*_=*4TI52#W!?:XD\BHK\IL/PH+R1%#N;6R9I 7TTNY\LKP7@@'2C%VI
M0A%4US;)MY8# H8I7G46&;ETAIO],@'O#M_+\!_'[:]5>57KZ.C&[I-.W S'
M8.K,BY-KG[-,ONQY:J.)50>2<#B8[, 3& :0\DQ>Q;I]&R31RPD&"J[1ZQ>(
MJ-W;1T@8R:S=PW5*55%9)0H@8I@ 0$-8^DN$8'@P!N/1PK=IAYN'J.''J&GR
MQSX$\8>.2-@Z.C"ZLC*2&5@;@@V(J[!W<DNKM"^M_P \@^#ZN_TCYE9AS[_A
MWU-];_U0?68/R5J)\KB\GFZU)?1)K(^*9JI+ZA=;@*:4K+^#L(WK/^0(;'U#
MBG;]_)/&B+UVW:+NT8IHZ<D;@NJFW*91=TNH?RVS<GYURN)2$#<1$/MCX\F3
M*(H@23\GX=P[ZQCU:ZL;6Z.[1FW7N:0<P!7'QU(\;*GM[L,0/KL9'MRQI=F[
M@?IJ]KK@Q"\'>.D'4E(Y)M>[$QCGEJ$?*4<QB#=-96/@5G*>Y%GJ*[U=T_.0
M>A1^Z5 HF333'65])T]=/Q1';ZP@7_-^?UUH/WOO+6^H.[,_>>XGY]7U"<R/
M:_*@X*D2 ]D<2!8T'T5%^-ZDKU=*BM-*4TI32E-*4TI32E-*4TI32E-*4TI3
M2E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI7HR<9&S4<^AYA
M@SE(J3:+L)&-D&Z3MB^9.DS(N6CMJN0Z+ANND<2G(8!*8H["&N" PL>(-*K%
M]QWV\]$SL\F,C\<54:U:W!%US5A5RBT<E/TB8C2.D7QRL)N.(8.E)M(*(.4"
M !$W@EV3"):MMB++#28QY9"/A_,?8?CKT7T6\SG43HMRZ9@.NI;.+7; R&;E
M2Y]YL:47;'8\25 :)CQ,=^->3NU<?<GO.U0&)H2LOIF]5F.XC0TG'$*W9*+.
M*3#Q\3.J$4=.2LP%L[;#U%!8VWP P[>/RUK#G;2C"@O(/"]7S;7_ !5??+WU
M3VCMCS"9'47=\WW;M_,^\'NRO+X393EXT;PD9C:Y4L%M<7-@:I>,>&7)V0=D
M9H8CG2JJ' @"L]A$T^H1V#ZXR@@;<?Z'<1U"Q@YA-A&;^T5LSR?-MY=<:$SG
M<^))P^;'#E.Y]BB"]_;:I*N+/88YC9]E(YQ8JN]IU6653,YD7""L>V!N.QE!
M//SC9G&$$I?CZ-.15'\E,1U=,/;F?DD&0<J?AWG\@)KS_P!0OZ0':.!COB=,
MM,R=2U(@A9\L?9L93]+PP3/*.^Q$0/TJN?\ ;W[3V!^"D''2$?'1MJR4B0%3
M6$[0QH^'>'1\I=U$@] [Y_+'((D&1=""P$'I03;D$2#.],T;&TY1R@&7T_AQ
M)]9K6UO_ *B[SZH:^VY=[YLF9J1!" ^[%"E[^'!$/<B0>@"['B[,W&I6-7BH
M332E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*5ZKW]%7_1?X,WZ;^B_ ?X?_!_/]S7!I6-X
C'^-O_"W[8_Q#_&W]O\]?)?G?H?!VTK*6OM2FE*:4II2O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>g923794ex10_13pg006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_13pg006.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .P$  P$1  (1 0,1 ?_$ -H   $$ P # 0
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MD(-(0:0A)6*^4BGE ;9<JK5P$O>'^T-@B883%'V"4)%VW$VX?#?7RIUI'Q*
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MF/2WC/87"=D[6J#ES?6WF[I<4IJB\H*6'7=-RJ:=L?K$(&EM*$],$^,=:_\
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M*L\">G^#*.T^8[1>]\]LG^\#E*SMV_DJCK6PAP->2ZXRIQ* IQ&8"TJGI)S
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M4"@1%NV2(@@B0-]B)(IE*FF4!'V  :^^DO&+);BG5ZG"5.$S).)^DQ1D\B>
M^/?'#S8R.3^?V+Y"]<+>6#,LRQMA5K,TBZM:7L!#PCZ27>5=VSD%G5+L4-WO
M&A5#*?A<@"Y4S]H!J 7:FHZ:^AZZ-Z[>\  3\(4!U]L>I7#N[MW;V[8T[<XH
MKT4O)5A<(+)#:ENLI45!*0X%)DX@X*E\:=,Q$L[SQS?3JL,>CE9TGQS2QZ6-
M&7_VG+R1FU69V7H^O^]-T<A*/EW8I] ;$1,Y$WV>SNZ:RJK)M,(*U-4^DXSG
M]F,:\-<P=WSMW-@:%V-W\S1Y7[O1,*RS\C2,<)ST]9RA+>&NO^.S+?(K+67.
M$/!>[8CJN$B3]&KG*"QW^SO:_D$]A<A'.(.MTV:E'IDG$G!("^7]83JL$3HE
M5[%5BETL3=I<?6[;*4-(1[H<&2O&6/HBZ[C*GF3;VU+?M_E#<M/7U=QT/+MK
M;38<I] U!3BT) $EG2)2"C.6 ,-)X4NOE\\QP>X;U9/R;_\ OC<@_1K@L:I7
M>O(E\9.&69B5]T"9<!\;^/R2/KIFC%F#D*4/Z LX]/\ X?R9_,J;U+'?U2O4
M?LC2+:W]J;:?^OT_[9$59O!O6)NZ>$'G+4JTQ6D[!8I7D-$0L:V(91S(2;W"
MM=19LFZ10$RKAVN8J9"AU,<P!J);?2MVPOA.*U+= ]<HWT[IJZDM?<UM>X5R
MM%&RS0*69RDD5"B3#N_38<P..<!PG=\=;EEJE4'+U#RI?)M_3KW8HFI2$E!6
M=:/?1\M!A/.F*<JDBN19LY31,=5NJB/J%*!BB/)M>KITT)I5K"'T+,P2,YXY
M_@(C?>MQWO&KY+1O&V4%56;=K*"G2AYEM3@"VPK4A?EA6G,$$_$,C":^I#YY
M\=K/Q+5XIXPR'6<KY1M-[IELM33'TLSM<7CJGU*0,]&4N$U!JO8F)=S4RLV9
MLVJBP+G,<QA*4 +W<>Z;A3*HU43)UOKD9#%( \3Z>D9#LHXKW=1<C)WY?*5Z
MALE/3O--E]):54.NC3H:2L!2M"05*5*4I8YPTGEXV#Z?3@3MMT#C+_R?LWL_
MLZI?S/;+1]#1_P V,UVY?_;;<WKN/[:+5W&4-^-W'W^I#$_\PX#4LIC_ $9O
M^(G[!&B&]_[:7?\ VI5?MW(K6<A@#_\ 4CQ4_J/CO^6^:!_2&HM5?VJ8/4-R
M^HQNMLT__!F^?[37^U9BUL^* ,G@;=/DW/3\Z1]2U6./6-!Z?!]!&>L?:(J-
M_3J?\$/*K_65+?S0O^H?M?\ Z)6?SROL,>@?>%AN[84O_+F/VS4,E]-IY$,"
M8/JN5^)^=[O7\4R-MR2YR-BRW7)\C U*SNGT9&P5EJ:]CD#(1<?.,#QK5RW(
MX53(X37.4IN\I2FM]LW*GITKH:DZ%%PE).1F<I^,2CO2X=W9N.IM>_\ :],Y
M74[-M0S4,LI*W6@DE2'2@344*U%)*09$"8E%B[G%Y.^)/$G MZODSFO&]IN)
MJM-(X[QU3[A7[3:[I:G4<NA!L6L5"2#U=K%&?JIG=/5P3;-VQ3F$PF I32:X
M76CHZ5;JW&R=) $P23[)QISQ;P=R#R'NVDM-);:QBA2^VI]]UI;33+2536I2
MG D$R!TI&)5(93,0+^*+CKD+%?A/\CN:\AQ+NO+<G<6YJN=/BG[99FNXI%9Q
M'9XJ/L@-5P(JFSL<M(OCM!, >JT225+N10HC'[/2K;L%4\\F1>2M4LL-)EA&
MUW/6\K/N#N<V=MVRNIJ&[)5T5.ZI,B/.54ME2)C,I2E.H="2,P8D:^FD#_ZM
M*5N  /\ 3%F7</\ Q,GK);8)79VRKJI4=+=[ ESU7@C*CI/V<,=]2KG_ #/B
MO%7%[&=(R%;,0XCSAE:7KN<,BTUP\82K> BT(([:!6DX\4GJ+!2-DI"14:IJ
M$%]^'@0>XA3%'@W14/LLLLI6IMEQR2U#\GPGTB4]EFT-L[AO]\O%SI6+AN"V
M6\.45,Z I*G%:]2]*L"4D)0"?AUX2.,.+C'Q2>!_'V-XO)U@=8DRW7#0K:<>
MY9R[R$5G6DZ0[4CA::>@E<(J"(J\ZG,W*V+V&'T^SN#;1-CVVEL.NI;=0!\;
MB]7VF,'?.=^Z*\7I=DI$5UOJ@X4)I:6A"/+]X@)$VE*,LM15(YSB(#C?GCA'
M*^?[$-BXMQN.L/\ %BD4*TXTJ,\R9Q^/J):YR,H-P3E;-&*2(1R2K><GWQVK
M9RX,"SWT"F$=SE#6'IZB@5N5I5')%&EM21T22!F/1TG&RF\-I\GL]H5PI=\+
MJ[CO6HK6ZAQLE3[[3:WFR&U!.HC0D:BE.")D "1B\N@6-E&3=VU5;OV#YNBZ
M:NFJY'+5VU<)E50<MG"1CI+MUTC@8ARB)3E$! 1#4_DE6(R,>6+B%M++3@*7
M$D@@B1!&!!!Q!'41I7E(K+_?YJ-*IO[?WY8G^8H&OCR6R9RQCXBE_P"2SR]\
MN>&_*>]X1A\48">U.$>O2UQ_8JO;W,H\8-Y)XV25<.FUQ9(K'59$;K;E3 .U
M<H^_4&N]WJ*"L4UY;)3+K.-\^V7MHXRYKV-47Z^5-P1?Z:L<:>0PXE"-) 4T
M0DH422G,SEX1':O]03RN>&*#C#'&93O.4!_W5O1/:;8?9?NGM]VL7_6*H.;3
M,O4J-B'>P/B)#2U"KO!(3/\ 7(\/YJ)E_)KRPM/#/!M!RICS'N.+--9 R1!U
MIVPO36QOX>(B9+&[JWN$X=")L$0Y*I^*)E*4ZRJH@D&WMZZSESJ%45/YK* L
MES(G#*-,.W/@[:/+V^KSM;<KM2U0V]M9;4RM*5$A]38UDI5T . &,07./.%G
MMT'[_@+C0??;?_L#(9?9\-LA!K _OZHZML_0J-U/[@'$4I?-W<_\LC_FH24]
MYG>1+]BNG6L3<<Z3-G*8&=HCJ/8+!*Q"H@(%>1C*X6R>@"/D3#W)J+M%P(8
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MCF8Q+GC'5<R;CV;.BN]KEE9BX03>M!$S.4C7:)T9"(EV1C"*+IJJBX2W'M.
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0CZOPGZ(\]4'LBL&JPC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>g923794ex10_14logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_14logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00$0 P$1  (1 0,1 ?_$ ,H  0 " P$  P$
M       ("@8'"04!! L" 0$  04! 0$!            !P,$!08("0$""A
M  8! P,"! ('! L!     0(#! 4&!P 1"!(3"2$4,2(5"B,607$RM1=W.5%A
M=K>1H<(S0R1T)35U.C@1  (! P($ P0$!0T,"@,   $" P 1! 4&(3$2!T$3
M"%%A(A1Q@9$RL4(C%0FAT5)B<K(S<[.T%C8X\(+2)#1TE'56%S<9DD-CDZ/#
M1%1DQ#4F.?_:  P# 0 "$0,1 #\ O\:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4H(@ "(CL >HB/H
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MS]T/WXKO;T2_\$.X?^;O_,Y*MK:EFO,:JI5<_P#J.L_\EU_\DFNHJC_XHO\
MQ'_EUZ39W_\ .7&_US_]]JTSG[E%0>(OW(TOE3*K\D/C>2Q]CS'5IL*A.I"L
MIWK%3&*B[$_.!3J(Q$9*]HSPY"F.5 3#ML ZL=0U/'TCN4V9E'IQS%&C']CU
M)8$^X'G[JV_9/;C6^Z'H%BVYMJ,S;@BSLK*AB!XS?+YC.\2^!=TZN@$@%@!5
MNJ,R'09JN-KA$7>I2=4>1P3#6RL;%$.H%Q%=H5_J24LB\.Q.Q!$!,*H*= %
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M?CPKUIWOJ,/I5[%;9UCM#H>G9>KZOCQ-EZO+CC(^)XEE^(@WM*21$"PB0(0
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M^HQ$<S3ZDTBG6=&(4W[7H&M,R.VFAR2]>*\\"$\55N%O8+\0!X<376&A>O\
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M;A6-Y5\=''C,7+_$O-VWFOX9KPNSAV--"*M9&-.[$&XG'+'ZM731;@SU05;
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4:4II2FE*:4II2FE*:4II2FE*_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>g923794ex10_15logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_15logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ .P$  P$1  (1 0,1 ?_$ -H   $$ P # 0
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MD(-(0:0A)6*^4BGE ;9<JK5P$O>'^T-@B883%'V"4)%VW$VX?#?7RIUI'Q*
M]L4GCIS/U_1&CA<QXELJY6E=RCCV;=G,!"-8JY5U^Y.<>@%(W;2*BIC#\ *.
MOE+["LE)EZX^=8R!$_3#D;AM[=^@#O[AW^ ^P=?9G*8QC[C.JP@TA&-4QA&-
MQU7 #&*$RRQ,9#28.45C.D(-(0:0@TA!I"#2$&D(-(0:0@TA!I"#2$>L3;;[
M[]-P_/[-M5E%)^K\7H@ X#[^NW0/V &DIX@X10$' 2)E./,/9JD5&49TBL&D
M(-(0:0@TA!I"#2$)^SV>!ID!,VJT2[*"KL P<RDS,2*Q4&4>Q;$$ZRZRANO0
M V*4NYCG$"E 3" :HM:$(\Q9DD10DCPG^&<4V_)I]1796M@L&(.(0FBF<<LY
MC)&\F/Z4FNHF843F,]0$5H\X[;@T9G(L0!V6<%-ND6#7;<TE&GH\#XQN]P+V
M<;@Y'IFMT[W<<MFTUD*;0D?TBH3F2-6#2#T4H3/02QBK?D;EYR-R?+NYBZ9B
MN#MX]7.NN5K+KQQ.Y01,/VVYR/%/;[5%3F^(CJ(NUE94>]K61UE'HEMKMOX.
MV>PFGH[%1/.IS<J@EY:O22[,8^*0!"'A.069*X\3?0V6KLT<I' Y3GLCUZ3N
M =]C(R"KM$X;^X2CJB'ZA'PJ='LC.W?A3A:^,>17V&T%/BAIIM7L6@)5]<38
M\$/J >3/'2=AJUEF>-D[&?K(-GS>547>'9-#'*4RA6XF5<1XE(&_JL!3[1#<
MR"H?9UF[?N2II5ANI4"CTSC3OEWL6LM;2NWGB*H\BO2"KY)U>MM7YK;D]2%'
M[NHD'Q$7P>*_*[$W+W%L5E+$\XA(1[Q!J,M$"X07D8!ZY1!8K9R* B1=JN7<
MS=R0/37* _=.4Y"]B458S7-!UH^R/,B\6>Z6"YO6:\,N4UTIW"EQMP24E23(
M@CP\#D1B(Z:U=1CHIA<W>2WDGR7YO\E\".+?,.P8.K<ZZQNUHL<_1C5*95S'
MXOT+)MB,J"%8F9LQ9:5.^6Z>J/S#GW$Z!!Z^MNKM]<MM&^EM/NZ9@&4T))^L
MF/2WC/87"=D[6J#ES?6WF[I<4IJB\H*6'7=-RJ:=L?K$(&EM*$],$^,=:_\
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M*L\">G^#*.T^8[1>]\]LG^\#E*SMV_DJCK6PAP->2ZXRIQ* IQ&8"TJGI)S
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M4"@1%NV2(@@B0-]B)(IE*FF4!'V  :^^DO&+);BG5ZG"5.$S).)^DQ1D\B>
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MYG>1+]BNG6L3<<Z3-G*8&=HCJ/8+!*Q"H@(%>1C*X6R>@"/D3#W)J+M%P(8
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MCF8Q+GC'5<R;CV;.BN]KEE9BX03>M!$S.4C7:)T9"(EV1C"*+IJJBX2W'M.
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0CZOPGZ(\]4'LBL&JPC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>g923794ex10_16logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794ex10_16logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 00$0 P$1  (1 0,1 ?_$ ,X  0 " P # 0$!
M       ("@8'"0($!0L! P$!  $$ P$!              <$!08( 0,) @H0
M   & 0,# @0!!P8/      $" P0%!@< $0@2$PDA%#$B%0I!46%Q(Q9W.3)U
MM;87MZ%2,U-C<]0E=L8G&#BX.A$  @$# @0#! ,'#0T) 0   0(# !$$!08A
M,1('01,(46$B%'&!,I&Q0B,5%@G1<K(S<[-TM'4V%S<XH5*"DD-3)#14E#56
M&?#!8I/#TV7%)CG_V@ , P$  A$#$0 _ +_&E*:4II2FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K4ELSUAF
MC*"C:LEU")7(HHBHV-,-G;I%9$P%52<-6!G3ANH0QMA Y2CKH?)@C^VZCZZX
MN!SK'87E+QYL+U./BLMTY=VJ8"D37?GCR"(_#=>11:-RA^<3 &OE<S%<V5UO
M2XY7K>3"082K1"0C'K218.B HV>L'*+QHX3'T!1!RW.HBL01#XE,(:J 01<<
M17->WKFE-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*5A&1<B5+%5/F;U=Y5&(K\(W%9RNH)1675'<$&3
M)$3%,Z?.C_*FF7U$=Q'8H"(=<LL<$9ED-D KZ56=@B LY(  %R2>   XDD\
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M!">08M(+D>X$GZN'&KOZ46V=C^DC<^=OR$S;3@U3*DRD4#S)(XX,)Q$IM?\
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M>UZ]2NVFE:GZ>?1SN+7-[H,+<&O&8XN+."LE\B%,6"-XC\0D91).PL"D97S
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MD,LTD1!$A  '0"+<[F_(7XLN/N";>ZW%7A[0?4=_DSKD@O\ RV.L,_I%R?\
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M4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4H(;^@^H#Z"
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DI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>g923794001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794001.jpg
M_]C_X  02D9)1@ ! 0$$L 2P  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
MM1   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#
M! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1
M Q$ /P#]4Z*** "BBFLZH,NP4>I.* '4444 %%)0K*XRA##U!S0 M%%% !11
M10 4444 %%%% !12%@" 2,GH,TM !1110 4444 %%%% !1110 444F1G&1F@
M!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\;7JRPF?P7XG4W$@!?[/'L7GKG=P.]=#KET+>&:]BTF[OW@*[8+9 SSJ0<[
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MUC3YA(%>&\@57P2/F #$;1^?6J6I^++G3;RXMHO"/B2ZCA? GM;='BD]-I+
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M?1/[WR]\D@9$VX)?:03Q_6O"_@W:,O[1'Q=:42"4R6<L^X@@_*R_*3[*/UH
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MM;SQI%J#QPMJD6D-#]K67$@B\Q6\KR_[I(!W=B *Z**&8(7GE9"G**O(Y]:
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M;3PGK$B&:.5-+N3N7JN(F((_'O0%RQ9+!?:3!=(T7FMM>1]X8G'WLX]:^:3
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MKPRDXS_+\J -!R"^Q6#;1DMN 8<BF+;R1M$Z':I<-M4YZCGH:II>".82H0K
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M>?6O?!TKFO$GPZT/Q7X@T76=9MFDO]"D,EK(DA3.>=K@?>4,%8 \94&NFIL
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MX0UV*YC50VE76\,0,?NFQG!I >>_".?P'=>';1OBEXI&I:S97+!;;7M89A&
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M,9D&3SM/(K\W/^">W]@?"+]HOXF6&K>)+2/3M/TWR+34=5E6U^UJ)?E<!SW
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MCQ[XBT[Q19:3H\%]%>)IRV<RR.%)4JIP5PU,1]%T444AA1110 4444 %%%%
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M,,I:PJ,R3L.X4=!W.!7S7^W/X+B\"?L\W6N1ZEJVHZ]_:^GQS:G=73M(RM,
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M_;T\>6^\><GA>S.TGG&U*^G*^8? Z#_AO+XB-A<_\(W9#/?[D=- ?3U%%%(
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MW\4O$3:'KUQYNIP+IUJLEP,C*^9MW!<*!@=J@/\ P4=^ 8Q_Q69Y_P"H?/\
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M,5JFUC>60,C(K '##D'W]JR_&'APZGX=U:QL88WFNM/FBM/-^[O="!D]ADT
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M_"#5G<H%6XLR2YP /M,7)-<9\1/AU/\ M*+87&ES_P!CZ/X<S)INHM$=^J7
MQF-@>MF2HW#^/MP.3H%V?G-^T]^RIX7^&FF>&=8^'YUFUT'Q'K*Z=9W.J.))
M;I>-TX0 ;4R?E'5ASQ6]XF_X)[6'@/0H=>\9>-7_ .$7O45[36].MTE!# $!
MK=F5R>OW"Q]J]U_;4UF7XFI\)/"6J6J>'/%-EXQBL[ZR92T<>=H2:+!&^%L9
M!'T.#7K_ ,+_ -GWQKI5AHVMRW?A"[U:WLHX[>76].NYGM !@A(O.V1G _A
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MC+;" /\ O@WFAMQ']WWKK* "BBB@ HHHH 9+$D\;1S(LD;@AE89# ]B*PO\
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M:[LPDF9"PC';;@DY-?H5H'[2?PYM]#TZ.7Q!*KI;1HP.DWG#*H!'^J]17#_
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M=J]G\,^")](^%@T&00Q:G=:=*+Q@^]6NYE)E8M@;AO8\^@%<O\//B/X6\#^
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M^@>"OB/X!^P2WDUXQN?#TCOYDK%FYW=,FE<9]AU\X_M0_P#)8/V?/^QQG_\
M28T?\(9^T_\ ]%'^&W_A-2?_ !=<CXT_9\_:%\>:_P"%-8UWXC?#\W?@W4&O
M]-,7A^55\UD*'<-W(P:0'UY25\Y'P;^T_GCXB_#8_P#<MR?_ !=!\(_M/@#'
MQ ^&I]_^$=E_^*H [G1=$A^)_C;5-;\1HMYHGA^\-EHMC)S%YT?^MN&7HS;C
MA<YP :]215C0*B@*HP !@"OA;6_V)_C!K6J7NH3>.?"D5SJ$[7$XM8[R!/,;
M[Q"+)@9KE- ^&WQ4_9]_:/\ AEH]]XULKT>+)+A)(89+IX)509Q,CN<^V,4P
M/T6'3BN,^-)(^$OBXJ2"-(N#Q_N&KNE6_C!;V(ZU>>'I+0-F1;6UE5R.P!9R
M/TKRW]K2W^)4_P )[]/AE-X>2(PW']N&_5LM9^6>(^OS_E[4=0,[]A QM\!K
M?R  @U&?C '.%S_.O8_B;<&T^'OB*98XIC%ITS".5=RMA3P1W%?/G_!/33-3
MTOX&1P Z6FG+J-QMCB60R"7"<EBQ&*]@^,%OXGF\(:TMC?\ A^STAM,<7DES
M:S22Q\'>R!6 (QT!HZBZ';>%Y#+X:TF1U1&>QA8J@PJDH. /2M2N4\"1:Y%X
M2TE-5N=*N)$BB EMH9$5[?8NTX8DAR.3VJEJ47Q'-]/_ &1<^"ELRY\@7%K<
MF0+VW$/C/T%(9UEUK%C97MI9WEY;07=\6%K!)*%>8J,D(#R<#DXJY7@DI*?&
M*SB^,DVEMK+6UJ?#)TQ)$5F$Y,P0.2=V1%OQ_#[9KWNF 4444@"BBB@ KAOB
M=>/:77A 1K"PG\0PQMYL6_ \N0\>AXZUW-<9\18[66^\)+?>=G^WHS"8\8#B
M*4C=GMP:: [.BBBD!RGQ3\:1?#SX>>(/$5P8P-*T^6:,2.%#R!<(N3ZL0*\B
M_8;\"W/A?X-+K.MB5M6\97LFJW3S2^:Y#\)EN_R@'\:XK]O#4=6\7:IX ^&7
MA748;6;Q/J2SZC T98RVZNJ@'L!RY_X!7U=H6D0:!HUCIMA&L5O8VZ01(HP%
M55 &/RI] +]%%%( HHHH **** "BBB@#B[37KZ3XMWVC-*/[.AT1+E(L#B0R
M[2<]>E=I6#;Z; OC.YOAILJ7+6"PG4"XVR+OSY8'J#SFMZ@ HHHH **** "B
MBB@ HHHH 0]*Y7P3KMWK&H>)HKZ3>FFZNUM -H&U!&AQ[\DUU1. 36%X9TZ*
MQN]::#3YK%KJ_:61Y'W"Y8JH\Q?0<8Q[4 ;U%%% !1110 4444 %%%% !5>_
MD:&RGDCP'CB9ER,C(!JQ4%\H>SG5E=U:-@43JPP>![T 8OP_U:YUWPAI=_J+
M1O<W4):1HTVJ3N(X';I70UA>";2#3_"^G6UE:7=A!%#A+:[.98AD\-[UNT %
M%%% !1110 4444 >:?'GXI:E\*?"^F7OAO2K;6-4UC6;;2[2VN;GR(_,F) +
M-C@#%? &G?&2?XK?M@^+$\4Z1I6EZS/X7G\.K"E^)+:*Y650)S*V,!,%\]<K
MQ7Z*_%;X5:;\6M#LM.UJ\U/3_P"SM0AU"TNM-G\F:&>(DHP;!]:_,[XN?#NS
M^$G[<^GZ%INO:C!8>([>&76-6U&]C$Q$S9E<R,NU>0.U- ?46J:YIGP:^&?C
M32/%^OZ3XBU'7-)N8[;Q;'>)//>RF%O+@N%!)0@X5<?*1CO7TK\(M5NM<^&7
MA>_U5XWO+O2;>29HUVJ6*#.!7CO[)_A_0_$?PXUDZE:V7B.*P\1:C9V>I7=O
M#.]S;QRE8V#A<-P!S7NW@O3+;1?"FE6&F6MQ8VEI:I'#;7'^LB4#A6]Q0Q&W
M1112&%%%% !1110 5\L_M"?\G>_ ' S^]OO_ $"OJ:OEK]H+_D[WX!_[]_\
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M+"0G;GUQ7:5C6]_;OXJNK-+Z=[J.T21[,_<C4L<...IZ=:V: "BBB@ HHHH
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MO]GZV\0Z[JFIZ1XM\7^'/[<._4K33+Q!;W+[ FXHZ-R54 ^N*XGPW^Q)X?\
M"&HW6H>&/&/C;2]0O$D2:ZM+J&.1@[!G&1%W(S5)@=M^S1KT6L_"^VLPUQ)=
M>&;N?1;R2=0&DEM7,9.1]X<#![UZO7&?"7X4Z1\'/"*>'_#4VH75O]IEN9;C
M4+CSIIYI&W.[-@9)-=G4@%?)6A G_@I)XB]O D7_ *&E?6M?)?A]1_P\B\2G
M!_Y$2'G_ (&E 'U9?@M87(4$L87  [G!KD_@Q:36'PK\+6]Y%);SPZ9$LD4@
M(9#CH0>:["X<1V\KN_EJJ$E_[O'6LOPC?Q:KX:TV\M;\ZI#<6R.EZ4"&X!'W
M\#IGTH V*\:^/&@W-QJ^@ZQ/X/N_'NAV4%Q;WNAVY1F+R%"DOEN0K@;&'MFO
M9:* /S8N?@;JFL>.+RZU_P"$_C23PO<7C7,&G062HT(,N]8@ VS 4;<^A([5
M]$_"[3];OOCEHU_X7^'7B#X=^#]/T*Y@U.*^V0Q7<S,IA"Q*2"5PQSQUKZ>H
MIW 0=.:6BBD 5\I_M ;F_;,^ BCH$OVQ^%?5E?*'[0+D?MI? 11QF*^_E30%
M3]NWPM'K6D0ZJ8/%+3:%"D\1L-/4VCMY@(\VXZICT%?/-UX@\0Z_XLCD\2ZE
M?:E9KX0UI;3S[PS[2+5]^TE5(/W1Z5]#_MBVWB37?B%X(\-Z#J_V33O$-S';
M7%H)&;>0^[<T9&UE&.<'(]*U_C+\.->U3P]J/BSQG:Z5IR^#_!VHV=I!8SF0
M7,L\85Y#P-JA0<#KS30BQ_P3PDDD_9OL&GC:%VU2YW1MC*8"#!Q]*]N^+$+W
M/PU\2Q01R2R2:;*JI&,LQ*] /6O&OV [46O[/MJN02VJ7#$@=<A*]N^(Q<>!
M-=\B]33I/L,FV[=BJPG'WB1R,4NHS3\/(8M TU&SE+2('/7A!6A5324>/2K-
M97$KK;H&<'.X[1DYJW2 **** "BBB@ HHHH *XOQ_'-)KO@@VZ%ECU_=*0,[
M5^S3\_F17:5PGQ'F:+Q'X ",1YGB(JV#U'V2XZT =W7S1X_U&W@_;>\ 6LDD
M0N;CPU,8XV;!(#R9('?BOI>OG'QO:0R?MK>!YWCC,T?ABXV.P!('F-T_.F@/
MHZBBBD 4444 %%%(3C&>] "T444 %%%% ',V>B3Q?$'4-6;R?LUQIT4"X?Y]
MRL2<CT]ZZ:N?L];67QM?:4+5%:WL8YS<@C<^YB-N/05T% !1110 A.!D]*IG
M6M/"@F_L@&8J#YZ\D=1UZUYI^TQXPC\+_#&^M6>6"YU_-A;7"W2VJ0.RD[WE
M8@(H //<D 5^>/AW3M0\5>)9AXL^%OC/4+2YB>ULM0TBXDMK& Q ;KE$#-O4
M@AV;.6&#FFD!^K\-[;W"AH)X9%8X!20$$_A4]?E_\*?$^I?!>;PQJ-M'K?BU
MK/5C"MA8Z@I)AV2+NN(-Q*,"Q()P< <5^G=M+Y]O%+M9/,0-M88(R,X-#5@)
M:***0"'I7,^#-"NM%NO$$E[Y>W4=6DN8=C9^1E4#/H>.E=/6'X9UM=7FU=%M
MOL_V#4'MR=V?-( .[VZT ;E%%% !1110 4444 %%%% !535H7N-,NX80"\L$
MB*"<9)4@5;JMJ,RV]A<S.N]8H7<KG&X $XH P/AEHUUX=\!Z)INJ*J7=G:A)
ME5MP#9)QGO745@>!-8@\0^$M+U*QMVM+>\MP\<#-N,8R>,]ZWZ "BBB@ HHH
MH **** "OA;QS\1)OAI^WUX@U.RTTZK<77A?3["&V\\1;GFGC0'<>!C.?PK[
MIK\Y_CSJ%M#^WZMG)/"MW?6NBK;0,^'F*W,;,%'<A03] :: ^VH/B-]INFT'
MQ7I5UX<UB^@9;-+J16@NW*\I%,#M+?[/!K4^%F@7?A;X=>'M(U8*+S3K".&<
M*P(#J.<$4?$_PY;^)O!&J6UT$$D,#7-K,1S!/&-\<BGL0P'(KRKP+^V3\'KC
MP?H\FN?$3P=I5^UG']JLI]8C\RWEQ\R-DYR#GK0![_17CW_#8?P0_P"BJ>!_
M_!Q%_C6M'^TO\*)0AC^(?A%@XRI&J1<C\Z0'I=%>8W'[3OPEM%!N?B+X0C#,
M$!;58AECT'6B7]IWX2P'$OQ&\'KSCG58O\: /3J*\IO?VK/@[IP4WWQ+\&P!
MONE]6B&?UJM_PU]\$\X_X6EX(S_V&(O\: /7Z^3_ (_ G]MCX"]_]&O_ ,*]
M2_X:\^"G_14O!'_@XB_QKP/QU\6?!GQ6_;3^"4GPW\4:)XDCL+:_%RVFW:SB
M$D<!B#P330SZWU_X?:%XHUS1]8URT>XU#09#+I\OVB11"Y&"VT, 3CU!KG/V
MBG,/P*\=,JJQ70[DA6Z'Y#7HU>=?M% 'X%^.@YP#H=QG_O@TD(\L_P""><\M
MU^S;ILUVBQS2:G=%U5MP&"HX/T KVCXOPM/\,/$T<:EF?390  3GBO'_ -@%
M47]G33!#C:=0N2,#']VO8OBW</:_#/Q)+"[1O'I\A5E."#CJ#3Z@=+IB[=.M
M1Z0H/_'15FJ^G?\ (/MLG/[E.?P%6*0!1110 4444 %%%% !7"?$97;Q'X *
M1LX7Q$2Q SM'V2XY-=W7"?$BXF@\2?#];>22-9O$924(Q =?LEP<'U&0#^%
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MF81@CR2<?(?<8KHCR*YSP;KESK3ZTMXD:"PU6:VBV)MRBXP3ZGGK0!TE%%%
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MD,1GD\\5\9ZI\/O^$$^$4/B#P#XX32HM9VV^H>&%>-Q8HLK2J278R;TD0$G
MZGBF(^J+OX&_ *%9UU#PKX%1;0OYPEC0&(IC=G)XQD9J32_V=_@+K5Y+::3X
M+\#WES H>6&&W1V0'H6 Z5\;Z!\/K?XG^#/%WCWQGX]O+?4-(:6>31=39(8=
M4*1!GQM97"O@#C/8XK[M^!WAW0X?".G^)]!L&L[KQ3I=E/=F5@\AVPA5!; )
MP.,]\9IL9G#]DSX. Y'PX\*_^ *UK^%_V>OAMX)UF#5O"/@KP_I.IVQ)AN[:
MS"21YZX/:O0Z*D!!7F_[23;?@)X]. V-!N< ]_D->DUYG^TO_P D \?XS_R
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M001)9F-)+A/,B4!L\;1W->[Z)\;OBBOAZ&"R\-VT5O:Z)).LJ-"&2WB8QF0
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M?RH \Y;PU\;M)U1]5TKP]HD^J2ZE<:BQ:/$22R@+@#S\[0H'U-2?#;1/B_\
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M[71D,K:/:ER^=Q;RESG/>NEKS?0/@WX=33;*:WO=9NE>&-Q*-3E"2\ A@N<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
7!1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>g923794002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g923794002.jpg
M_]C_X  02D9)1@ ! 0$$L 2P  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
MQ@#+ -  U0#; .  Y0#K /  ]@#[ 0$!!P$- 1,!&0$? 24!*P$R 3@!/@%%
M 4P!4@%9 6 !9P%N 74!? &# 8L!D@&: :$!J0&Q ;D!P0') =$!V0'A >D!
M\@'Z @,"# (4 AT")@(O C@"00)+ E0"70)G G$">@*$ HX"F *B JP"M@+!
M LL"U0+@ NL"]0,  PL#%@,A RT#. -# T\#6@-F W(#?@.* Y8#H@.N [H#
MQP/3 ^ #[ /Y! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C 2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C :=!J\&P ;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X +F NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P S9#/,-#0TF#4 -6@UT#8X-J0W##=X-
M^ X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[! )$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/ 5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$ 891B*&*\8U1CZ&2 9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H< APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D >:AZ4'KX>Z1\3'SX?:1^4'[\?ZB 5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_ D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K BLV*VDKG2O1+ 4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^) (T!D0*9 YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$ T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE
M3FY.MT\ 3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1 9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"
M](-7@[J$'82 A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K JMUJ^FL7*S0K42MN*XMKJ&O%J^+L "P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV ;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N W 7<BMT0W9;>'-ZB
MWRG?K^ VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#  ," @," @,#
M @,# P,#! <%! 0$! D&!P4'"@D+"PH)"@H,#1$.# P0# H*#A0/$!$2$Q,3
M"PX4%A02%A$2$Q+_VP!# 0,# P0$! @%!0@2# H,$A(2$A(2$A(2$A(2$A(2
M$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A+_P  1" 'Y @$#
M 2(  A$! Q$!_\0 'P   04! 0$! 0$           $" P0%!@<("0H+_\0
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MY%R,G(/!X[5SMQ_P3]^ MU$\8\4ZF+=SD0CQ"I53DG(!/N:]^_X91^$@)/\
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MOE7''%?:E%.X'GOP3\2>+/$7@RW/Q1T,Z%XBMB8KJ%5Q')@X#H>X->@TM%(
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M_#30/%T=D^G#7+-+C[*S[S%N'W<]Z[:@ HHHH **** "BBB@ I#2TAH ^/\
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MHT./M_MFF@/TP^'[%O ^@$C&=-@./^ "N@K"\"J$\&:$HZ+IT('_ 'P*W:3
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M58T7X&?#[PYJ=OJ.A>#]!L;ZU;,%Q#9JKQGU!IZ >6?'3]M3PY\$KW6-*O\
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M<&O:E4*,"N=^'W@'1_AAX0T[PUX1@>WTK2XO+@1W+MCJ23W).371T, HHHI
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M@"MVL+P+@^#=#QT_LZ'_ - %;M)@%%%% !1110 4444 %%%% !1110 4444
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M(17TO7S1^P;@?"S4V"A!)J4;X'0;K6$_UKZ7H8PHHHI %%%% !1110 4444
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M>VOA?Q-J9\0Z+K=HUUHNJO&JRJR8W12;>&X8$'V->MTAA1110 4444 %%%%
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M)4>\E61=[*6 &W&>.M*P'Z1? RYM+K0=7?251;/^V;E4VC +!CN/YUZ57!?
MWPZ?#?PQT.*=-EW=VZW=X?[TT@W.?Q)KO:& 4444@"BBB@ HHHH *:Z+(I5P
M&4]01D&G44 1M"C%"R(2GW<J./IZ4B6L,:X2*)1SP$ '/6I:* (T@C0*%CC
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MP<]J^H3TKYD\/0!?VYO%K!MF_P .V;'W.#30'TW2T44@"BBB@ HHHH ****
M"BBB@ HHHH *0G%+7C7Q4^)5[JBZIX8^'5[!;7UG;M)K6O/S;Z-"!EN?XI2
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M>&O$_C/2H_ACI7AWPU#J7AS4=)3^V=4:8*; B/Y0!GG/%#V \Q^._B3XBO\
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M)MX5_P"P+:?^B5KY7_X*82/'X,\&E#'@:C/G=_NQU]3?"PY^&?A/'_0$M/\
MT2M/H!U-(>AI:*0'C'AP#_AJKQ;CK_PC%KGV^=*]GKQGPV!_PU1XN(4Y/AJU
M!;/^TE>RTV)"T444AA1110 4444 %%%% !7R]X:L8I?V[_%]U(TQEB\.VBQ@
M2$* 5[CO7U#7R]X7N"?V\/&4**Y_XIRT)(4D#CUIH#ZAHHHI %%%% !1110
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M(-0TEA)9MJFF"YC4]C@R8([_ (5Z=XO_ &6OB#XWUQ-5USXIQ-=6UD]G9E-
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MUEK[MHIW ^-O''[#_P 1/B-X>30_&'QSUJ_TJ-E9+<Z4J %?N\B3/&*Y)/\
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M@M="T)Y+F6:=[J_O)0 ]U<2'<[D#@#)X'88H ]$HHHI %%%% !1110 4444
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MG@GX?Z#\/-+.G^$-/AT^V=_,D"9+2MC&YV/+'CJ:Z.I&%%%% !1110 4444
M(>E?+_@RY"_MU>.T8'YM L\<9_AKZAKY4\+74=I^WGXU-S<QV\4GA^U #N%#
MD)[TT!]5T55&JV1( O+4D^DR_P"-+_:=GQ_I=MST_>KS^M("S2$9&#WJN-2M
M&'RW5L?I*O\ C1_:5IC/VJVQZ^:O^- !9V$5@KBW# .VX@MGFK ((R.:JMJM
MD00+RUS_ -=E_P :\?\  >M^)O"7Q6UGPI?V<NH>#KE6U#3_ !!/>HPA9\;K
M8C.3SDCVH ]KJ-[B..1(W=%>3.Q2P!;'7 [UB>+/'.B^#/#M_K6N7]K#8Z=
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M'2],U;-C91ZHE].8UBA,:Y9<=3UK[TKY=^&H0?MN?$W:4+'3+/((Y_U2]Z:
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?*7[63;?V@?V?2.O\
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M^S3X0=G14^RY+$X%>XR7,4*JTTB(KD*I9L!B>@%)C1+13'D6-"\A"(HR68X
M%$<JRHKQ,'1AD,IR"*0#Z*0')I: "BBB@ HHHH **** "BBB@ HHHH ****
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M,FQW4$':?49%>(/_ ,$]/!LVF&QN?$OBV6.80_:F-Y\UPT))A9C_ +&<"FK
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MP;.\>TNV$[[F$CJ2W/U-?1]>.?#Q]W[0GQ, _AMK#_T77L=)C"BBB@ HHHH
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M'C_2%V''S/C/TK23]BSX*QJ5'P^T(ANN8<_UJ!OV(/@DV<^ -&Y.3\I_QHT
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M0 4444 %96N>)M-\.-8KK-TELVI7*6MJ&S^\E8X5?Q-:M>,?M'$"\^&^2?\
MD<;+H<9^<4(#V8=.:6BB@ HHHH **** "BBB@ JCK>M67AW2[C4=9N$M;*T0
MO-,YP$7U-7J\T_:1./@=XP)57VZ9*=I&0>.E 'H\$Z7,$<T#!XY5#(PZ$$9!
MJ2LKPH<^&-)^79_H,/R^GR"M6@ HHHH **** "BBB@ I"<#FEI&&1Q0!GZ'X
M@T[Q)9F[T*[@O;82-&987#+O4X89'<5HUXA^R&I'PKNL]1X@O\G_ +:5[?0
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M0'KN?K1GZUY"O[->FJA4^,_B$V>YUE<C_P AU&W[,VF,P9O&GQ%..W]M+_\
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MV:[F,G;\3?B-M)Z'48CQ_P!^JL)^SK<1H57XE?$09_ZB,7_QJ@1ZY?:C:Z9
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M5[V*X;PG\+(-"\02Z_KFJ7^OZW)&8TN;UAMMD/++$@X4$@<]?>NZH8PHHHI
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__
!V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
